PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	COHEN, CB; COHEN, PJ				COHEN, CB; COHEN, PJ			DO-NOT-RESUSCITATE ORDERS IN THE OPERATING-ROOM	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CARDIAC-ARREST; ANESTHESIA		UNIV PENN,SCH MED,PHILADELPHIA,PA 19104	University of Pennsylvania	COHEN, CB (corresponding author), HASTINGS CTR,BRIARCLIFF MANOR,NY 10510, USA.							Bosk C, 1979, FORGIVE REMEMBER MAN, V29, P31; BYRICK RJ, 1986, ANESTHESIOLOGY, V65, P213, DOI 10.1097/00000542-198608000-00016; COHEN CB, 1982, CRIT CARE MED, V10, P776, DOI 10.1097/00003246-198211000-00018; FRERICHS RL, 1988, ANESTHESIOLOGY, V68, P943, DOI 10.1097/00000542-198806000-00020; HOVIVIANDER M, 1980, BRIT J ANAESTH, V52, P483, DOI 10.1093/bja/52.5.483; KEENAN RL, 1985, JAMA-J AM MED ASSOC, V253, P2373, DOI 10.1001/jama.253.16.2373; KOUWENHOVEN WB, 1960, JAMA-J AM MED ASSOC, V173, P1064, DOI 10.1001/jama.1960.03020280004002; LONG WB, 1989, ANESTH ANALG, V69, P403; MACKEY DC, 1989, ANESTHESIOLOGY, V70, P866, DOI 10.1097/00000542-198905000-00026; OLSSON GL, 1988, ACTA ANAESTH SCAND, V32, P653, DOI 10.1111/j.1399-6576.1988.tb02804.x; President's Commission for the Study of Ethical Problems in Medicine and Biomedical and Behavioral Research, 1983, DECIDING FOREGO LIFE; ROSS J, 1986, HDB HOSPITAL ETHICS; TRUOG RD, 1991, ANESTHESIOLOGY, V74, P606, DOI 10.1097/00000542-199103000-00030; YOUNGNER SJ, 1986, HUMAN VALUES CRITICA, P15; 1987, GUIDELINES TERMINATI; 1986, JAMA-J AM MED ASSOC, V255, P2905; 1908, JOINT COMMISSION ACC	17	62	63	0	0	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 26	1991	325	26					1879	1882		10.1056/NEJM199112263252611	http://dx.doi.org/10.1056/NEJM199112263252611			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GW528	1961228				2022-12-28	WOS:A1991GW52800011
J	SWIFT, M; MORRELL, D; MASSEY, RB; CHASE, CL				SWIFT, M; MORRELL, D; MASSEY, RB; CHASE, CL			INCIDENCE OF CANCER IN 161 FAMILIES AFFECTED BY ATAXIA-TELANGIECTASIA	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BREAST-CANCER; FLUOROSCOPIC EXAMINATIONS; FEMALE BREAST; HETEROZYGOTES; IRRADIATION; TUBERCULOSIS; MORTALITY; CHEST; WOMEN; RADIOSENSITIVITY	Background. Ataxia-telangiectasia is an autosomal recessive syndrome in which cancers develop in affected homozygotes at a rate approximately 100 times higher than in unaffected age-matched subjects. Retrospective studies have shown that persons heterozygous for the ataxia-telangiectasia gene, who make up about 1 percent of the general population, also have an excess risk of cancer, particularly breast cancer in women. Patients with ataxia-telangiectasia and cells derived from homozygotes and heterozygotes are unusually sensitive to ionizing radiation. Methods. Cancer incidence and mortality, mortality from ischemic heart disease, and mortality from all causes were compared prospectively for a mean of 6.4 years in 1599 adult blood relatives of patients with ataxia-telangiectasia and 821 of their spouses, who served as controls, in 161 families affected by ataxia-telangiectasia. In a case-control substudy, we compared documented occupational and fluoroscopic diagnostic exposures to radiation in the 19 female blood relatives in whom breast cancer was first diagnosed during the period of prospective observation with the exposures in 57 matched blood relatives who did not have breast cancer. Results. Cancer rates were significantly higher in the group of blood relatives than in their spouses, specifically in the subgroup of 294 blood relatives who were known to be heterozygous for the ataxia-telangiectasia gene. The estimated risk of cancer of all types among heterozygotes as compared with noncarriers was 3.8 in men and 3.5 in women, and that for breast cancer in women was 5.1. Among the blood relatives, women with breast cancer were more likely to have been exposed to selected sources of ionizing radiation than controls without cancer (odds ratio = 5.8, P = 0.005). Male and female blood relatives also had 3-fold and 2.6-fold excess mortality from all causes, respectively, from the ages of 20 through 59 years. Conclusions. The ataxia-telangiectasia gene predisposes heterozygotes to cancer, particularly breast cancer in women. There is also excess mortality from all causes in adults under the age of 60. Diagnostic or occupational exposure to ionizing radiation probably increases the risk of breast cancer in women heterozygous for ataxia-telangiectasia.	UNIV N CAROLINA,DEPT MED,CHAPEL HILL,NC 27514; UNIV N CAROLINA,DEPT EPIDEMIOL,CHAPEL HILL,NC 27514	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	SWIFT, M (corresponding author), UNIV N CAROLINA,BIOL SCI RES CTR,CB 7250,CHAPEL HILL,NC 27599, USA.				NATIONAL CANCER INSTITUTE [R01CA014235] Funding Source: NIH RePORTER; NCI NIH HHS [CA14235] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BAINES CJ, 1989, CANCER, V63, P1816; BOICE JD, 1978, RADIAT RES, V73, P373, DOI 10.2307/3574828; BOICE JD, 1977, J NATL CANCER I, V59, P823, DOI 10.1093/jnci/59.3.823; BORRESEN AL, 1990, GENE CHROMOSOME CANC, V2, P339, DOI 10.1002/gcc.2870020412; COLE J, 1988, INT J RADIAT BIOL, V54, P929, DOI 10.1080/09553008814552331; CUNLIFFE PN, 1975, BRIT J RADIOL, V48, P374, DOI 10.1259/0007-1285-48-569-374; DELARUE NC, 1975, CAN MED ASSOC J, V112, P1405; GOTOFF SP, 1967, AM J DIS CHILD, V114, P617, DOI 10.1001/archpedi.1967.02090270073006; HEGGIE J C P, 1990, Australasian Physical and Engineering Sciences in Medicine, V13, P71; HENDRICK RE, 1990, RADIOLOGY, V174, P648, DOI 10.1148/radiology.174.3.2305044; HILDRETH NG, 1989, NEW ENGL J MED, V321, P1281, DOI 10.1056/NEJM198911093211901; HOWE GR, 1982, CANCER DETECT PREV, V5, P175; HUDA W, 1990, RADIOLOGY, V177, P813, DOI 10.1148/radiology.177.3.2243994; JANKOWSKI J, 1984, Health Physics, V46, P228; KLEINBAUM DG, 1982, EPIDEMIOLOGIC RES PR, P336; MANTEL N, 1959, J NATL CANCER I, V22, P719; MCCONVILLE CM, 1990, HUM GENET, V85, P215; MILLER AB, 1989, NEW ENGL J MED, V321, P1285, DOI 10.1056/NEJM198911093211902; MORGAN JL, 1968, AM J DIS CHILD, V116, P557, DOI 10.1001/archpedi.1968.02100020561022; MORRELL D, 1990, CANCER GENET CYTOGEN, V50, P119, DOI 10.1016/0165-4608(90)90245-6; MORRELL D, 1986, J NATL CANCER I, V77, P89; PADOVANI R, 1987, BRIT J RADIOL, V60, P155, DOI 10.1259/0007-1285-60-710-155; PIPPARD EC, 1988, CANCER RES, V48, P2929; ROTHMAN KJ, 1979, NIH DHEW791649 PUBL; SHORE RE, 1977, JNCI-J NATL CANCER I, V59, P813, DOI 10.1093/jnci/59.3.813; SWIFT M, 1976, CANCER RES, V36, P209; SWIFT M, 1983, LANCET, V1, P1049; SWIFT M, 1990, CANCER GENET CYTOGEN, V46, P21, DOI 10.1016/0165-4608(90)90004-T; SWIFT M, 1987, NEW ENGL J MED, V316, P1289, DOI 10.1056/NEJM198705213162101; SWIFT M, 1986, AM J HUM GENET, V39, P573; SWIFT M, 1974, AM J HUM GENET, V26, P304; SWIFT M, 1990, AM J HUM GENET, V47, P226; TAYLOR AMR, 1975, NATURE, V258, P427, DOI 10.1038/258427a0; TOKUNAGA M, 1987, RADIAT RES, V112, P243, DOI 10.2307/3577254; 1967, PHS PUBLICATION, V1693; 1981, GAO EMD811 GEN ACC O	36	746	764	0	9	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 26	1991	325	26					1831	1836		10.1056/NEJM199112263252602	http://dx.doi.org/10.1056/NEJM199112263252602			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GW528	1961222				2022-12-28	WOS:A1991GW52800002
J	IGLEHART, JK				IGLEHART, JK			EFFORTS TO ADDRESS THE PROBLEM OF PHYSICIAN SELF-REFERRAL	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		APPLEBY CR, 1991, HLTH WEEK       0729, P10; IGLEHART JK, 1990, NEW ENGL J MED, V322, P1682, DOI 10.1056/NEJM199006073222327; IGLEHART JK, 1989, NEW ENGL J MED, V321, P198, DOI 10.1056/NEJM198907203210327; PAGE L, 1991, AM MED NEWS     1028, V1, P26; RELMAN AS, 1991, NEW ENGL J MED, V325, P854, DOI 10.1056/NEJM199109193251205	5	23	23	0	1	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 19	1991	325	25					1820	1824		10.1056/NEJM199112193252523	http://dx.doi.org/10.1056/NEJM199112193252523			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GV739	1944492				2022-12-28	WOS:A1991GV73900028
J	WHEAT, LJ; CONNOLLYSTRINGFIELD, P; BLAIR, R; CONNOLLY, K; GARRINGER, T; KATZ, BP				WHEAT, LJ; CONNOLLYSTRINGFIELD, P; BLAIR, R; CONNOLLY, K; GARRINGER, T; KATZ, BP			HISTOPLASMOSIS RELAPSE IN PATIENTS WITH AIDS - DETECTION USING HISTOPLASMA-CAPSULATUM VARIETY CAPSULATUM ANTIGEN LEVELS	ANNALS OF INTERNAL MEDICINE			English	Article							ACQUIRED IMMUNODEFICIENCY SYNDROME; DIAGNOSIS	Objective: To assess the accuracy of Histoplasma capsulatum variety capsulatum polysaccharide antigen testing for the identification of histoplasmosis relapse in patients with the acquired immunodeficiency syndrome (AIDS). Design: A retrospective study using stored specimens. Setting. A referral center and several private hospitals. Patients: Twenty episodes of histoplasmosis relapse were evaluated in 17 patients with AIDS from November 1987 to August 1990. Controls included 30 patients with AIDS and histoplasmosis who did not have a relapse during maintenance therapy and who were initially tested during the same week as the patients with relapse. A second control group included seven patients with AIDS and histoplasmosis who were evaluated for relapse on 23 occasions; relapse, however, was excluded on each occasion. Measurements: To avoid interassay variability, specimens were tested for H.c. var. capsulatum polysaccharide antigen with the same radioimmunoassay. Main Outcome Measure: The change in the Hc. var. capsulatum polysaccharide antigen level during successful as opposed to unsuccessful maintenance therapy for the prevention of histoplasmosis relapse. Main Results: For the 20 episodes of relapse (17 patients), Hc. var. capsulatum antigen levels increased by at least 2 radioimmunoassay units in 12 of 14 serum specimens tested (85.7%; 95% Cl, 57.2% to 98.2%) and in 17 of 18 urine specimens tested (94.4%; Cl, 72.7% to 99.9%). Antigen levels increased in the urine or serum in 1 of 83 specimens (1.2%; Cl, 0.03% to 6.6%) obtained on 56 occasions (1.8%; Cl, 0.04% to 9.6%) from controls (specificity, 98.2%; Cl, 90.4% to 99.96%). In three cases of relapse, antigen levels increased before clinical relapse was suspected. Complement fixation titers increased by at least 2 dilutions in 4 of 11 cases (36.4%; Cl, 10.9% to 69.2%) but in 0 of 9 control patients (Cl, 0% to 28.3%). Conclusion: An increase in Hc. var. capsulatum polysaccharide antigen levels of 2 units or more strongly suggests histoplasmosis relapse. The presence of increasing titers of anti-Hc. var. capsulatum antibodies by complement fixation is less accurate for the diagnosis of relapse.	INDIANA UNIV, SCH MED, DEPT INTERNAL MED, INDIANAPOLIS, IN 46202 USA; REGENSTRIEF INST HLTH CARE, INDIANAPOLIS, IN USA; RICHARD L ROUNDBUSH VET ADM HOSP, INDIANAPOLIS, IN USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Regenstrief Institute Inc								MCKINSEY DS, 1989, ANN INTERN MED, V111, P655, DOI 10.7326/0003-4819-111-8-655; NETER J, 1974, APPLIED LINEAR STATI, P605; WHEAT J, 1982, ANN INTERN MED, V97, P680, DOI 10.7326/0003-4819-97-5-680; WHEAT LJ, 1986, NEW ENGL J MED, V314, P83, DOI 10.1056/NEJM198601093140205; WHEAT LJ, 1990, MEDICINE, V69, P361, DOI 10.1097/00005792-199011000-00004; WHEAT LJ, 1989, AM J MED, V87, P396, DOI 10.1016/S0002-9343(89)80820-4	6	98	99	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 15	1991	115	12					936	941		10.7326/0003-4819-115-12-936	http://dx.doi.org/10.7326/0003-4819-115-12-936			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GU417	1952490				2022-12-28	WOS:A1991GU41700004
J	WISE, KD; NAJAFI, K				WISE, KD; NAJAFI, K			MICROFABRICATION TECHNIQUES FOR INTEGRATED SENSORS AND MICROSYSTEMS	SCIENCE			English	Article							PRESSURE SENSOR; SILICON	Integrated sensors and actuators are rapidly evolving to provide an important link between very large scale integrated circuits and nonelectronic monitoring and control applications ranging from biomedicine to automated manufacturing. As they continue to expand, entire microsystems merging electrical, mechanical, thermal, optical, magnetic, and perhaps chemical components should be possible on a common substrate.			WISE, KD (corresponding author), UNIV MICHIGAN, CTR INTEGRATED SENSORS & CIRCUITS, ANN ARBOR, MI 48109 USA.							CHAU HL, 1988, IEEE T ELECTRON DEV, V35, P2355, DOI 10.1109/16.8814; CHEN LY, 1991, JUN IEEE INT C SOL S, P739; CHO ST, 1991, JUN P TRANSD 91 SAN, P400; CHO ST, 1985, DEC IEEE INT EL DEV, P499; DRAKE KL, 1988, IEEE T BIO-MED ENG, V35, P719, DOI 10.1109/10.7273; EHRFELD W, 1988, JUN P IEEE, P1; FAN LS, 1988, IEEE T ELECTRON DEV, V35, P724, DOI 10.1109/16.2523; FINNE RM, 1967, J ELECTROCHEM SOC, V114, P965, DOI 10.1149/1.2426793; GIANCHANDANI Y, 1991, IN PRESS DEC IEEE IN; GUCKEL H, 1991, JUN IEEE INT C SOL S; GUCKEL H, 1990, JUN SOL STAT SENS AC, P118; GUCKEL H, 1984, DEC IEEE INT EL DEV; HANNEBORG A, 1991, JAN IEEE WORKSH MICR, P92; HARRIS RM, 1990, JUN IEEE SOL STAT SE, P36; HETKE JF, 1990, SENSOR ACTUAT A-PHYS, V23, P999, DOI 10.1016/0924-4247(90)87076-U; HOOGERWERF AC, 1991, JUN IEEE INT C SOL S, P120; HOWE RT, 1988, J VAC SCI TECHNOL B, V6, P1809, DOI 10.1116/1.584158; HOWE RT, 1986, IEEE T ELECTRON DEV, V33, P499, DOI 10.1109/T-ED.1986.22519; IKEDA K, 1990, SENSOR ACTUAT A-PHYS, V21, P146, DOI 10.1016/0924-4247(90)85028-3; JI J, 1990, 1990 IEEE SOL STAT S, P107; KIM YW, 1991, JUN IEEE INT C SOL S, P651; KONG LC, 1990, 1990 IEEE SOL STAT S, P28; Lasky J. B., 1985, International Electron Devices Meeting. Technical Digest (Cat. No. 85CH2252-5), P684; LEPSELTE.MP, 1966, AT&T TECH J, V45, P233, DOI 10.1002/j.1538-7305.1966.tb00018.x; MEHREGANY M, 1988, IEEE T ELECTRON DEV, V35, P719, DOI 10.1109/16.2522; MEHREGANY M, 1990, SENSOR ACTUAT A-PHYS, V21, P173, DOI 10.1016/0924-4247(90)85033-Z; NAJAFI K, 1985, IEEE T ELECTRON DEV, V32, P1206, DOI 10.1109/T-ED.1985.22102; NATHANSON HC, 1967, IEEE T ELECTRON DEV, VED14, P117, DOI 10.1109/T-ED.1967.15912; OZDEMIR CH, 1991, JUN IEEE INT C SOL S, P132; PETERSEN KE, 1982, P IEEE, V70, P420, DOI 10.1109/PROC.1982.12331; QUATE CF, 1990, FEB P IEEE C MICR EL, P188; SPANGLER LJ, 1990, SENSOR ACTUAT A-PHYS, V24, P117, DOI 10.1016/0924-4247(90)80016-X; SUZUKI K, 1991, IN PRESS DEC IEEE IN, P625; WISE KD, 1991, JUN P TRANSD 91, P2; YOON E, 1990, 1990 IEEE SOL STAT S, P161; ZAPPE HH, 1990, FEB IEEE MICR SYST; ZHANG Y, 1990, JUN IEEE SOL STAT SE, P32; ZHANG ZL, 1991, JUN IEEE INT C SOL S, P520	38	212	237	4	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 29	1991	254	5036					1335	1342		10.1126/science.1962192	http://dx.doi.org/10.1126/science.1962192			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR777	1962192				2022-12-28	WOS:A1991GR77700044
J	BREO, DL				BREO, DL			MD-AIDED SUICIDE VOTED DOWN - BOTH SIDES SAY DEBATE TO CONTINUE	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																		HUMPHRY, FINAL EXIT; JEANS WAY	2	3	3	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 27	1991	266	20					2895	&		10.1001/jama.266.20.2895	http://dx.doi.org/10.1001/jama.266.20.2895			0	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GQ722	1942460				2022-12-28	WOS:A1991GQ72200041
J	SOLOMON, E; BORROW, J; GODDARD, AD				SOLOMON, E; BORROW, J; GODDARD, AD			CHROMOSOME-ABERRATIONS AND CANCER	SCIENCE			English	Article							T-CELL LEUKEMIA; CHRONIC LYMPHOCYTIC-LEUKEMIA; BREAKPOINT-CLUSTER REGION; POLYMERASE CHAIN-REACTION; HUMAN-MALIGNANT MELANOMA; WILMS TUMOR ASSOCIATION; HUMAN-BREAST; SHORT ARM; OVARIAN-CANCER; HUMAN GLIOMAS	Cancer may be defined as a progressive series of genetic events that occur in a single clone of cells because of alterations in a limited number of specific genes: the oncogenes and tumor suppressor genes. The association of consistent chromosome aberrations with particular types of cancer has led to the identification of some of these genes and the elucidation of their mechanisms of action. Consistent chromosome aberrations are observed not only in rare tumor types but also in the relatively common lung, colon, and breast cancers. Identification of additional mutated genes through other chromosomal abnormalities will lead to a more complete molecular description of oncogenesis.			SOLOMON, E (corresponding author), IMPERIAL CANC RES FUND, SOMAT CELL GENET LAB, LONDON WC2A 3PX, ENGLAND.							ADELAIDE J, 1988, ONCOGENE, V2, P413; ALI IU, 1987, SCIENCE, V238, P185, DOI 10.1126/science.3659909; ALI IU, 1989, ONCOGENE, V4, P89; APLAN PD, 1990, SCIENCE, V250, P1426, DOI 10.1126/science.2255914; ARMITAGE P, 1954, BRIT J CANCER, V8, P1, DOI 10.1038/bjc.1954.1; ARNOLD A, 1989, J CLIN INVEST, V83, P2034, DOI 10.1172/JCI114114; ATKIN NB, 1982, CANCER GENET CYTOGEN, V7, P209, DOI 10.1016/0165-4608(82)90068-1; ATKIN NB, 1981, HUM GENET, V58, P217, DOI 10.1007/BF00278715; ATKIN NB, 1985, HUM GENET, V70, P359, DOI 10.1007/BF00295378; ATKIN NB, 1985, CANCER GENET CYTOGEN, V15, P253, DOI 10.1016/0165-4608(85)90169-4; ATKIN NB, 1985, NEW ENGL J MED, V312, P315; ATKIN NB, 1983, CANCER GENET CYTOGEN, V10, P199, DOI 10.1016/0165-4608(83)90125-5; AURIAS A, 1984, CANCER GENET CYTOGEN, V12, P21, DOI 10.1016/0165-4608(84)90003-7; BAKER SJ, 1989, SCIENCE, V244, P217, DOI 10.1126/science.2649981; BAKHSHI A, 1985, CELL, V41, P899, DOI 10.1016/S0092-8674(85)80070-2; BALABAN G, 1982, CANCER GENET CYTOGEN, V6, P213, DOI 10.1016/0165-4608(82)90058-9; BALABAN G, 1984, CANCER GENET CYTOGEN, V3, P243; BALLESTER R, 1990, CELL, V63, P851, DOI 10.1016/0092-8674(90)90151-4; BECHER R, 1983, CANCER RES, V43, P5010; BEGLEY CG, 1989, P NATL ACAD SCI USA, V86, P2031, DOI 10.1073/pnas.86.6.2031; BERENSON JR, 1989, ONCOGENE, V4, P1111; BIGNER SH, 1988, CANCER RES, V48, P405; BISHOP DT, 1990, CYTOGENET CELL GENET, V55, P111, DOI 10.1159/000133001; BOEHM T, 1990, EMBO J, V9, P857, DOI 10.1002/j.1460-2075.1990.tb08183.x; BOEHM T, 1990, ONCOGENE, V5, P1103; BOEHM T, 1988, EMBO J, V7, P385, DOI 10.1002/j.1460-2075.1988.tb02825.x; BOEHM T, 1991, P NATL ACAD SCI USA, V88, P4367, DOI 10.1073/pnas.88.10.4367; BONETTA L, 1990, SCIENCE, V250, P994, DOI 10.1126/science.2173146; BORROW J, 1990, SCIENCE, V249, P1577, DOI 10.1126/science.2218500; BRODEUR GM, 1984, SCIENCE, V224, P1121, DOI 10.1126/science.6719137; BRODEUR GM, 1981, CANCER RES, V41, P4678; BROWNE S, 1990, INSUR MATH ECON, V9, P33, DOI 10.1016/0167-6687(90)90013-4; BUCHBERG AM, 1990, NATURE, V347, P291, DOI 10.1038/347291a0; CALL KM, 1990, CELL, V60, P509, DOI 10.1016/0092-8674(90)90601-A; CARTER BS, 1990, P NATL ACAD SCI USA, V87, P8751, DOI 10.1073/pnas.87.22.8751; CAVENEE WK, 1983, NATURE, V305, P779, DOI 10.1038/305779a0; CESARMAN E, 1987, SCIENCE, V238, P1272, DOI 10.1126/science.3685977; CHEN Q, 1990, EMBO J, V9, P415, DOI 10.1002/j.1460-2075.1990.tb08126.x; CHEN Q, 1990, J EXP MED, V172, P1403, DOI 10.1084/jem.172.5.1403; CLEARY ML, 1985, P NATL ACAD SCI USA, V82, P7439, DOI 10.1073/pnas.82.21.7439; COWAN JM, 1986, CANCER GENET CYTOGEN, V20, P255, DOI 10.1016/0165-4608(86)90081-6; DALEY GQ, 1990, SCIENCE, V247, P824, DOI 10.1126/science.2406902; DETHE H, 1991, CELL, V66, P675, DOI 10.1016/0092-8674(91)90113-D; DETHE H, 1990, NATURE, V347, P558, DOI 10.1038/347558a0; DEVILEE P, 1991, ONCOGENE, V6, P1705; DEVILEE P, 1991, ONCOGENE, V6, P311; DIEKMANN D, 1991, NATURE, V351, P400, DOI 10.1038/351400a0; DOBROVIC A, 1988, BLOOD, V72, P2063; DRACOPOLI NC, 1989, P NATL ACAD SCI USA, V86, P4614, DOI 10.1073/pnas.86.12.4614; DUBE I, IN PRESS BLOOD; DUMANSKI JP, 1987, P NATL ACAD SCI USA, V84, P9275, DOI 10.1073/pnas.84.24.9275; ECCLES DM, 1990, ONCOGENE, V5, P1599; EHLEN T, 1990, ONCOGENE, V5, P219; ELLISEN LW, 1991, CELL, V66, P649, DOI 10.1016/0092-8674(91)90111-B; FANTL V, 1990, EUR J CANCER, V26, P423, DOI 10.1016/0277-5379(90)90009-I; FEARON ER, 1990, SCIENCE, V247, P49, DOI 10.1126/science.2294591; FEARON ER, 1985, NATURE, V318, P377, DOI 10.1038/318377a0; FINGER LR, 1986, SCIENCE, V234, P982, DOI 10.1126/science.3490692; FINGER LR, 1989, P NATL ACAD SCI USA, V86, P5039, DOI 10.1073/pnas.86.13.5039; FONG CT, 1989, P NATL ACAD SCI USA, V86, P3753, DOI 10.1073/pnas.86.10.3753; FOULKES W, 1991, LANCET, V338, P444, DOI 10.1016/0140-6736(91)91065-3; FRANCKE U, 1979, CYTOGENET CELL GENET, V24, P185, DOI 10.1159/000131375; FREYD G, 1990, NATURE, V344, P876, DOI 10.1038/344876a0; FRIEDMAN E, 1990, J CLIN ENDOCR METAB, V71, P293, DOI 10.1210/jcem-71-2-293; FRIEND SH, 1986, NATURE, V323, P643, DOI 10.1038/323643a0; GEBHART E, 1986, BREAST CANCER RES TR, V8, P125, DOI 10.1007/BF01807701; GESSLER M, 1990, NATURE, V343, P774, DOI 10.1038/343774a0; GIBAS Z, 1986, CANCER GENET CYTOGEN, V19, P229, DOI 10.1016/0165-4608(86)90051-8; GIBAS Z, 1986, CANCER GENET CYTOGEN, V20, P191, DOI 10.1016/0165-4608(86)90074-9; GILBERT F, 1982, CANCER GENET CYTOGEN, V7, P33, DOI 10.1016/0165-4608(82)90105-4; GODDARD AD, IN PRESS SCIENCE; GRIMALDI JC, 1989, BLOOD, V73, P2081; GRODEN J, 1991, CELL, V66, P589, DOI 10.1016/0092-8674(81)90021-0; GRUNDY P, 1988, NATURE, V336, P374, DOI 10.1038/336374a0; HATANO M, 1991, SCIENCE, V253, P79, DOI 10.1126/science.1676542; HAUPT Y, 1991, CELL, V65, P753, DOI 10.1016/0092-8674(91)90383-A; HEIM S, 1989, ADV CANCER RES, V52, P1; HEIM S, 1988, CANCER GENET CYTOGEN, V32, P13, DOI 10.1016/0165-4608(88)90305-6; HEISTERKAMP N, 1990, NATURE, V344, P251, DOI 10.1038/344251a0; HERRARA L, 1981, AM J MED GENET, V25, P473; HERSKOWITZ I, 1987, NATURE, V329, P219, DOI 10.1038/329219a0; HINRICHS SH, 1985, CANCER GENET CYTOGEN, V14, P219, DOI 10.1016/0165-4608(85)90187-6; HOCKENBERY D, 1990, NATURE, V348, P334, DOI 10.1038/348334a0; HUANG A, 1990, SCIENCE, V250, P991, DOI 10.1126/science.2173145; HUFF V, 1988, NATURE, V336, P377, DOI 10.1038/336377a0; JAMES CD, 1988, CANCER RES, V48, P5546; JENKINS RB, 1989, CANCER GENET CYTOGEN, V39, P253, DOI 10.1016/0165-4608(89)90192-1; JENKINS RB, 1989, CYTOGENET CELL GENET, V51, P1019; JONES N, 1990, CELL, V61, P9, DOI 10.1016/0092-8674(90)90207-U; JOSLYN G, 1991, CELL, V66, P601, DOI 10.1016/0092-8674(81)90022-2; KAGAN J, 1989, P NATL ACAD SCI USA, V86, P4161, DOI 10.1073/pnas.86.11.4161; KAKATI S, 1977, CANCER, V40, P1173, DOI 10.1002/1097-0142(197709)40:3<1173::AID-CNCR2820400328>3.0.CO;2-T; KAKIZUKA A, 1991, CELL, V66, P663, DOI 10.1016/0092-8674(91)90112-C; KAMPS MP, 1990, CELL, V60, P547, DOI 10.1016/0092-8674(90)90658-2; KARLSSON O, 1990, NATURE, V344, P879, DOI 10.1038/344879a0; KAWASAKI ES, 1988, P NATL ACAD SCI USA, V85, P5698, DOI 10.1073/pnas.85.15.5698; KENNEDY MA, 1991, P NATL ACAD SCI USA, V88, P8900, DOI 10.1073/pnas.88.20.8900; KINZLER KW, 1991, SCIENCE, V251, P1366, DOI 10.1126/science.1848370; KINZLER KW, 1991, SCIENCE, V253, P661, DOI 10.1126/science.1651562; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; KNUDSON AG, 1972, J NATL CANCER I, V48, P313; KOHL NE, 1983, CELL, V35, P359, DOI 10.1016/0092-8674(83)90169-1; KONDO K, 1984, CANCER RES, V44, P5376; KONOPKA JB, 1984, CELL, V37, P1035, DOI 10.1016/0092-8674(84)90438-0; KONOPKA JB, 1991, CELL, V351, P400; KOUFOS A, 1984, NATURE, V309, P170, DOI 10.1038/309170a0; KOVACS G, 1988, P NATL ACAD SCI USA, V85, P1571, DOI 10.1073/pnas.85.5.1571; KOVACS G, 1981, CANCER GENET CYTOGEN, V3, P125, DOI 10.1016/0165-4608(81)90066-2; KOVACS G, 1987, INT J CANCER, V40, P171, DOI 10.1002/ijc.2910400208; KOVACS G, 1978, INT J CANCER, V21, P688, DOI 10.1002/ijc.2910210604; KURZROCK R, 1988, NEW ENGL J MED, V319, P990; KUSYK CJ, 1981, J NATL CANCER I, V66, P1021, DOI 10.1093/jnci/66.6.1021; LAFORGIA S, 1991, P NATL ACAD SCI USA, V88, P5036, DOI 10.1073/pnas.88.11.5036; LAMMIE GA, 1991, ONCOGENE, V6, P439; LEDBETTER DH, 1989, AM J HUM GENET, V44, P20; LEDER P, 1983, SCIENCE, V222, P765, DOI 10.1126/science.6356357; LEE MS, 1988, BLOOD, V72, P893; LEE WH, 1984, NATURE, V309, P458, DOI 10.1038/309458a0; LIBERMANN TA, 1985, NATURE, V313, P144, DOI 10.1038/313144a0; LIMPENS J, IN PRESS ONCOGENE; LU D, 1991, ONCOGENE, V6, P1235; LUKEIS R, 1990, GENE CHROMOSOME CANC, V2, P116, DOI 10.1002/gcc.2870020207; LUNDGREN R, 1988, CANCER GENET CYTOGEN, V35, P103, DOI 10.1016/0165-4608(88)90128-8; MANDAHL N, 1987, INT J CANCER, V39, P685, DOI 10.1002/ijc.2910390605; MANDAHL N, 1989, GENE CHROMOSOME CANC, V1, P9, DOI 10.1002/gcc.2870010104; MANDAHL N, 1988, HUM GENET, V79, P203, DOI 10.1007/BF00366238; MARK J, 1989, CANCER GENET CYTOGEN, V37, P215, DOI 10.1016/0165-4608(89)90051-4; MARK J, 1986, ANTICANCER RES, V6, P299; Mark J, 1977, Adv Cancer Res, V24, P165, DOI 10.1016/S0065-230X(08)61015-5; MARK J, 1990, CANCER GENET CYTOGEN, V44, P1, DOI 10.1016/0165-4608(90)90192-D; MCGUIRE EA, 1989, MOL CELL BIOL, V9, P2124, DOI 10.1128/MCB.9.5.2124; MCKEITHAN TW, 1986, P NATL ACAD SCI USA, V83, P6636, DOI 10.1073/pnas.83.17.6636; MCKEITHAN TW, 1987, P NATL ACAD SCI USA, V84, P9257, DOI 10.1073/pnas.84.24.9257; MEEKER TC, 1990, BLOOD, V76, P285; MELLENTIN JD, 1989, CELL, V58, P77, DOI 10.1016/0092-8674(89)90404-2; MERTENS F, 1987, CANCER GENET CYTOGEN, V28, P137, DOI 10.1016/0165-4608(87)90363-3; Mertens F., 1991, CATALOG CHROMOSOME A; MEYER KB, 1989, EMBO J, V8, P1959, DOI 10.1002/j.1460-2075.1989.tb03601.x; MITELMAN F, 1990, CYTOGENET CELL GENET, V55, P358, DOI 10.1159/000133022; MOLENAAR WM, 1989, LAB INVEST, V60, P266; MORGAN R, 1986, NEW ENGL J MED, V314, P1322; MOTOKURA T, 1991, NATURE, V350, P512, DOI 10.1038/350512a0; MULERIS M, 1985, ANN GENET-PARIS, V28, P208; NAYLOR SL, 1987, NATURE, V329, P451, DOI 10.1038/329451a0; NILBERT M, 1988, CYTOGENET CELL GENET, V49, P300, DOI 10.1159/000132682; NISHISHO I, 1991, SCIENCE, V253, P665, DOI 10.1126/science.1651563; NOURSE J, 1990, CELL, V60, P535, DOI 10.1016/0092-8674(90)90657-Z; NOWELL PC, 1960, SCIENCE, V132, P1497; OHNO H, 1990, CELL, V60, P991, DOI 10.1016/0092-8674(90)90347-H; ORKIN SH, 1984, NATURE, V309, P172, DOI 10.1038/309172a0; PANDOLFI PP, 1991, ONCOGENE, V6, P1285; PARMITER AH, 1986, CANCER RES, V46, P1526; PENDERSEN MI, 1986, CANCER GENET CYTOGEN, V20, P11; PETTERSSON S, 1990, NATURE, V344, P165, DOI 10.1038/344165a0; PRITCHARDJONES K, 1990, NATURE, V346, P194, DOI 10.1038/346194a0; RABBITTS TH, 1991, ADV IMMUNOL, V50, P119; REEVE AE, 1984, NATURE, V309, P174, DOI 10.1038/309174a0; REY JA, 1987, CANCER GENET CYTOGEN, V25, P355, DOI 10.1016/0165-4608(87)90197-X; REY JA, 1987, CANCER GENET CYTOGEN, V29, P223, DOI 10.1016/0165-4608(87)90233-0; REYNOLDS TC, 1987, CELL, V50, P107, DOI 10.1016/0092-8674(87)90667-2; RICCARDI VM, 1978, PEDIATRICS, V61, P604; RIMOKH R, 1991, GENE CHROMOSOME CANC, V3, P24, DOI 10.1002/gcc.2870030106; RODGERS CS, 1984, CANCER GENET CYTOGEN, V13, P95, DOI 10.1016/0165-4608(84)90052-9; ROSENBERG CL, 1991, ONCOGENE, V6, P449; ROWLEY JD, 1973, NATURE, V243, P290, DOI 10.1038/243290a0; ROWLEY JD, 1990, CANCER RES, V50, P3816; RUSSELL SEH, 1990, ONCOGENE, V5, P1581; RUSSO G, 1989, P NATL ACAD SCI USA, V86, P602, DOI 10.1073/pnas.86.2.602; SAIT SNJ, 1988, CANCER GENET CYTOGEN, V35, P47, DOI 10.1016/0165-4608(88)90120-3; SAIT SNJ, 1989, CANCER GENET CYTOGEN, V37, P157; SATO T, 1991, CANCER RES, V51, P5118; SATO T, 1990, CANCER RES, V50, P7184; SAWYERS CL, 1991, CELL, V64, P337, DOI 10.1016/0092-8674(91)90643-D; SCHMIDT MA, 1987, AM J MED GENET, V28, P771, DOI 10.1002/ajmg.1320280333; SEEGER RC, 1985, NEW ENGL J MED, V313, P1111, DOI 10.1056/NEJM198510313131802; SEIZINGER BR, 1986, NATURE, V322, P644, DOI 10.1038/322644a0; SHIMA EA, 1986, P NATL ACAD SCI USA, V83, P3439, DOI 10.1073/pnas.83.10.3439; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; SOLOMON E, 1987, NATURE, V328, P616, DOI 10.1038/328616a0; Sotelo-Avila C, 1976, Perspect Pediatr Pathol, V3, P255; SREEKANTAIAH C, 1989, CANCER GENET CYTOGEN, V39, P281, DOI 10.1016/0165-4608(89)90193-3; STENMAN G, 1986, HEREDITAS, V105, P233, DOI 10.1111/j.1601-5223.1986.tb00667.x; TAYLOR AMR, 1986, INT J CANCER, V37, P511, DOI 10.1002/ijc.2910370407; THEILLET C, 1990, ONCOGENE, V5, P147; THEILLET C, 1986, CANCER RES, V46, P4776; TIAINEN M, 1989, BRIT J CANCER, V60, P618, DOI 10.1038/bjc.1989.326; TIAINEN M, 1988, CANCER GENET CYTOGEN, V33, P251, DOI 10.1016/0165-4608(88)90035-0; TRENT JM, 1989, CANCER RES, V49, P420; TRENT JM, 1981, CANCER GENET CYTOGEN, V3, P279, DOI 10.1016/0165-4608(81)90037-6; TRENT JM, 1987, ONCOGENES HORMONES B; TSAI YC, 1990, CANCER RES, V50, P44; TSUDA T, 1988, JPN J CANCER RES, V79, P584, DOI 10.1111/j.1349-7006.1988.tb00026.x; TSUJIMOTO Y, 1985, SCIENCE, V229, P1390, DOI 10.1126/science.3929382; TSUJIMOTO Y, 1984, SCIENCE, V224, P1403, DOI 10.1126/science.6610211; TURCCAREL C, 1987, P NATL ACAD SCI USA, V84, P1981, DOI 10.1073/pnas.84.7.1981; TURCCAREL C, 1984, CANCER GENET CYTOGEN, V12, P1, DOI 10.1016/0165-4608(84)90002-5; TURCCAREL C, 1988, CANCER GENET CYTOGEN, V30, P145, DOI 10.1016/0165-4608(88)90103-3; TURCCAREL C, 1986, CANCER GENET CYTOGEN, V19, P361, DOI 10.1016/0165-4608(86)90069-5; TURCCAREL C, 1986, CANCER GENET CYTOGEN, V23, P291, DOI 10.1016/0165-4608(86)90011-7; VANDENBERGHE H, 1985, CANCER GENET CYTOGEN, V17, P189, DOI 10.1016/0165-4608(85)90016-0; VANLOHUIZEN M, 1991, CELL, V65, P737, DOI 10.1016/0092-8674(91)90382-9; VISKOCHIL D, 1990, CELL, V62, P187, DOI 10.1016/0092-8674(90)90252-A; VOGELSTEIN B, 1989, SCIENCE, V244, P207, DOI 10.1126/science.2565047; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; VONLINDERN M, 1990, MOL CELL BIOL, V10, P4016, DOI 10.1128/MCB.10.8.4016; WAGNER S, 1991, NATURE, V352, P189, DOI 10.1038/352189a0; WAKE N, 1980, CANCER RES, V40, P4512; WALLACE MR, 1990, SCIENCE, V249, P181, DOI 10.1126/science.2134734; WANG N, 1984, CANCER GENET CYTOGEN, V11, P479, DOI 10.1016/0165-4608(84)90028-1; WASMUTH JJ, 1989, CYTOGENET CELL GENET, V51, P137, DOI 10.1159/000132789; WHANGPENG J, 1984, CANCER GENET CYTOGEN, V11, P91, DOI 10.1016/0165-4608(84)90102-X; WHANGPENG J, 1982, SCIENCE, V215, P181, DOI 10.1126/science.6274023; WHANGPENG J, 1982, CANCER GENET CYTOGEN, V6, P119, DOI 10.1016/0165-4608(82)90077-2; YOKOTA J, 1987, P NATL ACAD SCI USA, V84, P9252, DOI 10.1073/pnas.84.24.9252; YONISHROUACH E, 1991, NATURE, V352, P345, DOI 10.1038/352345a0; YOSHIDA MA, 1986, CANCER RES, V46, P2139; YOSHIDA MA, 1986, CANCER GENET CYTOGEN, V20, P159, DOI 10.1016/0165-4608(86)90119-6; YOTAKA J, 1989, CANCER RES, V49, P3598; YUNIS E, 1981, HUM GENET, V56, P283, DOI 10.1007/BF00274680; YUNIS JJ, 1989, ADV PATHOL, V2, P147; YUNIS JJ, 1987, 1987 UCLA S REC ADV, P3; ZANG KD, 1982, CANCER GENET CYTOGEN, V6, P249, DOI 10.1016/0165-4608(82)90063-2; ZBAR B, 1987, NATURE, V327, P721, DOI 10.1038/327721a0; ZHOU DJ, 1987, CANCER RES, V47, P6123; ZUTTER M, 1990, P NATL ACAD SCI USA, V87, P3161, DOI 10.1073/pnas.87.8.3161	226	558	583	1	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 22	1991	254	5035					1153	1160		10.1126/science.1957167	http://dx.doi.org/10.1126/science.1957167			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ834	1957167				2022-12-28	WOS:A1991GQ83400034
J	MILNER, PF; KRAUS, AP; SEBES, JI; SLEEPER, LA; DUKES, KA; EMBURY, SH; BELLEVUE, R; KOSHY, M; MOOHR, JW; SMITH, J				MILNER, PF; KRAUS, AP; SEBES, JI; SLEEPER, LA; DUKES, KA; EMBURY, SH; BELLEVUE, R; KOSHY, M; MOOHR, JW; SMITH, J			SICKLE-CELL DISEASE AS A CAUSE OF OSTEONECROSIS OF THE FEMORAL-HEAD	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ALPHA-THALASSEMIA; AVASCULAR NECROSIS; ANEMIA; SEVERITY; GENE; HIP	Background and Methods. Osteonecrosis of the femoral head is an important complication of sickle cell disease. We studied 2590 patients who were over 5 years of age at entry and followed them for an average of 5.6 years. Patients were examined twice a year, and radiographs of the hips were taken at least twice: at study entry and approximately three years later. Results. At study entry, 9.8 percent of patients were found to have osteonecrosis of one or both femoral heads. On follow-up, patients with the hemoglobin SS genotype and alpha-thalassemia were at the greatest risk for osteonecrosis (age-adjusted incidence rate, 4.5 cases per 100 patient-years, as compared with 2.4 in patients with the hemoglobin SS genotype without alpha-thalassemia and 1.9 in those with the hemoglobin SC genotype). Although the rate of osteonecrosis in patients with the hemoglobin SC genotype did not differ significantly from that in patients with the hemoglobin SS genotype without alpha-thalassemia, osteonecrosis tended to develop in these patients later in life. Intermediate rates of osteonecrosis were observed among patients with the hemoglobin S-beta-0-thalassemia and the hemoglobin S-beta+-thalassemia genotypes (3.6 and 3.3 cases per 100 patient-years, respectively). Osteonecrosis was found in patients as young as five years old (1.8 cases per 100 patient-years for all genotypes). The frequency of painful crises and the hematocrit were positively associated with osteonecrosis. The mean corpuscular volume and serum aspartate aminotransferase level were negatively associated. Twenty-seven patients had hip arthroplasty during the study; 10 were under 25 years of age. Five of the 27 required reoperation 11 to 53 months after the initial operation. Conclusions. Osteonecrosis of the femoral head is common in patients with sickle cell disease, with an incidence ranging from about 2 to 4.5 cases per 100 patient-years. Patients with the hemoglobin SS genotype and alpha-thalassemia and those with frequent painful crises are at highest risk. The overall prevalence is about 10 percent. The results of hip arthroplasty are poor.	UNIV TENNESSEE CTR HLTH SCI, MEMPHIS, TN 38163 USA; NEW ENGLAND RES INST, WATERTOWN, MA USA; UNIV CALIF SAN FRANCISCO, SAN FRANCISCO, CA 94143 USA; INTERFAITH MED CTR, BROOKLYN, NY USA; UNIV ILLINOIS, CHICAGO, IL 60680 USA; UNIV ILLINOIS, CHICAGO, IL 60680 USA; WOODHULL SUNY HLTH SCI CTR, BROOKLYN, NY USA; COLUMBIA UNIV, HARLEM HOSP CTR, NEW YORK, NY 10027 USA	University of Tennessee System; University of Tennessee Health Science Center; HealthCore, Inc; University of California System; University of California San Francisco; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; Columbia University	MILNER, PF (corresponding author), MED COLL GEORGIA, ADULT SICKLE CELL CLIN, BLDG FR-100, AUGUSTA, GA 30912 USA.							BALLAS SK, 1989, HEMOGLOBIN, V13, P649, DOI 10.3109/03630268908998842; CHUNG SMK, 1969, J BONE JOINT SURG AM, VA 51, P33, DOI 10.2106/00004623-196951010-00003; CLARKE HJ, 1989, J BONE JOINT SURG BR, V71, P465, DOI 10.1302/0301-620X.71B3.2722941; CNAAN A, 1989, STAT MED, V8, P1255, DOI 10.1002/sim.4780081009; DIGGS LW, 1937, SOUTH MED J, V30, P249; EMBURY SH, 1982, NEW ENGL J MED, V306, P270, DOI 10.1056/NEJM198202043060504; EMBURY SH, 1979, J CLIN INVEST, V63, P1307, DOI 10.1172/JCI109426; EMBURY SH, 1980, J CLIN INVEST, V66, P1319, DOI 10.1172/JCI109984; ENSIGN MF, 1990, SEMIN ULTRASOUND CT, V11, P288; FARBER MD, 1985, J CHRON DIS, V38, P495, DOI 10.1016/0021-9681(85)90033-5; Ficat R P, 1983, Hip, P279; FICAT RP, 1985, J BONE JOINT SURG BR, V67, P3, DOI 10.1302/0301-620X.67B1.3155745; Fleiss J.L., 1986, DESIGN ANAL CLIN EXP; GASTON M, 1982, AM J PEDIAT HEMATOL, V4, P197; Glimcher M. J., 1979, CLIN ORTHOP RELAT R, V138, P284; GLIMCHER MJ, 1979, CLIN ORTHOP RELAT R, P273; GLIMCHER MJ, 1979, CLIN ORTHOP RELAT R, P283; Grinnan AG, 1935, AM J ROENTGENOL RADI, V34, P297; HANKER GJ, 1988, J BONE JOINT SURG AM, V70A, P499, DOI 10.2106/00004623-198870040-00004; HERNIGOU P, 1991, J BONE JOINT SURG AM, V73A, P81, DOI 10.2106/00004623-199173010-00011; HIGGS DR, 1982, NEW ENGL J MED, V306, P1441, DOI 10.1056/NEJM198206173062402; HUNGERFORD DS, 1989, ARTHRITIS RHEUM-US, V32, P801, DOI 10.1002/anr.1780320623; IWEGBU CG, 1985, J BONE JOINT SURG BR, V67, P29, DOI 10.1302/0301-620X.67B1.3968138; KALBFLEISCH JD, 1980, STATISTICAL ANAL FAI; LEE REJ, 1981, CLIN RADIOL, V32, P205, DOI 10.1016/S0009-9260(81)80162-6; LIEINJO LE, 1981, NUCLEIC ACIDS RES, V9, P3707, DOI 10.1093/nar/9.15.3707; LILIENFELD AM, 1980, F EPIDEMIOLOGY; PLATT OS, 1991, NEW ENGL J MED, V325, P11, DOI 10.1056/NEJM199107043250103; RIVER GL, 1961, BLOOD, V18, P385, DOI 10.1182/blood.V18.4.385.385; SAITO S, 1989, CLIN ORTHOP RELAT R, V244, P198; SERJEANT GR, 1989, ANN NY ACAD SCI, V565, P109, DOI 10.1111/j.1749-6632.1989.tb24157.x; SERJEANT GR, 1973, BRIT J RADIOL, V46, P935, DOI 10.1259/0007-1285-46-551-935; SERJEANT GR, 1985, SICKLE CELL DISEASE, P246; STEINBERG MH, 1984, BLOOD, V63, P1353; STEINBERG MH, 1983, BRIT J HAEMATOL, V55, P487, DOI 10.1111/j.1365-2141.1983.tb02164.x; STEINBERG MH, 1986, BLOOD, V68, P985; STULBERG BN, 1990, CLIN ORTHOP RELAT R, V261, P186; SWEET DE, 1981, DIAGNOSIS BONE JOINT, V3, P2780; UEO T, 1985, ARCH ORTHOP TRAUM SU, V104, P145, DOI 10.1007/BF00454690	39	230	233	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 21	1991	325	21					1476	1481		10.1056/NEJM199111213252104	http://dx.doi.org/10.1056/NEJM199111213252104			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GQ406	1944426				2022-12-28	WOS:A1991GQ40600004
J	WILENSKY, GR				WILENSKY, GR			PHYSICIAN PAYMENT REFORM	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material											WILENSKY, GR (corresponding author), HLTH CARE FINANCING ADM,BALTIMORE,MD 21207, USA.								0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 20	1991	266	19					2677	2677						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GP691	1942412				2022-12-28	WOS:A1991GP69100007
J	COCHRANE, M; HAM, C; HEGINBOTHAM, C; SMITH, R				COCHRANE, M; HAM, C; HEGINBOTHAM, C; SMITH, R			CONTEMPORARY THEME - RATIONING - AT THE CUTTING EDGE	BRITISH MEDICAL JOURNAL			English	Article									KINGS FUND COLL,HLTH POLICY & MANAGEMENT,LONDON W2 4HS,ENGLAND; KINGS FUND COLL,HLTH SERV MANAGEMENT,LONDON W2 4HS,ENGLAND		COCHRANE, M (corresponding author), SOUTHAMPTON & SW HAMPSHIRE HLTH AUTHOR,SOUTHAMPTON SO9 4WQ,ENGLAND.							THWAITES B, 1987, NHS END RAINBOW	1	20	20	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	OCT 26	1991	303	6809					1039	1042		10.1136/bmj.303.6809.1039	http://dx.doi.org/10.1136/bmj.303.6809.1039			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GM478	1954459	Green Published, Bronze			2022-12-28	WOS:A1991GM47800026
J	ELDER, AT; SHAW, TRD; TURNBULL, CM; STARKEY, IR				ELDER, AT; SHAW, TRD; TURNBULL, CM; STARKEY, IR			ELDERLY AND YOUNGER PATIENTS SELECTED TO UNDERGO CORONARY ANGIOGRAPHY	BRITISH MEDICAL JOURNAL			English	Article							ARTERY BYPASS-SURGERY	Objective - To establish and compare the characteristics of older (greater-than-or-equal-to 70 years) and younger patients with chest pain selected to undergo coronary angiography and by analysis of their subsequent management to assess the value of coronary angiography for older patients with chest pain. Design - Retrospective analysis of clinical case notes and coronary angiography reports. Setting - Cardiology department with referral population of one million in an Edinburgh hospital. Patients - 134 consecutive patients with chest pain aged 70 years or over investigated by coronary angiography between 1978 and 1988; 134 randomly selected patients aged under 70 investigated over the same period. Main outcome measures - Clinical and angiographic features at time of angiography and management after angiography. Results - Older patients represented a small, but increasing, proportion of those investigated. Older patients had more severe symptoms at the time of angiography, were taking more antianginal drugs, and had had their symptoms for longer than younger patients. At angiography more older patients had triple vessel coronary disease, left main stem stenosis, or left ventricular impairment. After angiography similar proportions of older and younger patients underwent coronary artery surgery, with more elderly patients requiring urgent operation; although operative mortality was higher for elderly patients, symptomatic benefit was similar to that in younger patients. Conclusions - Older patients with angina selected to undergo coronary angiography and subsequent coronary surgery have more severe symptoms and underlying cardiac disease. Earlier referral and investigation might yield a population with lower operative risk. Selection of patients for coronary angiography and coronary artery surgery should be based on the potential for benefit and should avoid "agism."	WESTERN GEN HOSP,DEPT CARDIOL,EDINBURGH EH4 2XV,SCOTLAND	University of Edinburgh	ELDER, AT (corresponding author), CITY HOSP EDINBURGH,DEPT GERIATR MED,EDINBURGH EH10 5SB,MIDLOTHIAN,SCOTLAND.			Elder, Andrew/0000-0003-3229-9601				CANON PJ, 1988, LANCET, V1, P979; CHAMBERLAIN D, 1990, BRIT HEART J, V64, P219; CHRISTAKIS GT, 1989, CIRCULATION, V80, P151; CURRIE CT, 1988, BRIT MED J, V295, P1586; GERSH BJ, 1983, CIRCULATION, V67, P483, DOI 10.1161/01.CIR.67.3.483; KENNEDY RD, 1977, BRIT HEART J, V39, P1121, DOI 10.1136/hrt.39.10.1121; MOCK MB, 1985, GERIATRIC HEART DISE, P358; 1990, POPULATION TRENDS, V62, P43	8	35	36	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	OCT 19	1991	303	6808					950	953		10.1136/bmj.303.6808.950	http://dx.doi.org/10.1136/bmj.303.6808.950			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GL127	1954417	Green Published, Bronze			2022-12-28	WOS:A1991GL12700019
J	CHAMBERLAIN, G				CHAMBERLAIN, G			ABC OF ANTENATAL CARE - MEDICAL PROBLEMS IN PREGNANCY .2.	BRITISH MEDICAL JOURNAL			English	Article											CHAMBERLAIN, G (corresponding author), ST GEORGE HOSP,SCH MED,DEPT OBSTET & GYNAECOL,LONDON,ENGLAND.								0	6	6	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JUN 1	1991	302	6788					1327	1330		10.1136/bmj.302.6788.1327	http://dx.doi.org/10.1136/bmj.302.6788.1327			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FQ444	1953855	Bronze, Green Published			2022-12-28	WOS:A1991FQ44400026
J	[Anonymous]				[Anonymous]			COAL-DUST AND COMPENSATION	LANCET			English	Editorial Material																		ATTFIELD MD, 1985, THORAX, V40, P132, DOI 10.1136/thx.40.2.132; Bradford-Hill A., 1965, P ROY SOC MED, V58, P295; COCKCROFT A, 1983, BRIT J IND MED, V40, P169; COCKCROFT A, 1982, THORAX, V37, P765, DOI 10.1136/thx.37.10.765; COCKCROFT A, 1982, LANCET, V2, P600; COCKCROFT AE, 1982, ANN OCCUP HYG, V26, P767, DOI 10.1093/annhyg/26.8.767; COLLINS HPR, 1988, BR J IND MED, V43, P55; GILSON JC, 1955, MED RES COUNCIL SPEC, P290; HURLEY JF, 1986, BRIT J IND MED, V43, P150; JACOBSEN M, 1980, LANCET, V2, P740; LOVE RG, 1982, THORAX, V37, P103; LYONS JP, 1974, BRIT J IND MED, V31, P36; LYONS JP, 1972, BRIT MED J, V1, P713, DOI 10.1136/bmj.1.5802.713; LYONS JP, 1981, CLIN RES PROC, V17, P75; MILLER BG, 1985, BRIT J IND MED, V42, P723; MORGAN WKC, 1986, AM REV RESPIR DIS, V639, P641; NAEYE RL, 1972, ANN NY ACAD SCI, V200, P381, DOI 10.1111/j.1749-6632.1972.tb40203.x; RAE S, 1971, INHALED PARTICLES, V3, P837; REICHEL G, 1986, RES REPORT BRONCHITI, P237; RUCKLEY VA, 1981, THORAX, V36, P716; RYDER R, 1970, BMJ-BRIT MED J, V3, P481, DOI 10.1136/bmj.3.5721.481; SEATON A, 1983, THORAX, V38, P241, DOI 10.1136/thx.38.4.241; SOUTAR CA, 1987, BRIT J IND MED, V44, P145; 1989, NI226 DEP SOC SEC; 1983, LANCET, V1, P626; 1988, REPORT IND INJURIES; 1950, RADIOLOGICAL CLASSIF	27	0	0	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	FEB 10	1990	335	8685					322	324						3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CM846	1967773				2022-12-28	WOS:A1990CM84600007
J	[Anonymous]				[Anonymous]			EXCHANGE-TRANSFUSION IN FALCIPARUM-MALARIA	LANCET			English	Editorial Material																		BAMBAUER R, 1984, PLASMA THER TRANSFUS, V5, P343; FILES JC, 1984, ANN INTERN MED, V100, P396, DOI 10.7326/0003-4819-100-3-396; MILLER KD, 1989, NEW ENGL J MED, V321, P65, DOI 10.1056/NEJM198907133210201; SADDLER M, 1990, NEW ENGL J MED, V322, P58, DOI 10.1056/NEJM199001043220113; SHWE T, 1988, T ROY SOC TROP MED H, V82, P665, DOI 10.1016/0035-9203(88)90187-3; STURCHLER D, 1989, PARASITOL TODAY, V5, P39, DOI 10.1016/0169-4758(89)90188-9; WARRELL DA, 1982, NEW ENGL J MED, V306, P313, DOI 10.1056/NEJM198202113060601; White N. J., 1986, Clinics in Tropical Medicine and Communicable Diseases, V1, P55; WHITE NJ, 1988, EUR J CLIN PHARMACOL, V34, P1, DOI 10.1007/BF01061409; 1986, T R SOC TROP MED H S, V80, P1; 1979, CHINESE MED J, V92, P811	11	0	0	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	FEB 10	1990	335	8685					324	325						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CM846	1967774				2022-12-28	WOS:A1990CM84600009
J	OBERMAN, A; WASSERTHEILSMOLLER, S; LANGFORD, HG; BLAUFOX, MD; DAVIS, BR; BLASZKOWSKI, T; ZIMBALDI, N; HAWKINS, CM				OBERMAN, A; WASSERTHEILSMOLLER, S; LANGFORD, HG; BLAUFOX, MD; DAVIS, BR; BLASZKOWSKI, T; ZIMBALDI, N; HAWKINS, CM			PHARMACOLOGIC AND NUTRITIONAL TREATMENT OF MILD HYPERTENSION - CHANGES IN CARDIOVASCULAR RISK STATUS	ANNALS OF INTERNAL MEDICINE			English	Article									YESHIVA UNIV ALBERT EINSTEIN COLL MED, BRONX, NY 10461 USA; UNIV MISSISSIPPI, MED CTR, JACKSON, MS 39216 USA; UNIV TEXAS, SCH PUBL HLTH, HOUSTON, TX 77025 USA; NHLBI, BETHESDA, MD 20205 USA	Yeshiva University; Albert Einstein College of Medicine; University of Mississippi; University of Mississippi Medical Center; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	OBERMAN, A (corresponding author), UNIV ALABAMA, DIV GEN & PREVENT MED, MEB ROOM 609, UNIV STN, BIRMINGHAM, AL 35294 USA.		Blaufox, MDonald/AAF-6965-2020	Blaufox, MDonald/0000-0002-4148-6866	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL030171, R01HL024369, R01HL030163] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-24369, HL-30163, HL-30171] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		[Anonymous], 1988, ARCH INTERN MED, V148, P1023; DAVIS BR, 1989, CONTROL CLIN TRIALS, V10, P11; GORDON T, 1971, FRAMINGHAM STUDY EPI; HEYDEN S, 1985, J CHRON DIS, V38, P281, DOI 10.1016/0021-9681(85)90073-6; Hypertension Detection Follow-up Program Cooperative Group, 1979, JAMA-J AM MED ASSOC, V242, P2562, DOI DOI 10.1001/JAMA.1979.03300230018021; KAPLAN NM, 1988, ANN INTERN MED, V109, P36, DOI 10.7326/0003-4819-109-1-36; LANGFORD HG, 1985, JAMA-J AM MED ASSOC, V253, P657, DOI 10.1001/jama.253.5.657; LARDINOIS CK, 1988, ARCH INTERN MED, V148, P1280, DOI 10.1001/archinte.148.6.1280; STAMLER R, 1989, ARCH INTERN MED, V149, P661, DOI 10.1001/archinte.149.3.661; STRASSER T, 1987, MILD HYPERTENSION DR, P285	10	60	60	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 15	1990	112	2					89	95		10.7326/0003-4819-112-2-89	http://dx.doi.org/10.7326/0003-4819-112-2-89			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CH536	1967210				2022-12-28	WOS:A1990CH53600002
J	HEATH, DA; SENIOR, PV; VARLEY, JM; BECK, F				HEATH, DA; SENIOR, PV; VARLEY, JM; BECK, F			PARATHYROID-HORMONE-RELATED PROTEIN IN TUMORS ASSOCIATED WITH HYPERCALCEMIA	LANCET			English	Article									UNIV LEICESTER,DEPT ANAT,LEICESTER LE1 7RH,ENGLAND; UNIV LEICESTER,DEPT PATHOL,LEICESTER LE1 7RH,ENGLAND	University of Leicester; University of Leicester	HEATH, DA (corresponding author), QUEEN ELIZABETH HOSP,DEPT MED,BIRMINGHAM B15 2TH,W MIDLANDS,ENGLAND.							BENDER RA, 1974, ANN INTERN MED, V80, P205, DOI 10.7326/0003-4819-80-2-205; BUDAYR AA, 1989, 71ST ANN M END SOC S, P42; CONNOR TB, 1956, J CLIN INVEST, V35, P697; DANKS JA, 1989, J BONE MINER RES, V4, P273; DOCHERTY HM, 1989, J MOL ENDOCRINOL, V2, P11, DOI 10.1677/jme.0.0020011; DOCHERTY HM, 1988, J ENDOCRINOL, V123, P487; FISKEN RA, 1980, Q J MED, V49, P405; GARDNER B, 1969, SURG GYNECOL OBSTETR, V128, P369; GLASKO CSB, 1971, BR MEDJ, V2, P573; HORIUCHI N, 1987, SCIENCE, V238, P1566, DOI 10.1126/science.3685994; IKEDA K, 1988, MOL ENDOCRINOL, V2, P1230, DOI 10.1210/mend-2-12-1230; KEMP BE, 1987, SCIENCE, V238, P1568, DOI 10.1126/science.3685995; LOVERIDGE N, 1980, CLIN ENDOCRINOL, V22, P135; MUNDY GR, 1982, METABOLISM, V31, P1247, DOI 10.1016/0026-0495(82)90012-9; MUNDY GR, 1988, J CLIN INVEST, V82, P1, DOI 10.1172/JCI113555; OMARTA M, 1987, LIVER, V1, P33; PLIMPTON CH, 1956, AM J MED, V21, P750; SENIOR PV, 1988, DEVELOPMENT, V104, P431; THIEDE MA, 1988, SCIENCE, V242, P278, DOI 10.1126/science.3175653; WALKER RA, 1989, J PATHOL, V158, P97, DOI 10.1002/path.1711580204	20	47	47	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	JAN 13	1990	335	8681					66	69		10.1016/0140-6736(90)90537-F	http://dx.doi.org/10.1016/0140-6736(90)90537-F			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CH516	1967417				2022-12-28	WOS:A1990CH51600002
J	LOVE, RR; WIEBE, DA; NEWCOMB, PA; CAMERON, L; LEVENTHAL, H; JORDAN, VC; FEYZI, J; DEMETS, DL				LOVE, RR; WIEBE, DA; NEWCOMB, PA; CAMERON, L; LEVENTHAL, H; JORDAN, VC; FEYZI, J; DEMETS, DL			EFFECTS OF TAMOXIFEN ON CARDIOVASCULAR RISK-FACTORS IN POSTMENOPAUSAL WOMEN	ANNALS OF INTERNAL MEDICINE			English	Article						TAMOXIFEN; CORONARY DISEASE; LIPOPROTEINS, HDL; CHOLESTEROL; MENOPAUSE; BREAST NEOPLASMS	PRIMARY BREAST-CANCER; PLASMA-LIPIDS; THERAPY; TRIAL; ESTROGEN; SERUM	Objective: To determine the effects of tamoxifen on risk factors for cardiovascular disease in disease-free postmenopausal women. Design: Double-blind, placebo-controlled, randomized 2-year clinical trial. Setting: University health sciences center. Patients: Clinically postmenopausal women (140) with a diagnosis of axillary node-negative breast cancer, who were disease-free by laboratory and clinical evaluations. Measurements: Levels of total cholesterol, high-density lipoprotein (HDL) cholesterol, triglycerides, apolipoprotein A-I, apolipoprotein B, glucose, weight, blood pressure, and reported exercise and work activity were measured. Main Results: Postmenopausal women receiving tamoxifen were evaluated at 3- or 6-month intervals during a 2-year assessment period and showed a mean decrease of 12% in total cholesterol levels (at 24 months - 0.672 mmol/L; 95% Cl, - 0.839 to -0.505 mmol/L) and a mean decrease of 20% in calculated low-density lipoprotein (LDL) cholesterol levels (at 24 months, - 0.725 mmol/L; 95% Cl, - 0.868 to - 0.583 mmol/L) (P < 0.001). Women with greater baseline cholesterol levels had greater decreases with tamoxifen treatment. Levels of HDL cholesterol decreased in patients treated with tamoxifen, but this decrease was only statistically significant at one of five measurement times. Apolipoprotein A-I levels increased significantly at the two time points at which it was measured (P = 0.02), and apolipoprotein B levels decreased significantly at these times (P < 0.01) in patients treated with tamoxifen. Plasma glucose levels, reported exercise and work activity, reported smoking, weight, and systolic and diastolic blood pressures did not change with treatment. Conclusion: During 2 years of treatment, tamoxifen showed generally favorable effects on the lipid and lipoprotein profile of treated postmenopausal women. These effects may partially explain the decrease in adverse events and in mortality related to coronary heart disease seen in patients receiving adjuvant tamoxifen treatment.	UNIV WISCONSIN, CTR CLIN CANC, CANC PREVENT PROGRAM, MADISON, WI 53706 USA; UNIV WISCONSIN, CTR CLIN CANC, BREAST PROGRAM, MADISON, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison			Jordan, V. Craig/H-4491-2011; JORDAN, V.Craig/AAX-3562-2020		NATIONAL CANCER INSTITUTE [R01CA050243] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA 50243] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		[Anonymous], 1988, NEW ENGL J MED, V319, P1681; BAGDADE JD, 1990, J CLIN ENDOCR METAB, V70, P1132, DOI 10.1210/jcem-70-4-1132; BERTELLI G, 1988, BREAST CANCER RES TR, V12, P307, DOI 10.1007/BF01811244; BOCCARDO F, 1990, J CLIN ONCOL, V8, P1310, DOI 10.1200/JCO.1990.8.8.1310; BRUNING PF, 1988, BRIT J CANCER, V58, P497, DOI 10.1038/bjc.1988.248; BUSH TL, 1987, CIRCULATION, V75, P1102, DOI 10.1161/01.CIR.75.6.1102; CURME HG, 1978, CLIN CHEM, V24, P1335; FALKSON HC, 1990, J CLIN ONCOL, V8, P599, DOI 10.1200/JCO.1990.8.4.599; FISHER B, 1987, ANN INTERN MED, V106, P649, DOI 10.7326/0003-4819-106-5-649; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; JORDAN VC, 1988, CANCER INVEST, V6, P589, DOI 10.3109/07357908809082124; LERNER LJ, 1990, CANCER RES, V50, P4177; LOVE RR, 1990, J NATL CANCER I, V82, P18, DOI 10.1093/jnci/82.1.18; LOVE RR, 1989, J CLIN ONCOL, V7, P803, DOI 10.1200/JCO.1989.7.6.803; LOVE RR, 1990, JNCI-J NATL CANCER I, V82, P1327, DOI 10.1093/jnci/82.16.1327; LOVE RR, 1991, ARCH INTERN MED, V151, P1842, DOI 10.1001/archinte.151.9.1842; LOVE RR, 1991, IN PRESS ARCH INTERN; MANOLIO TA, 1991, IN PRESS AM J EPIDEM; POWLES TJ, 1989, BRIT J CANCER, V60, P126, DOI 10.1038/bjc.1989.235; RIFAI N, 1986, CLIN CHEM, V32, P957; SCHAPIRA D, 1990, P AN M AM SOC CLIN, V9, P49; SEDLACEK S, 1989, Breast Cancer Research and Treatment, V14, P153; SKIPSKI VP, 1967, BIOCHEM J, V104, P340, DOI 10.1042/bj1040340; STEWART H, 1990, JUN CONS C ADJ THER; STEWART HJ, 1987, LANCET, V2, P171; WEI LJ, 1984, J AM STAT ASSOC, V79, P653, DOI 10.2307/2288413	26	335	352	0	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 1	1991	115	11					860	864		10.7326/0003-4819-115-11-860	http://dx.doi.org/10.7326/0003-4819-115-11-860			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GR171	1952472				2022-12-28	WOS:A1991GR17100004
J	DREYFUS, M; MAGNY, JF; BRIDEY, F; SCHWARZ, HP; PLANCHE, C; DEHAN, M; TCHERNIA, G				DREYFUS, M; MAGNY, JF; BRIDEY, F; SCHWARZ, HP; PLANCHE, C; DEHAN, M; TCHERNIA, G			TREATMENT OF HOMOZYGOUS PROTEIN-C DEFICIENCY AND NEONATAL PURPURA FULMINANS WITH A PURIFIED PROTEIN-C CONCENTRATE	NEW ENGLAND JOURNAL OF MEDICINE			English	Note							BOVINE PLASMA; SKIN NECROSIS; THROMBIN		HOP ANTOINE BECLERE, NEONATAL INTENS CARE UNIT, F-92141 CLAMART, FRANCE; HOP M LANNELONGUE, DEPT SURG, LE PLESSIS ROBINSON, FRANCE; IMMUNO, VIENNA, AUSTRIA	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Antoine-Beclere - APHP	DREYFUS, M (corresponding author), HOP ANTOINE BECLERE, HEMATOL LAB, 157 RUE PORTE TRIVAUX, F-92141 CLAMART, FRANCE.							ADCOCK DM, 1990, SEMIN THROMB HEMOST, V16, P283, DOI 10.1055/s-2007-1002681; ADCOCK DM, 1990, SEMIN THROMB HEMOST, V16, P333, DOI 10.1055/s-2007-1002686; ANDREW M, 1987, BLOOD, V70, P165, DOI 10.1182/blood.V70.1.165.165; AULETTA MJ, 1988, ARCH DERMATOL, V124, P1387, DOI 10.1001/archderm.124.9.1387; BARRETT PN, 1989, BIOTECHNOLOGIE PROTE, P399; CAEN J, 1975, METHODES EXPLORATION; ELSINGER F, 1986, VONWILLEBRAND FACTOR, P297; FRIBERGER P, 1978, HAEMOSTASIS, V7, P138; HARTMAN KR, 1989, AM J PEDIAT HEMATOL, V11, P395; HERMSEN VM, 1990, AM J OPHTHALMOL, V109, P609; HUBBARD AR, 1988, THROMB HAEMOSTASIS, V59, P464; KISIEL W, 1977, BIOCHEMISTRY-US, V16, P5824, DOI 10.1021/bi00645a029; MARLAR RA, 1989, J PEDIATR-US, V114, P528, DOI 10.1016/S0022-3476(89)80688-2; MARLAR RA, 1990, SEMIN THROMB HEMOST, V16, P299, DOI 10.1055/s-2007-1002683; MARLAR RA, 1982, BLOOD, V59, P1067; NICHAM F, 1988, ANN BIOL CLIN-PARIS, V46, P805; ODEGARD OR, 1975, THROMB RES, V6, P287, DOI 10.1016/0049-3848(75)90078-X; SCHWARZ HP, 1990, ADV AP BIOT, V11, P83; SHEN MC, 1987, THROMB HAEMOSTASIS, V58, P411; STENFLO J, 1976, J BIOL CHEM, V251, P355; TARRAS S, 1988, ARCH NEUROL-CHICAGO, V45, P214, DOI 10.1001/archneur.1988.00520260102029; TUDDENHAM EGD, 1989, THROMB RES, V53, P475, DOI 10.1016/0049-3848(89)90202-8; WARRIER AI, 1981, ACQUIRED BLEEDING DI, V1, P91; WILDE JT, 1989, BRIT J HAEMATOL, V71, P65, DOI 10.1111/j.1365-2141.1989.tb06276.x	24	231	238	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 28	1991	325	22					1565	1568		10.1056/NEJM199111283252207	http://dx.doi.org/10.1056/NEJM199111283252207			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GR380	1944440				2022-12-28	WOS:A1991GR38000007
J	MCMURRAY, RJ; CLARKE, OW; BARRASSO, JA; WYO, C; CLOHAN, DB; EPPS, CH; GLASSON, J; MCQUILLAN, R; PLOWS, CW; PUZAK, MA; ORENTLICHER, D; HALKOLA, KA				MCMURRAY, RJ; CLARKE, OW; BARRASSO, JA; WYO, C; CLOHAN, DB; EPPS, CH; GLASSON, J; MCQUILLAN, R; PLOWS, CW; PUZAK, MA; ORENTLICHER, D; HALKOLA, KA			SEXUAL MISCONDUCT IN THE PRACTICE OF MEDICINE	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Note							NATIONAL SURVEY; PATIENT; CONTACT; THERAPIST; ATTITUDES; PRACTITIONERS; PSYCHIATRISTS; INTIMACY; CLIENTS; CARE	The American Medical Association's Council on Ethical and Judicial Affairs recently reviewed the ethical implications of sexual or romantic relationships between physicians and patients. The Council has concluded that (1) sexual contact or a romantic relationship concurrent with the physician-patient relationship ship is unethical; (2) sexual contact or a romantic relationship with a former patient may be unethical under certain circumstances; (3) education on the ethical issues involved in sexual misconduct should be included throughout all levels of medical training; and (4) in the case of sexual misconduct, reporting offending colleagues is especially important.	AMER MED ASSOC,COUNCIL ETH & JUDICIAL AFFAIRS,515 N STATE ST,CHICAGO,IL 60610	American Medical Association								BELOTE B, 1974, THESIS CALIFORNIA SC; Bemmann K C, 1989, Wis Med J, V88, P11; BOUHOUTSOS J, 1983, PROF PSYCHOL-RES PR, V14, P185, DOI 10.1037/0735-7028.14.2.185; BURGESS AW, 1981, AM J PSYCHIAT, V138, P1335; CAMPBELL ML, 1989, PERSPECT BIOL MED, V32, P300; DEROSIS H, 1987, AM J PSYCHIAT, V144, P688; FELDMANSUMMERS S, 1984, J CONSULT CLIN PSYCH, V52, P1054, DOI 10.1037/0022-006X.52.6.1054; Gabbard G. O., 1989, SEXUAL EXPLOITATION; GARTRELL N, 1986, AM J PSYCHIAT, V143, P1126; GARTRELL N, 1987, AM J ORTHOPSYCHIAT, V57, P287, DOI 10.1111/j.1939-0025.1987.tb03539.x; GARTRELL N, 1988, AM J PSYCHIAT, V145, P690; GLASER RD, 1986, AM PSYCHOL, V41, P43, DOI 10.1037/0003-066X.41.1.43; GORLIN R, 1983, NEW ENGL J MED, V308, P1059, DOI 10.1056/NEJM198305053081804; GROVES JE, 1978, NEW ENGL J MED, V298, P883, DOI 10.1056/NEJM197804202981605; GUTHEIL TG, 1989, AM J PSYCHIAT, V146, P597; HERMAN JL, 1987, AM J PSYCHIAT, V144, P164; HOLROYD JC, 1977, AM PSYCHOL, V32, P843, DOI 10.1037/0003-066X.32.10.843; KARDENER SH, 1974, AM J PSYCHIAT, V131, P1134; KARDENER SH, 1973, AM J PSYCHIAT, V130, P1077, DOI 10.1176/ajp.130.10.1077; KARDENER SH, 1976, AM J PSYCHIAT, V133, P1324; KLUFT RP, 1989, PSYCHIAT CLIN N AM, V12, P483; MASTERS WH, 1976, AM J PSYCHIAT, V133, P548; MCCARTNEY JL, 1966, J SEX RES, V2, P227, DOI 10.1080/00224499.1966.10749568; MOORE RA, 1985, AM J PSYCHIAT, V142, P1043; PERRY JA, 1976, AM J PSYCHIAT, V133, P838; POPE KS, 1986, AM PSYCHOL, V41, P147, DOI 10.1037/0003-066X.41.2.147; RAPP MS, 1987, CAN MED ASSOC J, V137, P193; SEEMAN MV, 1987, CAN MED ASSOC J, V137, P699; Shepard M., 1971, LOVE TREATMENT SEXUA; ZELEN SL, 1985, PSYCHOTHERAPY, V22, P178, DOI 10.1037/h0085491; ZINN WM, 1988, JAMA-J AM MED ASSOC, V259, P3296, DOI 10.1001/jama.259.22.3296; 1987, REPORT CALIFORNIA SE; 1989, CURRENT OPINIONS COU; 1989, PRINCIPLES MED ETHIC	34	58	58	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 20	1991	266	19					2741	2745		10.1001/jama.1991.03470190089035	http://dx.doi.org/10.1001/jama.1991.03470190089035			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GP691	1942427				2022-12-28	WOS:A1991GP69100031
J	GREIDER, CW				GREIDER, CW			CHROMOSOME 1ST AID	CELL			English	Review							SACCHAROMYCES-CEREVISIAE; DICENTRIC CHROMOSOMES; TELOMERE ADDITION; SEQUENCES; ENDS				GREIDER, CW (corresponding author), COLD SPRING HARBOR LAB,COLD SPRING HARBOR,NY 11724, USA.			Greider, Carol/0000-0002-5494-8126				BIESSMANN H, 1990, CELL, V61, P663, DOI 10.1016/0092-8674(90)90478-W; BLACKBURN EH, 1984, ANNU REV BIOCHEM, V53, P163, DOI 10.1146/annurev.bi.53.070184.001115; BLACKBURN EH, 1991, NATURE, V350, P569, DOI 10.1038/350569a0; DUNN B, 1984, CELL, V39, P191, DOI 10.1016/0092-8674(84)90205-8; FORNEY JD, 1988, MOL CELL BIOL, V8, P251, DOI 10.1128/MCB.8.1.251; GILLEY D, 1988, MOL CELL BIOL, V8, P4765, DOI 10.1128/MCB.8.11.4765; GREIDER CW, 1991, MOL CELL BIOL, V11, P4572, DOI 10.1128/MCB.11.9.4572; HABER JE, 1984, GENETICS, V106, P207; HARRINGTON LA, 1991, NATURE, V353, P451, DOI 10.1038/353451a0; JAGER D, 1989, EMBO J, V8, P247, DOI 10.1002/j.1460-2075.1989.tb03370.x; McClintock B, 1942, P NATL ACAD SCI USA, V28, P458, DOI 10.1073/pnas.28.11.458; McClintock B, 1939, P NATL ACAD SCI USA, V25, P405, DOI 10.1073/pnas.25.8.405; MORIN GB, 1991, NATURE, V353, P454, DOI 10.1038/353454a0; MULLER F, 1991, CELL, V667; MURRAY AW, 1988, MOL CELL BIOL, V8, P4642, DOI 10.1128/MCB.8.11.4642; PIMPINELLI S, 1989, TRENDS GENET, V5, P310, DOI 10.1016/0168-9525(89)90114-5; SPANGLER EA, 1988, NUCLEIC ACIDS RES, V16, P5569, DOI 10.1093/nar/16.12.5569; Tobler H., 1986, Results and Problems in Cell Differentiation, V13, P1; Yao MC, 1989, MOBILE DNA, P715; YU GL, 1991, CELL, V67	20	82	94	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	NOV 15	1991	67	4					645	647		10.1016/0092-8674(91)90058-7	http://dx.doi.org/10.1016/0092-8674(91)90058-7			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GQ407	1934066				2022-12-28	WOS:A1991GQ40700002
J	OTTING, G; LIEPINSH, E; WUTHRICH, K				OTTING, G; LIEPINSH, E; WUTHRICH, K			PROTEIN HYDRATION IN AQUEOUS-SOLUTION	SCIENCE			English	Article							NUCLEAR MAGNETIC-RESONANCE; PANCREATIC TRYPSIN-INHIBITOR; SOLVENT SATURATION; WATER-MOLECULES; SPIN DIFFUSION; RELAXATION; NMR; SPECTROSCOPY; OXYTOCIN; CRYSTALS	High-resolution proton nuclear magnetic resonance studies of protein hydration in aqueous solution show that there are two qualitatively different types of hydration sites. A well-defined, small number of water molecules in the interior of the protein are in identical locations in the crystal structure and in solution, and their residence times are in the range from about 10(-2) to 10(-8) second. Hydration of the protein surface in solution is by water molecules with residence times in the subnanosecond range, even when they are located in hydration sites that contain well-ordered water in the x-ray structures of protein single crystals.			OTTING, G (corresponding author), SWISS FED INST TECHNOL,INST MOLEK BIOL & BIOPHYS,CH-8093 ZURICH,SWITZERLAND.		Otting, Gottfried/H-8413-2014	Otting, Gottfried/0000-0002-0563-0146				ABRAGAM A, 1961, PRINCIPLES NUCLEAR M; AYANT Y, 1977, J PHYS-PARIS, V38, P325, DOI 10.1051/jphys:01977003803032500; BERNDT K, UNPUB; BERNSTEIN FC, 1977, J MOL BIOL, V112, P535, DOI 10.1016/S0022-2836(77)80200-3; Blundell T.L., 1976, PROTEIN CRYSTALLOGRA; BOTHNERBY AA, 1984, J AM CHEM SOC, V106, P811, DOI 10.1021/ja00315a069; BRYANT RG, 1980, BIOPHYS J, V32, P3, DOI 10.1016/S0006-3495(80)84912-5; CLORE GM, 1990, BIOCHEMISTRY-US, V29, P567; DEISENHOFER J, 1975, ACTA CRYSTALLOGR B, V31, P238, DOI 10.1107/S0567740875002415; FUJIWARA T, 1985, J CHEM PHYS, V83, P3110, DOI 10.1063/1.449217; GILLEN KT, 1972, J CHEM PHYS, V57, P5117, DOI 10.1063/1.1678198; GLICKSON JD, 1976, BIOCHEMISTRY-US, V15, P1111, DOI 10.1021/bi00650a025; GLICKSON JD, 1975, PEPTIDES CHEM STRUCT, P787; HALLE B, 1981, J AM CHEM SOC, V103, P500, DOI 10.1021/ja00393a004; HRUBY VJ, 1981, TOPICS MOL PHARM, P100; KALK A, 1976, J MAGN RESON, V24, P343, DOI 10.1016/0022-2364(76)90115-3; KOENIG SH, 1988, BIOPHYS J, V53, P91, DOI 10.1016/S0006-3495(88)83069-8; KOSHLAND DE, 1966, BIOCHEMISTRY-US, V5, P365, DOI 10.1021/bi00865a047; MARANI R, UNPUB; MEIBOOM S, 1961, J CHEM PHYS, V34, P375, DOI 10.1063/1.1700960; MESSERLE BA, 1989, J MAGN RESON, V85, P608, DOI 10.1016/0022-2364(89)90252-7; OTTING G, 1991, J AM CHEM SOC, V113, P4363, DOI 10.1021/ja00011a068; OTTING G, 1991, Journal of Biomolecular NMR, V1, P209, DOI 10.1007/BF01877232; OTTING G, 1989, J AM CHEM SOC, V111, P1871, DOI 10.1021/ja00187a050; OTTING G, 1990, WATER IONS BIOMOLECU, P141; OTTING G, 1991, WATER IONS BIOMOLECU, V113, P4363; PITNER TP, 1974, NATURE, V250, P582, DOI 10.1038/250582a0; POLNASZEK CF, 1984, J CHEM PHYS, V81, P4038, DOI 10.1063/1.448147; Richards F. M., 1991, Scientific American, V264, P34; RICHARZ R, 1980, BIOCHEMISTRY-US, V19, P5189, DOI 10.1021/bi00564a006; RICHMOND TJ, 1984, J MOL BIOL, V178, P63, DOI 10.1016/0022-2836(84)90231-6; SAENGER W, 1987, ANNU REV BIOPHYS BIO, V16, P93; Schulz G. E., 1979, PRINCIPLES PROTEIN S; SOLOMON I, 1955, PHYS REV, V99, P559, DOI 10.1103/PhysRev.99.559; STOESZ JD, 1978, FEBS LETT, V91, P320, DOI 10.1016/0014-5793(78)81201-0; WAGNER G, 1987, J MOL BIOL, V196, P611, DOI 10.1016/0022-2836(87)90037-4; WLODAWER A, 1984, J MOL BIOL, V180, P301, DOI 10.1016/S0022-2836(84)80006-6; WLODAWER A, 1987, J MOL BIOL, V198, P469, DOI 10.1016/0022-2836(87)90294-4; WOOD SP, 1986, SCIENCE, V232, P633, DOI 10.1126/science.3008332; WUTHRICH K, 1989, SCIENCE, V243, P45, DOI 10.1126/science.2911719; WUTHRICH K, 1989, ACCOUNTS CHEM RES, V22, P36, DOI 10.1021/ar00157a006; Wuthrich K., 1986, NMR PROTEINS NUCL AC	43	750	759	0	104	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	NOV 15	1991	254	5034					974	980		10.1126/science.1948083	http://dx.doi.org/10.1126/science.1948083			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GP883	1948083				2022-12-28	WOS:A1991GP88300035
J	NIGHTINGALE, SL				NIGHTINGALE, SL			DIDANOSINE (DDI) APPROVED FOR ADVANCED HIV-INFECTION	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material											NIGHTINGALE, SL (corresponding author), US FDA,OFF HLTH AFFAIRS,PARKLAWN BLDG,5600 FISHERS LN,ROCKVILLE,MD 20857, USA.								0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 13	1991	266	18					2528	2528						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GN660	1942388				2022-12-28	WOS:A1991GN66000006
J	LI, J; TAYLOR, B				LI, J; TAYLOR, B			COMPARISON OF IMMUNIZATION RATES IN GENERAL-PRACTICE AND CHILD HEALTH CLINICS	BRITISH MEDICAL JOURNAL			English	Article							IMMUNIZATION	Objective - To compare immunisation uptake rates in general practice surgeries and community child health clinics. Design - Cohort study using data from a computerised child health system. Setting - Four health districts of North East Thames Regional Health Authority. Subjects - 3616 children born January to March 1990 and resident in the four districts at the end of january 1991. Main outcome measures - Immunisation uptake rates at 10-12 months of age, age at immunisation, scheduling performance at the two locations, and odds ratios of outstanding immunisations. Results - 80% of children registered at general practices had completed their third dose of pertussis immunisation compared with 68% of those at health clinics. Median ages at the third dose were 24 weeks and 29 weeks at the two locations respectively. Scheduling was more effective at general practice surgeries. Unscheduled immunisations were more likely to be given after the recommended age. Overall, children resident in rural and suburban areas had greater uptakes than those in inner cities. Odds ratios for not being fully immunised among children registered at health clinics were 1.4 times those among children immunised in general practice and 3.0 times greater among children resident in inner cities than among those in rural and suburban districts. Children who moved into a district, however, were no less likely to be fully immunised than children who were born there. Conclusions - The immunisation uptake rate was better in general practices than in child health clinics in both inner city and rural and suburban areas. Uptake may be increased with additional support to enable general practitioners to undertake immunisations, especially in inner cities.			LI, J (corresponding author), ROYAL FREE HOSP,SCH MED,DEPT COMMUNITY CHILD HLTH,LONDON NW3 2PF,ENGLAND.							BAKER MR, 1984, BRIT MED J, V288, P1075, DOI 10.1136/bmj.288.6423.1075; BEGG NT, 1985, BRIT MED J, V291, P1370, DOI 10.1136/bmj.291.6506.1370; BUSSEY AL, 1978, LANCET, V2, P450; JARMAN B, 1988, BMJ, V296, P2775; LINGAM S, 1986, BMJ, V292, P1717; NICOLL A, 1989, BRIT MED J, V299, P808, DOI 10.1136/bmj.299.6703.808; NORUSIS MJ, 1985, SPSS X ADV STATISTIC, P327; PECKHAM C, 1989, NATIONAL IMMUNISATIO; RICE P, 1984, INFORMATION DISTRICT; RILEY DJ, 1991, BRIT MED J, V302, P31, DOI 10.1136/bmj.302.6767.31; ROPER J, 1988, ARCH DIS CHILD, V63, P518, DOI 10.1136/adc.63.5.518; WALKER CHM, 1980, BMJ, V281, P1400; 1990, IMMUNISATION INFECTI; 1983, CHILD HLTH SYSTEM IN; 1988, IMMUNISATION INFECTI	15	16	16	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	OCT 26	1991	303	6809					1035	1038		10.1136/bmj.303.6809.1035	http://dx.doi.org/10.1136/bmj.303.6809.1035			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GM478	1954458	Bronze, Green Published			2022-12-28	WOS:A1991GM47800024
J	CHAMBERS, J; KILLORAN, A; MCNEILL, A; REID, D				CHAMBERS, J; KILLORAN, A; MCNEILL, A; REID, D			THE HEALTH OF THE NATION - RESPONSES - SMOKING	BRITISH MEDICAL JOURNAL			English	Article							MASS-MEDIA; CESSATION; INTERVENTIONS; MORTALITY; TOBACCO		HLTH EDUC AUTHOR,HLTH POLICY,LONDON WC1H 9TX,ENGLAND; HLTH EDUC AUTHOR,PUBL HLTH,LONDON WC1H 9TX,ENGLAND; HLTH EDUC AUTHOR,PROGRAMMES MANAGER,LONDON WC1H 9TX,ENGLAND	Public Health England				McNeill, Ann/0000-0002-6223-4000				AITKEN P, 1988, PUSHING SMOKE; AMOS A, 1990, BRIT MED J, V301, P1173, DOI 10.1136/bmj.301.6762.1173; BATTEN L, 1990, MANAGING CHANGE SMOK; BAUMAN KE, 1991, AM J PUBLIC HEALTH, V81, P597, DOI 10.2105/AJPH.81.5.597; COCK DG, 1986, LANCET, V2, P1376; CURRIE E, 1987, 44 HOUS COMM OFF REP, V122; DOLL R, 1976, BRIT MED J, V2, P1525, DOI 10.1136/bmj.2.6051.1525; FIORE MC, 1990, JAMA-J AM MED ASSOC, V263, P2760, DOI 10.1001/jama.263.20.2760; FLAY BR, 1987, AM J PUBLIC HEALTH, V77, P153, DOI 10.2105/AJPH.77.2.153; GODDARD E, 1990, CHILDREN START SMOKI; GODFREY C, 1988, BRIT MED J, V297, P339, DOI 10.1136/bmj.297.6644.339; GRAHAM H, 1987, SOC SCI MED, V25, P47, DOI 10.1016/0277-9536(87)90206-1; JAJICH CL, 1984, JAMA-J AM MED ASSOC, V252, P2831, DOI 10.1001/jama.252.20.2831; JAMROZIK K, 1984, BRIT MED J, V288, P1499, DOI 10.1136/bmj.288.6429.1499; KILLORAN AJ, 1991, HLTH SERVICES J 0829, P14; KOTTKE TE, 1988, JAMA-J AM MED ASSOC, V259, P2882, DOI 10.1001/jama.1988.03720190050031; MAYNARD A, 1987, BRIT J ADDICT, V82, P701; MGADZAH R, 1988, MARKETING WEEK  1021, P23; PIERCE JP, 1990, AM J PUBLIC HEALTH, V80, P565, DOI 10.2105/AJPH.80.5.565; RAW M, 1990, CLEARING AIR GUIDE A; ROBERTS JL, 1985, BIG KILL SMOKING EPI; ROBERTS JL, 1990, BEATING BAN; RUSSELL MAH, 1979, BRIT MED J, V2, P231, DOI 10.1136/bmj.2.6184.231; RYDER R, 1990, 47 HOUS COMM OFF REP, V166; SCHEPERS LG, 1989, HLTH BENEFITS PREVEN, V12; SHAPER AG, 1981, BRIT MED J, V283, P179, DOI 10.1136/bmj.283.6285.179; TOWNSEND J, 1991, EC MEASURES REDUCE C; TOWNSEND J, 1987, APPLIED EC, V19, P335; YOUNG PEOPLES HLTH L; 1990, SURVEY BRITAINS PERS; 1991, CMMD1523; 1983, HLTH SMOKING; 1988, 4TH IND SCI COMM SMO; 1990, SETTING TARGETS CORO; 1991, TOBACCO USE CALIFORN; 1991, WHICH WAY HLTH   FEB, P114; 1990, HLTH LIFESTYLE SURVE; 1990, NHS WHITE PAPER IMPL; 1991, CANADIANS SMOKING UP; 1990, GENERAL HOUSEHOLD SU	40	3	3	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	OCT 19	1991	303	6808					973	977		10.1136/bmj.303.6808.973	http://dx.doi.org/10.1136/bmj.303.6808.973			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GL127	1954426	Bronze, Green Published			2022-12-28	WOS:A1991GL12700030
J	VANDERPOEL, CL; REESINK, HW; SCHAASBERG, W; LEENTVAARKUYPERS, A; BAKKER, E; EXELOEHLERS, PJ; LELIE, PN				VANDERPOEL, CL; REESINK, HW; SCHAASBERG, W; LEENTVAARKUYPERS, A; BAKKER, E; EXELOEHLERS, PJ; LELIE, PN			INFECTIVITY OF BLOOD SEROPOSITIVE FOR HEPATITIS-C VIRUS-ANTIBODIES	LANCET			English	Article									MUNICIPAL HLTH SERV,DEPT INFECT DIS,AMSTERDAM,NETHERLANDS; NETHERLANDS RED CROSS,BLOOD TRANSFUS SERV,CENT LAB,AMSTERDAM,NETHERLANDS		VANDERPOEL, CL (corresponding author), RED CROSS BLOOD BANK,POB 9137,1006 AC AMSTERDAM,NETHERLANDS.							ALTER HJ, 1981, JAMA-J AM MED ASSOC, V246, P630, DOI 10.1001/jama.246.6.630; CONTRERAS M, 1989, LANCET, V2, P505; ESTEBAN JI, 1989, LANCET, V2, P294; JANOT C, 1989, LANCET, V2, P796; KOZIOL DE, 1986, ANN INTERN MED, V104, P488, DOI 10.7326/0003-4819-104-4-488; KUHNL P, 1989, LANCET, V2, P324; KUO G, 1989, SCIENCE, V244, P362, DOI 10.1126/science.2496467; REESINK HW, 1989, BLUT, V58, P1, DOI 10.1007/BF00320227; REESINK HW, 1988, VIRAL HEPATITIS LIVE, P558; STEANE EA, 1987, COMMUNICATION   0527, P2; VANDERPOEL CL, 1989, LANCET, V2, P297; WEINER AJ, 1990, LANCET, V335, P1, DOI 10.1016/0140-6736(90)90134-Q	12	264	266	0	2	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	MAR 10	1990	335	8689					558	560		10.1016/0140-6736(90)90347-8	http://dx.doi.org/10.1016/0140-6736(90)90347-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT653	1968574				2022-12-28	WOS:A1990CT65300002
J	ROSE, PE; STRUTHERS, GS; ROBERTSON, M; KAVI, J; CHANT, I; TAYLOR, CM				ROSE, PE; STRUTHERS, GS; ROBERTSON, M; KAVI, J; CHANT, I; TAYLOR, CM			FACTOR-VIII VONWILLEBRAND PROTEIN IN HEMOLYTIC UREMIC SYNDROME AND SYSTEMIC VASCULITIDES	LANCET			English	Article									CHILDRENS HOSP,DEPT PAEDIAT NEPHROL,BIRMINGHAM B16 8ET,W MIDLANDS,ENGLAND; COVENTRY & WARWICKSHIRE HOSP,DEPT RHEUMATOL,COVENTRY CV1 4FH,W MIDLANDS,ENGLAND		ROSE, PE (corresponding author), WARWICK GEN HOSP,DEPT HAEMATOL & MICROBIOL,PATHOL LAB,LAKIN RD,WARWICK CV34 5BJ,ENGLAND.							BLOMBACK B, 1978, THROMB RES, V12, P1177, DOI 10.1016/0049-3848(78)90072-5; DRUMMOND KN, 1985, NEW ENGL J MED, V312, P116, DOI 10.1056/NEJM198501103120211; GASSER C, 1955, Schweiz Med Wochenschr, V85, P905; KAVI J, 1987, LANCET, V2, P1035; LEUNG DYM, 1988, LANCET, V2, P183; MOAKE JL, 1984, BLOOD, V64, P592; NUSINOW SR, 1984, ARTHRITIS RHEUM, V27, P1405, DOI 10.1002/art.1780271211; OBRIG TG, 1987, LANCET, V2, P687; ROSE PE, 1984, ARCH DIS CHILD, V59, P1135, DOI 10.1136/adc.59.12.1135; ROSE PE, 1989, BLOOD REV, V3, P136, DOI 10.1016/0268-960X(89)90009-X; SHORT PE, 1982, MED LAB SCI, V39, P351; 1988, LANCET, V1, P1203; 1987, LANCET, V2, P1437	13	19	19	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	MAR 3	1990	335	8688					500	502		10.1016/0140-6736(90)90736-O	http://dx.doi.org/10.1016/0140-6736(90)90736-O			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT015	1968528				2022-12-28	WOS:A1990CT01500004
J	WOODLAND, D; HAPP, MP; BILL, J; PALMER, E				WOODLAND, D; HAPP, MP; BILL, J; PALMER, E			REQUIREMENT FOR COTOLEROGENIC GENE-PRODUCTS IN THE CLONAL DELETION OF I-E REACTIVE T-CELLS	SCIENCE			English	Article									NATL JEWISH CTR IMMUNOL & RESP MED, DIV BASIC SCI, DENVER, CO 80206 USA; UNIV COLORADO, HLTH SCI CTR, DEPT MICROBIOL & IMMUNOL, DENVER, CO 80262 USA	National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver					NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI022295, R01AI022259] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR037070] Funding Source: NIH RePORTER; NIAID NIH HHS [AI-22295, AI-22259] Funding Source: Medline; NIAMS NIH HHS [AR-37070] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ABE R, 1989, J EXP MED, V170, P1059, DOI 10.1084/jem.170.4.1059; BILL J, 1989, J EXP MED, V169, P1405, DOI 10.1084/jem.169.4.1405; BILL J, UNPUB; FESTENSTEIN H, 1976, TRANSPLANT P, V8, P339; FOWLKES BJ, 1989, ADV IMMUNOL, V44, P207; HAPP MP, 1989, P NATL ACAD SCI USA, V86, P6293, DOI 10.1073/pnas.86.16.6293; JONES B, 1982, IMMUNOGENETICS, V16, P243, DOI 10.1007/BF00343313; KANAGAWA O, 1989, CELL IMMUNOL, V119, P412, DOI 10.1016/0008-8749(89)90255-4; KAPPLER JW, 1987, CELL, V49, P273, DOI 10.1016/0092-8674(87)90568-X; KAPPLER JW, 1987, CELL, V49, P263, DOI 10.1016/0092-8674(87)90567-8; KAPPLER JW, 1988, NATURE, V332, P35, DOI 10.1038/332035a0; KAPPLER JW, 1981, J EXP MED, V153, P1198, DOI 10.1084/jem.153.5.1198; LYNCH DH, 1985, J IMMUNOL, V134, P2071; MACDONALD HR, 1988, NATURE, V332, P40, DOI 10.1038/332040a0; MARRACK P, 1988, NATURE, V332, P840, DOI 10.1038/332840a0; MISHELL RI, 1967, J EXP MED, V126, P423, DOI 10.1084/jem.126.3.423; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; OKADA CY, 1989, J EXP MED, V169, P1703, DOI 10.1084/jem.169.5.1703; OZATO K, 1980, J IMMUNOL, V124, P533; PULLEN AM, 1989, J IMMUNOL, V142, P3033; PULLEN AM, 1988, NATURE, V335, P796, DOI 10.1038/335796a0; REICH EP, 1989, NATURE, V341, P326, DOI 10.1038/341326a0; TAYLOR BA, 1987, ORIGIN INBRED MICE, P423; TOMONARI K, 1988, IMMUNOGENETICS, V28, P445, DOI 10.1007/BF00355377; TRAINA VL, 1981, J VIROL, V40, P735, DOI 10.1128/JVI.40.3.735-744.1981; VIDOVIC D, 1988, NATURE, V336, P222, DOI 10.1038/336222a0; WOODLAND D, UNPUB	27	238	240	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 23	1990	247	4945					964	967		10.1126/science.1968289	http://dx.doi.org/10.1126/science.1968289			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP906	1968289				2022-12-28	WOS:A1990CP90600040
J	KANG, S; OWENS, DR; VORA, JP; BRANGE, J				KANG, S; OWENS, DR; VORA, JP; BRANGE, J			COMPARISON OF INSULIN ANALOG B9ASPB27GLU AND SOLUBLE HUMAN INSULIN IN INSULIN-TREATED DIABETES	LANCET			English	Article									NOVO RES INST,DK-2880 BAGSVAERD,DENMARK	Novo Nordisk	KANG, S (corresponding author), UNIV COLL CARDIFF,DEPT MED,DIABET RES UNIT,CARDIFF CF4 4XN,S GLAM,WALES.							BERMAN M, 1980, DIABETES, V29, P50, DOI 10.2337/diab.29.1.50; BINDER C, 1969, ACTA PHARMACOL TOX, VS 27, P1; Blundell T., 1972, ADV PROTEIN CHEM, V26, P279; BRANGE J, 1988, NATURE, V333, P679, DOI 10.1038/333679a0; CARPENTIER JL, 1989, DIABETOLOGIA, V32, P627; DILLON RS, 1983, DIABETES CARE, V6, P399, DOI 10.2337/diacare.6.4.399; DIMITRIADIS GD, 1983, DIABETES CARE, V6, P374, DOI 10.2337/diacare.6.4.374; DREJER K, 1988, Diabetes Research and Clinical Practice, V5, pS231; EATON RP, 1980, DIABETES CARE, V3, P270, DOI 10.2337/diacare.3.2.270; EDSBERG B, 1987, BRIT MED J, V294, P1373, DOI 10.1136/bmj.294.6584.1373; HANNING I, 1985, DIABETOLOGIA, V28, P831, DOI 10.1007/BF00291073; HEDING LG, 1972, DIABETOLOGIA, V8, P260, DOI 10.1007/BF01225569; HOME PD, 1981, METABOLISM, V30, P439, DOI 10.1016/0026-0495(81)90177-3; KINMONTH AL, 1980, BRIT MED J, V280, P604, DOI 10.1136/bmj.280.6214.604; LEAN MEJ, 1985, BRIT MED J, V290, P105, DOI 10.1136/bmj.290.6462.105; LINDE B, 1986, DIABETES CARE, V9, P570, DOI 10.2337/diacare.9.6.570; LINDE B, 1985, DIABETOLOGIA, V28, P645, DOI 10.1007/BF00291968; MALHERBE C, 1969, DIABETOLOGIA, V5, P397, DOI 10.1007/BF00427978; MOSEKILDE E, 1989, J PHARMACOKINET BIOP, V17, P67, DOI 10.1007/BF01059088; NAKAGAWA S, 1973, DIABETES, V22, P590, DOI 10.2337/diab.22.8.590; OWENS DR, 1986, HUMAN INSULIN CLIN P, P46; PEHLING GB, 1984, MAYO CLIN PROC, V59, P751, DOI 10.1016/S0025-6196(12)65585-2; RIBEL U, 1988, Diabetes Research and Clinical Practice, V5, pS368; SCHADE DS, 1980, DIABETES CARE, V3, P9, DOI 10.2337/diacare.3.1.9; TAYLOR R, 1981, DIABETES CARE, V4, P377, DOI 10.2337/diacare.4.3.377; VANHAEFTEN TW, 1986, METABOLISM, V35, P649, DOI 10.1016/0026-0495(86)90173-3; VORA JP, 1988, BRIT MED J, V297, P1236, DOI 10.1136/bmj.297.6658.1236	27	35	38	0	1	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	FEB 10	1990	335	8685					303	306		10.1016/0140-6736(90)90602-2	http://dx.doi.org/10.1016/0140-6736(90)90602-2			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CM846	1967767				2022-12-28	WOS:A1990CM84600001
J	FAHEY, JL; TAYLOR, JMG; DETELS, R; HOFMANN, B; MELMED, R; NISHANIAN, P; GIORGI, JV				FAHEY, JL; TAYLOR, JMG; DETELS, R; HOFMANN, B; MELMED, R; NISHANIAN, P; GIORGI, JV			THE PROGNOSTIC VALUE OF CELLULAR AND SEROLOGIC MARKERS IN INFECTION WITH HUMAN IMMUNODEFICIENCY VIRUS TYPE-1	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									UNIV CALIF LOS ANGELES, SCH MED, JONSSON COMPREHENS CANC CTR, LOS ANGELES, CA 90024 USA; UNIV CALIF LOS ANGELES, SCH PUBL HLTH, LOS ANGELES, CA 90024 USA	UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles					NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P50AI015332, N01AI072631, U01AI023606] Funding Source: NIH RePORTER; NIAID NIH HHS [AI-15332, AI-23606, AI-72631] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALLAIN JP, 1987, NEW ENGL J MED, V317, P1114, DOI 10.1056/NEJM198710293171804; CHMIEL JS, 1987, AM J EPIDEMIOL, V126, P568, DOI 10.1093/oxfordjournals.aje.a114696; COX DR, 1972, J R STAT SOC B, V34, P187; DETELS R, 1987, INT J EPIDEMIOL, V16, P271, DOI 10.1093/ije/16.2.271; DETELS R, 1988, J ACQ IMMUN DEF SYND, V1, P390; DEWOLF F, 1987, BMJ-BRIT MED J, V295, P569, DOI 10.1136/bmj.295.6598.569; FAHEY JL, 1984, AM J MED, V76, P95, DOI 10.1016/0002-9343(84)90756-3; FAHEY JL, 1987, ANN INST PASTEUR IMM, V138, P245, DOI 10.1016/S0769-2625(87)80075-2; FAUCI AS, 1984, ANN INTERN MED, V100, P92, DOI 10.7326/0003-4819-100-1-92; FUCHS D, 1988, IMMUNOL TODAY, V9, P150, DOI 10.1016/0167-5699(88)91203-0; GIORGI JV, 1987, J CLIN IMMUNOL, V7, P140, DOI 10.1007/BF00916008; GIORGI JV, 1987, J IMMUNOL, V138, P3725; GIORGI JV, IN PRESS CLIN IMMUNO; GOEDERT JJ, 1986, SCIENCE, V231, P992, DOI 10.1126/science.3003917; HOFMANN B, 1987, BRIT MED J, V295, P293, DOI 10.1136/bmj.295.6593.293; HOFMANN B, IN PRESS AIDS; HUBER C, 1984, J EXP MED, V160, P310, DOI 10.1084/jem.160.1.310; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; KASLOW RA, 1987, AM J EPIDEMIOL, V126, P310, DOI 10.1093/aje/126.2.310; LACEY CJN, 1987, AIDS, V1, P123; LANE HC, 1983, NEW ENGL J MED, V309, P453, DOI 10.1056/NEJM198308253090803; LANE HC, 1985, NEW ENGL J MED, V313, P79, DOI 10.1056/NEJM198507113130204; LELIE PN, 1988, NEW ENGL J MED, V318, P1204, DOI 10.1056/NEJM198805053181814; MARTINEZMAZA O, 1987, J IMMUNOL, V138, P3720; MCDOUGAL JS, 1985, J IMMUNOL, V135, P3151; MELBYE M, 1986, ANN INTERN MED, V104, P496, DOI 10.7326/0003-4819-104-4-496; MELMED RN, 1989, J ACQ IMMUN DEF SYND, V2, P70; MOSS AR, 1988, BRIT MED J, V296, P745, DOI 10.1136/bmj.296.6624.745; MUNOZ A, 1988, J ACQ IMMUN DEF SYND, V1, P396; NAKAJIMA K, 1989, J IMMUNOL, V142, P531; NISHANIAN P, 1987, J CLIN MICROBIOL, V25, P395, DOI 10.1128/JCM.25.2.395-400.1987; POLK BF, 1987, NEW ENGL J MED, V316, P61, DOI 10.1056/NEJM198701083160201; PRINCE HE, 1988, J IMMUNOL, V140, P1139; PRINCE HE, 1984, J IMMUNOL, V133, P1313; SALAZARGONZALEZ JF, 1985, J IMMUNOL, V135, P1778; TAYLOR JMG, 1989, J ACQ IMMUN DEF SYND, V2, P114; WITTEK AE, 1987, ANN INTERN MED, V107, P286, DOI 10.7326/0003-4819-107-2-286; ZIEGLER I, 1986, EOS-RIV IMMUNOL, V6, P169	38	1079	1091	0	17	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 18	1990	322	3					166	172		10.1056/NEJM199001183220305	http://dx.doi.org/10.1056/NEJM199001183220305			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CH840	1967191				2022-12-28	WOS:A1990CH84000005
J	BARONDESS, JA				BARONDESS, JA			THE ACADEMIC HEALTH-CENTER AND THE PUBLIC AGENDA - WHOSE 3-LEGGED STOOL	ANNALS OF INTERNAL MEDICINE			English	Article							MEDICINE	The American academic health center has emerged from a tradition that bound research, teaching, and patient care. In recent decades major changes in its faculty array and activities have been generated by extramural funding patterns that have emphasized the research functions of the faculty and, more recently, subspecialty care by faculty members, to the detriment of teaching functions and of immersion in major health care and health promotion issues. The latter are arising more prominently in the public agenda than in the academic agenda. The academic health centers should re-examine their activities with particular attention to the opportunities afforded by this emergent public agenda in biomedicine and health.			BARONDESS, JA (corresponding author), NEW YORK ACAD MED, 2 E 103RD ST, NEW YORK, NY 10029 USA.							BARONDESS JA, 1990, DOCTORING AM LAST 10, P1; BROOK RH, 1990, DOCTORING AM LAST 10, P107; FLEXNER A, 1910, B CARNEGIE F ADV TEA, V4; FRIES JF, 1990, DOCTORING AM LAST 10, P13; HARVEY AM, 1981, SCI BEDSIDE CLIN RES, P105; Kuhn T. S., 1996, STRUCTURE SCI REVOLU; LURIE N, 1987, AM J PUBLIC HEALTH, V77, P801, DOI 10.2105/AJPH.77.7.801; MASON JO, 1990, DOCTORING AM LAST 10, P29; MCDERMOTT W, 1978, PERSPECT BIOL MED, V21, P167; RICHARDS P, 1990, LANCET, V336, P926, DOI 10.1016/0140-6736(90)92285-P; SCHROEDER SA, 1986, ANN INTERN MED, V104, P554, DOI 10.7326/0003-4819-104-4-554; TUCHMAN B, 1962, PROUD TOWER; WENNBERG JE, 1988, HEALTH AFFAIR, V7, P99, DOI 10.1377/hlthaff.7.1.99; 1990, DHHS PHS9050212 US D; 1989, HLTH US, P250	15	23	23	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 15	1991	115	12					962	967		10.7326/0003-4819-115-12-962	http://dx.doi.org/10.7326/0003-4819-115-12-962			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GU417	1952494				2022-12-28	WOS:A1991GU41700010
J	SLOAND, EM; PITT, E; CHIARELLO, RJ; NEMO, GJ				SLOAND, EM; PITT, E; CHIARELLO, RJ; NEMO, GJ			HIV TESTING - STATE-OF-THE-ART	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							HUMAN-IMMUNODEFICIENCY-VIRUS; POLYMERASE CHAIN-REACTION; AIDS-RELATED COMPLEX; AT-RISK INDIVIDUALS; BLOOD-DONORS; WESTERN BLOT; SEXUAL PARTNERS; HOMOSEXUAL MEN; SEROPOSITIVE INDIVIDUALS; SEROLOGICAL MARKERS		NIDA, ROCKVILLE, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA)	SLOAND, EM (corresponding author), NHLBI, BLDG 31, ROOM 5A21, 9000 ROCKVILLE PIKE, BETHESDA, MD 20892 USA.							ABBOTT MA, 1988, J INFECT DIS, V158, P1158, DOI 10.1093/infdis/158.6.1158; ADAMS CW, 1990, 6TH INT AIDS C SAN F, P125; ALLAIN JP, 1986, LANCET, V2, P1233; ALLAIN JP, 1987, NEW ENGL J MED, V317, P1114, DOI 10.1056/NEJM198710293171804; ALTER HJ, 1990, NEW ENGL J MED, V323, P1312, DOI 10.1056/NEJM199011083231905; ALTER HJ, 1987, ANN INST PASTEUR VIR, V138, P31, DOI 10.1016/S0769-2617(87)80071-0; ARCHIBALD DW, 1990, J ACQ IMMUN DEF SYND, V3, P954; BACKER U, 1988, AIDS, V2, P477, DOI 10.1097/00002030-198812000-00011; BAECKER U, 1988, 4TH P INT C AIDS STO, V2, P364; BEGGAR RJ, 1985, BMJ-BRIT MED J, V291, P997; BORKOWSKY W, 1989, J PEDIATR-US, V114, P940, DOI 10.1016/S0022-3476(89)80434-2; BUSCH MP, 1991, TRANSFUSION, V31, P129, DOI 10.1046/j.1537-2995.1991.31291142943.x; BUSCH MP, 1990, NEW ENGL J MED, V323, P1308, DOI 10.1056/NEJM199011083231904; BUSCH MP, 1990, TRANSFUSION, V30, P184, DOI 10.1046/j.1537-2995.1990.30290162908.x; BUSCH MP, 1991, TRANSFUSION, V31, P4, DOI 10.1046/j.1537-2995.1991.31191096183.x; BUSCH MP, IN PRESS TRANSFUSION; CARLSON JR, 1987, LANCET, V1, P361; Centers for Disease Control (CDC), 1989, MMWR Suppl, V38, P1; CHALMERS TC, 1986, JUL NAT I HLTH CONS; CLARK SJ, 1991, NEW ENGL J MED, V324, P954, DOI 10.1056/NEJM199104043241404; COMMBS RW, 1987, 27TH INT C ANT AG CH; COOMBS RW, 1989, NEW ENGL J MED, V321, P1626, DOI 10.1056/NEJM198912143212402; CUMMING PD, 1989, NEW ENGL J MED, V321, P941, DOI 10.1056/NEJM198910053211405; DICKOVER RE, 1990, J CLIN MICROBIOL, V28, P2130, DOI 10.1128/JCM.28.9.2130-2133.1990; DONAHUE JG, 1990, NEW ENGL J MED, V323, P1709; EDWARDS VM, 1989, AM J CLIN PATHOL, V91, P75, DOI 10.1093/ajcp/91.1.75; EPSTEIN J, 1991, 33RD M BLOOD PROD AD; ESTEBAN JI, 1985, LANCET, V2, P1083; FARZADEGAN H, 1988, ANN INTERN MED, V108, P785, DOI 10.7326/0003-4819-108-6-785; FISCHL MA, 1987, NEW ENGL J MED, V317, P185, DOI 10.1056/NEJM198707233170401; FORSTER SM, 1987, AIDS, V1, P235; FURLINI G, 1989, J MED VIROL, V28, P129, DOI 10.1002/jmv.1890280303; GAINES H, 1987, LANCET, V1, P1317; GENESCA J, 1989, LANCET, V2, P1023; GOLDSTEIN LC, 1987, TRANSFUSION, V27, P542; GOUDSMIT J, 1987, J INFECT DIS, V155, P558, DOI 10.1093/infdis/155.3.558; HARRIS C, 1983, NEW ENGL J MED, V308, P1181, DOI 10.1056/NEJM198305193082001; HEWLETT IK, 1990, J ACQ IMMUN DEF SYND, V3, P714; HEWLETT IK, 1988, J CLIN IMMUNOASSAY, V11, P161; HO DD, 1989, NEW ENGL J MED, V321, P1621, DOI 10.1056/NEJM198912143212401; HOLODNIY M, 1991, J INFECT DIS, V163, P862, DOI 10.1093/infdis/163.4.862; HORSBURGH CR, 1989, LANCET, V2, P637; HORSBURGH CR, 1990, J INFECT DIS, V162, P542, DOI 10.1093/infdis/162.2.542; IMAGAWA DT, 1989, NEW ENGL J MED, V320, P1458, DOI 10.1056/NEJM198906013202205; IRANI MS, 1991, NEW ENGL J MED, V325, P1174, DOI 10.1056/NEJM199110173251613; JACKSON JB, 1989, TRANSFUSION, V29, P265, DOI 10.1046/j.1537-2995.1989.29389162735.x; JACKSON JB, 1990, NEW ENGL J MED, V322, P217, DOI 10.1056/NEJM199001253220402; JACKSON JB, 1988, J CLIN MICROBIOL, V26, P1416, DOI 10.1128/JCM.26.7.1416-1418.1988; JASON J, 1989, J INFECT DIS, V160, P789, DOI 10.1093/infdis/160.5.789; JASON JM, 1986, JAMA-J AM MED ASSOC, V255, P212, DOI 10.1001/jama.255.2.212; JEHUDACOHEN T, 1990, P NATL ACAD SCI USA, V87, P3972, DOI 10.1073/pnas.87.10.3972; JOHNSON AM, 1988, AIDS, V2, P369, DOI 10.1097/00002030-198810000-00006; KLEINMAN S, 1988, TRANSFUSION, V28, P280, DOI 10.1046/j.1537-2995.1988.28388219161.x; KLEINMAN SH, 1989, TRANSFUSION, V29, P572, DOI 10.1046/j.1537-2995.1989.29789369672.x; LANGE JMA, 1986, BRIT MED J, V293, P1459, DOI 10.1136/bmj.293.6560.1459; LEE TH, 1991, AIDS, V5, P1201, DOI 10.1097/00002030-199110000-00008; LEFRERE JJ, 1990, LANCET, V335, P1400, DOI 10.1016/0140-6736(90)91277-H; LEFRERE JJ, 1990, LANCET, V336, P1386, DOI 10.1016/0140-6736(90)92947-G; LEFRERE JJ, 1991, TRANSFUSION, V31, P205, DOI 10.1046/j.1537-2995.1991.31391165168.x; LEITMAN SF, 1989, NEW ENGL J MED, V321, P917, DOI 10.1056/NEJM198910053211401; LEOUNG GS, 1990, NEW ENGL J MED, V323, P769, DOI 10.1056/NEJM199009203231201; LIFSON A, 1989, 5TH INT C AIDS MONTR; LIFSON AR, 1990, J INFECT DIS, V161, P436, DOI 10.1093/infdis/161.3.436; LOCHE M, 1988, LANCET, V2, P418; MARIOTTI M, 1990, AIDS, V4, P633, DOI 10.1097/00002030-199007000-00004; MOORE JP, 1989, AIDS, V3, P155, DOI 10.1097/00002030-198903000-00006; MUUL LM, 1990, J CELL BIOCH, V108; PARKMAN PD, 1990, USE GENETIC SYSTEMS; PAUL DA, 1987, J MED VIROL, V22, P357, DOI 10.1002/jmv.1890220408; PEZZELLA M, 1989, BRIT MED J, V298, P713, DOI 10.1136/bmj.298.6675.713; PIERCE GF, 1989, JAMA-J AM MED ASSOC, V261, P3434; ROGERS MF, 1989, NEW ENGL J MED, V320, P1649, DOI 10.1056/NEJM198906223202503; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SCHAEFER E, 1990, NATURE, V346, P687, DOI 10.1038/346687b0; SCHNITTMAN SM, 1990, ANN INTERN MED, V113, P438, DOI 10.7326/0003-4819-113-6-438; SCHNITTMAN SM, 1989, SCIENCE, V245, P305, DOI 10.1126/science.2665081; SCHOCHETMAN G, 1988, J INFECT DIS, V158, P1154, DOI 10.1093/infdis/158.6.1154; SCILLIAN JJ, 1989, BLOOD, V73, P2041; SHEPPARD HW, 1991, J ACQ IMMUN DEF SYND, V4, P277; SIMMONDS P, 1990, J VIROL, V64, P864, DOI 10.1128/JVI.64.2.864-872.1990; STRAMER SL, 1989, JAMA-J AM MED ASSOC, V262, P64, DOI 10.1001/jama.262.1.64; VANDERPOEL CL, 1989, VOX SANG, V56, P162; VOLBERDING PA, 1990, NEW ENGL J MED, V322, P941, DOI 10.1056/NEJM199004053221401; VONSYDOW M, 1988, BMJ-BRIT MED J, V296, P238, DOI 10.1136/bmj.296.6617.238; WARD JW, 1986, JAMA-J AM MED ASSOC, V256, P357, DOI 10.1001/jama.256.3.357; WARD JW, 1988, NEW ENGL J MED, V318, P473, DOI 10.1056/NEJM198802253180803; WINKELSTEIN W, 1990, ANN INTERN MED, V112, P797, DOI 10.7326/0003-4819-112-10-797; WOLINSKY SM, 1989, ANN INTERN MED, V111, P961, DOI 10.7326/0003-4819-111-12-961; 1989, ABBOTT LABORATORIES; 1989, GUIDELINES PREVENTIO; 1990, MMWR, V39, P380; 1990, MMWR, V39, P829; 1991, MMWR, V40, P21	93	56	56	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 27	1991	266	20					2861	2866		10.1001/jama.266.20.2861	http://dx.doi.org/10.1001/jama.266.20.2861			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GQ722	1942454				2022-12-28	WOS:A1991GQ72200035
J	RANGANATHAN, R; HARRIS, GL; STEVENS, CF; ZUKER, CS				RANGANATHAN, R; HARRIS, GL; STEVENS, CF; ZUKER, CS			A DROSOPHILA MUTANT DEFECTIVE IN EXTRACELLULAR CALCIUM-DEPENDENT PHOTORECEPTOR DEACTIVATION AND RAPID DESENSITIZATION	NATURE			English	Article								CALCIUM is involved in the adaptation of vertebrate photoreceptors to light 1,2 and may have a similar role in invertebrate phototransduction 3,4. But the molecular mechanisms mediating this stimulus-dependent regulation are not well understood in any G protein-coupled transduction system. We have developed a preparation of isolated Drosophila photoreceptors that has allowed us to carry out an electrophysiological characterization of the light-activated response in these sensory neurons using patch-clamp techniques. We report here that extracellular calcium entering through the light-activated conductance is a key regulator of both the activation and deactivation phases of the phototransduction cascade, and that inaC mutant photoreceptors 5 are specifically defective in the calcium-dependent deactivation mechanism. These data suggest that the light-dependent calcium influx inactivates this cascade through a biochemical pathway that requires the inaC gene product, and that this mechanism represents a molecular basis for stimulus-dependent regulation of visual transduction in Drosophila photoreceptors.	UNIV CALIF SAN DIEGO, HOWARD HUGHES MED INST, LA JOLLA, CA 92093 USA; UNIV CALIF SAN DIEGO, DEPT BIOL, LA JOLLA, CA 92093 USA; UNIV CALIF SAN DIEGO, DEPT NEUROSCI, LA JOLLA, CA 92093 USA; SALK INST BIOL STUDIES, LA JOLLA, CA 92093 USA; SAN DIEGO STATE UNIV, DEPT BIOL, SAN DIEGO, CA 92182 USA; SAN DIEGO STATE UNIV, INST MOLEC BIOL, SAN DIEGO, CA 92182 USA	Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Salk Institute; California State University System; San Diego State University; California State University System; San Diego State University								BAINBRIDGE SP, 1981, J EMBRYOL EXP MORPH, V66, P57; BROWN JE, 1974, J GEN PHYSIOL, V64, P643, DOI 10.1085/jgp.64.6.643; DIZHOOR AM, 1991, SCIENCE, V251, P915, DOI 10.1126/science.1672047; FAIN GL, 1990, TRENDS NEUROSCI, V13, P378, DOI 10.1016/0166-2236(90)90023-4; FEIN A, 1975, SCIENCE, V187, P1094, DOI 10.1126/science.1114339; Fein A., 1989, P173; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HARDIE RC, 1991, NEURON, V6, P477, DOI 10.1016/0896-6273(91)90255-X; HARDIE RC, 1983, PROGR SENSORY PHYSL, P1; HENGSTEN, 1967, KYBERNETIK, V3, P276; HORN R, 1988, J GEN PHYSIOL, V92, P145, DOI 10.1085/jgp.92.2.145; KAWAMURA S, 1991, NATURE, V349, P420, DOI 10.1038/349420a0; KOCH KW, 1988, NATURE, V334, P64, DOI 10.1038/334064a0; KOENIG JH, 1977, DROSOPHILA INFORMATI, V52, P50; LAMBRECHT HG, 1991, EMBO J, V10, P793, DOI 10.1002/j.1460-2075.1991.tb08011.x; LISMAN JE, 1972, J GEN PHYSIOL, V59, P701, DOI 10.1085/jgp.59.6.701; MATTHEWS HR, 1988, NATURE, V334, P67, DOI 10.1038/334067a0; NAKATANI K, 1988, NATURE, V334, P69, DOI 10.1038/334069a0; OTOUSA JE, 1985, CELL, V40, P839, DOI 10.1016/0092-8674(85)90343-5; Pak W.L., 1979, P67; PAK WL, 1975, HDB GENETICS, P703; PAYNE R, 1986, PHOTOBIOCH PHOTOBIOP, V13, P373; PAYNE R, 1986, J GEN PHYSIOL, V88, P127, DOI 10.1085/jgp.88.1.127; PUGH EN, 1990, VISION RES, V30, P1923, DOI 10.1016/0042-6989(90)90013-B; RUBIN LJ, 1985, BIOPHYS J, V47, P38; TOMLINSON A, 1988, DEVELOPMENT, V104, P183; TSIEN RY, 1980, BIOCHEMISTRY-US, V19, P2396, DOI 10.1021/bi00552a018; ZUKER CS, 1985, CELL, V40, P851, DOI 10.1016/0092-8674(85)90344-7	28	164	165	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 21	1991	354	6350					230	232		10.1038/354230a0	http://dx.doi.org/10.1038/354230a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ948	1961249				2022-12-28	WOS:A1991GQ94800049
J	WASHINGTON, AE; ARAL, SO; WOLNERHANSSEN, P; GRIMES, DA; HOLMES, KK				WASHINGTON, AE; ARAL, SO; WOLNERHANSSEN, P; GRIMES, DA; HOLMES, KK			ASSESSING RISK FOR PELVIC INFLAMMATORY DISEASE AND ITS SEQUELAE	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CHLAMYDIA-TRACHOMATIS INFECTION; SEXUALLY-TRANSMITTED DISEASES; ORAL-CONTRACEPTIVE USE; INTRAUTERINE-DEVICE; TUBAL INFERTILITY; UNITED-STATES; CIGARETTE-SMOKING; ECTOPIC PREGNANCY; CLINICAL-TRIAL; BARRIER-METHOD	To assess the risk for pelvic inflammatory disease (PID), a practitioner must evaluate the likelihood that a woman has PID or will be exposed to a sexually transmitted disease causing PID. Successful risk assessment depends on accurate information about variables influencing risk of PID. To determine the current state of knowledge about PID risk variables, we examined data in published reports. Data on each risk variable were scrutinized to discern which link(s) in the PID risk chain it affects (acquisition of a sexually transmitted disease, development of PID, or development of PID sequelae) and whether it is a risk marker or a risk factor. Most PID risk variables, particularly sexual behaviors, are associated with acquisition of a sexually transmitted disease, rather than development of PID itself. With the exception of age, demographic and social indicators of risk appear to be risk markers, while contraceptive practices appear more often to be risk factors than risk markers. Additional data are needed for most PID risk variables confidently to categorize them as risk factors. Enough information is available, however, to begin assessing risk for PID, so that appropriate counseling can ensue and timely diagnosis can be made.	CTR DIS CONTROL,DIV SEXUALLY TRANSMITTED DIS HIV PREVENT,ATLANTA,GA 30333; LUND UNIV,DEPT OBSTET & GYNECOL,S-22101 LUND,SWEDEN; UNIV SO CALIF,SCH MED,DEPT OBSTET & GYNECOL,LOS ANGELES,CA 90033; UNIV WASHINGTON,CTR AIDS & SEXUALLY TRANSMITTED DIS,SEATTLE,WA 98195	Centers for Disease Control & Prevention - USA; Lund University; University of Southern California; University of Washington; University of Washington Seattle	WASHINGTON, AE (corresponding author), UNIV CALIF SAN FRANCISCO,SCH MED,CTR REPROD HLTH POLICY RES,1388 SUTTER ST,11TH FLOOR,SAN FRANCISCO,CA 94143, USA.		, Holmes/K-6215-2019		NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI024768] Funding Source: NIH RePORTER; NIAID NIH HHS [AI24768] Funding Source: Medline; PHS HHS [282-88-0018] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		[Anonymous], 1989, GUIDE CLIN PREVENTIV; ARAL SO, 1985, AM J PUBLIC HEALTH, V75, P1216, DOI 10.2105/AJPH.75.10.1216; ARAL SO, 1991, JAMA-J AM MED ASSOC, V266, P2570, DOI 10.1001/jama.266.18.2570; ARAL SO, 1990, SEXUALLY TRANSMITTED, P19; ARYA OP, 1981, BRIT J VENER DIS, V57, P118; AUSTIN H, 1984, JAMA-J AM MED ASSOC, V251, P2822, DOI 10.1001/jama.251.21.2822; BEATON JH, 1984, INT J FERTIL, V29, P109; BELL TA, 1984, SEX TRANSM DIS, V11, P291, DOI 10.1097/00007435-198410000-00005; CATES W, 1990, EPIDEMIOL REV, V12, P199, DOI 10.1093/oxfordjournals.epirev.a036054; CHOW JM, 1990, JAMA-J AM MED ASSOC, V263, P3164, DOI 10.1001/jama.263.23.3164; CHOW WH, 1988, OBSTET GYNECOL, V71, P167; CHOW WH, 1985, AM J OBSTET GYNECOL, V153, P727, DOI 10.1016/0002-9378(85)90332-1; CRAMER DW, 1987, JAMA-J AM MED ASSOC, V257, P2446, DOI 10.1001/jama.257.18.2446; CRAMER DW, 1985, NEW ENGL J MED, V312, P941, DOI 10.1056/NEJM198504113121502; CROMER BA, 1987, SEX TRANSM DIS, V14, P125, DOI 10.1097/00007435-198707000-00001; DALING JR, 1985, NEW ENGL J MED, V312, P937, DOI 10.1056/NEJM198504113121501; DALING JR, 1986, SEX TRANSM DIS, V13, P16, DOI 10.1097/00007435-198601000-00004; DAN BB, 1990, JAMA-J AM MED ASSOC, V263, P3191; DARROW WW, 1989, SEX TRANSM DIS, V16, P157, DOI 10.1097/00007435-198907000-00008; EDWARDS WM, 1973, J REPROD MED, V11, P81; EGENOLF GF, 1956, OBSTET GYNECOL, V7, P23; FORREST KA, 1989, J NATL MED ASSOC, V81, P159; FULLILOVE RE, 1990, JAMA-J AM MED ASSOC, V263, P851, DOI 10.1001/jama.263.6.851; GLYNN R, 1963, OBSTET GYNECOL, V2, P640; GRIMES DA, 1987, CONTRACEPTION, V36, P97, DOI 10.1016/0010-7824(87)90063-1; GRIMES DA, 1990, SEXUALLY TRANSMITTED, P1087; HARRISON HR, 1985, AM J OBSTET GYNECOL, V153, P244, DOI 10.1016/S0002-9378(85)80105-8; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; HOBSON D, 1980, BRIT J VENER DIS, V56, P156; JUDSON FN, 1989, SEX TRANSM DIS, V16, P51, DOI 10.1097/00007435-198904000-00001; KARNAKY KJ, 1947, PRACTICAL OFFICE GYN, P106; KATZ BP, 1988, SEX TRANSM DIS, V15, P11, DOI 10.1097/00007435-198801000-00003; KELAGHAN J, 1982, JAMA-J AM MED ASSOC, V248, P184, DOI 10.1001/jama.248.2.184; KESSEL E, 1989, FERTIL STERIL, V51, P1; LEE NC, 1988, OBSTET GYNECOL, V72, P1; LEE NC, 1983, OBSTET GYNECOL, V62, P1; LIMSUWAN A, 1978, J MED ASS THAI, V61, P485; LOUV WC, 1988, J INFECT DIS, V158, P518, DOI 10.1093/infdis/158.3.518; MARCHBANKS PA, 1990, AM J OBSTET GYNECOL, V162, P639, DOI 10.1016/0002-9378(90)90973-B; MASLOW AS, 1988, AM J OBSTET GYNECOL, V159, P1006, DOI 10.1016/S0002-9378(88)80189-3; MCGOWAN L, 1965, AM J OBSTET GYNECOL, V93, P506, DOI 10.1016/0002-9378(65)90507-7; MCGREGOR JA, 1985, 6TH INT M INT SOC ST; MONIF GRG, 1980, AM J OBSTET GYNECOL, V137, P432, DOI 10.1016/0002-9378(80)91123-0; NEUMANN HH, 1976, NEW ENGL J MED, V295, P789; NEWTON W, 1985, J REPROD MED, V30, P82; ORDUNA BC, 1980, POLK COUNTY MED B, V51, P79; PADIAN N, 1990, SEX TRANSM DIS, V17, P200, DOI 10.1097/00007435-199010000-00010; PASLEY JN, 1985, SEX TRANSM DIS, V12, P155, DOI 10.1097/00007435-198507000-00012; PESSIONE F, 1988, SEX TRANSM DIS, V15, P119, DOI 10.1097/00007435-198804000-00012; PHIPPS WR, 1987, FERTIL STERIL, V48, P377; RANK RG, 1987, INFECT IMMUN, V55, P2317, DOI 10.1128/IAI.55.9.2317-2319.1987; ROLFS RT, 1990, SEP JOINT M CTR DIS; ROSENBERG MJ, 1987, JAMA-J AM MED ASSOC, V257, P2308, DOI 10.1001/jama.257.17.2308; ROTHMAN KJ, 1986, MODERN EPIDEMIOLOGY, pCH2; SELORS J, 1991, AM J OBSTET GYNECOL, V164, P113; SENANAYAKE P, 1980, AM J OBSTET GYNECOL, V138, P852, DOI 10.1016/0002-9378(80)91070-4; SINEI SKA, 1990, BRIT J OBSTET GYNAEC, V97, P412, DOI 10.1111/j.1471-0528.1990.tb01828.x; STOCK RJ, 1973, OBSTET GYNECOL, V42, P141; STONE KM, 1986, AM J OBSTET GYNECOL, V155, P180, DOI 10.1016/0002-9378(86)90108-0; SWEET RL, 1986, JAMA-J AM MED ASSOC, V255, P2062, DOI 10.1001/jama.255.15.2062; TAIT IA, 1980, BRIT J VENER DIS, V56, P37; TATUM HJ, 1975, JAMA-J AM MED ASSOC, V231, P711, DOI 10.1001/jama.231.7.711; THELIN I, 1980, BRIT J VENER DIS, V56, P259; WASHINGTON AE, 1990, JAMA-J AM MED ASSOC, V264, P2072, DOI 10.1001/jama.1990.03450160040014; WASHINGTON AE, 1984, JAMA-J AM MED ASSOC, V251, P2529, DOI 10.1001/jama.251.19.2529; WASHINGTON AE, 1985, J ADOLESCENT HEALTH, V6, P298, DOI 10.1016/S0197-0070(85)80067-X; WASHINGTON AE, 1985, JAMA-J AM MED ASSOC, V253, P2246, DOI 10.1001/jama.253.15.2246; WESTROM L, 1985, Acta Europaea Fertilitatis, V16, P21; WESTROM L, 1990, SEXUALLY TRANSMITTED, P593; WOLNERHANSSEN P, 1990, JAMA-J AM MED ASSOC, V263, P1936, DOI 10.1001/jama.263.14.1936; WOLNERHANSSEN P, 1990, JAMA-J AM MED ASSOC, V264, P2073, DOI 10.1001/jama.1990.03450160040016; WOLNERHANSSEN P, 1990, JAMA-J AM MED ASSOC, V263, P54, DOI 10.1001/jama.263.1.54; 1986, POPULATION REPORT SE, V50, pL274; 1987, TECHNICAL REPORT SER, V753; 1988, MMWR-MORBID MORTAL W, V37, P133; 1990, NOV TEL S CHIC; 1979, STUDY EPIDEMIOLOGIC	77	77	78	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 13	1991	266	18					2581	2586		10.1001/jama.266.18.2581	http://dx.doi.org/10.1001/jama.266.18.2581			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GN660	1942404				2022-12-28	WOS:A1991GN66000035
J	BRUNDAGE, RA; FOGARTY, KE; TUFT, RA; FAY, FS				BRUNDAGE, RA; FOGARTY, KE; TUFT, RA; FAY, FS			CALCIUM GRADIENTS UNDERLYING POLARIZATION AND CHEMOTAXIS OF EOSINOPHILS	SCIENCE			English	Article							CYTOLYTIC T-CELLS; AEQUORIN LUMINESCENCE; CONTRACTILE BASIS; AMEBOID MOVEMENT; POLYMORPHONUCLEAR LEUKOCYTES; SEQUENTIAL ACTIVATION; LIVING FIBROBLASTS; ACTIN-FILAMENTS; MYOSIN-I; ENDOCYTOSIS	The concentration of intracellular free calcium ([Ca2+]i) in polarized eosinophils was imaged during chemotaxis by monitoring fluorescence of the calcium-sensitive dye Fura-2 with a modified digital imaging microscope. Chemotactic stimuli caused [Ca2+]i to increase in a nonuniform manner that was related to cell activity. In cells moving persistently in one direction, [Ca2+]i was highest at the rear and lowest at the front of the cell. Before cells turned, [Ca2+]i transiently increased. The region of the cell that became the new leading edge had the lowest [Ca2+]i. These changes in [Ca2+]i provide a basis for understanding the organization and local activity of cytoskeletal proteins thought to underlie the directed migration of many cells.			BRUNDAGE, RA (corresponding author), UNIV MASSACHUSETTS,SCH MED,DEPT PHYSIOL,BIOMED IMAGING GRP,PROGRAM MOLEC MED,WORCESTER,MA 01605, USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL014523, R01HL014523] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL14523] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BRAY D, 1988, SCIENCE, V239, P883, DOI 10.1126/science.3277283; BRUNDAGE RT, UNPUB; CASSIMERIS L, 1990, J CELL BIOL, V110, P1067, DOI 10.1083/jcb.110.4.1067; COLLINS K, 1990, J CELL BIOL, V110, P1137, DOI 10.1083/jcb.110.4.1137; FORSCHER P, 1988, J CELL BIOL, V107, P1505, DOI 10.1083/jcb.107.4.1505; FUKUI Y, 1989, NATURE, V341, P328, DOI 10.1038/341328a0; GRAY LS, 1988, J IMMUNOL, V141, P2424; KAMM KE, 1985, ANNU REV PHARMACOL, V25, P593, DOI 10.1146/annurev.pharmtox.25.1.593; KOONCE MP, 1984, J CELL BIOL, V98, P1999, DOI 10.1083/jcb.98.6.1999; KURODA K, 1988, PROTOPLASMA, V144, P64, DOI 10.1007/BF01320282; MARKS PW, 1990, J CELL BIOL, V110, P43, DOI 10.1083/jcb.110.1.43; MARKS PW, 1991, J CELL BIOL, V112, P149, DOI 10.1083/jcb.112.1.149; MCKENNA NM, 1989, J CELL BIOL, V109, P1163, DOI 10.1083/jcb.109.3.1163; MOORE EDW, 1990, CELL CALCIUM, V11, P157, DOI 10.1016/0143-4160(90)90068-6; POENIE M, 1987, EMBO J, V6, P2223, DOI 10.1002/j.1460-2075.1987.tb02494.x; POENIE M, 1990, CELL CALCIUM, V11, P85, DOI 10.1016/0143-4160(90)90062-Y; POZZAN T, 1983, SCIENCE, V221, P1413, DOI 10.1126/science.6310757; SAWYER DW, 1985, SCIENCE, V230, P663, DOI 10.1126/science.4048951; SCANLON M, 1987, J BIOL CHEM, V262, P6308; SMITH SJ, 1988, SCIENCE, V242, P708, DOI 10.1126/science.3055292; SNYDERMAN R, 1981, SCIENCE, V213, P830, DOI 10.1126/science.6266014; STOSSEL TP, 1985, ANNU REV CELL BIOL, V1, P353, DOI 10.1146/annurev.cb.01.110185.002033; TAYLOR DL, 1982, PHILOS T ROY SOC B, V299, P185, DOI 10.1098/rstb.1982.0125; TAYLOR DL, 1980, J CELL BIOL, V86, P599, DOI 10.1083/jcb.86.2.599; Trinkaus J.P., 1984, CELLS ORGANS; WANG Y, 1982, P NATL ACAD SCI-BIOL, V79, P4660, DOI 10.1073/pnas.79.15.4660; WANG YL, 1985, J CELL BIOL, V101, P597, DOI 10.1083/jcb.101.2.597; YIN HL, 1979, NATURE, V281, P583, DOI 10.1038/281583a0; ZIGMOND SH, 1978, J CELL BIOL, V77, P269, DOI 10.1083/jcb.77.2.269	29	239	243	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	NOV 1	1991	254	5032					703	706		10.1126/science.1948048	http://dx.doi.org/10.1126/science.1948048			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN474	1948048				2022-12-28	WOS:A1991GN47400039
J	MANIOTIS, A; SCHLIWA, M				MANIOTIS, A; SCHLIWA, M			MICROSURGICAL REMOVAL OF CENTROSOMES BLOCKS CELL REPRODUCTION AND CENTRIOLE GENERATION IN BSC-1 CELLS	CELL			English	Article							SEA-URCHIN EGGS; MICROTUBULE ORGANIZING CENTERS; HAMSTER OVARY CELLS; SPINDLE POLES; PROTEIN-SYNTHESIS; GOLGI-APPARATUS; MOUSE OOCYTES; BASAL BODIES; M-PHASE; CYCLE	We have removed the centrosome from cultured BSC-1 cells by microsurgery, leaving enough cytoplasm with the nucleated cell fragment (karyoplast) to ensure survival and growth. In each experiment, we followed the fate of the karyoplast as well as the anucleate cell fragment (cytoplast) containing the original pair of centrioles. Experimental karyoplasts reestablish a juxtanuclear microtubule-organizing center, an astral array of microtubules, and a compact Golgi apparatus. They enter and presumably complete S phase, and they grow beyond the size of an average BSC-1 cell. However, they do not regenerate centrioles in time periods equivalent to more than 10 cell cycles and do not undergo cell division. Control-operated cells with centrosomes left in the karyoplast progress through the cell cycle, duplicate the centrosome, and form clonal cell colonies. We conclude that the removal of centrioles uncouples cell growth from cell reproduction and impedes centriole biogenesis and centrosome duplication.	UNIV CALIF BERKELEY,DEPT MOLEC & CELL BIOL,BERKELEY,CA 94720	University of California System; University of California Berkeley								BAILLY E, 1989, EMBO J, V8, P3985, DOI 10.1002/j.1460-2075.1989.tb08581.x; Bornens M., 1984, MEMBRANE STRUCTURE F, P99; BOVERI T, 1988, Z NATURWISS, V22, P865; BRE MH, 1987, J CELL BIOL, V105, P1283, DOI 10.1083/jcb.105.3.1283; BRENNER S, 1977, J CELL BIOL, V72, P368, DOI 10.1083/jcb.72.2.368; CALARCOGILLAM PD, 1983, CELL, V35, P621, DOI 10.1016/0092-8674(83)90094-6; COOPER MS, 1990, CELL, V61, P135, DOI 10.1016/0092-8674(90)90221-Y; DEBEC A, 1982, BIOL CELL, V44, P133; DELOZANNE A, 1987, SCIENCE, V236, P1086, DOI 10.1126/science.3576222; DESSEV G, 1991, J CELL BIOL, V112, P523, DOI 10.1083/jcb.112.4.523; DIETZ R, 1966, CHROMOSOMES TODAY, V1, P161; DIPPELL RV, 1968, P NATL ACAD SCI USA, V61, P461, DOI 10.1073/pnas.61.2.461; DIRKSEN ER, 1961, J BIOPHYS BIOCHEM CY, V11, P244, DOI 10.1083/jcb.11.1.244; FULTON C, 1971, J CELL BIOL, V51, P826, DOI 10.1083/jcb.51.3.826; FULTON C, 1971, ORIGIN CONTINUITY CE, V1, P170; GARD DL, 1990, J CELL BIOL, V110, P2033, DOI 10.1083/jcb.110.6.2033; HALL JL, 1989, CELL, V59, P121, DOI 10.1016/0092-8674(89)90875-1; HEPLER PK, 1974, ANNU REV PLANT PHYS, V25, P309, DOI 10.1146/annurev.pp.25.060174.001521; JOHNSON DE, 1991, J CELL BIOL, V113, P339, DOI 10.1083/jcb.113.2.339; JOHNSON KA, 1990, CELL, V62, P615, DOI 10.1016/0092-8674(90)90105-N; KALLENBACH RJ, 1982, CELL BIOL INT REP, V6, P1025, DOI 10.1016/0309-1651(82)90018-2; KARSENTI E, 1984, J CELL BIOL, V98, P1763, DOI 10.1083/jcb.98.5.1763; KOCHANSKI RS, 1990, J CELL BIOL, V110, P1599, DOI 10.1083/jcb.110.5.1599; KREIS TE, 1990, CELL MOTIL CYTOSKEL, V15, P67, DOI 10.1002/cm.970150202; KURIYAMA R, 1981, J CELL BIOL, V91, P814, DOI 10.1083/jcb.91.3.814; KURIYAMA R, 1989, CELL MOTIL CYTOSKEL, V12, P90, DOI 10.1002/cm.970120204; KURIYAMA R, 1984, J CELL SCI, V66, P277; LAMB NJC, 1990, CELL, V60, P151, DOI 10.1016/0092-8674(90)90725-T; LEWIN B, 1990, CELL, V61, P743, DOI 10.1016/0092-8674(90)90181-D; LIPSKY NG, 1985, SCIENCE, V228, P745, DOI 10.1126/science.2581316; LUSCHER B, 1991, EMBO J, V10, P865, DOI 10.1002/j.1460-2075.1991.tb08019.x; LWOFF A, 1950, KINETOSOMES DEV REPR; MARO B, 1985, J CELL BIOL, V101, P1665, DOI 10.1083/jcb.101.5.1665; MAZIA D, 1960, J BIOPHYS BIOCHEM CY, V7, P1, DOI 10.1083/jcb.7.1.1; MAZIA D, 1987, INT REV CYTOL, V100, P49; MAZIA D, 1984, EXP CELL RES, V153, P1, DOI 10.1016/0014-4827(84)90442-7; MAZIA D, 1978, UCLA S MOL CELL BIOL, V12, P1; MCNIVEN MA, 1988, J CELL BIOL, V106, P1593, DOI 10.1083/jcb.106.5.1593; NIGG EA, 1985, CELL, V41, P1039, DOI 10.1016/S0092-8674(85)80084-2; NURSE P, 1990, NATURE, V344, P503, DOI 10.1038/344503a0; PHILLIPS SG, 1976, J CELL BIOL, V70, P9, DOI 10.1083/jcb.70.1.9; PICARD A, 1987, NATURE, V327, P170, DOI 10.1038/327170a0; Pickett-Heaps J.D., 1969, CYTOBIOS, V3, P257; PRESCOTT DM, 1956, EXP CELL RES, V11, P86, DOI 10.1016/0014-4827(56)90192-6; RAFF EC, 1979, INT REV CYTOL, V39, P2; RAFF JW, 1988, J CELL BIOL, V107, P2009, DOI 10.1083/jcb.107.6.2009; SCHATTEN H, 1986, P NATL ACAD SCI USA, V83, P105, DOI 10.1073/pnas.83.1.105; SCHLIWA M, 1981, J CELL BIOL, V90, P222, DOI 10.1083/jcb.90.1.222; SLUDER G, 1990, J CELL BIOL, V110, P2025, DOI 10.1083/jcb.110.6.2025; SLUDER G, 1989, CELL MOTIL CYTOSKEL, V13, P264, DOI 10.1002/cm.970130405; SLUDER G, 1985, J CELL SCI, V76, P35; SLUDER G, 1985, J CELL BIOL, V100, P887, DOI 10.1083/jcb.100.3.887; SLUDER G, 1990, ADV CELL BIOL, V3, P221; SONNEBORN TM, 1970, S INT SOC CELL BIOL, V9; Van Beneden E, 1876, B ACAD R BELG, V41, P1160; VANDRE DD, 1984, P NATL ACAD SCI-BIOL, V81, P4439, DOI 10.1073/pnas.81.14.4439; VERDE F, 1991, J CELL BIOL, V112, P1177, DOI 10.1083/jcb.112.6.1177; VOROBJEV IA, 1987, INT REV CYTOL, V106, P227, DOI 10.1016/S0074-7696(08)61714-3; WEISENBERG RC, 1984, J CELL BIOL, V99, P1527, DOI 10.1083/jcb.99.4.1527; WHEATLEY DN, 1982, CENTRIOLE CENTRAL EN; Wilson EB., 1925, CELL DEV HEREDITY, V3rd edition; YATSU N, 1905, J EXP ZOOL, V2, P289; ZORN GA, 1979, CELL, V18, P659, DOI 10.1016/0092-8674(79)90121-1	63	181	186	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	NOV 1	1991	67	3					495	504		10.1016/0092-8674(91)90524-3	http://dx.doi.org/10.1016/0092-8674(91)90524-3			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GN664	1934057				2022-12-28	WOS:A1991GN66400006
J	HOFFMAN, BJ; MEZEY, E; BROWNSTEIN, MJ				HOFFMAN, BJ; MEZEY, E; BROWNSTEIN, MJ			CLONING OF A SEROTONIN TRANSPORTER AFFECTED BY ANTIDEPRESSANTS	SCIENCE			English	Article							BRAIN GABA TRANSPORTER; BLOOD-PLATELETS; MEMBRANE-VESICLES; UPTAKE INHIBITOR; 5-HYDROXYTRYPTAMINE; EXPRESSION; SYSTEM; CDNA; <H-3>IMIPRAMINE; DISORDERS	A complementary DNA clone for a serotonin (5HT) transporter has been isolated from rat basophilic leukemia cells. The complementary DNA sequence predicts a 653-amino acid protein with 12 to 13 putative transmembrane domains. The 5HT transporter has significant homology to the gamma-aminobutyric acid, dopamine, and norepinephrine transporters. Uptake by CV-1 cells expressing the transporter complementary DNA resembles 5HT uptake by platelets and brain synaptosomes; it is sensitive to antidepressants, amphetamine derivatives, and cocaine.	SEMMELWEIS UNIV MED,SCH MED,DEPT ANAT 1,H-1085 BUDAPEST 8,HUNGARY	Semmelweis University	HOFFMAN, BJ (corresponding author), NIMH,CELL BIOL LAB,BETHESDA,MD 20892, USA.		Brownstein, Michael/B-8609-2009; Mezey, Eva/A-8105-2008	Mezey, Eva/0000-0002-5907-4691				AGHAJANIAN GK, 1967, J PHARMACOL EXP THER, V156, P23; ANDERSEN PH, 1989, EUR J PHARMACOL, V166, P493, DOI 10.1016/0014-2999(89)90363-4; AXELROD J, 1963, J PHARMACOL EXP THER, V141, P161; BLACKBURN K. J., 1967, LIFE SCI, V6, P1653, DOI 10.1016/0024-3205(67)90176-2; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; COOPER SJ, 1989, TRENDS PHARMACOL SCI, V10, P56, DOI 10.1016/0165-6147(89)90076-X; FUERST TR, 1987, MOL CELL BIOL, V7, P2538, DOI 10.1128/MCB.7.7.2538; FULLER RW, 1990, NEUROPHARMACOLOGY SE, V600, P68; GUASTELLA J, 1990, SCIENCE, V249, P1303, DOI 10.1126/science.1975955; GUBLER U, 1983, GENE, V25, P263, DOI 10.1016/0378-1119(83)90230-5; HOFFMAN BM, UNPUB; HYTTEL J, 1982, PROG NEURO-PSYCHOPH, V6, P277, DOI 10.1016/S0278-5846(82)80179-6; KANNER BI, 1985, BIOCHIM BIOPHYS ACTA, V816, P403, DOI 10.1016/0005-2736(85)90508-5; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; KUHAR MJ, 1978, J NEUROCHEM, V31, P251, DOI 10.1111/j.1471-4159.1978.tb12456.x; KUHAR MJ, 1972, J PHARMACOL-PARIS, V181, P36; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LANGER SZ, 1983, NEUROPHARMACOLOGY, V22, P407, DOI 10.1016/0028-3908(83)90190-9; LINGJAERDE O, 1971, ACTA PHYSIOL SCAND, V81, P75, DOI 10.1111/j.1748-1716.1971.tb04878.x; NELSON H, 1990, FEBS LETT, V269, P181, DOI 10.1016/0014-5793(90)81149-I; OKAYAMA H, 1987, METHOD ENZYMOL, V154, P3; PACHOLCZYK T, 1991, NATURE, V350, P350, DOI 10.1038/350350a0; PLETSCHER A, 1987, INT J CARDIOL, V14, P177, DOI 10.1016/0167-5273(87)90007-6; RICUARTE G, 1985, SCIENCE, V229, P986; RITZ MC, 1989, J PHARMACOL EXP THER, V248, P1010; RUDNICK G, 1977, J BIOL CHEM, V252, P2170; SEED B, 1987, NATURE, V329, P840, DOI 10.1038/329840a0; Sneddon J M, 1973, Prog Neurobiol, V1, P151, DOI 10.1016/0301-0082(73)90019-1; STACEY RS, 1961, BRIT J PHARM CHEMOTH, V16, P284, DOI 10.1111/j.1476-5381.1961.tb01087.x; STAHL SM, 1977, ARCH GEN PSYCHIAT, V34, P509; USDIN T, IN PRESS P NATL ACAD; VONHEIJNE G, 1983, EUR J BIOCHEM, V133, P17; WHITE MK, 1989, NATURE, V340, P103, DOI 10.1038/340103b0; WOOD MD, 1986, NEUROPHARMACOLOGY, V25, P519, DOI 10.1016/0028-3908(86)90178-4	34	524	536	1	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	OCT 25	1991	254	5031					579	580		10.1126/science.1948036	http://dx.doi.org/10.1126/science.1948036			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GL799	1948036				2022-12-28	WOS:A1991GL79900053
J	MCAVOY, BR; RAZA, R				MCAVOY, BR; RAZA, R			CAN HEALTH-EDUCATION INCREASE UPTAKE OF CERVICAL SMEAR TESTING AMONG ASIAN WOMEN	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CYTOLOGY SCREENING-PROGRAM; CANCER; MORTALITY	Objectives-To determine the effects of three different methods of providing health education on the uptake of cervical smear testing among Asian women, and to evaluate the acceptability of different health education materials. Design-Prospective cohort study over one year of effects of written materials by post, personal visit to give written materials, and personal visit to show a video on the uptake of smear testing. Techniques included a personally administered questionnaire. Setting-Leicester, a city with a large Asian population. Subjects-737 randomly selected Asian women aged 18 to 52 who were not recorded on the central cytology laboratory's computer as ever having had a cervical smear test. 159 declined to participate or were not contactable. Interventions-Women were randomised into four groups: visited and shown a video (263), visited and shown a leaflet and fact sheet (219), posted a leaflet and fact sheet (131), not contacted at all (124). Main outcome measure-Cervical smear test recorded on computer within four months after intervention. Results-57 (37%, 26% of group) of the women visited and given leaflets and 80 (47%, 30% of group) shown the video attended for cervical smears. Only six (5%) of those who were not contacted and 14 (11%) of those sent leaflets had a smear test during the study. Conclusion-Health education interventions increased the uptake of cervical cytology among Asian women in Leicester who had never been tested. Personal visits were most effective irrespective of the health education materials used, but there was some evidence that home viewed videos may be particularly effective in one of the most hard to reach groups: Urdu speaking, Pakistani Moslems. Written translated materials sent by post were ineffective.	UNIV LEICESTER, DEPT COMMUNITY HLTH, GEN PRACTICE UNIT, LEICESTER LE2 7LX, W YORKSHIRE, ENGLAND	University of Leicester			Raza, Rizwan/B-4526-2012	Raza, Rizwan/0000-0003-0599-3630				ALLMAN ST, 1974, HLTH TRENDS, V6, P39; ANDERSON GH, 1988, BMJ-BRIT MED J, V296, P975, DOI 10.1136/bmj.296.6627.975; BAHL V, 1987, ASIAN MOTHER BABY CA; BALARAJAN R, 1984, BRIT MED J, V289, P1185, DOI 10.1136/bmj.289.6453.1185; Berrino F, 1986, IARC Sci Publ, P111; BOWLING A, 1989, BRIT MED J, V298, P545, DOI 10.1136/bmj.298.6673.545; CASSIDY M, 1988, RAISING ISSUES REV S; Chamberlain J, 1986, IARC Sci Publ, P161; CHAMBERLAIN J, 1984, BRIT MED J, V289, P853, DOI 10.1136/bmj.289.6449.853; CHISHOLM DK, 1984, BR J FAM PLANN, V10, P3; CHOYCE A, 1990, J EPIDEMIOL COMMUN H, V44, P52, DOI 10.1136/jech.44.1.52; Cohen J., 1977, STATISTICAL POWER AN, P179, DOI [10.1016/b978-0-12-179060-8.50011-6, DOI 10.1016/B978-0-12-179060-8.50011]; CRAMER DW, 1974, CANCER, V34, P2018, DOI 10.1002/1097-0142(197412)34:6<2018::AID-CNCR2820340621>3.0.CO;2-B; DONALDSON LJ, 1986, BRIT MED J, V293, P1079, DOI 10.1136/bmj.293.6554.1079; DONALDSON LJ, 1984, J EPIDEMIOL COMMUN H, V38, P203, DOI 10.1136/jech.38.3.203; EARDLEY A, 1985, SOC SCI MED, V20, P955, DOI 10.1016/0277-9536(85)90352-1; ELKIND AK, 1987, PUBLIC HEALTH, V101, P253, DOI 10.1016/S0033-3506(87)80076-8; ELLMAN R, 1984, J ROY COLL GEN PRACT, V34, P537; FRASER RC, 1982, J ROY COLL GEN PRACT, V32, P615; GATHERER A, 1979, MONOGRAPH HLTH ED CO, V2, P78; GEIRSSON G, 1986, IARC SCI PUBL, V76, P37; HAVELOCK CM, 1988, BRIT MED J, V297, P1384, DOI 10.1136/bmj.297.6660.1384; HOWARD J, 1987, SOC SCI MED, V24, P507, DOI 10.1016/0277-9536(87)90340-6; MACGREGOR JE, 1982, BRIT MED J, V284, P441, DOI 10.1136/bmj.284.6314.441; Matheson L M, 1985, Health Bull (Edinb), V43, P245; MCAVOY BR, 1988, HLTH TRENDS, V20, P11; PARKIN DM, 1984, B WORLD HEALTH ORGAN, V62, P163, DOI 10.1139/b84-027; PATERSON MEL, 1984, BRIT MED J, V289, P896, DOI 10.1136/bmj.289.6449.896; PETTERSSON F, 1982, TRENDS CANCER INCIDE, P293; WAHI PN, 1972, CANCER, V30, P720, DOI 10.1002/1097-0142(197209)30:3<720::AID-CNCR2820300320>3.0.CO;2-D; WALKER EM, 1983, BRIT J OBSTET GYNAEC, V90, P1087, DOI 10.1111/j.1471-0528.1983.tb06449.x; WARNER K, 1984, TRAINEE, V4, P112; 1982, 1982 IND COUNC MED R; 1988, SURVEY LEICESTER 198; 1987, OPCS FMI873 OFF POP, P4; 1986, CERVICAL CANCER SCRE, P1	36	63	63	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 6	1991	302	6780					833	836		10.1136/bmj.302.6780.833	http://dx.doi.org/10.1136/bmj.302.6780.833			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FF377	1958248	Green Published, Bronze			2022-12-28	WOS:A1991FF37700029
J	GONZALEZREYES, A; URQUIA, N; GEHRING, WJ; STRUHL, G; MORATA, G				GONZALEZREYES, A; URQUIA, N; GEHRING, WJ; STRUHL, G; MORATA, G			ARE CROSS-REGULATORY INTERACTIONS BETWEEN HOMEOTIC GENES FUNCTIONALLY SIGNIFICANT	NATURE			English	Article									UNIV BASEL,BIOCTR,CH-4056 BASEL,SWITZERLAND; COLUMBIA UNIV,HOWARD HUGHES MED INST,NEW YORK,NY 10032	University of Basel; Columbia University; Howard Hughes Medical Institute	GONZALEZREYES, A (corresponding author), UNIV AUTONOMA MADRID,CSIC,CTR BIOL MOLEC,CANTO BLANCO,E-28049 MADRID,SPAIN.		Gonzalez-Reyes, Acaimo/L-1993-2014	Gonzalez-Reyes, Acaimo/0000-0003-3048-0968; Morata, Gines/0000-0003-3274-5173				AKAM M, 1987, DEVELOPMENT, V101, P1; BEACHY PA, 1985, NATURE, V313, P545, DOI 10.1038/313545a0; BEACHY PA, 1988, CELL, V55, P1069, DOI 10.1016/0092-8674(88)90251-6; BIENZ M, 1988, NATURE, V333, P576, DOI 10.1038/333576a0; CARROLL SB, 1986, CELL, V47, P113, DOI 10.1016/0092-8674(86)90372-7; CHADWICK R, 1987, EMBO J, V6, P779, DOI 10.1002/j.1460-2075.1987.tb04820.x; GEHRING WJ, 1986, ANNU REV GENET, V20, P147, DOI 10.1146/annurev.ge.20.120186.001051; GIBSON G, 1988, DEVELOPMENT, V102, P657; HAFEN E, 1984, NATURE, V307, P287, DOI 10.1038/307287a0; KRASNOW MA, 1989, CELL, V57, P1031, DOI 10.1016/0092-8674(89)90341-3; KUZIORA MA, 1988, CELL, V55, P477, DOI 10.1016/0092-8674(88)90034-7; LEMOTTE PK, 1989, EMBO J, V8, P219, DOI 10.1002/j.1460-2075.1989.tb03367.x; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; MAHAFFEY JW, 1989, DEVELOPMENT, V105, P167; MARTINEZARIAS A, 1985, NATURE, V313, P639, DOI 10.1038/313639a0; MLODZIK M, 1988, EMBO J, V7, P2569, DOI 10.1002/j.1460-2075.1988.tb03106.x; MULLER M, 1988, EMBO J, V7, P4299, DOI 10.1002/j.1460-2075.1988.tb03328.x; PEIFER M, 1987, GENE DEV, V1, P891, DOI 10.1101/gad.1.9.891; REGULSKI M, 1987, EMBO J, V6, P767, DOI 10.1002/j.1460-2075.1987.tb04819.x; SANCHEZHERRERO E, 1985, NATURE, V313, P108, DOI 10.1038/313108a0; SCHNEUWLY S, 1987, NATURE, V325, P816, DOI 10.1038/325816a0; STRUHL G, 1983, J EMBRYOL EXP MORPH, V76, P297; STRUHL G, 1982, P NATL ACAD SCI-BIOL, V79, P7380, DOI 10.1073/pnas.79.23.7380; STRUHL G, 1981, NATURE, V293, P36, DOI 10.1038/293036a0; STRUHL G, 1989, NATURE, V338, P741, DOI 10.1038/338741a0; STRUHL G, 1985, CELL, V43, P507, DOI 10.1016/0092-8674(85)90180-1; WAKIMOTO BT, 1981, DEV BIOL, V81, P51, DOI 10.1016/0012-1606(81)90347-X; WIRZ J, 1986, EMBO J, V5, P3327, DOI 10.1002/j.1460-2075.1986.tb04647.x	28	123	124	0	5	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	MAR 1	1990	344	6261					78	80		10.1038/344078a0	http://dx.doi.org/10.1038/344078a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ972	1968232				2022-12-28	WOS:A1990CQ97200068
J	BRAHAMS, D				BRAHAMS, D			JUDICIAL WARNING ON VERY LATE ABORTIONS	LANCET			English	Editorial Material																		BRAHAMS D, 1989, LANCET, V1, P969; BRAHAMS D, 1987, LANCET, V1, P576	2	3	3	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	FEB 24	1990	335	8687					464	464		10.1016/0140-6736(90)90685-X	http://dx.doi.org/10.1016/0140-6736(90)90685-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CP907	1968181				2022-12-28	WOS:A1990CP90700016
J	CROSS, NCP; DEFRANCHIS, R; SEBASTIO, G; DAZZO, C; TOLAN, DR; GREGORI, C; ODIEVRE, M; VIDAILHET, M; ROMANO, V; MASCALI, G; ROMANO, C; MUSUMECI, S; STEINMANN, B; GITZELMANN, R; COX, TM				CROSS, NCP; DEFRANCHIS, R; SEBASTIO, G; DAZZO, C; TOLAN, DR; GREGORI, C; ODIEVRE, M; VIDAILHET, M; ROMANO, V; MASCALI, G; ROMANO, C; MUSUMECI, S; STEINMANN, B; GITZELMANN, R; COX, TM			MOLECULAR ANALYSIS OF ALDOLASE-B GENES IN HEREDITARY FRUCTOSE INTOLERANCE	LANCET			English	Article									INST MOLEC PATHOL,PARIS,FRANCE; HOP ANTOINE BECLERE,CLAMART,FRANCE; UNIV CATANIA,INST RES MENTAL RETARDAT & CEREBRAL DEV,I-95124 CATANIA,ITALY; ROYAL POSTGRAD MED SCH,DEPT HAEMATOL,LONDON W12 0HS,ENGLAND; ROYAL POSTGRAD MED SCH,DEPT MED,LONDON W12 0HS,ENGLAND; NAPLES UNIV,DEPT PAEDIAT,I-80138 NAPLES,ITALY; BOSTON UNIV,CTR BIOL SCI,BOSTON,MA 02215; CTR HOSP REG UNIV NANCY,VANDOEUVRE NANCY,FRANCE; UNIV CATANIA,DEPT PAEDIAT,I-95124 CATANIA,ITALY; UNIV ZURICH,DEPT PAEDIAT,CH-8006 ZURICH,SWITZERLAND	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Antoine-Beclere - APHP; University of Catania; Imperial College London; Imperial College London; University of Naples Federico II; Boston University; CHU de Nancy; University of Catania; University of Zurich			Romano, Corrado/B-9695-2008; Cross, Nicholas/B-4817-2009; Scavuzzo, Cataldo/D-5048-2017	Romano, Corrado/0000-0003-1049-0683; Cross, Nicholas/0000-0001-5481-2555; Tolan, Dean/0000-0002-0598-7241; Romano, Valentino/0000-0003-3238-5702; Scavuzzo, Cataldo/0000-0002-3905-4191				CHAMBERS RA, 1956, LANCET, V2, P340; COX TM, 1982, NEW ENGL J MED, V307, P537, DOI 10.1056/NEJM198208263070906; CROSS NCP, 1988, CELL, V53, P881, DOI 10.1016/S0092-8674(88)90349-2; CROSS NCP, 1989, Q J MED, V73, P1015; Diem K, 1970, DOCUMENTA GEIGY SCI, P85; FOULKES N, 1988, NUCLEIC ACIDS RES, V239, P487; Gitzelmann R, 1989, METABOLIC BASIS INHE, P399; Gitzelmann R, 1973, PADIATR FORTBILDK PR, V37, P40; GYLLENSTEN UB, 1988, P NATL ACAD SCI USA, V85, P7652, DOI 10.1073/pnas.85.20.7652; HERS H. G., 1961, ENZYMOL BIOL ET CLIN, V1, P4; KELLEY PM, 1986, PLANT PHYSIOL, V82, P1076, DOI 10.1104/pp.82.4.1076; LENCH N, 1988, LANCET, V1, P1356; MOCK DM, 1982, NEW ENGL J MED, V309, P764; OBERHAENSLI RD, 1987, LANCET, V2, P931; ODIEVRE M, 1978, AM J DIS CHILD, V132, P605, DOI 10.1001/archpedi.1978.02120310069014; ROSE IA, 1969, J BIOL CHEM, V244, P126; SAIKI RK, 1989, P NATL ACAD SCI USA, V86, P6230, DOI 10.1073/pnas.86.16.6230; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SCHULTE MJ, 1977, LANCET, V2, P188; STEINMANN B, 1981, HELV PAEDIATR ACTA, V36, P297; SYGUSCH J, 1987, P NATL ACAD SCI USA, V84, P7846, DOI 10.1073/pnas.84.22.7846; SYKES BC, 1983, LANCET, V2, P787; TOLAN DR, 1986, MOL BIOL MED, V3, P245	23	88	92	1	8	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	FEB 10	1990	335	8685					306	309		10.1016/0140-6736(90)90603-3	http://dx.doi.org/10.1016/0140-6736(90)90603-3			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CM846	1967768				2022-12-28	WOS:A1990CM84600002
J	WHITEHEAD, MI; FRASER, D; SCHENKEL, L; CROOK, D; STEVENSON, JC				WHITEHEAD, MI; FRASER, D; SCHENKEL, L; CROOK, D; STEVENSON, JC			TRANSDERMAL ADMINISTRATION OF ESTROGEN PROGESTAGEN HORMONE REPLACEMENT THERAPY	LANCET			English	Article									WYNN INST METAB RES LONDON, LONDON, ENGLAND; CIBA GEIGY AG, CH-4002 BASEL, SWITZERLAND	Imperial College London; Novartis	WHITEHEAD, MI (corresponding author), KINGS COLL, SCH MED, ACAD DEPT OBSTET & GYNAECOL, MENOPAUSE CLIN, DENMARK HILL, LONDON SE5 8RX, ENGLAND.			Crook, David/0000-0002-9587-3730				BUSH TL, 1987, CIRCULATION, V75, P1102, DOI 10.1161/01.CIR.75.6.1102; CHETKOWSKI RJ, 1986, NEW ENGL J MED, V314, P1615, DOI 10.1056/NEJM198606193142505; FRASER D, 1989, BRIT J OBSTET GYNAEC, V96, P776, DOI 10.1111/j.1471-0528.1989.tb03315.x; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; GIDEZ LI, 1982, J LIPID RES, V23, P1206; JENSEN J, 1986, BRIT J OBSTET GYNAEC, V93, P613, DOI 10.1111/j.1471-0528.1986.tb08035.x; MOUNT JN, 1988, J CLIN PATHOL, V41, P471, DOI 10.1136/jcp.41.4.471; OTTOSSON UB, 1985, AM J OBSTET GYNECOL, V151, P746, DOI 10.1016/0002-9378(85)90509-5; PAGANINIHILL A, 1989, BRIT J CANCER, V59, P445, DOI 10.1038/bjc.1989.91; PERSSON I, 1989, BRIT MED J, V298, P147, DOI 10.1136/bmj.298.6667.147; PETERSON HB, 1986, MENOPAUSE PHYSL PHAR, P275; ROSS RK, 1986, MENOPAUSE PHYSL PHAR, P209; WARNICK GR, 1978, J LIPID RES, V19, P65; WHITEHEAD MI, 1987, OBSTET GYN CLIN N AM, V14, P299; WHITEHEAD MI, 1981, NEW ENGL J MED, V305, P1599, DOI 10.1056/NEJM198112313052701	15	76	77	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 10	1990	335	8685					310	312		10.1016/0140-6736(90)90605-5	http://dx.doi.org/10.1016/0140-6736(90)90605-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CM846	1967769				2022-12-28	WOS:A1990CM84600003
J	OKAMOTO, K; OKAZAWA, H; OKUDA, A; SAKAI, M; MURAMATSU, M; HAMADA, H				OKAMOTO, K; OKAZAWA, H; OKUDA, A; SAKAI, M; MURAMATSU, M; HAMADA, H			A NOVEL OCTAMER BINDING TRANSCRIPTION FACTOR IS DIFFERENTIALLY EXPRESSED IN MOUSE EMBRYONIC-CELLS	CELL			English	Article											OKAMOTO, K (corresponding author), UNIV TOKYO, FAC MED, DEPT BIOCHEM, 7-3-1 HONGO, BUNKYO KU, TOKYO 113, JAPAN.		Hamada, Hiroshi/N-6374-2015	Hamada, Hiroshi/0000-0002-7196-5948				BANDZIULIS RJ, 1989, GENE DEV, V3, P431, DOI 10.1101/gad.3.4.431; BHAT K, 1988, MOL CELL BIOL, V8, P3251, DOI 10.1128/MCB.8.8.3251; BODNER M, 1988, CELL, V55, P505, DOI 10.1016/0092-8674(88)90037-2; BRULET P, 1983, P NATL ACAD SCI-BIOL, V80, P5641, DOI 10.1073/pnas.80.18.5641; CHIU R, 1988, CELL, V54, P541, DOI 10.1016/0092-8674(88)90076-1; COUREY AJ, 1988, CELL, V55, P887, DOI 10.1016/0092-8674(88)90144-4; DESPLAN C, 1988, CELL, V54, P1081, DOI 10.1016/0092-8674(88)90123-7; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; EDWARDS MKS, 1983, MOL CELL BIOL, V3, P2280, DOI 10.1128/MCB.3.12.2280; FINNEY M, 1988, CELL, V55, P757, DOI 10.1016/0092-8674(88)90132-8; FLETCHER C, 1987, CELL, V51, P773, DOI 10.1016/0092-8674(87)90100-0; GARDNER RL, 1979, J EMBRYOL EXP MORPH, V52, P141; GORMAN CM, 1985, CELL, V42, P519, DOI 10.1016/0092-8674(85)90109-6; GUNNING P, 1987, P NATL ACAD SCI USA, V84, P4831, DOI 10.1073/pnas.84.14.4831; HAMADA H, 1986, MOL CELL BIOL, V6, P4179, DOI 10.1128/MCB.6.12.4179; HAMADA H, 1986, MOL CELL BIOL, V6, P4185, DOI 10.1128/MCB.6.12.4185; HATA A, 1989, FEBS LETT, V252, P144, DOI 10.1016/0014-5793(89)80907-X; HATA A, 1989, J BIOL CHEM, V264, P6404; HERR W, 1988, GENE DEV, V2, P1513, DOI 10.1101/gad.2.12a.1513; HOEY T, 1988, NATURE, V332, P858, DOI 10.1038/332858a0; HOPE IA, 1985, CELL, V43, P177, DOI 10.1016/0092-8674(85)90022-4; INGRAHAM HA, 1988, CELL, V55, P519, DOI 10.1016/0092-8674(88)90038-4; JONES KA, 1985, CELL, V42, P559, DOI 10.1016/0092-8674(85)90113-8; JONESVILLENEUVE EMV, 1983, MOL CELL BIOL, V3, P2271, DOI 10.1128/MCB.3.12.2271; KO HS, 1988, CELL, V55, P135, DOI 10.1016/0092-8674(88)90016-5; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; LANDSCHULZ WH, 1988, GENE DEV, V2, P786, DOI 10.1101/gad.2.7.786; LENARDO MJ, 1989, SCIENCE, V243, P544, DOI 10.1126/science.2536195; LEVINE M, 1988, CELL, V55, P537, DOI 10.1016/0092-8674(88)90209-7; Maniatis T., 1982, MOL CLONING; MCBURNEY MW, 1982, DEV BIOL, V89, P503, DOI 10.1016/0012-1606(82)90338-4; MERMOD N, 1989, CELL, V58, P741, DOI 10.1016/0092-8674(89)90108-6; MITCHELL PJ, 1989, SCIENCE, V245, P371, DOI 10.1126/science.2667136; MULLER MM, 1988, NATURE, V336, P544, DOI 10.1038/336544a0; NAKABEPPU Y, 1988, CELL, V55, P907, DOI 10.1016/0092-8674(88)90146-8; PROCHOWNIK EV, 1986, NATURE, V322, P848, DOI 10.1038/322848a0; Rudnicki M.A., 1987, TERATOCARCINOMAS EMB; SAKAI M, IN PRESS CANCER RES; SCHEIDEREIT C, 1988, NATURE, V336, P551, DOI 10.1038/336551a0; SCHEIDEREIT C, 1987, CELL, V51, P783, DOI 10.1016/0092-8674(87)90101-2; SCHOLER HR, 1989, EMBO J, V8, P2543, DOI 10.1002/j.1460-2075.1989.tb08392.x; SEN R, 1986, CELL, V46, P705, DOI 10.1016/0092-8674(86)90346-6; SIVE HL, 1986, P NATL ACAD SCI USA, V83, P6382, DOI 10.1073/pnas.83.17.6382; SONIGO P, 1987, P NATL ACAD SCI USA, V84, P3768, DOI 10.1073/pnas.84.11.3768; SORGER PK, 1988, CELL, V54, P855, DOI 10.1016/S0092-8674(88)91219-6; STURM RA, 1988, NATURE, V336, P601, DOI 10.1038/336601a0; STURM RA, 1988, GENE DEV, V2, P1582, DOI 10.1101/gad.2.12a.1582; XI H, 1989, NATURE, V340, P35, DOI 10.1038/340035a0	48	634	672	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 9	1990	60	3					461	472		10.1016/0092-8674(90)90597-8	http://dx.doi.org/10.1016/0092-8674(90)90597-8			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CP237	1967980				2022-12-28	WOS:A1990CP23700013
J	[Anonymous]				[Anonymous]			LIGNEOUS CONJUNCTIVITIS	LANCET			English	Editorial Material																		Bateman J B, 1986, J Pediatr Ophthalmol Strabismus, V23, P137; BERLIN AJ, 1982, OPHTHALMIC SURG LAS, V13, P288; Chambers J D, 1969, Trans Am Acad Ophthalmol Otolaryngol, V73, P996; COOPER TJ, 1979, CAN J OPHTHALMOL, V14, P57; FIRAT T, 1974, AM J OPHTHALMOL, V78, P679, DOI 10.1016/S0002-9394(14)76307-X; FRANCOIS J, 1968, AM J OPHTHALMOL, V65, P674, DOI 10.1016/0002-9394(68)94380-8; FRIMODTMOLLER J, 1973, ACTA OPHTHALMOL, V51, P34; HIDAYAT AA, 1987, OPHTHALMOLOGY, V94, P949; KANAI A, 1971, AM J OPHTHALMOL, V72, P909, DOI 10.1016/0002-9394(71)91687-4; MCGRAND JC, 1969, BRIT J OPHTHALMOL, V53, P373, DOI 10.1136/bjo.53.6.373; MELIKIAN HE, 1985, ANN OPHTHALMOL, V17, P763; RUBIN A, 1989, BRIT J OBSTET GYNAEC, V96, P1228, DOI 10.1111/j.1471-0528.1989.tb03202.x; TERVAERT DC, 1986, DOC OPHTHALMOL, V64, P5, DOI 10.1007/BF00166679	13	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 13	1990	335	8681					84	84						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CH516	1967424				2022-12-28	WOS:A1990CH51600010
J	LUCEY, MR; KOLARS, JC; MERION, RM; CAMPBELL, DA; ALDRICH, M; WATKINS, PB				LUCEY, MR; KOLARS, JC; MERION, RM; CAMPBELL, DA; ALDRICH, M; WATKINS, PB			CYCLOSPORINE TOXICITY AT THERAPEUTIC BLOOD-LEVELS AND CYTOCHROME-P-450 IIIA	LANCET			English	Article									UNIV MICHIGAN,MED CTR,DEPT INTERNAL MED,6510 D MSRBI,1150 W MED CTR DR,ANN ARBOR,MI 48109; UNIV MICHIGAN,MED CTR,DEPT NEUROL,ANN ARBOR,MI 48109; UNIV MICHIGAN,MED CTR,DEPT SURG,ANN ARBOR,MI 48109	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan			Lucey, Michael/AAR-4571-2020	Kolars, Joseph/0000-0002-2603-188X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038149, R37GM038149] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-38149] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANNESLEY T, 1986, CLIN CHEM, V32, P1407; ARGUS MF, 1978, J NATL CANCER I, V61, P441; BROSEN K, 1989, EUR J CLIN PHARMACOL, V36, P537, DOI 10.1007/BF00637732; COMBALBERT J, 1989, DRUG METAB DISPOS, V17, P197; CONNEY AH, 1986, LIFE SCI, V39, P2493, DOI 10.1016/0024-3205(86)90103-7; DEGROEN PC, 1987, NEW ENGL J MED, V317, P861, DOI 10.1056/NEJM198710013171404; GONZALEZ FJ, 1988, NATURE, V331, P442, DOI 10.1038/331442a0; GUENGERICH FP, 1986, J BIOL CHEM, V261, P5051; JACQZ E, 1986, HEPATOLOGY, V6, P1020, DOI 10.1002/hep.1840060534; KAHAN BD, 1988, TRANSPLANTATION, V46, P631, DOI 10.1097/00007890-198811000-00002; KOLARS JC, 1989, CLIN RES, V37, pA933; KRONBACH T, 1988, CLIN PHARMACOL THER, V43, P630, DOI 10.1038/clpt.1988.87; MAHGOUB A, 1977, LANCET, V2, P584, DOI 10.1016/S0140-6736(77)91430-1; MORGAN MY, 1984, GUT, V25, P1057, DOI 10.1136/gut.25.10.1057; NAOUMOV NV, 1989, GUT, V30, P391, DOI 10.1136/gut.30.3.391; RYFFEL B, 1988, TRANSPL P, V20, P575; SAWCHUK RJ, 1986, J PHARM SCI, V75, P1151, DOI 10.1002/jps.2600751207; SELYE H, 1971, J PHARM SCI, V60, P1, DOI 10.1002/jps.2600600102; WATKINS PB, 1987, J CLIN INVEST, V80, P1029, DOI 10.1172/JCI113156; WATKINS PB, 1985, P NATL ACAD SCI USA, V82, P6310, DOI 10.1073/pnas.82.18.6310; WATKINS PB, 1989, J CLIN INVEST, V83, P688, DOI 10.1172/JCI113933; WATKINS PB, IN PRESS BIOCH PHARM; WRIGHTON SA, 1987, J CLIN INVEST, V80, P1017, DOI 10.1172/JCI113154	23	144	146	0	1	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	JAN 6	1990	335	8680					11	15		10.1016/0140-6736(90)90137-T	http://dx.doi.org/10.1016/0140-6736(90)90137-T			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG766	1967328	Green Submitted			2022-12-28	WOS:A1990CG76600004
J	BERNAUER, W; GRATWOHL, A; KELLER, A; DAICKER, B				BERNAUER, W; GRATWOHL, A; KELLER, A; DAICKER, B			MICROVASCULOPATHY IN THE OCULAR FUNDUS AFTER BONE-MARROW TRANSPLANTATION	ANNALS OF INTERNAL MEDICINE			English	Article							MALIGNANT ARTERIAL-HYPERTENSION; RADIATION RETINOPATHY; AUTOIMMUNE-DISEASES; CYCLOSPORIN-A; HOST DISEASE; MANIFESTATIONS; RECIPIENTS; GRAFT; IRRADIATION; LEUKEMIA	Objective: To determine the incidence and time course of retinal and optic-disk ischemia after bone marrow transplantation and to describe the clinical, fluorescein-angiographic, and histologic findings in patients with these ischemic fundus lesions. Design: Prospective cohort study; standardized clinical and ophthalmologic evaluation of all patients before bone marrow transplantation and 3, 6, and 12 months after transplantation (and when indicated). Setting: University hospitals in Basel, Switzerland. Patients: Consecutive patients (127) treated with allogeneic or autologous bone marrow grafts. Main Results: Thirteen of the 127 patients (10%; 95% Cl, 5% to 15%) had lesions of the ocular microcirculation. All patients had cotton-wool spots in the fundus of both eyes, and three patients also had bilateral optic-disk edema. Secondary changes included retinal hemorrhages and lipid deposits. The ischemic fundus lesions appeared during the first 6 months after transplantation and were reversible in 9 of the 13 patients. The lesions occurred only in patients who were treated with total body irradiation and were given cyclosporin A as prophylaxis for graft-versus-host disease. Conclusions: Ischemic fundus lesions area frequent complication after bone marrow transplantation. They were only observed in patients treated with total body irradiation and cyclosporin A. This combination of therapy appears to have an additive effect on the development of ocular and possibly generalized microvascular lesions.	KANTONSSPITAL, DEPT INNERE MED & FORSCH, HAEMATOL ABT, PETERSGRABEN 4, CH-4031 BASEL, SWITZERLAND; UNIV BASEL, HOSP EYE, CH-4051 BASEL, SWITZERLAND	Kantonsspital Aarau AG (KSA); University of Basel								BERNAUER W, 1991, KLIN MONATSBL AUGENH, V198, P447, DOI 10.1055/s-2008-1046007; BINAGHI M, 1983, J FR OPHTALMOL, V6, P881; BLOOM JN, 1988, ANN INTERN MED, V109, P963, DOI 10.7326/0003-4819-109-12-963; BROWN GC, 1982, OPHTHALMOLOGY, V89, P1494; COCCIA PF, 1988, BLOOD, V71, P888; COHEN DJ, 1984, ANN INTERN MED, V101, P667, DOI 10.7326/0003-4819-101-5-667; DAICKER B, 1988, OPHTHALMOLOGICA, V197, P169, DOI 10.1159/000309939; DIETERLE A, 1990, TRANSPLANTATION, V49, P1093, DOI 10.1097/00007890-199006000-00013; DUKEELDER S, 1972, SYSTEM OPHTHALMOLOGY, P981; DUKEELDER S, 1967, SYSTEM OPHTHALMOLOGY, V10, P23; FRANKLIN RM, 1983, OPHTHALMOLOGY, V90, P4; FREY FJ, 1990, SCHWEIZ MED WSCHR, V120, P772; GLOOR B, 1985, BRIT J OPHTHALMOL, V69, P320, DOI 10.1136/bjo.69.5.320; GRATWHOL AA, 1977, ANN INTERN MED, V87, P703, DOI 10.7326/0003-4819-87-6-703; GRATWOHL A, 1986, PROG ALLERGY, V38, P404; GRATWOHL A, 1983, NEW ENGL J MED, V308, P1101; HAMILTON DV, 1982, TRANSPLANT P, V14, P597; HAYREH SS, 1989, OPHTHALMOLOGICA, V198, P197, DOI 10.1159/000309999; HAYREH SS, 1989, OPHTHALMOLOGICA, V198, P216, DOI 10.1159/000310000; HAYREH SS, 1986, OPHTHALMOLOGY, V93, P74; HAYREH SS, 1989, OPHTHALMOLOGICA, V198, P230, DOI 10.1159/000310001; HAYREH SS, 1989, OPHTHALMOLOGICA, V198, P178, DOI 10.1159/000309998; HIRST LW, 1983, ARCH OPHTHALMOL-CHIC, V101, P580, DOI 10.1001/archopht.1983.01040010580010; JABS DA, 1983, ARCH OPHTHALMOL-CHIC, V101, P585, DOI 10.1001/archopht.1983.01040010585011; JACK MK, 1983, ARCH OPHTHALMOL-CHIC, V101, P1080; JOSS DV, 1982, LANCET, V1, P906; KINYOUN JL, 1984, ARCH OPHTHALMOL-CHIC, V102, P1473; KINYOUN JL, 1988, AM J OPHTHALMOL, V105, P470, DOI 10.1016/0002-9394(88)90237-1; LEISHMAN R, 1957, Br J Ophthalmol, V41, P641, DOI 10.1136/bjo.41.11.641; LIVESEY SJ, 1989, EYE, V3, P271, DOI 10.1038/eye.1989.37; Merriam GR., 1972, FRONT RAD THER ONCOL, P346; MIHATSCH MJ, 1988, KLIN WOCHENSCHR, V66, P43, DOI 10.1007/BF01713009; NOLL RB, 1984, ARCH NEUROL-CHICAGO, V41, P329, DOI 10.1001/archneur.1984.04050150111026; NUSSENBLATT RB, 1986, SURV OPHTHALMOL, V31, P159, DOI 10.1016/0039-6257(86)90035-4; OECHSLIN M, 1986, TRANSPLANTATION, V41, P60, DOI 10.1097/00007890-198601000-00012; PALESTINE AG, 1984, AM J MED, V77, P652, DOI 10.1016/0002-9343(84)90356-5; PEPOSE JS, 1985, OPHTHALMOLOGY, V92, P472; PILLUNAT LE, 1987, KLIN MONATSBL AUGENH, V190, P131, DOI 10.1055/s-2008-1050344; POMERANTZ RJ, 1987, NEW ENGL J MED, V317, P1643, DOI 10.1056/NEJM198712243172607; SPECK B, 1988, TRANSPLANT P, V20, P505; Speck B, 1989, Clin Transpl, P115; VOGLER WR, 1990, BONE MARROW TRANSPL, V6, P405; WOLFE JA, 1986, TRANSPLANTATION, V41, P541	43	58	59	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 15	1991	115	12					925	930		10.7326/0003-4819-115-12-925	http://dx.doi.org/10.7326/0003-4819-115-12-925			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GU417	1952488				2022-12-28	WOS:A1991GU41700002
J	SEELEY, DG; BROWNER, WS; NEVITT, MC; GENANT, HK; SCOTT, JC; CUMMINGS, SR				SEELEY, DG; BROWNER, WS; NEVITT, MC; GENANT, HK; SCOTT, JC; CUMMINGS, SR			WHICH FRACTURES ARE ASSOCIATED WITH LOW APPENDICULAR BONE MASS IN ELDERLY WOMEN	ANNALS OF INTERNAL MEDICINE			English	Article						OSTEOPOROSIS, POSTMENOPAUSAL; FRACTURES; BONE DENSITY; GERIATRICS; WOMENS HEALTH	HIP FRACTURE; OSTEOPOROSIS; RISK	Objective: To determine which types of fractures have an increased incidence in elderly women with low appendicular bone mass. Design: Prospective cohort study. Setting: Four clinical centers in the United States (Baltimore, Maryland; Minneapolis, Minnesota; Portland, Oregon; Monangehela Valley, Pennsylvania); and one coordinating center in San Francisco, California. Subjects: Ambulatory, nonblack women (9704) aged 65 years or more who were recruited from population-based listings. Measurements: We measured bone mass at the distal and proximal radius and calcaneus using single-photon absorptiometry. Fractures were verified radiographically. Associations were calculated as age-adjusted hazard ratios (with 95% CIs) per standard deviation decrease in bone mass. Main Results: During a mean follow-up of 2.23 years, 841 nonspinal fractures occurred in 753 women. The risks for fractures of the wrist, foot, humerus, hip, rib, toe, leg, pelvis, hand, and clavicle were significantly related to reduced bone mass (P < 0.05). These fractures represented 74% of nonspinal fractures. The overall hazard ratio for the occurrence of one or more of these fractures was 1.65 (CI, 1.49 to 1.82) at the distal radius. In a subsample of the cohort, vertebral fractures were also related to low bone mass. Fractures of the ankle, elbow, finger, and face, however, were not associated with bone mass at any measurement site; the overall hazard ratio for these fractures was 1.12 (CI, 0.96 to 1.30) at the distal radius. Conclusion: Most types of fractures have an increased incidence in elderly women with low bone mass.	UNIV MARYLAND, BALTIMORE, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	SEELEY, DG (corresponding author), UNIV CALIF SAN FRANCISCO, DEPT EPIDEMIOL & BIOSTAT, 74 NEW MONTGOMERY, SUITE 600, SAN FRANCISCO, CA 94105 USA.				NIAMS NIH HHS [AR35582] Funding Source: Medline; NIA NIH HHS [AG05407, AG05394] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR035582] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		COX DR, 1972, J R STAT SOC B, V34, P187; CUMMINGS SR, 1989, J GERONTOL, V44, pM107; CUMMINGS SR, 1985, EPIDEMIOL REV, V7, P178, DOI 10.1093/oxfordjournals.epirev.a036281; CUMMINGS SR, 1990, JAMA-J AM MED ASSOC, V263, P665, DOI 10.1001/jama.263.5.665; ESSES SI, 1989, J BONE MINER RES, V4, P715; GARDSELL P, 1989, CALCIFIED TISSUE INT, V44, P235, DOI 10.1007/BF02553757; HUI SL, 1989, ANN INTERN MED, V111, P355, DOI 10.7326/0003-4819-111-5-355; JENSEN GF, 1983, ACTA MED SCAND, V213, P61; LIPS P, 1987, INT S OSTEOPORSIS, P362; MELTON LJ, 1986, AM J EPIDEMIOL, V124, P254, DOI 10.1093/oxfordjournals.aje.a114383; MELTON LJ, 1982, CLIN ORTHOP RELAT R, V162, P144; MeltonIII L. J., 1988, OSTEOPOROSIS ETIOLOG, P133; OWEN RA, 1982, AM J PUBLIC HEALTH, V72, P605, DOI 10.2105/AJPH.72.6.605; Vega E, 1991, Osteoporos Int, V1, P81, DOI 10.1007/BF01880448; WASNICH RD, 1985, AM J OBSTET GYNECOL, V153, P745, DOI 10.1016/0002-9378(85)90338-2; 1984, JAMA-J AM MED ASSOC, V252, P799	16	496	507	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 1	1991	115	11					837	842		10.7326/0003-4819-115-11-837	http://dx.doi.org/10.7326/0003-4819-115-11-837			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GR171	1952469				2022-12-28	WOS:A1991GR17100001
J	KWON, IC; BAE, YH; KIM, SW				KWON, IC; BAE, YH; KIM, SW			ELECTRICALLY ERODIBLE POLYMER GEL FOR CONTROLLED RELEASE OF DRUGS	NATURE			English	Article							INTERMACROMOLECULAR COMPLEXES; SENSITIVE POLYMERS; PHASE-TRANSITION; DELIVERY; MEMBRANE	NEW controlled drug-delivery systems are being explored to overcome the disadvantages of conventional dosage forms 1. For example, stimulated drug-delivery has been used to overcome the tolerance problems that occur with a constant delivery rate, to mimic the physiological pattern of hormonal concentration and to supply drugs on demand 1,2. Stimuli-sensitive polymers, which are potentially useful for pulsed drug delivery, experience changes in either their structure or their chemical properties in response to changes in environmental conditions 2. Environmental stimuli include temperature 3,4, pH 5,6, light (ultraviolet 7 or visible 8), electric field 9-12 or certain chemicals 13. Volume changes of stimuli-sensitive gel networks are particularly responsive to external stimuli, but swelling is slow to occur 14,15. As well as being useful in the controlled release of drugs, such systems also provide insight into intermolecular interactions 16. Here we report on a novel polymeric system, which rapidly changes from a solid state to solution in response to small electric currents, by disintegration of the solid polymer complex into two water-soluble polymers. We show that the modulated release of insulin, and by extension other macromolecules, can be achieved with this polymeric system.			KWON, IC (corresponding author), UNIV UTAH,CTR CONTROLLED CHEM DELIVERY,421 WAKARA WAY,SALT LAKE CITY,UT 84108, USA.		KWON, ICK CHAN/AAS-4776-2020	KWON, ICK CHAN/0000-0003-1272-7074				BAE YH, 1987, MAKROMOL CHEM-RAPID, V8, P481; CHEN FL, 1988, POLYMER, V29, P2285, DOI 10.1016/0032-3861(88)90123-1; EISENBERG SR, 1984, J MEMBRANE SCI, V19, P173, DOI 10.1016/S0376-7388(00)80207-0; HIROKAWA Y, 1984, J CHEM PHYS, V81, P6379, DOI 10.1063/1.447548; HOFFMAN A S, 1986, Journal of Controlled Release, V4, P213; HOPFENBERG HB, 1976, CONTROLLED RELEASE P, pCH3; ILMAIN F, 1991, NATURE, V349, P400, DOI 10.1038/349400a0; ISHIHARA K, 1984, J POLYM SCI POL CHEM, V22, P881, DOI 10.1002/pol.1984.170220341; ISHIHARA K, 1984, J APPL POLYM SCI, V29, P211, DOI 10.1002/app.1984.070290119; Kost J., 1990, PULSED SELF REGULATE; KUHN W, 1950, NATURE, V165, P514, DOI 10.1038/165514a0; KWON IC, 1990, MAKROMOL CHEM-M SYMP, V33, P265, DOI 10.1002/masy.19900330123; LANGER R, 1990, SCIENCE, V249, P1527, DOI 10.1126/science.2218494; LICHKUS AM, 1988, MACROMOLECULES, V21, P2636, DOI 10.1021/ma00186a054; OSADA Y, 1981, J POLYM SCI POL LETT, V19, P303, DOI 10.1002/pol.1981.130190605; SIEGEL RA, 1988, MACROMOLECULES, V21, P3254, DOI 10.1021/ma00189a021; SUZUKI A, 1990, NATURE, V346, P345, DOI 10.1038/346345a0; TANAKA T, 1982, SCIENCE, V218, P467, DOI 10.1126/science.218.4571.467; TSUCHIDA E, 1982, ADV POLYM SCI, V45, P1	19	607	683	2	114	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	NOV 28	1991	354	6351					291	293		10.1038/354291a0	http://dx.doi.org/10.1038/354291a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT204	1956379				2022-12-28	WOS:A1991GT20400042
J	ROBINSON, JC				ROBINSON, JC			HMO MARKET PENETRATION AND HOSPITAL COST INFLATION IN CALIFORNIA	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HEALTH MAINTENANCE ORGANIZATIONS; PROMOTE QUALITY; COMPETITION; CARE; INSURANCE; EXPENSES; SERVICES; ECONOMY; GROWTH; 1990S	Objective. - Health maintenance organizations (HMOs) have stimulated price competition in California hospital markets since 1983, when the state legislature eliminated barriers to selective contracting by conventional health insurance plans. This study measures the impact of HMO-induced price competition on the rate of inflation in average cost per admission for 298 private, non-HMO hospitals between 1982 and 1988. Data. - HMO market penetration was calculated using discharge abstract data on insurance coverage, ZIP code of residence, and hospital of choice for 3.35 million patients in 1983 and 3.41 million patients in 1988. Data on hospital characteristics were obtained from the American Hospital Association and other sources. Results. - HMO coverage grew from an average of 8.3% of all admissions in local hospital markets in 1983 to 17.0% of all admissions in 1988. The average rate of growth in costs per admission between 1982 and 1988 was 9.4% lower in markets with relatively high HMO penetration compared with markets with relatively low HMO penetration (95% confidence interval, 5.2 to 13.8). Cost savings for these 298 hospitals are estimated at $1.04 billion for 1988. Conclusion. - Price competition between HMOs and conventional health insurers can significantly reduce hospital cost inflation if legislative barriers to selective contracting are removed. The impact of competition in California was modest, however, when evaluated in terms of the 74.5% average rate of California hospital cost inflation during these years.			ROBINSON, JC (corresponding author), UNIV CALIF BERKELEY,SCH PUBL HLTH,DEPT SOCIAL & ADM HLTH SCI,BERKELEY,CA 94720, USA.							BEAUCHAMP DE, 1990, NEW ENGL J MED, V323, P640, DOI 10.1056/NEJM199009063231005; BERGTHOLD L, 1984, J HEALTH POLIT POLIC, V9, P203, DOI 10.1215/03616878-9-2-203; BREYER F, 1987, J HEALTH ECON, V6, P147, DOI 10.1016/0167-6296(87)90004-X; DUAN N, 1983, J AM STAT ASSOC, V78, P605, DOI 10.2307/2288126; ENTHOVEN A, 1989, NEW ENGL J MED, V320, P94, DOI 10.1056/NEJM198901123200205; ENTHOVEN A, 1989, NEW ENGL J MED, V320, P29, DOI 10.1056/NEJM198901053200106; FEDER J, 1987, NEW ENGL J MED, V317, P867, DOI 10.1056/NEJM198710013171405; FELDMAN R, 1986, J HEALTH POLIT POLIC, V10, P675, DOI 10.1215/03616878-10-4-675; FRANK RG, 1985, INQUIRY-J HEALTH CAR, V22, P148; GRUMBACH K, 1991, JAMA-J AM MED ASSOC, V265, P2549, DOI 10.1001/jama.265.19.2549; HAY JW, 1984, SO EC J, V11, P831; JOSKOW PL, 1980, BELL J ECON, V11, P421, DOI 10.2307/3003372; LUFT HS, 1986, INQUIRY-J HEALTH CAR, V23, P83; LUFT HS, 1986, MILBANK Q, V64, P566, DOI 10.2307/3349926; LUFT HS, 1986, J HEALTH POLIT POLIC, V10, P625, DOI 10.1215/03616878-10-4-625; LUFT HS, 1981, HLTH MAINTENANCE ORG; MANNING WG, 1984, NEW ENGL J MED, V310, P1505, DOI 10.1056/NEJM198406073102305; MCLAUGHLIN CG, 1987, HEALTH SERV RES, V22, P183; MCLAUGHLIN CG, 1988, INQUIRY-J HEALTH CAR, V25, P207; MCLAUGHLIN CG, 1988, HEALTH SERV RES, V23, P421; MELNICK GA, 1988, JAMA-J AM MED ASSOC, V260, P2669, DOI 10.1001/jama.260.18.2669; Robinson J C, 1989, J Health Econ, V8, P437; ROBINSON JC, 1987, JAMA-J AM MED ASSOC, V257, P3241, DOI 10.1001/jama.257.23.3241; ROBINSON JC, 1988, MILBANK Q, V66, P465, DOI 10.2307/3349965; ROBINSON JC, 1988, JAMA-J AM MED ASSOC, V260, P2676, DOI 10.1001/jama.260.18.2676; SCHWARTZ WB, 1991, NEW ENGL J MED, V324, P1037, DOI 10.1056/NEJM199104113241506; SIU AL, 1988, JAMA-J AM MED ASSOC, V259, P1343, DOI 10.1001/jama.259.9.1343; THORNTON RJ, 1989, J LABOR RES, V10, P443, DOI 10.1007/BF02685335; ZELLNER BB, 1989, HEALTH SERV RES, V24, P409	29	89	89	1	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 20	1991	266	19					2719	2723		10.1001/jama.266.19.2719	http://dx.doi.org/10.1001/jama.266.19.2719			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GP691	1942424	Green Submitted			2022-12-28	WOS:A1991GP69100027
J	KUHN, R; RAJEWSKY, K; MULLER, W				KUHN, R; RAJEWSKY, K; MULLER, W			GENERATION AND ANALYSIS OF INTERLEUKIN-4 DEFICIENT MICE	SCIENCE			English	Article							STIMULATORY FACTOR-I; MURINE B-CELLS; MONOCLONAL-ANTIBODIES; T-CELL; MAST-CELLS; STEM-CELLS; SWITCH; IGE; RECOMBINATION; INDUCTION	Interleukin-4 (IL-4) promotes the growth and differentiation of many hematopoietic cells in vitro; in particular, it directs the immunoglobulin (Ig) class switch to IgG1 and IgE. Mice homozygous for a mutation that inactivates the IL-4 gene were generated to test the requirement for IL-4 in vivo. In the mutant mice T and B cell development was normal, but the serum levels of IgGl and IgE were strongly reduced. The IgG1 dominance in a T cell-dependent immune response was lost, and IgE was not detectable upon nematode infection. Thus, some but not all of the in vitro properties of IL-4 are critical for the physiology of the immune system in vivo.			KUHN, R (corresponding author), UNIV COLOGNE, INST GENET, W-5000 COLOGNE 41, GERMANY.		Muller, Werner/B-9044-2008; Kühn, Ralf/U-1278-2017	Muller, Werner/0000-0002-1297-9725; Kühn, Ralf/0000-0003-1694-9803				BANIYASH M, 1984, EUR J IMMUNOL, V14, P799, DOI 10.1002/eji.1830140907; BHATTACHARYA A, 1981, J IMMUNOL, V127, P2488; BROWN MA, 1987, CELL, V50, P809, DOI 10.1016/0092-8674(87)90339-4; CAPECCHI MR, 1989, SCIENCE, V244, P1288, DOI 10.1126/science.2660260; CARDING SR, 1991, IMMUNOL TODAY, V12, P239, DOI 10.1016/0167-5699(91)90037-T; COFFMAN RL, 1986, J IMMUNOL, V136, P4538; DIALYNAS DP, 1983, J IMMUNOL, V131, P2445; ESSER C, 1989, EMBO J, V8, P483, DOI 10.1002/j.1460-2075.1989.tb03401.x; FINKELMAN FD, 1986, P NATL ACAD SCI USA, V83, P9675, DOI 10.1073/pnas.83.24.9675; FINKELMAN FD, 1991, INT IMMUNOL, V3, P599, DOI 10.1093/intimm/3.6.599; FINKELMAN FD, 1990, ANNU REV IMMUNOL, V8, P303, DOI 10.1146/annurev.iy.08.040190.001511; GRUTZMANN R, 1981, THESIS U COLOGNE; HOOPER M, 1987, NATURE, V326, P292, DOI 10.1038/326292a0; ILLGES H, 1990, MOL BIOL B CELL DEV, V3, P109; ISAKSON PC, 1982, J EXP MED, V155, P734, DOI 10.1084/jem.155.3.734; KENDALL C, 1984, J IMMUNOL METHODS, V56, P319; KITAMURA D, 1991, NATURE, V350, P423, DOI 10.1038/350423a0; KUHN R, UNPUB; LEBRUN P, 1987, J IMMUNOL, V139, P1459; LEDBETTER JA, 1979, IMMUNOL REV, V47, P63, DOI 10.1111/j.1600-065X.1979.tb00289.x; MANSOUR SL, 1988, NATURE, V336, P348, DOI 10.1038/336348a0; MOSMANN T, 1991, IMMUNOL TODAY, V12, P257, DOI 10.1016/0167-5699(91)90121-9; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; MULLER W, 1989, EUR J IMMUNOL, V19, P923, DOI 10.1002/eji.1830190520; OHARA J, 1985, NATURE, V315, P333, DOI 10.1038/315333a0; OI VT, 1979, MOL IMMUNOL, V16, P1005, DOI 10.1016/0161-5890(79)90034-8; OTSUKA T, 1987, NUCLEIC ACIDS RES, V15, P333, DOI 10.1093/nar/15.1.333; PAUL WE, 1987, ANNU REV IMMUNOL, V5, P429, DOI 10.1146/annurev.iy.05.040187.002241; RADBRUCH A, 1986, P NATL ACAD SCI USA, V83, P3954, DOI 10.1073/pnas.83.11.3954; RENNICK D, 1987, P NATL ACAD SCI USA, V84, P6889, DOI 10.1073/pnas.84.19.6889; RETH M, 1981, THESIS U COLOGNE; ROTHMAN P, 1988, J EXP MED, V168, P2385, DOI 10.1084/jem.168.6.2385; SAVELKOUL HFJ, 1991, J IMMUNOL, V146, P1801; SEEMANN G, 1981, THESIS U COLOGNE; SIDERAS P, 1985, EUR J IMMUNOL, V15, P593, DOI 10.1002/eji.1830150612; THOMAS KR, 1987, CELL, V51, P503, DOI 10.1016/0092-8674(87)90646-5; WILLIAMS RL, 1988, NATURE, V336, P684, DOI 10.1038/336684a0; YENOFSKY RL, 1990, P NATL ACAD SCI USA, V87, P3435, DOI 10.1073/pnas.87.9.3435; ZLOTNIK A, 1987, J IMMUNOL, V138, P4275	39	1146	1184	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 1	1991	254	5032					707	710		10.1126/science.1948049	http://dx.doi.org/10.1126/science.1948049			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN474	1948049				2022-12-28	WOS:A1991GN47400040
J	HILLIS, DM; BULL, JJ				HILLIS, DM; BULL, JJ			OF GENES AND GENOMES	SCIENCE			English	Editorial Material											HILLIS, DM (corresponding author), UNIV TEXAS,DEPT ZOOL,AUSTIN,TX 78712, USA.		Hillis, David M/B-4278-2008; Hillis, David/L-5421-2019					ATCHLEY WR, 1991, SCIENCE, V254, P554, DOI 10.1126/science.1948030; Brooks DR, 1991, PHYLOGENY ECOLOGY BE; Eldredge N., 1980, PHYLOGENETIC PATTERN; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; FITCH WM, 1985, SCIENCE, V228, P1169, DOI 10.1126/science.4001935; FITCH WM, 1987, MOL MORPHOLOGY EVOLU, P203; Harvey P.H., 1991, COMP METHOD EVOLUTIO; JENKINS NA, 1982, J VIROL, V43, P26, DOI 10.1128/JVI.43.1.26-36.1982; Nei M., 1987, MOL EVOLUTIONARY GEN; Weiss R, 1982, RNA TUMOR VIRUSES; WHITE ME, 1991, UNITY OF EVOLUTIONARY BIOLOGY, VOLS 1 AND 2, P935; [No title captured]	12	9	9	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	OCT 25	1991	254	5031					528	528		10.1126/science.1948027	http://dx.doi.org/10.1126/science.1948027			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL799	1948027				2022-12-28	WOS:A1991GL79900037
J	HOLDEN, C				HOLDEN, C			COMMUTER SHUTTLE	SCIENCE			English	Editorial Material																			0	9	9	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	OCT 25	1991	254	5031					522	522						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL799	1948026				2022-12-28	WOS:A1991GL79900031
J	ROTHMAN, DL; MAGNUSSON, I; KATZ, LD; SHULMAN, RG; SHULMAN, GI				ROTHMAN, DL; MAGNUSSON, I; KATZ, LD; SHULMAN, RG; SHULMAN, GI			QUANTITATION OF HEPATIC GLYCOGENOLYSIS AND GLUCONEOGENESIS IN FASTING HUMANS WITH C-13 NMR	SCIENCE			English	Article							CONSCIOUS DOG; FASTED HUMANS; GLUCOSE-LOAD; INVIVO; SPECTROSCOPY; METABOLISM; PATHWAYS; LIVER	The rate of net hepatic glycogenolysis was assessed in humans by serially measuring hepatic glycogen concentration at 3- to 12-hour intervals during a 68-hour fast with C-13 nuclear magnetic resonance spectroscopy. The net rate of gluconeogenesis was calculated by subtracting the rate of net hepatic glycogenolysis from the rate of glucose production in the whole body measured with tritiated glucose. Gluconeogenesis accounted for 64 +/- 5% (mean +/- standard error of the mean) of total glucose production during the first 22 hours of fasting. In the subsequent 14-hour and 18-hour periods of the fast, gluconeogenesis accounted for 82 +/- 5% and 96 +/- 1% of total glucose production, respectively. These data show that gluconeogenesis accounts for a substantial fraction of total glucose production even during the first 22 hours of a fast in humans.	YALE UNIV,SCH MED,DEPT INTERNAL MED,NEW HAVEN,CT 06510; YALE UNIV,SCH MED,DEPT DIAGNOST RADIOL,NEW HAVEN,CT 06510; YALE UNIV,SCH MED,DEPT MOLEC BIOPHYS & BIOCHEM,NEW HAVEN,CT 06510	Yale University; Yale University; Yale University			Shulman, Gerald I./P-7176-2019	Shulman, Gerald I./0000-0003-1529-5668	NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000125] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK034576, R01DK040936] Funding Source: NIH RePORTER; NCRR NIH HHS [MO1-RR-00125-26] Funding Source: Medline; NIDDK NIH HHS [DK-34576, R01 DK040936, DK-40936] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ABUMRAD NN, 1982, AM J PHYSIOL, V242, pE398, DOI 10.1152/ajpendo.1982.242.6.E398; ADKINS BA, 1987, J CLIN INVEST, V79, P557, DOI 10.1172/JCI112847; BJOKMAN O, 1990, DIABETES, V39, P747; BJORKMAN O, 1982, DIABETES, V31, P516, DOI 10.2337/diabetes.31.6.516; BOTTOMLEY PA, 1989, MAGNET RESON MED, V12, P348, DOI 10.1002/mrm.1910120307; CHERRINGTON AD, 1986, HORMONAL CONTROL GLU, P15; CONSOLI A, 1987, J CLIN INVEST, V80, P1301; GRUETTER R, 1991, MAGNET RESON MED, V20, P327, DOI 10.1002/mrm.1910200216; HAASE A, 1986, J MAGN RESON, V67, P258, DOI 10.1016/0022-2364(86)90433-6; HETENYI G, 1983, BIOCHEM MED METAB B, V29, P372, DOI 10.1016/0006-2944(83)90073-X; HETENYI G, 1986, HORMONAL CONTROL GLU, P79; HULL WE, 1987, 6TH ANN M SOC MAGN R, P488; JACKSON CL, 1989, BIOCHEMISTRY-US, V28, P5024, DOI 10.1021/bi00438a018; JUE T, 1989, P NATL ACAD SCI USA, V86, P4489, DOI 10.1073/pnas.86.12.4489; KATZ J, 1985, AM J PHYSIOL, V248, pR391, DOI 10.1152/ajpregu.1985.248.4.R391; KREBS HA, 1963, ADV ENZYME REGUL, V1, P385; KREBS HA, 1966, BIOCHEM J, V101, P242, DOI 10.1042/bj1010242; KREISBERG RA, 1972, J CLIN ENDOCR METAB, V34, P876, DOI 10.1210/jcem-34-5-876; MAGNUSSON I, 1987, J CLIN INVEST, V80, P1748, DOI 10.1172/JCI113267; MCGARRY JD, 1984, J CLIN INVEST, V74, P1901; NILSSON LH, 1973, SCAND J CLIN LAB INV, V32, P325, DOI 10.3109/00365517309084355; ORDIDGE RJ, 1986, J MAGN RESON, V66, P283, DOI 10.1016/0022-2364(86)90031-4; OWEN OE, 1969, J CLIN INVEST, V48, P574, DOI 10.1172/JCI106016; SCHUMANN WC, 1991, J BIOL CHEM, V266, P6985; SHALWITZ RA, 1987, MAGNET RESON MED, V5, P462, DOI 10.1002/mrm.1910050508; SHULMAN GI, 1990, AM J PHYSIOL, V259, pE335, DOI 10.1152/ajpendo.1990.259.3.E335; SHULMAN GI, 1988, J BIOL CHEM, V263, P5027; SILLERUD LO, 1983, BIOCHEMISTRY-US, V22, P1987; SILVER MS, 1984, NATURE, V310, P681, DOI 10.1038/310681a0; STRISOWER EH, 1952, J BIOL CHEM, V198, P115; TAYLOR R, UNPUB; WAHREN J, 1972, J CLIN INVEST, V51, P1870, DOI 10.1172/JCI106989; WEINMAN E, 1952, PHYSIOL REV, V37, P252; ZANG LH, 1990, BIOCHEMISTRY-US, V29, P6815, DOI 10.1021/bi00481a009	34	424	432	0	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	OCT 25	1991	254	5031					573	576		10.1126/science.1948033	http://dx.doi.org/10.1126/science.1948033			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL799	1948033				2022-12-28	WOS:A1991GL79900050
J	HARTLEY, SB; CROSBIE, J; BRINK, R; KANTOR, AB; BASTEN, A; GOODNOW, CC				HARTLEY, SB; CROSBIE, J; BRINK, R; KANTOR, AB; BASTEN, A; GOODNOW, CC			ELIMINATION FROM PERIPHERAL LYMPHOID-TISSUES OF SELF-REACTIVE LYMPHOCYTES-B RECOGNIZING MEMBRANE-BOUND ANTIGENS	NATURE			English	Article							PROTEIN TYROSINE PHOSPHORYLATION; TRANSGENIC MICE; CLONAL DELETION; CELL TOLERANCE; T-CELLS; RECEPTOR; EXPRESSION; MATURE; STIMULATION; MECHANISMS	THE long-standing hypothesis 1,2 that tolerance to self antigens is mediated by either elimination 3-8 or functional inactivation (anergy; refs 9-11) of self-reactive lymphocytes is now accepted, but little is known about the factors responsible for initiating one process rather than the other. In the B-cell lineage, tolerant self-reactive cells persist in the peripheral lymphoid organs of transgenic mice expressing lysozyme and anti-lysozyme immunoglobulin genes 9, but are eliminated in similar transgenic mice expressing anti-major histocompatibility complex immunoglobulin genes 8. By modifying the structure of the lysozyme transgene and the isotype of the anti-lysozyme immunoglobulin genes, we demonstrate here that induction of anergy or deletion is not due to differences in antibody affinity or isotype, but to recognition of monomeric or oligomeric soluble antigen versus highly multivalent membrane-bound antigen. Our findings indicate that the degree of receptor crosslinking can have qualitatively distinct signalling consequences for lymphocyte development.	STANFORD UNIV, HOWARD HUGHES MED INST, STANFORD, CA 94305 USA; STANFORD UNIV, DEPT MICROBIOL & IMMUNOL, STANFORD, CA 94305 USA; STANFORD UNIV, BECKMAN CTR MOLEC & GENET MED, DEPT GENET, STANFORD, CA 94305 USA	Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University	HARTLEY, SB (corresponding author), UNIV SYDNEY, CENTENARY INST CANC MED & CELL BIOL, SYDNEY, NSW 2006, AUSTRALIA.		Brink, Robert/B-7910-2010; Goodnow, Christopher C/V-8108-2018	Brink, Robert/0000-0002-9586-3655; Goodnow, Christopher C/0000-0001-5296-6155				BRUNSWICK M, 1991, P NATL ACAD SCI USA, V88, P1311, DOI 10.1073/pnas.88.4.1311; Burnet F., 1959, CLONAL SELECTION THE, DOI DOI 10.5962/BHL.TITLE.8281; CAMBIER JC, 1987, ANNU REV IMMUNOL, V5, P175, DOI 10.1146/annurev.immunol.5.1.175; CAMPBELL MA, 1990, EMBO J, V9, P2125, DOI 10.1002/j.1460-2075.1990.tb07381.x; COFFMAN RL, 1983, IMMUNOL REV, V69, P5, DOI 10.1111/j.1600-065X.1983.tb00446.x; DEFRANCO AL, 1987, ANNU REV CELL BIOL, V3, P143; DINTZIS RZ, 1983, J IMMUNOL, V131, P2196; Forster I, 1989, Int Immunol, V1, P321, DOI 10.1093/intimm/1.4.321; GASCOIGNE NRJ, 1987, P NATL ACAD SCI USA, V84, P2936, DOI 10.1073/pnas.84.9.2936; GOLD MR, 1990, NATURE, V345, P810, DOI 10.1038/345810a0; GOODNOW CC, 1989, IMMUNE RESPONSE TO STRUCTURALLY DEFINED PROTEINS : THE LYSOZYME MODEL, P389; GOODNOW CC, 1989, NATURE, V342, P385, DOI 10.1038/342385a0; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; HARNETT MM, 1988, IMMUNOL TODAY, V9, P315, DOI 10.1016/0167-5699(88)91325-4; KAPPLER JW, 1987, CELL, V49, P273, DOI 10.1016/0092-8674(87)90568-X; KAPPLER JW, 1988, NATURE, V332, P35, DOI 10.1038/332035a0; KISIELOW P, 1988, NATURE, V333, P742, DOI 10.1038/333742a0; KLAUS GGB, 1976, BRIT MED BULL, V32, P141, DOI 10.1093/oxfordjournals.bmb.a071346; MACDONALD HR, 1988, NATURE, V332, P40, DOI 10.1038/332040a0; MORELLO D, 1986, EMBO J, V5, P1877, DOI 10.1002/j.1460-2075.1986.tb04439.x; MURPHY KM, 1990, SCIENCE, V250, P1720, DOI 10.1126/science.2125367; NEMAZEE D, 1989, P NATL ACAD SCI USA, V86, P8039, DOI 10.1073/pnas.86.20.8039; NEMAZEE DA, 1989, NATURE, V337, P562, DOI 10.1038/337562a0; NOSSAL GJV, 1983, ANNU REV IMMUNOL, V1, P33, DOI 10.1146/annurev.iy.01.040183.000341; PARKS DR, 1986, HDB EXPT IMMUNOLOGY, V1, P291; RAFF MC, 1975, J EXP MED, V142, P1052, DOI 10.1084/jem.142.5.1052; RAMMENSEE HG, 1989, NATURE, V339, P541, DOI 10.1038/339541a0; RAMSDELL F, 1989, SCIENCE, V246, P1038, DOI 10.1126/science.2511629; RETH M, 1991, IMMUNOL TODAY, V12, P196, DOI 10.1016/0167-5699(91)90053-V; SCHONRICH G, 1991, CELL, V65, P293, DOI 10.1016/0092-8674(91)90163-S; SHA WC, 1988, NATURE, V336, P73, DOI 10.1038/336073a0; SIDMAN CL, 1975, NATURE, V257, P149, DOI 10.1038/257149a0; SMITHGILL SJ, 1984, J IMMUNOL, V132, P963; STALL AM, 1988, P NATL ACAD SCI USA, V85, P3546, DOI 10.1073/pnas.85.10.3546; WEISS E, 1983, EMBO J, V2, P453, DOI 10.1002/j.1460-2075.1983.tb01444.x; Wyllie A H, 1980, Int Rev Cytol, V68, P251	37	589	592	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 24	1991	353	6346					765	769		10.1038/353765a0	http://dx.doi.org/10.1038/353765a0			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL696	1944535				2022-12-28	WOS:A1991GL69600072
J	GRIGG, MH; WOLFE, JHN				GRIGG, MH; WOLFE, JHN			ABC OF VASCULAR DISEASES - RAYNAUDS SYNDROME AND SIMILAR CONDITIONS	BRITISH MEDICAL JOURNAL			English	Article									ST MARYS HOSP,LONDON,ENGLAND	Imperial College London	GRIGG, MH (corresponding author), ALFRED HOSP,SURG,MELBOURNE,AUSTRALIA.								0	5	5	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	OCT 12	1991	303	6807					913	916		10.1136/bmj.303.6807.913	http://dx.doi.org/10.1136/bmj.303.6807.913			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GK221	1933010	Bronze, Green Published			2022-12-28	WOS:A1991GK22100030
J	TOWNSEND, J; FRANK, AO; FERMONT, D; DYER, S; KARRAN, O; WALGROVE, A; PIPER, M				TOWNSEND, J; FRANK, AO; FERMONT, D; DYER, S; KARRAN, O; WALGROVE, A; PIPER, M			TERMINAL CANCER CARE AND PATIENTS PREFERENCE FOR PLACE OF DEATH - A PROSPECTIVE-STUDY	BRITISH MEDICAL JOURNAL			English	Article											TOWNSEND, J (corresponding author), NORTHWICK PK HOSP & CLIN RES CTR,MRC,EPIDEMIOL & MED CARE UNIT,HARROW HA1 3UJ,MIDDX,ENGLAND.							ALLBROOK D, 1984, MED J AUSTRALIA, V141, P143, DOI 10.5694/j.1326-5377.1984.tb113057.x; BATES T, 1981, LANCET, V1, P1201, DOI 10.1016/S0140-6736(81)92361-8; CARTWRIGHT A, 1973, LIFE DEATH; Doyle D, 1982, J R Coll Gen Pract, V32, P285; FORD GR, 1978, HLTH TRENDS, V10, P73; HOCKLEY JM, 1988, BRIT MED J, V296, P1715, DOI 10.1136/bmj.296.6638.1715; HOSKIN PJ, 1988, J ROY SOC MED, V81, P341, DOI 10.1177/014107688808100615; MORRIS JN, 1986, J CHRON DIS, V39, P47, DOI 10.1016/0021-9681(86)90106-2; PARKES CM, 1985, LANCET, V1, P155; REES WD, 1982, BRIT MED J, V285, P1766, DOI 10.1136/bmj.285.6357.1766; Saunders C, 1981, HOSPICE LIVING IDEA; SPITZER WO, 1981, J CHRON DIS, V34, P585, DOI 10.1016/0021-9681(81)90058-8; TOWNSEND J, 1988, CONTINUING TERMINAL; 1987, CARE DYING GUIDE HLT; 1981, TERMINAL CARE REPORT; 1989, MORTALITY STATISTICS	16	379	383	1	4	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	SEP 1	1990	301	6749					415	417		10.1136/bmj.301.6749.415	http://dx.doi.org/10.1136/bmj.301.6749.415			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DW782	1967134	Green Published, Bronze			2022-12-28	WOS:A1990DW78200018
J	MACDOUGALL, IC; LEWIS, NP; SAUNDERS, MJ; COCHLIN, DL; DAVIES, ME; HUTTON, RD; FOX, KAA; COLES, GA; WILLIAMS, JD				MACDOUGALL, IC; LEWIS, NP; SAUNDERS, MJ; COCHLIN, DL; DAVIES, ME; HUTTON, RD; FOX, KAA; COLES, GA; WILLIAMS, JD			LONG-TERM CARDIORESPIRATORY EFFECTS OF AMELIORATION OF RENAL ANEMIA BY ERYTHROPOIETIN	LANCET			English	Article									CARDIFF ROYAL INFIRM, DEPT HAEMATOL, CARDIFF CF2 1SZ, S GLAM, WALES; CARDIFF ROYAL INFIRM, DEPT RADIOL, CARDIFF CF2 1SZ, S GLAM, WALES; UNIV HOSP WALES, DEPT CARDIOL, CARDIFF, WALES; LLANDOUGH HOSP, DEPT RESP MED, PENARTH GP6 1XX, S GLAM, WALES	Cardiff Royal Infirmary; Cardiff Royal Infirmary; Cardiff University	MACDOUGALL, IC (corresponding author), CARDIFF ROYAL INFIRM, INST NEPHROL, CARDIFF CF2 1SZ, S GLAM, WALES.		Fox, keith A A/I-3742-2013	Fox, Keith/0000-0002-0140-2752				COTES JE, 1972, CLIN SCI, V42, P325, DOI 10.1042/cs0420325; DEGOULET P, 1982, NEPHRON, V31, P103, DOI 10.1159/000182627; DEVEREUX RB, 1977, CIRCULATION, V55, P613, DOI 10.1161/01.CIR.55.4.613; DEVEREUX RB, 1984, AM J CARDIOL, V54, P592, DOI 10.1016/0002-9149(84)90255-8; DUKE M, 1969, CIRCULATION, V39, P503, DOI 10.1161/01.CIR.39.4.503; HIMELMAN RB, 1988, J AM COLL CARDIOL, V12, P915, DOI 10.1016/0735-1097(88)90454-8; HUTING J, 1988, NEPHRON, V49, P284, DOI 10.1159/000185077; Kramer W, 1986, Contrib Nephrol, V52, P97; LIPKIN DP, 1987, BRIT HEART J, V58, P559; LONDON GM, 1989, KIDNEY INT, V36, P878, DOI 10.1038/ki.1989.274; LOW I, 1989, CLIN NEPHROL, V31, P26; LUNDIN AP, 1989, SEMIN NEPHROL, V9, P22; MACDOUGALL IC, 1989, NEPHROL DIAL TRANSPL, V4, P319; MATSUMURA N, 1983, CIRCULATION, V68, P360, DOI 10.1161/01.CIR.68.2.360; MAYER G, 1988, KIDNEY INT, V34, P525, DOI 10.1038/ki.1988.213; MAYER G, 1989, CLIN SCI, V76, P265, DOI 10.1042/cs0760265; MAYER G, 1989, KIDNEY INT, V35, P316; NEFF MS, 1971, CIRCULATION, V43, P876, DOI 10.1161/01.CIR.43.6.876; Nonnast-Daniel B, 1988, Contrib Nephrol, V66, P185; RAINE AEG, 1988, LANCET, V1, P97; RAINE AEG, 1984, KIDNEY TRANSPLANTATI, P469; RICHARDSON TQ, 1959, AM J PHYSIOL, V197, P1167, DOI 10.1152/ajplegacy.1959.197.6.1167; ROSTAND SG, 1979, KIDNEY INT, V16, P600, DOI 10.1038/ki.1979.170; SCHAEFER RM, 1988, AM J NEPHROL, V8, P449, DOI 10.1159/000167652; SILBERBERG JS, 1989, KIDNEY INT, V36, P286, DOI 10.1038/ki.1989.192; TAYLOR HL, 1955, J APPL PHYSIOL, V8, P73, DOI 10.1152/jappl.1955.8.1.73	26	227	229	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 3	1990	335	8688					489	493		10.1016/0140-6736(90)90733-L	http://dx.doi.org/10.1016/0140-6736(90)90733-L			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT015	1968526				2022-12-28	WOS:A1990CT01500001
J	WINSTON, DJ; HO, WG; BRUCKNER, DA; CHAMPLIN, RE				WINSTON, DJ; HO, WG; BRUCKNER, DA; CHAMPLIN, RE			BETA-LACTAM ANTIBIOTIC-THERAPY IN FEBRILE GRANULOCYTOPENIC PATIENTS - A RANDOMIZED TRIAL COMPARING CEFOPERAZONE PLUS PIPERACILLIN, CEFTAZIDIME PLUS PIPERACILLIN, AND IMIPENEM ALONE	ANNALS OF INTERNAL MEDICINE			English	Article						AGRANULOCYTOSIS; ANTIBIOTICS, LACTAM; CEFOPERAZONE; CEFTAZIDIME; IMIPENEM; PIPERACILLIN	SERIOUS BACTERIAL-INFECTIONS; NEUTROPENIC CANCER-PATIENTS; PSEUDOMONAS-AERUGINOSA; 3RD-GENERATION CEPHALOSPORINS; MARROW TRANSPLANTATION; ANTIMICROBIAL AGENTS; EMPIRICAL-TREATMENT; ACUTE-LEUKEMIA; COMBINATION; BACTEREMIA	Objective: To compare the efficacy, toxicity, and cost-effectiveness of double beta-lactam therapy with monotherapy. Design: A randomized, controlled trial. Patients: Febrile, granulocytopenic patients (429). Interventions: Patients were randomly assigned to receive iv cefoperazone (3 g every 12 hours) plus piperacillin (75 mg/kg body weight every 6 hours), ceftazidime (2 g every 8 hours) plus piperacillin (75 mg/kg every 6 hours), or imipenem alone (1.0 g or 0.5 g every 6 hours). Patients also received prophylactic vitamin K. Measurements: Clinical improvement, eradication of the infecting organism, and toxicity in 403 evaluable patients with one or more infections. Main Results: Cefoperazone and ceftazidime, when given in combination with piperacillin, were equally effective (response rates of 75% (104 of 138 patients) and 74% (101 of 137 patients), respectively). Monotherapy with imipenem had a response rate of 82% (111 of 136 patients) and was as effective as double beta-lactam therapy. Overall antibiotic-related toxicity was minimal, although seizures were associated with high doses of imipenem. Seizures occurred in 3 of 29 patients (10.3%) who were receiving 4 g/d of imipenem, in 3 of 136 patients (2.2%) who were receiving cefoperazone plus piperacillin, in 0 of the 132 patients who were receiving ceftazidime plus piperacillin, and in 1 of 106 patients (0.9%) who were receiving 2 g/d of imipenem (P < 0.005). The 2-g daily dose of imipenem was as effective as the 4-g daily dose. Diarrhea was more frequent in patients receiving cefoperazone, whereas nausea occurred more often with imipenem. No antibiotic-related hemorrhage or nephrotoxicity was observed. Superinfections caused by beta-lactam-resistant, gram-negative bacilli were uncommon but occurred more frequently with double beta-lactam therapy than with imipenem monotherapy (11 of 268 patients compared with 1 of 135 patients; P = 0.06). Xanthomonas maltophilia superinfections occurred only in patients receiving imipenem (3 of 135 patients compared with 0 of 268 patients; P = 0.03). Imipenem monotherapy was the least expensive therapy. Conclusions: Cefoperazone and ceftazidime were equally effective when used in combination antibiotic therapy with piperacillin. Twice-daily cefoperazone is less expensive than ceftazidime given three times daily. Monotherapy with imipenem, at a daily dose of 2 g, is as efficacious as double beta-lactam therapy and costs less than combination therapy.			WINSTON, DJ (corresponding author), UNIV CALIF LOS ANGELES, CTR HLTH SCI, MED CTR, DEPT MED, ROOM 42-121, LOS ANGELES, CA 90024 USA.				NCI NIH HHS [CA-23175] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA023175] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ANAISSIE EJ, 1988, AM J MED, V84, P581, DOI 10.1016/0002-9343(88)90140-4; BODEY GP, 1990, CANCER, V65, P9, DOI 10.1002/1097-0142(19900101)65:1<9::AID-CNCR2820650105>3.0.CO;2-C; BODEY GP, 1966, ANN INTERN MED, V64, P328, DOI 10.7326/0003-4819-64-2-328; BUSTAMANTE CI, 1984, ANTIMICROB AGENTS CH, V26, P678, DOI 10.1128/AAC.26.5.678; CALANDRA G, 1988, AM J MED, V84, P911, DOI 10.1016/0002-9343(88)90071-X; CALANDRA T, 1987, NEW ENGL J MED, V317, P1692; COHEN J, 1983, LANCET, V2, P1452, DOI 10.1016/S0140-6736(83)90799-7; DANHAUER F J, 1982, Clinical Pharmacy, V1, P539; DEJACE P, 1986, AM J MED, V80, P29, DOI 10.1016/0002-9343(86)90476-6; DEJONGH CA, 1986, AM J MED, V80, P101; DEPAUW BE, 1987, NEW ENGL J MED, V316, P410; EISENBERG JM, 1989, JAMA-J AM MED ASSOC, V262, P2879, DOI 10.1001/jama.262.20.2879; FAINSTEIN V, 1984, ARCH INTERN MED, V144, P1766, DOI 10.1001/archinte.144.9.1766; FELD R, 1985, ARCH INTERN MED, V145, P1083, DOI 10.1001/archinte.145.6.1083; GRIBBLE MJ, 1983, ANTIMICROB AGENTS CH, V24, P388, DOI 10.1128/AAC.24.3.388; HESS DA, 1990, AM J HOSP PHARM, V47, P585, DOI 10.1093/ajhp/47.3.585; HO WG, 1986, CLIN HAEMATOL, V15, P873; HUGHES WT, 1990, J INFECT DIS, V161, P381, DOI 10.1093/infdis/161.3.381; JOHNSON DE, 1983, J ANTIMICROB CHEMOTH, V12, P89, DOI 10.1093/jac/12.suppl_D.89; JOHNSON MP, 1990, J INFECT DIS, V162, P981, DOI 10.1093/infdis/162.4.981; JONES RN, 1988, ANTIMICROBIC NEWSLET, V5, P85; JOSHI J, 1984, P INTERSCIENCE C ANT, P383; KARP JE, 1986, AM J MED, V81, P237, DOI 10.1016/0002-9343(86)90257-3; KENNEDY MS, 1983, TRANSPLANTATION, V35, P211, DOI 10.1097/00007890-198303000-00005; KIBBLER CC, 1989, ANTIMICROB AGENTS CH, V33, P503, DOI 10.1128/AAC.33.4.503; KLASTERSKY J, 1986, ANTIMICROB AGENTS CH, V29, P263, DOI 10.1128/AAC.29.2.263; KURTZ TO, 1981, ANTIMICROB AGENTS CH, V20, P239, DOI 10.1128/AAC.20.2.239; LAGAST H, 1984, INFECTION, V12, P190, DOI 10.1007/BF01640897; Lennette E.H, 1985, MANUAL CLIN MICROBIO, V4th ed.; LIANG R, 1990, ANTIMICROB AGENTS CH, V34, P1336, DOI 10.1128/AAC.34.7.1336; LIPSKY JJ, 1983, LANCET, V2, P192; MANGI RJ, 1988, AM J MED, V85, P44, DOI 10.1016/0002-9343(88)90174-X; MEYERS BR, 1985, AM J MED, V79, P96, DOI 10.1016/0002-9343(85)90268-2; NEU HC, 1982, ANN INTERN MED, V97, P408, DOI 10.7326/0003-4819-97-3-408; NORRBY SR, 1987, SCAND J INFECT DIS, P65; PEGRAM PS, 1989, J ANTIMICROB CHEMOTH, V24, P591, DOI 10.1093/jac/24.4.591; PICCART M, 1984, ANTIMICROB AGENTS CH, V30, P64; PIZZO PA, 1986, NEW ENGL J MED, V315, P552, DOI 10.1056/NEJM198608283150905; RUBIN M, 1988, ANN INTERN MED, V108, P30, DOI 10.7326/0003-4819-108-1-30; SATTLER FR, 1986, ANN INTERN MED, V105, P924, DOI 10.7326/0003-4819-105-6-924; Schimpff S C, 1978, J Infect Dis, V137, P14; SCHIMPFF SC, 1989, EUR J CANCER CLIN ON, V25, P1351, DOI 10.1016/0277-5379(89)90086-2; SCULIER JP, 1984, AM J MED, V76, P429, DOI 10.1016/0002-9343(84)90662-4; SHENEP JL, 1988, NEW ENGL J MED, V319, P1053, DOI 10.1056/NEJM198810203191604; STAMM WE, 1979, ANN INTERN MED, V91, P167, DOI 10.7326/0003-4819-91-2-167; TERMEER A, 1986, TRANSPLANTATION, V42, P220; THORNSBERRY C, 1985, AM J MED, V79, P14, DOI 10.1016/0002-9343(85)90255-4; WADE J, 1987, P INTERSCIENCE C ANT, P315; WADE JC, 1985, AM J MED, V78, P62, DOI 10.1016/0002-9343(85)90103-2; WADE JC, 1982, ANN INTERN MED, V97, P503, DOI 10.7326/0003-4819-97-4-503; WINSTON DJ, 1989, EUR J CANCER CLIN ON, V25, pS25; WINSTON DJ, 1988, AM J MED, V85, P21, DOI 10.1016/0002-9343(88)90171-4; WINSTON DJ, 1984, ANTIMICROB AGENTS CH, V26, P673, DOI 10.1128/AAC.26.5.673; WINSTON DJ, 1983, ARCH INTERN MED, V143, P32, DOI 10.1001/archinte.143.1.32; WINSTON DJ, 1984, AM J MED, V77, P442, DOI 10.1016/0002-9343(84)90100-1; 1987, PRIMAXIN PRODUCT MON	56	156	160	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 1	1991	115	11					849	859		10.7326/0003-4819-115-11-849	http://dx.doi.org/10.7326/0003-4819-115-11-849			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GR171	1952471				2022-12-28	WOS:A1991GR17100003
J	MAHONEY, PA; WEBER, U; ONOFRECHUK, P; BIESSMANN, H; BRYANT, PJ; GOODMAN, CS				MAHONEY, PA; WEBER, U; ONOFRECHUK, P; BIESSMANN, H; BRYANT, PJ; GOODMAN, CS			THE FAT TUMOR SUPPRESSOR GENE IN DROSOPHILA ENCODES A NOVEL MEMBER OF THE CADHERIN GENE SUPERFAMILY	CELL			English	Article							CELL-ADHESION MOLECULES; AFFECTING IMAGINAL DISKS; ANIMAL MORPHOGENESIS; NUCLEOTIDE-SEQUENCE; XENOPUS EMBRYOS; FASCICLIN-I; C-ELEGANS; MELANOGASTER; EXPRESSION; MUTATIONS	Recessive lethal mutations in the fat locus of Drosophila cause hyperplastic, tumor-like overgrowth of larval imaginal discs, defects in differentiation and morphogenesis, and death during the pupal stage. Clones of mutant cells induced by mitotic recombination demonstrate that the overgrowth phenotype is cell autonomous. Here we show that the fat locus encodes a novel member of the cadherin gene superfamily: an enormous transmembrane protein of over 5000 amino acids with a putative signal sequence, 34 tandem cadherin domains, four EGF-like repeats, a transmembrane domain, and a novel cytoplasmic domain. Two recessive lethal alleles contain alterations in the fat coding sequence, and the dominant fat allele, Gull, contains an insertion of a transposable element in the 33rd cadherin domain. Thus, this novel member of the cadherin gene superfamily functions as a tumor suppressor gene and is required for correct morphogenesis.	UNIV CALIF IRVINE,CTR DEV BIOL,IRVINE,CA 92717	University of California System; University of California Irvine	MAHONEY, PA (corresponding author), UNIV CALIF BERKELEY,HOWARD HUGHES MED INST,DEPT MOLEC & CELL BIOL,BERKELEY,CA 94720, USA.							ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; AUSTIN J, 1989, CELL, V58, P565, DOI 10.1016/0092-8674(89)90437-6; BEVILACQUA MP, 1989, SCIENCE, V243, P1160, DOI 10.1126/science.2466335; BIEBER AJ, 1989, CELL, V59, P447, DOI 10.1016/0092-8674(89)90029-9; BROWER DL, 1989, NATURE, V342, P285, DOI 10.1038/342285a0; BRYANT PJ, 1988, DEV BIOL, V129, P541, DOI 10.1016/0012-1606(88)90399-5; BRYANT PJ, 1985, DEV BIOL, V107, P355, DOI 10.1016/0012-1606(85)90317-3; BRYANT PJ, 1971, DEV BIOL, V24, P233, DOI 10.1016/0012-1606(71)90097-2; Bryant PJ, 1987, GENETIC REGULATION D, P339; Campos-Ortega J.A., 2013, EMBRYONIC DEV DROSOP; COLLINS JE, 1991, J CELL BIOL, V113, P381, DOI 10.1083/jcb.113.2.381; DETRICK RJ, 1990, NEURON, V4, P493, DOI 10.1016/0896-6273(90)90108-R; EDELMAN GM, 1987, P NATL ACAD SCI USA, V84, P8502, DOI 10.1073/pnas.84.23.8502; ELKINS T, 1990, CELL, V60, P565, DOI 10.1016/0092-8674(90)90660-7; FEARON ER, 1990, SCIENCE, V247, P49, DOI 10.1126/science.2294591; Finnegan D J, 1978, Cold Spring Harb Symp Quant Biol, V42 Pt 2, P1053; FUJIMORI T, 1990, DEVELOPMENT, V110, P97; GALLIN WJ, 1987, P NATL ACAD SCI USA, V84, P2808, DOI 10.1073/pnas.84.9.2808; GAMBLE JR, 1990, SCIENCE, V249, P414; GATEFF E, 1974, ROUX ARCH DEV BIOL, V176, P23, DOI 10.1007/BF00577830; GATEFF E, 1989, Critical Reviews in Oncogenesis, V1, P221; GOODWIN L, 1990, BIOCHEM BIOPH RES CO, V173, P1224, DOI 10.1016/S0006-291X(05)80917-9; GRENNINGLOH G, 1991, CELL, V67, P45, DOI 10.1016/0092-8674(91)90571-F; GRENNINGLOH G, 1990, COLD SPRING HARB SYM, V55, P323; HATTA K, 1986, NATURE, V320, P447, DOI 10.1038/320447a0; HATTA K, 1987, DEV BIOL, V120, P215, DOI 10.1016/0012-1606(87)90119-9; HATTA K, 1988, J CELL BIOL, V106, P873, DOI 10.1083/jcb.106.3.873; HERSKOWITZ I, 1987, NATURE, V329, P219, DOI 10.1038/329219a0; INGHAM PW, 1985, NATURE, V318, P439, DOI 10.1038/318439a0; JURSNICH VA, 1990, DEV BIOL, V140, P413, DOI 10.1016/0012-1606(90)90090-6; KARLIN S, 1990, P NATL ACAD SCI USA, V87, P2264, DOI 10.1073/pnas.87.6.2264; KLAMBT C, 1989, DEV BIOL, V133, P425, DOI 10.1016/0012-1606(89)90046-8; KNUST E, 1987, EMBO J, V6, P761, DOI 10.1002/j.1460-2075.1987.tb04818.x; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P857, DOI 10.1093/nar/12.2.857; LANGERSAFER PR, 1982, P NATL ACAD SCI-BIOL, V79, P4381, DOI 10.1073/pnas.79.14.4381; LEPTIN M, 1989, CELL, V56, P401, DOI 10.1016/0092-8674(89)90243-2; LIAW C W, 1990, Journal of Cell Biology, V111, p408A; LINDSLEY DL, 1968, CARNEGIE I WASH PUBL, V627; MACKRELL AJ, 1988, P NATL ACAD SCI USA, V85, P2633, DOI 10.1073/pnas.85.8.2633; Maniatis T., 1982, MOL CLONING; MARTIN P, 1977, DEV BIOL, V55, P213, DOI 10.1016/0012-1606(77)90168-3; MECHANIC S, 1991, IN PRESS P NATL ACAD, V88; MECHLER BM, 1985, EMBO J, V4, P1551, DOI 10.1002/j.1460-2075.1985.tb03816.x; MEGE RM, 1988, P NATL ACAD SCI USA, V85, P7274, DOI 10.1073/pnas.85.19.7274; MERZ R, 1990, ENVIRON HEALTH PERSP, V88, P163, DOI 10.2307/3431068; MIYATANI S, 1989, SCIENCE, V245, P631, DOI 10.1126/science.2762814; Mohr O, 1923, STUDIA MENDELIANA AD, P266; MOHR OTTO L., 1929, ZEITSCHR INDUKT ABSTAMMUNGS U VERERBUNGSLEHRE, V50, P113, DOI 10.1007/BF01742053; MONTELL DJ, 1988, CELL, V53, P463, DOI 10.1016/0092-8674(88)90166-3; Muller H.J, 1932, P 6 INT C GEN, V1, P213; MURPHY C, 1974, DEV BIOL, V39, P23, DOI 10.1016/S0012-1606(74)80005-9; NAGAFUCHI A, 1988, EMBO J, V7, P3679, DOI 10.1002/j.1460-2075.1988.tb03249.x; NAGAFUCHI A, 1987, NATURE, V329, P341, DOI 10.1038/329341a0; NOSE A, 1990, CELL, V61, P147, DOI 10.1016/0092-8674(90)90222-Z; NOSE A, 1987, EMBO J, V6, P3655, DOI 10.1002/j.1460-2075.1987.tb02698.x; NOSE A, 1986, J CELL BIOL, V103, P2649, DOI 10.1083/jcb.103.6.2649; NOSE A, 1988, CELL, V54, P993, DOI 10.1016/0092-8674(88)90114-6; OZAWA M, 1990, CELL, V63, P1033, DOI 10.1016/0092-8674(90)90506-A; PARKER AE, 1991, IN PRESS J BIOL CHEM, V260; RINGWALD M, 1987, EMBO J, V6, P3647, DOI 10.1002/j.1460-2075.1987.tb02697.x; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHEPHERD BM, 1984, J MOL BIOL, V180, P21, DOI 10.1016/0022-2836(84)90428-5; SNOW PM, 1989, CELL, V59, P313, DOI 10.1016/0092-8674(89)90293-6; STEWART M, 1972, DEV BIOL, V27, P71, DOI 10.1016/0012-1606(72)90113-3; SZIDONYA J, 1988, GENET RES, V51, P197, DOI 10.1017/S0016672300024290; TAKEICHI M, 1988, DEVELOPMENT, V102, P639; TAKEICHI M, 1987, TRENDS GENET, V3, P213, DOI 10.1016/0168-9525(87)90238-1; TAKEICHI M, 1990, ANNU REV BIOCHEM, V59, P237, DOI 10.1146/annurev.biochem.59.1.237; VANVACTOR D, 1988, CELL, V52, P281, DOI 10.1016/0092-8674(88)90517-X; WHARTON KA, 1985, CELL, V43, P567, DOI 10.1016/0092-8674(85)90229-6; WHEELER GN, 1991, IN PRESS P NATL ACAD; WHEELOCK MJ, 1987, J CELL BIOCHEM, V34, P187, DOI 10.1002/jcb.240340305; WILL BM, 1981, J MOL BIOL, V153, P897, DOI 10.1016/0022-2836(81)90458-7; WOODS DF, 1989, DEV BIOL, V134, P222, DOI 10.1016/0012-1606(89)90092-4; WOODS DF, 1991, CELL, V66, P451, DOI 10.1016/0092-8674(81)90009-X; YOCHEM J, 1989, CELL, V58, P553, DOI 10.1016/0092-8674(89)90436-4; YOCHEM J, 1988, NATURE, V335, P547, DOI 10.1038/335547a0; ZINN K, 1988, CELL, V53, P577, DOI 10.1016/0092-8674(88)90574-0; ZUSMAN S, 1990, DEVELOPMENT, V108, P391	80	394	407	0	20	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	NOV 29	1991	67	5					853	868		10.1016/0092-8674(91)90359-7	http://dx.doi.org/10.1016/0092-8674(91)90359-7			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GT755	1959133				2022-12-28	WOS:A1991GT75500005
J	MILLER, EK; LI, L; DESIMONE, R				MILLER, EK; LI, L; DESIMONE, R			A NEURAL MECHANISM FOR WORKING AND RECOGNITION MEMORY IN INFERIOR TEMPORAL CORTEX	SCIENCE			English	Article							STATE DEPENDENT ACTIVITY; MONKEY VISUAL-CORTEX; SHORT-TERM; RESPONSES; NEURONS; TASKS; V4	Inferior temporal (IT) cortex is critical for visual memory, but it is not known how IT neurons retain memories while new information is streaming into the visual system. Single neurons were therefore recorded from IT cortex of two rhesus monkeys performing tasks that required them to hold items in memory while concurrently viewing other items. The neuronal response to an incoming visual stimulus was attenuated if it matched a stimulus actively held in working memory, even when several other stimuli intervened. The neuronal response to novel stimuli declined as the stimuli became familiar to the animal. IT neurons appear to function as adaptive mnemonic "filters" that preferentially pass information about new, unexpected, or not recently seen stimuli.	NIMH,NEUROPSYCHOL LAB,BETHESDA,MD 20892	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)			Desimone, Robert/G-1121-2018; Miller, Earl K./AAE-8187-2019	Miller, Earl K./0000-0002-0582-6958				BAYLIS GC, 1987, EXP BRAIN RES, V65, P614; CARPENTER GA, 1990, NEURAL NETWORKS, V3, P129, DOI 10.1016/0893-6080(90)90085-Y; ESKANDAR EN, 1991, INVEST OPHTH VIS SCI, V32, P1036; FUSTER JM, 1982, J NEUROSCI, V2, P361; GAFFAN D, 1980, BRAIN RES, V196, P373, DOI 10.1016/0006-8993(80)90402-3; GROSS CG, 1972, J NEUROPHYSIOL, V35, P96, DOI 10.1152/jn.1972.35.1.96; HAENNY PE, 1988, EXP BRAIN RES, V69, P225, DOI 10.1007/BF00247569; HAENNY PE, 1988, EXP BRAIN RES, V69, P245, DOI 10.1007/BF00247570; HOREL JA, 1984, BEHAV NEUROSCI, V98, P310, DOI 10.1037/0735-7044.98.2.310; Hosmer D., 2000, APPL LOGISTIC REGRES, V2; Kohonen Teuvo, 1984, SELF ORG ASS MEMORY; MIKAMI A, 1980, BRAIN RES, V182, P65, DOI 10.1016/0006-8993(80)90830-6; MILLER EK, IN PRESS VIS NEUROSC; MISHKIN M, 1982, PHILOS T R SOC LONDO, V85, P95; MIYASHITA Y, 1988, NATURE, V331, P68, DOI 10.1038/331068a0; RICHES IP, 1991, J NEUROSCI, V11, P1763; ROLLS ET, 1989, EXP BRAIN RES, V76, P153; SQUIRE L, 1991, Society for Neuroscience Abstracts, V17, P4	18	507	514	2	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	NOV 29	1991	254	5036					1377	1379		10.1126/science.1962197	http://dx.doi.org/10.1126/science.1962197			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR777	1962197				2022-12-28	WOS:A1991GR77700056
J	DUNKLE, LM; ARVIN, AM; WHITLEY, RJ; ROTBART, HA; FEDER, HM; FELDMAN, S; GERSHON, AA; LEVY, ML; HAYDEN, GF; MCGUIRT, PV; HARRIS, J; BALFOUR, HH				DUNKLE, LM; ARVIN, AM; WHITLEY, RJ; ROTBART, HA; FEDER, HM; FELDMAN, S; GERSHON, AA; LEVY, ML; HAYDEN, GF; MCGUIRT, PV; HARRIS, J; BALFOUR, HH			A CONTROLLED TRIAL OF ACYCLOVIR FOR CHICKENPOX IN NORMAL-CHILDREN	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							VARICELLA-ZOSTER VIRUS; ACUTE HERPES-ZOSTER; ORAL ACYCLOVIR; IMMUNOCOMPROMISED PATIENTS; THERAPY; INFECTION; COMPLICATIONS	Background. Chickenpox, the primary infection caused by the varicella-zoster virus, affects more than 3 million children a year in the United States. Although usually self-limited, chickenpox can cause prolonged discomfort and is associated with infrequent but serious complications, Methods. To evaluate the effectiveness of acyclovir for the treatment of chickenpox, we conducted a multicenter, double-blind, placebo-controlled study involving 815 healthy children 2 to 12 years old who contracted chickenpox. Treatment with acyclovir was begun within the first 24 hours of rash and was administered orally in a dose of 20 mg per kilogram of body weight four times daily for five days. Results. The children treated with acyclovir had fewer varicella lesions than those given placebo (mean number, 294 vs. 347; P < 0.001), and a smaller proportion of them had more than 500 lesions (21 percent, as compared with 38 percent with placebo; P < 0.001). In over 95 percent of the recipients of acyclovir no new lesions formed after day 3, whereas new lesions were forming in 20 percent of the placebo recipients on day 6 or later. The recipients of acyclovir also had accelerated progression to the crusted and healed stages, less itching, and fewer residual lesions after 28 days. In the children treated with acyclovir the duration of fever and constitutional symptoms was limited to three to four days, whereas in 20 percent of the children given placebo illness lasted more than four days. There was no significant difference between groups in the distribution of 11 disease complications (1 0 bacterial skin infections and 1 case of transient cerebellar ataxia). Acyclovir was well tolerated, and there was no significant difference between groups in the titers of antibodies against varicella-zoster virus. Conclusions. Acyclovir is a safe treatment that reduces the duration and severity of chickenpox in normal children when therapy is initiated during the first 24 hours of rash. Whether treatment with acyclovir can reduce the rare, serious complications of chickenpox remains uncertain.	STANFORD UNIV,MED CTR,SCH MED,DEPT PEDIAT,DIV INFECT DIS,STANFORD,CA 94305; BURROUGHS WELLCOME CO,DEPT CLIN STAT,RES TRIANGLE PK,NC 27709; UNIV MISSISSIPPI,DEPT PEDIAT,JACKSON,MS 39216; COLUMBIA UNIV,DEPT PEDIAT,NEW YORK,NY 10027; UNIV MINNESOTA,DEPT LAB MED & PATHOL,MINNEAPOLIS,MN 55455; UNIV VIRGINIA,HLTH SCI CTR,DEPT PEDIAT,CHARLOTTESVILLE,VA 22903; BAYLOR COLL MED,DEPT PEDIAT,HOUSTON,TX 77030; BAYLOR COLL MED,DEPT DERMATOL,HOUSTON,TX 77030; BURROUGHS WELLCOME CO,DEPT INFECT DIS,RES TRIANGLE PK,NC 27709; UNIV COLORADO,DEPT PEDIAT,DENVER,CO 80202; UNIV CONNECTICUT,CTR HLTH,DEPT PEDIAT,FARMINGTON,CT 06032; UNIV CONNECTICUT,CTR HLTH,DEPT FAMILY MED,FARMINGTON,CT 06032; ST LOUIS UNIV,DEPT PEDIAT,ST LOUIS,MO 63103; UNIV ALABAMA,DEPT CLIN VIROL,BIRMINGHAM,AL 35294	Stanford University; Burroughs Wellcome Fund; University of Mississippi; Columbia University; University of Minnesota System; University of Minnesota Twin Cities; University of Virginia; Baylor College of Medicine; Baylor College of Medicine; Burroughs Wellcome Fund; University of Colorado System; University of Colorado Denver; University of Connecticut; University of Connecticut; Saint Louis University; University of Alabama System; University of Alabama Birmingham								BALFOUR HH, 1990, J PEDIATR-US, V116, P633, DOI 10.1016/S0022-3476(05)81618-X; BALFOUR HH, 1983, NEW ENGL J MED, V308, P1448, DOI 10.1056/NEJM198306163082404; BEAN B, 1982, LANCET, V2, P118; BEHRMAN R, 1983, NELSON TXB PEDIATRIC, P756; COBO LM, 1986, OPHTHALMOLOGY, V93, P763; COLE NL, 1986, J INFECT DIS, V153, P605, DOI 10.1093/infdis/153.3.605; COLLINS P, 1988, AM J MED, V85, P129; GUESS HA, 1986, PEDIATRICS, V78, P723; GUESS HA, 1984, AM J DIS CHILD, V184, P1055; HUFF JC, 1988, AM J MED, V85, P84; LICHTENSTEIN PK, 1983, NEW ENGL J MED, V309, P133, DOI 10.1056/NEJM198307213090302; MCKENDRICK MW, 1986, BRIT MED J, V293, P1529, DOI 10.1136/bmj.293.6561.1529; PETERSLUND NA, 1981, LANCET, V2, P827; PITEL PA, 1980, PEDIATRICS, V65, P631; PREBLUD SR, 1986, PEDIATRICS, V78, P728; PROBER CG, 1982, J PEDIATR-US, V101, P622, DOI 10.1016/S0022-3476(82)80725-7; SHEPP DH, 1986, NEW ENGL J MED, V314, P208, DOI 10.1056/NEJM198601233140404; STRAUS SE, 1988, ANN INTERN MED, V108, P221, DOI 10.7326/0003-4819-108-2-221; STRAUS SE, 1988, ANN INTERN MED, V109, P438; TRIEBWASSER JH, 1967, MEDICINE, V46, P409, DOI 10.1097/00005792-196709000-00003; WEBER DM, 1965, J AMER MED ASSOC, V192, P572, DOI 10.1001/jama.1965.03080190138035; WILLIAMS V, 1974, J INFECT DIS, V130, P669, DOI 10.1093/infdis/130.6.669	22	218	224	0	4	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 28	1991	325	22					1539	1544		10.1056/NEJM199111283252203	http://dx.doi.org/10.1056/NEJM199111283252203			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GR380	1944438				2022-12-28	WOS:A1991GR38000003
J	IMBERTI, L; SOTTINI, A; BETTINARDI, A; PUOTI, M; PRIMI, D				IMBERTI, L; SOTTINI, A; BETTINARDI, A; PUOTI, M; PRIMI, D			SELECTIVE DEPLETION IN HIV-INFECTION OF T-CELLS THAT BEAR SPECIFIC T-CELL RECEPTOR-V-BETA SEQUENCES	SCIENCE			English	Article							STAPHYLOCOCCAL ENTEROTOXINS; SUPERANTIGENS; INDUCTION; MURINE; CHAIN	The mechanism of T cell depletion during infection with the human immunodeficiency virus (HIV) is unclear. Examination of the repertoire of T cell receptor V (variable) regions m persons infected with HIV revealed the absence of a common set of V-beta-regions, whereas V-alpha usage was normal. The lack of these V-beta-segments did not appear to correlate with opportunistic infections. The selective elimination of T cells that express a defined set of V-beta-sequences may indicate the presence of an HIV-encoded superantigen, similar to those encoded by the long terminal repeat of the mouse mammary tumor virus.	OSPED CIVILE,DIV MALATTIE INFETT 1,BRESCIA,ITALY	Hospital Spedali Civili Brescia	IMBERTI, L (corresponding author), UNIV BRESCIA,SCH MED,INST CHEM,CNR,CONSORZIO BIOTECNOL,P SPEDALI CIVILI 1,I-25123 BRESCIA,ITALY.		Puoti, Massimo/AAA-6580-2020	Imberti, Luisa/0000-0002-2075-8391; Puoti, Massimo/0000-0003-3278-7138				ACHAORBEA H, 1991, NATURE, V350, P207, DOI 10.1038/350207a0; BACCALA R, 1991, P NATL ACAD SCI USA, V88, P2908, DOI 10.1073/pnas.88.7.2908; CERNY A, 1990, J EXP MED, V171, P315, DOI 10.1084/jem.171.1.315; CHOI YW, 1989, P NATL ACAD SCI USA, V86, P8941, DOI 10.1073/pnas.86.22.8941; CHOI YW, 1991, NATURE, V350, P203, DOI 10.1038/350203a0; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DAVIS MM, 1985, ANNU REV IMMUNOL, V3, P537, DOI 10.1146/annurev.iy.03.040185.002541; DYASON PJ, 1991, NATURE, V349, P531; FRANKEL WN, 1991, NATURE, V349, P526, DOI 10.1038/349526a0; HERMAN A, 1990, J EXP MED, V172, P709, DOI 10.1084/jem.172.3.709; HUGIN AW, 1991, SCIENCE, V252, P424, DOI 10.1126/science.1850169; JANEWAY C, 1991, NATURE, V349, P459, DOI 10.1038/349459a0; JANEWAY CA, 1990, CELL, V63, P659, DOI 10.1016/0092-8674(90)90130-7; KAPPLER J, 1989, SCIENCE, V244, P811, DOI 10.1126/science.2524876; KAPPLER JW, 1988, NATURE, V332, P35, DOI 10.1038/332035a0; MACDONALD HR, 1988, J EXP MED, V167, P2005, DOI 10.1084/jem.167.6.2005; MANTERO G, 1991, CLIN CHEM, V37, P422; MARRACK P, 1991, NATURE, V349, P524, DOI 10.1038/349524a0; MARRACK P, 1990, SCIENCE, V248, P705, DOI 10.1126/science.2185544; SOTTINI A, 1991, EUR J IMMUNOL, V21, P461, DOI 10.1002/eji.1830210231; STROMINGER JL, 1989, SCIENCE, V244, P943, DOI 10.1126/science.2658058; WILSON RK, 1988, IMMUNOL REV, V101, P149, DOI 10.1111/j.1600-065X.1988.tb00736.x; WOODLAND DL, 1991, NATURE, V349, P529, DOI 10.1038/349529a0	23	349	355	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	NOV 8	1991	254	5033					860	862		10.1126/science.1948066	http://dx.doi.org/10.1126/science.1948066			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN833	1948066				2022-12-28	WOS:A1991GN83300046
J	VALLELY, S				VALLELY, S			JUNIOR DOCTORS - THE NEW-DEAL - THE NEGOTIATING PERSPECTIVE	BRITISH MEDICAL JOURNAL			English	Article											VALLELY, S (corresponding author), ROYAL VICTORIA HOSP,RADIOL,BELFAST BT9 7AB,NORTH IRELAND.							DELAMOTHE T, 1990, BRIT MED J, V301, P1235; DOWIE R, 1989, PATTERNS HOSPITAL ME; 1991, JUNIOR DOCTORS NEW D; 1990, HEADS AGREEMENT MINI; 1987, HOSPITAL MED STAFFIN; 1990, CMND937; 1986, CMND9788	7	2	2	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	OCT 26	1991	303	6809					1050	1052		10.1136/bmj.303.6809.1050	http://dx.doi.org/10.1136/bmj.303.6809.1050			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GM478	1954462	Bronze, Green Published			2022-12-28	WOS:A1991GM47800029
J	SHIMADA, S; KITAYAMA, S; LIN, CL; PATEL, A; NANTHAKUMAR, E; GREGOR, P; KUHAR, M; UHL, G				SHIMADA, S; KITAYAMA, S; LIN, CL; PATEL, A; NANTHAKUMAR, E; GREGOR, P; KUHAR, M; UHL, G			CLONING AND EXPRESSION OF A COCAINE-SENSITIVE DOPAMINE TRANSPORTER COMPLEMENTARY-DNA	SCIENCE			English	Article							XENOPUS-LAEVIS OOCYTES; RAT STRIATUM; UPTAKE SITES; BINDING; NOREPINEPHRINE; INHIBITION; RECEPTORS; LIGAND; GABA	A rat dopamine (DA) transporter complementary DNA has been isolated with combined complementary DNA homology and expression approaches. The DA transporter is a 619-amino acid protein with 12 hydrophobic putative membrane-spanning domains and homology to the norepinephrine and gamma-aminobutyric acid transporters. The expressed complementary DNA confers transport of [H-3]DA in Xenopus oocytes and in COS cells. Binding of the cocaine analog [H-3]CFT {[H-3]2-beta-carbomethoxy-3-beta-(4-fluorophenyl)tropane} to transfected COS cell membranes yields a pharmacological profile similar to that in striatal membranes.	JOHNS HOPKINS UNIV,SCH MED,DEPT NEUROL,BALTIMORE,MD 21224; JOHNS HOPKINS UNIV,SCH MED,DEPT NEUROSCI,BALTIMORE,MD 21224	Johns Hopkins University; Johns Hopkins University			Lin, Chien-liang G/E-3513-2011					BANNON MJ, 1990, J NEUROCHEM, V54, P706, DOI 10.1111/j.1471-4159.1990.tb01929.x; BERGER P, 1985, EUR J PHARMACOL, V107, P289, DOI 10.1016/0014-2999(85)90075-5; BERGMAN J, 1989, J PHARMACOL EXP THER, V251, P150; BLAKELY RD, 1988, P NATL ACAD SCI USA, V85, P9846, DOI 10.1073/pnas.85.24.9846; BOJA JW, 1989, EUR J PHARMACOL, V173, P215, DOI 10.1016/0014-2999(89)90524-4; GUASTELLA J, 1990, SCIENCE, V249, P1303, DOI 10.1126/science.1975955; HORN AS, 1990, PROG NEUROBIOL, V34, P387, DOI 10.1016/0301-0082(90)90033-D; HYTTEL J, 1982, PROG NEURO-PSYCHOPH, V6, P277, DOI 10.1016/S0278-5846(82)80179-6; IVERSEN LL, 1976, HDB PSYCHOPHARMACOLO, P381; JAVITCH JA, 1984, MOL PHARMACOL, V26, P35; JAVORYAGID F, 1985, N-S ARCH PHARMACOL, V329, P227; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; KUHAR MJ, 1978, J NEUROCHEM, V31, P251, DOI 10.1111/j.1471-4159.1978.tb12456.x; KUHAR MJ, 1990, EUR NEUROL, V30, P15; MADRAS BK, 1989, MOL PHARMACOL, V36, P518; PACHOLCZYK T, 1991, NATURE, V350, P350, DOI 10.1038/350350a0; RITZ MC, 1987, SCIENCE, V237, P1219, DOI 10.1126/science.2820058; RITZ MC, 1990, LIFE SCI, V46, P635, DOI 10.1016/0024-3205(90)90132-B; SCHAEFFERJC, 1991, MOL BRAIN RES, V9, P271; SCHOEMAKER H, 1985, N-S ARCH PHARMACOL, V329, P227, DOI 10.1007/BF00501873; UHL GR, 1991, MOL BRAIN RES, V9, P23, DOI 10.1016/0169-328X(91)90126-I	21	548	564	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	OCT 25	1991	254	5031					576	578		10.1126/science.1948034	http://dx.doi.org/10.1126/science.1948034			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GL799	1948034				2022-12-28	WOS:A1991GL79900051
J	DUNCAN, ME; TIBAUX, G; PELZER, A; REIMANN, K; PEUTHERER, JF; SIMMONDS, P; YOUNG, H; JAMIL, Y; DAROUGHAR, S				DUNCAN, ME; TIBAUX, G; PELZER, A; REIMANN, K; PEUTHERER, JF; SIMMONDS, P; YOUNG, H; JAMIL, Y; DAROUGHAR, S			1ST COITUS BEFORE MENARCHE AND RISK OF SEXUALLY-TRANSMITTED DISEASE	LANCET			English	Article									UNIV EDINBURGH,DEPT BACTERIOL,EDINBURGH EH8 9YL,MIDLOTHIAN,SCOTLAND; STATE UNIV LIEGE,B-4000 LIEGE,BELGIUM; STATENS SERUM INST,DK-2300 COPENHAGEN S,DENMARK; INST OPHTHALMOL,LONDON WC1H 9QS,ENGLAND	University of Edinburgh; University of Liege; Statens Serum Institut; University of London; University College London				Simmonds, Peter/0000-0002-7964-4700	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BARRON SL, 1986, BRIT J OBSTET GYNAEC, V93, P787, DOI 10.1111/j.1471-0528.1986.tb08070.x; BOUVET E, 1989, LANCET, V1, P615; BUCKLEY JD, 1981, LANCET, V2, P1010; CLAY JC, 1988, GENITOURIN MED, V64, P135; DUNCAN ME, 1980, AM J OBSTET GYNECOL, V138, P1059, DOI 10.1016/0002-9378(80)91108-4; Edington G M, 1970, Afr J Med Sci, V1, P67; FORSEY T, 1980, J CLIN PATHOL, V33, P171, DOI 10.1136/jcp.33.2.171; GEBRESELASSIE L, 1983, B WORLD HEALTH ORGAN, V61, P991; JAGER O. A., 1963, Ethiopian Medical Journal, V1, P230; LENTNER C, 1984, GEIGY SCI TABLES, V3, P150; MUNOZ N, 1988, BRIT J CANCER, V57, P1, DOI 10.1038/bjc.1988.1; PERINE PL, 1980, AM J OBSTET GYNECOL, V138, P969, DOI 10.1016/0002-9378(80)91089-3; PEUTHERER JF, 1981, MED LAB SCI, V38, P355; PROUT MN, 1987, EPIDEMIOLOGY HLTH PO, pB117; REIMANN K, 1987, GENITOURIN MED, V63, P250; ROTKIN ID, 1973, CANCER RES, V33, P1353; SCHULZ KF, 1986, AFRICAN J STD, V3, P56; SKEGG DCG, 1982, LANCET, V2, P581; TREHARNE JD, 1977, J CLIN PATHOL, V30, P510, DOI 10.1136/jcp.30.6.510; WALKER ARP, 1985, S AFR MED J, V68, P316; YOUNG H, 1974, BRIT J VENER DIS, V50, P341	21	65	65	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	FEB 10	1990	335	8685					338	340		10.1016/0140-6736(90)90617-E	http://dx.doi.org/10.1016/0140-6736(90)90617-E			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CM846	1967779				2022-12-28	WOS:A1990CM84600014
J	LOPEZJARAMILLO, P; NARVAEZ, M; FELIX, C; LOPEZ, A				LOPEZJARAMILLO, P; NARVAEZ, M; FELIX, C; LOPEZ, A			DIETARY CALCIUM SUPPLEMENTATION AND PREVENTION OF PREGNANCY HYPERTENSION	LANCET			English	Letter											LOPEZJARAMILLO, P (corresponding author), CENT UNIV,FAC MED SCI,INVEST METAB & NUTR LAB,IQUIQUE & SODIRO,QUITO,ECUADOR.			Felix, Camilo/0000-0003-0224-2321				LOPEZ-JARAMILLO P, 1988, Jornal Brasileiro de Ginecologia, V98, P189; LOPEZJARAMILLO P, 1989, BRIT J OBSTET GYNAEC, V96, P648, DOI 10.1111/j.1471-0528.1989.tb03278.x; LOPEZJARAMILLO P, 1987, LIFE SCI, V40, P983; MACGILLVERAY I, 1983, PREECLAMPSIA; Moscoso H., 1987, REV FACULTAD CIENCIA, V12, P7; NARVAEZ M, 1990, INT J GYNECOL OBSTET, V31, P9, DOI 10.1016/0020-7292(90)90174-J; VILLAR J, 1987, OBSTET GYNECOL, V70, P317; WALLENBURG HCS, 1986, LANCET, V1, P1; WEIGEL M, IN PRESS ARCH LATINO	9	82	87	0	4	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	FEB 3	1990	335	8684					293	293		10.1016/0140-6736(90)90112-I	http://dx.doi.org/10.1016/0140-6736(90)90112-I			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CL815	1967748				2022-12-28	WOS:A1990CL81500035
J	JALIHAL, S; MORRIS, GK				JALIHAL, S; MORRIS, GK			ANTISTREPTOKINASE TITERS AFTER INTRAVENOUS STREPTOKINASE	LANCET			English	Article									CITY HOSP NOTTINGHAM,NOTTINGHAM NG5 1PB,ENGLAND; UNIV NOTTINGHAM HOSP,QUEENS MED CTR,DEPT CARDIOL,NOTTINGHAM NG7 2UH,ENGLAND	Nottingham University Hospital NHS Trust; Nottingham City Hospital; University of Nottingham	JALIHAL, S (corresponding author), UNIV NOTTINGHAM HOSP,QUEENS MED CTR,DEPT HAEMATOL,NOTTINGHAM NG7 2UH,ENGLAND.							ARGENT N, 1990, LANCET, P106; CALLAN MFC, 1990, LANCET, P106; DYKEWICZ M S, 1986, Archives of Internal Medicine, V146, P305, DOI 10.1001/archinte.146.2.305; MCGRATH KG, 1984, JAMA-J AM MED ASSOC, V252, P1314, DOI 10.1001/jama.252.10.1314; PAYNE ST, 1989, LANCET, V2, P1398	5	84	86	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	JAN 27	1990	335	8683					184	185		10.1016/0140-6736(90)90276-B	http://dx.doi.org/10.1016/0140-6736(90)90276-B			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CL185	1967665				2022-12-28	WOS:A1990CL18500002
J	DIMOPOULOS, MA; BARLOGIE, B; SMITH, TL; ALEXANIAN, R				DIMOPOULOS, MA; BARLOGIE, B; SMITH, TL; ALEXANIAN, R			HIGH SERUM LACTATE-DEHYDROGENASE LEVEL AS A MARKER FOR DRUG-RESISTANCE AND SHORT SURVIVAL IN MULTIPLE-MYELOMA	ANNALS OF INTERNAL MEDICINE			English	Article							PROGNOSTIC FACTORS; STAGING SYSTEM; BETA-2-MICROGLOBULIN; MICROGLOBULIN; LYMPHOMA	Objective: To evaluate serum lactate dehydrogenase (LDH) as a prognostic factor in previously untreated patients with multiple myeloma. Design: Study of 391 consecutive patients with uniformly treated multiple myeloma, followed until death in 63% of patients. Setting: Tertiary, referral cancer center. Patients: A total of 391 consecutive, previously untreated, symptomatic patients with various stages of multiple myeloma. Intervention: Various chemotherapy regimens that included doxorubicin or glucocorticoids, or both, with a consistent response rate (53%). Measurements: Outcomes included clinical response based on a 75% reduction of calculated tumor load and survival time from treatment. Univariate and multivariate analyses were used. Main Results: Eleven percent of patients showed a high serum LDH level of more than 5.0-mu-kat/L (300 U/L). An elevated LDH level was seen more frequently with a rise in the tumor load; an increased level was present in 26% of patients with high tumor mass. A high LDH level was associated with plasma cell leukemia or lymphoma-like clinical features (43%) and with plasma cell hypodiploidy (17%). Only 20% of patients with elevated LDH levels responded to chemotherapy compared with a response rate of 57% for patients with low levels of LDH. Using multivariate analysis, LDH was a significant independent predictor of response (P = 0.001), with an odds ratio of 0.25 (95% Cl, 0.11 to 0.57). A high LDH level was associated with a short median survival (9 months) and showed the highest relative risk (2.63; Cl, 1.75 to 3.95; P = 0.001). Conclusions: Elevation of the LDH level suggests the presence of occult extraosseous disease and high tumor mass. The LDH level is a predictor of a poor prognosis in selected patients who should be considered for early intensive treatment.	UNIV TEXAS, MD ANDERSON CANC CTR, BOX 1, 1515 HOLCOMBE BLVD, HOUSTON, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center			Dimopoulos, Meletios Athanasios/AAD-4130-2019	Dimopoulos, Meletios/0000-0001-8990-3254	NATIONAL CANCER INSTITUTE [R01CA037161, R01CA028771, P30CA016672] Funding Source: NIH RePORTER; NCI NIH HHS [CA-28771, CA-16672, CA-37161] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALEXANIAN R, 1975, CANCER, V36, P1192, DOI 10.1002/1097-0142(197510)36:4<1192::AID-CNCR2820360403>3.0.CO;2-I; ALEXANIAN R, 1990, AM J HEMATOL, V33, P86, DOI 10.1002/ajh.2830330203; ALEXANIAN R, 1985, AM J HEMATOL, V20, P345, DOI 10.1002/ajh.2830200405; BARLOGIE B, 1989, ANN INTERN MED, V110, P521, DOI 10.7326/0003-4819-110-7-521; BARLOGIE B, 1985, BLOOD, V66, P338; BARLOGIE B, 1989, J CLIN ONCOL, V7, P1514, DOI 10.1200/JCO.1989.7.10.1514; Cox, 1970, ANAL BINARY DATA, P87; COX DR, 1972, J R STAT SOC B, V34, P187; DALTON WS, 1989, J CLIN ONCOL, V7, P415, DOI 10.1200/JCO.1989.7.4.415; DURIE BGM, 1990, BLOOD, V75, P823; DURIE BGM, 1975, CANCER, V36, P842, DOI 10.1002/1097-0142(197509)36:3<842::AID-CNCR2820360303>3.0.CO;2-U; GOLDIE JH, 1983, CANCER TREAT REP, V67, P923; GOULD J, 1988, BLOOD, V71, P453; GREIPP PR, 1988, BLOOD, V72, P219; JAGANNATH S, 1990, BLOOD, V76, P1860; MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163; SALMON SE, 1978, NEW ENGL J MED, V298, P1321, DOI 10.1056/NEJM197806152982401; SIMONSSON B, 1987, EUR J CLIN INVEST, V17, P336, DOI 10.1111/j.1365-2362.1987.tb02197.x; SWAN F, 1989, J CLIN ONCOL, V7, P1518, DOI 10.1200/JCO.1989.7.10.1518; [No title captured]	20	152	155	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 15	1991	115	12					931	935		10.7326/0003-4819-115-12-931	http://dx.doi.org/10.7326/0003-4819-115-12-931			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GU417	1952489				2022-12-28	WOS:A1991GU41700003
J	TAN, EM				TAN, EM			AUTOANTIBODIES IN PATHOLOGY AND CELL BIOLOGY	CELL			English	Review							DNA-POLYMERASE-DELTA; AUXILIARY PROTEIN; TOPOISOMERASE-I				TAN, EM (corresponding author), SCRIPPS RES INST, WM KECK AUTOIMMUNE DIS CTR, DEPT MOLEC & EXPTL MED, LA JOLLA, CA 92037 USA.							AMAGAI M, 1991, CELL, V67, P869, DOI 10.1016/0092-8674(91)90360-B; CHAN EKL, 1991, IN PRESS J EXP MED; DANG CV, 1988, FASEB J, V2, P2376, DOI 10.1096/fasebj.2.8.2452112; GULDNER HH, 1986, CHROMOSOMA, V94, P132, DOI 10.1007/BF00286991; KASS S, 1990, CELL, V60, P897, DOI 10.1016/0092-8674(90)90338-F; MATSUI S, 1985, CHROMOSOMA, V92, P1, DOI 10.1007/BF00327238; MAUL GG, 1986, P NATL ACAD SCI USA, V83, P5145, DOI 10.1073/pnas.83.14.5145; MULLER MT, 1985, EMBO J, V4, P1237, DOI 10.1002/j.1460-2075.1985.tb03766.x; OLINS DE, 1989, J CELL BIOL, V109, P1399, DOI 10.1083/jcb.109.4.1399; SHARP PA, 1987, SCIENCE, V235, P766, DOI 10.1126/science.3544217; SURH CD, 1990, J IMMUNOL, V144, P2647; SUZUKA I, 1989, P NATL ACAD SCI USA, V86, P3189, DOI 10.1073/pnas.86.9.3189; SZABO A, 1991, CELL, V67, P325, DOI 10.1016/0092-8674(91)90184-Z; TAN CK, 1987, NUCLEIC ACIDS RES, V15, P9299, DOI 10.1093/nar/15.22.9299; Tan E.M., 1989, ADV IMMUNOL, V44, P151, DOI [10.1016/S0065-2776(08)60641-0, DOI 10.1016/S0065-2776(08)60641-0]	15	239	246	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 29	1991	67	5					841	842		10.1016/0092-8674(91)90356-4	http://dx.doi.org/10.1016/0092-8674(91)90356-4			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GT755	1959131				2022-12-28	WOS:A1991GT75500003
J	ROSENBLATT, M; FREILICH, B; KIRSCH, D				ROSENBLATT, M; FREILICH, B; KIRSCH, D			AIR BAGS - TRADE-OFFS	NEW ENGLAND JOURNAL OF MEDICINE			English	Letter											ROSENBLATT, M (corresponding author), MT SINAI HOSP,NEW YORK,NY 10028, USA.							EVANS L, 1990, ACCIDENT ANAL PREV, V22, P167, DOI 10.1016/0001-4575(90)90067-U; GREER CR, 17TH P C AM ASS AUT, P21; INGRAHAM HJ, 1991, NEW ENGL J MED, V324, P1599; LANGUIEDA K, 1972, NOV P STAPP CAR CRAS, P252; LESTINA DC, 1991, JAMA-J AM MED ASSOC, V265, P1409, DOI 10.1001/jama.265.11.1409; 1991, CONSUM REP, V56, P219	6	28	28	0	0	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 21	1991	325	21					1518	1519						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GQ406	1944435				2022-12-28	WOS:A1991GQ40600033
J	TOBIN, JR; DOYLE, TP; ACKERMAN, AD; BRENNER, JI				TOBIN, JR; DOYLE, TP; ACKERMAN, AD; BRENNER, JI			ASTEMIZOLE-INDUCED CARDIAC CONDUCTION DISTURBANCES IN A CHILD	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Note							TORSADE-DE-POINTES; HISTAMINE RECEPTORS; PHARMACOLOGICAL CHARACTERIZATION; OVERDOSE; SENSITIVITY; H1-RECEPTOR; ANTAGONISTS	The newly available antihistamine astemizole (Hismanal) has been previously associated with hemodynamically significant cardiac tachydysrhythmias. We describe a 3-year-old girl who developed multiple different cardiac dysrhythmias after an astemizole overdose. No hemodynamic compromise occurred, and the electrocardiogram returned to normal without use of antiarrhythmic agents within 7 hours.	UNIV MARYLAND,MED SYST,DIV PEDIAT CARDIOL,BALTIMORE,MD 21201; JOHNS HOPKINS UNIV,DEPT ANESTHESIOL & CRIT CARE MED,BALTIMORE,MD 21218; UNIV MARYLAND,MED SYST,DIV PEDIAT CRIT CARE MED,BALTIMORE,MD 21201	University System of Maryland; University of Maryland Baltimore; Johns Hopkins University; University System of Maryland; University of Maryland Baltimore								ARRANG JM, 1987, NEUROSCIENCE, V23, P149, DOI 10.1016/0306-4522(87)90279-X; ARRANG JM, 1987, NATURE, V327, P117, DOI 10.1038/327117a0; AWOUTERS FHL, 1983, ARZNEIMITTEL-FORSCH, V33-1, P381; BISHOP RO, 1989, ARCH EMERG MED, V6, P63; CRAFT TM, 1986, BRIT MED J, V292, P660, DOI 10.1136/bmj.292.6521.660; FREEDBERG RS, 1987, JAMA-J AM MED ASSOC, V257, P660, DOI 10.1001/jama.257.5.660; KINGSWOOD JC, 1986, HUM TOXICOL, V5, P43, DOI 10.1177/096032718600500108; LEVI R, 1974, EUR J PHARMACOL, V27, P330, DOI 10.1016/0014-2999(74)90008-9; LEVI R, 1975, EUR J PHARMACOL, V30, P328, DOI 10.1016/0014-2999(75)90117-X; LEVI R, 1982, KLIN WOCHENSCHR, V60, P965, DOI 10.1007/BF01716956; NIEMEGEERS CJE, 1986, AGENTS ACTIONS, V18, P141, DOI 10.1007/BF01988005; SIMONS FER, 1988, LANCET, V2, P624; SNOOK J, 1988, BRIT J CLIN PRACT, V42, P257; VERMA SC, 1977, J PHARMACOL EXP THER, V200, P352; 1989, MED LETT DRUGS THER, V31, P43	15	37	39	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 20	1991	266	19					2737	2740		10.1001/jama.266.19.2737	http://dx.doi.org/10.1001/jama.266.19.2737			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GP691	1942426				2022-12-28	WOS:A1991GP69100030
J	MARGOLIS, P; DRIKS, A; LOSICK, R				MARGOLIS, P; DRIKS, A; LOSICK, R			ESTABLISHMENT OF CELL TYPE BY COMPARTMENTALIZED ACTIVATION OF A TRANSCRIPTION FACTOR	SCIENCE			English	Article							DUPLICATED SPORULATION GENES; BACILLUS-SUBTILIS; RNA-POLYMERASE; SIGMA-FACTOR; ENDOSPORE FORMATION; EXPRESSION; SPOIIA; PROMOTER; MUTATIONS; PROTEINS	Early in the process of spore formation in Bacillus subtilis a septum is formed that partitions the sporangium into daughter cells called the forespore and the mother cell. The daughter cells each have their own chromosome but follow dissimilar programs of gene expression. Differential gene expression in the forespore is now shown to be established by the compartmentalized activity of the transcription factor sigma-F. The sigma-F factor is produced prior to septation, but is active only in the forespore compartment of the post-septation sporangium. The sigma-F factor is controlled by the products of sporulation operons spoIIA and spoIIE, which may be responsible for confining its activity to one of the daughter cells.	HARVARD UNIV,BIOL LABS,DEPT CELLULAR & DEV BIOL,CAMBRIDGE,MA 02138	Harvard University					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM018568, R01GM018568] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM18568] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		CUTTING S, 1991, GENE DEV, V5, P456, DOI 10.1101/gad.5.3.456; DRIKS A, IN PRESS P NAT ACAD; DRIKS A, UNPUB; ERRINGTON J, 1985, FEBS LETT, V188, P184, DOI 10.1016/0014-5793(85)80368-9; ERRINGTON J, 1986, J GEN MICROBIOL, V132, P2967; ERRINGTON J, 1990, GENETICS BIOTECHNOLO, V3, P257; FORT P, 1984, J GEN MICROBIOL, V130, P2147; FOULGER D, 1989, MOL MICROBIOL, V3, P1247, DOI 10.1111/j.1365-2958.1989.tb00275.x; FRANCESCONI SC, 1988, J BACTERIOL, V170, P5963, DOI 10.1128/jb.170.12.5963-5967.1988; GARDELLA T, 1989, J MOL BIOL, V206, P579, DOI 10.1016/0022-2836(89)90567-6; GHOLAMHOSEINIAN A, 1989, J BACTERIOL, V171, P5747, DOI 10.1128/jb.171.10.5747-5749.1989; GUZMAN PL, COMMUNICATION; IGO M, 1987, J BACTERIOL, V169, P3464, DOI 10.1128/jb.169.8.3464-3469.1987; IGO MM, 1986, J MOL BIOL, V191, P615, DOI 10.1016/0022-2836(86)90449-3; ILLING N, 1991, J BACTERIOL, V173, P3159, DOI 10.1128/JB.173.10.3159-3169.1991; JONAS RM, 1989, J BACTERIOL, V171, P5226, DOI 10.1128/jb.171.9.5226-5228.1989; JONAS RM, 1988, J BACTERIOL, V170, P507, DOI 10.1128/jb.170.2.507-511.1988; KARMAZYNCAMPELLI C, 1989, GENE DEV, V3, P150, DOI 10.1101/gad.3.2.150; LABELL TL, 1987, P NATL ACAD SCI USA, V84, P1784, DOI 10.1073/pnas.84.7.1784; LOSICK R, 1986, ANNU REV GENET, V20, P625, DOI 10.1146/annurev.ge.20.120186.003205; MARGOLIS PS, UNPUB; MASON JM, 1988, J BACTERIOL, V170, P239, DOI 10.1128/jb.170.1.239-244.1988; PARTRIDGE SR, 1991, MOL MICROBIOL, V5, P757, DOI 10.1111/j.1365-2958.1991.tb00746.x; PIGGOT PJ, 1976, BACTERIOL REV, V40, P908, DOI 10.1128/MMBR.40.4.908-962.1976; PIGGOT PJ, 1984, J GEN MICROBIOL, V130, P2123; RATHER PN, 1990, J BACTERIOL, V172, P709, DOI 10.1128/jb.172.2.709-715.1990; RAY C, 1988, J BACTERIOL, V170, P900, DOI 10.1128/jb.170.2.900-907.1988; SAVVA D, 1986, J GEN MICROBIOL, V132, P3005; SCHMIDT R, 1990, P NATL ACAD SCI USA, V87, P9221, DOI 10.1073/pnas.87.23.9221; SIEGELE DA, 1989, J MOL BIOL, V206, P591, DOI 10.1016/0022-2836(89)90568-8; STRAGIER P, 1990, MOL MICROBIOL, V4, P1801, DOI 10.1111/j.1365-2958.1990.tb02028.x; STRAGIER P, 1986, FEBS LETT, V195, P9, DOI 10.1016/0014-5793(86)80119-3; STRAGIER P, 1988, CELL, V52, P697, DOI 10.1016/0092-8674(88)90407-2; STRAGIER P, 1991, IN PRESS PROCARYOTIC, V47; SUN DX, 1991, J BACTERIOL, V173, P2977, DOI 10.1128/JB.173.9.2977-2984.1991; SUN DX, 1989, GENE DEV, V3, P141, DOI 10.1101/gad.3.2.141; SUSSMAN MD, 1991, J BACTERIOL, V173, P291, DOI 10.1128/jb.173.1.291-300.1991; TREMPY JE, 1985, J BACTERIOL, V161, P340, DOI 10.1128/JB.161.1.340-346.1985; WU JJ, 1989, J BACTERIOL, V171, P692, DOI 10.1128/jb.171.2.692-698.1989; YUDKIN MD, 1987, J GEN MICROBIOL, V133, P475; ZHENG LB, 1990, J MOL BIOL, V212, P645, DOI 10.1016/0022-2836(90)90227-D	41	153	156	1	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	OCT 25	1991	254	5031					562	565		10.1126/science.1948031	http://dx.doi.org/10.1126/science.1948031			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL799	1948031				2022-12-28	WOS:A1991GL79900046
J	MILLER, PD				MILLER, PD			MANPOWER AND HOURS OF WORK AGREEMENTS ARE COMPLEMENTARY .2.	BRITISH MEDICAL JOURNAL			English	Article											MILLER, PD (corresponding author), WATFORD DIST GEN HOSP,PSYCHIAT,WATFORD WD1 8HB,HERTS,ENGLAND.							DOWIE R, 1989, PATTERNS HOSPITAL ME; 1990, HEADS AGREEMENT MINI; 1987, HOSPITAL MED STAFFIN; 1986, HOSPITAL MED STAFFIN; 1990, DOH1989 JOINT PLANN, P87; 1990, JOINT PLANNING ADVIS	6	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	OCT 12	1991	303	6807					916	918		10.1136/bmj.303.6807.916	http://dx.doi.org/10.1136/bmj.303.6807.916			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GK221	1933011	Green Published, Bronze			2022-12-28	WOS:A1991GK22100031
J	DER, G; GUPTA, S; MURRAY, RM				DER, G; GUPTA, S; MURRAY, RM			IS SCHIZOPHRENIA DISAPPEARING	LANCET			English	Article									INST PSYCHIAT, DE CRESPIGNY PK, DENMARK HILL, LONDON SE5 8AF, ENGLAND				; Mortensen, Preben Bo/D-2358-2015; murray, robin/F-8658-2012	Der, Geoff/0000-0002-8677-073X; Mortensen, Preben Bo/0000-0002-5230-9865; murray, robin/0000-0003-0829-0519				Bleuler M., 1978, SCHIZOPHRENIC DISORD; COOPER JE, 1987, BRIT J PSYCHIAT, V151, P619, DOI 10.1192/bjp.151.5.619; DICKSON WE, 1986, PSYCHOL MED, V16, P521, DOI 10.1017/S003329170001028X; EAGLES JM, 1988, BRIT J PSYCHIAT, V152, P793, DOI 10.1192/bjp.152.6.793; EAGLES JM, 1985, BRIT J PSYCHIAT, V146, P151, DOI 10.1192/bjp.146.2.151; Hafner H., 1987, SEARCH CAUSES SCHIZO, P47; HARE E, 1986, BRIT J PSYCHIAT, V149, P554, DOI 10.1192/bjp.149.5.554; HARE E, 1983, BRIT J PSYCHIAT, V142, P439, DOI 10.1192/bjp.142.5.439; HARE EH, 1974, J PSYCHOSOM RES, V18, P283, DOI 10.1016/0022-3999(74)90011-7; JOYCE PR, 1987, AUST NZ J PSYCHIAT, V21, P82, DOI 10.3109/00048678709160903; MAHENDRA B, 1981, PSYCHOL MED, V11, P669, DOI 10.1017/S0033291700041155; MUNKJORGENSEN P, 1986, ACTA PSYCHIAT SCAND, V74, P379, DOI 10.1111/j.1600-0447.1986.tb06257.x; MUNKJORGENSEN P, 1986, ACTA PSYCHIAT SCAND, V73, P645, DOI 10.1111/j.1600-0447.1986.tb02738.x; ODEGARD O, 1971, SOC PSYCHIATR, V6, P53, DOI 10.1007/BF00578029; Oedegaard O, 1952, PSYCHIAT QUART, V26, P212, DOI 10.1007/BF01568460; PARKER G, 1985, BRIT J PSYCHIAT, V146, P377, DOI 10.1192/bjp.146.4.377; SARTORIUS N, 1986, PSYCHOL MED, V16, P909, DOI 10.1017/S0033291700011910; SAUGSTAD LF, 1989, SCHIZOPHRENIA BULL, V15, P9, DOI 10.1093/schbul/15.1.9; SYMONDS RL, 1981, PSYCHOL MED, V11, P193, DOI 10.1017/S0033291700053411; TORREY EF, 1989, PSYCHOL MED, V19, P285, DOI 10.1017/S0033291700012320; 1964, STATISTICAL REPORT S, V4; 1964, STATISTICAL REPORT S, V5; 1972, PSYCHIATRIC HOSPITAL; 1964, STATISTICAL REPORT S, V12; 1964, STATISTICAL REPORT S, V11; 1952, SUPPLEMENTS MENTAL H	26	161	163	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 3	1990	335	8688					513	516		10.1016/0140-6736(90)90745-Q	http://dx.doi.org/10.1016/0140-6736(90)90745-Q			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT015	1968536				2022-12-28	WOS:A1990CT01500012
J	HAY, PE; TAYLORROBINSON, D; WALDRON, S; GOLDMEIER, D				HAY, PE; TAYLORROBINSON, D; WALDRON, S; GOLDMEIER, D			AMOXYCILLIN, SYPHILIS, AND HIV-INFECTION	LANCET			English	Letter									ST MARYS HOSP,DEPT GENITOURINARY MED,LONDON W2 1NY,ENGLAND	Imperial College London	HAY, PE (corresponding author), CLIN RES CTR,DIV SEXUALLY TRANSMITTED DIS,HARROW HA1 3UJ,MIDDX,ENGLAND.							BATTEGAY M, 1989, LANCET, V2, P1100; DUNLOP EMC, 1985, GENITOURIN MED, V61, P293; HOOK EW, 1989, J INFECT DIS, V160, P530, DOI 10.1093/infdis/160.3.530; KOMHAUSER DM, 1989, LANCET, V2, P473; MORRISON RE, 1985, GENITOURIN MED, V61, P359	5	4	4	0	1	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	FEB 24	1990	335	8687					474	475		10.1016/0140-6736(90)90708-D	http://dx.doi.org/10.1016/0140-6736(90)90708-D			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CP907	1968195				2022-12-28	WOS:A1990CP90700038
J	GOUDIE, RB; SOUKOP, M; DAGG, JH; LEE, FD				GOUDIE, RB; SOUKOP, M; DAGG, JH; LEE, FD			HYPOTHESIS - SYMMETRICAL CUTANEOUS LYMPHOMA	LANCET			English	Article									GLASGOW ROYAL INFIRM,DEPT MED ONCOL,GLASGOW G4 0SF,SCOTLAND; WESTERN INFIRM & ASSOCIATED HOSP,MED UNIT,GLASGOW G11 6NT,SCOTLAND	University of Glasgow	GOUDIE, RB (corresponding author), UNIV GLASGOW,GLASGOW ROYAL INFIRM,DEPT PATHOL,GLASGOW G4 0SF,SCOTLAND.							BURNET FM, 1959, CLONAL SELECTION THE, P122; GOUDIE BM, 1983, SCOT MED J, V28, P343, DOI 10.1177/003693308302800406; Goudie R B, 1985, Curr Top Pathol, V74, P103; GOUDIE RB, 1989, J PATHOL, V158, P91, DOI 10.1002/path.1711580202; GOUDIE RB, 1974, LANCET, V1, P292; GOWANS JL, 1964, PROC R SOC SER B-BIO, V159, P257, DOI 10.1098/rspb.1964.0001; GRIESSER H, 1989, BLOOD, V73, P1402; KADIN ME, 1985, LANCET, V2, P864; MACKIE RM, 1986, TXB DERMATOLOGY, P1727; PATTERSON JAK, 1987, DERMATOLOGY GENERAL, P1086; STREETER PR, 1988, NATURE, V331, P41, DOI 10.1038/331041a0	11	19	19	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	FEB 10	1990	335	8685					316	318		10.1016/0140-6736(90)90607-7	http://dx.doi.org/10.1016/0140-6736(90)90607-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CM846	1967771				2022-12-28	WOS:A1990CM84600005
J	HALL, PL				HALL, PL			INSTITUTIONAL PATERNALISM	LANCET			English	Letter											HALL, PL (corresponding author), LEAVESDEN HOSP,ABBOTTS LANGLEY,WATFORD WD5 0NU,HERTS,ENGLAND.							BICKNELL J, 1989, BRIT MED J, V299, P1176, DOI 10.1136/bmj.299.6709.1176; CHAMBERS, 1990, LANCET, V335, P173	2	0	0	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	FEB 10	1990	335	8685					357	357		10.1016/0140-6736(90)90645-L	http://dx.doi.org/10.1016/0140-6736(90)90645-L			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CM846	1967793				2022-12-28	WOS:A1990CM84600045
J	ROSENLOF, K; FYHRQUIST, F; TENHUNEN, R				ROSENLOF, K; FYHRQUIST, F; TENHUNEN, R			ERYTHROPOIETIN, ALUMINUM, AND ANEMIA IN PATIENTS ON HEMODIALYSIS	LANCET			English	Article									UNIV HELSINKI, CENT HOSP, DEPT CLIN CHEM, SF-00170 HELSINKI 17, FINLAND	University of Helsinki; Helsinki University Central Hospital	ROSENLOF, K (corresponding author), UNIV HELSINKI, CENT HOSP, DEPT MED 4, UNIONINKATU 38, SF-00170 HELSINKI 17, FINLAND.							ALTMANN P, 1988, LANCET, V1, P1012; BEAUMONT C, 1984, EXP CELL RES, V154, P474, DOI 10.1016/0014-4827(84)90171-X; BROWN S, 1984, CLIN CHEM, V30, P1216; COCHRAN M, 1984, FEBS LETT, V176, P129, DOI 10.1016/0014-5793(84)80926-6; ESCHBACH JW, 1987, NEW ENGL J MED, V316, P73, DOI 10.1056/NEJM198701083160203; GRONHAGENRISKA C, 1989, ALUMINIUM AND IRON OVERLOAD IN HAEMODIALYSIS, P56; JACOBS K, 1985, NATURE, V313, P806, DOI 10.1038/313806a0; MCGONIGLE RJS, 1985, NEPHRON, V39, P1, DOI 10.1159/000183328; MLADENOVIC J, 1988, J CLIN INVEST, V81, P1661, DOI 10.1172/JCI113502; MOREB J, 1983, NEPHRON, V35, P196, DOI 10.1159/000183074; PASANEN AVO, 1980, INT J BIOCHEM, V12, P969; PASANEN AVO, 1985, SCAND J HAEMATOL, V34, P235; PASANEN AVO, 1982, ANN CLIN RES, V14, P61; ROSENLOF K, 1989, J INTERN MED, V226, P311, DOI 10.1111/j.1365-2796.1989.tb01401.x; RUTHERFORD T, 1979, P NATL ACAD SCI USA, V76, P833, DOI 10.1073/pnas.76.2.833; SANO S, 1961, J BIOL CHEM, V236, P1173; SASSA S, 1979, P NATL ACAD SCI USA, V76, P5321, DOI 10.1073/pnas.76.10.5321; TRAPP GA, 1983, LIFE SCI, V33, P311, DOI 10.1016/S0024-3205(83)80002-2; Van de Vyver F L, 1987, Contrib Nephrol, V55, P198; WINEARLS CG, 1986, LANCET, V2, P1175, DOI 10.1016/S0140-6736(86)92192-6	20	92	93	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 3	1990	335	8684					247	249						3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CL815	1967718				2022-12-28	WOS:A1990CL81500002
J	SIDEBOTHAM, RL; BARON, JH				SIDEBOTHAM, RL; BARON, JH			HYPOTHESIS - HELICOBACTER-PYLORI, UREASE, MUCUS, AND GASTRIC-ULCER	LANCET			English	Article									HAMMERSMITH HOSP,ROYAL POSTGRAD MED SCH,LONDON W12 0NN,ENGLAND	Imperial College London								ALLEN A, 1985, DIGEST DIS SCI, V30, P365; BAGSHAW PF, 1987, GUT, V28, P287, DOI 10.1136/gut.28.3.287; BATTEN JJ, 1989, CLIN SCI S21, V77, pP8; BATTEN JJ, 1988, CLIN SCI         S18, V74, pP53; BATTEN JJ, 1988, MUCUS RELATED TOPICS, P20; BEACHEY EH, 1981, J INFECT DIS, V143, P325, DOI 10.1093/infdis/143.3.325; BODE G, 1988, SCAND J GASTROENTERO, V23, P25, DOI 10.3109/00365528809091710; HAZELL SL, 1986, J INFECT DIS, V153, P658, DOI 10.1093/infdis/153.4.658; JONES GW, 1976, INFECT IMMUN, V14, P232, DOI 10.1128/IAI.14.1.232-239.1976; LAWRENCE AI, 1988, MUCUS RELATED TOPICS; LEE WI, 1977, GYNECOL OBSTET INVES, V8, P254, DOI 10.1159/000301094; LIPKIN M, 1987, PHYSL GASTROINTESTIN, P255; MATTSBYBALTZER I, 1988, CAMPYLOBACTER, V4, P141; MURTY VLN, 1984, BIOCHEM BIOPH RES CO, V121, P521, DOI 10.1016/0006-291X(84)90213-4; PEARSON JP, 1981, BIOCHEM J, V197, P155, DOI 10.1042/bj1970155; PRUUL H, 1988, CAMPYLOBACTER, V4, P404; RICHARDSON PS, 1978, RESPIRATORY TRACT MU, V54, P111; ROSE MC, 1984, BIOCHEM J, V222, P371, DOI 10.1042/bj2220371; SAROSIEK J, 1989, Gastroenterology, V96, pA441; SAROSIEK J, 1987, GASTROENTEROLOGY, V92, P1615; SIDEBOTHAM RL, 1989, CLIN SCI S21, V77, pP8; SLAYTER HS, 1984, EUR J BIOCHEM, V142, P209, DOI 10.1111/j.1432-1033.1984.tb08273.x; SLOMIANY BL, 1989, GASTROENTEROLOGY 2, V96, pA478; SNOOK J, 1986, LANCET, V2, P400; TASMANJONES C, 1987, DIGESTION, V37, P1, DOI 10.1159/000199552; THOMSEN L, 1989, SCAND J GASTROENTERO, V24, P761, DOI 10.3109/00365528909093119; TOMPKINS DS, 1987, J CLIN PATHOL, V40, P1387, DOI 10.1136/jcp.40.11.1387-a; YOUNAN F, 1982, GASTROENTEROLOGY, V82, P827	28	66	70	0	5	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	JAN 27	1990	335	8683					193	195		10.1016/0140-6736(90)90279-E	http://dx.doi.org/10.1016/0140-6736(90)90279-E			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CL185	1967668				2022-12-28	WOS:A1990CL18500005
J	MAYBERG, MR; WILSON, SE; YATSU, F; WEISS, DG; MESSINA, L; HERSHEY, LA; COLLING, C; ESKRIDGE, J; DEYKIN, D; WINN, HR				MAYBERG, MR; WILSON, SE; YATSU, F; WEISS, DG; MESSINA, L; HERSHEY, LA; COLLING, C; ESKRIDGE, J; DEYKIN, D; WINN, HR			CAROTID ENDARTERECTOMY AND PREVENTION OF CEREBRAL-ISCHEMIA IN SYMPTOMATIC CAROTID STENOSIS	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article								Objective. - To determine whether carotid endarterectomy provides protection against subsequent cerebral ischemia in men with ischemic symptoms in the distribution of significant (> 50%) ipsilateral internal carotid artery stenosis. Design. - Prospective, randomized, multicenter trial. Setting. - Sixteen university-affiliated Veterans Affairs medical centers. Patients. - Men who presented within 120 days of onset of symptoms that were consistent with transient ischemic attacks, transient monocular blindness, or recent small completed strokes between July 1988 and February 1991. Among 5000 patients screened, 189 individuals were randomized with angiographic internal carotid artery stenosis greater than 50% ipsilateral to the presenting symptoms. Forty-eight eligible patients who refused entry were followed up outside of the trial. Outcome Measures. - Cerebral infarction or crescendo transient ischemic attacks in the vascular distribution of the original symptoms or death within 30 days of randomization. Intervention. - Carotid endarterectomy plus the best medical care (n = 91) vs the best medical care alone (n = 98). Results. - At a mean follow-up of 11.9 months, there was a significant reduction in stroke or crescendo transient ischemic attacks in patients who received carotid endarterectomy (7.7%) compared with nonsurgical patients (19.4%), or an absolute risk reduction of 11.70% (P = .011). The benefit of surgery was more profound in patients with internal carotid artery stenosis greater than 70% (absolute risk reduction, 17.7%; P =.004). The benefit of surgery was apparent within 2 months after randomization, and only one stroke was noted in the surgical group beyond the 30-day perioperative period. Conclusions. - For a selected cohort of men with symptoms of cerebral or retinal ischemia in the distribution of a high-grade internal carotid artery stenosis, carotid endarterectomy can effectively reduce the risk of subsequent ipsilateral cerebral ischemia. The risk of cerebral ischemia in this subgroup of patients is considerably higher than previously estimated.	UNIV WASHINGTON, DEPT NEUROL SURG, SEATTLE, WA 98195 USA; UNIV WASHINGTON, DEPT RADIOL, SEATTLE, WA 98195 USA; VET AFFAIRS MED CTR, SEATTLE, WA USA; UNIV CALIF LOS ANGELES, HARBOR MED CTR, DEPT SURG, TORRANCE, CA 90509 USA; VET ADM WADSWORTH MED CTR, LOS ANGELES, CA 90073 USA; UNIV TEXAS, SCH MED, DEPT NEUROL, HOUSTON, TX 77025 USA; US DEPT VET AFFAIRS COOPERAT STUDIES PROGRAM COORD, PERRY POINT, MD USA; UNIV MICHIGAN, DEPT VASC SURG, ANN ARBOR, MI 48109 USA; VET ADM MED CTR, ANN ARBOR, MI 48105 USA; SUNY BUFFALO, DEPT NEUROL, BUFFALO, NY 14260 USA; VET ADM MED CTR, BUFFALO, NY 14215 USA; US DEPT VET AFFAIRS COOPERAT STUDIES PROGRAM, CLIN RES PHARM, ALBUQUERQUE, NM USA; US DEPT VET AFFAIRS COOPERAT STUDIES PROGRAM, BOSTON, MA USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of Texas System; University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; US Department of Veterans Affairs; Veterans Health Administration (VHA)	MAYBERG, MR (corresponding author), UNIV WASHINGTON, DEPT NEUROSURG, RI20, SEATTLE, WA 98195 USA.		Hershey, Linda Ann/H-7934-2019	Hershey, Linda/0000-0001-5090-6634; Mayberg, Marc/0000-0002-6718-7143				BARNETT HJM, 1984, STROKE, V15, P941, DOI 10.1161/01.STR.15.6.941; BARNETT HJM, 1978, NEW ENGL J MED, V299, P53; BOUSSER MG, 1983, STROKE, V14, P5, DOI 10.1161/01.STR.14.1.5; BROTT T, 1984, STROKE, V15, P950, DOI 10.1161/01.STR.15.6.950; CANDELISE L, 1982, STROKE, V13, P175, DOI 10.1161/01.STR.13.2.175; DYKEN ML, 1984, STROKE, V15, P948, DOI 10.1161/01.STR.15.6.948; EASTON JD, 1977, STROKE, V8, P565, DOI 10.1161/01.STR.8.5.565; FIELDS WS, 1970, J AMER MED ASSOC, V211, P1993, DOI 10.1001/jama.211.12.1993; FIELDS WS, 1977, STROKE, V8, P301, DOI 10.1161/01.STR.8.3.301; GARRAWAY WM, 1987, JAMA-J AM MED ASSOC, V258, P214, DOI 10.1001/jama.258.2.214; GROTTA JC, 1985, NEUROLOGY, V35, P632, DOI 10.1212/WNL.35.5.632; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; LEAPE LL, 1989, NEW ENGL J MED, V321, P653, DOI 10.1056/NEJM198909073211006; MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163; NORRIS JW, 1990, J NEUROL NEUROSUR PS, V53, P235, DOI 10.1136/jnnp.53.3.235; OJEMANN RG, 1983, SURGICAL MANAGEMENT; POKRAS R, 1988, STROKE, V19, P1289, DOI 10.1161/01.STR.19.10.1289; ROEDERER GO, 1984, STROKE, V15, P605, DOI 10.1161/01.STR.15.4.605; SUNDT TM, 1990, MAYO CLIN PROC, V65, P625, DOI 10.1016/S0025-6196(12)65124-6; SUNDT TM, 1975, MAYO CLIN PROC, V50, P301; TAYLOR DW, 1991, NEW ENGL J MED, V325, P445; THOMPSON JE, 1970, ANN SURG, V172, P663, DOI 10.1097/00000658-197010000-00012; WARLOW C, 1984, STROKE, V15, P1068, DOI 10.1161/01.STR.15.6.1068; WHISNANT JP, 1973, MAYO CLIN PROC, V48, P194; WHISNANT JP, 1983, MAYO CLIN PROC, V58, P171; WHISNANT JP, 1987, ANN NEUROL, V22, P72; WILSON SE, 1988, SURGERY, V104, P932; WINSLOW CM, 1988, NEW ENGL J MED, V318, P721, DOI 10.1056/NEJM198803243181201; WOLF PA, 1986, STROKE EPIDEMIOLOGIC, P3; 1991, LANCET, P1235; 1988, BMJ, V296, P320	31	709	736	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 18	1991	266	23					3289	3294		10.1001/jama.266.23.3289	http://dx.doi.org/10.1001/jama.266.23.3289			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GU964	1960828				2022-12-28	WOS:A1991GU96400027
J	DAVIS, I; ISHHOROWICZ, D				DAVIS, I; ISHHOROWICZ, D			APICAL LOCALIZATION OF PAIR-RULE TRANSCRIPTS REQUIRES 3' SEQUENCES AND LIMITS PROTEIN DIFFUSION IN THE DROSOPHILA BLASTODERM EMBRYO	CELL			English	Article							MATERNAL MESSENGER-RNA; SEGMENT-POLARITY GENE; FUSHI-TARAZU; PATTERN-FORMATION; INSITU HYBRIDIZATION; XENOPUS OOCYTES; BICOID PROTEIN; EXPRESSION; HUNCHBACK; ENCODES	The peripheral cytoplasm (periplasm) of the Drosophila blastoderm embryo is subdivided into apical and basal compartments by a layer of nuclei. We have demonstrated three classes of periplasmic transcript localization: apical, basal, and unlocalized (apical and basal), each of which depends on 3' sequences. We define 3' apical localization signals within the even-skipped, fushi tarazu, and hairy pair-rule segmentation genes and the alpha-1-tubulin and bicoid genes. 3' human alpha-globin sequences direct transcripts basally. Transcript destination depends on transcript structure, not on transcript stability or chromosomal location. Apical transcripts direct apical compartmentalization of cytoplasmic protein. We propose that apical localization of pair-rule transcripts restricts lateral protein diffusion, thereby allowing pair-rule proteins to define sharp boundaries and precise spatial domains.			DAVIS, I (corresponding author), IMPERIAL CANC RES FUND, DEV BIOL UNIT, DEPT ZOOL, OXFORD OX1 3PS, ENGLAND.		Davis, Ilan/F-4975-2010	Ish-Horowicz, David/0000-0001-5684-7129; Davis, Ilan/0000-0002-5385-3053				AKAM ME, 1985, EMBO J, V4, P1689, DOI 10.1002/j.1460-2075.1985.tb03838.x; Alberts B., 1989, MOL BIOL CELL; ARIAS AM, 1988, DEVELOPMENT, V103, P157; BAKER NE, 1988, DEV BIOL, V125, P96, DOI 10.1016/0012-1606(88)90062-0; BANERJEE U, 1987, CELL, V49, P281, DOI 10.1016/0092-8674(87)90569-1; BANERJEE U, 1987, CELL, V51, P151, DOI 10.1016/0092-8674(87)90020-1; BAUMGARTNER S, 1987, GENE DEV, V1, P1247, DOI 10.1101/gad.1.10.1247; BERLETH T, 1988, EMBO J, V7, P1749, DOI 10.1002/j.1460-2075.1988.tb03004.x; Campos-Ortega J.A., 2013, EMBRYONIC DEV DROSOP; DAVIS I, 1990, CELL BIOL INT REP, V14, pS9; DAVIS I, 1990, THESIS OXFORD U OXFO; DAVIS L, 1987, NATURE, V330, P477, DOI 10.1038/330477a0; DINARDO S, 1987, GENE DEV, V1, P1212, DOI 10.1101/gad.1.10.1212; DOE CQ, 1988, SCIENCE, V239, P170, DOI 10.1126/science.2892267; DRIEVER W, 1988, CELL, V54, P83, DOI 10.1016/0092-8674(88)90182-1; DRIEVER W, 1988, CELL, V54, P95, DOI 10.1016/0092-8674(88)90183-3; EDGAR BA, 1987, GENE DEV, V1, P1226, DOI 10.1101/gad.1.10.1226; EDGAR BA, 1989, DEV GENET, V10, P124, DOI 10.1002/dvg.1020100303; EDGAR BA, 1986, CELL, V47, P747, DOI 10.1016/0092-8674(86)90517-9; Erlich H.A., 1989, PCR TECHNOLOGY; FONTAINE B, 1988, EMBO J, V7, P603, DOI 10.1002/j.1460-2075.1988.tb02853.x; GARNER CC, 1988, NATURE, V336, P674, DOI 10.1038/336674a0; GAUL U, 1989, DEVELOPMENT, V107, P651; Gottlieb E, 1990, CURR OPIN CELL BIOL, V2, P1080, DOI 10.1016/0955-0674(90)90159-C; HAENLIN M, 1990, DEVELOPMENT, V110, P905; HARTLEY DA, 1987, EMBO J, V6, P3407, DOI 10.1002/j.1460-2075.1987.tb02664.x; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; HIROMI Y, 1985, CELL, V43, P603, DOI 10.1016/0092-8674(85)90232-6; HOOPER JE, 1989, CELL, V59, P751, DOI 10.1016/0092-8674(89)90021-4; Howard K, 1990, Semin Cell Biol, V1, P161; HULSKAMP M, 1990, NATURE, V346, P577, DOI 10.1038/346577a0; INGHAM P, 1988, DEVELOPMENT, V104, P51; INGHAM PW, 1988, NATURE, V331, P73, DOI 10.1038/331073a0; INGHAM PW, 1988, NATURE, V335, P25, DOI 10.1038/335025a0; INGHAM PW, 1985, NATURE, V318, P439, DOI 10.1038/318439a0; ISHHOROWICZ D, 1987, CELL, V51, P405, DOI 10.1016/0092-8674(87)90636-2; JAEGER JA, 1989, P NATL ACAD SCI USA, V86, P7706, DOI 10.1073/pnas.86.20.7706; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; KELLERMAN KA, 1990, GENE DEV, V4, P1936, DOI 10.1101/gad.4.11.1936; KOPCZYNSKI CC, 1989, DEVELOPMENT, V107, P623; LAUGHON A, 1984, NATURE, V310, P25, DOI 10.1038/310025a0; LAWRENCE JB, 1986, CELL, V45, P407, DOI 10.1016/0092-8674(86)90326-0; LAWRENCE PA, 1987, NATURE, V328, P440, DOI 10.1038/328440a0; LAWRENCE PA, 1989, DEVELOPMENT, V105, P761; LEHMANN R, 1991, DEVELOPMENT, V112, P679; MACDONALD PM, 1988, NATURE, V336, P595, DOI 10.1038/336595a0; MACDONALD PM, 1986, CELL, V47, P721, DOI 10.1016/0092-8674(86)90515-5; Mattaj IW, 1990, CURR OPIN CELL BIOL, V2, P528, DOI 10.1016/0955-0674(90)90138-5; MELTON DA, 1987, NATURE, V328, P80, DOI 10.1038/328080a0; MITCHISON TJ, 1983, DEV BIOL, V99, P261, DOI 10.1016/0012-1606(83)90275-0; NAKANO Y, 1989, NATURE, V341, P508, DOI 10.1038/341508a0; OFARRELL PH, 1989, SCIENCE, V246, P635, DOI 10.1126/science.2683080; PANKRATZ MJ, 1990, CELL, V61, P309, DOI 10.1016/0092-8674(90)90811-R; POLLOCK JA, 1990, GENE DEV, V4, P806, DOI 10.1101/gad.4.5.806; RAFF JW, 1990, DEVELOPMENT, V110, P1249; RALSTON E, 1989, SCIENCE, V244, P1066, DOI 10.1126/science.2543074; RIDDIHOUGH G, 1991, IN PRESS GENES DEV; ROTHBERG JM, 1990, GENE DEV, V4, P2169, DOI 10.1101/gad.4.12a.2169; RUSHLOW CA, 1989, EMBO J, V8, P3095, DOI 10.1002/j.1460-2075.1989.tb08461.x; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHWEISGUTH F, 1990, GENE DEV, V4, P922, DOI 10.1101/gad.4.6.922; SILVER PA, 1991, CELL, V64, P489, DOI 10.1016/0092-8674(91)90233-O; SIMONS K, 1990, CELL, V62, P207, DOI 10.1016/0092-8674(90)90357-K; Spradling AC, 1986, DROSOPHILA PRACTICAL, P175; STELLER H, 1985, EMBO J, V4, P167, DOI 10.1002/j.1460-2075.1985.tb02332.x; STJOHNSTON D, 1989, DEVELOPMENT, V107, P13; STRUHL G, 1989, CELL, V57, P1259, DOI 10.1016/0092-8674(89)90062-7; STRUHL G, 1985, NATURE, V318, P677, DOI 10.1038/318677a0; TAUTZ D, 1987, NATURE, V327, P383, DOI 10.1038/327383a0; TAUTZ D, 1989, CHROMOSOMA, V98, P81, DOI 10.1007/BF00291041; TEPASS U, 1990, CELL, V61, P787, DOI 10.1016/0092-8674(90)90189-L; TRAPP BD, 1987, P NATL ACAD SCI USA, V84, P7773, DOI 10.1073/pnas.84.21.7773; WEINER AJ, 1984, CELL, V37, P843, DOI 10.1016/0092-8674(84)90419-7; WEIR MP, 1985, NATURE, V318, P433, DOI 10.1038/318433a0; Wieschaus E., 1986, P199; YISRAELI JK, 1988, NATURE, V336, P592, DOI 10.1038/336592a0	77	134	135	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 29	1991	67	5					927	940		10.1016/0092-8674(91)90366-7	http://dx.doi.org/10.1016/0092-8674(91)90366-7			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GT755	1959136				2022-12-28	WOS:A1991GT75500012
J	RUSSELL, DM; DEMBIC, Z; MORAHAN, G; MILLER, JFAP; BURKI, K; NEMAZEE, D				RUSSELL, DM; DEMBIC, Z; MORAHAN, G; MILLER, JFAP; BURKI, K; NEMAZEE, D			PERIPHERAL DELETION OF SELF-REACTIVE B-CELLS	NATURE			English	Article							IMMUNOGLOBULIN-M; TRANSGENIC MICE; CLONAL DELETION; LYMPHOCYTES-B; T-CELL; TOLERANCE; SUSCEPTIBILITY; SUPPRESSION; EXPRESSION; ANTIGENS	B LYMPHOCYTES are key participants in the immune response because of their specificity, their ability to take up and present antigens to T cells, and their capacity to differentiate into antibody-secreting cells. To limit reactivity to self antigens, autospecific B cells can be functionally inactivated or deleted 1-4. Developing B cells that react with membrane antigens expressed in the bone, marrow are deleted from the peripheral lymphocyte pool 4-6. It is important to ascertain the fate of B cells that recognize membrane autoantigens expressed exclusively on peripheral tissues because B cells in the peripheral lymphoid organs are phenotypically and functionally distinct from bone-marrow B cells 7-9. Here we show that in immunoglobulin-transgenic mice, B cells specific for major histocompatibility complex class I antigen can be deleted if they encounter membrane-bound antigen at a post-bone-marrow stage of development. This deletion may be necessary to prevent organ-specific autoimmunity.	NATL JEWISH CTR IMMUNOL & RESP MED,DEPT PEDIAT,DIV BASIC SCI,1400 JACKSON ST,DENVER,CO 80206; HOFFMANN LA ROCHE AG,DEPT MOLEC BIOL,CH-4005 BASEL,SWITZERLAND; ROYAL MELBOURNE HOSP,WALTER & ELIZA HALL INST MED RES,PARKVILLE,VIC 3050,AUSTRALIA; ROYAL MELBOURNE HOSP,PARKVILLE,VIC 3050,AUSTRALIA; SANDOZ LTD,DEPT BIOTECHNOL,CH-4002 BASEL,SWITZERLAND; UNIV COLORADO,HLTH SCI CTR,DEPT MICROBIOL & IMMUNOL,DENVER,CO 80262	National Jewish Health; Roche Holding; Royal Melbourne Hospital; Walter & Eliza Hall Institute; Royal Melbourne Hospital; Novartis; Sandoz; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver			Morahan, Grant/T-7501-2019; Dembic, Zlatko/A-1833-2008	Dembic, Zlatko/0000-0002-9970-6497	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044809] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM044809] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALESMARTINEZ JE, 1988, P NATL ACAD SCI USA, V85, P6919, DOI 10.1073/pnas.85.18.6919; CHESTNUT RW, 1981, J IMMUNOL, V115, P1075; COFFMAN RL, 1981, NATURE, V289, P681, DOI 10.1038/289681a0; DEMBIC Z, 1986, NATURE, V320, P232, DOI 10.1038/320232a0; ERIKSON J, 1991, NATURE, V349, P331, DOI 10.1038/349331a0; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; GROSVELD FG, 1982, NUCLEIC ACIDS RES, V10, P67145; GU H, 1991, J EXP MED, V173, P1357, DOI 10.1084/jem.173.6.1357; Hardy R. R., 1986, HDB EXPT IMMUNOLOGY; JONES DT, 1987, J BIOL CHEM, V262, P13241; LEPTIN M, 1984, EUR J IMMUNOL, V14, P534, DOI 10.1002/eji.1830140610; MORAHAN G, 1989, P NATL ACAD SCI USA, V86, P3782, DOI 10.1073/pnas.86.10.3782; NAKAMURA RM, 1986, HDB EXPT IMMUNOLOGY; NEMAZEE D, 1991, IMMUNOL REV, V122, P117, DOI 10.1111/j.1600-065X.1991.tb00600.x; NEMAZEE D, 1989, P NATL ACAD SCI USA, V86, P8039, DOI 10.1073/pnas.86.20.8039; NEMAZEE DA, 1989, NATURE, V337, P562, DOI 10.1038/337562a0; NEMAZEE DA, 1987, P EMBO WORKSHOP TOLE, V2, P52; NOSSAL GJV, 1989, SCIENCE, V245, P147, DOI 10.1126/science.2526369; OZATO K, 1980, J IMMUNOL, V124, P533; RAFF MC, 1975, J EXP MED, V142, P1052, DOI 10.1084/jem.142.5.1052; RAMMENSEE HG, 1985, IMMUNOL TODAY, V6, P41, DOI 10.1016/0167-5699(85)90044-1; RON Y, 1987, J IMMUNOL, V138, P2848; SCOTT DW, 1977, J EXP MED, V146, P1473, DOI 10.1084/jem.146.6.1473; SIDMAN CL, 1975, NATURE, V257, P149, DOI 10.1038/257149a0; SIECKMAN D, 1987, FED PROC, V43, P488; STALL AM, 1984, J IMMUNOL, V132, P187; STEINMETZ M, 1981, CELL, V24, P125, DOI 10.1016/0092-8674(81)90508-0; TISCH R, 1988, P NATL ACAD SCI USA, V85, P6914, DOI 10.1073/pnas.85.18.6914; VITETTA ES, 1977, J EXP MED, V146, P1804, DOI 10.1084/jem.146.6.1804	29	325	328	0	3	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	NOV 28	1991	354	6351					308	311		10.1038/354308a0	http://dx.doi.org/10.1038/354308a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT204	1956380	Green Accepted			2022-12-28	WOS:A1991GT20400048
J	HANSENFLASCHEN, JH; BRAZINSKY, S; BASILE, C; LANKEN, PN				HANSENFLASCHEN, JH; BRAZINSKY, S; BASILE, C; LANKEN, PN			USE OF SEDATING DRUGS AND NEUROMUSCULAR BLOCKING-AGENTS IN PATIENTS REQUIRING MECHANICAL VENTILATION FOR RESPIRATORY-FAILURE - A NATIONAL SURVEY	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CRITICALLY ILL PATIENTS; ICU; ATRACURIUM; VECURONIUM; INFUSIONS; CARE; ITU	Objective. - To assess current use of sedating drugs and neuromuscular blocking agents in patients requiring mechanical ventilation at US hospitals that participate in the training of pulmonary fellows. Design. - Surveys were mailed in September 1990 to the head nurses of medical intensive care units at 265 US hospitals that were listed in an annual guide listing pulmonary fellowship training programs. In the survey, sedating drugs were defined as medications prescribed to treat anxiety, agitation, or sleeplessness. These included opiates, anesthetics, or neuroleptic agents when used for any of these purposes. Survey Respondents. - Surveys were received from nurses at 164 hospitals (62% response rate) representing 93 medical schools and 100 pulmonary fellowship training programs. Nearly half of the respondents worked at university hospitals. Most worked as head nurses in medical (70%) or medical-surgical (21 %) intensive care units (ICUs). Results. - Sedating drugs were given to patients undergoing mechanical ventilation at virtually all the ICUs surveyed, and 36% used these drugs routinely (> 70% of patients). Opiates and benzodiazepines were employed most commonly; haloperidol lactate was widely used as well. Intermittent intravenous injection was the preferred method of administration; 62% of the ICUs also gave these drugs by continuous intravenous infusion. Neuromuscular blocking agents were also used at nearly all the ICUs surveyed; however, most gave these drugs to fewer than 20% of patients experiencing respiratory failure. Orders for the use of sedating drugs and neuromuscular blocking agents were written exclusively by house staff at 65% of the ICUs surveyed. Conclusions. - Sedating drugs and neuromuscular blocking agents are widely used for patients requiring mechanical ventilation in ICUs at US teaching hospitals. There is considerable variation in the choice, frequency, and method of administration. Given the expense (up to $1000 a day) and the potential hazards to patients of prolonged deep sedation and paralysis, more research is warranted to determine optimal use of these drugs during mechanical ventilation.			HANSENFLASCHEN, JH (corresponding author), HOSP UNIV PENN,DEPT MED,DEPT PULM & CRIT CARE,874 MALONEY BLDG,3600 SPRUCE ST,PHILADELPHIA,PA 19104, USA.			Hansen-Flaschen, John/0000-0003-1989-7244				AITKENHEAD AR, 1989, LANCET, V2, P704, DOI 10.1016/S0140-6736(89)90770-8; BEEMER GH, 1987, ANAESTH INTENS CARE, V15, P83, DOI 10.1177/0310057X8701500111; BEVAN DR, 1988, MUSCLE RELAXANTS CLI; BION JF, 1987, INTENS CARE MED, V13, P215; CRIPPEN DW, 1990, CRIT CARE CLIN, V6, P369; DURBIN CG, 1991, CRIT CARE CLIN, V7, P489, DOI 10.1016/S0749-0704(18)30292-6; FARINA ML, 1981, INTENS CARE MED, V7, P125, DOI 10.1007/BF01738615; FIGGE H, 1987, J CRIT CARE, V2, P199, DOI 10.1016/0883-9441(87)90008-6; FISHMAN AP, 1988, PULMONARY DISEASES D; GRAMSTAD L, 1985, BRIT J ANAESTH, V57, P1052, DOI 10.1093/bja/57.11.1052; GRIFFITHS RB, 1986, ANAESTHESIA, V41, P375, DOI 10.1111/j.1365-2044.1986.tb13221.x; HANSENFLASCHEN JH, 1991, PULMONARY DISEASES D, P383; HARRIS CE, 1985, ANAESTHESIA, V45, P366; KENDALL MJ, 1972, BMJ, V2, P354; MARTYN J, 1986, ANESTHESIOLOGY, V65, P67, DOI 10.1097/00000542-198607000-00011; MENZA MA, 1988, HEART LUNG, V17, P238; MERRIMAN HM, 1981, INTENS CARE MED, V7, P217, DOI 10.1007/BF01702623; MILLERJONES CMH, 1980, ANAESTHESIA, V35, P1104, DOI 10.1111/j.1365-2044.1980.tb05052.x; NAGASHIMA H, 1988, CAN J ANAESTH, V35, P134, DOI 10.1007/BF03010652; OLDENHOF H, 1988, CLIN PHARMACOL THER, V43, P263, DOI 10.1038/clpt.1988.31; PARKER CJR, 1988, BRIT J ANAESTH, V61, P531, DOI 10.1093/bja/61.5.531; PARKER MM, 1984, CRIT CARE MED, V12, P69, DOI 10.1097/00003246-198401000-00018; PEAT SJ, 1988, ANAESTHESIA, V43, P962, DOI 10.1111/j.1365-2044.1988.tb05663.x; ROGERS RM, 1990, AM REV RESPIR DIS, V142, P495, DOI 10.1164/ajrccm/142.3.495; SEGREDO V, 1990, ANESTHESIOLOGY, V72, P566, DOI 10.1097/00000542-199003000-00030; SHOEMAKER W, 1989, TXB CRITICAL CARE; SLATER RM, 1988, ANAESTHESIA, V43, P250; Stevens DS, 1990, J INTENSIVE CARE MED, V5, P258; VESELIS RA, 1990, CRIT CARE CLIN, V6, P295; VIBYMOGENSEN J, 1982, BRIT J ANAESTH, V54, P209, DOI 10.1093/bja/54.2.209; WADON AJ, 1986, BRIT J ANAESTH, V58, pS64, DOI 10.1093/bja/58.suppl_1.64S; 1990, AM REV RESPIR DIS, V142, P955; 1989, AM HOSPITAL ASS GUID; 1991, AM BOARD INTERNA SPR	34	218	222	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 27	1991	266	20					2870	2875		10.1001/jama.266.20.2870	http://dx.doi.org/10.1001/jama.266.20.2870			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GQ722	1942456				2022-12-28	WOS:A1991GQ72200037
J	ADAMS, JM; CORY, S				ADAMS, JM; CORY, S			TRANSGENIC MODELS OF TUMOR-DEVELOPMENT	SCIENCE			English	Article							SV40 T-ANTIGEN; C-MYC GENE; HUMAN ALPHA-1-ANTITRYPSIN GENE; GROWTH-FACTOR PRODUCTION; PRE-B-CELLS; V-H-RAS; POLYOMA-VIRUS; NEU ONCOGENE; MICE BEARING; MOUSE MODEL	Numerous cancer-prone strains of mice have been created by the introduction of candidate tumor-promoting genes into fertilized eggs. Each transgenic strain is predisposed to develop specific types of tumors, but they usually arise stochastically because of the need for spontaneous mutation of genes that collaborate with the introduced oncogene. These mice are providing insights into the effects of individual oncogenes on cellular proliferation, differentiation, and viability, as well as on oncogene cooperativity. Their predisposed state imposes sensitivity to viral and chemical carcinogenesis, and the mice should prove valuable in tests of potential carcinogens, therapies, and preventive measures.			ADAMS, JM (corresponding author), ROYAL MELBOURNE HOSP, WALTER & ELIZA HALL INST MED RES, PARKVILLE, VIC 3050, AUSTRALIA.		Adams, Jerry M/E-1199-2013; Cory, Suzanne/E-1642-2013	Cory, Suzanne/0000-0002-6818-3451; Adams, Jerry/0000-0002-4360-8628	NATIONAL CANCER INSTITUTE [R01CA043540] Funding Source: NIH RePORTER; NCI NIH HHS [CA12421, CA43540] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AARONSON SA, 1991, SCIENCE, V254, P1146, DOI 10.1126/science.1659742; ABRAHAM KM, 1991, P NATL ACAD SCI USA, V88, P3977, DOI 10.1073/pnas.88.9.3977; ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0; ADAMS JM, 1991, BIOCHIM BIOPHYS ACTA, V1072, P9, DOI 10.1016/0304-419X(91)90004-5; AIZAWA S, 1990, EMBO J, V9, P2107, DOI 10.1002/j.1460-2075.1990.tb07379.x; ALEXANDER WS, 1989, MOL CELL BIOL, V9, P67, DOI 10.1128/MCB.9.1.67; ALEXANDER WS, 1989, ONCOGENE, V4, P575; AMES BN, 1990, P NATL ACAD SCI USA, V87, P7772, DOI 10.1073/pnas.87.19.7772; ANDRES AC, 1987, P NATL ACAD SCI USA, V84, P1299, DOI 10.1073/pnas.84.5.1299; ANDRES AC, 1988, GENE DEV, V2, P1486, DOI 10.1101/gad.2.11.1486; BAILLEUL B, 1990, CELL, V62, P697, DOI 10.1016/0092-8674(90)90115-U; BAKHSHI A, 1985, CELL, V41, P899, DOI 10.1016/S0092-8674(85)80070-2; BALMAIN A, 1988, ADV CANCER RES, V51, P147, DOI 10.1016/S0065-230X(08)60222-5; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; BAUTCH VL, 1987, CELL, V51, P529, DOI 10.1016/0092-8674(87)90122-X; BEHRINGER RR, 1988, P NATL ACAD SCI USA, V85, P2648, DOI 10.1073/pnas.85.8.2648; BELL RH, 1990, CARCINOGENESIS, V11, P1393, DOI 10.1093/carcin/11.8.1393; BISHOP JM, 1991, CELL, V64, P235, DOI 10.1016/0092-8674(91)90636-D; BOS JL, 1989, CANCER RES, V49, P4682; BOUCHARD L, 1989, CELL, V57, P931, DOI 10.1016/0092-8674(89)90331-0; BRADL M, 1991, P NATL ACAD SCI USA, V88, P164, DOI 10.1073/pnas.88.1.164; BREUER M, 1989, NATURE, V340, P61, DOI 10.1038/340061a0; BREUER M, 1991, CANCER RES, V51, P958; BRINSTER RL, 1984, CELL, V37, P367, DOI 10.1016/0092-8674(84)90367-2; BUTEL JS, 1990, INTERVIROLOGY, V31, P85, DOI 10.1159/000150142; CAPECCHI MR, 1989, SCIENCE, V244, P1288, DOI 10.1126/science.2660260; CHEN JD, 1989, J VIROL, V63, P2204, DOI 10.1128/JVI.63.5.2204-2214.1989; CHEN SH, 1987, CELL, V51, P7, DOI 10.1016/0092-8674(87)90005-5; CHISARI FV, 1989, CELL, V59, P1145, DOI 10.1016/0092-8674(89)90770-8; CHOI YW, 1987, J VIROL, V61, P3013, DOI 10.1128/JVI.61.10.3013-3019.1987; CHOI YW, 1988, MOL CELL BIOL, V8, P3382, DOI 10.1128/MCB.8.8.3382; CLEARY ML, 1985, P NATL ACAD SCI USA, V82, P7439, DOI 10.1073/pnas.82.21.7439; COMPERE SJ, 1988, BIOCHIM BIOPHYS ACTA, V948, P129, DOI 10.1016/0304-419X(88)90008-X; CORY S, 1986, ADV CANCER RES, V47, P189, DOI 10.1016/S0065-230X(08)60200-6; CORY S, 1988, ANNU REV IMMUNOL, V6, P25; CORY S, UNPUB; DALEMANS W, 1990, BIOLOGICALS, V18, P191, DOI 10.1016/1045-1056(90)90006-L; DALRYMPLE SA, 1990, J VIROL, V64, P1182, DOI 10.1128/JVI.64.3.1182-1191.1990; DILDROP R, 1989, EMBO J, V8, P1121, DOI 10.1002/j.1460-2075.1989.tb03482.x; DRAGANI TA, 1990, CARCINOGENESIS, V11, P953, DOI 10.1093/carcin/11.6.953; DUNSFORD HA, 1990, CANCER RES, V50, P3400; EFRAT S, 1987, EMBO J, V6, P2699, DOI 10.1002/j.1460-2075.1987.tb02562.x; EFRAT S, 1988, NEURON, V1, P605, DOI 10.1016/0896-6273(88)90110-9; ESCOT C, 1986, P NATL ACAD SCI USA, V83, P4834, DOI 10.1073/pnas.83.13.4834; FAAS SJ, 1987, J EXP MED, V165, P417, DOI 10.1084/jem.165.2.417; FIELD LJ, 1988, SCIENCE, V239, P1029, DOI 10.1126/science.2964082; FOLKMAN J, 1989, NATURE, V339, P58, DOI 10.1038/339058a0; FOX N, 1989, SCIENCE, V244, P460, DOI 10.1126/science.2785714; GARVIN AM, 1990, INT IMMUNOL, V2, P173, DOI 10.1093/intimm/2.2.173; GILBERT PX, 1988, J CELL SCI, V90, P433; GREAVES DR, 1989, CELL, V56, P979, DOI 10.1016/0092-8674(89)90631-4; GROSVELD F, 1987, CELL, V51, P975, DOI 10.1016/0092-8674(87)90584-8; HAMMANG JP, 1990, NEURON, V4, P775, DOI 10.1016/0896-6273(90)90204-S; HANAHAN D, 1989, SCIENCE, V246, P1265, DOI 10.1126/science.2686032; HANAHAN D, 1988, ANNU REV GENET, V22, P479, DOI 10.1146/annurev.ge.22.120188.002403; HANAHAN D, 1985, NATURE, V315, P115, DOI 10.1038/315115a0; HARIHARAN IK, 1989, MOL CELL BIOL, V9, P2798, DOI 10.1128/MCB.9.7.2798; HARRIS AB, UNPUB; HARRIS AW, 1988, CURR TOP MICROBIOL, V141, P82; HARRIS AW, 1990, CURR TOP MICROBIOL, V166, P165; HARRIS AW, 1988, J EXP MED, V167, P353, DOI 10.1084/jem.167.2.353; HAUPT Y, 1991, CELL, V65, P753, DOI 10.1016/0092-8674(91)90383-A; HEISTERKAMP N, 1990, NATURE, V344, P251, DOI 10.1038/344251a0; HELD WA, 1989, EMBO J, V8, P183, DOI 10.1002/j.1460-2075.1989.tb03363.x; HINRICHS SH, 1987, SCIENCE, V237, P1340, DOI 10.1126/science.2888191; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; HUNTER T, 1991, CELL, V64, P249, DOI 10.1016/0092-8674(91)90637-E; IWAMOTO T, 1990, ONCOGENE, V5, P535; JAT PS, 1991, P NATL ACAD SCI USA, V88, P5096, DOI 10.1073/pnas.88.12.5096; JHAPPAN C, 1990, CELL, V61, P1137, DOI 10.1016/0092-8674(90)90076-Q; KANDEL J, 1991, CELL, V66, P1095, DOI 10.1016/0092-8674(91)90033-U; KIM CM, 1991, NATURE, V351, P317, DOI 10.1038/351317a0; KLEINSZANTO A, 1991, P NATL ACAD SCI USA, V88, P169, DOI 10.1073/pnas.88.1.169; KNOWLES BB, 1990, AM J PATHOL, V137, P259; KOIKE K, 1989, P NATL ACAD SCI USA, V86, P5615, DOI 10.1073/pnas.86.14.5615; LACEY M, 1986, NATURE, V322, P609, DOI 10.1038/322609a0; LANGDON WY, 1988, ONCOGENE RES, V3, P271; LANGDON WY, 1989, ONCOGENE RES, V4, P253; LANGDON WY, 1986, CELL, V47, P11, DOI 10.1016/0092-8674(86)90361-2; LAVIGUEUR A, 1989, MOL CELL BIOL, V9, P3982, DOI 10.1128/MCB.9.9.3982; LEDER A, 1990, P NATL ACAD SCI USA, V87, P9178, DOI 10.1073/pnas.87.23.9178; LEDER A, 1986, CELL, V45, P485, DOI 10.1016/0092-8674(86)90280-1; LEE GH, 1990, CARCINOGENESIS, V11, P1145, DOI 10.1093/carcin/11.7.1145; LEVINE AJ, 1991, NATURE, V351, P453, DOI 10.1038/351453a0; LEVINE DS, 1991, P NATL ACAD SCI USA, V88, P6427, DOI 10.1073/pnas.88.15.6427; LI H, 1991, JPN J CANCER RES, V82, P4, DOI 10.1111/j.1349-7006.1991.tb01736.x; LINDGREN V, 1989, P NATL ACAD SCI USA, V86, P5025, DOI 10.1073/pnas.86.13.5025; LOEB LA, 1991, CANCER RES, V51, P3075; LUSCHER B, 1990, GENE DEV, V4, P2025, DOI 10.1101/gad.4.12a.2025; MAHON KA, 1987, SCIENCE, V235, P1622, DOI 10.1126/science.3029873; MALKIN D, 1990, SCIENCE, V250, P1233, DOI 10.1126/science.1978757; MANGUES R, 1990, ONCOGENE, V5, P1491; Marks J, 1988, Prog Clin Biol Res, V284, P163; MATSUI Y, 1990, CELL, V61, P1147, DOI 10.1016/0092-8674(90)90077-R; MCDONNELL TJ, 1990, MOL CELL BIOL, V10, P1901, DOI 10.1128/MCB.10.5.1901; MCDONNELL TJ, 1991, NATURE, V349, P254, DOI 10.1038/349254a0; MCDONNELL TJ, 1989, CELL, V57, P79, DOI 10.1016/0092-8674(89)90174-8; MELLON PL, 1990, NEURON, V5, P1, DOI 10.1016/0896-6273(90)90028-E; MESSING A, 1988, ONCOGENE RES, V3, P87; MESSING A, 1985, NATURE, V316, P461, DOI 10.1038/316461a0; METCALF D, 1989, CANCER RES, V49, P2305; MOROY T, 1990, EMBO J, V9, P3659, DOI 10.1002/j.1460-2075.1990.tb07577.x; MULLER WJ, 1988, CELL, V54, P105, DOI 10.1016/0092-8674(88)90184-5; MULLER WJ, 1990, EMBO J, V9, P907, DOI 10.1002/j.1460-2075.1990.tb08188.x; MURPHY D, 1987, AM J PATHOL, V129, P552; NERENBERG M, 1987, SCIENCE, V237, P1324, DOI 10.1126/science.2888190; NOWELL PC, 1986, CANCER RES, V46, P2203; NUSSE R, 1988, TRENDS GENET, V4, P291, DOI 10.1016/0168-9525(88)90172-2; NUSSENZWEIG MC, 1988, NATURE, V336, P446, DOI 10.1038/336446a0; OBRIEN JM, 1990, ARCH OPHTHALMOL-CHIC, V108, P1145, DOI 10.1001/archopht.1990.01070100101043; ORIAN JM, 1990, JNCI-J NATL CANCER I, V82, P393, DOI 10.1093/jnci/82.5.393; ORNITZ DM, 1987, SCIENCE, V238, P188, DOI 10.1126/science.2821617; PALMITER RD, 1985, NATURE, V316, P457, DOI 10.1038/316457a0; PALMITER RD, 1986, ANNU REV GENET, V20, P465, DOI 10.1146/annurev.ge.20.120186.002341; PERKINS A, 1990, P NATL ACAD SCI USA, V87, P8398, DOI 10.1073/pnas.87.21.8398; QUAIFE CJ, 1987, CELL, V48, P1023, DOI 10.1016/0092-8674(87)90710-0; RASSOULZADEGAN M, 1990, ONCOGENE, V5, P1507; REYNOLDS RK, 1988, P NATL ACAD SCI USA, V85, P3135, DOI 10.1073/pnas.85.9.3135; ROSENBAUM H, 1989, EMBO J, V8, P749, DOI 10.1002/j.1460-2075.1989.tb03435.x; ROSENBAUM H, 1990, EMBO J, V9, P897, DOI 10.1002/j.1460-2075.1990.tb08187.x; RUTHER U, 1989, ONCOGENE, V4, P861; RUTHER U, 1987, NATURE, V325, P412, DOI 10.1038/325412a0; SAGER R, 1989, SCIENCE, V246, P1406, DOI 10.1126/science.2574499; SAKEI N, 1990, KOBE J MED, V36, P37; SANDGREN EP, 1990, CELL, V61, P1121, DOI 10.1016/0092-8674(90)90075-P; SANDGREN EP, 1989, ONCOGENE, V4, P715; SANDGREN EP, 1991, P NATL ACAD SCI USA, V88, P93, DOI 10.1073/pnas.88.1.93; SAWYERS CL, 1991, CELL, V64, P337, DOI 10.1016/0092-8674(91)90643-D; SCHMIDT EV, 1988, P NATL ACAD SCI USA, V85, P6047, DOI 10.1073/pnas.85.16.6047; SCHOENENBERGER CA, 1988, EMBO J, V7, P169, DOI 10.1002/j.1460-2075.1988.tb02797.x; SCHUH AC, 1990, NATURE, V346, P756, DOI 10.1038/346756a0; SELL S, 1991, CANCER RES, V51, P1278; SEPULVEDA AR, 1989, CANCER RES, V49, P6108; SIDMAN CL, 1988, CURR TOP MICROBIOL, V141, P94; SIGMUND CD, 1990, P NATL ACAD SCI USA, V87, P7993, DOI 10.1073/pnas.87.20.7993; SINN E, 1987, CELL, V49, P465, DOI 10.1016/0092-8674(87)90449-1; SIPPOLATHIELE M, 1989, MOL CELL BIOL, V9, P925, DOI 10.1128/MCB.9.3.925; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; SMALL JA, 1986, P NATL ACAD SCI USA, V83, P8288, DOI 10.1073/pnas.83.21.8288; SOLOMON E, 1991, SCIENCE, V254, P1153, DOI 10.1126/science.1957167; SPANOPOULOU E, 1989, NATURE, V342, P185, DOI 10.1038/342185a0; STEWART TA, 1984, CELL, V38, P627, DOI 10.1016/0092-8674(84)90257-5; STRASSER A, 1990, CURR TOP MICROBIOL, V166, P175; STRASSER A, 1991, P NATL ACAD SCI USA, V88, P8661, DOI 10.1073/pnas.88.19.8661; STRASSER A, 1990, NATURE, V348, P331, DOI 10.1038/348331a0; STRASSER A, IN PRESS CELL; SUDA Y, 1987, EMBO J, V6, P4055, DOI 10.1002/j.1460-2075.1987.tb02751.x; SUDA Y, 1990, EMBO J, V9, P181, DOI 10.1002/j.1460-2075.1990.tb08094.x; TEITELMAN S, 1990, AM J PATHOL, V136, P1349; TSUJIMOTO Y, 1984, SCIENCE, V226, P1097, DOI 10.1126/science.6093263; TSUKAMOTO AS, 1988, CELL, V55, P619, DOI 10.1016/0092-8674(88)90220-6; VANLOHUIZEN M, 1989, CELL, V56, P673, DOI 10.1016/0092-8674(89)90589-8; VANLOHUIZEN M, 1991, CELL, V65, P737, DOI 10.1016/0092-8674(91)90382-9; VASSAR R, 1991, GENE DEV, V5, P714, DOI 10.1101/gad.5.5.714; VAUX DL, 1988, NATURE, V335, P440, DOI 10.1038/335440a0; VERBEEK S, 1991, MOL CELL BIOL, V11, P1176, DOI 10.1128/MCB.11.2.1176; VOGEL J, 1988, NATURE, V335, P606, DOI 10.1038/335606a0; WEINBERG RA, 1989, CANCER RES, V49, P3713; WEINBERG RA, 1991, SCIENCE, V254, P1138, DOI 10.1126/science.1659741; WILLIAMS RL, 1988, CELL, V52, P121; WINDLE JJ, 1990, NATURE, V343, P665, DOI 10.1038/343665a0; YEE SP, 1989, MOL CELL BIOL, V9, P5491, DOI 10.1128/MCB.9.12.5491; YUKAWA K, 1989, J EXP MED, V170, P711, DOI 10.1084/jem.170.3.711	163	288	294	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 22	1991	254	5035					1161	1167		10.1126/science.1957168	http://dx.doi.org/10.1126/science.1957168			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ834	1957168				2022-12-28	WOS:A1991GQ83400035
J	RABBITTS, TH				RABBITTS, TH			TRANSLOCATIONS, MASTER GENES, AND DIFFERENCES BETWEEN THE ORIGINS OF ACUTE AND CHRONIC LEUKEMIAS	CELL			English	Review							CHROMOSOME-TRANSLOCATION; CELL; PROTEIN				RABBITTS, TH (corresponding author), MRC,MOLEC BIOL LAB,CAMBRIDGE CB2 2QH,ENGLAND.		Rabbitts, Terence/D-6262-2016	Rabbitts, Terence/0000-0002-4982-2609				BEGLEY CG, 1989, P NATL ACAD SCI USA, V86, P2031, DOI 10.1073/pnas.86.6.2031; BLACKWOOD EM, 1991, SCIENCE, V251, P1211, DOI 10.1126/science.2006410; BOEHM T, 1991, P NATL ACAD SCI USA, V88, P3927, DOI 10.1073/pnas.88.9.3927; BOEHM T, 1991, P NATL ACAD SCI USA, V88, P4367, DOI 10.1073/pnas.88.10.4367; CHEN Q, 1990, EMBO J, V9, P415, DOI 10.1002/j.1460-2075.1990.tb08126.x; DETHE H, 1991, CELL, V66, P675, DOI 10.1016/0092-8674(91)90113-D; DUBE ID, 1991, IN PRESS BLOOD; ELLISEN LW, 1991, CELL, V66, P649, DOI 10.1016/0092-8674(91)90111-B; GREAVES MF, 1986, SCIENCE, V234, P697, DOI 10.1126/science.3535067; GREENBERG JM, 1990, NATURE, V344, P158, DOI 10.1038/344158a0; HATANO M, 1991, SCIENCE, V253, P79, DOI 10.1126/science.1676542; HEISTERKAMP N, 1990, NATURE, V344, P251, DOI 10.1038/344251a0; HENDERSON S, 1991, CELL, V65, P1107, DOI 10.1016/0092-8674(91)90007-L; HOCKENBERRY D, 1991, NATURE, V348, P334; HSU HL, 1991, MOL CELL BIOL, V11, P3037, DOI 10.1128/MCB.11.6.3037; KAKIZUKA A, 1991, CELL, V66, P663, DOI 10.1016/0092-8674(91)90112-C; KAMPS MP, 1990, CELL, V60, P547, DOI 10.1016/0092-8674(90)90658-2; KENNEDY MA, 1991, P NATL ACAD SCI USA, V88, P8900, DOI 10.1073/pnas.88.20.8900; LIMPENS J, 1991, IN PRESS ONCOGENE; LU M, 1991, EMBO J, V10, P2905, DOI 10.1002/j.1460-2075.1991.tb07840.x; MCDONNELL TJ, 1989, MOL CELL BIOL, V9, P2124; MEEKER TC, 1990, BLOOD, V76, P285; MELLENTTIN JD, 1990, CELL, V60, P535; OETTINGER MA, 1990, SCIENCE, V248, P1517, DOI 10.1126/science.2360047; OHNO H, 1990, CELL, V60, P991, DOI 10.1016/0092-8674(90)90347-H; ROYERPOKORA B, 1991, IN PRESS ONCOGENE; SAWYERS CL, 1991, CELL, V64, P337, DOI 10.1016/0092-8674(91)90643-D; XIA Y, 1991, IN PRESS P NATL ACAD	28	298	311	0	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	NOV 15	1991	67	4					641	644		10.1016/0092-8674(91)90057-6	http://dx.doi.org/10.1016/0092-8674(91)90057-6			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GQ407	1934065				2022-12-28	WOS:A1991GQ40700001
J	COCHRANE, CG; REVAK, SD				COCHRANE, CG; REVAK, SD			PULMONARY SURFACTANT PROTEIN-B (SP-B) - STRUCTURE-FUNCTION-RELATIONSHIPS	SCIENCE			English	Article							BIOPHYSICAL ACTIVITY; PHOSPHOLIPIDS; SEQUENCE; CDNA	SP-B is a protein in pulmonary surfactant that is, in greatest part, responsible for resistance to surface tension and prevention of collapse of pulmonary alveoli. Peptides of 21 residues, synthesized following the sequence of SP-B or resembling the hydrophobic and hydrophilic domains of SP-B (such as RLLLLRLLLLRLLLLRLLLLR, R, Arg, and L, Leu), enhanced the abilities of phospholipids to reduce surface tension both in vitro and in vivo. Intermittent positively charged residues were essential for this activity. The SP-B-like peptides were found by tryptophan fluorescence to partition within the phospholipid layer in contact with both polar head groups and acyl side chains. These data, together with findings that the SP-B-related peptides increase inter- and intramolecular order of the phospholipid layer, suggest that SP-B resists surface tension by increasing lateral stability of the phospholipid layer.			COCHRANE, CG (corresponding author), SCRIPPS RES INST, DEPT IMMUNOL, 10666 N TORREY PINES RD, LA JOLLA, CA 92037 USA.				NHLBI NIH HHS [HL-23584] Funding Source: Medline; NIGMS NIH HHS [GM-37696] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL023584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM037696] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAATZ JE, 1990, BIOCHEMISTRY-US, V29, P6714, DOI 10.1021/bi00480a022; COCHRANE CG, 1990, PEDIATR RES, V27, pA297; COCHRANE CG, UNPUB; CURSTEDT T, 1987, EUR J BIOCHEM, V168, P255, DOI 10.1111/j.1432-1033.1987.tb13414.x; EMRIE PA, 1989, BIOCHIM BIOPHYS ACTA, V994, P215, DOI 10.1016/0167-4838(89)90296-3; ENHORNING G, 1977, J APPL PHYSIOL, V43, P198, DOI 10.1152/jappl.1977.43.2.198; FINAZZIAGRO A, 1970, BIOCHEMISTRY-US, V9, P2009, DOI 10.1021/bi00811a023; HALLMAN M, 1983, PEDIATRICS, V71, P473; HAWGOOD S, 1989, AM J PHYSIOL, V257, pL13; JOHANSSON J, 1988, BIOCHEMISTRY-US, V27, P3544, DOI 10.1021/bi00410a002; MERRIFIELD RB, 1963, J AM CHEM SOC, V85, P2149, DOI 10.1021/ja00897a025; OLAFSON RW, 1987, BIOCHEM BIOPH RES CO, V148, P1406, DOI 10.1016/S0006-291X(87)80288-7; REVAK SD, 1986, AM REV RESPIR DIS, V134, P1258; REVAK SD, 1991, PEDIATR RES, V29, P460, DOI 10.1203/00006450-199105010-00010; SHIFFER K, 1988, BIOCHEMISTRY-US, V27, P2689, DOI 10.1021/bi00408a008; VENKITARAMAN AR, 1990, CHEM PHYS LIPIDS, V53, P157, DOI 10.1016/0009-3084(90)90041-O; VINCENT JS, 1991, BIOCHEMISTRY-US, V30, P8395, DOI 10.1021/bi00098a017; WARING A, 1989, Peptide Research, V2, P308; XU JJ, 1989, BIOCHEM BIOPH RES CO, V160, P325, DOI 10.1016/0006-291X(89)91659-8; YU SH, 1988, BIOCHIM BIOPHYS ACTA, V961, P337	20	278	288	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	OCT 25	1991	254	5031					566	568		10.1126/science.1948032	http://dx.doi.org/10.1126/science.1948032			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL799	1948032				2022-12-28	WOS:A1991GL79900047
J	BLACK, ME; SCHEUER, MA; VICTOR, C; BENZEVAL, M; GILL, M; JUDGE, K				BLACK, ME; SCHEUER, MA; VICTOR, C; BENZEVAL, M; GILL, M; JUDGE, K			UTILIZATION BY HOMELESS PEOPLE OF ACUTE HOSPITAL SERVICES IN LONDON	BRITISH MEDICAL JOURNAL			English	Article								Objectives - To estimate the numbers and distribution of homeless people in London; to quantify the utilisation of acute inpatient services by homeless people in two health authorities; and to predict the total numbers of admissions in homeless people in district health authorities across London. Design - Data were collected from various sources on the distribution of homeless people across London boroughs. All unplanned acute inpatient admissions during November 1990 to relevant hospitals were identified. Setting - Bloomsbury and Paddington and North Kensington, two former inner London district health authorities. Subjects - Homeless people in London residing in bed and breakfast and private sector leased accommodation, residing in hostels, and of no fixed abode. Main outcome measures - Number and cost of acute unplanned admissions in homeless people in two health authorities in November 1990; predicted number of such admissions each year in district health authorities in London. Results - There were at least 60000 homeless people in London in March 1990. The majority were housed in temporary accommodation (55 412). There were at least 3295 hostel dwellers and 651 people sleeping rough. Homeless people accounted for 105 (8%) of the 1256 acute unbooked admissions in residents of Bloomsbury and Paddington and North Kensington health authorities in November 1990. Considerable variations in the pattern of acute unplanned admissions in homeless people were observed in the two districts with respect to housing status and specialty of admission. The total number of acute unplanned admissions in homeless people across London each year was estimated at 7598, ranging from 38 in Bexley to 1515 in Parkside. Conclusions - The results have fundamental implications for resource allocation across London. Allocation must take better account of the heterogeneity, uneven distribution, and extra health needs of homeless people.	KINGS FUND INST,LONDON NW1 7NF,ENGLAND; BLOOMSBURY & ISLINGTON HLTH AUTHOR,DEPT PUBL HLTH MED,LONDON WC1E 6DB,ENGLAND; PARKSIDE HLTH AUTHOR,DEPT PUBL HLTH MED,LONDON W2 1PF,ENGLAND				Benzeval, Michaela/J-3163-2015	Benzeval, Michaela/0000-0002-0372-2098; Victor, Christina/0000-0002-4213-3974				BARRY A, 1991, 84 U YORK CTR HLTH E; BRAMLEY G, 1987, HOMELESSNESS LONDON; CANTER D, 1990, FACES HOMELESSNESS L; CONNELLY J, 1990, PUBLIC HEALTH, V104, P109, DOI 10.1016/S0033-3506(05)80361-0; CONWAY J, 1988, PRESCRIPTION POOR HL; EVANS A, 1989, RESPONDING HOMELESSN; NEWMAN R, 1989, LONDON HOSTELS DIREC; PRIEST RG, 1976, J PSYCHIATRY, V128, P130; SCHEUER MA, 1991, 4 KINGS FUND I OCC P; SHANKS NJ, 1988, J EPIDEMIOL COMMUN H, V42, P183, DOI 10.1136/jech.42.2.183; STERN R, 1988, MARGINS MAINSTREAM C; THOMAS A, 1989, LIVING TEMPORARY ACC; VICTOR CR, 1989, BRIT MED J, V229, P725; 1991, 1991 CENSUS PRELIMIN; 1991, HOUSING HOMELESSNESS; 1989, WORKING PATIENTS; 1990, EL90MB22 DEP HLTH; 1989, HOMELESS FAMILIES TH; 1990, ACTIONS LOCAL AUTHOR; 1990, LOCATION HOMELESS HO; 1988, HOMELESSNESS USE TEM	21	13	13	0	5	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	OCT 19	1991	303	6808					958	961		10.1136/bmj.303.6808.958	http://dx.doi.org/10.1136/bmj.303.6808.958			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GL127	1954419	Green Published, Bronze			2022-12-28	WOS:A1991GL12700021
J	NOURSE, J; MELLENTIN, JD; GALILI, N; WILKINSON, J; STANBRIDGE, E; SMITH, SD; CLEARY, ML				NOURSE, J; MELLENTIN, JD; GALILI, N; WILKINSON, J; STANBRIDGE, E; SMITH, SD; CLEARY, ML			CHROMOSOMAL TRANSLOCATION-T(1-19) RESULTS IN SYNTHESIS OF A HOMEOBOX FUSION MESSENGER-RNA THAT CODES FOR A POTENTIAL CHIMERIC TRANSCRIPTION FACTOR	CELL			English	Article									UNIV CALIF IRVINE,DEPT MICROBIOL & MOLEC GENET,IRVINE,CA 92717; UNIV CHICAGO,DEPT PEDIAT,CHICAGO,IL 60637	University of California System; University of California Irvine; University of Chicago	NOURSE, J (corresponding author), STANFORD UNIV,MED CTR,SCH MED,DEPT PATHOL,EXPTL ONCOL LAB,STANFORD,CA 94305, USA.				NCI NIH HHS [CA42106, 5T32 CA09302, CA42971] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R37CA042971, T32CA009302, R01CA042971, R01CA042106] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ASTELL CR, 1981, CELL, V27, P15, DOI 10.1016/0092-8674(81)90356-1; BARKER PE, 1987, CANCER GENET CYTOGEN, V25, P379, DOI 10.1016/0165-4608(87)90204-4; BEIDENKAPP H, 1988, NATURE, V335, P835; BLATT C, 1988, EMBO J, V7, P4283, DOI 10.1002/j.1460-2075.1988.tb03326.x; BODNER M, 1988, CELL, V55, P505, DOI 10.1016/0092-8674(88)90037-2; BOEHM T, 1989, FASEB J, V3, P2344, DOI 10.1096/fasebj.3.12.2676678; BOHMANN D, 1987, SCIENCE, V238, P1386, DOI 10.1126/science.2825349; BUSKIN JN, 1990, IN PRESS MOL CELL BI; CARROLL AJ, 1984, BLOOD, V63, P721; CASANOVA J, 1988, EMBO J, V7, P1097, DOI 10.1002/j.1460-2075.1988.tb02918.x; CAUDY M, 1988, GENE DEV, V2, P843, DOI 10.1101/gad.2.7.843; CHENLEVY Z, 1989, MOL CELL BIOL, V9, P701, DOI 10.1128/MCB.9.2.701; CHIU R, 1988, CELL, V54, P541, DOI 10.1016/0092-8674(88)90076-1; CHURCH GM, 1985, NATURE, V313, P798, DOI 10.1038/313798a0; CLEARY ML, 1986, CELL, V47, P19, DOI 10.1016/0092-8674(86)90362-4; CLEARY ML, 1988, J EXP MED, V167, P682, DOI 10.1084/jem.167.2.682; CLERC RG, 1988, GENE DEV, V2, P1570, DOI 10.1101/gad.2.12a.1570; CLINE TW, 1976, GENETICS, V84, P723; CORY S, 1986, ADV CANCER RES, V47, P189, DOI 10.1016/S0065-230X(08)60200-6; CRONMILLER C, 1987, CELL, V48, P479, DOI 10.1016/0092-8674(87)90198-X; DOI S, 1987, BLOOD, V70, P1619; EPHRUSSI A, 1985, SCIENCE, V227, P134, DOI 10.1126/science.3917574; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FINDLEY HW, 1982, BLOOD, V60, P1305; FJOSE A, 1985, NATURE, V313, P284, DOI 10.1038/313284a0; GEHRING WJ, 1987, SCIENCE, V236, P1245, DOI 10.1126/science.2884726; GRIMALDI JC, 1989, BLOOD, V73, P2081; HEISTERKAMP N, 1983, NATURE, V306, P239, DOI 10.1038/306239a0; HENTHORN P, 1990, IN PRESS SCIENCE; HOEY T, 1988, NATURE, V332, P858, DOI 10.1038/332858a0; INGRAHAM HA, 1988, CELL, V55, P519, DOI 10.1016/0092-8674(88)90038-4; JACK I, 1986, CANCER GENET CYTOGEN, V19, P261, DOI 10.1016/0165-4608(86)90055-5; KEEGAN L, 1986, SCIENCE, V231, P699, DOI 10.1126/science.3080805; KO HS, 1988, CELL, V55, P135, DOI 10.1016/0092-8674(88)90016-5; KONGSUWAN K, 1989, NUCLEIC ACIDS RES, V17, P1881, DOI 10.1093/nar/17.5.1881; KONOPKA JB, 1984, CELL, V37, P1035, DOI 10.1016/0092-8674(84)90438-0; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; LIPMAN DJ, 1985, SCIENCE, V227, P1435, DOI 10.1126/science.2983426; MCGINNIS W, 1984, CELL, V37, P403, DOI 10.1016/0092-8674(84)90370-2; MCGUIRE EA, 1989, MOL CELL BIOL, V9, P2124, DOI 10.1128/MCB.9.5.2124; MELLENTIN JD, 1989, SCIENCE, V246, P379, DOI 10.1126/science.2799390; MELLENTIN JD, 1989, CELL, V58, P77, DOI 10.1016/0092-8674(89)90404-2; MICHAEL PM, 1985, CANCER GENET CYTOGEN, V17, P79, DOI 10.1016/0165-4608(85)90105-0; MICHAEL PM, 1984, CANCER GENET CYTOGEN, V22, P89; MITELMAN F, 1987, CANCER CYTOGENETICS; MOSS LG, 1988, MOL CELL BIOL, V8, P2620, DOI 10.1128/MCB.8.6.2620; MULLER MM, 1988, NATURE, V336, P544, DOI 10.1038/336544a0; MURRE C, 1989, CELL, V56, P777, DOI 10.1016/0092-8674(89)90682-X; MURRE C, 1989, CELL, V58, P537, DOI 10.1016/0092-8674(89)90434-0; NORRANDER J, 1983, GENE, V26, P101, DOI 10.1016/0378-1119(83)90040-9; OSHEA EK, 1989, SCIENCE, V243, P538, DOI 10.1126/science.2911757; ROWE A, 1988, EMBO J, V7, P1107, DOI 10.1002/j.1460-2075.1988.tb02919.x; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SASSONECORSI P, 1988, CELL, V54, P553, DOI 10.1016/0092-8674(88)90077-3; SCHEIDEREIT C, 1988, NATURE, V336, P551, DOI 10.1038/336551a0; SCOTT MP, 1990, IN PRESS ANN REV BIO; SHTIVELMAN E, 1985, NATURE, V315, P550, DOI 10.1038/315550a0; SMITH SD, 1988, BLOOD, V71, P395; SMITH SD, 1989, BLOOD, V73, P2182; STURM RA, 1988, NATURE, V336, P601, DOI 10.1038/336601a0; STURM RA, 1988, GENE DEV, V2, P1582, DOI 10.1101/gad.2.12a.1582; TAO W, 1987, P NATL ACAD SCI USA, V84, P4180, DOI 10.1073/pnas.84.12.4180; THOMPSON LH, 1989, GENOMICS, V5, P670, DOI 10.1016/0888-7543(89)90107-9; TREISMAN J, 1989, CELL, V59, P553; TSUJIMOTO Y, 1986, P NATL ACAD SCI USA, V83, P5214, DOI 10.1073/pnas.83.14.5214; WILLIAMS DL, 1984, CELL, V36, P101, DOI 10.1016/0092-8674(84)90078-3	67	649	664	0	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	FEB 23	1990	60	4					535	545		10.1016/0092-8674(90)90657-Z	http://dx.doi.org/10.1016/0092-8674(90)90657-Z			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CQ723	1967982				2022-12-28	WOS:A1990CQ72300004
J	DENT, AL; MATIS, LA; HOOSHMAND, F; WIDACKI, SM; BLUESTONE, JA; HEDRICK, SM				DENT, AL; MATIS, LA; HOOSHMAND, F; WIDACKI, SM; BLUESTONE, JA; HEDRICK, SM			SELF-REACTIVE GAMMA-DELTA T-CELLS ARE ELIMINATED IN THE THYMUS	NATURE			English	Article									UNIV CALIF SAN DIEGO, CTR CANC, LA JOLLA, CA 92093 USA; US FDA, CTR BIOL EVALUAT & RES, DIV CYTOKINE BIOL, BETHESDA, MD 20892 USA; UNIV CHICAGO, BEN MAY LAB CANC RES, CHICAGO, IL 60637 USA	University of California System; University of California San Diego; US Food & Drug Administration (FDA); University of Chicago	DENT, AL (corresponding author), UNIV CALIF SAN DIEGO, DEPT BIOL, LA JOLLA, CA 92093 USA.		Hedrick, Stephen M/E-9171-2010	Hedrick, Stephen/0000-0002-6345-8751				AUGUSTIN A, 1989, NATURE, V340, P239, DOI 10.1038/340239a0; BLUESTONE JA, 1987, NATURE, V326, P82, DOI 10.1038/326082a0; BLUESTONE JA, 1988, J EXP MED, V168, P1899, DOI 10.1084/jem.168.5.1899; BRENNER MB, 1986, NATURE, V322, P145, DOI 10.1038/322145a0; CHIEN YH, 1987, NATURE, V327, P677, DOI 10.1038/327677a0; CRISPE IN, 1987, NATURE, V329, P336, DOI 10.1038/329336a0; CRON RQ, 1988, J IMMUNOL, V141, P1074; DEVILLARTAY JP, 1988, NATURE, V335, P170, DOI 10.1038/335170a0; ELLIOTT JF, 1988, NATURE, V331, P627; EVANS GA, 1989, GENE, V79, P9, DOI 10.1016/0378-1119(89)90088-7; FOWLKES BJ, 1989, ADV IMMUNOL, V44, P207, DOI 10.1016/S0065-2776(08)60643-4; FOWLKES BJ, 1987, NATURE, V329, P251, DOI 10.1038/329251a0; GARMAN RD, 1986, CELL, V45, P733, DOI 10.1016/0092-8674(86)90787-7; GOODMAN T, 1988, NATURE, V333, P855, DOI 10.1038/333855a0; HAMMERLING GJ, 1982, P NATL ACAD SCI-BIOL, V79, P4737, DOI 10.1073/pnas.79.15.4737; HATA S, 1988, SCIENCE, V240, P1541, DOI 10.1126/science.3259726; HOGAN B, 1986, MANIPULATING MOUSE E; HOULDEN BA, IN PRESS COLD SPRING, V54; ITOHARA S, 1989, P NATL ACAD SCI USA, V86, P5094, DOI 10.1073/pnas.86.13.5094; IWASHIMA M, 1988, P NATL ACAD SCI USA, V85, P8161, DOI 10.1073/pnas.85.21.8161; KAYE J, 1989, NATURE, V341, P746, DOI 10.1038/341746a0; KISIELOW P, 1984, J IMMUNOL, V133, P1117; KISIELOW P, 1988, NATURE, V333, P742, DOI 10.1038/333742a0; KUBO RT, 1989, J IMMUNOL, V142, P2736; LANIER LL, 1987, J EXP MED, V165, P1076, DOI 10.1084/jem.165.4.1076; LEO O, 1987, P NATL ACAD SCI USA, V84, P1374, DOI 10.1073/pnas.84.5.1374; LEW AM, 1986, SCIENCE, V234, P1401, DOI 10.1126/science.3787252; Maniatis T., 1982, MOL CLONING; MIESCHER GC, 1988, J IMMUNOL, V140, P1779; PARDOLL DM, 1987, NATURE, V326, P79, DOI 10.1038/326079a0; PARDOLL DM, 1988, J IMMUNOL, V140, P4091; PARNES JR, 1989, ADV IMMUNOL, V44, P265, DOI 10.1016/S0065-2776(08)60644-6; RAULET DH, 1989, ANNU REV IMMUNOL, V7, P175, DOI 10.1146/annurev.iy.07.040189.001135; SHA WC, 1988, NATURE, V336, P73, DOI 10.1038/336073a0; SORGER SB, 1987, J EXP MED, V165, P279, DOI 10.1084/jem.165.2.279; SOWDER JT, 1988, J EXP MED, V167, P315, DOI 10.1084/jem.167.2.315; STINGL G, 1987, P NATL ACAD SCI USA, V84, P4586, DOI 10.1073/pnas.84.13.4586; TEH HS, 1988, NATURE, V335, P229, DOI 10.1038/335229a0; VONBOEHMER H, 1988, ANNU REV IMMUNOL, V6, P309, DOI 10.1146/annurev.iy.06.040188.001521; WEISS A, 1986, P NATL ACAD SCI USA, V83, P6998, DOI 10.1073/pnas.83.18.6998; WINOTO A, 1989, NATURE, V338, P430, DOI 10.1038/338430a0	41	216	217	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 22	1990	343	6260					714	719		10.1038/343714a0	http://dx.doi.org/10.1038/343714a0			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP807	1968227				2022-12-28	WOS:A1990CP80700048
J	MANSEL, RE; DOGLIOTTI, L				MANSEL, RE; DOGLIOTTI, L			EUROPEAN MULTICENTER TRIAL OF BROMOCRIPTINE IN CYCLICAL MASTALGIA	LANCET			English	Article									UNIV TURIN,DEPT BIOMED INTERNAL MED & CLIN ONCOL,I-10124 TURIN,ITALY	University of Turin	MANSEL, RE (corresponding author), UNIV HOSP S MANCHESTER,NELL LANE,MANCHESTER M20 8LR,LANCS,ENGLAND.							BLICHERTTOFT M, 1979, BRIT MED J, V1, P237, DOI 10.1136/bmj.1.6158.237; DOGLIOTTI L, 1986, FIBROCYSTIC BREAST D, P46; DURNING P, 1982, BRIT J SURG, V69, P248, DOI 10.1002/bjs.1800690505; GROOM GV, 1980, J PHYSIOL-LONDON, V306, pP39; HINTON CP, 1986, BRIT J CLIN PRACT, V40, P368; HUGHES LE, 1987, LANCET, V2, P1316, DOI 10.1016/S0140-6736(87)91204-9; KUMAR S, 1985, CLIN ENDOCRINOL, V23, P699, DOI 10.1111/j.1365-2265.1985.tb01131.x; MANSEL RE, 1982, LANCET, V1, P928; MANSEL RE, 1978, BRIT J SURG, V65, P724, DOI 10.1002/bjs.1800651015; MARTINCOMIN J, 1976, OBSTET GYNECOL, V48, P703; PARLATI E, 1987, ACTA OBSTET GYN SCAN, V66, P483, DOI 10.3109/00016348709015721; PREECE PE, 1976, LANCET, V2, P670; PYE JK, 1985, LANCET, V2, P373; SANDRUCCI S, 1986, ANN NY ACAD SCI, V464, P626, DOI 10.1111/j.1749-6632.1986.tb16090.x; SCHULZ KD, 1975, ARCH GYNAKOL, V220, P83, DOI 10.1007/BF00673151; WISBEY JR, 1983, LANCET, V2, P672	16	57	60	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	JAN 27	1990	335	8683					190	193		10.1016/0140-6736(90)90278-D	http://dx.doi.org/10.1016/0140-6736(90)90278-D			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CL185	1967667				2022-12-28	WOS:A1990CL18500004
J	YANKNER, BA; MESULAM, MM				YANKNER, BA; MESULAM, MM			SEMINARS IN MEDICINE OF THE BETH-ISRAEL-HOSPITAL, BOSTON - BETA-AMYLOID AND THE PATHOGENESIS OF ALZHEIMERS-DISEASE	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							PAIRED HELICAL FILAMENTS; HEREDITARY CEREBRAL-HEMORRHAGE; PROTEASE NEXIN-II; AGED HUMAN BRAIN; SENILE DEMENTIA; NEUROFIBRILLARY TANGLES; CHOLINERGIC NEURONS; PRECURSOR PROTEIN; NUCLEUS BASALIS; DOWNS-SYNDROME		HARVARD UNIV,SCH MED,DEPT NEUROL,BOSTON,MA 02115; BETH ISRAEL HOSP,DEPT NEUROL,BOSTON,MA 02215	Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center	YANKNER, BA (corresponding author), CHILDRENS HOSP MED CTR,DEPT NEUROL,330 LONGWOOD AVE,BOSTON,MA 02115, USA.				NIA NIH HHS [R29-AG-09229] Funding Source: Medline; NINDS NIH HHS [NS-20285, KO8-NS-01240] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS001240, R01NS020285] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R29AG009229] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ABRAHAM CR, 1991, BIOCHEM BIOPH RES CO, V174, P790, DOI 10.1016/0006-291X(91)91487-W; ABRAHAM CR, 1988, CELL, V52, P487, DOI 10.1016/0092-8674(88)90462-X; Alzheimer A., 1907, ALLGEMEINE Z PSYCHIA, V64, P146, DOI DOI 10.1002/CA.980080612; BARCIKOWSKA M, 1989, ACTA NEUROPATHOL, V78, P225, DOI 10.1007/BF00687751; BARDE YA, 1982, EMBO J, V1, P549, DOI 10.1002/j.1460-2075.1982.tb01207.x; BARROW CJ, 1991, SCIENCE, V253, P179, DOI 10.1126/science.1853202; BARTUS RT, 1982, SCIENCE, V217, P408, DOI 10.1126/science.7046051; BEAL MF, 1985, SCIENCE, V229, P289, DOI 10.1126/science.2861661; BENSON MD, 1989, TRENDS NEUROSCI, V12, P88, DOI 10.1016/0166-2236(89)90162-8; BLESSED G, 1968, BRIT J PSYCHIAT, V114, P797, DOI 10.1192/bjp.114.512.797; BRAAK H, 1986, NEUROSCI LETT, V65, P351, DOI 10.1016/0304-3940(86)90288-0; BRAAK H, 1988, NEUROPATH APPL NEURO, V14, P39, DOI 10.1111/j.1365-2990.1988.tb00864.x; CATALDO AM, 1990, P NATL ACAD SCI USA, V87, P3861, DOI 10.1073/pnas.87.10.3861; COHEN DH, 1983, J EXP MED, V158, P623, DOI 10.1084/jem.158.2.623; CRYSTAL H, 1988, NEUROLOGY, V38, P1682, DOI 10.1212/WNL.38.11.1682; CRYSTAL HA, 1982, ANN NEUROL, V12, P186, DOI 10.1002/ana.410120210; DAVIES L, 1988, NEUROLOGY, V38, P1688, DOI 10.1212/WNL.38.11.1688; DAVIES P, 1980, NATURE, V288, P279, DOI 10.1038/288279a0; DAVIES P, 1976, LANCET, V2, P1403; DAVIS KL, 1986, NEW ENGL J MED, V315, P1286, DOI 10.1056/NEJM198611133152008; DAYAN AD, 1970, ACTA NEUROPATHOL, V16, P95, DOI 10.1007/BF00687664; DAYAN AD, 1970, ACTA NEUROPATHOL, V16, P85, DOI 10.1007/BF00687663; DRACHMAN DA, 1974, ARCH NEUROL-CHICAGO, V30, P113, DOI 10.1001/archneur.1974.00490320001001; ESCH FS, 1990, SCIENCE, V248, P1122, DOI 10.1126/science.2111583; EVANS DA, 1989, JAMA-J AM MED ASSOC, V262, P2551, DOI 10.1001/jama.262.18.2551; FADEN AI, 1976, ARCH NEUROL-CHICAGO, V33, P278, DOI 10.1001/archneur.1976.00500040062010; GABUZDA DH, 1991, SOC NEUR ABSTR, V17, P1104; GEULA C, 1989, NEUROSCIENCE, V33, P469, DOI 10.1016/0306-4522(89)90399-0; GIACCONE G, 1989, NEUROSCI LETT, V97, P232, DOI 10.1016/0304-3940(89)90169-9; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; GOEDERT M, 1988, P NATL ACAD SCI USA, V85, P4051, DOI 10.1073/pnas.85.11.4051; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; GRUNDKEIQBAL I, 1986, J BIOL CHEM, V261, P6084; HAMOS JE, 1989, NEUROLOGY, V39, P355, DOI 10.1212/WNL.39.3.355; HEFTI F, 1989, NEUROBIOL AGING, V10, P515, DOI 10.1016/0197-4580(89)90118-8; HESTON LL, 1966, ARCH NEUROL-CHICAGO, V15, P225, DOI 10.1001/archneur.1966.00470150003001; HSIAO K, 1989, NATURE, V338, P342, DOI 10.1038/338342a0; HSIAO KK, 1990, SCIENCE, V250, P1587, DOI 10.1126/science.1980379; HYMAN BT, 1984, SCIENCE, V225, P1168, DOI 10.1126/science.6474172; HYMAN BT, 1988, ANN NEUROL, V23, P371, DOI 10.1002/ana.410230410; HYMAN BT, 1990, NEUROLOGY, V40, P1721, DOI 10.1212/WNL.40.11.1721; ISHII T, 1966, ACTA NEUROPATHOL, V6, P181, DOI 10.1007/BF00686763; JOACHIM CL, 1989, NATURE, V341, P226, DOI 10.1038/341226a0; JOACHIM CL, 1989, AM J PATHOL, V135, P309; JOSLIN G, 1991, J BIOL CHEM, V266, P11282; JOSLIN G, 1991, J BIOL CHEM, V266, P21897; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; KATZMAN R, 1986, NEW ENGL J MED, V314, P964, DOI 10.1056/NEJM198604103141506; KEMPER TL, 1983, BANBURY REPORT, V15, P31; KHACHATURIAN ZS, 1985, ARCH NEUROL-CHICAGO, V42, P1097, DOI 10.1001/archneur.1985.04060100083029; KIDD M, 1963, NATURE, V197, P192, DOI 10.1038/197192b0; KITAGUCHI N, 1988, NATURE, V331, P530, DOI 10.1038/331530a0; KONDO J, 1988, NEURON, V1, P827, DOI 10.1016/0896-6273(88)90130-4; KOO EH, 1990, P NATL ACAD SCI USA, V87, P1561, DOI 10.1073/pnas.87.4.1561; KOSIK KS, 1988, NEURON, V1, P817, DOI 10.1016/0896-6273(88)90129-8; KOSIK KS, 1986, P NATL ACAD SCI USA, V83, P4044, DOI 10.1073/pnas.83.11.4044; KOWALL NW, 1987, ANN NEUROL, V22, P639, DOI 10.1002/ana.410220514; KOWALL NW, 1991, P NATL ACAD SCI USA, V88, P7247, DOI 10.1073/pnas.88.16.7247; LAI F, 1989, ARCH NEUROL-CHICAGO, V46, P849, DOI 10.1001/archneur.1989.00520440031017; LEE VMY, 1991, SCIENCE, V251, P675, DOI 10.1126/science.1899488; LEVY E, 1990, SCIENCE, V248, P1124, DOI 10.1126/science.2111584; MAISONPIERRE PC, 1990, SCIENCE, V247, P1446, DOI 10.1126/science.2321006; MANN DMA, 1989, NEUROBIOL AGING, V10, P397, DOI 10.1016/0197-4580(89)90073-0; MANN DMA, 1989, J NEUROL SCI, V89, P169, DOI 10.1016/0022-510X(89)90019-1; MANN DMA, 1984, J NEUROL NEUROSUR PS, V47, P201, DOI 10.1136/jnnp.47.2.201; MASLIAH E, 1991, AM J PATHOL, V138, P235; MASLIAH E, 1989, NEUROSCI LETT, V103, P234, DOI 10.1016/0304-3940(89)90582-X; MASTERS CL, 1985, EMBO J, V4, P2757, DOI 10.1002/j.1460-2075.1985.tb04000.x; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; MCKEE AC, 1991, ANN NEUROL, V30, P156, DOI 10.1002/ana.410300206; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; MESULAM MM, 1982, ANN NEUROL, V11, P592, DOI 10.1002/ana.410110607; MESULAM MM, 1987, ANN NEUROL, V22, P683, DOI 10.1002/ana.410220603; MESULAM MM, 1986, NEUROSCIENCE, V17, P275, DOI 10.1016/0306-4522(86)90242-3; MORI H, 1987, SCIENCE, V235, P1641, DOI 10.1126/science.3029875; NARUSE S, 1991, LANCET, V337, P978, DOI 10.1016/0140-6736(91)91612-X; NELSON RB, 1990, J BIOL CHEM, V265, P3836; NUKINA N, 1986, J BIOCHEM-TOKYO, V99, P1541, DOI 10.1093/oxfordjournals.jbchem.a135625; OLTERSDORF T, 1989, NATURE, V341, P144, DOI 10.1038/341144a0; PERRY G, 1987, P NATL ACAD SCI USA, V84, P3033, DOI 10.1073/pnas.84.9.3033; PFEFFER RI, 1987, AM J EPIDEMIOL, V125, P420, DOI 10.1093/oxfordjournals.aje.a114548; PHILLIPS HS, 1990, SCIENCE, V250, P290, DOI 10.1126/science.1688328; Pogacar S, 1984, R I Med J, V67, P181; PONTE P, 1988, NATURE, V331, P525, DOI 10.1038/331525a0; PRICE DL, 1986, ANNU REV NEUROSCI, V9, P489; QUON D, 1991, NATURE, V352, P239, DOI 10.1038/352239a0; ROHER AE, 1991, BIOCHEM BIOPH RES CO, V174, P572, DOI 10.1016/0006-291X(91)91455-L; ROSENBLATT DE, 1989, ANN NEUROL, V26, P628, DOI 10.1002/ana.410260507; ROSSOR MN, 1980, NEUROSCI LETT, V20, P373, DOI 10.1016/0304-3940(80)90177-9; ROTH M, 1966, NATURE, V209, P109, DOI 10.1038/209109a0; RUMBLE B, 1989, NEW ENGL J MED, V320, P1446, DOI 10.1056/NEJM198906013202203; SAPER CB, 1985, NEUROLOGY, V35, P1089, DOI 10.1212/WNL.35.8.1089; SCHELLENBERG GD, 1988, SCIENCE, V241, P1507, DOI 10.1126/science.3420406; SCHOENBERG BS, 1987, ANN NEUROL, V22, P724, DOI 10.1002/ana.410220608; SELKOE DJ, 1988, P NATL ACAD SCI USA, V85, P7341, DOI 10.1073/pnas.85.19.7341; SISODIA SS, 1990, SCIENCE, V248, P492, DOI 10.1126/science.1691865; SMITH JS, 1981, LANCET, V1, P824; SMITH RP, 1990, SCIENCE, V248, P1126, DOI 10.1126/science.2111585; SNOW AD, 1988, AM J PATHOL, V133, P456; STGEORGEHYSLOP PH, 1987, SCIENCE, V235, P885, DOI 10.1126/science.2880399; STGEORGEHYSLOP PH, 1990, NATURE, V347, P194, DOI 10.1038/347194a0; TAGLIAVINI F, 1988, NEUROSCI LETT, V93, P191, DOI 10.1016/0304-3940(88)90080-8; TANZI RE, 1987, NATURE, V329, P156, DOI 10.1038/329156a0; TANZI RE, 1988, NATURE, V331, P528, DOI 10.1038/331528a0; TERRY RD, 1981, ANN NEUROL, V10, P184, DOI 10.1002/ana.410100209; TERRY RD, 1963, J NEUROPATH EXP NEUR, V22, P629, DOI 10.1097/00005072-196310000-00005; TERRY RD, 1972, ADV BEHAV BIOL, V3, P89; TERRY RD, 1983, CONT NEUROLOGY SERIE, V22, P51; THAL LJ, 1983, ANN NEUROL, V13, P491, DOI 10.1002/ana.410130504; TOMLINSON BE, 1970, J NEUROL SCI, V11, P205, DOI 10.1016/0022-510X(70)90063-8; TOMLINSON BE, 1981, J NEUROL SCI, V49, P419, DOI 10.1016/0022-510X(81)90031-9; UEDA K, 1990, J NEUROSCI, V10, P3295; VAN BROECKHOVEN C, 1987, NATURE, V329, P153; VANDUINEN SG, 1987, P NATL ACAD SCI USA, V84, P5991; VANNOSTRAND WE, 1990, SCIENCE, V248, P745, DOI 10.1126/science.2110384; WEIDEMANN A, 1989, CELL, V57, P115, DOI 10.1016/0092-8674(89)90177-3; WHITEHOUSE PJ, 1982, SCIENCE, V215, P1237, DOI 10.1126/science.7058341; WHITEHOUSE PJ, 1981, ANN NEUROL, V10, P122, DOI 10.1002/ana.410100203; WHITSON JS, 1989, SCIENCE, V243, P1488, DOI 10.1126/science.2928783; WILCOCK GK, 1982, J NEUROL SCI, V56, P343, DOI 10.1016/0022-510X(82)90155-1; WIRAK DO, 1991, SCIENCE, V253, P323, DOI 10.1126/science.1857970; WISCHIK CM, 1988, P NATL ACAD SCI USA, V85, P4506, DOI 10.1073/pnas.85.12.4506; WOLOZIN B, 1988, P NATL ACAD SCI USA, V85, P6202, DOI 10.1073/pnas.85.16.6202; WOLOZIN BL, 1986, SCIENCE, V232, P648, DOI 10.1126/science.3083509; YANKNER B A, 1991, Neurology, V41, P270; YANKNER BA, 1989, SCIENCE, V245, P417, DOI 10.1126/science.2474201; YANKNER BA, 1990, SCIENCE, V250, P279, DOI 10.1126/science.2218531; YANKNER BA, 1990, P NATL ACAD SCI USA, V87, P9020, DOI 10.1073/pnas.87.22.9020; 1991, LANCET, V337, P1342	130	204	208	0	0	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 26	1991	325	26					1849	1857						9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GW528	1961223				2022-12-28	WOS:A1991GW52800005
J	TRIER, JS				TRIER, JS			MEDICAL PROGRESS - CELIAC SPRUE	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							GLUTEN-SENSITIVE ENTEROPATHY; T-CELL LYMPHOMA; SMALL INTESTINAL-MUCOSA; ALPHA-BETA HETERODIMER; HLA-DQ; INTRAEPITHELIAL LYMPHOCYTES; DERMATITIS-HERPETIFORMIS; ORGAN-CULTURE; FREE DIET; MALIGNANT HISTIOCYTOSIS		HARVARD UNIV, CTR DIGEST DIS, BOSTON, MA 02115 USA	Harvard University	TRIER, JS (corresponding author), HARVARD UNIV, BRIGHAM & WOMENS HOSP, SCH MED, DEPT MED, 75 FRANCIS ST, BOSTON, MA 02115 USA.							ASCHER H, 1991, ARCH DIS CHILD, V66, P608, DOI 10.1136/adc.66.5.608; AUSTIN LL, 1988, GUT, V29, P200, DOI 10.1136/gut.29.2.200; BAILEY DS, 1989, GUT, V30, P78, DOI 10.1136/gut.30.1.78; BAKER AL, 1978, ANN INTERN MED, V89, P505, DOI 10.7326/0003-4819-89-4-505; BAKLIEN K, 1977, SCAND J GASTROENTERO, V12, P149, DOI 10.1080/00365521.1977.12031127; BARRESI G, 1988, HISTOCHEMISTRY, V88, P105, DOI 10.1007/BF00493292; BARTELS D, 1983, NUCLEIC ACIDS RES, V11, P2961, DOI 10.1093/nar/11.10.2961; BERNSTEIN EF, 1988, GASTROENTEROLOGY, V95, P199, DOI 10.1016/0016-5085(88)90312-5; BJARNASON I, 1983, LANCET, V1, P323; BRANDTZAEG P, 1989, GASTROENTEROLOGY, V97, P1562, DOI 10.1016/0016-5085(89)90406-X; BRANDTZAEG P, 1991, INT CONGR SER, V939, P29; BROCCHI E, 1988, NEW ENGL J MED, V319, P741, DOI 10.1056/NEJM198809223191202; BUGAWAN TL, 1989, NATURE, V339, P470, DOI 10.1038/339470a0; BYE WA, 1984, CURRENT THERAPY GAST, P147; CALABUIG M, 1990, J PEDIATR GASTR NUTR, V10, P435, DOI 10.1097/00005176-199005000-00004; CICLITIRA PJ, 1984, CLIN SCI, V66, P357, DOI 10.1042/cs0660357; CICLITIRA PJ, 1987, POSTGRAD MED J, V63, P767, DOI 10.1136/pgmj.63.743.767; CICLITIRA PJ, 1986, CLIN EXP IMMUNOL, V64, P119; COLACO J, 1987, ARCH DIS CHILD, V62, P706, DOI 10.1136/adc.62.7.706; COLLIN P, 1989, SCAND J GASTROENTERO, V24, P81, DOI 10.3109/00365528909092243; COLOMBEL JF, 1990, GUT, V31, P1345, DOI 10.1136/gut.31.12.1345; COLYER J, 1987, CLIN SCI, V72, P593, DOI 10.1042/cs0720593; Cooke WT, 1984, COELIAC DIS; CORAZZA GR, 1983, GUT, V24, P228, DOI 10.1136/gut.24.3.228; CORAZZA GR, 1982, GUT, V23, P415, DOI 10.1136/gut.23.5.415; CRABBE PA, 1967, AM J MED, V42, P319, DOI 10.1016/0002-9343(67)90031-9; CRABTREE JE, 1989, CLIN EXP IMMUNOL, V77, P345; CRAIG RM, 1988, GASTROENTEROLOGY, V95, P223, DOI 10.1016/0016-5085(88)90318-6; DAVIDSON AGF, 1987, CLIN CHIM ACTA, V163, P1, DOI 10.1016/0009-8981(87)90031-3; DERITIS G, 1988, GASTROENTEROLOGY, V94, P41, DOI 10.1016/0016-5085(88)90607-5; DICKE W K, 1953, Acta Paediatr, V42, P34, DOI 10.1111/j.1651-2227.1953.tb05563.x; DICKE WK, 1950, THESIS U UTRECHT UTR; DIMAGNO EP, 1972, GASTROENTEROLOGY, V63, P25; DOBBINS WO, 1964, GASTROENTEROLOGY, V47, P471; DOUGLAS AP, 1970, CLIN SCI, V38, P11, DOI 10.1042/cs0380011; EBERT EC, 1990, CLIN EXP IMMUNOL, V82, P81; EIDELMAN S, 1966, MEDICINE, V45, P111, DOI 10.1097/00005792-196603000-00002; FALCHUK ZM, 1974, J CLIN INVEST, V53, P487, DOI 10.1172/JCI107582; FALCHUK ZM, 1974, GUT, V15, P947, DOI 10.1136/gut.15.12.947; FORNASIERI A, 1987, BRIT MED J, V295, P78, DOI 10.1136/bmj.295.6590.78; FRY L, 1973, LANCET, V1, P288; GARST PM, 1980, GLUTEN FREE COOKING; Gee S., 1888, ST BARTHOLOMEWS HOSP, V24, P17; GRECO L, 1989, EUR J PEDIATR, V148, P610, DOI 10.1007/BF00441511; GRODZINSKY E, 1990, INT ARCH ALLER A IMM, V92, P119, DOI 10.1159/000235201; HALSTENSEN TS, 1989, SCAND J IMMUNOL, V30, P665, DOI 10.1111/j.1365-3083.1989.tb02474.x; HALSTENSEN TS, 1990, EUR J IMMUNOL, V20, P1825, DOI 10.1002/eji.1830200829; HARRIS OD, 1967, AM J MED, V42, P899, DOI 10.1016/0002-9343(67)90071-X; HAURI HP, 1978, GUT, V19, P1090, DOI 10.1136/gut.19.12.1090; HAY JE, 1988, ANN INTERN MED, V109, P713, DOI 10.7326/0003-4819-109-9-713; HERRERA M, 1989, HUM IMMUNOL, V26, P272, DOI 10.1016/0198-8859(89)90005-0; HOLMES GKT, 1976, GUT, V17, P612, DOI 10.1136/gut.17.8.612; HOLMES GKT, 1989, GUT, V30, P333, DOI 10.1136/gut.30.3.333; HOWDLE PD, 1984, SCAND J GASTROENTERO, V19, P41, DOI 10.1080/00365521.1984.12005681; HOWDLE PD, 1989, SCAND J GASTROENTERO, V24, P282, DOI 10.3109/00365528909093047; HOWELL MD, 1988, P NATL ACAD SCI USA, V85, P222, DOI 10.1073/pnas.85.1.222; ISAACSON P, 1978, LANCET, V1, P67; ISAACSON PG, 1985, LANCET, V2, P688; JABBARI M, 1988, GASTROENTEROLOGY, V95, P1518, DOI 10.1016/S0016-5085(88)80071-4; JONES B, 1984, AM J ROENTGENOL, V142, P1127, DOI 10.2214/ajr.142.6.1127; JUBY LD, 1989, GASTROENTEROLOGY, V96, P79, DOI 10.1016/0016-5085(89)90767-1; KAGNOFF MF, 1989, P NATL ACAD SCI USA, V86, P6274, DOI 10.1073/pnas.86.16.6274; KAGNOFF MF, 1987, GUT, V28, P995, DOI 10.1136/gut.28.8.995; KAGNOFF MF, 1984, J EXP MED, V160, P1544, DOI 10.1084/jem.160.5.1544; KAGNOFF MF, 1990, GUT, V31, P497, DOI 10.1136/gut.31.5.497; KAGNOFF MF, 1991, TXB GASTROENTEROLOGY, P1503; KASARDA DD, 1984, P NATL ACAD SCI-BIOL, V81, P4712, DOI 10.1073/pnas.81.15.4712; KASARDA DD, 1976, ADV CEREAL SCI TECHN, P158; KATZ SI, 1980, ANN INTERN MED, V93, P857, DOI 10.7326/0003-4819-93-6-857; KELLY J, 1988, TISSUE ANTIGENS, V31, P151, DOI 10.1111/j.1399-0039.1988.tb02076.x; KENRICK KG, 1970, GUT, V11, P635, DOI 10.1136/gut.11.8.635; KRAINICK H G, 1958, Helv Paediatr Acta, V13, P432; KUMAR V, 1989, IMMUNOL INVEST, V18, P533, DOI 10.3109/08820138909112261; LAVO B, 1990, GASTROENTEROLOGY, V99, P703, DOI 10.1016/0016-5085(90)90958-4; LAVO B, 1989, AM J MED, V87, P655, DOI 10.1016/0002-9343(89)90726-2; LEVENSON SD, 1985, GASTROENTEROLOGY, V89, P1; LEVINE RA, 1966, NEW ENGL J MED, V274, P1109, DOI 10.1056/NEJM196605192742003; LOFT DE, 1990, LANCET, V335, P1293, DOI 10.1016/0140-6736(90)91183-B; LOGAN RFA, 1986, GASTROENTEROLOGY, V90, P334, DOI 10.1016/0016-5085(86)90929-7; LOGAN RFA, 1983, BMJ-BRIT MED J, V286, P95, DOI 10.1136/bmj.286.6359.95; LOGAN RFA, 1989, GASTROENTEROLOGY, V97, P265, DOI 10.1016/0016-5085(89)90060-7; LOGAN RFA, 1978, LANCET, V1, P230; LORENZSONN V, 1982, GASTROENTEROLOGY, V82, P838; MACDONALD TT, 1977, CELL TISSUE KINET, V10, P301, DOI 10.1111/j.1365-2184.1977.tb00298.x; MACDONALD TT, 1988, J EXP MED, V167, P1341, DOI 10.1084/jem.167.4.1341; MACDONALD WC, 1965, NEW ENGL J MED, V272, P448, DOI 10.1056/NEJM196503042720903; MADARA JL, 1980, LAB INVEST, V43, P255; MAKI M, 1989, ARCH DIS CHILD, V64, P1604, DOI 10.1136/adc.64.11.1604; MANN JG, 1970, AM J MED, V48, P357, DOI 10.1016/0002-9343(70)90066-5; MANTZARIS G, 1991, SCAND J GASTROENTERO, V26, P392, DOI 10.3109/00365529108996500; MANTZARIS GJ, 1990, GUT, V31, P668, DOI 10.1136/gut.31.6.668; MARSH MN, 1989, IMMUNOL INVEST, V18, P509, DOI 10.3109/08820138909112260; MATON PN, 1985, GASTROENTEROLOGY, V88, P391, DOI 10.1016/0016-5085(85)90497-4; MATUCHANSKY C, 1984, GASTROENTEROLOGY, V87, P606; MCGUIGAN JE, 1964, GASTROENTEROLOGY, V47, P636; MEARIN ML, 1983, GUT, V24, P532, DOI 10.1136/gut.24.6.532; MEARIN ML, 1987, NETH J MED, V31, P279; MIDHAGEN G, 1988, SCAND J GASTROENTERO, V23, P1000, DOI 10.3109/00365528809090160; MISRA RC, 1966, BRIT MED J, V2, P1230, DOI 10.1136/bmj.2.5524.1230; MYLOTTE M, 1973, BMJ-BRIT MED J, V1, P703, DOI 10.1136/bmj.1.5855.703; MYLOTTE M, 1974, Q J MED, V43, P359; NEILD GH, 1981, LANCET, V1, P811; NIELSEN OH, 1985, SCAND J GASTROENTERO, V20, P13, DOI 10.3109/00365528509089626; OFARRELLY C, 1986, BRIT MED J, V293, P908, DOI 10.1136/bmj.293.6552.908; OTLEY C, 1990, DERMATOL CLIN, V8, P759; PAULLEY JW, 1954, BRIT MED J, V2, P1318, DOI 10.1136/bmj.2.4900.1318; POLANCO I, 1981, GENETICS COELIAC DIS, P211; Quaroni A, 1980, Methods Cell Biol, V21B, P403; RAFALSKI JA, 1984, EMBO J, V3, P1409, DOI 10.1002/j.1460-2075.1984.tb01985.x; RUBIN CE, 1970, GASTROENTEROLOGY, V58, P409; RUBIN CE, 1960, GASTROENTEROLOGY, V38, P28; RUBIN CE, 1961, ANNU REV MED, V12, P39, DOI 10.1146/annurev.me.12.020161.000351; RUBIN CE, 1962, INTESTINAL BIOPSY, P67; SCOTT H, 1987, SCAND J IMMUNOL, V26, P563, DOI 10.1111/j.1365-3083.1987.tb02290.x; SCOTT H, 1990, SCAND J GASTROENTERO, V25, P287, DOI 10.1080/00365521.1990.12067105; SELBY WS, 1979, DIGEST DIS SCI, V24, P684, DOI 10.1007/BF01314465; SHAH A, 1990, Q J MED, V74, P283; SHANAHAN F, 1982, Q J MED, V51, P329; SHINER M, 1960, GASTROENTEROLOGY, V38, P419; SHUSTER S, 1968, LANCET, V1, P1101; SINCLAIR TS, 1983, GUT, V24, pA494; SKERRITT JH, 1991, LANCET, V337, P379, DOI 10.1016/0140-6736(91)91163-O; SOLLID LM, 1990, TISSUE ANTIGENS, V36, P136, DOI 10.1111/j.1399-0039.1990.tb01816.x; SOLLID LM, 1989, J EXP MED, V169, P345, DOI 10.1084/jem.169.1.345; SPENCER J, 1988, AM J PATHOL, V132, P1; SPURKLAND A, 1990, HUM IMMUNOL, V29, P157, DOI 10.1016/0198-8859(90)90111-2; STENHAMMAR L, 1982, ACTA PAEDIATR SCAND, V71, P625, DOI 10.1111/j.1651-2227.1982.tb09486.x; STEVENS FM, 1987, ARCH DIS CHILD, V62, P465, DOI 10.1136/adc.62.5.465; STOKES PL, 1976, Q J MED, V45, P567; STROBER W, 1986, J ALLERGY CLIN IMMUN, V78, P202, DOI 10.1016/0091-6749(86)90013-8; SWINSON CM, 1983, LANCET, V1, P111; Thaysen TEH, 1935, Q J MED, V4, P359; TIWARI JL, 1985, HLA DISEASE ASS, P236; TOSI R, 1983, CLIN IMMUNOL IMMUNOP, V28, P395, DOI 10.1016/0090-1229(83)90106-X; Trier J S, 1980, Methods Cell Biol, V21B, P365; TRIER JS, 1978, GASTROENTEROLOGY, V75, P307; TRIER JS, 1988, HOSP PRACT, V23, P195; TRIER JS, 1970, NEW ENGL J MED, V283, P1245, DOI 10.1056/NEJM197012032832302; TRIER JS, 1989, GASTROINTESTINAL DIS, P1134; VAN DE KAMER J H, 1953, Acta Paediatr, V42, P223, DOI 10.1111/j.1651-2227.1953.tb05586.x; VOLTA U, 1991, DIGEST DIS SCI, V36, P752, DOI 10.1007/BF01311232; WALKERSMITH JA, 1990, ARCH DIS CHILD, V65, P909, DOI 10.1136/adc.65.8.909; WEINMAN MD, 1989, GASTROENTEROLOGY, V97, P1193, DOI 10.1016/0016-5085(89)91690-9; WEINSTEI.WM, 1970, NEW ENGL J MED, V283, P1297, DOI 10.1056/NEJM197012102832401; WEINSTEIN WM, 1974, GASTROENTEROLOGY, V66, P489; WEINSTEIN WM, 1971, GASTROENTEROLOGY, V60, P362; WEISER MM, 1976, LANCET, V1, P567; WOLBER R, 1990, GASTROENTEROLOGY, V98, P310, DOI 10.1016/0016-5085(90)90819-M; WOLBER R, 1990, HUM PATHOL, V21, P1092, DOI 10.1016/0046-8177(90)90144-T; WOOD MN, 1972, DELICIOUS EASY RICE; WOOD MN, 1982, COPING GLUTEN FREE D; WOOD MN, 1967, GOURMET FOOD WHEAT F; YARDLEY JH, 1962, NEW ENGL J MED, V267, P1173, DOI 10.1056/NEJM196212062672303	153	436	444	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 12	1991	325	24					1709	1719		10.1056/NEJM199112123252406	http://dx.doi.org/10.1056/NEJM199112123252406			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GU418	1944472				2022-12-28	WOS:A1991GU41800006
J	BENOWITZ, NL				BENOWITZ, NL			NICOTINE REPLACEMENT THERAPY DURING PREGNANCY	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CIGARETTE-SMOKING; BLOOD-FLOW; MATERNAL SMOKING; CARBON-MONOXIDE; CHEWING-GUM; CESSATION; CHILDREN; EXPOSURE; MOTHERS; SYSTEMS		UNIV CALIF SAN FRANCISCO,DEPT MED,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT PSYCHIAT,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT PHARM,SAN FRANCISCO,CA 94143	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	BENOWITZ, NL (corresponding author), SAN FRANCISCO GEN HOSP,MED CTR,DIV CLIN PHARMACOL & EXPTL THERAPEUT,1011 POTRERO AVE,BLDG 30,SAN FRANCISCO,CA 94110, USA.				NIDA NIH HHS [DA01696, DA02277] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA002277, P50DA001696, R37DA002277] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		AHLSTEN G, 1990, BIOL NEONATE, V58, P271; BENOWITZ NL, 1987, CLIN PHARMACOL THER, V41, P467, DOI 10.1038/clpt.1987.58; BENOWITZ NL, 1991, CLIN PHARMACOL THER, V50, P286, DOI 10.1038/clpt.1991.138; BENOWITZ NL, 1984, CLIN PHARMACOL THER, V36, P74, DOI 10.1038/clpt.1984.142; BENOWITZ NL, 1990, J PHARMACOL EXP THER, V254, P1000; BENOWITZ NL, 1988, NEW ENGL J MED, V319, P1318; BENOWITZ NL, 1988, CLIN PHARMACOL THER, V44, P23, DOI 10.1038/clpt.1988.107; BENOWITZ NL, 1988, NICOTINE REPLACEMENT, P187; BENOWITZ NL, 1986, NEW ENGL J MED, V315, P1639; BUREAU MA, 1982, PEDIATRICS, V69, P371; DAVIS RL, 1990, AM J DIS CHILD, V144, P1297, DOI 10.1001/archpedi.1990.02150360019010; DIVERS WA, 1981, AM J OBSTET GYNECOL, V141, P625, DOI 10.1016/S0002-9378(15)33301-9; ERSHOFF DH, 1990, PUBLIC HEALTH REP, V105, P340; FINGERHUT LA, 1990, AM J PUBLIC HEALTH, V80, P541, DOI 10.2105/AJPH.80.5.541; FRIED PA, 1990, J DEV BEHAV PEDIATR, V11, P49; GARN SM, 1981, AM J DIS CHILD, V135, P503, DOI 10.1001/archpedi.1981.02130300003003; Hickner J, 1990, J Am Board Fam Pract, V3, P39; HURT RD, 1990, MAYO CLIN PROC, V65, P1529, DOI 10.1016/S0025-6196(12)62186-7; LAM W, 1987, LANCET, V2, P27; LEHTOVIRTA P, 1983, BRIT J OBSTET GYNAEC, V90, P710, DOI 10.1111/j.1471-0528.1983.tb09299.x; LEHTOVIRTA P, 1978, BRIT J OBSTET GYNAEC, V85, P729, DOI 10.1111/j.1471-0528.1978.tb15592.x; LONGO LD, 1976, SCIENCE, V194, P523, DOI 10.1126/science.973133; LONGO LD, 1977, AM J OBSTET GYNECOL, V129, P69, DOI 10.1016/0002-9378(77)90824-9; MACARTHUR C, 1987, BRIT J OBSTET GYNAEC, V94, P293; MANNING FA, 1976, BRIT J OBSTET GYNAEC, V83, P262, DOI 10.1111/j.1471-0528.1976.tb00823.x; NAEYE RL, 1984, OBSTET GYNECOL, V64, P601; NAVARRO HA, 1988, J PHARMACOL EXP THER, V244, P940; NAVARRO HA, 1989, J PHARMACOL EXP THER, V251, P894; NIEBURG P, 1985, JAMA-J AM MED ASSOC, V253, P2998, DOI 10.1001/jama.253.20.2998; PETERSON DR, 1979, BEHAVIORAL ASSESSMEN, V1, P221; PHILIPP K, 1984, GYNECOL OBSTET INVES, V17, P179, DOI 10.1159/000299145; RESNIK R, 1979, J CLIN INVEST, V63, P1133, DOI 10.1172/JCI109406; SEXTON M, 1984, JAMA-J AM MED ASSOC, V251, P911, DOI 10.1001/jama.251.7.911; STILLMAN RJ, 1986, FERTIL STERIL, V46, P545; STOCKBAUER JW, 1991, PUBLIC HEALTH REP, V106, P52; TONNESEN P, 1991, NEW ENGL J MED, V325, P311, DOI 10.1056/NEJM199108013250503; TONNESEN P, 1988, NEW ENGL J MED, V318, P15, DOI 10.1056/NEJM198801073180104; WILLIAMSON DF, 1989, JAMA-J AM MED ASSOC, V261, P70; 1983, 4108891284 DEP HLTH, P191; 1990, MMWR, V39, P662; 1990, MMWR, V39, P659; 1990, PHS CDC908416 DEP HL	42	95	95	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 11	1991	266	22					3174	3177		10.1001/jama.266.22.3174	http://dx.doi.org/10.1001/jama.266.22.3174			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GT654	1956108				2022-12-28	WOS:A1991GT65400029
J	STRASSER, A; HARRIS, AW; CORY, S				STRASSER, A; HARRIS, AW; CORY, S			BCL-2 TRANSGENE INHIBITS T-CELL DEATH AND PERTURBS THYMIC SELF-CENSORSHIP	CELL			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; MONOCLONAL-ANTIBODY; DNA FRAGMENTATION; MEMBRANE PROTEIN; BETA-CHAIN; B-CELLS; RECEPTOR; EXPRESSION; ANTIGEN; TRANSLOCATION	Early death is the fate of most developing T lymphocytes. Because bcl-2 can promote cell survival, we tested its impact in mice expressing an E-mu-bcl-2 transgene within the T lymphoid compartment. The T cells showed remarkably sustained viability and some spontaneous differentiation in vitro. They also resisted killing by lymphotoxic agents. Although total T cell numbers and the rate of thymic involution were unaltered, the response to immunization was enhanced, consistent with reduced death of activated T cells. No T cells reactive with self-superantigens appeared in the lymph nodes, but an excess was found in the thymus. These observations, together with previous findings on B cells, suggest that modulated bcl-2 expression is a determinant of life and death in normal lymphocytes.			STRASSER, A (corresponding author), ROYAL MELBOURNE HOSP,WALTER & ELIZA HALL INST MED RES,PARKVILLE,VIC 3050,AUSTRALIA.		Strasser, Andreas/C-7581-2013; Cory, Suzanne/E-1642-2013	Strasser, Andreas/0000-0002-5020-4891; Cory, Suzanne/0000-0002-6818-3451	NATIONAL CANCER INSTITUTE [R01CA043540] Funding Source: NIH RePORTER; NCI NIH HHS [CA43540] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ACHAORBEA H, 1985, EUR J IMMUNOL, V15, P31, DOI 10.1002/eji.1830150107; ACHAORBEA H, 1991, NATURE, V350, P207, DOI 10.1038/350207a0; BAKHSHI A, 1985, CELL, V41, P899, DOI 10.1016/S0092-8674(85)80070-2; BEHLKE MA, 1986, P NATL ACAD SCI USA, V83, P767, DOI 10.1073/pnas.83.3.767; BLACKMAN M, 1990, SCIENCE, V248, P1335, DOI 10.1126/science.1972592; CHENLEVY Z, 1989, MOL CELL BIOL, V9, P701, DOI 10.1128/MCB.9.2.701; CHOI YW, 1991, NATURE, V350, P203, DOI 10.1038/350203a0; CLEARY ML, 1986, CELL, V47, P19, DOI 10.1016/0092-8674(86)90362-4; DAVIS MM, 1990, ANNU REV BIOCHEM, V59, P475, DOI 10.1146/annurev.biochem.59.1.475; DELLABONA P, 1990, CELL, V62, P1115, DOI 10.1016/0092-8674(90)90388-U; DIALYNAS DP, 1983, IMMUNOL REV, V74, P29, DOI 10.1111/j.1600-065X.1983.tb01083.x; DUVALL E, 1986, IMMUNOL TODAY, V7, P115, DOI 10.1016/0167-5699(86)90152-0; EGERTON M, 1990, P NATL ACAD SCI USA, V87, P2579, DOI 10.1073/pnas.87.7.2579; GOODMAN T, 1989, J EXP MED, V170, P1569, DOI 10.1084/jem.170.5.1569; HASKINS K, 1984, J EXP MED, V160, P452, DOI 10.1084/jem.160.2.452; HENDERSON S, 1991, CELL, V65, P1107, DOI 10.1016/0092-8674(91)90007-L; HENGARTNER H, 1988, NATURE, V336, P388, DOI 10.1038/336388a0; HOCKENBERY D, 1990, NATURE, V348, P334, DOI 10.1038/348334a0; HOCKENBERY DM, 1991, P NATL ACAD SCI USA, V88, P6961, DOI 10.1073/pnas.88.16.6961; HOUSTON LL, 1980, J IMMUNOL, V125, P837; KAPPLER JW, 1987, CELL, V49, P273, DOI 10.1016/0092-8674(87)90568-X; KAPPLER JW, 1988, NATURE, V332, P35, DOI 10.1038/332035a0; KARASUYAMA H, 1988, EUR J IMMUNOL, V18, P97, DOI 10.1002/eji.1830180115; KAWABE Y, 1991, NATURE, V349, P245, DOI 10.1038/349245a0; KIZAKI H, 1989, J IMMUNOL, V143, P1790; KUBO RT, 1989, J IMMUNOL, V142, P2736; LEDBETTER JA, 1979, IMMUNOL REV, V47, P63, DOI 10.1111/j.1600-065X.1979.tb00289.x; LEO O, 1987, P NATL ACAD SCI USA, V84, P1374, DOI 10.1073/pnas.84.5.1374; LIU YJ, 1991, EUR J IMMUNOL, V21, P1905, DOI 10.1002/eji.1830210819; MACDONALD HR, 1990, NATURE, V343, P642, DOI 10.1038/343642a0; MACDONALD HR, 1988, NATURE, V332, P40, DOI 10.1038/332040a0; MACDONALD HR, 1991, EUR J IMMUNOL, V21, P1963, DOI 10.1002/eji.1830210827; MARRACK P, 1987, SCIENCE, V238, P1073, DOI 10.1126/science.3317824; MCDONNELL TJ, 1990, MOL CELL BIOL, V10, P1901, DOI 10.1128/MCB.10.5.1901; MCDONNELL TJ, 1991, NATURE, V349, P254, DOI 10.1038/349254a0; MCDONNELL TJ, 1989, CELL, V57, P79, DOI 10.1016/0092-8674(89)90174-8; NUNEZ G, 1990, J IMMUNOL, V144, P3602; OHASHI PS, 1990, NATURE, V346, P861, DOI 10.1038/346861a0; PETRIE HT, 1990, J EXP MED, V172, P1583, DOI 10.1084/jem.172.6.1583; PEZZELLA F, 1990, AM J PATHOL, V137, P225; PULLEN AM, 1990, CELL, V61, P1365, DOI 10.1016/0092-8674(90)90700-O; PULLEN AM, 1988, NATURE, V335, P796, DOI 10.1038/335796a0; SCOLLAY R, 1984, IMMUNOL REV, V82, P79, DOI 10.1111/j.1600-065X.1984.tb01118.x; SHI YF, 1990, J IMMUNOL, V144, P3326; SHI YF, 1991, J IMMUNOL, V146, P3340; SMITH CA, 1989, NATURE, V337, P181, DOI 10.1038/337181a0; STAERZ UD, 1985, J IMMUNOL, V134, P3994; STRASSER A, 1990, CURR TOP MICROBIOL, V166, P175; STRASSER A, 1991, P NATL ACAD SCI USA, V88, P8661, DOI 10.1073/pnas.88.19.8661; STRASSER A, 1990, NATURE, V348, P331, DOI 10.1038/348331a0; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; TSUJIMOTO Y, 1987, ONCOGENE, V2, P3; TSUJIMOTO Y, 1984, SCIENCE, V226, P1097, DOI 10.1126/science.6093263; TSUJIMOTO Y, 1989, ONCOGENE, V4, P1331; UNKELESS JC, 1979, J EXP MED, V150, P580, DOI 10.1084/jem.150.3.580; VAUX DL, 1988, NATURE, V335, P440, DOI 10.1038/335440a0; VONBOEHMER H, 1990, SCIENCE, V248, P1369, DOI 10.1126/science.1972594; WEBB S, 1990, CELL, V63, P1249, DOI 10.1016/0092-8674(90)90420-J; WHITE J, 1989, CELL, V56, P27, DOI 10.1016/0092-8674(89)90980-X; WYLLIE AH, 1980, NATURE, V284, P555, DOI 10.1038/284555a0	60	1076	1121	0	13	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	NOV 29	1991	67	5					889	899		10.1016/0092-8674(91)90362-3	http://dx.doi.org/10.1016/0092-8674(91)90362-3			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GT755	1959134				2022-12-28	WOS:A1991GT75500008
J	FALLOON, J; KOVACS, J; HUGHES, W; ONEILL, D; POLIS, M; DAVEY, RT; ROGERS, M; LAFON, S; FEUERSTEIN, I; LANCASTER, D; LAND, M; TUAZON, C; DOHN, M; GREENBERG, S; LANE, HC; MASUR, H				FALLOON, J; KOVACS, J; HUGHES, W; ONEILL, D; POLIS, M; DAVEY, RT; ROGERS, M; LAFON, S; FEUERSTEIN, I; LANCASTER, D; LAND, M; TUAZON, C; DOHN, M; GREENBERG, S; LANE, HC; MASUR, H			A PRELIMINARY EVALUATION OF 566C80 FOR THE TREATMENT OF PNEUMOCYSTIS PNEUMONIA IN PATIENTS WITH THE ACQUIRED-IMMUNODEFICIENCY-SYNDROME	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HYDROXYNAPHTHOQUINONE; POTENT	Background. The drug 566C80 is an investigational hydroxynaphthoquinone that is active against Pneumocystis carinii in vitro and in animal models. Initial studies in humans indicate that 566C80 is safe and has adequate bioavailability after oral administration. Methods. We conducted an open-label trial of 566C80 in 34 adults with the acquired immunodeficiency syndrome (AIDS) and untreated pneumocystis pneumonia. All the patients had a partial pressure of arterial oxygen of at least 60 mm Hg while breathing room air. They were enrolled sequentially in three cohorts taking 566C80 at different dosages, all administered orally: 750 mg three times daily for 5 days, then twice daily for 16 days; 750 mg three times daily for 21 days; and 750 mg four times daily for 21 days. Results. All 34 patients survived, and 27 (79 percent) were successfully treated with 566C80 alone. The mean partial pressure of oxygen in 33 patients was 78 mm Hg at entry and 93 mm Hg after the course of 566C80 (P < 0.001). In five patients (15 percent) the drug was discontinued because of lack of response. In four patients (12 percent), the drug was discontinued because of toxicity (fever and rash in two patients each). In two of these, treatment was considered to have succeeded because 566C80 was not discontinued because of toxicity until after day 14. Five of the successfully treated patients had rashes that resolved despite continued therapy. In nine patients, serum alanine aminotransferase levels rose above 100 U per liter. During the first three months after the completion of therapy, pneumocystis pneumonia recurred in 4 of the 27 successfully treated patients, and another 3 patients had recurrences between month 3 and month 6 of follow-up. The mean (+/- SEM) steady-state plasma levels of 566C80 were similar in the three cohorts: 16.3 +/- 2.10, 20.4 +/- 2.48, and 18.9 +/- 3.08-mu-g per milliliter in the patients taking the drug twice daily, three times daily, and four times daily, respectively. Conclusions. From these preliminary data, the investigational compound 566C80 appears to be a safe, effective, and well-tolerated therapy for P. carinii pneumonia of mild-to-moderate severity in patients with AIDS.	WARREN G MAGNUSON CLIN CTR, DEPT RADIOL, BETHESDA, MD 20892 USA; NIAID, BETHESDA, MD 20892 USA; ST JUDE CHILDRENS RES HOSP, MEMPHIS, TN 38101 USA; BURROUGHS WELLCOME CO, RES TRIANGLE PK, NC 27709 USA; GEORGE WASHINGTON UNIV, MED CTR, WASHINGTON, DC 20037 USA; REG MED CTR, MEMPHIS, TN USA; BAPTIST MEM HOSP, MEMPHIS, TN 38146 USA; UNIV CINCINNATI, CINCINNATI, OH 45221 USA; BAYLOR COLL MED, HOUSTON, TX 77030 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); St Jude Children's Research Hospital; Burroughs Wellcome Fund; George Washington University; Baptist Memorial Hospital Memphis; University System of Ohio; University of Cincinnati; Baylor College of Medicine	FALLOON, J (corresponding author), WARREN G MAGNUSON CLIN CTR, DEPT CRIT CARE MED, BLDG 10, RM 7D43, BETHESDA, MD 20892 USA.		Kovacs, Joseph/AAU-6105-2021	Kovacs, Joseph/0000-0002-5191-9880; Polis, Michael/0000-0002-9151-2268				ARAUJO FG, 1991, ANTIMICROB AGENTS CH, V35, P293, DOI 10.1128/AAC.35.2.293; FRY M, 1984, BIOCHEM PHARMACOL, V33, P2115, DOI 10.1016/0006-2952(84)90581-1; HAMMOND DJ, 1985, MOL BIOCHEM PARASIT, V14, P97, DOI 10.1016/0166-6851(85)90109-4; HUDSON AT, 1985, PARASITOLOGY, V90, P45, DOI 10.1017/S0031182000049003; HUGHES WT, 1990, ANTIMICROB AGENTS CH, V34, P225, DOI 10.1128/AAC.34.2.225; HUGHES WT, 1991, J INFECT DIS, V163, P843, DOI 10.1093/infdis/163.4.843; HUSKINSONMARK J, 1991, J INFECT DIS, V164, P170, DOI 10.1093/infdis/164.1.170; MASUR H, 1991, 7TH INT C AIDS FLOR; RAO NA, 1989, AM J OPHTHALMOL, V107, P218, DOI 10.1016/0002-9394(89)90303-6; 1990, NEW ENGL J MED, V323, P1500	10	82	82	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 28	1991	325	22					1534	1538		10.1056/NEJM199111283252202	http://dx.doi.org/10.1056/NEJM199111283252202			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GR380	1944437	Bronze			2022-12-28	WOS:A1991GR38000002
J	GILKS, C				GILKS, C			AIDS, MONKEYS AND MALARIA	NATURE			English	Editorial Material							LENTIVIRUSES		KENYA GOVT MED RES CTR, NAIROBI, KENYA	Kenya Medical Research Institute	GILKS, C (corresponding author), JOHN RADCLIFFE HOSP, NUFFIELD DEPT CLIN MED, OXFORD OX3 9DU, ENGLAND.		Gilks, Charles/B-4184-2012	Gilks, Charles/0000-0002-8953-3123				Blacklock B., 1922, Annals of Tropical Medicine and Parasitology, V16, P99; COATNEY GR, 1968, AM J TROP MED HYG, V17, P145; COATNEY GR, 1971, PRIMATE MALARIAS; CONTACOS PG, 1970, AM J TROP MED HYG, V19, P190, DOI 10.4269/ajtmh.1970.19.190; DESROSIERS RC, 1989, AIDS RES HUM RETROV, V5, P465, DOI 10.1089/aid.1989.5.465; Garnham PCC., 1966, MALARIA PARASITES OT; HIRSCH VM, 1989, NATURE, V339, P389, DOI 10.1038/339389a0; KARPAS A, 1990, NATURE, V348, P578, DOI 10.1038/348578a0; MCLURE M, 1990, NEW SCI         0730, P54; OWUSU SK, 1991, NATURE, V350, P184, DOI 10.1038/350184a0; PEETERS M, 1989, AIDS, V3, P625, DOI 10.1097/00002030-198910000-00001; Rodhain J., 1939, Annales de la Societe Belge de Medecine Tropicale, V19, P563; Rodhain J., 1943, Annales de la Societe Belge de Medecine Tropicale, V23; Rodhain J., 1955, Annales de la Societe Belge de Medecine Tropicale, V35, P757; Rodhain J., 1936, Annales de la Societe Belge de Medecine Tropicale, V16, P521; SCHNEIDER J, 1988, AIDS, V2, P1, DOI 10.1097/00002030-198802000-00001	16	15	15	1	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 28	1991	354	6351					262	262		10.1038/354262a0	http://dx.doi.org/10.1038/354262a0			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT204	1956378	Bronze			2022-12-28	WOS:A1991GT20400021
J	ROY, AL; MEISTERERNST, M; POGNONEC, P; ROEDER, RG				ROY, AL; MEISTERERNST, M; POGNONEC, P; ROEDER, RG			COOPERATIVE INTERACTION OF AN INITIATOR-BINDING TRANSCRIPTION INITIATION-FACTOR AND THE HELIX LOOP HELIX ACTIVATOR USF	NATURE			English	Article							RNA POLYMERASE-II; MAJOR LATE PROMOTER; GENETIC SPECIFICITY; UPSTREAM ELEMENT; DNA-BINDING; TATA; PROTEINS; IDENTIFICATION; PURIFICATION; EXPRESSION	TRANSCRIPTION initiation by mammalian RNA polymerase II is effected by multiple common factors 1,2 interacting through minimal promoter elements and regulated by gene-specific factors 3 interacting with distal control elements. Minimal promoter elements that can function independently or together, depending on the specific promoter, include the upstream TATA box 4,5 and a pyrimidine-rich initiator 6-8 (Inr) overlapping the transcription start site. The binding of TFIID to the TATA element 4,9 promotes the assembly of other factors into a preinitiation complex 10-12 but factors which function at the Inr have not been defined. We show here that a novel factor (TFII-I) binds specifically to Inr elements, supports basal transcription from the adenovirus major late promoter and is immunologically related to the helix-loop-helix activator USF (ref. 13). We further show that TFII-I also binds to the upstream high-affinity USF site (E box), that USF also binds to the Inr, and that TFII-I and USF interact cooperatively at both Inr and E box sites. Thus, TFII-I represents a novel type of transcription initiation factor whose interactions at multiple promoter elements may aid novel communication mechanisms between upstream regulatory factors and the general transcriptional machinery.			ROY, AL (corresponding author), ROCKEFELLER UNIV,BIOCHEM & MOLEC BIOL LAB,NEW YORK,NY 10021, USA.							BLACKWOOD EM, 1991, SCIENCE, V251, P1149; BREATHNACH R, 1981, ANNU REV BIOCHEM, V50, P349, DOI 10.1146/annurev.bi.50.070181.002025; BURATOWSKI S, 1989, CELL, V56, P549, DOI 10.1016/0092-8674(89)90578-3; CARTHEW RW, 1985, CELL, V43, P439, DOI 10.1016/0092-8674(85)90174-6; DAVIS RL, 1990, CELL, V60, P733, DOI 10.1016/0092-8674(90)90088-V; GREGOR PD, 1990, GENE DEV, V4, P1730, DOI 10.1101/gad.4.10.1730; GROSSCHEDL R, 1980, P NATL ACAD SCI-BIOL, V77, P1432, DOI 10.1073/pnas.77.3.1432; HOFFMANN A, 1990, NATURE, V346, P387, DOI 10.1038/346387a0; MALDONADO E, 1990, MOL CELL BIOL, V10, P6335, DOI 10.1128/MCB.10.12.6335; MANIATIS T, 1987, SCIENCE, V236, P1237, DOI 10.1126/science.3296191; MATSUI T, 1980, J BIOL CHEM, V255, P1992; MEISTERENST M, 1991, CELL, V66, P1; MIYAMOTO NG, 1985, EMBO J, V4, P3563, DOI 10.1002/j.1460-2075.1985.tb04118.x; MURRE C, 1989, CELL, V56, P777, DOI 10.1016/0092-8674(89)90682-X; MURRE C, 1989, CELL, V58, P537, DOI 10.1016/0092-8674(89)90434-0; NAKAJIMA N, 1988, MOL CELL BIOL, V8, P4028, DOI 10.1128/MCB.8.10.4028; NAKATANI Y, 1990, NATURE, V348, P86, DOI 10.1038/348086a0; POGNONEC P, 1991, MOL CELL BIOL, V11, P5125, DOI 10.1128/MCB.11.10.5125; PRENDERGAST GC, 1991, CELL, V65, P395, DOI 10.1016/0092-8674(91)90457-A; SAWADOGO M, 1985, CELL, V43, P165, DOI 10.1016/0092-8674(85)90021-2; SMALE ST, 1989, CELL, V57, P103, DOI 10.1016/0092-8674(89)90176-1; SMALE ST, 1990, P NATL ACAD SCI USA, V87, P4509, DOI 10.1073/pnas.87.12.4509; SUMIMOTO H, 1990, P NATL ACAD SCI USA, V87, P9158, DOI 10.1073/pnas.87.23.9158; VANDYKE MW, 1988, SCIENCE, V241, P1335, DOI 10.1126/science.3413495	24	439	444	0	6	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	NOV 21	1991	354	6350					245	248		10.1038/354245a0	http://dx.doi.org/10.1038/354245a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ948	1961251				2022-12-28	WOS:A1991GQ94800054
J	HO, PS; KAGAWA, TF; TSENG, K; SCHROTH, GP; ZHOU, GW				HO, PS; KAGAWA, TF; TSENG, K; SCHROTH, GP; ZHOU, GW			PREDICTION OF A CRYSTALLIZATION PATHWAY FOR Z-DNA HEXANUCLEOTIDES	SCIENCE			English	Article							CRYSTAL-STRUCTURE; BASE-PAIRS; MOLECULAR-STRUCTURE; B-DNA; TRANSITION; FRAGMENT	Crystallization of macromolecules for structural studies has long been a hit-or-miss process. The crystallization of hexanucleotides as Z-DNA was studied, and it was shown that the cation concentration for crystal formation could be predicted from solvation free energy (SFE) calculations. Solution studies on the conformation and solubilities of the hexanucleotides showed that a critical concentration of the DNA in the Z-conformation must be present in solution to effect crystallization. The SFE calculations therefore predict the propensity of the hexanucleotides to adopt the left-handed conformation and the driving force required to reach this critical concentration relative to the intrinsic solubility of Z-DNA for crystallization.			HO, PS (corresponding author), OREGON STATE UNIV,DEPT BIOCHEM & BIOPHYS,CORVALLIS,OR 97331, USA.		Ho, Pui/AAF-8838-2020; Ho, Pui S/F-6186-2014	Ho, Pui/0000-0002-8082-4311; Ho, Pui S/0000-0002-8082-4311				COLL M, 1988, NUCLEIC ACIDS RES, V16, P8695, DOI 10.1093/nar/16.17.8695; COLL M, 1986, J BIOMOL STRUCT DYN, V4, P157, DOI 10.1080/07391102.1986.10506337; FUJII S, 1982, NUCLEIC ACIDS RES, V10, P7879, DOI 10.1093/nar/10.23.7879; HO PS, 1988, J PHYS CHEM-US, V92, P939, DOI 10.1021/j100315a017; JOVIN TM, 1987, ANNU REV PHYS CHEM, V38, P521, DOI 10.1146/annurev.pc.38.100187.002513; KAGAWA TF, 1989, BIOCHEMISTRY-US, V28, P6642, DOI 10.1021/bi00442a017; Tseng K. T., UNPUB; WANG AHJ, 1979, NATURE, V282, P680, DOI 10.1038/282680a0; WANG AHJ, 1984, CELL, V37, P321, DOI 10.1016/0092-8674(84)90328-3; ZHOU GW, 1990, BIOCHEMISTRY-US, V29, P7229, DOI 10.1021/bi00483a010	10	12	12	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	NOV 15	1991	254	5034					1003	1006		10.1126/science.1948069	http://dx.doi.org/10.1126/science.1948069			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GP883	1948069				2022-12-28	WOS:A1991GP88300044
J	YU, GL; BLACKBURN, EH				YU, GL; BLACKBURN, EH			DEVELOPMENTALLY PROGRAMMED HEALING OF CHROMOSOMES BY TELOMERASE IN TETRAHYMENA	CELL			English	Article							TERMINAL TRANSFERASE-ACTIVITY; SACCHAROMYCES-CEREVISIAE; EUPLOTES-CRASSUS; MACRONUCLEAR DNA; OXYTRICHA-NOVA; SEQUENCE; YEAST; THERMOPHILA; CLONING; RNA	Healing of a broken chromosome end in eukaryotes involves acquisition of a telomere. During macronuclear development in ciliated protozoans, germline chromosomes are fragmented into linear subchromosomes, whose ends are healed by de novo addition of telomeres. We showed previously that the ribonucleoprotein enzyme telomerase elongates preexisting telomeres by synthesizing one telomeric DNA strand, using a template sequence in the RNA moiety of the enzyme. By marking telomerase with a mutation in the telomerase RNA template, which causes synthesis of novel telomeric sequences, we now show that in the ciliate Tetrahymena, telomerase directly adds telomeric DNA onto nontelomeric sequences during developmentally controlled chromosome healing. Unexpectedly, one telomerase RNA template mutation converted telomerase from an enzyme that normally synthesizes precisely templated sequences to a less precise polymerase that sometimes synthesizes irregular telomeric repeats in vivo.	UNIV CALIF SAN FRANCISCO,DEPT MICROBIOL & IMMUNOL,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT BIOCHEM & BIOPHYS,SAN FRANCISCO,CA 94143	University of California System; University of California San Francisco; University of California System; University of California San Francisco					NIGMS NIH HHS [GM26259, GM32565] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032565, R37GM026259, R01GM026259] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAIRD SE, 1989, GENE DEV, V3, P585, DOI 10.1101/gad.3.5.585; BAROIN A, 1987, NUCLEIC ACIDS RES, V15, P1717, DOI 10.1093/nar/15.4.1717; BLACKBURN EH, 1990, SCIENCE, V249, P489, DOI 10.1126/science.2200120; BLACKBURN EH, 1989, GENOME, V31, P553, DOI 10.1139/g89-104; BLACKBURN EH, 1991, NATURE, V350, P569, DOI 10.1038/350569a0; BROWN WRA, 1989, NATURE, V338, P774, DOI 10.1038/338774a0; Bruns P.J., 1986, P27; BUDARF M, 1987, NUCLEIC ACIDS RES, V15, P6273, DOI 10.1093/nar/15.15.6273; BUDARF ML, 1986, J BIOL CHEM, V261, P363; CHALLONER PB, 1986, NUCLEIC ACIDS RES, V14, P6299, DOI 10.1093/nar/14.15.6299; CHENG JF, 1989, NUCLEIC ACIDS RES, V17, P6109, DOI 10.1093/nar/17.15.6109; CHIOU S, 1981, P NATL ACAD SCI USA, V78, P2263; CROSS SH, 1989, NATURE, V338, P771, DOI 10.1038/338771a0; EMERY HS, 1981, CELL, V26, P411, DOI 10.1016/0092-8674(81)90210-5; FORNEY JD, 1988, MOL CELL BIOL, V8, P251, DOI 10.1128/MCB.8.1.251; GREIDER CW, 1989, NATURE, V337, P331, DOI 10.1038/337331a0; GREIDER CW, 1991, MOL CELL BIOL, V11, P4572, DOI 10.1128/MCB.11.9.4572; GREIDER CW, 1987, CELL, V51, P887, DOI 10.1016/0092-8674(87)90576-9; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; HERRICK G, 1987, J PROTOZOOL, V34, P429, DOI 10.1111/j.1550-7408.1987.tb03207.x; JACQUES JP, 1991, GENE DEV, V5, P707, DOI 10.1101/gad.5.5.707; Karrer K.M., 1986, P85; KING BO, 1982, CELL, V31, P177, DOI 10.1016/0092-8674(82)90417-2; KISS GB, 1981, MOL CELL BIOL, V1, P535, DOI 10.1128/MCB.1.6.535; KLOBUTCHER LA, 1984, CELL, V36, P1045, DOI 10.1016/0092-8674(84)90054-0; LARSON DD, 1986, CELL, V47, P229, DOI 10.1016/0092-8674(86)90445-9; Maniatis T., 1982, MOL CLONING; McDonald B.B., 1973, P287; MORIN GB, 1989, CELL, V59, P521, DOI 10.1016/0092-8674(89)90035-4; Orias E., 1986, P45; PAN W, 1991, Acta Genetica Sinica, V18, P127; PENNOCK DG, 1988, MOL CELL BIOL, V8, P2681, DOI 10.1128/MCB.8.7.2681; PONZI M, 1985, EMBO J, V4, P2991, DOI 10.1002/j.1460-2075.1985.tb04034.x; RIETHMAN HC, 1989, P NATL ACAD SCI USA, V86, P6240, DOI 10.1073/pnas.86.16.6240; SHAMPAY J, 1984, NATURE, V310, P154, DOI 10.1038/310154a0; SHAMPAY J, 1988, P NATL ACAD SCI USA, V85, P534, DOI 10.1073/pnas.85.2.534; SHIPPENLENTZ D, 1990, SCIENCE, V247, P546, DOI 10.1126/science.1689074; SHIPPENLENTZ D, 1989, MOL CELL BIOL, V9, P2761, DOI 10.1128/MCB.9.6.2761; SPANGLER EA, 1988, NUCLEIC ACIDS RES, V16, P5569, DOI 10.1093/nar/16.12.5569; SZOSTAK JW, 1982, CELL, V29, P245, DOI 10.1016/0092-8674(82)90109-X; WANG SS, 1990, MOL CELL BIOL, V10, P4415, DOI 10.1128/MCB.10.8.4415; YAO MC, 1987, CELL, V48, P779, DOI 10.1016/0092-8674(87)90075-4; YOKOYAMA R, 1986, NUCLEIC ACIDS RES, V14, P2109, DOI 10.1093/nar/14.5.2109; YU GL, 1989, P NATL ACAD SCI USA, V86, P8487, DOI 10.1073/pnas.86.21.8487; ZAHLER AM, 1988, NUCLEIC ACIDS RES, V16, P6953, DOI 10.1093/nar/16.14.6953	45	191	210	0	18	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	NOV 15	1991	67	4					823	832		10.1016/0092-8674(91)90077-C	http://dx.doi.org/10.1016/0092-8674(91)90077-C			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GQ407	1934071				2022-12-28	WOS:A1991GQ40700019
J	ANDERSSON, S; BERMAN, DM; JENKINS, EP; RUSSELL, DW				ANDERSSON, S; BERMAN, DM; JENKINS, EP; RUSSELL, DW			DELETION OF STEROID 5-ALPHA-REDUCTASE 2-GENE IN MALE PSEUDOHERMAPHRODITISM	NATURE			English	Article							SEXUAL-DIFFERENTIATION; 5ALPHA-REDUCTASE; EXPRESSION; ENZYME; GENOME; RAT; FIBROBLASTS; INHIBITOR; CLONING; VIRUS	THE conversion of testosterone into dihydrotestosterone by steroid 5-alpha-reductase is a key reaction in androgen action, and is essential both for the formation of the male phenotype during embryogenesis and for androgen-mediated growth of tissues such as the prostate Single gene defects that impair this conversion lead to pseudohermaphroditism in which 46 X, Y males have male internal urogenital tracts, but female external genitalia 3. We have described the isolation of a human 5-alpha-reductase complementary DNA from prostate . Subsequent cloning and genetic studies showed that this gene (designated 5-alpha-reductase 1) was normal in patients with 5-alpha-reductase deficiency 26. We report here the isolation of a second 5-alpha-reductase cDNA by expression cloning and the polymerase chain reaction. The biochemical and pharmacological properties of this cDNA-encoded enzyme (designated 5-alpha-reductase 2) are consistent with it being the major isozyme in genital tissue. A deletion in this gene is present in two related individuals with male pseudohermaphroditism caused by 5-alpha-reductase deficiency. These results verify the existence of at least two 5-alpha-reductases in man and provide insight into a fundamental hormone-mediated event in male sexual differentiation.	UNIV TEXAS,SW MED CTR,DEPT MOLEC GENET,DALLAS,TX 75235	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas			berman, david/HIR-4177-2022	Russell, David/0000-0002-0277-403X; berman, david/0000-0001-5985-3698	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL020948] Funding Source: NIH RePORTER; NHLBI NIH HHS [P01 HL020948] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ANDERSSON S, 1990, P NATL ACAD SCI USA, V87, P3640, DOI 10.1073/pnas.87.10.3640; ANDERSSON S, 1989, J BIOL CHEM, V264, P16249; ANDERSSON S, 1989, J BIOL CHEM, V264, P8222; [Anonymous], METABOLIC BASIS INHE; BROOKS JR, 1981, ENDOCRINOLOGY, V109, P830, DOI 10.1210/endo-109-3-830; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; GEORGE FW, 1991, P NATL ACAD SCI USA, V88, P8044, DOI 10.1073/pnas.88.18.8044; GORMAN CM, 1990, DNA PROTEIN ENG TECH, V2, P3; HERSKOWITZ I, 1989, NATURE, V342, P749, DOI 10.1038/342749a0; HOBBS HH, 1990, ANNU REV GENET, V24, P133, DOI 10.1146/annurev.ge.24.120190.001025; HOROVITZ HR, 1991, NATURE, V351, P535; IMPERATOMCGINLEY J, 1991, CLIN ENDOCRINOL, V34, P293, DOI 10.1111/j.1365-2265.1991.tb03769.x; JENKINS EP, IN PRESS J CLIN INVE; LAUX G, 1988, EMBO J, V7, P769, DOI 10.1002/j.1460-2075.1988.tb02874.x; LEHRMAN MA, 1985, SCIENCE, V227, P140, DOI 10.1126/science.3155573; LIANG T, 1985, ENDOCRINOLOGY, V117, P571, DOI 10.1210/endo-117-2-571; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MOORE RJ, 1976, J BIOL CHEM, V251, P5895; MOORE RJ, 1975, J BIOL CHEM, V250, P7168; RASSART E, 1986, J VIROL, V60, P910, DOI 10.1128/JVI.60.3.910-919.1986; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; Sambrook J, 1989, MOL CLONING LABORATO; SHINOZAKI K, 1986, EMBO J, V5, P2043, DOI 10.1002/j.1460-2075.1986.tb04464.x; STRATHMANN M, 1989, P NATL ACAD SCI USA, V86, P7407, DOI 10.1073/pnas.86.19.7407; VERMEULEN A, 1989, PROSTATE, V14, P45, DOI 10.1002/pros.2990140106; WILSON JD, 1985, HARVEY LECT, V79, P145; WILSON JD, 1975, ENDOCRINOLOGY, V25, P491	27	612	636	0	15	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	NOV 14	1991	354	6349					159	161		10.1038/354159a0	http://dx.doi.org/10.1038/354159a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GP880	1944596	Green Accepted			2022-12-28	WOS:A1991GP88000063
J	OTOOLE, TE; MANDELMAN, D; FORSYTH, J; SHATTIL, SJ; PLOW, EF; GINSBERG, MH				OTOOLE, TE; MANDELMAN, D; FORSYTH, J; SHATTIL, SJ; PLOW, EF; GINSBERG, MH			MODULATION OF THE AFFINITY OF INTEGRIN-ALPHA-IIB-BETA-3 (GPIIB-IIIA) BY THE CYTOPLASMIC DOMAIN OF ALPHA-IIB	SCIENCE			English	Article							MEMBRANE GLYCOPROTEIN-IIB; FIBRINOGEN RECEPTOR; PLATELET ACTIVATION; MONOCLONAL-ANTIBODY; ADHESION; BINDING; EXPRESSION; INTEGRINS; SEQUENCE; SUBUNITS	Intracellular signaling alters integrin adhesive functions in inflammation, immune responses, hemostasis, thrombosis, and retinal development. By truncating the cytoplasmic domain of alpha-IIb, the affinity of integrin alpha-IIb-beta-3, for ligand was increased. Reconstitution with the cytoplasmic domain from integrin alpha-5 did not reverse the increased affinity. Thus, the cytoplasmic domain of the alpha-subunit of GPIIb-IIIa controls ligand binding affinity, which suggests mechanisms for inside-out transmembrane signaling through integrins. These findings imply the existence of hitherto unappreciated hereditary and acquired thrombotic disorders in humans.	SCRIPPS RES INST, COMM VASC BIOL, LA JOLLA, CA 92037 USA; UNIV PENN, CTR CANC, PHILADELPHIA, PA 19104 USA	Scripps Research Institute; University of Pennsylvania			O'Toole, Timothy/I-4172-2013		NHLBI NIH HHS [HL16411, HL 39150, HL28235] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL016411, R01HL039150, R01HL028235] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALTIERI DC, 1988, J CELL BIOL, V107, P1893, DOI 10.1083/jcb.107.5.1893; BENNETT JS, 1979, J CLIN INVEST, V64, P1393, DOI 10.1172/JCI109597; BRASS LF, 1986, J BIOL CHEM, V261, P6838; COLLER BS, 1983, J CLIN INVEST, V72, P325, DOI 10.1172/JCI110973; DUSTIN ML, 1989, NATURE, V341, P619, DOI 10.1038/341619a0; FRELINGER AL, 1990, J BIOL CHEM, V265, P6346; FROJMOVIC MM, 1991, BLOOD, V78, P369; HIBBS ML, 1991, SCIENCE, V251, P1611, DOI 10.1126/science.1672776; HYNES RO, 1987, CELL, V48, P549, DOI 10.1016/0092-8674(87)90233-9; KUNICKI TJ, 1981, J CLIN INVEST, V67, P717, DOI 10.1172/JCI110088; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; LOFTUS JC, 1988, J BIOL CHEM, V263, P11025; Maniatis T., 1982, MOL CLONING; MARGUERIE GA, 1980, J BIOL CHEM, V255, P154; MCEVER RP, 1983, J BIOL CHEM, V258, P5269; MUNKER R, 1991, HEMATOLOGY BASIC PRI, P817; MUNSON PJ, 1980, ANAL BIOCHEM, V107, P220, DOI 10.1016/0003-2697(80)90515-1; NEUGEBAUER KM, 1991, NATURE, V350, P68, DOI 10.1038/350068a0; OTOOLE TE, 1990, CELL REGUL, V1, P883, DOI 10.1091/mbc.1.12.883; OTOOLE TE, 1989, BLOOD, V74, P14; PLOW EF, 1981, J BIOL CHEM, V256, P9477; RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619; SHATTIL SJ, 1987, J BIOL CHEM, V262, P992; SHATTIL SJ, 1985, J BIOL CHEM, V260, P1107; SHAW LM, 1990, J CELL BIOL, V110, P2167, DOI 10.1083/jcb.110.6.2167; SOLOWSKA J, 1989, J CELL BIOL, V109, P853, DOI 10.1083/jcb.109.2.853; SUZUKI S, 1987, J BIOL CHEM, V262, P14080; TAMURA RN, IN PRESS P NATL ACAD; TAUB R, 1989, J BIOL CHEM, V264, P259; WOODS VL, 1986, J BIOL CHEM, V261, P5242	30	311	316	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	NOV 8	1991	254	5033					845	847		10.1126/science.1948065	http://dx.doi.org/10.1126/science.1948065			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN833	1948065				2022-12-28	WOS:A1991GN83300041
J	BEZANILLA, F; PEROZO, E; PAPAZIAN, DM; STEFANI, E				BEZANILLA, F; PEROZO, E; PAPAZIAN, DM; STEFANI, E			MOLECULAR-BASIS OF GATING CHARGE IMMOBILIZATION IN SHAKER POTASSIUM CHANNELS	SCIENCE			English	Article							SODIUM-CHANNEL; XENOPUS OOCYTES; SQUID AXON; DROSOPHILA; INACTIVATION; ACTIVATION; CURRENTS; LOCUS; GENE; CDNA	Voltage-dependent ion channels respond to changes in the membrane potential by means of charged voltage sensors intrinsic to the channel protein. Changes in transmembrane potential cause movement of these charged residues, which results in conformational changes in the channel. Movements of the charged sensors can be detected as currents known as gating currents. Measurement of the gating currents of the Drosophila Shaker potassium channel indicates that the charge on the voltage sensor of the channels is progressively immobilized by prolonged depolarizations. The charge is not immobilized in a mutant of the channel that lacks inactivation. These results show that the region of the molecule responsible for inactivation interacts, directly or indirectly, with the voltage sensor to prevent the return of the charge to its original position. The gating transitions between closed states of the channel appear not to be independent, suggesting that the channel subunits interact during activation.	BAYLOR COLL MED,DEPT PHYSIOL & MOLEC BIOPHYS,HOUSTON,TX 77030	Baylor College of Medicine	BEZANILLA, F (corresponding author), UNIV CALIF LOS ANGELES,SCH MED,DEPT PHYSIOL,LOS ANGELES,CA 90024, USA.				NHLBI NIH HHS [HL37044] Funding Source: Medline; NIGMS NIH HHS [R01 GM043459-12, R01 GM043459-16, R01 GM043459-15S1, R01 GM043459-09, R01 GM043459-11, GM43459, R01 GM043459-15, GM30376, R01 GM043459-17, R01 GM043459-13, R01 GM043459, R01 GM043459-10, R01 GM043459-14] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL037044] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM030376, R01GM030376, R01GM043459] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Almers W, 1978, Rev Physiol Biochem Pharmacol, V82, P96, DOI 10.1007/BFb0030498; ARMSTRONG CM, 1977, J GEN PHYSIOL, V70, P567, DOI 10.1085/jgp.70.5.567; BAUMANN A, 1987, EMBO J, V6, P3419, DOI 10.1002/j.1460-2075.1987.tb02665.x; BEZANILLA F, 1982, J GEN PHYSIOL, V79, P21, DOI 10.1085/jgp.79.1.21; BEZANILLA F, 1977, J GEN PHYSIOL, V70, P549, DOI 10.1085/jgp.70.5.549; CHOI KL, 1991, P NATL ACAD SCI USA, V88, P5092, DOI 10.1073/pnas.88.12.5092; COLE KS, 1960, BIOPHYS J, V1, P161; GILLY WF, 1982, J GEN PHYSIOL, V79, P935, DOI 10.1085/jgp.79.6.935; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; KAMB A, 1987, CELL, V50, P405, DOI 10.1016/0092-8674(87)90494-6; KAMB A, 1988, NEURON, V1, P421, DOI 10.1016/0896-6273(88)90192-4; MACKINNON R, 1991, NATURE, V350, P232, DOI 10.1038/350232a0; MACKINNON R, 1991, Biophysical Journal, V59, p404A; NODA M, 1984, NATURE, V312, P121, DOI 10.1038/312121a0; PAPAZIAN DM, 1987, SCIENCE, V237, P749, DOI 10.1126/science.2441470; PAPAZIAN DM, 1991, NATURE, V349, P305, DOI 10.1038/349305a0; SCHWARZ TL, 1988, NATURE, V331, P137, DOI 10.1038/331137a0; STIMERS JR, 1987, J GEN PHYSIOL, V89, P521, DOI 10.1085/jgp.89.4.521; STIMERS JR, 1985, J GEN PHYSIOL, V85, P65, DOI 10.1085/jgp.85.1.65; STUHMER W, 1991, PFLUG ARCH EUR J PHY, V418, P423, DOI 10.1007/BF00550881; STUHMER W, 1989, NATURE, V339, P597, DOI 10.1038/339597a0; TAGLIALATELA M, IN PRESS BIOPHYS J; TAGLIALATELA M, UNPUB; TAYLOR RE, 1983, J GEN PHYSIOL, V81, P773, DOI 10.1085/jgp.81.6.773; TEMPEL BL, 1987, SCIENCE, V237, P770, DOI 10.1126/science.2441471; TIMPE LC, 1988, NATURE, V331, P143, DOI 10.1038/331143a0; TIMPE LC, 1988, NEURON, V1, P659, DOI 10.1016/0896-6273(88)90165-1; TORO L, IN PRESS NEUR SOC AB; WHITE MM, 1985, J GEN PHYSIOL, V85, P539, DOI 10.1085/jgp.85.4.539; YELLEN G, 1991, SCIENCE, V251, P939, DOI 10.1126/science.2000494; ZAGOTTA WN, 1990, J GEN PHYSIOL, V95, P29, DOI 10.1085/jgp.95.1.29; ZAGOTTA WN, 1990, SCIENCE, V250, P568, DOI 10.1126/science.2122520	33	186	189	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	NOV 1	1991	254	5032					679	683		10.1126/science.1948047	http://dx.doi.org/10.1126/science.1948047			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN474	1948047				2022-12-28	WOS:A1991GN47400031
J	LEON, DA				LEON, DA			INFLUENCE OF BIRTH-WEIGHT ON DIFFERENCES IN INFANT-MORTALITY BY SOCIAL-CLASS AND LEGITIMACY	BRITISH MEDICAL JOURNAL			English	Article								Objective - To investigate the influence of birth weight on the pronounced social class differences in infant mortality in Britain. Design - Analysis of routine data on births and infant deaths. Setting - England and Wales. Subjects - All live births and infant deaths, 1983-5. Main outcome measure - Mortality in infants by social class, birth weight, and legitimacy according to birth and death certificates. Results - Neonatal and postneonatal mortality (deaths/1000 births) increased with social class. Neonatal and postneonatal mortality was 4.2/1000 and 2.3/1000 respectively for social class I and 6.8/1000 and 5.6/1000 respectively for social class V. Mortality was lower among births registered within marriage (postneonatal 3.5/1000; neonatal 5.2/1000) than among those jointly registered outside marriage (5.1/1000; 6.4/1000); mortality was highest in those solely registered outside marriage (7-2/1000; 7.0/1000). For neonatal mortality the effect of social class varied with birth weight. Social class had little effect on neonatal mortality in low birthweight babies and increasing effect in heavier babies. For postneonatal mortality the effect of social class was similar for all birth weights and was almost as steep as for all birth weights combined. Conclusion - Birth weight mediates little of the effect of social class on postneonatal mortality.			LEON, DA (corresponding author), UNIV LONDON LONDON SCH HYG & TROP MED,DEPT EPIDEMIOL & POPULAT SCI,LONDON WC1E 7HT,ENGLAND.		Leon, David A/G-2195-2010	Leon, David A/0000-0001-9747-1762				ACHESON ED, 1990, LANCET, V336, P1482; ADELSTEIN AM, 1980, 41 STUD MED POP SUBJ; AITKIN M, 1989, STATISTICAL MODELLIN; [Anonymous], 1980, INEQUALITIES HLTH RE; [Anonymous], 1980, CLASSIFICATION OCCUP; BAKER RJ, 1978, GLIM SYSTEM; BROOKE OG, 1989, BRIT MED J, V298, P795, DOI 10.1136/bmj.298.6676.795; MACFARLANE A, 1988, BRIT MED J, V296, P230, DOI 10.1136/bmj.296.6617.230; MALLOY MH, 1988, AM J EPIDEMIOL, V128, P46, DOI 10.1093/oxfordjournals.aje.a114957; McCullagh P., 1983, GEN LINEAR MODELS, DOI [10.1007/978-1-4899-3244-0, DOI 10.1007/978-1-4899-3244-0]; MORRIS JN, 1955, LANCET, V1, P554; Pharoah P O, 1979, Epidemiol Rev, V1, P170; RODRIGUES L, 1989, OPCS POPULATION TREN, V55, P7; WILCOX AJ, 1986, INT J EPIDEMIOL, V15, P188, DOI 10.1093/ije/15.2.188; 1978, OFFICE POPULATION DS, V1; 1990, DH321 OFF POP CENS S; 1988, OFFICE POPULATION DS, V8	17	24	25	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	OCT 19	1991	303	6808					964	967		10.1136/bmj.303.6808.964	http://dx.doi.org/10.1136/bmj.303.6808.964			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GL127	1954421	Green Published, Bronze			2022-12-28	WOS:A1991GL12700023
J	SARACCI, R				SARACCI, R			IS NECROPSY A VALID MONITOR OF CLINICAL-DIAGNOSIS PERFORMANCE	BRITISH MEDICAL JOURNAL			English	Article							AUTOPSY; DECLINE	Objective - To improve the validity of comparisons between clinical and postmortem diagnoses when postmortem diagnosis is used to monitor clinical diagnosis performance. Design - Analysis of elementary examples. Main outcome measures - Sensitivity and specificity of clinical and postmortem diagnoses and confirmation and agreement rates. Sensitivity and specificity permit valid comparisons of clinical and postmortem diagnoses among different procedures, sites, or times whereas agreement and confirmation rates may be misleading. Estimates of sensitivity and specificity, however, can be severely distorted by factors such as non-random selection of cases for necropsy or by unrecognised errors in postmortem diagnosis. Such distortion may be minimised by (a) estimating the likely magnitude of errors in postmortem diagnosis, (b) specifying standard conditions for performing necropsies, and (c) ensuring an unbiased sample of moderate size rather than a large biased sample. Conclusion - Sensitivity and specificity should be used as measures of agreement between clinical and postmortem diagnoses. Implication - Monitoring of clinical diagnosis performance by necropsy surveys requires ensuring accuracy of pathological examinations and validity of study design and analysis.			SARACCI, R (corresponding author), INT AGCY RES CANC,ANALYT EPIDEMIOL UNIT,F-69372 LYONS,FRANCE.							AHRONHEIM JC, 1983, JAMA-J AM MED ASSOC, V250, P1182, DOI 10.1001/jama.250.9.1182; BRITTON M, 1974, ACTA MED SCAND, V196, P203; BURROWS S, 1975, JAMA-J AM MED ASSOC, V233, P441, DOI 10.1001/jama.233.5.441; CAMERON HM, 1980, BRIT MED J, V281, P985, DOI 10.1136/bmj.281.6246.985; CAMERON HM, 1977, BRIT MED J, V1, P1577, DOI 10.1136/bmj.1.6076.1577; GELLER S, 1983, SCI AM, V248, P110; GOLDMAN L, 1983, NEW ENGL J MED, V308, P1000, DOI 10.1056/NEJM198304283081704; KIRCHER T, 1985, NEW ENGL J MED, V313, P1263, DOI 10.1056/NEJM198511143132005; PEACOCK SJ, 1988, J PATHOL, V156, P9, DOI 10.1002/path.1711560105; ROBERTS WC, 1978, NEW ENGL J MED, V299, P332, DOI 10.1056/NEJM197808172990704; SILVESTRI F, 1988, Pathologica (Genoa), V80, P523; STERNBY NH, 1991, IARC SCI PUBL, V112, P217; UEMURA K, 1964, B WORLD HEALTH ORGAN, V31, P297	13	34	35	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	OCT 12	1991	303	6807					898	900		10.1136/bmj.303.6807.898	http://dx.doi.org/10.1136/bmj.303.6807.898			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GK221	1933005	Bronze, Green Published			2022-12-28	WOS:A1991GK22100024
J	LOWRY, S				LOWRY, S			THE HEALTH OF THE NATION - RESPONSES - HOUSING	BRITISH MEDICAL JOURNAL			English	Article							ASTHMA											BOARDMAN B, 1987, DEFINING AFFORDABLE; BURR ML, 1980, THORAX, V35, P513, DOI 10.1136/thx.35.7.513; BURR ML, 1988, J ROY SOC HEALTH, V108, P99, DOI 10.1177/146642408810800311; CONWAY J, 1988, PRESCRIPTION POOR HL; DYER C, 1990, BRIT MED J, V301, P781; FOSTER S, 1991, URGENT NEED HOMES; Lowry S., 1991, HOUSING HLTH; LOWRY S, 1991, HOUSING HLTH, P59; MARTIN CJ, 1987, BRIT MED J, V294, P1125, DOI 10.1136/bmj.294.6580.1125; ORIORDAN MC, 1990, HUMAN EXPOSURE RADON; PLATT SD, 1989, BRIT MED J, V298, P1673, DOI 10.1136/bmj.298.6689.1673; RAMSDEN SS, 1988, J ROY COLL PHYS LOND, V22, P16; 1989, HOMELESS FAMILIES TH; 1991, CM1523	14	9	9	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	OCT 5	1991	303	6806					838	840		10.1136/bmj.303.6806.838	http://dx.doi.org/10.1136/bmj.303.6806.838			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GH946	1932978	Green Published, Bronze			2022-12-28	WOS:A1991GH94600030
J	MOXON, ER				MOXON, ER			THE SCOPE OF IMMUNIZATION	LANCET			English	Article									JOHN RADCLIFFE HOSP,INST MOLEC MED,OXFORD OX3 9DU,ENGLAND	University of Oxford	MOXON, ER (corresponding author), JOHN RADCLIFFE HOSP,DEPT PAEDIAT,OXFORD OX3 9DU,ENGLAND.							ANDERSON RM, 1985, NATURE, V318, P323, DOI 10.1038/318323a0; DORMAN CJ, IN PRESS NATURE; DUBOS R, 1987, MIRAGE HLTH; HOISETH SK, 1981, NATURE, V291, P238, DOI 10.1038/291238a0; MACKETT M, 1984, J VIROL, V49, P857, DOI 10.1128/JVI.49.3.857-864.1984; MILLER JF, 1989, SCIENCE, V243, P916, DOI 10.1126/science.2537530; PLAYFAIR JHL, 1990, IMMUNOL TODAY, V11, P25; SCHWELBE J, 1912, GESAMMALTE WERKE VON, V1, P650	8	10	12	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	FEB 24	1990	335	8687					448	451		10.1016/0140-6736(90)90675-U	http://dx.doi.org/10.1016/0140-6736(90)90675-U			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CP907	1968177				2022-12-28	WOS:A1990CP90700011
J	VEERMAN, DP; VANMONTFRANS, GA; WIELING, W				VEERMAN, DP; VANMONTFRANS, GA; WIELING, W			EFFECTS OF CUFF INFLATION ON SELF-RECORDED BLOOD-PRESSURE	LANCET			English	Article											VEERMAN, DP (corresponding author), UNIV AMSTERDAM, ACAD MED CTR, DEPT INTERNAL MED, 1105 AZ AMSTERDAM, NETHERLANDS.							Andersen A R, 1985, Scand J Prim Health Care, V3, P71, DOI 10.3109/02813438509013920; EVANS CE, 1989, J HYPERTENS, V7, P133; IMHOLZ BPM, 1988, CARDIOVASC RES, V22, P390, DOI 10.1093/cvr/22.6.390; JOHNSON AL, 1978, CAN MED ASSOC J, V119, P1034; JULIUS S, 1989, HYPERTENSION, V13, P422, DOI 10.1161/01.HYP.13.5.422; KIRKENDALL WM, 1980, CIRCULATION, V62, pA114; LAHER MS, 1981, IRISH MED J, V74, P113; LASSEN A, 1989, J PHYSIOL-LONDON, V409, P333, DOI 10.1113/jphysiol.1989.sp017500; LIND AR, 1983, HDB PHYSL 2 2, V3, P947, DOI DOI 10.1002/CPHY.CP020326; PARATI G, 1989, HYPERTENSION, V13, P647, DOI 10.1161/01.HYP.13.6.647; PERLOFF D, 1983, JAMA-J AM MED ASSOC, V249, P2792, DOI 10.1001/jama.249.20.2792; PICKERING TG, 1989, J HYPERTENS, V7, pS65; REDMAN S, 1984, NEW ZEAL MED J, V97, P180; SHAPIRO AP, 1963, J CLIN INVEST, V42, P1890, DOI 10.1172/JCI104874; SOKOLOW M, 1966, CIRCULATION, V34, P279; STRASSER T, 1988, J HYPERTENS, V6, P257; VEERMAN DP, 1988, J HYPERTENS, V6, pS77, DOI 10.1097/00004872-198812040-00020; WESSELING KH, 1985, CARDIOVASC RES, V19, P139, DOI 10.1093/cvr/19.3.139; 1979, LANCET, V1, P137	19	33	33	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 24	1990	335	8687					451	453		10.1016/0140-6736(90)90676-V	http://dx.doi.org/10.1016/0140-6736(90)90676-V			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CP907	1968178				2022-12-28	WOS:A1990CP90700012
J	NITTA, T; SATO, K; YAGITA, H; OKUMURA, K; ISHII, S				NITTA, T; SATO, K; YAGITA, H; OKUMURA, K; ISHII, S			PRELIMINARY TRIAL OF SPECIFIC TARGETING THERAPY AGAINST MALIGNANT GLIOMA	LANCET			English	Article									JUNTENDO UNIV,SCH MED,DEPT IMMUNOL,2-1-1 HONGO,BUNKYO KU,TOKYO 113,JAPAN; JUNTENDO UNIV,SCH MED,DEPT NEUROL SURG,TOKYO 113,JAPAN	Juntendo University; Juntendo University								BURGER PC, 1987, CANCER, V59, P1617, DOI 10.1002/1097-0142(19870501)59:9<1617::AID-CNCR2820590916>3.0.CO;2-X; ETTINGHAUSEN SE, 1988, JNCI-J NATL CANCER I, V80, P177, DOI 10.1093/jnci/80.3.177; GRIMM EA, 1982, J EXP MED, V155, P1823, DOI 10.1084/jem.155.6.1823; GRIMM EA, 1983, J EXP MED, V157, P884, DOI 10.1084/jem.157.3.884; ITOH K, 1988, J EXP MED, V168, P1419, DOI 10.1084/jem.168.4.1419; JACOBS SK, 1986, CANCER RES, V46, P2101; JOHNSON GD, 1978, HDB EXPT IMMUNOLOGY, V3, P1; JUNG G, 1988, IMMUNOL TODAY, V9, P257, DOI 10.1016/0167-5699(88)91304-7; LOTZE MT, 1986, CANCER, V58, P2764, DOI 10.1002/1097-0142(19861215)58:12<2764::AID-CNCR2820581235>3.0.CO;2-Z; MERCHANT RE, 1988, NEUROSURGERY, V23, P725, DOI 10.1227/00006123-198812000-00007; NITTA T, 1989, EUR J IMMUNOL, V19, P1437, DOI 10.1002/eji.1830190814; PEREZ P, 1986, J EXP MED, V163, P166, DOI 10.1084/jem.163.1.166; PEREZ P, 1986, J IMMUNOL, V137, P2069; ROSENBERG SA, 1987, NEW ENGL J MED, V316, P889, DOI 10.1056/NEJM198704093161501; ROSENBERG SA, 1985, NEW ENGL J MED, V313, P1485, DOI 10.1056/NEJM198512053132327; ROSENBERG SA, 1986, SCIENCE, V233, P1318, DOI 10.1126/science.3489291; ROSENSTEIN M, 1986, J IMMUNOL, V137, P1735; STAERZ UD, 1985, NATURE, V314, P628, DOI 10.1038/314628a0; TITUS JA, 1987, J IMMUNOL, V138, P4018; UEDA R, 1988, LUNG CANCER, V4, P96; WEST WH, 1987, NEW ENGL J MED, V316, P898, DOI 10.1056/NEJM198704093161502; 1979, HISTOLOGICAL TYPING	22	236	277	0	2	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	FEB 17	1990	335	8686					368	371		10.1016/0140-6736(90)90205-J	http://dx.doi.org/10.1016/0140-6736(90)90205-J			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN988	1968115				2022-12-28	WOS:A1990CN98800002
J	HARRIS, AL; CANTWELL, BMJ; CARMICHAEL, J; WILSON, R; FARNDON, J; DAWES, P; GHANI, S; EVANS, RGB				HARRIS, AL; CANTWELL, BMJ; CARMICHAEL, J; WILSON, R; FARNDON, J; DAWES, P; GHANI, S; EVANS, RGB			COMPARISON OF SHORT-TERM AND CONTINUOUS CHEMOTHERAPY (MITOZANTRONE) FOR ADVANCED BREAST-CANCER	LANCET			English	Article									UNIV NEWCASTLE UPON TYNE,NEWCASTLE GEN HOSP,CLIN ONCOL UNIT,NEWCASTLE TYNE NE1 7RU,TYNE & WEAR,ENGLAND	Newcastle General Hospital; Newcastle University - UK			Harris, Adrian L/ABA-3343-2020	Harris, Adrian L/0000-0003-1376-8409				AHMANN FR, 1987, CANCER, V59, P239, DOI 10.1002/1097-0142(19870115)59:2<239::AID-CNCR2820590211>3.0.CO;2-C; ALLEGRA JC, 1985, INVEST NEW DRUG, V3, P153; ANDERSSON M, 1987, ROLE MITOXANTRONE MA, P31; [Anonymous], 1979, WHO HDB REPORTING RE; BATIST G, 1983, ANN INTERN MED, V98, P472, DOI 10.7326/0003-4819-98-4-472; COATES A, 1987, NEW ENGL J MED, V317, P1490, DOI 10.1056/NEJM198712103172402; CORNBLEET MA, 1984, EUR J CANCER CLIN ON, V20, P1141, DOI 10.1016/0277-5379(84)90122-6; FISHER B, 1989, J CLIN ONCOL, V7, P572, DOI 10.1200/JCO.1989.7.5.572; FISHER RI, 1979, ANN INTERN MED, V90, P761, DOI 10.7326/0003-4819-90-5-761; HARRIS AL, 1984, ADV MED, V20, P313; HAYWARD JL, 1977, EUR J CANCER, V13, P89, DOI 10.1016/0014-2964(77)90234-1; HENDERSON IC, 1987, ROLE MITOXANTRONE MA, P49; JAIN KK, 1985, J CLIN ONCOL, V3, P818, DOI 10.1200/JCO.1985.3.6.818; LANDYS K, 1985, INVEST NEW DRUG, V3, P133; MACAULAY V, 1986, RANDOMIZED TRIALS CA, P273; MOURIDSEN HT, 1985, INVEST NEW DRUG, V3, P139, DOI 10.1007/BF00174161; NEIDHART JA, 1986, J CLIN ONCOL, V4, P672, DOI 10.1200/JCO.1986.4.5.672; PACCAGNELLA A, 1983, EUR J CANCER CLIN ON, V19, P1345, DOI 10.1016/0277-5379(93)90002-M; PASTAN I, 1987, NEW ENGL J MED, V316, P1388; ROSNER D, 1987, CANCER, V59, P874, DOI 10.1002/1097-0142(19870301)59:5<874::AID-CNCR2820590503>3.0.CO;2-O; SHPALL EJ, 1988, J NATL CANCER I, V80, P204, DOI 10.1093/jnci/80.3.204; SMALLEY RV, 1976, CANCER RES, V36, P3911; STEINER R, 1983, EUR J CANCER CLIN ON, V19, P1553, DOI 10.1016/0277-5379(83)90085-8; STUARTHARRIS RC, 1982, CANCER CHEMOTH PHARM, V8, P179; WILSON KS, 1986, CANCER TREAT REP, V70, P1021	25	74	74	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	JAN 27	1990	335	8683					186	190		10.1016/0140-6736(90)90277-C	http://dx.doi.org/10.1016/0140-6736(90)90277-C			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CL185	1967666				2022-12-28	WOS:A1990CL18500003
J	HADORN, DC; BROOK, RH				HADORN, DC; BROOK, RH			THE HEALTH-CARE RESOURCE-ALLOCATION DEBATE - DEFINING OUR TERMS	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article								The problem of health care distribution in the United States demands immediate action. Many different solutions have been proposed to slow rising health care costs and to improve access to care for the poor and uninsured. Debate among proponents of these various proposals might be advanced if a common language were adopted with regard to certain key terms instead of the various meanings currently assigned to these terms. For this reason, we propose and defend the following three definitions: (1) rationing is the societal toleration of inequitable access to health services acknowledged to be necessary by reference to necessary-care guidelines; (2) health care needs are desires for services that have been reasonably well demonstrated to provide significant net benefit for patients with specified clinical conditions; and (3) basic benefit plans are insurance packages that provide for all and only acknowledged health care needs, again by reference to appropriate clinical guidelines.	UNIV CALIF LOS ANGELES,CTR HLTH SCI,DEPT MED & HLTH SCI,LOS ANGELES,CA 90024	University of California System; University of California Los Angeles	HADORN, DC (corresponding author), RAND CORP,DEPT SOCIAL POLICY,1700 MAIN ST,POB 2138,SANTA MONICA,CA 90406, USA.		Embrett, Mark G./H-4466-2014	Embrett, Mark G./0000-0002-3969-0219	AHRQ HHS [T32 HS 00007] Funding Source: Medline	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		AARON H, 1990, SCIENCE, V247, P418, DOI 10.1126/science.2300804; AARON HJ, 1984, PAINFUL PRESCRIPTION; Blank R.H., 1988, RATIONING MED; BRINDLE CB, 1986, ISSUES SCI TECHNOL, V3, P68; BROOK RH, 1990, NEW ENGL J MED, V323, P1173, DOI 10.1056/NEJM199010253231705; BROOK RH, 1990, HLTH POLICY, V14, P177; CALLAHAN D, 1990, NEW ENGL J MED, V322, P1810, DOI 10.1056/NEJM199006213222511; CALLAHAN D, 1988, HASTINGS CENT REP, V18, P14, DOI 10.2307/3562403; CERNE F, 1991, AM MED NEWS     0624, P8; CHASSIN MR, 1987, JAMA-J AM MED ASSOC, V258, P2533, DOI 10.1001/jama.258.18.2533; CHASSIN MR, 1989, APPROPRIATENESS SELE; GRUMET GW, 1989, NEW ENGL J MED, V321, P607, DOI 10.1056/NEJM198908313210909; HADORN D, 1991, DESIGNING FAIR REASO; HADORN DC, 1991, SOC SCI MED, V32, P773, DOI 10.1016/0277-9536(91)90303-T; HADORN DC, 1991, JAMA-J AM MED ASSOC, V265, P2218, DOI 10.1001/jama.265.17.2218; MCDONALD JC, 1988, JAMA-J AM MED ASSOC, V259, P725, DOI 10.1001/jama.259.5.725; PARK RE, 1986, AM J PUBLIC HEALTH, V76, P766, DOI 10.2105/AJPH.76.7.766; RAPAPORT FT, 1987, JAMA-J AM MED ASSOC, V257, P3118; REAGAN MD, 1988, NEW ENGL J MED, V319, P1149, DOI 10.1056/NEJM198810273191708; RELMAN AS, 1990, NEW ENGL J MED, V322, P1809, DOI 10.1056/NEJM199006213222510; RELMAN AS, 1990, NEW ENGL J MED, V323, P911, DOI 10.1056/NEJM199009273231310; SCANLON W, 1976, J PHILOS, V19, P665; SELKER HP, 1987, JAMA-J AM MED ASSOC, V257, P1181, DOI 10.1001/jama.257.9.1181; SINGER DE, 1983, NEW ENGL J MED, V309, P1155, DOI 10.1056/NEJM198311103091905; WELCH HG, 1989, NEW ENGL J MED, V321, P1261, DOI 10.1056/NEJM198911023211809; WINSLOW CM, 1988, JAMA-J AM MED ASSOC, V260, P505, DOI 10.1001/jama.260.4.505; 1983, SECURING ACCESS HLTH; 1990, CALL ACTION; 1988, HLTH POLICY AGENDA A; 1987, AM HERITAGE ILLUSTRA, P493	30	41	41	0	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 18	1991	266	23					3328	3331		10.1001/jama.266.23.3328	http://dx.doi.org/10.1001/jama.266.23.3328			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GU964	1960833				2022-12-28	WOS:A1991GU96400033
J	WEINSTEIN, LS; SHENKER, A; GEJMAN, PV; MERINO, MJ; FRIEDMAN, E; SPIEGEL, AM				WEINSTEIN, LS; SHENKER, A; GEJMAN, PV; MERINO, MJ; FRIEDMAN, E; SPIEGEL, AM			ACTIVATING MUTATIONS OF THE STIMULATORY G-PROTEIN IN THE MCCUNE-ALBRIGHT SYNDROME	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HUMAN PITUITARY-TUMORS; HEREDITARY OSTEODYSTROPHY; ADENYLYL CYCLASE; CUSHING SYNDROME; ALPHA; GENE; DNA; POLYMERASE; CHAIN; ALTER	Background. The McCune-Albright syndrome is a sporadic disease characterized by polyostotic fibrous dysplasia, cafe au lait spots, sexual precocity, and hyperfunction of multiple endocrine glands. These manifestations may be explained by a somatic mutation in affected tissues that results in activation of the signal-transduction pathway generating cyclic AMP (cAMP). We analyzed DNA from tissues of patients with the McCune-Albright syndrome for the presence of activating mutations of the gene for the a subunit of the G protein (G(s)alpha) that stimulates cAMP formation. Methods. Genomic DNA fragments encompassing regions (exons 8 and 9) previously found to contain activating missense mutations of the G(s)alpha gene (gsp mutations) in sporadically occurring pituitary tumors were amplified in tissues from four patients with the McCune-Albright syndrome by the polymerase chain reaction. The amplified DNA was analyzed for mutations by denaturing gradient gel electrophoresis and allele-specific oligonucleotide hybridization. Results. We detected one of two activating mutations within exon 8 of the G(s)alpha gene in tissues from all four patients, including affected endocrine organs (gonads, adrenal glands, thyroid, and pituitary) and tissues not classically involved in the McCune-Albright syndrome. In two of the patients histidine was substituted for arginine at position 201 of G(s)alpha, and in the other two patients cysteine was substituted for the same arginine residue. In each patient the proportion of cells affected varied from tissue to tissue. In two endocrine organs, the highest proportion of mutant alleles was found in regions of abnormal cell proliferation. Conclusions. Mutations within exon 8 of the G(s)alpha gene that result in increased activity of the Gs protein and increased cAMP formation are present in various tissues of patients with the McCune-Albright syndrome. Somatic mutation of this gene early in embryogenesis could result in the mosaic population of normal and mutant-bearing tissues that may underlie the clinical manifestations of this disease.	NIMH, CLIN NEUROGENET BRANCH, BETHESDA, MD 20892 USA; NCI, PATHOL LAB, BETHESDA, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	WEINSTEIN, LS (corresponding author), NIDDK, MOLEC PATHOPHYSIOL BRANCH, BLDG 10, RM 8D-17, BETHESDA, MD 20892 USA.		Weinstein, Lee S/I-5575-2015	Weinstein, Lee/0000-0002-1899-5152				Albright F, 1937, NEW ENGL J MED, V216, P727, DOI 10.1056/NEJM193704292161701; BENJAMIN DR, 1973, ARCH PATHOL, V96, P175; BIRNBAUMER L, 1990, BIOCHIM BIOPHYS ACTA, V1031, P163, DOI 10.1016/0304-4157(90)90007-Y; BNEDICT PH, 1962, METABOLISM, V11, P30; BOURNE HR, 1990, NATURE, V348, P125, DOI 10.1038/348125a0; Bruch H, 1936, AM J DIS CHILD, V52, P863, DOI 10.1001/archpedi.1936.04140040093008; BURTON FH, 1991, NATURE, V350, P74, DOI 10.1038/350074a0; CASTRILLO JL, 1991, SCIENCE, V253, P197, DOI 10.1126/science.1677216; CHANSON P, 1991, 73RD END SOC ANN M, P425; CHOCHUNG YS, 1991, LIFE SCI, V48, P1123, DOI 10.1016/0024-3205(91)90449-L; CLEMENTI E, 1990, ONCOGENE, V5, P1059; DANON M, 1975, J PEDIATR-US, V87, P917, DOI 10.1016/S0022-3476(75)80905-X; DARMIENTO M, 1983, J PEDIATR-US, V102, P584, DOI 10.1016/S0022-3476(83)80192-9; DAVIS LG, 1986, BASIC METHODS MOL BI, P47; DIFRANCESCO D, 1991, NATURE, V351, P145, DOI 10.1038/351145a0; DIGEORGE AM, 1975, J PEDIATR-US, V87, P1018, DOI 10.1016/S0022-3476(75)80952-8; DUMONT JE, 1989, TRENDS BIOCHEM SCI, V14, P67, DOI 10.1016/0968-0004(89)90046-7; FEUILLAN PP, 1990, J CLIN ENDOCR METAB, V71, P1596, DOI 10.1210/jcem-71-6-1596; FOSTER CM, 1984, J CLIN ENDOCR METAB, V58, P1161, DOI 10.1210/jcem-58-6-1161; FREISSMUTH M, 1989, J BIOL CHEM, V264, P21907; GRAZIANO MP, 1989, J BIOL CHEM, V264, P15475; GREER CE, 1991, AM J CLIN PATHOL, V95, P117, DOI 10.1093/ajcp/95.2.117; HAPPLE R, 1986, CLIN GENET, V29, P321; JEANPIERRE M, 1987, NUCLEIC ACIDS RES, V15, P9611, DOI 10.1093/nar/15.22.9611; KOZASA T, 1988, P NATL ACAD SCI USA, V85, P2081, DOI 10.1073/pnas.85.7.2081; LANDIS CA, 1989, NATURE, V340, P692, DOI 10.1038/340692a0; LEE PA, 1986, JAMA-J AM MED ASSOC, V256, P2980; LERMAN LS, 1987, METHOD ENZYMOL, V155, P482; LYONS J, 1990, SCIENCE, V249, P655, DOI 10.1126/science.2116665; MacMahon H E, 1971, Pathol Annu, V6, P81; MAENHAUT C, 1991, BIOCHIMIE, V73, P29, DOI 10.1016/0300-9084(91)90070-H; MASTERS SB, 1989, J BIOL CHEM, V264, P15467; MAURAS N, 1986, ACTA ENDOCRINOL-COP, V113, P207; MYERS RM, 1987, METHOD ENZYMOL, V155, P501; PATTEN JL, 1990, NEW ENGL J MED, V322, P1412, DOI 10.1056/NEJM199005173222002; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SHEFFIELD VC, 1989, P NATL ACAD SCI USA, V86, P232, DOI 10.1073/pnas.86.1.232; SHIBATA D, 1988, CANCER RES, V48, P4564; SIMON MI, 1991, SCIENCE, V252, P802, DOI 10.1126/science.1902986; SUAREZ HG, 1991, ONCOGENE, V6, P677; WATERMAN MR, 1989, RECENT PROG HORM RES, V45, P533; WEINSTEIN LS, 1990, P NATL ACAD SCI USA, V87, P8287, DOI 10.1073/pnas.87.21.8287; YATANI A, 1990, SCIENCE, V249, P1163, DOI 10.1126/science.1697697; ZACHARY I, 1990, BIOCHEM BIOPH RES CO, V168, P1184, DOI 10.1016/0006-291X(90)91154-K; 1975, NEW ENGL J MED, V292, P199	45	1205	1249	0	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 12	1991	325	24					1688	1695		10.1056/NEJM199112123252403	http://dx.doi.org/10.1056/NEJM199112123252403			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GU418	1944469	Bronze			2022-12-28	WOS:A1991GU41800003
J	TROST, BM				TROST, BM			THE ATOM ECONOMY - A SEARCH FOR SYNTHETIC EFFICIENCY	SCIENCE			English	Article							CATALYZED INTRAMOLECULAR <4; DIELS-ALDER REACTION; 2 CYCLO-ADDITION; ENE REACTIONS; ISOMERIZATION REACTION; ASYMMETRIC INDUCTION; ORGANIC-SYNTHESIS; CYCLIZATION; COMPLEXES; ALKYNES	Efficient synthetic methods required to assemble complex molecular arrays include reactions that are both selective (chemo-, regio-, diastereo-, and enantio-) and economical in atom count (maximum number of atoms of reactants appearing in the products). Methods that involve simply combining two or more building blocks with any other reactant needed only catalytically constitute the highest degree of atom economy. Transition metal-catalyzed methods that are both selective and economical for formation of cyclic structures, of great interest for biological purposes, represent an important starting point for this long-term goal. The limited availability of raw materials, combined with environmental concerns, require the highlighting of these goals			TROST, BM (corresponding author), STANFORD UNIV, DEPT CHEM, STANFORD, CA 94305 USA.							ARMSTRONG RW, 1989, J AM CHEM SOC, V111, P7530, DOI 10.1021/ja00201a038; AYER WA, 1981, TETRAHEDRON, V37, P2199, DOI 10.1016/S0040-4020(01)97979-7; BHATARAH P, 1990, J CHEM SOC PERK T 1, P2603, DOI 10.1039/p19900002603; BHATARAH P, 1991, J CHEM SOC CHEM COMM, P277, DOI 10.1039/c39910000277; BINGER P, 1987, TOP CURR CHEM, V135, P77; BINGER P, 1988, TETRAHEDRON LETT, V29, P4539, DOI 10.1016/S0040-4039(00)80541-9; BIRD CW, 1967, TRANSITION METAL INT, V1, pCH1; Bogdanovlc B., 1979, ADV ORGANOMET CHEM, VVolume 17, P105, DOI [10.1016/s0065-3055(08)60322-6, DOI 10.1016/S0065-3055(08)60322-6]; BONNEMAN.H, 1974, SYNTHESIS-STUTTGART, P575; BONNEMANN H, 1985, B SOC CHIM BELG, V94, P635; BOOR J, 1979, ZIEGLERNATTA CATALYS; BROWN LD, 1978, J AM CHEM SOC, V100, P8232, DOI 10.1021/ja00494a034; BRUN P, 1983, TETRAHEDRON LETT, V24, P385, DOI 10.1016/S0040-4039(00)81414-8; BRUNNER H, 1990, ANGEW CHEM INT EDIT, V29, P652, DOI 10.1002/anie.199006521; DIECK HT, 1983, ANGEW CHEM INT EDIT, V22, P778; DIECK HT, 1985, ANGEW CHEM INT EDIT, V24, P781; DUNACH E, 1985, J AM CHEM SOC, V107, P1664, DOI 10.1021/ja00292a033; EARL RA, 1984, J ORG CHEM, V49, P4786, DOI 10.1021/jo00199a009; FUNAKOSHI K, 1989, CHEM PHARM BULL, V37, P1776; FUNK RL, 1980, J AM CHEM SOC, V102, P5253, DOI 10.1021/ja00536a023; GEIGER RE, 1984, HELV CHIM ACTA, V67, P1274, DOI 10.1002/hlca.19840670513; GRIGG JF, 1985, J CHEM SOC P1, P1745; GRIGG R, 1982, TETRAHEDRON LETT, V23, P2691, DOI 10.1016/S0040-4039(00)87433-X; GROSS RS, 1990, J AM CHEM SOC, V112, P9436, DOI 10.1021/ja00181a079; HUGHES RP, 1973, J ORGANOMET CHEM, V63, P451, DOI 10.1016/S0022-328X(73)80058-0; JOLLY RS, 1990, J AM CHEM SOC, V112, P4965, DOI 10.1021/ja00168a055; KEIM W, 1982, COMPREHENSIVE ORGANO, V8, P371; KIJI J, 1977, J ORGANOMET CHEM, V140, P317, DOI 10.1016/S0022-328X(00)89352-3; LAUTENS M, 1989, ORGANOMETALLICS, V8, P2733, DOI 10.1021/om00113a034; LAUTENS M, 1990, J AM CHEM SOC, V112, P5627, DOI 10.1021/ja00170a030; LEE GM, 1990, J ORG CHEM, V55, P1281, DOI 10.1021/jo00291a034; LEWIS RT, 1988, J CHEM SOC CHEM COMM, P948, DOI 10.1039/c39880000948; LYONS JE, 1978, J CHEM SOC CHEM COMM, P638, DOI 10.1039/c39780000638; LYONS JE, 1978, J CHEM SOC CHEM COMM, P636, DOI 10.1039/c39780000636; MATSUDA I, 1987, TETRAHEDRON LETT, V28, P3361, DOI 10.1016/S0040-4039(00)95512-6; MILLER RW, 1980, J NAT PROD, V43, P425, DOI 10.1021/np50010a001; MOSELEY K, 1974, J CHEM SOC DALTON, P169, DOI 10.1039/dt9740000169; NAGASHIMA H, 1984, J CHEM SOC CHEM COMM, P652, DOI 10.1039/c39840000652; NAIMAN A, 1977, ANGEW CHEM INT EDIT, V16, P708, DOI 10.1002/anie.197707081; NAKANO T, 1982, CHEM LETT, P1255, DOI 10.1246/cl.1982.1255; NARASAKA K, 1988, CHEM LETT, P1609, DOI 10.1246/cl.1988.1609; NEESON SJ, 1989, TETRAHEDRON, V45, P6239, DOI 10.1016/S0040-4020(01)85134-6; OPPOLZER W, 1978, ANGEW CHEM INT EDIT, V17, P476, DOI 10.1002/anie.197804761; OPPOLZER W, 1987, HELV CHIM ACTA, V70, P1477, DOI 10.1002/hlca.19870700604; PIERS WE, 1990, SYNLETT, P74; RAUTENSTRAUCH V, 1990, ANGEW CHEM INT EDIT, V29, P1413, DOI 10.1002/anie.199014131; REIDER PJ, 1982, TETRAHEDRON LETT, V23, P2293, DOI 10.1016/S0040-4039(00)87324-4; Roberts J.D., 1962, ORG REACTIONS, V12, P1; SAKAI K, 1984, TETRAHEDRON LETT, V25, P961, DOI 10.1016/S0040-4039(01)80074-5; SCHORE NE, 1988, CHEM REV, V88, P1081, DOI 10.1021/cr00089a006; SHIMIZU I, 1985, TETRAHEDRON LETT, V26, P3825, DOI 10.1016/S0040-4039(00)89261-8; Sinn H., 1980, ADV ORGANOMET CHEM, V18, P99; SNIDER BB, 1980, ACCOUNTS CHEM RES, V13, P426, DOI 10.1021/ar50155a007; STEGLICH W, 1981, PURE APPL CHEM, V53, P1233, DOI 10.1351/pac198153061233; TAKACS JM, 1987, J AM CHEM SOC, V109, P2200, DOI 10.1021/ja00241a059; TAKACS JM, 1987, J AM CHEM SOC, V109, P2542, DOI 10.1021/ja00242a065; TAMAO K, 1988, J AM CHEM SOC, V110, P1286, DOI 10.1021/ja00212a045; TKATCHENKO I, 1982, COMPREHENSIVE ORGANO, V8, P101; Trost B.M., UNPUB; Trost B. M., 1982, COMPREHENSIVE ORGANO, V8, P799, DOI DOI 10.1016/B978-008046518-0.00121-5; TROST BM, 1986, TETRAHEDRON LETT, V27, P5695, DOI 10.1016/S0040-4039(00)85303-4; TROST BM, 1987, TETRAHEDRON LETT, V28, P375, DOI 10.1016/S0040-4039(00)95732-0; TROST BM, 1988, J AM CHEM SOC, V110, P7933, DOI 10.1021/ja00231a085; TROST BM, 1985, J AM CHEM SOC, V107, P6123, DOI 10.1021/ja00307a059; TROST BM, 1988, J AM CHEM SOC, V110, P1636, DOI 10.1021/ja00213a054; TROST BM, 1991, J AM CHEM SOC, V113, P701, DOI 10.1021/ja00002a064; TROST BM, 1987, J AM CHEM SOC, V109, P3792, DOI 10.1021/ja00246a054; TROST BM, 1987, J AM CHEM SOC, V109, P3486, DOI 10.1021/ja00245a064; TROST BM, 1989, J AM CHEM SOC, V111, P8745, DOI 10.1021/ja00205a041; TROST BM, 1991, J AM CHEM SOC, V113, P5076, DOI 10.1021/ja00013a062; TROST BM, 1989, TETRAHEDRON LETT, V30, P651, DOI 10.1016/S0040-4039(01)80273-2; TROST BM, 1987, TETRAHEDRON LETT, V28, P1611, DOI 10.1016/S0040-4039(00)95372-3; TROST BM, 1989, ANGEW CHEM INT EDIT, V28, P1173, DOI 10.1002/anie.198911731; TROST BM, 1982, J AM CHEM SOC, V104, P6112, DOI 10.1021/ja00386a045; TROST BM, 1983, J AM CHEM SOC, V105, P5940, DOI 10.1021/ja00356a051; TROST BM, 1983, SCIENCE, V219, P245, DOI 10.1126/science.219.4582.245; TROST BM, 1986, ANGEW CHEM INT EDIT, V25, P1, DOI 10.1002/anie.198600013; TROST BM, 1991, J AM CHEM SOC, V113, P1850, DOI 10.1021/ja00005a070; TROST BM, 1987, J AM CHEM SOC, V109, P4753, DOI 10.1021/ja00249a067; TROST BM, 1990, ACCOUNTS CHEM RES, V23, P34, DOI 10.1021/ar00170a004; TROST BM, 1985, J AM CHEM SOC, V107, P4586, DOI 10.1021/ja00301a056; TROST BM, 1989, ANGEW CHEM INT EDIT, V28, P1502, DOI 10.1002/anie.198915021; TROST BM, 1988, J AM CHEM SOC, V110, P8239, DOI 10.1021/ja00232a048; TROST BM, 1989, J ORG CHEM, V54, P2271, DOI 10.1021/jo00271a006; TSUDA T, 1990, J ORG CHEM, V55, P2554, DOI 10.1021/jo00295a061; TSUDA T, 1990, J ORG CHEM, V55, P2978, DOI 10.1021/jo00296a083; Ulrich H., 1967, CYCLOADDITION REACTI; VOLLHARDT KP, 1974, J AM CHEM SOC, V96, P4996, DOI 10.1021/ja00822a052; VOLLHARDT KPC, 1984, ANGEW CHEM INT EDIT, V23, P539, DOI 10.1002/anie.198405393; Wakatsuki Y., 1973, TETRAHEDRON LETT, V14, P3383, DOI 10.1016/s0040-4039(01)86920-3; WENDER PA, 1987, TETRAHEDRON LETT, V28, P2221, DOI 10.1016/S0040-4039(00)96085-4; WENDER PA, 1988, J AM CHEM SOC, V110, P5904, DOI 10.1021/ja00225a055; WENDER PA, 1989, J AM CHEM SOC, V111, P6432, DOI 10.1021/ja00198a071; Winter M. J., 1985, CHEM METAL CARBON BO, V3; YAMAGO S, 1989, TETRAHEDRON, V45, P3081, DOI 10.1016/S0040-4020(01)80134-4; YASUDA H, 1987, ANGEW CHEM INT EDIT, V26, P723, DOI 10.1002/anie.198707231	96	3846	3891	17	871	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 6	1991	254	5037					1471	1477		10.1126/science.1962206	http://dx.doi.org/10.1126/science.1962206			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT903	1962206				2022-12-28	WOS:A1991GT90300030
J	JEFFREYS, AJ; MACLEOD, A; TAMAKI, K; NEIL, DL; MONCKTON, DG				JEFFREYS, AJ; MACLEOD, A; TAMAKI, K; NEIL, DL; MONCKTON, DG			MINISATELLITE REPEAT CODING AS A DIGITAL APPROACH TO DNA TYPING	NATURE			English	Article								Most DNA typing systems used in forensic and legal medicine assay allelic length variation at tandem repetitive DNA regions such as minisatellites. A simple alternative approach that displays patterns of variant repeat units along minisatellite alleles is described here. This produces DNA profiles as extraordinarily variable digital sequences appropriate for forensic investigations, including computer databasing, and for analysing allele diversity and the role of recombination in minisatellite instability.			JEFFREYS, AJ (corresponding author), UNIV LEICESTER, DEPT GENET, UNIV RD, LEICESTER LE1 7RH, ENGLAND.		; Monckton, Darren/B-4943-2013	Neil, David/0000-0002-9994-9536; Monckton, Darren/0000-0002-8298-8264				ARMOUR JAL, 1989, GENOMICS, V4, P328, DOI 10.1016/0888-7543(89)90338-8; BAIRD M, 1986, AM J HUM GENET, V39, P489; BALAZS I, 1989, AM J HUM GENET, V44, P182; BOERWINKLE E, 1989, P NATL ACAD SCI USA, V86, P212, DOI 10.1073/pnas.86.1.212; BUDOWLE B, 1991, AM J HUM GENET, V48, P841; CHAKRABORTY R, 1991, EXPER SUPPL, V58, P127; CHANDLEY AC, 1988, CYTOGENET CELL GENET, V48, P152, DOI 10.1159/000132613; DEVLIN B, 1990, SCIENCE, V249, P1416, DOI 10.1126/science.2205919; GRAY IC, 1991, P ROY SOC B-BIOL SCI, V243, P241, DOI 10.1098/rspb.1991.0038; HAGELBERG E, 1991, NATURE, V352, P427, DOI 10.1038/352427a0; JARMAN AP, 1986, EMBO J, V5, P1857, DOI 10.1002/j.1460-2075.1986.tb04437.x; JEFFREYS AJ, 1988, NUCLEIC ACIDS RES, V16, P10953, DOI 10.1093/nar/16.23.10953; JEFFREYS AJ, 1991, EXPER SUPPL, V58, P1; JEFFREYS AJ, 1985, NATURE, V317, P818, DOI 10.1038/317818a0; JEFFREYS AJ, 1990, CELL, V60, P473, DOI 10.1016/0092-8674(90)90598-9; JEFFREYS AJ, 1985, NATURE, V316, P76, DOI 10.1038/316076a0; JEFFREYS AJ, 1991, AM J HUM GENET, V48, P824; JEFFREYS AJ, 1985, NATURE, V314, P67, DOI 10.1038/314067a0; LANDER ES, 1989, NATURE, V339, P501, DOI 10.1038/339501a0; LITT M, 1989, AM J HUM GENET, V44, P397; NAKAMURA Y, 1987, NUCLEIC ACIDS RES, V15, P2537, DOI 10.1093/nar/15.6.2537; NAKAMURA Y, 1987, SCIENCE, V235, P1616, DOI 10.1126/science.3029872; ODELBERG SJ, 1989, GENOMICS, V5, P915, DOI 10.1016/0888-7543(89)90134-1; OWERBACH D, 1984, GENE, V32, P475, DOI 10.1016/0378-1119(84)90021-0; PAGE D C, 1987, Genomics, V1, P243, DOI 10.1016/0888-7543(87)90051-6; ROYLE NJ, 1988, GENOMICS, V3, P352, DOI 10.1016/0888-7543(88)90127-9; SIMMLER MC, 1987, EMBO J, V6, P963, DOI 10.1002/j.1460-2075.1987.tb04846.x; SMITH JC, 1990, J FORENSIC SCI SOC, V30, P19, DOI 10.1016/S0015-7368(90)73298-7; TAUTZ D, 1989, NUCLEIC ACIDS RES, V17, P6463, DOI 10.1093/nar/17.16.6463; WEBER JL, 1989, AM J HUM GENET, V44, P388; WOLFF RK, 1989, GENOMICS, V5, P382, DOI 10.1016/0888-7543(89)90076-1; WOLFF RK, 1988, GENOMICS, V3, P347, DOI 10.1016/0888-7543(88)90126-7; WONG Z, 1986, NUCLEIC ACIDS RES, V14, P4605, DOI 10.1093/nar/14.11.4605; WONG Z, 1987, ANN HUM GENET, V51, P269, DOI 10.1111/j.1469-1809.1987.tb01062.x	34	364	390	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 21	1991	354	6350					204	209		10.1038/354204a0	http://dx.doi.org/10.1038/354204a0			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ948	1961248				2022-12-28	WOS:A1991GQ94800040
J	MOUY, R; SEGER, R; BOURQUIN, JP; VEBER, F; BLANCHE, S; GRISCELLI, C; FISCHER, A				MOUY, R; SEGER, R; BOURQUIN, JP; VEBER, F; BLANCHE, S; GRISCELLI, C; FISCHER, A			INTERFERON-GAMMA FOR CHRONIC GRANULOMATOUS-DISEASE	NEW ENGLAND JOURNAL OF MEDICINE			English	Letter							TRIMETHOPRIM		UNIV ZURICH,KINDERKLIN,CH-8091 ZURICH,SWITZERLAND	University of Zurich	MOUY, R (corresponding author), HOP NECKER ENFANTS MALAD,F-75743 PARIS,FRANCE.		Bourquin, Jean-Pierre/C-2802-2011	Bourquin, Jean-Pierre/0000-0001-6571-6227				MARGOLIS DM, 1990, J INFECT DIS, V162, P723, DOI 10.1093/infdis/162.3.723; MOUY R, 1989, J PEDIATR-US, V114, P555, DOI 10.1016/S0022-3476(89)80693-6; WEENING RS, 1983, J PEDIATR-US, V103, P127, DOI 10.1016/S0022-3476(83)80798-7; 1991, NEW ENGL J MED, V324, P509	4	32	32	0	0	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 21	1991	325	21					1516	1516						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GQ406	1944433				2022-12-28	WOS:A1991GQ40600026
J	BERGER, R; JUST, M; GLUCK, R; GRASSI, M; WEGMANN, A				BERGER, R; JUST, M; GLUCK, R; GRASSI, M; WEGMANN, A			MEASLES VACCINATION IN EARLY INFANCY	LANCET			English	Letter									SWISS SERUM & VACCINE INST,BERN,SWITZERLAND		BERGER, R (corresponding author), UNIV BASEL,CHILDRENS HOSP,CH-4005 BASEL,SWITZERLAND.							TIDJANI O, 1989, LANCET, V2, P1357; WHITTLE H, 1988, LANCET, V2, P811	2	3	3	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	MAR 3	1990	335	8688					540	540		10.1016/0140-6736(90)90773-X	http://dx.doi.org/10.1016/0140-6736(90)90773-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT015	1968549				2022-12-28	WOS:A1990CT01500035
J	KAMPS, MP; MURRE, C; SUN, XH; BALTIMORE, D				KAMPS, MP; MURRE, C; SUN, XH; BALTIMORE, D			A NEW HOMEOBOX GENE CONTRIBUTES THE DNA-BINDING DOMAIN OF THE T(1-19) TRANSLOCATION PROTEIN IN PRE-B ALL	CELL			English	Article									MIT,DEPT BIOL,CAMBRIDGE,MA 02139	Massachusetts Institute of Technology (MIT)	KAMPS, MP (corresponding author), WHITEHEAD INST BIOMED RES,9 CAMBRIDGE CTR,CAMBRIDGE,MA 02142, USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM039458] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 39458] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDERSON JE, 1987, NATURE, V326, P846, DOI 10.1038/326846a0; ANDERSON WF, 1981, NATURE, V290, P754, DOI 10.1038/290754a0; ASTELL CR, 1981, CELL, V27, P15, DOI 10.1016/0092-8674(81)90356-1; BLATT C, 1988, BIOCHEM BIOPH RES CO, V156, P1265, DOI 10.1016/S0006-291X(88)80769-1; BLATT C, 1988, EMBO J, V7, P4283, DOI 10.1002/j.1460-2075.1988.tb03326.x; CARROLL AJ, 1984, BLOOD, V63, P761; CHOU DY, 1978, ANNU REV BIOCHEM, V47, P251; Dayhoff M. O., 1978, ATLAS PROTEIN SEQ S3, V5, P345; FRASCH M, 1987, EMBO J, V6, P749, DOI 10.1002/j.1460-2075.1987.tb04817.x; GEHRING WJ, 1986, ANNU REV GENET, V20, P147, DOI 10.1146/annurev.ge.20.120186.001051; HOLLAND PWH, 1988, GENE DEV, V2, P773, DOI 10.1101/gad.2.7.773; KONGSUWAN K, 1989, NUCLEIC ACIDS RES, V17, P1881, DOI 10.1093/nar/17.5.1881; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; LENARDO M, 1987, SCIENCE, V236, P1573, DOI 10.1126/science.3109035; MATTHEWS BW, 1982, COLD SPRNG HARBOR S, V50, P263; MCKAY DB, 1981, NATURE, V290, P744, DOI 10.1038/290744a0; MELLENTIN JD, 1989, SCIENCE, V246, P379, DOI 10.1126/science.2799390; MERMOD N, 1989, CELL, V58, P741, DOI 10.1016/0092-8674(89)90108-6; MILLER AM, 1985, NATURE, V314, P598, DOI 10.1038/314598a0; MONDRAGON A, 1989, J MOL BIOL, V205, P189, DOI 10.1016/0022-2836(89)90375-6; MURRE C, 1989, CELL, V56, P777, DOI 10.1016/0092-8674(89)90682-X; MURRE C, 1989, CELL, V58, P537, DOI 10.1016/0092-8674(89)90434-0; NASMYTH K, 1987, SCIENCE, V237, P1162, DOI 10.1126/science.3306917; NOURSE J, 1990, CELL, V60, P535, DOI 10.1016/0092-8674(90)90657-Z; OTTING G, 1988, EMBO J, V7, P4305, DOI 10.1002/j.1460-2075.1988.tb03329.x; PABO CO, 1982, NATURE, V298, P443, DOI 10.1038/298443a0; POOLE SJ, 1985, CELL, V40, P37, DOI 10.1016/0092-8674(85)90306-X; QIAN YQ, 1989, CELL, V59, P573, DOI 10.1016/0092-8674(89)90040-8; ROBERTSON M, 1988, NATURE, V336, P522, DOI 10.1038/336522a0; SANTORO C, 1988, NATURE, V334, P218, DOI 10.1038/334218a0; SAUER RT, 1988, GENE DEV, V2, P807, DOI 10.1101/gad.2.7.807; SAUER RT, 1982, NATURE, V298, P447, DOI 10.1038/298447a0; SCHEVITZ RW, 1985, NATURE, V317, P782, DOI 10.1038/317782a0; SCOTT MP, 1989, BIOCHIM BIOPHYS ACTA, V989, P25, DOI 10.1016/0304-419X(89)90033-4; SCOTT MP, 1987, CELL, V51, P689, DOI 10.1016/0092-8674(87)90092-4; SEN R, 1986, CELL, V46, P705, DOI 10.1016/0092-8674(86)90346-6; STEITZ TA, 1982, P NATL ACAD SCI-BIOL, V79, P3097, DOI 10.1073/pnas.79.10.3097; TREISMAN J, 1989, CELL, V59, P553; WILLIAMS DL, 1984, CELL, V36, P101, DOI 10.1016/0092-8674(84)90078-3	39	680	691	0	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	FEB 23	1990	60	4					547	555		10.1016/0092-8674(90)90658-2	http://dx.doi.org/10.1016/0092-8674(90)90658-2			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CQ723	1967983				2022-12-28	WOS:A1990CQ72300005
J	LENZI, M; BALLARDINI, G; FUSCONI, M; CASSANI, F; SELLERI, L; VOLTA, U; ZAULI, D; BIANCHI, FB				LENZI, M; BALLARDINI, G; FUSCONI, M; CASSANI, F; SELLERI, L; VOLTA, U; ZAULI, D; BIANCHI, FB			TYPE-2 AUTOIMMUNE HEPATITIS AND HEPATITIS-C VIRUS-INFECTION	LANCET			English	Article									UNIV BOLOGNA,IST CLIN MED GEN & TERAPIA MED,CATTEDRA SEMEIOT MED,I-40126 BOLOGNA,ITALY	University of Bologna			Vento, Sandro/I-1662-2017	Vento, Sandro/0000-0003-0084-4062; Volta, Umberto/0000-0003-3405-3808				CRIVELLI O, 1983, CLIN EXP IMMUNOL, V54, P232; ESTEBAN JI, 1989, LANCET, V2, P294; HOMBERG JC, 1984, CLIN EXP IMMUNOL, V55, P561; HOMBERG JC, 1987, HEPATOLOGY, V7, P1333, DOI 10.1002/hep.1840070626; KUO G, 1989, SCIENCE, V244, P362, DOI 10.1126/science.2496467; LENZI M, 1984, CLIN EXP IMMUNOL, V55, P36; LENZI M, 1988, J IMMUNOL METHODS, V111, P253, DOI 10.1016/0022-1759(88)90134-2; LOEPER J, 1989, Journal of Hepatology, V9, pS55, DOI 10.1016/0168-8278(89)90286-9; MANNS MP, 1989, J CLIN INVEST, V83, P1066, DOI 10.1172/JCI113949; SHIMIZU YK, 1979, SCIENCE, V205, P197, DOI 10.1126/science.451589	10	262	262	0	3	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	FEB 3	1990	335	8684					258	259		10.1016/0140-6736(90)90070-L	http://dx.doi.org/10.1016/0140-6736(90)90070-L			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CL815	1967721				2022-12-28	WOS:A1990CL81500005
J	NEWRICK, PG; BRAATVEDT, G; HANCOCK, J; CORRALL, RJM				NEWRICK, PG; BRAATVEDT, G; HANCOCK, J; CORRALL, RJM			SELF-MANAGEMENT OF ADRENAL INSUFFICIENCY BY RECTAL HYDROCORTISONE	LANCET			English	Article											NEWRICK, PG (corresponding author), BRISTOL ROYAL INFIRM & GEN HOSP,DEPT MED,BRISTOL BS2 8HW,AVON,ENGLAND.							BARTON RN, 1981, CLIN SCI, V61, P399, DOI 10.1042/cs0610399; CANN PA, 1987, LANCET, V1, P922; DEBOER AG, 1982, CLIN PHARMACOKINET, V7, P285, DOI 10.2165/00003088-198207040-00002; LIMA JJ, 1980, CLIN PHARMACOL THER, V28, P262, DOI 10.1038/clpt.1980.159; STONER HB, 1979, CLIN SCI, V56, P563, DOI 10.1042/cs0560563; 1989, MARTINDALE EXTRA PHA, P872	6	14	14	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	JAN 27	1990	335	8683					212	213		10.1016/0140-6736(90)90289-H	http://dx.doi.org/10.1016/0140-6736(90)90289-H			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CL185	1967677				2022-12-28	WOS:A1990CL18500014
J	BONIFACIO, E; BINGLEY, PJ; SHATTOCK, M; DEAN, BM; DUNGER, D; GALE, EAM; BOTTAZZO, GF				BONIFACIO, E; BINGLEY, PJ; SHATTOCK, M; DEAN, BM; DUNGER, D; GALE, EAM; BOTTAZZO, GF			QUANTIFICATION OF ISLET-CELL ANTIBODIES AND PREDICTION OF INSULIN-DEPENDENT DIABETES	LANCET			English	Article									UNIV COLL & MIDDLESEX SCH MED,DEPT IMMUNOL,ARTHUR STANLEY HOUSE,40-50 TOTTENHAM ST,LONDON WC1P 9PG,ENGLAND; ST BARTHOLOMEWS HOSP,DEPT DIABET & IMMUNOGENET,LONDON EC1A 7BE,ENGLAND; JOHN RADCLIFFE HOSP,DEPT PAEDIAT,OXFORD OX3 9DU,ENGLAND	University of London; University College London; University of London; Queen Mary University London; University of Oxford			Bonifacio, Ezio/E-7700-2010	Bonifacio, Ezio/0000-0002-8704-4713; Dunger, Professor David/0000-0002-2566-9304				BONIFACIO E, 1988, J IMMUNOL METHODS, V106, P83, DOI 10.1016/0022-1759(88)90274-8; BOTTAZZO GF, 1986, DIABETOLOGIA, V29, P125, DOI 10.1007/BF00456124; BOTTAZZO GF, 1980, LANCET, V1, P668; BOTTAZZO GF, 1986, DIABETES ANN, V2, P13; BRUINING GJ, 1989, LANCET, V1, P1100; COLMAN PG, 1987, DIABETES ANN, V4; CUTLER S J, 1958, J Chronic Dis, V8, P699, DOI 10.1016/0021-9681(58)90126-7; Galen RS, 1975, NORMALITY PREDICTIVE; GLEICHMANN H, 1987, IMMUNOL TODAY, V8, P167, DOI 10.1016/0167-5699(87)90028-4; HEROLD KC, 1988, NEW ENGL J MED, V38, P701; POCOCK SJ, 1985, CLIN TRIALS, P123; TARN AC, 1988, LANCET, V1, P845	12	360	360	0	6	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	JAN 20	1990	335	8682					147	149		10.1016/0140-6736(90)90013-U	http://dx.doi.org/10.1016/0140-6736(90)90013-U			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CJ979	1967440				2022-12-28	WOS:A1990CJ97900012
J	HENDRY, WF; HUGHES, L; SCAMMELL, G; PRYOR, JP; HARGREAVE, TB				HENDRY, WF; HUGHES, L; SCAMMELL, G; PRYOR, JP; HARGREAVE, TB			COMPARISON OF PREDNISOLONE AND PLACEBO IN SUBFERTILE MEN WITH ANTIBODIES TO SPERMATOZOA	LANCET			English	Article									QUEEN CHARLOTTES MATERN HOSP,LONDON,ENGLAND; ST PETERS HOSP,LONDON WC2A 2EX,ENGLAND; WESTERN GEN HOSP,EDINBURGH EH4 2XU,MIDLOTHIAN,SCOTLAND	Imperial College London; University of London; University College London; University of Edinburgh								ALEXANDER NJ, 1983, INT J FERTIL, V28, P63; [Anonymous], 1989, Int J Androl, V12, P254; BUTLER WT, 1973, J CLIN INVEST, V52, P2629, DOI 10.1172/JCI107455; DEALMEIDA M, 1985, INT J ANDROL, V8, P111; FELSON DT, 1987, LANCET, V1, P902; FREDRICSSON B, 1988, ANDROLOGIA, V20, P238; Friberg J, 1974, Acta Obstet Gynecol Scand Suppl, V36, P21; HAAS GG, 1987, FERTIL STERIL, V47, P295; HENDRY WF, 1986, BRIT J UROL, V58, P709, DOI 10.1111/j.1464-410X.1986.tb05918.x; HENDRY WF, 1981, FERTIL STERIL, V36, P351; HENDRY WF, 1982, FERTIL STERIL, V38, P120; HENDRY WF, 1977, BRIT J UROL, V49, P757, DOI 10.1111/j.1464-410X.1977.tb04567.x; HENDRY WF, 1979, LANCET, V2, P498; HENDRY WF, 1986, FERTIL STERIL, V45, P249; HENDRY WF, 1981, RECENT ADV UROLOGY A, V3, P339; HENDRY WF, 1987, RECENT ADV UROL ANDR, V4, P313; HILLS M, 1979, BRIT J CLIN PHARMACO, V8, P7, DOI 10.1111/j.1365-2125.1979.tb05903.x; JAGER S, 1980, INT J ANDROL, V3, P1, DOI 10.1111/j.1365-2605.1980.tb00090.x; JAGER S, 1978, INT J FERTIL, V23, P12; LEWIS DA, 1983, J AFFECT DISORDERS, V5, P319, DOI 10.1016/0165-0327(83)90022-8; MAHADEVAN MM, 1984, FERTIL STERIL, V42, P400; MORGAN H, 1977, LANCET, V1, P1228; NILSSON S, 1979, BRIT J UROL, V51, P591, DOI 10.1111/j.1464-410X.1979.tb03609.x; PARSLOW JM, 1985, FERTIL STERIL, V43, P621; PRYOR JP, 1978, BRIT J UROL, V50, P47, DOI 10.1111/j.1464-410X.1978.tb02765.x; SHULMAN JF, 1982, FERTIL STERIL, V38, P591; SHULMAN S, 1976, LANCET, V2, P1243; STANWELLSMITH RE, 1984, BRIT J UROL, V56, P422, DOI 10.1111/j.1464-410X.1984.tb05836.x; STEDRONSKA J, 1983, AM J REPROD IMMUNOL, V3, P89, DOI 10.1111/j.1600-0897.1983.tb00221.x; TSUKUI S, 1988, J IN VITRO FERTIL EM, V5, P123, DOI 10.1007/BF01131173	30	93	96	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	JAN 13	1990	335	8681					85	88		10.1016/0140-6736(90)90548-J	http://dx.doi.org/10.1016/0140-6736(90)90548-J			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CH516	1967425				2022-12-28	WOS:A1990CH51600011
J	NUCHTERN, JG; BIDDISON, WE; KLAUSNER, RD				NUCHTERN, JG; BIDDISON, WE; KLAUSNER, RD			CLASS-II MHC MOLECULES CAN USE THE ENDOGENOUS PATHWAY OF ANTIGEN PRESENTATION	NATURE			English	Article									NINCDS,NEUROIMMUNOL BRANCH,BETHESDA,MD 20892	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	NUCHTERN, JG (corresponding author), NICHHD,CELL BIOL & METAB BRANCH,BETHESDA,MD 20892, USA.							BLUM JS, 1988, P NATL ACAD SCI USA, V85, P3975, DOI 10.1073/pnas.85.11.3975; COWAN EP, 1987, P NATL ACAD SCI USA, V84, P5014, DOI 10.1073/pnas.84.14.5014; FLEISCHER B, 1985, J IMMUNOL, V135, P2800; FRAZER KB, 1978, MEASLES VIRUS ITS BI, P74; GERMAIN RN, 1986, NATURE, V322, P687, DOI 10.1038/322687a0; GOTCH F, 1987, NATURE, V326, P881, DOI 10.1038/326881a0; HELENIUS A, 1982, J GEN VIROL, V58, P47, DOI 10.1099/0022-1317-58-1-47; HELENIUS A, 1980, J CELL BIOL, V84, P404, DOI 10.1083/jcb.84.2.404; HOGAN KT, 1988, J EXP MED, V168, P725, DOI 10.1084/jem.168.2.725; JACOBSON S, 1989, J VIROL, V63, P1756, DOI 10.1128/JVI.63.4.1756-1762.1989; LIPPINCOTTSCHWARTZ J, 1989, CELL, V56, P801, DOI 10.1016/0092-8674(89)90685-5; LONG EO, 1989, IMMUNOL TODAY, V10, P45, DOI 10.1016/0167-5699(89)90303-4; MALISSEN B, 1984, CELL, V36, P319, DOI 10.1016/0092-8674(84)90225-3; MATLIN KS, 1981, J CELL BIOL, V91, P601, DOI 10.1083/jcb.91.3.601; MISUMI Y, 1986, J BIOL CHEM, V261, P1398; MOORE MW, 1988, CELL, V54, P777, DOI 10.1016/S0092-8674(88)91043-4; MORRISON LA, 1986, J EXP MED, V163, P903, DOI 10.1084/jem.163.4.903; NUCHTERN JG, 1989, NATURE, V339, P223, DOI 10.1038/339223a0; ROTHBARD JB, 1988, CELL, V52, P515, DOI 10.1016/0092-8674(88)90464-3; SEKALY RP, 1988, P NATL ACAD SCI USA, V85, P1209, DOI 10.1073/pnas.85.4.1209; SHIMOJO N, 1989, J IMMUNOL, V143, P2939; STOCKINGER B, 1989, CELL, V56, P683, DOI 10.1016/0092-8674(89)90590-4; SWEETSER MT, 1989, NATURE, V342, P180, DOI 10.1038/342180a0; TAKATSUKI A, 1985, AGR BIOL CHEM TOKYO, V49, P899, DOI 10.1080/00021369.1985.10866826; TOWNSEND A, 1988, J EXP MED, V168, P1211, DOI 10.1084/jem.168.4.1211; TOWNSEND A, 1989, NATURE, V340, P443, DOI 10.1038/340443a0; TOWNSEND ARM, 1986, NATURE, V324, P575, DOI 10.1038/324575a0; TOWNSEND ARM, 1985, CELL, V42, P457, DOI 10.1016/0092-8674(85)90103-5; WHITE J, 1980, J CELL BIOL, V87, P264, DOI 10.1083/jcb.87.1.264; WHITE J, 1981, J CELL BIOL, V89, P674, DOI 10.1083/jcb.89.3.674; YEWDELL JW, 1989, SCIENCE, V244, P1072, DOI 10.1126/science.2471266; YEWDELL JW, 1988, SCIENCE, V239, P637, DOI 10.1126/science.3257585	32	291	294	0	2	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	JAN 4	1990	343	6253					74	76		10.1038/343074a0	http://dx.doi.org/10.1038/343074a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG614	1967486				2022-12-28	WOS:A1990CG61400058
J	BRAVEMAN, PA; EGERTER, S; BENNETT, T; SHOWSTACK, J				BRAVEMAN, PA; EGERTER, S; BENNETT, T; SHOWSTACK, J			DIFFERENCES IN HOSPITAL RESOURCE-ALLOCATION AMONG SICK NEWBORNS ACCORDING TO INSURANCE-COVERAGE	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article								Objective. - To assess whether newborns insurance coverage was associated with differences in the allocation of hospital services. Design. - Retrospective analysis of computerized hospital discharge data, comparing resource allocation among newborns according to insurance status, controlling for race/ethnicity, diagnoses, hospital characteristics (ownership, teaching status, nursery level), and disposition. Setting. - All California civilian acute-care hospitals. Patients. - Population-based sample, excluding out-of-hospital and military hospital births. Resource allocation was studied among all newborns discharged in 1987 with evidence of serious problems (N = 29 751). Main Outcome Measures. - Length of stay, total charges, and charges per day. Results. - Sick newborns without insurance received fewer inpatient services than comparable privately insured newborns with either indemnity or prepaid coverage. This pattern was observed across all hospital ownership types. Mean stay was 15.7 days for all privately insured newborns (15.6 days for those with indemnity and 15.7 days for those with prepaid coverage), 14.8 days for Medicaid-covered newborns, and 13.2 days for uninsured newborns (P < .001). Length of stay, total charges, and charges per day were 16%, 28%, and 10% less, respectively, for the uninsured than for all privately insured newborns (P < .001). Resources for newborns covered by Medicaid were generally greater than for the uninsured and less than for the privately insured. Both uninsured and Medicaid-covered newborns were found to have more severe medical problems than the privately insured. Conclusions. - The findings cannot be explained by differences in medical need or by differences in non-medically indicated services; they constitute prima facie evidence of inequities that need to be addressed by policy changes.	UNIV CALIF SAN FRANCISCO, SCH MED, INST HLTH POLICY STUDIES, SAN FRANCISCO, CA 94143 USA	University of California System; University of California San Francisco	BRAVEMAN, PA (corresponding author), UNIV CALIF SAN FRANCISCO, SCH MED, DEPT FAMILY & COMMUNITY MED, BOX 0900, SAN FRANCISCO, CA 94143 USA.		Showstack, Jonathan/L-6556-2013	Showstack, Jonathan/0000-0002-1367-419X				ADAY LA, 1978, HEALTH SERV RES, V13, P369; ADAY LA, 1984, AM J PUBLIC HEALTH, V74, P1331, DOI 10.2105/AJPH.74.12.1331; Amler RW, 1987, CLOSING GAP BURDEN U; BAZZOLI GJ, 1986, HEALTH SERV RES, V21, P353; Becker E R, 1983, Inquiry, V20, P248; BRAVEMAN P, 1989, NEW ENGL J MED, V321, P508, DOI 10.1056/NEJM198908243210805; BROWN ER, 1988, CHANGES HLTH INSURAN; CAPER P, 1988, NEW ENGL J MED, V318, P1535, DOI 10.1056/NEJM198806093182310; COHODES DR, 1986, INQUIRY-J HEALTH CAR, V23, P227; DAVIS K, 1983, MILBANK FUND Q, V61, P149, DOI 10.2307/3349903; DAVIS K, 1981, ANNU REV PUBL HEALTH, V2, P159, DOI 10.1146/annurev.pu.02.050181.001111; DOWD BE, 1986, MED CARE, V24, P694, DOI 10.1097/00005650-198608000-00005; EPSTEIN AM, 1990, NEW ENGL J MED, V322, P1122, DOI 10.1056/NEJM199004193221606; FUCHS VR, 1987, NEW ENGL J MED, V316, P1154, DOI 10.1056/NEJM198704303161812; GORDON T, 1986, PEDIATRICS, V77, P29; HADLEY J, 1991, JAMA-J AM MED ASSOC, V265, P374, DOI 10.1001/jama.265.3.374; JOHNSON AN, 1989, INQUIRY-J HEALTH CAR, V26, P388; LINCOLN R, 1987, BLESSED EVENTS BOTTO; MARMOT MG, 1978, J EPIDEMIOL COMMUN H, V32, P244, DOI 10.1136/jech.32.4.244; MURRAY JL, 1988, NEW ENGL J MED, V319, P1385, DOI 10.1056/NEJM198811243192105; NUTTER DO, 1987, NEW ENGL J MED, V316, P1156, DOI 10.1056/NEJM198704303161813; SHOWSTACK JA, 1984, AM J PUBLIC HEALTH, V74, P1003, DOI 10.2105/AJPH.74.9.1003; STARFIELD B, 1985, HEALTH SERV RES, V19, P817; STERN RS, 1989, ARCH INTERN MED, V149, P1185, DOI 10.1001/archinte.149.5.1185; WEISFELD VD, 1987, 2 R WOOD JOHNS F SPE; WEISSMAN J, 1989, JAMA-J AM MED ASSOC, V261, P3572, DOI 10.1001/jama.261.24.3572; WENNEKER MB, 1990, JAMA-J AM MED ASSOC, V264, P1255, DOI 10.1001/jama.264.10.1255; WISE PH, 1985, NEW ENGL J MED, V313, P360, DOI 10.1056/NEJM198508083130605; 1980, PHS801260 US DEP HLT, P1; 1985, SAS USERS GUIDE STAT; 1987, AM HOSPITAL ASS GUID; [No title captured]	32	80	80	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 18	1991	266	23					3300	3308		10.1001/jama.266.23.3300	http://dx.doi.org/10.1001/jama.266.23.3300			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GU964	1960830				2022-12-28	WOS:A1991GU96400029
J	LONG, W; CORBET, A; COTTON, R; COURTNEY, S; MCGUINESS, G; WALTER, D; WATTS, J; SMYTH, J; BARD, H; CHERNICK, V				LONG, W; CORBET, A; COTTON, R; COURTNEY, S; MCGUINESS, G; WALTER, D; WATTS, J; SMYTH, J; BARD, H; CHERNICK, V			A CONTROLLED TRIAL OF SYNTHETIC SURFACTANT IN INFANTS WEIGHING 1250 G OR MORE WITH RESPIRATORY-DISTRESS SYNDROME	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RANDOMIZED CONTROLLED TRIAL; BRONCHOPULMONARY DYSPLASIA; THERAPY; BIRTH; LAMBS	Background. Surfactant-replacement therapy is now recognized as a lifesaving and safe intervention in small premature infants, but there is little evidence concerning its risks and benefits in larger premature infants. Methods. We conducted a placebo-controlled, blinded trial in 1237 infants with respiratory distress who were enrolled at 23 hospitals in the United States and 13 hospitals in Canada. At entry all the infants weighed at least 1250 g, were receiving mechanical ventilation, and had a ratio of arterial to alveolar oxygen tension below 0.22. The initial dose of either the synthetic surfactant (Exosurf, 5 ml per kilogram of body weight) or air (the placebo) was administered less than 24 hours after birth, with a second dose given 12 hours later. A total of 614 infants were assigned to receive surfactant, and 623 to receive placebo. Results, Fewer infants in the surfactant group than in the placebo group died before 28 days of age or survived at 28 days with bronchopulmonary dysplasia (7 percent vs. 12 percent, P = 0.002). In the first 28 days of life, there were fewer deaths due to respiratory distress syndrome in the surfactant group (1 percent vs. 3 percent, P = 0.043), lower overall neonatal mortality (4 percent vs. 7 percent, P = 0.04), and a lower incidence of bronchopulmonary dysplasia (3 percent vs. 6 percent, P = 0.008). There was also a significantly lower incidence of pulmonary air leaks, intraventricular hemorrhage, patent ductus arteriosus, seizures, hypotension, and pulmonary hypertension in the surfactant group. The infants treated with surfactant were weaned from oxygen and mechanical ventilation significantly sooner than those given placebo, and they less often required high-frequency ventilation or extracorporeal membrane oxygenation. The primary side effect observed more frequently among the infants who received surfactant treatment was pulmonary hemorrhage (six infants vs. one infant, P = 0.055). Conclusions. In infants weighing at least 1250 g at birth who have respiratory distress syndrome, treatment with two doses of synthetic surfactant improves survival and reduces perinatal morbidity.	UNIV N CAROLINA, DEPT PEDIAT, CHAPEL HILL, NC 27514 USA; BAYLOR COLL MED, DEPT PEDIAT, HOUSTON, TX 77030 USA; VANDERBILT UNIV, DEPT PEDIAT, NASHVILLE, TN 37240 USA; WRIGHT STATE UNIV, DEPT PEDIAT, DAYTON, OH 45435 USA; UNIV IOWA, DEPT PEDIAT, IOWA CITY, IA USA; UNIV ARKANSAS, DEPT PEDIAT, LITTLE ROCK, AR 72204 USA; MCMASTER UNIV, DEPT PEDIAT, HAMILTON L8S 4L8, ONTARIO, CANADA; UNIV BRITISH COLUMBIA, DEPT PEDIAT, VANCOUVER V6T 1W5, BC, CANADA; UNIV MONTREAL, DEPT PEDIAT, MONTREAL H3C 3J7, QUEBEC, CANADA; UNIV MANITOBA, DEPT PEDIAT, WINNIPEG R3T 2N2, MANITOBA, CANADA	University of North Carolina; University of North Carolina Chapel Hill; Baylor College of Medicine; Vanderbilt University; University System of Ohio; Wright State University Dayton; University of Iowa; University of Arkansas System; University of Arkansas Fayetteville; University of Arkansas Little Rock; McMaster University; University of British Columbia; Universite de Montreal; University of Manitoba	LONG, W (corresponding author), WELLCOME RES LABS, DIV CLIN RES, 3030 CORNWALLIS RD, RES TRIANGLE PK, NC 27709 USA.							BONIKOS DS, 1976, HUM PATHOL, V7, P643, DOI 10.1016/S0046-8177(76)80077-9; BOSE C, 1990, J PEDIATR-US, V117, P947, DOI 10.1016/S0022-3476(05)80143-X; CORBET A, 1991, J PEDIATR-US, V118, P277, DOI 10.1016/S0022-3476(05)80502-5; DIXON WJ, 1969, INTRO STATISTICAL AN, P222; DURAND DJ, 1985, J PEDIATR-US, V107, P775, DOI 10.1016/S0022-3476(85)80416-9; Edwards DK, 1982, LUNG DEV BIOL CLIN P, V2, P47; FLEISS JL, 1981, STATISTICAL METHODS, P160; Friedman L, 1985, FUNDAMENTALS CLIN TR, P83; GERDES J, 1991, PEDIATR RES, V29, pA214; GITLIN JD, 1987, PEDIATRICS, V79, P31; HENNES HM, 1991, AM J DIS CHILD, V145, P102, DOI 10.1001/archpedi.1991.02160010108027; HOEKSTRA RE, 1991, PEDIATRICS, V88, P10; HORBAR JD, 1989, NEW ENGL J MED, V320, P959; HORBAR JD, 1990, EUR J PEDIATR, V149, P416, DOI 10.1007/BF02009663; HURT H, 1983, J PEDIATR-US, V102, P450, DOI 10.1016/S0022-3476(83)80675-1; KENDIG JW, 1988, PEDIATRICS, V82, P756; LIECHTY EA, 1991, PEDIATRICS, V88, P19; LONG W, 1991, J PEDIATR-US, V118, P595, DOI 10.1016/S0022-3476(05)83388-8; LONG W, IN PRESS J PEDIATR; LONG WA, 1988, CLIN CRIT CARE MED, V13, P21; MORLEY CJ, 1987, BRIT MED J, V294, P991; OBRODOVICH HM, 1985, AM REV RESPIR DIS, V132, P694; PHIBBS RH, 1991, PEDIATRICS, V88, P1; ROBERTSON B, 1988, PEDIATRICS, V82, P683; SOLL RF, 1991, PEDIATR RES, V29, pA267; SPEER CP, IN PRESS PEDIATRICS; TOOLEY WH, 1987, AM REV RESPIR DIS, V136, P651, DOI 10.1164/ajrccm/136.3.651; VANHOUTEN J, IN PRESS J PEDIATR	28	162	164	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 12	1991	325	24					1696	1703		10.1056/NEJM199112123252404	http://dx.doi.org/10.1056/NEJM199112123252404			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GU418	1944470				2022-12-28	WOS:A1991GU41800004
J	RIGOTTI, NA; PASHOS, CL				RIGOTTI, NA; PASHOS, CL			NO-SMOKING LAWS IN THE UNITED-STATES - AN ANALYSIS OF STATE AND CITY ACTIONS TO LIMIT SMOKING IN PUBLIC PLACES AND WORKPLACES	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NONSMOKERS	Objective. - To assess the prevalence, content, and growth of state and city laws restricting smoking in public places and workplaces in the United States and to identify factors associated with their passage. Design. - A mailed survey of city clerks in US cities with a population of 25 000 or greater (N = 980) and review of existing data sources confirmed the status of smoking restrictions in 902 (92%) of the cities in the sample. State laws were identified by contacting each state's Legislative Reference Bureau (100% response). Content of laws was coded using previously developed categories. Main Outcome Measures. - Prevalence, comprehensiveness, and cumulative incidence of no-smoking laws in states and in cities with a population of 25 000 or greater. Results. - By July 1989, 44 states and 500 (51%) of the cities in our sample had adopted some smoking restriction, but content varied widely. While 42% of cities limited smoking in government buildings, 27% in public places, 24% in restaurants, and 18% in private workplaces, only 17% of cities and 20% of states had comprehensive laws restricting smoking in all four of these sites. The number of city no-smoking laws increased tenfold from 1980 to 1989. City no-smoking laws were independently associated with population size, geography, state tobacco production, and adult smoking prevalence. Laws were more common in larger cities, Western cities, and states with fewer adult smokers. Laws were less common in tobacco-producing states and in the South. Conclusions. - No-smoking laws are more widespread than previously appreciated, especially at the local level, reflecting a rapid pace of city government action in the 1980s. Nonetheless, comprehensive laws, which are most likely to provide meaningful protection from environmental tobacco smoke exposure, remain uncommon and represent a major gap in smoking control policy. Laws are most needed in smaller and non-Western cities and in states that produce tobacco and have a higher proportion of smokers.	HARVARD UNIV,JOHN F KENNEDY SCH GOVT,INST STUDY SMOKING BEHAV & POLICY,CAMBRIDGE,MA 02138	Harvard University	RIGOTTI, NA (corresponding author), HARVARD UNIV,MASSACHUSETTS GEN HOSP,SCH MED,GEN INTERNAL MED UNIT,FRUIT ST,BOSTON,MA 02114, USA.				NCI NIH HHS [1-RO3-CA48386-01] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R03CA048386] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		GRISE VN, 1988, USDA589 EC RES SERV, P16; HANAUER P, 1985, NEW YORK STATE J MED, V85, P369; MARTIN MJ, 1986, AM J PUBLIC HEALTH, V76, P585, DOI 10.2105/AJPH.76.5.585; MEHTA CR, 1983, J AM STAT ASSOC, V78, P427, DOI 10.2307/2288652; PERTSCHUK M, 1989, NIH90479 DEP HLTH HU; REPACE JL, 1985, ENVIRON INT, V11, P3, DOI 10.1016/0160-4120(85)90098-4; RIGOTTI NA, 1989, NEW YORK STATE J MED, V89, P19; RIGOTTI NA, IN PRESS AM J PUBLIC; Rosner B., 1986, FUNDAMENTALS BIOSTAT, V2nd, P442; SAMUELS B, 1991, JAMA-J AM MED ASSOC, V266, P2110, DOI 10.1001/jama.266.15.2110; SORENSEN G, 1991, AM J PUBLIC HEALTH, V81, P202; STILLMAN FA, 1990, JAMA-J AM MED ASSOC, V264, P1565, DOI 10.1001/jama.264.12.1565; 1988, STATE LEGISLATED ACT; 1989, INTIMIDATION ALBUQUE; 1989, STATE LEGISLATED ACI; COUNTY CITY DATA BOO; 1989, CDC898411 DEP HLTH H; 1991, DATA FACT SHEET US C; 1986, CDC878398 DEP HLTH H; 1988, MATRIX LOCAL SMOKING; 1991, IND CREATES SMOKERS; 1988, CITY EMPLOYMENT GE86	22	46	46	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 11	1991	266	22					3162	3167						6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GT654	1956105				2022-12-28	WOS:A1991GT65400026
J	CALMES, SH				CALMES, SH			THE HISTORY OF CRETE	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 27	1991	266	20					2821	2821						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GQ722	1942440				2022-12-28	WOS:A1991GQ72200008
J	CLASSEN, DC; PESTOTNIK, SL; EVANS, RS; BURKE, JP				CLASSEN, DC; PESTOTNIK, SL; EVANS, RS; BURKE, JP			COMPUTERIZED SURVEILLANCE OF ADVERSE DRUG EVENTS IN HOSPITAL PATIENTS	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MEDICAL INPATIENTS; INDUCED ILLNESS; PROGRAM	Objective. - To develop a new method to improve the detection and characterization of adverse drug events (ADEs) in hospital patients. Design. - Prospective study of all patients admitted to our hospital over an 18-month period. Setting. - LDS Hospital, Salt Lake City, Utah, a 520-bed tertiary care center affiliated with the University of Utah School of Medicine, Salt Lake City. Patients. - We developed a computerized ADE monitor, and computer programs were written using an integrated hospital information system to allow for multiple source detection of potential ADEs occurring in hospital patients. Signals of potential ADEs, both voluntary and automated, included sudden medication stop orders, antidote ordering, and certain abnormal laboratory values. Each day, a list of all potential ADEs from these sources was generated, and a pharmacist reviewed the medical records of all patients with possible ADEs for accuracy and causality. Verified ADEs were characterized as mild, moderate, or severe and as type A (dose-dependent or predictable) or type B (idiosyncratic or allergic) reactions, and causality was further measured using a standardized scoring method. Outcome Measure. - The number and characterization of ADEs detected. Results. - Over 18 months, we monitored 36 653 hospitalized patients. There were 731 verified ADEs identified in 648 patients, 701 ADEs were characterized as moderate or severe, and 664 were classified as type A reactions. During this same period, only nine ADEs were identified using traditional detection methods. Physicians, pharmacists, and nurses voluntarily reported 92 of the 731 ADEs detected using this automated system. The other 631 ADEs were detected from automated signals, the most common of which were diphenhydramine hydrochloride and naloxone hydrochloride use, high serum drug levels, leukopenia, and the use of phytonadione and antidiarrheals. The most common symptoms and signs were pruritus, nausea and/or vomiting, rash, and confusion-lethargy. The most common drug classes involved were analgesics, anti-infectives, and cardiovascular agents. Conclusion. - We believe that screening for ADEs with a computerized hospital information system offers a potential method for improving the detection and characterization of these events in hospital patients.	UNIV UTAH,SCH MED,DIV INFECT DIS MED,SALT LAKE CITY,UT 84112	Utah System of Higher Education; University of Utah	CLASSEN, DC (corresponding author), LATTER DAY ST HOSP,DEPT CLIN EPIDEMIOL,8TH AVE & C ST,SALT LAKE CITY,UT 84143, USA.				AHRQ HHS [HS06028] Funding Source: Medline	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		[Anonymous], 1969, World Health Organ Tech Rep Ser, V425, P5; BENNETT BS, 1977, AM J HOSP PHARM, V34, P931, DOI 10.1093/ajhp/34.9.931; BERRY LL, 1988, AM J HOSP PHARM, V45, P1534, DOI 10.1093/ajhp/45.7.1534; CARANASOS GJ, 1974, JAMA-J AM MED ASSOC, V228, P713, DOI 10.1001/jama.228.6.713; CLASSEN DC, 1990, 6TH INT C PHARM AN; CLUFF LE, 1975, MAJOR PROBLEMS INTER, P5; EDLAVITCH SA, 1988, ARCH INTERN MED, V148, P1499, DOI 10.1001/archinte.148.7.1499; GURWITZ JH, 1991, ANN INTERN MED, V114, P956, DOI 10.7326/0003-4819-114-11-956; JACINTO MS, 1983, AM J HOSP PHARM, V40, P444, DOI 10.1093/ajhp/40.3.444; JICK H, 1974, NEW ENGL J MED, V291, P824, DOI 10.1056/NEJM197410172911605; JICK H, 1984, J ALLERGY CLIN IMMUN, V74, P555, DOI 10.1016/0091-6749(84)90106-4; KARCH FE, 1975, JAMA-J AM MED ASSOC, V234, P1236, DOI 10.1001/jama.234.12.1236; LEAPE LL, 1991, NEW ENGL J MED, V324, P377, DOI 10.1056/NEJM199102073240605; MALIEKAL J, 1990, HOSP FORMUL, V25, P436; MCCOLLAM A, 1989, INFUSION, V12, P3; MELMON KL, 1971, NEW ENGL J MED, V284, P1361; MICHEL DJ, 1986, AM J HOSP PHARM, V43, P1709, DOI 10.1093/ajhp/43.7.1709; MILLER RR, 1974, ARCH INTERN MED, V134, P219, DOI 10.1001/archinte.134.2.219; MILLER RR, 1977, AM J HOSP PHARM, V34, P753, DOI 10.1093/ajhp/34.7.753; MILLER RR, 1973, AM J HOSP PHARM, V30, P584, DOI 10.1093/ajhp/30.7.584; MIWA LJ, 1989, J PHARM PRACT, V2, P214; NARANJO CA, 1981, CLIN PHARMACOL THER, V30, P239, DOI 10.1038/clpt.1981.154; NELSON RW, 1983, AM J HOSP PHARM, V40, P445, DOI 10.1093/ajhp/40.3.445; OUSLANDER JG, 1981, ANN INTERN MED, V95, P711, DOI 10.7326/0003-4819-95-6-711; PEARSON KC, 1989, J PHARM PRACT, V2, P209; PORTER J, 1977, JAMA-J AM MED ASSOC, V237, P879, DOI 10.1001/jama.237.9.879; PRYOR TA, 1991, INFECT CONT HOSP EP, V12, P239; RAWLINS MD, 1981, BRIT MED J, V282, P974, DOI 10.1136/bmj.282.6268.974; ROGERS AS, 1988, ARCH INTERN MED, V148, P1596, DOI 10.1001/archinte.148.7.1596; ROSSI AC, 1988, JAMA-J AM MED ASSOC, V259, P1203, DOI 10.1001/jama.259.8.1203; SALAZAR TA, 1989, J PHARM P, V2, P245; SANAZARO PJ, 1991, JAMA-J AM MED ASSOC, V265, P1977, DOI 10.1001/jama.265.15.1977; SEIDL LG, 1966, B JOHNS HOPKINS HOSP, V119, P299; SHAPIRO S, 1971, J AMER MED ASSOC, V216, P467, DOI 10.1001/jama.216.3.467; STEEL K, 1981, NEW ENGL J MED, V304, P638, DOI 10.1056/NEJM198103123041104; TALLEY RB, 1974, JAMA-J AM MED ASSOC, V229, P1043, DOI 10.1001/jama.1974.03230460011003; TATRO DS, 1979, AM J HOSP PHARM, V36, P198, DOI 10.1093/ajhp/36.2.198; 1991, ACCREDITATION MANUAL; 1984, WHO DEMNC84153E PUBL	39	549	567	0	18	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 27	1991	266	20					2847	2851		10.1001/jama.266.20.2847	http://dx.doi.org/10.1001/jama.266.20.2847			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GQ722	1942452	Green Published			2022-12-28	WOS:A1991GQ72200032
J	NESS, RB; KELLY, JV; KILLIAN, CD				NESS, RB; KELLY, JV; KILLIAN, CD			HOUSE STAFF RECRUITMENT TO MUNICIPAL AND VOLUNTARY NEW-YORK-CITY RESIDENCY PROGRAMS DURING THE AIDS EPIDEMIC	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACQUIRED IMMUNODEFICIENCY SYNDROME; MEDICAL-STUDENTS ATTITUDES; INTERNAL MEDICINE	Objective. - To determine the impact on house staff recruitment of large numbers of patients with the acquired immunodeficiency syndrome (AIDS). Design. - Trends in yearly survey data from the National Resident Matching Program from 1983 to 1990 were examined for residency programs in New York City, NY, where AIDS is epidemic, in the four largest US cities with the fewest AIDS cases, and nationally. Within New York City, trends were compared for residency programs serving large numbers of AIDS patients (high AIDS) and for other programs (low AIDS). Main Outcome Measures. - Number of matches in each study year as compared with the baseline year of 1983 and the yearly percentage of positions offered that were filled by matches. Results. - During the study period, New York City experienced a greater decline in US graduate matches than did the four low-AIDS cities or the nation. Within New York City, recruitment to municipal programs, all with large AIDS patient populations, dropped from 241 to 173 matches (28.2%) despite a 3.6% increase in positions. However, recruitment to both high-AIDS and low-AIDS voluntary programs improved in all years except 1990. After controlling for numbers of offered positions, high-AIDS and low-AIDS voluntary programs again showed similar trends until 1990. Conclusions. - These observations cannot be attributed to AIDS alone. Multiple economic and social factors, including AIDS, may have contributed.	ASSOC AMER MED COLL,WASHINGTON,DC 20036	Association of American Medical Colleges	NESS, RB (corresponding author), UNIV PENN,DEPT MED,CEU,ROOM 332R,NEB 6095,420 SERV DR,PHILADELPHIA,PA 19104, USA.				AHRQ HHS [HS06428-01] Funding Source: Medline	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		BERNSTEIN CA, 1990, ACAD MED, V65, P458, DOI 10.1097/00001888-199007000-00010; BRENNAN TA, 1987, ANN INTERN MED, V107, P581, DOI 10.7326/0003-4819-107-4-581; COOKE M, 1989, NEW ENGL J MED, V321, P1334, DOI 10.1056/NEJM198911093211911; CURREY CJ, 1990, ACAD MED, V65, P472, DOI 10.1097/00001888-199007000-00015; GRAETTINGER JS, 1988, ANN INTERN MED, V108, P101, DOI 10.7326/0003-4819-108-1-101; IMPERATO PJ, 1988, NEW YORK STATE J MED, V88, P223; KELLY JA, 1987, J MED EDUC, V62, P549; KLUG J, 1988, CLIN PSYCHIATR NEWS, V2, P21; LINK RN, 1988, AM J PUBLIC HEALTH, V78, P455, DOI 10.2105/AJPH.78.4.455; NESS R, 1989, ACAD MED, V64, P588, DOI 10.1097/00001888-198910000-00009; THOMAS RI, 1990, ACAD MED, V65, P482, DOI 10.1097/00001888-199007000-00019; WACHTER RM, 1986, NEW ENGL J MED, V314, P177, DOI 10.1056/NEJM198601163140310; WHALEN JP, 1987, J MED EDUC, V62, P53; YEDIDIA M, 1990, FACTORS INFLUENCING; 1987, ANN SURVEY HOSPITALS; 1988, JAMA-J AM MED ASSOC, V159, P2817; 1987, MMWR, V36, P285; 1988, ANN SURVEY HOSPITALS; 1990, NRMP DATA APRIL 1990; 1989, AIDS DATA COMP ADULT; 1986, MMWR, V35, P757; 1987, NRMP DATA APRIL 1987; 1990, HIV AIDS SURVEILLANC, P1	23	14	14	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 27	1991	266	20					2843	2846						4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GQ722	1942451				2022-12-28	WOS:A1991GQ72200031
J	BROOKS, DD; SMITH, DR; ANDERSON, RJ				BROOKS, DD; SMITH, DR; ANDERSON, RJ			MEDICAL APARTHEID - AN AMERICAN PERSPECTIVE	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INFANT-MORTALITY RATES; STAGE RENAL-DISEASE; SOUTH-AFRICA; UNITED-STATES; RACIAL-DIFFERENCES; EXCESS MORTALITY; HEALTH; COMMUNITY; CAPE	The suppressive policies and practices of apartheid in South Africa have directly contributed to preventable morbidity and mortality in black Africans. Due to socioeconomic segregation ("functional apartheid"), America's citizens of color also suffer excess death and disability. Health status measurements in the United States confirm the failure of the current fragmented health care system to recognize or respond to the unmet need or the barriers that exist. Predictably, the changes needed to improve the health status of black South Africans are similar to those that are necessary to remedy the situation in the United States. Community-Oriented Primary Care is a health service provision model that holds promise as a comprehensive community-based strategy that can begin to address some of the shortcomings of the current medical care systems of both nations.	PARKLAND MEM HOSP & AFFILIATED INST,OFF PRESIDENT,DALLAS,TX 75235		BROOKS, DD (corresponding author), COMMUNITY ORIENTED PRIMARY CARE PROGRAM,6263 HARRY HINES BLVD,SUITE 401,DALLAS,TX 75235, USA.							ABKIEWICZ SR, 1987, S AFR MED J, V72, P361; BOTHA JL, 1985, S AFR MED J, V67, P977; BOURNE BE, 1988, S AFR MED J, V73, P230; Connor E, 1983, COMMUNITY ORIENTED P; DANA MR, 1990, JAMA-J AM MED ASSOC, V264, P2400, DOI 10.1001/jama.264.18.2400; DIETRICH HJ, 1990, BEST MED FIND BEST H, P18; Eggers P W, 1984, Health Care Financ Rev, V5, P69; GOLD CH, 1982, S AFR MED J, V61, P263; HADLEY J, 1991, JAMA-J AM MED ASSOC, V265, P374, DOI 10.1001/jama.265.3.374; Kark S. L., 1981, PRACTICE COMMUNITY O; KETTLES AN, 1987, S AFR MED J, V72, P317; KLOPPER JML, 1988, S AFR MED J, V74, P319; KNUTZEN VK, 1977, S AFR MED J, V51, P392; MCCORD C, 1990, NEW ENGL J MED, V322, P173, DOI 10.1056/NEJM199001183220306; MJI D, 1990, S AFR MED J, V78, P122; MOLTENO CD, 1989, S AFR MED J, V75, P575; NIGHTINGALE EO, 1990, JAMA-J AM MED ASSOC, V264, P2097, DOI 10.1001/jama.264.16.2097; NUTTING PA, 1985, JAMA-J AM MED ASSOC, V253, P1763, DOI 10.1001/jama.253.12.1763; OTTEN MW, 1990, JAMA-J AM MED ASSOC, V263, P845, DOI 10.1001/jama.263.6.845; RIP MR, 1988, S AFR MED J, V73, P224; ROSTAND SG, 1982, NEW ENGL J MED, V306, P1276, DOI 10.1056/NEJM198205273062106; SCHWARTZ E, 1990, INT J EPIDEMIOL, V19, P591, DOI 10.1093/ije/19.3.591; SEEDAT YK, 1984, S AFR MED J, V65, P956; TREVINO FM, 1991, JAMA-J AM MED ASSOC, V265, P233, DOI 10.1001/jama.265.2.233; WYNDHAM CH, 1986, S AFR MED J, V70, P281; YACH D, 1988, S AFR MED J, V73, P232; 1989, S AFR MED J, V75, P560; 1991, STATE AM CHILDREN, P60; 1989, WORKFORCE 2000 WORK, P89; 1990, S AFR MED J, V77, P12; 1991, JAMA-J AM MED ASSOC, V265, P248; 1989, JAMA-J AM MED ASSOC, V263, P2344; 1991, WOMEN CHILDREN 1ST P, P14	33	10	12	0	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 20	1991	266	19					2746	2749		10.1001/jama.266.19.2746	http://dx.doi.org/10.1001/jama.266.19.2746			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GP691	1942428				2022-12-28	WOS:A1991GP69100032
J	ZURAVLEFF, JJ; PROIA, AD				ZURAVLEFF, JJ; PROIA, AD			AMYLOID DEPOSITION IN THE EYELIDS	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									DUKE UNIV,MED CTR,DEPT PATHOL,DURHAM,NC 27710	Duke University	ZURAVLEFF, JJ (corresponding author), DUKE UNIV,MED CTR,DEPT OPHTHALMOL,DURHAM,NC 27710, USA.				NEI NIH HHS [R01 EY05883] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY005883] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		JAKOBIEC FA, 1986, OPHTHALMIC PATHOLOGY, V3, P2807; Knowles D M 2nd, 1975, Surv Ophthalmol, V19, P367; Lever WFS-LG., 1990, HISTOPATHOLOGY SKIN, P452	3	3	3	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 20	1991	266	19					2693	2693						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GP691	1942415				2022-12-28	WOS:A1991GP69100011
J	SCOTT, DL; WHITE, SP; BROWNING, JL; ROSA, JJ; GELB, MH; SIGLER, PB				SCOTT, DL; WHITE, SP; BROWNING, JL; ROSA, JJ; GELB, MH; SIGLER, PB			STRUCTURES OF FREE AND INHIBITED HUMAN SECRETORY PHOSPHOLIPASE-A2 FROM INFLAMMATORY EXUDATE	SCIENCE			English	Article							NON-PANCREATIC PHOSPHOLIPASE-A2; RHEUMATOID SYNOVIAL-FLUID; TRANSITION-STATE ANALOG; CRYSTAL-STRUCTURE; SOLUBLE PHOSPHOLIPASE-A2; VENOM PHOSPHOLIPASE-A2; RESOLUTION; COMPLEX; PURIFICATION; EXPRESSION	Phospholipase A2 (PLA2) participates in a wide range of cellular processes including inflammation and transmembrane signaling. A human nonpancreatic secretory PLA2 (hnps-PLA2) has been identified that is found in high concentrations in the synovial fluid of patients with rheumatoid arthritis and in the plasma of patients with septic shock. This enzyme is secreted from certain cell types in response to the proinflammatory cytokines, tumor necrosis factor or interleukin-1. The crystal structures of the calcium-bound form of this enzyme have been determined at physiological pH both in the presence [2.1 angstrom (angstrom) resolution] and absence (2.2 angstrom resolution) of a transition-state analogue. Although the critical features that suggest the chemistry of catalysis are identical to those inferred from the crystal structures of other extracellular PLA2s, the shape of the hydrophobic channel of hnps-PLA2 is uniquely modulated by substrate binding.	YALE UNIV,DEPT MOLEC BIOPHYS & BIOCHEM,NEW HAVEN,CT 06511; BIOGEN INC,DEPT CELL BIOL & IMMUNOL,CAMBRIDGE,MA 02142; BIOGEN INC,DEPT PROT CHEM,CAMBRIDGE,MA 02142; UNIV WASHINGTON,DEPT CHEM,SEATTLE,WA 98195; YALE UNIV,HOWARD HUGHES MED INST,NEW HAVEN,CT 06511; UNIV WASHINGTON,DEPT BIOCHEM,SEATTLE,WA 98195	Yale University; Biogen; Biogen; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; Yale University; University of Washington; University of Washington Seattle				gelb, michael/0000-0001-7000-5219; Browning, Jeffrey/0000-0001-9168-5233	NHLBI NIH HHS [HL36235] Funding Source: Medline; NIGMS NIH HHS [GM22324] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R23HL036235, R01HL036235, R37HL036235] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM022324] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABITA JP, 1972, EUR J BIOCHEM, V30, P37, DOI 10.1111/j.1432-1033.1972.tb02069.x; ACHARI A, 1987, COLD SPRING HARB SYM, V52, P441, DOI 10.1101/SQB.1987.052.01.051; ACHARI A, UNPUB; BOMALASKI JS, 1991, J IMMUNOL, V146, P3904; Browning J.F., UNPUB; BRUNGER AT, 1987, SCIENCE, V235, P458, DOI 10.1126/science.235.4787.458; BRUNIE S, 1985, J BIOL CHEM, V260, P9742; CHANG J, 1987, BIOCHEM PHARMACOL, V36, P2429, DOI 10.1016/0006-2952(87)90512-0; CLARK JD, 1990, P NATL ACAD SCI USA, V87, P7708, DOI 10.1073/pnas.87.19.7708; Crowther R. A., 1972, MOL REPLACEMENT METH, P173; CROWTHER RA, 1967, ACTA CRYSTALLOGR, V23, P544, DOI 10.1107/S0365110X67003172; DENNIS EA, 1987, BIO-TECHNOL, V5, P1294, DOI 10.1038/nbt1287-1294; DIJKSTRA BW, 1981, J MOL BIOL, V147, P97, DOI 10.1016/0022-2836(81)90081-4; DIJKSTRA BW, 1983, J MOL BIOL, V168, P163, DOI 10.1016/S0022-2836(83)80328-3; FINZEL BC, 1987, J APPL CRYSTALLOGR, V20, P53, DOI 10.1107/S0021889887087144; FITZGERALD PMD, 1988, J APPL CRYSTALLOGR, V21, P273, DOI 10.1107/S0021889887012299; GANS KR, 1990, ADV EXPT MED BIOL, P155; GONZALEZBURITICA H, 1989, ANN RHEUM DIS, V48, P557, DOI 10.1136/ard.48.7.557; GONZALEZBURITICA H, 1989, ANN RHEUM DIS, V48, P267, DOI 10.1136/ard.48.4.267; HARA S, 1988, J BIOCHEM-TOKYO, V104, P326, DOI 10.1093/oxfordjournals.jbchem.a122467; HEINRIKSON RL, 1977, J BIOL CHEM, V252, P4313; Hendrickson W. A., 1981, BIOMOLECULAR STRUCTU, V1, P43; HOLLAND DR, 1990, J BIOL CHEM, V265, P17649; IRVINE RF, 1982, BIOCHEM J, V204, P3, DOI 10.1042/bj2040003; KANDA A, 1989, BIOCHEM BIOPH RES CO, V163, P42, DOI 10.1016/0006-291X(89)92096-2; KRAMER RM, 1989, J BIOL CHEM, V264, P5768; KRAMER RM, 1990, ADV EXPT MED BIOL, P35; KURIHARA H, 1991, BIOCHIM BIOPHYS ACTA, V1082, P285, DOI 10.1016/0005-2760(91)90204-U; LAM BK, 1990, ADV EXPT MED BIOL, P183; MARSHALL LA, 1990, ADV EXPT MED BIOL, P169; NAKANO T, 1990, FEBS LETT, V273, P23, DOI 10.1016/0014-5793(90)81042-M; OTWINOWSKI Z, 1988, NATURE, V335, P321, DOI 10.1038/335321a0; PIETERSON WA, 1974, BIOCHEMISTRY-US, V13, P1455, DOI 10.1021/bi00704a021; PRUZANSKI W, 1991, INFLAMMATION, V15, P127, DOI 10.1007/BF00917507; PRUZANSKI W, 1986, J INVEST DERMATOL, V86, P380, DOI 10.1111/1523-1747.ep12285639; RENETSEDER R, 1985, J BIOL CHEM, V260, P1627; SAMUELSSON B, 1987, DRUGS, V33, P2, DOI 10.2165/00003495-198700331-00003; SCHALKWIJK CG, 1990, BIOCHIM BIOPHYS ACTA, V1044, P139, DOI 10.1016/0005-2760(90)90229-Q; SCOTT DC, UNPUB; SCOTT DL, 1990, SCIENCE, V250, P1541, DOI 10.1126/science.2274785; SCOTT DL, 1990, SCIENCE, V250, P1563, DOI 10.1126/science.2274788; SEILHAMER JJ, 1989, J BIOCHEM, V106, P38, DOI 10.1093/oxfordjournals.jbchem.a122815; SEILHAMER JJ, 1989, J BIOL CHEM, V264, P5335; SHAW JO, 1978, AM J PATHOL, V91, P517; SNYDER F, 1985, MED RES REV, V5, P107, DOI 10.1002/med.2610050105; STEFANSKI E, 1986, J BIOCHEM-TOKYO, V100, P1297, DOI 10.1093/oxfordjournals.jbchem.a121836; THUNNISSEN MMGM, 1990, NATURE, V347, P689, DOI 10.1038/347689a0; VADAS P, 1986, LAB INVEST, V55, P391; VADAS P, 1986, Arthritis and Rheumatism, V29, pS37; VANDENBERGH CJ, 1989, J CELL BIOCHEM, V39, P379, DOI 10.1002/jcb.240390404; WAITE M, 1987, HDB LIPID RES, V5; WEISS J, 1990, ADV EXPT MED BIOL, P102; WERY JP, 1991, NATURE, V352, P79, DOI 10.1038/352079a0; WHITE SP, 1990, SCIENCE, V250, P1560, DOI 10.1126/science.2274787; WONG K, 1990, ADV EXPT MED BIOL; YUAN W, 1990, BIOCHEMISTRY-US, V29, P6082, DOI 10.1021/bi00477a028; YUAN W, 1988, J AM CHEM SOC, V110, P2665, DOI 10.1021/ja00216a059	57	259	263	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	NOV 15	1991	254	5034					1007	1010		10.1126/science.1948070	http://dx.doi.org/10.1126/science.1948070			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GP883	1948070				2022-12-28	WOS:A1991GP88300045
J	HOLDEN, C				HOLDEN, C			TREATING AIDS WITH WORTS	SCIENCE			English	Editorial Material																		1989, SCIENCE, V252, P287	1	9	9	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	OCT 25	1991	254	5031					522	522						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL799	1948026				2022-12-28	WOS:A1991GL79900028
J	HAVRAN, WL; ALLISON, JP				HAVRAN, WL; ALLISON, JP			ORIGIN OF THY-1+ DENDRITIC EPIDERMAL-CELLS OF ADULT MICE FROM FETAL THYMIC PRECURSORS	NATURE			English	Article									UNIV CALIF BERKELEY, DEPT MOLEC & CELL BIOL, DIV IMMUNOL, BERKELEY, CA 94720 USA	University of California System; University of California Berkeley	HAVRAN, WL (corresponding author), UNIV CALIF BERKELEY, CANC RES LAB, BERKELEY, CA 94720 USA.			Allison, James/0000-0001-8980-5697				ASARNOW DM, 1988, CELL, V55, P837, DOI 10.1016/0092-8674(88)90139-0; ASARNOW DM, 1989, NATURE, V341, P60, DOI 10.1038/341060a0; BERGSTRESSER PR, 1985, J INVEST DERMATOL, V85, pS85, DOI 10.1111/1523-1747.ep12275516; BERGSTRESSER PR, 1984, J INVEST DERMATOL, V83, P83, DOI 10.1111/1523-1747.ep12262587; BONYHADI M, 1987, NATURE, V330, P574, DOI 10.1038/330574a0; CHIEN YH, 1987, NATURE, V330, P722, DOI 10.1038/330722a0; DIALYNAS DP, 1983, J IMMUNOL, V131, P2445; ELLIOTT JF, 1988, NATURE, V331, P627; FOWLKES BJ, 1989, ADV IMMUNOL, V44, P207; GARMAN RD, 1986, CELL, V45, P733, DOI 10.1016/0092-8674(86)90787-7; HAVRAN WL, 1989, P NATL ACAD SCI USA, V86, P4185, DOI 10.1073/pnas.86.11.4185; HAVRAN WL, 1989, J IMMUNOL, V142, P1422; HAVRAN WL, 1987, NATURE, V330, P170, DOI 10.1038/330170a0; HAVRAN WL, 1988, NATURE, V335, P443, DOI 10.1038/335443a0; ITO K, 1989, P NATL ACAD SCI USA, V86, P631, DOI 10.1073/pnas.86.2.631; KONING F, 1987, SCIENCE, V236, P834, DOI 10.1126/science.2883729; KUZIEL WA, 1987, NATURE, V328, P263, DOI 10.1038/328263a0; LANCKI DW, 1984, IMMUNOL REV, V81, P65, DOI 10.1111/j.1600-065X.1984.tb01105.x; NIXONFULTON JL, 1988, J IMMUNOL, V141, P1897; STINGL G, 1987, P NATL ACAD SCI USA, V84, P2430, DOI 10.1073/pnas.84.8.2430; SULLIVAN S, 1985, J INVEST DERMATOL, V84, P491, DOI 10.1111/1523-1747.ep12273454; TOMOOKA S, 1987, J IMMUNOL, V139, P3986; TSCHACHLER E, 1983, J INVEST DERMATOL, V81, P282, DOI 10.1111/1523-1747.ep12518326; YOKOYAMA WM, 1987, J EXP MED, V165, P1725, DOI 10.1084/jem.165.6.1725	24	282	291	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 1	1990	344	6261					68	70		10.1038/344068a0	http://dx.doi.org/10.1038/344068a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ972	1968230				2022-12-28	WOS:A1990CQ97200064
J	STEWART, PM; BEASTALL, GH; SHACKLETON, CHL; EDWARDS, CRW				STEWART, PM; BEASTALL, GH; SHACKLETON, CHL; EDWARDS, CRW			5-ALPHA-REDUCTASE ACTIVITY IN POLYCYSTIC OVARY SYNDROME	LANCET			English	Article									WESTERN GEN HOSP, DEPT MED, EDINBURGH EH4 2XU, MIDLOTHIAN, SCOTLAND; CHILDRENS HOSP MED CTR NO CALIF, OAKLAND, CA 94609 USA; GLASGOW ROYAL INFIRM, GLASGOW G4 0SF, SCOTLAND	University of Edinburgh; University of Glasgow								ABRAHAM GE, 1981, OBSTET GYNECOL, V57, P158; BIRNBAUM MD, 1984, OBSTET GYNECOL, V63, P445; DIJKSTRA AC, 1987, J INVEST DERMATOL, V89, P87, DOI 10.1111/1523-1747.ep12580432; FISHER LK, 1978, J CLIN ENDOCR METAB, V47, P653, DOI 10.1210/jcem-47-3-653; GIVENS JR, 1975, J CLIN ENDOCR METAB, V40, P988, DOI 10.1210/jcem-40-6-988; GLASS AR, 1981, METABOLISM, V30, P89, DOI 10.1016/0026-0495(81)90224-9; IMPERATOMCGINLEY J, 1986, J CLIN ENDOCR METAB, V63, P1313, DOI 10.1210/jcem-63-6-1313; KANDEEL FR, 1980, CLIN ENDOCRINOL, V13, P601, DOI 10.1111/j.1365-2265.1980.tb03429.x; LACHELIN GCL, 1979, J CLIN ENDOCR METAB, V49, P892, DOI 10.1210/jcem-49-6-892; LOUGHLIN T, 1986, J CLIN ENDOCR METAB, V62, P142, DOI 10.1210/jcem-62-1-142; MAUVAISJARVIS P, 1986, CLIN ENDOCRINOL META, V15, P307, DOI 10.1016/S0300-595X(86)80027-5; MCKENNA TJ, 1988, NEW ENGL J MED, V318, P558, DOI 10.1056/NEJM198803033180906; MIGEON CJ, 1963, METABOLISM, V12, P718; MOORE A, 1983, CLIN ENDOCRINOL, V18, P391, DOI 10.1111/j.1365-2265.1983.tb00584.x; PHILLIPOU G, 1985, J STEROID BIOCHEM, V22, P435, DOI 10.1016/0022-4731(85)90451-0; POLSON DW, 1988, LANCET, V1, P870; SERAFINI P, 1985, J CLIN ENDOCR METAB, V60, P349, DOI 10.1210/jcem-60-2-349; STEWART PM, 1988, J CLIN INVEST, V82, P340, DOI 10.1172/JCI113592; STEWART PM, 1987, LANCET, V2, P821; TAYLOR NF, 1984, J ENDOCRINOLOGY S, V102, P90, DOI DOI 10.1677/JOE.0.102S00NP; WERK EE, 1964, J CLIN INVEST, V43, P1824, DOI 10.1172/JCI105056; WILSON EA, 1979, AM J OBSTET GYNECOL, V134, P56, DOI 10.1016/0002-9378(79)90796-8; ZUMOFF B, 1983, J STEROID BIOCHEM, V18, P437, DOI 10.1016/0022-4731(83)90062-6; ZUMOFF B, 1974, J CLIN ENDOCR METAB, V38, P169, DOI 10.1210/jcem-38-2-169	24	164	167	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 24	1990	335	8687					431	433		10.1016/0140-6736(90)90664-Q	http://dx.doi.org/10.1016/0140-6736(90)90664-Q			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CP907	1968168				2022-12-28	WOS:A1990CP90700002
J	GABERT, J; THURET, I; CARCASSONNE, Y; MARANINCHI, D; MANNONI, P				GABERT, J; THURET, I; CARCASSONNE, Y; MARANINCHI, D; MANNONI, P			RESIDUAL BCR ABL TRANSCRIPTS IN CHRONIC MYELOID-LEUKEMIA	LANCET			English	Letter									INST PAOLI CALMETTES,DEPT HAEMATOL,F-13273 MARSEILLE,FRANCE; INSERM,U119,F-13258 MARSEILLE 09,FRANCE	UNICANCER; Institut Paoli-Calmette (IPC); Institut National de la Sante et de la Recherche Medicale (Inserm)	GABERT, J (corresponding author), INST PAOLI CALMETTES,DEPT CELL & MOLEC BIOL,F-13273 MARSEILLE,FRANCE.							GABERT J, 1989, LANCET, V2, P1125; HUGHES, 1990, LANCET, V335, P50; LANGE W, 1989, BLOOD, V73, P1735; MORGAN GJ, 1989, LANCET, V1, P928	4	5	5	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	FEB 17	1990	335	8686					417	418		10.1016/0140-6736(90)90258-7	http://dx.doi.org/10.1016/0140-6736(90)90258-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN988	1968151				2022-12-28	WOS:A1990CN98800045
J	COATS, AJS; ADAMOPOULOS, S; MEYER, TE; CONWAY, J; SLEIGHT, P				COATS, AJS; ADAMOPOULOS, S; MEYER, TE; CONWAY, J; SLEIGHT, P			EFFECTS OF PHYSICAL-TRAINING IN CHRONIC HEART-FAILURE	LANCET			English	Article											COATS, AJS (corresponding author), JOHN RADCLIFFE HOSP,DEPT CARDIOVASC MED,OXFORD OX3 9DU,ENGLAND.		Coats, Andrew J Stewart/E-4451-2012	Coats, Andrew J Stewart/0000-0002-2771-4260				ARMITAGE P, 1987, STATISTICAL METHODS; ASTRAND PO, 1987, TXB WORK PHYSL PHYSL; BARRY AJ, 1966, AM J CARDIOL, V17, P1, DOI 10.1016/0002-9149(66)90254-2; BLOMQVIST CG, 1983, ANNU REV PHYSIOL, V45, P169, DOI 10.1146/annurev.ph.45.030183.001125; CLAUSEN JP, 1976, PROG CARDIOVASC DIS, V18, P459, DOI 10.1016/0033-0620(76)90012-8; CONN EH, 1982, AM J CARDIOL, V49, P296, DOI 10.1016/0002-9149(82)90504-5; DETRY JMR, 1971, CIRCULATION, V44, P109, DOI 10.1161/01.CIR.44.1.109; ECKSTEIN RW, 1957, CIRC RES, V5, P230, DOI 10.1161/01.RES.5.3.230; HELLERSTEIN HK, 1967, CAN MED ASSOC J, V96, P901; HILLS M, 1979, BRIT J CLIN PHARMACO, V8, P7, DOI 10.1111/j.1365-2125.1979.tb05903.x; LEE AP, 1979, CIRCULATION, V60, P1519, DOI 10.1161/01.CIR.60.7.1519; LETAC B, 1977, CIRCULATION, V56, P375, DOI 10.1161/01.CIR.56.3.375; LIPKIN DP, 1985, BRIT HEART J, V54, P321; MCHENRY MM, 1974, AM J CARDIOL, V33, P752, DOI 10.1016/0002-9149(74)90216-1; McPherson B D, 1967, J Sports Med Phys Fitness, V7, P95; SCHEUER J, 1977, ANNU REV PHYSIOL, V39, P221, DOI 10.1146/annurev.ph.39.030177.001253; SHABETAI R, 1988, CIRCULATION, V78, P775, DOI 10.1161/01.CIR.78.3.775; SULLIVAN MJ, 1989, CIRCULATION, V79, P324, DOI 10.1161/01.CIR.79.2.324; SULLIVAN MJ, 1988, CIRCULATION, V78, P506, DOI 10.1161/01.CIR.78.3.506; WILLIAMS RS, 1985, CARDIOVASC CLIN, V15, P218; 1988, LANCET, V1, P489	21	330	338	0	10	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	JAN 13	1990	335	8681					63	66		10.1016/0140-6736(90)90536-E	http://dx.doi.org/10.1016/0140-6736(90)90536-E			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CH516	1967416				2022-12-28	WOS:A1990CH51600001
J	FLETCHER, A				FLETCHER, A			SCREENING FOR CANCER OF THE CERVIX IN ELDERLY WOMEN	LANCET			English	Article											FLETCHER, A (corresponding author), HAMMERSMITH HOSP,ROYAL POSTGRAD MED SCH,DEPT MED,DIV GERIATR MED,EPIDEMIOL RES UNIT,LONDON W12 0HS,ENGLAND.							ALDERSON M, 1978, J EPIDEMIOL COMMUN H, V32, P175, DOI 10.1136/jech.32.3.175; BOYES DA, 1982, CLIN INVEST MED, V5, P1; Charny M C, 1987, Health Trends, V19, P3; Draper G J, 1982, Health Trends, V14, P37; DUGUID HLD, 1985, LANCET, V2, P1053; DUNN JE, 1967, CANCER, V20, P1899, DOI 10.1002/1097-0142(196711)20:11<1899::AID-CNCR2820201116>3.0.CO;2-C; EVANS DMD, 1981, BRIT MED J, V282, P689, DOI 10.1136/bmj.282.6265.689; FRUCHTER RG, 1980, AM J PUBLIC HEALTH, V70, P418, DOI 10.2105/AJPH.70.4.418; GOODWIN JS, 1986, J AM GERIATR SOC, V34, P20, DOI 10.1111/j.1532-5415.1986.tb06335.x; HUSAIN OAN, 1976, TUMORI, V62, P303, DOI 10.1177/030089167606200308; JOHANNESSON G, 1982, ACTA OBSTET GYN SCAN, V61, P199, DOI 10.3109/00016348209156556; KAPP DS, 1983, INT J RADIAT ONCOL, V9, P445, DOI 10.1016/0360-3016(83)90060-3; KASHGARI.M, 1970, AM J EPIDEMIOL, V92, P211, DOI 10.1093/oxfordjournals.aje.a121201; MACGREGOR JE, 1985, BMJ-BRIT MED J, V290, P1543, DOI 10.1136/bmj.290.6481.1543; MANDELBLATT J, 1986, JAMA-J AM MED ASSOC, V256, P367, DOI 10.1001/jama.256.3.367; MANDELBLATT JS, 1985, MT SINAI J MED, V52, P284; MCCORMICK JS, 1989, LANCET, V2, P207; MEANWELL CA, 1988, BRIT MED J, V296, P386, DOI 10.1136/bmj.296.6619.386; NASIELL K, 1983, OBSTET GYNECOL, V61, P609; OLSEN F, 1988, INT J EPIDEMIOL, V17, P501; OSTER S, 1980, MT SINAI J MED, V47, P192; PARKIN DM, 1982, PUBLIC HEALTH, V96, P3, DOI 10.1016/S0033-3506(82)80023-1; PARKIN DM, 1985, BRIT J OBSTET GYNAEC, V92, P150, DOI 10.1111/j.1471-0528.1985.tb01067.x; ROBERTS ADG, 1985, BRIT MED J, V290, P281, DOI 10.1136/bmj.290.6464.281; ROBERTSON JH, 1988, BRIT MED J, V297, P18, DOI 10.1136/bmj.297.6640.18; SADEGHI SB, 1984, AM J OBSTET GYNECOL, V148, P726, DOI 10.1016/0002-9378(84)90555-6; STERN E, 1963, ACTA CYTOL, V7, P357; WEINTRAUB NT, 1987, J AM GERIATR SOC, V35, P870, DOI 10.1111/j.1532-5415.1987.tb02340.x; 1987, WORKING PARTY CERVIC; [No title captured]; 1984, PP2 OFF POP CEN SURV, V12; 1988, REPORT SURVEY IMPLEM; 1986, MORBIDITY STATISTICS; 1986, BRIT MED J, V293, P659	34	38	38	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	JAN 13	1990	335	8681					97	99		10.1016/0140-6736(90)90552-G	http://dx.doi.org/10.1016/0140-6736(90)90552-G			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CH516	1967429				2022-12-28	WOS:A1990CH51600015
J	GRAY, RH; CAMPBELL, OM; APELO, R; ESLAMI, SS; ZACUR, H; RAMOS, RM; GEHRET, JC; LABBOK, MH				GRAY, RH; CAMPBELL, OM; APELO, R; ESLAMI, SS; ZACUR, H; RAMOS, RM; GEHRET, JC; LABBOK, MH			RISK OF OVULATION DURING LACTATION	LANCET			English	Article									JOHNS HOPKINS UNIV,SCH MED,DEPT OBSTET & GYNECOL,BALTIMORE,MD 21205; JOSEPH FABELLA MEM HOSP,MANILA,PHILIPPINES	Johns Hopkins University	GRAY, RH (corresponding author), JOHNS HOPKINS UNIV,SCH HYG & PUBL HLTH,DEPT POPULAT DYNAM,615 N WOLFE ST,BALTIMORE,MD 21205, USA.		zacur, howard/W-2170-2019	Labbok, Miriam/0000-0001-9515-3963; Campbell, Oona/0000-0002-9311-0115	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD016879] Funding Source: NIH RePORTER; NICHD NIH HHS [R01-HD-16879-01] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ANDERSEN AN, 1982, AM J OBSTET GYNECOL, V143, P673, DOI 10.1016/0002-9378(82)90113-2; BHATIA S, 1987, International Journal of Gynecology and Obstetrics, V25, P1, DOI 10.1016/0020-7292(87)90394-8; Bongaarts J., 1983, DETERMINANTS FERTILI, V1, P103; ELIAS MF, 1986, J BIOSOC SCI, V18, P1, DOI 10.1017/S0021932000006441; GRADY WR, 1986, FAM PLANN PERSPECT, V18, P200, DOI 10.2307/2134978; GRAY RH, 1987, J CLIN ENDOCR METAB, V64, P645, DOI 10.1210/jcem-64-4-645; HEARTWELL SF, 1983, OBSTET GYNECOL, V61, P31; Hull V J, 1983, World Health Stat Q, V36, P168; LABBOK MH, 1983, NEW ENGL J MED, V308, P51; MCNEILLY AS, 1985, PHYSL REPRODUCTION L, P1; Miller R. G., 1981, SURVIVAL ANAL; PRATT WF, 1984, POPULATION B, V39, P1; Rivera R, 1985, J Biosoc Sci Suppl, V9, P127; STERN JM, 1986, CLIN ENDOCRINOL, V25, P247, DOI 10.1111/j.1365-2265.1986.tb01689.x; 1983, WORLD HLTH STATIST Q, V36, P92; 1988, LANCET, V2, P1204; 1983, B WORLD HEALTH ORGAN, V61, P371	17	123	125	0	5	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	JAN 6	1990	335	8680					25	29		10.1016/0140-6736(90)90147-W	http://dx.doi.org/10.1016/0140-6736(90)90147-W			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG766	1967336	hybrid			2022-12-28	WOS:A1990CG76600013
J	WEINER, AJ; KUO, G; BRADLEY, DW; BONINO, F; SARACCO, G; LEE, C; ROSENBLATT, J; CHOO, QL; HOUGHTON, M				WEINER, AJ; KUO, G; BRADLEY, DW; BONINO, F; SARACCO, G; LEE, C; ROSENBLATT, J; CHOO, QL; HOUGHTON, M			DETECTION OF HEPATITIS-C VIRAL SEQUENCES IN NON-A-HEPATITIS NON-B-HEPATITIS	LANCET			English	Article									CTR DIS CONTROL,HEPATITIS BRANCH,ATLANTA,GA 30333; SAN GIOVANNI BATTISTA MOLINETTE HOSP,TURIN,ITALY	Centers for Disease Control & Prevention - USA; A.O.U. Citta della Salute e della Scienza di Torino; AOU San Giovanni Battista-Molinette	WEINER, AJ (corresponding author), CHIRON CORP,4560 HORTON ST,EMERYVILLE,CA 94608, USA.		Rosenblatt, Jody/AAD-4260-2019; Bonino, Ferruccio/C-6036-2018; Bonino, Ferruccio/B-7522-2013	Rosenblatt, Jody/0000-0001-9460-5868; Bonino, Ferruccio/0000-0001-9942-0328; Saracco, Giorgio Maria/0000-0001-5310-4143				ALTER HJ, 1978, LANCET, V1, P459; ALTER HJ, 1975, LANCET, V2, P838, DOI 10.1016/S0140-6736(75)90234-2; ALTER HJ, 1985, INFECTION IMMUNITY B, P47; BRADLEY DW, 1985, J VIROL METHODS, V10, P307, DOI 10.1016/0166-0934(85)90047-3; BRADLEY DW, 1979, J MED VIROL, V3, P253, DOI 10.1002/jmv.1890030403; BRADLEY DW, 1986, SEMIN LIVER DIS, V6, P56, DOI 10.1055/s-2008-1040794; BRADLEY DW, 1981, VIRAL HEPATITIS, P319; CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; DIENSTAG JL, 1986, SEMIN LIVER DIS, V6, P67, DOI 10.1055/s-2008-1040795; ESTEBAN JI, 1989, LANCET, V2, P294; FEINSTONE SM, 1981, J INFECT DIS, V144, P588, DOI 10.1093/infdis/144.6.588; FEINSTONE SM, 1975, NEW ENGL J MED, V292, P767, DOI 10.1056/NEJM197504102921502; KNODELL RG, 1975, GASTROENTEROLOGY, V69, P1278; KUHNL P, 1989, LANCET, V2, P324; KUO G, 1989, SCIENCE, V244, P362, DOI 10.1126/science.2496467; ROGGENDORF M, 1989, LANCET, V2, P324; ROSENBERG S, 1984, NATURE, V312, P77, DOI 10.1038/312077a0; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; VANDERPOEL CL, 1989, LANCET, V2, P297	19	663	690	0	13	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	JAN 6	1990	335	8680					1	3		10.1016/0140-6736(90)90134-Q	http://dx.doi.org/10.1016/0140-6736(90)90134-Q			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG766	1967327				2022-12-28	WOS:A1990CG76600001
J	DUNCAN, JJ; GORDON, NF; SCOTT, CB				DUNCAN, JJ; GORDON, NF; SCOTT, CB			WOMEN WALKING FOR HEALTH AND FITNESS - HOW MUCH IS ENOUGH	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DENSITY-LIPOPROTEIN CHOLESTEROL; CORONARY HEART-DISEASE; ALL-CAUSE MORTALITY; PHYSICAL-ACTIVITY; EXERCISE; PLASMA; MEN	Objective. - We studied whether the quantity and quality of walking necessary to decrease the risk of cardiovascular disease among women differed substantially from that required to improve cardiorespiratory fitness. Design. - A randomized, controlled, dose-response clinical trial with a follow-up of 24 weeks. Setting. - A private, nonprofit biomedical research facility. Participants. - One hundred two sedentary premenopausal women, 20 to 40 years of age, were randomized to one of four treatment groups; 59 completed the study (16 aerobic walkers [8.0-km/h group], 12 brisk walkers [6.4-km/h group], 18 strollers [4.8-km/h group], and 13 sedentary controls). Eighty-one percent were white, 17% black, and 2% Hispanic. Intervention. - Intervention groups walked 4.8 km per day, 5 days per week at 8.0 km/h, 6.4 km/h, or 4.8 km/h on a tartan-surfaced, 1.6-km track for 24 weeks. Main Outcome Measures. - Fitness (determined by maximal oxygen uptake) and cardiovascular risk factors (determined by resting blood pressure and serum lipid and lipoprotein levels). Results. - As compared with controls, maximal oxygen uptake increased significantly (P < .0001) and in a dose-response manner (aerobic walkers > brisk walkers > strollers). In contrast, high-density lipoprotein cholesterol concentrations were not dose related and increased significantly (P < .05) and to the same extent among women who experienced considerable improvements in their physical fitness (8.0-km/h group, +0.08 mmol/L) and those who had only minimal improvements in fitness (4.8-km/h group, +0.08 mmol/L). High-density lipoprotein cholesterol also increased among the 6.4-km/h group, but did not attain statistical significance (+0.06 mmol/L; P = .06). Dietary patterns revealed no significant differences among groups. Conclusion. - Thus, we conclude that vigorous exercise is not necessary for women to obtain meaningful improvements in their lipoprotein profile. Walking at intensities that do not have a major impact on cardiorespiratory fitness may nonetheless produce equally favorable changes in the cardiovascular risk profile.			DUNCAN, JJ (corresponding author), COOPER INST AEROB RES,DIV EXERCISE PHYSIOL,12330 PRESTON RD,DALLAS,TX 75230, USA.			Gordon, Neil/0000-0002-9450-0326				American College of Sports Medicine position stand, 1990, MED SCI SPORTS EXERC, V22, P265; ASSMANN G, 1983, CLIN CHEM, V29, P2026; BALKE B, 1959, U S Armed Forces Med J, V10, P675; BLAIR SN, 1989, JAMA-J AM MED ASSOC, V262, P2395, DOI 10.1001/jama.262.17.2395; BROWNELL KD, 1982, CIRCULATION, V65, P477, DOI 10.1161/01.CIR.65.3.477; FREY MAB, 1982, METABOLISM, V31, P1142, DOI 10.1016/0026-0495(82)90165-2; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; GOLDBERG L, 1985, MED CLIN N AM, V69, P41; HARTUNG G H, 1990, Medicine and Science in Sports and Exercise, V22, pS47, DOI 10.1249/00005768-199004000-00282; HASKELL WL, 1986, ACTA MED SCAND S, V711, P25; LAPORTE RE, 1983, LANCET, V1, P1212; LEON AS, 1987, JAMA-J AM MED ASSOC, V258, P2388, DOI 10.1001/jama.258.17.2388; LEWIS S, 1976, AM J CLIN NUTR, V29, P151, DOI 10.1093/ajcn/29.2.151; MANNINEN V, 1988, JAMA-J AM MED ASSOC, V260, P641, DOI 10.1001/jama.260.5.641; MOLL ME, 1979, ATHEROSCLEROSIS, V34, P159, DOI 10.1016/0021-9150(79)90137-0; PAFFENBARGER RS, 1986, NEW ENGL J MED, V314, P605, DOI 10.1056/NEJM198603063141003; POLLOCK ML, 1990, EXERCISE HLTH DIS EV, P371; Pollock ML, 1990, J CARDIOPULM REHABIL, V10, P235; ROTKIS T, 1981, METABOLISM, V30, P994, DOI 10.1016/0026-0495(81)90099-8; RYAN AJ, 1983, PHYSICIAN SPORTS MED, P11; Siri W., 1961, TECHNIQUES MEASURING, P223; WOOD PD, 1988, NEW ENGL J MED, V319, P1173, DOI 10.1056/NEJM198811033191801; WOOD PD, 1990, EXERCISE, FITNESS, AND HEALTH, P409; WOOD PD, 1984, CLIN METABOLIC ASPEC, P133; 1987, RECOMMENDATIONS HUMA	25	264	268	0	13	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 18	1991	266	23					3295	3299		10.1001/jama.266.23.3295	http://dx.doi.org/10.1001/jama.266.23.3295			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GU964	1960829				2022-12-28	WOS:A1991GU96400028
J	VAITKEVICIUS, PV; ESSERWEIN, DM; MAYNARD, AK; OCONNOR, FC; FLEG, JL				VAITKEVICIUS, PV; ESSERWEIN, DM; MAYNARD, AK; OCONNOR, FC; FLEG, JL			FREQUENCY AND IMPORTANCE OF POSTPRANDIAL BLOOD-PRESSURE REDUCTION IN ELDERLY NURSING-HOME PATIENTS	ANNALS OF INTERNAL MEDICINE			English	Article						FRAIL ELDERLY; NURSING HOMES; HYPOTENSION; POSTPRANDIAL PERIOD; SYNCOPE	ORTHOSTATIC HYPOTENSION; HEMODYNAMIC-CHANGES; RESPONSES; INGESTION	Objective: To determine the frequency and importance of postprandial reductions in systolic blood pressure in debilitated, elderly patients receiving nursing home care. Design: Cohort study. Setting: Community-based, university-affiliated, teaching nursing home. Patients: A total of 113 volunteer nursing-home residents with a mean (+/- SD) age of 78 +/- 9 years; seven residents who refused the test meal served as controls. Intervention: Participants had sequential blood pressure measurements for 90 minutes after the administration of a standardized meal. Measurements and Main Results: Of 113 patients, 109 (96%) showed a postprandial reduction in systolic blood pressure (mean reduction, 17.9 +/- 15.5 mm Hg) within 75 minutes; 41 patients (36%) had a reduction in systolic blood pressure of more than 20 mm Hg. Twelve patients (11%) had a reduction in systolic blood pressure to less than 100 mm Hg (mean systolic blood pressure, 88 +/- 6.4 mm Hg); two of these patients became acutely symptomatic. Multiple regression analysis showed that higher premeal systolic blood pressure, a history of syncope, treatment with vasodilators, and dependent posture of the lower extremities during the postprandial period were all associated with a more severe postprandial decline in systolic blood pressure. Systolic blood pressure in noneating control subjects did not change during the same observation period. No significant differences in the mean systolic blood pressure nadir were found between the 14 patients who died during the follow-up period (mean follow-up, 6.1 +/- 3.8 months) and those who survived. Conclusion: Postprandial reductions in systolic blood pressure among elderly nursing-home patients are common, often large, and potentially symptomatic, but they do not generally presage subsequent intermediate-term mortality.	NIA, FRANCIS SCOTT KEY MED CTR, GERONTOL RES CTR, CARDIOVASC SCI LAB, BALTIMORE, MD 21224 USA; JOHNS HOPKINS UNIV, SCH MED, DIV GERIATR MED, BALTIMORE, MD 21205 USA; FRANCIS SCOTT KEY MED CTR, BALTIMORE, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Johns Hopkins University					NIA NIH HHS [5T32AG00120-03] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [T32AG000120] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		FAGAN TC, 1986, AM J CARDIOL, V58, P636, DOI 10.1016/0002-9149(86)90291-2; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Heberden W., 1772, MED T COLL PHYSICIAN, V2, P59; JANSEN RWMM, 1987, AM J CARDIOL, V60, P1087, DOI 10.1016/0002-9149(87)90358-4; JONSSON PV, 1990, ARCH INTERN MED, V150, P1518, DOI 10.1001/archinte.150.7.1518; KANNEL WB, 1985, HDB BIOL AGING, P859; KELBAEK H, 1989, ARCH INTERN MED, V149, P363, DOI 10.1001/archinte.149.2.363; KELBAEK H, 1987, J APPL PHYSIOL, V63, P1862, DOI 10.1152/jappl.1987.63.5.1862; LAKATTA EG, 1987, CIRCULATION, V75, P69; LIPSITZ LA, 1986, J AM GERIATR SOC, V34, P267, DOI 10.1111/j.1532-5415.1986.tb04222.x; LIPSITZ LA, 1983, NEW ENGL J MED, V309, P81, DOI 10.1056/NEJM198307143090205; LIPSITZ LA, 1986, J CHRON DIS, V39, P619, DOI 10.1016/0021-9681(86)90187-6; LIPSITZ LA, 1989, NEW ENGL J MED, V321, P952; LIU K, 1983, GERONTOLOGIST, V23, P92, DOI 10.1093/geront/23.1.92; LIU K, 1984, GERONTOLOGIST, V24, P70, DOI 10.1093/geront/24.1.70; MICIELI G, 1987, NEUROLOGY, V37, P386, DOI 10.1212/WNL.37.3.386; PEITZMAN SJ, 1989, ARCH INTERN MED, V149, P286, DOI 10.1001/archinte.149.2.286; ROBERTSON D, 1981, AM J CARDIOL, V48, P1048, DOI 10.1016/0002-9149(81)90319-2; ROBINSON BJ, 1985, AGE AGEING, V14, P168, DOI 10.1093/ageing/14.3.168; SHERMAN RA, 1988, AM J KIDNEY DIS, V12, P37, DOI 10.1016/S0272-6386(88)80069-6	20	90	90	1	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 1	1991	115	11					865	870		10.7326/0003-4819-115-11-865	http://dx.doi.org/10.7326/0003-4819-115-11-865			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GR171	1952473				2022-12-28	WOS:A1991GR17100005
J	SHEPHERD, GM				SHEPHERD, GM			SENSORY TRANSDUCTION - ENTERING THE MAINSTREAM OF MEMBRANE SIGNALING	CELL			English	Review							CYCLIC-GMP; CONDUCTANCE				SHEPHERD, GM (corresponding author), YALE UNIV,SCH MED,NEUROBIOL SECT,NEW HAVEN,CT 06510, USA.							BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; FESENKO EE, 1985, NATURE, V313, P310, DOI 10.1038/313310a0; FIRESTEIN S, 1991, IN PRESS J NEUROSCI; HUDSPETH AJ, 1989, NATURE, V341, P397, DOI 10.1038/341397a0; KAUPP UB, 1991, TRENDS NEUROSCI, V14, P150; KINNAMON SC, 1988, TRENDS NEUROSCI, V11, P491, DOI 10.1016/0166-2236(88)90010-0; NAKAMURA T, 1987, NATURE, V325, P442, DOI 10.1038/325442a0; PACE U, 1985, NATURE, V316, P255, DOI 10.1038/316255a0; PICKLES JO, 1984, HEARING RES, V15, P103, DOI 10.1016/0378-5955(84)90041-8; REED RR, 1990, CELL, V60, P1, DOI 10.1016/0092-8674(90)90706-K; ROPER SD, 1989, ANNU REV NEUROSCI, V12, P329, DOI 10.1146/annurev.ne.12.030189.001553; STRYER L, 1986, ANNU REV NEUROSCI, V9, P87, DOI 10.1146/annurev.ne.09.030186.000511; YAU KW, 1989, ANNU REV NEUROSCI, V12, P289, DOI 10.1146/annurev.ne.12.030189.001445	13	51	59	1	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	NOV 29	1991	67	5					845	851		10.1016/0092-8674(91)90358-6	http://dx.doi.org/10.1016/0092-8674(91)90358-6			7	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GT755	1959132				2022-12-28	WOS:A1991GT75500004
J	HART, MJ; EVA, A; EVANS, T; AARONSON, SA; CERIONE, RA				HART, MJ; EVA, A; EVANS, T; AARONSON, SA; CERIONE, RA			CATALYSIS OF GUANINE-NUCLEOTIDE EXCHANGE ON THE CDC42HS PROTEIN BY THE DBL ONCOGENE PRODUCT	NATURE			English	Article							GTP-BINDING PROTEINS; SACCHAROMYCES-CEREVISIAE; MOLECULAR-CLONING; CELL POLARITY; HUMAN HOMOLOG; GENE; PURIFICATION; CYCLE; G25K; IDENTIFICATION	THE superfamily of low molecular mass GTP-binding proteins, for which the ras proteins are prototypes, has been implicated in the regulation of diverse biological activities including protein trafficking, secretion, and cell growth and differentiation 1-3. One member of this family, CDC42Hs (originally referred to as Gp or G25K) 4-5, seems to be the human homologue of the Saccharomyces cerevisiae cell-division-cycle protein, CDC42Sc (refs 6-9). A second S. cerevisiae protein, CDC24 (ref. 10), which is known from complementation studies to act with CDC42Sc to regulate the development of normal cell shape and the selection of nonrandom budding sites in yeast, contains a region with sequence similarity to the dbl oncogene product 11-14. Here we show that dbl specifically catalyses the dissociation of GDP from CDC42Hs and thereby qualifies as a highly selective guanine nucleotide exchange factor for the GTP-binding protein. Although guanine nucleotide exchange activities have been previously described for other members of the Ras-related GTP-binding protein family 15-17, this is the first demonstration, to our knowledge, of the involvement of a human oncogenic protein in catalysing exchange activity.	CORNELL UNIV,DEPT PHARMACOL,ITHACA,NY 14853; NCI,CELLULAR & MOLEC BIOL LAB,BETHESDA,MD 20892; GENENTECH INC,DEPT CELL BIOL,S SAN FRANCISCO,CA 94080	Cornell University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Roche Holding; Genentech	HART, MJ (corresponding author), CORNELL UNIV,DEPT BIOCHEM CELLULAR & MOLEC BIOL,ITHACA,NY 14853, USA.		Eva, Alessandra/J-8268-2016	Eva, Alessandra/0000-0003-2949-078X; Hart, Matthew/0000-0002-2683-480X				ADAMS AEM, 1990, J CELL BIOL, V111, P131, DOI 10.1083/jcb.111.1.131; BOURNE HR, 1990, NATURE, V348, P125, DOI 10.1038/348125a0; EVA A, 1985, NATURE, V316, P273, DOI 10.1038/316273a0; EVA A, 1988, P NATL ACAD SCI USA, V85, P2061, DOI 10.1073/pnas.85.7.2061; EVANS T, 1986, J BIOL CHEM, V261, P7052; Evans T, 1991, CURR OPIN CELL BIOL, V3, P185, DOI 10.1016/0955-0674(91)90137-N; GRAZIANI G, 1989, ONCOGENE, V4, P823; GRAZIANI G, IN PRESS ONCOGENE; HALL A, 1990, SCIENCE, V249, P635, DOI 10.1126/science.2116664; HART MJ, 1990, J BIOL CHEM, V265, P5990; HART MJ, IN PRESS J BIOL CHEM; HUANG YK, 1990, P NATL ACAD SCI USA, V87, P8008, DOI 10.1073/pnas.87.20.8008; JOHNSON DI, 1990, J CELL BIOL, V111, P143, DOI 10.1083/jcb.111.1.143; MUNEMITSU S, 1990, MOL CELL BIOL, V10, P5977, DOI 10.1128/MCB.10.11.5977; POLAKIS PG, 1989, BIOCHEM BIOPH RES CO, V160, P25, DOI 10.1016/0006-291X(89)91615-X; POLAKIS PG, 1989, J BIOL CHEM, V264, P16378; RON D, 1988, EMBO J, V7, P2465, DOI 10.1002/j.1460-2075.1988.tb03093.x; RON D, 1991, NEW BIOL, V3, P372; SHINJO K, 1990, P NATL ACAD SCI USA, V87, P9853, DOI 10.1073/pnas.87.24.9853; SLOAT BF, 1981, J CELL BIOL, V89, P395, DOI 10.1083/jcb.89.3.395; WOLFMAN A, 1990, SCIENCE, V248, P67, DOI 10.1126/science.2181667; YAMAMOTO T, 1990, J BIOL CHEM, V265, P16626	22	389	400	0	5	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	NOV 28	1991	354	6351					311	314		10.1038/354311a0	http://dx.doi.org/10.1038/354311a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT204	1956381				2022-12-28	WOS:A1991GT20400049
J	GARNICK, DW; HENDRICKS, AM; BRENNAN, TA				GARNICK, DW; HENDRICKS, AM; BRENNAN, TA			CAN PRACTICE GUIDELINES REDUCE THE NUMBER AND COSTS OF MALPRACTICE CLAIMS	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PROFESSIONAL LIABILITY; PHYSICIANS; STANDARDS; SYSTEM; CARE	Practice guidelines have the potential to reduce the number of malpractice cases and the costs of settling them. However, for practice guidelines to exert any influence, they must be assumed to be (1) developed for conditions or procedures that frequently lead to events for which negligence claims are filed; (2) widely accepted in the medical profession; (3) fully integrated into clinical practice; and (4) straightforward and readily interpreted in a litigation setting. Because the validity of each of these assumptions can be questioned, the idea that inserting practice guidelines into the existing litigation process will generate large savings in the near future is overly optimistic.	BRIGHAM & WOMENS HOSP, DIV GEN MED, BOSTON, MA 02115 USA; HARVARD UNIV, SCH MED, BOSTON, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	GARNICK, DW (corresponding author), HARVARD UNIV, SCH PUBL HLTH, PROGRAM HLTH CARE FINANCING & INSURANCE, BOSTON, MA 02115 USA.		Garnick, Deborah w/I-9009-2012					ABRAHAM KS, 1988, JAMA-J AM MED ASSOC, V260, P68, DOI 10.1001/jama.260.1.68; [Anonymous], 1986, COSTS COMPENSATION P; BIERIG JR, 1990, MAR CAP CONS C APPR; BRENNAN TA, 1991, NEW ENGL J MED, V324, P370, DOI 10.1056/NEJM199102073240604; BRENNAN TA, 1989, U PITT LAW REV, V51, P1; BRENNAN TA, 1991, J HEALTH POLIT POLIC, V16, P67, DOI 10.1215/03616878-16-1-67; CHASSIN MR, 1988, INQUIRY-J HEALTH CAR, V25, P437; DANZON P, 1989, LIABILITY PERSPECTIV; Danzon P.M, 1985, MED MALPRACTICE; EDDY DM, 1990, JAMA-J AM MED ASSOC, V263, P3077, DOI 10.1001/jama.263.22.3077; EDDY DM, 1988, HEALTH AFFAIR, V7, P19, DOI 10.1377/hlthaff.7.1.19; EICHHORN JH, 1989, ANESTHESIOLOGY, V70, P572, DOI 10.1097/00000542-198904000-00002; FEILD DJ, 1987, J AM COLL CARDIOL, V10, P935, DOI 10.1016/S0735-1097(87)80294-2; Field MJ, 1990, CLIN PRACTICE GUIDEL; FRANKLIN M, 1987, TORT LAW ALTERNATIVE; GRILLI R, 1991, MED CARE, V29, P50, DOI 10.1097/00005650-199101000-00005; HARVEY IM, 1987, LANCET, V1, P145; HAYWARD RSA, 1991, ANN INTERN MED, V114, P758, DOI 10.7326/0003-4819-114-9-758; HENDERSON JA, 1986, LAW CONTEMP PROBL, V49, P243, DOI 10.2307/1191425; HIRSHFELD EB, 1990, JAMA-J AM MED ASSOC, V263, P1556; Holzer J F, 1990, QRB Qual Rev Bull, V16, P71; HUGHES D, 1990, MED PROFESSIONAL LIA, P2; Kelly J T, 1990, QRB Qual Rev Bull, V16, P54; KOSECOFF J, 1987, JAMA-J AM MED ASSOC, V258, P2708, DOI 10.1001/jama.258.19.2708; Leape L L, 1990, QRB Qual Rev Bull, V16, P42; LEAPE LL, 1991, NEW ENGL J MED, V324, P377, DOI 10.1056/NEJM199102073240605; LOMAS J, 1989, NEW ENGL J MED, V321, P1306, DOI 10.1056/NEJM198911093211906; MANUEL BM, 1990, NEW ENGL J MED, V322, P627, DOI 10.1056/NEJM199003013220912; PUSEY A, 1991, ANNOTATED DIRECTORY, P2; RELMAN AS, 1990, NEW ENGL J MED, V322, P626, DOI 10.1056/NEJM199003013220911; REYNOLDS RA, 1987, JAMA-J AM MED ASSOC, V257, P2776, DOI 10.1001/jama.257.20.2776; ROBINSON GO, 1986, LAW CONTEMP PROBL, V49, P5, DOI 10.2307/1191413; ROPER WL, 1988, NEW ENGL J MED, V319, P1197, DOI 10.1056/NEJM198811033191805; SALES P, 1987, TECH REV, V10, P43; STEPHENSON GM, 1990, REP MED GUIDELINES O, V1, P7; WEILER P, 1990, CALL ACTION, V2; WESSEL, 1988, JURIMETRICS J, V28, P379; 1988, MONITORING HLTH CARE; 1990, GAOTHRD9024 GEN ACC; 1988, PROFESSIONAL LIABILI; 1990, PATIENTS DOCTORS LAW; 1989, LISTING PRACTICE GUI	42	56	57	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 27	1991	266	20					2856	2860		10.1001/jama.266.20.2856	http://dx.doi.org/10.1001/jama.266.20.2856			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GQ722	1942453				2022-12-28	WOS:A1991GQ72200034
J	CURFMAN, GD				CURFMAN, GD			INOTROPIC THERAPY FOR HEART-FAILURE - AN UNFULFILLED PROMISE	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							MILRINONE; AMRINONE; AGENT; TRIAL											BAIM DS, 1983, NEW ENGL J MED, V309, P748, DOI 10.1056/NEJM198309293091302; BENOTTI JR, 1978, NEW ENGL J MED, V299, P1373, DOI 10.1056/NEJM197812212992501; BRAUNWALD E, 1991, NEW ENGL J MED, V325, P351, DOI 10.1056/NEJM199108013250508; COHN JN, 1991, NEW ENGL J MED, V325, P303, DOI 10.1056/NEJM199108013250502; DIBIANCO R, 1989, NEW ENGL J MED, V320, P677, DOI 10.1056/NEJM198903163201101; ECHT DS, 1991, NEW ENGL J MED, V324, P781, DOI 10.1056/NEJM199103213241201; JAIN P, 1991, CIRCULATION, V84, P796, DOI 10.1161/01.CIR.84.2.796; KATZ AM, 1978, NEW ENGL J MED, V299, P1409, DOI 10.1056/NEJM197812212992508; KATZ AM, 1990, NEW ENGL J MED, V322, P100; MASSIE B, 1985, CIRCULATION, V71, P963, DOI 10.1161/01.CIR.71.5.963; PACKER M, 1991, NEW ENGL J MED, V325, P1468, DOI 10.1056/NEJM199111213252103; PACKER M, 1988, J AM COLL CARDIOL, V12, P1299, DOI 10.1016/0735-1097(88)92615-0; SCHROEDER JS, 1991, NEW ENGL J MED, V324, P1805, DOI 10.1056/NEJM199106203242509; SWEDBERG K, 1987, NEW ENGL J MED, V316, P1429; SWEET CS, 1988, EUR J PHARMACOL, V147, P29, DOI 10.1016/0014-2999(88)90630-9; URETSKY BF, 1990, CIRCULATION, V82, P774, DOI 10.1161/01.CIR.82.3.774; WYNNE J, 1980, AM J CARDIOL, V45, P1245, DOI 10.1016/0002-9149(80)90485-3; YUSUF S, 1991, NEW ENGL J MED, V325, P293, DOI 10.1056/NEJM199108013250501; YUSUF S, 1989, HYPERTENSION, V0013; 1990, LANCET, P1	20	52	52	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 21	1991	325	21					1509	1510		10.1056/NEJM199111213252111	http://dx.doi.org/10.1056/NEJM199111213252111			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GQ406	1944430				2022-12-28	WOS:A1991GQ40600011
J	SAKAI, K; MIYASHITA, Y				SAKAI, K; MIYASHITA, Y			NEURAL ORGANIZATION FOR THE LONG-TERM-MEMORY OF PAIRED ASSOCIATES	NATURE			English	Article							INFERIOR TEMPORAL NEURONS; CORTEX; MONKEY; LOBECTOMY; CORRELATE; STIMULUS; MACAQUE	MOST of our long-term memories of episodes or objects are organized so that we can retrieve them by association. Clinical neuropsychologists assess human memory by the paired-associate learning test, in which a series of paired words or figures is presented and the subject is then asked to retrieve the other pair member associated with each cue 1. Patients with lesions of the temporal lobe show marked impairment in this test 2-6. In our study, we trained monkeys in a pair-association task 7 using a set of computer-generated paired patterns. We found two types of task-related neurons in the anterior temporal cortex. One type selectively responded to both pictures of the paired associates. The other type, which had the strongest response to one picture during the cue presentation, exhibited increasing activity during the delay period when the associate of that picture was used as a cue. These results provide new evidence that single neurons acquire selectivity for visual patterns through associative learning. They also indicate neural mechanisms for storage and retrieval in the long-term memory of paired associates.			SAKAI, K (corresponding author), UNIV TOKYO,SCH MED,DEPT PHYSIOL,7-3-1 HONGO,BUNKYO KU,TOKYO 113,JAPAN.		Miyashita, Yasushi/B-7171-2019; Rohlf, F J/A-8710-2008	Miyashita, Yasushi/0000-0003-3496-8637; 				ARTOLA A, 1987, NATURE, V330, P649, DOI 10.1038/330649a0; BRUCE CJ, 1985, J NEUROPHYSIOL, V53, P603, DOI 10.1152/jn.1985.53.3.603; Darley, 1967, BRAIN MECH UNDERLY, P122; DESIMONE R, 1984, J NEUROSCI, V4, P2051; FREGNAC Y, 1988, NATURE, V333, P367, DOI 10.1038/333367a0; FUNAHASHI S, 1989, J NEUROPHYSIOL, V61, P331, DOI 10.1152/jn.1989.61.2.331; GOLDSTEIN LH, 1988, CORTEX, V24, P41, DOI 10.1016/S0010-9452(88)80016-9; GROSS CG, 1972, J NEUROPHYSIOL, V35, P96, DOI 10.1152/jn.1972.35.1.96; INSAUSTI R, 1987, J COMP NEUROL, V264, P356, DOI 10.1002/cne.902640306; JONES MK, 1974, NEUROPSYCHOLOGIA, V12, P21, DOI 10.1016/0028-3932(74)90023-2; MAURITZ KH, 1986, EXP BRAIN RES, V61, P229; MEYER V, 1955, J NEUROL NEUROSUR PS, V18, P44, DOI 10.1136/jnnp.18.1.44; Milner B, 1972, Clin Neurosurg, V19, P421; MIYASHITA Y, 1988, NATURE, V331, P68, DOI 10.1038/331068a0; MIYASHITA Y, 1988, NATURE, V335, P817, DOI 10.1038/335817a0; MURRAY E A, 1988, Society for Neuroscience Abstracts, V14, P2; PERRETT DI, 1982, EXP BRAIN RES, V47, P329; PETRIDES M, 1985, NEUROPSYCHOLOGIA, V23, P601, DOI 10.1016/0028-3932(85)90062-4; ROLLS ET, 1989, J NEUROSCI, V9, P1835; SCHWARTZ EL, 1983, P NATL ACAD SCI-BIOL, V80, P5776, DOI 10.1073/pnas.80.18.5776; Snedecor GW, 1989, STAT METHODS, P97; Squire L. R., 1984, MEMORY CONSOLIDATION, P185; WEBSTER MJ, 1991, J NEUROSCI, V11, P1095; Wechsler D., 1945, WECHSLER MEMORY SCAL; ZAHN CT, 1972, IEEE T COMPUT, VC 21, P269, DOI 10.1109/TC.1972.5008949	25	513	517	0	21	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	NOV 14	1991	354	6349					152	155		10.1038/354152a0	http://dx.doi.org/10.1038/354152a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GP880	1944594				2022-12-28	WOS:A1991GP88000061
J	SLOANE, DL; LEUNG, R; CRAIK, CS; SIGAL, E				SLOANE, DL; LEUNG, R; CRAIK, CS; SIGAL, E			A PRIMARY DETERMINANT FOR LIPOXYGENASE POSITIONAL SPECIFICITY	NATURE			English	Article							LOW-DENSITY-LIPOPROTEIN; HUMAN RETICULOCYTE 15-LIPOXYGENASE; MOLECULAR-CLONING; SUBSTRATE-SPECIFICITY; HUMAN 5-LIPOXYGENASE; IRON ENVIRONMENT; EXPRESSION; PROTEIN; CDNA; 12-LIPOXYGENASE	THE three mammalian lipoxygenases are named according to the carbon position (5, 12 or 15) at which they catalyse the oxygenation of arachidonic acid 1; they are implicated in inflammatory disorders, for example 15-lipoxygenase is induced in atherosclerosis 2 and can oxidize low-density lipoprotein to its atherogenic form 3,4. To identify what determines this positional specificity, we have exchanged conserved differences in the isoforms of 12- and 15-lipoxygenases. Substitution of methionine with valine at position 418 of human 15-lipoxygenase results in an enzyme that performs 12- and 15-lipoxygenation equally. This effect can be mimicked by incubating wild-type 15-lipoxygenase with a synthetically altered substrate which has its doubly allylic methylene carbons shifted by one carbon relative to arachidonic acid. Other mutations at the neighbouring amino acids 416 and 417 give an enzyme which performs 12- and 15-lipoxygenation in a ratio of 15:1. These results indicate that this region might position the substrate in the active site.	UNIV CALIF SAN FRANCISCO,CARDIOVASC RES INST,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT PHARMACEUT CHEM,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT MED,SAN FRANCISCO,CA 94143	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco								BALCAREK JM, 1988, J BIOL CHEM, V263, P13937; BRYANT RW, 1982, J BIOL CHEM, V257, P6050; CRAIK CS, 1985, SCIENCE, V228, P291, DOI 10.1126/science.3838593; DEMARZO N, IN PRESS AM J PHYSL; DIXON RAF, 1988, P NATL ACAD SCI USA, V85, P416, DOI 10.1073/pnas.85.2.416; DUNHAM WR, 1990, EUR J BIOCHEM, V190, P611, DOI 10.1111/j.1432-1033.1990.tb15616.x; FERSHT AR, 1985, NATURE, V314, P235, DOI 10.1038/314235a0; FUNK CD, 1990, P NATL ACAD SCI USA, V87, P5638, DOI 10.1073/pnas.87.15.5638; HAMBERG M, 1967, J BIOL CHEM, V242, P5329; KUHN H, 1990, J BIOL CHEM, V265, P16300; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; MATSUMOTO T, 1988, P NATL ACAD SCI USA, V85, P26, DOI 10.1073/pnas.85.1.26; NAVARATNAM S, 1988, BIOCHIM BIOPHYS ACTA, V956, P70, DOI 10.1016/0167-4838(88)90299-3; NGUYEN T, IN PRESS J BIOL CHEM; PISTORIUS EK, 1974, J BIOL CHEM, V249, P3183; PONDER JW, 1987, J MOL BIOL, V1939, P7751; SAMUELSSON B, 1987, SCIENCE, V237, P1171, DOI 10.1126/science.2820055; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHIBATA D, 1988, J BIOL CHEM, V263, P6816; SIGAL E, 1988, BIOCHEM BIOPH RES CO, V157, P457, DOI 10.1016/S0006-291X(88)80271-7; SIGAL E, 1990, J BIOL CHEM, V265, P5113; SLOANE DL, 1990, BIOMED BIOCHIM ACTA, V49, pS11; SPARROW CP, 1988, J LIPID RES, V29, P745; STEINBERG D, 1989, NEW ENGL J MED, V320, P915; WELLS JA, 1987, P NATL ACAD SCI USA, V84, P5167, DOI 10.1073/pnas.84.15.5167; WILKS HM, 1988, SCIENCE, V242, P1541, DOI 10.1126/science.3201242; YLAHERTTUALA S, 1990, P NATL ACAD SCI USA, V87, P6959, DOI 10.1073/pnas.87.18.6959; YOSHIMOTO T, 1990, P NATL ACAD SCI USA, V87, P2142, DOI 10.1073/pnas.87.6.2142	28	191	194	0	11	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	NOV 14	1991	354	6349					149	152		10.1038/354149a0	http://dx.doi.org/10.1038/354149a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GP880	1944593				2022-12-28	WOS:A1991GP88000060
J	WASHINGTON, AE; KATZ, P				WASHINGTON, AE; KATZ, P			COST OF AND PAYMENT SOURCE FOR PELVIC INFLAMMATORY DISEASE - TRENDS AND PROJECTIONS, 1983 THROUGH 2000	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INFERTILE WOMEN; UNITED-STATES	Pelvic inflammatory disease (PID) and its sequelae affect millions of women in the United States at substantial costs. To estimate these total costs annually and to determine payment sources, we analyzed data from local, state, and national sources. Direct costs for PID and PID-associated ectopic pregnancy and infertility were estimated to be $2.7 billion, and indirect costs were estimated to be $1.5 billion, for a total cost of $4.2 billion in 1990. Overall, private insurance covered the largest portion of the direct costs of PID (41%), followed by public payment sources (30%). However, the proportion of payments made by private insurance appears to be decreasing, while that by public payment sources is increasing. In the year 2000, costs associated with PID are projected to approach $10 billion if the current PID incidence persists, with an increasing proportion of this expense burdening public institutions. Prevention of PID is needed both to reduce human suffering and to contain rising costs.	UNIV CALIF SAN FRANCISCO,SCH MED,DEPT OBSTET GYNECOL & REPROD SCI,SAN FRANCISCO,CA 94109; UNIV CALIF SAN FRANCISCO,SCH MED,DEPT EPIDEMIOL & BIOSTAT,SAN FRANCISCO,CA 94109	University of California System; University of California San Francisco; University of California System; University of California San Francisco	WASHINGTON, AE (corresponding author), UNIV CALIF SAN FRANCISCO,SCH MED,CTR REPROD HLTH POLICY RES,INST HLTH POLICY STUDIES,SAN FRANCISCO,CA 94109, USA.				NIAID NIH HHS [AI24768] Funding Source: Medline; PHS HHS [282-88-0018] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI024768] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BLENDON RJ, 1986, NEW ENGL J MED, V314, P1160, DOI 10.1056/NEJM198605013141806; CATES W, 1990, EPIDEMIOL REV, V12, P199, DOI 10.1093/oxfordjournals.epirev.a036054; FORREST J, 1989, NEED AVAILABILITY FI; GUMP DW, 1983, AM J OBSTET GYNECOL, V146, P153, DOI 10.1016/0002-9378(83)91044-X; HIRSCH MB, 1987, FERTIL STERIL, V47, P618; METHOD MW, 1987, J REPROD MED, V32, P759; NETTLEMAN MD, 1989, SEX TRANSM DIS, V16, P36, DOI 10.1097/00007435-198901000-00008; Rice D P, 1985, Health Care Financ Rev, V7, P61; ROLFS RT, 1990, SEP P CTR DIS CONTR; SCHIFF RL, 1986, NEW ENGL J MED, V314, P552, DOI 10.1056/NEJM198602273140905; SWEET RL, 1990, INFECT DIS FEMALE GE, P241; WASHINGTON AE, 1991, JAMA-J AM MED ASSOC, V266, P2574, DOI 10.1001/jama.266.18.2574; WASHINGTON AE, 1984, JAMA-J AM MED ASSOC, V251, P2529, DOI 10.1001/jama.251.19.2529; WASHINGTON AE, 1986, JAMA-J AM MED ASSOC, V255, P1735, DOI 10.1001/jama.255.13.1735; WASHINGTON AE, 1985, J ADOLESCENT HEALTH, V6, P298, DOI 10.1016/S0197-0070(85)80067-X; WESTROM L, 1981, BRIT MED J, V282, P15, DOI 10.1136/bmj.282.6257.15; WESTROM L, 1980, AM J OBSTET GYNECOL, V138, P880, DOI 10.1016/0002-9378(80)91077-7; 1987, PHS871589 US DEP HLT; 1989, PATIENT DISCHARGE DA; 1989, INT CLASSIFICATION D; 1989, SOCIOECONOMIC CHARAC; 1989, STATISTICAL ABSTRACT; 1991, MMWR-MORBID MORTAL W, V40, pS1; 1988, SEXUALLY TRANSMITTED; 1990, MMWR-MORBID MORTAL W, V39, P401	25	153	158	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 13	1991	266	18					2565	2569		10.1001/jama.266.18.2565	http://dx.doi.org/10.1001/jama.266.18.2565			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GN660	1942401				2022-12-28	WOS:A1991GN66000032
J	CUNNINGHAM, BC; ULTSCH, M; DEVOS, AM; MULKERRIN, MG; CLAUSER, KR; WELLS, JA				CUNNINGHAM, BC; ULTSCH, M; DEVOS, AM; MULKERRIN, MG; CLAUSER, KR; WELLS, JA			DIMERIZATION OF THE EXTRACELLULAR DOMAIN OF THE HUMAN GROWTH-HORMONE RECEPTOR BY A SINGLE HORMONE MOLECULE	SCIENCE			English	Article							MONOCLONAL-ANTIBODIES; SCANNING MUTAGENESIS; PROLACTIN RECEPTOR; ESCHERICHIA-COLI; SUPERFAMILY; FAMILY	Human growth hormone (hGH) forms a 1:2 complex with the extracellular domain of its receptor-binding protein (hGHbp) as studied by crystallization, size exclusion chromatography, calorimetry, and a previously undescribed fluorescence quenching assay. These and other experiments with protein engineered variants of hGH have led to the identification of the binding determinants for two distinct but adjacent sites on hGH for the hGHbp, and the data indicated that there are two overlapping binding sites on the hGHbp for hGH. Furthermore, the binding of hGH to the hGHbp occurred sequentially; a first hGHbp molecule bound to site 1 on hGH and then a second hGHbp bound to site 2. Hormone-induced receptor dimerization is proposed to be relevant to the signal transduction mechanism for the hGH receptor and other related cytokine receptors.	GENENTECH INC,DEPT PROT ENGN,460 POINT SAN BRUNO BLVD,S SAN FRANCISCO,CA 94080; GENENTECH INC,DEPT MED & ANALYT CHEM,S SAN FRANCISCO,CA 94080; GENENTECH INC,DEPT PROT CHEM,S SAN FRANCISCO,CA 94080	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech			Wells, Jim A/O-9854-2016	Clauser, Karl/0000-0002-1052-9456				ABDELMEGUID SS, 1987, P NATL ACAD SCI USA, V84, P6434, DOI 10.1073/pnas.84.18.6434; BARNARD R, 1985, BIOCHEM J, V231, P459, DOI 10.1042/bj2310459; BARNARD R, 1984, ENDOCRINOLOGY, V115, P1805, DOI 10.1210/endo-115-5-1805; BASS S, 1990, PROTEINS, V8, P309, DOI 10.1002/prot.340080405; BAZAN JF, 1990, P NATL ACAD SCI USA, V87, P6934, DOI 10.1073/pnas.87.18.6934; BEWLEY TA, 1970, ARCH BIOCHEM BIOPHYS, V138, P338, DOI 10.1016/0003-9861(70)90315-2; BINDER L, 1990, MOL ENDOCRINOL, V4, P7; CLARK RD, UNPUB; COSMAN D, 1990, TRENDS BIOCHEM SCI, V15, P265, DOI 10.1016/0968-0004(90)90051-C; CUNNINGHAM BA, UNPUB; CUNNINGHAM BC, 1991, P NATL ACAD SCI USA, V88, P3407, DOI 10.1073/pnas.88.8.3407; CUNNINGHAM BC, 1990, SCIENCE, V247, P1461, DOI 10.1126/science.2321008; CUNNINGHAM BC, 1989, SCIENCE, V243, P1330, DOI 10.1126/science.2466339; CUNNINGHAM BC, 1989, SCIENCE, V244, P1081, DOI 10.1126/science.2471267; DEVOS B, UNPUB; DUKOVICH M, 1987, NATURE, V327, P518, DOI 10.1038/327518a0; ELBERG G, 1990, J BIOL CHEM, V265, P14770; FENDLEY B, UNPUB; FUH G, 1990, J BIOL CHEM, V265, P3111; GRIEP MA, 1988, BIOCHEMISTRY-US, V27, P5210, DOI 10.1021/bi00414a040; GUNTHER N, 1990, J BIOL CHEM, V265, P22082; ITOH N, 1990, SCIENCE, V247, P324, DOI 10.1126/science.2404337; LAX I, 1991, J BIOL CHEM, V266, P13828; LOWMAN HB, 1991, J BIOL CHEM, V260, P10982; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; McPherson A., 1989, PREPARATION ANAL PRO; MULKERRIN MG, UNPUB; OLSON KB, UNPUB; PATTHY L, 1990, CELL, V61, P13, DOI 10.1016/0092-8674(90)90208-V; TESHIGAWARA K, 1987, J EXP MED, V165, P223, DOI 10.1084/jem.165.1.223; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; YARDEN Y, 1988, ANNU REV BIOCHEM, V57, P443, DOI 10.1146/annurev.bi.57.070188.002303	32	841	892	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	NOV 8	1991	254	5033					821	825		10.1126/science.1948064	http://dx.doi.org/10.1126/science.1948064			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN833	1948064				2022-12-28	WOS:A1991GN83300034
J	HENNECKE, F; KOLMAR, H; BRUNDL, K; FRITZ, HJ				HENNECKE, F; KOLMAR, H; BRUNDL, K; FRITZ, HJ			THE VSR GENE-PRODUCT OF ESCHERICHIA-COLI K-12 IS A STRAND-SPECIFIC AND SEQUENCE-SPECIFIC DNA MISMATCH ENDONUCLEASE	NATURE			English	Article							SHORT PATCH REPAIR; ESCHERICHIA-COLI; POLYMERASE-I; LAMBDA; 5-METHYL-CYTOSINE; RECOMBINATION; METHYLATION; GLYCOSYLASE; REPRESSOR; MECHANISM	IN Escherichia coli K-12, the Dcm methyltransferase catalyses methylation of the inner cytosine residue in the sequence CC(A)/(T)GG 1,2. Hydrolytic deamination of 5-methylcytosine bases in DNA leads to thymine residues, and hence to T/G mismatches, pre-mutagenic DNA lesions consisting of two natural DNA constituents and thus devoid of an obvious marker of the damaged DNA strand. These mismatches are corrected by the VSP repair pathway, which is characterized by very short patches of DNA repair synthesis 3,4. It depends on genes vsr 5 and polA 6 and is strongly stimulated by mutL and mutS 7-9. The vsr gene product (Vsr; M(r) 18,000) was purified and characterized as a DNA mismatch endonuclease, a unique and hitherto unknown type of enzyme. Vsr endonuclease nicks double-stranded DNA within the sequence CT(A)/(T)GN or NT(A)/(T)GG next to the underlined thymidine residue, which is mismatched to 2'-deoxyguanosine. The incision is mismatch-dependent and strand-specific. These results illustrate how Vsr endonuclease initiates VSP mismatch repair.			HENNECKE, F (corresponding author), UNIV GOTTINGEN,INST MOLEK GENET,GRISEBACHSTR 8,W-3400 GOTTINGEN,GERMANY.		Kolmar, Harald/AAK-8316-2021	Kolmar, Harald/0000-0002-8210-1993				AU KG, 1989, P NATL ACAD SCI USA, V86, P8877, DOI 10.1073/pnas.86.22.8877; BAMBARA RA, 1978, J BIOL CHEM, V253, P413; BEAUCAGE SL, 1981, TETRAHEDRON LETT, V22, P1859, DOI 10.1016/S0040-4039(01)90461-7; CARTWRIGHT SJ, 1984, BIOCHEM J, V221, P505, DOI 10.1042/bj2210505; COULONDRE C, 1978, NATURE, V274, P775, DOI 10.1038/274775a0; DZIDIC S, 1989, MOL GEN GENET, V217, P254, DOI 10.1007/BF02464889; HANCK T, 1989, NUCLEIC ACIDS RES, V17, P5844, DOI 10.1093/nar/17.14.5844; JONES M, 1987, J MOL BIOL, V194, P155, DOI 10.1016/0022-2836(87)90724-8; KRAMER B, 1984, CELL, V38, P879, DOI 10.1016/0092-8674(84)90283-6; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; LIEB M, 1987, J BACTERIOL, V169, P5241, DOI 10.1128/jb.169.11.5241-5246.1987; LIEB M, 1985, MOL GEN GENET, V199, P465; LIEB M, 1986, GENETICS, V114, P1041; LIEB M, 1983, MOL GEN GENET, V191, P118, DOI 10.1007/BF00330898; Maniatis T., 1982, MOL CLONING; MARINUS MG, 1973, MOL GEN GENET, V127, P47, DOI 10.1007/BF00267782; Maxam A M, 1980, Methods Enzymol, V65, P499; POHLNER J, 1987, NATURE, V325, P458, DOI 10.1038/325458a0; REYNAUD CA, 1987, CELL, V48, P379, DOI 10.1016/0092-8674(87)90189-9; SCHLAGMAN S, 1976, J BACTERIOL, V126, P990, DOI 10.1128/JB.126.2.990-996.1976; SOHAIL A, 1990, J BACTERIOL, V172, P4214, DOI 10.1128/jb.172.8.4214-4221.1990; STANSSENS P, 1989, NUCLEIC ACIDS RES, V17, P4441, DOI 10.1093/nar/17.12.4441; VONWILCKENBERGMANN B, 1982, P NATL ACAD SCI-BIOL, V79, P2427; WIEBAUER K, 1990, P NATL ACAD SCI USA, V87, P5842, DOI 10.1073/pnas.87.15.5842; WYSOCKI LJ, 1989, ANNU REV BIOCHEM, V58, P509; ZELL R, 1987, EMBO J, V6, P1809, DOI 10.1002/j.1460-2075.1987.tb02435.x	26	125	128	1	4	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	OCT 24	1991	353	6346					776	778		10.1038/353776a0	http://dx.doi.org/10.1038/353776a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL696	1944537				2022-12-28	WOS:A1991GL69600075
J	[Anonymous]				[Anonymous]			FISH OILS AND DIABETIC MICROVASCULAR DISEASE	LANCET			English	Editorial Material																		BANG HO, 1980, AM J CLIN NUTR, V33, P2657, DOI 10.1093/ajcn/33.12.2657; BANG HO, 1976, ACTA MED SCAND, V200, P69; DANG AQ, 1988, METABOLISM, V37, P1065, DOI 10.1016/0026-0495(88)90069-8; DYERBERG J, 1975, AM J CLIN NUTR, V28, P958, DOI 10.1093/ajcn/28.9.958; GLAUBER H, 1988, ANN INTERN MED, V108, P663, DOI 10.7326/0003-4819-108-5-663; HAINES AP, 1986, THROMB RES, V43, P643, DOI 10.1016/0049-3848(86)90101-5; JENSEN T, 1989, NEW ENGL J MED, V321, P1572, DOI 10.1056/NEJM198912073212304; JONES DB, 1983, BRIT MED J, V286, P173, DOI 10.1136/bmj.286.6360.173; KROMHOUT D, 1985, NEW ENGL J MED, V312, P1205, DOI 10.1056/NEJM198505093121901; LEAF A, 1988, NEW ENGL J MED, V318, P549, DOI 10.1056/NEJM198803033180905; RUDERMAN NB, 1984, PROG CARDIOVASC DIS, V26, P373, DOI 10.1016/0033-0620(84)90011-2; SCHECTMAN G, 1988, DIABETES, V37, P1567, DOI 10.2337/diabetes.37.11.1567; STACPOOLE PW, 1989, METABOLISM, V38, P946, DOI 10.1016/0026-0495(89)90004-8; TAKAHASHI R, 1984, DIABETOLOGIA, V26, P134; VONSCHACKY C, 1987, ANN INTERN MED, V107, P890, DOI 10.7326/0003-4819-107-6-890; WEINER BH, 1986, NEW ENGL J MED, V315, P841, DOI 10.1056/NEJM198610023151401; 1980, LANCET, V1, P464	17	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 3	1990	335	8688					508	509						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT015	1968531				2022-12-28	WOS:A1990CT01500007
J	KAHN, JC; PATEY, M; DUBOISRANDE, JL; MERLET, P; CASTAIGNE, A; LIMALEXANDRE, C; LECOMTE, JM; DUBOC, D; GROS, C; SCHWARTZ, JC				KAHN, JC; PATEY, M; DUBOISRANDE, JL; MERLET, P; CASTAIGNE, A; LIMALEXANDRE, C; LECOMTE, JM; DUBOC, D; GROS, C; SCHWARTZ, JC			EFFECT OF SINORPHAN ON PLASMA ATRIAL NATRIURETIC FACTOR IN CONGESTIVE HEART-FAILURE	LANCET			English	Letter									HOP HENRI MONDOR,CARDIOL SERV,F-94010 CRETEIL,FRANCE; HOP COCHIN,BIOPROJET LAB,F-75674 PARIS 14,FRANCE; INSERM,CTR PAUL BROCA,NEUROBIOL & PHARMACOL UNIT,F-75014 PARIS,FRANCE; HOP COCHIN,CARDIOL SERV,F-75674 PARIS 14,FRANCE	Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite	KAHN, JC (corresponding author), HOP POISSY,POISSY,FRANCE.							GOETZ KL, 1988, AM J PHYSIOL, V254, pE1, DOI 10.1152/ajpendo.1988.254.1.E1; GROS C, 1989, P NATL ACAD SCI USA, V86, P7580, DOI 10.1073/pnas.86.19.7580; LAFFERTY HM, 1989, CIRC RES, V65, P640, DOI 10.1161/01.RES.65.3.640; NORTHRIDGE DB, 1989, LANCET, V2, P591; OLINS GM, 1989, MOL CELL ENDOCRINOL, V61, P201, DOI 10.1016/0303-7207(89)90131-7; SCHWARTZ JC, IN PRESS TRENDS DRUG; SCHWARTZ JC, 1989, DESIGN ENZYME INHIBI, P206	7	65	66	0	2	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	JAN 13	1990	335	8681					118	119		10.1016/0140-6736(90)90595-V	http://dx.doi.org/10.1016/0140-6736(90)90595-V			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CH516	1967410				2022-12-28	WOS:A1990CH51600053
J	MOLER, FW; BANDY, KP; CUSTER, JR				MOLER, FW; BANDY, KP; CUSTER, JR			RIBAVIRIN FOR SEVERE RSV INFECTION	NEW ENGLAND JOURNAL OF MEDICINE			English	Letter							WATER				MOLER, FW (corresponding author), UNIV MICHIGAN,ANN ARBOR,MI 48109, USA.							BURTON GG, 1991, RESPIRATORY CARE GUI; CHENEY FW, 1968, ANESTHESIOLOGY, V29, P1099, DOI 10.1097/00000542-196811000-00004; FLICK MR, 1977, CHEST, V71, P366, DOI 10.1378/chest.71.3.366; LILKER ES, 1981, NEW ENGL J MED, V305, P702; SHAPIRO BA, 1985, CLIN APPLICATION RES; SHEPPARD D, 1983, AM REV RESPIR DIS, V127, P691; SMITH DW, 1991, NEW ENGL J MED, V325, P24, DOI 10.1056/NEJM199107043250105; TAMER MA, 1970, J PEDIATR-US, V77, P1051, DOI 10.1016/S0022-3476(70)80092-0	8	15	15	0	0	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 26	1991	325	26					1884	1885						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GW528	1961230				2022-12-28	WOS:A1991GW52800017
J	FISCHER, PM; SCHWARTZ, MP; RICHARDS, JW; GOLDSTEIN, AO; ROJAS, TH				FISCHER, PM; SCHWARTZ, MP; RICHARDS, JW; GOLDSTEIN, AO; ROJAS, TH			BRAND LOGO RECOGNITION BY CHILDREN AGED 3 TO 6 YEARS - MICKEY-MOUSE AND OLD-JOE-THE-CAMEL	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CIGARETTE ADVERTISEMENTS; SMOKING; COMMERCIALS; PROMOTION; PRODUCTS	Objective. - Little is known about the influence of advertising on very young children. We, therefore, measured product logo recognition by subjects aged 3 to 6 years. Design. - Children were instructed to match logos with one of 12 products pictured on a game board. Twenty-two logos were tested, including those representing children's products, adult products, and those for two popular cigarette brands (Camel and Marlboro). Setting. - Preschools in Augusta and Atlanta, Ga. Participants. - A convenience sample of 229 children attending preschool. Results. - The children demonstrated high rates of logo recognition. When analyzed by product category, the level of recognition of cigarette logos was intermediate between children's and adult products. The recognition rates of The Disney Channel logo and Old Joe (the cartoon character promoting Camel cigarettes) were highest in their respective product categories. Recognition rates increased with age. Approximately 30% of 3-year-old children correctly matched Old Joe with a picture of a cigarette compared with 91.3% of 6-year-old children. Conclusion. - Very young children see, understand, and remember advertising. Given the serious health consequences of smoking, the exposure of children to environmental tobacco advertising may represent an important health risk and should be studied further.	UNIV N CAROLINA,DEPT FAMILY MED,CHAPEL HILL,NC 27514	University of North Carolina; University of North Carolina Chapel Hill	FISCHER, PM (corresponding author), MED COLL GEORGIA,DEPT FAMILY MED,AUGUSTA,GA 30912, USA.							AITKEN PP, 1990, BRIT J ADDICT, V85, P399; AITKEN PP, 1987, BRIT J ADDICT, V82, P615; AITKEN PP, 1988, HLTH PROMOTION, V2, P219; ARMSTRONG BK, 1990, MED J AUSTRALIA, V152, P117, DOI 10.5694/j.1326-5377.1990.tb125117.x; BLUM A, 1991, NEW ENGL J MED, V324, P913, DOI 10.1056/NEJM199103283241310; CHAPMAN S, 1982, AM J PUBLIC HEALTH, V72, P491, DOI 10.2105/AJPH.72.5.491; Charlton A., 1986, HLTH ED J, V45, P75; DAVIS RM, 1987, NEW ENGL J MED, V316, P725, DOI 10.1056/NEJM198703193161206; DONOHUE TR, 1980, J ADVERTISING RES, V20, P51; GOLDBERG ME, 1978, J CONSUM RES, V5, P73, DOI 10.1086/208717; GOLDSTEIN AO, 1987, J PEDIATR-US, V110, P488, DOI 10.1016/S0022-3476(87)80523-1; GORN GJ, 1985, J CONSUM RES, V11, P962, DOI 10.1086/209030; Leckenby J., 1983, CURRENT ISSUES RES A, P135; LEVIT EM, 1981, J LAW ECON, V24, P545; MCNEAL JU, 1987, CHILDREN CONSUMERS, P5; RICHARDS JW, 1990, WORLD SMOKING HLTH, V15, P12; SELDON BJ, 1989, REV ECON STAT, V71, P673, DOI 10.2307/1928110; SIEGEL S, 1988, NONPARAMETRIC STAT B, P75; Tye J B, 1987, J Public Health Policy, V8, P492, DOI 10.2307/3342275; WARNER KE, 1987, NEW ENGL J MED, V316, P745, DOI 10.1056/NEJM198703193161210; 1989, DHHS CDC898411 PUBL; 1990, MMWR, V39, P261	22	238	239	0	48	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 11	1991	266	22					3145	3148		10.1001/jama.266.22.3145	http://dx.doi.org/10.1001/jama.266.22.3145			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GT654	1956101	Green Submitted			2022-12-28	WOS:A1991GT65400022
J	GOSTIN, LO; BRANDT, AM; CLEARY, PD				GOSTIN, LO; BRANDT, AM; CLEARY, PD			TOBACCO LIABILITY AND PUBLIC-HEALTH POLICY	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							CIGARETTE-SMOKING; UNHEALTHY PRODUCT; UNITED-STATES; MAGAZINES; RISK; SOLD		HARVARD UNIV,SCH MED,DEPT HLTH CARE POLICY,BOSTON,MA 02115; UNIV N CAROLINA,SCH MED,DEPT SOCIAL MED,CHAPEL HILL,NC 27514	Harvard University; Harvard Medical School; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	GOSTIN, LO (corresponding author), AMER SOC LAW & MED,OFF EXECUT DIRECTOR,765 COMMONWEALTH AVE,16TH FLOOR,BOSTON,MA 02215, USA.		Cleary, Paul/AAF-7048-2019					AGINS T, 1988, WALL ST J       0422; ALTMAN DG, 1987, J COMMUN, V37, P95, DOI 10.1111/j.1460-2466.1987.tb01010.x; BLUM A, 1991, NEW ENGL J MED, V324, P913, DOI 10.1056/NEJM199103283241310; BRANDT AM, 1990, DAEDALUS-US, V119, P155; CAVILIA JW, 1991, NY TIMES        0410, P24; CHALOUPKA F, 1991, J POLIT ECON, V99, P722, DOI 10.1086/261776; CHAPMAN S, 1990, AM J PUBLIC HEALTH, V80, P537, DOI 10.2105/AJPH.80.5.537; CHAPMAN S, 1986, SMOKING OUT BARONS C, P79; CLEARY PD, 1988, MILBANK Q, V66, P185; COOPER R, 1985, NEW YORK STATE J MED, V85, P344; DOLL R, 1952, BMJ-BRIT MED J, V2, P1271, DOI 10.1136/bmj.2.4797.1271; DOMENICI PV, 1991, NY TIMES        0606, pA25; ESCOBEDO LG, 1990, JAMA-J AM MED ASSOC, V264, P1550, DOI 10.1001/jama.264.12.1550; FIORE MC, 1989, JAMA-J AM MED ASSOC, V261, P49, DOI 10.1001/jama.261.1.49; FRITSCHLER AL, 1969, SMOKING POLITICS POL; GREENHOUSE L, 1991, NY TIMES        0326; HAMMOND E C, 1958, J Am Med Assoc, V166, P1159; HAMMOND EC, 1958, JAMA-J AM MED ASSOC, V166, P1294, DOI 10.1001/jama.1958.02990110030007; HEADEN SW, 1991, AM J PUBLIC HEALTH, V81, P854, DOI 10.2105/AJPH.81.7.854; HUBER PW, 1988, LIABILITY LEGAL REVO; JANSON D, 1988, NY TIMES        0313; JANSON D, 1988, NY TIMES        0602; JANSON D, 1988, NY TIMES        0407; KNOWLES JH, 1977, DAEDALUS, V106, P57; KOLATA G, 1988, NY TIMES        0617; Ledwith F., 1984, HLTH ED J, V43, P85, DOI DOI 10.1177/001789698404300402; LEVENTHAL H, 1980, PSYCHOL BULL, V88, P370, DOI 10.1037/0033-2909.88.2.370; LEWIT EM, 1981, J LAW ECON, V24, P545, DOI 10.1086/466999; MCKENNA, 1988, U CHICAGO LAW REV, V55, P943; RILEY P, 1909, BOSTON COLL LAW REV, V30, P1103; TRIBE L, 1986, NATION          0607, P788; VICUSI WK, 1991, REFORMING PRODUCTS L; WALD ML, 1988, NY TIMES        0214; WARNER KE, 1986, SELLING SMOKE CIGARE; WHITESIDE T, 1971, SELLING DEATH CIGARE; WILLIAMS L, 1986, WALL ST J       1006; WYNDER EL, 1950, JAMA-J AM MED ASSOC, V143, P329, DOI 10.1001/jama.1950.02910390001001; 1991, NY TIMES        0201; 1984, TIME            0409, P91; 1989, CDC898411 DEP HLTH H; 1986, ST JOHNS LAW REV, V32, P754; 1964, PHS PUBLICATION, V1103; 1964, FED REGISTER, V29, P8324; 1989, PHS CDC888406 DEP HL; 1991, TOBACCO PRODUCTS L B, V61, P1	45	15	15	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 11	1991	266	22					3178	3182		10.1001/jama.266.22.3178	http://dx.doi.org/10.1001/jama.266.22.3178			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GT654	1956109				2022-12-28	WOS:A1991GT65400030
J	PAMULAPATI, M; TEAGUE, S; STELZER, P; THADANI, U				PAMULAPATI, M; TEAGUE, S; STELZER, P; THADANI, U			SUCCESSFUL SURGICAL REPAIR OF A RUPTURED ANEURYSM OF THE SINUS OF VALSALVA IN EARLY-PREGNANCY	ANNALS OF INTERNAL MEDICINE			English	Note						SINUS OF VALSALVA; AORTIC RUPTURE; AORTIC ANEURYSM; PREGNANCY; HEART SURGERY	DOPPLER	Congenital aneurysm of a sinus of Valsalva is a rare clinical entity in the western hemisphere; rupture during pregnancy is even rarer. We report a case of a ruptured sinus of Valsalva aneurysm into the right ventricle during the second trimester of pregnancy. Despite a classical presentation, the diagnosis was initially missed. Clinical findings, together with color Doppler echocardiography and aortic root angiography, confirmed the diagnosis, and the lesion was successfully repaired using cardiopulmonary bypass. The pregnancy progressed without problems, and a normal baby girl was delivered at term. This case illustrates the need for early diagnosis and urgent surgical repair for an unusual cardiac problem in pregnancy.	UNIV OKLAHOMA, HLTH SCI CTR, CARDIOVASC SECT, POB 26901, 55P-300, OKLAHOMA CITY, OK 73190 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center								BECKER RM, 1983, ANN THORAC SURG, V36, P453, DOI 10.1016/S0003-4975(10)60486-9; BURAKOVSKY VI, 1988, J THORAC CARDIOV SUR, V95, P836; CHIA BL, 1988, AM HEART J, V115, P686, DOI 10.1016/0002-8703(88)90824-1; CHIANG CW, 1988, AM HEART J, V116, P1283, DOI 10.1016/0002-8703(88)90453-X; CHOW LC, 1988, CHEST, V94, P462, DOI 10.1378/chest.94.3.462; CRIPPS T, 1987, BRIT HEART J, V57, P490; DEBAKEY ME, 1983, GIBBONS SURGERY CHES, V2, P947; SAKAKIBARA S, 1962, AM HEART J, V63, P708, DOI 10.1016/0002-8703(62)90018-2; SZEKELY P, 1973, BRIT HEART J, V35, P1293; VERGHESE M, 1986, ANN THORAC SURG, V41, P284, DOI 10.1016/S0003-4975(10)62770-1	10	11	12	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 1	1991	115	11					880	882		10.7326/0003-4819-115-11-880	http://dx.doi.org/10.7326/0003-4819-115-11-880			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GR171	1952476				2022-12-28	WOS:A1991GR17100008
J	SUTER, B; STEWARD, R				SUTER, B; STEWARD, R			REQUIREMENT FOR PHOSPHORYLATION AND LOCALIZATION OF THE BICAUDAL-D PROTEIN IN DROSOPHILA OOCYTE DIFFERENTIATION	CELL			English	Article							GENE; MELANOGASTER; OOGENESIS; EMBRYOS; SEGMENTATION; POLYMERASE; POLARITY; SEQUENCE; ELEGANS; REGION	In the Drosophila female the product of the germline stem cell, the cystoblast, gives rise to 16 interconnected cystocytes. One of them differentiates into the oocyte, while the 15 others become polyploid nurse cells. Bk-D is required for the differentiation of an oocyte and hence for fertility. Recessive mutations in Bic-D block the oocyte-specific accumulation of its own and other RNAs. Based on its properties and distribution, the Bic-D protein appears to be a component of a cytoskeletal transport or anchoring system. Additional results suggest that the phosphorylation of the Bic-D protein is essential for its accumulation in the pro-oocyte and that this process leads to the gradual localization to the pro-oocyte of factors required for oocyte differentiation.			SUTER, B (corresponding author), PRINCETON UNIV,DEPT MOLEC BIOL,MOFFETT LAB A13,PRINCETON,NJ 08544, USA.							BOPP D, 1991, GENE DEV, V5, P403, DOI 10.1101/gad.5.3.403; BROWN EH, 1964, GROWTH, V28, P41; CARPENTER ATC, 1975, CHROMOSOMA, V1, P157; DAVIDSON EH, 1990, DEVELOPMENT, V108, P365; EPHRUSSI A, 1991, CELL, V66, P37, DOI 10.1016/0092-8674(91)90137-N; GUTZEIT HO, 1982, J EMBRYOL EXP MORPH, V67, P101; HAENLIN M, 1987, EMBO J, V6, P801, DOI 10.1002/j.1460-2075.1987.tb04822.x; HIGUCHI RG, 1989, NUCLEIC ACIDS RES, V17, P5865, DOI 10.1093/nar/17.14.5865; JACKSON SP, 1990, CELL, V63, P155, DOI 10.1016/0092-8674(90)90296-Q; KIMHA J, 1991, CELL, V66, P23, DOI 10.1016/0092-8674(91)90136-M; King R. C., 1970, OVARIAN DEV DROSOPHI; KOCH EA, 1967, J MORPHOL, V121, P55, DOI 10.1002/jmor.1051210106; KOCH EA, 1966, J MORPHOL, V119, P283, DOI 10.1002/jmor.1051190303; KOCH EA, 1983, CELL TISSUE RES, V228, P21; KOCH EA, 1969, Z ZELLFORSCH MIK ANA, V102, P129, DOI 10.1007/BF00336421; LEHMANN R, 1986, CELL, V47, P141, DOI 10.1016/0092-8674(86)90375-2; Mahowald A.P., 1980, Genetics and Biology of Drosophila, V2d, P141; MAHOWALD AP, 1980, J CELL BIOL, V45, P306; MCKEARIN DM, 1990, GENE DEV, V4, P2242, DOI 10.1101/gad.4.12b.2242; MEYER GF, 1961, Z ZELLFORSCH MIK ANA, V54, P238, DOI 10.1007/BF00338705; MOHLER J, 1986, GENETICS, V112, P803; SCHRIEFER LA, 1989, J MOL BIOL, V207, P451, DOI 10.1016/0022-2836(89)90267-2; SCHUPBACH T, 1991, IN PRESS GENETICS; SEYDOUX G, 1989, CELL, V57, P1237, DOI 10.1016/0092-8674(89)90060-3; SPRADLING A, 1992, IN PRESS DROSOPHILA; STEINHAUER WR, 1989, MOL CELL BIOL, V9, P5726, DOI 10.1128/MCB.9.12.5726; STEWARD R, 1986, GENETICS, V113, P665; Steward R., 1987, UCLA (University of California Los Angeles) Symposia on Molecular and Cellular Biology New Series, V51, P39; STORTO PD, 1989, DEV GENET, V10, P70, DOI 10.1002/dvg.1020100203; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; SUTER B, 1989, GENE DEV, V3, P1957, DOI 10.1101/gad.3.12a.1957; TAUTZ D, 1989, CHROMOSOMA, V98, P81, DOI 10.1007/BF00291041; Telfer W. H., 1975, Advances Insect Physiol, V11, P223, DOI 10.1016/S0065-2806(08)60164-2; WHARTON RP, 1989, CELL, V59, P881, DOI 10.1016/0092-8674(89)90611-9; WIESCHAUS E, 1979, DEV BIOL, V68, P29, DOI 10.1016/0012-1606(79)90241-0; YISRAELI JK, 1990, DEVELOPMENT, V108, P289; ZOLLER MJ, 1984, DNA-J MOLEC CELL BIO, V3, P479, DOI 10.1089/dna.1.1984.3.479	37	207	207	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	NOV 29	1991	67	5					917	926		10.1016/0092-8674(91)90365-6	http://dx.doi.org/10.1016/0092-8674(91)90365-6			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GT755	1959135				2022-12-28	WOS:A1991GT75500011
J	CHOWRIRA, BM; BERZALHERRANZ, A; BURKE, JM				CHOWRIRA, BM; BERZALHERRANZ, A; BURKE, JM			NOVEL GUANOSINE REQUIREMENT FOR CATALYSIS BY THE HAIRPIN RIBOZYME	NATURE			English	Article							TOBACCO RINGSPOT VIRUS; T7 RNA-POLYMERASE; SATELLITE RNA; SEQUENCE; CLEAVAGE	THERE is much interest in the development of 'designer ribozymes' to target destruction of RNAs in vitro and in vivo 1. Engineering of ribozymes with novel specificities requires detailed knowledge of the ribozyme-substrate interaction, and a rigorous evaluation of sequence specificity. The hairpin ribozyme catalyses an efficient and reversible site-specific cleavage reaction 2-4. We have used mutagenesis and in vitro selection strategies to show that RNA cleavage and ligation has an absolute requirement for guanosine immediately 3' to the cleavage-ligation site. This G is not required for efficient substrate binding, rather, its 2-amino group is an essential component of the active site required for catalysis.	UNIV VERMONT, MARKEY CTR MOLEC GENET, DEPT MICROBIOL & MOLEC GENET, BURLINGTON, VT 05405 USA	University of Vermont			, John/AAB-5945-2021; Berzal-Herranz, Alfredo/K-8614-2014	Berzal-Herranz, Alfredo/0000-0003-3722-7973				BURKARD U, 1988, J BIOL CHEM, V263, P2447; CARTER BJ, 1990, J BIOL CHEM, V265, P7100; CECH TR, 1990, ANNU REV BIOCHEM, V59, P543, DOI 10.1146/annurev.bi.59.070190.002551; CECH TR, 1988, JAMA-J AM MED ASSOC, V260, P3030; CHOWRIRA BM, 1991, BIOCHEMISTRY-US, V30, P8518, DOI 10.1021/bi00099a003; DOUDNA JA, 1990, J ORG CHEM, V55, P5547, DOI 10.1021/jo00308a003; FEDOR MJ, 1990, P NATL ACAD SCI USA, V87, P1668, DOI 10.1073/pnas.87.5.1668; FELDSTEIN PA, 1989, GENE, V82, P53, DOI 10.1016/0378-1119(89)90029-2; GREEN CJ, 1988, J BIOL CHEM, V263, P652; HAMPEL A, 1990, NUCLEIC ACIDS RES, V18, P299, DOI 10.1093/nar/18.2.299; HAMPEL A, 1989, BIOCHEMISTRY-US, V28, P4929, DOI 10.1021/bi00438a002; HASELOFF J, 1989, GENE, V82, P43, DOI 10.1016/0378-1119(89)90028-0; KOIZUMI M, 1991, BIOCHEMISTRY-US, V30, P5145, DOI 10.1021/bi00235a005; MILLIGAN JF, 1989, METHOD ENZYMOL, V180, P51; PYLE AM, 1990, P NATL ACAD SCI USA, V87, P8187, DOI 10.1073/pnas.87.21.8187; RUBINO L, 1990, J GEN VIROL, V71, P1897, DOI 10.1099/0022-1317-71-9-1897; RUFFNER DE, 1990, BIOCHEMISTRY-US, V29, P10695, DOI 10.1021/bi00499a018; VANTOL H, 1990, NUCLEIC ACIDS RES, V18, P1971, DOI 10.1093/nar/18.8.1971	18	143	163	1	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 28	1991	354	6351					320	322		10.1038/354320a0	http://dx.doi.org/10.1038/354320a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT204	1956383				2022-12-28	WOS:A1991GT20400052
J	FORSTER, DP; JOZAN, P				FORSTER, DP; JOZAN, P			HEALTH IN EASTERN-EUROPE	LANCET			English	Article									HUNGARIAN CENT STAT OFF, DEPT POPULAT STAT, BUDAPEST, HUNGARY		FORSTER, DP (corresponding author), UNIV NEWCASTLE UPON TYNE, SCH MED, DIV COMMUNITY MED, NEWCASTLE UPON TYNE NE2 4HH, ENGLAND.							DHOUTAUD A, 1984, SOCIOL HEALTH ILL, V6, P30, DOI 10.1111/1467-9566.ep10777358; DOLL R, 1981, JNCI-J NATL CANCER I, V66, P1191, DOI 10.1093/jnci/66.6.1192; FORSTER DP, 1984, SOC POLICY ADMIN, V18, P247, DOI 10.1111/j.1467-9515.1984.tb00211.x; Fukuyama F., 1989, FIN HIST; HERZLICH C, 1969, SANTE MALADIE ANAL U; HILL AB, 1984, SHORT TXB MED STAT, P170; Jozan P, 1987, SOME FEATURES MORTAL; WALSH D, 1982, PUBLIC HLTH EUROPE, V17; Waterhouse J., 1976, CANCER INCIDENCE 5 C, V3, P456; 1989, GLOBAL STRATEGY HLTH; 1983, WORLD HLTH STATISTIC; 1988, ANN REPORT REGIONAL; 1982, 1982 WORLD BANK WORL	13	39	39	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 24	1990	335	8687					458	460		10.1016/0140-6736(90)90678-X	http://dx.doi.org/10.1016/0140-6736(90)90678-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CP907	1968180				2022-12-28	WOS:A1990CP90700014
J	SHAM, JST; WEI, WI; ZONG, YS; CHOY, D; GUO, YQ; LUO, Y; LIN, ZX; NG, MH				SHAM, JST; WEI, WI; ZONG, YS; CHOY, D; GUO, YQ; LUO, Y; LIN, ZX; NG, MH			DETECTION OF SUBCLINICAL NASOPHARYNGEAL CARCINOMA BY FIBEROPTIC ENDOSCOPY AND MULTIPLE BIOPSY	LANCET			English	Article									SHANTOU UNIV,COLL MED,DEPT PATHOL & ONCOL,SHANTOU,PEOPLES R CHINA; UNIV HONG KONG,QUEEN MARY HOSP,DEPT SURG,HONG KONG,HONG KONG; UNIV HONG KONG,QUEEN MARY HOSP,DEPT MICROBIOL,HONG KONG,HONG KONG; ZHONGSHAN PEOPLES HOSP,ZHONGSHAN,PEOPLES R CHINA; GUANGDONG PROV PEOPLES HOSP,GUANGZHOU,PEOPLES R CHINA	Shantou University; University of Hong Kong; University of Hong Kong; Guangdong Academy of Medical Sciences & Guangdong General Hospital	SHAM, JST (corresponding author), UNIV HONG KONG,QUEEN MARY HOSP,DEPT RADIOTHERAPY & ONCOL,HONG KONG,HONG KONG.			wei, william/0000-0002-6281-7126				BOON ME, 1987, CANCER-AM CANCER SOC, V59, P862, DOI 10.1002/1097-0142(19870215)59:4<862::AID-CNCR2820590434>3.0.CO;2-P; BOYES DA, 1981, GYNECOL ONCOL, V12, pS143, DOI 10.1016/0090-8258(81)90070-6; CHEN JY, 1989, J MED VIROL, V27, P269, DOI 10.1002/jmv.1890270403; CHOA G, 1974, J LARYNGOL OTOL, V88, P145, DOI 10.1017/S0022215100078488; DETHE G, 1985, EPSTEIN BARR VIRUS R, P237; HENLE G, 1976, INT J CANCER, V17, P1, DOI 10.1002/ijc.2910170102; HENLE G, 1985, ADV VIRAL ONCOL, P201; HO HC, 1978, LANCET, V1, P436; HO HC, 1976, BRIT J CANCER, V34, P655, DOI 10.1038/bjc.1976.228; Ho HC, 1972, IARC SCI PUBL, V2, P357; LANIER AP, 1980, INT J CANCER, V26, P133, DOI 10.1002/ijc.2910260203; LAU WH, 1983, NASOPHARYNGEAL CARCI, P125; LEVINE PH, 1980, INT J CANCER, V26, P741, DOI 10.1002/ijc.2910260607; Prasad U, 1979, Med J Malaysia, V33, P222; SHAM JST, 1989, CANCER, V64, P1838, DOI 10.1002/1097-0142(19891101)64:9<1838::AID-CNCR2820640914>3.0.CO;2-C; SHAM JST, IN PRESS BR J RADIOL; SHAPIRO S, 1989, WORLD J SURG, V13, P9, DOI 10.1007/BF01671148; SHAPIRO S, 1971, J AMER MED ASSOC, V215, P1777; TABAR L, 1985, LANCET, V1, P829, DOI 10.1016/S0140-6736(85)92204-4; YU MC, 1989, INT J CANCER, V43, P1077, DOI 10.1002/ijc.2910430621; ZENG Y, 1984, CHINESE MED J-PEKING, V97, P155; ZENG Y, 1985, INT J CANCER, V36, P545, DOI 10.1002/ijc.2910360505; ZENG Y, 1982, INT J CANCER, V29, P139, DOI 10.1002/ijc.2910290204	23	90	107	0	5	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	FEB 17	1990	335	8686					371	374		10.1016/0140-6736(90)90206-K	http://dx.doi.org/10.1016/0140-6736(90)90206-K			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN988	1968116				2022-12-28	WOS:A1990CN98800003
J	GRACE, ND				GRACE, ND			PREVENTION OF RECURRENT VARICEAL BLEEDING - IS SURGICAL RESCUE THE ANSWER	ANNALS OF INTERNAL MEDICINE			English	Editorial Material											GRACE, ND (corresponding author), TUFTS UNIV, FAULKNER & LEMUEL SHATTUCK HOSP, SCH MED, BOSTON, MA 02130 USA.							BARSOUM MS, 1982, BRIT J SURG, V69, P76, DOI 10.1002/bjs.1800690206; BURROUGHS AK, 1983, NEW ENGL J MED, V309, P1539, DOI 10.1056/NEJM198312223092502; CELLO JP, 1987, NEW ENGL J MED, V316, P11, DOI 10.1056/NEJM198701013160103; COLOMBO M, 1989, HEPATOLOGY, V9, P433, DOI 10.1002/hep.1840090315; DEFRANCHIS R, 1988, NEW ENGL J MED, V319, P983; GATTA A, 1987, DIGESTION, V37, P22, DOI 10.1159/000199483; GRACE ND, 1988, HEPATOLOGY, V8, P1475, DOI 10.1002/hep.1840080602; GRACE ND, 1988, SURGERY LIVER, P303; GRACE ND, 1990, IN PRESS PROGR HEPAT; GRAHAM DY, 1981, GASTROENTEROLOGY, V80, P800; HENDERSON JM, 1989, IN PRESS ANN INTERN, V112; JACKSON FC, 1971, ANN SURG, V174, P672, DOI 10.1097/00000658-197110000-00012; KORULA J, 1985, HEPATOLOGY, V5, P584, DOI 10.1002/hep.1840050410; LEBREC D, 1984, HEPATOLOGY, V4, P355, DOI 10.1002/hep.1840040301; MARBET UA, 1988, SCAND J GASTROENTERO, V23, P369, DOI 10.3109/00365528809093881; PAQUET KJ, 1985, HEPATOLOGY, V5, P580, DOI 10.1002/hep.1840050409; QUEUNIET AM, 1987, GASTROEN CLIN BIOL, V11, P41; RESNICK RH, 1974, GASTROENTEROLOGY, V67, P843; REYNOLDS TB, 1981, GASTROENTEROLOGY, V80, P1005; RIKKERS LF, 1987, ANN SURG, V206, P261, DOI 10.1097/00000658-198709000-00004; RUEFF B, 1976, LANCET, V1, P655; SODERLUND C, 1985, ACTA CHIR SCAND, V151, P449; SPINA GP, 1988, AM J SURG, V155, P564, DOI 10.1016/S0002-9610(88)80411-2; TERBLANCHE J, 1983, LANCET, V2, P1328; TERES J, 1987, HEPATOLOGY, V7, P430, DOI 10.1002/hep.1840070303; VILLENEUVE JP, 1986, HEPATOLOGY, V6, P1239, DOI 10.1002/hep.1840060602; WARREN WD, 1986, ANN SURG, V203, P454, DOI 10.1097/00000658-198605000-00002; WESTABY D, 1985, HEPATOLOGY, V5, P827, DOI 10.1002/hep.1840050520	28	6	7	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 15	1990	112	4					242	244		10.7326/0003-4819-112-4-242	http://dx.doi.org/10.7326/0003-4819-112-4-242			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN554	1967520				2022-12-28	WOS:A1990CN55400002
J	MACLENNAN, DH; DUFF, C; ZORZATO, F; FUJII, J; PHILLIPS, M; KORNELUK, RG; FRODIS, W; BRITT, BA; WORTON, RG				MACLENNAN, DH; DUFF, C; ZORZATO, F; FUJII, J; PHILLIPS, M; KORNELUK, RG; FRODIS, W; BRITT, BA; WORTON, RG			RYANODINE RECEPTOR GENE IS A CANDIDATE FOR PREDISPOSITION TO MALIGNANT HYPERTHERMIA	NATURE			English	Article									CHILDRENS HOSP EASTERN ONTARIO,DIV GENET,OTTAWA K1H 8L1,ONTARIO,CANADA; UNIV TORONTO,DEPT MED GENET,TORONTO M5G 1X8,ONTARIO,CANADA; UNIV TORONTO,TORONTO GEN HOSP,DEPT ANAESTHESIA,TORONTO M5G 2C4,ONTARIO,CANADA; UNIV TORONTO,TORONTO GEN HOSP,DEPT PHARMACOL,TORONTO M5G 2C4,ONTARIO,CANADA; HOSP SICK CHILDREN,DEPT GENET,TORONTO M5G 1X8,ONTARIO,CANADA	University of Ottawa; Children's Hospital of Eastern Ontario; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	MACLENNAN, DH (corresponding author), UNIV TORONTO,CHARLES H BEST INST,BANTING & BEST DEPT MED RES,112 COLL ST,TORONTO M5G 1L6,ONTARIO,CANADA.							BRITT BA, 1989, MALIGNANT HYPERTHERM, P53; BRITT BA, 1987, MALIGNANT HYPERTHERM, P11; DAVIES W, 1988, ANIM GENET, V19, P203, DOI 10.1111/j.1365-2052.1988.tb00809.x; ENDO M, 1983, BIOMED RES-TOKYO, V4, P83, DOI 10.2220/biomedres.4.83; HULSEBOS T, 1986, NUCLEIC ACIDS RES, V14, P7137, DOI 10.1093/nar/14.17.7137; Humphries S E, 1983, Mol Biol Med, V1, P463; IAIZZO PA, 1988, PFLUG ARCH EUR J PHY, V411, P648, DOI 10.1007/BF00580861; KALOW W, 1970, LANCET, V2, P895, DOI 10.1016/S0140-6736(70)92069-6; KALOW W, 1987, MALIGNANT HYPERTHERM, P155; KIM DH, 1984, BIOCHIM BIOPHYS ACTA, V775, P320, DOI 10.1016/0005-2736(84)90187-1; MACKENZIE AE, UNPUB AM J HUM GENET; MCCARTHY TV, 1990, NATURE, V343, P562, DOI 10.1038/343562a0; MICKELSON JR, 1988, J BIOL CHEM, V263, P9310; NELSON TE, 1983, J CLIN INVEST, V72, P862, DOI 10.1172/JCI111057; OBRIEN PJ, 1986, CAN J VET RES, V50, P318; OHNISHI ST, 1983, FEBS LETT, V161, P103; SCHEPENS J, 1987, NUCLEIC ACIDS RES, V15, P3193, DOI 10.1093/nar/15.7.3193; SCHEPENS J, 1987, NUCLEIC ACIDS RES, V15, P3192, DOI 10.1093/nar/15.7.3192; SCHONK D, 1989, GENOMICS, V4, P384, DOI 10.1016/0888-7543(89)90346-7; SMEETS H, 1989, NUCLEIC ACIDS RES, V17, P3325, DOI 10.1093/nar/17.8.3325; SMEETS H, 1989, NUCLEIC ACIDS RES, V17, P3324, DOI 10.1093/nar/17.8.3324; SMEETS H, 1987, NUCLEIC ACIDS RES, V15, P8120, DOI 10.1093/nar/15.19.8120; ZORZATO F, 1990, J BIOL CHEM, V265, P2244; [No title captured]	24	481	489	0	27	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	FEB 8	1990	343	6258					559	561		10.1038/343559a0	http://dx.doi.org/10.1038/343559a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CM830	1967823				2022-12-28	WOS:A1990CM83000066
J	EDDE, B; ROSSIER, J; LECAER, JP; DESBRUYERES, E; GROS, F; DENOULET, P				EDDE, B; ROSSIER, J; LECAER, JP; DESBRUYERES, E; GROS, F; DENOULET, P			POSTTRANSLATIONAL GLUTAMYLATION OF ALPHA-TUBULIN	SCIENCE			English	Article									CNRS,PHYSIOL NERVEUSE LAB,F-91198 GIF SUR YVETTE,FRANCE	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	EDDE, B (corresponding author), COLL FRANCE,BIOCHIM CELLULAIRE LAB,F-75231 PARIS 05,FRANCE.							BERWALDNETTER Y, 1981, P NATL ACAD SCI-BIOL, V78, P1245, DOI 10.1073/pnas.78.2.1245; BIDLINGMEYER BA, 1984, J CHROMATOGR, V336, P93, DOI 10.1016/S0378-4347(00)85133-6; COWAN NJ, 1987, CYTOSKELETON CELL DI, P157; DENOULET P, 1988, STRUCTURE FUNCTIONS, P231; EDDE B, 1989, BIOL CELL, V65, P109; EDDE B, 1987, DEV BIOL, V123, P549, DOI 10.1016/0012-1606(87)90413-1; EDDE B, UNPUB; FIELD DJ, 1988, ELECTROPHORESIS, V9, P555, DOI 10.1002/elps.1150090915; GARD DL, 1985, J CELL BIOL, V100, P764, DOI 10.1083/jcb.100.3.764; GREER K, 1989, CELL MOVEMENT, V2, P47; LECAER JP, 1988, ANAL BIOCHEM, V169, P246, DOI 10.1016/0003-2697(88)90281-3; LEDIZET M, 1987, P NATL ACAD SCI USA, V84, P572; LHERNAULT SW, 1985, BIOCHEMISTRY-US, V24, P473, DOI 10.1021/bi00323a034; LITTAUER UZ, 1986, P NATL ACAD SCI USA, V83, P7162, DOI 10.1073/pnas.83.19.7162; MACCIONI RB, 1988, EMBO J, V7, P1957, DOI 10.1002/j.1460-2075.1988.tb03033.x; MATSUBARA H, 1970, METHOD ENZYMOL, V19, P642; RAYBIN D, 1977, J CELL BIOL, V73, P492, DOI 10.1083/jcb.73.2.492; SERRANO L, 1986, J BIOL CHEM, V261, P7076; VALLEE RB, 1982, J CELL BIOL, V92, P435, DOI 10.1083/jcb.92.2.435; VILLASANTE A, 1986, MOL CELL BIOL, V6, P2409, DOI 10.1128/MCB.6.7.2409; WOLFF A, 1982, NEUROSCI LETT, V31, P323, DOI 10.1016/0304-3940(82)90041-6	21	446	456	0	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JAN 5	1990	247	4938					83	85		10.1126/science.1967194	http://dx.doi.org/10.1126/science.1967194			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG620	1967194				2022-12-28	WOS:A1990CG62000042
J	PUI, CH; RIBEIRO, RC; HANCOCK, ML; RIVERA, GK; EVANS, WE; RAIMONDI, SC; HEAD, DR; BEHM, FG; MAHMOUD, MH; SANDLUND, JT; CRIST, WM				PUI, CH; RIBEIRO, RC; HANCOCK, ML; RIVERA, GK; EVANS, WE; RAIMONDI, SC; HEAD, DR; BEHM, FG; MAHMOUD, MH; SANDLUND, JT; CRIST, WM			ACUTE MYELOID-LEUKEMIA IN CHILDREN TREATED WITH EPIPODOPHYLLOTOXINS FOR ACUTE LYMPHOBLASTIC-LEUKEMIA	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACUTE NONLYMPHOCYTIC LEUKEMIA; CHROMOSOME-ABERRATIONS; DNA TOPOISOMERASES; ETOPOSIDE; TENIPOSIDE; CHEMOTHERAPY; VM-26; CELLS; LUNG; CLASSIFICATION	Background and Methods. Treatment of cancer with the epipodophyllotoxins (etoposide and teniposide) has been linked to the development of acute myeloid leukemia (AML) in children and adults, but the factors that might influence the risk of this complication of therapy are poorly defined. We therefore assessed the importance of potential risk factors for secondary AML in 734 consecutive children with acute lymphoblastic leukemia who attained complete remission and received continuation (maintenance) treatment according to different schedules of epipodophyllotoxin administration. Results. Secondary AML was diagnosed in 21 of the 734 patients, in 17 of whom this complication was the initial adverse event. Prolonged administration of epipodophyllotoxin (teniposide with or without etoposide) twice weekly or weekly was independently associated with the development of secondary AML (P < 0.01 by Cox regression analysis). The overall cumulative risk of AML at six years was 3.8 percent (95 percent confidence interval, 2.3 percent to 6.1 percent); but within the subgroups treated twice weekly or weekly, the risks were 12.3 percent (95 percent confidence interval, 5.7 percent to 25.4 percent) and 12.4 percent (95 percent confidence interval, 6.1 percent to 24.4 percent), respectively. In the subgroups not treated with epipodophyllotoxins or treated with them only during remission induction or every two weeks during continuation treatment, the highest cumulative risk was 1.6 percent (95 percent confidence interval, 0.4 percent to 6.1 percent). After adjustment for treatment frequency, there was no apparent relation between the total dose of epipodophyllotoxins and the development of secondary AML. The relative hazard of etoposide as compared with teniposide could not be determined. Conclusions. The risk of epipodophyllotoxin-related AML depends largely on the schedule of drug administration. Other factors, including the cumulative dose of epipodophyllotoxin, radiotherapy, and the initial biologic features of the leukemic blast cells, do not appear to have critical roles.	ST JUDE CHILDRENS RES HOSP, DEPT PATHOL & LAB MED, MEMPHIS, TN 38101 USA; ST JUDE CHILDRENS RES HOSP, DEPT BIOSTAT & INFORMAT SYST, MEMPHIS, TN 38101 USA; ST JUDE CHILDRENS RES HOSP, DIV PHARMACEUT, MEMPHIS, TN 38101 USA; UNIV TENNESSEE, CTR HLTH SCI, COLL MED, DEPT PEDIAT & PATHOL, MEMPHIS, TN 38163 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center	PUI, CH (corresponding author), ST JUDE CHILDRENS RES HOSP, DEPT HEMATOL ONCOL, 332 N LAUDERDALE, POB 318, MEMPHIS, TN 38101 USA.		Evans, William E./C-2069-2012; Pui, Ching-Hon/N-8076-2018; Raimondi, Susana C/N-8166-2018	Evans, William E./0000-0002-9333-5322; Pui, Ching-Hon/0000-0003-0303-5658; 	NCI NIH HHS [CA-20180, CA-21765] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA021765, P01CA020180] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALLEN LM, 1975, EUR J CANCER, V11, P697, DOI 10.1016/0014-2964(75)90043-2; BENNETT JM, 1981, BRIT J HAEMATOL, V47, P553, DOI 10.1111/j.1365-2141.1981.tb02684.x; BENNETT JM, 1985, ANN INTERN MED, V103, P620, DOI 10.7326/0003-4819-103-4-620; BLANCY E, 1989, FUNDAM CLIN PHARM, V3, P363, DOI 10.1111/j.1472-8206.1989.tb00677.x; CHESON BD, 1990, J CLIN ONCOL, V8, P813, DOI 10.1200/JCO.1990.8.5.813; COX DR, 1972, J R STAT SOC B, V34, P187; DEMARINI DM, 1987, MUTAT RES, V187, P141, DOI 10.1016/0165-1218(87)90081-4; DEVORE R, 1989, ANN INTERN MED, V110, P704, DOI 10.7326/0003-4819-110-9-740; DILLEHAY LE, 1989, MUTAT RES, V215, P15, DOI 10.1016/0027-5107(89)90213-3; FRY DW, 1990, BIOCHEM PHARMACOL, V40, P1981, DOI 10.1016/0006-2952(90)90227-C; Harnden DG, 1985, INT SYSTEM HUMAN CYT; KALBFLEISCH JD, 1980, STATISTICAL ANAL FAI; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; KAUFMANN S, 1991, CANCER CELL-MON REV, V3, P24; LONG BH, 1985, CANCER RES, V45, P3106; LONG BH, 1983, P AM ASSOC CANC RES, V24, P321; MARASCHIN J, 1990, INT J CANCER, V46, P808, DOI 10.1002/ijc.2910460511; ODWYER PJ, 1985, NEW ENGL J MED, V312, P692, DOI 10.1056/NEJM198503143121106; ODWYER PJ, 1984, CANCER TREAT REP, V68, P1455; PEDERSENBJERGAARD J, 1990, BLOOD, V76, P1083; PRATT CB, 1991, TOXICITY ANTICANCER, P28; PRIETO F, 1990, CANCER GENET CYTOGEN, V45, P1, DOI 10.1016/0165-4608(90)90061-E; PUI CH, 1990, LANCET, V336, P1130, DOI 10.1016/0140-6736(90)92607-J; PUI CH, 1986, BLOOD, V67, P1688; PUI CH, 1985, LANCET, V2, P410; PUI CH, 1989, NEW ENGL J MED, V321, P136, DOI 10.1056/NEJM198907203210302; PUI CH, 1990, LANCET, V336, P417, DOI 10.1016/0140-6736(90)91956-B; R&DEG;rth M., 1991, P AN M AM SOC CLIN, V10, P221; RATAIN MJ, 1987, BLOOD, V70, P1412; RIVERA GK, 1991, LANCET, V337, P61, DOI 10.1016/0140-6736(91)90733-6; ROSS W, 1984, CANCER RES, V44, P5857; Schneider E, 1990, Adv Pharmacol, V21, P149, DOI 10.1016/S1054-3589(08)60342-7; STAHELIN HF, 1991, CANCER RES, V51, P5; STEWART CF, 1989, CLIN PHARMACOL THER, V45, P49, DOI 10.1038/clpt.1989.8; WILLIAMS DL, 1984, CANCER GENET CYTOGEN, V13, P239, DOI 10.1016/0165-4608(84)90046-3; YALOWICH JC, 1988, P AM ASSOC CANC RES, V29, P317; YANG L, 1987, P NATL ACAD SCI USA, V84, P950, DOI 10.1073/pnas.84.4.950	37	612	618	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 12	1991	325	24					1682	1687		10.1056/NEJM199112123252402	http://dx.doi.org/10.1056/NEJM199112123252402			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GU418	1944468				2022-12-28	WOS:A1991GU41800002
J	ROCHE, PA; MARKS, MS; CRESSWELL, P				ROCHE, PA; MARKS, MS; CRESSWELL, P			FORMATION OF A NINE-SUBUNIT COMPLEX BY HLA CLASS-II GLYCOPROTEINS AND THE INVARIANT CHAIN	NATURE			English	Article							LYMPHOBLASTOID CELL; BETA-CHAIN; ANTIGENS; PROTEINS; BINDING; GLYCOSYLATION; ASSOCIATION; PEPTIDE	HLA CLASS II molecules are heterodimeric transmembrane glycoproteins that bind and present processed antigenic peptides to CD4-positive T lymphocytes. Intracellularly, class II molecules associate with a third subunit termed the invariant (1) chain. Here we describe the physical characteristics of the intracellular class II alpha-beta-I complex. Chemical crosslinking, size exclusion chromatography and sedimentation velocity studies demonstrate that the alpha-beta-I complex is a nine-subunit transmembrane protein that contains three alpha-beta-dimers associated with an I chain trimer. The organization of class II alpha- and beta-subunits in such a multimer may have a role in the documented ability of the I chain to inhibit peptide binding to class II molecules 1-3. In addition, the formation of the nine-chain complex may induce the structural changes necessary to overcome the cytoplasmic retention signal responsible for the localization of free I chain in the endoplasmic reticulum, releasing class II-I chain complexes for transport to endosomes 4-6.	DUKE UNIV,MED CTR,DEPT MICROBIOL & IMMUNOL,DURHAM,NC 27710	Duke University			Marks, Michael S/Q-7223-2019	Marks, Michael S/0000-0001-7435-7262; Roche, Paul/0000-0002-8949-9172				BAKKE O, 1990, CELL, V63, P707, DOI 10.1016/0092-8674(90)90137-4; DEKRETSER TA, 1982, EUR J IMMUNOL, V12, P214, DOI 10.1002/eji.1830120309; GUY K, 1982, EUR J IMMUNOL, V12, P942, DOI 10.1002/eji.1830121109; HELENIUS A, 1972, J BIOL CHEM, V247, P3656; KELNER DN, 1986, J IMMUNOL, V137, P2632; LAMB CA, 1991, P NATL ACAD SCI USA, V88, P5998, DOI 10.1073/pnas.88.14.5998; LOTTEAU V, 1990, NATURE, V348, P600, DOI 10.1038/348600a0; MACHAMER CE, 1984, P NATL ACAD SCI-BIOL, V81, P1287, DOI 10.1073/pnas.81.5.1287; MACHAMER CE, 1982, J IMMUNOL, V129, P2564; MARKS MS, 1990, J CELL BIOL, V111, P839, DOI 10.1083/jcb.111.3.839; MARKS MS, 1989, THESIS DUKE U; MARTIN RG, 1961, J BIOL CHEM, V236, P1372; POLLET RJ, 1981, J BIOL CHEM, V256, P2118; ROCHE PA, 1990, J IMMUNOL, V144, P1849; ROCHE PA, 1990, NATURE, V345, P615, DOI 10.1038/345615a0; ROCHE PA, 1991, P NATL ACAD SCI USA, V88, P3150, DOI 10.1073/pnas.88.8.3150; SANT AJ, 1983, J EXP MED, V158, P1979, DOI 10.1084/jem.158.6.1979; SANT AJ, 1985, J EXP MED, V162, P1916, DOI 10.1084/jem.162.6.1916; SOBERS HA, 1968, HDB BIOCH, pJ248; STRUBIN M, 1986, EMBO J, V5, P3483, DOI 10.1002/j.1460-2075.1986.tb04673.x; TANFORD C, 1974, BIOCHEMISTRY-US, V13, P2369, DOI 10.1021/bi00708a021; TEYTON L, 1990, NATURE, V348, P39, DOI 10.1038/348039a0	22	311	315	0	7	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	DEC 5	1991	354	6352					392	394		10.1038/354392a0	http://dx.doi.org/10.1038/354392a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT761	1956401				2022-12-28	WOS:A1991GT76100051
J	GUTHRIE, PB; SEGAL, M; KATER, SB				GUTHRIE, PB; SEGAL, M; KATER, SB			INDEPENDENT REGULATION OF CALCIUM REVEALED BY IMAGING DENDRITIC SPINES	NATURE			English	Article							LONG-TERM POTENTIATION; SYNAPTIC TRANSMISSION; PYRAMIDAL CELLS; HIPPOCAMPAL; NEURONS; ACCUMULATION; 4-AMINOPYRIDINE; STIMULATION; ENHANCEMENT; MICROSCOPY	THE dendritic spine is a basic structural unit of neuronal organization. It is assumed to be a primary locus of synaptic plasticity, and to undergo long-term morphological and functional changes 1-6, at least some of which are regulated by intracellular calcium concentrations 7-11. It is known that physiological stimuli can cause marked increases in intracellular calcium levels in hippocampal dendritic shafts 12,13, but it is completely unknown to what extent such changes in the dendrites would also be seen by calcium-sensing structures within spines. Will calcium levels in all spines change in parallel with the dendrite or will there be a heterogeneous response? This study, through direct visualization and measurement of intracellular calcium concentrations in individual living spines, demonstrates that experimentally evoked changes in calcium concentrations in the dendritic shaft ([Ca2+]d) are frequently not parallelled in the spine ([Ca2+]s). This isolation is not caused by a physical diffusion barrier. This report provides, to our knowledge, the first direct demonstration of autonomous spine function.	COLORADO STATE UNIV, DEPT ANAT & NEUROBIOL, PROGRAM NEURONAL GROWTH & DEV, FT COLLINS, CO USA; WEIZMANN INST SCI, CTR NEUROSCI, IL-76100 REHOVOT, ISRAEL	Colorado State University; Weizmann Institute of Science			SEGAL, MENAHEM/K-1577-2012					ANDREWS SB, 1988, P NATL ACAD SCI USA, V85, P1682, DOI 10.1073/pnas.85.5.1682; BENTLEY D, 1991, J NEUROSCI, V11, P1300; Brown T.H., 1989, NEURAL MODELS PLASTI, P266; BUCKLE PJ, 1982, J PHYSIOL-LONDON, V326, P109, DOI 10.1113/jphysiol.1982.sp014180; CONNOR JA, 1986, P NATL ACAD SCI USA, V83, P6179, DOI 10.1073/pnas.83.16.6179; COSS RG, 1985, BEHAV NEURAL BIOL, V44, P151, DOI 10.1016/S0163-1047(85)90170-0; FIFKOVA E, 1989, ANN NY ACAD SCI, V568, P131; FIFKOVA E, 1985, CELL MOL NEUROBIOL, V5, P47, DOI 10.1007/BF00711085; FIFKOVA E, 1983, BRAIN RES, V266, P163, DOI 10.1016/0006-8993(83)91322-7; FIFKOVA E, 1977, J NEUROCYTOL, V6, P211, DOI 10.1007/BF01261506; GAMBLE E, 1987, SCIENCE, V236, P1311, DOI 10.1126/science.3495885; HARRIS KM, 1989, J NEUROSCI, V9, P2982; HOLMES WR, 1990, J NEUROPHYSIOL, V63, P1148, DOI 10.1152/jn.1990.63.5.1148; KAWATO M, 1983, J THEOR BIOL, V103, P507, DOI 10.1016/0022-5193(83)90280-1; LEVRAM V, 1987, BIOPHYS J, V52, P571, DOI 10.1016/S0006-3495(87)83246-0; LYNCH G, 1983, NATURE, V305, P719, DOI 10.1038/305719a0; MALENKA RC, 1988, SCIENCE, V242, P81, DOI 10.1126/science.2845577; MATTSON MP, 1990, DEV BRAIN RES, V52, P201, DOI 10.1016/0165-3806(90)90236-R; MATTSON MP, 1988, J NEUROSCI RES, V20, P331, DOI 10.1002/jnr.490200307; MILLER JP, 1985, BRAIN RES, V325, P325, DOI 10.1016/0006-8993(85)90333-6; PONGRACZ F, 1985, NEUROSCIENCE, V15, P933, DOI 10.1016/0306-4522(85)90244-1; REGEHR WG, 1990, NATURE, V345, P807, DOI 10.1038/345807a0; REGEHR WG, 1989, NATURE, V341, P533, DOI 10.1038/341533a0; SEGAL M, 1984, J NEUROSCI, V4, P604; SEGAL M, 1987, BRAIN RES, V414, P285, DOI 10.1016/0006-8993(87)90008-4; SEGEV I, 1988, J NEUROPHYSIOL, V60, P499, DOI 10.1152/jn.1988.60.2.499; SHEPHERD GM, 1985, P NATL ACAD SCI USA, V82, P2192, DOI 10.1073/pnas.82.7.2192; SMITH SJ, 1983, NATURE, V304, P350, DOI 10.1038/304350a0; TSIEN RY, 1985, CELL CALCIUM, V6, P145, DOI 10.1016/0143-4160(85)90041-7; WICKENS J, 1988, PROG NEUROBIOL, V31, P507, DOI 10.1016/0301-0082(88)90013-5; WILLIAMS S, 1989, NEURON, V3, P583, DOI 10.1016/0896-6273(89)90268-7; WINSLOW RL, 1989, P NATL ACAD SCI USA, V86, P387, DOI 10.1073/pnas.86.1.387	32	216	217	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 7	1991	354	6348					76	80		10.1038/354076a0	http://dx.doi.org/10.1038/354076a0			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN829	1944573				2022-12-28	WOS:A1991GN82900062
J	FARRELL, RWR; PEMBERTON, MN; PARKER, AJ; BUFFIN, JT				FARRELL, RWR; PEMBERTON, MN; PARKER, AJ; BUFFIN, JT			SUDDEN DEAFNESS AFTER DENTAL SURGERY	BRITISH MEDICAL JOURNAL			English	Article							HEARING-LOSS				FARRELL, RWR (corresponding author), ROYAL HALLAMSHIRE HOSP,DEPT OTOLARYNGOL & MED AUDIOL,SHEFFIELD S10 2JF,S YORKSHIRE,ENGLAND.							COLES RRA, 1985, BRIT DENT J, V159, P209, DOI 10.1038/sj.bdj.4805687; HALLBERG O E, 1956, Laryngoscope, V66, P1237; IGARASHI M, 1969, LARYNGOSCOPE, V79, P603, DOI 10.1288/00005537-196904000-00005; NORRIS CH, 1988, DRUGS, V36, P754, DOI 10.2165/00003495-198836060-00005; SIMMONS FB, 1973, LARYNGOSCOPE, V83, P1221, DOI 10.1288/00005537-197308000-00005	5	18	18	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	OCT 26	1991	303	6809					1034	1034		10.1136/bmj.303.6809.1034	http://dx.doi.org/10.1136/bmj.303.6809.1034			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GM478	1954457	Bronze, Green Published			2022-12-28	WOS:A1991GM47800023
J	HARRIS, R				HARRIS, R			MEDICAL GENETICS	BRITISH MEDICAL JOURNAL			English	Article											HARRIS, R (corresponding author), ST MARYS HOSP,DEPT MED GENET,MANCHESTER M13 0JH,LANCS,ENGLAND.							BULOW S, 1987, DAN MED BULL, V34, P1; MCKUSICK VA, 1991, NATURE, V352, P279, DOI 10.1038/352279a0; OBERLE I, 1991, SCIENCE, V252, P1097, DOI 10.1126/science.252.5009.1097; OWEN DJ, 1991, ANTENATAL DIAGNOSIS, P353; PECKHAM M, 1991, LANCET, V338, P367, DOI 10.1016/0140-6736(91)90494-A; RONA RJ, 1989, J MED GENET, V26, P226, DOI 10.1136/jmg.26.4.226; WALD N, 1991, ANTENATAL DIAGNOSIS, P45; YU S, 1991, SCIENCE, V252, P1179, DOI 10.1126/science.252.5009.1179; 1991, PURCHASERS GUIDELINE; 1991, CMMD1523; 1990, TEACHING GENETICS ME; 1991, CLIN GENETICS 1990; 1989, PRENATAL DIAGNOSIS G	13	5	5	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	OCT 19	1991	303	6808					977	979		10.1136/bmj.303.6808.977	http://dx.doi.org/10.1136/bmj.303.6808.977			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GL127	1954427	Green Published, Bronze			2022-12-28	WOS:A1991GL12700031
J	SMITH, J				SMITH, J			THE NEW NHS - 6 MONTHS ON - WEST SUFFOLK - CHANGES IN THE OFFING	BRITISH MEDICAL JOURNAL			English	Article																			0	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	OCT 19	1991	303	6808					979	981		10.1136/bmj.303.6808.979	http://dx.doi.org/10.1136/bmj.303.6808.979			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GL127	1954428	Bronze, Green Published			2022-12-28	WOS:A1991GL12700032
J	PECKHAM, CS; TEDDER, RS; BRIGGS, M; ADES, AE; HJELM, M; WILCOX, AH; PARRAMEJIA, N; OCONNOR, C				PECKHAM, CS; TEDDER, RS; BRIGGS, M; ADES, AE; HJELM, M; WILCOX, AH; PARRAMEJIA, N; OCONNOR, C			PREVALENCE OF MATERNAL HIV-INFECTION BASED ON UNLINKED ANONYMOUS TESTING OF NEWBORN BABIES	LANCET			English	Article									UNIV COLL & MIDDLESEX SCH MED,SCH PATHOL,DEPT MED MICROBIOL,VIROL SECT,LONDON W1,ENGLAND; HOSP SICK CHILDREN,DEPT CLIN BIOCHEM,LONDON WC1N 3JH,ENGLAND; ST HELIER HOSP,DEPT CHEM PATHOL,CARSHALTON SM5 1AA,SURREY,ENGLAND	University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; St Helier Hospital	PECKHAM, CS (corresponding author), INST CHILD HLTH,DEPT PAEDIAT EPIDEMIOL,BIRMINGHAM B16 8ET,W MIDLANDS,ENGLAND.			Tedder, Richard/0000-0002-9672-5721				BARBARA JAJ, 1989, MED LAB SCI, V46, P135; BLANCHE S, 1989, NEW ENGL J MED, V320, P1643, DOI 10.1056/NEJM198906223202502; EVANS BA, 1988, BRIT MED J, V296, P473, DOI 10.1136/bmj.296.6620.473; GILL ON, 1989, BRIT MED J, V299, P1295, DOI 10.1136/bmj.299.6711.1295; GRANT DB, 1988, BRIT MED J, V296, P1355, DOI 10.1136/bmj.296.6633.1355; HEPTONSTALL J, 1989, COMMUNICAB DIS REP, V48, P3; HOFF R, 1988, NEW ENGL J MED, V318, P525, DOI 10.1056/NEJM198803033180901; HULL HF, 1988, JAMA-J AM MED ASSOC, V260, P935, DOI 10.1001/jama.260.7.935; IPPOLITO G, 1989, DETECTION ANTI HIV A, P141; KRASINSKI K, 1988, NEW ENGL J MED, V318, P185; LANDESMAN S, 1987, JAMA-J AM MED ASSOC, V258, P2701, DOI 10.1001/jama.258.19.2701; MINKOFF HL, 1988, NEW ENGL J MED, V319, P1018; NOVICK LF, 1989, JAMA-J AM MED ASSOC, V261, P1745, DOI 10.1001/jama.261.12.1745; 1989, MMWR, V38; 1988, LANCET, V2, P1039; 1987, REPORT RCOG SUBCOMMI	16	66	66	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	MAR 3	1990	335	8688					516	519		10.1016/0140-6736(90)90746-R	http://dx.doi.org/10.1016/0140-6736(90)90746-R			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT015	1968537				2022-12-28	WOS:A1990CT01500013
J	LINDSELL, DRM				LINDSELL, DRM			ULTRASOUND IMAGING OF PANCREAS AND BILIARY-TRACT	LANCET			English	Article											LINDSELL, DRM (corresponding author), JOHN RADCLIFFE HOSP,DEPT RADIOL,OXFORD OX3 9DU,ENGLAND.							AMOUYAL P, 1989, LANCET, V2, P1195; BARON RL, 1987, RADIOLOGY, V162, P419, DOI 10.1148/radiology.162.2.3797655; CAMPBELL JP, 1988, RADIOLOGY, V167, P341, DOI 10.1148/radiology.167.2.3282254; COOPERBERG PL, 1982, REAL TIME ULTRASONOG, V10, P71; DARWEESH RMA, 1988, AM J ROENTGENOL, V151, P63, DOI 10.2214/ajr.151.1.63; DOOMS GC, 1986, RADIOLOGY, V159, P89, DOI 10.1148/radiology.159.1.3006122; FREENY PC, 1988, RADIOLOGY, V166, P125, DOI 10.1148/radiology.166.1.2827228; GIBSON RN, 1986, RADIOLOGY, V160, P43, DOI 10.1148/radiology.160.1.3520654; IISHI H, 1986, CANCER, V57, P1947, DOI 10.1002/1097-0142(19860515)57:10<1947::AID-CNCR2820571010>3.0.CO;2-H; IRVING HC, 1989, BRIT MED J, V298, P977, DOI 10.1136/bmj.298.6679.977; JONES SN, 1988, CLIN RADIOL, V39, P43, DOI 10.1016/S0009-9260(88)80339-8; LAING FC, 1986, RADIOLOGY, V160, P39, DOI 10.1148/radiology.160.1.3012631; LAING FC, 1984, AM J ROENTGENOL, V143, P949, DOI 10.2214/ajr.143.5.949; NESBIT GM, 1988, AM J ROENTGENOL, V151, P933, DOI 10.2214/ajr.151.5.933; REIMAN TH, 1987, RADIOLOGY, V163, P49, DOI 10.1148/radiology.163.1.3823456; SCHARSCHMIDT BF, 1983, NEW ENGL J MED, V308, P1515, DOI 10.1056/NEJM198306233082507; SUMMERFIELD JA, 1988, GUT, V29, P741, DOI 10.1136/gut.29.6.741	17	66	66	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	FEB 17	1990	335	8686					390	393		10.1016/0140-6736(90)90217-S	http://dx.doi.org/10.1016/0140-6736(90)90217-S			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN988	1968124				2022-12-28	WOS:A1990CN98800012
J	YOST, CS; LOPEZ, CD; PRUSINER, SB; MYERS, RM; LINGAPPA, VR				YOST, CS; LOPEZ, CD; PRUSINER, SB; MYERS, RM; LINGAPPA, VR			NONHYDROPHOBIC EXTRACYTOPLASMIC DETERMINANT OF STOP TRANSFER IN THE PRION PROTEIN	NATURE			English	Article									UNIV CALIF SAN FRANCISCO,DEPT PHYSIOL,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT NEUROL,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT BIOCHEM & BIOPHYS,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT MED,SAN FRANCISCO,CA 94143	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	YOST, CS (corresponding author), UNIV CALIF SAN FRANCISCO,DEPT ANESTHESIA,SAN FRANCISCO,CA 94143, USA.			Lingappa, Vishwanath R./0000-0003-0962-6571				ADAMS GA, 1985, CELL, V41, P1007, DOI 10.1016/S0092-8674(85)80081-7; BASLER K, 1986, CELL, V46, P417, DOI 10.1016/0092-8674(86)90662-8; BLOBEL G, 1980, P NATL ACAD SCI-BIOL, V77, P1496, DOI 10.1073/pnas.77.3.1496; BOEKE JD, 1982, P NATL ACAD SCI-BIOL, V79, P5200, DOI 10.1073/pnas.79.17.5200; CARLSON GA, 1986, CELL, V46, P503, DOI 10.1016/0092-8674(86)90875-5; CUTLER DF, 1986, J CELL BIOL, V102, P902, DOI 10.1083/jcb.102.3.902; DAVIS GL, 1987, J CELL BIOL, V105, P1191, DOI 10.1083/jcb.105.3.1191; DAVIS NG, 1985, CELL, V41, P607, DOI 10.1016/S0092-8674(85)80033-7; DOYLE C, 1986, J CELL BIOL, V103, P1193, DOI 10.1083/jcb.103.4.1193; EISENBERG D, 1984, ANNU REV BIOCHEM, V53, P595, DOI 10.1146/annurev.bi.53.070184.003115; GETHING MJ, 1982, NATURE, V300, P598, DOI 10.1038/300598a0; GILMORE R, 1985, CELL, V42, P497, DOI 10.1016/0092-8674(85)90107-2; HANSEN W, 1986, CELL, V45, P397, DOI 10.1016/0092-8674(86)90325-9; HAY B, 1987, BIOCHEMISTRY-US, V26, P8110, DOI 10.1021/bi00399a014; HAY B, 1987, MOL CELL BIOL, V7, P914, DOI 10.1128/MCB.7.2.914; HSIAO K, 1989, NATURE, V338, P342, DOI 10.1038/338342a0; LINGAPPA VR, 1989, J CLIN INVEST, V83, P739, DOI 10.1172/JCI113952; LINGAPPA VR, 1984, P NATL ACAD SCI-BIOL, V81, P456, DOI 10.1073/pnas.81.2.456; LIPP J, 1988, J CELL BIOL, V106, P1813, DOI 10.1083/jcb.106.6.1813; MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035; MEYER RK, 1986, P NATL ACAD SCI USA, V83, P2310, DOI 10.1073/pnas.83.8.2310; OESCH B, 1985, CELL, V40, P735, DOI 10.1016/0092-8674(85)90333-2; PERARA E, 1985, J CELL BIOL, V101, P2292, DOI 10.1083/jcb.101.6.2292; PERARA E, 1989, PROTEIN TRANSFER ORG, P3; PRUSINER SB, 1987, NEW ENGL J MED, V317, P1571, DOI 10.1056/NEJM198712173172505; ROSE JK, 1982, CELL, V30, P753, DOI 10.1016/0092-8674(82)90280-X; ROTHMAN RE, 1988, J BIOL CHEM, V263, P10470; SIEGEL V, 1988, CELL, V52, P39, DOI 10.1016/0092-8674(88)90529-6; SIVASUBRAMANIAN N, 1987, P NATL ACAD SCI USA, V84, P1, DOI 10.1073/pnas.84.1.1; STAHL N, 1988, FASEB J, V2, pA989; STAHL N, 1987, CELL, V51, P229, DOI 10.1016/0092-8674(87)90150-4; SZCZESNASKORUPA E, 1988, P NATL ACAD SCI USA, V85, P738, DOI 10.1073/pnas.85.3.738; WESTAWAY D, 1987, CELL, V51, P651, DOI 10.1016/0092-8674(87)90134-6; WIDEMANN M, 1987, NATURE, V328, P830; YOST CS, 1983, CELL, V34, P759; ZERIAL M, 1987, CELL, V48, P147, DOI 10.1016/0092-8674(87)90365-5	36	116	118	0	4	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	FEB 15	1990	343	6259					669	672		10.1038/343669a0	http://dx.doi.org/10.1038/343669a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN989	1968226				2022-12-28	WOS:A1990CN98900073
J	MILNER, AD; UPTON, CJ; GREEN, J; STOKES, GM				MILNER, AD; UPTON, CJ; GREEN, J; STOKES, GM			A DEVICE FOR DOMICILIARY NEONATAL RESUSCITATION	LANCET			English	Article									CITY HOSP NOTTINGHAM,DEPT NEONATAL MED,NOTTINGHAM NG5 1PD,ENGLAND	Nottingham University Hospital NHS Trust; Nottingham City Hospital	MILNER, AD (corresponding author), UNIV NOTTINGHAM HOSP,DEPT CHILD HLTH,NOTTINGHAM NG7 2UH,ENGLAND.							FIELD D, 1986, ARCH DIS CHILD, V61, P300, DOI 10.1136/adc.61.3.300; HOSKYNS EW, 1987, ARCH DIS CHILD, V62, P663, DOI 10.1136/adc.62.7.663; PALME C, 1985, LANCET, V1, P207; SHARDONOFSKY FR, 1989, PEDIATR PULM, V6, P14, DOI 10.1002/ppul.1950060106; VYAS H, 1986, PEDIATR PULM, V2, P189, DOI 10.1002/ppul.1950020403; 1988, NEWSLETTER, V8, P6	6	2	2	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	FEB 3	1990	335	8684					273	275		10.1016/0140-6736(90)90081-F	http://dx.doi.org/10.1016/0140-6736(90)90081-F			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CL815	1967731				2022-12-28	WOS:A1990CL81500015
J	CHAPMAN, RW; FORMAN, D; PETO, R; SMALLWOOD, R				CHAPMAN, RW; FORMAN, D; PETO, R; SMALLWOOD, R			LIVER-TRANSPLANTATION FOR ACUTE HEPATIC-FAILURE	LANCET			English	Review									AUSTIN HOSP,GASTROENTEROL UNIT,HEIDELBERG,VIC 3084,AUSTRALIA; IMPERIAL CANC RES FUND,CANC EPIDEMIOL UNIT,LONDON WC2A 3PX,ENGLAND; IMPERIAL CANC RES FUND,MRC,CLIN TRIAL SERV UNIT,LONDON WC2A 3PX,ENGLAND; RADCLIFFE INFIRM,NUFFIELD DEPT CLIN MED,OXFORD OX2 6HE,ENGLAND	Austin Research Institute; Florey Institute of Neuroscience & Mental Health; Cancer Research UK; Cancer Research UK; Radcliffe Infirmary; University of Oxford	CHAPMAN, RW (corresponding author), JOHN RADCLIFFE HOSP,DEPT GASTROENTEROL,OXFORD OX3 9DU,ENGLAND.							[Anonymous], 1979, GUT, V20, P620; BERGER RL, 1966, NEW ENGL J MED, V274, P497, DOI 10.1056/NEJM196603032740906; BERK PD, 1978, GASTROENTEROLOGY, V74, P789; BERK PD, 1988, GASTROENTEROLOGY, V94, P1228, DOI 10.1016/0016-5085(88)90018-2; BERNUAU J, 1986, HEPATOLOGY, V6, P648, DOI 10.1002/hep.1840060417; BISMUTH H, 1987, LANCET, V2, P674; BISMUTH H, 1987, ANN INTERN MED, V107, P337, DOI 10.7326/0003-4819-107-2-337; CHALMERS TC, 1976, CONTROVERSY SURGERY, P3; CHANG TMS, 1973, LANCET, V2, P1371; CHRISTENSEN E, 1984, SCAND J GASTROENTERO, V19, P90, DOI 10.1080/00365521.1984.12005691; DUCCI H, 1952, GASTROENTEROLOGY, V21, P357; EMOND JC, 1989, GASTROENTEROLOGY, V96, P1583, DOI 10.1016/0016-5085(89)90530-1; GAZZARD BG, 1974, LANCET, V1, P1301; GIMSON AES, 1986, HEPATOLOGY, V6, P288, DOI 10.1002/hep.1840060222; GIMSON AES, 1982, LANCET, V2, P681; GREGORY PB, 1976, NEW ENGL J MED, V294, P681, DOI 10.1056/NEJM197603252941301; OGRADY JG, 1988, GASTROENTEROLOGY, V94, P1186, DOI 10.1016/0016-5085(88)90011-X; OGRADY JG, 1989, GASTROENTEROLOGY, V97, P439, DOI 10.1016/0016-5085(89)90081-4; OPOLON DP, 1978, GUT, V19, P783; PELEMAN RR, 1987, HEPATOLOGY, V7, P484, DOI 10.1002/hep.1840070312; PETO R, 1976, BRIT J CANCER, V34, P585, DOI 10.1038/bjc.1976.220; POWELL LW, 1989, AUST NZ J MED, V19, P369, DOI 10.1111/j.1445-5994.1989.tb00284.x; RAKELA J, 1985, MAYO CLIN PROC, V60, P289, DOI 10.1016/S0025-6196(12)60534-5; REDEKER AG, 1976, NEW ENGL J MED, V294, P728; REDEKER AG, 1973, LANCET, V1, P3; RINGE B, 1986, TRANSPL P, V18, P86; SILK DBA, 1977, LANCET, V2, P1; Trey C, 1970, Prog Liver Dis, V3, P282; TYGSTRUP N, 1986, SEMIN LIVER DIS, V6, P129, DOI 10.1055/s-2008-1040596; TYGSTRUP N, 1981, CLIN GASTROENTEROL, V10, P151; VICKERS C, 1988, J HEPATOL, V7, P143, DOI 10.1016/S0168-8278(88)80475-6; WARE AJ, 1974, AM J GASTROENTEROL, V62, P130; 1987, LANCET, V2, P1248	33	75	77	0	1	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	JAN 6	1990	335	8680					32	35		10.1016/0140-6736(90)90150-4	http://dx.doi.org/10.1016/0140-6736(90)90150-4			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG766	1967338				2022-12-28	WOS:A1990CG76600015
J	GUDGEON, AM; HEATH, DI; HURLEY, P; JEHANLI, A; PATEL, G; WILSON, C; SHENKIN, A; AUSTEN, BM; IMRIE, CW; HERMONTAYLOR, J				GUDGEON, AM; HEATH, DI; HURLEY, P; JEHANLI, A; PATEL, G; WILSON, C; SHENKIN, A; AUSTEN, BM; IMRIE, CW; HERMONTAYLOR, J			TRYPSINOGEN ACTIVATION PEPTIDES ASSAY IN THE EARLY PREDICTION OF SEVERITY OF ACUTE-PANCREATITIS	LANCET			English	Article									ST GEORGE HOSP,SCH MED,DEPT SURG,LONDON SW17 0RE,ENGLAND; GLASGOW ROYAL INFIRM,DEPT SURG,GLASGOW G4 0SF,SCOTLAND; GLASGOW ROYAL INFIRM,DEPT BIOCHEM,GLASGOW G4 0SF,SCOTLAND	St Georges University London; University of Glasgow; University of Glasgow				Imrie, Clem/0000-0002-1190-7084				CORFIELD AP, 1985, LANCET, V2, P403; GUDGEON A M, 1988, Pancreas, V3, P599; GUY O, 1978, BIOCHEMISTRY-US, V17, P1669, DOI 10.1021/bi00602a014; HERMONTAYLOR J, 1985, SCAND J GASTROENTERO, V20, P39, DOI 10.3109/00365528509092226; HERMONTAYLOR J, 1981, CLIN CHIM ACTA, V109, P203, DOI 10.1016/0009-8981(81)90335-1; HURLEY P, 1988, GASTROENTEROLOGY, V94, pA198; HURLEY PR, 1988, J IMMUNOL METHODS, V111, P195, DOI 10.1016/0022-1759(88)90127-5; IMRIE CW, 1978, BRIT J SURG, V65, P337, DOI 10.1002/bjs.1800650514; MAYER AD, 1984, J CLIN PATHOL, V37, P207, DOI 10.1136/jcp.37.2.207; MCMAHON MJ, 1980, BRIT J SURG, V67, P22, DOI 10.1002/bjs.1800670107; OSBORNE DH, 1981, BRIT J SURG, V68, P758, DOI 10.1002/bjs.1800681103; RINDERKNECHT H, 1986, DIGEST DIS SCI, V31, P314, DOI 10.1007/BF01318124; STEER ML, 1988, ANNU REV MED, V39, P95, DOI 10.1146/annurev.me.39.020188.000523; STEINBERG WM, 1987, GASTROENTEROLOGY, V93, P1420, DOI 10.1016/0016-5085(87)90275-7; WILSON C, 1989, BRIT J SURG, V76, P177, DOI 10.1002/bjs.1800760224	15	228	231	0	2	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	JAN 6	1990	335	8680					4	8		10.1016/0140-6736(90)90135-R	http://dx.doi.org/10.1016/0140-6736(90)90135-R			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG766	1967341				2022-12-28	WOS:A1990CG76600002
J	MELLINS, E; SMITH, L; ARP, B; COTNER, T; CELIS, E; PIOUS, D				MELLINS, E; SMITH, L; ARP, B; COTNER, T; CELIS, E; PIOUS, D			DEFECTIVE PROCESSING AND PRESENTATION OF EXOGENOUS ANTIGENS IN MUTANTS WITH NORMAL HLA CLASS-II GENES	NATURE			English	Article									UNIV WASHINGTON,DEPT GENET,SEATTLE,WA 98195; UNIV WASHINGTON,DEPT IMMUNOL,SEATTLE,WA 98195; T CELL SCI,CAMBRIDGE,MA 02139	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	MELLINS, E (corresponding author), UNIV WASHINGTON,DEPT PEDIAT,SEATTLE,WA 98195, USA.							BABBITT BP, 1985, NATURE, V317, P359, DOI 10.1038/317359a0; BILLING RJ, 1976, J IMMUNOL, V117, P1589; BJORKMAN PJ, 1987, NATURE, V329, P506, DOI 10.1038/329506a0; BUUS S, 1988, SCIENCE, V242, P1045, DOI 10.1126/science.3194755; CELLS E, 1988, J IMMUNOL, V140, P1808; CLARK EA, 1984, LEUCOCYTE TYPING; COTNER T, 1988, J BIOL CHEM, V264, P11107; CRESSWELL P, 1977, EUR J IMMUNOL, V7, P636, DOI 10.1002/eji.1830070911; DEMOTZ S, 1989, J IMMUNOL, V142, P394; DORKEN B, IN PRESS LEUCOCYTE T, V4; GLADSTONE P, 1982, P NATL ACAD SCI-BIOL, V79, P1235, DOI 10.1073/pnas.79.4.1235; GLADSTONE P, 1978, NATURE, V271, P459, DOI 10.1038/271459a0; GLADSTONE P, 1980, SOMAT CELL GENET, V6, P285, DOI 10.1007/BF01538802; GUY K, 1982, EUR J IMMUNOL, V12, P942, DOI 10.1002/eji.1830121109; JOHNSON JP, 1982, J EXP MED, V156, P104, DOI 10.1084/jem.156.1.104; JONES PP, 1979, MOL IMMUNOL, V16, P51, DOI 10.1016/0161-5890(79)90027-0; KONING F, 1984, HUM IMMUNOL, V9, P221, DOI 10.1016/0198-8859(84)90027-2; LANE R, 1986, METHOD ENZYMOL, V121, P174; LANZAVECCHIA A, 1985, NATURE, V314, P537, DOI 10.1038/314537a0; LEVINE F, 1985, P NATL ACAD SCI USA, V82, P3741, DOI 10.1073/pnas.82.11.3741; MELLINS E, 1988, J EXP MED, V168, P1531, DOI 10.1084/jem.168.5.1531; MELLINS E, 1987, HUM IMMUNOL, V18, P211, DOI 10.1016/0198-8859(87)90086-3; MILLER AD, 1986, MOL CELL BIOL, V6, P2895, DOI 10.1128/MCB.6.8.2895; NOWELL J, 1985, J EXP MED, V162, P1371, DOI 10.1084/jem.162.4.1371; PIOUS D, 1985, J EXP MED, V162, P1193, DOI 10.1084/jem.162.4.1193; PIOUS D, 1983, BANBURY REP COLD SPR, V14, P61; SACHS JA, 1986, TISSUE ANTIGENS, V28, P199; SAITO T, 1987, NATURE, V325, P125, DOI 10.1038/325125a0; SHIMONKEVITZ R, 1983, J EXP MED, V158, P303, DOI 10.1084/jem.158.2.303; WATSON AJ, 1983, NATURE, V304, P358, DOI 10.1038/304358a0; ZIEGLER HK, 1982, P NATL ACAD SCI-BIOL, V79, P175, DOI 10.1073/pnas.79.1.175; ZIEGLER K, 1981, P NATL ACAD SCI USA, V79, P1869	32	251	253	0	6	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	JAN 4	1990	343	6253					71	74		10.1038/343071a0	http://dx.doi.org/10.1038/343071a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG614	1967485				2022-12-28	WOS:A1990CG61400057
J	LURAIN, JR				LURAIN, JR			FAMILIAL OVARIAN-CANCER	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							CARCINOMA				LURAIN, JR (corresponding author), NORTHWESTERN UNIV,SCH MED,CHICAGO,IL 60611, USA.							LURAIN JR, 1979, GYNECOL ONCOL, V8, P185, DOI 10.1016/0090-8258(79)90024-6; LYNCH HT, 1978, CANCER-AM CANCER SOC, V41, P1543, DOI 10.1002/1097-0142(197804)41:4<1543::AID-CNCR2820410444>3.0.CO;2-Y; LYNCH HT, 1982, OBSTET GYNECOL, V59, P589; PIVER MS, 1984, OBSTET GYNECOL, V64, P195; TOBACMAN JK, 1982, LANCET, V2, P795	5	2	2	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 18	1991	266	23					3343	3343						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GU964	1960838				2022-12-28	WOS:A1991GU96400038
J	TANG, WJ; GILMAN, AG				TANG, WJ; GILMAN, AG			TYPE-SPECIFIC REGULATION OF ADENYLYL CYCLASE BY G-PROTEIN BETA-GAMMA-SUBUNITS	SCIENCE			English	Article							PIG CEREBRAL-CORTEX; GTP-BINDING PROTEINS; ADENOSINE-3',5'-MONOPHOSPHATE METABOLISM; ALPHA-SUBUNITS; ADENOSINE; PURIFICATION; RESPONSES; HISTAMINE; ONTOGENY; NOREPINEPHRINE	Heterotrimeric guanine nucleotide-binding regulatory proteins (G proteins) dissociate into guanosine triphosphate (GTP)bound alpha-subunits and a complex of beta and gamma-subunits after interaction with receptors. The GTP-alpha subunit complex activates appropriate effectors, such as adenylyl cyclase, retinal phosphodiesterase, phospholipase C, and ion channels. G protein beta-gamma-subunits have been found to have regulatory effects on certain types of adenylyl cyclase. In the presence of G(s-alpha), the alpha-subunit of the G protein that activates adenylyl cyclase, one form of adenylyl cyclase was inhibited by beta-gamma, some forms were activated by beta-gamma and some forms were not affected by beta-gamma. These interactions suggest mechanisms for communication between distinct signal-transducing pathways.	UNIV TEXAS,SW MED CTR,DEPT PHARMACOL,DALLAS,TX 75235	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas				Tang, Wei-Jen/0000-0002-8267-8995	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034497, R37GM034497] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM34497] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAKALYAR HA, 1990, SCIENCE, V250, P1403, DOI 10.1126/science.2255909; BLUMER KJ, 1991, ANNU REV PHYSIOL, V53, P37; BROWN AM, 1990, ANNU REV PHYSIOL, V52, P197, DOI 10.1146/annurev.ph.52.030190.001213; CASEY PJ, 1989, BIOCHEMISTRY-US, V28, P611, DOI 10.1021/bi00428a029; FEINSTEIN P, IN PRESS P NATL ACAD; GAO B, IN PRESS P NATL ACAD; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; GILMAN AG, 1984, CELL, V36, P577, DOI 10.1016/0092-8674(84)90336-2; GRAZIANO MP, 1989, J BIOL CHEM, V264, P409; GROEBE DR, 1990, NUCLEIC ACIDS RES, V18, P4033, DOI 10.1093/nar/18.13.4033; ITOH H, 1991, J BIOL CHEM, V266, P16226; KATADA T, 1987, J BIOL CHEM, V262, P11897; KATADA T, 1984, J BIOL CHEM, V259, P3586; KITTS PA, 1990, NUCLEIC ACIDS RES, V18, P5667, DOI 10.1093/nar/18.19.5667; KRUPINSKI J, 1989, SCIENCE, V244, P1558, DOI 10.1126/science.2472670; KRUPINSKI J, COMMUNICATION; LOGOTHETIS DE, 1987, NATURE, V325, P321, DOI 10.1038/325321a0; PANG IH, 1989, P NATL ACAD SCI USA, V86, P7814, DOI 10.1073/pnas.86.20.7814; POSSEE RD, 1987, NUCLEIC ACIDS RES, V15, P10233, DOI 10.1093/nar/15.24.10233; RALL TW, 1987, MOL CELL BIOCHEM, V73, P157; SATTIN A, 1975, J PHARMACOL EXP THER, V192, P22; SHONK RF, 1987, MOL CELL BIOCHEM, V73, P141; SHONK RF, 1987, MOL CELL BIOCHEM, V73, P169; SIMON MI, 1991, SCIENCE, V252, P802, DOI 10.1126/science.1902986; SMIGEL MD, 1986, J BIOL CHEM, V261, P1976; STERNWEIS PC, 1981, J BIOL CHEM, V256, P1517; TANG WJ, 1991, J BIOL CHEM, V266, P8595	27	847	858	0	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	DEC 6	1991	254	5037					1500	1503		10.1126/science.1962211	http://dx.doi.org/10.1126/science.1962211			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT903	1962211				2022-12-28	WOS:A1991GT90300038
J	FAN, CM; MANIATIS, T				FAN, CM; MANIATIS, T			GENERATION OF P50 SUBUNIT OF NF-KAPPA-B BY PROCESSING OF P105 THROUGH AN ATP-DEPENDENT PATHWAY	NATURE			English	Article							INTERFERON GENE-REGULATION; ENHANCER-BINDING-PROTEIN; REL; PURIFICATION; MEDIATOR	THE transcription factor NF-kappa-B is a heterodimer consisting of two proteins encoded by different members of the rel gene family (p50 and p65) 1-7. The p50 subunit is unusual among DNA-binding proteins in that its functional form is encoded in an open reading frame of relative molecular mass 105,000 (p105; ref. 4). The N-terminal region of this open reading frame encodes p50, whereas the remaining C terminus contains ankyrin repeats. Although p50 binds to DNA, full-length p105 translated in vitro does not 4,5. The mechanism by which p50 is generated in vivo, and the fate of the C-terminal region of p105 have not been established. Here we show that functional p50 is produced by ATP-dependent proteolysis of p105. Moreover, we find that the C-terminal half of p 105 is not required for processing in vivo, and is rapidly degraded on processing. We propose that the C-terminal region of p105 is involved in the cytoplasmic assembly of the complex between the p50/p65 heterodimer and the inhibitor I-kappa-B.			FAN, CM (corresponding author), HARVARD UNIV,DEPT BIOCHEM & MOLEC BIOL,7 DIVIN AVE,CAMBRIDGE,MA 02138, USA.							BAEUERLE PA, 1989, GENE DEV, V3, P1689, DOI 10.1101/gad.3.11.1689; BALLARD DW, 1990, CELL, V63, P803, DOI 10.1016/0092-8674(90)90146-6; FAN CM, 1989, EMBO J, V8, P101, DOI 10.1002/j.1460-2075.1989.tb03353.x; FIELD J, 1988, MOL CELL BIOL, V8, P2159, DOI 10.1128/MCB.8.5.2159; GHOSH S, 1990, CELL, V62, P1019, DOI 10.1016/0092-8674(90)90276-K; HARLOW E, 1988, ANTIBODIES LABORATOR; HASKILL S, 1991, CELL, V65, P1281, DOI 10.1016/0092-8674(91)90022-Q; HERSHKO A, 1988, J BIOL CHEM, V263, P15237; INOUE J, 1991, P NATL ACAD SCI USA, V88, P3715, DOI 10.1073/pnas.88.9.3715; KAWAKAMI K, 1988, P NATL ACAD SCI USA, V85, P4700, DOI 10.1073/pnas.85.13.4700; KIERAN M, 1990, CELL, V62, P1007, DOI 10.1016/0092-8674(90)90275-J; LENARDO MJ, 1989, CELL, V57, P287, DOI 10.1016/0092-8674(89)90966-5; LENARDO MJ, 1989, CELL, V58, P227, DOI 10.1016/0092-8674(89)90833-7; MUNRO S, 1987, CELL, V48, P899, DOI 10.1016/0092-8674(87)90086-9; NOLAN GP, 1991, CELL, V64, P961, DOI 10.1016/0092-8674(91)90320-X; RECHSTEINER M, 1991, CELL, V66, P615, DOI 10.1016/0092-8674(91)90104-7; RIVIERE Y, 1991, NATURE, V350, P625, DOI 10.1038/350625a0; RUBEN SM, 1991, SCIENCE, V251, P1490, DOI 10.1126/science.2006423; TANAKA M, 1990, CELL, V60, P375, DOI 10.1016/0092-8674(90)90589-7	19	282	292	0	12	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	DEC 5	1991	354	6352					395	398		10.1038/354395a0	http://dx.doi.org/10.1038/354395a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT761	1956402				2022-12-28	WOS:A1991GT76100052
J	HENKIN, R				HENKIN, R			COOLING THE BURN FROM HOT PEPPERS	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter											HENKIN, R (corresponding author), TASTE & SMELL CLIN,WASHINGTON,DC, USA.								0	10	10	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 20	1991	266	19					2766	2766						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GP691	1942431				2022-12-28	WOS:A1991GP69100037
J	WONG, MMY; FOSKETT, JK				WONG, MMY; FOSKETT, JK			OSCILLATIONS OF CYTOSOLIC SODIUM DURING CALCIUM OSCILLATIONS IN EXOCRINE ACINAR-CELLS	SCIENCE			English	Article							MANDIBULAR SALIVARY-GLAND; AGONIST-INDUCED ACTIVATION; NA+/H+ EXCHANGE; INTRACELLULAR PH; SECRETION; AMILORIDE; FLUID	In acinar cells from rat salivary glands, cholinergic agonists cause oscillations in cytoplasmic free calcium concentration, which then drive oscillations of cell volume that reflect oscillating cell solute content and fluid secretion. By quantitative fluorescence ratio microscopy of an intracellular indicator dye for sodium, it has now been shown that large amplitude oscillations of sodium concentration were associated with the calcium and cell volume oscillations. Both calcium and sodium oscillations were dependent on the continued presence of calcium in the extracellular medium and were abolished by the specific sodium-potassium adenosine triphosphatase inhibitor ouabain. Thus, calcium oscillations in salivary acinar cells, by modulating the activities of ion transport pathways in the plasma membrane, can cause significant oscillations of monovalent ions that may in turn feed back to regulate calcium oscillations and fluid secretion.	HOSP SICK CHILDREN,RES INST,DIV CELL BIOL,555 UNIV AVE,TORONTO M5G 1X8,ONTARIO,CANADA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)			Foskett, Kevin/R-2549-2019	Foskett, J. Kevin/0000-0002-8854-0268				BERRIDGE MJ, 1990, J BIOL CHEM, V265, P9583; CASE RM, 1984, J PHYSIOL-LONDON, V349, P619, DOI 10.1113/jphysiol.1984.sp015177; DISSING S, 1990, AM J PHYSIOL, V259, pG1044, DOI 10.1152/ajpgi.1990.259.6.G1044; FOSKETT JK, 1988, AM J PHYSIOL, V255, pC566, DOI 10.1152/ajpcell.1988.255.4.C566; FOSKETT JK, 1990, AM J PHYSIOL, V259, pC998; FOSKETT JK, 1991, J BIOL CHEM, V266, P14535; FOSKETT JK, 1989, SCIENCE, V244, P1582, DOI 10.1126/science.2500708; FOSKETT JK, 1991, J BIOL CHEM, V266, P2778; FOSKETT JK, IN PRESS AM J PHYSL; JACOB R, 1990, BIOCHIM BIOPHYS ACTA, V1052, P427, DOI 10.1016/0167-4889(90)90152-4; LAU KR, 1990, J PHYSIOL-LONDON, V425, P407, DOI 10.1113/jphysiol.1990.sp018111; MANGANEL M, 1989, J MEMBRANE BIOL, V111, P191, DOI 10.1007/BF01871782; MANGANEL M, 1990, J BIOL CHEM, V265, P4284; MARTINEZ JR, 1989, EUR J PHARMACOL, V164, P335, DOI 10.1016/0014-2999(89)90474-3; MELVIN JE, 1988, J BIOL CHEM, V263, P19564; MINTA A, 1989, J BIOL CHEM, V264, P19449; NOVAK I, 1989, PFLUG ARCH EUR J PHY, V414, P68, DOI 10.1007/BF00585628; PIRANI D, 1987, PFLUG ARCH EUR J PHY, V408, P178, DOI 10.1007/BF00581349; POULSEN JH, 1987, J DENT RES, V66, P608, DOI 10.1177/00220345870660024401; SMAJE LH, 1986, PFLUEGERS ARCH, V406, P4925; SOLTOFF SP, 1989, J GEN PHYSIOL, V93, P285, DOI 10.1085/jgp.93.2.285; STEWARD MC, 1989, PFLUG ARCH EUR J PHY, V414, P200, DOI 10.1007/BF00580964; TURNER RJ, 1986, J MEMBRANE BIOL, V94, P143, DOI 10.1007/BF01871194; Wong M, UNPUB	24	60	60	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	NOV 15	1991	254	5034					1014	1016		10.1126/science.1948071	http://dx.doi.org/10.1126/science.1948071			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GP883	1948071				2022-12-28	WOS:A1991GP88300047
J	SPAINK, HP; SHEELEY, DM; VANBRUSSEL, AAN; GLUSHKA, J; YORK, WS; TAK, T; GEIGER, O; KENNEDY, EP; REINHOLD, VN; LUGTENBERG, BJJ				SPAINK, HP; SHEELEY, DM; VANBRUSSEL, AAN; GLUSHKA, J; YORK, WS; TAK, T; GEIGER, O; KENNEDY, EP; REINHOLD, VN; LUGTENBERG, BJJ			A NOVEL HIGHLY UNSATURATED FATTY-ACID MOIETY OF LIPO-OLIGOSACCHARIDE SIGNALS DETERMINES HOST SPECIFICITY OF RHIZOBIUM	NATURE			English	Article							LEGUMINOSARUM BV VICIAE; SYM PLASMID PRL1JI; ROOT EXUDATE; NODULATION REGION; NOD GENE; MELILOTI; PROTEIN; ENCODES; NODULES; MUTANTS	In Rhizobium leguminosarum biovar viciae, the nodABC and nodFEL operons are involved in the production of lipo-oligosaccharide signals which mediate host specificity. The structure of these metabolites and those produced in nod mutants links the nodE and nodL genes to specific chemical features of the signal molecules. A nodE-determined, highly unsaturated fatty acid and a nodL-determined O-acetyl substituent are essential for the ability of the signals to induce nodule meristems on the host plant Vicia sativa.	HARVARD UNIV,SCH PUBL HLTH,DEPT NUTR,BOSTON,MA 02115; COMPLEX CARBOHYDRATE RES CTR,ATHENS,GA 30602; HARVARD UNIV,SCH MED,DEPT BIOL CHEM & MOLEC PHARMACOL,BOSTON,MA 02115	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School	SPAINK, HP (corresponding author), LEIDEN UNIV,DEPT PLANT MOLEC BIOL,NONNENST 3,2311 VJ LEIDEN,NETHERLANDS.		Geiger, Otto/F-6356-2019; Spaink, Herman P./S-3586-2017	Geiger, Otto/0000-0002-7794-1568; Spaink, Herman P./0000-0003-4128-9501				BARKER SA, 1958, J CHEM SOC, V451, P2218; BIBB MJ, 1989, EMBO J, V8, P2727, DOI 10.1002/j.1460-2075.1989.tb08414.x; Breitmaier E., 1987, CARBON 13 NMR SPECTR; CIUCANU I, 1984, CARBOHYD RES, V131, P209, DOI 10.1016/0008-6215(84)85242-8; DEMAAGD RA, 1989, J BACTERIOL, V171, P6764, DOI 10.1128/jb.171.12.6764-6770.1989; DOWNIE JA, 1983, EMBO J, V2, P947, DOI 10.1002/j.1460-2075.1983.tb01526.x; DOWNIE JA, 1990, MOL GEN GENET, V222, P81, DOI 10.1007/BF00283027; DOWNIE JA, 1989, MOL MICROBIOL, V3, P1649, DOI 10.1111/j.1365-2958.1989.tb00150.x; ECONOMOU A, 1990, EMBO J, V9, P349, DOI 10.1002/j.1460-2075.1990.tb08117.x; FINAN TM, 1985, CELL, V40, P869, DOI 10.1016/0092-8674(85)90346-0; GEIGER O, 1991, J BACTERIOL, V173, P2872, DOI 10.1128/JB.173.9.2872-2878.1991; HAHN MG, IN PRESS MOL PLANT P, pCH2; HOOYKAAS PJJ, 1982, PLASMID, V8, P73, DOI 10.1016/0147-619X(82)90042-7; LEROUGE P, 1990, NATURE, V344, P781, DOI 10.1038/344781a0; LONG SR, 1989, CELL, V56, P203, DOI 10.1016/0092-8674(89)90893-3; MUSSO RE, 1973, BIOCHEMISTRY-US, V12, P553, DOI 10.1021/bi00727a031; RECOURT K, 1991, PLANT MOL BIOL, V16, P841, DOI 10.1007/BF00015076; RECOURT K, 1991, THESIS U LEIDEN; ROCHE P, 1991, J BIOL CHEM, V266, P10933; ROCHE P, 1991, ADV MOL GENETICS PLA, V1, P119; SCHWEDOCK J, 1990, NATURE, V348, P644, DOI 10.1038/348644a0; SHEARMAN CA, 1986, EMBO J, V5, P647, DOI 10.1002/j.1460-2075.1986.tb04262.x; SHEELEY DM, 1991, ANAL BIOCHEM, V193, P240, DOI 10.1016/0003-2697(91)90016-M; SPAINK HP, 1989, EMBO J, V8, P2811, DOI 10.1002/j.1460-2075.1989.tb08427.x; SPAINK HP, 1987, PLANT MOL BIOL, V9, P27, DOI 10.1007/BF00017984; SPAINK HP, 1991, ADV MOL GENETICS PLA, V1, P142; SPAINK HP, IN PRESS MOL PL MICR; STELLNER K, 1973, ARCH BIOCHEM BIOPHYS, V155, P464, DOI 10.1016/0003-9861(73)90138-0; TRUCHET G, 1989, PROTOPLASMA, V149, P82, DOI 10.1007/BF01322980; TRUCHET G, 1991, NATURE, V351, P670, DOI 10.1038/351670a0; TRUCHET G, 1980, DIFFERENTIATION, V16, P163, DOI 10.1111/j.1432-0436.1980.tb01072.x; VANBRUSSEL AAN, 1986, J BACTERIOL, V165, P517, DOI 10.1128/jb.165.2.517-522.1986; VANBRUSSEL AAN, 1990, J BACTERIOL, V172, P5394, DOI 10.1128/jb.172.9.5394-5401.1990; WIJFFELMAN CA, 1985, ARCH MICROBIOL, V143, P225, DOI 10.1007/BF00411240	34	452	468	3	40	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	NOV 14	1991	354	6349					125	130		10.1038/354125a0	http://dx.doi.org/10.1038/354125a0			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GP880	1944592				2022-12-28	WOS:A1991GP88000051
J	SCHLOTTERER, C; AMOS, B; TAUTZ, D				SCHLOTTERER, C; AMOS, B; TAUTZ, D			CONSERVATION OF POLYMORPHIC SIMPLE SEQUENCE LOCI IN CETACEAN SPECIES	NATURE			English	Article							DNA; EVOLUTION	LENGTH polymorphisms within simple-sequence loci occur ubiquitously in non-coding eukaryotic DNA and can be highly informative in the analysis of natural populations 1-4. Simple-sequence length polymorphisms (SSLP) in the long-finned pilot whale Globicephala melas (Delphinidae) have provided useful information on the mating system as well as on the genetic structure of populations 5. We have therefore tested whether the polymerase chain reaction primers designed for Globicephala could also be used to uncover variability in other whale species. Homologous loci could indeed be amplified from a diverse range of whales, including all toothed (Odontoceti) and baleen whales (Mysticeti) tested. Cloning and sequencing these loci from 11 different species revealed an unusually high conservation of sequences flanking the simple-sequence stretches, averaging 3.2% difference over 35-40 Myr. This represents the lowest divergence rate for neutral nucleotide positions found for any species group so far and raises the possible need for a re-evaluation of the age of the modern whales. On the other hand, the high conservation of non-coding sequences in whales simplifies the application of SSLP DNA fingerprinting in cetacean species, as primers designed for one species will often uncover variability in other species.	UNIV MUNICH,INST GENET,W-8000 MUNICH 19,GERMANY; UNIV CAMBRIDGE,DEPT GENET,CAMBRIDGE CB2 3EH,ENGLAND	University of Munich; University of Cambridge			Tautz, Diethard/D-4304-2011; Schlötterer, Christian/Q-5264-2019; Schlötterer, Christian/G-6326-2010; Tautz, Diethard/H-8436-2014	Schlötterer, Christian/0000-0003-4710-6526; Schlötterer, Christian/0000-0003-4710-6526; Tautz, Diethard/0000-0002-0460-5344				Amos W., 1991, REP INT WHAL COMMN, P255; BARNES LG, 1985, MAR MAMMAL SCI, V1, P15, DOI 10.1111/j.1748-7692.1985.tb00530.x; BULMER M, 1987, NATURE, V325, P728, DOI 10.1038/325728a0; FORDYCE RE, 1980, PALAEOGEOGR PALAEOCL, V31, P319, DOI 10.1016/0031-0182(80)90024-3; HOELZEL AR, 1988, NATURE, V333, P305, DOI 10.1038/333305a0; HOELZEL AR, 1991, REP INT WHALING COMM, V13, P171; LI WH, 1987, J MOL EVOL, V25, P330, DOI 10.1007/BF02603118; LITT M, 1989, AM J HUM GENET, V44, P397; MOORE SS, 1991, GENOMICS, V10, P654, DOI 10.1016/0888-7543(91)90448-N; PENTREATH RJ, 1979, 3RD P NEA SEM MAR EC; SAKAI RK, 1988, SCIENCE, V239, P487; TAUTZ D, 1990, BIOESSAYS, V12, P44, DOI 10.1002/bies.950120111; TAUTZ D, 1984, NUCLEIC ACIDS RES, V12, P4127, DOI 10.1093/nar/12.10.4127; TAUTZ D, 1986, NATURE, V322, P652, DOI 10.1038/322652a0; TAUTZ D, 1989, NUCLEIC ACIDS RES, V17, P6463, DOI 10.1093/nar/17.16.6463; WEBER JL, 1989, AM J HUM GENET, V44, P388; WILSON AC, 1987, TRENDS GENET, V3, P241, DOI 10.1016/0168-9525(87)90257-5	17	292	320	1	32	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	NOV 7	1991	354	6348					63	65		10.1038/354063a0	http://dx.doi.org/10.1038/354063a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN829	1944571				2022-12-28	WOS:A1991GN82900058
J	DESCOMBES, P; SCHIBLER, U				DESCOMBES, P; SCHIBLER, U			A LIVER-ENRICHED TRANSCRIPTIONAL ACTIVATOR PROTEIN, LAP, AND A TRANSCRIPTIONAL INHIBITORY PROTEIN, LIP, ARE TRANSLATED FROM THE SAME MESSENGER-RNA	CELL			English	Article							DNA-BINDING PROTEINS; LEUCINE ZIPPER PROTEINS; AUG INITIATOR CODON; EUKARYOTIC RIBOSOMES; MAMMALIAN-CELLS; C/EBP FAMILY; ALBUMIN GENE; SEQUENCE; EXPRESSION; DOMAIN	LAP, a transcriptional activator, and LIP, a transcriptional repressor, are translated from a single mRNA species by using two AUGs within the same reading frame. These two proteins share the 145 C-terminal amino acids that contain the basic DNA-binding domain and the leucine zipper dimerization helix. Probably owing to its higher affinity for its DNA cognate sequences, LIP can attenuate the transcriptional stimulation by LAP in substoichiometric amounts. As revealed by transient transfection experiments, a moderate increase in the LAP/LIP ratio results in a significantly higher transcriptional activation of an appropriate target gene. The LAP/LIP ratio increases about 5-fold during terminal rat liver differentiation and is thus likely to modulate the activity of LAP in the intact animal.			DESCOMBES, P (corresponding author), DEPT BIOL MOLEC SCI 2,30 QUAI ERNEST ANSERMET,CH-1211 GENEVA 4,SWITZERLAND.							ACKLAND P, 1990, NATURE, V343, P662; AKIRA S, 1990, EMBO J, V9, P1897, DOI 10.1002/j.1460-2075.1990.tb08316.x; AUWERX J, 1991, CELL, V64, P983, DOI 10.1016/0092-8674(91)90322-P; BAEUERLE PA, 1988, SCIENCE, V242, P540, DOI 10.1126/science.3140380; BAICHWAL VR, 1990, CELL, V63, P815, DOI 10.1016/0092-8674(90)90147-7; BENEZRA R, 1990, CELL, V61, P49, DOI 10.1016/0092-8674(90)90214-Y; BIRKENMEIER EH, 1989, GENE DEV, V3, P1146, DOI 10.1101/gad.3.8.1146; BOUCHE G, 1987, P NATL ACAD SCI USA, V84, P6770, DOI 10.1073/pnas.84.19.6770; CHANG CJ, 1990, MOL CELL BIOL, V10, P6642, DOI 10.1128/MCB.10.12.6642; CHOE J, 1989, J VIROL, V63, P1743, DOI 10.1128/JVI.63.4.1743-1755.1989; CLEMENS MJ, 1984, TRANSCRIPTION TRANSL, P211; DESCOMBES P, 1990, GENE DEV, V4, P1541, DOI 10.1101/gad.4.9.1541; FALVEY E, 1991, FASEB J, V5, P309, DOI 10.1096/fasebj.5.3.2001790; FRIEDMAN AD, 1989, GENE DEV, V3, P1314, DOI 10.1101/gad.3.9.1314; HANN SR, 1988, CELL, V52, P185, DOI 10.1016/0092-8674(88)90507-7; HINNEBUSCH AG, 1990, TRENDS BIOCHEM SCI, V15, P148, DOI 10.1016/0968-0004(90)90215-W; HU JC, 1990, SCIENCE, V250, P1400, DOI 10.1126/science.2147779; JOHNSON PF, 1989, ANNU REV BIOCHEM, V58, P799, DOI 10.1146/annurev.biochem.58.1.799; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P3873, DOI 10.1093/nar/12.9.3873; KOZAK M, 1981, NUCLEIC ACIDS RES, V9, P5233, DOI 10.1093/nar/9.20.5233; KOZAK M, 1986, CELL, V47, P481, DOI 10.1016/0092-8674(86)90609-4; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAMBERT PF, 1990, J VIROL, V64, P950, DOI 10.1128/JVI.64.2.950-956.1990; LAMBERT PF, 1987, CELL, V50, P69, DOI 10.1016/0092-8674(87)90663-5; LANDSCHULZ WH, 1989, SCIENCE, V243, P1681, DOI 10.1126/science.2494700; LANDSCHULZ WH, 1988, GENE DEV, V2, P786, DOI 10.1101/gad.2.7.786; LICHTSTEINER S, 1987, CELL, V51, P963, DOI 10.1016/0092-8674(87)90583-6; MITCHELL PJ, 1989, SCIENCE, V245, P371, DOI 10.1126/science.2667136; MUELLER CR, 1990, CELL, V61, P279, DOI 10.1016/0092-8674(90)90808-R; NAKABEPPU Y, 1991, CELL, V64, P751, DOI 10.1016/0092-8674(91)90504-R; PEABODY DS, 1989, J BIOL CHEM, V264, P5031; POLI V, 1990, CELL, V63, P643, DOI 10.1016/0092-8674(90)90459-R; Ptashne M., 1986, A GENETIC SWITCH; RUSCONI S, 1990, GENE, V89, P211, DOI 10.1016/0378-1119(90)90008-F; Sambrook J, 1989, MOL CLONING LABORATO; SARIS CJM, 1991, EMBO J, V10, P655, DOI 10.1002/j.1460-2075.1991.tb07994.x; STRUHL G, 1989, CELL, V57, P1259, DOI 10.1016/0092-8674(89)90062-7; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; SUN XH, 1991, CELL, V64, P459, DOI 10.1016/0092-8674(91)90653-G; TREACY MN, 1991, NATURE, V350, P577, DOI 10.1038/350577a0; VINSON CR, 1989, SCIENCE, V246, P911, DOI 10.1126/science.2683088; WUARIN J, 1990, CELL, V63, P1257, DOI 10.1016/0092-8674(90)90421-A	44	925	938	2	11	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	NOV 1	1991	67	3					569	579		10.1016/0092-8674(91)90531-3	http://dx.doi.org/10.1016/0092-8674(91)90531-3			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GN664	1934061				2022-12-28	WOS:A1991GN66400013
J	LENARDO, MJ				LENARDO, MJ			INTERLEUKIN-2 PROGRAMS MOUSE ALPHA-BETA-LYMPHOCYTES-T FOR APOPTOSIS	NATURE			English	Article							STAPHYLOCOCCAL ENTEROTOXIN-B; CELL ANTIGEN RECEPTOR; STIMULATORY FACTOR-I; MONOCLONAL-ANTIBODY; PROLIFERATION; INVIVO; ACTIVATION; CLONES; UNRESPONSIVENESS; THYMOCYTES	ANTIGEN receptor stimulation of mature alpha-beta-T lymphocytes can lead either to proliferation or death 1-4. Programmed cell death, termed apoptosis, leads to the clonal deletion of both thymocytes and mature T cells that establishes tolerance 5-9. How a mature T cell selects between proliferation and death is not understood. Here I show that interleukin-2 (IL-2) is a critical determinant of the choice between these two fates. Both CD4+ and CD8+ T cells previously exposed to IL-2 undergo apoptosis after antigen-receptor stimulation. Antibody blockade of IL-2 but not IL-4 reverses the marked reduction of lymph node V-beta-38+ T cells caused in mice by the bacterial superantigen Staphylococcus aureus enterotoxin B. IL-2 may thus participate in a feedback regulatory mechanism by predisposing mature T lymphocytes to apoptosis.			LENARDO, MJ (corresponding author), NIAID,IMMUNOL LAB,BLDG 10,RM 11N311,BETHESDA,MD 20892, USA.							ASHWELL JD, 1986, J IMMUNOL, V137, P2572; CRISPE IN, 1985, NATURE, V317, P627, DOI 10.1038/317627a0; FINKELMAN FD, 1986, P NATL ACAD SCI USA, V83, P9675, DOI 10.1073/pnas.83.24.9675; HASKINS K, 1984, J EXP MED, V160, P452, DOI 10.1084/jem.160.2.452; HECHT TT, 1983, J IMMUNOL, V131, P1049; JANSSEN O, 1991, J IMMUNOL, V146, P35; JONES LA, 1990, SCIENCE, V250, P1726, DOI 10.1126/science.2125368; KANAGAWA O, 1989, J EXP MED, V170, P1513, DOI 10.1084/jem.170.5.1513; KAWABE Y, 1991, NATURE, V349, P245, DOI 10.1038/349245a0; LEO O, 1987, P NATL ACAD SCI USA, V84, P1374, DOI 10.1073/pnas.84.5.1374; LIU Y, 1990, Journal of Experimental Medicine, V172, P1735, DOI 10.1084/jem.172.6.1735; MACDONALD HR, 1990, NATURE, V343, P642, DOI 10.1038/343642a0; MALEK TR, 1984, J IMMUNOL, V133, P1976; MARRACK P, 1990, J EXP MED, V171, P455, DOI 10.1084/jem.171.2.455; MONOD J, 1961, COLD SPRING HARB SYM, V26, P389, DOI 10.1101/SQB.1961.026.01.048; MUELLER DL, 1989, J IMMUNOL, V142, P2617; MURPHY KM, 1990, SCIENCE, V250, P1720, DOI 10.1126/science.2125367; NAU GJ, 1987, J IMMUNOL, V139, P114; OHARA J, 1985, NATURE, V315, P333, DOI 10.1038/315333a0; PENIT C, 1988, J IMMUNOL, V140, P3315; ROCHA B, 1991, SCIENCE, V251, P1225, DOI 10.1126/science.1900951; RUSSELL JH, 1991, P NATL ACAD SCI USA, V88, P2151, DOI 10.1073/pnas.88.6.2151; SMITH CA, 1989, NATURE, V337, P181, DOI 10.1038/337181a0; STAERZ UD, 1985, J IMMUNOL, V134, P3994; TENTORI L, 1988, J EXP MED, V168, P1741, DOI 10.1084/jem.168.5.1741; WEAVER CT, 1988, P NATL ACAD SCI USA, V85, P8181, DOI 10.1073/pnas.85.21.8181; WEBB S, 1990, CELL, V63, P1249, DOI 10.1016/0092-8674(90)90420-J; WHITE J, 1989, CELL, V56, P27, DOI 10.1016/0092-8674(89)90980-X; WILLIAMS ME, 1990, J IMMUNOL, V144, P1208	29	970	1004	0	12	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	OCT 31	1991	353	6347					858	861		10.1038/353858a0	http://dx.doi.org/10.1038/353858a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM732	1944559				2022-12-28	WOS:A1991GM73200064
J	RAMSAY, LE; YEO, WW; JACKSON, PR				RAMSAY, LE; YEO, WW; JACKSON, PR			DIETARY REDUCTION OF SERUM-CHOLESTEROL CONCENTRATION - TIME TO THINK AGAIN	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CORONARY HEART-DISEASE; PRIMARY PREVENTION; PLASMA-CHOLESTEROL; RISK-FACTORS; PROJECT; TRIAL; INTERVENTION; MORTALITY; FAT; MEN	Objective - To evaluate the long term efficacy of diets in lowering serum cholesterol concentration. Design - Descriptive overview of 16 published controlled trials of six months' duration or longer. Setting - Trials had been conducted in hospital clinics (6), industry (3), mental hospitals or institutions (3), and in general populations (4). Patients - Trials had been conducted in high risk subjects (5), in unselected healthy subjects (6), or for secondary prevention in patients with coronary heart disease (5). Women were included in only four trials. Interventions - Diets equivalent to the step 1 diet were employed in eight trials, with individual intervention by dietitians (3) or occupational physicians (2) or with population advice (3). Intensive diets which were more rigorous than the step 2 diet were employed in eight trials. Main outcome measures - Net change in serum total cholesterol concentration in subjects receiving treatment with diet compared with values in control of subjects after six months to 10 years. Results - In five trials with the step 1 diet as individual intervention the net reduction in serum cholesterol concentration ranged from 0% to 4% over six months to six years. In trials with population education reductions in cholesterol concentrations were 0.6-2.0% over five to 10 years. When population and individual dietary advice were combined changes in cholesterol concentration ranged from a fall of 2.1% to a rise of 1.0% over four to 10 years. Diets more intensive than the step 2 diet reduced serum cholesterol concentration by 13% over five years in selected high risk men in the population; by 6.5-15.1% over two to five years in hospital outpatients; and by 12.8-15.5% over one to four and a half years in patients in institutions. Conclusions - The response to a step 1 diet is too small to have any value in the clinical management of adults with serum cholesterol concentrations above 6.5 mmol/l. Current guidelines recommend screening of serum cholesterol concentration in healthy subjects, followed by treatment with a step 1 diet. The guidelines should be reviewed to provide a more realistic estimate of the effect of a step 1 diet and of the likely need for lipid lowering drugs,			RAMSAY, LE (corresponding author), UNIV SHEFFIELD, ROYAL HALLAMSHIRE HOSP, DEPT RADIAT PHYS, PHARMACOL & THERAPEUT SECT, SHEFFIELD S10 2JF, S YORKSHIRE, ENGLAND.			Yeo, Wilfred/0000-0001-9554-5203				AHRENS EH, 1979, LANCET, V2, P1345; AHRENS EH, 1985, LANCET, V1, P1085; [Anonymous], 1965, LANCET, V2, P501; [Anonymous], 1968, LANCET, V2, P693; BERNSTEIN MJ, 1985, JAMA-J AM MED ASSOC, V253, P2080; BRETT AS, 1989, NEW ENGL J MED, V321, P676, DOI 10.1056/NEJM198909073211009; BURR ML, 1989, LANCET, V2, P757; CLEEMAN JI, 1988, ARCH INTERN MED, V148, P36, DOI 10.1001/archinte.148.1.36; CURZIO JL, 1989, J HYPERTENS, V7, pS254, DOI 10.1097/00004872-198900076-00123; DAYTON S, 1968, LANCET, V2, P1060, DOI 10.1016/S0140-6736(68)91531-6; EDINGTON J, 1987, BMJ-BRIT MED J, V294, P333, DOI 10.1136/bmj.294.6568.333; FARQUHAR JW, 1990, JAMA-J AM MED ASSOC, V264, P359, DOI 10.1001/jama.264.3.359; FEHILY AM, 1987, HUM NUTR-APPL NUTR, V41A, P319; FRANTZ ID, 1989, ARTERIOSCLEROSIS, V9, P129, DOI 10.1161/01.ATV.9.1.129; HJERMANN I, 1981, LANCET, V2, P1303; Hjermann I, 1980, J Oslo City Hosp, V30, P3; ISLES CG, 1989, BMJ-BRIT MED J, V298, P920, DOI 10.1136/bmj.298.6678.920; JONES DB, 1982, BRIT MED J, V284, P1233, DOI 10.1136/bmj.284.6324.1233; KJELSBERG MO, 1982, JAMA-J AM MED ASSOC, V248, P1465; KRISTIANSEN IS, 1991, BRIT MED J, V302, P1119, DOI 10.1136/bmj.302.6785.1119; Leren P, 1966, Acta Med Scand Suppl, V466, P1; LEWIS B, 1987, EUR HEART J, V8, P77; LEWIS B, 1980, BMJ-BRIT MED J, V281, P177, DOI 10.1136/bmj.281.6234.177; LEWIS B, 1989, HDB CORONARY HEART D; MANT D, 1991, BRIT MED J, V302, P1057, DOI 10.1136/bmj.302.6784.1057; MCNAMARA DJ, 1982, ARCH INTERN MED, V142, P1121, DOI 10.1001/archinte.142.6.1121; MULDOON MF, 1990, BMJ-BRIT MED J, V301, P309, DOI 10.1136/bmj.301.6747.309; PEDOE HT, 1982, EUR HEART J, V3, P184; PUSKA P, 1979, BRIT MED J, V2, P1173, DOI 10.1136/bmj.2.6199.1173; PUSKA P, 1983, BRIT MED J, V287, P1840, DOI 10.1136/bmj.287.6408.1840; REID V, 1987, HUM NUTR-APPL NUTR, V41A, P311; REID V, 1984, HUM NUTR-APPL NUTR, V38A, P279; RELMAN AS, 1988, NEW ENGL J MED, V318, P245, DOI 10.1056/NEJM198801283180410; ROSE G, 1983, LANCET, V1, P1062; ROSE G, 1986, LANCET, V1, P869; ROSE G, 1980, BRIT MED J, V1, P747; ROSE GA, 1965, BMJ-BRIT MED J, V1, P1531, DOI 10.1136/bmj.1.5449.1531; SHAPER AG, 1985, BRIT MED J, V291, P480, DOI 10.1136/bmj.291.6493.480; SHAPER AG, 1986, BRIT MED J, V293, P474, DOI 10.1136/bmj.293.6545.474; SHEPHERD J, 1987, BRIT MED J, V295, P1245, DOI 10.1136/bmj.295.6608.1245; STEINBERG D, 1985, LANCET, V2, P205; THOMPSON GR, 1989, BRIT J HOSP MED, V42, P268; THOMPSON GR, 1989, PRESCRIBERS J, V29, P221; TUNSTALLPEDOE H, 1988, CURR OPIN CARDIOL, V3, P550; TUNSTALLPEDOE H, 1989, BRIT MED J, V299, P625, DOI 10.1136/bmj.299.6699.625; TURPEINEN O, 1979, INT J EPIDEMIOL, V8, P99, DOI 10.1093/ije/8.2.99; TYROLER HA, 1989, AM J MED, V87, pS14, DOI 10.1016/S0002-9343(89)80594-7; WILHELMSEN L, 1986, EUR HEART J, V7, P279, DOI 10.1093/oxfordjournals.eurheartj.a062065; 1987, BRIT HEART J, V57, P188; 1988, LANET, V1, P333; 1987, DRUG THER B, V25, P89; 1990, BLOOD CHOLESTEROL TE	52	200	200	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 19	1991	303	6808					953	957		10.1136/bmj.303.6808.953	http://dx.doi.org/10.1136/bmj.303.6808.953			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GL127	1954418	Green Published, Bronze			2022-12-28	WOS:A1991GL12700020
J	TOGNONI, G; ALLI, C; AVANZINI, F; BETTELLI, G; COLOMBO, F; CORSO, R; MARCHIOLI, R; ZUSSINO, A				TOGNONI, G; ALLI, C; AVANZINI, F; BETTELLI, G; COLOMBO, F; CORSO, R; MARCHIOLI, R; ZUSSINO, A			RANDOMIZED CLINICAL-TRIALS IN GENERAL-PRACTICE - LESSONS FROM A FAILURE	BRITISH MEDICAL JOURNAL			English	Article							HYPERTENSION; PHARMACOLOGY; EXPERIENCE		MARIO NEGRI INST PHARMACOL RES,CLIN PHARMACOL LAB,I-20157 MILAN,ITALY; CONSORZIO MARIO NEGRI SUD,S MARIA IMBARO,CHIETI,ITALY	Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Consorzio Mario Negri Sud				Avanzini, Fausto/0000-0002-4029-2891				[Anonymous], 1990, Lancet, V336, P65; [Anonymous], 1986, Lancet, V1, P397; AVANZINI F, 1989, CLIN CARDIOL, V12, P283; AVANZINI F, 1987, BRIT MED J, V294, P157, DOI 10.1136/bmj.294.6565.157; COOPE J, 1984, BMJ-BRIT MED J, V288, P880, DOI 10.1136/bmj.288.6421.880; Dahlof B, 1987, J Hypertens Suppl, V5, pS607; Greer A L, 1988, Int J Technol Assess Health Care, V4, P5; GRILLI R, 1991, MED CARE, V29, P50, DOI 10.1097/00005650-199101000-00005; HOWIE JGR, 1979, RES GENERAL PRACTICE; KANNEL WB, 1988, GERIATR CARDIOVASC, V1, P5; ORME M, 1990, EUR J CLIN PHARMACOL, V38, P101; STAESSEN J, 1990, J HYPERTENS, V8, P393, DOI 10.1097/00004872-199005000-00001; TOGNONI G, 1990, STAT MED, V9, P17, DOI 10.1002/sim.4780090108; TOGNONI G, 1986, LANCET, V2, P1028; VILLELLA M, 1989, J HUM HYPERTENS, V3, P221; VOEGEL JHK, 1991, CLIN CARDIOL, V14, P5; YUSUF S, 1984, STAT MED, V3, P409, DOI 10.1002/sim.4780030421; 1989, DRUG UTILIZATION BIB; 1988, J CLIN EPIDEMIOL, V41, P1197	19	100	102	0	7	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	OCT 19	1991	303	6808					969	971		10.1136/bmj.303.6808.969	http://dx.doi.org/10.1136/bmj.303.6808.969			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GL127	1954424	Bronze, Green Published			2022-12-28	WOS:A1991GL12700028
J	DARGIE, HJ; GRANT, S				DARGIE, HJ; GRANT, S			EXERCISE	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CORONARY HEART-DISEASE; PHYSICAL-ACTIVITY; LEISURE-TIME; RISK-FACTORS; ATTACK; HEALTH; DEATH		UNIV GLASGOW, DEPT PHYS EDUC & SPORTS SCI, GLASGOW G12 8QQ, SCOTLAND	University of Glasgow	DARGIE, HJ (corresponding author), WESTERN INFIRM & ASSOCIATED HOSP, GLASGOW G11 6NT, SCOTLAND.							[Anonymous], 1990, Med Sci Sports Exerc, V22, P265; BOUCHARD C, 1988, EXERCISE FITNESS HLT, P3; BRAY GA, 1988, EXERCISE FITNESS HLT, P497; COOPER KH, 1976, JAMA-J AM MED ASSOC, V236, P166, DOI 10.1001/jama.236.2.166; DISHMAN RK, 1990, 24 P WORLD C SPORTS, P11; DUNCAN JJ, 1985, JAMA-J AM MED ASSOC, V254, P2609, DOI 10.1001/jama.254.18.2609; DURNIN JVG, 1984, UNPUB COMA COMMITTEE; FENTEM P, 1987, EXERCISE HEART HLTH, P110; Fentem P.H., 1988, NEW CASE EXERCISE; FIATARONE MA, 1990, JAMA-J AM MED ASSOC, V263, P3029, DOI 10.1001/jama.263.22.3029; FOLKINS CH, 1981, AM PSYCHOL, V36, P373, DOI 10.1037/0003-066X.36.4.373; GARFINKEL PE, 1988, EXERCISE FITNESS HLT, P455; GOLDBERG AP, 1986, NEPHRON, V42, P311, DOI 10.1159/000183694; GOLDBERG L, 1987, SPORTS MED, V4, P307, DOI 10.2165/00007256-198704050-00001; LAW MR, 1991, BMJ-BRIT MED J, V303, P453, DOI 10.1136/bmj.303.6800.453; Leon A S, 1977, Ann N Y Acad Sci, V301, P561, DOI 10.1111/j.1749-6632.1977.tb38230.x; MARCUS BH, 1991, AM J CARDIOL, V68, P406, DOI 10.1016/0002-9149(91)90843-A; MORRIS JN, 1953, LANCET, V265, P1053; MORRIS JN, 1990, BRIT HEART J, V63, P325; MORRIS JN, 1973, LANCET, V1, P333; NORTHCOTE RJ, 1984, SPORTS MED, V1, P181, DOI 10.2165/00007256-198401030-00002; OCONNOR GT, 1989, CIRCULATION, V80, P234, DOI 10.1161/01.CIR.80.2.234; PAFFENBARGER RS, 1978, AM J EPIDEMIOL, V108, P161, DOI 10.1093/oxfordjournals.aje.a112608; POOLE GW, 1984, SPORTS MED, V1, P341, DOI 10.2165/00007256-198401050-00002; POWELL KE, 1987, ANNU REV PUBL HEALTH, V8, P253, DOI 10.1146/annurev.publhealth.8.1.253; SHEPHARD RJ, 1986, SPORTS MED, V3, P26, DOI 10.2165/00007256-198603010-00004; SMITH EL, 1987, PHYSICIAN SPORTSMED, V15, P91; SULLIVAN MJ, 1988, CIRCULATION, V78, P506, DOI 10.1161/01.CIR.78.3.506; TODD IC, 1990, BRIT HEART J, V64, P14; TUNSTALLPEDOE H, 1989, SCOT MED J, V34, P556, DOI 10.1177/003693308903400604; TUNSTALLPEDOE H, 1975, LANCET, V2, P833; WORK JA, 1989, PHYSICIAN SPORTSMED, V17, P226, DOI 10.1080/00913847.1989.11709746; 1991, HLTH ED SCOTLAND NAT; 1987, BRIT HEART J, V57, P188; 1990, PREVENTION CORONARY; 1991, J R COLL PHYSICIANS, V25, P193; 1991, CM1523; [No title captured]	38	9	9	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 12	1991	303	6807					910	912		10.1136/bmj.303.6807.910	http://dx.doi.org/10.1136/bmj.303.6807.910			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GK221	1933009	Green Published, Bronze			2022-12-28	WOS:A1991GK22100029
J	JAHRLING, PB; GEISBERT, TW; DALGARD, DW; JOHNSON, ED; KSIAZEK, TG; HALL, WC; PETERS, CJ				JAHRLING, PB; GEISBERT, TW; DALGARD, DW; JOHNSON, ED; KSIAZEK, TG; HALL, WC; PETERS, CJ			PRELIMINARY-REPORT - ISOLATION OF EBOLA VIRUS FROM MONKEYS IMPORTED TO USA	LANCET			English	Article									HAZLETON RES PROD,RESTON,VA; PATHOL ASSOCIATES INC,FREDERICK,MD		JAHRLING, PB (corresponding author), USA,MED RES INST INFECT DIS,DIV DIS ASSESSMENT,FREDERICK,MD 21701, USA.							[Anonymous], 1978, Bull World Health Organ, V56, P271; [Anonymous], 1978, Bull World Health Organ, V56, P247; ARBORIO M, 1989, RES VIROLOGY, V140, P165, DOI 10.1016/S0923-2516(89)80094-9; JAHRLING PB, 1989, DIAGNOSTIC PROCEDURE, P857; LONDON WT, 1977, NATURE, V268, P344, DOI 10.1038/268344a0; MEEGAN J, 1989, RES VIROLOGY, V140, P59, DOI 10.1016/S0923-2516(89)80085-8; RICHMAN DD, 1983, J INFECT DIS, V147, P268, DOI 10.1093/infdis/147.2.268; 1990, MMWR, V39, P22	8	287	311	1	60	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	MAR 3	1990	335	8688					502	505		10.1016/0140-6736(90)90737-P	http://dx.doi.org/10.1016/0140-6736(90)90737-P			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT015	1968529				2022-12-28	WOS:A1990CT01500005
J	PHIPPS, JH; LEWIS, BV; ROBERTS, T; PRIOR, MV; HAND, JW; ELDER, M; FIELD, SB				PHIPPS, JH; LEWIS, BV; ROBERTS, T; PRIOR, MV; HAND, JW; ELDER, M; FIELD, SB			TREATMENT OF FUNCTIONAL MENORRHAGIA BY RADIOFREQUENCY-INDUCED THERMAL ENDOMETRIAL ABLATION	LANCET			English	Article									HAMMERSMITH HOSP,MRC,CYCLOTRON UNIT,HYPERTHERMIA SECT,LONDON W12 0HS,ENGLAND; ROYAL POSTGRAD MED SCH,INST OBSTET & GYNAECOL,LONDON W12 0HS,ENGLAND	Imperial College London; Imperial College London	PHIPPS, JH (corresponding author), WATFORD DIST GEN HOSP,DEPT OBSTET & GYNAECOL,VICARAGE RD,WATFORD WD1 8HB,HERTS,ENGLAND.		Hand, Jeff/AAF-1503-2020	Hand, Jeffrey/0000-0002-4898-9511				ASHERMAN JG, 1948, J OBSTET GYN BRIT EM, V55, P23; ASTRAHAN MA, 1989, INT J HYPERTHER, V5, P383; COAKLEY WT, 1979, J THERM BIOL, V4, P85, DOI 10.1016/0306-4565(79)90051-2; DAVIS J, 1987, BAILLIERE CLIN OB GY, V1, P331, DOI 10.1016/S0950-3552(87)80058-5; DECHERNEY A, 1983, OBSTET GYNECOL, V61, P392; DROEGEMUELLER W, 1971, OBSTET GYNECOL, V38, P256; GOLDRATH MH, 1987, GYNAECOLOGICAL LASER, P253; LOMANO JM, 1988, AM J OBSTET GYNECOL, V159, P152, DOI 10.1016/0002-9378(88)90512-1; SUGAHARA T, 1989, HYPERTHERMIC ONCOLOG	9	77	86	0	2	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	FEB 17	1990	335	8686					374	376		10.1016/0140-6736(90)90207-L	http://dx.doi.org/10.1016/0140-6736(90)90207-L			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN988	1968117				2022-12-28	WOS:A1990CN98800004
J	HOGG, KJ; GEMMILL, JD; BURNS, JMA; LIFSON, WK; RAE, AP; DUNN, FG; HILLIS, WS				HOGG, KJ; GEMMILL, JD; BURNS, JMA; LIFSON, WK; RAE, AP; DUNN, FG; HILLIS, WS			ANGIOGRAPHIC PATENCY STUDY OF ANISTREPLASE VERSUS STREPTOKINASE IN ACUTE MYOCARDIAL-INFARCTION	LANCET			English	Article									UNIV GLASGOW, STOBHILL GEN HOSP, DEPT MED & THERAPEUT, GLASGOW G21 3UW, SCOTLAND	University of Glasgow								ANDERSON JL, 1988, J AM COLL CARDIOL, V11, P1153, DOI 10.1016/0735-1097(88)90276-8; [Anonymous], 1988, LANCET, V2, P349; [Anonymous], 1986, Lancet, V1, P397; BEEN M, 1985, BRIT HEART J, V53, P253; BONNIER HJRM, 1988, AM J CARDIOL, V62, P25, DOI 10.1016/0002-9149(88)91359-8; BROCHIER ML, 1987, DRUGS, V33, P140, DOI 10.2165/00003495-198700333-00023; BUCKNALL C, 1988, BRIT HEART J, V59, P9; CHAMBERLAIN DA, 1988, LANCET, V1, P545; DEWOOD MA, 1980, NEW ENGL J MED, V303, P897, DOI 10.1056/NEJM198010163031601; FERRES H, 1987, DRUGS, V33, P33, DOI 10.2165/00003495-198700333-00005; Geltman E M, 1987, Cardiol Clin, V5, P91; GEMMILL JD, 1988, BRIT HEART J, V60, P361; HILLIS WS, 1986, SCOT MED J, V31, P25, DOI 10.1177/003693308603100106; HILLIS WS, 1987, DRUGS, V33, P117, DOI 10.2165/00003495-198700333-00019; HILLIS WS, 1985, BRIT HEART J, V53, P78; HORNUNG RS, 1985, BRIT HEART J, V53, P662; LOPEZSENDON J, 1988, CIRCULATION S2, V2, P277; NOEL J, 1987, AM HEART J, V113, P395, DOI 10.1016/0002-8703(87)90287-0; PASSAMANI E, 1985, NEW ENGL J MED, V312, P932; SHEEHAN FH, 1987, CIRCULATION, V75, P817, DOI 10.1161/01.CIR.75.4.817; SHERRY S, 1987, AM J CARDIOL, V59, P984, DOI 10.1016/0002-9149(87)91139-8; SMITH RAG, 1981, NATURE, V290, P505, DOI 10.1038/290505a0; VERSTRAETE M, 1987, AM J CARDIOL, V60, P231, DOI 10.1016/0002-9149(87)90219-0; VERSTRAETE M, 1985, LANCET, V1, P842, DOI 10.1016/S0140-6736(85)92208-1; WEATHERBEE TC, 1984, CURR THER RES CLIN E, V35, P433; WILCOX RG, 1988, LANCET, V2, P525; 1987, G ITAL CARDIOL, V17, P20	27	63	63	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 3	1990	335	8684					254	258		10.1016/0140-6736(90)90069-H	http://dx.doi.org/10.1016/0140-6736(90)90069-H			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CL815	1967720				2022-12-28	WOS:A1990CL81500004
J	GOLDSTEIN, JL; BROWN, MS				GOLDSTEIN, JL; BROWN, MS			REGULATION OF THE MEVALONATE PATHWAY	NATURE			English	Review									UNIV TEXAS, SW MED CTR, DEPT INTERNAL MED, DALLAS, TX 75235 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	GOLDSTEIN, JL (corresponding author), UNIV TEXAS, SW MED CTR, DEPT MOLEC GENET, DALLAS, TX 75235 USA.							ANDERSON RGW, 1983, J CELL SCI, V63, P1; BASSON ME, 1988, MOL CELL BIOL, V8, P3797, DOI 10.1128/MCB.8.9.3797; BECK LA, 1988, J CELL BIOL, V107, P1307, DOI 10.1083/jcb.107.4.1307; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; BROWN MS, 1978, J BIOL CHEM, V253, P1121; BROWN MS, 1975, J BIOL CHEM, V250, P2502; BROWN MS, 1980, J LIPID RES, V21, P505; CASEY PJ, 1989, P NATL ACAD SCI USA, V86, P8323, DOI 10.1073/pnas.86.21.8323; CHANG TY, 1982, BIOCHEMISTRY-US, V21, P5316, DOI 10.1021/bi00264a030; CHANG TY, 1980, J BIOL CHEM, V255, P7787; CHIN DJ, 1984, NATURE, V308, P613, DOI 10.1038/308613a0; CHIN DJ, 1982, P NATL ACAD SCI-BIOL, V79, P1185, DOI 10.1073/pnas.79.4.1185; CLARKE CF, 1987, MOL CELL BIOL, V7, P3138, DOI 10.1128/MCB.7.9.3138; CLARKE S, 1988, P NATL ACAD SCI USA, V85, P4643, DOI 10.1073/pnas.85.13.4643; DAWSON PA, 1988, J BIOL CHEM, V263, P3372; DAWSON PA, 1989, J BIOL CHEM, V264, P16798; DAWSON PA, 1989, J BIOL CHEM, V264, P9046; DOHLMAN HG, 1987, BIOCHEMISTRY-US, V26, P2657, DOI 10.1021/bi00384a001; DYNAN WS, 1986, TRENDS GENET, V2, P196, DOI 10.1016/0168-9525(86)90226-X; ENDO A, 1988, KLIN WOCHENSCHR, V66, P421, DOI 10.1007/BF01745510; FAIRBANKS KP, 1984, J BIOL CHEM, V259, P1546; FARNSWORTH CC, 1989, J BIOL CHEM, V264, P20422; GERTLER FB, 1988, MOL CELL BIOL, V8, P2713, DOI 10.1128/MCB.8.7.2713; GIBBS JB, 1989, MICROBIOL REV, V53, P171, DOI 10.1128/MMBR.53.2.171-185.1989; GIBSON DM, 1985, REGULATION HMG COA R, P80; GIL G, 1987, P NATL ACAD SCI USA, V84, P1863, DOI 10.1073/pnas.84.7.1863; GIL G, 1986, J BIOL CHEM, V261, P3717; GIL G, 1988, P NATL ACAD SCI USA, V85, P8963, DOI 10.1073/pnas.85.23.8963; GIL G, 1988, J BIOL CHEM, V263, P19009; GIL G, 1985, CELL, V41, P249, DOI 10.1016/0092-8674(85)90078-9; GOLDSTEIN JL, 1984, J LIPID RES, V25, P1450; GOLDSTEIN JL, 1975, J BIOL CHEM, V250, P8487; GOLDSTEIN JL, 1977, REV BIOCH, V48, P897; GOUD B, 1988, CELL, V53, P753, DOI 10.1016/0092-8674(88)90093-1; GRUENBAUM Y, 1988, J CELL BIOL, V106, P585, DOI 10.1083/jcb.106.3.585; GUTIERREZ L, 1989, EMBO J, V8, P1093, DOI 10.1002/j.1460-2075.1989.tb03478.x; HABENICHT AJR, 1980, J BIOL CHEM, V255, P5134; Hall R H, 1970, Prog Nucleic Acid Res Mol Biol, V10, P57; HANCOCK JF, 1989, J CELL, V57, P1167; HARDIE DG, 1989, TRENDS BIOCHEM SCI, V14, P20; JINGAMI H, 1987, J CELL BIOL, V104, P1693, DOI 10.1083/jcb.104.6.1693; KADONAGA JT, 1986, TRENDS BIOCHEM SCI, V11, P20, DOI 10.1016/0968-0004(86)90226-4; KAMIYA Y, 1978, BIOCHEM BIOPH RES CO, V83, P1077, DOI 10.1016/0006-291X(78)91505-X; KAMIYA Y, 1979, AGR BIOL CHEM TOKYO, V43, P1049, DOI 10.1080/00021369.1979.10863559; KANDUTSCH AA, 1978, SCIENCE, V201, P498, DOI 10.1126/science.663671; KRIEGER M, 1978, P NATL ACAD SCI USA, V75, P5052, DOI 10.1073/pnas.75.10.5052; LEARNED RM, 1989, P NATL ACAD SCI USA, V86, P2779, DOI 10.1073/pnas.86.8.2779; LEONARD S, 1988, BIOCHIM BIOPHYS ACTA, V947, P101, DOI 10.1016/0304-4157(88)90021-4; LISCUM L, 1989, J CELL BIOL, V108, P1625, DOI 10.1083/jcb.108.5.1625; LISCUM L, 1985, J BIOL CHEM, V260, P522; LUSKEY KL, 1985, J BIOL CHEM, V260, P271; LUSKEY KL, 1983, J BIOL CHEM, V258, P8462; MA PTS, 1986, P NATL ACAD SCI USA, V83, P8370, DOI 10.1073/pnas.83.21.8370; MALTESE WA, 1987, BIOCHEM J, V246, P441, DOI 10.1042/bj2460441; MCGRATH JP, 1989, NATURE, V340, P400, DOI 10.1038/340400a0; MELANCON P, 1987, CELL, V51, P1053, DOI 10.1016/0092-8674(87)90591-5; METHERALL JE, 1989, J BIOL CHEM, V264, P15634; MOSLEY ST, 1983, J BIOL CHEM, V258, P3875; NAKANISHI M, 1988, J BIOL CHEM, V263, P8929; OSBORNE TF, 1988, J BIOL CHEM, V263, P3380; OSBORNE TF, 1985, CELL, V42, P203, DOI 10.1016/S0092-8674(85)80116-1; PANINI SR, 1989, J BIOL CHEM, V264, P11044; PATHAK RK, 1986, J CELL BIOL, V102, P2158, DOI 10.1083/jcb.102.6.2158; PENTCHEV PG, 1987, FASEB J, V1, P40, DOI 10.1096/fasebj.1.1.3609608; QUESNEYHUNEEUS V, 1979, P NATL ACAD SCI USA, V76, P5056, DOI 10.1073/pnas.76.10.5056; RAJAVASHISTH TB, 1989, SCIENCE, V245, P640, DOI 10.1126/science.2562787; RAJKOVIC A, 1989, P NATL ACAD SCI USA, V86, P8217, DOI 10.1073/pnas.86.21.8217; REPKO EM, 1989, J BIOL CHEM, V264, P9945; REYNOLDS GA, 1985, J BIOL CHEM, V260, P369; REYNOLDS GA, 1984, CELL, V38, P275, DOI 10.1016/0092-8674(84)90549-X; SAKAGAMI Y, 1981, SCIENCE, V212, P1525, DOI 10.1126/science.212.4502.1525; SANTORO C, 1988, NATURE, V334, P218, DOI 10.1038/334218a0; SCHAFER WR, 1989, SCIENCE, V245, P379, DOI 10.1126/science.2569235; SCHMIDT RA, 1984, J BIOL CHEM, V259, P175; SEGEV N, 1988, CELL, V52, P915, DOI 10.1016/0092-8674(88)90433-3; SKALNIK DG, 1988, J BIOL CHEM, V263, P6836; SKALNIK DG, 1985, DNA-J MOLEC CELL BIO, V4, P439, DOI 10.1089/dna.1985.4.439; SMITH JR, 1988, J BIOL CHEM, V263, P18480; SMITH JR, IN PRESS J BIOL CHEM; SUDHOF TC, 1987, CELL, V48, P1061, DOI 10.1016/0092-8674(87)90713-6; SUDHOF TC, 1987, J BIOL CHEM, V262, P10773; SUDHOF TC, 1985, SCIENCE, V228, P815, DOI 10.1126/science.2988123; TAYLOR FR, 1984, J BIOL CHEM, V259, P2382; WOLDA SL, 1988, J BIOL CHEM, V263, P5997; WOODWARD HD, 1988, J BIOL CHEM, V263, P18411	85	4597	4764	10	287	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 1	1990	343	6257					425	430		10.1038/343425a0	http://dx.doi.org/10.1038/343425a0			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL818	1967820				2022-12-28	WOS:A1990CL81800049
J	CHELALA, CA				CHELALA, CA			CENTRAL-AMERICA - THE COST OF WAR	LANCET			English	Editorial Material																		BENJAMIN M, 1987, HONDURAS REAL LOSER; CHELALA CA, 1989, WALL STREET J   0105; GARFIELD RM, 1987, AM J PUBLIC HEALTH, V77, P615, DOI 10.2105/AJPH.77.5.615; MYERS A, 1988, LINKS, V5, P13; YOPO B, 1988, NICARAGUA CHILDREN W; 1988, NICARAGUAN PERSP SUM, P6; 1988, WHO PAYS PRICE COST; 1988, EC SOCIAL PROGR LATI; 1989, AIDS SURVEILLANCE AM; 1988, MORTALIDAD NINEZ CEN; 1984, PLAN PRIORIDADES SAL; 1989, AM J PUBLIC HEALTH, V79, P424; 1988, READING VITAL SIGNS; 1989, AM 1989 CONSENSUS AC; 1988, INT BANK RECONSTRUCT	15	12	12	0	1	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	JAN 20	1990	335	8682					153	154						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CJ979	1967442				2022-12-28	WOS:A1990CJ97900014
J	[Anonymous]				[Anonymous]			MAGNETIC-RESONANCE AND THE REVIVAL OF ARTERIAL SCLEROSIS	LANCET			English	Editorial Material																		ARMSTRONG ML, 1970, CIRC RES, V27, P59, DOI 10.1161/01.RES.27.1.59; ARMSTRONG ML, 1972, CIRC RES, V30, P675, DOI 10.1161/01.RES.30.6.675; Aschoff L., 1933, ARTERIOSCLEROSIS SUR, P1; BEHLING RW, 1989, NATURE, V341, P321, DOI 10.1038/341321a0; BLANKENHORN DH, 1989, CIRCULATION, V79, P1, DOI 10.1161/01.CIR.79.1.1; BLANKENHORN DH, 1987, JAMA-J AM MED ASSOC, V257, P3233, DOI 10.1001/jama.257.23.3233; BOGREN HG, 1989, AM HEART J, V118, P234, DOI 10.1016/0002-8703(89)90181-6; BOGREN HG, 1989, AM HEART J, V117, P1214, DOI 10.1016/0002-8703(89)90399-2; BRENSIKE JF, 1984, CIRCULATION, V69, P313, DOI 10.1161/01.CIR.69.2.313; CARO CG, 1985, J PHYSIOL-LONDON, V365, pP93; DUFFIELD RGM, 1983, LANCET, V2, P639; FARRAR DJ, 1980, CIRC RES, V47, P425, DOI 10.1161/01.RES.47.3.425; FARRAR DJ, 1984, CARDIOVASC RES, V18, P107, DOI 10.1093/cvr/18.2.107; FIRMIN DN, 1988, 7TH P ANN M SOC MAGN, P122; GRIFFITH TM, 1988, J AM COLL CARDIOL, V12, P797, DOI 10.1016/0735-1097(88)90324-5; HACKETT D, 1988, EUR HEART J, V9, P1317, DOI 10.1093/oxfordjournals.eurheartj.a062449; HASSON JE, 1985, J VASC SURG, V2, P419, DOI 10.1067/mva.1985.avs0020419; KLIPSTEIN RH, 1987, BRIT HEART J, V58, P316; KRAMSCH DM, 1985, DRUGS AFFECTING LIPI, V8, P323; LEAROYD BM, 1966, CIRC RES, V18, P278, DOI 10.1161/01.RES.18.3.278; MOHIADDIN RH, 1989, BRIT HEART J, V62, P81; MOHIADDIN RH, 1989, BRIT HEART J, V62, P90; MOHIADDIN RH, 1989, BRIT MED BULL, V45, P968, DOI 10.1093/oxfordjournals.bmb.a072377; PICKERING GW, 1963, AM J MED, V34, P7; REES S, 1989, RADIOLOGY, V173, P499, DOI 10.1148/radiology.173.2.2798882; ROACH MR, 1957, CAN J BIOCHEM PHYS, V35, P681, DOI 10.1139/o57-080; STARY HC, 1972, MED PRIMATOL, P356; STEHLING M, 1987, LANCET, V2, P964; Virchow R, 1856, GESAMMELTE ABH, P458; VITA JA, 1989, J AM COLL CARDIOL, V14, P1193, DOI 10.1016/0735-1097(89)90416-6; 1976, B WORLD HEALTH ORGAN, V53, P485	31	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 20	1990	335	8682					139	140						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CJ979	1967435				2022-12-28	WOS:A1990CJ97900006
J	WAPNER, RJ; DAVIS, GH; JOHNSON, A; WEINBLATT, VJ; FISCHER, RL; JACKSON, LG; CHERVENAK, FA; MCCULLOUGH, LB				WAPNER, RJ; DAVIS, GH; JOHNSON, A; WEINBLATT, VJ; FISCHER, RL; JACKSON, LG; CHERVENAK, FA; MCCULLOUGH, LB			SELECTIVE REDUCTION OF MULTIFETAL PREGNANCIES	LANCET			English	Article									CORNELL UNIV, MED CTR, NEW YORK HOSP, DEPT OBSTET & GYNECOL, NEW YORK, NY 10021 USA; BAYLOR UNIV, CTR ETH MED & PUBL ISSUES, HOUSTON, TX 77030 USA; THOMAS JEFFERSON UNIV, DEPT OBSTET & GYNECOL, DIV MATERNAL FETAL MED, PHILADELPHIA, PA 19107 USA; THOMAS JEFFERSON UNIV, DEPT MED, DIV GENET & FETAL MED, PHILADELPHIA, PA 19107 USA	Cornell University; NewYork-Presbyterian Hospital; Baylor University; Jefferson University; Jefferson University			Chervenak, Frank/P-3555-2017; Sampiev, Abdulmutalip/O-9577-2017	Chervenak, Frank/0000-0002-4600-0853; Sampiev, Abdulmutalip/0000-0002-5100-2239; Wapner, Ronald/0000-0003-0727-1244				ABERG A, 1978, LANCET, V2, P990; ANNAS G, 1984, NEW ENGL J MED, V316, P1213; ANTSAKLIS A, 1984, PRENATAL DIAG, V4, P289, DOI 10.1002/pd.1970040408; BECK L, 1980, GEBURTSH FRAUENHEILK, V40, P397, DOI 10.1055/s-2008-1037329; BENIRSCHKE K, 1961, NY J MED, V61, P1499; BERKOWITZ RL, 1988, NEW ENGL J MED, V318, P1043, DOI 10.1056/NEJM198804213181607; Dumez Y, 1986, Contrib Gynecol Obstet, V15, P50; EVANS MI, 1988, OBSTET GYNECOL, V71, P289; FARQUHARSON DF, 1988, AM J OBSTET GYNECOL, V158, P413, DOI 10.1016/0002-9378(88)90167-6; FINK IJ, 1982, J ULTRAS MED, V1, P337, DOI 10.7863/jum.1982.1.8.337; GOLBUS MS, 1988, AM J MED GENET, V31, P339, DOI 10.1002/ajmg.1320310211; ITSKOVITZ J, 1989, AM J OBSTET GYNECOL, V160, P215, DOI 10.1016/0002-9378(89)90125-7; JACKSON L, 1987, AM J HUM GENET, V3, P826; KERENYI TD, 1981, NEW ENGL J MED, V304, P1525, DOI 10.1056/NEJM198106183042505; KORANYI G, 1975, ACTA PAEDIATR HUNG, V16, P119; LANDY HJ, 1986, AM J OBSTET GYNECOL, V155, P14, DOI 10.1016/0002-9378(86)90068-2; LUBCHENCO LO, 1963, PEDIATRICS, V32, P793; MELNICK M, 1977, LANCET, V2, P1287; MOORE CM, 1969, J PEDIATR, V74, P523, DOI 10.1016/S0022-3476(69)80034-X; NEWMAN RB, 1989, AM J OBSTET GYNECOL, V161, P547, DOI 10.1016/0002-9378(89)90354-2; PETRES RE, 1981, NEW ENGL J MED, V305, P1218; REDWINE FO, 1984, ACTA GENET MED GEMEL, V33, P35, DOI 10.1017/S0001566000007467; REISMAN LE, 1966, AM J DIS CHILD, V111, P541, DOI 10.1001/archpedi.1966.02090080119011; RODECK CH, 1984, ACTA GENET MED GEMEL, V33, P57, DOI 10.1017/S0001566000007509; RODECK CH, 1982, PRENATAL DIAG, V2, P189, DOI 10.1002/pd.1970020308; ROMERO R, 1984, NEW ENGL J MED, V310, P772, DOI 10.1056/NEJM198403223101207; SKELLY H, 1982, AM J OBSTET GYNECOL, V142, P595, DOI 10.1016/0002-9378(82)90769-4; TIETZE C, 1986, INDUCED ABORTION WOR, P11	28	117	118	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 13	1990	335	8681					90	93		10.1016/0140-6736(90)90550-O	http://dx.doi.org/10.1016/0140-6736(90)90550-O			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CH516	1967427				2022-12-28	WOS:A1990CH51600013
J	GASTON, RS; JULIAN, BA; DIETHELM, AG; CURTIS, JJ				GASTON, RS; JULIAN, BA; DIETHELM, AG; CURTIS, JJ			EFFECTS OF ENALAPRIL ON ERYTHROCYTOSIS AFTER RENAL-TRANSPLANTATION	ANNALS OF INTERNAL MEDICINE			English	Note							ERYTHROPOIETIN; HYPERTENSION; RENIN		UNIV ALABAMA, DEPT SURG, BIRMINGHAM, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	GASTON, RS (corresponding author), UNIV ALABAMA, MED CTR, DIV NEPHROL, UAB STN, BIRMINGHAM, AL 35294 USA.		Gaston, Robert/AAR-2932-2020					AEBERHARD JM, 1990, TRANSPLANTATION, V50, P613, DOI 10.1097/00007890-199010000-00017; BAKRIS GL, 1990, NEW ENGL J MED, V323, P86, DOI 10.1056/NEJM199007123230203; FRIMAN S, 1990, NEPHROL DIAL TRANSPL, V5, P969, DOI 10.1093/ndt/5.11.969; GOULD AB, 1980, J LAB CLIN MED, V96, P523; ISLAM MS, 1990, TRANSPLANT INT, V3, P222, DOI 10.1111/j.1432-2277.1990.tb01928.x; JACKSON B, 1990, J LAB CLIN MED, V115, P21; MURRAY BM, 1990, AM J KIDNEY DIS, V16, P66, DOI 10.1016/S0272-6386(12)80787-6; THOMAS DJ, 1977, LANCET, V2, P941, DOI 10.1016/S0140-6736(77)90885-6; VLAHAKOS DV, 1991, AM J KIDNEY DIS, V17, P199, DOI 10.1016/S0272-6386(12)81129-2; WICKRE CG, 1983, KIDNEY INT, V23, P731, DOI 10.1038/ki.1983.86; WILLIAMS GH, 1988, NEW ENGL J MED, V319, P1517	11	66	67	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 15	1991	115	12					954	955		10.7326/0003-4819-115-12-954	http://dx.doi.org/10.7326/0003-4819-115-12-954			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GU417	1952492				2022-12-28	WOS:A1991GU41700008
J	FEIGHERY, E; ALTMAN, DG; SHAFFER, G				FEIGHERY, E; ALTMAN, DG; SHAFFER, G			THE EFFECTS OF COMBINING EDUCATION AND ENFORCEMENT TO REDUCE TOBACCO SALES TO MINORS - A STUDY OF 4 NORTHERN CALIFORNIA COMMUNITIES	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							YOUNG ADULTHOOD; DRUG-USE; PROGRESSION; ADOLESCENCE; CIGARETTES; PATTERNS; CHILDREN	Objective. - To examine the effects of a community education and law enforcement intervention on illegal tobacco sales to minors. Design. - A 2-year, before and after trial with retail stores as the unit of analysis. Setting. - Implementation occurred in four suburban California communities with populations of 25000 to 100000. Participants. - All the retail stores in one intervention community and half the retail stores, randomly selected, in the other three intervention communities (n = 169) were visited by minors aged 14 to 16 years with the intent to purchase tobacco. Intervention. - Ongoing community and merchant education and four law enforcement operations were conducted. Main Outcome Measures. - Over-the-counter and vending machine sales of tobacco to minors were the primary outcomes. Results. - Among a cohort of stores visited by minors at the pretest (n = 104) in June 1988, 71% sold tobacco over the counter and 92% sold tobacco through vending machines. At posttest 2 in May 1990, 24% sold tobacco over the counter and 93% sold tobacco through vending machines. Of the 31 stores issued citations, 16 were followed into the courts where the fines were dismissed or reduced. Conclusions. - Education alone had a limited effect on reducing illegal tobacco sales to minors. It did promote community support for more aggressive enforcement strategies. Education plus enforcement decreased significantly over-the-counter sales; vending machine sales were unaffected by these interventions. The lack of support at the judicial level may temper the effectiveness of enforcement. Legislative remedies addressing judicial obstacles and vending machine sales are needed.	N BAY HLTH RESOURCES CTR,PETALUMA,CA		FEIGHERY, E (corresponding author), STANFORD UNIV,MED CTR,SCH MED,CTR RES DIS PREVENT,1000 WELCH RD,STANFORD,CA 94305, USA.							ALTMAN DG, 1991, AM J PUBLIC HEALTH, V81, P891, DOI 10.2105/AJPH.81.7.891; ALTMAN DG, 1989, JAMA-J AM MED ASSOC, V261, P80, DOI 10.1001/jama.261.1.80; ASHLEY MJ, 1988, ANNU REV PUBL HEALTH, V9, P233; DIFRANZA JR, 1987, JAMA-J AM MED ASSOC, V257, P3387, DOI 10.1001/jama.257.24.3387; DIFRANZA JR, 1990, JAMA-J AM MED ASSOC, V263, P2784, DOI 10.1001/jama.263.20.2784; FLEMING R, 1989, ADDICT BEHAV, V14, P261, DOI 10.1016/0306-4603(89)90057-9; GREYDANUS DE, 1989, JAMA-J AM MED ASSOC, V261, P99, DOI 10.1001/jama.261.1.99; HOLDER HD, 1988, JAN I MED PAN OPP RE; HOLDER HD, 1987, ADV SUBST ABUSE S1, V1, P405; KIRN TF, 1987, JAMA-J AM MED ASSOC, V257, P3323; MILGRAM GG, 1986, HDB PREVENTION, P243; YAMAGUCHI K, 1984, AM J PUBLIC HEALTH, V74, P668, DOI 10.2105/AJPH.74.7.668; YAMAGUCHI K, 1984, AM J PUBLIC HEALTH, V74, P673, DOI 10.2105/AJPH.74.7.673; 1989, SURGEON GENERALS WOR; 1990, YOUTH ACCESS CIGARET; 1988, 888406 DEP HLTH HUM; 1990, TOBACCO USE CALIFORN	17	83	83	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 11	1991	266	22					3168	3171						4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GT654	1956106				2022-12-28	WOS:A1991GT65400027
J	FRANK, E; WINKLEBY, MA; ALTMAN, DG; ROCKHILL, B; FORTMANN, SP				FRANK, E; WINKLEBY, MA; ALTMAN, DG; ROCKHILL, B; FORTMANN, SP			PREDICTORS OF PHYSICIANS SMOKING CESSATION ADVICE	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							STANFORD 5-CITY PROJECT; QUIT	Objectives. - To determine the percentage of smokers reporting that a physician had ever advised them to smoke less or to stop smoking, and the effect of time, demographics, medical history, and cigarette dependence on the likelihood that respondents would state that a physician had ever advised them to stop smoking. Design and Setting. - Data were collected from the Stanford Five-City Project, a communitywide health education intervention program. The two treatment and three control cities were located in northern and central California. As there was no significant difference between treatment and control cities regarding cessation advice, data were pooled for these analyses. Participants. - There were five cross-sectional, population-based Five-City Project surveys (conducted in 1979-1980, 1981-1982, 1983-1984, 1985-1986, and 1989-1990); these surveys randomly sampled households and included all residents aged 12 to 74 years. Main Outcome Measures. - Improved smoking advice rates over time in all towns was an a priori hypothesis. Results. - Of the 2710 current smokers, 48.8% stated that their physicians had ever advised them to smoke less or stop smoking. Respondents were more likely to have been so advised if they smoked more cigarettes per day, were surveyed later in the decade, had more off ice visits in the last year, or were older. In 1979-1980, 44.1% of smokers stated that they had ever been advised to smoke less or to quit by a physician, vs 49.8% of smokers in 1989-1990 (P < .07). Only 3.6% of 1672 ex-smokers stated that their physicians had helped them quit. Conclusion. - These findings suggest that physicians still need to increase smoking cessation counseling to all patients, particularly adolescents and other young smokers, minorities, and those without cigarette-related disease.	STANFORD UNIV, MED CTR,SCH MED,STANFORD CTR RES DIS PREVENT, 1000 WELCH RD, STANFORD, CA 94305 USA; STANFORD UNIV, MED CTR, SCH MED, DEPT MED, STANFORD, CA 94305 USA	Stanford University; Stanford University				Frank, Erica/0000-0001-7159-5417	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL021906, T32HL007034] Funding Source: NIH RePORTER; NHLBI NIH HHS [5T32-HL-07034, 1 R01-HL-21906] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ANDA RF, 1987, JAMA-J AM MED ASSOC, V257, P1916; COOPER R, 1985, NEW YORK STATE J MED, V85, P344; CUMMINGS SR, 1989, J GEN INTERN MED, V4, P482, DOI 10.1007/BF02599545; FARQUHAR JW, 1985, AM J EPIDEMIOL, V122, P323, DOI 10.1093/oxfordjournals.aje.a114104; FARQUHAR JW, 1990, JAMA-J AM MED ASSOC, V264, P359, DOI 10.1001/jama.264.3.359; FIORE MC, 1990, JAMA-J AM MED ASSOC, V263, P2760, DOI 10.1001/jama.263.20.2760; FORTMANN SP, 1985, PREV MED, V14, P70, DOI 10.1016/0091-7435(85)90022-2; GLYNN TJ, 1990, PROG CLIN BIOL RES, V339, P11; OCKENE JK, 1991, J GEN INTERN MED, V6, P1, DOI 10.1007/BF02599381; PASSEL JS, 1980, APR ANN M POP ASS AM; STRECHER VJ, 1991, J GEN INTERN MED, V6, P9, DOI 10.1007/BF02599383; DHHS CDC878397 PUBL; 1987, AAFP STOP SMOKING KI; 1986, DHHS NIH862178 PUBL; 1976, ADULT USE TOBACCO 19; DHHS CDC908416 PUBL; 1990, 7TH WORLD C TOB HLTH; 1987, MMWR, V36, P252; 1990, MMWR, V39, P58	19	163	163	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 11	1991	266	22					3139	3144		10.1001/jama.266.22.3139	http://dx.doi.org/10.1001/jama.266.22.3139			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GT654	1956100				2022-12-28	WOS:A1991GT65400021
J	WANG, J; BEDZYK, MJ; PENNER, TL; CAFFREY, M				WANG, J; BEDZYK, MJ; PENNER, TL; CAFFREY, M			STRUCTURAL STUDIES OF MEMBRANES AND SURFACE-LAYERS UP TO 1,000 A THICK USING X-RAY STANDING WAVES	NATURE			English	Article							BRAGG-DIFFRACTION; INTERFACE; REFLECTION; FIELDS	THE X-ray standing wave (XSW) method, developed in the 1960s, was used originally to determine heavy atom positions in and on silicon and germanium single crystals 1-7. An X-ray standing wave generated by the interference of coherent incident and reflected beams excites X-ray fluorescence from the heavy atom, the intensity of which as a function of incident angle provides an indication of the atom's distance from the X-ray reflecting surface. The availability of X-ray mirrors and the ability to prepare layered synthetic microstructures has made possible the study of biologically relevant structures using the XSW technique on length scales of typically tens to hundreds of angstroms 8-12, allowing heavy atoms in such structures to be located with angstrom or subangstrom resolution. Many model biological systems (such as Langmuir-Blodgett films, which mimic membranes) require access to still larger scales, but it is not obvious that an XSW will remain coherent over such length scales. Here we report studies of a lipid multilayer system using the XSW method, in which we have been able to locate the metal atoms in a zinc arachidate bilayer with angstrom resolution at a distance of almost 1,000 angstrom above the surface of a gold mirror. Our results indicate that the XSW technique should be useful for structural studies of supramolecular aggregates, receptor-ligand interactions and multi-membrane stacks, in which length scales of this order are encountered.	CORNELL UNIV,CORNELL HIGH ENERGY SYNCHROTRON SOURCE,ITHACA,NY 14853; EASTMAN DENT CTR,CORP RES LABS,ROCHESTER,NY 14620	Cornell University; Eastman Chemical Company; University of Rochester	WANG, J (corresponding author), OHIO STATE UNIV,DEPT CHEM,COLUMBUS,OH 43210, USA.		Bedzyk, Michael J/B-7503-2009; Bedzyk, Michael J/K-6903-2013					ANDERSEN SK, 1976, PHYS REV LETT, V37, P1141, DOI 10.1103/PhysRevLett.37.1141; BATTERMAN BW, 1969, PHYS REV LETT, V22, P703, DOI 10.1103/PhysRevLett.22.703; BATTERMAN BW, 1964, PHYS REV A, V133, P759; BECKER RS, 1983, PHYS REV LETT, V50, P153, DOI 10.1103/PhysRevLett.50.153; BEDZYK MJ, 1985, PHYS REV B, V31, P4110, DOI 10.1103/PhysRevB.31.4110; BEDZYK MJ, 1990, SCIENCE, V248, P52, DOI 10.1126/science.2321026; BEDZYK MJ, 1989, PHYS REV LETT, V62, P1376, DOI 10.1103/PhysRevLett.62.1376; BEDZYK MJ, 1988, SCIENCE, V241, P1788, DOI 10.1126/science.3175619; BLOCH JM, 1985, PHYS REV LETT, V54, P1039, DOI 10.1103/PhysRevLett.54.1039; COWAN PL, 1980, PHYS REV LETT, V44, P1680, DOI 10.1103/PhysRevLett.44.1680; DEBOER DKG, 1991, PHYS REV B, V44, P498, DOI 10.1103/PhysRevB.44.498; GOLOVCHENKO JA, 1982, PHYS REV LETT, V49, P560, DOI 10.1103/PhysRevLett.49.560; GOLOVCHENKO JA, 1974, PHYS REV B, V10, P4239, DOI 10.1103/PhysRevB.10.4239; IIDA A, 1985, JPN J APPL PHYS 2, V24, pL675, DOI 10.1143/JJAP.24.L675; MARRA WC, 1979, J APPL PHYS, V50, P6927, DOI 10.1063/1.325845; PARRATT LG, 1954, PHYS REV, V95, P359, DOI 10.1103/PhysRev.95.359; ZHELUDEVA SI, 1990, THIN SOLID FILMS, V193, P395, DOI 10.1016/S0040-6090(05)80049-5	17	62	64	1	15	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	DEC 5	1991	354	6352					377	380		10.1038/354377a0	http://dx.doi.org/10.1038/354377a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT761	1956399				2022-12-28	WOS:A1991GT76100045
J	MCCREA, PD; TURCK, CW; GUMBINER, B				MCCREA, PD; TURCK, CW; GUMBINER, B			A HOMOLOG OF THE ARMADILLO PROTEIN IN DROSOPHILA (PLAKOGLOBIN) ASSOCIATED WITH E-CADHERIN	SCIENCE			English	Article							CELL-ADHESION MOLECULES; SEGMENT POLARITY GENE; MAMMARY ONCOGENE INT-1; CYTOPLASMIC DOMAIN; SEQUENCE; IDENTIFICATION; EXPRESSION; ECTODERM; WINGLESS; SURFACE	Three cytoplasmic proteins, called catenins, bind to the cytoplasmic tail of the epithelial cell-cell adhesion molecule E-cadherin. The complementary DNA sequence was determined for the 92-kilodalton beta-catenin of Xenopus laevis. The sequence is homologous to mammalian plakoglobin, a protein of desmosomal and zonula adherens cell junctions, and to the plakoglobin homolog in Drosophila melanogaster, the product of the segment polarity gene armadillo. A monoclonal antibody to bovine plakoglobin recognizes the analogous beta-catenin in the Madin-Darby canine kidney (MDCK) cell tine. Armadillo plakoglobin may link E-cadherin to the underlying actin cytoskeleton at cell-cell junctions; the E-cadherin-catenin protein complex may also participate in the transmission of developmental information.	UNIV CALIF SAN FRANCISCO,HOWARD HUGHES MED INST,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT MED,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT PHYSIOL,SAN FRANCISCO,CA 94143	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	MCCREA, PD (corresponding author), UNIV CALIF SAN FRANCISCO,DEPT PHARMACOL,SAN FRANCISCO,CA 94143, USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM013060, R37GM037432, R01GM037432] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM37432, 5-F32-GM-13060] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BILOFSKY HS, 1988, NUCLEIC ACIDS RES, V16, P1861, DOI 10.1093/nar/16.5.1861; BLASCHUK OW, 1990, DEV BIOL, V139, P227, DOI 10.1016/0012-1606(90)90290-Y; BRADLEY RS, 1990, EMBO J, V9, P1569, DOI 10.1002/j.1460-2075.1990.tb08276.x; CHOI YS, 1989, J CELL BIOL, V108, P2449, DOI 10.1083/jcb.108.6.2449; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; COWIN P, 1986, CELL, V46, P1063, DOI 10.1016/0092-8674(86)90706-3; FENG DF, 1987, J MOL EVOL, V25, P351, DOI 10.1007/BF02603120; FRANKE WW, 1989, P NATL ACAD SCI USA, V86, P4027, DOI 10.1073/pnas.86.11.4027; GOODWIN L, 1990, BIOCHEM BIOPH RES CO, V173, P1224, DOI 10.1016/S0006-291X(05)80917-9; GUMBINER B, 1986, J CELL BIOL, V102, P457, DOI 10.1083/jcb.102.2.457; HIRANO S, 1987, J CELL BIOL, V105, P2501, DOI 10.1083/jcb.105.6.2501; HYNES RO, 1973, P NATL ACAD SCI USA, V70, P3170, DOI 10.1073/pnas.70.11.3170; Kemler R, 1989, CURR OPIN CELL BIOL, V1, P892, DOI 10.1016/0955-0674(89)90055-0; KINTNER CR, 1987, DEVELOPMENT, V99, P311; KOCH PJ, 1990, EUR J CELL BIOL, V53, P1; KORMAN NJ, 1989, NEW ENGL J MED, V321, P631, DOI 10.1056/NEJM198909073211002; MCCREA PD, 1991, J BIOL CHEM, V266, P4514; NAGAFUCHI A, 1991, CELL, V65, P849, DOI 10.1016/0092-8674(91)90392-C; NAGAFUCHI A, 1988, EMBO J, V7, P3679, DOI 10.1002/j.1460-2075.1988.tb03249.x; NOSE A, 1990, CELL, V61, P147, DOI 10.1016/0092-8674(90)90222-Z; NUSSE R, 1984, NATURE, V307, P131, DOI 10.1038/307131a0; NUSSE R, 1988, TRENDS GENET, V4, P291, DOI 10.1016/0168-9525(88)90172-2; OZAWA M, 1989, EMBO J, V8, P1711, DOI 10.1002/j.1460-2075.1989.tb03563.x; OZAWA M, 1990, P NATL ACAD SCI USA, V87, P4246, DOI 10.1073/pnas.87.11.4246; PAPKOFF J, 1990, MOL CELL BIOL, V10, P2723, DOI 10.1128/MCB.10.6.2723; PEIFER M, 1990, CELL, V63, P1167, DOI 10.1016/0092-8674(90)90413-9; PEIFER M, 1991, DEVELOPMENT, V111, P1029; RIGGLEMAN B, 1990, CELL, V63, P549, DOI 10.1016/0092-8674(90)90451-J; RIGGLEMAN B, 1989, GENE DEV, V3, P96, DOI 10.1101/gad.3.1.96; RIJSEWIJK F, 1987, CELL, V50, P649, DOI 10.1016/0092-8674(87)90038-9; TAKEICHI M, 1990, ANNU REV BIOCHEM, V59, P237, DOI 10.1146/annurev.biochem.59.1.237	31	569	595	1	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	NOV 29	1991	254	5036					1359	1361		10.1126/science.1962194	http://dx.doi.org/10.1126/science.1962194			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR777	1962194				2022-12-28	WOS:A1991GR77700050
J	KELLY, JP; NICHOLS, JS; FILLEY, CM; LILLEHEI, KO; RUBINSTEIN, D; KLEINSCHMIDTDEMASTERS, BK				KELLY, JP; NICHOLS, JS; FILLEY, CM; LILLEHEI, KO; RUBINSTEIN, D; KLEINSCHMIDTDEMASTERS, BK			CONCUSSION IN SPORTS - GUIDELINES FOR THE PREVENTION OF CATASTROPHIC OUTCOME	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Note							HEAD-INJURIES; CEREBRAL CONCUSSION; CONTACT-SPORTS; BRAIN EDEMA; TOMOGRAPHY; TRAUMA; MILD	Concussion (defined as a traumatically induced alteration in mental status, not necessarily with loss of consciousness) is a common form of sports-related injury too often dismissed as trivial by physicians, athletic trainers, coaches, sports reporters, and athletes themselves. While head injuries can occur in virtually any form of athletic activity, they occur most frequently in contact sports, such as football, boxing, and martial arts competition, or from high-velocity collisions or falls in basketball, soccer, and ice hockey. The pathophysiology of concussion is less well understood than that of severe head injury, and it has received less attention as a result. We describe a high school football player who died of diffuse brain swelling after repeated concussions without loss of consciousness. Guidelines have been developed to reduce the risk of such serious catastrophic outcomes after concussion in sports.	UNIV COLORADO,SCH MED,DEPT SURG,DIV NEUROSURG,BOULDER,CO 80309; UNIV COLORADO,SCH MED,DEPT RADIOL,BOULDER,CO 80309; UNIV COLORADO,SCH MED,DEPT PATHOL,BOULDER,CO 80309; UNIV COLORADO,SCH MED,DEPT PSYCHIAT,BOULDER,CO 80309	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Boulder; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Boulder; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Boulder; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Boulder	KELLY, JP (corresponding author), UNIV COLORADO,HLTH SCI CTR,SCH MED,DEPT NEUROL,BOX B-183,4200 E 9TH AVE,DENVER,CO 80262, USA.							BRUCE DA, 1981, J NEUROSURG, V54, P170, DOI 10.3171/jns.1981.54.2.0170; CANTU RC, 1986, PHYSICIAN SPORTSMED, V14, P75, DOI 10.1080/00913847.1986.11709197; CANTU RC, 1988, SPORTS MED DIGEST, V10, P1; FEKETE JF, 1968, CAN MED ASSOC J, V99, P1234; FISHER CM, 1966, NEUROLOGY, V16, P826, DOI 10.1212/WNL.16.8.826; FISHMAN RA, 1975, NEW ENGL J MED, V293, P706, DOI 10.1056/NEJM197510022931407; GEISLER FH, 1990, NEUROLOGIC EMERGENCI, P135; GENTRY LR, 1988, AM J ROENTGENOL, V150, P673, DOI 10.2214/ajr.150.3.673; GERBERICH SG, 1983, AM J PUBLIC HEALTH, V73, P1370, DOI 10.2105/AJPH.73.12.1370; GOLDSTEIN M, 1990, ANN NEUROL, V27, P327, DOI 10.1002/ana.410270315; GRONWALL D, 1975, LANCET, V2, P995; JENKINS A, 1986, LANCET, V2, P445; JORDAN BD, 1990, JAMA-J AM MED ASSOC, V263, P1670, DOI 10.1001/jama.263.12.1670; LANGFITT TW, 1965, NEUROLOGY, V15, P622, DOI 10.1212/WNL.15.7.622; LEVI L, 1990, NEUROSURGERY, V27, P429, DOI 10.1227/00006123-199009000-00015; LEVIN HS, 1987, J NEUROSURG, V66, P706, DOI 10.3171/jns.1987.66.5.0706; MCQUILLEN JB, 1988, AM J FOREN MED PATH, V9, P12, DOI 10.1097/00000433-198803000-00004; MOODY RA, 1968, J NEUROSURG, V29, P586, DOI 10.3171/jns.1968.29.6.0586; Nelson W. E., 1984, PHYSICIAN SPORTSMED, V12, P103; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; POVLISHOCK JT, 1985, J CENT NERV SYST TRA, V2, P285; SAUNDERS RL, 1984, JAMA-J AM MED ASSOC, V252, P538, DOI 10.1001/jama.252.4.538; TORG JS, 1985, JAMA-J AM MED ASSOC, V254, P3439, DOI 10.1001/jama.254.24.3439; UNTERHARNSCHEIDT F, 1970, TEX REP BIOL MED, V28, P421; WILBERGER JE, 1989, CLIN SPORT MED, V8, P1; YARNELL PR, 1970, LANCET, V1, P863; 1991, REPORT SPORTS MED CO; 1966, CLIN NEUROSURG, V12, P386	28	251	256	0	42	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 27	1991	266	20					2867	2869		10.1001/jama.266.20.2867	http://dx.doi.org/10.1001/jama.266.20.2867			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GQ722	1942455				2022-12-28	WOS:A1991GQ72200036
J	HUNZIKER, W; WHITNEY, JA; MELLMAN, I				HUNZIKER, W; WHITNEY, JA; MELLMAN, I			SELECTIVE-INHIBITION OF TRANSCYTOSIS BY BREFELDIN-A IN MDCK CELLS	CELL			English	Article							POLYMERIC IMMUNOGLOBULIN RECEPTOR; CANINE KIDNEY-CELLS; ENDOPLASMIC-RETICULUM; INTRACELLULAR-TRANSPORT; SECRETORY PROTEINS; RAT HEPATOCYTES; GOLGI PROTEINS; EXPRESSION; ENDOSOMES; PATHWAYS	Treatment of most cells with brefeldin A (BFA) leads to the retrieval of the Golgi complex to the endoplasmic reticulum, presumably reflecting an inhibition of cytoplasmic coat protein binding to Golgi membranes. Although BFA has been thought to act only on biosynthetic organelles, we now show that this drug also reversibly blocks polymeric immunoglobulin receptor-mediated transcytosis in MDCK cells. The action of BFA on transcytosis was selective, since internalization, recycling, and intracellular degradation were unaffected. The block occurred early on the transcytotic pathway, probably before the translocation of IgA-containing vesicles from the basal to the apical cytoplasm. Although BFA caused MDCK cell endosomes to become more tubular, the organization of the Golgi and binding of the 110 kd Golgi coat protein beta-COP was surprisingly unaffected. These results suggest that in MDCK cells, endocytic organelles contain a BFA-sensitive coat that regulates their organization and function even though the Golgi coat is BFA resistant.			HUNZIKER, W (corresponding author), YALE UNIV, SCH MED, DEPT CELL BIOL, NEW HAVEN, CT 06510 USA.		Mellman, Ira/ABG-5896-2020; Hunziker, Walter/B-3140-2010; Hunziker, Walter/GSM-8190-2022	Hunziker, Walter/0000-0002-5265-4933; 				ALLAN VJ, 1986, J CELL BIOL, V103, P2229, DOI 10.1083/jcb.103.6.2229; BARTLES JR, 1987, J CELL BIOL, V105, P1241, DOI 10.1083/jcb.105.3.1241; BOMSEL M, 1990, CELL, V62, P719, DOI 10.1016/0092-8674(90)90117-W; BRANDLI AW, 1990, J CELL BIOL, V111, P2909, DOI 10.1083/jcb.111.6.2909; BREITFELD PP, 1990, J CELL BIOL, V111, P2365, DOI 10.1083/jcb.111.6.2365; BREITFELD PP, 1989, J CELL BIOL, V109, P475, DOI 10.1083/jcb.109.2.475; CASANOVA JE, 1990, SCIENCE, V248, P742, DOI 10.1126/science.2110383; COOPER MS, 1990, CELL, V61, P135, DOI 10.1016/0092-8674(90)90221-Y; DOMS RW, 1989, J CELL BIOL, V109, P61, DOI 10.1083/jcb.109.1.61; DONALDSON JG, 1990, J CELL BIOL, V111, P2295, DOI 10.1083/jcb.111.6.2295; DUDEN R, 1991, CELL, V64, P649, DOI 10.1016/0092-8674(91)90248-W; FUJIWARA T, 1988, J BIOL CHEM, V263, P18545; GEUZE HJ, 1984, CELL, V37, P195, DOI 10.1016/0092-8674(84)90315-5; HOPPE CA, 1985, J CELL BIOL, V101, P2113, DOI 10.1083/jcb.101.6.2113; HUNZIKER W, 1989, J CELL BIOL, V109, P3291, DOI 10.1083/jcb.109.6.3291; HUNZIKER W, 1991, CELL, V66, P907, DOI 10.1016/0092-8674(91)90437-4; HUNZIKER W, 1990, EMBO J, V9, P3515, DOI 10.1002/j.1460-2075.1990.tb07560.x; KTISTAKIS NT, 1991, J CELL BIOL, V113, P1009, DOI 10.1083/jcb.113.5.1009; LIPPINCOTTSCHWARTZ J, 1990, CELL, V60, P821, DOI 10.1016/0092-8674(90)90096-W; LIPPINCOTTSCHWARTZ J, 1991, CELL, V67, P601, DOI 10.1016/0092-8674(91)90534-6; LIPPINCOTTSCHWARTZ J, 1989, CELL, V56, P801, DOI 10.1016/0092-8674(89)90685-5; LUZIO JP, 1990, BIOCHEM J, V270, P97, DOI 10.1042/bj2700097; MALHOTRA V, 1989, CELL, V58, P329, DOI 10.1016/0092-8674(89)90847-7; MISUMI Y, 1986, J BIOL CHEM, V261, P1398; MOSTOV KE, 1985, CELL, V43, P389, DOI 10.1016/0092-8674(85)90166-7; MOSTOV KE, 1986, CELL, V46, P613, DOI 10.1016/0092-8674(86)90887-1; NUCHTERN JG, 1989, NATURE, V339, P223, DOI 10.1038/339223a0; ODA K, 1987, FEBS LETT, V214, P135, DOI 10.1016/0014-5793(87)80028-5; ORCI L, 1986, CELL, V46, P171, DOI 10.1016/0092-8674(86)90734-8; ORCI L, 1991, CELL, V64, P1183; PARTON RG, 1989, J CELL BIOL, V109, P3259, DOI 10.1083/jcb.109.6.3259; SANDVIG K, 1991, IN PRESS J CELL BIOL; SCHMID SL, 1988, CELL, V52, P73, DOI 10.1016/0092-8674(88)90532-6; SERAFINI T, 1991, NATURE, V349, P214, DOI 10.1038/349215a0; SZTUL E, 1991, CELL, V64, P81, DOI 10.1016/0092-8674(91)90210-P	35	255	257	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 1	1991	67	3					617	627		10.1016/0092-8674(91)90535-7	http://dx.doi.org/10.1016/0092-8674(91)90535-7			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GN664	1934063	hybrid			2022-12-28	WOS:A1991GN66400017
J	BARR, GS; COATESWORTH, AP				BARR, GS; COATESWORTH, AP			PASSIVE SMOKING AND OTITIS-MEDIA WITH EFFUSION	BRITISH MEDICAL JOURNAL			English	Article							CHILDREN		QUEEN ELIZABETH HOSP,DEPT OTOLARYNGOL,BIRMINGHAM B15 2TH,W MIDLANDS,ENGLAND	University of Birmingham								HINTON AE, 1989, J LARYNGOL OTOL, V103, P559, DOI 10.1017/S0022215100109326; MAW AR, 1987, SCOTT BROWNS OTOLARY, V6, P159; RICHARDSON K, 1976, BRIT J AUDIOL, V10, P117; ROBINSON GC, 1967, CAN MED ASSOC J, V97, P1199; STRACHAN DP, 1989, BRIT MED J, V298, P1549, DOI 10.1136/bmj.298.6687.1549	5	17	18	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	OCT 26	1991	303	6809					1032	1033		10.1136/bmj.303.6809.1032	http://dx.doi.org/10.1136/bmj.303.6809.1032			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GM478	1954455	Green Published, Bronze			2022-12-28	WOS:A1991GM47800021
J	KEAYS, R; HARRISON, PM; WENDON, JA; FORBES, A; GOVE, C; ALEXANDER, GJM; WILLIAMS, R				KEAYS, R; HARRISON, PM; WENDON, JA; FORBES, A; GOVE, C; ALEXANDER, GJM; WILLIAMS, R			INTRAVENOUS ACETYLCYSTEINE IN PARACETAMOL INDUCED FULMINANT HEPATIC-FAILURE - A PROSPECTIVE CONTROLLED TRIAL	BRITISH MEDICAL JOURNAL			English	Article							ACUTE LIVER-FAILURE; N-ACETYLCYSTEINE; ACETAMINOPHEN OVERDOSE; COMPLICATIONS; MANAGEMENT; PROGNOSIS; MICE	Objective - To see whether intravenous acetylcysteine would improve outcome in patients with fulminant hepatic failure after paracetamol overdose. Design - A prospective randomised controlled study. Setting - The Institute of Liver Studies, King's College Hospital, London. Patients - 50 consecutive patients (21 male) aged 16-60 with fulminant hepatic failure after paracetamol overdose who had not previously received acetylcysteine. Interventions - Conventional intensive liver care plus either acetylcysteine (25 patients) in the same dose regimen as used early after a paracetamol overdose, except that the infusion was continued until recovery from encephalopathy or death, or an equivalent volume of 5% dextrose (25 patients). Main outcome measures - Survival; incidence of cerebral oedema, renal failure, and hypotension requiring inotropic support; liver function as assessed by prolongation of the prothrombin time; and degree of encephalopathy. Results - The rate of survival was significantly higher in the acetylcysteine treated group than in the controls (48% (12/25 patients) upsilon 20% (5/25); p = 0.037, 95% confidence interval for difference in proportions surviving 3% to 53%). Acetylcysteine treated patients had a lower incidence of cerebral oedema (40% (10/25) upsilon 68% (17/25); p = 0.047, 95% confidence interval for difference in incidence 2% to 54%), and fewer developed hypotension requiring inotropic support (48% (12/25) upsilon 80% (20/25); p = 0.018, 95% confidence interval 7% to 57%). Rates of deterioration and recovery of liver function, however, were similar in the two groups. No adverse reactions to acetylcysteine were seen. Conclusions - Acetylcysteine is safe and effective in fulminant hepatic failure after paracetamol over dose.	KINGS COLL,SCH MED & DENT,INST LIVER STUDIES,LONDON SE5 8RX,ENGLAND	University of London; King's College London			Harrison, Phillip M/D-5374-2009	opoku, anita/0000-0001-7243-8157; Forbes, Alastair/0000-0001-7416-9843				ARTMAN M, 1984, TOXICOL APPL PHARM, V72, P324, DOI 10.1016/0041-008X(84)90317-X; ARUOMA OI, 1989, FREE RADICAL BIO MED, V6, P593, DOI 10.1016/0891-5849(89)90066-X; BANDA PW, 1987, TOXICOL LETT, V36, P89, DOI 10.1016/0378-4274(87)90045-2; BIHARI DJ, 1986, SEMIN LIVER DIS, V6, P119, DOI 10.1055/s-2008-1040595; BRAGANZA JM, 1986, LANCET, V1, P914; DELEVE LD, 1990, HEPATOLOGY, V12, P1009; HAENEN G, 1989, THIOLS OXIDATIVE STR, P151; HARRISON PM, 1990, LANCET, V335, P1572, DOI 10.1016/0140-6736(90)91388-Q; HARRISON PM, 1991, NEW ENGL J MED, V324, P1852, DOI 10.1056/NEJM199106273242604; HARRISON PM, 1990, BMJ-BRIT MED J, V301, P964, DOI 10.1136/bmj.301.6758.964; KNAUS WA, 1985, ANN SURG, V202, P685, DOI 10.1097/00000658-198512000-00004; MINERS JO, 1984, BIOCHEM PHARMACOL, V33, P2995, DOI 10.1016/0006-2952(84)90599-9; MODIG J, 1988, ACTA CHIR SCAND, V154, P169; OGRADY JG, 1989, BAILLIERE CLIN GASTR, V3, P75, DOI 10.1016/0950-3528(89)90047-X; OGRADY JG, 1986, SCHWEIZ MED WSCHR, V116, P541; OGRADY JG, 1988, GASTROENTEROLOGY, V94, P1186, DOI 10.1016/0016-5085(88)90011-X; OGRADY JG, 1989, GASTROENTEROLOGY, V97, P439, DOI 10.1016/0016-5085(89)90081-4; PARKER D, 1990, HUM EXP TOXICOL, V9, P25, DOI 10.1177/096032719000900106; PRESCOTT LF, 1979, BRIT MED J, V2, P1097, DOI 10.1136/bmj.2.6198.1097; PRESCOTT LF, 1989, EUR J CLIN PHARMACOL, V37, P501, DOI 10.1007/BF00558131; RUMACK BH, 1981, ARCH INTERN MED, V141, P380, DOI 10.1001/archinte.141.3.380; TIRMENSTEIN MA, 1990, J BIOL CHEM, V265, P3059; Trey C, 1970, Prog Liver Dis, V3, P282; WILLIAMS R, 1988, POSTGRAD MED J, V64, P769, DOI 10.1136/pgmj.64.756.769	24	312	327	0	12	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	OCT 26	1991	303	6809					1026	1029		10.1136/bmj.303.6809.1026	http://dx.doi.org/10.1136/bmj.303.6809.1026			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GM478	1954453	Bronze, Green Published			2022-12-28	WOS:A1991GM47800019
J	ATCHLEY, WR; FITCH, WM				ATCHLEY, WR; FITCH, WM			GENE TREES AND THE ORIGINS OF INBRED STRAINS OF MICE	SCIENCE			English	Article							MOUSE STRAINS; DNA; EVOLUTION; PHYLOGENY; POPULATIONS; ASSOCIATION; MORPHOLOGY; DISTANCES	Extensive data on genetic divergence among 24 inbred strains of mice provide an opportunity to examine the concordance of gene trees and species trees, especially whether structured subsamples of loci give congruent estimates of phylogenetic relationships. Phylogenetic analyses of 144 separate loci reproduce almost exactly the known genealogical relationships among these 24 strains. Partitioning these loci into structured subsets representing loci coding for proteins, the immune system and endogeneous viruses give incongruent phylogenetic results. The gene tree based on protein loci provides an accurate picture of the genealogical relationships among strains; however, gene trees based upon immune and viral data show significant deviations from known genealogical affinities.	UNIV CALIF IRVINE,DEPT ECOL & EVOLUTIONARY BIOL,IRVINE,CA 92717	University of California System; University of California Irvine	ATCHLEY, WR (corresponding author), N CAROLINA STATE UNIV,DEPT GENET,RALEIGH,NC 27695, USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM045344] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-45344] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ATCHLEY WR, 1988, GENETICS, V120, P239; BLEDSOE AH, 1990, J MOL EVOL, V30, P247, DOI 10.1007/BF02099994; CHEN S, 1980, CELL, V21, P849, DOI 10.1016/0092-8674(80)90448-1; COULAM CB, 1987, AM J REPROD IMMUNOL, V14, P54; DIETZ EJ, 1983, SYST ZOOL, V32, P21, DOI 10.2307/2413216; FERRIS SD, 1983, GENETICS, V105, P681; FESTING MFW, 1989, GENET RES, V53, P45, DOI 10.1017/S0016672300027853; Festing MFW, 1979, INBRED STRAINS BIOME; FITCH WM, 1971, SYST ZOOL, V20, P406, DOI 10.2307/2412116; FITCH WM, 1985, SCIENCE, V228, P1169, DOI 10.1126/science.4001935; FITCH WM, 1987, MOL MORPHOLOGY EVOLU, P203; HEDRICK PW, 1988, GENETICS, V119, P199; HILLIS DM, 1987, ANNU REV ECOL SYST, V18, P23, DOI 10.1146/annurev.es.18.110187.000323; HINGS I, 1985, J REPROD IMMUNOL, V7, P337, DOI 10.1016/0165-0378(85)90028-2; JENKINS NA, 1982, J VIROL, V43, P26, DOI 10.1128/JVI.43.1.26-36.1982; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; KOZAK CA, 1985, ADV CANCER RES, V44, P295, DOI 10.1016/S0065-230X(08)60030-5; KOZAK CA, 1986, CURR TOP MICROBIOL, V127, P349; LOWENSTEIN JM, 1985, AM SCI, V73, P541; Lyon M., 1989, GENETIC VARIANTS STR; MCLELLAN T, 1984, AM J HUM GENET, V36, P836; Nei M., 1987, MOL EVOLUTIONARY GEN; PAMILO P, 1988, MOL BIOL EVOL, V5, P568; Patterson C., 1987, MOL MORPHOLOGY EVOLU; RYMAN N, 1983, HUM HERED, V333, P93; SIBLEY CG, 1984, J MOL EVOL, V20, P2, DOI 10.1007/BF02101980; STAATS J, 1985, CANCER RES, V45, P945; SYTSMA KJ, 1990, TRENDS ECOL EVOL, V5, P104, DOI 10.1016/0169-5347(90)90163-8; TAKAHATA N, 1989, GENETICS, V122, P957; WARNER CM, 1988, BIOL REPROD, V38, P17, DOI 10.1095/biolreprod38.1.17; WAYNE RK, 1986, J MAMMAL, V67, P441, DOI 10.2307/1381275; Weiss R, 1982, RNA TUMOR VIRUSES; WU CI, 1991, GENETICS, V127, P429; WYSS AR, 1987, MOL BIOL EVOL, V4, P99	34	144	147	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	OCT 25	1991	254	5031					554	558		10.1126/science.1948030	http://dx.doi.org/10.1126/science.1948030			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL799	1948030				2022-12-28	WOS:A1991GL79900044
J	BERNADT, M; GUNNING, L; QUENSTEDT, M				BERNADT, M; GUNNING, L; QUENSTEDT, M			PATIENTS ACCESS TO THEIR OWN PSYCHIATRIC RECORDS	BRITISH MEDICAL JOURNAL			English	Article									BECKENHAM HOSP,KENT BR3 3QL,ENGLAND		BERNADT, M (corresponding author), UNIV LONDON KINGS COLL HOSP,DEPT PSYCHOL MED,LONDON SE5 9RS,ENGLAND.							ALTMAN JH, 1980, NEW ENGL J MED, V302, P169, DOI 10.1056/NEJM198001173020310; GILL MW, 1986, BRIT MED J, V293, P1278, DOI 10.1136/bmj.293.6557.1278; 1990, ACCESS HLTH RECORDS	3	22	22	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	OCT 19	1991	303	6808					967	967		10.1136/bmj.303.6808.967	http://dx.doi.org/10.1136/bmj.303.6808.967			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GL127	1954422	Bronze, Green Published			2022-12-28	WOS:A1991GL12700024
J	REIZENSTEIN, P				REIZENSTEIN, P			QUALITY AND HEALTH-CARE IN SWEDEN	BRITISH MEDICAL JOURNAL			English	Article									KAROLINSKA HOSP,INST RADIAT PROTECT,S-10401 STOCKHOLM 60,SWEDEN	Karolinska Institutet; Karolinska University Hospital	REIZENSTEIN, P (corresponding author), KAROLINSKA HOSP,HAEMATOL LAB,POB 60500,S-10401 STOCKHOLM 60,SWEDEN.							BRITTON M, 1990, J INTERN MED, V228, P139; ECKERLUND I, 1986, SPRI RAPPORT STOCKHO, P204; MATTSSON B, 1984, THESIS U STOCKHOLM S; OHLSSON R, 1990, IHE INFORMATION LUND, V1, P3; OSBY E, 1989, MED ONCOL TUMOR PHAR, V6, P131; REIZENSTEIN P, 1984, BIOMED PHARMACOTHER, V38, P194; REIZENSTEIN P, 1968, PATIENT HLTH CARE OR, P82; REIZENSTEIN P, 1987, LAKARTIDNINGEN, V84, P1680; Svardsudd K, 1990, Qual Assur Health Care, V2, P243	9	3	3	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	OCT 12	1991	303	6807					900	902		10.1136/bmj.303.6807.900	http://dx.doi.org/10.1136/bmj.303.6807.900			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GK221	1933006	Green Published, Bronze			2022-12-28	WOS:A1991GK22100025
J	VANDERHEIJDE, DMFM; VANRIEL, PLCM; NUVERZWART, IH; VANDEPUTTE, LBA				VANDERHEIJDE, DMFM; VANRIEL, PLCM; NUVERZWART, IH; VANDEPUTTE, LBA			SULFASALAZINE VERSUS HYDROXYCHLOROQUINE IN RHEUMATOID-ARTHRITIS - 3-YEAR FOLLOW-UP	LANCET			English	Letter									ST DEVENTERZIEKENHUIZEN,DEPT RHEUMATOL,DEVENTER,NETHERLANDS	Deventer Hospital	VANDERHEIJDE, DMFM (corresponding author), UNIV HOSP NIJMEGEN,DEPT RHEUMATOL,6525 GA NIJMEGEN,NETHERLANDS.		van Riel, P.L.C.M./H-8082-2014					GOFTON JP, 1983, J RHEUMATOL, V10, P177; PAULUS H, 1982, ANN RHEUM DIS, V41, P54; PAULUS HE, 1982, ANN RHEUM DIS, V41, P26, DOI 10.1136/ard.41.Suppl_1.26; SITUNAYAKE RD, 1987, ANN RHEUM DIS, V46, P177, DOI 10.1136/ard.46.3.177; VANDERHEIJDE DM, 1989, LANCET, V1, P1036, DOI 10.1016/S0140-6736(89)92442-2	5	62	64	0	2	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	MAR 3	1990	335	8688					539	539		10.1016/0140-6736(90)90771-V	http://dx.doi.org/10.1016/0140-6736(90)90771-V			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT015	1968547				2022-12-28	WOS:A1990CT01500033
J	GRIBBEN, JG; DEVEREUX, S; THOMAS, NSB; KEIM, M; JONES, HM; GOLDSTONE, AH; LINCH, DC				GRIBBEN, JG; DEVEREUX, S; THOMAS, NSB; KEIM, M; JONES, HM; GOLDSTONE, AH; LINCH, DC			DEVELOPMENT OF ANTIBODIES TO UNPROTECTED GLYCOSYLATION SITES ON RECOMBINANT HUMAN GM-CSF	LANCET			English	Article									UNIV COLL & MIDDLESEX SCH MED,FAC CLIN SCI,DEPT HAEMATOL,LONDON WC1E 6HX,ENGLAND	University of London; University College London			Devereux, Stephen/B-4766-2009	Devereux, Stephen/0000-0002-8046-0386	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ANTIN JH, 1988, NEW ENGL J MED, V319, P1628; ANTMAN KS, 1988, NEW ENGL J MED, V319, P593, DOI 10.1056/NEJM198809083191001; BRANDT SJ, 1988, NEW ENGL J MED, V318, P869, DOI 10.1056/NEJM198804073181401; CANTRELL MA, 1985, P NATL ACAD SCI USA, V82, P6250, DOI 10.1073/pnas.82.18.6250; CEBON J, 1988, BLOOD, V72, P1340; DEVEREAUX S, 1989, BONE MARROW TRANSPL, V4, P49; GILLIS S, 1987, BEHRING I MITT, V83, P1; GROOPMAN JE, 1987, NEW ENGL J MED, V317, P593, DOI 10.1056/NEJM198709033171003; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MAYER P, 1987, BLOOD, V70, P206; MORRISSEY PJ, 1987, J IMMUNOL, V139, P1113; VOLLER A, 1976, B WORLD HEALTH ORGAN, V53, P55; WONG GG, 1985, SCIENCE, V228, P810, DOI 10.1126/science.3923623	13	165	178	0	8	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	FEB 24	1990	335	8687					434	437		10.1016/0140-6736(90)90665-R	http://dx.doi.org/10.1016/0140-6736(90)90665-R			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CP907	1968169				2022-12-28	WOS:A1990CP90700003
J	DEKROM, MCTFM; KNIPSCHILD, PG; KESTER, ADM; SPAANS, F				DEKROM, MCTFM; KNIPSCHILD, PG; KESTER, ADM; SPAANS, F			EFFICACY OF PROVOCATIVE TESTS FOR DIAGNOSIS OF CARPAL-TUNNEL SYNDROME	LANCET			English	Article									STATE UNIV LIMBURG HOSP,DEPT EPIDEMIOL & HLTH CARE RES,MAASTRICHT,NETHERLANDS; STATE UNIV LIMBURG HOSP,DEPT CLIN NEUROPHYSIOL,MAASTRICHT,NETHERLANDS; STATE UNIV LIMBURG,DEPT MED INFORMAT & STAT,6200 MD MAASTRICHT,NETHERLANDS	Maastricht University; Maastricht University; Maastricht University	DEKROM, MCTFM (corresponding author), STATE UNIV LIMBURG HOSP,DEPT NEUROL,POB 1918,6201 BX MAASTRICHT,NETHERLANDS.							AEBIOCHSNER C, 1979, FORTSCHR NEUROL PSYC, V47, P307; BENINI A, 1975, KARPAL TUNNEL SYNDRO; BOWLES AP, 1983, ANN NEUROL, V13, P689, DOI 10.1002/ana.410130627; BRENNINKMEYER R, 1979, ACTA NEUROL SCAND, V60, P119; BUCHTHAL F, 1974, J NEUROL NEUROSUR PS, V37, P340, DOI 10.1136/jnnp.37.3.340; DUENSING F, 1974, Z NEUROL, V206, P267, DOI 10.1007/BF00316540; GELLMAN H, 1986, J BONE JOINT SURG AM, V68A, P735, DOI 10.2106/00004623-198668050-00015; GELMERS HJ, 1979, ACTA NEUROCHIR, V49, P255, DOI 10.1007/BF01808965; GILLIATT RW, 1953, LANCET, V2, P595; GOLDING DN, 1986, BRIT J RHEUMATOL, V25, P388; HELLER L, 1986, EUR NEUROL, V25, P40, DOI 10.1159/000115985; HEYWOOD PL, 1987, BRIT MED J, V294, P660, DOI 10.1136/bmj.294.6573.660-a; JOHNSON EW, 1981, ARCH PHYS MED REHAB, V62, P206; KENDALL D, 1960, BRIT MED J, V2, P1633, DOI 10.1136/bmj.2.5213.1633; KNIPSCHILD P, 1988, BRIT MED J, V297, P1578, DOI 10.1136/bmj.297.6663.1578; LUTHY F, 1962, SCHWEIZ MED WSCHR, V92, P1573; MOSSMAN SS, 1987, BRIT MED J, V294, P680, DOI 10.1136/bmj.294.6573.680; MUMENTHALER M, 1987, LASIONEN PERIPHERER, P243; MUMENTHALER M, 1982, SCHULTER ARM SCHMERZ, P93; PHALEN GS, 1970, J AMER MED ASSOC, V212, P1365, DOI 10.1001/jama.212.8.1365; PHALEN GS, 1957, JAMA-J AM MED ASSOC, V164, P524, DOI 10.1001/jama.1957.02980050014005; PRYSEPHILLIPS WEM, 1984, J NEUROL NEUROSUR PS, V47, P870, DOI 10.1136/jnnp.47.8.870; REDMOND MD, 1988, MUSCLE NERVE, V11, P511, DOI 10.1002/mus.880110515; SPAANS F, 1984, CURRENT PRACTICE CLI, P233; STEVENS JC, 1987, MUSCLE NERVE, V10, P99, DOI 10.1002/mus.880100202; STEWART JD, 1978, BRIT MED J, V2, P1125, DOI 10.1136/bmj.2.6145.1125-a; SZABO RM, 1984, J BONE JOINT SURG AM, V66A, P60, DOI 10.2106/00004623-198466010-00009; TINEL J, 1915, PRESSE MED, V23, P388; WALTON J, 1985, BRAINS DISEASES NERV, P505; [No title captured]; [No title captured]	31	129	131	0	4	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	FEB 17	1990	335	8686					393	395		10.1016/0140-6736(90)90218-T	http://dx.doi.org/10.1016/0140-6736(90)90218-T			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN988	1968125	Bronze			2022-12-28	WOS:A1990CN98800013
J	MACLENNAN, AH; GREEN, RC; OSHEA, R; BROOKES, C; MORRIS, D				MACLENNAN, AH; GREEN, RC; OSHEA, R; BROOKES, C; MORRIS, D			ROUTINE HOSPITAL ADMISSION IN TWIN PREGNANCY BETWEEN 26 AND 30 WEEKS GESTATION	LANCET			English	Article									FLINDERS UNIV,MED CTR,BEDFORD PK,SA 5042,AUSTRALIA	Flinders University South Australia	MACLENNAN, AH (corresponding author), UNIV ADELAIDE,QUEEN VICTORIA HOSP,DEPT OBSTET & GYNAECOL,160 FULLARTON RD,ROSE PK,SA 5067,AUSTRALIA.							CROWTHER C, 1989, EFFECTIVE CARE PREGN, P624; CROWTHER CA, 1989, BRIT J OBSTET GYNAEC, V96, P850, DOI 10.1111/j.1471-0528.1989.tb03327.x; HARTIKAINENSORRI AL, 1984, J PERINAT MED, V12, P31; Komaromy B, 1977, Int J Gynaecol Obstet, V15, P262; MEHTA CR, 1985, J AM STAT ASSOC, V80, P969, DOI 10.2307/2288562; Patel N, 1983, SCOTTISH TWIN STUDY; RYDSTROM H, 1987, ACTA OBSTET GYNECOL, V66, P361; SAUNDERS MC, 1985, LANCET, V2, P793, DOI 10.1016/S0140-6736(85)90792-5; TRESMONTANT R, 1983, ACTA GENET MED GEMEL, V32, P99, DOI 10.1017/S0001566000006371; ZILBERT AW, 1980, NOVA SCOTIA B MED, V153, P45	10	34	35	0	1	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	FEB 3	1990	335	8684					267	269		10.1016/0140-6736(90)90079-K	http://dx.doi.org/10.1016/0140-6736(90)90079-K			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CL815	1967729				2022-12-28	WOS:A1990CL81500013
J	ROBERTS, MM; ALEXANDER, FE; ANDERSON, TJ; CHETTY, U; DONNAN, PT; FORREST, P; HEPBURN, W; HUGGINS, A; KIRKPATRICK, AE; LAMB, J; MUIR, BB; PRESCOTT, RJ				ROBERTS, MM; ALEXANDER, FE; ANDERSON, TJ; CHETTY, U; DONNAN, PT; FORREST, P; HEPBURN, W; HUGGINS, A; KIRKPATRICK, AE; LAMB, J; MUIR, BB; PRESCOTT, RJ			EDINBURGH TRIAL OF SCREENING FOR BREAST-CANCER - MORTALITY AT 7 YEARS	LANCET			English	Article									UNIV LEEDS,DEPT PATHOL,CTR LEUKAEMIA RES FUND,17 SPRINGFIELD MOUNT,LEEDS LS2 9NG,W YORKSHIRE,ENGLAND; UNIV EDINBURGH,EDINBURGH BREAST SCREENING CTR,EDINBURGH EH8 9YL,MIDLOTHIAN,SCOTLAND; UNIV EDINBURGH,MED STAT UNIT,EDINBURGH EH8 9YL,MIDLOTHIAN,SCOTLAND; UNIV EDINBURGH,DEPT PATHOL,EDINBURGH EH8 9YL,MIDLOTHIAN,SCOTLAND; UNIV EDINBURGH,DEPT CLIN SURG,EDINBURGH EH8 9YL,MIDLOTHIAN,SCOTLAND; ROYAL INFIRM,DEPT RADIOL,EDINBURGH EH3 9HB,MIDLOTHIAN,SCOTLAND	University of Leeds; University of Edinburgh; University of Edinburgh; University of Edinburgh; University of Edinburgh; Royal Infirmary of Edinburgh				Donnan, Peter/0000-0001-7828-0610				ALEXANDER F, 1989, J EPIDEMIOL COMMUN H, V43, P29, DOI 10.1136/jech.43.1.29; ANDERSSON I, 1988, BRIT MED J, V297, P943, DOI 10.1136/bmj.297.6654.943; AXTELL LM, 1976, DHEW NIH77992 PUBL; BRINKLEY D, 1984, BRIT MED J, V289, P465, DOI 10.1136/bmj.289.6443.465; CHETTY U, 1983, BRIT J SURG, V70, P607, DOI 10.1002/bjs.1800701013; CORNFIELD J, 1978, AM J EPIDEMIOL, V108, P100, DOI 10.1093/oxfordjournals.aje.a112592; DAY NE, 1989, WORLD J SURG, V13, P3, DOI 10.1007/BF01671147; Habbema J D, 1983, Stat Med, V2, P279, DOI 10.1002/sim.4780020224; HUNT SM, 1988, PUBLIC HEALTH, V102, P3, DOI 10.1016/S0033-3506(88)80004-0; LOGAN WPD, 1982, IARC SCI PUBLICATION, V36; LUNDGREN B, 1988, BRIT MED J, V297, P1266, DOI 10.1136/bmj.297.6658.1266; MACLEAN U, 1984, J EPIDEMIOL COMMUN H, V38, P278, DOI 10.1136/jech.38.4.278; MCEWEN J, 1989, BRIT MED J, V299, P104, DOI 10.1136/bmj.299.6691.104; PEETERS PHM, 1989, INT J CANCER, V43, P226, DOI 10.1002/ijc.2910430209; ROBERTS MM, 1986, J EPIDEMIOL COMMUN H, V40, P338, DOI 10.1136/jech.40.4.338; ROBERTS MM, 1984, BRIT J CANCER, V47, P1; SHAPIRO S, 1982, JNCI-J NATL CANCER I, V69, P349; TABAR L, 1989, J EPIDEMIOL COMMUN H, V43, P107, DOI 10.1136/jech.43.2.107; TABAR L, 1985, LANCET, V1, P829, DOI 10.1016/S0140-6736(85)92204-4; VENET W, 1986, FINAL REPORT EVALUAT; WILLIAMS DA, 1982, J R STAT SOC C-APPL, V31, P144; 1986, OCCUPATIONAL MORTALI; 1987, LIFE TABLES 1980 198; 1987, STD8734 DHHS; 1988, LANCET, V2, P411	25	370	372	0	2	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	FEB 3	1990	335	8684					241	246						6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CL815	1967717				2022-12-28	WOS:A1990CL81500001
J	CEGIELSKI, JP; RAMAIYA, K; LALLINGER, GJ; MTULIA, IA; MBAGA, IM				CEGIELSKI, JP; RAMAIYA, K; LALLINGER, GJ; MTULIA, IA; MBAGA, IM			PERICARDIAL DISEASE AND HUMAN-IMMUNODEFICIENCY-VIRUS IN DAR-ES-SALAAM, TANZANIA	LANCET			English	Article									DUKE UNIV,MED CTR,DIV INFECT DIS & INT HLTH,DURHAM,NC 27710; UNIV DAR ES SALAAM,MUHIMBILI MED CTR,DEPT MED,DAR ES SALAAM,TANZANIA	Duke University; University of Dar es Salaam								ANDERSON DW, 1988, 3RD INT C AIDS WASH, P9; BLASER MJ, 1986, REV INFECT DIS, V8, P21; CAMMAROSANO C, 1985, J AM COLL CARDIOL, V5, P703, DOI 10.1016/S0735-1097(85)80397-1; CHAISSON RE, 1987, AM REV RESPIR DIS, V136, P570, DOI 10.1164/ajrccm/136.3.570; COLEBUNDERS R, 1987, LANCET, V1, P492; CORALLO S, 1988, EUR HEART J, V9, P887, DOI 10.1093/oxfordjournals.eurheartj.a062583; DALLI E, 1987, AM HEART J, V114, P905, DOI 10.1016/0002-8703(87)90807-6; DCRUZ IA, 1986, AM HEART J, V112, P1100, DOI 10.1016/0002-8703(86)90331-5; FINK L, 1984, AM J CARDIOL, V54, P1161, DOI 10.1016/S0002-9149(84)80178-2; FREEDBERG RS, 1987, NEW YORK STATE J MED, V87, P304; GILL PS, 1987, J CLIN ONCOL, V5, P216, DOI 10.1200/JCO.1987.5.2.216; HANDWERGER S, 1987, CHEST, V91, P176, DOI 10.1378/chest.91.2.176; HIMELMAN RB, 1989, J AM COLL CARDIOL, V13, P1030, DOI 10.1016/0735-1097(89)90256-8; LANGER E, 1988, DEUT MED WOCHENSCHR, V113, P1187, DOI 10.1055/s-2008-1067791; LEVY WS, 1988, 4TH INT C AIDS STOCK, V1, P401; LORELL BH, 1988, HEART DISEASE, P1484; MALU K, 1988, ARCH MAL COEUR VAISS, V81, P207; NIEDT GW, 1988, KAPOSIS SARCOMA TEXT, P271; PALLANGYO PK, 1989, 25TH MED ASS TANZ AN; PITCHENIK AE, 1984, ANN INTERN MED, V101, P641, DOI 10.7326/0003-4819-101-5-641; PITCHENIK AE, 1987, AM REV RESPIR DIS, V135, P875, DOI 10.1164/arrd.1987.135.4.875; QUINN TC, 1986, SCIENCE, V234, P955, DOI 10.1126/science.3022379; REILLY JM, 1988, AM J CARDIOL, V62, P789, DOI 10.1016/0002-9149(88)91223-4; SUNDERAM G, 1986, JAMA-J AM MED ASSOC, V256, P362, DOI 10.1001/jama.256.3.362; URASSA W, 1989, 4TH INT C AIDS ASS C; VERCAUTEREN G, 1987, EUR J CLIN MICROBIOL, V6, P132, DOI 10.1007/BF02018193; ZUGER A, 1986, ANN INTERN MED, V104, P234, DOI 10.7326/0003-4819-104-2-234; 1988, JAMA-J AM MED ASSOC, V259, P338	28	80	81	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	JAN 27	1990	335	8683					209	212		10.1016/0140-6736(90)90288-G	http://dx.doi.org/10.1016/0140-6736(90)90288-G			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CL185	1967676				2022-12-28	WOS:A1990CL18500013
J	BERSTEN, AD; HOLT, AW; VEDIG, AE; SKOWRONSKI, GA; BAGGOLEY, CJ				BERSTEN, AD; HOLT, AW; VEDIG, AE; SKOWRONSKI, GA; BAGGOLEY, CJ			TREATMENT OF SEVERE CARDIOGENIC PULMONARY-EDEMA WITH CONTINUOUS POSITIVE AIRWAY PRESSURE DELIVERED BY FACE MASK	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACUTE RESPIRATORY-FAILURE; CONGESTIVE HEART-FAILURE; MYOCARDIAL-INFARCTION; FUROSEMIDE; PEEP	Background. Severe cardiogenic pulmonary edema is a frequent cause of respiratory failure, and many patients with this condition require endotracheal intubation and mechanical ventilation. We investigated whether continuous positive airway pressure delivered by means of a face mask had physiologic benefit and would reduce the need for intubation and mechanical ventilation. Methods. We randomly assigned 39 consecutive patients with respiratory failure due to severe cardiogenic pulmonary edema to receive either oxygen alone or oxygen plus continuous positive airway pressure delivered through a face mask. It was not possible to blind the investigators to the assigned treatment. Physiologic measurements were made over the subsequent 24 hours, and the patients were followed to hospital discharge. Results. After 30 minutes, both respiratory rate and arterial carbon dioxide tension had decreased more in the patients who received oxygen plus continuous positive airway pressure. The mean (+/- SD) respiratory rate at 30 minutes decreased from 32 +/- 6 to 33 +/- 9 breaths per minute in the patients receiving oxygen alone and from 35 +/- 8 to 27 +/- 6 breaths per minute in those receiving oxygen plus continuous positive airway pressure (P = 0.008); the arterial carbon dioxide tension decreased from 64 +/- 17 to 62 +/- 14 mm Hg in those receiving oxygen alone and from 58 +/- 8 to 46 +/- 4 mm Hg in those receiving oxygen plus continuous positive airway pressure (P < 0.001). The patients receiving continuous positive airway pressure also had a greater increase in the arterial pH (oxygen alone, from 7.15 +/- 0.11 to 7.18 +/- 0.18; oxygen plus continuous positive airway pressure, from 7.18 +/- 0.08 to 7.28 +/- 0.06; P < 0.001) and in the ratio of arterial oxygen tension to the fraction of inspired oxygen (oxygen alone, from 136 +/- 4 to 126 +/- 47; oxygen plus continuous positive airway pressure, from 138 +/- 32 to 206 +/- 126; P = 0.01). After 24 hours, however, there were no significant differences between the two treatment groups in any of these respiratory indexes. Seven (35 percent) of the patients who received oxygen alone but none who received oxygen plus continuous positive airway pressure required intubation and mechanical ventilation (P = 0.005). However, no significant difference was found in in-hospital mortality (oxygen alone, 4 of 20 patients; oxygen plus continuous positive airway pressure, 2 of 19; P = 0.36) or the length of the hospital stay. Conclusions. Continuous positive airway pressure delivered by face mask in patients with severe cardiogenic pulmonary edema can result in early physiologic improvement and reduce the need for intubation and mechanical ventilation. This short-term study could not establish whether continuous positive airway pressure has any long-term benefit or whether a larger study would have shown a difference in mortality between the treatment groups.	FLINDERS UNIV,MED CTR,DEPT EMERGENCY MED,BEDFORD PK,SA 5042,AUSTRALIA	Flinders University South Australia	BERSTEN, AD (corresponding author), FLINDERS UNIV,MED CTR,DEPT INTENS CARE,INTENS CARE UNIT,BEDFORD PK,SA 5042,AUSTRALIA.			Bersten, Andrew/0000-0001-9908-394X				BERSTEN AD, 1991, CRIT CARE MED, V19, P266, DOI 10.1097/00003246-199102000-00024; BROSEGHINI C, 1988, AM REV RESPIR DIS, V138, P355, DOI 10.1164/ajrccm/138.2.355; BUDA AJ, 1979, NEW ENGL J MED, V301, P453, DOI 10.1056/NEJM197908303010901; BUSSMANN WD, 1978, AM J CARDIOL, V41, P931, DOI 10.1016/0002-9149(78)90736-1; CALVIN JE, 1981, AM REV RESPIR DIS, V124, P121; DIKSHIT K, 1973, NEW ENGL J MED, V288, P1087, DOI 10.1056/NEJM197305242882102; FRANCIS GS, 1985, ANN INTERN MED, V103, P1, DOI 10.7326/0003-4819-103-1-1; KATZ JA, 1985, ANESTHESIOLOGY, V63, P598, DOI 10.1097/00000542-198512000-00008; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; LESCH M, 1968, NEW ENGL J MED, V279, P115, DOI 10.1056/NEJM196807182790301; LIGHT RW, 1983, ARCH INTERN MED, V143, P429, DOI 10.1001/archinte.143.3.429; NELSON GIC, 1983, LANCET, V1, P730; PINGLETON SK, 1988, AM REV RESPIR DIS, V137, P1463, DOI 10.1164/ajrccm/137.6.1463; POULTON PE, 1936, LANCET, V2, P981; RASANEN J, 1985, AM J CARDIOL, V55, P296, DOI 10.1016/0002-9149(85)90364-9; RIZK NW, 1982, AM J MED, V72, P381, DOI 10.1016/0002-9343(82)90491-0; ROUSSOS C, 1982, NEW ENGL J MED, V307, P786, DOI 10.1056/NEJM198209233071304; SHARP JT, 1958, J CLIN INVEST, V37, P111, DOI 10.1172/JCI103577	18	386	402	0	4	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 26	1991	325	26					1825	1830		10.1056/NEJM199112263252601	http://dx.doi.org/10.1056/NEJM199112263252601			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GW528	1961221				2022-12-28	WOS:A1991GW52800001
J	SUTHERLAND, GR; GEDEON, A; KORNMAN, L; DONNELLY, A; BYARD, RW; MULLEY, JC; KREMER, E; LYNCH, M; PRITCHARD, M; YU, S; RICHARDS, RI				SUTHERLAND, GR; GEDEON, A; KORNMAN, L; DONNELLY, A; BYARD, RW; MULLEY, JC; KREMER, E; LYNCH, M; PRITCHARD, M; YU, S; RICHARDS, RI			PRENATAL-DIAGNOSIS OF FRAGILE X-SYNDROME BY DIRECT DETECTION OF THE UNSTABLE DNA-SEQUENCE	NEW ENGLAND JOURNAL OF MEDICINE			English	Note									QUEEN VICTORIA HOSP,ADELAIDE,AUSTRALIA; ADELAIDE CHILDRENS HOSP INC,DEPT HISTOPATHOL,ADELAIDE,SA 5006,AUSTRALIA		SUTHERLAND, GR (corresponding author), ADELAIDE CHILDRENS HOSP INC,DEPT CYTOGENET & MOLEC GENET,ADELAIDE,SA 5006,AUSTRALIA.		Sutherland, Grant Robert/D-2606-2012; Kremer, EJ/P-9838-2019; Kremer, Eric J/D-3734-2013; Richards, Robert/ABE-6423-2020; Gedeon, Agi/G-7890-2011	Kremer, EJ/0000-0001-6114-7530; Byard, Roger/0000-0002-0524-5942; Richards, Robert Ian/0000-0002-5978-6453				JENKINS EC, 1991, AM J MED GENET, V38, P447, DOI 10.1002/ajmg.1320380262; KOGAN SC, 1987, NEW ENGL J MED, V317, P985, DOI 10.1056/NEJM198710153171603; KREMER EJ, 1991, SCIENCE, V252, P1711, DOI 10.1126/science.1675488; OBERLE I, 1991, SCIENCE, V252, P1097, DOI 10.1126/science.252.5009.1097; PURVISSMITH SG, 1988, AM J MED GENET, V30, P337, DOI 10.1002/ajmg.1320300134; RICHARDS RI, 1991, AM J HUM GENET, V48, P1051; SHERMAN SL, 1984, ANN HUM GENET, V48, P21, DOI 10.1111/j.1469-1809.1984.tb00830.x; Sutherland G, 1985, FRAGILE SITES HUMAN; SUTHERLAND GR, 1990, CLIN GENET, V37, P2; SUTHERS GK, 1991, AM J HUM GENET, V48, P460; YU S, 1991, SCIENCE, V252, P1179, DOI 10.1126/science.252.5009.1179	11	96	98	0	1	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 12	1991	325	24					1720	1722		10.1056/NEJM199112123252407	http://dx.doi.org/10.1056/NEJM199112123252407			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GU418	1944473				2022-12-28	WOS:A1991GU41800007
J	JASON, LA; JI, PY; ANES, MD; BIRKHEAD, SH				JASON, LA; JI, PY; ANES, MD; BIRKHEAD, SH			ACTIVE ENFORCEMENT OF CIGARETTE CONTROL LAWS IN THE PREVENTION OF CIGARETTE SALES TO MINORS	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CHILDREN; TOBACCO	Objective. - To assess the effect that cigarette legislation would have on reducing merchant sales rates of cigarettes to minors and the affect on adolescent smoking behavior. Design. - Observational survey of merchant selling behaviors and adolescent smoking habits before and after passage of legislation. Setting. - The setting for the merchant survey was Woodridge, III (population 25200), a suburban community of Chicago. The surveys were distributed to adolescents in the local junior high school. Participants. - Convenience sample of both merchants and adolescent students. Intervention. - Passage of community antismoking legislation. Main Outcome Measures. - Percentage of stores selling cigarettes to minors in Woodridge and percentage of students who had experimented with cigarettes or were regular smokers. Results. - Merchant sales rates in Woodridge decreased from a baseline of 70% before legislation to less than 5% in 1.5 years of compliance checking after legislation. Student surveys showed that the rates of cigarette experimentation and regular use of cigarettes by adolescents were reduced by over 50%. Conclusion. - Cigarette control laws can be effective in significantly reducing the rate of cigarettes sold by merchants and rates of cigarette use by adolescents. Key elements of successful legislation implementation are consistent compliance checking and heightened community awareness of the problems and prevalence of adolescent smoking.			JASON, LA (corresponding author), DE PAUL UNIV,DEPT PSYCHOL,2323 N SEMINARY AVE,CHICAGO,IL 60614, USA.							ALTMAN DG, 1989, JAMA-J AM MED ASSOC, V261, P80, DOI 10.1001/jama.261.1.80; DIFRANZA JR, 1987, JAMA-J AM MED ASSOC, V257, P3387, DOI 10.1001/jama.257.24.3387; DIFRANZA JR, 1990, JAMA-J AM MED ASSOC, V263, P2784, DOI 10.1001/jama.263.20.2784; PIERCE JP, 1989, JAMA-J AM MED ASSOC, V261, P61, DOI 10.1001/jama.261.1.61; 1989, TOBACCO YOUTH RE AUT, V4, P6; 1988, TOBACCO YOUTH RE AUT, V3, P1; 1990, TOBACCO YOUTH RE AUT, V4, P17	7	199	200	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 11	1991	266	22					3159	3161		10.1001/jama.266.22.3159	http://dx.doi.org/10.1001/jama.266.22.3159			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GT654	1956104				2022-12-28	WOS:A1991GT65400025
J	KATKOV, WN; FRIEDMAN, LS; CODY, H; EVANS, A; KUO, G; CHOO, QL; HOUGHTON, M; DIENSTAG, JL				KATKOV, WN; FRIEDMAN, LS; CODY, H; EVANS, A; KUO, G; CHOO, QL; HOUGHTON, M; DIENSTAG, JL			ELEVATED SERUM ALANINE AMINOTRANSFERASE LEVELS IN BLOOD-DONORS - THE CONTRIBUTION OF HEPATITIS-C VIRUS	ANNALS OF INTERNAL MEDICINE			English	Note						BLOOD DONORS; HEPATITIS, VIRAL, NON-A, NON-B; HEPATITIS-C VIRUS; ALANINE AMINOTRANSFERASE; HEPATITIS ANTIBODIES	NON-B-HEPATITIS; TRANSFUSION-TRANSMITTED VIRUSES; NON-A; RECIPIENTS; ANTIBODY; RISK	In 1983, anticipating the introduction of alanine aminotransferase (ALT) screening to limit the frequency of transfusion-associated non-A, non-B hepatitis, we evaluated 100 consecutive blood donors with elevated ALT levels. To assess the role of hepatitis C virus (HCV) in blood donors with ALT elevations, we tested donor sera for antibody to HCV (anti-HCV). Antibody was detected and "confirmed" by a second-generation recombinant immunoblot assay (RIBA-2) in 17% of donors. Aminotransferase levels were higher in donors with anti-HCV. Antibody to HCV was more frequent in donors with persistent ALT elevations and in those who used intravenous drugs; anti-HCV was less frequent in donors who were overweight, who drank alcohol regularly, and who had no alternative explanation for an elevated ALT level. We conclude that asymptomatic ALT elevations are infrequently associated with HCV infection, unless the elevation is substantial, persistent, or associated with intravenous drug use. Hepatitis C virus infection is an unlikely cause of asymptomatic ALT elevations in persons who drink alcohol regularly or who are obese; however, HCV infection is a more likely cause of ALT elevations in thin persons who do not drink alcohol regularly.	HARVARD UNIV, MASSACHUSETTS GEN HOSP, SCH MED, GASTROINTESTINAL UNIT, BOSTON, MA 02114 USA; HARVARD UNIV, SCH PUBL HLTH, BOSTON, MA 02115 USA; THOMAS JEFFERSON UNIV, JEFFERSON MED COLL, PHILADELPHIA, PA 19107 USA; CHIRON CORP, EMERYVILLE, CA USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Jefferson University; Novartis				Dienstag, Jules/0000-0001-7024-0980; Houghton, Michael/0000-0003-3762-6771	NIDDK NIH HHS [T32-DK07191] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007191] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AACH RD, 1981, NEW ENGL J MED, V304, P989, DOI 10.1056/NEJM198104233041701; ALTER HJ, 1981, JAMA-J AM MED ASSOC, V246, P630, DOI 10.1001/jama.246.6.630; FRIEDMAN LS, 1987, ANN INTERN MED, V107, P137, DOI 10.7326/0003-4819-107-2-137; KOZIOL DE, 1986, ANN INTERN MED, V104, P488, DOI 10.7326/0003-4819-104-4-488; KUO G, 1989, SCIENCE, V244, P362, DOI 10.1126/science.2496467; MACFARLANE DG, 1990, LANCET, V335, P727, DOI 10.1016/0140-6736(90)90843-T; PALMER M, 1990, GASTROENTEROLOGY, V99, P1408, DOI 10.1016/0016-5085(90)91169-7; SHERMAN KE, 1982, J INFECT DIS, V145, P383, DOI 10.1093/infdis/145.3.383; STEVENS CE, 1984, ANN INTERN MED, V101, P733, DOI 10.7326/0003-4819-101-6-733; VANDERPOEL CL, 1991, LANCET, V337, P317, DOI 10.1016/0140-6736(91)90942-I	10	39	39	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 1	1991	115	11					882	884		10.7326/0003-4819-115-11-882	http://dx.doi.org/10.7326/0003-4819-115-11-882			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GR171	1952477				2022-12-28	WOS:A1991GR17100009
J	SULLIVAN, LW				SULLIVAN, LW			EFFECTS OF DISCRIMINATION AND RACISM ON ACCESS TO HEALTH-CARE	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material											SULLIVAN, LW (corresponding author), US DEPT HHS,WASHINGTON,DC 20201, USA.								0	10	10	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 20	1991	266	19					2674	2674		10.1001/jama.266.19.2674	http://dx.doi.org/10.1001/jama.266.19.2674			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GP691	1942411				2022-12-28	WOS:A1991GP69100006
J	BARDWELL, JCA; MCGOVERN, K; BECKWITH, J				BARDWELL, JCA; MCGOVERN, K; BECKWITH, J			IDENTIFICATION OF A PROTEIN REQUIRED FOR DISULFIDE BOND FORMATION INVIVO	CELL			English	Article							ESCHERICHIA-COLI K-12; MEMBRANE-PROTEIN; SECRETORY PROTEINS; PHYSICAL-MECHANISM; BINDING PROTEIN; ISOMERASE; THIOREDOXIN; SEQUENCE; TOPOLOGY; GENE	We describe a mutation (dsbA) that renders Escherichia coli severely defective in disulfide bond formation. In dsbA mutant cells, pulse-labeled beta-lactamase, alkaline phosphatase, and OmpA are secreted but largely lack disulfide bonds. These disulfideless proteins may represent in vivo folding intermediates, since they are protease sensitive and chase slowly into stable oxidized forms. The dsbA gene codes for a 21,000 M(r) periplasmic protein containing the sequence cys-pro-his-cys, which resembles the active sites of certain disulfide oxidoreductases. The purified DsbA protein is capable of reducing the disulfide bonds of insulin, an activity that it shares with these disulfide oxidoreductases. Our results suggest that disulfide bond formation is facilitated by DsbA in vivo.			BARDWELL, JCA (corresponding author), HARVARD UNIV, SCH MED, DEPT MICROBIOL & MOLEC GENET, BOSTON, MA 02115 USA.				NIGMS NIH HHS [5 R37 GM38922] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM038922] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AMES GF, 1984, J BACTERIOL, V160, P1181, DOI 10.1128/JB.160.3.1181-1183.1984; BACHMANN BJ, 1990, MICROBIOL REV, V54, P130, DOI 10.1128/MMBR.54.2.130-197.1990; BARDWELL JCA, 1988, J BACTERIOL, V170, P2977, DOI 10.1128/jb.170.7.2977-2983.1988; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BULLEID NJ, 1988, NATURE, V335, P649, DOI 10.1038/335649a0; CHEN R, 1980, P NATL ACAD SCI-BIOL, V77, P4592, DOI 10.1073/pnas.77.8.4592; DOIG AJ, 1991, J MOL BIOL, V217, P389, DOI 10.1016/0022-2836(91)90551-G; DUBOSE RF, 1991, EVOLUTION AT THE MOLECULAR LEVEL, P58; EDMAN JC, 1985, NATURE, V317, P267, DOI 10.1038/317267a0; FREEDMAN RB, 1989, CELL, V57, P1069, DOI 10.1016/0092-8674(89)90043-3; FREEDMAN RB, 1991, CONFORMATIONS FORCES, P204; FROSHAUER S, 1988, J MOL BIOL, V200, P501, DOI 10.1016/0022-2836(88)90539-6; GILBERT HF, 1990, ADV ENZYMOL RAMB, V63, P69; Gurd F R, 1972, Methods Enzymol, V25, P424, DOI 10.1016/S0076-6879(72)25038-8; HARDING MW, 1989, NATURE, V341, P758, DOI 10.1038/341758a0; HARTMAN H, 1990, MOL BIOL EVOL, V7, P247; HAWKINS HC, 1991, BIOCHEM J, V275, P349, DOI 10.1042/bj2750349; HOLMGREN A, 1979, J BIOL CHEM, V254, P9627; HOLMGREN A, 1989, J BIOL CHEM, V264, P13963; KIM EE, 1991, J MOL BIOL, V218, P449, DOI 10.1016/0022-2836(91)90724-K; KOHARA Y, 1987, CELL, V50, P495, DOI 10.1016/0092-8674(87)90503-4; KONINGS WN, 1982, P NATL ACAD SCI-BIOL, V79, P5480, DOI 10.1073/pnas.79.18.5480; KRAUSE G, 1991, J BIOL CHEM, V266, P9494; LAMANTIA M, 1991, P NATL ACAD SCI USA, V88, P4453, DOI 10.1073/pnas.88.10.4453; LANDRY SJ, 1991, TRENDS BIOCHEM SCI, V16, P159, DOI 10.1016/0968-0004(91)90060-9; LUNDSTROM J, 1990, J BIOL CHEM, V265, P9114; LYLES MM, 1991, BIOCHEMISTRY-US, V30, P613, DOI 10.1021/bi00217a004; MANOIL C, 1986, SCIENCE, V233, P1403, DOI 10.1126/science.3529391; MICHAELIS S, 1983, J BACTERIOL, V154, P366, DOI 10.1128/JB.154.1.366-374.1983; PETERS T, 1982, J BIOL CHEM, V257, P8847; POLLITT S, 1983, J BACTERIOL, V153, P27, DOI 10.1128/JB.153.1.27-32.1983; RANDALL LL, 1986, CELL, V46, P921, DOI 10.1016/0092-8674(86)90074-7; ROBILLARD GT, 1981, BIOCHEMISTRY-US, V20, P5025, DOI 10.1021/bi00520a032; ROTHMAN JE, 1989, CELL, V59, P591, DOI 10.1016/0092-8674(89)90005-6; RUSSELL CB, 1989, J BACTERIOL, V171, P2609, DOI 10.1128/jb.171.5.2609-2613.1989; SAMPSON BA, 1989, GENETICS, V122, P491; SCHEELE G, 1982, J BIOL CHEM, V257, P2277; SCHIEBEL E, 1991, CELL, V64, P927, DOI 10.1016/0092-8674(91)90317-R; SCHULTZ SC, 1987, PROTEINS, V2, P290, DOI 10.1002/prot.340020405; Silhavy T. J., 1984, EXPT GENE FUSIONS; TAKAHASHI N, 1989, NATURE, V337, P473, DOI 10.1038/337473a0; TANI K, 1990, J BIOL CHEM, V265, P17341; TANIYAMA Y, 1991, J BIOL CHEM, V266, P6456; WAY JC, 1984, GENE, V32, P369, DOI 10.1016/0378-1119(84)90012-X	44	861	896	2	44	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 1	1991	67	3					581	589		10.1016/0092-8674(91)90532-4	http://dx.doi.org/10.1016/0092-8674(91)90532-4			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GN664	1934062				2022-12-28	WOS:A1991GN66400014
J	BARTEL, DP; ZAPP, ML; GREEN, MR; SZOSTAK, JW				BARTEL, DP; ZAPP, ML; GREEN, MR; SZOSTAK, JW			HIV-1 REV REGULATION INVOLVES RECOGNITION OF NON-WATSON-CRICK BASE-PAIRS IN VIRAL-RNA	CELL			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; BACTERIOPHAGE-T4 DNA-POLYMERASE; MESSENGER-RNA; TARGET SEQUENCE; RIBOSOMAL-RNA; TRANS-ACTIVATOR; SECONDARY STRUCTURE; RIBONUCLEIC-ACID; XENOPUS OOCYTES; BINDING-SITES	We have used an iterative in vitro genetic selection to identify the important structural features of the viral RNA element bound by the Rev protein of human immunodeficiency virus type 1 (HIV-1). Functional Rev-binding RNAs were selected from a pool of 10(13) variants of the wild-type Rev-binding domain. Bases conserved among the binding species define a 20 nucleotide core binding element. Covariation of some of these conserved bases indicates that the Rev-binding element is a stem-bulge-stem with a G:G base pair in the bulge. Mutational studies show that this non-Watson-Crick base pair is required for Rev binding in vitro and Rev responsiveness in vivo. We propose that the G:G base pair distorts the sugar-phosphate backbone of viral RNA and that this distortion is a critical determinant of recognition by Rev.	UNIV MASSACHUSETTS,MED CTR,PROGRAM MOLEC MED,WORCESTER,MA 01605	University of Massachusetts System; University of Massachusetts Worcester	BARTEL, DP (corresponding author), MASSACHUSETTS GEN HOSP,DEPT MOLEC BIOL,BOSTON,MA 02114, USA.							AMREIN H, 1988, CELL, V55, P1025, DOI 10.1016/0092-8674(88)90247-4; BLACKWELL TK, 1990, SCIENCE, V250, P1104, DOI 10.1126/science.2174572; BROWN BD, 1990, GENE DEV, V4, P1925, DOI 10.1101/gad.4.11.1925; CALNAN BJ, 1991, SCIENCE, V252, P1167, DOI 10.1126/science.252.5009.1167; CAREY J, 1983, BIOCHEMISTRY-US, V22, P2601, DOI 10.1021/bi00280a002; COCHRANE AW, 1990, P NATL ACAD SCI USA, V87, P1198, DOI 10.1073/pnas.87.3.1198; CULLEN BR, 1989, CELL, V58, P423, DOI 10.1016/0092-8674(89)90420-0; DALY TJ, 1989, NATURE, V342, P816, DOI 10.1038/342816a0; DAYTON ET, 1989, SCIENCE, V246, P1625, DOI 10.1126/science.2688093; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; EMERMAN M, 1989, CELL, V57, P1155, DOI 10.1016/0092-8674(89)90053-6; FEINBERG MB, 1986, CELL, V46, P807, DOI 10.1016/0092-8674(86)90062-0; FELBER BK, 1989, P NATL ACAD SCI USA, V86, P1495, DOI 10.1073/pnas.86.5.1495; GREEN R, 1990, NATURE, V347, P406, DOI 10.1038/347406a0; GUTELL RR, 1990, P NATL ACAD SCI USA, V87, P663, DOI 10.1073/pnas.87.2.663; HAMMARSKJOLD ML, 1989, J VIROL, V63, P1959; HEAPHY S, 1990, CELL, V60, P685, DOI 10.1016/0092-8674(90)90671-Z; HOLLAND SM, 1990, J VIROL, V64, P5966, DOI 10.1128/JVI.64.12.5966-5975.1990; HOPE TJ, 1990, P NATL ACAD SCI USA, V87, P7787, DOI 10.1073/pnas.87.19.7787; HOPE TJ, 1990, J VIROL, V64, P5360, DOI 10.1128/JVI.64.11.5360-5366.1990; HUANG XJ, 1991, J VIROL, V65, P2131, DOI 10.1128/JVI.65.4.2131-2134.1991; KJEMS J, 1991, P NATL ACAD SCI USA, V88, P683, DOI 10.1073/pnas.88.3.683; LEVITT M, 1969, NATURE, V224, P759, DOI 10.1038/224759a0; LIN YS, 1989, NATURE, V340, P656, DOI 10.1038/340656a0; MALIM MH, 1990, CELL, V60, P675, DOI 10.1016/0092-8674(90)90670-A; MALIM MH, 1989, NATURE, V338, P254, DOI 10.1038/338254a0; MICHEL F, 1990, J MOL BIOL, V216, P585, DOI 10.1016/0022-2836(90)90386-Z; MILLIGAN JF, 1987, NUCLEIC ACIDS RES, V15, P8783, DOI 10.1093/nar/15.21.8783; MULLIS KB, 1987, METHOD ENZYMOL, V155, P335; OAKES MI, 1990, J MOL BIOL, V211, P907, DOI 10.1016/0022-2836(90)90083-X; OLIPHANT AR, 1989, MOL CELL BIOL, V9, P2944, DOI 10.1128/MCB.9.7.2944; OLSEN HS, 1990, SCIENCE, V247, P845, DOI 10.1126/science.2406903; POLLOCK R, 1990, NUCLEIC ACIDS RES, V18, P6197, DOI 10.1093/nar/18.21.6197; ROBERTSON DL, 1990, NATURE, V344, P467, DOI 10.1038/344467a0; ROSEN CA, 1988, P NATL ACAD SCI USA, V85, P2071, DOI 10.1073/pnas.85.7.2071; SAENGER W, 1984, PRINCIPLES NUCLEIC A; SODROSKI J, 1986, NATURE, V321, P412, DOI 10.1038/321412a0; STERN S, 1988, J MOL BIOL, V201, P683, DOI 10.1016/0022-2836(88)90467-6; SUGIMOTO N, 1987, BIOCHEMISTRY-US, V26, P4554, DOI 10.1021/bi00388a058; THIESEN HJ, 1990, NUCLEIC ACIDS RES, V18, P3203, DOI 10.1093/nar/18.11.3203; TRAUB W, 1982, NUCLEIC ACIDS RES, V10, P2701, DOI 10.1093/nar/10.8.2701; TUERK C, 1990, J MOL BIOL, V213, P749, DOI 10.1016/S0022-2836(05)80261-X; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; TUERK C, 1988, P NATL ACAD SCI USA, V85, P1364, DOI 10.1073/pnas.85.5.1364; WOESE CR, 1983, MICROBIOL REV, V47, P621, DOI 10.1128/MMBR.47.4.621-669.1983; WOESE CR, 1990, P NATL ACAD SCI USA, V87, P8467, DOI 10.1073/pnas.87.21.8467; YISRAELI JK, 1990, DEVELOPMENT, V108, P289; ZAPP ML, 1991, P NATL ACAD SCI USA, V88, P7734, DOI 10.1073/pnas.88.17.7734; ZAPP ML, 1989, NATURE, V342, P714, DOI 10.1038/342714a0	49	373	403	0	15	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	NOV 1	1991	67	3					529	536		10.1016/0092-8674(91)90527-6	http://dx.doi.org/10.1016/0092-8674(91)90527-6			8	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GN664	1934059				2022-12-28	WOS:A1991GN66400009
J	SPITZER, MW; SEMPLE, MN				SPITZER, MW; SEMPLE, MN			INTERAURAL PHASE CODING IN AUDITORY MIDBRAIN - INFLUENCE OF DYNAMIC STIMULUS FEATURES	SCIENCE			English	Article							INFERIOR COLLICULUS; SOUND LOCALIZATION; MOVEMENT ANGLE; NEURONS; CAT; MECHANISMS; FREQUENCY; MOTION	A laterally located sound source stimulates the two ears at slightly different times, generating interaural phase disparities (IPDs) that are used for sound localization. Under natural conditions, such interaural cues are likely to be constantly changing, or dynamic. In the inferior colliculus of gerbils and cats, the nonlinearities in the coding of dynamic interaural phase cues are demonstrated. Responses to ecologically realistic phase cues are more reflective of the change of IPD than of the absolute IPDs over which that change occurs. This observation is inconsistent with the established view that directional information is coded in terms of absolute IPD.			SPITZER, MW (corresponding author), UNIV CALIF IRVINE,DEPT ANAT & NEUROBIOL,IRVINE,CA 92717, USA.				NIDCD NIH HHS [DC00364] Funding Source: Medline	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		ALTMAN JA, 1968, EXP NEUROL, V22, P13, DOI 10.1016/0014-4886(68)90016-2; GOLDBERG JM, 1969, J NEUROPHYSIOL, V32, P613, DOI 10.1152/jn.1969.32.4.613; GRANTHAM DW, 1986, J ACOUST SOC AM, V79, P1939, DOI 10.1121/1.393201; JEFFRESS LA, 1948, J COMP PHYSIOL PSYCH, V41, P35, DOI 10.1037/h0061495; KUWADA S, 1979, SCIENCE, V206, P586, DOI 10.1126/science.493964; Perrott D R, 1979, J Aud Res, V19, P277; PERROTT DR, 1977, J ACOUST SOC AM, V62, P1463, DOI 10.1121/1.381675; PERROTT DR, 1988, J ACOUST SOC AM, V83, P1522, DOI 10.1121/1.395908; REALE RA, 1990, J NEUROPHYSIOL, V64, P1247, DOI 10.1152/jn.1990.64.4.1247; ROSE JE, 1966, J NEUROPHYSIOL, V29, P288, DOI 10.1152/jn.1966.29.2.288; ROTH GL, 1980, J ACOUST SOC AM, V68, P1643, DOI 10.1121/1.385196; STRYBEL TZ, 1989, PERCEPT PSYCHOPHYS, V45, P371, DOI 10.3758/BF03204951; SULLIVAN WE, 1986, BRAIN BEHAV EVOLUT, V28, P109, DOI 10.1159/000118696; YIN TCT, 1990, J NEUROPHYSIOL, V64, P465, DOI 10.1152/jn.1990.64.2.465; YIN TCT, 1983, J NEUROPHYSIOL, V50, P1000, DOI 10.1152/jn.1983.50.4.1000	15	77	80	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	NOV 1	1991	254	5032					721	724		10.1126/science.1948053	http://dx.doi.org/10.1126/science.1948053			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN474	1948053				2022-12-28	WOS:A1991GN47400045
J	WESTWOOD, JT; CLOS, J; WU, C				WESTWOOD, JT; CLOS, J; WU, C			STRESS-INDUCED OLIGOMERIZATION AND CHROMOSOMAL RELOCALIZATION OF HEAT-SHOCK FACTOR	NATURE			English	Article							DNA-BINDING PROPERTIES; DROSOPHILA-MELANOGASTER; TRANSCRIPTION FACTOR; RNA-POLYMERASE; PROTEINS; INVITRO; GENE; ACTIVATION; LOCALIZATION; UPSTREAM	The induction of heat-shock transcription factor (HSF) binding to DNA is accomplished by a heat-induced oligomerization. The transition to the induced state is accompanied by a chromosomal redistribution of HSF to the heat-shock puff sites. Over 150 additional chromosomal sites also accumulate HSF, including developmental loci that are repressed during heat shock. These findings suggest an unforeseen role for HSF as a repressor of normal gene activity during heat stress.			WESTWOOD, JT (corresponding author), NCI, BIOCHEM LAB, BG 37, RM 4C-09, BETHESDA, MD 20892 USA.							AMIN J, 1988, MOL CELL BIOL, V8, P3761, DOI 10.1128/MCB.8.9.3761; ANDERSSON LO, 1972, FEBS LETT, V20, P199, DOI 10.1016/0014-5793(72)80793-2; Ashburner M, 1972, Results Probl Cell Differ, V4, P101; ASHBURNER M, 1970, CHROMOSOMA, V31, P356, DOI 10.1007/BF00321231; BECKER J, 1990, EUR J BIOCHEM, V189, P553, DOI 10.1111/j.1432-1033.1990.tb15522.x; BONNER JJ, 1982, CHROMOSOMA, V85, P93, DOI 10.1007/BF00344596; BONNER JJ, 1976, CELL, V8, P43, DOI 10.1016/0092-8674(76)90183-5; Bridges CB, 1935, J HERED, V26, P60, DOI 10.1093/oxfordjournals.jhered.a104022; BURTIS KC, 1990, CELL, V61, P85, DOI 10.1016/0092-8674(90)90217-3; CLOS J, 1990, CELL, V63, P1085, DOI 10.1016/0092-8674(90)90511-C; DIGNAM AD, 1983, METHOD ENZYMOL, V191, P582; ELLIS RJ, 1991, ANNU REV BIOCHEM, V60, P321, DOI 10.1146/annurev.bi.60.070191.001541; HOVEMANN B, 1986, MOL GEN GENET, V204, P334, DOI 10.1007/BF00425519; JAKOBSEN BK, 1991, EMBO J, V10, P369, DOI 10.1002/j.1460-2075.1991.tb07958.x; JAMRICH M, 1977, P NATL ACAD SCI USA, V74, P2079, DOI 10.1073/pnas.74.5.2079; KING WJ, 1984, NATURE, V307, P745, DOI 10.1038/307745a0; LAKHOTIA SC, 1987, J GENET, V66, P139, DOI 10.1007/BF02931660; LARSON JS, 1988, NATURE, V335, P372, DOI 10.1038/335372a0; Lefevre G., 1976, GENET BIOL DROSOPHIL, P31; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; LIS JT, 1981, GENE, V15, P67, DOI 10.1016/0378-1119(81)90105-0; LIS JT, 1981, NUCLEIC ACIDS RES, V9, P5297, DOI 10.1093/nar/9.20.5297; MASON PJ, 1982, J MOL BIOL, V156, P21, DOI 10.1016/0022-2836(82)90456-9; Morimoto RI, 1990, STRESS PROTEINS BIOL; MOSSER DD, 1990, P NATL ACAD SCI USA, V87, P3748, DOI 10.1073/pnas.87.10.3748; PALTER KB, 1986, MOL CELL BIOL, V6, P1187, DOI 10.1128/MCB.6.4.1187; PARDUE ML, 1977, CHROMOSOMA, V63, P135, DOI 10.1007/BF00292726; PARKER CS, 1984, CELL, V36, P357, DOI 10.1016/0092-8674(84)90229-0; PELHAM HRB, 1982, CELL, V30, P517, DOI 10.1016/0092-8674(82)90249-5; PELHAM HRB, 1990, STRESS PROTEINS BIOL, P287; PERISIC O, 1989, CELL, V59, P797, DOI 10.1016/0092-8674(89)90603-X; PERKINS LA, 1990, MOL CELL BIOL, V10, P3232, DOI 10.1128/MCB.10.6.3232; RABINDRAN SK, 1991, P NATL ACAD SCI USA, V88, P6906, DOI 10.1073/pnas.88.16.6906; RITOSSA F, 1962, EXPERIENTIA, V18, P571, DOI 10.1007/BF02172188; SARGE KD, IN PRESS GENES DEV; SCHARF KD, 1990, EMBO J, V9, P4495, DOI 10.1002/j.1460-2075.1990.tb07900.x; SCHUETZ TJ, 1991, P NATL ACAD SCI USA, V88, P6911, DOI 10.1073/pnas.88.16.6911; SEGRAVES WA, 1990, GENE DEV, V4, P204, DOI 10.1101/gad.4.2.204; SILVER LM, 1976, P NATL ACAD SCI USA, V73, P423, DOI 10.1073/pnas.73.2.423; SORGER PK, 1991, CELL, V65, P363, DOI 10.1016/0092-8674(91)90452-5; SORGER PK, 1989, CELL, V59, P807, DOI 10.1016/0092-8674(89)90604-1; SORGER PK, 1988, CELL, V54, P855, DOI 10.1016/S0092-8674(88)91219-6; SPRADLING A, 1977, J MOL BIOL, V109, P559, DOI 10.1016/S0022-2836(77)80091-0; THUMMEL CS, 1990, BIOESSAYS, V12, P561, DOI 10.1002/bies.950121202; URNESS LD, 1990, CELL, V63, P47, DOI 10.1016/0092-8674(90)90287-O; WELSHONS WV, 1984, NATURE, V307, P747, DOI 10.1038/307747a0; WIEDERRECHT G, 1988, CELL, V54, P841, DOI 10.1016/S0092-8674(88)91197-X; WIEDERRECHT G, 1987, CELL, V48, P507, DOI 10.1016/0092-8674(87)90201-7; WU C, 1984, NATURE, V311, P81, DOI 10.1038/311081a0; WU C, 1984, NATURE, V309, P229, DOI 10.1038/309229a0; WU C, 1987, SCIENCE, V238, P1247, DOI 10.1126/science.3685975; WU C, 1985, NATURE, V317, P84, DOI 10.1038/317084a0; WU C, 1990, STRESS PROTEINS BIOL, P429; XIAO H, 1988, SCIENCE, V239, P1139, DOI 10.1126/science.3125608; ZIMARINO V, 1990, SCIENCE, V249, P546, DOI 10.1126/science.2200124; ZINK B, 1989, NATURE, V337, P468, DOI 10.1038/337468a0	56	320	328	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 31	1991	353	6347					822	823		10.1038/353822a0	http://dx.doi.org/10.1038/353822a0			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM732	1944557				2022-12-28	WOS:A1991GM73200051
J	OSHEA, EK; KLEMM, JD; KIM, PS; ALBER, T				OSHEA, EK; KLEMM, JD; KIM, PS; ALBER, T			X-RAY STRUCTURE OF THE GCN4 LEUCINE ZIPPER, A 2-STRANDED, PARALLEL COILED COIL	SCIENCE			English	Article							MULTIWIRE AREA DETECTOR; ATF CDNA CLONES; MODEL PROTEIN; ALPHA-HELICES; TROPOMYOSIN; CRYSTALLOGRAPHY; DIFFRACTOMETER; STABILIZATION; DISTORTIONS; REFINEMENT	The x-ray crystal structure of a peptide corresponding to the leucine zipper of the yeast transcriptional activator GCN4 has been determined at 1.8 angstrom resolution. The peptide forms a parallel, two-stranded coiled coil of alpha helices packed as in the "knobs-into-holes" model proposed by Crick in 1953. Contacts between the helices include ion pairs and an extensive hydrophobic interface that contains a distinctive hydrogen bond. The conserved leucines, like the residues in the alternate hydrophobic repeat, make side-to-side interactions (as in a handshake) in every other layer of the dimer interface. The crystal structure of the GCN4 leucine zipper suggests a key role for the leucine repeat, but also shows how other features of the coiled coil contribute to dimer formation.	WHITEHEAD INST BIOMED RES,CAMBRIDGE,MA 02142; MIT,DEPT CHEM,CAMBRIDGE,MA 02139; UNIV UTAH,SCH MED,DEPT BIOCHEM,SALT LAKE CITY,UT 84132; MIT,DEPT BIOL,CAMBRIDGE,MA 02139; UNIV UTAH,DEPT CHEM,SALT LAKE CITY,UT 84112	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Utah System of Higher Education; University of Utah; Massachusetts Institute of Technology (MIT); Utah System of Higher Education; University of Utah	OSHEA, EK (corresponding author), HOWARD HUGHES MED INST,9 CAMBRIDGE CTR,CAMBRIDGE,MA 02142, USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044162] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 44162] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BANNER DW, 1987, J MOL BIOL, V196, P657, DOI 10.1016/0022-2836(87)90039-8; BLUNDELL T, 1983, NATURE, V306, P281, DOI 10.1038/306281a0; BOURNE H, 1991, CELL, V66, P589; BOURNE HR, 1991, NATURE, V351, P188, DOI 10.1038/351188a0; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; BRUNGER AT, 1987, SCIENCE, V235, P458, DOI 10.1126/science.235.4787.458; CHAKRABARTI P, 1986, BIOPOLYMERS, V25, P1087, DOI 10.1002/bip.360250609; CHOTHIA C, 1981, J MOL BIOL, V145, P215, DOI 10.1016/0022-2836(81)90341-7; COHEN C, 1986, TRENDS BIOCHEM SCI, V11, P245, DOI 10.1016/0968-0004(86)90186-6; COHEN C, 1990, PROTEINS, V7, P1, DOI 10.1002/prot.340070102; CONWAY JF, 1990, INT J BIOL MACROMOL, V12, P328, DOI 10.1016/0141-8130(90)90023-4; CRICK FHC, 1953, ACTA CRYSTALLOGR, V6, P685, DOI 10.1107/S0365110X53001952; CRICK FHC, 1953, ACTA CRYSTALLOGR, V6, P689, DOI 10.1107/S0365110X53001964; CRICK FHC, 1952, NATURE, V170, P882, DOI 10.1038/170882b0; CUSACK S, 1990, NATURE, V347, P249, DOI 10.1038/347249a0; FISCHETTI VA, 1991, SCI AM, V264, P58, DOI 10.1038/scientificamerican0691-58; FITZGERALD PMD, 1988, J APPL CRYSTALLOGR, V21, P273, DOI 10.1107/S0021889887012299; GAIRE M, 1990, NUCLEIC ACIDS RES, V18, P3467, DOI 10.1093/nar/18.12.3467; GOODMAN EM, UNPUB; GUILTINAN MJ, 1990, SCIENCE, V250, P267, DOI 10.1126/science.2145628; HAI TW, 1989, GENE DEV, V3, P2083, DOI 10.1101/gad.3.12b.2083; HARBURY P, UNPUB; HENDRICKSON WA, 1971, ACTA CRYSTALL B-STRU, VB 27, P1474, DOI 10.1107/S0567740871004187; HENDRICKSON WA, 1979, ACTA CRYSTALLOGR A, V35, P158, DOI 10.1107/S0567739479000279; HINNEBUSCH AG, 1984, P NATL ACAD SCI-BIOL, V81, P6442, DOI 10.1073/pnas.81.20.6442; HODGES R S, 1990, Peptide Research, V3, P123; Hodges R. S., 1972, COLD SPRING HARB SYM, V37, P299; HOWARD AJ, 1985, METHOD ENZYMOL, V114, P452; HU JC, 1990, SCIENCE, V250, P1400, DOI 10.1126/science.2147779; JOHNSON PF, 1989, ANNU REV BIOCHEM, V58, P799, DOI 10.1146/annurev.biochem.58.1.799; Jones E. W., 1982, MOL BIOL YEAST SACCH, P181; JONES TA, 1978, J APPL CRYSTALLOGR, V11, P268, DOI 10.1107/S0021889878013308; Kerppola TK, 1991, CURR OPIN STRUC BIOL, V1, P71, DOI 10.1016/0959-440X(91)90014-K; KINZLER KW, 1991, SCIENCE, V253, P661, DOI 10.1126/science.1651562; KUNTZ ID, 1991, J AM CHEM SOC, V113, P1406, DOI 10.1021/ja00004a050; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; LAU SYM, 1984, J BIOL CHEM, V259, P3253; MARTINZANCA D, 1986, NATURE, V319, P743, DOI 10.1038/319743a0; MCLACHLAN AD, 1975, J MOL BIOL, V98, P293, DOI 10.1016/S0022-2836(75)80119-7; MCLACHLAN AD, 1983, J MOL BIOL, V164, P605, DOI 10.1016/0022-2836(83)90053-0; MCLACHLAN AD, 1978, J MOL BIOL, V122, P493; MCLACHLAN AD, 1975, J MOL BIOL, V52, P281; NISHIZAWA M, 1989, P NATL ACAD SCI USA, V86, P771; OAS TG, 1990, BIOCHEMISTRY-US, V29, P2891, DOI 10.1021/bi00464a001; ONEIL KT, 1990, SCIENCE, V250, P646, DOI 10.1126/science.2237415; OSHEA EK, 1989, SCIENCE, V243, P538, DOI 10.1126/science.2911757; OSHEA EK, 1989, SCIENCE, V245, P646, DOI 10.1126/science.2503872; PARRY DAD, 1982, BIOSCIENCE REP, V2, P1017, DOI 10.1007/BF01122170; PAULING L, 1953, NATURE, V171, P59, DOI 10.1038/171059a0; PONDER JW, 1987, J MOL BIOL, V193, P775, DOI 10.1016/0022-2836(87)90358-5; RAMAKRISHNAN C, 1965, BIOPHYS J, V5, P909, DOI 10.1016/S0006-3495(65)86759-5; RASMUSSEN R, 1991, P NATL ACAD SCI USA, V88, P561, DOI 10.1073/pnas.88.2.561; ROYER WE, 1989, J BIOL CHEM, V264, P21052; SMITH JL, 1982, COMPUTATIONAL CRYSTA, P209; STRUHL K, 1989, TRENDS BIOCHEM SCI, V14, P137, DOI 10.1016/0968-0004(89)90145-X; TALBOT JA, 1982, ACCOUNTS CHEM RES, V15, P224, DOI 10.1021/ar00079a006; TRONRUD DE, 1987, ACTA CRYSTALLOGR A, V43, P489, DOI 10.1107/S0108767387099124; VINSON CR, 1989, SCIENCE, V246, P911, DOI 10.1126/science.2683088; WANG BC, 1985, METHOD ENZYMOL, V115, P90; XUONG NH, 1985, ACTA CRYSTALLOGR B, V41, P267, DOI 10.1107/S0108768185002105	60	1347	1413	1	125	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	OCT 25	1991	254	5031					539	544		10.1126/science.1948029	http://dx.doi.org/10.1126/science.1948029			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL799	1948029				2022-12-28	WOS:A1991GL79900040
J	DOYLE, P				DOYLE, P			JUNIOR DOCTORS - THE NEW-DEAL - CHANGING PATTERNS OF WORK	BRITISH MEDICAL JOURNAL			English	Article							HOUSE OFFICERS				DOYLE, P (corresponding author), DEPT HLTH,NHS MANAGEMENT EXECUT,DIV MANPOWER & EDUC,LONDON W1N 5TB,ENGLAND.							DENT THS, 1990, BRIT MED J, V300, P713, DOI 10.1136/bmj.300.6726.713; DOWIE R, 1989, PATTERNS HOSPITAL ME; FINN A, 1988, BMJ-BRIT MED J, V296, P343, DOI 10.1136/bmj.296.6618.343; FIRTHCOZENS J, 1987, BRIT MED J, V295, P533, DOI 10.1136/bmj.295.6597.533; NASMYTH DG, 1991, BRIT MED J, V302, P93, DOI 10.1136/bmj.302.6768.93; ORTON DI, 1989, BRIT MED J, V298, P21, DOI 10.1136/bmj.298.6665.21; TURNBULL NB, 1990, BRIT MED J, V301, P1191, DOI 10.1136/bmj.301.6762.1191; 1991, JUNIOR DOCTORS NEW D; 1948, CMND7420; 1987, HOSPITAL MED STAFFIN; 1986, HOSPITAL MED STAFFIN	11	7	7	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	OCT 19	1991	303	6808					982	984		10.1136/bmj.303.6808.982	http://dx.doi.org/10.1136/bmj.303.6808.982			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GL127	1954429	Green Published, Bronze			2022-12-28	WOS:A1991GL12700033
J	SIMS, A				SIMS, A			FOR DEBATE - EVEN BETTER SERVICES - A PSYCHIATRIC PERSPECTIVE	BRITISH MEDICAL JOURNAL			English	Editorial Material							CARE				SIMS, A (corresponding author), ROYAL COLL PSYCHIAT,LONDON SW1X 8PG,ENGLAND.							ANDREWS G, 1989, AM J PSYCHIAT, V146, P881; [Anonymous], 1989, CM555; [Anonymous], 1989, CM849; JENKINS R, 1991, SETTING STANDARDS SE; KENNEDY P, 1990, BETTER WAY CLIN DIRE, P211; Powell E., 1961, EMERGING PATTERNS ME; REED J, IN PRESS PSYCHIATRIC; SIMS A, 1989, PSYCHIAT B, V13, P285; TYRER P, 1989, BRIT MED J, V299, P298, DOI 10.1136/bmj.299.6694.298; WOOFF K, 1988, BRIT J PSYCHIAT, V153, P30, DOI 10.1192/bjp.153.1.30; 1990, CLIN PSYCHOL PROJECT; IN PRESS PSYCHIATRIC; 1975, BETTER SERVICES MENT; 1971, BMJ, V2, P724; 1989, MENTAL HLTH 1990S CU; 1989, WORKING PATIENTS CON; 1989, ESTATE CODE PROPERTY	17	14	14	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	MAY 4	1991	302	6784					1061	1063		10.1136/bmj.302.6784.1061	http://dx.doi.org/10.1136/bmj.302.6784.1061			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FK563	1958249	Green Published, Bronze			2022-12-28	WOS:A1991FK56300025
J	MIKL, J; CZERWENKA, K; SALZER, H; SPONA, J; AIGINGER, P; KUBISTA, E; SEVELDA, P; STAFFEN, A; ZIELINSKI, CC				MIKL, J; CZERWENKA, K; SALZER, H; SPONA, J; AIGINGER, P; KUBISTA, E; SEVELDA, P; STAFFEN, A; ZIELINSKI, CC			ADJUVANT TAMOXIFEN IN POSTMENOPAUSAL STAGE-II BREAST-CANCER 5 YEARS ON	LANCET			English	Letter									UNIV HOSP VIENNA,DEPT OBSTET & GYNAECOL,A-1090 VIENNA,AUSTRIA; UNIV HOSP VIENNA,DEPT SURG 2,A-1090 VIENNA,AUSTRIA	University Hospital Vienna; University Hospital Vienna	MIKL, J (corresponding author), UNIV HOSP VIENNA,DEPT MED 2,A-1090 VIENNA,AUSTRIA.							BONADONNA G, 1985, LANCET, V1, P976; ZIELINSKI CC, 1986, LANCET, V2, P1164; ZIELINSKI CC, 1989, CANCER, V63, P113	3	3	3	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	MAR 3	1990	335	8688					541	541		10.1016/0140-6736(90)90775-Z	http://dx.doi.org/10.1016/0140-6736(90)90775-Z			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT015	1968551				2022-12-28	WOS:A1990CT01500037
J	[Anonymous]				[Anonymous]			THE NEWEST HUMAN HERPESVIRUS COMES INTO FOCUS	LANCET			English	Editorial Material																		ABLASHI DV, 1987, NATURE, V329, P207, DOI 10.1038/329207a0; ASANO Y, 1989, J PEDIATR-US, V114, P535, DOI 10.1016/S0022-3476(89)80689-4; ASANO Y, 1989, LANCET, V2, P1391; BALACHANDRAN N, 1989, J VIROL, V63, P2835, DOI 10.1128/JVI.63.6.2835-2840.1989; BRIGGS M, 1988, LANCET, V1, P1058; BROWN NA, 1988, LANCET, V2, P396; DUBEDAT S, 1989, LANCET, V2, P1463; EFSTATHIOU S, 1988, LANCET, V1, P63; EIZURU Y, 1989, LANCET, V1, P40; HIGASHI K, 1989, J GEN VIROL, V70, P3171, DOI 10.1099/0022-1317-70-12-3171; HORVAT RT, 1989, J VIROL, V63, P970, DOI 10.1128/JVI.63.2.970-973.1989; JARRETT RF, 1988, LEUKEMIA, V2, P496; JOSEPHS SF, 1988, LEUKEMIA, V2, P132; JOSEPHS SF, 1986, SCIENCE, V234, P601, DOI 10.1126/science.3020691; KNOWLES WA, 1988, LANCET, V2, P912; LOPEZ C, 1988, J INFECT DIS, V157, P1271, DOI 10.1093/infdis/157.6.1271; LUSSO P, 1987, LANCET, V2, P743; NIEDERMAN JC, 1988, LANCET, V2, P817; OKUNO T, 1989, J CLIN MICROBIOL, V27, P651, DOI 10.1128/JCM.27.4.651-653.1989; PIETROBONI GR, 1988, LANCET, V1, P1059; SALAHUDDIN SZ, 1986, SCIENCE, V234, P596, DOI 10.1126/science.2876520; SHAPIRO L, 1965, J AMER MED ASSOC, V194, P680, DOI 10.1001/jama.1965.03090190102038; SUGA S, 1989, PEDIATRICS, V83, P1003; TAKAHASHI K, 1988, LANCET, V1, P1463; TEDDER RS, 1987, LANCET, V2, P390; WARD KN, 1989, J MED VIROL, V28, P68; YAMANISHI K, 1988, LANCET, V1, P1065; YOSHIKAWA T, 1989, PEDIATRICS, V84, P675; 1986, LANCET, V2, P1430	29	0	0	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	FEB 10	1990	335	8685					325	326						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CM846	1967775				2022-12-28	WOS:A1990CM84600010
J	KLAUSER, AG; SCHINDLBECK, NE; MULLERLISSNER, SA				KLAUSER, AG; SCHINDLBECK, NE; MULLERLISSNER, SA			SYMPTOMS IN GASTROESOPHAGEAL REFLUX DISEASE	LANCET			English	Article									UNIV MUNICH, MED & CHIRURG KLIN INNENSTADT, DEPT GASTROENTEROL, W-8000 MUNICH 2, GERMANY	University of Munich								BENZ LJ, 1972, GASTROENTEROLOGY, V62, P1; BOUCHIER IAD, 1982, CLIN SKILLS, P1; DAVIES HA, 1985, J CLIN GASTROENTEROL, V7, P477, DOI 10.1097/00004836-198512000-00007; DEMEESTER TR, 1980, J THORAC CARDIOV SUR, V79, P656; FITZGERALD JM, 1989, CAN MED ASSOC J, V140, P520; FLEMING PR, 1985, FRENCHS INDEX DIFFER, P378; FUCHS KH, 1987, SURGERY, V102, P575; GROSS R, 1989, DTSH ARZTEBLATT, V38, P2643; HEWSON EG, 1989, GUT, V30, P305, DOI 10.1136/gut.30.3.305; HOGAN WJ, 1989, GASTROINTESTINAL DIS, P594; HOPE RA, 1989, OXFORD HDB CLIN MED, P22; HORROCKS JC, 1978, GUT, V19, P19, DOI 10.1136/gut.19.1.19; HORROCKS JC, 1975, BRIT MED J, V3, P421, DOI 10.1136/bmj.3.5980.421; JOHNSSON F, 1988, GUT, V29, P886, DOI 10.1136/gut.29.7.886; JOHNSSON F, 1987, SCAND J GASTROENTERO, V22, P714, DOI 10.3109/00365528709011148; KLAUSER AG, 1989, AM J GASTROENTEROL, V84, P362; LACHENBRUCH PA, 1975, DISCRIMINANT ANAL; PAUKER SG, 1988, CECIL TXB MED, P74; RICHTER JE, 1982, ANN INTERN MED, V97, P93, DOI 10.7326/0003-4819-97-1-93; ROKKAS TH, 1987, ITAL J GASTROENTEROL, V19, P176; SCHINDLBECK NE, 1987, GASTROENTEROLOGY, V93, P85, DOI 10.1016/0016-5085(87)90318-0; SCHOFIELD PM, 1989, DIGESTION, V42, P70, DOI 10.1159/000199828; SMITH JL, 1989, GASTROENTEROLOGY, V96, P683; WAHL PW, 1977, BIOMETRICS, V33, P479, DOI 10.2307/2529362; WIENER GJ, 1988, AM J GASTROENTEROL, V83, P358; WIENER GJ, 1988, DIGEST DIS SCI, V33, P1127, DOI 10.1007/BF01535789	26	613	635	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 27	1990	335	8683					205	208		10.1016/0140-6736(90)90287-F	http://dx.doi.org/10.1016/0140-6736(90)90287-F			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CL185	1967675				2022-12-28	WOS:A1990CL18500012
J	CORNELLBELL, AH; FINKBEINER, SM; COOPER, MS; SMITH, SJ				CORNELLBELL, AH; FINKBEINER, SM; COOPER, MS; SMITH, SJ			GLUTAMATE INDUCES CALCIUM WAVES IN CULTURED ASTROCYTES - LONG-RANGE GLIAL SIGNALING	SCIENCE			English	Article									YALE UNIV, SCH MED, NEW HAVEN, CT 06510 USA	Yale University	CORNELLBELL, AH (corresponding author), YALE UNIV, HOWARD HUGHES MED INST, MOLEC NEUROBIOL SECT, NEW HAVEN, CT 06510 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS012961, R01NS016671] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 07205] Funding Source: Medline; NINDS NIH HHS [NS-12961-14, NS16671-09] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BARRES BA, 1989, NEURON, V2, P1375, DOI 10.1016/0896-6273(89)90076-7; BARRES BA, 1989, J NEUROSCI, V9, P3169; BERRIDGE MJ, 1989, NATURE, V341, P197, DOI 10.1038/341197a0; BOWMAN CL, 1984, NATURE, V311, P656, DOI 10.1038/311656a0; BREHM P, 1989, NEURON, V3, P191, DOI 10.1016/0896-6273(89)90032-9; BUCHANAN JW, UNPUB; CSERR HF, 1986, ANN NY ACAD SCI, V481, P1, DOI 10.1111/j.1749-6632.1986.tb27134.x; FINKBEINER S, 1988, P NATL ACAD SCI USA, V85, P4071, DOI 10.1073/pnas.85.11.4071; FINKBEINER SM, UNPUB; FORSCHER P, 1987, J NEUROSCI, V7, P3600; GRAF P, 1987, BIOCHEM J, V241, P933, DOI 10.1042/bj2410933; HONORE T, 1988, SCIENCE, V241, P701, DOI 10.1126/science.2899909; JACOB R, 1988, NATURE, V335, P40, DOI 10.1038/335040a0; JENSEN AM, IN PRESS J NEUROSCI; KAO JPY, 1989, J BIOL CHEM, V264, P8179; KETTENMANN H, 1985, J NEUROSCI, V5, P3295; MACVICAR BA, 1987, NATURE, V329, P242, DOI 10.1038/329242a0; MACVICAR BA, 1984, SCIENCE, V226, P1345, DOI 10.1126/science.6095454; MARRERO H, 1989, NATURE, V339, P378, DOI 10.1038/339378a0; PEARCE B, 1986, NEUROSCI LETT, V72, P335, DOI 10.1016/0304-3940(86)90537-9; PENNER R, 1988, NATURE, V334, P499, DOI 10.1038/334499a0; PETERS A, 1962, J ANAT, V96, P237; PIN JP, 1984, FEBS LETT, V175, P31, DOI 10.1016/0014-5793(84)80563-3; RAFF MC, 1983, J NEUROSCI, V3, P1289; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; RINK TJ, 1989, TRENDS NEUROSCI, V12, P43, DOI 10.1016/0166-2236(89)90133-1; SAEZ JC, 1989, P NATL ACAD SCI USA, V86, P2708, DOI 10.1073/pnas.86.8.2708; SCHOEPP DD, 1988, J NEUROCHEM, V50, P1605, DOI 10.1111/j.1471-4159.1988.tb03050.x; Shank RP, 1988, GLUTAMINE GLUTAMATE, VII, P3; SLADECZEK F, 1988, TRENDS NEUROSCI, V11, P545, DOI 10.1016/0166-2236(88)90183-X; SUGIYAMA H, 1987, NATURE, V325, P531, DOI 10.1038/325531a0; SUGIYAMA H, 1989, NEURON, V3, P129, DOI 10.1016/0896-6273(89)90121-9; USOWICZ MM, 1989, NATURE, V339, P380, DOI 10.1038/339380a0; VILVEN J, 1988, NATURE, V336, P587, DOI 10.1038/336587a0; WOODS NM, 1986, NATURE, V319, P600, DOI 10.1038/319600a0; YAMADA KA, 1989, J NEUROSCI, V9, P3230	36	1455	1478	1	78	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 26	1990	247	4941					470	473		10.1126/science.1967852	http://dx.doi.org/10.1126/science.1967852			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK705	1967852				2022-12-28	WOS:A1990CK70500044
J	FLEMING, AF				FLEMING, AF			ANTIMALARIAL PROPHYLAXIS IN PREGNANT NIGERIAN WOMEN	LANCET			English	Letter											FLEMING, AF (corresponding author), GERMAN PRIMATE CTR, W-3400 GOTTINGEN, GERMANY.							FLEMING A F, 1968, Journal of Obstetrics and Gynaecology of the British Commonwealth, V75, P425; FLEMING AF, 1986, ANN TROP MED PARASIT, V80, P211, DOI 10.1080/00034983.1986.11812006; FLEMING AF, 1989, T ROY SOC TROP MED H, V83, P441, DOI 10.1016/0035-9203(89)90241-1; FLEMING AF, 1988, GLOBAL IMPACT AIDS, P357; MORLEY D, 1964, BRIT MED J, V1, P667, DOI 10.1136/bmj.1.5384.667; NAHLEN BL, 1989, LANCET, V2, P830, DOI 10.1016/S0140-6736(89)92998-X; PANG LW, 1989, B WORLD HEALTH ORGAN, V67, P51; ROLFE M, 1988, T ROY SOC TROP MED H, V82, P554, DOI 10.1016/0035-9203(88)90502-0	8	6	6	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 6	1990	335	8680					45	45		10.1016/0140-6736(90)90167-4	http://dx.doi.org/10.1016/0140-6736(90)90167-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG766	1967344				2022-12-28	WOS:A1990CG76600027
J	VANDERGOOT, FG; GONZALEZMANAS, JM; LAKEY, JH; PATTUS, F				VANDERGOOT, FG; GONZALEZMANAS, JM; LAKEY, JH; PATTUS, F			A MOLTEN-GLOBULE MEMBRANE-INSERTION INTERMEDIATE OF THE PORE-FORMING DOMAIN OF COLICIN-A	NATURE			English	Article							PHOSPHOLIPID MONOLAYERS; LIPID BILAYERS; PROTEINS; CHANNEL; STATE; PEPTIDE; TRANSLOCATION; MECHANISM; LIPOSOMES; FRAGMENT	THE 'molten' globular conformation of a protein is compact with a native secondary structure but a poorly defined tertiary structure 1,2. Molten globular states are intermediates in protein folding and unfolding 3-5 and they may be involved in the translocation or insertion of proteins into membranes 6. Here we investigate the membrane insertion of the pore-forming domain of colicin A, a bacteriocin that depolarizes the cytoplasmic membrane of sensitive cells 7-9. We find that this pore-forming domain, the insertion of which depends on pH (refs 10, 11), undergoes a native to molten globule transition at acidic pH. The variation of the kinetic constant of membrane insertion of the protein into negatively charged lipid vesicles as a function of the interfacial pH correlates with the appearance of the acidic molten globular state, indicating that this state could be an intermediate formed during the insertion of colicin A into membranes.			VANDERGOOT, FG (corresponding author), EUROPEAN MOLEC BIOL LAB,MEYERHOFSTR 1,W-6900 HEIDELBERG,GERMANY.		van der Goot, Gisou G/B-2279-2012	van der Goot, Gisou G/0000-0002-8522-274X				BRUNDEN KR, 1984, J BIOL CHEM, V259, P7682; BYCHKOVA VE, 1988, FEBS LETT, V238, P231, DOI 10.1016/0014-5793(88)80485-X; CRAMER WA, 1990, MOL MICROBIOL, V4, P519, DOI 10.1111/j.1365-2958.1990.tb00619.x; DOLGIKH DA, 1981, FEBS LETT, V136, P311, DOI 10.1016/0014-5793(81)80642-4; EAST JM, 1982, BIOCHEMISTRY-US, V21, P4144, DOI 10.1021/bi00260a035; EISENBERG M, 1979, BIOCHEMISTRY-US, V18, P5213, DOI 10.1021/bi00590a028; EWBANK JJ, 1991, NATURE, V350, P518, DOI 10.1038/350518a0; FINK AL, 1990, CURRENT RES PROTEIN, P417; FRENETTE M, 1989, BIOCHEMISTRY-US, V28, P2509, DOI 10.1021/bi00432a024; GOTO Y, 1990, BIOCHEMISTRY-US, V29, P3480, DOI 10.1021/bi00466a009; GOTO Y, 1990, P NATL ACAD SCI USA, V87, P573, DOI 10.1073/pnas.87.2.573; JIANG JX, 1991, BIOCHEMISTRY-US, V30, P3857, DOI 10.1021/bi00230a008; LAKEY JH, 1991, EUR J BIOCHEM, V196, P599, DOI 10.1111/j.1432-1033.1991.tb15855.x; LAKEY JH, 1991, J MOL BIOL, V219, P639; LOHNER K, 1991, BIOCHEMISTRY-US, V30, P6620, DOI 10.1021/bi00240a035; MENESTRINA G, 1989, BIOPHYS J, V55, P393, DOI 10.1016/S0006-3495(89)82833-4; MERRILL AR, 1990, BIOCHEMISTRY-US, V29, P5829, DOI 10.1021/bi00476a026; OHGUSHI M, 1983, FEBS LETT, V164, P21, DOI 10.1016/0014-5793(83)80010-6; OLNES S, 1988, TRENDS BIOCHEM SCI, V13, P348; PARKER MW, 1990, TRENDS BIOCHEM SCI, V15, P126, DOI 10.1016/0968-0004(90)90205-P; PARKER MW, 1989, NATURE, V337, P93, DOI 10.1038/337093a0; PARKER MW, IN PRESS J MOL BIOL; PATTUS F, 1985, EUR J BIOCHEM, V152, P681, DOI 10.1111/j.1432-1033.1985.tb09248.x; PATTUS F, 1990, EXPERIENTIA, V46, P180; PATTUS F, 1983, BIOCHEMISTRY-US, V22, P5698, DOI 10.1021/bi00294a003; PTITSYN OB, 1990, FEBS LETT, V262, P20, DOI 10.1016/0014-5793(90)80143-7; RAMSAY G, 1990, BIOCHEMISTRY-US, V29, P8677, DOI 10.1021/bi00489a024; SCHWARZ G, 1987, BIOPHYS J, V52, P685, DOI 10.1016/S0006-3495(87)83263-0; SLATIN SL, 1988, INT J BIOCHEM, V20, P737, DOI 10.1016/0020-711X(88)90058-4; SONG HY, 1991, J BACTERIOL, V173, P2927, DOI 10.1128/JB.173.9.2927-2934.1991; WINISKI AP, 1986, BIOCHEMISTRY-US, V25, P8206, DOI 10.1021/bi00373a013	31	405	411	0	13	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	DEC 5	1991	354	6352					408	410		10.1038/354408a0	http://dx.doi.org/10.1038/354408a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT761	1956406				2022-12-28	WOS:A1991GT76100056
J	KORNBERG, RD; LORCH, Y				KORNBERG, RD; LORCH, Y			IRRESISTIBLE FORCE MEETS IMMOVABLE OBJECT - TRANSCRIPTION AND THE NUCLEOSOME	CELL			English	Review							RNA POLYMERASE-II; CHROMATIN; INVITRO; GENE; DNA; DISPLACEMENT; INITIATION; PROMOTER; BINDING; YEAST				KORNBERG, RD (corresponding author), STANFORD UNIV,MED CTR,SCH MED,DEPT CELL BIOL,STANFORD,CA 94305, USA.							ARCHER TK, 1991, MOL CELL BIOL, V11, P688, DOI 10.1128/MCB.11.2.688; BONNEANDREA C, 1990, NATURE, V343, P719, DOI 10.1038/343719a0; CHASMAN DI, 1990, GENE DEV, V4, P503, DOI 10.1101/gad.4.4.503; CLARKADAMS CD, 1988, GENE DEV, V2, P150, DOI 10.1101/gad.2.2.150; CROSTON GE, 1991, SCIENCE, V251, P643, DOI 10.1126/science.1899487; DARST SA, 1991, CELL, V66, P121, DOI 10.1016/0092-8674(91)90144-N; DURRIN LK, 1991, CELL, V65, P1023, DOI 10.1016/0092-8674(91)90554-C; DYNLACHT BD, 1988, J BIOL CHEM, V263, P19259; ERICSSON C, 1990, CELL, V60, P73, DOI 10.1016/0092-8674(90)90717-S; FASCHER KD, 1990, EMBO J, V9, P2523, DOI 10.1002/j.1460-2075.1990.tb07432.x; FLANAGAN PM, 1991, NATURE, V350, P436, DOI 10.1038/350436a0; GROSS DS, 1988, ANNU REV BIOCHEM, V57, P159, DOI 10.1146/annurev.bi.57.070188.001111; GROSVELD F, 1987, CELL, V51, P975, DOI 10.1016/0092-8674(87)90584-8; GRUNSTEIN M, 1990, ANNU REV CELL BIOL, V6, P643, DOI 10.1146/annurev.cellbio.6.1.643; HAN M, 1988, CELL, V55, P1137, DOI 10.1016/0092-8674(88)90258-9; KNEZETIC JA, 1986, CELL, V45, P95, DOI 10.1016/0092-8674(86)90541-6; LORCH Y, 1987, CELL, V49, P203, DOI 10.1016/0092-8674(87)90561-7; LORCH Y, 1988, CELL, V55, P743, DOI 10.1016/0092-8674(88)90128-6; PERLMANN T, 1988, EMBO J, V7, P3073, DOI 10.1002/j.1460-2075.1988.tb03172.x; PINA B, 1990, CELL, V60, P719, DOI 10.1016/0092-8674(90)90087-U; SIMPSON RT, 1990, NATURE, V343, P387, DOI 10.1038/343387a0; STRINGER KF, 1990, NATURE, V345, P783, DOI 10.1038/345783a0; TAYLOR ICA, 1991, GENE DEV, V5, P1285, DOI 10.1101/gad.5.7.1285; THOMA F, 1979, J CELL BIOL, V83, P403, DOI 10.1083/jcb.83.2.403; THOMA F, 1991, TRENDS GENET, V7, P175, DOI 10.1016/0168-9525(91)90429-T; WASYLYK B, 1979, EUR J BIOCHEM, V98, P317, DOI 10.1111/j.1432-1033.1979.tb13191.x; WOLFFE A P, 1990, New Biologist, V2, P211; WOLFFE AP, 1988, SCIENCE, V241, P1626, DOI 10.1126/science.3420414; WORKMAN JL, 1988, CELL, V55, P211, DOI 10.1016/0092-8674(88)90044-X; WORKMAN JL, 1987, CELL, V51, P613, DOI 10.1016/0092-8674(87)90130-9; WORKMAN JL, 1991, CELL, V64, P533, DOI 10.1016/0092-8674(91)90237-S	31	150	152	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	NOV 29	1991	67	5					833	836		10.1016/0092-8674(91)90354-2	http://dx.doi.org/10.1016/0092-8674(91)90354-2			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GT755	1959130				2022-12-28	WOS:A1991GT75500001
J	TOBIAS, JW; SHRADER, TE; ROCAP, G; VARSHAVSKY, A				TOBIAS, JW; SHRADER, TE; ROCAP, G; VARSHAVSKY, A			THE N-END RULE IN BACTERIA	SCIENCE			English	Article							UBIQUITIN-PROTEIN LIGASE; SHORT-LIVED PROTEIN; ESCHERICHIA-COLI; TRANSFER RNA; MULTIUBIQUITIN CHAIN; AMINO-ACID; DEGRADATION; PROTEOLYSIS; RECOGNITION; SPECIFICITY	The N-end rule relates the in vivo half-life of a protein to the identity of its amino-terminal residue. Distinct versions of the N-end rule operate in all eukaryotes examined. It is shown that the bacterium Escherichia coli also has the N-end rule pathway. Amino-terminal arginine, lysine, leucine, phenylalanine, tyrosine, and tryptophan confer 2-minute half-lives on a test protein; the other amino-terminal residues confer greater than 10-hour half-fives on the same protein. Amino-terminal arginine and lysine are secondary destabilizing residues in E. coli because their activity depends on their conjugation to the primary destabilizing residues leucine or phenylalanine by leucine, phenylalanine-transfer RNA-protein transferase. The adenosine triphosphate-dependent protease Clp (Ti) is required for the degradation of N-end rule substrates in E. coli.			TOBIAS, JW (corresponding author), MIT,DEPT BIOL,CAMBRIDGE,MA 02139, USA.			Rocap, Gabrielle/0000-0001-7253-611X	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK039520, R01DK039520, R56DK039520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031530] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK39520] Funding Source: Medline; NIGMS NIH HHS [GM31530] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARFIN SM, 1988, BIOCHEMISTRY-US, V27, P7979, DOI 10.1021/bi00421a001; BACHMAIR A, 1989, CELL, V56, P1019, DOI 10.1016/0092-8674(89)90635-1; BACHMAIR A, 1986, SCIENCE, V234, P179, DOI 10.1126/science.3018930; BAKER RT, 1991, P NATL ACAD SCI USA, V88, P1090, DOI 10.1073/pnas.88.4.1090; BALZI E, 1990, J BIOL CHEM, V265, P7464; BANUETT F, 1986, J MOL BIOL, V187, P213, DOI 10.1016/0022-2836(86)90229-9; BARTEL B, 1990, EMBO J, V9, P3179, DOI 10.1002/j.1460-2075.1990.tb07516.x; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; DEGROOT RJ, 1990, EMBO J, V9, P2631, DOI 10.1002/j.1460-2075.1990.tb07445.x; DEGROOT RJ, 1991, P NATL ACAD SCI USA, V88, P8967, DOI 10.1073/pnas.88.20.8967; DEUTCH CE, 1984, METHOD ENZYMOL, V106, P198; DOHMEN RJ, 1991, P NATL ACAD SCI USA, V88, P7351, DOI 10.1073/pnas.88.16.7351; ELIAS S, 1990, J BIOL CHEM, V265, P15511; GOFF SA, 1987, J BIOL CHEM, V262, P4508; GONDA DK, 1989, J BIOL CHEM, V264, P16700; GOTTESMAN S, 1989, ANNU REV GENET, V23, P163, DOI 10.1146/annurev.ge.23.120189.001115; GREGORI L, 1990, J BIOL CHEM, V265, P8354; HIREL PH, 1989, P NATL ACAD SCI USA, V86, P8247, DOI 10.1073/pnas.86.21.8247; JOHNSON ES, 1990, NATURE, V346, P287, DOI 10.1038/346287a0; JOHNSTON RF, 1990, ELECTROPHORESIS, V11, P355, DOI 10.1002/elps.1150110503; KAJI A, 1963, BIOCHEM BIOPH RES CO, V67, P1136; LEIBOWITZ MJ, 1971, J BIOL CHEM, V246, P5207; MAURIZI MR, 1990, J BIOL CHEM, V265, P12536; METCALF WW, 1990, J BACTERIOL, V172, P3191, DOI 10.1128/jb.172.6.3191-3200.1990; NEIDHARDT FC, 1987, ESCHERICHIA COLI SAL, V2, P1334; Olson TS, 1989, CURR OPIN CELL BIOL, V1, P1194, DOI 10.1016/S0955-0674(89)80071-7; PARCELL DA, 1989, J BIOL CHEM, V264, P7590; REISS Y, 1988, J BIOL CHEM, V263, P2693; SOFFER RL, 1974, P NATL ACAD SCI USA, V71, P1004, DOI 10.1073/pnas.71.3.1004; SOFFER RL, 1980, TRANSFER RNA BIOL AS, P493; STRAUS DB, 1988, GENE DEV, V2, P1851, DOI 10.1101/gad.2.12b.1851; TOBIAS JM, UNPUB; TOBIAS JW, 1991, J BIOL CHEM, V266, P12021; TOWNSEND A, 1988, J EXP MED, V168, P1211, DOI 10.1084/jem.168.4.1211; VARSHAVSKY A, 1991, CELL, V64, P13, DOI 10.1016/0092-8674(91)90202-A; Varshavsky A., 1988, UBIQUITIN, P287; WAY JC, 1984, GENE, V32, P369, DOI 10.1016/0378-1119(84)90012-X; WOO KM, 1989, J BIOL CHEM, V264, P2088	38	431	450	0	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	NOV 29	1991	254	5036					1374	1377		10.1126/science.1962196	http://dx.doi.org/10.1126/science.1962196			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR777	1962196				2022-12-28	WOS:A1991GR77700055
J	BROOME, CV; BREIMAN, RF				BROOME, CV; BREIMAN, RF			PNEUMOCOCCAL VACCINE - PAST, PRESENT, AND FUTURE	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							IMMUNIZATION				BROOME, CV (corresponding author), CTR DIS CONTROL,ATLANTA,GA 30333, USA.							[Anonymous], MMWR MORB MORTAL WKL; BROOME CV, 1981, REV INFECT DIS, V3, pS82; FEDSON DS, 1990, JAMA-J AM MED ASSOC, V264, P1117; KLEIN RS, 1986, ARCH INTERN MED, V146, P327, DOI 10.1001/archinte.146.2.327; KLUGMAN KP, 1990, CLIN MICROBIOL REV, V3, P171, DOI 10.1128/CMR.3.2.171-196.1990; LAFORCE FM, 1988, ANN INTERN MED, V108, P757, DOI 10.7326/0003-4819-108-5-757; MERCAT A, 1991, CHEST, V99, P147, DOI 10.1378/chest.99.1.147; SCHWARTZ B, 1990, JAMA-J AM MED ASSOC, V264, P1154; SHAPIRO ED, 1991, NEW ENGL J MED, V325, P1453, DOI 10.1056/NEJM199111213252101; 1990, GUIDE ADULT IMMUNIZA, P91	10	44	44	0	0	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 21	1991	325	21					1506	1508		10.1056/NEJM199111213252109	http://dx.doi.org/10.1056/NEJM199111213252109			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GQ406	1944428				2022-12-28	WOS:A1991GQ40600009
J	STANLEY, PH				STANLEY, PH			WE DONT HAVE A COMPUTER	BRITISH MEDICAL JOURNAL			English	Article											STANLEY, PH (corresponding author), HLTH CTR,BOVEY TRACEY TQ13 9HZ,DEVON,ENGLAND.								0	2	2	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	OCT 19	1991	303	6808					971	972		10.1136/bmj.303.6808.971	http://dx.doi.org/10.1136/bmj.303.6808.971			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GL127	1954425	Bronze, Green Published			2022-12-28	WOS:A1991GL12700029
J	WANG, J; CHENIVESSE, X; HENGLEIN, B; BRECHOT, C				WANG, J; CHENIVESSE, X; HENGLEIN, B; BRECHOT, C			HEPATITIS-B VIRUS INTEGRATION IN A CYCLIN-A GENE IN A HEPATOCELLULAR-CARCINOMA	NATURE			English	Article									INST PASTEUR,HYBRIDOTEST,F-75724 PARIS,FRANCE	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	WANG, J (corresponding author), CHU NECKER,INSERM,U75,156 RUE VAUGIRARD,F-75730 PARIS,FRANCE.							BEASLEY RP, 1984, SEMIN LIVER DIS, V4, P113, DOI 10.1055/s-2008-1040651; BLANQUET V, 1988, HUM GENET, V80, P274, DOI 10.1007/BF01790096; BRECHOT C, 1980, NATURE, V286, P533, DOI 10.1038/286533a0; BRIZUELA L, 1989, P NATL ACAD SCI USA, V86, P4362, DOI 10.1073/pnas.86.12.4362; BUCHKOVICH K, 1989, CELL, V58, P1097, DOI 10.1016/0092-8674(89)90508-4; CHEN PL, 1989, CELL, V58, P1193, DOI 10.1016/0092-8674(89)90517-5; DECAPRIO JA, 1989, CELL, V58, P1085, DOI 10.1016/0092-8674(89)90507-2; DEJEAN A, 1986, NATURE, V322, P70, DOI 10.1038/322070a0; DETHE H, 1987, NATURE, V330, P667, DOI 10.1038/330667a0; DRAETTA G, 1988, CELL, V54, P17, DOI 10.1016/0092-8674(88)90175-4; DRAETTA G, 1989, CELL, V56, P829, DOI 10.1016/0092-8674(89)90687-9; GIORDANO A, 1989, CELL, V58, P981, DOI 10.1016/0092-8674(89)90949-5; GOEBL M, 1988, CELL, V54, P739; HINO O, 1989, J VIROL, V63, P2638, DOI 10.1128/JVI.63.6.2638-2643.1989; HSU TY, 1988, CELL, V55, P627, DOI 10.1016/0092-8674(88)90221-8; KEW MC, 1984, SEMIN LIVER DIS, V4, P136, DOI 10.1055/s-2008-1040653; LABBE JC, 1989, EMBO J, V8, P3053, DOI 10.1002/j.1460-2075.1989.tb08456.x; LEHNER CF, 1989, CELL, V56, P957, DOI 10.1016/0092-8674(89)90629-6; MCVEY D, 1989, NATURE, V341, P503, DOI 10.1038/341503a0; MEIJER L, 1989, EMBO J, V8, P2275, DOI 10.1002/j.1460-2075.1989.tb08353.x; MINSHULL J, 1989, CELL, V56, P947, DOI 10.1016/0092-8674(89)90628-4; MORGAN DO, 1989, CELL, V57, P775, DOI 10.1016/0092-8674(89)90792-7; MORIA AO, 1989, CELL, V58, P193; MURRAY AW, 1989, NATURE, V339, P275, DOI 10.1038/339275a0; NAGAYA T, 1987, GENE DEV, V1, P773, DOI 10.1101/gad.1.8.773; PASQUINELLI C, 1988, J VIROL, V62, P629, DOI 10.1128/JVI.62.2.629-632.1988; PINES J, 1989, CELL, V58, P833, DOI 10.1016/0092-8674(89)90936-7; PINES J, 1989, EMBO J, V58, P833; ROGLER CE, 1985, SCIENCE, V230, P319, DOI 10.1126/science.2996131; SAGUMA K, 1984, HEPATOLOGY, V8, P1642; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHENOY S, 1989, CELL, V57, P763, DOI 10.1016/0092-8674(89)90791-5; SOLOMON M, 1988, CELL, V54, P738, DOI 10.1016/S0092-8674(88)90933-6; STANDART N, 1987, DEV BIOL, V124, P248, DOI 10.1016/0012-1606(87)90476-3; SWENSON KI, 1986, CELL, V47, P861, DOI 10.1016/0092-8674(86)90801-9; TIOLLAIS P, 1985, NATURE, V317, P489, DOI 10.1038/317489a0; TOKINO T, 1987, J VIROL, V61, P3848, DOI 10.1128/JVI.61.12.3848-3854.1987; WESTENDORF JM, 1989, J CELL BIOL, V108, P1431, DOI 10.1083/jcb.108.4.1431; YAGINUMA K, 1987, J VIROL, V61, P1808, DOI 10.1128/JVI.61.6.1808-1813.1987	39	666	705	1	17	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	FEB 8	1990	343	6258					555	557		10.1038/343555a0	http://dx.doi.org/10.1038/343555a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CM830	1967822				2022-12-28	WOS:A1990CM83000064
J	[Anonymous]				[Anonymous]			SURROGATE MEASURES IN CLINICAL-TRIALS	LANCET			English	Editorial Material																		[Anonymous], 1988, LANCET, V2, P349; [Anonymous], 1986, LANCET, V1, P397; CHAMBERLAIN DA, 1988, LANCET, V1, P545; CUMBERLAND DC, 1989, MED INT, V68, P2834; WILCOX RG, 1988, LANCET, V2, P525; 1989, LANCET, V2, P958	6	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 3	1990	335	8684					261	262						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CL815	1967722				2022-12-28	WOS:A1990CL81500006
J	CHEHAB, FF; KAN, YW				CHEHAB, FF; KAN, YW			DETECTION OF SICKLE-CELL-ANEMIA MUTATION BY COLOR DNA AMPLIFICATION	LANCET			English	Article									APPL BIOSYST INC, FOSTER CITY, CA USA; UNIV CALIF SAN FRANCISCO, DEPT MED, SAN FRANCISCO, CA 94143 USA; UNIV CALIF SAN FRANCISCO, DEPT LAB MED, SAN FRANCISCO, CA 94143 USA; UNIV CALIF SAN FRANCISCO, HOWARD HUGHES MED INST, SAN FRANCISCO, CA 94143 USA	Thermo Fisher Scientific; Applied Biosystems; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco					NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK016666, R37DK016666] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK-16666] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		CHANG JC, 1982, NEW ENGL J MED, V307, P30, DOI 10.1056/NEJM198207013070105; CHEHAB FF, 1989, MODERN PATHOL, V2, P75; CHEHAB FF, 1987, NATURE, V329, P293, DOI 10.1038/329293b0; CHEHAB FF, 1989, P NATL ACAD SCI USA, V86, P9178, DOI 10.1073/pnas.86.23.9178; CONNER BJ, 1983, P NATL ACAD SCI-BIOL, V80, P278, DOI 10.1073/pnas.80.1.278; COTTON RGH, 1988, P NATL ACAD SCI USA, V85, P4397, DOI 10.1073/pnas.85.12.4397; KAN YW, 1978, LANCET, V2, P910; KAN YW, 1976, NEW ENGL J MED, V294, P1039, DOI 10.1056/NEJM197605062941905; KAZAZIAN HH, 1988, BLOOD, V72, P1107; MYERS RM, 1985, SCIENCE, V12, P42; ORKIN SH, 1982, NEW ENGL J MED, V307, P32, DOI 10.1056/NEJM198207013070106; RUBIN EM, 1989, HUM GENET, V82, P134, DOI 10.1007/BF00284045; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SAIKI RK, 1986, NATURE, V324, P163, DOI 10.1038/324163a0; SHEFFIELD VC, 1989, P NATL ACAD SCI USA, V86, P232, DOI 10.1073/pnas.86.1.232; SMITH LM, 1986, NATURE, V321, P674, DOI 10.1038/321674a0	16	39	54	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 6	1990	335	8680					15	17		10.1016/0140-6736(90)90138-U	http://dx.doi.org/10.1016/0140-6736(90)90138-U			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG766	1967329				2022-12-28	WOS:A1990CG76600005
J	GRUNDY, SM; BARONDESS, JA; BELLEGIE, NJ; FROMM, H; GREENWAY, F; HALSTED, CH; HUTH, EJ; KUMANYIKA, SK; REISIN, E; ROBINSON, MK; STEVENS, J; TWOMEY, PL; VIEDERMAN, M; ZIPF, W				GRUNDY, SM; BARONDESS, JA; BELLEGIE, NJ; FROMM, H; GREENWAY, F; HALSTED, CH; HUTH, EJ; KUMANYIKA, SK; REISIN, E; ROBINSON, MK; STEVENS, J; TWOMEY, PL; VIEDERMAN, M; ZIPF, W			GASTROINTESTINAL SURGERY FOR SEVERE OBESITY	ANNALS OF INTERNAL MEDICINE			English	Article								Surgeons, gastroenterologists, endocrinologists, Psychiatrists, nutritionists, and other health care professionals, as well as members of the public convened to address nonsurgical treatments for severe obesity, surgical treatments for severe obesity, and criteria for selection, the efficacy, and risks of surgical treatments for severe obesity, and the need for future research on and epidemiologic evaluation of these therapies. The National Institutes of Health Consensus Development Panel recommended that patients seeking therapy for severe obesity for the first time should be considered for treatment in a nonsurgical program that integrates a dietary regimen, appropriate exercise, behavior modification, and psychological support; that gastric restrictive or bypass procedures could be considered for well-informed and motivated patients in whom the operative risks were acceptable; that patients who are candidates for surgical procedures should be selected carefully after evaluation by a multidisciplinary team with medical, surgical, psychiatric, and nutritional expertise; that surgery be done by a surgeon who has substantial experience in the particular procedure and who works in a clinical setting with adequate support for all aspects of management and assessment; and that patients undergo lifelong medical surveillance after surgery.	NEW YORK ACAD MED,NEW YORK,NY 10029; SURG CLIN,WACO,TX 76710; GEORGE WASHINGTON UNIV,DIV GASTROENTEROL & NUTR,WASHINGTON,DC 20037; UNIV CALIF LOS ANGELES,SCH MED,MARINA DEL REY,CA 90292; UNIV CALIF DAVIS,DIV CLIN NUTR & METAB,DAVIS,CA 95616; PENN STATE UNIV,DEPT NUTR,UNIV PK,PA 16802; PENN STATE UNIV,CTR BIOSTAT & EPIDEMIOL,UNIV PK,PA 16802; LOUISIANA STATE UNIV,MED CTR,SCH MED,NEW ORLEANS,LA 70112; UNIV ILLINOIS,COLL ASSOCIATED HLTH PROFESS,CHICAGO,IL 60612; MED UNIV S CAROLINA,DEPT BIOSTAT EPIDEMIOL & SYST SCI,CHARLESTON,SC 29425; UNIV CALIF DAVIS,MARTINEZ,CA 94553; CORNELL UNIV,MED CTR,NEW YORK HOSP,COLL MED,NEW YORK,NY 10021; OHIO STATE UNIV,CHILDRENS HOSP,DEPT PEDIAT & PHYSIOL,COLUMBUS,OH 43205	New York Academy of Medicine; George Washington University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Davis; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Louisiana State University System; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Medical University of South Carolina; University of California System; University of California Davis; Cornell University; NewYork-Presbyterian Hospital; University System of Ohio; Ohio State University; Nationwide Childrens Hospital	GRUNDY, SM (corresponding author), UNIV TEXAS,SW MED CTR,CTR HUMAN NUTR,5323 HARRY HINES BLVD,DALLAS,TX 75235, USA.								0	1126	1167	0	15	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572	0003-4819			ANN INTERN MED	Ann. Intern. Med.	DEC 15	1991	115	12					956	961						6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GU417	1952493				2022-12-28	WOS:A1991GU41700009
J	BARR, E; LEIDEN, JM				BARR, E; LEIDEN, JM			SYSTEMIC DELIVERY OF RECOMBINANT PROTEINS BY GENETICALLY MODIFIED MYOBLASTS	SCIENCE			English	Article							MEDIATED GENE-TRANSFER; HUMAN ADENOSINE-DEAMINASE; TROPONIN-C GENE; HUMAN FACTOR-IX; HEMOPHILIA-B; BONE-MARROW; STEM-CELLS; EXPRESSION; MUSCLE; TRANSPLANTATION	The ability to stably deliver recombinant proteins to the systemic circulation would facilitate the treatment of a variety of acquired and inherited diseases. To explore the feasibility of the use of genetically engineered myoblasts as a recombinant protein delivery system, stable transfectants of the murine C2C12 myoblast cell line were produced that synthesize and secrete high levels of human growth hormone (hGH) in vitro. Mice injected with hGH-transfected myoblasts had significant levels of hGH in both muscle and serum that were stable for at least 3 weeks after injection. Histological examination of muscles injected with beta-galactosidase-expressing C2C12 myoblasts demonstrated that many of the injected cells had fused to form multinucleated myotubes. Thus, genetically engineered myoblasts can bc used for the stable delivery of recombinant proteins into the circulation.	UNIV MICHIGAN,MED CTR,HOWARD HUGHES MED INST,ANN ARBOR,MI 48109; UNIV MICHIGAN,MED CTR,DEPT INTERNAL MED,ANN ARBOR,MI 48109	Howard Hughes Medical Institute; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan					NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK042718] Funding Source: NIH RePORTER; NIDDK NIH HHS [1 P01 DK42718-01] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ARMENTANO D, 1990, P NATL ACAD SCI USA, V87, P6141, DOI 10.1073/pnas.87.16.6141; BARR E, UNPUB; BLAU HM, 1981, P NATL ACAD SCI-BIOL, V78, P5623, DOI 10.1073/pnas.78.9.5623; BLAU HM, 1985, SCIENCE, V230, P758, DOI 10.1126/science.2414846; CULVER K, 1991, P NATL ACAD SCI USA, V88, P3155, DOI 10.1073/pnas.88.8.3155; DZIERZAK EA, 1988, NATURE, V331, P35, DOI 10.1038/331035a0; EVANS WS, 1987, AM J PHYSIOL, V252, pE549, DOI 10.1152/ajpendo.1987.252.4.E549; FAVIA A, 1989, J CLIN ENDOCR METAB, V68, P535; FLOWERS MED, 1990, P NATL ACAD SCI USA, V87, P2349, DOI 10.1073/pnas.87.6.2349; HOLL RW, 1991, J CLIN ENDOCR METAB, V72, P854, DOI 10.1210/jcem-72-4-854; HUGHES SM, 1990, NATURE, V345, P350, DOI 10.1038/345350a0; KALEKO M, 1990, BLOOD, V75, P1733; KARPATI G, 1989, AM J PATHOL, V135, P27; LAW PK, 1988, MUSCLE NERVE, V11, P525, DOI 10.1002/mus.880110602; LIN H, 1990, CIRCULATION, V82, P2217, DOI 10.1161/01.CIR.82.6.2217; Mammen E F, 1983, Semin Thromb Hemost, V9, P1, DOI 10.1055/s-2007-1004999; MILLER DG, 1990, MOL CELL BIOL, V10, P4239, DOI 10.1128/MCB.10.8.4239; NABEL EG, 1990, SCIENCE, V249, P1285, DOI 10.1126/science.2119055; PALMER TD, 1989, BLOOD, V73, P438; PARMACEK MS, 1990, J BIOL CHEM, V265, P15970; PARMACEK MS, 1989, J BIOL CHEM, V264, P13217; PARTRIDGE TA, 1989, NATURE, V337, P176, DOI 10.1038/337176a0; PONDER KP, 1991, P NATL ACAD SCI USA, V88, P1217, DOI 10.1073/pnas.88.4.1217; PRICE J, 1987, P NATL ACAD SCI USA, V84, P156, DOI 10.1073/pnas.84.1.156; RUDMAN D, 1981, NEW ENGL J MED, V305, P123, DOI 10.1056/NEJM198107163050302; SCHARFMANN R, 1991, P NATL ACAD SCI USA, V88, P4626, DOI 10.1073/pnas.88.11.4626; SCHIFFRIN A, 1982, DIABETES, V31, P255, DOI 10.2337/diabetes.31.3.255; WILSON JM, 1990, P NATL ACAD SCI USA, V87, P439, DOI 10.1073/pnas.87.1.439; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0	29	272	324	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	DEC 6	1991	254	5037					1507	1509		10.1126/science.1962212	http://dx.doi.org/10.1126/science.1962212			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT903	1962212				2022-12-28	WOS:A1991GT90300040
J	DHAWAN, J; PAN, LC; PAVLATH, GK; TRAVIS, MA; LANCTOT, AM; BLAU, HM				DHAWAN, J; PAN, LC; PAVLATH, GK; TRAVIS, MA; LANCTOT, AM; BLAU, HM			SYSTEMIC DELIVERY OF HUMAN GROWTH-HORMONE BY INJECTION OF GENETICALLY ENGINEERED MYOBLASTS	SCIENCE			English	Article							DIRECT GENE-TRANSFER; THERAPY; EXPRESSION; INVIVO; CELLS; MICE; DNA; IMPLANTATION; DYSTROPHIN; PROGRESS	A recombinant gene encoding human growth hormone (hGH) was stably introduced into cultured myoblasts with a retroviral vector. After injection of genetically engineered myoblasts into mouse muscle, hGH could be detected in serum for 3 months. The fate of injected myoblasts was assessed by coinfecting the cells with two retroviral vectors, one encoding hGH and the other encoding beta-galactosidase from Escherichia coli. These results provide evidence that myoblasts, which can fuse into preexisting multinucleated myofibers that are vascularized and innervated, may be advantageous as vehicles for systemic delivery of recombinant proteins.	STANFORD UNIV, MED CTR, SCH MED, DEPT PHARMACOL, STANFORD, CA 94305 USA	Stanford University					NIA NIH HHS [AG-09521] Funding Source: Medline; NICHD NIH HHS [HD-18179] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD018179] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG009521, R37AG009521] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ACSADI G, 1991, NATURE, V352, P815, DOI 10.1038/352815a0; ALFORD FP, 1973, J CLIN ENDOCR METAB, V37, P515, DOI 10.1210/jcem-37-4-515; AUFFRAY C, 1980, EUR J BIOCHEM, V107, P303; BLAU HM, 1981, P NATL ACAD SCI-BIOL, V78, P5623, DOI 10.1073/pnas.78.9.5623; BLAU HM, 1985, SCIENCE, V230, P758, DOI 10.1126/science.2414846; DANOS O, 1988, P NATL ACAD SCI USA, V85, P6460, DOI 10.1073/pnas.85.17.6460; FAUSTMAN D, 1991, SCIENCE, V252, P1700, DOI 10.1126/science.1710828; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FRIEDMANN T, 1989, SCIENCE, V244, P1275, DOI 10.1126/science.2660259; GARVER RI, 1987, SCIENCE, V237, P762, DOI 10.1126/science.3497452; GUSSONI E, UNPUB; Hughes S., UNPUB; HUGHES SM, 1990, NATURE, V345, P350, DOI 10.1038/345350a0; KAPLAN SL, 1986, LANCET, V1, P697; KARPATI G, 1989, AM J PATHOL, V135, P27; KOLLER BH, 1989, P NATL ACAD SCI USA, V86, P8932, DOI 10.1073/pnas.86.22.8932; LIN H, 1990, CIRCULATION, V82, P2217, DOI 10.1161/01.CIR.82.6.2217; LINDAHL A, 1990, INT CONGR SER, V925, P383; MILLER AD, 1990, BLOOD, V76, P271; MILLER SC, 1988, GENE DEV, V2, P330, DOI 10.1101/gad.2.3.330; MORGAN JE, 1990, J CELL BIOL, V111, P2437, DOI 10.1083/jcb.111.6.2437; MORGAN JR, 1987, SCIENCE, V237, P1476; NABEL EG, 1990, SCIENCE, V249, P1285, DOI 10.1126/science.2119055; PALMER TD, 1991, P NATL ACAD SCI USA, V88, P1330, DOI 10.1073/pnas.88.4.1330; PAN L, UNPUB; PARTRIDGE TA, 1991, NATURE, V352, P757, DOI 10.1038/352757a0; PARTRIDGE TA, 1989, NATURE, V337, P176, DOI 10.1038/337176a0; PARTRIDGE TA, 1988, J CELL BIOCHEM     S, V12, P331; PAVLATH GK, UNPUB; PEETERS S, 1977, ENDOCRINOLOGY, V101, P1164, DOI 10.1210/endo-101-4-1164; PETERSON CA, 1990, CELL, V62, P493, DOI 10.1016/0092-8674(90)90014-6; ROEDERER M, 1991, Methods (Orlando), V2, P248, DOI 10.1016/S1046-2023(05)80067-2; RUDMAN D, 1990, NEW ENGL J MED, V323, P1, DOI 10.1056/NEJM199007053230101; SALOMON F, 1989, NEW ENGL J MED, V321, P1797, DOI 10.1056/NEJM198912283212605; SCHARFMANN R, 1991, P NATL ACAD SCI USA, V88, P4626, DOI 10.1073/pnas.88.11.4626; SELDEN RF, 1987, SCIENCE, V236, P714, DOI 10.1126/science.3472348; SHIZURU JA, 1987, SCIENCE, V237, P278, DOI 10.1126/science.2955518; STLOUIS D, 1988, P NATL ACAD SCI USA, V85, P3150; TASSIN AM, 1985, J CELL BIOL, V101, P630, DOI 10.1083/jcb.101.2.630; TEUMER J, 1990, FASEB J, V4, P3245, DOI 10.1096/fasebj.4.14.2227214; WEBSTER C, 1988, EXP CELL RES, V174, P252, DOI 10.1016/0014-4827(88)90159-0; WEBSTER C, 1990, SOMAT CELL MOLEC GEN, V16, P557, DOI 10.1007/BF01233096; WOLFF JA, 1990, SCIENCE, V247, P1465, DOI 10.1126/science.1690918; ZIJLSTRA M, 1989, NATURE, V342, P435, DOI 10.1038/342435a0	44	328	382	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 6	1991	254	5037					1509	1512		10.1126/science.1962213	http://dx.doi.org/10.1126/science.1962213			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT903	1962213				2022-12-28	WOS:A1991GT90300041
J	FERRIN, LJ; CAMERINIOTERO, RD				FERRIN, LJ; CAMERINIOTERO, RD			SELECTIVE CLEAVAGE OF HUMAN DNA - RECA-ASSISTED RESTRICTION ENDONUCLEASE (RARE) CLEAVAGE	SCIENCE			English	Article							TRIPLE-HELIX FORMATION; SITE-SPECIFIC CLEAVAGE; CYSTIC-FIBROSIS GENE; ESCHERICHIA-COLI; PROTEIN; SEQUENCES; IDENTIFICATION; PURIFICATION; CHROMOSOME; DUPLEX	Current methods for sequence-specific cleavage of large segments of DNA are severely limited because of the paucity of possible cleavage sites. A method is described whereby any Eco RI site can be targeted for specific cleavage. The technique is based on the ability of RecA protein from Escherichia coli to pair an oligonucleotide to its homologous sequence in duplex DNA and to form a three-stranded complex. This complex is protected from Eco RI methylase; after methylation and RecA protein removal, Eco RI restriction enzyme cleavage was limited to the site previously protected from methylation. When pairs of oligonucleotides are used, a specific fragment can be cleaved out of genomes. The method was tested on lambda-phage, Escherichia coli, and human DNA. Fragments exceeding 500 kilobases in length and yields exceeding 80 percent could be obtained.	NIDDKD,GENET & BIOCHEM BRANCH,BETHESDA,MD 20892	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)								BEAL PA, 1991, SCIENCE, V251, P1360, DOI 10.1126/science.2003222; COX MM, 1981, J BIOL CHEM, V256, P4676; CRAIG NL, 1981, J BIOL CHEM, V256, P8039; DANIELS DL, 1983, LAMBDA, V2, P519; FERRIN LJ, UNPUB; GRIFFITH J, 1985, BIOCHEMISTRY-US, V24, P158, DOI 10.1021/bi00322a022; HSIEH P, 1990, GENE DEV, V4, P1951, DOI 10.1101/gad.4.11.1951; HSIEH P, 1989, J BIOL CHEM, V264, P5089; HSIEH PL, UNPUB; KOHARA Y, 1987, CELL, V50, P495, DOI 10.1016/0092-8674(87)90503-4; KOOB M, 1990, SCIENCE, V250, P271, DOI 10.1126/science.2218529; KOWALCZYKOWSKI SC, UNPUB; MCCLELLAND M, 1987, METHOD ENZYMOL, V155, P22; MOSER HE, 1987, SCIENCE, V238, P645, DOI 10.1126/science.3118463; PEI DH, 1990, P NATL ACAD SCI USA, V87, P9858, DOI 10.1073/pnas.87.24.9858; RAO BJ, 1991, P NATL ACAD SCI USA, V88, P2984, DOI 10.1073/pnas.88.8.2984; RIORDAN JR, 1989, SCIENCE, V245, P1066; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; RUDD KE, 1990, NUCLEIC ACIDS RES, V18, P313, DOI 10.1093/nar/18.2.313; STROBEL SA, 1991, NATURE, V350, P172, DOI 10.1038/350172a0; UHLIN BE, 1981, J BACTERIOL, V148, P386, DOI 10.1128/JB.148.1.386-390.1981; WILSON WW, 1990, ANAL BIOCHEM, V191, P370, DOI 10.1016/0003-2697(90)90234-Z; ZIELENSKI J, 1991, GENOMICS, V10, P214, DOI 10.1016/0888-7543(91)90503-7	23	199	232	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	DEC 6	1991	254	5037					1494	1497		10.1126/science.1962209	http://dx.doi.org/10.1126/science.1962209			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT903	1962209				2022-12-28	WOS:A1991GT90300036
J	NIELSEN, PE; EGHOLM, M; BERG, RH; BUCHARDT, O				NIELSEN, PE; EGHOLM, M; BERG, RH; BUCHARDT, O			SEQUENCE-SELECTIVE RECOGNITION OF DNA BY STRAND DISPLACEMENT WITH A THYMINE-SUBSTITUTED POLYAMIDE	SCIENCE			English	Article							TRIPLE-HELIX FORMATION; SITE-SPECIFIC CLEAVAGE; DUPLEX DNA; INTERCALATING AGENTS; MAJOR GROOVE; BINDING; PROTEIN; MOTIF; INHIBITION; COMPLEX	A polyamide nucleic acid (PNA) was designed by detaching the deoxyribose phosphate backbone of DNA in a computer model and replacing it with an achiral polyamide backbone. On the basis of this model, oligomers consisting of thymine-linked aminoethylglycyl units were prepared. These oligomers recognize their complementary target in double-stranded DNA by strand displacement The displacement is made possible by the extraordinarily high stability of the PNA-DNA hybrids. The results show that the backbone of DNA can be replaced by a polyamide, with the resulting oligomer retaining base-specific hybridization.	HC ORSTED INST,DEPT ORGAN CHEM,DK-2100 COPENHAGEN 0,DENMARK; RISO NATL LAB,DEPT MAT,POLYMER GRP,DK-4000 ROSKILDE,DENMARK	University of Copenhagen; Technical University of Denmark	NIELSEN, PE (corresponding author), PANUM INST,DEPT BIOCHEM B,MED BIOTECHNOL RES CTR,BLEGDAMSVEJ 3C,DK-2200 COPENHAGEN N,DENMARK.		Berg, Rolf H/C-6339-2009	/0000-0001-8771-330X				BEAL PA, 1991, SCIENCE, V251, P1360, DOI 10.1126/science.2003222; BIRG F, 1990, NUCLEIC ACIDS RES, V18, P2901, DOI 10.1093/nar/18.10.2901; BRENNAN RG, 1989, J BIOL CHEM, V264, P1903; DERVAN PB, 1986, SCIENCE, V232, P464, DOI 10.1126/science.2421408; DREW HR, 1984, J MOL BIOL, V176, P535, DOI 10.1016/0022-2836(84)90176-1; EBRIGHT RH, 1990, P NATL ACAD SCI USA, V87, P2882, DOI 10.1073/pnas.87.8.2882; FEDOROVA OS, 1988, FEBS LETT, V228, P273, DOI 10.1016/0014-5793(88)80014-0; FRANCOIS JC, 1988, NUCLEIC ACIDS RES, V16, P11431, DOI 10.1093/nar/16.24.11431; GRIFFIN LC, 1989, SCIENCE, V245, P967, DOI 10.1126/science.2549639; GUERON M, 1987, NATURE, V328, P89, DOI 10.1038/328089a0; HELENE C, 1990, BIOCHIM BIOPHYS ACTA, V1049, P99, DOI 10.1016/0167-4781(90)90031-V; HORNE DA, 1990, J AM CHEM SOC, V112, P2435, DOI 10.1021/ja00162a063; JEPPESEN C, 1989, EUR J BIOCHEM, V182, P437, DOI 10.1111/j.1432-1033.1989.tb14850.x; JEPPESEN C, 1989, NUCLEIC ACIDS RES, V17, P4947, DOI 10.1093/nar/17.13.4947; MACK DP, 1990, J AM CHEM SOC, V112, P4604, DOI 10.1021/ja00167a102; MACK DP, 1988, J AM CHEM SOC, V110, P7572, DOI 10.1021/ja00230a067; MAHER LJ, 1989, SCIENCE, V245, P725, DOI 10.1126/science.2549631; MOSER HE, 1987, SCIENCE, V238, P645, DOI 10.1126/science.3118463; NIELSEN PE, 1991, BIOCONJUGATE CHEM, V2, P1, DOI 10.1021/bc00007a001; NIELSEN PE, 1989, BIOCHEMISTRY-US, V27, P6338; OLLIS DL, 1987, CHEM REV, V87, P981, DOI 10.1021/cr00081a006; PEI D, 1990, J AM CHEM SOC, V112, P4579, DOI 10.1021/ja00167a085; SAUER RT, 1990, NATURE, V347, P514, DOI 10.1038/347514b0; SCHLEIF R, 1988, SCIENCE, V241, P1182, DOI 10.1126/science.2842864; SLUKA JP, 1987, SCIENCE, V238, P1129, DOI 10.1126/science.3120311; STROBEL SA, 1990, SCIENCE, V249, P73, DOI 10.1126/science.2195655; SUN JS, 1989, P NATL ACAD SCI USA, V86, P9198, DOI 10.1073/pnas.86.23.9198; WAKELIN LPG, 1990, J MED CHEM, V33, P2039, DOI 10.1021/jm00169a039; [No title captured]	29	2725	3863	15	382	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	DEC 6	1991	254	5037					1497	1500		10.1126/science.1962210	http://dx.doi.org/10.1126/science.1962210			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT903	1962210				2022-12-28	WOS:A1991GT90300037
J	PETERSON, MG; INOSTROZA, J; MAXON, ME; FLORES, O; ADMON, A; REINBERG, D; TJIAN, R				PETERSON, MG; INOSTROZA, J; MAXON, ME; FLORES, O; ADMON, A; REINBERG, D; TJIAN, R			STRUCTURE AND FUNCTIONAL-PROPERTIES OF HUMAN GENERAL TRANSCRIPTION FACTOR-IIE	NATURE			English	Article							RNA POLYMERASE-II; BINDING-PROTEIN; PURIFICATION; INITIATION; ACTIVATION; SEQUENCES; CELLS	The general transcription factor IIE (TFIIE) is an essential component of the eukaryotic RNA polymerase 11 initiation complex. We have isolated human complementary DNA clones for both the subunits of TFIIE. Using purified recombinant proteins we find that both subunits are essential to form a stable preinitiation complex and to reconstitute basal-level and Sp1-activated transcription in vitro. Analysis of their predicted amino-acid sequences reveals several intriguing structural motifs that could provide insight into the role of TFIIE in transcription initiation.	UNIV MED & DENT NEW JERSEY,ROBERT WOOD JOHNSON MED SCH,PISCATAWAY,NJ 08854	Rutgers State University New Brunswick; Rutgers State University Medical Center	PETERSON, MG (corresponding author), UNIV CALIF BERKELEY,HOWARD HUGHES MED INST,DEPT MOLEC & CELL BIOL,BERKELEY,CA 94720, USA.			Reinberg, Danny/0000-0003-4288-2016; Admon, Arie/0000-0003-0504-3950				ARIAS JA, 1991, J BIOL CHEM, V266, P8055; ARIKAN E, 1986, NUCLEIC ACIDS RES, V14, P2637, DOI 10.1093/nar/14.6.2637; BAIROCH A, 1988, NATURE, V331, P22, DOI 10.1038/331022a0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURATOWSKI S, 1989, CELL, V56, P549, DOI 10.1016/0092-8674(89)90578-3; CHEN CJ, 1986, CELL, V47, P381, DOI 10.1016/0092-8674(86)90595-7; DON RH, 1991, NUCLEIC ACIDS RES, V19, P4008, DOI 10.1093/nar/19.14.4008; FLORES O, 1990, J BIOL CHEM, V265, P5629; FOOTE SJ, 1989, CELL, V57, P921, DOI 10.1016/0092-8674(89)90330-9; HA I, 1991, NATURE, V352, P689, DOI 10.1038/352689a0; HOEY T, 1990, CELL, V61, P1179, DOI 10.1016/0092-8674(90)90682-5; HUSAIN I, 1986, J BIOL CHEM, V261, P4895; INOSTROZA J, 1991, J BIOL CHEM, V266, P9304; JOHNSON PF, 1989, ANNU REV BIOCHEM, V58, P799, DOI 10.1146/annurev.biochem.58.1.799; KNIGHTON DR, 1991, SCIENCE, V253, P407, DOI 10.1126/science.1862342; LATHE R, 1985, J MOL BIOL, V183, P1, DOI 10.1016/0022-2836(85)90276-1; MALDONADO E, 1990, MOL CELL BIOL, V10, P6335, DOI 10.1128/MCB.10.12.6335; MERMELSTEIN FH, 1989, BIOCHIM BIOPHYS ACTA, V1009, P1, DOI 10.1016/0167-4781(89)90071-7; MERMOD N, 1989, CELL, V58, P741, DOI 10.1016/0092-8674(89)90108-6; MITCHELL PJ, 1989, SCIENCE, V245, P371, DOI 10.1126/science.2667136; OHKUMA Y, 1990, P NATL ACAD SCI USA, V87, P9163, DOI 10.1073/pnas.87.23.9163; PERKINS KK, 1990, GENE DEV, V4, P822, DOI 10.1101/gad.4.5.822; PETERSON MG, 1990, SCIENCE, V248, P1625, DOI 10.1126/science.2363050; PUGH BF, 1990, CELL, V61, P1187, DOI 10.1016/0092-8674(90)90683-6; REINBERG D, 1987, J BIOL CHEM, V262, P3310; SALTZMAN AG, 1989, FASEB J, V3, P1723, DOI 10.1096/fasebj.3.6.2649403	26	179	183	0	1	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	DEC 5	1991	354	6352					369	373						5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT761	1956398				2022-12-28	WOS:A1991GT76100042
J	NASRIN, N; BUGGS, C; KONG, XF; CARNAZZA, J; GOEBL, M; ALEXANDERBRIDGES, M				NASRIN, N; BUGGS, C; KONG, XF; CARNAZZA, J; GOEBL, M; ALEXANDERBRIDGES, M			DNA-BINDING PROPERTIES OF THE PRODUCT OF THE TESTIS-DETERMINING GENE AND A RELATED PROTEIN	NATURE			English	Article							SEX-DETERMINING REGION; MOTIF; EXPRESSION; HOMOLOGY; CLONING; CELLS; SRY	THE upstream region of the human glyceraldehyde-3-phosphate dehydrogenase gene contains an insulin-response element (IRE-A) responsible for insulin-dependent transcription of the gene (ref. 1). The open reading frame of a rat complementary DNA encoding a protein (IRE-ABP) that binds to this sequence contains an HMG box motif 2 that is 67% identical to the mouse candidate gene for the testis-determining factor SRY, and 98% identical to the mouse SRY-like gene, alpha-4(refs 3, 4). Here we report that IRE-ABP and SRY bind to IRE-A DNA with comparable specificity in a DNase-I footprinting assay. Two females with sex reversal were found to have a single amino-acid substitution in the HMG box domain of SRY at position 3 and 7, respectively 5,6. SRY derivatives containing corresponding mutations do not make contact with IRE-A DNA. These results are direct evidence that mouse SRY-like proteins are sequence-specific DNA-binding proteins and identify two amino acids critical to this interaction. Moreover, IRE-A is a candidate SRY-response element.	HARVARD UNIV,MASSACHUSETTS GEN HOSP,SCH MED,HOWARD HUGHES MED INST,DIABET UNIT,50 BLOSSOM ST,BOSTON,MA 02114; HARVARD UNIV,MASSACHUSETTS GEN HOSP,SCH MED,MED SERV,BOSTON,MA 02114	Harvard University; Harvard Medical School; Massachusetts General Hospital; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Massachusetts General Hospital								BERTA P, 1990, NATURE, V348, P448, DOI 10.1038/348448A0; GUBBAY J, 1990, NATURE, V346, P245, DOI 10.1038/346245a0; JAGER RJ, 1990, NATURE, V348, P452, DOI 10.1038/348452a0; JANTZEN HM, 1990, NATURE, V344, P830, DOI 10.1038/344830a0; JUTTE NHPM, 1982, J REPROD FERTIL, V65, P431, DOI 10.1530/jrf.0.0650431; KOOPMAN P, 1990, NATURE, V348, P450, DOI 10.1038/348450a0; LABRIE F, 1984, ENDOCRINOLOGY, P615; NASRIN N, 1990, P NATL ACAD SCI USA, V87, P5273, DOI 10.1073/pnas.87.14.5273; ROBINSON R, 1981, BIOL REPROD, V24, P1032, DOI 10.1095/biolreprod24.5.1032; SINCLAIR AH, 1990, NATURE, V346, P240, DOI 10.1038/346240a0; SINGH H, 1988, CELL, V52, P415, DOI 10.1016/S0092-8674(88)80034-5; SKINNER MK, 1991, ENDOCR REV, V12, P45, DOI 10.1210/edrv-12-1-45; STAUDT LM, 1988, SCIENCE, V241, P577, DOI 10.1126/science.3399892; TRAVIS A, 1991, GENE DEV, V5, P880, DOI 10.1101/gad.5.5.880; VANDEWETERING M, 1991, EMBO J, V10, P123, DOI 10.1002/j.1460-2075.1991.tb07928.x; WATERMAN M L, 1990, New Biologist, V2, P621; WATERMAN ML, 1991, GENE DEV, V5, P656, DOI 10.1101/gad.5.4.656	17	172	175	0	0	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	NOV 28	1991	354	6351					317	320		10.1038/354317a0	http://dx.doi.org/10.1038/354317a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT204	1956382				2022-12-28	WOS:A1991GT20400051
J	TIMSIT, Y; VILBOIS, E; MORAS, D				TIMSIT, Y; VILBOIS, E; MORAS, D			BASE-PAIRING SHIFT IN THE MAJOR GROOVE OF (CA)N TRACTS BY B-DNA CRYSTAL-STRUCTURES	NATURE			English	Article							A-DNA; SEQUENCES; CONFORMATION; REFINEMENT; HYDRATION; MUTATION; MISMATCH; EXCHANGE	THE crystal packing of the B-DNA dodecamer d(ACCGGCGCCACA). d(TGTGGCGCCGGT) is characterized by the reciprocal fit of double helices with specific base-backbone interactions in the major groove. Cooling the crystals below -10-degrees-C stabilizes a new conformational state with a long-range sequence-dependent one-step shift in the major-groove base pairing. The tilt of the bases leads to the disruption of the Watson-Crick pairing in the major groove and to the formation of interactions with the 5' neighbour of their complement. This alteration propagates along the helical axis over more than half a turn. As a result, the molecular structure is normal when seen from the minor groove side and mismatched in the major groove. Comparison with a parent isomorphous dodecamer structure corresponding to the codon 10-13 of the c-Ha-ras proto-oncogene shows that this new structural feature is sequence dependent and clearly favoured by (CA)n tracts. As(CA)n tracts of DNA are involved both in recombination and in transcription, this new recognition pattern should be considered in the analysis of the various processes involving the reading of the genetic information.			TIMSIT, Y (corresponding author), INST BIOL MOLEC & CELLULAIRE,CRISTALLOG BIOL LAB,15 RUE DESCARTES,F-67000 STRASBOURG,FRANCE.		Timsit, Youri/AAL-2412-2021	Timsit, Youri/0000-0003-0601-7201				BOLSHOY A, 1991, P NATL ACAD SCI USA, V88, P2312, DOI 10.1073/pnas.88.6.2312; CHEUNG S, 1984, P NATL ACAD SCI-BIOL, V81, P3665, DOI 10.1073/pnas.81.12.3665; COLL M, 1987, P NATL ACAD SCI USA, V84, P8385, DOI 10.1073/pnas.84.23.8385; COWIE A, 1988, MOL CELL BIOL, V8, P3122, DOI 10.1128/MCB.8.8.3122; FUCHS RPP, 1981, NATURE, V294, P657, DOI 10.1038/294657a0; HUNTER WN, 1987, NUCLEIC ACIDS RES, V15, P6589, DOI 10.1093/nar/15.16.6589; HUNTER WN, 1986, NATURE, V320, P552, DOI 10.1038/320552a0; JAIN S, 1989, BIOCHEMISTRY-US, V28, P2360, DOI 10.1021/bi00432a002; JARMAN AP, 1989, TRENDS GENET, V5, P367, DOI 10.1016/0168-9525(89)90171-6; KENNARD O, 1985, J BIOMOL STRUCT DYN, V3, P205, DOI 10.1080/07391102.1985.10508412; KUNKEL TA, 1988, J BIOL CHEM, V263, P14784; LU P, 1983, J BIOMOL STRUCT DYN, V1, P509, DOI 10.1080/07391102.1983.10507458; MCNAMARA PT, 1990, J BIOMOL STRUCT DYN, V8, P529, DOI 10.1080/07391102.1990.10507827; NELSON HCM, 1987, NATURE, V330, P221, DOI 10.1038/330221a0; PRIVE GG, 1987, SCIENCE, V238, P498, DOI 10.1126/science.3310237; PRIVE GG, 1991, J MOL BIOL, V217, P177, DOI 10.1016/0022-2836(91)90619-H; REDDY EP, 1982, NATURE, V300, P149, DOI 10.1038/300149a0; RODGERS J, 1983, NATURE, V305, P101; SHEN SH, 1981, CELL, V26, P191, DOI 10.1016/0092-8674(81)90302-0; STREISINGER G, 1966, COLD SPRING HARB SYM, V31, P77, DOI 10.1101/SQB.1966.031.01.014; SUSSMAN JL, 1977, ACTA CRYSTALLOGR A, V33, P800, DOI 10.1107/S0567739477001958; TIMSIT Y, 1989, NATURE, V341, P459, DOI 10.1038/341459a0; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; TRECO D, 1986, MOL CELL BIOL, V6, P3934, DOI 10.1128/MCB.6.11.3934; USDIN K, 1989, J BIOL CHEM, V264, P20736; WEBSTER GD, 1990, P NATL ACAD SCI USA, V87, P6693, DOI 10.1073/pnas.87.17.6693; WESTHOF E, 1985, J MOL BIOL, V184, P119, DOI 10.1016/0022-2836(85)90048-8	27	97	97	0	5	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	NOV 14	1991	354	6349					167	170		10.1038/354167a0	http://dx.doi.org/10.1038/354167a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GP880	1944598				2022-12-28	WOS:A1991GP88000066
J	SHAANAN, B; LIS, H; SHARON, N				SHAANAN, B; LIS, H; SHARON, N			STRUCTURE OF A LEGUME LECTIN WITH AN ORDERED N-LINKED CARBOHYDRATE IN COMPLEX WITH LACTOSE	SCIENCE			English	Article							X-RAY-DIFFRACTION; 3-DIMENSIONAL STRUCTURE; CONCANAVALIN-A; CRYSTAL-STRUCTURE; ERYTHRINA-CORALLODENDRON; SACCHARIDE-BINDING; FC-FRAGMENT; OLIGOSACCHARIDES; RECOGNITION; RESOLUTION	The three-dimensional structure of the lactose complex of the Erythrina corallodendron lectin (EcorL), a dimer of N-glycosylated subunits, was determined crystallographically and refined at 2.0 angstrom resolution to an R value of 0.19. The tertiary structure of the subunit is similar to that of other legume lectins, but interference by the bulky N-linked heptasaccharide, which is exceptionally well ordered in the crystal, forces the EcorL dimer into a drastically different quaternary structure. Only the galactose moiety of the lactose ligand resides within the combining site. The galactose moiety is oriented differently from ligands in the mannose-glucose specific legume lectins and is held by hydrophobic interactions with Ala88, Tyr106, Phe131, and Ala218, and by seven hydrogen bonds, four of which are to the conserved Asp89, Asn133, and NH of Gly107. The specificity of legume lectins toward the different C-4 epimers appears to be associated with extensive variations in the outline of the variable parts of the binding sites.	WEIZMANN INST SCI, DEPT BIOPHYS, IL-76100 REHOVOT, ISRAEL	Weizmann Institute of Science	SHAANAN, B (corresponding author), NIADDKD, MOLEC BIOL LAB, BETHESDA, MD 20892 USA.		Shaanan, Boaz/F-1202-2012	Shaanan, Boaz/0000-0001-8925-4362				ADAR R, 1989, FEBS LETT, V257, P81, DOI 10.1016/0014-5793(89)81791-0; AMZEL LM, 1979, ANNU REV BIOCHEM, V48, P961, DOI 10.1146/annurev.bi.48.070179.004525; ARANGO R, 1990, FEBS LETT, V264, P109, DOI 10.1016/0014-5793(90)80777-G; ASHFORD D, 1987, EUR J BIOCHEM, V166, P311, DOI 10.1111/j.1432-1033.1987.tb13516.x; ASHWELL G, 1974, ADV ENZYMOL RAMB, V41, P99; ASHWELL G, 1982, ANNU REV BIOCHEM, V51, P531, DOI 10.1146/annurev.bi.51.070182.002531; BECKER JW, 1975, J BIOL CHEM, V250, P1513; BECKER JW, 1991, T AM CRYSTALLOGR ASS, V25, P37; BODE W, 1989, BIOCHEMISTRY-US, V28, P1951, DOI 10.1021/bi00431a001; BOURNE Y, 1990, PROTEINS, V8, P365, DOI 10.1002/prot.340080410; BOURNE Y, 1990, J MOL BIOL, V214, P571, DOI 10.1016/0022-2836(90)90199-V; BOUWSTRA JB, 1990, EUR J BIOCHEM, V190, P113, DOI 10.1111/j.1432-1033.1990.tb15553.x; BRANDLEY BK, 1990, CELL, V63, P861, DOI 10.1016/0092-8674(90)90487-Y; BRISSON JR, 1983, BIOCHEMISTRY-US, V22, P3680, DOI 10.1021/bi00284a022; Brunger AT, 1988, CRYSTALLOGRAPHIC COM, V3, P126; CARSON M, 1987, J MOL GRAPHICS, V5, P103, DOI 10.1016/0263-7855(87)80010-3; Davies D R, 1975, Contemp Top Mol Immunol, V4, P127; DEBOECK H, 1984, ARCH BIOCHEM BIOPHYS, V234, P297, DOI 10.1016/0003-9861(84)90352-7; DEISENHOFER J, 1981, BIOCHEMISTRY-US, V20, P2361, DOI 10.1021/bi00512a001; DELBAERE LT, 1991, T AM CRYSTALLOGR ASS, V25, P51; DELBAERE LTJ, 1990, CAN J CHEM, V68, P1116, DOI 10.1139/v90-172; DEREWENDA Z, 1989, EMBO J, V8, P2189, DOI 10.1002/j.1460-2075.1989.tb08341.x; EDELMAN GM, 1972, P NATL ACAD SCI USA, V69, P2580, DOI 10.1073/pnas.69.9.2580; EINSPAHR H, 1986, J BIOL CHEM, V261, P6518; FITZGERALD PMD, 1988, J APPL CRYSTALLOGR, V21, P273, DOI 10.1107/S0021889887012299; FUJINAGA M, 1987, J APPL CRYSTALLOGR, V20, P517, DOI 10.1107/S0021889887086102; HARDMAN KD, 1982, J MOL BIOL, V157, P69, DOI 10.1016/0022-2836(82)90513-7; HARDMAN KD, 1972, BIOCHEMISTRY-US, V11, P4910, DOI 10.1021/bi00776a006; HENDRICKSON WA, 1980, COMPUTING CRYSTALLOG; HOMANS SW, 1987, BIOCHEMISTRY-US, V26, P6553, DOI 10.1021/bi00394a040; HOMANS SW, 1987, BIOCHEMISTRY-US, V26, P6571, DOI 10.1021/bi00395a001; HOWARD AJ, 1987, J APPL CRYSTALLOGR, V20, P383, DOI 10.1107/S0021889887086436; KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P916, DOI 10.1107/S0021889888007903; LIS H, 1985, PHYTOCHEMISTRY, V24, P2803, DOI 10.1016/0031-9422(85)80004-2; LOONTIENS FG, UNPUB; QUIOCHO FA, 1990, PHILOS T R SOC B, V326, P341, DOI 10.1098/rstb.1990.0016; QUIOCHO FA, 1986, ANNU REV BIOCHEM, V55, P287, DOI 10.1146/annurev.bi.55.070186.001443; REEKE GN, 1975, J BIOL CHEM, V250, P1525; REEKE GN, 1988, CURR TOP MICROBIOL, V139, P35; REEKE GN, 1986, SCIENCE, V234, P1108, DOI 10.1126/science.3775378; ROSEN SD, 1990, AM J RESP CELL MOL, V3, P397, DOI 10.1165/ajrcmb/3.5.397; SAPER MA, 1987, J MOL BIOL, V193, P823, DOI 10.1016/0022-2836(87)90363-9; SHAANAN B, UNPUB; SHARON N, 1990, FASEB J, V4, P3198, DOI 10.1096/fasebj.4.14.2227211; SHARON N, 1989, SCIENCE, V246, P227, DOI 10.1126/science.2552581; SKEHEL JJ, 1984, P NATL ACAD SCI-BIOL, V81, P1779, DOI 10.1073/pnas.81.6.1779; SUCK D, 1984, EMBO J, V3, P2423, DOI 10.1002/j.1460-2075.1984.tb02149.x; SUTTON BJ, 1983, BIOCHEM SOC T, V11, P130, DOI 10.1042/bst0110130; VARGHESE JN, 1983, NATURE, V303, P35, DOI 10.1038/303035a0; WEIS WI, 1990, J MOL BIOL, V212, P737, DOI 10.1016/0022-2836(90)90234-D; WILLIAMS RL, 1987, J BIOL CHEM, V262, P16020; WILSON IA, 1981, NATURE, V289, P366, DOI 10.1038/289366a0; WRIGHT CS, 1990, J MOL BIOL, V215, P635, DOI 10.1016/S0022-2836(05)80174-3	54	265	268	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 8	1991	254	5033					862	866		10.1126/science.1948067	http://dx.doi.org/10.1126/science.1948067			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN833	1948067				2022-12-28	WOS:A1991GN83300047
J	MEISTERERNST, M; ROEDER, RG				MEISTERERNST, M; ROEDER, RG			FAMILY OF PROTEINS THAT INTERACT WITH TFIID AND REGULATE PROMOTER ACTIVITY	CELL			English	Article							RNA POLYMERASE-II; GENERAL TRANSCRIPTION FACTOR; IMMEDIATE EARLY PROTEIN; MAJOR LATE PROMOTER; PREINITIATION COMPLEX; FUNCTIONAL DOMAINS; BINDING-PROTEIN; TATA FACTOR; INITIATION; ACTIVATION	A family of proteins was shown to bind cooperatively with TFIID to core promoters, as previously demonstrated for the general initiation factor TFIIA. These factors form distinct complexes with TFIID, fall to bind DNA in the absence of TFIID, differ chromatographically from TFIIA, and compete with TFIIA for binding to TFIID. Our results suggest the formation of heterogeneous preinitiation complexes at the step involving TFIIA interactions. This establishes a molecular switch that regulates basal level transcription in vitro and has consequences for transcriptional activation by gene-specific activators.			MEISTERERNST, M (corresponding author), ROCKEFELLER UNIV,BIOCHEM & MOLEC BIOL LAB,NEW YORK,NY 10021, USA.				NATIONAL CANCER INSTITUTE [R35CA042567] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI027397] Funding Source: NIH RePORTER; NCI NIH HHS [CA42567] Funding Source: Medline; NIAID NIH HHS [AI27397] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ABMAYR SM, 1988, GENE DEV, V2, P542, DOI 10.1101/gad.2.5.542; BURATOWSKI S, 1988, NATURE, V334, P37, DOI 10.1038/334037a0; BURATOWSKI S, 1989, CELL, V56, P549, DOI 10.1016/0092-8674(89)90578-3; CORMACK BP, 1991, CELL, V65, P341, DOI 10.1016/0092-8674(91)90167-W; GASCH A, 1990, NATURE, V346, P390, DOI 10.1038/346390a0; GILL G, 1991, CELL, V65, P333, DOI 10.1016/0092-8674(91)90166-V; HAHN S, 1989, EMBO J, V8, P3379, DOI 10.1002/j.1460-2075.1989.tb08501.x; HOFFMANN A, 1990, NATURE, V346, P387, DOI 10.1038/346387a0; HOFFMANN A, 1990, GENE DEV, V4, P1141, DOI 10.1101/gad.4.7.1141; HORIKOSHI M, 1990, CELL, V61, P1171, DOI 10.1016/0092-8674(90)90681-4; HORIKOSHI M, 1988, CELL, V54, P665, DOI 10.1016/S0092-8674(88)80011-4; HORIKOSHI M, 1988, CELL, V54, P1033, DOI 10.1016/0092-8674(88)90118-3; INOSTROZA J, 1991, J BIOL CHEM, V266, P9304; KAO CC, 1990, SCIENCE, V248, P1646, DOI 10.1126/science.2194289; LIN YS, 1991, CELL, V64, P971, DOI 10.1016/0092-8674(91)90321-O; MALDONADO E, 1990, MOL CELL BIOL, V10, P6335, DOI 10.1128/MCB.10.12.6335; MALIK S, 1991, IN PRESS P NATL ACAD; MATSUI T, 1980, J BIOL CHEM, V255, P1992; MEISTERERNST M, 1990, P NATL ACAD SCI USA, V87, P9153, DOI 10.1073/pnas.87.23.9153; MEISTERERNST M, 1991, CELL, V66, P981, DOI 10.1016/0092-8674(91)90443-3; MURRE C, 1989, CELL, V56, P777, DOI 10.1016/0092-8674(89)90682-X; MURRE C, 1989, CELL, V58, P537, DOI 10.1016/0092-8674(89)90434-0; NAKAJIMA N, 1988, MOL CELL BIOL, V8, P4028, DOI 10.1128/MCB.8.10.4028; PETERSON MG, 1990, SCIENCE, V248, P1625, DOI 10.1126/science.2363050; POON D, 1991, IN PRESS MOL CELL BI; PTASHNE M, 1990, NATURE, V346, P329, DOI 10.1038/346329a0; PTASHNE M, 1988, NATURE, V335, P683, DOI 10.1038/335683a0; PUGH BF, 1990, CELL, V61, P1187, DOI 10.1016/0092-8674(90)90683-6; REDDY P, 1991, CELL, V65, P349, DOI 10.1016/0092-8674(91)90168-X; REINBERG D, 1987, J BIOL CHEM, V262, P3322; SAMUELS M, 1986, J BIOL CHEM, V261, P2003; SAWADOGO M, 1990, ANNU REV BIOCHEM, V59, P711, DOI 10.1146/annurev.bi.59.070190.003431; SAWADOGO M, 1985, CELL, V43, P165, DOI 10.1016/0092-8674(85)90021-2; STRINGER KF, 1990, NATURE, V345, P783, DOI 10.1038/345783a0; SUMIMOTO H, 1990, P NATL ACAD SCI USA, V87, P9158, DOI 10.1073/pnas.87.23.9158; VANDYKE MW, 1988, SCIENCE, V241, P1335, DOI 10.1126/science.3413495; WORKMAN JL, 1988, CELL, V55, P211, DOI 10.1016/0092-8674(88)90044-X; WORKMAN JL, 1987, CELL, V51, P613, DOI 10.1016/0092-8674(87)90130-9; WORKMAN JL, 1990, EMBO J, V9, P1299, DOI 10.1002/j.1460-2075.1990.tb08239.x	39	281	285	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	NOV 1	1991	67	3					557	567		10.1016/0092-8674(91)90530-C	http://dx.doi.org/10.1016/0092-8674(91)90530-C			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GN664	1934060				2022-12-28	WOS:A1991GN66400012
J	OPPENHEIMER, DG; HERMAN, PL; SIVAKUMARAN, S; ESCH, J; MARKS, MD				OPPENHEIMER, DG; HERMAN, PL; SIVAKUMARAN, S; ESCH, J; MARKS, MD			A MYB GENE REQUIRED FOR LEAF TRICHOME DIFFERENTIATION IN ARABIDOPSIS IS EXPRESSED IN STIPULES	CELL			English	Article							AGROBACTERIUM-TUMEFACIENS; C-MYB; MEDIATED TRANSFORMATION; GLABROUS1 GENE; TI-PLASMID; THALIANA; PROTOONCOGENE; SEQUENCES; EXPLANTS; PLANTS	The GL1 gene is required for the initiation of differentiation of hair cells (trichomes) on the crucifer, Arabidopsis thaliana. This gene has been localized to a 4.5 kb DNA fragment by molecular complementation of gl1 mutants. DNA sequence analysis has shown that the protein encoded by GL1 contains a Myb DNA-binding motif. Southern analysis and subsequence analysis of isolated-lambda clones has established that GL1 is a member of an extensive myb gene family in Arabidopsis. The putative GL1 promoter directs the expression of the GUS reporter gene in non-trichome-bearing structures that appear to be stipules. This pattern of expression suggests that GL1 may control the synthesis of a diffusible signal that activates the developmental pathway for trichome differentiation.			OPPENHEIMER, DG (corresponding author), UNIV NEBRASKA,SCH BIOL SCI,LINCOLN,NE 68588, USA.		Marks, Michael/ABF-3973-2020; Oppenheimer, David G/A-2781-2008	Marks, Michael/0000-0002-0136-3431; Oppenheimer, David G/0000-0002-0471-3118	NATIONAL CENTER FOR RESEARCH RESOURCES [S07RR007055] Funding Source: NIH RePORTER; NCRR NIH HHS [S07RR07055] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		An G., 1989, PLANT MOL BIOL MANUA, P1, DOI [DOI 10.1007/978-94-009-0951-9, 10.1007/978-94-017-5294-7_3]; BERRY JO, 1985, MOL CELL BIOL, V5, P2238, DOI 10.1128/MCB.5.9.2238; BEVAN M, 1984, NUCLEIC ACIDS RES, V12, P8711, DOI 10.1093/nar/12.22.8711; BROWN JWS, 1986, NUCLEIC ACIDS RES, V14, P9549, DOI 10.1093/nar/14.24.9549; BRUMBAUGH JA, 1988, P NATL ACAD SCI USA, V85, P5610, DOI 10.1073/pnas.85.15.5610; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; FELDMANN KA, 1989, SCIENCE, V243, P1351, DOI 10.1126/science.243.4896.1351; FELDMANN KA, 1986, PLANT SCI, V47, P63, DOI 10.1016/0168-9452(86)90011-7; FELDMANN KA, 1987, MOL GEN GENET, V208, P1, DOI 10.1007/BF00330414; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; HENIKOFF S, 1984, GENE, V28, P351, DOI 10.1016/0378-1119(84)90153-7; HERMAN PL, 1989, PLANT CELL, V1, P1051, DOI 10.1105/tpc.1.11.1051; HOEKEMA A, 1983, NATURE, V303, P179, DOI 10.1038/303179a0; JACKSON D, 1991, PLANT CELL, V3, P115, DOI 10.1105/tpc.3.2.115; JEFFERSON RA, 1987, EMBO J, V6, P3901; KATZEN AL, 1985, CELL, V41, P449, DOI 10.1016/S0092-8674(85)80018-0; KOORNNEEF M, 1982, MUTAT RES, V93, P109, DOI 10.1016/0027-5107(82)90129-4; Koornneef M., 1981, ARABID INF SERV, V18, P45; LEECHEN S, 1967, CAN J GENET CYTOL, V9, P381, DOI 10.1139/g67-039; Lipsick J S, 1986, Gene Amplif Anal, V4, P73; LUSCHER B, 1990, GENE DEV, V4, P2235, DOI 10.1101/gad.4.12b.2235; MAJELLO B, 1986, P NATL ACAD SCI USA, V83, P9636, DOI 10.1073/pnas.83.24.9636; Maniatis T., 1982, MOL CLONING; MARKS MD, 1989, PLANT CELL, V1, P1043, DOI 10.1105/tpc.1.11.1043; MARKS MD, 1991, IN PRESS MOL BIOL PL; MAROCCO A, 1989, MOL GEN GENET, V216, P183, DOI 10.1007/BF00334354; MOELLING K, 1985, CELL, V40, P983, DOI 10.1016/0092-8674(85)90358-7; MUCENSKI ML, 1991, CELL, V65, P677, DOI 10.1016/0092-8674(91)90099-K; NAGEL R, 1990, FEMS MICROBIOL LETT, V67, P325, DOI [10.1016/0378-1097(90)90017-K, 10.1111/j.1574-6968.1990.tb04041.x]; NOMURA N, 1988, NUCLEIC ACIDS RES, V16, P11075, DOI 10.1093/nar/16.23.11075; ODELL JT, 1985, NATURE, V313, P810, DOI 10.1038/313810a0; PAZARES J, 1987, EMBO J, V6, P3553, DOI 10.1002/j.1460-2075.1987.tb02684.x; SAKURA H, 1989, P NATL ACAD SCI USA, V86, P5758, DOI 10.1073/pnas.86.15.5758; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SIEGEL BA, 1989, SCIENCE, V244, P580, DOI 10.1126/science.244.4904.580; SINHA N, 1990, DEV BIOL, V141, P203, DOI 10.1016/0012-1606(90)90115-Y; Steeves T.A., 1989, PATTERNS PLANT DEV, DOI 10.1017/CBO9780511626227; VALVEKENS D, 1988, P NATL ACAD SCI USA, V85, P5536, DOI 10.1073/pnas.85.15.5536; VOLLBRECHT E, 1991, NATURE, V350, P241, DOI 10.1038/350241a0	39	523	570	6	99	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	NOV 1	1991	67	3					483	493		10.1016/0092-8674(91)90523-2	http://dx.doi.org/10.1016/0092-8674(91)90523-2			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GN664	1934056				2022-12-28	WOS:A1991GN66400005
J	PELHAM, HRB				PELHAM, HRB			MULTIPLE TARGETS FOR BREFELDIN-A	CELL			English	Review							VESICULAR TRANSPORT; PROTEINS				PELHAM, HRB (corresponding author), MRC, MOLEC BIOL LAB, CAMBRIDGE CB2 2QH, ENGLAND.							DONALDSON JG, 1990, J CELL BIOL, V111, P2295, DOI 10.1083/jcb.111.6.2295; DUDEN R, 1991, CELL, V64, P649, DOI 10.1016/0092-8674(91)90248-W; GODA Y, 1989, FASEB J, V3, P2488, DOI 10.1096/fasebj.3.13.2680705; Goldstein L S, 1991, Trends Cell Biol, V1, P93, DOI 10.1016/0962-8924(91)90036-9; HUNZIKER W, 1991, J CELL BIOL, V114, P881; LIPPINCOTTSCHWARTZ J, 1990, CELL, V60, P821, DOI 10.1016/0092-8674(90)90096-W; LIPPINCOTTSCHWARTZ J, 1991, CELL, V67, P601, DOI 10.1016/0092-8674(91)90534-6; ORCI L, 1989, CELL, V56, P357, DOI 10.1016/0092-8674(89)90239-0; ORCI L, 1991, CELL, V64, P1183; PEARSE BMF, 1990, ANNU REV CELL BIOL, V6, P151, DOI 10.1146/annurev.cb.06.110190.001055; SERAFINI T, 1991, NATURE, V349, P214, DOI 10.1038/349215a0; VALLEE RB, 1990, ANNU REV BIOCHEM, V59, P909, DOI 10.1146/annurev.biochem.59.1.909; WOOD SA, 1991, CELL, V67, P591, DOI 10.1016/0092-8674(91)90533-5	13	352	357	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 1	1991	67	3					449	451		10.1016/0092-8674(91)90517-3	http://dx.doi.org/10.1016/0092-8674(91)90517-3			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GN664	1934055				2022-12-28	WOS:A1991GN66400001
J	METCALF, D				METCALF, D			CONTROL OF GRANULOCYTES AND MACROPHAGES - MOLECULAR, CELLULAR, AND CLINICAL ASPECTS	SCIENCE			English	Article							COLONY-STIMULATING FACTOR; GM-CSF; PHASE-I/II; MULTI-CSF; GROWTH-FACTORS; CELLS; RECEPTORS; MICE; HEMATOPOIESIS; DIFFERENTIATION	The production and functional activity of two important white blood cells, the granulocytes and macrophages, are regulated mainly by a group of glycoprotein colony-stimulating factors. The colony-stimulating factors have been mass-produced with recombinant technology and are now proving of value in preventing or suppressing infections in a variety of individuals with subnormal or defective formation of blood cells.			METCALF, D (corresponding author), ROYAL MELBOURNE HOSP, WALTER & ELIZA HALL INST MED RES, PARKVILLE, VIC 3050, AUSTRALIA.							ANTIN JH, 1988, BLOOD, V72, P705; BAZAN JF, 1990, P NATL ACAD SCI USA, V87, P6934, DOI 10.1073/pnas.87.18.6934; BODEY GP, 1966, ANN INTERN MED, V64, P328, DOI 10.7326/0003-4819-64-2-328; BONILLA MA, 1989, NEW ENGL J MED, V320, P1574, DOI 10.1056/NEJM198906153202402; BRADLEY TR, 1966, AUST J EXP BIOL MED, V44, P287, DOI 10.1038/icb.1966.28; BRONCHUD MH, 1987, BRIT J CANCER, V56, P809, DOI 10.1038/bjc.1987.295; CLARK SC, 1987, SCIENCE, V236, P1229, DOI 10.1126/science.3296190; CYNSHI O, 1991, LEUKEMIA, V5, P75; DINARELLO CA, 1991, BLOOD, V77, P1627; DUHRSEN U, 1988, BLOOD, V72, P2074; GABRILOVE JL, 1988, J CLIN INVEST, V82, P1454, DOI 10.1172/JCI113751; GASSON JC, 1991, BLOOD, V77, P1131, DOI 10.1182/blood.V77.6.1131.1131; GLINIAK BC, 1990, CELL, V63, P1073, DOI 10.1016/0092-8674(90)90510-L; GOUGH NM, 1990, COLONY STIMULATING F, P111; GROOPMAN JE, 1987, NEW ENGL J MED, V317, P593, DOI 10.1056/NEJM198709033171003; HAMMOND WP, 1989, NEW ENGL J MED, V320, P1306, DOI 10.1056/NEJM198905183202003; HAMMOND WP, 1991, J CLIN INVEST, V87, P704, DOI 10.1172/JCI115049; HAYASHIDA K, 1990, P NATL ACAD SCI USA, V87, P9655, DOI 10.1073/pnas.87.24.9655; Heyworth CM, 1990, GROWTH FACTORS, V2, P197, DOI 10.3109/08977199009071506; HORIGUCHI J, 1987, BLOOD, V69, P1259; ICHIKAWA Y, 1966, P NATL ACAD SCI USA, V56, P488, DOI 10.1073/pnas.56.2.488; Kelso A, 1990, Adv Immunol, V48, P69, DOI 10.1016/S0065-2776(08)60752-X; LANG RA, 1987, CELL, V51, P675, DOI 10.1016/0092-8674(87)90136-X; LIESCHKE GJ, 1989, ANN INTERN MED, V110, P357, DOI 10.7326/0003-4819-110-5-357; MATSUMOTO M, 1987, INFECT IMMUN, V55, P2715, DOI 10.1128/IAI.55.11.2715-2720.1987; METCALF D, 1991, P NATL ACAD SCI USA, V88, P6239, DOI 10.1073/pnas.88.14.6239; METCALF D, 1986, BLOOD, V68, P46; METCALF D, 1987, EXP HEMATOL, V15, P1; METCALF D, 1990, P NATL ACAD SCI USA, V87, P4670, DOI 10.1073/pnas.87.12.4670; METCALF D, 1985, LEUKEMIA RES, V9, P35, DOI 10.1016/0145-2126(85)90020-7; METCALF D, 1989, LEUKEMIA, V3, P349; Metcalf D, 1988, MOL CONTROL BLOOD CE; METCALF D, 1984, HEMOPOIETIC COLONIES; MOLINEUX G, 1990, BLOOD, V75, P563; NEMUNAITIS J, 1988, BLOOD, V72, P834; NICOLA NA, 1991, BRIT J HAEMATOL, V77, P133, DOI 10.1111/j.1365-2141.1991.tb07967.x; NICOLA NA, 1989, ANNU REV BIOCHEM, V58, P45; NICOLA NA, 1990, COLONY STIMULATING F, P77; PARK LS, 1989, J BIOL CHEM, V264, P5420; RENNICK D, 1987, BLOOD, V69, P682; ROHRSCHNEIDER LR, 1989, MOL CELL BIOL, V9, P5081, DOI 10.1128/MCB.9.11.5081; SHERIDAN WP, 1989, LANCET, V2, P891; SHERR CJ, 1990, BLOOD, V75, P1; STEIN J, 1990, BLOOD, V76, P1308, DOI 10.1182/blood.V76.7.1308.bloodjournal7671308; TALMADGE JE, 1989, BLOOD, V73, P2093; TESHIMA H, 1989, EXP HEMATOL, V17, P853; TESHIMA T, 1990, EXP HEMATOL, V18, P316; WALKER F, 1985, CELL, V43, P269, DOI 10.1016/0092-8674(85)90032-7; WHETTON AD, 1989, BIOCHIM BIOPHYS ACTA, V989, P111, DOI 10.1016/0304-419X(89)90038-3; WIKTORJEDRZEJCZAK W, 1990, P NATL ACAD SCI USA, V87, P4828, DOI 10.1073/pnas.87.12.4828; ZSEBO KM, 1990, CELL, V63, P195, DOI 10.1016/0092-8674(90)90300-4; ZSEBO KM, 1988, BLOOD, V71, P99	52	380	391	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 25	1991	254	5031					529	533		10.1126/science.1948028	http://dx.doi.org/10.1126/science.1948028			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL799	1948028				2022-12-28	WOS:A1991GL79900038
J	CHAVRIER, P; GORVEL, JP; STELZER, E; SIMONS, K; GRUENBERG, J; ZERIAL, M				CHAVRIER, P; GORVEL, JP; STELZER, E; SIMONS, K; GRUENBERG, J; ZERIAL, M			HYPERVARIABLE C-TERMINAL DOMAIN OF RAB PROTEINS ACTS AS A TARGETING SIGNAL	NATURE			English	Article							GTP-BINDING-PROTEINS; MOLECULAR-CLONING; CELL-LINE; SECRETION; TRANSFERRIN; FAMILY; CDNAS; BRAIN; GENES; VIRUS	MAMMALIAN cells express many ras-like low molecular mass GTP-binding proteins (rab proteins) 1-6 that are highly homologous to the Ypt1 and Sec4 proteins involved in controlling secretion in yeast 7-9. Owing to their structural similarity and to their variety, rab proteins have been postulated to act as specific regulators of membrane traffic in exocytosis and endocytosis 10, and rab5 has been shown to be involved in early endosome fusion in vitro 11. In agreement with their postulated functions, all rab proteins studied so far have been found in distinct subcompartments along the exocytic or endocytic pathways 5,11-13. To define the region mediating their specific localization, we transiently expressed rab2, rab5 and rab7 hybrid proteins in BHK cells, and determined their intracellular localization by immunofluorescence confocal microscopy and subcellular fractionation. Here we present evidence that the highly variable C-terminal domain contains structural elements necessary for the association of rab proteins with their specific target membranes in the endocytic pathway.	EUROPEAN MOLEC BIOL LAB, POSTFACH 102209, W-6900 HEIDELBERG, GERMANY	European Molecular Biology Laboratory (EMBL)			CHAVRIER, Philippe/AAG-2645-2020; Stelzer, Ernst H K/A-7648-2011; CHAVRIER, Philippe/B-4707-2010; Gorvel, Jean-Pierre/O-1332-2018	CHAVRIER, Philippe/0000-0002-7351-733X; Stelzer, Ernst H K/0000-0003-1545-0736; CHAVRIER, Philippe/0000-0002-7351-733X; Gorvel, Jean-Pierre/0000-0002-2829-9804; Simons, Kai/0000-0002-9231-9996				BOURNE HR, 1990, NATURE, V348, P125, DOI 10.1038/348125a0; BUCCI C, 1988, NUCLEIC ACIDS RES, V16, P9979, DOI 10.1093/nar/16.21.9979; CHAVRIER P, 1990, CELL, V62, P317, DOI 10.1016/0092-8674(90)90369-P; CHAVRIER P, 1990, MOL CELL BIOL, V10, P6578, DOI 10.1128/MCB.10.12.6578; DESCHENES RJ, 1987, MOL CELL BIOL, V7, P2344, DOI 10.1128/MCB.7.7.2344; FUERST TR, 1986, P NATL ACAD SCI USA, V83, P8122, DOI 10.1073/pnas.83.21.8122; GALLWITZ D, 1983, NATURE, V306, P704, DOI 10.1038/306704a0; GOUD B, 1990, NATURE, V345, P553, DOI 10.1038/345553a0; GROVEL JP, 1991, CELL, V64, P915; GUTIERREZ L, 1989, EMBO J, V8, P1093, DOI 10.1002/j.1460-2075.1989.tb03478.x; HANCOCK JF, 1990, CELL, V63, P133, DOI 10.1016/0092-8674(90)90294-O; HANCOCK JF, 1989, CELL, V57, P1167, DOI 10.1016/0092-8674(89)90054-8; HOPKINS CR, 1983, CELL, V35, P321, DOI 10.1016/0092-8674(83)90235-0; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; MATSUI Y, 1988, J BIOL CHEM, V263, P11071; MOLENAAR CMT, 1988, EMBO J, V7, P971, DOI 10.1002/j.1460-2075.1988.tb02903.x; SALMINEN A, 1987, CELL, V49, P527, DOI 10.1016/0092-8674(87)90455-7; SCHMID SL, 1988, CELL, V52, P73, DOI 10.1016/0092-8674(88)90532-6; SEGEV N, 1988, CELL, V52, P915, DOI 10.1016/0092-8674(88)90433-3; TOUCHOT N, 1987, P NATL ACAD SCI USA, V84, P8210, DOI 10.1073/pnas.84.23.8210; VONMOLLARD GF, 1990, P NATL ACAD SCI USA, V87, P1988, DOI 10.1073/pnas.87.5.1988; WALWORTH NC, 1989, EMBO J, V8, P1685, DOI 10.1002/j.1460-2075.1989.tb03560.x; WILLUMSEN BM, 1984, EMBO J, V3, P2581, DOI 10.1002/j.1460-2075.1984.tb02177.x; ZAHRAOUI A, 1989, J BIOL CHEM, V264, P12394; ZERIAL M, 1986, EMBO J, V5, P1543, DOI 10.1002/j.1460-2075.1986.tb04395.x	25	340	347	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 24	1991	353	6346					769	772		10.1038/353769a0	http://dx.doi.org/10.1038/353769a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL696	1944536	Bronze			2022-12-28	WOS:A1991GL69600073
J	HARRISON, SC				HARRISON, SC			A STRUCTURAL TAXONOMY OF DNA-BINDING DOMAINS	NATURE			English	Review							TRANSCRIPTION FACTOR-IIIA; MAGNETIC-RESONANCE SPECTROSCOPY; LEUCINE ZIPPER; ESCHERICHIA-COLI; GLUCOCORTICOID RECEPTOR; CRYSTAL-STRUCTURE; AMINO-ACIDS; RESOLUTION STRUCTURE; ACTIVATOR PROTEIN; ESTROGEN-RECEPTOR		HARVARD UNIV, DEPT BIOCHEM & MOLEC BIOL, CAMBRIDGE, MA 02138 USA	Harvard University	HARRISON, SC (corresponding author), HARVARD UNIV, HOWARD HUGHES MED INST, 7 DIVIN AVE, CAMBRIDGE, MA 02138 USA.							AGGARWAL AK, 1988, SCIENCE, V242, P899, DOI 10.1126/science.3187531; ANDERSON WF, 1981, NATURE, V290, P754, DOI 10.1038/290754a0; ARTHUR AK, 1988, J VIROL, V62, P1999, DOI 10.1128/JVI.62.6.1999-2006.1988; BERG JM, 1988, P NATL ACAD SCI USA, V85, P99, DOI 10.1073/pnas.85.1.99; BRAM RJ, 1985, P NATL ACAD SCI USA, V82, P43, DOI 10.1073/pnas.82.1.43; BREG JN, 1990, NATURE, V346, P586, DOI 10.1038/346586a0; BRENNAN RG, 1990, P NATL ACAD SCI USA, V87, P8165, DOI 10.1073/pnas.87.20.8165; BROWN RS, 1985, FEBS LETT, V186, P271, DOI 10.1016/0014-5793(85)80723-7; CAREY M, 1989, J MOL BIOL, V209, P423, DOI 10.1016/0022-2836(89)90007-7; DANIELSEN M, 1989, CELL, V57, P1131, DOI 10.1016/0092-8674(89)90050-0; FRANKEL AD, 1988, SCIENCE, V240, P70, DOI 10.1126/science.2832944; FREEDMAN LP, 1988, NATURE, V334, P543, DOI 10.1038/334543a0; GARTENBERG MR, 1990, P NATL ACAD SCI USA, V87, P6034, DOI 10.1073/pnas.87.16.6034; GINIGER E, 1985, CELL, V40, P767, DOI 10.1016/0092-8674(85)90336-8; HAHN S, 1989, CELL, V58, P1173, DOI 10.1016/0092-8674(89)90515-1; HAI T, 1988, GENE DEV, V2, P1216, DOI 10.1101/gad.2.10.1216; HANES SD, 1989, CELL, V57, P1275, DOI 10.1016/0092-8674(89)90063-9; HARD T, 1990, SCIENCE, V249, P157, DOI 10.1126/science.2115209; HARRISON SC, 1990, ANNU REV BIOCHEM, V59, P933, DOI 10.1146/annurev.bi.59.070190.004441; HILL DE, 1986, SCIENCE, V234, P451, DOI 10.1126/science.3532321; JACOBS G, 1990, New Biologist, V2, P583; JOHNSTON M, 1987, MICROBIOL REV, V51, P458, DOI 10.1128/MMBR.51.4.458-476.1987; JORDAN SR, 1988, SCIENCE, V242, P893, DOI 10.1126/science.3187530; KAPTEIN R, 1985, J MOL BIOL, V182, P179, DOI 10.1016/0022-2836(85)90036-1; KELEHER CA, 1988, CELL, V53, P927, DOI 10.1016/S0092-8674(88)90449-7; Kerppola TK, 1991, CURR OPIN STRUC BIOL, V1, P71, DOI 10.1016/0959-440X(91)90014-K; KIERAN M, 1990, CELL, V62, P1007, DOI 10.1016/0092-8674(90)90275-J; KISSINGER CR, 1990, CELL, V63, P579, DOI 10.1016/0092-8674(90)90453-L; KLEVIT RE, 1990, PROTEINS, V7, P215, DOI 10.1002/prot.340070303; KOSTREWA D, 1991, NATURE, V349, P178, DOI 10.1038/349178a0; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; LEE MS, 1989, SCIENCE, V245, P635, DOI 10.1126/science.2503871; LEE W, 1987, NATURE, V325, P368, DOI 10.1038/325368a0; LUISI BF, 1991, NATURE, V352, P497, DOI 10.1038/352497a0; MADER S, 1989, NATURE, V338, P271, DOI 10.1038/338271a0; MCBRIDE AA, 1988, EMBO J, V7, P533, DOI 10.1002/j.1460-2075.1988.tb02842.x; MILLER J, 1985, EMBO J, V4, P1609, DOI 10.1002/j.1460-2075.1985.tb03825.x; MONDRAGON A, 1989, J MOL BIOL, V205, P179, DOI 10.1016/0022-2836(89)90374-4; MONDRAGON A, 1989, J MOL BIOL, V205, P189, DOI 10.1016/0022-2836(89)90375-6; MONDRAGON A, 1991, J MOL BIOL, V219, P321, DOI 10.1016/0022-2836(91)90568-Q; MURRE C, 1989, CELL, V56, P777, DOI 10.1016/0092-8674(89)90682-X; NARDELLI J, 1991, NATURE, V349, P175, DOI 10.1038/349175a0; NYE JA, 1990, P NATL ACAD SCI USA, V87, P3992, DOI 10.1073/pnas.87.10.3992; OAKLEY MG, 1990, SCIENCE, V248, P847, DOI 10.1126/science.2111578; OAS TG, 1990, BIOCHEMISTRY-US, V29, P2891, DOI 10.1021/bi00464a001; ONEIL KT, 1990, SCIENCE, V249, P774, DOI 10.1126/science.2389143; ORKIN SH, 1990, CELL, V63, P665, DOI 10.1016/0092-8674(90)90133-Y; OSHEA EK, 1989, SCIENCE, V243, P538, DOI 10.1126/science.2911757; OSHEA EK, 1989, SCIENCE, V245, P646, DOI 10.1126/science.2503872; OTTING G, 1990, EMBO J, V9, P3085, DOI 10.1002/j.1460-2075.1990.tb07505.x; OTWINOWSKI Z, 1988, NATURE, V335, P321, DOI 10.1038/335321a0; PABO CO, 1990, SCIENCE, V247, P1210, DOI 10.1126/science.2315694; PABO CO, 1982, NATURE, V298, P443, DOI 10.1038/298443a0; PABO CO, 1984, ANNU REV BIOCHEM, V53, P293, DOI 10.1146/annurev.bi.53.070184.001453; PATEL L, 1990, NATURE, V347, P572, DOI 10.1038/347572a0; PAVLETICH NP, 1991, SCIENCE, V252, P809, DOI 10.1126/science.2028256; PELHAM HRB, 1980, P NATL ACAD SCI-BIOL, V77, P4170, DOI 10.1073/pnas.77.7.4170; PHILLIPS SEV, 1989, NATURE, V341, P711, DOI 10.1038/341711a0; Phillips SEV, 1991, CURR OPIN STRUC BIOL, V1, P89, DOI 10.1016/0959-440X(91)90016-M; QIAN YQ, 1989, CELL, V59, P573, DOI 10.1016/0092-8674(89)90040-8; RAFFERTY JB, 1989, NATURE, V341, P705, DOI 10.1038/341705a0; SCHEVITZ RW, 1985, NATURE, V317, P782, DOI 10.1038/317782a0; SCHULTZ SC, 1991, SCIENCE, V253, P1001, DOI 10.1126/science.1653449; SCHWABE JWR, 1990, NATURE, V348, P458, DOI 10.1038/348458a0; SHUMAN JD, 1990, SCIENCE, V249, P771, DOI 10.1126/science.2202050; SORGER PK, 1989, CELL, V59, P807, DOI 10.1016/0092-8674(89)90604-1; SUMMERS MF, 1990, BIOCHEMISTRY-US, V29, P329, DOI 10.1021/bi00454a005; TALANIAN RV, 1990, SCIENCE, V249, P769, DOI 10.1126/science.2389142; TANAKA I, 1984, NATURE, V310, P376, DOI 10.1038/310376a0; TAO P, 1990, P NATL ACAD SCI USA, V87, P2077, DOI 10.1073/pnas.87.6.2077; UMESONO K, 1989, CELL, V57, P1139, DOI 10.1016/0092-8674(89)90051-2; VINSON CR, 1989, SCIENCE, V246, P911, DOI 10.1126/science.2683088; WEBER IT, 1987, J MOL BIOL, V198, P311, DOI 10.1016/0022-2836(87)90315-9; WEISS MA, 1990, NATURE, V347, P575, DOI 10.1038/347575a0; WEISS MA, 1990, BIOCHEMISTRY-US, V29, P8020, DOI 10.1021/bi00487a004; WHARTON RP, 1984, CELL, V38, P361, DOI 10.1016/0092-8674(84)90491-4; WHITE SW, 1989, PROTEINS, V5, P281, DOI 10.1002/prot.340050405; YANG CC, 1989, CELL, V57, P869, DOI 10.1016/0092-8674(89)90801-5; YOU QM, 1990, NUCLEIC ACIDS RES, V18, P5055, DOI 10.1093/nar/18.17.5055	79	554	594	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 24	1991	353	6346					715	719		10.1038/353715a0	http://dx.doi.org/10.1038/353715a0			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL696	1944532				2022-12-28	WOS:A1991GL69600055
J	HAPPLE, R; KOOPMAN, R; MIER, PD				HAPPLE, R; KOOPMAN, R; MIER, PD			HYPOTHESIS - VASCULAR TWIN NEVI AND SOMATIC RECOMBINATION IN MAN	LANCET			English	Article											HAPPLE, R (corresponding author), CATHOLIC UNIV NIJMEGEN,DEPT DERMATOL,POB 9101,6500 HB NIJMEGEN,NETHERLANDS.							GERMAN J, 1973, J INVEST DERMATOL, V60, P427; GERMAN J, 1964, SCIENCE, V144, P298, DOI 10.1126/science.144.3616.298; GRAF U, 1984, ENVIRON MUTAGEN, V6, P153, DOI 10.1002/em.2860060206; HAMM H, 1986, HAUTARZT, V37, P388; HARRISON BJ, 1977, HEREDITY, V38, P169, DOI 10.1038/hdy.1977.22; KAFER E, 1988, MUTAT RES, V201, P385, DOI 10.1016/0027-5107(88)90026-7; Metz CW, 1916, J EXP ZOOL, V21, P213, DOI 10.1002/jez.1400210204; PATTERSON JT, 1929, P NATL ACAD SCI USA, V16, P109; RAFF M, 1981, WIEN KLIN WOCHENSCHR, V93, P3; SHAW MW, 1965, GENETICS, V51, P181; Stern C, 1936, GENETICS, V21, P625; VIG BK, 1982, MUTAT RES, V99, P339, DOI 10.1016/0165-1110(82)90050-1; VOGEL F, 1974, HUMANGENETIK, V25, P265, DOI 10.1007/BF00336904	13	44	44	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	FEB 17	1990	335	8686					376	378		10.1016/0140-6736(90)90209-N	http://dx.doi.org/10.1016/0140-6736(90)90209-N			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN988	1968118				2022-12-28	WOS:A1990CN98800005
J	OWEN, S; MORGANSTERN, M; HEPWORTH, J; WOODCOCK, A				OWEN, S; MORGANSTERN, M; HEPWORTH, J; WOODCOCK, A			CONTROL OF HOUSE DUST MITE ANTIGEN IN BEDDING	LANCET			English	Article									WYTHENSHAWE HOSP,REG DEPT RESP PHYSIOL,MANCHESTER M23 9LT,LANCS,ENGLAND	Wythenshawe Hospital NHS Foundation Trust; Wythenshawe Hospital				Woodcock, Ashley/0000-0002-5428-8578				[Anonymous], 1989, J ALLERGY CLIN IMMUN, V83, P416; BURR ML, 1976, LANCET, V1, P333; DORWARD AJ, 1988, THORAX, V43, P98, DOI 10.1136/thx.43.2.98; KERREBIJN KF, 1970, BRONCHITIS, V3, P38; KORSGAARD J, 1983, AM REV RESPIR DIS, V128, P231; MITCHELL EB, 1985, CLIN ALLERGY, V15, P235, DOI 10.1111/j.1365-2222.1985.tb02280.x; PLATTSMILLS TAE, 1987, J ALLERGY CLIN IMMUN, V80, P755, DOI 10.1016/S0091-6749(87)80261-0; PLATTSMILLS TAE, 1982, LANCET, V2, P675; TOVEY ER, 1981, NATURE, V289, P592, DOI 10.1038/289592a0; WALSHAW MJ, 1986, Q J MED, V58, P199	10	123	127	0	1	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	FEB 17	1990	335	8686					396	397		10.1016/0140-6736(90)90219-U	http://dx.doi.org/10.1016/0140-6736(90)90219-U			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN988	1968126				2022-12-28	WOS:A1990CN98800014
J	STRADLING, JR; THOMAS, G; WARLEY, ARH; WILLIAMS, P; FREELAND, A				STRADLING, JR; THOMAS, G; WARLEY, ARH; WILLIAMS, P; FREELAND, A			EFFECT OF ADENOTONSILLECTOMY ON NOCTURNAL HYPOXEMIA, SLEEP DISTURBANCE, AND SYMPTOMS IN SNORING CHILDREN	LANCET			English	Article									RADCLIFFE INFIRM,DEPT OTOLARYNGOL,OXFORD OX2 6HE,ENGLAND	Radcliffe Infirmary	STRADLING, JR (corresponding author), CHURCHILL HOSP,OSLER CHEST UNIT,OXFORD OX3 7LJ,ENGLAND.				Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		AHLQVISTRASTAD J, 1988, ACTA PAEDIATR SCAND, V77, P831, DOI 10.1111/j.1651-2227.1988.tb10764.x; ASHER T, 1988, PEDIATR PULM, V4, P139; BRODSKY L, 1987, INT J PEDIATR OTORHI, V13, P149, DOI 10.1016/0165-5876(87)90091-7; BROUILLETTE RT, 1982, J PEDIATR-US, V100, P31, DOI 10.1016/S0022-3476(82)80231-X; DAVIES SC, 1989, LANCET, V2, P283; DRAKELEE AB, 1983, PRACTITIONER, V227, P929; FINKELSTEIN JW, 1972, J CLIN ENDOCR METAB, V35, P665, DOI 10.1210/jcem-35-5-665; FRANK Y, 1983, PEDIATRICS, V71, P737; GUILHAUME A, 1982, PEDIATR RES, V16, P299, DOI 10.1203/00006450-198204000-00011; GUILLEMINAULT C, 1987, PEDIATR PULM, V3, P429, DOI 10.1002/ppul.1950030610; GUILLEMINAULT C, 1981, LUNG, V159, P275, DOI 10.1007/BF02713925; HENDLEY JO, 1984, NEW ENGL J MED, V310, P717, DOI 10.1056/NEJM198403153101110; HULTCRANTZ E, 1988, CLIN PEDIATR, V27, P350, DOI 10.1177/000992288802700709; LAURIKAINEN E, 1987, INT J PEDIATR OTORHI, V12, P303, DOI 10.1016/S0165-5876(87)80006-X; MADDERN BR, 1989, ANN OTO RHINOL LARYN, V98, P174, DOI 10.1177/000348948909800302; MAUER KW, 1983, MAYO CLIN PROC, V58, P349; PILCHER JJ, 1987, HUM NEUROBIOL, V6, P45; POTSIC WP, 1986, OTOLARYNG HEAD NECK, V94, P476, DOI 10.1177/019459988609400412; POTSIC WP, 1988, INT ANESTHESIOL CLIN, V26, P58, DOI 10.1097/00004311-198802610-00012; POTSIC WP, 1987, LARYNGOSCOPE, V97, P1430; SHER AE, 1986, INT J PEDIATR OTORHI, V11, P135, DOI 10.1016/S0165-5876(86)80008-8; Stradling JR., 1988, J AMBUL MONIT, V1, P217; SWIFT AC, 1988, J LARYNGOL OTOL, V102, P419, DOI 10.1017/S0022215100105249; VANSOMEREN VH, 1989, BRIT MED J, V298, P1076, DOI 10.1136/bmj.298.6680.1076; WARLEY ARH, 1987, THORAX, V42, P892, DOI 10.1136/thx.42.11.892; WILKINSON AR, 1981, BRIT MED J, V282, P1579, DOI 10.1136/bmj.282.6276.1579	26	300	307	0	8	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	FEB 3	1990	335	8684					249	253		10.1016/0140-6736(90)90068-G	http://dx.doi.org/10.1016/0140-6736(90)90068-G			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CL815	1967719				2022-12-28	WOS:A1990CL81500003
J	[Anonymous]				[Anonymous]			THE LOMAX AFFAIR	LANCET			English	Editorial Material																		[Anonymous], 1933, LANCET, Vi, P668; HARDING TW, 1990, BRIT J PSYCHIAT, V156, P180, DOI 10.1192/bjp.156.2.180; Lomax M., 1921, EXPERIENCES ASYLUM D; 1989, LANCET, V2, P1492	4	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 3	1990	335	8684					264	265						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CL815	1967725				2022-12-28	WOS:A1990CL81500009
J	WEGNER, CD; GUNDEL, RH; REILLY, P; HAYNES, N; LETTS, LG; ROTHLEIN, R				WEGNER, CD; GUNDEL, RH; REILLY, P; HAYNES, N; LETTS, LG; ROTHLEIN, R			INTERCELLULAR-ADHESION MOLECULE-1 (ICAM-1) IN THE PATHOGENESIS OF ASTHMA	SCIENCE			English	Article									BOEHRINGER INGELHEIM PHARMACEUT INC,DEPT IMMUNOL,RIDGEFIELD,CT 06877	Boehringer Ingelheim	WEGNER, CD (corresponding author), BOEHRINGER INGELHEIM PHARMACEUT INC,DEPT PHARMACOL,RIDGEFIELD,CT 06877, USA.							ANDERSON DC, 1985, J INFECT DIS, V152, P668, DOI 10.1093/infdis/152.4.668; ANDERSON DC, 1987, ANNU REV MED, V38, P175, DOI 10.1146/annurev.med.38.1.175; BARTON RW, 1989, J IMMUNOL, V143, P1278; BOULET LP, 1983, J ALLERGY CLIN IMMUN, V71, P399, DOI 10.1016/0091-6749(83)90069-6; BOUSHEY HA, 1980, AM REV RESPIR DIS, V121, P389; CHANYEUNG M, 1982, AM J MED, V72, P411, DOI 10.1016/0002-9343(82)90497-1; DEMONCHY JGR, 1985, AM REV RESPIR DIS, V131, P373; DURHAM SR, 1985, CLIN ALLERGY, V15, P411, DOI 10.1111/j.1365-2222.1985.tb02290.x; DUSTIN ML, 1988, J EXP MED, V167, P1323, DOI 10.1084/jem.167.4.1323; DUSTIN ML, 1986, J IMMUNOL, V137, P245; EMPEY DW, 1976, AM REV RESPIR DIS, V113, P131; FRIGAS E, 1986, J ALLERGY CLIN IMMUN, V77, P527, DOI 10.1016/0091-6749(86)90341-6; GUENTER CA, 1981, AM REV RESPIR DIS, V123, P79; GUNDEL RH, 1989, AM REV RESPIR DIS, V140, P629, DOI 10.1164/ajrccm/140.3.629; HARGREAVE FE, 1981, J ALLERGY CLIN IMMUN, V68, P347, DOI 10.1016/0091-6749(81)90132-9; HUNNINGHAKE GW, 1981, AM REV RESPIR DIS, V123, P407; HUNNINGHAKE GW, 1979, AM J PATHOL, V97, P149; JUNIPER EF, 1981, THORAX, V36, P575, DOI 10.1136/thx.36.8.575; KOHL S, 1984, J IMMUNOL, V133, P2972; LAITINEN LA, 1985, AM REV RESPIR DIS, V131, P599, DOI 10.1164/arrd.1985.131.4.599; LAM S, 1979, J ALLERGY CLIN IMMUN, V63, P28, DOI 10.1016/0091-6749(79)90158-1; LAM S, 1983, J ALLERGY CLIN IMMUN, V72, P134, DOI 10.1016/0091-6749(83)90520-1; LEIFERMAN KM, 1985, NEW ENGL J MED, V313, P282, DOI 10.1056/NEJM198508013130502; MARLIN SD, 1987, CELL, V51, P813, DOI 10.1016/0092-8674(87)90104-8; MARTZ E, 1985, MECHANISMS CELL MEDI, V2, P1; MULLARKEY MF, 1980, J ALLERGY CLIN IMMUN, V65, P122, DOI 10.1016/0091-6749(80)90196-7; MYGIND N, 1979, ALLERGY, V34, P195, DOI 10.1111/j.1398-9995.1979.tb01699.x; PETERS MS, 1983, J INVEST DERMATOL, V81, P39, DOI 10.1111/1523-1747.ep12538380; RIDING GA, 1981, J IMMUNOL METHODS, V46, P113, DOI 10.1016/0022-1759(81)90338-0; ROSSI GA, 1984, AM REV RESPIR DIS, V129, P850, DOI 10.1164/arrd.1984.129.5.850; ROTHLEIN R, 1986, J IMMUNOL, V137, P1270; ROTHLEIN R, 1988, J IMMUNOL, V141, P1665; RYAN G, 1982, THORAX, V37, P423, DOI 10.1136/thx.37.6.423; SHERTER CB, 1981, CLIN CHEST MED, V2, P67; SMITH CW, 1988, J CLIN INVEST, V82, P1746, DOI 10.1172/JCI113788; SMITH CW, 1989, STRUCTURE FUNCTION M; SOTOMAYOR H, 1984, AM REV RESPIR DIS, V130, P56; SPRY CJF, 1985, INT ARCH ALLER A IMM, V77, P252, DOI 10.1159/000233803; STRATH M, 1985, J IMMUNOL METHODS, V83, P209, DOI 10.1016/0022-1759(85)90242-X; TODD RF, 1988, HEMATOL ONCOL CLIN N, V2, P13; WANTZIN GL, 1989, J AM ACAD DERMATOL, V20, P782; WARDLAW AJ, 1988, AM REV RESPIR DIS, V137, P62, DOI 10.1164/ajrccm/137.1.62; WEGNER C, UNPUB; WEGNER C D, 1989, American Review of Respiratory Disease, V139, pA324	44	879	925	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JAN 26	1990	247	4941					456	459		10.1126/science.1967851	http://dx.doi.org/10.1126/science.1967851			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK705	1967851				2022-12-28	WOS:A1990CK70500039
J	BUSCHARD, K; JORGENSEN, M; AAEN, K; BOCK, T; JOSEFSEN, K				BUSCHARD, K; JORGENSEN, M; AAEN, K; BOCK, T; JOSEFSEN, K			PREVENTION OF DIABETES-MELLITUS IN BB RATS BY NEONATAL STIMULATION OF BETA-CELLS	LANCET			English	Article											BUSCHARD, K (corresponding author), KOMMUNE HOSP COPENHAGEN,BARTHOLIN INST,DK-1399 COPENHAGEN K,DENMARK.			Buschard, Karsten/0000-0002-0126-7423				AAEN K, 1989, DIABETES S2, V38, pA71; APPEL MC, 1989, DIABETOLOGIA, V32, pA461; ASSAN R, 1985, LANCET, V1, P67; ATKINSON MA, 1989, DIABETES S2, V38, pA87; BOTTAZZO GF, 1989, BRIT MED BULL, V45, P37, DOI 10.1093/oxfordjournals.bmb.a072319; BUSCHARD K, 1987, BMJ-BRIT MED J, V294, P275, DOI 10.1136/bmj.294.6567.275; BUSCHARD K, 1985, DAN MED BULL, V32, P139; BUSCHARD K, 1988, APMIS, V96, P342, DOI 10.1111/j.1699-0463.1988.tb05313.x; FREINKEL N, 1984, DIABETES, V33, P1028, DOI 10.2337/diabetes.33.11.1028; GOTFREDSEN CF, 1985, DIABETOLOGIA, V28, P933, DOI 10.1007/BF00703140; GRASSO S, 1973, DIABETES, V22, P349, DOI 10.2337/diab.22.5.349; HEDING LG, 1980, DIABETOLOGIA, V19, P427, DOI 10.1007/BF00281821; HOLE RL, 1988, AM J PHYSIOL, V254, pE167, DOI 10.1152/ajpendo.1988.254.2.E167; KING KC, 1974, DIABETES, V23, P816, DOI 10.2337/diab.23.10.816; LEITER EH, 1987, AM J PATHOL, V128, P380; LIKE AA, 1986, DIABETES, V35, pA74; MORDES JP, 1987, DIABETES METAB REV, V3, P725, DOI 10.1002/dmr.5610030307; OTONKOSKI T, 1988, J CLIN ENDOCR METAB, V67, P734, DOI 10.1210/jcem-67-4-734; OTONKOSKI T, 1988, DIABETES, V37, P286, DOI 10.2337/diabetes.37.3.286; TUCH BE, 1985, DIABETOLOGIA, V28, P28, DOI 10.1007/BF00276996; WARRAM JH, 1988, DIABETES, V37, P1328, DOI 10.2337/diabetes.37.10.1328; WARRAM JH, 1984, NEW ENGL J MED, V311, P149, DOI 10.1056/NEJM198407193110304	22	36	36	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	JAN 20	1990	335	8682					134	135		10.1016/0140-6736(90)90004-O	http://dx.doi.org/10.1016/0140-6736(90)90004-O			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CJ979	1967433				2022-12-28	WOS:A1990CJ97900004
J	BAUD, FJ; BARRIOT, P; TOFFIS, V; RIOU, B; VICAUT, E; LECARPENTIER, Y; BOURDON, R; ASTIER, A; BISMUTH, C				BAUD, FJ; BARRIOT, P; TOFFIS, V; RIOU, B; VICAUT, E; LECARPENTIER, Y; BOURDON, R; ASTIER, A; BISMUTH, C			ELEVATED BLOOD CYANIDE CONCENTRATIONS IN VICTIMS OF SMOKE-INHALATION	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CARBON-MONOXIDE; COMBUSTION PRODUCTS; EXPOSURE DURATION; GLASGOW AREA; FIRE DEATHS; INTOXICATION; CARBOXYHEMOGLOBIN; TOXICITY; PYRUVATE; GLUCOSE	Background. The nature of the toxic gases that cause death from smoke inhalation is not known. In addition to carbon monoxide, hydrogen cyanide may be responsible, but its role is uncertain, because blood cyanide concentrations are often measured only long after exposure. Methods. We measured cyanide concentrations in blood samples obtained at the scene of residential fires from 109 fire victims before they received any treatment. We compared the results with those in 114 persons with drug intoxication (40 subjects), carbon monoxide intoxication (29 subjects), or trauma (45 subjects). The metabolic effect of smoke inhalation was assessed by measuring plasma lactate at the time of admission to the hospital in 39 patients who did not have severe burns. Results. The mean (+/- SD) blood cyanide concentrations in the 66 surviving fire victims (21.6 +/- 36.4-mu-mol per liter, P < 0.001) and the 43 victims who died (116.4 +/- 89.6-mu-mol per liter, P < 0.001) were significantly higher than those in the 114 control subjects (5.0 +/- 5.5-mu-mol per liter). Among the 43 victims who died, the blood cyanide concentrations were above 40-mu-mol per liter in 32 (74 percent), and above 100-mu-mol per liter in 20 of these (46 percent). There was a significant correlation between blood cyanide and carbon monoxide concentrations in the fire victims (P < 0.001). Plasma lactate concentrations at the time of hospital admission correlated more closely with blood cyanide concentrations than with blood carbon monoxide concentrations. Plasma lactate concentrations above 10 mmol per liter were a sensitive indicator of cyanide intoxication, as defined by the presence of a blood cyanide concentration above 40-mu-mol per liter. Conclusions. Residential fires may cause cyanide poisoning. At the time of a patient's hospital admission, an elevated plasma lactate concentration is a useful indicator of cyanide toxicity in fire victims who do not have severe burns.	BRIGADE SAPEURS POMPIERS PARIS,SERV MED,PARIS,FRANCE; UNIV PARIS 07,HOP FERNAND WIDAL,TOXIKOL LAB,F-75475 PARIS 10,FRANCE; HOP HENRI MONDOR,TOXIKOL LAB,F-94010 CRETEIL,FRANCE; ECOLE POLYTECH,LOAENSTA,INSERM,U275,F-91128 PALAISEAU,FRANCE; HOP BICETRE,F-94270 LE KREMLIN BICETR,FRANCE; UNIV PARIS 06,HOP PITIE SALPETRIERE,DEPT ANESTHESIE REANIMAT,PARIS,FRANCE	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut Polytechnique de Paris; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	BAUD, FJ (corresponding author), UNIV PARIS 07,HOP FERNAND WIDAL,DEPT BIOPHYS,200 RUE FAUBOURG ST DENIS,F-75010 PARIS,FRANCE.							ALARIE Y, 1985, ANNU REV PHARMACOL, V25, P325, DOI 10.1146/annurev.pa.25.040185.001545; ANDERSON RA, 1982, MED SCI LAW, V22, P35, DOI 10.1177/002580248202200106; ANDERSON RA, 1981, MED SCI LAW, V21, P175, DOI 10.1177/002580248102100305; ANDERSON RC, 1986, ANAL METHODS HUMAN T, P289; Ballantyne B., 1987, CLIN EXPT TOXICOLOGY, P248; BERTOL E, 1983, FORENSIC SCI INT, V22, P111, DOI 10.1016/0379-0738(83)90002-6; BIRKY MM, 1981, B NEW YORK ACAD MED, V57, P997; BRIGHT JE, 1988, HUM TOXICOL, V7, P183, DOI 10.1177/096032718800700214; CLARK CJ, 1981, LANCET, V1, P1332; ELLENHORN MJ, 1988, MED TOXICOLOGY DIAGN, P888; FABRE R, 1960, PRECIS TOXICOLOGIE, V1, P120; FELDSTEIN M, 1954, J LAB CLIN MED, V44, P166; HALL AH, 1989, J TOXICOL CLIN EXPER, V9, P3; HOLLANDER M, 1973, NONPARAMETRIC STATIS; Karter Jr MJ, 1986, FIRE J, V80, P26; Linnell J. L., 1987, CLIN EXPT TOXICOLOGY, P427; Loke J, 1988, PATHOPHYSIOLOGY TREA, P453; MARBACH EP, 1967, CLIN CHEM, V13, P314; Marrs T., 1987, CLIN EXPT TOXICOLOGY, P217; Marrs T. C, 1987, CLIN EXPT TOXICOLOGY, P383; MIERLEY MC, 1983, JAMA-J AM MED ASSOC, V249, P1466, DOI 10.1001/jama.249.11.1466; MOORE SJ, 1987, J PHARMACOL EXP THER, V242, P70; MOUREU H, 1957, Arch Mal Prof, V18, P116; NORRIS JC, 1986, TOXICOLOGY, V40, P121, DOI 10.1016/0300-483X(86)90073-9; PURSER DA, 1984, ARCH ENVIRON HEALTH, V39, P394, DOI 10.1080/00039896.1984.10545871; Rieders F, 1975, METHODOLOGY ANAL TOX, VI, P113; RIOU B, 1990, J NEUROSURG ANESTH, V2, P296, DOI 10.1097/00008506-199012000-00008; RIOU B, 1991, ANESTHESIOLOGY, V74, P552, DOI 10.1097/00000542-199103000-00025; SILVERMAN SH, 1988, J TRAUMA, V28, P171, DOI 10.1097/00005373-198802000-00007; SOKAL JA, 1985, J APPL TOXICOL, V5, P395, DOI 10.1002/jat.2550050611; SOKAL JA, 1985, ARCH TOXICOL, V57, P196, DOI 10.1007/BF00290887; SYMINGTON IS, 1978, LANCET, V2, P91; TERRILL JB, 1978, SCIENCE, V200, P1343, DOI 10.1126/science.208143; Troup C. M., 1987, CLIN EXPT TOXICOLOGY, P22; Vogel S, 1987, CLIN EXPT TOXICOLOGY, P451; YAMAMOTO K, 1975, Z RECHTSMED, V76, P11, DOI 10.1007/BF02116793; ZIKRIA BA, 1972, J TRAUM, V12, P641, DOI 10.1097/00005373-197208000-00001	37	296	305	0	15	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 19	1991	325	25					1761	1766		10.1056/NEJM199112193252502	http://dx.doi.org/10.1056/NEJM199112193252502			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GV739	1944484				2022-12-28	WOS:A1991GV73900002
J	CAMM, AJ; GARRATT, CJ				CAMM, AJ; GARRATT, CJ			ADENOSINE AND SUPRAVENTRICULAR TACHYCARDIA	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							PARKINSON-WHITE SYNDROME; PECTORIS-LIKE PAIN; RECIPROCATING JUNCTIONAL TACHYCARDIA; ATRIOVENTRICULAR NODAL CONDUCTION; MAMMALIAN VENTRICULAR MYOCYTES; EXCITED ATRIAL-FIBRILLATION; INTRAVENOUS ADENOSINE; REENTRANT TACHYCARDIA; COMPLEX TACHYCARDIA; THERAPEUTIC USE		ROYAL BROMPTON NATL HEART & LUNG HOSP,DEPT CARDIOL,LONDON,ENGLAND	Imperial College London	CAMM, AJ (corresponding author), ST GEORGE HOSP,SCH MED,DEPT CARDIOL SCI,CRANMER TERRACE,LONDON SW17 0RE,ENGLAND.							BARDENHEUER H, 1983, CIRC RES, V51, P263; BELARDINELLI L, 1983, CIRC RES, V53, P287, DOI 10.1161/01.RES.53.3.287; BELARDINELLI L, 1988, J PHYSIOL-LONDON, V405, P615, DOI 10.1113/jphysiol.1988.sp017352; BELARDINELLI L, 1983, AM J PHYSIOL, V244, pH734, DOI 10.1152/ajpheart.1983.244.5.H734; BELARDINELLI L, 1989, PROG CARDIOVASC DIS, V32, P73, DOI 10.1016/0033-0620(89)90015-7; BELHASSEN B, 1988, CIRCULATION, V77, P795, DOI 10.1161/01.CIR.77.4.795; BELHASSEN B, 1989, AM HEART J, V118, P634, DOI 10.1016/0002-8703(89)90289-5; BELHASSEN B, 1988, AM J CARDIOL, V62, P835, DOI 10.1016/0002-9149(88)91240-4; BELHASSEN B, 1983, CIRCULATION, V68, P827, DOI 10.1161/01.CIR.68.4.827; BERNE RM, 1964, PHYSIOL REV, V44, P1, DOI 10.1152/physrev.1964.44.1.1; BERNE RM, 1963, AM J PHYSIOL, V204, P317, DOI 10.1152/ajplegacy.1963.204.2.317; BIAGGIONI I, 1986, LIFE SCI, V39, P2229, DOI 10.1016/0024-3205(86)90401-7; BRUGADA P, 1991, CIRCULATION, V83, P1649, DOI 10.1161/01.CIR.83.5.1649; CLARKE B, 1987, LANCET, V1, P299; CLEMO HF, 1986, CIRC RES, V59, P427, DOI 10.1161/01.RES.59.4.427; CONRADSON TBG, 1987, ACTA PHYSIOL SCAND, V129, P387, DOI 10.1111/j.1748-1716.1987.tb08082.x; CREA F, 1990, CIRCULATION, V81, P164, DOI 10.1161/01.CIR.81.1.164; CUSHLEY MJ, 1983, BRIT J CLIN PHARMACO, V15, P161, DOI 10.1111/j.1365-2125.1983.tb01481.x; CUSHLEY MJ, 1984, AM REV RESPIR DIS, V129, P380; DANCY M, 1985, LANCET, V2, P320; DIMARCO J P, 1988, Journal of the American College of Cardiology, V11, p227A; DIMARCO JP, 1985, J AM COLL CARDIOL, V6, P417, DOI 10.1016/S0735-1097(85)80181-9; DIMARCO JP, 1983, CIRCULATION, V68, P1254, DOI 10.1161/01.CIR.68.6.1254; DIMARCO JP, 1990, ANN INTERN MED, V113, P104, DOI 10.7326/0003-4819-113-2-104; DOBSON JG, 1983, CIRC RES, V52, P151, DOI 10.1161/01.RES.52.2.151; Drury AN, 1929, J PHYSIOL-LONDON, V68, P213, DOI 10.1113/jphysiol.1929.sp002608; ELLENBOGEN KA, 1990, CIRCULATION, V81, P821, DOI 10.1161/01.CIR.81.3.821; EPSTEIN ML, 1985, PEDIATRICS, V75, P737; FAVALE S, 1985, J AM COLL CARDIOL, V5, P1212, DOI 10.1016/S0735-1097(85)80027-9; GARRATT C, 1989, LANCET, V2, P219; GARRATT C, 1989, AM J CARDIOL, V64, P1310, DOI 10.1016/0002-9149(89)90573-0; GARRATT C, 1989, LANCET, V1, P367; GARRATT CJ, 1990, AM J CARDIOL, V65, P868, DOI 10.1016/0002-9149(90)91428-9; GARRATT CJ, IN PRESS CIRCULATION; GRECO R, 1982, CIRCULATION, V66, P504, DOI 10.1161/01.CIR.66.3.504; GRIFFITH MJ, 1989, CLIN CARDIOL, V12, P409, DOI 10.1002/clc.4960120712; GRIFFITH MJ, 1988, LANCET, V1, P672; GULAMHUSEIN S, 1982, CIRCULATION, V65, P348, DOI 10.1161/01.CIR.65.2.348; HAINES DE, 1990, J AM COLL CARDIOL, V15, P1345, DOI 10.1016/S0735-1097(10)80025-7; HINTZE TH, 1985, AM J PHYSIOL, V249, pH554, DOI 10.1152/ajpheart.1985.249.3.H554; Honey RM, 1930, Q J MED, V23, P485, DOI 10.1093/qjmed/os-23.92.485; ISENBERG G, 1984, CIRC RES, V55, P309, DOI 10.1161/01.RES.55.3.309; JACOB AS, 1985, ANN EMERG MED, V14, P159, DOI 10.1016/S0196-0644(85)81080-5; Jezer A, 1933, AM HEART J, V9, P252, DOI 10.1016/S0002-8703(33)90719-X; JOHNSON EA, 1956, NATURE, V178, P1174, DOI 10.1038/1781174a0; KIRK CR, 1987, ARCH DIS CHILD, V62, P1265, DOI 10.1136/adc.62.12.1265; KLEIN GJ, 1983, AM J CARDIOL, V52, P292, DOI 10.1016/0002-9149(83)90125-X; KRIKLER DM, 1974, POSTGRAD MED J, V50, P447, DOI 10.1136/pgmj.50.585.447; KURACHI Y, 1986, PFLUG ARCH EUR J PHY, V407, P264, DOI 10.1007/BF00585301; LERMAN BB, 1987, CIRCULATION, V76, P21, DOI 10.1161/01.CIR.76.1.21; LERMAN BB, 1986, CIRCULATION, V74, P270, DOI 10.1161/01.CIR.74.2.270; LERMAN BB, 1989, CIRCULATION, V80, P1536, DOI 10.1161/01.CIR.80.6.1536; MCGOVERN B, 1986, ANN INTERN MED, V104, P791, DOI 10.7326/0003-4819-104-6-791; MONTEIRO E C, 1986, British Journal of Pharmacology, V87, p184P; MOSER GH, 1989, AM J PHYSIOL, V256, pC799, DOI 10.1152/ajpcell.1989.256.4.C799; MOTTE G, 1972, NOUV PRESSE MED, V1, P3057; MUNOZ A, 1984, EUR HEART J, V5, P735, DOI 10.1093/oxfordjournals.eurheartj.a061734; NEWBY AC, 1984, TRENDS BIOCHEM SCI, V9, P42, DOI 10.1016/0968-0004(84)90176-2; NUNAIN S O, 1991, Journal of the American College of Cardiology, V17, p39A; OLSSON RA, 1990, PHYSIOL REV, V70, P761, DOI 10.1152/physrev.1990.70.3.761; OVERHOLT ED, 1988, AM J CARDIOL, V61, P336, DOI 10.1016/0002-9149(88)90940-X; PELLEG A, 1987, J PHARMACOL EXP THER, V242, P791; PELLEG A, 1985, AM J CARDIOL, V55, P571, DOI 10.1016/0002-9149(85)90249-8; PERELMAN MS, 1987, BRIT HEART J, V58, P528; PERROT B, 1984, EUR HEART J, V5, P382, DOI 10.1093/oxfordjournals.eurheartj.a061672; PUECH P, 1985, CARDIAC ELECTROPHYSI, P443; RANKIN AC, 1987, LANCET, V2, P472; RANKIN AC, 1990, Q J MED, V74, P203; RANKIN AC, 1990, AM HEART J, V119, P316, DOI 10.1016/S0002-8703(05)80022-5; RANKIN AC, 1989, BRIT HEART J, V62, P195; REID PG, 1990, EUR HEART J, V11, P1018, DOI 10.1093/oxfordjournals.eurheartj.a059629; RINNE C, 1988, AM HEART J, V115, P1042, DOI 10.1016/0002-8703(88)90074-9; SAITO D, 1986, BRIT HEART J, V55, P291; SCHAMROTH L, 1972, BMJ-BRIT MED J, V1, P660, DOI 10.1136/bmj.1.5801.660; SCHRADER J, 1977, PFLUG ARCH EUR J PHY, V372, P29, DOI 10.1007/BF00582203; SHARMA AD, 1990, AM J MED, V88, P337, DOI 10.1016/0002-9343(90)90486-W; SOMLO E, 1955, LANCET, V1, P1125; SPARKS HV, 1986, CIRC RES, V58, P193, DOI 10.1161/01.RES.58.2.193; STEWART RB, 1986, ANN INTERN MED, V104, P766, DOI 10.7326/0003-4819-104-6-766; SYLVEN C, 1986, BRIT MED J, V293, P227, DOI 10.1136/bmj.293.6541.227; SYLVEN C, 1987, EUR HEART J, V8, P738, DOI 10.1093/eurheartj/8.7.738; SYLVEN C, 1989, EUR HEART J, V10, P48, DOI 10.1093/oxfordjournals.eurheartj.a059380; TAVIOT B, 1986, PRESSE MED, V15, P1103; TILL J, 1989, BRIT HEART J, V62, P204; VISKIN S, 1990, AM HEART J, V120, P180, DOI 10.1016/0002-8703(90)90176-X; WATT AH, 1986, BRIT J CLIN PHARMACO, V21, P227, DOI 10.1111/j.1365-2125.1986.tb05180.x; WATT AH, 1987, BRIT MED J, V294, P10, DOI 10.1136/bmj.294.6563.10; WAYNE EJ, 1949, BRIT HEART J, V11, P55; WELLENS HJJ, 1978, AM J MED, V64, P27, DOI 10.1016/0002-9343(78)90176-6; WEST GA, 1985, PFLUG ARCH EUR J PHY, V403, P75, DOI 10.1007/BF00583285	93	193	198	1	1	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 5	1991	325	23					1621	1629		10.1056/NEJM199112053252306	http://dx.doi.org/10.1056/NEJM199112053252306			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GR770	1944450				2022-12-28	WOS:A1991GR77000006
J	CLEM, RJ; FECHHEIMER, M; MILLER, LK				CLEM, RJ; FECHHEIMER, M; MILLER, LK			PREVENTION OF APOPTOSIS BY A BACULOVIRUS GENE DURING INFECTION OF INSECT CELLS	SCIENCE			English	Article							NUCLEAR POLYHEDROSIS-VIRUS; HOMOLOGOUS DNA; DEATH; EXPRESSION; GENOME; VECTORS; INVITRO; PROTEIN; REGION	Programmed cell death is an active process of self destruction that is important in both the development and maintenance of multicellular animals. The molecular mechanisms controlling activation or suppression of programmed cell death are largely unknown. Apoptosis, a morphologically and biochemically defined type of programmed cell death commonly seen in vertebrates, was found to be initiated during baculovirus replication in insect cells. A specific viral gene product, p35, was identified as being responsible for blocking the apoptotic response. Identification of the function of this gene will allow further definition of the molecular pathways involved in the regulation of programmed cell death and may identify the role of apoptosis in invertebrate viral defense systems.	UNIV GEORGIA, DEPT GENET, ATHENS, GA 30602 USA; UNIV GEORGIA, DEPT ENTOMOL, ATHENS, GA 30602 USA; UNIV GEORGIA, DEPT ZOOL, ATHENS, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia			GUO, Zhaoyu/AAS-5699-2020	Clem, Rollie/0000-0002-2368-720X	NIAID NIH HHS [AI23719] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI023719, R01AI023719] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		CASADABAN MJ, 1980, J BACTERIOL, V143, P971, DOI 10.1128/JB.143.2.971-980.1980; CHEN LB, 1989, METHOD CELL BIOL, V29, P103; CLEM RJ, UNPUB; CLOUSTON WM, 1985, MED HYPOTHESES, V18, P399, DOI 10.1016/0306-9877(85)90107-0; COCHRAN MA, 1983, J VIROL, V45, P961, DOI 10.1128/JVI.45.3.961-970.1983; DICKSON JA, 1991, J VIROL, V65, P4006, DOI 10.1128/JVI.65.8.4006-4016.1991; FRIESEN PD, 1987, J VIROL, V61, P2264, DOI 10.1128/JVI.61.7.2264-2272.1987; GIORGI F, 1976, J EMBRYOL EXP MORPH, V35, P521; GUARINO LA, 1986, J VIROL, V60, P215, DOI 10.1128/JVI.60.1.215-223.1986; HENDERSON S, 1991, CELL, V65, P1107, DOI 10.1016/0092-8674(91)90007-L; HINK WF, 1970, NATURE, V226, P466, DOI 10.1038/226466b0; HOCKENBERY D, 1990, NATURE, V348, P334, DOI 10.1038/348334a0; Kerr J.F.R., 1987, P93; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; LEE HH, 1978, J VIROL, V27, P754, DOI 10.1128/JVI.27.3.754-767.1978; LIU AF, 1986, J GEN VIROL, V67, P2565, DOI 10.1099/0022-1317-67-11-2565; LOCKSHIN RA, 1985, COMPREHENSIVE INSECT, V2, P301; MARTZ E, 1989, IMMUNOL TODAY, V10, P79, DOI 10.1016/0167-5699(89)90231-4; MILLER LK, 1988, ANNU REV MICROBIOL, V42, P177, DOI 10.1146/annurev.micro.42.1.177; NISSEN MS, 1989, J VIROL, V63, P493, DOI 10.1128/JVI.63.2.493-503.1989; OREILLY DR, 1988, J VIROL, V62, P3109, DOI 10.1128/JVI.62.9.3109-3119.1988; PIPAN N, 1980, ZOOMORPHOLOGIE, V94, P217, DOI 10.1007/BF01081936; SMITH WA, 1982, TISSUE CELL, V14, P243, DOI 10.1016/0040-8166(82)90022-2; VAUGHN JL, 1977, IN VITRO CELL DEV B, V13, P213; VOLKMAN LE, 1982, APPL ENVIRON MICROB, V44, P227, DOI 10.1128/AEM.44.1.227-233.1982; Walker N I, 1988, Methods Achiev Exp Pathol, V13, P18; WILSON ME, 1986, VIROLOGY, V151, P315, DOI 10.1016/0042-6822(86)90052-8; Wyllie A H, 1980, Int Rev Cytol, V68, P251; WYLLIE AH, 1980, NATURE, V284, P555, DOI 10.1038/284555a0; YONISHROUACH E, 1991, NATURE, V352, P345, DOI 10.1038/352345a0	30	687	767	3	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 29	1991	254	5036					1388	1390		10.1126/science.1962198	http://dx.doi.org/10.1126/science.1962198			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR777	1962198				2022-12-28	WOS:A1991GR77700060
J	DROUFFE, JM; MAGGS, AC; LEIBLER, S				DROUFFE, JM; MAGGS, AC; LEIBLER, S			COMPUTER-SIMULATIONS OF SELF-ASSEMBLED MEMBRANES	SCIENCE			English	Article							THERMAL FLUCTUATIONS; STATISTICAL-MECHANICS; MOLECULAR-DYNAMICS; BENDING ELASTICITY; FLUID MEMBRANES; HEXATIC ORDER; IONIC GEL; VESICLES; UNDULATIONS; CURVATURE	Molecular dynamics simulations in three dimensions of particles that self-assemble to form two-dimensional, membrane-like objects are presented. Anisotropic, multibody forces, chosen so as to mimic real interactions between amphiphilic molecules, generate a finite rigidity and compressibility of the assembled membranes, as well as a finite line tension at their free edges. This model and its generalizations can be used to study a large class of phenomena taking place in fluctuating membranes. For instance, both fluid and solid-like phases, separated by a phase transition, are obtained and some of the large-scale properties of these membranes studied. In particular, thermal undulations of quasi-spherical fluid vesicles are analyzed, in a manner similar to recent experiments in lipid systems.	SERV PHYS THEOR SACLAY,F-91191 GIF SUR YVETTE,FRANCE; ECOLE SUPER PHYS & CHIM IND,PHYSICOCHIM THEOR LAB,F-75231 PARIS 05,FRANCE	UDICE-French Research Universities; PSL Research University Paris; Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI)								ABRAHAM FF, 1990, SCIENCE, V249, P393, DOI 10.1126/science.249.4967.393; ABRAHAM FF, 1989, PHYS REV LETT, V62, P1757, DOI 10.1103/PhysRevLett.62.1757; Alberts B., 1989, MOL BIOL CELL; BAILLIE CF, 1990, NUCL PHYS B, V335, P469, DOI 10.1016/0550-3213(90)90504-7; BEYSENS D, IN PRESS DYNAMICAL P; BIVAS I, 1987, J PHYS-PARIS, V48, P855, DOI 10.1051/jphys:01987004805085500; CATTERALL SM, 1989, PHYS LETT B, V220, P207, DOI 10.1016/0370-2693(89)90038-5; CICOTTI G, 1987, MOL DYNAMICS MONTE C; DAVID F, 1987, J PHYS-PARIS, V48, P2059, DOI 10.1051/jphys:0198700480120205900; ENGELHARDT H, 1985, J PHYS LETT-PARIS, V46, pL395, DOI 10.1051/jphyslet:01985004608039500; EVANS DJ, 1977, MOL PHYS, V34, P327, DOI 10.1080/00268977700101761; FAUCON JF, 1989, J PHYS-PARIS, V50, P2389, DOI 10.1051/jphys:0198900500170238900; HELFRICH W, 1988, PHYS REV A, V38, P3065, DOI 10.1103/PhysRevA.38.3065; HELFRICH W, 1985, J PHYS-PARIS, V46, P1263, DOI 10.1051/jphys:019850046070126300; HELFRICH W, 1973, Z NATURFORSCH C, VC 28, P693, DOI 10.1515/znc-1973-11-1209; HO JS, 1990, EUROPHYS LETT, V12, P295, DOI 10.1209/0295-5075/12/4/002; HO JS, 1990, PHYS REV A, V41, P5745; HUSE DA, 1988, J PHYS-PARIS, V49, P605, DOI 10.1051/jphys:01988004904060500; Israelachvili JN, 1985, INTERMOLECULAR SURFA; KANTOR Y, 1986, PHYS REV LETT, V57, P791, DOI 10.1103/PhysRevLett.57.791; KANTOR Y, 1987, PHYS REV A, V38, P4020; LEIBLER S, 1990, NATURE, V348, P586, DOI 10.1038/348586a0; LEIBLER S, 1989, PHYS REP, V184, P265, DOI 10.1016/0370-1573(89)90044-6; LIPOWSKY R, 1990, PHYS REV LETT, V65, P2893, DOI 10.1103/PhysRevLett.65.2893; LIPOWSKY R, 1991, NATURE, V349, P475, DOI 10.1038/349475a0; MEUNIER J, 1987, PHYSICS AMPHIPHILIC; MILNER ST, 1987, PHYS REV A, V36, P4371, DOI 10.1103/PhysRevA.36.4371; Nelson D., 1988, Random Fluctuations and Pattern Growth: Experiments and Models. Proceedings of the NATO Advanced Study Institute, P193; NELSON DR, 1987, J PHYS-PARIS, V48, P1085, DOI 10.1051/jphys:019870048070108500; NELSON DR, 1989, STATISTICAL MECHANIC; PELITI L, 1985, PHYS REV LETT, V54, P1690, DOI 10.1103/PhysRevLett.54.1690; RENKEN RL, 1991, NUCL PHYS B, V354, P328, DOI 10.1016/0550-3213(91)90358-5; SCHNEIDER MB, 1984, J PHYS-PARIS, V45, P1457, DOI 10.1051/jphys:019840045090145700; SMIT B, 1990, NATURE, V348, P624, DOI 10.1038/348624a0; STOKKE BT, 1986, EUR BIOPHYS J BIOPHY, V13, P219, DOI 10.1007/BF00260369; STOKKE BT, 1986, EUR BIOPHYS J BIOPHY, V13, P203, DOI 10.1007/BF00260368	36	146	148	0	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	NOV 29	1991	254	5036					1353	1356		10.1126/science.1962193	http://dx.doi.org/10.1126/science.1962193			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR777	1962193				2022-12-28	WOS:A1991GR77700048
J	SHAPIRO, ED; BERG, AT; AUSTRIAN, R; SCHROEDER, D; PARCELLS, V; MARGOLIS, A; ADAIR, RK; CLEMENS, JD				SHAPIRO, ED; BERG, AT; AUSTRIAN, R; SCHROEDER, D; PARCELLS, V; MARGOLIS, A; ADAIR, RK; CLEMENS, JD			THE PROTECTIVE EFFICACY OF POLYVALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HIGH-RISK PATIENTS; INFLUENZAE TYPE-B; COST-EFFECTIVENESS; PNEUMONIA; IMMUNIZATION; INFECTIONS; CHILDREN; DISEASE	Background. Although the protective efficacy of pneumococcal polysaccharide vaccine has been demonstrated in randomized trials in young African gold miners, there has been controversy about its efficacy in older Americans at risk for serious pneumococcal infections. To assess the vaccine's protective efficacy against invasive pneumococcal infections, we conducted a hospital-based case-control study of the efficacy of pneumococcal vaccine in adults with a condition recognized to be an indication for receiving the vaccine. Methods. From 1984 to 1990, adults in whom Streptococcus pneumoniae was isolated from any normally sterile site were identified by prospective surveillance in the microbiology laboratories of 11 large hospitals; those with an indication for pneumococcal vaccine were enrolled as case patients. For each case patient, one control was matched according to age, underlying illness, and site of hospitalization. We contacted all providers of medical care to ascertain each subject's history of immunization with pneumococcal vaccine. Isolates of S. pneumoniae were serotyped by an investigator unaware of the subject's vaccination history. Results. Thirteen percent of the 1054 case patients and 20 percent of the 1054 matched controls had received pneumococcal vaccine (P < 0.001). When vaccine was given in either its 14-valent or its 23-valent form, its aggregate protective efficacy (calculated as a percentage: 1 minus the odds ratio of having been vaccinated times 100) against infections caused by the serotypes represented in the vaccine was 56 percent (95 percent confidence interval, 42 percent to 67 percent; P < 0.00001) for all 983 patients infected with a serotype represented in the vaccine, 61 percent for a subgroup of 808 immunocompetent patients (95 percent confidence interval, 47 percent to 72 percent; P < 0.00001), and 21 percent for a subgroup of 175 immunocompromised patients (95 percent confidence interval, -55 percent to 60 percent; P = 0.48). The vaccine was not efficacious against infections caused by serotypes not represented in the vaccine (protective efficacy, -73 percent; 95 percent confidence interval, -263 percent to 18 percent; P = 0.15). Conclusions. Polyvalent pneumococcal vaccine is efficacious in preventing invasive pneumococcal infections in immunocompetent patients with indications for its administration. This vaccine should be used more widely.	YALE UNIV,SCH MED,DEPT EPIDEMIOL,NEW HAVEN,CT 06510; UNIV PENN,SCH MED,DEPT RES MED,PHILADELPHIA,PA 19104; NICHHD,DIV EPIDEMIOL STAT & PREVENT RES,BETHESDA,MD 20892	Yale University; University of Pennsylvania; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	SHAPIRO, ED (corresponding author), YALE UNIV,SCH MED,DEPT PEDIAT,333 CEDAR ST,NEW HAVEN,CT 06510, USA.				NIA NIH HHS [AG04884] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG004884] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		AHONKHAI VI, 1979, NEW ENGL J MED, V301, P26, DOI 10.1056/NEJM197907053010106; AITKIN M, 1989, STATISTICAL MODELLIN; AUSTRIAN R, 1984, NEW ENGL J MED, V310, P651, DOI 10.1056/NEJM198403083101010; AUSTRIAN R, 1976, MT SINAI J MED, V43, P699; Austrian R, 1976, Trans Assoc Am Physicians, V89, P184; AUSTRIAN R, 1984, BACTERIAL VACCINES, P279; Bliss EA, 1934, J IMMUNOL, V27, P95; BOLAN G, 1986, ANN INTERN MED, V104, P1, DOI 10.7326/0003-4819-104-1-1; BROOME CV, 1980, NEW ENGL J MED, V303, P549, DOI 10.1056/NEJM198009043031003; CLEMENS JD, 1984, REV INFECT DIS, V6, P589; FEDSON DS, 1982, INFECT CONT HOSP EP, V3, P303, DOI 10.1017/S0195941700056381; FEDSON DS, 1987, CHEST, V91, P436, DOI 10.1378/chest.91.3.436; Fleiss JL, 1981, STAT METHODS RATES P; FORRESTER HL, 1987, AM J MED, V83, P425, DOI 10.1016/0002-9343(87)90751-0; GAILLAT J, 1985, REV EPIDEMIOL SANTE, V33, P437; GIEBINK GS, 1979, JAMA-J AM MED ASSOC, V241, P2736, DOI 10.1001/jama.241.25.2736; HALLORAN ME, 1991, AM J EPIDEMIOL, V133, P323, DOI 10.1093/oxfordjournals.aje.a115884; Henrichsen J., 1979, J INFECTION       S2, V1, P31; LIN KT, 1982, IMMUNOLOGY, V46, P333; PATRICK KM, 1981, JAMA-J AM MED ASSOC, V245, P473, DOI 10.1001/jama.245.5.473; RILEY ID, 1986, LANCET, V2, P877; ROBBINS JB, 1983, J INFECT DIS, V148, P1136, DOI 10.1093/infdis/148.6.1136; Schlesselman JJ, 1982, CASE CONTROL STUDIES; SCHNEERSON R, 1986, INFECT IMMUN, V52, P519, DOI 10.1128/IAI.52.2.519-528.1986; SCHNEERSON R, 1984, INFECT IMMUN, V45, P582, DOI 10.1128/IAI.45.3.582-591.1984; SCHWARTZ JS, 1982, ANN INTERN MED, V96, P208, DOI 10.7326/0003-4819-96-2-208; SHAPIRO ED, 1984, ANN INTERN MED, V101, P325, DOI 10.7326/0003-4819-101-3-325; SHAPIRO ED, 1987, NEW ENGL J MED, V316, P1272; SIMBERKOFF MS, 1986, NEW ENGL J MED, V315, P1318, DOI 10.1056/NEJM198611203152104; SIMS RV, 1988, ANN INTERN MED, V108, P653, DOI 10.7326/0003-4819-108-5-653; SISK JE, 1986, ANN INTERN MED, V104, P79, DOI 10.7326/0003-4819-104-1-79; SMIT P, 1977, JAMA-J AM MED ASSOC, V238, P2613, DOI 10.1001/jama.238.24.2613; WEBSTER LESLIE T., 1931, JOUR EXP MED, V53, P535, DOI 10.1084/jem.53.4.535; WILLEMS JS, 1980, NEW ENGL J MED, V303, P553, DOI 10.1056/NEJM198009043031004; 1984, MMWR, V33, P281; 1978, MMWR, V27, P25; 1982, ANN INTERN MED, V96, P206; 1984, MMWR, V33, P273	38	812	854	0	26	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 21	1991	325	21					1453	1460		10.1056/NEJM199111213252101	http://dx.doi.org/10.1056/NEJM199111213252101			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GQ406	1944423				2022-12-28	WOS:A1991GQ40600001
J	ZUGER, A				ZUGER, A			BOTH SIDES OF THE STORY	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 20	1991	266	19					2684	2684						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GP691	1942414				2022-12-28	WOS:A1991GP69100010
J	WUTHRICH, K; VONFREYBERG, B; WEBER, C; WIDER, G; TRABER, R; WIDMER, H; BRAUN, W				WUTHRICH, K; VONFREYBERG, B; WEBER, C; WIDER, G; TRABER, R; WIDMER, H; BRAUN, W			RECEPTOR-INDUCED CONFORMATION CHANGE OF THE IMMUNOSUPPRESSANT CYCLOSPORINE-A	SCIENCE			English	Editorial Material							NUCLEAR-MAGNETIC-RESONANCE; CIS-TRANS ISOMERASE; 2D H-1-NMR SPECTRA; DOUBLE-HALF-FILTER; NMR-SPECTROSCOPY; BINDING-PROTEIN; CYCLOPHILIN		SANDOZ PHARMA AG,PRAKLIN FORSCH,CH-4002 BASEL,SWITZERLAND	Novartis; Sandoz	WUTHRICH, K (corresponding author), SWISS FED INST TECHNOL,INST MOLEK BIOL & BIOPHYS,CH-8093 ZURICH,SWITZERLAND.		Braun, Werner/A-6642-2012	Wider, Gerhard/0000-0001-9366-7645				BOREL JF, 1986, CICLOSPORIN; FESIK SW, 1988, NATURE, V332, P865, DOI 10.1038/332865a0; FESIK SW, 1988, BIOCHEMISTRY-US, V27, P8297, DOI 10.1021/bi00422a001; FESIK SW, 1991, BIOCHEMISTRY-US, V30, P6575; FISCHER G, 1989, NATURE, V337, P476, DOI 10.1038/337476a0; GRIFFEY RH, 1987, Q REV BIOPHYS, V19, P51, DOI 10.1017/S0033583500004029; HANDSCHUMACHER RE, 1984, SCIENCE, V226, P544, DOI 10.1126/science.6238408; KALLEN J, 1991, NATURE, V353, P276, DOI 10.1038/353276a0; KAWAMUKAI M, 1989, J BACTERIOL, V171, P4525, DOI 10.1128/JB.171.8.4525-4529.1989; KESSLER H, 1990, HELV CHIM ACTA, V73, P1818, DOI 10.1002/hlca.19900730703; KOLETSKY AJ, 1986, J IMMUNOL, V137, P1054; Lautz J, 1987, J Comput Aided Mol Des, V1, P219, DOI 10.1007/BF01677046; LAUTZ J, 1990, BIOPOLYMERS, V29, P1969; LOOSLI HR, 1985, HELV CHIM ACTA, V68, P682, DOI 10.1002/hlca.19850680319; MICHNICK SW, 1991, SCIENCE, V252, P836, DOI 10.1126/science.1709301; MOORE JM, 1991, NATURE, V351, P248, DOI 10.1038/351248a0; OTTING G, 1986, J MAGN RESON, V70, P500, DOI 10.1016/0022-2364(86)90144-7; OTTING G, 1989, J MAGN RESON, V85, P586, DOI 10.1016/0022-2364(89)90249-7; OTTING G, 1990, Q REV BIOPHYS, V23, P39, DOI 10.1017/S0033583500005412; SCHREIBER SL, 1991, SCIENCE, V251, P283, DOI 10.1126/science.1702904; TAKAHASHI N, 1989, NATURE, V337, P473, DOI 10.1038/337473a0; VANDUYNE GD, 1991, SCIENCE, V252, P839, DOI 10.1126/science.1709302; WEBER C, 1991, BIOCHEMISTRY-US, V30, P6563, DOI 10.1021/bi00240a029; WENGER RM, 1985, ANGEW CHEM INT EDIT, V24, P77, DOI 10.1002/anie.198500773; WIDER G, 1990, J AM CHEM SOC, V112, P9015, DOI 10.1021/ja00180a076; WIDER G, 1991, J AM CHEM SOC, V113, P4676, DOI 10.1021/ja00012a044; WUTHRICH K, 1991, FEBS LETT, V285, P237, DOI 10.1016/0014-5793(91)80808-G	27	78	78	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	NOV 15	1991	254	5034					953	954		10.1126/science.1948082	http://dx.doi.org/10.1126/science.1948082			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GP883	1948082				2022-12-28	WOS:A1991GP88300030
J	HANSEN, MA; OVERGAARD, K; RIIS, BJ; CHRISTIANSEN, C				HANSEN, MA; OVERGAARD, K; RIIS, BJ; CHRISTIANSEN, C			ROLE OF PEAK BONE MASS AND BONE LOSS IN POSTMENOPAUSAL OSTEOPOROSIS - 12 YEAR STUDY	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PHOTON-ABSORPTIOMETRY; VERTEBRAL FRACTURES; SINGLE-PHOTON; WOMEN	Objective - To examine the role of peak bone mass and subsequent postmenopausal bone loss in the development of osteoporosis and the reliability of identifying women at risk from one bone mass measurement and one biochemical assessment of the future bone loss. Design - Population based study. Setting - Outpatient clinic for research into osteoporosis. Subjects - 178 healthy early postmenopausal women who had participated in a two year study in 1977. 154 of the women underwent follow up examination in 1989, of whom 33 were excluded because of diseases or taking drugs known to affect calcium metabolism. Main outcome measures - Bone mineral content of the forearm and values of biochemical markers of bone turnover. Results - The average reduction in bone mineral content during 1977-89 was 20%, but the fast losers had lost 10.0% more than had the slow loser group (mean loss 26.6% in fast losers and 16.6% in slow losers; p < 0.001). Prediction of future bone mineral content using baseline bone mineral content and estimated rate of loss gave results almost identical with the actual bone mineral content measured in 1989. Seven women had had a Colles; fracture and 20 a spinal compression fracture. The group with Colles' fracture had low baseline bone mineral content (34.7 (95% confidence interval 31.3 to 38.1) units-upsilon 39.4 (38.1 to 40.8) units in women with no fracture) whereas the group with spinal fracture had a normal baseline bone mineral content (38.1 (35.0 to 41.1) units) but an increased rate of loss (-2.4 (-3.5 to -1.3)%/year v -1.8 (-2.1 to -1.5)%/year in women with no fracture). Conclusions - One baseline measurement of bone mass combined with a single estimation of the rate of bone loss can reliably identify the women at menopause who are at highest risk of developing osteoporosis later in life. The rate of loss may have an independent role in likelihood of vertebral fracture.			HANSEN, MA (corresponding author), UNIV COPENHAGEN, GLOSTRUP HOSP, DEPT CLIN CHEM, DK-2600 GLOSTRUP, DENMARK.							BROWN JP, 1984, LANCET, V1, P1091; Christiansen C, 1990, Osteoporos Int, V1, P35, DOI 10.1007/BF01880414; CHRISTIANSEN C, 1987, LANCET, V1, P1106; CUMMINGS SR, 1990, JAMA-J AM MED ASSOC, V263, P665, DOI 10.1001/jama.263.5.665; GEUSENS P, 1986, J NUCL MED, V27, P1540; Hansen M A, 1991, Osteoporos Int, V1, P95; HASSAGER C, 1991, OSTEOPOROSIS INT, V1, P226; HUI SL, 1989, ANN INTERN MED, V111, P355, DOI 10.7326/0003-4819-111-5-355; MELTON LJ, 1989, AM J EPIDEMIOL, V129, P1000, DOI 10.1093/oxfordjournals.aje.a115204; MELTON LJ, 1988, OSTEOPOROSIS ETIOLOG, P111; NILAS L, 1987, J NUCL MED, V28, P960; NILAS L, 1985, J NUCL MED, V26, P1257; OTT SM, 1987, J BONE MINER RES, V2, P201; RIGGS BL, 1990, NEW ENGL J MED, V322, P802, DOI 10.1056/NEJM199003223221203; RIIS BJ, 1989, THESIS HANDELSTRYKKE, P16; ROSS PD, 1988, J BONE MINER RES, V3, P1; 1989, FRACTURED NECK FEMUR	17	438	450	0	17	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 19	1991	303	6808					961	964		10.1136/bmj.303.6808.961	http://dx.doi.org/10.1136/bmj.303.6808.961			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GL127	1954420	Green Published			2022-12-28	WOS:A1991GL12700022
J	DELAMOTHE, T				DELAMOTHE, T			THE NEW NHS - 6 MONTHS ON - EAST-BIRMINGHAM - RUNNING FASTER ON THE SPOT	BRITISH MEDICAL JOURNAL			English	Article																		MCCONVILLE A, GETTING STARTED; MCCONVILLE A, BETTER HLTH E BIRMIN	2	2	2	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	OCT 5	1991	303	6806					842	844		10.1136/bmj.303.6806.842	http://dx.doi.org/10.1136/bmj.303.6806.842			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GH946	1932980	Bronze, Green Published			2022-12-28	WOS:A1991GH94600032
J	LUI, SF; LEUNG, CB; LI, PKT; LAI, KN				LUI, SF; LEUNG, CB; LI, PKT; LAI, KN			PAIN AFTER SUBCUTANEOUS INJECTION OF ERYTHROPOIETIN	BRITISH MEDICAL JOURNAL			English	Letter											LUI, SF (corresponding author), CHINESE UNIV HONG KONG,PRINCE WALES HOSP,DEPT MED,SHA TIN,HONG KONG.		Li, Philip K. T./D-4051-2017					FRENKEN LAM, 1991, BRIT MED J, V303, P288, DOI 10.1136/bmj.303.6797.288; LUI SF, 1990, CLIN NEPHROL, V33, P47; LUI SF, IN PRESS CLIN NEPHRO	3	9	9	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	OCT 5	1991	303	6806					856	856		10.1136/bmj.303.6806.856	http://dx.doi.org/10.1136/bmj.303.6806.856			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GH946	1932990	Green Published			2022-12-28	WOS:A1991GH94600063
J	ILLES, P; REGENOLD, JT				ILLES, P; REGENOLD, JT			INTERACTION BETWEEN NEUROPEPTIDE-Y AND NORADRENALINE ON CENTRAL CATECHOLAMINE NEURONS	NATURE			English	Article											ILLES, P (corresponding author), UNIV FREIBURG,DEPT PHARMACOL,HERMANN HERDER STR 5,W-7800 FREIBURG,GERMANY.							AGHAJANIAN GK, 1982, SCIENCE, V215, P1394, DOI 10.1126/science.6278591; AGHAJANIAN GK, 1987, NEUROPHARMACOLOGY, V26, P793, DOI 10.1016/0028-3908(87)90054-2; CHERUBINI E, 1988, J PHYSIOL-LONDON, V406, P431, DOI 10.1113/jphysiol.1988.sp017389; DUNLAP K, 1987, TRENDS NEUROSCI, V10, P241, DOI 10.1016/0166-2236(87)90166-4; EVERITT BJ, 1984, NEUROSCIENCE, V11, P443, DOI 10.1016/0306-4522(84)90036-8; FUXE K, 1989, NEUROSCI LETT, V101, P337, DOI 10.1016/0304-3940(89)90556-9; HOLETS VR, 1988, NEUROSCIENCE, V24, P893, DOI 10.1016/0306-4522(88)90076-0; REGENOLD JT, 1988, NEUROSCI LETT, V92, P347, DOI 10.1016/0304-3940(88)90615-5; Starke K, 1981, Rev Physiol Biochem Pharmacol, V88, P199, DOI 10.1007/BFb0034538; TIMMERMANS PBMWM, 1982, J MED CHEM, V25, P1389, DOI 10.1021/jm00354a001; WARDROUTLEDGE C, 1988, TRENDS PHARMACOL SCI, V9, P209, DOI 10.1016/0165-6147(88)90087-9; WILLIAMS JT, 1985, NEUROSCIENCE, V14, P95, DOI 10.1016/0306-4522(85)90166-6; WILLIAMS JT, 1984, MOL PHARMACOL, V26, P489; WILLIAMS JT, 1982, NATURE, V299, P74, DOI 10.1038/299074a0	14	78	78	0	1	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	MAR 1	1990	344	6261					62	63		10.1038/344062a0	http://dx.doi.org/10.1038/344062a0			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ972	1968229				2022-12-28	WOS:A1990CQ97200061
J	KERN, W; BORN, J; KERNER, W; FEHM, HL				KERN, W; BORN, J; KERNER, W; FEHM, HL			COUNTER-REGULATORY HORMONE RESPONSES TO HUMAN AND PORCINE INSULIN INDUCED HYPOGLYCEMIA	LANCET			English	Letter									UNIV ULM,DEPT INTERNAL MED,W-7900 ULM,GERMANY	Ulm University	KERN, W (corresponding author), UNIV ULM,DEPT APPL PHYS,W-7900 ULM,GERMANY.		Born, Jan/K-2596-2016	Born, Jan/0000-0002-1847-6248				HEINE RJ, 1989, LANCET, V2, P946; KERN W, 1989, ACTA ENDOCRINOL-COP, V1, P1; TEUSCHER A, 1987, LANCET, V2, P382	3	1	1	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	FEB 24	1990	335	8687					485	485		10.1016/0140-6736(90)90726-L	http://dx.doi.org/10.1016/0140-6736(90)90726-L			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CP907	1968213				2022-12-28	WOS:A1990CP90700061
J	MOL, MJTM; STALENHOEF, AFH				MOL, MJTM; STALENHOEF, AFH			ADRENOCORTICAL FUNCTION IN PATIENTS ON SIMVASTATIN	LANCET			English	Letter											MOL, MJTM (corresponding author), UNIV HOSP NIJMEGEN,DEPT INTERNAL MED,6500 HB NIJMEGEN,NETHERLANDS.		Stalenhoef, A.F.H./H-8094-2014					CANDRINA, 1990, LANCET, V335, P53; MOL MJTM, 1989, CLIN ENDOCRINOL, V31, P679, DOI 10.1111/j.1365-2265.1989.tb01293.x; PONT A, 1984, ARCH INTERN MED, V144, P2150, DOI 10.1001/archinte.144.11.2150	3	9	9	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	FEB 17	1990	335	8686					412	413		10.1016/0140-6736(90)90245-Z	http://dx.doi.org/10.1016/0140-6736(90)90245-Z			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN988	1968138				2022-12-28	WOS:A1990CN98800031
J	DEVITA, C; GERACI, E; MAURI, F; TAVAZZI, L; FRANZOSI, MG; MAGGIONI, AP; MEZZANOTTE, G; TOGNONI, G; VOLPI, A				DEVITA, C; GERACI, E; MAURI, F; TAVAZZI, L; FRANZOSI, MG; MAGGIONI, AP; MEZZANOTTE, G; TOGNONI, G; VOLPI, A			GISSI-2 - MORTALITY PLUS EXTENSIVE LEFT-VENTRICULAR DAMAGE AS ENDPOINT	LANCET			English	Letter											DEVITA, C (corresponding author), MARIO NEGRI INST PHARMACOL RES,I-20157 MILAN,ITALY.		Tavazzi, Luigi/ABD-5119-2020; Maggioni, Aldo Pietro/AAL-5334-2020	Tavazzi, Luigi/0000-0003-0336-8356; Maggioni, Aldo Pietro/0000-0003-2764-6779				BOUNOUS EP, 1988, J AM COLL CARDIOL, V11, P35, DOI 10.1016/0735-1097(88)90163-5; MARINO P, 1989, J AM COLL CARDIOL, V14, P1149, DOI 10.1016/0735-1097(89)90409-9; NORRIS RM, 1988, LANCET, V1, P104; Swan H J, 1976, Am J Cardiol, V37, P413, DOI 10.1016/0002-9149(76)90292-7; TOGNONI G, IN PRESS STAT MED; VANDEWERF F, 1989, LANCET, V1, P1367; WHITE HD, 1989, LANCET, V2, P676; WHITE HD, 1989, NEW ENGL J MED, V320, P817, DOI 10.1056/NEJM198903303201301; 1989, ANN INTERN MED, V110, P485	9	26	26	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	FEB 3	1990	335	8684					289	289		10.1016/0140-6736(90)90104-D	http://dx.doi.org/10.1016/0140-6736(90)90104-D			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CL815	1967740				2022-12-28	WOS:A1990CL81500025
J	WATKINS, J; WILD, G; APPLEYARD, TN; HARDY, G				WATKINS, J; WILD, G; APPLEYARD, TN; HARDY, G			COMPLEMENT ACTIVATION BY POLYSTARCH AND GELATINE VOLUME EXPANDERS	LANCET			English	Letter									NO GEN HOSP,DEPT ANESTHESIA,SHEFFIELD S5 7AU,S YORKSHIRE,ENGLAND; OXFORD NUTR SYST LTD,OXFORD,ENGLAND	Northern General Hospital	WATKINS, J (corresponding author), ROYAL HALLAMSHIRE HOSP,DEPT IMMUNOL,SHEFFIELD S10 2JF,S YORKSHIRE,ENGLAND.							RING J, 1977, LANCET, V1, P466; RING J, 1976, EUR SURG RES, V8, P398; WATKINS J, 1989, LANCET, V1, P897	3	8	8	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	JAN 27	1990	335	8683					233	233		10.1016/0140-6736(90)90335-3	http://dx.doi.org/10.1016/0140-6736(90)90335-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CL185	1967706				2022-12-28	WOS:A1990CL18500046
J	BRAHAMS, D				BRAHAMS, D			BENZODIAZEPINES AND SEXUAL FANTASIES	LANCET			English	Editorial Material																		BRAHAMS D, 1989, LANCET, V1, P1339; Dundee J W, 1986, SAAD Dig, V6, P173; DUNDEE JW, IN PRESS SAAD DIG	3	10	10	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	JAN 20	1990	335	8682					157	157		10.1016/0140-6736(90)90019-2	http://dx.doi.org/10.1016/0140-6736(90)90019-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CJ979	1967444				2022-12-28	WOS:A1990CJ97900015
J	BRAHAMS, D				BRAHAMS, D			WHO OWNS PATIENTS DATA	LANCET			English	Editorial Material																		DEAN A, 1989, LANCET, V2, P1340; 1989, LANCET, V2, P1078	2	2	2	0	1	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	JAN 6	1990	335	8680					39	40		10.1016/0140-6736(90)90155-X	http://dx.doi.org/10.1016/0140-6736(90)90155-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG766	1967340				2022-12-28	WOS:A1990CG76600018
J	KRIVIT, W; SHAPIRO, E; KENNEDY, W; LIPTON, M; LOCKMAN, L; SMITH, S; SUMMERS, CG; WENGER, DA; TSAI, MY; RAMSAY, NKC; KERSEY, JH; YAO, JK; KAYE, E				KRIVIT, W; SHAPIRO, E; KENNEDY, W; LIPTON, M; LOCKMAN, L; SMITH, S; SUMMERS, CG; WENGER, DA; TSAI, MY; RAMSAY, NKC; KERSEY, JH; YAO, JK; KAYE, E			TREATMENT OF LATE INFANTILE METACHROMATIC LEUKODYSTROPHY BY BONE-MARROW TRANSPLANTATION	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									UNIV MINNESOTA,DEPT PEDIAT,BONE MARROW TRANSPLANT PROGRAM,MINNEAPOLIS,MN 55455; UNIV MINNESOTA,DIV PEDIAT NEUROL,MINNEAPOLIS,MN 55455; UNIV MINNESOTA,DEPT OPHTHALMOL,MINNEAPOLIS,MN 55455; UNIV MINNESOTA,DEPT LAB MED & PATHOL,MINNEAPOLIS,MN 55455; THOMAS JEFFERSON UNIV,JEFFERSON MED COLL,DEPT MED GENET,PHILADELPHIA,PA 19107; DEPT VET AFFAIRS,PITTSBURGH,PA; NEW ENGLAND MED CTR,BOSTON,MA 02111	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Jefferson University; Tufts Medical Center				Tsai, Michael/0000-0001-7553-3408	NATIONAL CANCER INSTITUTE [P01CA021737] Funding Source: NIH RePORTER; NCI NIH HHS [CA-21737] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ABRAHAM D, 1985, BIOCHEM BIOPH RES CO, V129, P417, DOI 10.1016/0006-291X(85)90167-6; BALDINGER S, 1987, CLIN GENET, V31, P70; BAYEVER E, 1985, LANCET, V2, P471; BLAZAR BR, 1985, BLOOD, V66, P1436; BROOKS SE, 1981, LYSOSOMES LYSOSOMAL, P195; CLARKE JTR, 1989, AM J MED GENET, V33, P10, DOI 10.1002/ajmg.1320330104; DUBOIS G, 1977, AM J HUM GENET, V29, P191; GRUBER HE, 1985, P NATL ACAD SCI USA, V82, P6662, DOI 10.1073/pnas.82.19.6662; HEIER L, 1983, PEDIATR RADIOL, V13, P313, DOI 10.1007/BF01625956; HICKEY WF, 1988, SCIENCE, V239, P290, DOI 10.1126/science.3276004; HOOGERBRUGGE PM, 1988, SCIENCE, V239, P1035, DOI 10.1126/science.3278379; HOOGERBRUGGE PM, 1989, UCLA S MOL CELLULAR, V91, P331; Kihara H, 1973, Birth Defects Orig Artic Ser, V9, P19; KOLODNY EH, 1989, METABOLIC BASIS INHE, V2, P1721; KRIVIT W, 1987, AM J MED SCI, V294, P80, DOI 10.1097/00000441-198708000-00004; KRIVIT W, IN PRESS BONE MARROW; KRIVIT W, 1989, UCLA S MOL CELLULAR, V91, P367; KRIVIT W, 1987, EXPT HEMATOLOGY TODA, P189; KUDOH T, 1981, J LAB CLIN MED, V98, P704; Ladisch S, 1986, Birth Defects Orig Artic Ser, V22, P69; Lipton M, 1986, Birth Defects Orig Artic Ser, V22, P57; LOTT IT, 1976, J PEDIATR-US, V89, P438, DOI 10.1016/S0022-3476(76)80546-X; MACFAUL R, 1982, ARCH DIS CHILD, V57, P168, DOI 10.1136/adc.57.3.168; NORTON WT, 1982, ACTA NEUROPATHOL, V57, P188, DOI 10.1007/BF00685388; OLSEN I, 1983, NATURE, V306, P75, DOI 10.1038/306075a0; PERRY VH, 1988, TRENDS NEUROSCI, V11, P273, DOI 10.1016/0166-2236(88)90110-5; PERRY VH, 1989, NEUROIMMUNE NETWORKS, P119; RAMSAY NKC, 1982, NEW ENGL J MED, V306, P392, DOI 10.1056/NEJM198202183060703; Rourke BP., 1987, CLIN NEUROPSYCHOL, V1, P209, DOI [DOI 10.1080/13854048708520056, 10.1080/13854048708520056]; SCHIFFER MS, 1978, J LAB CLIN MED, V92, P841; SHULL RM, 1988, PEDIATR RES, V24, P347, DOI 10.1203/00006450-198809000-00015; STRIKER GE, 1979, J EXP MED, V149, P127, DOI 10.1084/jem.149.1.127; TAYLOR RM, 1988, TRANSPLANT P, V20, P89; WIESMANN UN, 1971, NEW ENGL J MED, V284, P672; YAO JK, 1981, J NEUROL SCI, V52, P179, DOI 10.1016/0022-510X(81)90003-4; YAO JK, 1983, BIOCHIM BIOPHYS ACTA, V751, P1, DOI 10.1016/0005-2760(83)90249-7; YEAGER AM, 1987, EXPT HEMATOLOGY TODA, P36	37	112	113	0	0	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 4	1990	322	1					28	32		10.1056/NEJM199001043220106	http://dx.doi.org/10.1056/NEJM199001043220106			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG234	1967188				2022-12-28	WOS:A1990CG23400006
J	ROSENZWEIG, A; WATKINS, H; HWANG, DS; MIRI, M; MCKENNA, W; TRAILL, TA; SEIDMAN, JG; SEIDMAN, CE				ROSENZWEIG, A; WATKINS, H; HWANG, DS; MIRI, M; MCKENNA, W; TRAILL, TA; SEIDMAN, JG; SEIDMAN, CE			PRECLINICAL DIAGNOSIS OF FAMILIAL HYPERTROPHIC CARDIOMYOPATHY BY GENETIC-ANALYSIS OF BLOOD-LYMPHOCYTES	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MYOSIN HEAVY-CHAIN; LEFT-VENTRICULAR HYPERTROPHY; AMINO-ACID-SEQUENCE; MOLECULAR-BASIS; SUDDEN-DEATH; CLINICAL MANIFESTATIONS; PATHO-PHYSIOLOGY; SKELETAL-MUSCLE; DNA-SEQUENCE; ALPHA	Background. The clinical diagnosis of familial hypertrophic cardiomyopathy is usually made on the basis of the physical examination, electrocardiogram, and echocardiogram. Making an accurate diagnosis can be particularly difficult in children, who may not have cardiac hypertrophy until adulthood. Recently, we demonstrated that mutations in the cardiac myosin heavy-chain genes cause familial hypertrophic cardiomyopathy in some families. We report a diagnostic test for familial hypertrophic cardiomyopathy that relies on the detection of mutations in the beta-myosin heavy-chain gene in circulating lymphocytes that we used to evaluate three generations of a family, including the children. Methods and Results. Using the polymerase chain reaction, we found that normal and mutant beta-cardiac myosin heavy-chain genes are transcribed in circulating lymphocytes. This allowed us to examine beta-cardiac myosin heavy-chain messenger RNA from blood lymphocytes, even though ordinary expression of the gene is virtually restricted to the heart. Base sequences amplified from this messenger RNA were analyzed with a ribonuclease protection assay to identify small deletions, abnormal splicing, or missense mutations. Using this technique we identified a novel missense mutation in a patient with familial hypertrophic cardiomyopathy. We evaluated 15 of the patient' s adult relatives and found perfect agreement with the clinical diagnosis (8 affected and 7 not affected). Clinical analysis of 14 of the children (age, 1 to 20 years) of these affected family members revealed 1 child with echocardiographic findings diagnostic of familial hypertrophic cardiomyopathy. However, genetic analyses showed that six other children had also inherited the missense mutation and might later manifest the disease. Conclusions. Transcripts of beta-cardiac myosin heavy-chain gene can be detected in blood lymphocytes and used to screen for mutations that cause familial hypertrophic cardiomyopathy. This approach makes practical the identification of mutations responsible for this disorder and may be applicable to other diseases in which direct analysis is difficult because the mutated gene is expressed only in certain tissues. Preclinical or prenatal screening in an affected family will make it possible to study the disease longitudinally and to develop preventive interventions.	MASSACHUSETTS GEN HOSP,CARDIAC UNIT,BOSTON,MA 02114; BRIGHAM & WOMENS HOSP,DIV CARDIOL,BOSTON,MA 02115; ST GEORGE HOSP,SCH MED,DEPT CARDIOL SCI,LONDON,ENGLAND; TAICHUNG VET GEN HOSP,DIV CARDIOL,TAICHUNG,TAIWAN; JOHNS HOPKINS UNIV HOSP,DIV CARDIOL,BALTIMORE,MD 21205; HOWARD HUGHES MED INST,BOSTON,MA	Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; St Georges University London; Taichung Veterans General Hospital; Johns Hopkins University; Johns Hopkins Medicine; Howard Hughes Medical Institute	ROSENZWEIG, A (corresponding author), HARVARD UNIV,SCH MED,DEPT GENET,25 SHATTUCK ST,BOSTON,MA 02115, USA.		McKenna, William J/C-3243-2008; Rosenzweig, Anthony/AAD-7893-2019	McKenna, William J/0000-0001-7994-2460; Watkins, Hugh/0000-0002-5287-9016	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL035877, R01HL046320] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL35877, HL02228, HL46320] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ANTONARAKIS SE, 1989, NEW ENGL J MED, V320, P153, DOI 10.1056/NEJM198901193200305; Ausubel FM, 1988, MOL REPROD DEV; CHELLY J, 1988, NATURE, V333, P858, DOI 10.1038/333858a0; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; COTTON RGH, 1989, BIOCHEM J, V263, P1; DIBB NJ, 1989, J MOL BIOL, V205, P603, DOI 10.1016/0022-2836(89)90229-5; FORRESTER K, 1987, NATURE, V327, P298, DOI 10.1038/327298a0; GEISTERFERLOWRANCE AAT, 1990, CELL, V62, P999, DOI 10.1016/0092-8674(90)90274-I; GREGOR P, 1989, INT J CARDIOL, V23, P335, DOI 10.1016/0167-5273(89)90193-9; GROSS-BELLARD MM, 1973, EUR J BIOCHEM, V36, P32, DOI 10.1111/j.1432-1033.1973.tb02881.x; HARBARTH P, 1988, DNA-J MOLEC CELL BIO, V7, P297, DOI 10.1089/dna.1988.7.297; HEJTMANCIK JF, 1991, CIRCULATION, V83, P1592, DOI 10.1161/01.CIR.83.5.1592; HOLCOMBE R F, 1987, Genomics, V1, P287, DOI 10.1016/0888-7543(87)90058-9; JAENICKE T, 1990, GENOMICS, V8, P194, DOI 10.1016/0888-7543(90)90272-V; JARCHO JA, 1989, NEW ENGL J MED, V321, P1372, DOI 10.1056/NEJM198911163212005; JUNG G, 1989, GENE, V82, P269, DOI 10.1016/0378-1119(89)90052-8; KARN J, 1983, P NATL ACAD SCI-BIOL, V80, P4253, DOI 10.1073/pnas.80.14.4253; KAUFMAN DL, 1990, GENOMICS, V8, P656, DOI 10.1016/0888-7543(90)90252-P; LICHTER P, 1986, EUR J BIOCHEM, V160, P419, DOI 10.1111/j.1432-1033.1986.tb09989.x; LIEW CC, 1990, NUCLEIC ACIDS RES, V18, P3647, DOI 10.1093/nar/18.12.3647; LOMPRE AM, 1984, J BIOL CHEM, V259, P6437; MAHDAVI V, 1982, NATURE, V297, P659, DOI 10.1038/297659a0; MARON BJ, 1976, CIRCULATION, V53, P9, DOI 10.1161/01.CIR.53.1.9; MARON BJ, 1986, J AM COLL CARDIOL, V7, P204, DOI 10.1016/S0735-1097(86)80283-2; MARON BJ, 1987, NEW ENGL J MED, V316, P844, DOI 10.1056/NEJM198704023161405; MARON BJ, 1981, AM J CARDIOL, V48, P418, DOI 10.1016/0002-9149(81)90068-0; MARON BJ, 1987, NEW ENGL J MED, V316, P780, DOI 10.1056/NEJM198703263161305; MARON BJ, 1980, CIRCULATION, V62, P218, DOI 10.1161/01.CIR.62.2.218; MARON BJ, 1978, AM J CARDIOL, V41, P803, DOI 10.1016/0002-9149(78)90717-8; MARON BJ, 1986, NEW ENGL J MED, V315, P610, DOI 10.1056/NEJM198609043151003; MCKENNA W, 1981, AM J CARDIOL, V47, P532, DOI 10.1016/0002-9149(81)90535-X; MCKENNA WJ, 1988, J AM COLL CARDIOL, V11, P351, DOI 10.1016/0735-1097(88)90101-5; MCKENNA WJ, 1989, DISEASES HEART, P933; MCKUSICK VA, 1989, NEW ENGL J MED, V320, P910, DOI 10.1056/NEJM198904063201406; MCNALLY EM, 1989, J MOL BIOL, V210, P665, DOI 10.1016/0022-2836(89)90141-1; MOLINA MI, 1987, J BIOL CHEM, V262, P6478; MYERS RM, 1985, SCIENCE, V230, P1242, DOI 10.1126/science.4071043; PERRY LW, 1980, J PEDIATR-US, V97, P677, DOI 10.1016/S0022-3476(80)80040-0; ROBERTS RG, 1990, LANCET, V336, P1523, DOI 10.1016/0140-6736(90)93305-9; ROZEK CE, 1986, P NATL ACAD SCI USA, V83, P2128, DOI 10.1073/pnas.83.7.2128; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SARKAR G, 1989, SCIENCE, V244, P331, DOI 10.1126/science.2565599; SHAPIRO LM, 1983, J AM COLL CARDIOL, V2, P437, DOI 10.1016/S0735-1097(83)80269-1; SHOHET RV, 1989, P NATL ACAD SCI USA, V86, P7726, DOI 10.1073/pnas.86.20.7726; SMABROOK J, 1989, MOL CLONING LABORATO; SOLOMON SD, 1990, J CLIN INVEST, V86, P993, DOI 10.1172/JCI114802; SOLOMON SD, 1990, AM J HUM GENET, V47, P389; STEDMAN HH, 1990, J BIOL CHEM, V265, P3568; STREHLER EE, 1986, J MOL BIOL, V190, P291, DOI 10.1016/0022-2836(86)90003-3; Surawicz B, 1978, Am J Cardiol, V41, P130, DOI 10.1016/0002-9149(78)90147-9; TANIGAWA G, 1990, CELL, V62, P991, DOI 10.1016/0092-8674(90)90273-H; TONG SW, 1990, J BIOL CHEM, V265, P4893; WIGLE ED, 1985, PROG CARDIOVASC DIS, V28, P1, DOI 10.1016/0033-0620(85)90024-6; YANAGISAWA M, 1987, J MOL BIOL, V198, P143, DOI 10.1016/0022-2836(87)90302-0	54	156	164	0	2	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 19	1991	325	25					1753	1760		10.1056/NEJM199112193252501	http://dx.doi.org/10.1056/NEJM199112193252501			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GV739	1944483				2022-12-28	WOS:A1991GV73900001
J	KOU, WH; CALKINS, H; LEWIS, RR; BOLLING, SF; KIRSCH, MM; LANGBERG, JJ; DEBUITLEIR, M; SOUSA, J; ELATASSI, R; MORADY, F				KOU, WH; CALKINS, H; LEWIS, RR; BOLLING, SF; KIRSCH, MM; LANGBERG, JJ; DEBUITLEIR, M; SOUSA, J; ELATASSI, R; MORADY, F			INCIDENCE OF LOSS OF CONSCIOUSNESS DURING AUTOMATIC IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR SHOCKS	ANNALS OF INTERNAL MEDICINE			English	Article							COMPLICATIONS; SURVIVAL	Objective: To determine the incidence of loss of consciousness occurring in association with shocks delivered by automatic implantable cardioverter-defibrillators (AICD) in patients who had undergone implantation as treatment for ventricular tachycardia or ventricular fibrillation. Design: Cohort study. Setting: Two major tertiary medical care facilities. Patients: A total of 180 patients who had undergone implantation of an AICD for treatment of ventricular tachycardia or ventricular fibrillation. Intervention: Implantation of an AICD that delivered only high-energy shock. Measurements: During a mean (+/- SD) follow-up period of 16 +/- 12 months, the incidence of loss of consciousness occurring in association with spontaneous AICD shocks was determined. Various clinical factors were analyzed to identify predictors of loss of consciousness that occurred during AICD shocks. Main Results: Of the 180 patients who received an AICD, 106 patients (59%) experienced AICD shocks during follow-up. Sixteen of the 180 patients (9%) experienced loss of consciousness; 13 of these 16 patients had syncope and 3 died suddenly, in association with AICD shocks. The absence of syncope during one AICD shock did not always predict the absence of syncope during subsequent shocks. Syncope could not be predicted by age, sex, history of syncope, left ventricular function, type of underlying heart disease, electrophysiologic findings, rate of ventricular tachycardia, antiarrhythmic medications, and type of pulse generator implanted. Conclusions: Patients with sustained ventricular tachycardia or ventricular fibrillation who receive an AICD that delivers only high-energy shock therapy are at moderate risk for experiencing loss of consciousness during AICD shocks. No clinical variables were found to be predictors of syncope. Therefore, driving and other activities that require patients to be extra vigilant should not be assumed to be safe after implantation of an AICD that delivers only high-energy shock.	UNIV MICHIGAN HOSP, DIV CARDIOL, ANN ARBOR, MI 48109 USA; UNIV MICHIGAN HOSP, DIV THORAC SURG, ANN ARBOR, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	KOU, WH (corresponding author), VET AFFAIRS MED CTR, CARDIOL SECT 111A, 2215 FULLER RD, ANN ARBOR, MI 48105 USA.							AXTELL KA, 1990, CIRCULATION, V82, P211; CRANCER A, 1968, J AMER MED ASSOC, V205, P272, DOI 10.1001/jama.1968.03140310030006; ECHT DS, 1985, CIRCULATION, V71, P289, DOI 10.1161/01.CIR.71.2.289; HANSOTIA P, 1991, NEW ENGL J MED, V324, P22, DOI 10.1056/NEJM199101033240105; KALBFLEISCH KR, 1989, AM J CARDIOL, V64, P199, DOI 10.1016/0002-9149(89)90457-8; KELLY PA, 1988, J AM COLL CARDIOL, V11, P1278, DOI 10.1016/0735-1097(88)90292-6; KOU WH, 1990, AM HEART J, V120, P208, DOI 10.1016/0002-8703(90)90181-V; LEHMANN MH, 1988, AM J CARDIOL, V62, P803, DOI 10.1016/0002-9149(88)91226-X; MIROWSKI M, 1981, AM HEART J, V102, P265, DOI 10.1016/S0002-8703(81)80017-8; STEINBERG JS, 1991, AM J CARDIOL, V67, P95, DOI 10.1016/0002-9149(91)90109-X; WALLER JA, 1965, NEW ENGL J MED, V273, P1413, DOI 10.1056/NEJM196512232732605; YSANDER L, 1966, BRIT J IND MED, V23, P28	12	51	51	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 15	1991	115	12					942	945		10.7326/0003-4819-115-12-942	http://dx.doi.org/10.7326/0003-4819-115-12-942			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GU417	1952491				2022-12-28	WOS:A1991GU41700005
J	DAHLBERG, JE; LUND, E				DAHLBERG, JE; LUND, E			HOW DOES IIIXII MAKE U6	SCIENCE			English	Editorial Material							RNA POLYMERASE-III; 3' END FORMATION; U1 SNRNA; TRANSCRIPTION INITIATION; PROMOTER ELEMENTS; U2 SNRNA; GENE; INVITRO; REQUIRES; SPECIFICITY				DAHLBERG, JE (corresponding author), UNIV WISCONSIN,DEPT BIOMOLEC CHEM,MADISON,WI 53706, USA.				NIGMS NIH HHS [GM30220] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM030220, R37GM030220] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BROW DA, 1990, GENE DEV, V4, P1345, DOI 10.1101/gad.4.8.1345; CARBON P, 1987, CELL, V51, P71, DOI 10.1016/0092-8674(87)90011-0; Dahlberg JE, 1988, STRUCTURE FUNCTION M, P38, DOI [10.1007/978-3-642- 73020-7_2, DOI 10.1007/978-3-642-73020-7_2]; DAS G, 1988, EMBO J, V7, P503, DOI 10.1002/j.1460-2075.1988.tb02838.x; DEVEGVAR HEN, 1989, NUCLEIC ACIDS RES, V17, P9305, DOI 10.1093/nar/17.22.9305; DEVEGVAR HEN, 1986, CELL, V47, P259; GEIDUSCHEK EP, 1988, ANNU REV BIOCHEM, V57, P873, DOI 10.1146/annurev.bi.57.070188.004301; GUNDERSON SI, 1990, GENE DEV, V4, P2048, DOI 10.1101/gad.4.12a.2048; GUTHRIE C, 1988, ANNU REV GENET, V22, P387, DOI 10.1146/annurev.ge.22.120188.002131; HERNANDEZ N, 1986, CELL, V47, P249, DOI 10.1016/0092-8674(86)90447-2; HERNANDEZ N, 1988, EMBO J, V7, P3125, DOI 10.1002/j.1460-2075.1988.tb03179.x; HERNANDEZ N, IN PRESS TRANSCRIPTI; KASSAVETIS GA, 1990, CELL, V60, P235, DOI 10.1016/0092-8674(90)90739-2; KUNKEL GR, 1991, BIOCHIM BIOPHYS ACTA, V1088, P1, DOI 10.1016/0167-4781(91)90146-D; KUNKEL GR, 1988, GENE DEV, V2, P196, DOI 10.1101/gad.2.2.196; LESCURE A, 1991, NUCLEIC ACIDS RES, V19, P435, DOI 10.1093/nar/19.3.435; LOBO SM, 1989, CELL, V58, P55, DOI 10.1016/0092-8674(89)90402-9; LOBO SM, 1991, GENE DEV, V5, P1477, DOI 10.1101/gad.5.8.1477; LUND E, 1989, EMBO J, V8, P287, DOI 10.1002/j.1460-2075.1989.tb03375.x; MARGOTTIN F, 1991, SCIENCE, V251, P424, DOI 10.1126/science.1989075; MATTAJ IW, 1988, CELL, V55, P435, DOI 10.1016/0092-8674(88)90029-3; MOENNE A, 1990, EMBO J, V9, P271, DOI 10.1002/j.1460-2075.1990.tb08105.x; PTASHNE M, 1990, NATURE, V346, P329, DOI 10.1038/346329a0; PUGH BF, 1990, CELL, V61, P1187, DOI 10.1016/0092-8674(90)90683-6; REDDY R, 1988, J BIOL CHEM, V263, P15980; SAWADOGO M, 1990, ANNU REV BIOCHEM, V59, P711, DOI 10.1146/annurev.bi.59.070190.003431; SIMMEN KA, 1991, EMBO J, V10, P1853, DOI 10.1002/j.1460-2075.1991.tb07711.x; Steitz J. A., 1988, STRUCTURE FUNCTION M, P115; WAIBEL F, 1990, NUCLEIC ACIDS RES, V18, P3451, DOI 10.1093/nar/18.12.3451; WAIBEL F, 1990, NATURE, V346, P199, DOI 10.1038/346199a0; WALDSCHMIDT R, 1991, EMBO J, V10, P2595, DOI 10.1002/j.1460-2075.1991.tb07801.x	31	32	32	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	DEC 6	1991	254	5037					1462	1463		10.1126/science.1962205	http://dx.doi.org/10.1126/science.1962205			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT903	1962205				2022-12-28	WOS:A1991GT90300028
J	CUEVAS, P; CARCELLER, F; ORTEGA, S; ZAZO, M; NIETO, I; GIMENEZGALLEGO, G				CUEVAS, P; CARCELLER, F; ORTEGA, S; ZAZO, M; NIETO, I; GIMENEZGALLEGO, G			HYPOTENSIVE ACTIVITY OF FIBROBLAST GROWTH-FACTOR	SCIENCE			English	Article							PLASMINOGEN-ACTIVATOR PRODUCTION; CAPILLARY ENDOTHELIAL-CELLS; DNA-SYNTHESIS; BLOOD-PRESSURE; NITRIC-OXIDE; K+ CHANNELS; L-ARGININE; BINDING; HEPARIN; GENE	Acidic and basic fibroblast growth factors (FGFs) are members of a family of proteins that are broad-spectrum mitogens, have diverse hormone-like activities, and function in tumorigenesis. FGF's ability to raise the concentration of intracellular calcium ion suggests that FGF could induce the synthesis of endothelium-derived relaxing factor (EDRF) and consequently vasodilation. Systemic administration of FGF decreased arterial blood pressure. This effect was mediated by EDRF and by adenosine triphosphate-sensitive potassium ion channels. The hypotensive effect of FGF was segregated from its mitogenic activity by protein engineering. These results extend the range of FGF autocrine activities and potential therapeutic applications, emphasize the role of endothelium as an arterial blood pressure-regulating organ, and provide insight on the structural basis of FGF functions.	CSIC, CTR INVEST BIOL, VELAZQUEZ 144, E-28006 MADRID, SPAIN; HOSP UNIV RAMON Y CAJAL, E-28034 MADRID, SPAIN	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Consiglio Nazionale delle Ricerche (CNR); Hospital Universitario Ramon y Cajal								AISAKA K, 1989, BIOCHEM BIOPH RES CO, V160, P881, DOI 10.1016/0006-291X(89)92517-5; BAIRD A, 1985, P NATL ACAD SCI USA, V82, P5545, DOI 10.1073/pnas.82.16.5545; BAIRD A, 1986, REGUL PEPTIDES, V16, P243, DOI 10.1016/0167-0115(86)90023-6; BURGESS WH, 1989, ANNU REV BIOCHEM, V58, P575, DOI 10.1146/annurev.bi.58.070189.003043; CUEVAS P, UNPUB; FINCH PW, 1989, SCIENCE, V245, P752, DOI 10.1126/science.2475908; FLAUMENHAFT R, 1990, J CELL BIOL, V111, P1651, DOI 10.1083/jcb.111.4.1651; FUKUTO JM, 1990, BIOCHEM BIOPH RES CO, V168, P458, DOI 10.1016/0006-291X(90)92343-X; GIMENEZGALLEGO G, 1985, SCIENCE, V230, P1385, DOI 10.1126/science.4071057; GIMENEZGALLEGO G, UNPUB; IMAMURA T, 1990, SCIENCE, V249, P1567, DOI 10.1126/science.1699274; KAN M, 1989, P NATL ACAD SCI USA, V86, P7432, DOI 10.1073/pnas.86.19.7432; LINEMEYER DL, 1987, BIO-TECHNOL, V5, P960, DOI 10.1038/nbt0987-960; MAYER B, 1989, BIOCHEM BIOPH RES CO, V164, P678, DOI 10.1016/0006-291X(89)91513-1; MCNEIL PL, 1989, J CELL BIOL, V109, P811, DOI 10.1083/jcb.109.2.811; MOSCATELLI D, 1988, J CELL BIOL, V107, P753, DOI 10.1083/jcb.107.2.753; MOSCATELLI D, 1987, J CELL PHYSIOL, V131, P123, DOI 10.1002/jcp.1041310118; MOSCATELLI D, 1991, ANN NY ACAD SCI, V638, P177, DOI 10.1111/j.1749-6632.1991.tb49028.x; MOSCATELLI D, 1986, P NATL ACAD SCI USA, V83, P2091, DOI 10.1073/pnas.83.7.2091; NELSON MT, 1990, NATURE, V344, P770, DOI 10.1038/344770a0; PANDIELLA A, 1989, BIOCHEM BIOPH RES CO, V163, P1325, DOI 10.1016/0006-291X(89)91123-6; PRESTA M, 1986, MOL CELL BIOL, V6, P4060, DOI 10.1128/MCB.6.11.4060; QUAST U, 1989, TRENDS PHARMACOL SCI, V10, P431, DOI 10.1016/S0165-6147(89)80003-3; REES DD, 1989, P NATL ACAD SCI USA, V86, P3375, DOI 10.1073/pnas.86.9.3375; ROSENGART TK, 1989, CIRC RES, V64, P227, DOI 10.1161/01.RES.64.2.227; SAKSELA O, 1990, J CELL BIOL, V110, P767, DOI 10.1083/jcb.110.3.767; SAKSELA O, 1988, J CELL BIOL, V107, P743, DOI 10.1083/jcb.107.2.743; SANCHEZPUELLES JM, 1990, GENE, V89, P69, DOI 10.1016/0378-1119(90)90207-8; SANZ MJM, 1990, FEBS LETT, V232, P308; SATO Y, 1988, J CELL BIOL, V107, P1199, DOI 10.1083/jcb.107.3.1199; THOMAS KA, 1986, TRENDS BIOCHEM SCI, V11, P1; VANE J, 1990, NATURE, V348, P673, DOI 10.1038/348673a0	32	226	242	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	NOV 22	1991	254	5035					1208	1210		10.1126/science.1957172	http://dx.doi.org/10.1126/science.1957172			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ834	1957172				2022-12-28	WOS:A1991GQ83400049
J	EASTERBROOK, PJ; KERULY, JC; CREAGHKIRK, T; RICHMAN, DD; CHAISSON, RE; MOORE, RD				EASTERBROOK, PJ; KERULY, JC; CREAGHKIRK, T; RICHMAN, DD; CHAISSON, RE; MOORE, RD			RACIAL AND ETHNIC-DIFFERENCES IN OUTCOME IN ZIDOVUDINE-TREATED PATIENTS WITH ADVANCED HIV DISEASE	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							AIDS-RELATED COMPLEX; PLACEBO-CONTROLLED TRIAL; PNEUMOCYSTIS-CARINII PNEUMONIA; RECEIVING ZIDOVUDINE; AZIDOTHYMIDINE AZT; DOUBLE-BLIND; EXPERIENCE; EFFICACY; SURVIVAL	Objectives. - To determine if racial-ethnic differences exist in survival, disease progression, and development of myelosuppression in zidovudine-treated patients with advanced human immunodeficiency virus (HIV) disease. Design. - Prospective observational study. Setting. - Hospital and private clinics in 12 metropolitan centers. Patients. - The study included 754 non-Hispanic white, 165 black, and 106 Hispanic- patients with the acquired immunodeficiency syndrome (AIDS) or advanced AIDS-related complex (ARC) who received up to 2 years of zidovudine therapy. Outcome Measures. - Survival, development of Pneumocystis carinii pneumonia (PCP), other opportunistic infections, and myelosuppression. Results. - At initiation of zidovudine therapy, Hispanic and particularly black patients had more advanced HIV disease than white patients, as indicated by lower baseline CD4+ counts, hematocrits, and AIDS-defining diagnoses. Black patients with AIDS also had a worse prognosis compared with white and Hispanic patients with AIDS. The product-limit survival rates at 2 years for white, black, and Hispanic patients with AIDS were 40%, 27%, and 39%, respectively (black vs white, P = .01; Hispanic vs white, P = .32, by the log-rank test). The respective proportions of patients who developed PCP at 2 years were 46%, 66%, and 44% (black vs white, P = .0001; Hispanic vs white, P = .86) and for other opportunistic infections the proportions were 56%, 63%, and 63%, respectively (black vs white, P = .03; Hispanic vs white, P = .09). There were no significant racial-ethnic differences in survival or in the development of opportunistic infections for patients with ARC, and there were no differences in the incidence of myelosuppression or dose reduction or suspension for patients with either ARC or AIDS. After adjusting for more advanced HIV disease (mainly low CD4+ counts and hematocrits), black race was no longer a significant independent predictor of survival. Adjustment for racial differences in the use of PCP prophylaxis accounted for most of the excess risk for the development of PCP in black patients compared with white patients with AIDS. Conclusions. - Racial differences in survival and the development of opportunistic infections are mainly due to the more advanced HIV disease in black patients when zidovudine therapy is started and to their less frequent use of PCP prophylaxis. Innovative approaches are needed to ensure more widespread use of and earlier access to zidovudine therapy and PCP prophylaxis.	BURROUGHS WELLCOME CO,RES TRIANGLE PK,NC 27709; UNIV CALIF SAN DIEGO,DEPT MED,LA JOLLA,CA 92093; UNIV CALIF SAN DIEGO,DEPT PATHOL,LA JOLLA,CA 92093	Burroughs Wellcome Fund; University of California System; University of California San Diego; University of California System; University of California San Diego	EASTERBROOK, PJ (corresponding author), JOHNS HOPKINS UNIV HOSP,SCH MED,DEPT MED,1830 MONUMENT ST,ROOM 8059,BALTIMORE,MD 21205, USA.		Easterbrook, Philippa J/A-3937-2009	Easterbrook, Philippa/0000-0002-2603-5418				BACCHETTI P, 1988, J INFECT DIS, V157, P1044, DOI 10.1093/infdis/157.5.1044; BAKEMAN R, 1987, J NATL MED ASSOC, V79, P921; COX DR, 1972, J R STAT SOC B, V34, P187; CREAGHKIRK T, 1988, JAMA-J AM MED ASSOC, V260, P3009, DOI 10.1001/jama.260.20.3009; DOURNON E, 1988, LANCET, V2, P1297; FISCHL MA, 1989, JAMA-J AM MED ASSOC, V262, P2405; FISCHL MA, 1988, JAMA-J AM MED ASSOC, V259, P1185, DOI 10.1001/jama.259.8.1185; FISCHL MA, 1987, NEW ENGL J MED, V317, P185, DOI 10.1056/NEJM198707233170401; FRIEDLAND GH, 1991, J ACQ IMMUN DEF SYND, V4, P144; GOLDEN JA, 1989, LANCET, V1, P654; HAMILTON JD, 1991, CLIN RES, V39, pA216; JACKSON L, 1990, 6TH INT C AIDS SAN F; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; MOORE RD, 1991, NEW ENGL J MED, V324, P1412, DOI 10.1056/NEJM199105163242006; MOORE RD, 1991, ARCH INTERN MED, V151, P981, DOI 10.1001/archinte.151.5.981; PINCHING AJ, 1989, J INFECTION, V18, P33, DOI 10.1016/S0163-4453(89)80078-7; RICHMAN DD, 1988, AM J MED, V85, P208; ROTHENBERG R, 1987, NEW ENGL J MED, V317, P1297, DOI 10.1056/NEJM198711193172101; SELIK RM, 1988, AM J PUBLIC HEALTH, V78, P1539, DOI 10.2105/AJPH.78.12.1539; SELTZER R, 1988, AIDS PUBLIC POLICY J, V3, P31; STAMBUK D, 1989, Q J MED, V262, P161; STEINBERG JP, 1989, J ACQ IMMUN DEF SYND, V2, P229; WILLIAMS I, 1989, J INFECTION, V18, P23, DOI 10.1016/S0163-4453(89)80077-5; 1987, MMWR, V36, pS1; 1988, MMWR, V37, P1	25	87	88	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 20	1991	266	19					2713	2718		10.1001/jama.266.19.2713	http://dx.doi.org/10.1001/jama.266.19.2713			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GP691	1942423				2022-12-28	WOS:A1991GP69100026
J	BLAKELY, RD; BERSON, HE; FREMEAU, RT; CARON, MG; PEEK, MM; PRINCE, HK; BRADLEY, CC				BLAKELY, RD; BERSON, HE; FREMEAU, RT; CARON, MG; PEEK, MM; PRINCE, HK; BRADLEY, CC			CLONING AND EXPRESSION OF A FUNCTIONAL SEROTONIN TRANSPORTER FROM RAT-BRAIN	NATURE			English	Article							IMIPRAMINE BINDING-SITES; TRITIATED IMIPRAMINE; DEPRESSED-PATIENTS; UPTAKE INHIBITOR; GABA TRANSPORTER; LIGAND-BINDING; POLYMERASE; PLATELETS; DOPAMINE; PROTEIN	SELECTIVE antagonism of serotonin (5-hydroxytryptamine, 5HT) and noradrenaline transport by antidepressants is a key element in the 'amine' hypothesis of affective disorders 1. Uptake 2,3 and/or transport sites 4-5 of 5HT have been reported to be reduced in platelets of patients suffering from depression and in post-mortem brain samples of depressed patients 6 and suicide victims 7. To date there has been little molecular information available on the structure and regulation of 5HT transporters. Using the polymerase chain reaction 8 with degenerate oligonucleotides 9 derived from two highly conserved regions of the transporters for noradrenaline 10 and gamma-aminobutyric acid 11 (GABA), we have identified a large family of related gene products expressed in rodent brain. One of these products hybridizes to a single 3.7-kilobase RNA restricted to rat midbrain and brainstem, where it is highly enriched within the serotonergic raphe complex. Transfection with a single 2.3-kilobase brainstem complementary DNA clone is sufficient to confer expression of a Na+-dependent 5HT transporter upon non-neural cells, with transport selectively and potently antagonized by 5HT uptake-specific antidepressants, including paroxetine, citalopram and fluoxetine.	EMORY UNIV, SCH MED, PROGRAM NEUROSCI, ATLANTA, GA 30322 USA; DUKE UNIV, SCH MED, DEPT NEUROBIOL, DURHAM, NC 27710 USA; DUKE UNIV, SCH MED, DEPT CELL BIOL & MED, DURHAM, NC 27710 USA	Emory University; Duke University; Duke University	BLAKELY, RD (corresponding author), EMORY UNIV, SCH MED, DEPT ANAT & CELL BIOL, ATLANTA, GA 30322 USA.							ANDERSEN PH, 1989, EUR J PHARMACOL, V166, P493, DOI 10.1016/0014-2999(89)90363-4; ASHTON H, 1987, BRIAN SYSTEMS DISORD, P283; BLAKELY RD, 1991, ANAL BIOCHEM, V194, P302, DOI 10.1016/0003-2697(91)90233-J; BRILEY MS, 1980, SCIENCE, V209, P303, DOI 10.1126/science.7384806; COOL DR, 1991, J BIOL CHEM, V266, P15750; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; FREMEAU RT, 1991, P NATL ACAD SCI USA, V88, P3772, DOI 10.1073/pnas.88.9.3772; FUERST TR, 1986, P NATL ACAD SCI USA, V83, P8122, DOI 10.1073/pnas.83.21.8122; FULLER RW, 1990, ANN NY ACAD SCI, V600, P68, DOI 10.1111/j.1749-6632.1990.tb16873.x; GRAHAM D, 1989, BIOCHEM PHARMACOL, V38, P3819, DOI 10.1016/0006-2952(89)90591-1; GUASTELLA J, 1990, SCIENCE, V249, P1303, DOI 10.1126/science.1975955; HINSON JP, 1989, J ENDOCRINOL, V121, P253, DOI 10.1677/joe.0.1210253; HOLZWARTH MA, 1985, NEUROENDOCRINOLOGY, V41, P230, DOI 10.1159/000124182; HYTTEL J, 1977, PSYCHOPHARMACOLOGY, V51, P225, DOI 10.1007/BF00431629; KEMP BE, 1990, TRENDS BIOCHEM SCI, V15, P342, DOI 10.1016/0968-0004(90)90073-K; KOBILKA BK, 1988, SCIENCE, V240, P1310, DOI 10.1126/science.2836950; KOE BK, 1976, J PHARMACOL EXP THER, V199, P649; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LASSEN J B, 1978, European Journal of Pharmacology, V47, P351; LEMBERGER L, 1978, CLIN PHARMACOL THER, V23, P421; MARCUSSON JO, 1989, PSYCHOPHARMACOLOGY, V99, P17, DOI 10.1007/BF00634446; MAXWELL RA, 1978, HDB PSYCHOPHARMACOLO, P83; MELTZER HY, 1981, ARCH GEN PSYCHIAT, V38, P1322; NELSON H, 1990, FEBS LETT, V269, P181, DOI 10.1016/0014-5793(90)81149-I; PACHOLCZYK T, 1991, NATURE, V350, P350, DOI 10.1038/350350a0; PAUL SM, 1981, ARCH GEN PSYCHIAT, V38, P1315; PERRY EK, 1983, BRIT J PSYCHIAT, V142, P188, DOI 10.1192/bjp.142.2.188; RATHE R, 1985, J MOL BIOL, V183, P1; RICHELSON E, 1990, MAYO CLIN PROC, V65, P1227, DOI 10.1016/S0025-6196(12)62747-5; RITZ MC, 1990, LIFE SCI, V46, P635, DOI 10.1016/0024-3205(90)90132-B; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; Sambrook J, 1989, MOL CLONING LABORATO; STANLEY M, 1982, SCIENCE, V216, P1337, DOI 10.1126/science.7079769; Steinbusch H. W., 1983, CHEM NEUROANATOMY, P131; STRADER CD, 1989, FASEB J, V3, P1825, DOI 10.1096/fasebj.3.7.2541037; SURANYICADOTTE BE, 1985, LIFE SCI, V36, P795, DOI 10.1016/0024-3205(85)90201-2; VERHOFSTAD AAJ, 1983, NEUROSCIENCE, V10, P1443, DOI 10.1016/0306-4522(83)90125-2; VONHEIJNE G, 1983, EUR J BIOCHEM, V133, P17	39	711	728	1	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 7	1991	354	6348					66	70		10.1038/354066a0	http://dx.doi.org/10.1038/354066a0			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN829	1944572				2022-12-28	WOS:A1991GN82900059
J	BOYS, RJ; FORSTER, DP; JOZAN, P				BOYS, RJ; FORSTER, DP; JOZAN, P			MORTALITY FROM CAUSES AMENABLE AND NON-AMENABLE TO MEDICAL-CARE - THE EXPERIENCE OF EASTERN-EUROPE	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HEALTH-SERVICES; DECLINE; 20TH-CENTURY	Objective - To investigate comparative national trends in mortality from conditions amenable to timely, appropriate medical care and from those considered not to be amenable to such care. Design - Analysis of trends in direct age standardised mortality from the 1950s to 1987. Setting - Four eastern European nations (Hungary, Czechoslovakia, Poland, the German Democratic Republic) and two western European (the Federal Republic of Germany and England and Wales) and two North American nations (United States and Canada). Subjects - The total populations of the relevant countries during the period examined. Main outcome measures - Proportional changes over time in age standardised mortality. Mortality from amenable and non-amenable causes was restricted to the age group 0-64. Results - A divergence in the trends for all cause mortality between eastern Europe and the western nations occurred in about 1970, when the rates in western countries steadily declined but those in eastern Europe remained fairly static. In the age group 0-64 mortality from causes considered amenable to medical care fell less quickly in eastern Europe than in the West, particularly after 1970. In the same age group, mortality from non-amenable causes rose in eastern European countries from the late 1960s compared with substantial declines in such mortality in the West. Conclusions - Non-amenable causes of death seem to be the principal, but not exclusive, reason for lack of improvement in trends in all cause mortality in eastern Europe from 1970. The agenda for action in eastern Europe should give priority to a healthier lifestyle and improvement of the environment though not neglect enhancements in the quality and efficiency of direct health services.	UNIV NEWCASTLE UPON TYNE, SCH MED, SCH HLTH CARE SCI, DIV EPIDEMIOL & PUBL HLTH, NEWCASTLE UPON TYNE NE2 4HH, ENGLAND; UNIV NEWCASTLE UPON TYNE, DEPT MATH & STAT, NEWCASTLE UPON TYNE NE1 7RU, TYNE & WEAR, ENGLAND; HUNGARIAN CENT STAT OFF, DEPT POPULAT & HLTH, H-1525 BUDAPEST 2, HUNGARY	Newcastle University - UK; Newcastle University - UK								ALDERSON MR, 1988, MMWR-MORBID MORTAL W, P15; [Anonymous], 1988, LANCET, V2, P349; AUSTER R, 1972, ESSAYS EC HLTH MED C, P135; FORSTER DP, 1984, SOC POLICY ADMIN, V18, P247, DOI 10.1111/j.1467-9515.1984.tb00211.x; FORSTER DP, 1990, LANCET, V335, P458, DOI 10.1016/0140-6736(90)90678-X; JEDRYCHOWSKI W, 1990, J EPIDEMIOL COMMUN H, V44, P114, DOI 10.1136/jech.44.2.114; JOZAN P, 1987, STUDIES MORTALITY 1; KLEINMAN JC, 1982, AM J PUBLIC HEALTH, V72, P125, DOI 10.2105/AJPH.72.2.125; MACKENBACH JP, 1990, J EPIDEMIOL COMMUN H, V44, P106, DOI 10.1136/jech.44.2.106; MARTINI CJM, 1977, INT J HEALTH SERV, V7, P293, DOI 10.2190/XFYT-R576-0R6C-RJ4M; MCCORMICK J, 1988, LANCET, V2, P839; MCKEOWN T, 1975, POP STUD-J DEMOG, V29, P391, DOI 10.2307/2173935; MCKINLAY JB, 1977, MILBANK FUND Q, V55, P405, DOI 10.2307/3349539; NORSKABOROWKA I, 1990, LANCET, P1392; POIKOLAINEN K, 1986, LANCET, V1, P199; RUTSTEIN DD, 1976, NEW ENGL J MED, V294, P582, DOI 10.1056/NEJM197603112941104; RUTSTEIN DD, 1980, NEW ENGL J MED, V302, P1146; SCHWEITZER J, 1990, FINANCE DEV      DEC, P6; SMART RG, 1989, BRIT J ADDICT, V84, P743; TERRIS M, 1990, J PUBLIC HLTH POLICY, V11, P5; Waterhouse J., 1976, CANCER INCIDENCE 5 C, V3, P456; WHITEHEAD C, 1990, NEW SCI, V127, P20; 1990, REFORM HLTH CARE CZE; 1989, GLOBAL STRATEGY HLTH; 1989, WORLD HLTH STATISTIC, P431; 1983, WORLD HLTH STATISTIC; 1988, WORK WHO EUROPEAN RE	27	61	61	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 12	1991	303	6807					879	883		10.1136/bmj.303.6807.879	http://dx.doi.org/10.1136/bmj.303.6807.879			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GK221	1933003	Bronze, Green Published			2022-12-28	WOS:A1991GK22100020
J	HARRINGTON, JM				HARRINGTON, JM			WORK RELATED DISEASE AND INJURIES	BRITISH MEDICAL JOURNAL			English	Article							HEALTH				HARRINGTON, JM (corresponding author), UNIV BIRMINGHAM,INST OCCUPAT HLTH,BIRMINGHAM B15 2TT,W MIDLANDS,ENGLAND.							AW TC, 1989, BMJ, V303, P68; BAKER EL, 1989, AM J PUBLIC HLTH S1, V79, P64; CARTER JT, 1991, BRIT J IND MED, V48, P289; Doll R, 1981, THE CAUSES OF CANCER; FOX AJ, 1978, J EPIDEMIOL COMMUN H, V32, P73, DOI 10.1136/jech.32.2.73; HARRINGTON JM, 1990, J ROY COLL PHYS LOND, V24, P189; HARRINGTON JM, IN PRESS HUNTERS DIS; LEGGE T, 1934, IND MALADIES; MERIDITH SK, 1991, BR J IND MED, V48, P292; MULLAN RJ, 1991, AM J IND MED, V19, P775, DOI 10.1002/ajim.4700190610; OLSEN O, 1991, J EPIDEMIOL COMMUN H, V45, P4, DOI 10.1136/jech.45.1.4; PLESS IB, 1991, BRIT MED J, V303, P462, DOI 10.1136/bmj.303.6800.462; SCHILLING RSF, 1989, BRIT J IND MED, V46, P683; WILLIAMS CJ, 1991, BMJ, V303, P576; 1990, HLTH SAFETY STATISTI; 1991, CM1523	16	8	8	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	OCT 12	1991	303	6807					908	910		10.1136/bmj.303.6807.908	http://dx.doi.org/10.1136/bmj.303.6807.908			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GK221	1933008	Green Published, Bronze			2022-12-28	WOS:A1991GK22100028
J	FLANAGAN, RJ; MEREDITH, TJ; RUPRAH, M; ONYON, LJ; LIDDLE, A				FLANAGAN, RJ; MEREDITH, TJ; RUPRAH, M; ONYON, LJ; LIDDLE, A			ALKALINE DIURESIS FOR ACUTE-POISONING WITH CHLOROPHENOXY HERBICIDES AND IOXYNIL	LANCET			English	Article											FLANAGAN, RJ (corresponding author), GUYS & ST THOMAS HOSP,POISONS UNIT,ST THOMAS ST,LONDON SE1 9RT,ENGLAND.							ABIKHALIL F, 1988, 24TH INT ASS FOR TOX, P512; AKERBLOM M, 1983, J CHROMATOGR, V258, P302, DOI 10.1016/S0021-9673(00)96431-8; ARNOLD EK, 1989, VET HUM TOXICOL, V31, P121; BRODY TM, 1952, P SOC EXP BIOL MED, V80, P533; CONSO F, 1977, ARCH MAL PROF MED, V38, P674; DICKEY W, 1988, POSTGRAD MED J, V64, P681, DOI 10.1136/pgmj.64.755.681; DONE AK, 1971, MOD TREAT, V8, P528; FLANAGAN RJ, 1989, CLIN CHEM, V35, P1342; FRASER AD, 1984, J FORENSIC SCI, V29, P1237; HILL JB, 1973, NEW ENGL J MED, V288, P1110, DOI 10.1056/NEJM197305242882107; KANCIR CB, 1988, J TOXICOL-CLIN TOXIC, V26, P257, DOI 10.3109/15563658809000352; MATTHEW H, 1979, TREATMENT COMMON ACU; MEULENBELT J, 1988, HUM TOXICOL, V7, P289, DOI 10.1177/096032718800700312; MOFFAT AC, 1986, CLARKES ISOLATION ID, P965; OREILLY JF, 1984, POSTGRAD MED J, V60, P76, DOI 10.1136/pgmj.60.699.76; OSTERLOH J, 1983, J ANAL TOXICOL, V7, P125, DOI 10.1093/jat/7.3.125; PRESCOTT LF, 1979, BRIT J CLIN PHARMACO, V7, P111, DOI 10.1111/j.1365-2125.1979.tb00906.x; PRESCOTT LF, 1982, BRIT MED J, V285, P1383, DOI 10.1136/bmj.285.6352.1383; SMYSL B, 1977, ARCH TOXICOL, V37, P241, DOI 10.1007/BF00355494; VESEY CJ, 1985, CLIN CHEM, V31, P270; WELLS WDE, 1981, CLIN TOXICOL, V18, P273	21	28	30	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	FEB 24	1990	335	8687					454	458		10.1016/0140-6736(90)90677-W	http://dx.doi.org/10.1016/0140-6736(90)90677-W			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CP907	1968179				2022-12-28	WOS:A1990CP90700013
J	ELRAFIE, M; HASSOUNA, WA; HIRSCHHORN, N; LOZA, S; MILLER, P; NAGATY, A; NASSER, S; RIYAD, S				ELRAFIE, M; HASSOUNA, WA; HIRSCHHORN, N; LOZA, S; MILLER, P; NAGATY, A; NASSER, S; RIYAD, S			EFFECT OF DIARRHEAL DISEASE-CONTROL ON INFANT AND CHILDHOOD MORTALITY IN EGYPT - REPORT FROM THE NATIONAL-CONTROL-OF-DIARRHEAL-DISEASES-PROJECT	LANCET			English	Article									NATL CONTROL DIARRHEAL DIS PROJECT, GIZA, EGYPT									EWBANK DC, 1984, DATA BASES MORTALITY; Hirschhorn N., 1989, Health Policy and Planning, V4, P343, DOI 10.1093/heapol/4.4.343; KIELMANN AA, 1986, TROP MED PARASITOL, V37, P15; KIELMANN AA, 1985, TROP MED PARASITOL, V36, P191; MOSLEY WH, 1988, NOV CHILD SURV PROGR; NEWELL KW, 1988, SOC SCI MED, V26, P903, DOI 10.1016/0277-9536(88)90409-1; RASHAD H, 1989, J BIOSOC SCI, P105; RASHAD H, 1981, W ASIA N AFRICA REGI; SANTOSHAM M, 1987, Journal of Diarrhoeal Diseases Research, V5, P270; TEKCE B, 1982, STUD FAMILY PLANN, V13, P315, DOI 10.2307/1965803; 1986, INFANT CHILD MORTALI; 1988, LANCET, V2, P145; 1988, STATE EGYPTIAN CHILD; 1982, 9 NAT AC SCI COMM PO	14	50	51	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 10	1990	335	8685					334	338						5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CM846	1967778				2022-12-28	WOS:A1990CM84600013
J	GAUTIER, J; MINSHULL, J; LOHKA, M; GLOTZER, M; HUNT, T; MALLER, JL				GAUTIER, J; MINSHULL, J; LOHKA, M; GLOTZER, M; HUNT, T; MALLER, JL			CYCLIN IS A COMPONENT OF MATURATION-PROMOTING FACTOR FROM XENOPUS	CELL			English	Article									UNIV COLORADO,SCH MED,DEPT PHARMACOL,DENVER,CO 80262; UNIV COLORADO,SCH MED,DEPT CELLULAR & STRUCT BIOL,DENVER,CO 80262; UNIV CAMBRIDGE,DEPT BIOCHEM,CAMBRIDGE CB2 1QW,ENGLAND	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Cambridge	GAUTIER, J (corresponding author), UNIV CALIF SAN FRANCISCO,DEPT BIOCHEM & BIOPHYS,SAN FRANCISCO,CA 94143, USA.		Gautier, jean/A-2774-2008; Hunt, Tim/O-8544-2019	Hunt, Tim/0000-0001-5174-6038				ADLAKHA RC, 1988, J CELL BIOL, V106, P1445, DOI 10.1083/jcb.106.5.1445; ANDERSON CW, 1973, J VIROL, V12, P241, DOI 10.1128/JVI.12.2.241-252.1973; ARION D, 1988, CELL, V55, P371, DOI 10.1016/0092-8674(88)90060-8; BLAKE MS, 1984, ANAL BIOCHEM, V136, P175, DOI 10.1016/0003-2697(84)90320-8; BOOHER R, 1988, EMBO J, V7, P2321, DOI 10.1002/j.1460-2075.1988.tb03075.x; BRIZUELA L, 1987, EMBO J, V6, P3507, DOI 10.1002/j.1460-2075.1987.tb02676.x; CYERT MS, 1988, CELL, V53, P185, DOI 10.1016/0092-8674(88)90380-7; CYERT MS, 1988, DEV BIOL, V129, P209, DOI 10.1016/0012-1606(88)90175-3; DRAETTA G, 1988, CELL, V54, P17, DOI 10.1016/0092-8674(88)90175-4; DRAETTA G, 1989, CELL, V56, P829, DOI 10.1016/0092-8674(89)90687-9; DUNPHY WG, 1988, CELL, V54, P423, DOI 10.1016/0092-8674(88)90205-X; DUNPHY WG, 1989, CELL, V58, P181, DOI 10.1016/0092-8674(89)90414-5; ERIKSON E, 1989, J BIOL CHEM, V264, P19577; EVANS T, 1983, CELL, V33, P389, DOI 10.1016/0092-8674(83)90420-8; GAUTIER J, 1989, NATURE, V339, P626, DOI 10.1038/339626a0; GAUTIER J, 1988, CELL, V54, P433, DOI 10.1016/0092-8674(88)90206-1; GERHART J, 1984, J CELL BIOL, V98, P1247, DOI 10.1083/jcb.98.4.1247; GOEBL M, 1988, CELL, V54, P739; GOULD KL, 1989, NATURE, V342, P39, DOI 10.1038/342039a0; HAGAN I, 1988, J CELL SCI, V91, P587; HARLOW E, 1988, ANTIBODIES LABORATOR; HASHIMOTO N, 1988, DEV BIOL, V126, P242, DOI 10.1016/0012-1606(88)90135-2; Johnson R A, 1979, Adv Cyclic Nucleotide Res, V10, P135; KISHIMOTO T, 1982, EXP CELL RES, V137, P121, DOI 10.1016/0014-4827(82)90014-3; KISHIMOTO T, 1976, NATURE, V260, P321, DOI 10.1038/260321a0; LABBE JC, 1989, EMBO J, V8, P3053, DOI 10.1002/j.1460-2075.1989.tb08456.x; LABBE JC, 1989, CELL, V57, P253, DOI 10.1016/0092-8674(89)90963-X; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEHNER CF, 1989, CELL, V56, P957, DOI 10.1016/0092-8674(89)90629-6; LOHKA MJ, 1983, SCIENCE, V220, P719, DOI 10.1126/science.6601299; LOHKA MJ, 1985, J CELL BIOL, V101, P518, DOI 10.1083/jcb.101.2.518; LOHKA MJ, 1988, P NATL ACAD SCI USA, V85, P3009, DOI 10.1073/pnas.85.9.3009; MALLER J, 1977, DEV BIOL, V58, P295, DOI 10.1016/0012-1606(77)90093-8; Maniatis T., 1982, MOL CLONING; MASUI Y, 1971, J EXP ZOOL, V177, P129, DOI 10.1002/jez.1401770202; Masui Y., 1987, MOL REGULATION NUCLE, P1; MEIJER L, 1989, EMBO J, V8, P2275, DOI 10.1002/j.1460-2075.1989.tb08353.x; MEIJER L, 1984, INT REV CYTOL, V86, P129, DOI 10.1016/S0074-7696(08)60179-5; MIAKELYE R, 1985, CELL, V41, P165, DOI 10.1016/0092-8674(85)90071-6; MINSHULL J, 1989, CELL, V56, P947, DOI 10.1016/0092-8674(89)90628-4; MORLA AO, 1989, CELL, V58, P193, DOI 10.1016/0092-8674(89)90415-7; MURRAY AW, 1988, NATURE, V335, P207, DOI 10.1038/335207a0; MURRAY AW, 1989, NATURE, V339, P280, DOI 10.1038/339280a0; MURRAY AW, 1989, NATURE, V339, P275, DOI 10.1038/339275a0; PINES J, 1987, EMBO J, V6, P2987, DOI 10.1002/j.1460-2075.1987.tb02604.x; PINES J, 1989, CELL, V58, P833, DOI 10.1016/0092-8674(89)90936-7; REMAUT E, 1983, NUCLEIC ACIDS RES, V11, P4677, DOI 10.1093/nar/11.14.4677; SAGATA N, 1989, NATURE, V342, P512, DOI 10.1038/342512a0; SCZAKIEL G, 1987, NUCLEIC ACIDS RES, V15, P1878, DOI 10.1093/nar/15.4.1878; SMITH LD, 1971, DEV BIOL, V25, P232, DOI 10.1016/0012-1606(71)90029-7; SOLOMON M, 1988, CELL, V54, P738, DOI 10.1016/S0092-8674(88)90933-6; STANDART N, 1987, DEV BIOL, V124, P248, DOI 10.1016/0012-1606(87)90476-3; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; STUDIER FW, 1990, IN PRESS METH ENZYMO; SWENSON KI, 1986, CELL, V47, P861, DOI 10.1016/0092-8674(86)90801-9; WASSERMAN WJ, 1975, EXP CELL RES, V91, P381, DOI 10.1016/0014-4827(75)90118-4; WEINTRAUB H, 1982, CR ACAD SCI III-VIE, V295, P787; WHITFIELD WGF, 1989, NATURE, V338, P337, DOI 10.1038/338337a0; WITTENBERG C, 1988, CELL, V54, P1061, DOI 10.1016/0092-8674(88)90121-3; [No title captured]	60	585	594	1	27	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	FEB 9	1990	60	3					487	494		10.1016/0092-8674(90)90599-A	http://dx.doi.org/10.1016/0092-8674(90)90599-A			8	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CP237	1967981				2022-12-28	WOS:A1990CP23700015
J	SCHULZ, B; BANUETT, F; DAHL, M; SCHLESINGER, R; SCHAFER, W; MARTIN, T; HERSKOWITZ, I; KAHMANN, R				SCHULZ, B; BANUETT, F; DAHL, M; SCHLESINGER, R; SCHAFER, W; MARTIN, T; HERSKOWITZ, I; KAHMANN, R			THE B-ALLELES OF U-MAYDIS, WHOSE COMBINATIONS PROGRAM PATHOGENIC DEVELOPMENT, CODE FOR POLYPEPTIDES CONTAINING A HOMEODOMAIN-RELATED MOTIF	CELL			English	Article									UNIV CALIF SAN FRANCISCO,DEPT BIOCHEM & BIOPHYS,SAN FRANCISCO,CA 94143	University of California System; University of California San Francisco	SCHULZ, B (corresponding author), INST GENBIOL FORSCH BERLIN GMBH,IHNESTR 63,W-1000 BERLIN 33,GERMANY.		Schlesinger, Ramona/W-2620-2018	Schlesinger, Ramona/0000-0002-7716-4439	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI018738, R37AI018738] Funding Source: NIH RePORTER; NIAID NIH HHS [AI 18738] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ARNDT KT, 1987, SCIENCE, V237, P874, DOI 10.1126/science.3303332; Ausubel FM., 1988, CURRENT PROTOCOLS MO; BANUETT F, 1989, P NATL ACAD SCI USA, V86, P5878, DOI 10.1073/pnas.86.15.5878; BURGLIN TR, 1988, CELL, V53, P339, DOI 10.1016/0092-8674(88)90153-5; CASSELTON LA, 1978, FILAMENTOUS FUNGI, V3, P275; CHRISTENSEN JJ, 1963, AM PHYTOPATHOL SOC M, V2; DAY PR, 1971, P NATL ACAD SCI USA, V68, P533, DOI 10.1073/pnas.68.3.533; GOUTTE C, 1988, CELL, V52, P875, DOI 10.1016/0092-8674(88)90429-1; Gurr S. J., 1987, SPECIAL PUBLICATIONS, P93; HOLLIDAY R, 1961, GENET RES, V2, P204, DOI 10.1017/S0016672300000719; Holliday R., 1974, HDB GENETICS, P575, DOI 10.1007/978-1-4899-1710-2_31; JOHNSON AD, 1985, CELL, V42, P237, DOI 10.1016/S0092-8674(85)80119-7; KELLY M, 1988, EMBO J, V7, P1537, DOI 10.1002/j.1460-2075.1988.tb02973.x; KOUZARIDES T, 1988, NATURE, V336, P646, DOI 10.1038/336646a0; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; KRONSTAD JW, 1989, P NATL ACAD SCI USA, V86, P978, DOI 10.1073/pnas.86.3.978; KUHN J, 1972, J THEOR BIOL, V35, P77, DOI 10.1016/0022-5193(72)90193-2; LANDSCHULZ WH, 1989, SCIENCE, V243, P1681, DOI 10.1126/science.2494700; LAUGHON A, 1984, NATURE, V310, P25, DOI 10.1038/310025a0; Maniatis T., 1982, MOL CLONING; MILLER AM, 1984, EMBO J, V3, P1061, DOI 10.1002/j.1460-2075.1984.tb01927.x; NAKABEPPU Y, 1988, CELL, V55, P907, DOI 10.1016/0092-8674(88)90146-8; OSHEA EK, 1989, SCIENCE, V245, P646, DOI 10.1126/science.2503872; OTWINOWSKI Z, 1988, NATURE, V335, P321, DOI 10.1038/335321a0; PUHALLA JE, 1970, GENET RES, V16, P229, DOI 10.1017/S0016672300002457; PUHALLA JE, 1968, GENETICS, V60, P461; QIAN YQ, 1989, CELL, V59, P573, DOI 10.1016/0092-8674(89)90040-8; RAPER CA, 1983, SECONDARY METABOLISM, P195; RAUSCHER FJ, 1988, GENE DEV, V2, P1687, DOI 10.1101/gad.2.12b.1687; ROWELL JB, 1955, PHYTOPATHOLOGY, V45, P370; ROWELL JB, 1954, PHYTOPATHOLOGY, V44, P356; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCOTT MP, 1989, BIOCHIM BIOPHYS ACTA, V989, P25, DOI 10.1016/0304-419X(89)90033-4; SHEPHERD JCW, 1984, NATURE, V310, P70, DOI 10.1038/310070a0; STERN S, 1989, NATURE, V341, P624, DOI 10.1038/341624a0; TSUKUDA T, 1988, MOL CELL BIOL, V8, P3703, DOI 10.1128/MCB.8.9.3703; ULLRICH RC, 1978, GENETICS, V88, P709; WANG J, 1988, P NATL ACAD SCI USA, V85, P865, DOI 10.1073/pnas.85.3.865; ZHANG RG, 1987, NATURE, V327, P591, DOI 10.1038/327591a0; [No title captured]	40	338	352	1	12	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	JAN 26	1990	60	2					295	306		10.1016/0092-8674(90)90744-Y	http://dx.doi.org/10.1016/0092-8674(90)90744-Y			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CL816	1967554	hybrid			2022-12-28	WOS:A1990CL81600013
J	PHAIR, J; MUNOZ, A; DETELS, R; KASLOW, R; RINALDO, C; SAAH, A				PHAIR, J; MUNOZ, A; DETELS, R; KASLOW, R; RINALDO, C; SAAH, A			THE RISK OF PNEUMOCYSTIS-CARINII PNEUMONIA AMONG MEN INFECTED WITH HUMAN IMMUNODEFICIENCY VIRUS TYPE-1	NEW ENGLAND JOURNAL OF MEDICINE			English	Article											PHAIR, J (corresponding author), NORTHWESTERN UNIV,SCH MED,CTR COMPREHENS AIDS,680 N LAKE SHORE DR,SUITE 1106,CHICAGO,IL 60611, USA.			Kingsley, Lawrence/0000-0002-7000-8556; Vermund, Sten/0000-0001-7289-8698; Wolinsky, Steven/0000-0002-9625-6697	NIAID NIH HHS [AI-32511, AI-32513, AI-32520] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI032520, N01AI032513, N01AI032511] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		CHMIEL JS, 1987, AM J EPIDEMIOL, V126, P568, DOI 10.1093/oxfordjournals.aje.a114696; GIORGI JV, IN PRESS CLIN IMMUNO; HAY JW, 1988, J ACQ IMMUN DEF SYND, V1, P466; KASLOW RA, 1987, ANN INTERN MED, V107, P474, DOI 10.7326/0003-4819-107-4-474; KASLOW RA, 1987, AM J EPIDEMIOL, V126, P310, DOI 10.1093/aje/126.2.310; Miller R. G., 1981, SURVIVAL ANAL; PIFER LL, 1978, PEDIATRICS, V61, P35; POLK BF, 1987, NEW ENGL J MED, V316, P61, DOI 10.1056/NEJM198701083160201; TAYLOR JMG, 1989, J ACQ IMMUN DEF SYND, V2, P114; WALZER P, 1976, NCI MONOGRAPH, V43; 1987, MMWR S1, V36, pS3; 1986, SUGI SUPPLEMENTAL LI	12	587	603	0	6	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 18	1990	322	3					161	165		10.1056/NEJM199001183220304	http://dx.doi.org/10.1056/NEJM199001183220304			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CH840	1967190	Bronze			2022-12-28	WOS:A1990CH84000004
J	NIDORF, SM; PARSONS, RW; THOMPSON, PL; JAMROZIK, KD; HOBBS, MST				NIDORF, SM; PARSONS, RW; THOMPSON, PL; JAMROZIK, KD; HOBBS, MST			REDUCED RISK OF DEATH AT 28 DAYS IN PATIENTS TAKING A BETA-BLOCKER BEFORE ADMISSION TO HOSPITAL WITH MYOCARDIAL-INFARCTION	BRITISH MEDICAL JOURNAL			English	Article									QUEEN ELIZABETH II MED CTR,DIV PUBL HLTH,NEDLANDS,WA 6009,AUSTRALIA	University of Western Australia	NIDORF, SM (corresponding author), QUEEN ELIZABETH II MED CTR,DEPT CARDIOVASC MED,NEDLANDS,WA 6009,AUSTRALIA.		Thompson, Peter L/P-1071-2014					[Anonymous], 1986, Lancet, V2, P57; GOLDBERG R, 1979, JOHNS HOPKINS MED J, V144, P73; GOLDSTEIN S, 1983, CIRCULATION, V67, P53; GOMEZMARIN O, 1987, NEW ENGL J MED, V316, P1353, DOI 10.1056/NEJM198705283162201; JURGENSEN HJ, 1981, BRIT HEART J, V45, P583; MARTIN CA, 1988, ACTA MED SCAND S, V728, P40; NORRIS RM, 1980, BRIT HEART J, V43, P617; PEDERSEN TR, 1983, CIRCULATION, V67, P49; PETER T, 1978, CIRCULATION, V57, P1091, DOI 10.1161/01.CIR.57.6.1091; Prineas R., 1982, MINNESOTA CODE MANUA; THOMPSON PL, 1988, AUST NZ J MED, V18, P327, DOI 10.1111/j.1445-5994.1988.tb02045.x; TUNSTALL-PEDOE H, 1988, Journal of Clinical Epidemiology, V41, P105; YUSUF S, 1985, PROG CARDIOVASC DIS, V27, P335, DOI 10.1016/S0033-0620(85)80003-7; YUSUF S, 1983, CIRCULATION, V67, P32; 1983, CIRCULATION S1, V67, P26; 1985, EUR HEART J, V6, P199; 1985, MONICA57 MEM; 1987, EPIC EPIDEMIOLOGICAL	18	38	38	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JAN 13	1990	300	6717					71	74		10.1136/bmj.300.6717.71	http://dx.doi.org/10.1136/bmj.300.6717.71			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CJ080	1967956	Green Published, Bronze			2022-12-28	WOS:A1990CJ08000011
J	LOU, HC; HENRIKSEN, L; BRUHN, P				LOU, HC; HENRIKSEN, L; BRUHN, P			FOCAL CEREBRAL-DYSFUNCTION IN DEVELOPMENTAL LEARNING-DISABILITIES	LANCET			English	Article									RIGSHOSP,DEPT NEUROL,DK-2100 COPENHAGEN O,DENMARK	Rigshospitalet	LOU, HC (corresponding author), JOHN F KENNEDY INST,DK-2600 GLOSTRUP,DENMARK.							ANNETT M, 1961, INTELLECTUAL DISABIL; CAVINESS VS, 1989, BRAIN DEV-JPN, V11, P1; DUFFY FH, 1980, ANN NEUROL, V7, P412, DOI 10.1002/ana.410070505; GODDARD BA, 1975, J NUCL MED, V16, P280; HUSSEY H, 1967, ACTA PAEDOPSYCHIATR, V34, P130; IVERSEN SD, 1977, NEOSTRIATUM, P195; LASSEN NA, 1981, STROKE, V12, P284, DOI 10.1161/01.STR.12.3.284; LOU HC, 1984, ARCH NEUROL-CHICAGO, V41, P825, DOI 10.1001/archneur.1984.04050190031010; LOU HC, 1989, ARCH NEUROL-CHICAGO, V46, P48, DOI 10.1001/archneur.1989.00520370050018; LOU HC, IN PRESS BRAIN DEV; LURIA A R, 1973, P3; RAPIN I, 1982, INT REV CHILD NEUROL, P131; RAYNAUD C, 1989, CEREBRAL BLOOD FL S1, V9, pS323; ROLLS ET, 1983, EXP BRAIN RES S, V7, P97; RUTTER M, 1980, ED HLTH BEHAVIOR; VILLABLANCA JR, 1982, ACTA NEUROBIOL EXP, V12, P227; VORSTRUP S, 1988, ACTA NEUROL SCA S114, V77, P15	17	158	160	0	5	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	JAN 6	1990	335	8680					8	11		10.1016/0140-6736(90)90136-S	http://dx.doi.org/10.1016/0140-6736(90)90136-S			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CG766	1967380				2022-12-28	WOS:A1990CG76600003
J	HUG, G; BOVE, KE; SOUKUP, S				HUG, G; BOVE, KE; SOUKUP, S			LETHAL NEONATAL MULTIORGAN DEFICIENCY OF CARNITINE PALMITOYLTRANSFERASE-II	NEW ENGLAND JOURNAL OF MEDICINE			English	Note							ACYLCARNITINE; MUSCLE; MYOGLOBINURIA; MEMBRANE; RAT		CHILDRENS HOSP MED CTR,DIV PATHOL,CINCINNATI,OH 45229; CHILDRENS HOSP MED CTR,DIV HUMAN GENET,CINCINNATI,OH 45229	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center	HUG, G (corresponding author), CHILDRENS HOSP MED CTR,DIV ENZYMOL,CINCINNATI,OH 45229, USA.							BERTORINI T, 1980, NEUROLOGY, V30, P263, DOI 10.1212/WNL.30.3.263; CORR PB, 1989, J CLIN INVEST, V83, P927, DOI 10.1172/JCI113978; CRABTREE B, 1972, BIOCHEM J, V130, P697, DOI 10.1042/bj1300697; CRIDDLE DN, 1990, BRIT J PHARMACOL, V99, P477, DOI 10.1111/j.1476-5381.1990.tb12953.x; DEMAUGRE F, 1991, J CLIN INVEST, V87, P859, DOI 10.1172/JCI115090; DIMAURO S, 1973, SCIENCE, V182, P929, DOI 10.1126/science.182.4115.929; HALE DE, 1985, PEDIATR RES, V19, P666, DOI 10.1203/00006450-198507000-00006; HUG G, 1989, PEDIATR RES, V25, pA115; KOBAYASHI A, 1989, BIOCHIM BIOPHYS ACTA, V986, P83, DOI 10.1016/0005-2736(89)90275-7; LOPASCHUK GD, 1988, CIRC RES, V63, P1036, DOI 10.1161/01.RES.63.6.1036; MARQUIS NR, 1965, J BIOL CHEM, V240, P2193; MCGARRY JD, 1976, J LIPID RES, V17, P277; MURTHY MSR, 1990, BIOCHEM J, V268, P599, DOI 10.1042/bj2680599; PANDE SV, 1968, J BIOL CHEM, V243, P352; Papadimitriou A., 1986, MYOLOGY, V1, P1697; SAKATA K, 1989, CARDIOVASC RES, V23, P505, DOI 10.1093/cvr/23.6.505; SCHOLTE HR, 1979, J NEUROL SCI, V40, P39, DOI 10.1016/0022-510X(79)90007-8; VANTOL A, 1974, BIOCHIM BIOPHYS ACTA, V357, P14, DOI 10.1016/0005-2728(74)90107-8; WOELTJE KF, 1990, J BIOL CHEM, V265, P10714; ZINN AB, 1991, PEDIATR RES, V29, pA73	20	117	117	0	1	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 26	1991	325	26					1862	1864		10.1056/NEJM199112263252607	http://dx.doi.org/10.1056/NEJM199112263252607			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GW528	1961225	Bronze			2022-12-28	WOS:A1991GW52800007
J	GILSANZ, V; ROE, TF; MORA, S; COSTIN, G; GOODMAN, WG				GILSANZ, V; ROE, TF; MORA, S; COSTIN, G; GOODMAN, WG			CHANGES IN VERTEBRAL BONE-DENSITY IN BLACK GIRLS AND WHITE GIRLS DURING CHILDHOOD AND PUBERTY	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MINERAL CONTENT; CHILDREN; MASS; OSTEOPOROSIS; WOMEN	Background. The prevalence of osteoporosis and the incidence of vertebral fractures are lower in black women than in white women, findings generally attributed to racial differences in adult bone mass. Little is known, however, about the factors that contribute to racial variations in bone mass or the time of life when such differences become manifest. This study was done to characterize the changes in vertebral bone density at various stages of sexual development in black and white females. Methods. We measured cancellous vertebral bone density by quantitative computed tomography in 75 black female subjects between 2 and 20 years old and 75 whites matched for age and stage of sexual development. Results. The vertebral bone density did not differ between black girls and white girls before puberty. Bone density increased during puberty in each racial group, but the magnitude of the increase from prepubertal values was substantially greater in black than in white subjects (34 percent vs. 11 percent). Conclusions. The marked difference between black and white females in cancellous vertebral bone density occurs during a relatively brief period late in puberty. Metabolic and hormonal events related to the achievement of sexual maturity during adolescence may be important determinants of racial differences in bone mass in women.	UNIV SO CALIF,CHILDRENS HOSP,SCH MED,DIV ENDOCRINOL,LOS ANGELES,CA 90027; VET AFFAIRS MED CTR,MED SERV,SEPULVEDA,CA; VET AFFAIRS MED CTR,RES SERV,SEPULVEDA,CA; UNIV CALIF LOS ANGELES,SCH MED,SAN FERNANDO VALLEY PROGRAM,LOS ANGELES,CA 90024	Children's Hospital Los Angeles; University of Southern California; US Department of Veterans Affairs; Veterans Health Administration (VHA); US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	GILSANZ, V (corresponding author), UNIV SO CALIF,CHILDRENS HOSP,SCH MED,DEPT RADIOL,4650 SUNSET BLVD,LOS ANGELES,CA 90027, USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK035423] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK-35423] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BELL NH, 1985, J CLIN INVEST, V76, P470, DOI 10.1172/JCI111995; BELL NH, 1991, J BONE MINER RES, V6, P719; COHN SH, 1977, METABOLISM, V26, P171, DOI 10.1016/0026-0495(77)90052-X; CUMMINGS SR, 1985, EPIDEMIOL REV, V7, P178, DOI 10.1093/oxfordjournals.epirev.a036281; DIXON WJ, 1983, INTRO STATISTICAL AN; GARN SM, 1972, J PEDIATR-US, V80, P965, DOI 10.1016/S0022-3476(72)80008-8; GARN SM, 1964, SCIENCE, V143, P1439, DOI 10.1126/science.143.3613.1439; GARN SM, 1972, AM J PHYS ANTHROPOL, V37, P127, DOI 10.1002/ajpa.1330370116; GILSANZ V, 1988, RADIOLOGY, V166, P847, DOI 10.1148/radiology.166.3.3340782; GILSANZ V, 1988, AM J PHYSIOL, V255, pE416, DOI 10.1152/ajpendo.1988.255.4.E416; GILSANZ V, 1988, J BONE MINER RES, V3, pS90; GLASTRE C, 1990, J CLIN ENDOCR METAB, V70, P1330, DOI 10.1210/jcem-70-5-1330; Greulich WW., 1959, CALIF MED, V91, P53; LI JY, 1989, AM J DIS CHILD, V143, P1346, DOI 10.1001/archpedi.1989.02150230104034; MEIER DE, 1991, J CLIN ENDOCR METAB, V72, P703, DOI 10.1210/jcem-72-3-703; MELTON LJ, 1987, OSTEOPOROTIC SYNDROM, P1; POLLITZER WS, 1989, AM J CLIN NUTR, V50, P1244, DOI 10.1093/ajcn/50.6.1244; POLLITZER WS, 1990, AM J CLIN NUTR, V52, P181; RAISZ LG, 1989, ANNU REV MED, V40, P251; REID IR, 1986, BRIT MED J, V292, P1547, DOI 10.1136/bmj.292.6535.1547; REID IR, 1990, J CLIN ENDOCR METAB, V70, P1452, DOI 10.1210/jcem-70-5-1452; SCHUTTE JE, 1984, J APPL PHYSIOL, V56, P1647, DOI 10.1152/jappl.1984.56.6.1647; SOUTHARD RN, 1991, RADIOLOGY, V179, P735, DOI 10.1148/radiology.179.3.2027984; TANNER JM, 1978, TXB PEDIAT, P249; TROTTER M, 1960, J BONE JOINT SURG AM, V42, P50, DOI 10.2106/00004623-196042010-00005; VAUGHAN VC, 1987, NELSON TXB PEDIATRIC, P24	26	298	303	0	5	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 5	1991	325	23					1597	1600		10.1056/NEJM199112053252302	http://dx.doi.org/10.1056/NEJM199112053252302			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GR770	1944449				2022-12-28	WOS:A1991GR77000002
J	OHKUMA, Y; SUMIMOTO, H; HOFFMANN, A; SHIMASAKI, S; HORIKOSHI, M; ROEDER, RG				OHKUMA, Y; SUMIMOTO, H; HOFFMANN, A; SHIMASAKI, S; HORIKOSHI, M; ROEDER, RG			STRUCTURAL MOTIFS AND POTENTIAL SIGMA-HOMOLOGIES IN THE LARGE SUBUNIT OF HUMAN GENERAL TRANSCRIPTION FACTOR TFIIE	NATURE			English	Article							RNA POLYMERASE-II; TATA BOX; SEQUENCE; PROTEIN; CLONING	THE general transcription factor TFIIE has an essential role in eukaryotic transcription initiation together with RNA polymerase II and other general factors 1,2 . Human TFIIE consists of two subunits of relative molecular mass 57,000 (TFIIE-alpha) and 34,000 (TFIIE-beta) 3-5 and joins the preinitiation complex after RNA polymerase II and TFIIF (ref. 5). Here we report the cloning and structure of a complementary DNA encoding 2 functional human TFIIE-alpha. TFIIE-alpha is necessary for transcription initiation together with TFIIE-beta, and recombinant TFIIE-alpha can fully replace the natural subunit in an in vitro transcription assay. The sequence contains several interesting structural motifs 6 (leucine repeat, zinc finger and helix-turn-helix) and sequence similarities to bacterial sigma-factors that suggest direct involvement in the regulation of transcription initiation.	WHITTIER INST DIABET & ENDOCRINOL,LA JOLLA,CA 92037		OHKUMA, Y (corresponding author), ROCKEFELLER UNIV,BIOCHEM & MOLEC BIOL LAB,NEW YORK,NY 10021, USA.							ALLISON LA, 1985, CELL, V42, P599, DOI 10.1016/0092-8674(85)90117-5; BROYLES SS, 1986, P NATL ACAD SCI USA, V83, P3141, DOI 10.1073/pnas.83.10.3141; CONAWAY JW, 1991, J BIOL CHEM, V266, P7804; FLORES O, 1989, J BIOL CHEM, V264, P8913; HELMANN JD, 1988, ANNU REV BIOCHEM, V57, P839, DOI 10.1146/annurev.bi.57.070188.004203; HIRASHIMA S, 1988, J BIOL CHEM, V263, P3858; HIRATA M, 1991, NATURE, V349, P617, DOI 10.1038/349617a0; HOFFMANN A, 1990, NATURE, V346, P387, DOI 10.1038/346387a0; HORIKOSHI M, 1990, CELL, V61, P1171, DOI 10.1016/0092-8674(90)90681-4; HORIKOSHI M, 1988, CELL, V54, P665, DOI 10.1016/S0092-8674(88)80011-4; HORIKOSHI M, 1989, NATURE, V341, P299, DOI 10.1038/341299a0; INOSTROZA J, 1991, J BIOL CHEM, V266, P9304; JOHNSON PF, 1989, ANNU REV BIOCHEM, V58, P799, DOI 10.1146/annurev.biochem.58.1.799; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; LIN YS, 1991, CELL, V64, P971, DOI 10.1016/0092-8674(91)90321-O; MALIK S, IN PRESS P NATN ACAD; MCCRACKEN S, 1991, SCIENCE, V253, P900, DOI 10.1126/science.1652156; MILLER J, 1985, EMBO J, V4, P1609, DOI 10.1002/j.1460-2075.1985.tb03825.x; OHKUMA Y, 1990, P NATL ACAD SCI USA, V87, P9163, DOI 10.1073/pnas.87.23.9163; OLLIS DL, 1985, NATURE, V313, P762, DOI 10.1038/313762a0; PTASHNE M, 1988, NATURE, V335, P683, DOI 10.1038/335683a0; ROSENBERG UB, 1986, NATURE, V319, P336, DOI 10.1038/319336a0; SALTZMAN AG, 1989, FASEB J, V3, P1723, DOI 10.1096/fasebj.3.6.2649403; SAWADOGO M, 1990, ANNU REV BIOCHEM, V59, P711, DOI 10.1146/annurev.bi.59.070190.003431; SAWADOGO M, 1985, P NATL ACAD SCI USA, V82, P4394, DOI 10.1073/pnas.82.13.4394; SCHEIDEREIT C, 1988, NATURE, V336, P551, DOI 10.1038/336551a0; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; SUMIMOTO H, 1990, P NATL ACAD SCI USA, V87, P9158, DOI 10.1073/pnas.87.23.9158; SUMIMOTO H, 1991, NATURE, V354, P401, DOI 10.1038/354401a0; WOYCHIK NA, 1990, TRENDS BIOCHEM SCI, V15, P347, DOI 10.1016/0968-0004(90)90074-L	30	90	92	0	0	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	DEC 5	1991	354	6352					398	401		10.1038/354398a0	http://dx.doi.org/10.1038/354398a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT761	1956403				2022-12-28	WOS:A1991GT76100053
J	CHOI, HK; TONG, L; MINOR, W; DUMAS, P; BOEGE, U; ROSSMANN, MG; WENGLER, G				CHOI, HK; TONG, L; MINOR, W; DUMAS, P; BOEGE, U; ROSSMANN, MG; WENGLER, G			STRUCTURE OF SINDBIS VIRUS CORE PROTEIN REVEALS A CHYMOTRYPSIN-LIKE SERINE PROTEINASE AND THE ORGANIZATION OF THE VIRION	NATURE			English	Article							SEMLIKI FOREST VIRUS; ALPHA-LYTIC PROTEASE; AMINO-ACID-SEQUENCE; CAPSID PROTEIN; RNA VIRUSES; NONSTRUCTURAL PROTEINS; CYSTEINE PROTEASES; MOSAIC-VIRUS; RESOLUTION; ALPHAVIRUSES	Sindbis virus consists of a nucleocapsid core surrounded by a lipid membrane through which penetrate 80 glycoprotein trimers. The structure of the core protein comprising the coat surrounding the genomic RNA has been determined. The polypeptide fold from residue 114 to residue 264 is homologous to that of chymotrypsin-like serine proteinases with catalytic residues His 141, Asp 163 and Ser 215 of the core protein positioned as in other serine proteinases. The C-terminal tryptophan remains in the P1 substrate site subsequent to the autocatalytic cis cleavage of the capsid protein, thus rendering the proteinase inactive. Model building of the Sindbis core protein dimer shows that the nucleocapsid is likely to have T = 4 quasisymmetry.	PURDUE UNIV, DEPT BIOL SCI, W LAFAYETTE, IN 47907 USA; UNIV ALBERTA, DEPT BIOCHEM, EDMONTON T6G 2H7, ALBERTA, CANADA; UNIV GIESSEN, INST VIROL, W-6300 GIESSEN, GERMANY	Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Alberta; Justus Liebig University Giessen			Minor, Wladek/F-3096-2014	Minor, Wladek/0000-0001-7075-7090; Tong, Liang/0000-0002-0563-6468				ABADZAPATERO C, 1980, NATURE, V286, P33, DOI 10.1038/286033a0; AHLQUIST P, 1985, J VIROL, V53, P536, DOI 10.1128/JVI.53.2.536-542.1985; ALIPERTI G, 1978, VIROLOGY, V90, P366, DOI 10.1016/0042-6822(78)90321-5; ANDINO R, 1990, CELL, V63, P369, DOI 10.1016/0092-8674(90)90170-J; ANTHONY RP, 1991, J VIROL, V65, P1187, DOI 10.1128/JVI.65.3.1187-1194.1991; BAZAN JF, 1988, P NATL ACAD SCI USA, V85, P7872, DOI 10.1073/pnas.85.21.7872; BIRKTOFT JJ, 1972, J MOL BIOL, V68, P187, DOI 10.1016/0022-2836(72)90210-0; BODE W, 1978, J MOL BIOL, V118, P99, DOI 10.1016/0022-2836(78)90246-2; BOEGE U, 1989, J MOL BIOL, V208, P79, DOI 10.1016/0022-2836(89)90089-2; BOEGE U, 1983, EUR J BIOCHEM, V133, P415, DOI 10.1111/j.1432-1033.1983.tb07479.x; BOEGE U, 1981, VIROLOGY, V113, P293, DOI 10.1016/0042-6822(81)90156-2; BONE R, 1987, BIOCHEMISTRY-US, V26, P7609, DOI 10.1021/bi00398a012; CASPAR DLD, 1962, COLD SPRING HARB SYM, V27, P1, DOI 10.1101/sqb.1962.027.001.005; CONNOLLY ML, 1985, J MOL GRAPHICS, V3, P19, DOI 10.1016/0263-7855(85)80009-6; COOMBS K, 1987, J MOL BIOL, V195, P359, DOI 10.1016/0022-2836(87)90657-7; COOMBS K, 1987, VIRUS RES, V7, P131, DOI 10.1016/0168-1702(87)90075-X; COOMBS K, 1984, VIRUS RES, V1, P297, DOI 10.1016/0168-1702(84)90018-2; COOMBS KM, 1989, J VIROL, V63, P883, DOI 10.1128/JVI.63.2.883-891.1989; DESSENS JT, 1991, VIROLOGY, V184, P738, DOI 10.1016/0042-6822(91)90444-G; ENZMANN PJ, 1979, VIROLOGY, V95, P501, DOI 10.1016/0042-6822(79)90504-X; FREEMAN R, 1981, J MICROSC-OXFORD, V122, P275, DOI 10.1111/j.1365-2818.1981.tb01267.x; FUJINAGA M, 1985, J MOL BIOL, V184, P479, DOI 10.1016/0022-2836(85)90296-7; FULLER SD, 1987, EMBO J, V6, P1099, DOI 10.1002/j.1460-2075.1987.tb04864.x; FULLER SD, 1987, CELL, V48, P923, DOI 10.1016/0092-8674(87)90701-X; GORBALENYA AE, 1989, FEBS LETT, V243, P103, DOI 10.1016/0014-5793(89)80109-7; HAHN CS, 1990, J VIROL, V64, P3069, DOI 10.1128/JVI.64.6.3069-3073.1990; HAHN CS, 1988, P NATL ACAD SCI USA, V85, P5997, DOI 10.1073/pnas.85.16.5997; HAHN CS, 1985, P NATL ACAD SCI USA, V82, P4648, DOI 10.1073/pnas.82.14.4648; HAMMERLE T, 1991, J BIOL CHEM, V266, P5412; Harrison S. C., 1986, TOGAVIRIDAE FLAVIVIR, P21; HARRISON SC, 1978, NATURE, V276, P368, DOI 10.1038/276368a0; HASELOFF J, 1984, P NATL ACAD SCI-BIOL, V81, P4358, DOI 10.1073/pnas.81.14.4358; HORZINEK M, 1969, J VIROL, V4, P514, DOI 10.1128/JVI.4.4.514-520.1969; Kaariainen L, 1978, Curr Top Microbiol Immunol, V82, P15; KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P916, DOI 10.1107/S0021889888007903; KEAN KM, 1991, VIROLOGY, V181, P609, DOI 10.1016/0042-6822(91)90894-H; KRAULIS P, IN PRESS J APPL CRYS; KRAUSSLICH HG, 1988, ANNU REV BIOCHEM, V57, P701, DOI 10.1146/annurev.bi.57.070188.003413; Liljas A., 1974, ANNU REV BIOCHEM, V43, P475; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; MCKENNA R, UNPUB NATURE; MELANCON P, 1987, J VIROL, V61, P1301, DOI 10.1128/JVI.61.5.1301-1309.1987; METSIKKO K, 1990, J VIROL, V64, P4678; NAMBA K, 1986, SCIENCE, V231, P1401, DOI 10.1126/science.3952490; ROSSMANN MG, 1989, ANNU REV BIOCHEM, V58, P533, DOI 10.1146/annurev.bi.58.070189.002533; ROSSMANN MG, 1962, ACTA CRYSTALLOGR, V15, P24, DOI 10.1107/S0365110X62000067; ROSSMANN MG, 1975, J BIOL CHEM, V250, P7525; ROSSMANN MG, IN PRESS J APPL CRYS; SCHEEFERS H, 1980, P NATL ACAD SCI-BIOL, V77, P7277, DOI 10.1073/pnas.77.12.7277; Schlesinger, 1986, TOGAVIRIDAE FLAVIVIR, P35, DOI 10.1007/978-1-4757-0785-4_3; Schlesinger S., 1986, TOGAVIRIDAE FLAVIVIR, P121, DOI [10.1007/978-1-4757-0785-4_5, DOI 10.1007/978-1-4757-0785-4_5]; SCUPHAM RK, 1977, J VIROL, V22, P568; SHOPE RE, 1980, TOGAVIRUSES BIOL STR, P47; SIMMONS DT, 1974, J MOL BIOL, V86, P397, DOI 10.1016/0022-2836(74)90027-8; SIMONS K, 1984, ADV PROTEIN CHEM, V36, P79, DOI 10.1016/S0065-3233(08)60296-X; STRAUSS EG, 1984, VIROLOGY, V133, P92, DOI 10.1016/0042-6822(84)90428-8; STRAUSS JH, 1988, ANNU REV MICROBIOL, V42, P657, DOI 10.1146/annurev.mi.42.100188.003301; Strauss JH, 1990, SEMIN VIROL, V1, P347; TSAO J, 1991, SCIENCE, V251, P1456, DOI 10.1126/science.2006420; ULMANEN I, 1979, VIROLOGY, V99, P265, DOI 10.1016/0042-6822(79)90006-0; VALEGARD K, 1990, NATURE, V345, P36, DOI 10.1038/345036a0; VANSTEEG H, 1984, EUR J BIOCHEM, V138, P473; VAUX DJT, 1988, NATURE, V336, P36, DOI 10.1038/336036a0; VOGEL RH, 1986, NATURE, V320, P533, DOI 10.1038/320533a0; VONBONSDORFF CH, 1975, J VIROL, V16, P141, DOI 10.1128/JVI.16.1.141-145.1975; WEISS B, 1989, J VIROL, V63, P5310, DOI 10.1128/JVI.63.12.5310-5318.1989; WENGLER G, 1984, VIROLOGY, V132, P401, DOI 10.1016/0042-6822(84)90045-X; WENGLER G, 1982, VIROLOGY, V118, P401, DOI 10.1016/0042-6822(82)90359-2	68	262	268	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 7	1991	354	6348					37	43		10.1038/354037a0	http://dx.doi.org/10.1038/354037a0			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN829	1944569				2022-12-28	WOS:A1991GN82900049
J	GOLUMBEK, PT; LAZENBY, AJ; LEVITSKY, HI; JAFFEE, LM; KARASUYAMA, H; BAKER, M; PARDOLL, DM				GOLUMBEK, PT; LAZENBY, AJ; LEVITSKY, HI; JAFFEE, LM; KARASUYAMA, H; BAKER, M; PARDOLL, DM			TREATMENT OF ESTABLISHED RENAL-CANCER BY TUMOR-CELLS ENGINEERED TO SECRETE INTERLEUKIN-4	SCIENCE			English	Article							STIMULATORY FACTOR-I; CYTOLYTIC T-CELLS; LYMPHOCYTES-T; MONOCLONAL-ANTIBODY; GENERATION; EXPRESSION; PEPTIDE; GENE; DNA	The generation of antigen-specific antitumor immunity is the ultimate goal in cancer immunotherapy. When cells from a spontaneously arising murine renal cell tumor were engineered to secrete large doses of interleukin-4 (IL-4) locally, they were rejected in a predominantly T cell-independent manner. However, animals that rejected the IL-4-transfected tumors developed T cell-dependent systemic immunity to the parental tumor. This systemic immunity was tumor-specific and primarily mediated by CD8+ T cells. Established parental tumors could be cured by the systemic immune response generated by injection of the genetically engineered tumors. These results provide a rationale for the use of lymphokine gene-transfected tumor cells as a modality for cancer therapy.	JOHNS HOPKINS UNIV, DEPT MED, BALTIMORE, MD 21205 USA; JOHNS HOPKINS UNIV, DEPT PATHOL, BALTIMORE, MD 21205 USA; JOHNS HOPKINS UNIV, DEPT IMMUNOL, BALTIMORE, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University			Karasuyama, Hajime/A-7966-2011	Karasuyama, Hajime/0000-0003-0689-0836				DIALYNAS DP, 1983, J IMMUNOL, V131, P2445; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; FEARON ER, 1990, CELL, V60, P397, DOI 10.1016/0092-8674(90)90591-2; FERNANDEZBOTRAN R, 1986, P NATL ACAD SCI USA, V83, P9689, DOI 10.1073/pnas.83.24.9689; GOLUMBEK P, UNPUB; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; GRUSBY MJ, 1990, CELL, V60, P451, DOI 10.1016/0092-8674(90)90596-7; HAVRAN WL, 1987, NATURE, V330, P170, DOI 10.1038/330170a0; HEWITT HB, 1976, BRIT J CANCER, V33, P241, DOI 10.1038/bjc.1976.37; HULI J, 1987, J EXP MED, V165, P157, DOI 10.1084/jem.165.1.157; KARASUYAMA H, 1988, EUR J IMMUNOL, V18, P97, DOI 10.1002/eji.1830180115; LURQUIN C, 1989, CELL, V58, P293, DOI 10.1016/0092-8674(89)90844-1; MANN R, 1983, CELL, V33, P153, DOI 10.1016/0092-8674(83)90344-6; MARX JL, 1989, SCIENCE, V245, P813, DOI 10.1126/science.2672332; MARYANSKI JL, 1986, NATURE, V324, P578, DOI 10.1038/324578a0; Mathe G, 1971, Adv Cancer Res, V14, P1, DOI 10.1016/S0065-230X(08)60517-5; MOORE MW, 1988, CELL, V54, P777, DOI 10.1016/S0092-8674(88)91043-4; MULLIGAN RC, 1991, NOBEL SYMP, V80, P143; MURPHY GP, 1973, JNCI-J NATL CANCER I, V50, P1013, DOI 10.1093/jnci/50.4.1013; OHARA J, 1985, NATURE, V315, P333, DOI 10.1038/315333a0; PAUL WE, 1987, ANNU REV IMMUNOL, V5, P429, DOI 10.1146/annurev.iy.05.040187.002241; SALUP RR, 1985, J UROLOGY, V134, P1236, DOI 10.1016/S0022-5347(17)47702-0; SARMIENTO M, 1980, J IMMUNOL, V125, P2665; SPRINGER T, 1979, EUR J IMMUNOL, V9, P301, DOI 10.1002/eji.1830090410; TEPPER RI, 1989, CELL, V57, P503, DOI 10.1016/0092-8674(89)90925-2; TOWNSEND ARM, 1986, CELL, V44, P959, DOI 10.1016/0092-8674(86)90019-X; TRENN G, 1988, J IMMUNOL, V140, P1101; WIDMER MB, 1987, NATURE, V326, P795, DOI 10.1038/326795a0; WIGLER M, 1979, P NATL ACAD SCI USA, V76, P1373, DOI 10.1073/pnas.76.3.1373	29	776	836	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 1	1991	254	5032					713	716		10.1126/science.1948050	http://dx.doi.org/10.1126/science.1948050			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN474	1948050				2022-12-28	WOS:A1991GN47400042
J	DELAMOTHE, T				DELAMOTHE, T			THE HEALTH OF THE NATION - RESPONSE - SOCIAL INEQUALITIES IN HEALTH	BRITISH MEDICAL JOURNAL			English	Article																		ALESINA A, 1991, 565 CTR EC POL RES D; BARKER DJP, 1990, BRIT MED J, V301, P1111, DOI 10.1136/bmj.301.6761.1111; BLANE D, 1990, BRIT MED J, V301, P429, DOI 10.1136/bmj.301.6749.429; BRINDLE D, 1991, GARDIAN         0913, P4; Hills J., 1990, STATE WELFARE WELFAR; Hills J., 1990, CHANGING TAX TAX SYS; JACOBSON B, 1991, NATIONS HLTH STRATEG; JENKINS SP, 1991, FISCAL STUDIES, V512, P1; LOWRY S, 1991, BRIT MED J, V303, P838, DOI 10.1136/bmj.303.6806.838; MARMOT MG, 1989, BRIT MED J, V299, P1547, DOI 10.1136/bmj.299.6715.1547; MAUDE F, 1991, 104 HOUS COMM OFF RE; QUCK A, 1991, INCOME HLTH; ROWTHORN B, IN PRESS EC LEGACY 1; SMITH GD, 1990, BMJ-BRIT MED J, V301, P373, DOI 10.1136/bmj.301.6748.373; VAGERO D, 1989, LANCET, V2, P35, DOI 10.1016/S0140-6736(89)90266-3; Wilkinson RG, 1986, CLASS HLTH RES LONGI; WILKINSON RG, 1991, IN PRESS BMJ; 1986, OCCUPATIONAL MORTALI; 1991, STATE PUBLIC HLTH 19; 1988, OCCUPATIONAL MORTALI; 1991, COM9129 EUR COMM FIN; 1990, STATE PUBLIC HLTH 19; 1991, LOW INCOME STATISTIC; 1991, CM1523; 1991, MORTALITY STATISTICS	25	26	26	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	OCT 26	1991	303	6809					1046	1050		10.1136/bmj.303.6809.1046	http://dx.doi.org/10.1136/bmj.303.6809.1046			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GM478	1954461	Green Published, Bronze			2022-12-28	WOS:A1991GM47800028
J	HALES, CN; BARKER, DJP; CLARK, PMS; COX, LJ; FALL, C; OSMOND, C; WINTER, PD				HALES, CN; BARKER, DJP; CLARK, PMS; COX, LJ; FALL, C; OSMOND, C; WINTER, PD			FETAL AND INFANT GROWTH AND IMPAIRED GLUCOSE-TOLERANCE AT AGE 64	BMJ-BRITISH MEDICAL JOURNAL			English	Article							DIABETES-MELLITUS; HEART-DISEASE; INSULIN; HYPERTENSION; PREVALENCE; RISK; LIFE	Objective - To discover whether reduced fetal and infant growth is associated with non-insulin dependent diabetes and impaired glucose tolerance in adult life. Design - Follow up study of men born during 1920-30 whose birth weights and weights at 1 year were known. Setting - Hertfordshire, England. Subjects - 468 men born in east Hertfordshire and still living there. Main outcome measures-Fasting plasma glucose, insulin, proinsulin, and 32-33 split proinsulin concentrations and plasma glucose and insulin concentrations 30 and 120 minutes after a 75 g glucose drink. Results - 93 men had impaired glucose tolerance or hitherto undiagnosed diabetes. They had had a lower mean birth weight and a lower weight at 1 year. The proportion of men with impaired glucose tolerance fell progressively from 26% (6/23) among those who had weighed 18 lb (8-16 kg) or less at 1 year to 13% (3/24) among those who had weighed 27 lb (12.25 kg) or more. Corresponding figures for diabetes were 17% (4/23) and nil (0/24). Plasma glucose concentrations at 30 and 120 minutes fell with increasing birth weight and weight at 1 year. Plasma 32-33 split proinsulin concentration fell with increasing weight at 1 year. All these trends were significant and independent of current body mass. Blood pressure was inversely related to birth weight and strongly related to plasma glucose and 32-33 split proinsulin concentrations. Conclusions - Reduced growth in early life is strongly linked with impaired glucose tolerance and non-insulin dependent diabetes. Reduced early growth is also related to a raised plasma concentration of 32-33 split proinsulin, which is interpreted as a sign of beta-cell dysfunction. Reduced intrauterine growth is linked with high blood pressure, which may explain the association between hypertension and impaired glucose tolerance.	SOUTHAMPTON GEN HOSP, MRC, ENVIRONM EPIDEMIOL UNIT, SOUTHAMPTON SO9 4XY, HANTS, ENGLAND	University of Southampton	HALES, CN (corresponding author), UNIV CAMBRIDGE, ADDENBROOKES HOSP, DEPT CLIN BIOCHEM, CAMBRIDGE CB2 2QR, ENGLAND.			Osmond, Clive/0000-0002-9054-4655				[Anonymous], 1989, LANCET, V2, P839; [Anonymous], 1980, CLASSIFICATION OCCUP; BARKER DJP, 1989, LANCET, V2, P577; BARKER DJP, 1991, J ROY COLL PHYS LOND, V25, P129; BARKER DJP, 1990, BRIT MED J, V301, P259, DOI 10.1136/bmj.301.6746.259; COHEN MP, 1988, DIABETES, V37, P824, DOI 10.2337/diabetes.37.6.824; FREINKEL N, 1980, DIABETES, V29, P1023, DOI 10.2337/diabetes.29.12.1023; FULLER JH, 1980, LANCET, V1, P1373; HARRIS MI, 1987, DIABETES, V36, P523, DOI 10.2337/diabetes.36.4.523; Hellerstrom C, 1988, PATHOLOGY ENDOCRINE, P141; JOHANNSSON A, 1985, CLIN CHIM ACTA, V148, P119, DOI 10.1016/0009-8981(85)90221-9; KLOPPEL G, 1985, SURV SYN PATHOL RES, V4, P110; Kunst A., 1984, METHOD ENZYMAT AN, VVI, P163; MODAN M, 1985, J CLIN INVEST, V75, P809, DOI 10.1172/JCI111776; NEWMAN B, 1987, DIABETOLOGIA, V30, P763; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; SOBEY WJ, 1989, BIOCHEM J, V260, P535, DOI 10.1042/bj2600535; STAMLER J, 1975, J CHRON DIS, V28, P527, DOI 10.1016/0021-9681(75)90060-0; SWENNE I, 1987, DIABETES, V36, P454, DOI 10.2337/diabetes.36.4.454; TEMPLE RC, 1989, LANCET, V1, P293, DOI 10.1016/S0140-6736(89)91306-8; van Assche F A, 1979, Contrib Gynecol Obstet, V5, P44	21	2017	2075	2	73	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 26	1991	303	6809					1019	1022		10.1136/bmj.303.6809.1019	http://dx.doi.org/10.1136/bmj.303.6809.1019			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GM478	1954451	Bronze, Green Published			2022-12-28	WOS:A1991GM47800017
J	KILTY, JE; LORANG, D; AMARA, SG				KILTY, JE; LORANG, D; AMARA, SG			CLONING AND EXPRESSION OF A COCAINE-SENSITIVE RAT DOPAMINE TRANSPORTER	SCIENCE			English	Article							BRAIN GABA TRANSPORTER; NOREPINEPHRINE UPTAKE; BINDING	The action of dopamine and other monoamine neurotransmitters at synapses is terminated predominantly by high-affinity reuptake into presynaptic terminals by specific sodium-dependent neurotransmitter transport proteins. A complementary DNA encoding a rat dopamine transporter has been isolated that exhibits high sequence similarity with the previously cloned norepinephrine and gamma-aminobutyric acid transporters. Transient expression of the complementary DNA in HeLa cells confirms the cocaine sensitivity of this transporter.	OREGON HLTH SCI UNIV,INST VOLLUM,PORTLAND,OR 97201; YALE UNIV,PROGRAM NEUROSCI,NEW HAVEN,CT 06510	Oregon Health & Science University; Yale University				Amara, Susan/0000-0001-8914-1106				AMARA S, UNPUB; BLAKELY RD, 1991, ANAL BIOCHEM, V194, P302, DOI 10.1016/0003-2697(91)90233-J; BOJA JW, 1989, EUR J PHARMACOL, V173, P215, DOI 10.1016/0014-2999(89)90524-4; FUERST TR, 1986, P NATL ACAD SCI USA, V83, P8122, DOI 10.1073/pnas.83.21.8122; GUASTELLA J, 1990, SCIENCE, V249, P1303, DOI 10.1126/science.1975955; JAVITCH JA, 1984, MOL PHARMACOL, V26, P35; NELSON H, 1990, FEBS LETT, V269, P181, DOI 10.1016/0014-5793(90)81149-I; PACHOLCZYK T, 1991, NATURE, V350, P350, DOI 10.1038/350350a0; RICHELSON E, 1984, EUR J PHARMACOL, V104, P277, DOI 10.1016/0014-2999(84)90403-5; RITZ MC, 1987, SCIENCE, V237, P1219, DOI 10.1126/science.2820058; SIMERLY RB, 1990, J COMP NEUROL, V294, P76, DOI 10.1002/cne.902940107	11	480	492	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	OCT 25	1991	254	5031					578	579		10.1126/science.1948035	http://dx.doi.org/10.1126/science.1948035			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GL799	1948035				2022-12-28	WOS:A1991GL79900052
J	RUTHERFORD, W; GABRIEL, R				RUTHERFORD, W; GABRIEL, R			AUDIT OF OUTPATIENT LETTERS	BRITISH MEDICAL JOURNAL			English	Article									ST MARYS HOSP,RENAL UNIT,LONDON W2 1NY,ENGLAND	Imperial College London								LOCK PM, 1989, NEPHROL DIAL TRANSPL, V4, P119; MASON DL, 1991, WHICH            FEB, P94; RICHARDS T, 1991, BRIT MED J, V302, P611; RYLANCE G, 1990, BRIT MED J, V300, P608, DOI 10.1136/bmj.300.6724.608-c; TATTERSALL R, 1990, DIABETIC MED, V7, P917, DOI 10.1111/j.1464-5491.1990.tb01330.x	5	13	13	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	OCT 19	1991	303	6808					968	968		10.1136/bmj.303.6808.968	http://dx.doi.org/10.1136/bmj.303.6808.968			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GL127	1954423	Green Published, Bronze			2022-12-28	WOS:A1991GL12700025
J	THOMAS, DJ; WOLFE, JHN				THOMAS, DJ; WOLFE, JHN			ABC OF VASCULAR DISEASES - CAROTID ENDARTERECTOMY	BRITISH MEDICAL JOURNAL			English	Article											THOMAS, DJ (corresponding author), ST MARYS HOSP,LONDON,ENGLAND.								0	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	OCT 19	1991	303	6808					985	987		10.1136/bmj.303.6808.985	http://dx.doi.org/10.1136/bmj.303.6808.985			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GL127	1954430	Bronze, Green Published			2022-12-28	WOS:A1991GL12700035
J	KERN, F				KERN, F			NORMAL PLASMA-CHOLESTEROL IN AN 88-YEAR-OLD MAN WHO EATS 25 EGGS A DAY - MECHANISMS OF ADAPTATION	NEW ENGLAND JOURNAL OF MEDICINE			English	Note							STEADY-STATE KINETICS; COENZYME-A REDUCTASE; DIETARY-CHOLESTEROL; SERUM-CHOLESTEROL; BILE-ACIDS; BIOSYNTHESIS; LIPOPROTEINS; HOMEOSTASIS; ABSORPTION; METABOLISM				KERN, F (corresponding author), UNIV COLORADO,SCH MED,DEPT MED,DIV GASTROENTEROL,4200 E 9TH AVE,BOX B-158,DENVER,CO 80262, USA.				NCRR NIH HHS [5MO1 RR00051] Funding Source: Medline; NIDDK NIH HHS [5P30 DK34914, R01 DK31765] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000051] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK031765, P30DK034914] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AHRENS EH, 1984, J LIPID RES, V25, P1442; BEYNEN AC, 1985, ATHEROSCLEROSIS, V57, P19, DOI 10.1016/0021-9150(85)90134-0; BHATTACHARYYA AK, 1981, J LIPID RES, V22, P16; CHOW SL, 1978, LIPIDS, V13, P239, DOI 10.1007/BF02533662; CLARKSON TB, 1971, ARCH PATHOL, V92, P37; CLARKSON TB, 1985, ANN NY ACAD SCI, V454, P28, DOI 10.1111/j.1749-6632.1985.tb11842.x; EVERSON GT, 1991, J CLIN INVEST, V87, P237, DOI 10.1172/JCI114977; EVERSON GT, 1987, J LIPID RES, V28, P238; EVERSON GT, 1988, J LIPID RES, V29, P68; FOGELMAN AM, 1979, J LIPID RES, V20, P379; GRUNDY SM, 1983, ANNU REV NUTR, V3, P71, DOI 10.1146/annurev.nu.03.070183.000443; GRUNDY SM, 1990, J LIPID RES, V31, P1149; HARWOOD HJ, 1987, J CLIN INVEST, V79, P1125, DOI 10.1172/JCI112928; HEGSTED DM, 1986, AM J CLIN NUTR, V44, P299, DOI 10.1093/ajcn/44.2.299; JONES DC, 1975, J FOOD SCI, V40, P2, DOI 10.1111/j.1365-2621.1975.tb03723.x; KANDUTSCH AA, 1973, J BIOL CHEM, V248, P8408; KASANIEMI YA, 1987, J CLIN INVEST, V80, P578; KATAN MB, 1986, AM J EPIDEMIOL, V123, P221, DOI 10.1093/oxfordjournals.aje.a114231; KERN F, 1987, J LIPID RES, V28, P828; LIN DS, 1980, J LIPID RES, V21, P1042; MARANHAO RC, 1983, J LIPID RES, V24, P167; MCNAMARA DJ, 1987, J CLIN INVEST, V79, P1729, DOI 10.1172/JCI113013; Miettinen T A, 1988, Agents Actions Suppl, V26, P53; MISTRY P, 1981, J CLIN INVEST, V67, P493, DOI 10.1172/JCI110058; MYANT NB, 1981, BIOL CHOLESTROL RELA, P466; NESTEL PJ, 1976, METABOLISM, V25, P1591, DOI 10.1016/0026-0495(76)90112-8; PATEL DD, 1984, BIOCHEM J, V219, P461, DOI 10.1042/bj2190461; QUINTAO E, 1971, J LIPID RES, V12, P233; SIPERSTEIN MD, 1952, P SOC EXP BIOL MED, V81, P720, DOI 10.3181/00379727-81-19999; STRAKA MS, 1990, J BIOL CHEM, V265, P7145; THOMSON ABR, 1981, PHYSL GASTROINTESTIN, V2, P1147; THURNHOFER H, 1990, BIOCHEMISTRY-US, V29, P2142, DOI 10.1021/bi00460a026	32	106	112	0	3	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 28	1991	324	13					896	899		10.1056/NEJM199103283241306	http://dx.doi.org/10.1056/NEJM199103283241306			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FD111	1953841				2022-12-28	WOS:A1991FD11100006
J	STURM, AW; MOSTERT, R; ROUING, PJE; VANKLINGEREN, B; VANALPHEN, L				STURM, AW; MOSTERT, R; ROUING, PJE; VANKLINGEREN, B; VANALPHEN, L			OUTBREAK OF MULTIRESISTANT NON-ENCAPSULATED HEMOPHILUS-INFLUENZAE INFECTIONS IN A PULMONARY REHABILITATION CENTER	LANCET			English	Article									PULM REHABIL CTR HORNERHEIDE,HORN,NETHERLANDS; NATL INST PUBL HLTH & ENVIRONM PROTECT,BILTHOVEN,NETHERLANDS; UNIV AMSTERDAM,DEPT MED MICROBIOL,AMSTERDAM,NETHERLANDS	Netherlands National Institute for Public Health & the Environment; University of Amsterdam	STURM, AW (corresponding author), ST LAURENTIUS HOSP,DEPT MED MICROBIOL,POB 920,6040 AX ROERMOND,NETHERLANDS.							ALPHEN LV, 1983, J BACTERIOL, V155, P878; CAMPOS J, 1984, ANTIMICROB AGENTS CH, V25, P706, DOI 10.1128/AAC.25.6.706; FERNANDEZROBLAS R, 1988, J ANTIMICROB CHEMOTH, V22, P867, DOI 10.1093/jac/22.6.867; GLODE MP, 1976, J PEDIATR-US, V88, P36, DOI 10.1016/S0022-3476(76)80723-8; GROENEVELD K, 1988, J INFECT DIS, V158, P360, DOI 10.1093/infdis/158.2.360; KADO CI, 1981, J BACTERIOL, V145, P1365, DOI 10.1128/JB.145.3.1365-1373.1981; KILIAN M, 1976, J GEN MICROBIOL, V93, P9, DOI 10.1099/00221287-93-1-9; MURPHY TF, 1987, REV INFECT DIS, V9, P1; MURPHY TF, 1987, J INFECT DIS, V156, P723, DOI 10.1093/infdis/156.5.723; PATTERSON JE, 1988, J INFECT DIS, V157, P1002, DOI 10.1093/infdis/157.5.1002; STEERS EDWARD, 1959, ANTIBIOT AND CHEMOTHER, V9, P307; STURM AW, 1986, J MED MICROBIOL, V21, P349, DOI 10.1099/00222615-21-4-349; TURK DC, 1984, J MED MICROBIOL, V18, P1, DOI 10.1099/00222615-18-1-1; VANALPHEN L, 1988, EUR J CLIN MICROBIOL, V7, P309; VANALPHEN L, 1983, J INFECT DIS, V148, P75, DOI 10.1093/infdis/148.1.75; WARD JI, 1978, J PEDIATR-US, V92, P713, DOI 10.1016/S0022-3476(78)80134-6; WARD JI, 1979, NEW ENGL J MED, V301, P122, DOI 10.1056/NEJM197907193010302	17	28	28	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	JAN 27	1990	335	8683					214	216		10.1016/0140-6736(90)90291-C	http://dx.doi.org/10.1016/0140-6736(90)90291-C			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CL185	1967678				2022-12-28	WOS:A1990CL18500015
J	JOESOEF, MR; BERAL, V; ROLFS, RT; ARAL, SO; CRAMER, DW				JOESOEF, MR; BERAL, V; ROLFS, RT; ARAL, SO; CRAMER, DW			ARE CAFFEINATED BEVERAGES RISK-FACTORS FOR DELAYED CONCEPTION	LANCET			English	Article									HARVARD UNIV,BRIGHAM & WOMENS HOSP,SCH MED,DEPT OBSTET & GYNECOL,BOSTON,MA 02115	Harvard University; Brigham & Women's Hospital; Harvard Medical School	JOESOEF, MR (corresponding author), CTR DIS CONTROL,CTR PREVENT SERV,DIV SEXUALLY TRANSMITTED DIS,1600 CLIFTON RD NE,MAIL STOP E02,ATLANTA,GA 30333, USA.							BAIRD DD, 1986, AM J EPIDEMIOL, V124, P479; CRAMER DW, 1987, JAMA-J AM MED ASSOC, V257, P2446, DOI 10.1001/jama.257.18.2446; CRAMER DW, 1985, NEW ENGL J MED, V312, P941, DOI 10.1056/NEJM198504113121502; CRAMER DW, 1986, JAMA-J AM MED ASSOC, V255, P1904; HOWE G, 1985, BRIT MED J, V290, P1697, DOI 10.1136/bmj.290.6483.1697; PHIPPS WR, 1987, FERTIL STERIL, V48, P377; WILCOX A, 1988, LANCET, V2, P1453	7	69	69	0	1	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	JAN 20	1990	335	8682					136	137		10.1016/0140-6736(90)90005-P	http://dx.doi.org/10.1016/0140-6736(90)90005-P			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CJ979	1967434				2022-12-28	WOS:A1990CJ97900005
J	EVERITT, DE; AVORN, J				EVERITT, DE; AVORN, J			SYSTEMIC EFFECTS OF MEDICATIONS USED TO TREAT GLAUCOMA	ANNALS OF INTERNAL MEDICINE			English	Article									BROCKTON W ROXBURY VET AFFAIRS MED CTR, BOSTON, MA USA; HARVARD UNIV, SCH MED, BOSTON, MA 02115 USA	Harvard University; Harvard University; Harvard Medical School	EVERITT, DE (corresponding author), BETH ISRAEL HOSP, PROGRAM ANAL CLIN STRATEGIES, 333 LONGWOOD AVE, BOSTON, MA 02215 USA.				NEI NIH HHS [EY-07715] Funding Source: Medline; FDA HHS [FD-0015D] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY007715] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); FDA HHS; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		AHMAD S, 1979, LANCET, V2, P1028; ALVAN G, 1980, CLIN PHARMACOKINET, V5, P95, DOI 10.2165/00003088-198005010-00004; ARRIGG CA, 1981, ARCH OPHTHALMOL-CHIC, V99, P1969; BALLIN NORMAN, 1966, INVEST OPHTHALMOL, V5, P125; BLOCK ER, 1978, SURV OPHTHALMOL, V23, P169, DOI 10.1016/0039-6257(78)90152-2; BOYER WP, 1978, OPHTHALMOLOGY, V85, P259; CHRAI SS, 1973, J PHARM SCI, V62, P1112, DOI 10.1002/jps.2600620712; DAVIDORF FH, 1987, CONT OPHTHALMIC FORU, V5, P4; EPSTEIN E, 1965, AM J OPHTHALMOL, V59, P109, DOI 10.1016/0002-9394(65)95031-2; FLEMINGER R, 1978, BMJ-BRIT MED J, V1, P1182, DOI 10.1136/bmj.1.6121.1182; FRAUNFELDER FT, 1979, OPHTHALMOLOGY, V86, P126; GOODMAN LS, 1985, PHARMACOL BASIS THER, P105; GRECO J J, 1973, Annals of Ophthalmology, V5, P57; HARRIS LS, 1986, AM J OPHTHALMOL, V102, P274, DOI 10.1016/0002-9394(86)90157-1; HAYES LP, 1989, J AM GERIATR SOC, V37, P261, DOI 10.1111/j.1532-5415.1989.tb06818.x; HISCOX PEA, 1965, AM J OPHTHALMOL, V60, P425, DOI 10.1016/0002-9394(65)90705-1; HUMPHREYS JA, 1963, ARCH OPHTHALMOL-CHIC, V69, P737; LANSCHE RK, 1966, AM J OPHTHALMOL, V61, P95, DOI 10.1016/0002-9394(66)90752-5; LEBLANC RP, 1981, OPHTHALMOLOGY, V88, P244; LEIER CV, 1986, ANN INTERN MED, V104, P197, DOI 10.7326/0003-4819-104-2-197; LESKE MC, 1983, AM J EPIDEMIOL, V118, P166, DOI 10.1093/oxfordjournals.aje.a113626; LEWIS RV, 1985, BRIT J CLIN PHARMACO, V19, P826, DOI 10.1111/j.1365-2125.1985.tb02721.x; LICHTER PR, 1978, AM J OPHTHALMOL, V85, P495, DOI 10.1016/S0002-9394(14)75247-X; LITTMANN L, 1987, ARCH INTERN MED, V147, P586, DOI 10.1001/archinte.147.3.586; MALLETTE LE, 1977, ARCH INTERN MED, V137, P1013, DOI 10.1001/archinte.137.8.1013; MCMAHON CD, 1979, AM J OPHTHALMOL, V88, P736, DOI 10.1016/0002-9394(79)90674-3; MOSTELLER MW, 1985, MODERN MANAGEMENT OC, P179; NELSON WP, 1987, AM J OPHTHALMOL, V104, P97, DOI 10.1016/0002-9394(87)90313-8; NEWELL FW, 1986, OPHTHALMOLOGY PRINCI, P378; NOLAN BT, 1982, JAMA-J AM MED ASSOC, V247, P1567, DOI 10.1001/jama.247.11.1567; NOVACK GD, 1987, SURV OPHTHALMOL, V31, P307, DOI 10.1016/0039-6257(87)90116-0; ORLANDO RG, 1986, AM J OPHTHALMOL, V102, P275, DOI 10.1016/0002-9394(86)90158-3; PAYKEL ES, 1982, J CLIN PSYCHOPHARM, V2, P14, DOI 10.1097/00004714-198202000-00004; PETRIE WM, 1982, AM J PSYCHIAT, V139, P92; PHELPS CD, 1980, SURV OPHTHALMOL, V25, P175, DOI 10.1016/0039-6257(80)90095-8; REYES PF, 1987, J NEUROL NEUROSUR PS, V50, P113, DOI 10.1136/jnnp.50.1.113; ROHOLT PC, 1987, ARCH OPHTHALMOL-CHIC, V105, P1172; SCHOENE RB, 1984, AM J OPHTHALMOL, V97, P86, DOI 10.1016/0002-9394(84)90450-1; SHORE JH, 1987, J CLIN PSYCHOPHARM, V7, P264; SPIRITUS EM, 1985, AM J OPHTHALMOL, V100, P492, DOI 10.1016/0002-9394(85)90532-X; Tierney D W, 1987, J Am Optom Assoc, V58, P722; VANBUSKIRK EM, 1980, OPHTHALMOLOGY, V87, P447; VANBUSKIRK EM, 1984, AM J OPHTHALMOL, V98, P623, DOI 10.1016/0002-9394(84)90250-2; VAUGHAN D, 1986, GENERAL OPHTHALMOLOG, P184; VESTAL RE, 1979, CLIN PHARMACOL THER, V26, P181; WALLACE TR, 1979, ANN OPHTHALMOL, V11, P1563; WERBLIN TP, 1979, JAMA-J AM MED ASSOC, V241, P2817; 1986, DRUG EVALUATIONS, P327	48	89	90	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 15	1990	112	2					120	125		10.7326/0003-4819-112-2-120	http://dx.doi.org/10.7326/0003-4819-112-2-120			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CH536	1967209				2022-12-28	WOS:A1990CH53600007
J	DIRCKX, JH				DIRCKX, JH			SUMMARIZING THE OBSTETRIC HISTORY	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter																		CUNNINGHAM FG, 1989, WILLIAMS OBSTETRICS, P258; DANFORTH DN, 1986, OBSTET GYNECOL, P647; HACKER NF, 1986, ESSENTIALS OBSTETRIC, P22; WYNN RM, 1988, OBSTET GYNECOL, P4	4	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 18	1991	266	23					3344	3344		10.1001/jama.266.23.3344	http://dx.doi.org/10.1001/jama.266.23.3344			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GU964	1960839				2022-12-28	WOS:A1991GU96400040
J	MANLEY, M; EPPS, RP; HUSTEN, C; GLYNN, T; SHOPLAND, D				MANLEY, M; EPPS, RP; HUSTEN, C; GLYNN, T; SHOPLAND, D			CLINICAL INTERVENTIONS IN TOBACCO CONTROL - A NATIONAL-CANCER-INSTITUTE TRAINING-PROGRAM FOR PHYSICIANS	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SMOKING CESSATION; RANDOMIZED TRIAL; SMOKERS; QUIT				MANLEY, M (corresponding author), NCI,DIV CANC PREVENT & CONTROL,CANC CONTROL SCI PROGRAM,EPN-241,BALTIMORE,MD 21211, USA.							COHEN SJ, 1989, ANN INTERN MED, V110, P648, DOI 10.7326/0003-4819-110-8-648; CUMMINGS SR, 1989, ANN INTERN MED, V110, P640, DOI 10.7326/0003-4819-110-8-640; GLYNN T, 1989, NIH893064 DEP HLTH H; GLYNN TJ, 1990, HEALTH EDUC QUART, V17, P329, DOI 10.1177/109019819001700308; GLYNN TJ, 1990, ADV CANCER CONTROL; KOTTKE TE, 1989, JAMA-J AM MED ASSOC, V261, P2101, DOI 10.1001/jama.261.14.2101; OCKENE JK, 1991, J GEN INTERN MED, V6, P1, DOI 10.1007/BF02599381; PROCHASKA JO, 1983, J CONSULT CLIN PSYCH, V51, P390, DOI 10.1037/0022-006X.51.3.390; SCHULTZ JM, 1991, MMWR, V40, P62; WELLS KB, 1984, MED CARE, V22, P360, DOI 10.1097/00005650-198404000-00007; WILSON DM, 1988, JAMA-J AM MED ASSOC, V260, P1570, DOI 10.1001/jama.260.11.1570; 1990, CDC878396 DEP HLTH H, P38	12	66	69	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 11	1991	266	22					3172	3173		10.1001/jama.266.22.3172	http://dx.doi.org/10.1001/jama.266.22.3172			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GT654	1956107				2022-12-28	WOS:A1991GT65400028
J	MCFALLNGAI, MJ; RUBY, EG				MCFALLNGAI, MJ; RUBY, EG			SYMBIONT RECOGNITION AND SUBSEQUENT MORPHOGENESIS AS EARLY EVENTS IN AN ANIMAL-BACTERIAL MUTUALISM	SCIENCE			English	Article							EUPRYMNA-SCOLOPES; SQUID	Bacterial colonization of the developing tight organ of the squid Euprymna scolopes is shown to be highly specific, with the establishment of a successful association resulting only when the juvenile host is exposed to seawater containing one of a subset of Vibrio fischeri strains. Before a symbiotic infection the organ has elaborate epithelial structures covered with cilia and microvilli that are involved in the transfer of bacteria to the incipient symbiotic tissue. These structures regressed within days following infection; however, they were retained in uninfected animals, suggesting that the initiation of symbiosis influences, and is perhaps a prerequisite for, the normal developmental program of the juvenile host.			MCFALLNGAI, MJ (corresponding author), UNIV SO CALIF,DEPT BIOL SCI,LOS ANGELES,CA 90089, USA.							ARNOLD J M, 1972, Veliger, V14, P361; BLAKE PA, 1980, ANNU REV MICROBIOL, V34, P341, DOI 10.1146/annurev.mi.34.100180.002013; BOETTCHER KJ, 1990, J BACTERIOL, V172, P3701, DOI 10.1128/jb.172.7.3701-3706.1990; FINLAY BB, 1989, MICROBIOL REV, V53, P210, DOI 10.1128/MMBR.53.2.210-230.1989; FUKASAWA S, 1986, AGR BIOL CHEM TOKYO, V50, P1645, DOI 10.1080/00021369.1986.10867623; GILTURNES MS, 1989, SCIENCE, V246, P116, DOI 10.1126/science.2781297; GORDON HA, 1971, BACTERIOL REV, V35, P390, DOI 10.1128/MMBR.35.4.390-429.1971; HACKETT KJ, 1986, SCIENCE, V232, P1253, DOI 10.1126/science.232.4755.1253; HALVERSON LJ, 1986, MICROBIOL REV, V50, P193, DOI 10.1128/MMBR.50.2.193-225.1986; HASTINGS JW, 1987, SYMBIOSIS, V4, P3; ISBERG RR, 1991, SCIENCE, V252, P934, DOI 10.1126/science.1674624; LEE K-H, 1991, Abstracts of the General Meeting of the American Society for Microbiology, V91, P194; LONG SR, 1989, CELL, V56, P203, DOI 10.1016/0092-8674(89)90893-3; MCFALLNGAI M, 1990, BIOL BULL, V179, P332, DOI 10.2307/1542325; MCFALLNGAI MJ, 1990, ENDOCYTOBIOLOGY, V4, P319; MCFALLNGAI MJ, UNPUB; MEIGHEN EA, 1991, MICROBIOL REV, V55, P123, DOI 10.1128/MMBR.55.1.123-142.1991; Nealson KH, 1978, METHOD ENZYMOL, V57, P153; NESIS KN, 1982, CEPHALOPODS WORLD, P70; REICHELT JL, 1977, ARCH MICROBIOL, V112, P157, DOI 10.1007/BF00429329; ROLFE BG, 1988, ANNU REV PLANT PHYS, V39, P297, DOI 10.1146/annurev.pp.39.060188.001501; SAKAZAKI R, 1981, PROKARYOTES, V2, pCH103; WEI SL, 1989, MAR BIOL, V103, P541, DOI 10.1007/BF00399586	23	249	254	1	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	DEC 6	1991	254	5037					1491	1493		10.1126/science.1962208	http://dx.doi.org/10.1126/science.1962208			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT903	1962208				2022-12-28	WOS:A1991GT90300035
J	MCDONALD, NQ; LAPATTO, R; MURRAYRUST, J; GUNNING, J; WLODAWER, A; BLUNDELL, TL				MCDONALD, NQ; LAPATTO, R; MURRAYRUST, J; GUNNING, J; WLODAWER, A; BLUNDELL, TL			NEW-PROTEIN FOLD REVEALED BY A 2.3-A RESOLUTION CRYSTAL-STRUCTURE OF NERVE GROWTH-FACTOR	NATURE			English	Article							NEUROTROPHIC FACTOR; MOLECULAR-CLONING; FACTOR RECEPTOR; NEUROTOXIN; BINDING	NERVE growth factor (NGF) 1 is a member of an expanding family of neurotrophic factors (including brain-derived neurotrophic factor 2 and the neurotrophins 3,4) that control the development and survival of certain neuronal populations both in the peripheral and in the central nervous systems 5. Its biological effects are mediated by a high-affinity ligand-receptor interaction and a tyrosine kinase signalling pathway 6,7. A potential use for NGF and its relatives in the treatment of neurological disorders such as Alzheimer's disease 8 and Parkinson's disease 9 requires an understanding of the structure-function relationships of NGF. NGF is a dimeric molecule, with 118 amino acids per protomer. We report the crystal structure of the murine NGF dimer at 2.3-angstrom resolution, which reveals a novel protomer structure consisting of three antiparallel pairs of beta-strands, together forming a flat surface. Two subunits associate through this surface, thus burying a total of 2,332 angstrom 2. Four loop regions, which contain many of the variable residues observed between different NGF-related molecules, may determine the different receptor specificities. A clustering of positively charged side chains may provide a complementary interaction with the acidic low-affinity NGF receptor. The structure provides a model for rational design of analogues of NGF and its relatives and for testing the NGF-receptor recognition determinants critical for signal transduction.	UNIV LONDON BIRKBECK COLL,IMPERIAL CANC RES FUND,STRUCT MOLEC BIOL UNIT,MALET ST,LONDON WC1E 7HX,ENGLAND; UNIV LONDON BIRKBECK COLL,DEPT CRYSTALLOG,LONDON WC1E 7HX,ENGLAND; NCI,FREDERICK CANC RES & DEV CTR,ABL,BASIC RES PROGRAM,FREDERICK,MD 21701	Cancer Research UK; University of London; Birkbeck University London; University of London; Birkbeck University London; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick								ALMASSY RJ, 1983, J MOL BIOL, V170, P497, DOI 10.1016/S0022-2836(83)80159-4; ANGELETT.RH, 1971, P NATL ACAD SCI USA, V68, P2417, DOI 10.1073/pnas.68.10.2417; BARDE YA, 1989, NEURON, V2, P1525, DOI 10.1016/0896-6273(89)90040-8; BRUNGER AT, 1989, ACTA CRYSTALLOGR A, V45, P50, DOI 10.1107/S0108767388009195; CAMPBELL ID, 1989, PROGR GROWTH FACTOR, V1; CAMPBELL ID, 1990, J CELL SCI S, V13, P5; CHOTHIA C, 1975, NATURE, V256, P705, DOI 10.1038/256705a0; CHOTHIA C, 1989, NATURE, V342, P877, DOI 10.1038/342877a0; DARLING TL, 1984, CELL CULTURE METHODS, V4, P79; DREISSEN H, 1989, J APPL CRYSTALLOGR, V22, P510; DUNBAR JC, 1984, J PROTEIN CHEM, V3, P349, DOI 10.1007/BF01025171; FLOWER DR, IN PRESS J MOL GRAPH; FRAZIER WA, 1973, BIOCHEMISTRY-US, V12, P3281, DOI 10.1021/bi00741a021; GILSON MK, 1987, J COMPUT CHEM, V9, P327; HALLBOOK F, 1991, NEURON, V6, P845, DOI 10.1016/0896-6273(91)90180-8; HEMPSTEAD BL, 1991, NATURE, V350, P678, DOI 10.1038/350678a0; HOHN A, 1990, NATURE, V344, P339, DOI 10.1038/344339a0; HUBBARD TJP, 1987, PROTEIN ENG, V1, P159, DOI 10.1093/protein/1.3.159; HYMAN C, 1991, NATURE, V350, P230, DOI 10.1038/350230a0; IBANEZ CF, 1991, EMBO J, V10, P2105, DOI 10.1002/j.1460-2075.1991.tb07743.x; IBANEZ CF, 1990, EMBO J, V9, P1477, DOI 10.1002/j.1460-2075.1990.tb08265.x; JONES TA, 1978, J APPL CRYSTALLOGR, V11, P268, DOI 10.1107/S0021889878013308; KAPLAN DR, 1991, NATURE, V350, P158, DOI 10.1038/350158a0; LAMBALLE F, 1991, CELL, V66, P967, DOI 10.1016/0092-8674(91)90442-2; LEIBROCK J, 1989, NATURE, V341, P149, DOI 10.1038/341149a0; LESLIE AGW, 1987, ACTA CRYSTALLOGR, V43, P143; LESLIE AGW, 1986, DARESBURY LAB INF Q, V18, P33; LEVIMONTALCINI R, 1987, EMBO J, V6, P1145, DOI 10.1002/j.1460-2075.1987.tb02347.x; LONGO FM, 1990, CELL REGUL, V1, P189, DOI 10.1091/mbc.1.2.189; LOW BW, 1976, P NATL ACAD SCI USA, V73, P2991, DOI 10.1073/pnas.73.9.2991; RADEKE MJ, 1987, NATURE, V325, P593, DOI 10.1038/325593a0; RODRIGUEZTEBAR A, 1990, NEURON, V4, P487, DOI 10.1016/0896-6273(90)90107-Q; Server A C, 1977, Adv Protein Chem, V31, P339, DOI 10.1016/S0065-3233(08)60221-1; SOPPET D, 1991, CELL, V65, P895, DOI 10.1016/0092-8674(91)90396-G; SQUINTO SP, 1991, CELL, V65, P885, DOI 10.1016/0092-8674(91)90395-F; WALKINSHAW MD, 1980, P NATL ACAD SCI-BIOL, V77, P2400, DOI 10.1073/pnas.77.5.2400; WILLIAMS R, 1982, J BIOL CHEM, V257, P13321; WLODAWER A, 1975, P NATL ACAD SCI USA, V72, P777, DOI 10.1073/pnas.72.3.777; YANKNER BA, 1990, P NATL ACAD SCI USA, V87, P9020, DOI 10.1073/pnas.87.22.9020	39	441	475	0	19	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	DEC 5	1991	354	6352					411	414		10.1038/354411a0	http://dx.doi.org/10.1038/354411a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT761	1956407				2022-12-28	WOS:A1991GT76100057
J	HARIHARAN, IK; CARTHEW, RW; RUBIN, GM				HARIHARAN, IK; CARTHEW, RW; RUBIN, GM			THE DROSOPHILA ROUGHENED MUTATION - ACTIVATION OF A RAP HOMOLOG DISRUPTS EYE DEVELOPMENT AND INTERFERES WITH CELL DETERMINATION	CELL			English	Article							ELEGANS VULVAR INDUCTION; NUCLEOTIDE-SEQUENCE; TYROSINE KINASE; GENE; PROTEIN; DOMAIN; MELANOGASTER; ENCODES; REGION; FATE	Roughened is a dominant mutation of D. melanogaster that disrupts eye development. The majority of the ommatidia in the adult eye lack a single photoreceptor cell, which is most commonly the R7 cell. The Roughened mutation disrupts the early stages of photoreceptor cell determination. Roughened is a dominant gain-of-function mutation that results from a single amino acid change (Phe157 to Leu) in the Drosophila Rap1 protein. Loss of function Rap1 mutations are lethal. Drosophila Rap1 protein is 88% identical to human rap1A/K-rev1 protein, a putative antagonist of ras action.			HARIHARAN, IK (corresponding author), UNIV CALIF BERKELEY,DEPT MOLEC & CELL BIOL,HOWARD HUGHES MED INST,BERKELEY,CA 94720, USA.			Rubin, Gerald/0000-0001-8762-8703				AROIAN RV, 1990, NATURE, V348, P693, DOI 10.1038/348693a0; ASHBURNER M, 1989, DROSOPHILA LABORATOR; BAKER BS, 1982, P NATL ACAD SCI-BIOL, V79, P1205, DOI 10.1073/pnas.79.4.1205; BANERJEE U, 1990, NEURON, V4, P177, DOI 10.1016/0896-6273(90)90093-U; BEITEL GJ, 1990, NATURE, V348, P503, DOI 10.1038/348503a0; CARTHEW RW, 1990, CELL, V63, P561, DOI 10.1016/0092-8674(90)90452-K; DEVOS AM, 1988, SCIENCE, V239, P888, DOI 10.1126/science.2448879; Frech M, 1990, SCIENCE, V249, P169, DOI 10.1126/science.2164710; HAFEN E, 1987, SCIENCE, V236, P55, DOI 10.1126/science.2882603; HALL A, 1990, SCIENCE, V249, P635, DOI 10.1126/science.2116664; HAN M, 1990, CELL, V63, P921, DOI 10.1016/0092-8674(90)90495-Z; HART AC, 1990, GENE DEV, V4, P1835, DOI 10.1101/gad.4.11.1835; HATA Y, 1990, J BIOL CHEM, V265, P7101; HORTSCH M, 1990, NEURON, V4, P697, DOI 10.1016/0896-6273(90)90196-M; KIMMEL BE, 1990, GENE DEV, V4, P712, DOI 10.1101/gad.4.5.712; KITAYAMA H, 1989, CELL, V56, P77, DOI 10.1016/0092-8674(89)90985-9; LEV Z, 1985, MOL CELL BIOL, V5, P1540, DOI 10.1128/MCB.5.6.1540; LEWIS EB, 1968, DROSOPHILA INFORM SE, V43, P193; LINDSLEY DL, 1968, CARNEGIE I WASH PUBL, V627; MCCORMICK F, 1989, CELL, V56, P5, DOI 10.1016/0092-8674(89)90976-8; NEUMANSILBERBERG FS, 1984, CELL, V37, P1027; PIZON V, 1988, NUCLEIC ACIDS RES, V16, P7719, DOI 10.1093/nar/16.15.7719; PIZON V, 1988, ONCOGENE, V3, P201; RUBIN GM, 1989, CELL, V57, P519, DOI 10.1016/0092-8674(89)90120-7; RUBIN GM, 1991, IMNM PRESS CELL; Sambrook J, 1989, MOL CLONING LABORATO; SANTOS E, 1989, FASEB J, V3, P2151, DOI 10.1096/fasebj.3.10.2666231; SCHEJTER ED, 1985, EMBO J, V4, P407, DOI 10.1002/j.1460-2075.1985.tb03643.x; SLITER TJ, 1989, GENETICS, V123, P327; TOMLINSON A, 1987, DEV BIOL, V123, P264, DOI 10.1016/0012-1606(87)90448-9; TOMLINSON A, 1986, DEV BIOL, V218, P341; VALENCIA A, 1991, BIOCHEMISTRY-US, V30, P4637, DOI 10.1021/bi00233a001	32	117	119	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	NOV 15	1991	67	4					717	722		10.1016/0092-8674(91)90066-8	http://dx.doi.org/10.1016/0092-8674(91)90066-8			6	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GQ407	1934069				2022-12-28	WOS:A1991GQ40700008
J	WICK, MJ; MADARA, JL; FIELDS, BN; NORMARK, SJ				WICK, MJ; MADARA, JL; FIELDS, BN; NORMARK, SJ			MOLECULAR CROSS TALK BETWEEN EPITHELIAL-CELLS AND PATHOGENIC MICROORGANISMS	CELL			English	Editorial Material							RECEPTOR; PROTEINS; ABILITY		HARVARD UNIV, SCH MED, DEPT MICROBIOL & MOLEC GENET, BOSTON, MA 02115 USA; BRIGHAM & WOMENS HOSP, DEPT PATHOL, BOSTON, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	WICK, MJ (corresponding author), WASHINGTON UNIV, SCH MED, DEPT MOLEC MICROBIOL, ST LOUIS, MO 63110 USA.							ALDOVINI A, 1991, NATURE, V351, P479, DOI 10.1038/351479a0; BLISKA JB, 1991, P NATL ACAD SCI USA, V88, P1187, DOI 10.1073/pnas.88.4.1187; FALKOW S, 1991, CELL, V65, P1099, DOI 10.1016/0092-8674(91)90003-H; GAILLARD JL, 1991, CELL, V65, P1127, DOI 10.1016/0092-8674(91)90009-N; GLICK GD, 1991, J AM CHEM SOC, V113, P4701, DOI 10.1021/ja00012a060; GORANSSON M, 1990, NATURE, V344, P682, DOI 10.1038/344682a0; HIGGINS CF, 1990, MOL MICROBIOL, V4, P2007, DOI 10.1111/j.1365-2958.1990.tb00559.x; HOPKINS CR, 1990, NATURE, V346, P335, DOI 10.1038/346335a0; ISBERG RR, 1991, SCIENCE, V252, P934, DOI 10.1126/science.1674624; JONSSON AB, 1991, EMBO J, V10, P477, DOI 10.1002/j.1460-2075.1991.tb07970.x; LEE CA, 1990, P NATL ACAD SCI USA, V87, P4304, DOI 10.1073/pnas.87.11.4304; MAKINO S, 1991, EMBO J, V10, P1307, DOI 10.1002/j.1460-2075.1991.tb07649.x; MATTER K, 1990, CELL, V60, P429, DOI 10.1016/0092-8674(90)90594-5; MOOSEKER MS, 1985, ANNU REV CELL BIOL, V1, P209, DOI 10.1146/annurev.cellbio.1.1.209; PARSOT C, 1991, P NATL ACAD SCI USA, V88, P1641, DOI 10.1073/pnas.88.5.1641; REN R, 1990, CELL, V63, P353, DOI 10.1016/0092-8674(90)90168-E; ROSQVIST R, 1988, INFECT IMMUN, V56, P2139, DOI 10.1128/IAI.56.8.2139-2143.1988; ROSSMANN MG, 1989, J BIOL CHEM, V264, P14587; SANSONETTI PJ, 1991, REV INFECT DIS, V13, pS285; SAUTER NK, 1989, BIOCHEMISTRY-US, V28, P8388, DOI 10.1021/bi00447a018; SIMONS K, 1990, CELL, V62, P207, DOI 10.1016/0092-8674(90)90357-K; STROMBERG N, 1991, P NATL ACAD SCI USA, V88, P9340, DOI 10.1073/pnas.88.20.9340; Trowbridge IS, 1991, CURR OPIN CELL BIOL, V3, P1062, DOI 10.1016/0955-0674(91)90130-Q; WHITE JM, 1989, CELL, V56, P725, DOI 10.1016/0092-8674(89)90674-0; WINNER L, 1991, INFECT IMMUN, V59, P977, DOI 10.1128/IAI.59.3.977-982.1991; YOUNG RA, 1990, ANNU REV IMMUNOL, V8, P401, DOI 10.1146/annurev.immunol.8.1.401	26	61	62	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 15	1991	67	4					651	659						9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GQ407	1934067				2022-12-28	WOS:A1991GQ40700003
J	BISCHOFF, FR; PONSTINGL, H				BISCHOFF, FR; PONSTINGL, H			CATALYSIS OF GUANINE-NUCLEOTIDE EXCHANGE ON RAN BY THE MITOTIC REGULATOR RCC1	NATURE			English	Article							CHROMOSOME CONDENSATION; HUMAN-GENE; PROTEIN; ONSET; CLONING; MUTANT; CDNA; DNA; GDP	THE product of the gene RCC1 (regulator of chromosome condensation) in a BHK cell line is involved in the control of mitotic events 1. Homologous genes have been found in Xenopus 2, Drosophila 3 and yeast 4,5. A human genomic DNA fragment and complementary DNA that complement a temperature-sensitive mutation of RCC1 in BHK21 cells 6,7 encode a protein of relative molecular mass 45,000 (M(r) 45K) which is located in the nucleus and binds to chromatin 8. We have recently isolated a protein from HeLa cells that strongly binds an anti-RCC1 antibody and has the same molecular mass, DNA-binding properties, and amino-acid sequence as the 205 residues already identified 9. HeLa cell RCC1 is complexed to a protein of M(r) 25K (ref. 9). We have shown 10 that this 25K protein has a sequence homologous to the translated reading frame of TC4, a cDNA found by screening a human teratocarcinoma cDNA library with oligonucleotides coding for a ras consensus sequence 11, and that the protein binds GDP and GTP. We have referred to this protein as the Ran protein (ras-related nuclear protein). In addition to the fraction of Ran protein complexed to RCC1, a 25-fold molar excess of the protein over RCC1 was found in the nucleoplasm of HeLa cells. Here we show that RCC1 specifically catalyses the exchange of guanine nucleotides on the Ran protein but not on the protein c-Ha-ras p2l (p21ras).	DEUTSCH KREBSFORSCHUNGSZENTRUM,MOLEC BIOL MITOSIS PROJECT,NEUENHEIMER FELD 280,W-6900 HEIDELBERG,GERMANY	Helmholtz Association; German Cancer Research Center (DKFZ)								AEBI M, 1990, MOL GEN GENET, V224, P72, DOI 10.1007/BF00259453; BISCHOFF FR, 1990, P NATL ACAD SCI USA, V87, P8617, DOI 10.1073/pnas.87.21.8617; BISCHOFF FR, IN PRESS P NATN ACAD; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; CHARDIN P, 1991, CANCER CELL-MON REV, V3, P117; CLARK KL, 1989, MOL CELL BIOL, V9, P2682, DOI 10.1128/MCB.9.6.2682; CRECHET JB, 1990, SCIENCE, V248, P866, DOI 10.1126/science.2188363; DRIVAS GT, 1990, MOL CELL BIOL, V10, P1793, DOI 10.1128/MCB.10.4.1793; FRASCH M, 1991, EMBO J, V10, P1225, DOI 10.1002/j.1460-2075.1991.tb08064.x; JOHN J, 1988, J BIOL CHEM, V263, P11792; KAI R, 1986, MOL CELL BIOL, V6, P2027, DOI 10.1128/MCB.6.6.2027; MATSUMOTO T, 1991, CELL, V66, P347, DOI 10.1016/0092-8674(91)90624-8; NISHIMOTO T, 1978, CELL, V15, P475, DOI 10.1016/0092-8674(78)90017-X; NISHITANI H, 1991, EMBO J, V10, P1555, DOI 10.1002/j.1460-2075.1991.tb07675.x; NISHITANI H, 1990, J BIOCHEM-TOKYO, V107, P228, DOI 10.1093/oxfordjournals.jbchem.a123031; OHTSUBO M, 1987, GENE DEV, V1, P585, DOI 10.1101/gad.1.6.585; OHTSUBO M, 1989, J CELL BIOL, V109, P1389, DOI 10.1083/jcb.109.4.1389; VALENCIA A, 1991, BIOCHEMISTRY-US, V30, P4637, DOI 10.1021/bi00233a001; WEST M, 1990, FEBS LETT, V259, P245, DOI 10.1016/0014-5793(90)80019-F; WOLFMAN A, 1990, SCIENCE, V248, P67, DOI 10.1126/science.2181667	20	559	571	0	21	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	NOV 7	1991	354	6348					80	82		10.1038/354080a0	http://dx.doi.org/10.1038/354080a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN829	1944575				2022-12-28	WOS:A1991GN82900063
J	WERTHEIM, SL; SIDMAN, RL				WERTHEIM, SL; SIDMAN, RL			DATABASES FOR NEUROSCIENCE	NATURE			English	Database Review											WERTHEIM, SL (corresponding author), HARVARD UNIV,NEW ENGLAND REG PRIMATE RES CTR,SCH MED,1 PINE HILL DR,SOUTHBOROUGH,MA 01772, USA.							ALLEN BA, 1990, 3 DIMENSIONAL NEUROI, P211; BLOOM FE, 1989, BRAIN BROWSER; BOOKSTEIN FL, 1991, LECT NOTES COMPUT SC, V511, P326, DOI 10.1007/BFb0033763; BRINKLEY JF, 1991, IN PRESS 15TH P ANN; Capowski J.J., 1989, COMPUTER TECHNIQUES; ENO K, IN PRESS 15TH P ANN; PEARLSTEIN RA, 1986, ANAL QUANT CYTOL, V8, P89; Pechura C.M., 1991, MAPPING BRAIN ITS FU; PROTHERO JS, 1989, P NATL COMPUT GRAPHI, V1, P187; RODGERS WT, 1990, 3 DIMENSIONAL NEUROI, P123; Sidman Richard L., 1971, ATLAS MOUSE BRAIN SP; TOGA AW, 1990, 3 DIMENSIONAL NEUROI; TOGA AW, 1990, 3 DIMENSIONAL NEUROI, P251; Wertheim S. L., 1990, Fourteenth Annual Symposium on Computer Applications in Medical Care. Standards in Medical Informatics. A Conference of the American Medical Informatics Association, P389; WERTHEIM SI, 1989, 13TH ANN S COMP APPL, P399	15	0	0	0	2	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	NOV 7	1991	354	6348					88	89		10.1038/354088a0	http://dx.doi.org/10.1038/354088a0			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN829	1944577				2022-12-28	WOS:A1991GN82900067
J	YASUDA, LF; YAO, MC				YASUDA, LF; YAO, MC			SHORT INVERTED REPEATS AT A FREE END SIGNAL LARGE PALINDROMIC DNA FORMATION IN TETRAHYMENA	CELL			English	Article							RIBOSOMAL-RNA GENES; NUCLEOTIDE-SEQUENCE; EXTRACHROMOSOMAL RDNA; CHROMOSOME BREAKAGE; DEVELOPING NUCLEI; AMPLIFICATION; THERMOPHILA; DUPLICATION; PYRIFORMIS; CONSERVATION	Large palindromic DNAs are formed in many cell types, but their molecular mechanism is unknown. During nuclear differentiation in Tetrahymena, the ribosomal RNA genes (rDNA) are converted from a single integrated copy to an extrachromosomal head-to-head palindrome. Using in vitro mutagenesis and Tetrahymena transformation, we show that two properties of the rDNA are necessary and sufficient for palindrome formation. The first is a pair of 42 bp inverted repeats found at the rDNA's 5' end. Its inverted symmetry, but not specific sequence, is important. The second is a free end next to the repeats. It is normally created by chromosome breakage in vivo, but can also be provided by restriction endonuclease cutting before transformation. We also demonstrate that the ability to form palindromes is not restricted to developing nuclei, but is present in vegetative cells as well. This process may represent a general mechanism for palindrome formation in eukaryotes.			YASUDA, LF (corresponding author), FRED HUTCHINSON CANC RES CTR,DIV BASIC SCI,SEATTLE,WA 98104, USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026210, F32GM013293] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM26210, 5 F32 GM13293-02] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AUSTERBERRY CF, 1984, P NATL ACAD SCI-BIOL, V81, P7383, DOI 10.1073/pnas.81.23.7383; AUSTERBERRY CF, 1987, MOL CELL BIOL, V7, P435, DOI 10.1128/MCB.7.1.435; BEVERLEY SM, 1984, CELL, V38, P431, DOI 10.1016/0092-8674(84)90498-7; BLACKBURN EH, 1978, J MOL BIOL, V120, P33, DOI 10.1016/0022-2836(78)90294-2; BRUNS PJ, 1985, P NATL ACAD SCI USA, V82, P2844, DOI 10.1073/pnas.82.9.2844; CHALLONER PB, 1986, NUCLEIC ACIDS RES, V14, P6299, DOI 10.1093/nar/14.15.6299; COCKBURN AF, 1978, CHROMOSOMA, V70, P19, DOI 10.1007/BF00292212; DIN N, 1979, J MOL BIOL, V134, P555, DOI 10.1016/0022-2836(79)90367-X; ENGBERG J, 1983, NUCLEIC ACIDS RES, V11, P4939, DOI 10.1093/nar/11.14.4939; ENGBERG J, 1976, J MOL BIOL, V104, P455, DOI 10.1016/0022-2836(76)90281-3; FORD M, 1986, CELL, V45, P425, DOI 10.1016/0092-8674(86)90328-4; FORD M, 1985, P NATL ACAD SCI USA, V82, P3370, DOI 10.1073/pnas.82.10.3370; GALL JG, 1974, P NATL ACAD SCI USA, V71, P3078, DOI 10.1073/pnas.71.8.3078; GODISKA R, 1990, CELL, V61, P1237, DOI 10.1016/0092-8674(90)90688-B; Gorovsky M A, 1975, Methods Cell Biol, V9, P311, DOI 10.1016/S0091-679X(08)60080-1; HYRIEN O, 1988, EMBO J, V7, P407, DOI 10.1002/j.1460-2075.1988.tb02828.x; KAN NC, 1981, J MOL BIOL, V153, P1151, DOI 10.1016/0022-2836(81)90472-1; KARRER KM, 1976, J MOL BIOL, V104, P421, DOI 10.1016/0022-2836(76)90280-1; KING BO, 1982, CELL, V31, P177, DOI 10.1016/0092-8674(82)90417-2; KISS GB, 1981, GENE, V13, P281, DOI 10.1016/0378-1119(81)90032-9; LARSON DD, 1986, CELL, V47, P229, DOI 10.1016/0092-8674(86)90445-9; LILLEY DMJ, 1984, CELL, V36, P413, DOI 10.1016/0092-8674(84)90234-4; ORIAS E, 1988, GENE, V70, P295, DOI 10.1016/0378-1119(88)90201-6; PAN WC, 1981, CELL, V23, P459, DOI 10.1016/0092-8674(81)90141-0; PASSANANTI C, 1987, EMBO J, V6, P1697, DOI 10.1002/j.1460-2075.1987.tb02420.x; RUIZ JC, 1988, MOL CELL BIOL, V8, P4302, DOI 10.1128/MCB.8.10.4302; Sambrook J, 1989, MOL CLONING LABORATO; SPANGLER EA, 1985, J BIOL CHEM, V260, P6334; STARK GR, 1989, CELL, V57, P901, DOI 10.1016/0092-8674(89)90328-0; SWEENEY R, 1989, EMBO J, V8, P933, DOI 10.1002/j.1460-2075.1989.tb03454.x; TONDRAVI MM, 1986, P NATL ACAD SCI USA, V83, P4369, DOI 10.1073/pnas.83.12.4369; VOGT VM, 1976, J MOL BIOL, V106, P567, DOI 10.1016/0022-2836(76)90252-7; WALTON JD, 1986, CELL, V46, P857, DOI 10.1016/0092-8674(86)90067-X; WEST SC, 1985, P NATL ACAD SCI USA, V82, P6445, DOI 10.1073/pnas.82.19.6445; YAO MC, 1985, MOL CELL BIOL, V5, P1260, DOI 10.1128/MCB.5.6.1260; YAO MC, 1987, CELL, V48, P779, DOI 10.1016/0092-8674(87)90075-4; YAO MC, 1974, P NATL ACAD SCI USA, V71, P3082, DOI 10.1073/pnas.71.8.3082; YAO MC, 1990, CELL, V63, P763, DOI 10.1016/0092-8674(90)90142-2; YAO MC, 1989, MOL CELL BIOL, V9, P1092, DOI 10.1128/MCB.9.3.1092; YAO MC, 1977, CELL, V12, P121, DOI 10.1016/0092-8674(77)90190-8; YAO MC, 1981, CELL, V24, P765, DOI 10.1016/0092-8674(81)90102-1; YU GL, 1988, P NATL ACAD SCI USA, V85, P5151, DOI 10.1073/pnas.85.14.5151	42	53	53	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	NOV 1	1991	67	3					505	516		10.1016/0092-8674(91)90525-4	http://dx.doi.org/10.1016/0092-8674(91)90525-4			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GN664	1934058				2022-12-28	WOS:A1991GN66400007
J	BREIMER, LH; MIKHAILIDIS, DP				BREIMER, LH; MIKHAILIDIS, DP			A THESIS FOR ALL SEASONS	NATURE			English	Editorial Material											BREIMER, LH (corresponding author), UNIV LONDON,ROYAL FREE HOSP,SCH MED,DEPT CHEM PATHOL & HUMAN METAB,LONDON NW3 2PF,ENGLAND.		Mikhailidis, Dimitri P/A-1869-2013	Mikhailidis, Dimitri P/0000-0002-9566-2263					0	16	16	0	0	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	OCT 31	1991	353	6347					789	790		10.1038/353789a0	http://dx.doi.org/10.1038/353789a0			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM732	1944551				2022-12-28	WOS:A1991GM73200028
J	MAYOU, R; SEAGROATT, V; GOLDACRE, M				MAYOU, R; SEAGROATT, V; GOLDACRE, M			USE OF PSYCHIATRIC-SERVICES BY PATIENTS IN A GENERAL-HOSPITAL	BRITISH MEDICAL JOURNAL			English	Article							SUBSTANCE USE; DISORDERS; CONSULTATIONS; ANXIETY; PAIN	Objective - To identify physical disorders associated with increased rate of use of psychiatric services. Design - Retrospective analysis of routine s of general hospital inpatient records linked with those of psychiatric care, for inpatients with physical disorders with possible psychiatric associations and for controls. Setting - Oxfordshire health district. Subjects - Inpatients aged 15-64 years discharged from general hospitals during 1975-85 with a diagnosis among 14 selected diagnostic groups (including potentially life threatening conditions, chronic disabling diseases, and non-specific symptomatic conditions) and control inpatients with acute conditions. Main outcome measures - Observed and expected numbers of patients receiving psychiatric care. Results - Observed use of psychiatric services before and after index admission was close to that expected for controls. For most other diagnoses the observed use was significantly increased in the year preceding and that subsequent to the admission. For four diagnostic groups it was significantly greater in the year after admission than in that before (acute myocardial infarction (ratio before to after 2.17, 95% confidence interval 1.5 to 3.3), cancer (2.05, 1.7 to 2.5), diabetes mellitus (1.89, 1.4 to 2.9), and chest pain (1.78, 1.3 to 2.4)). During four years after the admission the use of psychiatric services was significantly higher than in the general population for nonsPecific symptomatic conditions (observed/expected: abdominal pain 1.7, chest pain 2.0, and headache 4.2), cirrhosis of the liver (10.4), and fractures in road accidents and other fractures (1.3, 1.6). Conclusions - More patients with certain physical conditions used psychiatric services. Alternative methods of service delivery may be needed, especially for disabling chronic physical illness, alcohol related disorders, and non-specific symptomatic conditions.	UNIV OXFORD,DEPT PUBL HLTH & PRIMARY CARE,CLIN EPIDEMIOL UNIT,OXFORD OX3 7LF,ENGLAND	University of Oxford	MAYOU, R (corresponding author), UNIV OXFORD,WARNEFORD HOSP,DEPT PSYCHIAT,OXFORD OX3 7JX,ENGLAND.							ACHESON ED, 1967, MEDICAL RECORD LINKA; BARSKY AJ, 1986, MED CARE, V24, P548, DOI 10.1097/00005650-198606000-00009; BERKSON J, 1946, BIOMETRICS BULL, V2, P47, DOI 10.2307/3002000; BRESLOW NE, 1987, STAT METHODS CANC RE, V2, P68; COLMAN M, 1986, INT J EPIDEMIOL, V15, P134; Devis T, 1984, POPULATION TRENDS, V36, P18; EASTWOOD MR, 1972, PSYCHOL MED, V2, P363, DOI 10.1017/S0033291700045177; FITZPATRICK RM, 1987, J NEUROL NEUROSUR PS, V44, P1061; FULOP G, 1989, HOSP COMMUNITY PSYCH, V40, P80; GILL LE, 1987, TXB MED RECORD LINKA, V3, P39; Goldberg D., 1983, INT J REHABIL RES, V6, P127, DOI [10.1097/00004356-198303000-00021, DOI 10.1097/00004356-198303000-00021]; HANKIN JR, 1982, ARCH GEN PSYCHIAT, V39, P225; HENGEVELD MW, 1984, GEN HOSP PSYCHIAT, V6, P271, DOI 10.1016/0163-8343(84)90021-5; KESSLER LG, 1987, AM J PUBLIC HEALTH, V77, P18, DOI 10.2105/AJPH.77.1.18; MAYOU R, 1988, J PSYCHOSOM RES, V32, P541, DOI 10.1016/0022-3999(88)90038-4; MAYOU R, 1986, BRIT J PSYCHIAT, V149, P172, DOI 10.1192/bjp.149.2.172; MAYOU R, 1989, J PSYCHOSOM RES, V33, P393, DOI 10.1016/0022-3999(89)90001-9; RANG EH, 1970, BRIT J PREV SOC MED, V24, P47; REGIER DA, 1978, ARCH GEN PSYCHIAT, V35, P685; STEWART AL, 1989, JAMA-J AM MED ASSOC, V262, P907, DOI 10.1001/jama.262.7.907; WALLEN J, 1987, ARCH GEN PSYCHIAT, V44, P163; WELLS KB, 1989, AM J PSYCHIAT, V146, P1440; WELLS KB, 1989, GEN HOSP PSYCHIAT, V11, P320, DOI 10.1016/0163-8343(89)90119-9	23	11	11	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	OCT 26	1991	303	6809					1029	1032		10.1136/bmj.303.6809.1029	http://dx.doi.org/10.1136/bmj.303.6809.1029			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GM478	1954454	Green Published, Bronze			2022-12-28	WOS:A1991GM47800020
J	NEEQUAYE, JE; BYRNE, J; LEVINE, PH				NEEQUAYE, JE; BYRNE, J; LEVINE, PH			MENARCHE AND REPRODUCTION AFTER TREATMENT FOR AFRICAN BURKITTS-LYMPHOMA	BRITISH MEDICAL JOURNAL			English	Article							GONADAL DAMAGE		NCI,EPIDEMIOL & BIOSTAT PROGRAM,EPN 400,BETHESDA,MD 20892; UNIV GHANA,SCH MED,DEPT CHILD HLTH,BURKITTS TUMOR PROJECT,ACCRA,GHANA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Ghana					DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS [N01CP051009] Funding Source: NIH RePORTER; NCI NIH HHS [N01-CP-51009] Funding Source: Medline	DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Epidemiology & Genetics); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BURKITT D, 1967, CANCER, V20, P756, DOI 10.1002/1097-0142(1967)20:5<756::AID-CNCR2820200530>3.0.CO;2-P; KOYAMA H, 1977, CANCER, V36, P1401; QUIGLEY C, 1989, NEW ENGL J MED, V321, P143, DOI 10.1056/NEJM198907203210303; RIVKEES SA, 1988, JAMA-J AM MED ASSOC, V259, P2123; WATSON AR, 1986, FERTIL STERIL, V46, P331	5	3	3	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	OCT 26	1991	303	6809					1033	1033		10.1136/bmj.303.6809.1033	http://dx.doi.org/10.1136/bmj.303.6809.1033			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GM478	1954456	Green Published, Bronze			2022-12-28	WOS:A1991GM47800022
J	LEFF, J				LEFF, J			SCHIZOPHRENIA IN THE MELTING POT	NATURE			English	Editorial Material							BRAIN				LEFF, J (corresponding author), INST PSYCHIAT,MRC,SOCIAL & COMMUNITY PSYCHIAT UNIT,DE CRESPIGNY PK,LONDON SE5 8AF,ENGLAND.							ASCHAUER H, 1989, SCHIZOPHR RES, V2, P39; BENES FM, 1989, SCHIZOPHRENIA BULL, V15, P585, DOI 10.1093/schbul/15.4.585; BOGERTS B, 1990, SCHIZOPHR RES, V3, P295, DOI 10.1016/0920-9964(90)90013-W; BOYD JH, 1986, SCHIZOPHRENIA BULL, V12, P173, DOI 10.1093/schbul/12.2.173; DER G, 1990, LANCET, V335, P513, DOI 10.1016/0140-6736(90)90745-Q; LEFF JP, 1987, BRIT J PSYCHIAT, V151, P156; OCALLAGHAN E, 1991, LANCET, V337, P1248, DOI 10.1016/0140-6736(91)92919-S; SARTORIUS N, 1986, PSYCHOL MED, V16, P909, DOI 10.1017/S0033291700011910; SEIDMAN LJ, 1983, PSYCHOL BULL, V94, P195, DOI 10.1037/0033-2909.94.2.195; SHELTON RC, 1986, NEUROLOGY SCHIZOPHRE; SHERRINGTON R, 1988, NATURE, V336, P164, DOI 10.1038/336164a0; 1979, SCHIZOPHRENIA INT FO	12	9	9	0	1	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	OCT 24	1991	353	6346					693	694		10.1038/353693a0	http://dx.doi.org/10.1038/353693a0			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GL696	1944525				2022-12-28	WOS:A1991GL69600026
J	STRINGER, MD; CAPPS, SNJ				STRINGER, MD; CAPPS, SNJ			RATIONALIZING THE MANAGEMENT OF SWALLOWED COINS IN CHILDREN	BRITISH MEDICAL JOURNAL			English	Article							FOREIGN-BODIES	Objective - To assess the management of swallowed coins in children and identify aspects that could be improved. Design - Study of records of three hospital departments for 1986-90. Setting - Accident and emergency, radiology, and operating theatre departments in a children's hospital. Subjects - 50 children reported to have ingested coins. Main outcome measures - Radiological investigations performed, position of coin, symptoms of child, and surgical intervention. Results - 50 children were recorded to have swallowed coins during 1986-90. Five children had only chest radiography, five only abdominal radiography, and 40 had both. A coin was detected in the oesophagus in 15 children, six of whom had symptoms, and below the cardia in 26, none of whom had symptoms; no coin was seen in nine children. Eleven children had further abdominal radiographs despite the absence of gastrointestinal symptoms; one child had a coin removed from the stomach. Conclusions - Children are being unnecessarily exposed to radiation and surgical intervention, and a consensus on management of swallowed coins is needed. Most children require only a single chest and neck radiograph.			STRINGER, MD (corresponding author), QUEEN MARYS HOSP CHILDREN,DEPT PAEDIAT SURG,CARSHALTON SM5 4NR,SURREY,ENGLAND.							BROWN WM, 1971, BMJ-BRIT MED J, V4, P620, DOI 10.1136/bmj.4.5787.620-a; Groff D. B., 1986, PEDIATR SURG, P907; JONES PG, 1963, MED J AUSTRALIA, V50, P236; MANDELL GA, 1977, PEDIATRICS, V60, P460; SPITZ L, 1971, BMJ-BRIT MED J, V4, P469, DOI 10.1136/bmj.4.5785.469; 1989, LANCET, V2, P659	6	30	30	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JUN 1	1991	302	6788					1321	1322		10.1136/bmj.302.6788.1321	http://dx.doi.org/10.1136/bmj.302.6788.1321			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FQ444	1953854	Green Published, Bronze			2022-12-28	WOS:A1991FQ44400023
J	BONSEL, GJ; KLOMPMAKER, IJ; VANTVEER, F; HABBEMA, JDF; SLOOFF, MJH				BONSEL, GJ; KLOMPMAKER, IJ; VANTVEER, F; HABBEMA, JDF; SLOOFF, MJH			USE OF PROGNOSTIC MODELS FOR ASSESSMENT OF VALUE OF LIVER-TRANSPLANTATION IN PRIMARY BILIARY-CIRRHOSIS	LANCET			English	Article									ACAD ZIEKENHUIS GRONINGEN,LIVER TRANSPLANT GRP,GRONINGEN,NETHERLANDS	University of Groningen	BONSEL, GJ (corresponding author), ERASMUS UNIV,FAC MED,DEPT PUBL HLTH & SOCIAL MED,POB 1738,3000 DR ROTTERDAM,NETHERLANDS.							BISMUTH H, 1987, LANCET, V2, P674; Bonsel G J, 1989, Ned Tijdschr Geneeskd, V133, P1406; BONSEL GJ, 1988, COSTS EFFECTS LIVER, V4; BONSEL GJ, IN PRESS TRANSPL P; BUXTON M, 1985, COSTS BENEFITS HEART, P171; CHRISTENSEN E, 1985, GASTROENTEROLOGY, V88, P156, DOI 10.1016/S0016-5085(85)80148-7; Conn H O, 1981, Hepatology, V1, P673, DOI 10.1002/hep.1840010617; CUTHBERT JA, 1986, AM J MED SCI, V291, P286, DOI 10.1097/00000441-198604000-00012; DICKSON ER, 1989, HEPATOLOGY, V10, P1, DOI 10.1002/hep.1840100102; KLOMPMAKER IJ, IN PRESS TRANSPLANTA; KROM RAF, 1983, TRANSPLANT P, V15, P1276; MADDREY WC, 1988, HEPATOLOGY, V8, P948, DOI 10.1002/hep.1840080440; MARKUS BH, 1989, NEW ENGL J MED, V320, P1709, DOI 10.1056/NEJM198906293202602; NEUBERGER J, 1986, TRANSPLANTATION, V41, P713, DOI 10.1097/00007890-198606000-00009; OGRADY JG, 1988, GUT, V29, P566, DOI 10.1136/gut.29.5.566; PUGH RNH, 1973, BRIT J SURG, V60, P646, DOI 10.1002/bjs.1800600817; SCHARSCHMIDT BF, 1984, HEPATOLOGY, V4, pS95, DOI 10.1002/hep.1840040723; SLOOFF MJH, 1989, TRANSPLANT P, V21, P2328; STARZL TE, 1989, NEW ENGL J MED, V321, P1014, DOI 10.1056/NEJM198910123211505; STARZL TE, 1989, NEW ENGL J MED, V321, P1092, DOI 10.1056/NEJM198910193211606; VANDERPUTTEN ABMM, 1987, LIVER, V7, P84	21	65	65	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	MAR 3	1990	335	8688					493	497		10.1016/0140-6736(90)90734-M	http://dx.doi.org/10.1016/0140-6736(90)90734-M			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT015	1968527				2022-12-28	WOS:A1990CT01500002
J	MARLIN, SD; STAUNTON, DE; SPRINGER, TA; STRATOWA, C; SOMMERGRUBER, W; MERLUZZI, VJ				MARLIN, SD; STAUNTON, DE; SPRINGER, TA; STRATOWA, C; SOMMERGRUBER, W; MERLUZZI, VJ			A SOLUBLE FORM OF INTERCELLULAR-ADHESION MOLECULE-1 INHIBITS RHINOVIRUS INFECTION	NATURE			English	Article									CTR BLOOD RES, BOSTON, MA 02115 USA; ERNST BOEHRINGER INST ARZNEIMITTELFORSCH, A-1120 VIENNA, AUSTRIA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM)	MARLIN, SD (corresponding author), BOEHRINGER INGELHEIM PHARMACEUT INC, DEPT IMMUNOL, 90 E RIDGE, RIDGEFIELD, CT 06877 USA.							ABRAHAM G, 1984, J VIROL, V51, P340, DOI 10.1128/JVI.51.2.340-345.1984; COLONNO RJ, 1987, POSITIVE STRAND RNA, P92; DUSTIN ML, 1988, IMMUNOL TODAY, V9, P213, DOI 10.1016/0167-5699(88)91216-9; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; GREVE JM, 1989, CELL, V56, P839, DOI 10.1016/0092-8674(89)90688-0; KISHIMOTO TK, 1989, ADV IMMUNOL, V46, P149, DOI 10.1016/S0065-2776(08)60653-7; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; MARLIN SD, 1987, CELL, V51, P813, DOI 10.1016/0092-8674(87)90104-8; MITCHELL PJ, 1986, MOL CELL BIOL, V6, P425, DOI 10.1128/MCB.6.2.425; MULLIGAN RC, 1981, P NATL ACAD SCI-BIOL, V78, P2072, DOI 10.1073/pnas.78.4.2072; PETERSON A, 1988, CELL, V54, P65, DOI 10.1016/0092-8674(88)90180-8; ROSSMANN MG, 1989, J BIOL CHEM, V264, P14587; ROTHLEIN R, 1986, J IMMUNOL, V137, P1270; ROTHLEIN R, 1988, J IMMUNOL, V141, P1665; SPERBER SJ, 1988, ANTIMICROB AGENTS CH, V32, P409, DOI 10.1128/AAC.32.4.409; SPRINGER TA, 1987, ANNU REV IMMUNOL, V5, P223, DOI 10.1146/annurev.immunol.5.1.223; STAUNTON DE, 1989, CELL, V56, P849, DOI 10.1016/0092-8674(89)90689-2; STAUNTON DE, 1988, CELL, V52, P925, DOI 10.1016/0092-8674(88)90434-5; TOMASSINI JE, 1989, P NATL ACAD SCI USA, V86, P4907, DOI 10.1073/pnas.86.13.4907; WAWRYK SO, 1989, IMMUNOL REV, V108, P135, DOI 10.1111/j.1600-065X.1989.tb00016.x	20	265	302	1	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 1	1990	344	6261					70	72		10.1038/344070a0	http://dx.doi.org/10.1038/344070a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ972	1968231				2022-12-28	WOS:A1990CQ97200065
J	HARRIES, AD				HARRIES, AD			TUBERCULOSIS AND HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION IN DEVELOPING-COUNTRIES	LANCET			English	Review											HARRIES, AD (corresponding author), UNIV LIVERPOOL, LIVERPOOL SCH TROP MED, PEMBROKE PL, LIVERPOOL L3 5QA, ENGLAND.							[Anonymous], 1985, TUBERCLE, V66, P161; [Anonymous], 1975, Tubercle, V56, P269; [Anonymous], 1989, Tubercle, V70, P5; [Anonymous], 1978, Tubercle, V59, P155; CARSWELL JW, 1986, LANCET, V1, P1217; CATHEBRAS P, 1988, INT C SER, V810, P66; COLEBUNDERS RL, 1988, JAMA-J AM MED ASSOC, V259, P352, DOI 10.1001/jama.1988.03720030020015; COLEBUNDERS RL, 1988, INT C SER, V810, P222; KRIRTSKI AL, 1989, AM REV RESPIR DIS, V139, pA185; KRITSKI A L, 1989, American Review of Respiratory Disease, V139, pA147; KRITSKI A L, 1988, American Review of Respiratory Disease, V137, P494; LEPAGE P, 1988, INFECT CONT HOSP EP, V9, P200, DOI 10.1086/645833; LESTER FT, 1988, ETHIOPIAN MED J, V26, P139; LEVI GC, 1988, INT C SER, V810, P66; MANN J, 1986, JAMA-J AM MED ASSOC, V256, P346, DOI 10.1001/jama.1986.03380030048011; MANN JM, 1986, JAMA-J AM MED ASSOC, V256, P3099, DOI 10.1001/jama.256.22.3099; MBOLIDI CD, 1988, PRESSE MED, V17, P872; MCLEOD D T, 1988, American Review of Respiratory Disease, V137, P119; MEERAN K, 1989, BRIT MED J, V298, P364, DOI 10.1136/bmj.298.6670.364; MERLIN M, 1986, EVALUATION PREVALENC; Miller A B, 1966, Tubercle, V47, P33; NAMBUYA A, 1988, J CLIN PATHOL, V41, P93, DOI 10.1136/jcp.41.1.93; NARAQI S, 1980, MED J AUSTRALIA, V1, P480, DOI 10.5694/j.1326-5377.1980.tb135045.x; NINANE J, 1988, ARCH DIS CHILD, V63, P1268, DOI 10.1136/adc.63.10.1268; Pape JW, 1988, BAILLIERE CLIN TROP, V3, P31; PEARSON CA, 1978, J TROP MED HYG, V81, P238; PITCHENIK AE, 1983, ANN INTERN MED, V98, P112, DOI 10.7326/0003-4819-98-1-112_2; PITCHENIK AE, 1984, ANN INTERN MED, V101, P641, DOI 10.7326/0003-4819-101-5-641; RWANDAN HIV, 1989, LANCET, V1, P941; SELWYN PA, 1989, NEW ENGL J MED, V320, P545, DOI 10.1056/NEJM198903023200901; Slutkin G, 1988, Bull Int Union Tuberc Lung Dis, V63, P21; STYBLO K, 1986, RECENT ADV RESPIRATO, P77; SUNDERAM G, 1986, JAMA-J AM MED ASSOC, V256, P362, DOI 10.1001/jama.256.3.362; VONREYN CF, 1987, LANCET, V2, P669; WILLAME JC, 1988, ANN SOC BELG MED TR, V68, P165; 1989, GLOBAL PROGRAMME AID; 1990, WEEKLY EPIDEMIOLOGIC	37	245	245	0	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 17	1990	335	8686					387	390		10.1016/0140-6736(90)90216-R	http://dx.doi.org/10.1016/0140-6736(90)90216-R			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN988	1968123				2022-12-28	WOS:A1990CN98800011
J	MATKOVIC, V; APSELOFF, G; SHEPARD, DR; GERBER, N				MATKOVIC, V; APSELOFF, G; SHEPARD, DR; GERBER, N			USE OF GALLIUM TO TREAT PAGETS-DISEASE OF BONE - A PILOT-STUDY	LANCET			English	Article											MATKOVIC, V (corresponding author), OHIO STATE UNIV, COLL MED,DEPT PHARMACOL,BONE & MINERAL METAB LAB, 5198 GRAVES HALL, 333 W 10TH AVE, COLUMBUS, OH 43210 USA.				NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000034] Funding Source: NIH RePORTER; NCRR NIH HHS [M01-RR00034] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		ANGHILERI LJ, 1988, J NUCL MED, V29, P663; BIJVOET OLM, 1968, LANCET, V1, P876; BIJVOET OLM, 1989, CLIN DISORDERS BONE, P525; BLUMENTHAL NC, 1989, CALCIFIED TISSUE INT, V45, P81, DOI 10.1007/BF02561406; BOCKMAN RS, 1986, CALCIFIED TISSUE INT, V39, P376, DOI 10.1007/BF02555174; CHITAMBAR CR, 1988, BLOOD, V72, P1930; DEDEUXCHAISNES CN, 1964, MEDICINE, V43, P233, DOI 10.1097/00005792-196405000-00004; DONNELLY R, 1989, CALCIFIED TISSUE INT, V44, P138, DOI 10.1007/BF02556473; DUDLEY HC, 1949, J PHARMACOL EXP THER, V96, P224; DUDLEY HC, 1952, J PHARMACOL EXP THER, V106, P129; DULL TA, 1963, NEW ENGL J MED, V268, P132, DOI 10.1056/NEJM196301172680305; GOVERDE BC, 1972, CLIN CHIM ACTA, V41, P29, DOI 10.1016/0009-8981(72)90492-5; HAMILTON EI, 1979, CHEM ELEMENTS MAN, P363; KANIS JA, 1987, CLIN ORTHOP RELAT R, P99; Kay HD, 1929, BRIT J EXP PATHOL, V10, P253; KRAKOFF IH, 1979, CANCER, V44, P1722, DOI 10.1002/1097-0142(197911)44:5<1722::AID-CNCR2820440528>3.0.CO;2-C; LARSON SM, 1978, SEMIN NUCL MED, V8, P193, DOI 10.1016/S0001-2998(78)80028-2; LARSON SM, 1980, JNCI-J NATL CANCER I, V64, P41; MILLS BG, 1988, J NUCL MED, V29, P1083; MILLS BG, 1976, SCIENCE, V194, P201, DOI 10.1126/science.959849; NUSSBAUM SR, 1987, CLIN CHEM, V33, P1364; PAPAPOULOS SE, 1987, J CLIN ENDOCR METAB, V65, P89, DOI 10.1210/jcem-65-1-89; PIOLI G, 1989, CALCIFIED TISSUE INT, V45, P257, DOI 10.1007/BF02556047; Rasmussen Alan H., 1974, ETHNOL SCAND, V1974, P117; REBEL A, 1974, REV RHUM, V41, P767; RYAN WG, 1969, ANN INTERN MED, V70, P549, DOI 10.7326/0003-4819-70-3-549; SINGER FR, 1977, PAGETS DISEASE BONE, P23; SMITH R, 1971, LANCET, V1, P945; WALTON RJ, 1977, EUR J CLIN INVEST, V7, P37, DOI 10.1111/j.1365-2362.1977.tb01567.x; WALTON RJ, 1975, LANCET, V2, P309, DOI 10.1016/S0140-6736(75)92736-1; WARRELL RP, 1988, ANN INTERN MED, V108, P669, DOI 10.7326/0003-4819-108-5-669; WARRELL RP, 1984, J CLIN INVEST, V73, P1487, DOI 10.1172/JCI111353; WOODHOUSE NJ, 1971, LANCET, V1, P1139	33	55	55	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 13	1990	335	8681					72	75		10.1016/0140-6736(90)90540-L	http://dx.doi.org/10.1016/0140-6736(90)90540-L			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CH516	1967419				2022-12-28	WOS:A1990CH51600004
J	KOVALCHIK, MT				KOVALCHIK, MT			THEO STORY	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 18	1991	266	23					3340	3340						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GU964	1960837				2022-12-28	WOS:A1991GU96400037
J	MCMURRY, MP; CERQUEIRA, MT; CONNOR, SL; CONNOR, WE				MCMURRY, MP; CERQUEIRA, MT; CONNOR, SL; CONNOR, WE			CHANGES IN LIPID AND LIPOPROTEIN LEVELS AND BODY-WEIGHT IN TARAHUMARA INDIANS AFTER CONSUMPTION OF AN AFFLUENT DIET	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PIMA-INDIANS; HDL CHOLESTEROL; PLASMA-LIPIDS; MEXICO; COUNTRIES; DISEASE; WOMEN; FOOD; FAT	Background. Major new public health problems occur in developing countries as they become more affluent and change their traditional dietary patterns. To study this phenomenon in microcosm, we substituted an "affluent" diet for the traditional diet of a group of Tarahumara Indians, a Mexican people known to consume a low-fat, high-fiber diet and to have a very low incidence of risk factors for coronary heart disease. Methods. Thirteen Tarahumara Indians (five women and eight men [including one adolescent]) consumed their traditional diet (2700 kcal per day) for one week, and were then fed a diet typical of affluent societies, which contained excessive calories (41 00 kcal per day), total fat, saturated fat, and cholesterol, for five weeks. Results. After five weeks of consuming the affluent diet, the subjects' mean (+/- SE) plasma cholesterol level increased by 31 percent, from 121 +/- 5 to 159 +/- 6 mg per deciliter (3.13 +/- 0.13 to 4.11 +/- 0.16 mmol per liter, P < 0.001). The increase in the plasma cholesterol level was primarily in the low-density lipoprotein (LDL) fraction, which rose 39 percent, from 72 +/- 3 to 100 +/- 4 mg per deciliter (1.86 +/- 0.08 to 2.59 +/- 0.10 mmol per liter, P < 0.001). High-density lipoprotein (HDL) cholesterol, usually low in this population, increased by 31 percent, from 32 +/- 2 to 42 +/- 3 mg per deciliter (0.83 +/- 0.05 to 1.09 +/- 0.08 mmol per liter). Consequently, the ratio of LDL to HDL levels changed little (2.25 with the base-line diet and 2.38 with the affluent diet). Plasma triglyceride levels increased by 18 percent, from 91 +/- 8 to 108 +/- 11 mg per deciliter (1.03 +/- 0.09 to 1.22 +/- 0.12 mmol per liter, P < 0.05), with a significant increase in the very-low-density lipoprotein triglyceride fraction. All the subjects gained weight, with a mean increase of 3.8 kg (7 percent). Conclusions. When Tarahumara Indians from a population with virtually no coronary risk factors consumed for a short time a hypercaloric diet typical of a more affluent society, they had dramatic increases in plasma lipid and lipoprotein levels and body weight. If sustained, such changes might increase their risk of coronary heart disease.	OREGON HLTH SCI UNIV, DEPT MED, CLIN NUTR & LIPID METAB SECT, L465, PORTLAND, OR 97201 USA	Oregon Health & Science University					NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL037940] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK040566] Funding Source: NIH RePORTER; NCRR NIH HHS [RR00334] Funding Source: Medline; NHLBI NIH HHS [HL37940] Funding Source: Medline; NIDDK NIH HHS [DK40566] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BOUCHARD C, 1990, NEW ENGL J MED, V322, P1477, DOI 10.1056/NEJM199005243222101; CERQUEIRA MT, 1979, AM J CLIN NUTR, V32, P905, DOI 10.1093/ajcn/32.4.905; CONNOR SE, 1986, NEW AM DIET; CONNOR SL, 1982, CIRCULATION, V65, P1290, DOI 10.1161/01.CIR.65.7.1290; CONNOR SL, 1989, J AM DIET ASSOC, V89, P807; CONNOR SL, 1989, J AM DIET ASSOC, V89, P1236; CONNOR WE, 1978, AM J CLIN NUTR, V31, P1131, DOI 10.1093/ajcn/31.7.1131; DODU SRA, 1988, CARDIOLOGY, V75, P56, DOI 10.1159/000174349; GROOM D, 1971, AM HEART J, V81, P304, DOI 10.1016/0002-8703(71)90099-8; Health. & N.R.C.U.C.o.D.a., 1989, DIET HLTH IMPLICATIO; HOWARD BV, 1983, CIRCULATION, V68, P714, DOI 10.1161/01.CIR.68.4.714; KASHIWAGI A, 1985, METABOLISM, V34, P364, DOI 10.1016/0026-0495(85)90226-4; KNUIMAN JT, 1980, ATHEROSCLEROSIS, V36, P529, DOI 10.1016/0021-9150(80)90245-2; MCMURRY MP, 1985, AM J CLIN NUTR, V41, P1289, DOI 10.1093/ajcn/41.6.1289; MCMURRY MP, 1982, AM J CLIN NUTR, V35, P741, DOI 10.1093/ajcn/35.4.741; MILLER DS, 1967, AM J CLIN NUTR, V20, P1212, DOI 10.1093/ajcn/20.11.1212; MILLER GJ, 1982, LANCET, V2, P1270; NORMAN J, 1976, NATL GEOGR, V149, P702; PISUNYER FX, 1988, MODERN NUTRITION HLT, P797; REID JM, 1971, AM J CLIN NUTR, V24, P1281; SAAD MF, 1988, NEW ENGL J MED, V319, P1500, DOI 10.1056/NEJM198812083192302; Sims E A, 1968, Trans Assoc Am Physicians, V81, P153; SOWERS MF, 1981, J AM DIET ASSOC, V79, P536; Trowell HC, 1981, W DIS THEIR EMERGENC; TROWELL HC, 1981, W DISEASES THEIR EME, P427; WEST KM, 1981, W DISEASES THEIR EME, P129; 1987, CLINFO REFERENCE MAN, V2; 1988, DHHS PHS8850210 DEP, P83; 1988, CIRCULATION, V77, pA721; 1974, DHEW NIH75628 PUBL, P1	30	76	77	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 12	1991	325	24					1704	1708		10.1056/NEJM199112123252405	http://dx.doi.org/10.1056/NEJM199112123252405			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GU418	1944471				2022-12-28	WOS:A1991GU41800005
J	PIERCE, JP; GILPIN, E; BURNS, DM; WHALEN, E; ROSBROOK, B; SHOPLAND, D; JOHNSON, M				PIERCE, JP; GILPIN, E; BURNS, DM; WHALEN, E; ROSBROOK, B; SHOPLAND, D; JOHNSON, M			DOES TOBACCO ADVERTISING TARGET YOUNG-PEOPLE TO START SMOKING - EVIDENCE FROM CALIFORNIA	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							UNITED-STATES; CIGARETTE-SMOKING; TRENDS	Objective. - To evaluate whether tobacco advertising encourages teenagers younger than 18 years to start smoking. Design. - Comparison of 1990 California telephone survey data with data from a 1986 national telephone survey (both used a random-digit dialing system); 95% confidence intervals were calculated. To test our hypothesis, we considered whether the perception of advertising was related to age, whether the pattern of market share across age and sex groups followed the pattern of perceived advertising, and whether changes in market share paralleled changes in advertising as perceived by the youngest age group. Participants. - There were 24296 adults and 5040 teenagers. Results. - The most advertised brands of cigarettes were Marlboro, according to 33.6% of adults and 41.8% of teenagers, and Camel, according to 13.7% of adults and 28.5% of teenagers-named most often by 12- to 13-year-olds (34.2%). The brands that were purchased most often were Marlboro and Camel. Together these were the brands of choice of 79.9% of males and 85% of females aged 12 through 17 years. Marlboro's market share increased in youths and young adults up to age 24 years and then decreased gradually with age; Camel's market share decreased abruptly with age: it was the brand of choice of 24.5% +/- 5.8% of males aged 12 through 17 years but was chosen by only 12.7% +/- 3.6% of males aged 18 through 24 years; for females, 21.7% +/- 13.7% aged 12 through 17 years chose Camels, while only 5.5% +/- 3.2% aged 18 through 24 years preferred this brand. Both Marlboro and Camel brands had a higher market share in California in 1990 compared with that for the United States in 1986. Of interest is that the market share for Camel increased among the younger smokers but was more evenly distributed for Marlboro. Conclusions. - Perception of advertising is higher among young smokers; market-share patterns across age and sex groups follow the perceived advertising patterns; and changes in market share resulting from advertising occur mainly in younger smokers. Cigarette advertising encourages youth to smoke and should be banned.	CALIF DEPT HLTH SERV,TOBACCO CONTROL SECT,SACRAMENTO,CA; NCI,BETHESDA,MD 20892	California Department of Health Care Services; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	PIERCE, JP (corresponding author), UNIV CALIF SAN DIEGO,POPULAT STUDIES CANC PREVENT,2251 SAN DIEGO AVE,SUITE B-111,SAN DIEGO,CA 92110, USA.			Pierce, John/0000-0002-0075-7471				[Anonymous], 1982, JACKKNIFE BOOTSTRAP; BIRD L, 1991, ADWEEKS MARKETI 0520, P20; BLUM A, 1991, NEW ENGL J MED, V324, P913, DOI 10.1056/NEJM199103283241310; CHAPMAN S, 1989, BRIT J ADDICT, V84, P1267; CHAPMAN S, 1982, AM J PUBLIC HEALTH, V72, P491, DOI 10.2105/AJPH.72.5.491; DAVIS RM, 1987, NEW ENGL J MED, V316, P725, DOI 10.1056/NEJM198703193161206; DOOLITTLE DE, 1991, TOBACCO REP      FEB, P14; FIORE MC, 1989, JAMA-J AM MED ASSOC, V261, P49, DOI 10.1001/jama.261.1.49; GOAD GP, 1991, WALL ST J       0729; GRISOM TE, 1991, WASHINGTON POST 0601, P21; HATZIANDREU EJ, 1990, J NATL CANCER I, V82, P1402, DOI 10.1093/jnci/82.17.1402; KLINTZNER M, 1991, BR J ADDICT, V86, P287; PIERCE JP, 1991, J NATL CANCER I, V83, P1009, DOI 10.1093/jnci/83.14.1009; PIERCE JP, 1990, MED J AUSTRALIA, V152, P113, DOI 10.5694/j.1326-5377.1990.tb125114.x; PIERCE JP, 1989, JAMA-J AM MED ASSOC, V261, P56, DOI 10.1001/jama.261.1.56; PIERCE JP, 1990, SMOKING CESSATION OR; RAFTERY J, 1989, BRIT J ADDICT, V84, P1241; Tye J B, 1987, J Public Health Policy, V8, P492, DOI 10.2307/3342275; WAKSBERG J, 1978, J AM STAT ASSOC, V73, P40, DOI 10.2307/2286513; WARNER KE, 1989, AM J PUBLIC HEALTH, V79, P144, DOI 10.2105/AJPH.79.2.144; WATERSON MJ, 1982, ADVERTISING CIGARETT; 1986, TOBACCO USE 1986 MET; 1988, CDC888406 DEP HLTH H; 1989, CDC898411 DEP HLTH H; 1986, NIH862687 DEP HLTH H; 1990, MMWR, V39, P261	26	197	200	0	14	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 11	1991	266	22					3154	3158		10.1001/jama.266.22.3154	http://dx.doi.org/10.1001/jama.266.22.3154			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GT654	1956103				2022-12-28	WOS:A1991GT65400024
J	BAXT, WG				BAXT, WG			USE OF AN ARTIFICIAL NEURAL NETWORK FOR THE DIAGNOSIS OF MYOCARDIAL-INFARCTION	ANNALS OF INTERNAL MEDICINE			English	Article						MYOCARDIAL INFARCTION; ARTIFICIAL INTELLIGENCE; EMERGENCY MEDICINE; MODELS, THEORETICAL; DIAGNOSIS, COMPUTER-AIDED	RECOGNITION; EMERGENCY; PROTOCOL	Objective: To validate prospectively the use of an artificial neural network to identify myocardial infarction in patients presenting to an emergency department with anterior chest pain. Design: Prospective, blinded testing. Setting: Tertiary university teaching center. Patients: A total of 331 consecutive adult patients presenting with anterior chest pain. Measurements: Diagnostic sensitivity and specificity with regard to the diagnosis of acute myocardial infarction. Main Results: An artificial neural network was trained on clinical pattern sets retrospectively derived from the cases of 351 patients hospitalized with a high likelihood of having myocardial infarction. It was prospectively tested on 331 consecutive patients presenting to an emergency department with anterior chest pain. The ability of the network to distinguish patients with from those without acute myocardial infarction was compared with that of physicians caring for the same patients. The physicians had a diagnostic sensitivity of 77.7% (95% CI, 77.0% to 82.9%) and a diagnostic specificity of 84.7% (CI, 84.0% to 86.4%). The artificial neural network had a sensitivity of 97.2% (CI, 97.2% to 97.5%; P = 0.033) and a specificity of 96.2% (CI, 96.2% to 96.4%; P < 0.001). Conclusion: An artificial neural network trained to identify myocardial infarction in adult patients presenting to an emergency department may be a valuable aid to the clinical diagnosis of myocardial infarction; however, this possibility must be confirmed through prospective testing on a larger patient sample.			BAXT, WG (corresponding author), UNIV CALIF SAN DIEGO, MED CTR, DEPT EMERGENCY MED, 225 DICKINSON ST, 8676, SAN DIEGO, CA 92103 USA.							BAILEY BJR, 1980, TECHNOMETRICS, V22, P583, DOI 10.2307/1268196; BAXT WG, 1991, NEURAL COMPUT, V2, P480; BOUNDS DG, 1990, NEURAL NETWORKS, V3, P583, DOI 10.1016/0893-6080(90)90008-9; CIOS KJ, 1990, IEEE ENG MED BIOL, V9, P58, DOI 10.1109/51.59215; EBERHART RC, 1991, 4TH P ANN IEEE S COM, P298; GALLANT SI, 1988, COMMUN ACM, V31, P152, DOI 10.1145/42372.42377; GOLDMAN L, 1988, NEW ENGL J MED, V318, P797, DOI 10.1056/NEJM198803313181301; HARRISON RF, 1991, P INT JOINT C NEURAL, V1, P1; HIRAIWA A, 1990, IEEE ENG MED BIOL, V9, P39, DOI 10.1109/51.59211; HUDSON DL, 1988, 12TH S COMP APPL MED, V12, P251; KAUFMAN JJ, 1990, IEEE ENG MED BIOL, V9, P23, DOI 10.1109/51.59209; MARCONI L, 1989, P INT JOINT C NEURAL, V2, P577; McClelland J. L., 1988, EXPLORATIONS PARALLE, P121; MCDONALD CJ, 1976, NEW ENGL J MED, V295, P1351, DOI 10.1056/NEJM197612092952405; MULSANT GH, 1988, 12TH S COMP APPL MED, V12, P245; POZEN MW, 1984, NEW ENGL J MED, V310, P1273, DOI 10.1056/NEJM198405173102001; REGGIA JA, 1985, COMPUTERS MED, V2; Rumelhart G.E., 1986, PARALLEL DISTRIBUTED, P318, DOI DOI 10.1016/B978-1-4832-1446-7.50035-2; RUSNAK RA, 1989, ANN EMERG MED, V18, P1029, DOI 10.1016/S0196-0644(89)80924-2; SAITO K, 1988, P IEEE INT C NEURAL, V1, P255; SMITH JW, 1988, 12TH S COMP APPL MED, V12, P261; SZOLOVITS P, 1988, ANN INTERN MED, V108, P80, DOI 10.7326/0003-4819-108-1-80; WEIGEND AS, 1990, PREDICTING FUTURE CO; Widrow G, 1960, CONVENTION RECORD 4, P96; Yoon Y. O., 1989, J NEURAL NETWORK SUM, P43	25	337	346	0	59	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 1	1991	115	11					843	848		10.7326/0003-4819-115-11-843	http://dx.doi.org/10.7326/0003-4819-115-11-843			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GR171	1952470				2022-12-28	WOS:A1991GR17100002
J	GRUBB, BP; GERARD, G; ROUSH, K; TEMESYARMOS, P; ELLIOTT, L; HAHN, H; SPANN, C				GRUBB, BP; GERARD, G; ROUSH, K; TEMESYARMOS, P; ELLIOTT, L; HAHN, H; SPANN, C			DIFFERENTIATION OF CONVULSIVE SYNCOPE AND EPILEPSY WITH HEAD-UP TILT TESTING	ANNALS OF INTERNAL MEDICINE			English	Article						SYNCOPE; EPILEPSY; HEAD-UP TILT TABLE; CONVULSIONS; ISOPROTERENOL	NEURALLY MEDIATED HYPOTENSION; UNKNOWN ORIGIN; UNEXPLAINED SYNCOPE; HEALTHY-SUBJECTS; BRADYCARDIA; ISOPROTERENOL; DISOPYRAMIDE; PREVENTION; RECURRENT; RESPONSES	Objective: To evaluate the usefulness of head-upright tilt table testing in the differential diagnosis of convulsive syncope from epileptic seizures in patients with recurrent idiopathic seizure-like episodes. Design: Prospective, nonrandomized study. Setting: Electrophysiology laboratory of a university hospital. Patients: Fifteen patients (8 men and 7 women patients; mean age, 29 +/- 20 years) with recurrent unexplained seizure-like episodes, unresponsive to anti-seizure medication. Measurements: Head-upright tilt table testing with or without isoproterenol infusion. Five patients who were initially tilt positive had a second tilt test with continuous electroencephalographic (EEG) recording. Main Results: Syncope associated with tonic-clonic seizure-like activity occurred in six patients (40%) during the baseline tilt and in four patients (27%) during isoproterenol infusion (total positive tests, 67%). The EEG showed diffuse brain wave slowing (not typical of epileptic seizures) in five of five patients during the convulsive episode. All patients who had positive test results eventually become tilt table negative after therapy, and over a mean follow-up period of 21 +/- 2 months, no further seizure-like episodes have occurred. Conclusion: Upright tilt table testing combined with isoproterenol infusion may be useful to distinguish convulsive syncope from epileptic seizures.			GRUBB, BP (corresponding author), MED COLL OHIO, DIV CARDIOL, 3000 ARLINGTON AVE, POB 10008, TOLEDO, OH 43699 USA.							ABISAMRA F, 1988, PACE, V11, P1202, DOI 10.1111/j.1540-8159.1988.tb03973.x; ALMQUIST A, 1989, NEW ENGL J MED, V320, P346, DOI 10.1056/NEJM198902093200603; BRAHAM J, 1981, ANN NEUROL, V10, P277, DOI 10.1002/ana.410100318; CASTAUT H, 1958, ELECTROECEPHALOGR CL, V10, P607; CHEN MY, 1988, CIRCULATION, V78, P239; CHOSY JJ, 1965, J PSYCHOSOM RES, V9, P189, DOI 10.1016/0022-3999(65)90032-2; DEVINSKY O, 1990, SEMIN NEUROL, V10, P321, DOI 10.1055/s-2008-1063976; DUVOISIN RC, 1962, ARCH NEUROL-CHICAGO, V7, P219, DOI 10.1001/archneur.1962.04210030057008; ENGEL J, 1989, SEIZURES EPILEPSY, P340; EPSTEIN SE, 1968, CIRCULATION, V37, P524, DOI 10.1161/01.CIR.37.4.524; FERGUSON DW, 1983, CIRCULATION, V67, P802, DOI 10.1161/01.CIR.67.4.802; GAMACHE C, 1991, PACE, V14, P663; GASTAUT H, 1957, LANCET, V2, P1018; GASTAUT H, 1974, EPILEPSIES, P815; GLICK G, 1963, AM J MED, V34, P42, DOI 10.1016/0002-9343(63)90037-8; GOLDENBERG IF, 1987, CIRCULATION, V76, P133; GROSSI D, 1987, FUNCT NEUROL, V11, P457; GRUBB BP, 1991, AM J MED, V90, P6, DOI 10.1016/0002-9343(91)90499-N; GRUBB BP, 1991, CIRCULATION, V84, P1157, DOI 10.1161/01.CIR.84.3.1157; GURVITCH AM, 1966, ELECTROEN CLIN NEURO, V21, P355, DOI 10.1016/0013-4694(66)90041-1; HAINSWORTH R, 1988, CLIN SCI, V74, P17, DOI 10.1042/cs0740017; HAUSER WA, 1975, EPILEPSIA, V16, P1, DOI 10.1111/j.1528-1157.1975.tb04721.x; HAUSER WA, 1990, EPILEPSY FREQUENCY C, P21; JAEGER FJ, 1987, CLIN RES, V35, pA832; KLEIN LJ, 1964, AM J MED, V37, P263, DOI 10.1016/0002-9343(64)90010-5; LATHERS CM, 1990, EPILEPSY SUDDEN DEAT, P485; LIN JTY, 1982, ANN NEUROL, V11, P525, DOI 10.1002/ana.410110513; LLOYDSMITH DL, 1958, ELECTROEN CLIN NEURO, V10, P153, DOI 10.1016/0013-4694(58)90111-1; MALONEY JD, 1988, CLEV CLIN J MED, V55, P542, DOI 10.3949/ccjm.55.6.542; MARK AL, 1983, J AM COLL CARDIOL, V1, P90, DOI 10.1016/S0735-1097(83)80014-X; MCLARAN CJ, 1986, BRIT HEART J, V55, P53; MILSTEIN S, 1989, J AM COLL CARDIOL, V14, P1626, DOI 10.1016/0735-1097(89)90006-5; MILSTEIN S, 1989, PACE, V12, P117, DOI 10.1111/pace.1989.12.p1.117; MILSTEIN S, 1990, AM J CARDIOL, V65, P1339, DOI 10.1016/0002-9149(90)91324-Y; MORADY F, 1982, ANN INTERN MED, V96, P337, DOI 10.7326/0003-4819-96-3-337; PEDLEY TA, 1983, EPILEPSIA, V24, pS31, DOI 10.1111/j.1528-1157.1983.tb04641.x; RAVIELE A, 1990, AM J CARDIOL, V65, P1322, DOI 10.1016/0002-9149(90)91321-V; REA RF, 1989, J AM COLL CARDIOL, V14, P1633, DOI 10.1016/0735-1097(89)90007-7; SAPIRE DW, 1983, AM HEART J, V106, P1406; SCHEUER ML, 1990, NEW ENGL J MED, V323, P1468; SHELDON RS, 1991, PACE, V14, P662; SHVARTZ E, 1968, AEROSPACE MED, V39, P1094; SHVARTZ E, 1970, AEROSPACE MED, V41, P253; STRASBERG B, 1989, AM HEART J, V118, P923, DOI 10.1016/0002-8703(89)90225-1; Thoren P, 1979, Rev Physiol Biochem Pharmacol, V86, P1, DOI 10.1007/BFb0031531; VARGAS E, 1984, GERONTOLOGY, V30, P253, DOI 10.1159/000212640; VOGT FB, 1967, AEROSPACE MED, V38, P564; WAXMAN MB, 1989, AM J CARDIOL, V63, P58, DOI 10.1016/0002-9149(89)91076-X	48	142	144	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 1	1991	115	11					871	876		10.7326/0003-4819-115-11-871	http://dx.doi.org/10.7326/0003-4819-115-11-871			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GR171	1952474				2022-12-28	WOS:A1991GR17100006
J	YOUNG, B; HERSCHLAG, D; CECH, TR				YOUNG, B; HERSCHLAG, D; CECH, TR			MUTATIONS IN A NONCONSERVED SEQUENCE OF THE TETRAHYMENA RIBOZYME INCREASE ACTIVITY AND SPECIFICITY	CELL			English	Article							GROUP-I INTRON; SELF-SPLICING RNA; CIRCULARIZED INTERVENING SEQUENCE; THERMOPHILA RIBOZYME; KINETIC DESCRIPTION; RIBONUCLEASE-P; BINDING-SITE; CLEAVAGE; SUBSTRATE; CATALYSIS	The RNA substrate-binding site of the Tetrahymena ribozyme is connected to the catalytic core by the joining region J1/2. Although J1/2 is not conserved among group I introns, small insertions or deletions in this sequence have dramatic effects, enhancing the turnover number and sequence specificity of ribozyme-catalyzed RNA cleavage. Measurements of rate constants for individual steps in the reaction have revealed the basis of these improvements. Ironically, the higher turnover and specificity both result from decreased affinity for RNA, rather than better cleavage. These results provide evidence that the nonconserved J1/2 sequence positions the RNA substrate to optimize tertiary interactions and ensure cleavage at the position corresponding to the 5' splice site. The wild-type RNA is well adapted to its biological function, and its limitations in multiple turnover can be corrected by mutation.	UNIV COLORADO, HOWARD HUGHES MED INST, DEPT MOLEC CELLULAR & DEV, BOULDER, CO 80309 USA; UNIV COLORADO, HOWARD HUGHES MED INST, DEPT CHEM & BIOCHEM, BOULDER, CO 80309 USA	Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder; Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder								ALBERY WJ, 1976, BIOCHEMISTRY-US, V15, P5631, DOI 10.1021/bi00670a032; ALTMAN S, 1989, ADV ENZYMOL RAMB, V62, P1; BARFOD ET, 1989, MOL CELL BIOL, V9, P3657, DOI 10.1128/MCB.9.9.3657; BEAUDRY AA, 1990, BIOCHEMISTRY-US, V29, P6534, DOI 10.1021/bi00479a027; BEEN MD, 1991, SCIENCE, V252, P434, DOI 10.1126/science.2017681; BEEN MD, 1986, CELL, V47, P207, DOI 10.1016/0092-8674(86)90443-5; BEEN MD, 1987, COLD SPRING HARB SYM, V52, P147, DOI 10.1101/SQB.1987.052.01.019; BONNEAU PR, 1991, J AM CHEM SOC, V113, P1026, DOI 10.1021/ja00003a043; CECH TR, 1990, ANNU REV BIOCHEM, V59, P543, DOI 10.1146/annurev.bi.59.070190.002551; CECH TR, 1987, SCIENCE, V236, P1532, DOI 10.1126/science.2438771; COUTURE S, 1990, J MOL BIOL, V215, P345, DOI 10.1016/S0022-2836(05)80356-0; DANENBERG PV, 1989, BIOCHEMISTRY-US, V28, P6779, DOI 10.1021/bi00442a035; DOUDNA JA, 1989, P NATL ACAD SCI USA, V86, P7402, DOI 10.1073/pnas.86.19.7402; DOUDNA JA, 1989, NATURE, V339, P519, DOI 10.1038/339519a0; DOWNS WD, 1990, BIOCHEMISTRY-US, V29, P5605, DOI 10.1021/bi00475a027; Fersht A., 1985, ENZYME STRUCTURE MEC; FERSHT AR, 1974, PROC R SOC SER B-BIO, V187, P397, DOI 10.1098/rspb.1974.0084; FREIER SM, 1986, P NATL ACAD SCI USA, V83, P9373, DOI 10.1073/pnas.83.24.9373; GOOD NE, 1966, BIOCHEMISTRY-US, V5, P467, DOI 10.1021/bi00866a011; HERSCHLAG D, 1991, BIOCHEMISTRY-US, V30, P4844, DOI 10.1021/bi00234a003; HERSCHLAG D, 1990, BIOCHEMISTRY-US, V29, P10172, DOI 10.1021/bi00496a004; HERSCHLAG D, 1990, BIOCHEMISTRY-US, V29, P10159, DOI 10.1021/bi00496a003; HERSCHLAG D, 1991, P NATL ACAD SCI USA, V88, P6921, DOI 10.1073/pnas.88.16.6921; HERSCHLAG D, 1990, NATURE, V344, P405, DOI 10.1038/344405a0; JACQUIER A, 1987, CELL, V50, P17, DOI 10.1016/0092-8674(87)90658-1; JENCKS WP, 1975, ADV ENZYMOL RAMB, V43, P219; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; MCSWIGGEN JA, 1989, SCIENCE, V244, P679, DOI 10.1126/science.2470150; MICHEL F, 1990, NATURE, V347, P578, DOI 10.1038/347578a0; MICHEL F, 1989, NATURE, V342, P391, DOI 10.1038/342391a0; MICHEL F, 1990, J MOL BIOL, V216, P585, DOI 10.1016/0022-2836(90)90386-Z; MILLIGAN JF, 1987, NUCLEIC ACIDS RES, V15, P8783, DOI 10.1093/nar/15.21.8783; MURPHY FL, 1989, P NATL ACAD SCI USA, V86, P9218, DOI 10.1073/pnas.86.23.9218; PACE NR, 1990, J BIOL CHEM, V265, P3587; PRICE JV, 1985, NUCLEIC ACIDS RES, V13, P1871, DOI 10.1093/nar/13.6.1871; PYLE AM, 1990, P NATL ACAD SCI USA, V87, P8187, DOI 10.1073/pnas.87.21.8187; PYLE AM, 1991, NATURE, V350, P628, DOI 10.1038/350628a0; RUFFNER DE, 1990, BIOCHEMISTRY-US, V29, P10695, DOI 10.1021/bi00499a018; SOLOMON BM, 1990, BIOCHEMISTRY-US, V29, P7303, DOI 10.1021/bi00483a021; SUGIMOTO N, 1989, CHEM LETT, P2223, DOI 10.1246/cl.1989.2223; SUGIMOTO N, 1989, NUCLEIC ACIDS RES, V17, P355, DOI 10.1093/nar/17.1.355; SUGIMOTO N, 1988, BIOCHEMISTRY-US, V27, P6384, DOI 10.1021/bi00417a029; WARING RB, 1986, NATURE, V321, P133, DOI 10.1038/321133a0; WAUGH DS, 1989, SCIENCE, V244, P1569, DOI 10.1126/science.2472671; YOUNG B, 1990, THESIS U COLORADO BO; ZAUG AJ, 1986, NATURE, V324, P429, DOI 10.1038/324429a0; ZAUG AJ, 1988, BIOCHEMISTRY-US, V27, P8924, DOI 10.1021/bi00425a008; ZAUG AJ, 1984, SCIENCE, V224, P574, DOI 10.1126/science.6200938	48	77	80	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 29	1991	67	5					1007	1019		10.1016/0092-8674(91)90373-7	http://dx.doi.org/10.1016/0092-8674(91)90373-7			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GT755	1959129				2022-12-28	WOS:A1991GT75500019
J	HENDERSON, BE; ROSS, RK; PIKE, MC				HENDERSON, BE; ROSS, RK; PIKE, MC			TOWARD THE PRIMARY PREVENTION OF CANCER	SCIENCE			English	Article							MALIGNANT BRAIN-TUMORS; SQUAMOUS-CELL CANCERS; LOS-ANGELES COUNTY; SERUM VITAMIN-E; BREAST-CANCER; BETA-CAROTENE; RISK-FACTORS; LUNG-CANCER; COLON CANCER; ALCOHOL-CONSUMPTION	This the threshold of an era when many of the most prevalent human cancers can, to a significant extent, be prevented through life-style changes or medical interventions. For lung cancer, the leading cause of cancer deaths in the United States, the major cause, cigarette smoking, is known and strategies for reducing smoking are slowly succeeding. Dietary changes can reduce the risk of developing large bowel cancer, the second most common cancer overall. The etiology of the major cancer in women, cancer of the breast, is sufficiently well understood that large-scale medical intervention trials are imminent. Recent changes in the incidence and mortality of these and the other major human cancers are reviewed with a brief explanation as to why these changes have occurred, followed by a summary of the state of knowledge regarding the major causes of cancer.	UNIV SO CALIF, SCH MED, KENNETH NORRIS JR COMPREHENS CANC CTR, LOS ANGELES, CA 90033 USA	University of Southern California	HENDERSON, BE (corresponding author), UNIV SO CALIF, SCH MED, DEPT PREVENT MED, 1441 EASTLAKE AVE, LOS ANGELES, CA 90033 USA.							AMES BN, 1990, P NATL ACAD SCI USA, V87, P7772, DOI 10.1073/pnas.87.19.7772; BARRA S, 1990, INT J CANCER, V46, P1017, DOI 10.1002/ijc.2910460612; BEASLEY RP, 1981, LANCET, V2, P1129; BERAL V, 1991, LANCET, V337, P805, DOI 10.1016/0140-6736(91)92513-2; BERGKVIST L, 1989, NEW ENGL J MED, V321, P293, DOI 10.1056/NEJM198908033210505; BERNSTEIN L, 1990, CANCER CAUSE CONTROL, V1, P51, DOI 10.1007/BF00053183; BERNSTEIN L, 1987, BRIT J CANCER, V55, P681, DOI 10.1038/bjc.1987.139; BERNSTEIN L, 1989, CANCER RES, V49, P466; Bernstein L, 1985, J Cancer Res Clin Oncol, V110, P184, DOI 10.1007/BF00402738; BERNSTEIN L, 1990, CANCER PREV PHILADEL, V90, P1; BLOCK G, 1991, AM J CLIN NUTR, V53, pS270, DOI 10.1093/ajcn/53.1.270S; BLOT WJ, 1988, CANCER RES, V48, P3282; BLOT WJ, 1989, CANCER PREV, V89, P1; BOSLAND MD, 1989, PROSTATIC CARCINOGEN; BOYLE P, 1990, JNCI-J NATL CANCER I, V82, P1594, DOI 10.1093/jnci/82.20.1594; BROWN CC, 1988, J NATL CANCER I, V80, P43, DOI 10.1093/jnci/80.1.43; BURING JE, 1989, CANCER PREV PHILADEL, V89, P1; CARTWRIGHT RA, 1982, LANCET, V2, P842; CASAGRANDE JT, 1979, LANCET, V2, P170; COGGON D, 1989, J NATL CANCER I, V81, P1178, DOI 10.1093/jnci/81.15.1178; CORREA P, 1988, CANCER RES, V48, P3554; DOLL R, 1990, P NUTR SOC, V49, P119, DOI 10.1079/PNS19900018; DOLL R, 1981, JNCI-J NATL CANCER I, V66, P1191, DOI 10.1093/jnci/66.6.1192; ELWOOD JM, 1984, INT J CANCER, V34, P603, DOI 10.1002/ijc.2910340504; FEX G, 1984, JNCI-J NATL CANCER I, V73, P1463; FORMAN D, 1990, INT J CANCER, V46, P608, DOI 10.1002/ijc.2910460410; GAIL MH, 1991, JNCI-J NATL CANCER I, V83, P695, DOI 10.1093/jnci/83.10.695; GAO YT, 1987, INT J CANCER, V40, P604, DOI 10.1002/ijc.2910400505; GAO YT, 1990, BRIT J CANCER, V2, P982; GARABRANT DH, 1984, AM J EPIDEMIOL, V119, P1005, DOI 10.1093/oxfordjournals.aje.a113805; GARLAND C, 1985, LANCET, V1, P307, DOI 10.1016/S0140-6736(85)91082-7; GREENBERG ER, 1990, NEW ENGL J MED, V323, P789, DOI 10.1056/NEJM199009203231204; GREIG NH, 1990, JNCI-J NATL CANCER I, V82, P1621, DOI 10.1093/jnci/82.20.1621; HAENSZEL W, 1972, JNCI-J NATL CANCER I, V49, P969; HARLOW SD, 1991, AM J EPIDEMIOL, V133, P38, DOI 10.1093/oxfordjournals.aje.a115800; HAUSEN HZ, 1991, SCIENCE, V254, P1167, DOI 10.1126/science.1659743; HELZLSOUER KJ, 1989, CANCER RES, V49, P6144; HENDERSON BE, 1982, CANCER RES, V42, P3232; HENDERSON BE, 1989, J NATL CANCER I, V81, P320, DOI 10.1093/jnci/81.5.320; HENDERSON BE, 1988, BRIT J CANCER, V57, P216, DOI 10.1038/bjc.1988.46; HENDERSON BE, 1988, CANCER RES, V48, P246; HENDERSON BE, 1983, BRIT J CANCER, V48, P437, DOI 10.1038/bjc.1983.210; HERBST AL, 1986, AM J OBSTET GYNECOL, V154, P814, DOI 10.1016/0002-9378(86)90464-3; HILLER JE, 1990, CANCER CAUSE CONTROL, V1, P101, DOI 10.1007/BF00053189; HIRYAMA T, 1971, GANN MONOGR, V11, P3; HIRYAMA T, 1986, DIET NUTRITION CANCE, P41; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; HOWE GR, 1991, J NATL CANCER I, V83, P336, DOI 10.1093/jnci/83.5.336; HOWE GR, 1990, CANCER CAUSE CONTROL, V1, P99, DOI 10.1007/BF00053188; HSING AW, 1990, CANCER RES, V50, P6836; JONES DY, 1987, JNCI-J NATL CANCER I, V79, P465; JONES PA, 1991, CANCER RES, V51, P3617; JOOSSENS J V, 1981, Nutrition and Cancer, V2, P250; JORDAN VC, 1990, CANCER PREV PHILADEL, V90, P1; KEY TJA, 1988, BRIT J CANCER, V57, P205, DOI 10.1038/bjc.1988.44; KEY TJA, 1988, EUR J CANCER CLIN ON, V24, P29, DOI 10.1016/0277-5379(88)90173-3; KEY TJA, 1990, BRIT J CANCER, V62, P631, DOI 10.1038/bjc.1990.344; KNEKT P, 1990, J NATL CANCER I, V82, P864, DOI 10.1093/jnci/82.10.864; KNEKT P, 1988, AM J EPIDEMIOL, V127, P28, DOI 10.1093/oxfordjournals.aje.a114788; KOK FJ, 1987, AM J EPIDEMIOL, V125, P12, DOI 10.1093/oxfordjournals.aje.a114493; KOK FJ, 1987, NEW ENGL J MED, V316, P1416; KRIPKE ML, 1989, CANCER PREV PHILADEL, V89, P1; LANZA E, 1989, CANCER PREV PHILADEL, V89, P1; LAW MR, 1989, BRIT J CANCER, V59, P686, DOI 10.1038/bjc.1989.142; LEE JAH, 1989, PHOTOCHEM PHOTOBIOL, V50, P493, DOI 10.1111/j.1751-1097.1989.tb05554.x; LONGNECKER MP, 1990, CANCER CAUSE CONTROL, V1, P59, DOI 10.1007/BF00053184; LONGNECKER MP, 1988, JAMA-J AM MED ASSOC, V260, P652; MENKES MS, 1986, NEW ENGL J MED, V315, P1250, DOI 10.1056/NEJM198611133152003; MILLER BA, 1991, CANCER CAUSE CONTROL, V2, P67, DOI 10.1007/BF00053123; MILLS P, 1989, CANCER-AM CANCER SOC, V64, P582, DOI 10.1002/1097-0142(19890801)64:3&lt;582::AID-CNCR2820640304&gt;3.0.CO;2-V; MILLS PK, 1989, CANCER, V64, P598, DOI 10.1002/1097-0142(19890801)64:3&lt;598::AID-CNCR2820640306&gt;3.0.CO;2-6; MORGAN JW, 1988, AM J EPIDEMIOL, V128, P918; MUIR C, 1987, IARC PUBL, V88; NIERENBERG DW, 1989, AM J EPIDEMIOL, V130, P511, DOI 10.1093/oxfordjournals.aje.a115365; NIGRO JM, 1989, NATURE, V342, P705, DOI 10.1038/342705a0; NOBLE RL, 1977, CANCER RES, V37, P1929; NOMURA A, 1987, J NATL CANCER I, V79, P103; NOMURA A, 1991, NEW ENGL J MED, V325, P1132, DOI 10.1056/NEJM199110173251604; NOMURA AMY, 1985, CANCER RES, V45, P2369; PAGANINIHILL A, 1989, BRIT MED J, V299, P1247, DOI 10.1136/bmj.299.6710.1247; PARSONNET J, 1991, NEW ENGL J MED, V325, P1127, DOI 10.1056/NEJM199110173251603; PATIERNO SR, 1989, CANCER RES, V49, P1038; PETERSON WL, 1991, NEW ENGL J MED, V324, P1043, DOI 10.1056/NEJM199104113241507; PETO J, 1981, BANBURY REPORT, V9, P51; PETO R, 1990, 15TH INT CANC C HAMB; PIKE MC, 1989, BRIT J CANCER, V60, P142, DOI 10.1038/bjc.1989.237; PIKE MC, 1990, ACCOMPLISHMENTS CANC, P327; PRENTICE RL, 1990, CANCER CAUSE CONTROL, V1, P81, DOI 10.1007/BF00053187; PRENTICE RL, 1990, J NATL CANCER I, V82, P1310, DOI 10.1093/jnci/82.16.1310; PRESTONMARTIN S, 1990, CANCER RES, V50, P7415; PRESTONMARTIN S, 1989, CANCER RES, V49, P6137; PRESTONMARTIN S, 1989, BRIT J CANCER, V59, P639, DOI 10.1038/bjc.1989.130; RIES LAG, 1990, NIH902789 PUBL; ROSS R, 1986, JNCI-J NATL CANCER I, V76, P45; ROSS RK, 1989, CANCER RES, V49, P1045; ROSS RK, 1988, GENITOURINARY CANCER, P40; SALONEN JT, 1985, BMJ-BRIT MED J, V290, P417, DOI 10.1136/bmj.290.6466.417; SCHOBER SE, 1987, AM J EPIDEMIOL, V126, P1033, DOI 10.1093/oxfordjournals.aje.a114742; SEVERSON RK, 1989, CANCER RES, V49, P1857; SHIKE M, 1990, CANCER PREV PHILADEL, V90, P1; SHIMIZU H, 1990, BRIT J CANCER, V62, P451, DOI 10.1038/bjc.1990.316; SIMANOWSKI UA, 1986, GUT, V27, P278, DOI 10.1136/gut.27.3.278; SPICER DV, 1991, J NATL CANCER I, V83, P63, DOI 10.1093/jnci/83.1.63; SPICER DV, 1991, CONTRACEPTION, V44, P289, DOI 10.1016/0010-7824(91)90019-C; STAHELIN HB, 1991, AM J CLIN NUTR, V53, pS265, DOI 10.1093/ajcn/53.1.265S; STEMMERMANN GN, 1984, CANCER RES, V44, P4633; STRYKER WS, 1988, AM J EPIDEMIOL, V127, P283, DOI 10.1093/oxfordjournals.aje.a114804; SUBAR AF, 1990, AM J PUBLIC HEALTH, V80, P1323, DOI 10.2105/AJPH.80.11.1323; THOMAS DC, 32 U SO CAL DEP PREV; TOMATIS L, 1990, WHO INT AGENCY RES C, V100; TSUGANE S, 1991, CANCER CAUSE CONTROL, V2, P165, DOI 10.1007/BF00056209; TUYNS AJ, 1979, INT J CANCER, V23, P443, DOI 10.1002/ijc.2910230402; VILLARD L, 1990, INT J EPIDEMIOL, V19, P255, DOI 10.1093/ije/19.2.255; VIRTAMO J, 1987, CANCER, V60, P145, DOI 10.1002/1097-0142(19870715)60:2<145::AID-CNCR2820600203>3.0.CO;2-U; VOGELSTEIN B, 1990, NATURE, V348, P681, DOI 10.1038/348681a0; WALD NJ, 1984, BRIT J CANCER, V49, P321, DOI 10.1038/bjc.1984.50; WALD NJ, 1987, BRIT J CANCER, V56, P69, DOI 10.1038/bjc.1987.156; WARGOVICH MJ, 1984, CANCER LETT, V23, P253, DOI 10.1016/0304-3835(84)90091-0; WHITE E, 1990, J NATL CANCER I, V82, P1546, DOI 10.1093/jnci/82.19.1546; WHITTLE HC, 1991, LANCET, V337, P747, DOI 10.1016/0140-6736(91)91367-4; WILLETT WC, 1990, NEW ENGL J MED, V323, P1664, DOI 10.1056/NEJM199012133232404; WILLETT WC, 1983, LANCET, V2, P130, DOI 10.1016/S0140-6736(83)90116-2; WILLETT WC, 1987, NEW ENGL J MED, V316, P22, DOI 10.1056/NEJM198701013160105; WILLETT WC, 1984, NEW ENGL J MED, V310, P430, DOI 10.1056/NEJM198402163100705; WILLETT WC, 1990, CANCER CAUSE CONTROL, V1, P53; WU AH, 1987, BRIT J CANCER, V55, P687, DOI 10.1038/bjc.1987.140; YU MC, 1986, JNCI-J NATL CANCER I, V77, P351; YU MC, 1986, CANCER RES, V46, P956; 1990, VITAL STATISTICS U A, V2; 1984, DHHS PHS851232 PUBL; 1991, DHHS PHS9150212 PUBL; 1988, NIH882789 PUBL	132	332	340	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 22	1991	254	5035					1131	1138		10.1126/science.1957166	http://dx.doi.org/10.1126/science.1957166			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ834	1957166				2022-12-28	WOS:A1991GQ83400031
J	BAIN, J				BAIN, J			THE NEW NHS - 6 MONTHS ON - BUDGET HOLDING - THE 1ST 150 DAYS IN CALVERTON	BRITISH MEDICAL JOURNAL			English	Article																			0	4	4	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	OCT 12	1991	303	6807					907	908		10.1136/bmj.303.6807.907	http://dx.doi.org/10.1136/bmj.303.6807.907			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GK221	1933007	Bronze, Green Published			2022-12-28	WOS:A1991GK22100027
J	BOWIE, C				BOWIE, C			LESSONS FROM THE PERTUSSIS-VACCINE COURT TRIAL	LANCET			English	Editorial Material											BOWIE, C (corresponding author), SOMERSET HLTH AUTHOR,WELLSPRINGS RD,TAUNTON TA2 7PQ,SOMERSET,ENGLAND.			Bowie, Cam/0000-0002-6956-3691				DYER C, 1988, BRIT MED J, V296, P1189, DOI 10.1136/bmj.296.6630.1189; GRIFFITH AH, 1989, VACCINE, V7, P199, DOI 10.1016/0264-410X(89)90229-6; 1981, WHOOPING COUGH REPOR; 1989, CANADIAN IMMUNIZATIO; 1988, IMMUNISATION INFECTI	5	14	14	0	3	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	FEB 17	1990	335	8686					397	399		10.1016/0140-6736(90)90220-Y	http://dx.doi.org/10.1016/0140-6736(90)90220-Y			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CN988	1968127				2022-12-28	WOS:A1990CN98800015
J	BRAHAMS, D				BRAHAMS, D			BRAIN BANKS	LANCET			English	Editorial Material																		BRAHAMS D, 1988, LANCET, V2, P1151; MASON JK, 1987, BUTTERWORTHS MED LEG, P274	2	3	3	0	1	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	FEB 3	1990	335	8684					282	283		10.1016/0140-6736(90)90089-N	http://dx.doi.org/10.1016/0140-6736(90)90089-N			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CL815	1967735				2022-12-28	WOS:A1990CL81500019
J	ALTMAN, DG; DORE, CJ				ALTMAN, DG; DORE, CJ			RANDOMIZATION AND BASE-LINE COMPARISONS IN CLINICAL-TRIALS	LANCET			English	Article									CLIN RES CTR,MED STAT SECT,HARROW HA1 3UJ,MIDDX,ENGLAND		ALTMAN, DG (corresponding author), IMPERIAL CANC RES FUND,MED STAT LAB,POB 123,LINCOLNS INN FIELDS,LONDON WC2A 3PX,ENGLAND.		Dore, Caroline J/J-4716-2012	Dore, Caroline J/0000-0001-9796-4970				Altman D G, 1982, Stat Med, V1, P59, DOI 10.1002/sim.4780010109; ALTMAN DG, 1986, LANCET, V2, P639; ALTMAN DG, 1985, STATISTICIAN, V34, P125; ALTMAN DG, 1989, STATISTICS CONFIDENC, P83; CHALMERS TC, 1981, CONTROL CLIN TRIALS, V2, P31, DOI 10.1016/0197-2456(81)90056-8; DERSIMONIAN R, 1982, NEW ENGL J MED, V306, P1332, DOI 10.1056/NEJM198206033062204; EVANS M, 1984, ARCH SURG-CHICAGO, V119, P109; GARDNER MJ, 1989, STATISTICS CONFIDENC, P101; GOTZSCHE PC, 1989, CONTROL CLIN TRIALS, V10, P31, DOI 10.1016/0197-2456(89)90017-2; GRANT A, 1989, BRIT J OBSTET GYNAEC, V96, P397, DOI 10.1111/j.1471-0528.1989.tb02412.x; HUGHES WT, 1987, NEW ENGL J MED, V316, P1627, DOI 10.1056/NEJM198706253162604; KEIRSE MJNC, 1988, ACTA OBSTET GYN SCAN, V67, P731, DOI 10.3109/00016349809004298; LAVORI PW, 1983, NEW ENGL J MED, V309, P1291, DOI 10.1056/NEJM198311243092105; LIBERATI A, 1986, J CLIN ONCOL, V4, P942, DOI 10.1200/JCO.1986.4.6.942; MEINERT CL, 1984, CONTROL CLIN TRIALS, V5, P328, DOI 10.1016/S0197-2456(84)80013-6; MOSTELLER F, 1980, CONTROL CLIN TRIALS, V1, P37, DOI 10.1016/S0197-2456(80)80006-7; POCOCK SJ, 1987, NEW ENGL J MED, V317, P426, DOI 10.1056/NEJM198708133170706; Pocock SJ, 1983, CLIN TRIALS PRACTICA, P66; ROTHMAN KJ, 1977, CANCER, V39, P1771, DOI 10.1002/1097-0142(197704)39:4+<1771::AID-CNCR2820390803>3.0.CO;2-2; SIMON R, 1985, CANCER TREAT REP, V69, P1; TYSON JE, 1983, J PEDIATR-US, V102, P10, DOI 10.1016/S0022-3476(83)80277-7; Zelen M, 1983, Prog Clin Biol Res, V132E, P57	22	347	362	0	10	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	JAN 20	1990	335	8682					149	153		10.1016/0140-6736(90)90014-V	http://dx.doi.org/10.1016/0140-6736(90)90014-V			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CJ979	1967441				2022-12-28	WOS:A1990CJ97900013
J	BERAL, V; PETERMAN, TA; BERKELMAN, RL; JAFFE, HW				BERAL, V; PETERMAN, TA; BERKELMAN, RL; JAFFE, HW			KAPOSIS SARCOMA AMONG PERSONS WITH AIDS - A SEXUALLY-TRANSMITTED INFECTION	LANCET			English	Article									CTR DIS CONTROL, ATLANTA, GA 30333 USA	Centers for Disease Control & Prevention - USA								BEASLEY RP, 1981, LANCET, V2, P1129; BERAL V, 1989, 5TH INT C AIDS MONTR; BIGGAR RJ, 1984, J NATL CANCER I, V73, P89; BOUQUETY JC, 1989, AM J TROP MED HYG, V40, P323, DOI 10.4269/ajtmh.1989.40.323; CLUMECK N, 1984, NEW ENGL J MED, V310, P492, DOI 10.1056/NEJM198402233100804; DARROW WW, 1987, AM J PUBLIC HEALTH, V77, P479, DOI 10.2105/AJPH.77.4.479; DEJARLAIS DC, 1984, NEW ENGL J MED, V310, P1119; DREW WL, 1988, LANCET, V1, P66; Fraumeni J F Jr, 1977, Natl Cancer Inst Monogr, V47, P121; FRIEDMANKIEN AE, 1990, LANCET, V335, P168, DOI 10.1016/0140-6736(90)90041-3; GILLES K, 1987, NEW ENGL J MED, V317, P630, DOI 10.1056/NEJM198709033171012; GUTIERREZORTEGA P, 1989, ARCH DERMATOL, V125, P432, DOI 10.1001/archderm.125.3.432; HAVERKOS HW, 1985, SEX TRANSM DIS, V12, P203, DOI 10.1097/00007435-198510000-00007; HAVERKOS HW, 1985, NEW ENGL J MED, V312, P1518; HOLMBERG SD, 1988, LANCET, V2, P746; JACOBSEN L, 1989, AUG M SOC EP RES; KINLEN LJ, 1979, BRIT MED J, V2, P1461, DOI 10.1136/bmj.2.6203.1461; KINLEN LJ, 1982, CANCER SURV, V1, P567; LIFSON AR, IN PRESS AM J EPIDEM; MARMOR M, 1984, ANN INTERN MED, V100, P809, DOI 10.7326/0003-4819-100-6-809; MORTIMER PP, 1987, LANCET, V1, P280; OETTLE AG, 1964, JNCI-J NATL CANCER I, V33, P383; OSMOND D, 1985, APR INT C AIDS ATL; PENN I, 1979, TRANSPLANTATION, V27, P8, DOI 10.1097/00007890-197901000-00003; PIOT P, 1984, LANCET, V2, P65; ROTHENBERG R, 1987, NEW ENGL J MED, V317, P1297, DOI 10.1056/NEJM198711193172101; RUTHERFORD GW, 1989, J INFECT DIS, V159, P569, DOI 10.1093/infdis/159.3.569; SALAHUDDIN SZ, 1988, SCIENCE, V242, P430, DOI 10.1126/science.2459779; SCOTT GB, 1984, NEW ENGL J MED, V310, P76, DOI 10.1056/NEJM198401123100202; VANDENBROUCKE JP, 1989, AM J EPIDEMIOL, V129, P455, DOI 10.1093/oxfordjournals.aje.a115156; VANDEPERRE P, 1984, LANCET, V2, P62; WARD JW, 1988, TRANSFUSION, V28, P298, DOI 10.1046/j.1537-2995.1988.28488265252.x; WINKELSTEIN W, 1988, AM J PUBLIC HEALTH, V78, P1472, DOI 10.2105/AJPH.78.11.1472; AIDS PUBLIC INFORMAT; 1987, MMWR S1S, V36, pS1; 1988, MMWR, V37, P293; 1988, MMWR, V37, P286	37	913	936	0	15	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 20	1990	335	8682					123	128		10.1016/0140-6736(90)90001-L	http://dx.doi.org/10.1016/0140-6736(90)90001-L			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CJ979	1967430	Green Submitted			2022-12-28	WOS:A1990CJ97900001
J	HARABUCHI, Y; YAMANAKA, N; KATAURA, A; IMAI, S; KINOSHITA, T; MIZUNO, F; OSATO, T				HARABUCHI, Y; YAMANAKA, N; KATAURA, A; IMAI, S; KINOSHITA, T; MIZUNO, F; OSATO, T			EPSTEIN-BARR VIRUS IN NASAL T-CELL LYMPHOMAS IN PATIENTS WITH LETHAL MIDLINE GRANULOMA	LANCET			English	Article									HOKKAIDO UNIV,SCH MED,INST CANC,DEPT VIROL,SAPPORO,HOKKAIDO 060,JAPAN; SAPPORO MED COLL,DEPT OTOLARYNGOL,SAPPORO,HOKKAIDO 060,JAPAN	Hokkaido University; Sapporo Medical University								ABO W, 1982, LANCET, V1, P1272; EPSTEIN MA, 1979, EPSTEINBARR VIRUS, P1; HARABUCHI Y, 1985, ARCH OTO-RHINO-LARYN, V242, P89, DOI 10.1007/BF00464413; HENLE G, 1976, INT J CANCER, V17, P1, DOI 10.1002/ijc.2910170102; HENLE W, 1970, SCIENCE, V169, P188, DOI 10.1126/science.169.3941.188; JONES JF, 1988, NEW ENGL J MED, V318, P733, DOI 10.1056/NEJM198803243181203; KIKUTA H, 1988, NATURE, V333, P455, DOI 10.1038/333455a0; LIPPMAN SM, 1987, CANCER, V59, P936, DOI 10.1002/1097-0142(19870301)59:5<936::AID-CNCR2820590514>3.0.CO;2-F; OKANO M, 1984, LANCET, V2, P933; OSATO T, 1986, HUMAN ONCOGENIC VIRU, P185; REEDMAN BM, 1973, INT J CANCER, V11, P499, DOI 10.1002/ijc.2910110302; SCHMITZ H, 1972, ARCH GES VIRUSFORSCH, V37, P332, DOI 10.1007/BF01241456; TEO CG, 1987, P NATL ACAD SCI USA, V84, P8473, DOI 10.1073/pnas.84.23.8473; VILDE JL, 1985, NEW ENGL J MED, V313, P1161; WANG D, 1985, CELL, V43, P831, DOI 10.1016/0092-8674(85)90256-9; WANG F, 1987, P NATL ACAD SCI USA, V84, P3452, DOI 10.1073/pnas.84.10.3452; YAMANAKA N, 1985, ANN OTO RHINOL LARYN, V94, P207, DOI 10.1177/000348948509400223; YOUNG L, 1989, NEW ENGL J MED, V321, P1080, DOI 10.1056/NEJM198910193211604	18	478	487	0	3	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	JAN 20	1990	335	8682					128	130		10.1016/0140-6736(90)90002-M	http://dx.doi.org/10.1016/0140-6736(90)90002-M			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CJ979	1967431				2022-12-28	WOS:A1990CJ97900002
J	MORTIMER, MJ; GOOD, PA; MARSTERS, JB; ADDY, DP				MORTIMER, MJ; GOOD, PA; MARSTERS, JB; ADDY, DP			VISUAL EVOKED-RESPONSES IN CHILDREN WITH MIGRAINE - A DIAGNOSTIC-TEST	LANCET			English	Article									BIRMINGHAM & MIDLAND EYE HOSP,BIRMINGHAM B3 2NS,ENGLAND									BILLE B, 1962, ACTA PEDIATR S136, V51, P13; BRINCIOTTI M, 1988, 7TH P MIGR TRUST I S, P39; DOENICKE A, 1988, LANCET, V1, P1309; EDMEADS J, 1988, HEADACHE, V28, P568, DOI 10.1111/j.1526-4610.1988.hed2808568.x; HOCKADAY JM, 1987, DEV MED CHILD NEUROL, V29, P258; JAY GW, 1982, HEADACHE, V22, P110, DOI 10.1111/j.1526-4610.1982.hed2203110.x; MARSTERS JB, 1988, HEADACHE, V28, P526, DOI 10.1111/j.1526-4610.1988.hed2808526.x; MORTIMER MJ, IN PRESS HEADACHE; OCONNOR PS, 1981, OPHTHALMOLOGY, V88, P999; PEATFIELD R, 1988, MED DIALOGUE, V192, P2; PRENSKY AR, 1988, MIGRAINE CLIN CONCEP, P43; SILLANPAA M, 1983, HEADACHE, V23, P15; SIMON RH, 1983, HEADACHE, V23, P201; SPIERINGS ELH, 1980, HEADACHE, V20, P143, DOI 10.1111/j.1526-4610.1980.hed2003143.x; WATERS WE, 1967, MODERN TOPICS MIGRAI, P12; 1988, CEPHALALGIA S, V8, P7	16	34	34	0	1	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	JAN 13	1990	335	8681					75	77		10.1016/0140-6736(90)90541-C	http://dx.doi.org/10.1016/0140-6736(90)90541-C			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CH516	1967420				2022-12-28	WOS:A1990CH51600005
J	SMITH, DP; RANGANATHAN, R; HARDY, RW; MARX, J; TSUCHIDA, T; ZUKER, CS				SMITH, DP; RANGANATHAN, R; HARDY, RW; MARX, J; TSUCHIDA, T; ZUKER, CS			PHOTORECEPTOR DEACTIVATION AND RETINAL DEGENERATION MEDIATED BY A PHOTORECEPTOR-SPECIFIC PROTEIN-KINASE-C	SCIENCE			English	Article							LIMULUS VENTRAL PHOTORECEPTORS; DROSOPHILA-MELANOGASTER; LIGHT ADAPTATION; PHOSPHOLIPASE-C; PHORBOL ESTERS; PHOSPHOINOSITIDE HYDROLYSIS; MOLECULAR HETEROGENEITY; CALCIUM-CONCENTRATION; CYTOPLASMIC CALCIUM; CELLS	The protein kinase C (PKC) family of serine-threonine kinases has been implicated in the regulation of a variety of signaling cascades. One member of this family, eye-PKC, is expressed exclusively in the Drosophila visual system. The inaC (inactivation-no-afterpotential C) locus was shown to be the structural gene for eye-PKC. Analysis of the light response from inaC mutants showed that this kinase is required for the deactivation and rapid desensitization of the visual cascade. Light adaptation was also defective in inaC mutant flies. In flies carrying the retinal degeneration mutation rdgB, absence of eye-PKC suppressed photoreceptor cell degeneration. These results indicate that eye-PKC functions in the light-dependent regulation of the phototransduction cascade in Drosophila.	UNIV CALIF SAN DIEGO,HOWARD HUGHES MED INST,LA JOLLA,CA 92093; UNIV CALIF SAN DIEGO,DEPT BIOL,LA JOLLA,CA 92093; UNIV CALIF SAN DIEGO,DEPT NEUROSCI,LA JOLLA,CA 92093	Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego				Smith, Dean/0000-0002-4271-0436				BACIGALUPO J, 1991, P NATL ACAD SCI USA, V88, P7938, DOI 10.1073/pnas.88.18.7938; BACILUPO J, 1990, TRANSDUCTION BIOL SY; BAYLOR DA, 1979, J PHYSIOL-LONDON, V288, P613; BLOOMQUIST BT, 1988, CELL, V54, P723, DOI 10.1016/S0092-8674(88)80017-5; BROWN JE, 1984, NATURE, V311, P160, DOI 10.1038/311160a0; COLLEY NJ, 1990, J CELL SCI, V95, P11; DECOUET HG, 1987, EUR J CELL BIOL, V44, P50; DIZHOOR AM, 1991, SCIENCE, V251, P915, DOI 10.1126/science.1672047; FAIN GL, 1989, J PHYSIOL-LONDON, V416, P215, DOI 10.1113/jphysiol.1989.sp017757; FEIN A, 1984, NATURE, V311, P157, DOI 10.1038/311157a0; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HARRIS WA, 1977, J GEN PHYSIOL, V69, P261, DOI 10.1085/jgp.69.3.261; HILMAN P, 1983, PHYSIOL REV, V63, P668; HORN R, 1988, J GEN PHYSIOL, V92, P145, DOI 10.1085/jgp.92.2.145; HOUSE C, 1987, SCIENCE, V238, P1726, DOI 10.1126/science.3686012; KARESS RE, 1984, CELL, V38, P135, DOI 10.1016/0092-8674(84)90534-8; KIKKAWA U, 1988, COLD SPRING HARB SYM, V53, P97, DOI 10.1101/SQB.1988.053.01.015; KIKUCHI A, 1986, CANCER RES, V46, P3401; KOCH KW, 1988, NATURE, V334, P64, DOI 10.1038/334064a0; KORENBROT JI, 1989, VISION RES, V29, P939, DOI 10.1016/0042-6989(89)90108-9; KUHN H, 1987, J RECEPTOR RES, V7, P283, DOI 10.3109/10799898709054990; LABARCA R, 1984, BIOCHEM BIOPH RES CO, V123, P703, DOI 10.1016/0006-291X(84)90286-9; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEVINE H, 1990, MECH DEVELOP, V33, P19, DOI 10.1016/0925-4773(90)90131-5; LIDSLEY DL, 1990, DROSOPH INFO SER, V68, P125; LISMAN JE, 1972, J GEN PHYSIOL, V59, P701, DOI 10.1085/jgp.59.6.701; MATTHEWS HR, 1988, NATURE, V334, P67, DOI 10.1038/334067a0; MCMILLAN M, 1986, BIOCHEM BIOPH RES CO, V134, P970, DOI 10.1016/S0006-291X(86)80515-0; MINKE B, 1975, J COMP PHYSIOL, V98, P345, DOI 10.1007/BF00709805; MINKE B, 1990, P NATL ACAD SCI USA, V87, P113, DOI 10.1073/pnas.87.1.113; MINKE B, 1986, MOL MECHANISM PHOTOR, P241; NAKATANI K, 1988, NATURE, V334, P69, DOI 10.1038/334069a0; NISHIZUKA Y, 1984, NATURE, V308, P693, DOI 10.1038/308693a0; NISHIZUKA Y, 1988, NATURE, V334, P661, DOI 10.1038/334661a0; NISHIZUKA Y, 1986, SCIENCE, V233, P305, DOI 10.1126/science.3014651; OREVI N, UNPUB; Pak W.L., 1979, P67; PAYNE R, 1986, J GEN PHYSIOL, V88, P127, DOI 10.1085/jgp.88.1.127; RANGANATHAN R, IN PRESS NATURE; ROSENTHAL A, 1987, EMBO J, V6, P433, DOI 10.1002/j.1460-2075.1987.tb04773.x; RYU SH, 1990, J BIOL CHEM, V265, P17941; Saibil H., 1990, Seminars in the Neurosciences, V2, P15; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SCHAEFFER E, 1989, CELL, V57, P403, DOI 10.1016/0092-8674(89)90915-X; SHEARMAN MS, 1989, PHARMACOL REV, V41, P211; Smith D, UNPUB; SMITH DP, 1991, ANNU REV CELL BIOL, V7, P161; STAMNES MA, 1991, CELL, V65, P219, DOI 10.1016/0092-8674(91)90156-S; STARK WS, 1985, INT J INSECT MORPHOL, V14, P243, DOI 10.1016/0020-7322(85)90057-1; STRYER L, 1986, ANNU REV NEUROSCI, V9, P87, DOI 10.1146/annurev.ne.09.030186.000511; SUH PG, 1988, CELL, V54, P161, DOI 10.1016/0092-8674(88)90548-X; SVED J, 1986, DROSOPH INFO SERV, V73, P169; YAMADA T, 1990, SCIENCE, V248, P483, DOI 10.1126/science.2158671; YAMAGATA K, 1990, NEURON, V2, P469; YOKOHAMA H, 1988, BIOCHEM J, V255, P957, DOI 10.1042/bj2550957; YOSHIOKA T, 1983, BIOCHEM BIOPH RES CO, V111, P567, DOI 10.1016/0006-291X(83)90344-3; ZICK Y, 1986, P NATL ACAD SCI USA, V83, P9294, DOI 10.1073/pnas.83.24.9294	57	212	213	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	DEC 6	1991	254	5037					1478	1484		10.1126/science.1962207	http://dx.doi.org/10.1126/science.1962207			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT903	1962207				2022-12-28	WOS:A1991GT90300031
J	SPRINGER, TA				SPRINGER, TA			THE NEXT CLUSTER OF DIFFERENTIATION (CD) WORKSHOP	NATURE			English	Article											SPRINGER, TA (corresponding author), HARVARD UNIV,SCH MED,CTR BLOOD RES,800 HUNTINGTON AVE,BOSTON,MA 02115, USA.							Bernard A., 1984, LEUCOCYTE TYPING; GILKS WR, 1988, LEUKOCYTE TYPING DIS, V3; GILKS WR, 1990, LEUKOCYTE TYPING DAT, V4; KNAPPD W, 1989, LEUKOCYTE TYPING, V4; MCMICHAEL AJ, 1987, LEUKOCYTE TYPING, V3; REINHERZ EL, 1986, LEUKOCYTE TYPING 2, V2	6	0	1	0	2	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	DEC 5	1991	354	6352					415	416		10.1038/354415a0	http://dx.doi.org/10.1038/354415a0			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT761	1956408				2022-12-28	WOS:A1991GT76100058
J	HUANG, D; SWANSON, EA; LIN, CP; SCHUMAN, JS; STINSON, WG; CHANG, W; HEE, MR; FLOTTE, T; GREGORY, K; PULIAFITO, CA; FUJIMOTO, JG				HUANG, D; SWANSON, EA; LIN, CP; SCHUMAN, JS; STINSON, WG; CHANG, W; HEE, MR; FLOTTE, T; GREGORY, K; PULIAFITO, CA; FUJIMOTO, JG			OPTICAL COHERENCE TOMOGRAPHY	SCIENCE			English	Article							NERVE-FIBER LAYER; MICROSCOPE; REFLECTANCE; THICKNESS; GLAUCOMA; SYSTEM; HEAD	A technique called optical coherence tomography (OCT) has been developed for noninvasive cross-sectional imaging in biological systems. OCT uses low-coherence interferometry to produce a two-dimensional image of optical scattering from internal tissue microstructure in a way that is analogous to ultrasonic pulse-echo imaging. OCT has longitudinal and lateral spatial resolutions of a few micrometers and can detect reflected signals as small as approximately 10(-10) of the incident optical power. Tomographic imaging is demonstrated in vitro in the peripapillary area of the retina and in the coronary artery, two clinically relevant examples that are representative of transparent and turbid media, respectively.	MIT,DEPT ELECT ENGN & COMP SCI,CAMBRIDGE,MA 02139; MIT,ELECTR RES LAB,CAMBRIDGE,MA 02139; MIT,LINCOLN LAB,LEXINGTON,MA 02173; HARVARD UNIV,SCH MED,DEPT OPHTHALMOL,BOSTON,MA 02115; MASSACHUSETTS EYE & EAR HOSP,LASER RES LAB,BOSTON,MA 02114; MASSACHUSETTS GEN HOSP,WELLMAN LABS,BOSTON,MA 02114	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Lincoln Laboratory; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital			Zysk, Adam M/B-8575-2008; Schuman, Joel S/K-7304-2012; Schuman, Joel S/M-2389-2019; Wu, Binlin/K-4854-2015	Schuman, Joel S/0000-0002-8885-3766; Schuman, Joel S/0000-0002-8885-3766; Wu, Binlin/0000-0002-7729-4663; Huang, David/0000-0003-2592-8393	NIGMS NIH HHS [R01 GM035459, 1-R01-GM35459-06] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035459] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDERSSONENGELS S, 1990, OPT LETT, V15, P1179, DOI 10.1364/OL.15.001179; BILLE JF, 1990, NONINVASIVE DIAGNOST, P528; CHANCE B, 1988, P NATL ACAD SCI USA, V85, P471; CHEN H, 1991, OPT LETT, V16, P487, DOI 10.1364/OL.16.000487; DAMADIAN R, 1977, PHYSIOL CHEM PHYS M, V9, P97; DAVIDOVI.P, 1971, APPL OPTICS, V10, P1615, DOI 10.1364/AO.10.001615; FERCHER AF, 1988, OPT LETT, V13, P186, DOI 10.1364/OL.13.000186; FUJIMOTO JG, 1986, OPT LETT, V11, P150, DOI 10.1364/OL.11.000150; GILGEN HH, 1989, J LIGHTWAVE TECHNOL, V7, P1255; HAUS HA, 1984, WAVES FIELDS OPTOELE, P379; HITZENBERGER CK, 1991, INVEST OPHTH VIS SCI, V32, P616; HOUNDFIELD GN, 1973, BRIT J RADIOL, V46, P1016, DOI 10.1259/0007-1285-46-552-1016; HUANG D, 1991, LASER SURG MED, V11, P5; JACQUES SL, 1989, IEEE T BIO-MED ENG, V36, P1155, DOI 10.1109/10.42109; JINDRA LF, 1989, OPHTHALMIC SURG LAS, V20, P370; KINO GS, 1990, APPL OPTICS, V29, P3775, DOI 10.1364/AO.29.003775; KNIGHTON RW, 1989, INVEST OPHTH VIS SCI, V30, P2393; KRUSE FE, 1989, OPHTHALMOLOGY, V96, P1320; LEE BS, 1990, APPL OPTICS, V29, P3784, DOI 10.1364/AO.29.003784; Quigley H A, 1986, Trans Am Ophthalmol Soc, V84, P920; QUIGLEY HA, 1982, ARCH OPHTHALMOL-CHIC, V100, P807; QUIGLEY HA, 1989, AM J OPHTHALMOL, V107, P453, DOI 10.1016/0002-9394(89)90488-1; SOMMER A, 1989, AM J OPHTHALMOL, V107, P186, DOI 10.1016/0002-9394(89)90221-3; SOMMER A, 1991, ARCH OPHTHALMOL-CHIC, V109, P77, DOI 10.1001/archopht.1991.01080010079037; SPEARS KG, 1989, IEEE T BIO-MED ENG, V36, P1210, DOI 10.1109/10.42116; STERN D, 1989, INVEST OPHTH VIS SCI, V30, P99; TAKADA K, 1987, APPL OPTICS, V26, P1603, DOI 10.1364/AO.26.001603; TAKENORI T, 1989, OPHTHALMOLOGY, V96, P1315; WANG L, 1991, SCIENCE, V253, P769, DOI 10.1126/science.253.5021.769; WEBB RH, 1987, APPL OPTICS, V26, P1492, DOI 10.1364/AO.26.001492; WEINREB RN, 1990, ARCH OPHTHALMOL-CHIC, V108, P557, DOI 10.1001/archopht.1990.01070060105058; WEINREB RN, 1989, INT OPHTHALMOL, V13, P25, DOI 10.1007/BF02028633; WILD JJ, 1952, SCIENCE, V115, P226, DOI 10.1126/science.115.2983.226; WILLIAMS RD, 1980, INV OPHTHALMOL VIS S, V19, P653; Wilson T., 1984, THEORY PRACTICE SCAN; YOO KM, 1991, OPT LETT, V16, P1068, DOI 10.1364/OL.16.001068; YOUNGQUIST RC, 1987, OPT LETT, V12, P158, DOI 10.1364/OL.12.000158; ZEIMER RC, 1989, ARCH OPHTHALMOL-CHIC, V107, P1006, DOI 10.1001/archopht.1989.01070020068031; ANSI Z136 AM NAT STA	39	10537	11314	92	1595	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	NOV 22	1991	254	5035					1178	1181		10.1126/science.1957169	http://dx.doi.org/10.1126/science.1957169			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ834	1957169	Green Accepted			2022-12-28	WOS:A1991GQ83400038
J	KERPPOLA, TK; CURRAN, T				KERPPOLA, TK; CURRAN, T			DNA BENDING BY FOS AND JUN - THE FLEXIBLE HINGE MODEL	SCIENCE			English	Article							TRANSCRIPTION FACTOR AP-1; INTEGRATION HOST FACTOR; LEUCINE ZIPPER; BINDING DOMAIN; PROTEIN COMPLEXES; BASIC REGION; PRODUCT; RECOGNITION; ACTIVATION; ONCOGENE	DNA bending is essential for the assembly of multiprotein complexes that contact several DNA sequence elements. An approach based on phasing analysis was developed that allows determination of both the directed DNA bend angle and the orientation of DNA bending. This technique has been applied to the analysis of DNA bending by the transcription regulatory proteins Fos and Jun. Complexes that contained different combinations of full-length and truncated Fos and Jun induced DNA bends of different magnitudes and orientations. The DNA bends induced by the individual proteins were determined on the basis of a quantitative model for DNA bending by dimeric complexes. This information was used to visualize the consequences of DNA bending by Fos and Jun for the structures of Fos-Jun-DNA and Jun-DNA complexes.	ROCHE INST MOLEC BIOL,DEPT MOLEC ONCOL & VIROL,NUTLEY,NJ 07110				Kerppola, Tom/AFK-6155-2022; Kerppola, Tom/AAG-4457-2022; Curran, Tom/D-7515-2011; Curran, Tom/F-5234-2018; Curran, Thomas/AAE-7631-2019; Curran, Tom/C-1164-2008	Kerppola, Tom/0000-0002-0611-9446; Kerppola, Tom/0000-0002-0611-9446; Curran, Tom/0000-0003-1444-7551; Curran, Thomas/0000-0003-1444-7551; Curran, Tom/0000-0003-1444-7551				ABATE C, 1991, MOL CELL BIOL, V11, P3624, DOI 10.1128/MCB.11.7.3624; ABATE C, 1990, P NATL ACAD SCI USA, V87, P1032, DOI 10.1073/pnas.87.3.1032; BOHMANN D, 1987, SCIENCE, V238, P1386, DOI 10.1126/science.2825349; COHEN DR, 1989, GENE DEV, V3, P173, DOI 10.1101/gad.3.2.173; COHEN DR, 1990, ONCOGENE, V5, P929; CURRAN T, 1988, CELL, V55, P305; GARTENBERG MR, 1990, P NATL ACAD SCI USA, V87, P6034, DOI 10.1073/pnas.87.16.6034; GENTZ R, 1989, SCIENCE, V243, P1695, DOI 10.1126/science.2494702; GOBER JW, 1990, GENE DEV, V4, P1494, DOI 10.1101/gad.4.9.1494; HAGERMAN PJ, 1985, BIOCHEMISTRY-US, V24, P7033, DOI 10.1021/bi00346a001; HAI T, 1991, P NATL ACAD SCI USA, V88, P3720, DOI 10.1073/pnas.88.9.3720; HOOVER TR, 1990, CELL, V63, P11, DOI 10.1016/0092-8674(90)90284-L; KERPPOLA TK, 1991, CELL, V66, P317, DOI 10.1016/0092-8674(91)90621-5; KOO HS, 1986, NATURE, V320, P501, DOI 10.1038/320501a0; KOUZARIDES T, 1988, NATURE, V336, P646, DOI 10.1038/336646a0; LANDSCHULZ WH, 1989, SCIENCE, V243, P1681, DOI 10.1126/science.2494700; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; MITCHELL PJ, 1989, SCIENCE, V245, P371, DOI 10.1126/science.2667136; MORGAN JI, 1991, ANNU REV NEUROSCI, V14, P421, DOI 10.1146/annurev.ne.14.030191.002225; NAKABEPPU Y, 1988, CELL, V55, P907, DOI 10.1016/0092-8674(88)90146-8; NAKABEPPU Y, 1989, EMBO J, V8, P3833, DOI 10.1002/j.1460-2075.1989.tb08561.x; NYE JA, 1990, P NATL ACAD SCI USA, V87, P3992, DOI 10.1073/pnas.87.10.3992; OAKLEY MG, 1990, SCIENCE, V248, P847, DOI 10.1126/science.2111578; ONEIL KT, 1990, SCIENCE, V249, P774, DOI 10.1126/science.2389143; PATEL L, 1990, NATURE, V347, P572, DOI 10.1038/347572a0; RAUSCHER FJ, 1988, SCIENCE, V240, P1010, DOI 10.1126/science.3130660; RICHARDSON JS, 1988, SCIENCE, V240, P1648, DOI 10.1126/science.3381086; RISSE G, 1989, EMBO J, V8, P3825, DOI 10.1002/j.1460-2075.1989.tb08560.x; ROJO F, 1990, J MOL BIOL, V211, P713, DOI 10.1016/0022-2836(90)90072-T; TALANIAN RV, 1990, SCIENCE, V249, P769, DOI 10.1126/science.2389142; THOMPSON JF, 1988, NUCLEIC ACIDS RES, V16, P9687, DOI 10.1093/nar/16.20.9687; TURNER R, 1989, SCIENCE, V243, P1689, DOI 10.1126/science.2494701; VINSON CR, 1989, SCIENCE, V246, P911, DOI 10.1126/science.2683088; WEISS MA, 1990, NATURE, V347, P575, DOI 10.1038/347575a0; WU HM, 1984, NATURE, V308, P509, DOI 10.1038/308509a0; ZERIAL M, 1989, EMBO J, V8, P805, DOI 10.1002/j.1460-2075.1989.tb03441.x; ZINKEL SS, 1987, NATURE, V328, P178, DOI 10.1038/328178a0; ZINKEL SS, 1991, J MOL BIOL, V219, P201, DOI 10.1016/0022-2836(91)90562-K	38	186	188	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	NOV 22	1991	254	5035					1210	1214		10.1126/science.1957173	http://dx.doi.org/10.1126/science.1957173			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ834	1957173				2022-12-28	WOS:A1991GQ83400050
J	SIMON, MA; BOWTELL, DDL; DODSON, GS; LAVERTY, TR; RUBIN, GM				SIMON, MA; BOWTELL, DDL; DODSON, GS; LAVERTY, TR; RUBIN, GM			RAS1 AND A PUTATIVE GUANINE-NUCLEOTIDE EXCHANGE FACTOR PERFORM CRUCIAL STEPS IN SIGNALING BY THE SEVENLESS PROTEIN TYROSINE KINASE	CELL			English	Article							ELEGANS VULVAR INDUCTION; EGF RECEPTOR HOMOLOG; FAINT-LITTLE-BALL; CELL FATE; DROSOPHILA-MELANOGASTER; SACCHAROMYCES-CEREVISIAE; TRANSPOSABLE ELEMENT; CYCLASE PATHWAY; CDC25 GENE; WHITE GENE	We have conducted a genetic screen for mutations that decrease the effectiveness of signaling by a protein tyrosine kinase, the product of the Drosophila melanogaster sevenless gene. These mutations define seven genes whose wild-type products may be required for signaling by sevenless. Four of the seven genes also appear to be essential for signaling by a second protein tyrosine kinase, the product of the Ellipse gene. The putative products of two of these seven genes have been identified. One encodes a ras protein. The other locus encodes a protein that is homologous to the S. cerevisiae CDC25 protein, an activator of guanine nucleotide exchange by ras proteins. These results suggest that the stimulation of ras protein activity is a key element in the signaling by sevenless and Ellipse and that this stimulation may be achieved by activating the exchange of GTP for bound GDP by the ras protein.	UNIV CALIF BERKELEY,DEPT MOLEC & CELL BIOL,BERKELEY,CA 94720	University of California System; University of California Berkeley	SIMON, MA (corresponding author), UNIV CALIF BERKELEY,HOWARD HUGHES MED INST,BERKELEY,CA 94720, USA.		Bowtell, David/H-1007-2016	Bowtell, David/0000-0001-9089-7525; Rubin, Gerald/0000-0001-8762-8703				AMBROSIO L, 1989, NATURE, V342, P288, DOI 10.1038/342288a0; AROIAN RV, 1990, NATURE, V348, P693, DOI 10.1038/348693a0; BAKER NE, 1989, NATURE, V340, P150, DOI 10.1038/340150a0; BASLER K, 1988, CELL, V54, P299; BEITEL GJ, 1990, NATURE, V348, P503, DOI 10.1038/348503a0; BISHOP JM, 1991, CELL, V64, P235, DOI 10.1016/0092-8674(91)90636-D; BLACKMAN RK, 1989, EMBO J, V8, P211, DOI 10.1002/j.1460-2075.1989.tb03366.x; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; BOURNE HR, 1990, NATURE, V348, P125, DOI 10.1038/348125a0; BOWTELL DDL, 1988, GENE DEV, V2, P620, DOI 10.1101/gad.2.6.620; BROCK HW, 1987, GENE, V51, P129, DOI 10.1016/0378-1119(87)90301-5; BROEK D, 1987, CELL, V48, P789, DOI 10.1016/0092-8674(87)90076-6; CAMONIS JH, 1986, EMBO J, V5, P375, DOI 10.1002/j.1460-2075.1986.tb04222.x; CANTLEY LC, 1991, CELL, V64, P281, DOI 10.1016/0092-8674(91)90639-G; CAPON DJ, 1983, NATURE, V302, P33, DOI 10.1038/302033a0; CARTHEW RW, 1990, CELL, V63, P561, DOI 10.1016/0092-8674(90)90452-K; CASANOVA J, 1989, GENE DEV, V3, P2025, DOI 10.1101/gad.3.12b.2025; CHANT J, 1991, CELL, V65, P1213, DOI 10.1016/0092-8674(91)90016-R; CRECHET JB, 1990, SCIENCE, V248, P866, DOI 10.1126/science.2188363; CROSS M, 1991, CELL, V64, P271, DOI 10.1016/0092-8674(91)90638-F; DAMAK F, 1991, MOL CELL BIOL, V11, P202, DOI 10.1128/MCB.11.1.202; FEIG LA, 1988, MOL CELL BIOL, V8, P3235, DOI 10.1128/MCB.8.8.3235; FINCHAM VJ, 1986, J VIROL, V58, P694, DOI 10.1128/JVI.58.2.694-699.1986; FRANCESCHINI N, 1971, KYBERNETIK, V9, P159, DOI 10.1007/BF02215177; GIBBS JB, 1988, P NATL ACAD SCI USA, V85, P5026, DOI 10.1073/pnas.85.14.5026; HAFEN E, 1987, SCIENCE, V236, P55, DOI 10.1126/science.2882603; HAN M, 1990, CELL, V63, P921, DOI 10.1016/0092-8674(90)90495-Z; HART AC, 1990, GENE DEV, V4, P1835, DOI 10.1101/gad.4.11.1835; HAZELRIGG T, 1984, CELL, V36, P469, DOI 10.1016/0092-8674(84)90240-X; HENKEMEYER M, 1990, CELL, V63, P949, DOI 10.1016/0092-8674(90)90498-4; HUGHES DA, 1990, NATURE, V344, P355, DOI 10.1038/344355a0; JONES S, 1991, MOL CELL BIOL, V11, P2641, DOI 10.1128/MCB.11.5.2641; KARESS RE, 1984, CELL, V38, P135, DOI 10.1016/0092-8674(84)90534-8; KEMPHUES KJ, 1980, CELL, V21, P445, DOI 10.1016/0092-8674(80)90481-X; KIMMEL BE, 1990, GENE DEV, V4, P712, DOI 10.1101/gad.4.5.712; KLEMENZ R, 1987, NUCLEIC ACIDS RES, V15, P3947, DOI 10.1093/nar/15.10.3947; KRAMER H, 1991, NATURE, V352, P207, DOI 10.1038/352207a0; LEVIS R, 1985, EMBO J, V4, P3489, DOI 10.1002/j.1460-2075.1985.tb04108.x; LEWIS EB, 1968, DROSOPHILA INFORM SE, V43, P193; LINDSLEY DL, 1972, GENETICS, V71, P157; LIVNEH E, 1985, CELL, V40, P599, DOI 10.1016/0092-8674(85)90208-9; Muller HJ, 1931, ANAT REC, V51, P110; NEUMANSILBERBERG FS, 1984, CELL, V37, P1027; POWERS S, 1991, CELL, V65, P1225, DOI 10.1016/0092-8674(91)90017-S; PRICE JV, 1989, CELL, V56, P1085, DOI 10.1016/0092-8674(89)90641-7; REINKE R, 1988, CELL, V55, P321, DOI 10.1016/0092-8674(88)90055-4; ROBINSON LC, 1987, SCIENCE, V235, P1218, DOI 10.1126/science.3547648; ROGGE RD, 1991, CELL, V64, P39, DOI 10.1016/0092-8674(91)90207-F; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHEJTER ED, 1989, CELL, V56, P1093, DOI 10.1016/0092-8674(89)90642-9; SMITH MR, 1986, NATURE, V320, P540, DOI 10.1038/320540a0; SPRENGER F, 1989, NATURE, V338, P478, DOI 10.1038/338478a0; TOMLINSON A, 1987, DEV BIOL, V123, P264, DOI 10.1016/0012-1606(87)90448-9; TOMLINSON A, 1986, SCIENCE, V231, P400, DOI 10.1126/science.231.4736.400; TRAHEY M, 1987, SCIENCE, V238, P542, DOI 10.1126/science.2821624; WOODRUFF RC, 1979, GENETICS, V92, P133	57	752	758	0	26	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	NOV 15	1991	67	4					701	716		10.1016/0092-8674(91)90065-7	http://dx.doi.org/10.1016/0092-8674(91)90065-7			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GQ407	1934068				2022-12-28	WOS:A1991GQ40700007
J	STRANG, J				STRANG, J			THE HEALTH OF THE NATION - RESPONSES - INJECTING DRUG MISUSE	BMJ-BRITISH MEDICAL JOURNAL			English	Article							USERS; NOTIFICATION; ENGLAND; SYSTEM; AIDS				STRANG, J (corresponding author), BETHLEM ROYAL & MAUDSLEY HOSP, DRUG DEPENDENCE CLIN RES & TREATMENT UNIT, BECKENHAM BR3 3BX, ENGLAND.		Strang, John/H-5460-2011	Strang, John/0000-0002-5413-2725				BALL JC, 1988, J HEALTH SOC BEHAV, V29, P214, DOI 10.2307/2137033; BLACK D, 1988, J ROY SOC HEALTH, V108, P83, DOI 10.1177/146642408810800304; BRETTLE RP, 1987, BRIT MED J, V295, P421, DOI 10.1136/bmj.295.6595.421; Buning E., 1990, AIDS DRUG MISUSE CHA, P153; CARBALLO M, 1990, AIDS DRUG MISUSE, P16; DAWE S, 1991, BRIT J ADDICT, V86, P977; De Alarcon R, 1972, Psychol Med, V2, P293; DONMALL M, 1990, DRUGLINK, V5, P10; EDWARDS G, 1981, B WORLD HEALTH ORGAN, V59, P225; EDWARDS G, 1981, DRUG PROBLEMS BRITAI, P25; FARRELL M, 1990, BRIT J ADDICT, V85, P1657; GHODSE AH, 1977, BRIT MED J, V1, P1381, DOI 10.1136/bmj.1.6073.1381; GLANZ A, 1986, BRIT MED J, V293, P427, DOI 10.1136/bmj.293.6544.427; GLANZ A, 1989, BRIT MED J, V299, P1076, DOI 10.1136/bmj.299.6707.1076; GOSSOP M, 1988, BRIT J ADDICT, V83, P1159; JAMESON A, 1984, DEALING DRUG MISUSE; JOHNSON AM, 1991, BRIT MED J, V303, P573, DOI 10.1136/bmj.303.6802.573; LOVE J, 1985, BRIT J ADDICT, V80, P435; MacGregor S., 1990, DRUG SERVICES ENGLAN; MADEN A, 1991, BRIT MED J, V302, P880, DOI 10.1136/bmj.302.6781.880; MCGLOTHLIN WH, 1981, ARCH GEN PSYCHIAT, V38, P1055; OPPENHEIMER E, 1988, BRIT J ADDICT, V83, P635; PARKER H, 1987, BRIT J ADDICT, V82, P147; ROBERTSON R, 1990, AIDS DRUG MISUSE CHA; SMART RG, 1974, BRIT J ADDICT, V69, P225; STIMSON GV, 1988, BRIT MED J, V296, P1717, DOI 10.1136/bmj.296.6638.1717; Strang J., 1987, Health Trends, V19, P16; STRANG J, 1985, BRIT J PSYCHIAT, V147, P195, DOI 10.1192/bjp.147.2.195; STRANG J, 1990, LANCET, V335, P740, DOI 10.1016/0140-6736(90)90865-3; STRANG J, 1990, AIDS DRUG MISUSE CHA; STRANG J, 1989, DRUGS BRIT SOC RESPO; 1988, HLTH ALL AUSTR, P45; 1985, 5TH HOUS COMM INT RE; 1989, REPORT AIDS DRUG M 2; 1984, REPORT PREVENTION; 1984, GUIDELINES GOOD CLIN; 1990, WHO20 Q REP; 1986, MCCLELLAND REPORT; 1991, STATISTICS MISUSE DR; 1982, REPORT TREATMENT REH; 1988, REPORT AIDS DRUG M 1; 1985, DRUG MISUSE PREVALEN; 1991, CM1523; 1988, WATKINS REPORT; 1990, HLTH PEOPLE 2000; 1988, IMMUNISATION INFECTI; 1986, TACKLING DRUG MISUSE	47	5	5	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 26	1991	303	6809					1043	1046		10.1136/bmj.303.6809.1043	http://dx.doi.org/10.1136/bmj.303.6809.1043			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GM478	1954460	Bronze, Green Published			2022-12-28	WOS:A1991GM47800027
J	LIMBERG, B				LIMBERG, B			DIAGNOSIS OF LARGE-BOWEL TUMORS BY COLONIC SONOGRAPHY	LANCET			English	Article											LIMBERG, B (corresponding author), UNIV FRANKFURT,ACAD HOSP,KLINIKUM DARMSTADT,DEPT INTERNAL MED 2,GRAFENSTR 9,W-6100 DARMSTADT,GERMANY.							ALDRIDGE MC, 1986, LANCET, V2, P833; CHURCH JM, 1988, DIS COLON RECTUM, V31, P50, DOI 10.1007/BF02552570; Eddy D., 1980, CA-CANCER J CLIN, V30, P194; EIDE TJ, 1986, INT J CANCER, V38, P173, DOI 10.1002/ijc.2910380205; FARRANDS PA, 1983, DIS COLON RECTUM, V26, P727; FLEISCHER DE, 1989, JAMA-J AM MED ASSOC, V261, P580, DOI 10.1001/jama.261.4.580; GILBERT DA, 1984, GASTROINTEST ENDOSC, V30, P143; GROSSMAN S, 1988, GASTROENTEROLOGY, V94, P395, DOI 10.1016/0016-5085(88)90427-1; HARDCASTLE JD, 1989, LANCET, V1, P1160; HOFF G, 1986, SCAND J GASTROENTERO, V21, P853, DOI 10.3109/00365528609011130; KEWENTER J, 1988, CANCER, V62, P645, DOI 10.1002/1097-0142(19880801)62:3<645::AID-CNCR2820620333>3.0.CO;2-#; LETSOU G, 1987, DIS COLON RECTUM, V30, P839, DOI 10.1007/BF02555420; LIEBERMAN DA, 1988, ARCH INTERN MED, V148, P473, DOI 10.1001/archinte.148.2.473; LIMBERG B, 1989, J CLIN ULTRASOUND, V17, P25, DOI 10.1002/jcu.1870170106; LIMBERG B, IN PRESS J CLIN ULTR; LINDSAY DC, 1988, BRIT MED J, V296, P167, DOI 10.1136/bmj.296.6616.167; MUTO T, 1975, CANCER, V36, P2251, DOI 10.1002/cncr.2820360944; NEUGUT AI, 1988, GASTROENTEROLOGY, V95, P492, DOI 10.1016/0016-5085(88)90511-2; ROZEN P, 1987, CANCER-AM CANCER SOC, V60, P2553, DOI 10.1002/1097-0142(19871115)60:10<2553::AID-CNCR2820601034>3.0.CO;2-S; SCHWERK W, 1979, J CLIN ULTRASOUND, V7, P425, DOI 10.1002/jcu.1870070604; SIANESI M, 1984, DIS COLON RECTUM, V27, P168, DOI 10.1007/BF02555665; SILVERBERG E, 1987, CA-CANCER J CLIN, V37, P2; SIMON JB, 1985, GASTROENTEROLOGY, V88, P820, DOI 10.1016/0016-5085(85)90158-1; SPENCER RJ, 1984, MAYO CLIN PROC, V59, P305, DOI 10.1016/S0025-6196(12)61425-6; STROHM WD, 1984, SCAND J GASTROENTERO, V19, P7; TATE JJT, 1988, GUT, V29, P1322, DOI 10.1136/gut.29.10.1322; TATE JJT, 1988, BRIT J SURG, V75, P1016, DOI 10.1002/bjs.1800751021; WARDEN MJ, 1986, DIS COLON RECTUM, V30, P52	28	39	39	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	JAN 20	1990	335	8682					144	146		10.1016/0140-6736(90)90012-T	http://dx.doi.org/10.1016/0140-6736(90)90012-T			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CJ979	1967439				2022-12-28	WOS:A1990CJ97900011
J	HARTL, WH; JAUCH, KW; HERNDON, DN; COHNERT, TU; WOLFE, RR; SCHILDBERG, FW				HARTL, WH; JAUCH, KW; HERNDON, DN; COHNERT, TU; WOLFE, RR; SCHILDBERG, FW			EFFECT OF LOW-DOSE BRADYKININ ON GLUCOSE-METABOLISM AND NITROGEN-BALANCE IN SURGICAL PATIENTS	LANCET			English	Article									UNIV TEXAS,MED BRANCH,GALVESTON,TX 77550; SHRINERS BURN INST,GALVESTON,TX 77550	University of Texas System; University of Texas Medical Branch Galveston	HARTL, WH (corresponding author), UNIV MUNICH,KLINIKUM GROSSHADERN,DEPT SURG,MARCHIONINISTR 15,W-8000 MUNICH 70,GERMANY.		hartl, Wolfgang/I-1981-2012; Herndon, David/AAC-3354-2020		NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK033952, R01DK034817] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK-34817, DK-33952] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BARROW SE, 1986, BRIT J PHARMACOL, V87, P243, DOI 10.1111/j.1476-5381.1986.tb10177.x; BEGUM N, 1985, DIABETES, V34, P29, DOI 10.2337/diabetes.34.1.29; CAVAROCCHI NC, 1986, WORLD J SURG, V10, P468, DOI 10.1007/BF01655311; DIETZE G, 1978, H-S Z PHYSIOL CHEM, V359, P369; DIETZE G, 1984, ADV EXP MED BIOL, V167, P63; FAUVE RM, 1979, ANN INST PASTEUR IMM, VC130, P743; GOLDSTEIN RH, 1984, J BIOL CHEM, V259, P9263; HARTL W H, 1988, Surgical Forum (Chicago), V39, P53; HARTL W H, 1987, Surgical Forum (Chicago), V38, P4; HARTL WH, 1989, METABOLISM, V38, P878, DOI 10.1016/0026-0495(89)90235-7; HASSELGREN PO, 1988, ARCH SURG-CHICAGO, V123, P992; LEIGHTON B, 1985, BIOCHEM J, V227, P337, DOI 10.1042/bj2270337; MERTZ DP, 1963, N-S ARCH EX PATH PH, V244, P405; NORRYD C, 1975, ACTA CHIR SCAND, V141, P119; NOWAK J, 1984, ANN CLIN RES, V16, P269; PONTING GA, 1988, LANCET, V1, P438, DOI 10.1016/S0140-6736(88)91232-9; RADRIZZANI D, 1986, SURG GYNECOL OBSTET, V163, P37; Reeds P. J., 1986, Control and manipulation of animal growth. Proceedings of the 43rd Nottingham Easter School in Agricultural Science., P161; RENNIE MJ, 1985, BRIT MED BULL, V41, P257, DOI 10.1093/oxfordjournals.bmb.a072060; SHAW JHF, 1985, SURGERY, V97, P557; STEHLE P, 1989, LANCET, V1, P231; TUTEN MB, 1985, JPEN-PARENTER ENTER, V9, P709, DOI 10.1177/0148607185009006709; WIMHURST JM, 1974, EUR J BIOCHEM, V42, P33, DOI 10.1111/j.1432-1033.1974.tb03311.x; WOLFE RR, 1986, AM J PHYSIOL, V250, pE306, DOI 10.1152/ajpendo.1986.250.3.E306; WOLFE RR, 1989, DIABETES METAB REV, V5, P149, DOI 10.1002/dmr.5610050205	25	24	26	0	1	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	JAN 13	1990	335	8681					69	71		10.1016/0140-6736(90)90538-G	http://dx.doi.org/10.1016/0140-6736(90)90538-G			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CH516	1967418				2022-12-28	WOS:A1990CH51600003
J	SUMIMOTO, H; OHKUMA, Y; SINN, E; KATO, H; SHIMASAKI, S; HORIKOSHI, M; ROEDER, RG				SUMIMOTO, H; OHKUMA, Y; SINN, E; KATO, H; SHIMASAKI, S; HORIKOSHI, M; ROEDER, RG			CONSERVED SEQUENCE MOTIFS IN THE SMALL SUBUNIT OF HUMAN GENERAL TRANSCRIPTION FACTOR TFIIE	NATURE			English	Article							RNA POLYMERASE-II; SIGMA-FACTORS; INITIATION; PROTEINS; PURIFICATION; SPECIFICITY; EXPRESSION; BINDING; MYOD	A GENERAL initiation factor, TFIIE, is essential for transcription initiation by RNA polymerase II in conjunction with other general factors 1,2 . TFIIE is a heterotetramer containing two subunits of relative molecular mass 57,000 (TFIIE-alpha) and two of 34,000 (TFIIE-beta) 3,4. TFIIE-beta is required in conjunction with TFIIE-alpha for transcription initiation. Here we report the cloning and expression of a complementary DNA encoding a functional human TFIIE-beta. Recombinant TFIIE-beta could replace the natural TFIIE-beta for transcription in conjunction with TFIIE-alpha. Amino-acid sequence comparisons reveal regions with sequence similarities to: subregion 3 of bacterial or factors 6; a region of RAP30 (the small subunit of TFIIF) with sequence similarity to a sigma-factor subregion implicated in binding to RNA polymerase 7; and a portion of the basic region-helix-loop-helix motif found in several enhancer-binding proteins 8-10. These potential homologies have implications for the role of TFIIE in preinitiation complex assembly and function.	WHITTIER INST DIABET & ENDOCRINOL,DEPT MOLEC ENDOCRINOL,LA JOLLA,CA 92037		SUMIMOTO, H (corresponding author), ROCKEFELLER UNIV,BIOCHEM & MOLEC BIOL LAB,NEW YORK,NY 10021, USA.							CAI MJ, 1990, CELL, V61, P437, DOI 10.1016/0092-8674(90)90525-J; CONAWAY JW, 1991, J BIOL CHEM, V266, P7804; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; FLORES O, 1989, J BIOL CHEM, V264, P8913; GORBALENYA AE, 1989, NUCLEIC ACIDS RES, V17, P8413, DOI 10.1093/nar/17.21.8413; GRIBSKOV M, 1986, NUCLEIC ACIDS RES, V14, P6745, DOI 10.1093/nar/14.16.6745; HELMANN JD, 1988, ANNU REV BIOCHEM, V57, P839, DOI 10.1146/annurev.bi.57.070188.004203; HOFFMANN A, 1990, NATURE, V346, P387, DOI 10.1038/346387a0; HORIKOSHI M, 1989, NATURE, V341, P299, DOI 10.1038/341299a0; HU YF, 1990, GENE DEV, V4, P1741, DOI 10.1101/gad.4.10.1741; INOSTROZA J, 1991, J BIOL CHEM, V266, P9304; JOHNSON PF, 1989, ANNU REV BIOCHEM, V58, P799, DOI 10.1146/annurev.biochem.58.1.799; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P857, DOI 10.1093/nar/12.2.857; LESZCZYNSKI JF, 1986, SCIENCE, V234, P849, DOI 10.1126/science.3775366; LUSCHER B, 1990, GENE DEV, V4, P2235, DOI 10.1101/gad.4.12b.2235; MALIK S, IN PRESS P NATN ACAD; MATSUI T, 1980, J BIOL CHEM, V255, P1992; MCCRACKEN S, 1991, SCIENCE, V253, P900, DOI 10.1126/science.1652156; MURRE C, 1989, CELL, V56, P777, DOI 10.1016/0092-8674(89)90682-X; OHKUMA Y, 1990, P NATL ACAD SCI USA, V87, P9163, DOI 10.1073/pnas.87.23.9163; OHKUMA Y, 1991, NATURE, V354, P398, DOI 10.1038/354398a0; OLSON EN, 1990, GENE DEV, V4, P1454, DOI 10.1101/gad.4.9.1454; REINBERG D, 1987, J BIOL CHEM, V262, P3310; ROSENBERG AH, 1987, GENE, V56, P125, DOI 10.1016/0378-1119(87)90165-X; SALTZMAN AG, 1989, FASEB J, V3, P1723, DOI 10.1096/fasebj.3.6.2649403; SAWADOGO M, 1990, ANNU REV BIOCHEM, V59, P711, DOI 10.1146/annurev.bi.59.070190.003431; SAWADOGO M, 1985, P NATL ACAD SCI USA, V82, P4394, DOI 10.1073/pnas.82.13.4394; SAWADOGO M, 1984, J BIOL CHEM, V259, P5321; SCHEIDEREIT C, 1988, NATURE, V336, P551, DOI 10.1038/336551a0; SUMIMOTO H, 1990, P NATL ACAD SCI USA, V87, P9158, DOI 10.1073/pnas.87.23.9158	30	79	80	0	2	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	DEC 5	1991	354	6352					401	404		10.1038/354401a0	http://dx.doi.org/10.1038/354401a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT761	1956404				2022-12-28	WOS:A1991GT76100054
J	WOLF, SM; BOYLE, P; CALLAHAN, D; FINS, JJ; JENNINGS, B; NELSON, JL; BARONDESS, JA; BROCK, DW; DRESSER, R; EMANUEL, L; JOHNSON, S; LANTOS, J; MASON, DR; MEZEY, M; ORENTLICHER, D; ROUSE, F				WOLF, SM; BOYLE, P; CALLAHAN, D; FINS, JJ; JENNINGS, B; NELSON, JL; BARONDESS, JA; BROCK, DW; DRESSER, R; EMANUEL, L; JOHNSON, S; LANTOS, J; MASON, DR; MEZEY, M; ORENTLICHER, D; ROUSE, F			SOURCES OF CONCERN ABOUT THE PATIENT SELF-DETERMINATION ACT	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LIFE-SUSTAINING TREATMENT; ELDERLY OUTPATIENTS; ADVANCE DIRECTIVES; PHYSICIANS; DECISIONS; RESUSCITATION; PREFERENCES; ATTITUDES; FUTILITY; PROXIES		NEW YORK ACAD MED, NEW YORK, NY 10029 USA; BROWN UNIV, PROVIDENCE, RI 02912 USA; CASE WESTERN RESERVE UNIV, CLEVELAND, OH 44106 USA; HARVARD UNIV, SCH MED, BOSTON, MA 02115 USA; ST LOUIS UNIV, ST LOUIS, MO 63108 USA; UNIV CHICAGO, CHICAGO, IL 60637 USA; AMER ASSOC RETIRED PERSONS, WASHINGTON, DC 20049 USA; NYU, NEW YORK, NY 10003 USA; AMER MED ASSOC, CHICAGO, IL 60610 USA; CHOICE DYING, NEW YORK, NY 10107 USA	New York Academy of Medicine; Brown University; Case Western Reserve University; Harvard University; Harvard Medical School; Saint Louis University; University of Chicago; American Association of Retired Persons (AARP); New York University; American Medical Association	WOLF, SM (corresponding author), HASTINGS CTR, 255 ELM RD, BRIARCLIFF MANOR, NY 10510 USA.		Boyle, Peter/A-4380-2014	Boyle, Peter/0000-0001-6251-0610; Nelson, Jamie/0000-0003-2624-556X; Fins, Joseph/0000-0002-7221-0053				ACKERMAN F, 1989, NY TIMES        1013, pA32; ANNAS GJ, 1987, HASTINGS CENT REP, V17, P20; ANNAS GJ, 1991, NEW ENGL J MED, V324, P1210, DOI 10.1056/NEJM199104253241711; BRETT AS, 1991, JAMA-J AM MED ASSOC, V266, P825, DOI 10.1001/jama.266.6.825; BUCHANAN AE, 1989, DECIDING OTHERS ETHI, P152; CALLAHAN D, 1991, HASTINGS CENT REP, V21, P30, DOI 10.2307/3562999; DANIS M, 1991, NEW ENGL J MED, V324, P882, DOI 10.1056/NEJM199103283241304; DAVIDSON KW, 1989, JAMA-J AM MED ASSOC, V262, P2415, DOI 10.1001/jama.262.17.2415; DOUKAS DJ, 1991, J FAM PRACTICE, V32, P145; Dresser R, 1989, ADV DIRECTIVES MED, P155; EISENDRATH SJ, 1983, JAMA-J AM MED ASSOC, V249, P2054, DOI 10.1001/jama.249.15.2054; EMANUEL L, 1991, J AM GERIATR SOC, V39, P1221; EMANUEL LL, 1990, CLIN RES, V38, pA738; EMANUEL LL, 1989, JAMA-J AM MED ASSOC, V261, P3288, DOI 10.1001/jama.261.22.3288; EMANUEL LL, 1991, NEW ENGL J MED, V324, P889, DOI 10.1056/NEJM199103283241305; EMANUEL LL, 1989, AM J MED, V86, P87, DOI 10.1016/0002-9343(89)90234-9; EVERHART MA, 1990, CHEST, V97, P159, DOI 10.1378/chest.97.1.159; FINUCANE TE, 1988, J GEN INTERN MED, V3, P322, DOI 10.1007/BF02595788; FORROW L, 1991, NEW ENGL J MED, V325, P1255; GAMBLE ER, 1991, ARCH INTERN MED, V151, P277, DOI 10.1001/archinte.151.2.277; Gibson Joan McIver, 1990, Generations, V14, P51; GRECO PJ, 1991, ANN INTERN MED, V115, P639, DOI 10.7326/0003-4819-115-8-639; HARDIN SB, 1991, CLIN RES, V39, pA626; KOHN M, 1988, J AM GERIATR SOC, V36, P840, DOI 10.1111/j.1532-5415.1988.tb04270.x; LANTOS JD, 1989, AM J MED, V87, P81; LAPUMA J, 1991, JAMA-J AM MED ASSOC, V266, P402, DOI 10.1001/jama.266.3.402; LO B, 1986, ARCH INTERN MED, V146, P1613, DOI 10.1001/archinte.146.8.1613; MEISEL A, 1989, RIGHT DIE; MILES SH, 1989, NEW ENGL J MED, V321, P48, DOI 10.1056/NEJM198907063210110; MOLLOY DW, 1991, CAN MED ASSOC J, V145, P307; ORENTLICHER D, 1990, JAMA-J AM MED ASSOC, V264, P2444, DOI 10.1001/jama.264.18.2444; OUSLANDER JG, 1989, ARCH INTERN MED, V149, P1367, DOI 10.1001/archinte.149.6.1367; President's Commission for the Study of Ethical Problems in Medicine and Biomedical and Behavioral Research, 1982, MAKING HLTH CARE DEC, V1; SECKLER AB, 1991, ANN INTERN MED, V115, P92, DOI 10.7326/0003-4819-115-2-92; SHMERLING RH, 1988, J GEN INTERN MED, V3, P317, DOI 10.1007/BF02595786; SILVERSTEIN MD, 1991, MAYO CLIN PROC, V66, P906, DOI 10.1016/S0025-6196(12)61577-8; TENO J, 1990, J GEN INTERN MED, V5, P490, DOI 10.1007/BF02600877; TOMLINSON T, 1990, GERONTOLOGIST, V30, P54, DOI 10.1093/geront/30.1.54; UHLMANN RF, 1988, J GERONTOL, V43, pM115, DOI 10.1093/geronj/43.5.M115; VANMCCRARY S, 1989, JAMA-J AM MED ASSOC, V262, P2411, DOI 10.1001/jama.1989.03430170073031; WEIR RF, 1990, JAMA-J AM MED ASSOC, V264, P1846, DOI 10.1001/jama.264.14.1846; WHITE ML, 1991, JAMA-J AM MED ASSOC, V266, P410, DOI 10.1001/jama.1991.03470030110035; YOUNGER SJ, 1988, JAMA-J AM MED ASSOC, V260, P2094, DOI 10.1001/jama.260.14.2094; YOUNGNER SJ, 1990, JAMA-J AM MED ASSOC, V264, P1295, DOI 10.1001/jama.264.10.1295; ZWEIBEL NR, 1989, GERONTOLOGIST, V29, P615, DOI 10.1093/geront/29.5.615; 1991, REFUSAL TREATMENT LE; 1987, GUIDELINES TERMINATI	47	132	133	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 5	1991	325	23					1666	1671		10.1056/NEJM199112053252334	http://dx.doi.org/10.1056/NEJM199112053252334			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GR770	1944466				2022-12-28	WOS:A1991GR77000040
J	GRIBBEN, JG; FREEDMAN, AS; NEUBERG, D; ROY, DC; BLAKE, KW; WOO, SD; GROSSBARD, ML; RABINOWE, SN; CORAL, F; FREEMAN, GJ; RITZ, J; NADLER, LM				GRIBBEN, JG; FREEDMAN, AS; NEUBERG, D; ROY, DC; BLAKE, KW; WOO, SD; GROSSBARD, ML; RABINOWE, SN; CORAL, F; FREEMAN, GJ; RITZ, J; NADLER, LM			IMMUNOLOGICAL PURGING OF MARROW ASSESSED BY PCR BEFORE AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR B-CELL LYMPHOMA	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NON-HODGKINS-LYMPHOMA; ACUTE LYMPHOBLASTIC-LEUKEMIA; DOSE COMBINATION CHEMOTHERAPY; BREAKPOINT-CLUSTER REGION; MONOCLONAL-ANTIBODY; FOLLICULAR LYMPHOMAS; CHROMOSOMAL TRANSLOCATION; BREAST-CANCER; T(14-18); ANTIGEN	Background. The use of autologous bone marrow transplantation is increasing in the management of advanced cancers. Many investigators have attempted to "purge" autologous marrow of residual tumor cells because of concern that reinfused tumor cells might contribute to relapse. The efficacy of purging remains unproved. Methods. We performed clonogenic assays in a tumor cell line in culture to determine the efficiency of immunologic purging. Amplification by the polymerase chain reaction (PCR) was used to detect residual lymphoma cells before and after purging of bone marrow from 114 patients with B-cell non-Hodgkin's lymphoma in whom a translocation (t(l4;18)) that could be amplified by PCR was detected at the time of their initial evaluation. Results. Immunologic purging in vitro resulted in a 3-to-6-log destruction of cells in the tumor cell line. Residual lymphoma cells were detected by PCR in the bone marrow of all patients before purging. No lymphoma cells could be detected in the marrow of 57 patients after purging. Disease-free survival was increased in these 57 patients as compared with those whose marrow contained detectable residual lymphoma (P < 0.00001). The ability to purge residual lymphoma cells was not associated with the degree of bone marrow involvement (P = 0.4494) or the previous response to therapy (P = 0.1298). Conclusions. The inability to purge residual lymphoma cells was the most important prognostic indicator in predicting relapse. These results provide evidence of the clinical usefulness of ex vivo purging of autologous bone marrow in the treatment of patients with lymphoma and suggest that the reinfusion of malignant cells in autologous marrow contributes to relapse.	HARVARD UNIV,SCH MED,DANA FARBER CANC INST,DIV BIOSTAT,BOSTON,MA 02115; HARVARD UNIV,SCH MED,DEPT MED,BOSTON,MA 02115	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School	GRIBBEN, JG (corresponding author), HARVARD UNIV,SCH MED,DANA FARBER CANC INST,DIV TUMOR IMMUNOL,44 BINNEY ST,BOSTON,MA 02115, USA.		Jones, Jeffrey A/E-9827-2013; Freeman, Gordon/AAC-5380-2019	Freeman, Gordon/0000-0002-7210-5616; Roy, Denis-Claude/0000-0002-5921-1692; Grossbard, Michael/0000-0002-3919-3028	NATIONAL CANCER INSTITUTE [P01CA034183, R01CA040216] Funding Source: NIH RePORTER; FIC NIH HHS [TWO4496] Funding Source: Medline; NCI NIH HHS [CA-34183, CA-40216] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AISENBERG AC, 1988, BLOOD, V71, P969; ARMITAGE JO, 1989, BLOOD, V73, P1749; BAKHSHI A, 1985, CELL, V41, P899, DOI 10.1016/S0092-8674(85)80070-2; BALL ED, 1990, BLOOD, V75, P1199; BENJAMIN D, 1983, BLOOD, V61, P1017; BERLINER N, 1986, BLOOD, V67, P80; CLEARY ML, 1986, J EXP MED, V164, P315, DOI 10.1084/jem.164.1.315; CLEARY ML, 1984, P NATL ACAD SCI-BIOL, V81, P593, DOI 10.1073/pnas.81.2.593; CLEARY ML, 1985, P NATL ACAD SCI USA, V82, P7439, DOI 10.1073/pnas.82.21.7439; COSSMAN J, 1984, AM J PATHOL, V115, P117; COX DR, 1972, J R STAT SOC B, V34, P187; Cox DR., 1970, ANAL BINARY DATA; CRESCENZI M, 1988, P NATL ACAD SCI USA, V85, P4869, DOI 10.1073/pnas.85.13.4869; FREEDMAN AS, 1987, LEUKEMIA, V1, P9; FREEDMAN AS, 1985, J IMMUNOL, V134, P2228; FREEDMAN AS, 1990, J CLIN ONCOL, V8, P784, DOI 10.1200/JCO.1990.8.5.784; FREI E, 1989, J CLIN ONCOL, V7, P515, DOI 10.1200/JCO.1989.7.4.515; GRANINGER WB, 1987, J CLIN INVEST, V80, P1512, DOI 10.1172/JCI113235; GRIBBEN JG, 1989, J CLIN ONCOL, V7, P1621, DOI 10.1200/JCO.1989.7.11.1621; GRIBBEN JG, 1989, BLOOD, V73, P340; GRIBBEN JG, IN PRESS BLOOD; HIGUCHI R, 1986, PCR TECHNOLOGY, P31; HURD DD, 1988, AM J MED, V85, P829; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; KWOK S, 1989, NATURE, V339, P490; LEE MS, 1987, BLOOD, V70, P90; LEE MS, 1987, SCIENCE, V237, P175, DOI 10.1126/science.3110950; MEHTA CR, 1984, BIOMETRICS, V40, P819, DOI 10.2307/2530927; NADLER LM, 1984, LANCET, V2, P427; NADLER LM, 1981, J CLIN INVEST, V67, P134, DOI 10.1172/JCI110005; NADLER LM, 1980, J IMMUNOL, V125, P570; NEGRIN RS, 1991, BLOOD, V77, P654; NGAN BY, 1989, BLOOD, V73, P1759; PETERS WP, 1988, J CLIN ONCOL, V6, P1368, DOI 10.1200/JCO.1988.6.9.1368; PETO R, 1972, J R STAT SOC SER A-G, V135, P185, DOI 10.2307/2344317; PHILIP T, 1987, NEW ENGL J MED, V316, P1493, DOI 10.1056/NEJM198706113162401; RITZ J, 1981, BLOOD, V58, P648; RITZ J, 1980, NATURE, V283, P583, DOI 10.1038/283583a0; ROY DC, 1990, LEUKEMIA RES, V14, P407, DOI 10.1016/0145-2126(90)90026-6; STEIN RS, 1976, CANCER, V37, P629, DOI 10.1002/1097-0142(197602)37:2<629::AID-CNCR2820370204>3.0.CO;2-K; TAKVORIAN T, 1987, NEW ENGL J MED, V316, P1499, DOI 10.1056/NEJM198706113162402; TASWELL C, 1981, J IMMUNOL, V126, P1614; TSUJIMOTO Y, 1985, SCIENCE, V229, P1390, DOI 10.1126/science.3929382; UCKUN FM, 1987, BLOOD, V69, P361; WALLERSTEIN R, 1990, J CLIN ONCOL, V8, P1782, DOI 10.1200/JCO.1990.8.11.1782; WEISS LM, 1987, NEW ENGL J MED, V317, P1185, DOI 10.1056/NEJM198711053171904; YUNIS JJ, 1989, NEW ENGL J MED, V320, P1047, DOI 10.1056/NEJM198904203201605; YUNIS JJ, 1982, NEW ENGL J MED, V307, P1231, DOI 10.1056/NEJM198211113072002	49	692	715	0	0	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 28	1991	325	22					1525	1533		10.1056/NEJM199111283252201	http://dx.doi.org/10.1056/NEJM199111283252201			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GR380	1944436				2022-12-28	WOS:A1991GR38000001
J	ALTIERI, DC; ETINGIN, OR; FAIR, DS; BRUNCK, TK; GELTOSKY, JE; HAJJAR, DP; EDGINGTON, TS				ALTIERI, DC; ETINGIN, OR; FAIR, DS; BRUNCK, TK; GELTOSKY, JE; HAJJAR, DP; EDGINGTON, TS			STRUCTURALLY HOMOLOGOUS LIGAND-BINDING OF INTEGRIN MAC-1 AND VIRAL GLYCOPROTEIN-C RECEPTORS	SCIENCE			English	Article							COAGULATION FACTOR-X; ENDOTHELIAL-CELLS; BLOOD COAGULATION; ALPHA-CHYMOTRYPSIN; FACTOR-VA; ACTIVATION; THROMBIN; CLONING; SUBUNIT; SITE	Three spatially distant surface loops were found to mediate the interaction of the coagulation protein factor X with the leukocyte integrin Mac-1. This interacting region, which by computational modeling defines a three-dimensional macromotif in the catalytic domain, was also recognized by glycoprotein C (gC), a factor X receptor expressed on herpes simplex virus (HSV)-infected endothelial cells. Peptidyl mimicry of each loop inhibited factor X binding to Mac-1 and gC, blocked monocyte generation of thrombin, and prevented monocyte adhesion to HSV-infected endothelium. These data link the ligand recognition of Mac-1 to established mechanisms of receptor-mediated vascular injury.	UNIV TEXAS, CTR HLTH, DEPT BIOCHEM, TYLER, TX 75710 USA; CORVAS INT INC, SAN DIEGO, CA 92121 USA; RW JOHNSON PHARMACEUT RES INST, SAN DIEGO, CA 92121 USA; CORNELL UNIV, MED CTR, COLL MED, DEPT BIOCHEM, NEW YORK, NY 10021 USA; CORNELL UNIV, MED CTR, COLL MED, DEPT PATHOL, NEW YORK, NY 10021 USA	University of Texas System; University of Texas at Tyler; University of Texas-Health Sciences Center at Tyler (UTHSCT); Johnson & Johnson; Johnson & Johnson USA; Cornell University; Cornell University	ALTIERI, DC (corresponding author), SCRIPPS RES INST, DEPT IMMUNOL, LA JOLLA, CA 92037 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL016411, R01HL043773] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL 43773, HL 46408, P01 HL 16411] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALTIERI DC, 1988, J BIOL CHEM, V263, P7007; ALTIERI DC, 1988, P NATL ACAD SCI USA, V85, P7462, DOI 10.1073/pnas.85.20.7462; ARNAOUT MA, 1990, BLOOD, V75, P1037; ARNAOUT MA, 1988, P NATL ACAD SCI USA, V85, P2776, DOI 10.1073/pnas.85.8.2776; BARSHAVIT R, 1983, SCIENCE, V220, P728, DOI 10.1126/science.6836310; BENDITT EP, 1983, P NATL ACAD SCI-BIOL, V80, P6386, DOI 10.1073/pnas.80.20.6386; BERNSTEIN FC, 1977, J MOL BIOL, V112, P535, DOI 10.1016/S0022-2836(77)80200-3; BLEVINS RA, 1985, J BIOL CHEM, V260, P4264; BODE W, 1983, J MOL BIOL, V164, P237, DOI 10.1016/0022-2836(83)90077-3; BROZE GJ, 1982, J CLIN INVEST, V70, P526, DOI 10.1172/JCI110644; BRUNCK TK, COMMUNICATION; CHATTOPADHYAY A, 1989, J BIOL CHEM, V264, P11035; CORBI AL, 1988, J BIOL CHEM, V263, P12403; ETINGIN OR, 1990, CELL, V61, P657, DOI 10.1016/0092-8674(90)90477-V; FRIEDMAN HM, 1984, NATURE, V309, P633, DOI 10.1038/309633a0; FRINK RJ, 1983, J VIROL, V45, P634, DOI 10.1128/JVI.45.2.634-647.1983; FUNG MR, 1985, P NATL ACAD SCI USA, V82, P3591, DOI 10.1073/pnas.82.11.3591; GLENN KC, 1979, NATURE, V278, P711, DOI 10.1038/278711a0; GREER J, 1990, PROTEINS, V7, P317, DOI 10.1002/prot.340070404; HAJJAR DP, 1987, J CLIN INVEST, V80, P1317, DOI 10.1172/JCI113208; HANSON SR, 1988, P NATL ACAD SCI USA, V85, P3184, DOI 10.1073/pnas.85.9.3184; KISHIMOTO TK, 1987, CELL, V48, P681, DOI 10.1016/0092-8674(87)90246-7; LAM SCT, 1987, J BIOL CHEM, V262, P947; MARQUART M, 1983, ACTA CRYSTALLOGR B, V39, P480, DOI 10.1107/S010876818300275X; MARUYAMA I, 1984, J CLIN INVEST, V74, P224, DOI 10.1172/JCI111405; NIEMETZ J, 1971, NATURE-NEW BIOL, V232, P247, DOI 10.1038/newbio232247a0; RUOSLAHTI E, 1991, J CLIN INVEST, V87, P1, DOI 10.1172/JCI114957; SANTORO SA, 1987, CELL, V48, P867, DOI 10.1016/0092-8674(87)90083-3; SAWYER L, 1978, J MOL BIOL, V118, P137, DOI 10.1016/0022-2836(78)90412-6; SPRINGER TA, 1990, NATURE, V346, P425, DOI 10.1038/346425a0; STERN DM, 1985, J BIOL CHEM, V260, P6717; TRACY PB, 1979, J BIOL CHEM, V254, P354; VISSER MR, 1988, P NATL ACAD SCI USA, V85, P8227, DOI 10.1073/pnas.85.21.8227; ZIMMERMAN GA, 1985, J CLIN INVEST, V76, P2235, DOI 10.1172/JCI112232; [No title captured]	35	50	50	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	NOV 22	1991	254	5035					1200	1202		10.1126/science.1957171	http://dx.doi.org/10.1126/science.1957171			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ834	1957171				2022-12-28	WOS:A1991GQ83400046
J	HUA, QX; SHOELSON, SE; KOCHOYAN, M; WEISS, MA				HUA, QX; SHOELSON, SE; KOCHOYAN, M; WEISS, MA			RECEPTOR-BINDING REDEFINED BY A STRUCTURAL SWITCH IN A MUTANT HUMAN INSULIN	NATURE			English	Article								CRYSTAL Structures of insulin have been determined in various distinct forms 1-5, the relevance of which to receptor recognition has long been the subject of speculation 2,6,7. Recently the crystal structure of an inactive insulin analogue has been determined and, surprisingly, found to have a conformation identical to native insulin 8,9. On this basis Dodson and colleagues have suggested that the known insulin crystal structures reflect an inactive conformation, and that a change in conformation is required for activity-specifically, the carboxy terminal residues of the B-chain are proposed to separate from the amino terminal residues of the A-chain 8. Here we report the solution structure of an active insulin mutant 7,10, determined by two-dimensional NMR, which supports this hypothesis. In the mutant, the carboxy terminal beta-turn and beta-strand of the B-chain are destabilized and do not pack across the rest of the molecule. We suggest that analogous detachment of the carboxy terminal region of the B-chain occurs in native insulin on binding to its receptor. Our finding that partial unfolding of the B-chain exposes an alternative protein surface rationalizes the receptor-binding properties of a series of anomalous insulin analogues 7,11-13, including a mutant insulin associated with diabetes mellitus in man 14,15.	MASSACHUSETTS GEN HOSP, DEPT MED, BOSTON, MA 02114 USA; CHINESE ACAD SCI, INST BIOPHYS, BEIJING, PEOPLES R CHINA; BRIGHAM & WOMENS HOSP, JOSLIN DIABET CTR, BOSTON, MA 02115 USA; BRIGHAM & WOMENS HOSP, DEPT MED, BOSTON, MA 02115 USA; HARVARD UNIV, SCH MED, DEPT MED, BOSTON, MA 02115 USA; CNRS, UA 32, F-91128 PALAISEAU, FRANCE	Harvard University; Massachusetts General Hospital; Chinese Academy of Sciences; Institute of Biophysics, CAS; Harvard University; Brigham & Women's Hospital; Joslin Diabetes Center, Inc.; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Centre National de la Recherche Scientifique (CNRS)								BADGER J, 1991, ACTA CRYSTALLOGR B, V47, P127, DOI 10.1107/S0108768190009570; BAKER EN, 1988, PHILOS T R SOC LON B, V319, P389; BENTLEY G, 1976, NATURE, V261, P166, DOI 10.1038/261166a0; BI RC, 1984, BIOPOLYMERS, V23, P391, DOI DOI 10.1002/BIP.360230302; BOELENS R, 1990, EUR J BIOCHEM, V191, P147, DOI 10.1111/j.1432-1033.1990.tb19104.x; BRANGE J, 1988, NATURE, V333, P679, DOI 10.1038/333679a0; BROWN H, 1955, BIOCHEM J, V60, P556, DOI 10.1042/bj0600556; CASARETTO M, 1987, BIOL CHEM H-S, V368, P709, DOI 10.1515/bchm3.1987.368.1.709; CHOTHIA C, 1983, NATURE, V302, P500, DOI 10.1038/302500a0; CLORE GM, 1989, CRIT REV BIOCHEM MOL, V24, P479, DOI 10.3109/10409238909086962; DAI JB, 1987, SCI CHINA SER B, V30, P55; DEREWENDA U, 1989, NATURE, V338, P594, DOI 10.1038/338594a0; DEREWENDA U, 1991, J MOL BIOL, V220, P425, DOI 10.1016/0022-2836(91)90022-X; DODSON EJ, 1983, BIOPOLYMERS, V22, P281, DOI 10.1002/bip.360220137; HUA QX, 1991, BIOCHEMISTRY-US, V30, P5505, DOI 10.1021/bi00236a025; HUA QX, UNPUB J MOL BIOL; KLINE AD, 1990, BIOCHEMISTRY-US, V29, P2906, DOI 10.1021/bi00464a003; KOBAYASHI M, 1982, BIOCHEM BIOPH RES CO, V107, P329, DOI 10.1016/0006-291X(82)91708-9; KRISTENSEN SM, 1991, J MOL BIOL, V218, P221, DOI 10.1016/0022-2836(91)90886-B; MARKUSSEN J, 1985, INT J PEPT PROT RES, V26, P70; MIRMIRA RG, 1989, J BIOL CHEM, V264, P6349; NAKAGAWA SH, 1986, J BIOL CHEM, V261, P7332; NANJO K, 1986, J CLIN INVEST, V77, P514, DOI 10.1172/JCI112331; PULLEN RA, 1976, NATURE, V259, P369, DOI 10.1038/259369a0; SHOELSON S, 1983, NATURE, V302, P540, DOI 10.1038/302540a0; SHOELSON SE, UNPUB BIOCHEMISTRY; Steiner D. F., 1990, ENDOCRINOLOGY, P1263; WANG SH, 1991, J PROTEIN CHEM, V10, P313, DOI 10.1007/BF01025630; WEISS MA, 1991, BIOCHEMISTRY-US, V30, P7373, DOI 10.1021/bi00244a004; WUTHRICH K, 1989, METHOD ENZYMOL, V177, P125	30	234	249	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 21	1991	354	6350					238	241		10.1038/354238a0	http://dx.doi.org/10.1038/354238a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ948	1961250				2022-12-28	WOS:A1991GQ94800052
J	PACKER, M; CARVER, JR; RODEHEFFER, RJ; IVANHOE, RJ; DIBIANCO, R; ZELDIS, SM; HENDRIX, GH; BOMMER, WJ; ELKAYAM, U; KUKIN, ML; MALLIS, GI; SOLLANO, JA; SHANNON, J; TANDON, PK; DEMETS, DL				PACKER, M; CARVER, JR; RODEHEFFER, RJ; IVANHOE, RJ; DIBIANCO, R; ZELDIS, SM; HENDRIX, GH; BOMMER, WJ; ELKAYAM, U; KUKIN, ML; MALLIS, GI; SOLLANO, JA; SHANNON, J; TANDON, PK; DEMETS, DL			EFFECT OF ORAL MILRINONE ON MORTALITY IN SEVERE CHRONIC HEART-FAILURE	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CHRONIC CARDIAC-FAILURE; CYCLIC-AMP; MYOCARDIAL-INFARCTION; MULTICENTER TRIAL; CLINICAL-TRIALS; THERAPY; VASODILATOR; SURVIVAL; CAPTOPRIL; AMRINONE	Background. Milrinone, a phosphodiesterase inhibitor, enhances cardiac contractility by increasing intracellular levels of cyclic AM P, but the long-term effect of this type of positive inotropic agent on the survival of patients with chronic heart failure has not been determined. Methods. We randomly assigned 1088 patients with severe chronic heart failure (New York Heart Association class III or IV) and advanced left ventricular dysfunction to double-blind treatment with 40 mg of oral milrinone daily (561 patients) or placebo (527 patients). In addition, all patients received conventional therapy with digoxin, diuretics, and a converting-enzyme inhibitor throughout the trial. The median period of follow-up was 6.1 months (range, 1 day to 20 months). Results. As compared with placebo, milrinone therapy was associated with a 28 percent increase in mortality from all causes (95 percent confidence interval, 1 to 61 percent; P = 0.038) and a 34 percent increase in cardiovascular mortality (95 percent confidence interval, 6 to 69 percent; P = 0.016). The adverse effect of milrinone was greatest in patients with the most severe symptoms (New York Heart Association class IV), who had a 53 percent increase in mortality (95 percent confidence interval, 13 to 107 percent; P = 0.006). Milrinone did not have a beneficial effect on the survival of any subgroup. Patients treated with milrinone had more hospitalizations (44 vs. 39 percent, P = 0.041), were withdrawn from double-blind therapy more frequently (12.7 vs. 8.7 percent, P = 0.041), and had serious adverse cardiovascular reactions, including hypotension (P = 0.006) and syncope (P = 0.002), more often than the patients given placebo. Conclusions. Our findings indicate that despite its beneficial hemodynamic actions, long-term therapy with oral milrinone increases the morbidity and mortality of patients with severe chronic heart failure. The mechanism by which the drug exerts its deleterious effects is unknown.	JEANES ST AGNES HOSP,PHILADELPHIA,PA; MAYO CLIN & MAYO GRAD SCH MED,ROCHESTER,MN 55901; FLORIDA HEART GRP,ORLANDO,FL; WASHINGTON ADVENTIST HOSP,TAKOMA PK,MD; WINTHORP UNIV HOSP,MINEOLA,NY; MED UNIV S CAROLINA,CHARLESTON,SC 29425; UNIV CALIF DAVIS,SACRAMENTO MED CTR,SACRAMENTO,CA 95817; UNIV SO CALIF,SCH MED,LOS ANGELES,CA 90033; SUNY STONY BROOK,STONY BROOK,NY 11794; VET AFFAIRS MED CTR,NORTHPORT,NY; STERLING RES GRP,MALVERN,PA; UNIV WISCONSIN,CTR BIOSTAT,MADISON,WI 53706	Mayo Clinic; Winthrop University Hospital; Medical University of South Carolina; University of California System; University of California Davis; University of Southern California; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Wisconsin System; University of Wisconsin Madison	PACKER, M (corresponding author), CUNY MT SINAI SCH MED,DIV CARDIOL,CTR HEART FAILURE RES,1 GUSTAVE LEVY PL,NEW YORK,NY 10029, USA.							BAIM DS, 1983, NEW ENGL J MED, V309, P748, DOI 10.1056/NEJM198309293091302; CHESEBRO J H, 1988, Journal of the American College of Cardiology, V11, p144A; COHN JN, 1986, NEW ENGL J MED, V314, P1547, DOI 10.1056/NEJM198606123142404; COX DR, 1972, J R STAT SOC B, V34, P187; DIBIANCO R, 1989, NEW ENGL J MED, V320, P677, DOI 10.1056/NEJM198903163201101; DIES F, 1986, CIRCULATION, V74, P38; DIES F, 1989, CIRCULATION S, V2, P175; EBBESEN P, 1976, VIRCHOWS ARCH A, V372, P89, DOI 10.1007/BF00427084; FELDMAN MD, 1987, CIRCULATION, V75, P331, DOI 10.1161/01.CIR.75.2.331; GOLDBERG AD, 1990, CIRCULATION, V82, P673; JAIN P, 1991, CIRCULATION, V84, P796, DOI 10.1161/01.CIR.84.2.796; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; LAN KKG, 1983, BIOMETRIKA, V70, P659, DOI 10.2307/2336502; LEE JC, 1980, RES COMMUN CHEM PATH, V27, P305; LEJEMTEL TH, 1985, CIRCULATION, V7, P364; LUDMER PL, 1986, CIRCULATION, V73, P130, DOI 10.1161/01.CIR.73.1.130; MARTORANA PA, 1971, J PHARM PHARMACOL, V23, P200, DOI 10.1111/j.2042-7158.1971.tb08642.x; MASSIE B, 1985, CIRCULATION, V71, P963, DOI 10.1161/01.CIR.71.5.963; Newman T J, 1988, Am J Med, V84, P140, DOI 10.1016/0002-9343(88)90221-5; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; PACKER M, 1984, CIRCULATION, V70, P1038, DOI 10.1161/01.CIR.70.6.1038; PACKER M, 1988, J AM COLL CARDIOL, V12, P1299, DOI 10.1016/0735-1097(88)92615-0; PACKER M, 1990, CIRCULATION, V82, P77; PACKER M, 1988, CIRCULATION, V77, P721, DOI 10.1161/01.CIR.77.4.721; PACKER M, 1987, CIRCULATION, V75, P55; PACKER M, 1989, AM J CARDIOL, V63, pA41, DOI 10.1016/0002-9149(89)90392-5; PFEFFER JM, 1985, CIRC RES, V57, P84, DOI 10.1161/01.RES.57.1.84; PFEFFER MA, 1988, NEW ENGL J MED, V319, P80, DOI 10.1056/NEJM198807143190204; PFEFFER MA, 1985, CIRCULATION, V72, P406, DOI 10.1161/01.CIR.72.2.406; PODZUWEIT T, 1976, LANCET, V1, P341; ROUBIN GS, 1984, CIRCULATION, V69, P955, DOI 10.1161/01.CIR.69.5.955; SIMONTON CA, 1985, J AM COLL CARDIOL, V6, P453, DOI 10.1016/S0735-1097(85)80185-6; SWEET CS, 1988, EUR J PHARMACOL, V147, P29, DOI 10.1016/0014-2999(88)90630-9; TANAKA M, 1980, JPN CIRC J, V44, P971, DOI 10.1253/jcj.44.971; URETSKY BF, 1985, J AM COLL CARDIOL, V5, P1414, DOI 10.1016/S0735-1097(85)80358-2; URETSKY BF, 1990, CIRCULATION, V82, P774, DOI 10.1161/01.CIR.82.3.774; WEBER KT, 1982, CIRCULATION, V66, P1262, DOI 10.1161/01.CIR.66.6.1262; WEISHAAR RE, 1987, CIRC RES, V61, P539, DOI 10.1161/01.RES.61.4.539; WILMSHURST PT, 1984, CARDIOVASC RES, V18, P302, DOI 10.1093/cvr/18.5.302; YUSUF S, 1990, CIRCULATION, V82, P673; 1987, NEW ENGL J MED, V316, P1429; 1990, LANCET, P698	42	1699	1776	1	27	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 21	1991	325	21					1468	1475		10.1056/NEJM199111213252103	http://dx.doi.org/10.1056/NEJM199111213252103			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GQ406	1944425				2022-12-28	WOS:A1991GQ40600003
J	HOLDEN, C				HOLDEN, C			GENETIC BILL VETOED	SCIENCE			English	Editorial Material																		1991, SCIENCE, V253, P1484	1	9	9	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	OCT 25	1991	254	5031					522	522						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL799	1948026				2022-12-28	WOS:A1991GL79900029
J	LIMAN, ER; HESS, P; WEAVER, F; KOREN, G				LIMAN, ER; HESS, P; WEAVER, F; KOREN, G			VOLTAGE-SENSING RESIDUES IN THE S4 REGION OF A MAMMALIAN K+ CHANNEL	NATURE			English	Article							POTASSIUM CHANNEL; SODIUM-CHANNEL; DROSOPHILA; OOCYTES	THE ability of ion-channel proteins to respond to a change of the transmembrane voltage is one of the basic mechanisms underlying electrical excitability of nerve and muscle membranes. The voltage sensor has been postulated to be the fourth putative transmembrane segment 1 (S4) of voltage-activated Na+, Ca2+ and K+ channels 1-5. Mutations of positively charged residues within S4 alter gating of Na 4 and Shaker-type K+ channels 5, but quantitative correlations between the charge or a residue in S4 and the gating valence of the channel have not yet been established. Here, with improved resolution of the voltage dependence of steady-state activation, we present estimates of the equivalent gating valence with sufficient precision to allow quantitative examination of the contribution of individual charged residues to the gating valence of a mammalian non-inactivating K+ channel. We conclude that at least part of the gating charge associated with channel activation is indeed contributed by charged residues within the S4 segment.	HARVARD UNIV,SCH MED,DEPT CELLULAR & MOLEC PHYSIOL,25 SHATTUCK ST,BOSTON,MA 02115; HARVARD UNIV,SCH MED,PROGRAM NEUROSCI,BOSTON,MA 02115; BRIGHAM & WOMENS HOSP,DEPT CARDIOL,BOSTON,MA 02115	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital			Liman, Emily/AAC-7383-2021	liman, emily/0000-0003-4765-5496				Almers W, 1978, Rev Physiol Biochem Pharmacol, V82, P96, DOI 10.1007/BFb0030498; AULD VJ, 1990, P NATL ACAD SCI USA, V87, P323, DOI 10.1073/pnas.87.1.323; BAUMANN A, 1988, EMBO J, V7, P2457, DOI 10.1002/j.1460-2075.1988.tb03092.x; BENNDORF K, 1989, EUR BIOPHYS J BIOPHY, V17, P257, DOI 10.1007/BF00254283; BEZANILLA F, 1982, NATURE, V296, P657, DOI 10.1038/296657a0; CATTERALL WA, 1988, SCIENCE, V242, P50, DOI 10.1126/science.2459775; CHRISTIE MJ, 1989, SCIENCE, V244, P221, DOI 10.1126/science.2539643; CONTI F, 1989, EUR BIOPHYS J BIOPHY, V17, P53, DOI 10.1007/BF00257102; GILLY WMF, 1982, J GEN PHYSIOL, V70, P965; GUY HR, 1990, TRENDS NEUROSCI, V13, P201; HILLE B, 1984, IONIC CHANNELS EXCIT, P1; KOREN G, 1990, NEURON, V4, P39, DOI 10.1016/0896-6273(90)90442-I; LOGOTHETIS D E, 1991, Biophysical Journal, V59, p196A; LOPEZ GA, 1991, NEURON, V7, P327, DOI 10.1016/0896-6273(91)90271-Z; MACKINNON R, 1991, NATURE, V350, P232, DOI 10.1038/350232a0; MCCORMACK K, 1991, P NATL ACAD SCI USA, V88, P2931, DOI 10.1073/pnas.88.7.2931; NODA M, 1984, NATURE, V312, P121, DOI 10.1038/312121a0; PAPAZIAN DM, 1987, SCIENCE, V237, P749, DOI 10.1126/science.2441470; PAPAZIAN DM, 1991, NATURE, V349, P305, DOI 10.1038/349305a0; STUEHMER W, 1989, Nature (London), V339, P597; SWENSON RP, 1981, NATURE, V291, P427, DOI 10.1038/291427a0; TANABE T, 1987, NATURE, V328, P313, DOI 10.1038/328313a0; YOOL AJ, 1991, NATURE, V349, P700, DOI 10.1038/349700a0; ZAGOTTA WN, 1990, J GEN PHYSIOL, V95, P29, DOI 10.1085/jgp.95.1.29	24	249	252	0	8	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	OCT 24	1991	353	6346					752	756		10.1038/353752a0	http://dx.doi.org/10.1038/353752a0			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL696	1944534				2022-12-28	WOS:A1991GL69600068
J	REILLY, DT; WOLFE, JHN				REILLY, DT; WOLFE, JHN			THE YOUNG PATIENT WITH CLAUDICATION	BRITISH MEDICAL JOURNAL			English	Article									ST MARYS HOSP,LONDON,ENGLAND	Imperial College London	REILLY, DT (corresponding author), WATFORD DIST GEN HOSP,WATFORD,ENGLAND.								0	4	4	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	OCT 5	1991	303	6806					845	848		10.1136/bmj.303.6806.845	http://dx.doi.org/10.1136/bmj.303.6806.845			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GH946	1932981	Bronze, Green Published			2022-12-28	WOS:A1991GH94600033
J	PSATY, BM; KOEPSELL, TD; WAGNER, EH; LOGERFO, JP; INUI, TS				PSATY, BM; KOEPSELL, TD; WAGNER, EH; LOGERFO, JP; INUI, TS			THE RELATIVE RISK OF INCIDENT CORONARY HEART-DISEASE ASSOCIATED WITH RECENTLY STOPPING THE USE OF BETA-BLOCKERS	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article									UNIV WASHINGTON,DEPT MED,SEATTLE,WA 98195; UNIV WASHINGTON,DEPT EPIDEMIOL,SEATTLE,WA 98195; UNIV WASHINGTON,DEPT HLTH SERV,SEATTLE,WA 98195; GRP HLTH COOPERAT PUGET SOUND,CTR HLTH STUDIES,SEATTLE,WA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Group Health Cooperative								BOLLI P, 1981, CIRCULATION, V64, P1130, DOI 10.1161/01.CIR.64.6.1130; EGSTRUP K, 1988, AM J CARDIOL, V61, P1219, DOI 10.1016/0002-9149(88)91158-7; FRISHMAN WH, 1987, AM J CARDIOL, V59, pF26, DOI 10.1016/0002-9149(87)90038-5; HART GR, 1981, ARCH INTERN MED, V141, P1125, DOI 10.1001/archinte.141.9.1125; HELD PH, 1989, BMJ-BRIT MED J, V299, P1187, DOI 10.1136/bmj.299.6709.1187; HOUSTON MC, 1988, AM HEART J, V116, P515, DOI 10.1016/0002-8703(88)90627-8; JICK H, 1979, NEW ENGL J MED, V300, P218, DOI 10.1056/NEJM197902013000502; McCullagh P., 1983, GEN LINEAR MODELS, DOI [10.1007/978-1-4899-3244-0, DOI 10.1007/978-1-4899-3244-0]; MULCAHY D, 1988, LANCET, V2, P755; OLSSON G, 1988, EUR HEART J, V9, P365, DOI 10.1093/oxfordjournals.eurheartj.a062512; PSATY BM, 1987, J GEN INTERN MED, V2, P381, DOI 10.1007/BF02596362; PSATY BM, 1989, JAMA-J AM MED ASSOC, V261, P2087, DOI 10.1001/jama.261.14.2087; REITHMANN C, 1987, KLIN WOCHENSCHR, V65, P308, DOI 10.1007/BF01745384; Schlesselman JJ, 1982, CASE CONTROL STUDIES; SHEPARD DS, 1977, AM J PUBLIC HEALTH, V67, P743, DOI 10.2105/AJPH.67.8.743; WALDEN RJ, 1982, AM HEART J, V104, P515, DOI 10.1016/0002-8703(82)90149-1; WIKSTRAND J, 1987, J CLIN PHARM THER, V12, P347, DOI 10.1111/j.1365-2710.1987.tb00548.x; YUSUF S, 1985, PROG CARDIOVASC DIS, V27, P335, DOI 10.1016/S0033-0620(85)80003-7; 1981, EUR HEART J, V2, P389; 1984, EUR HEART J, V5, P189	20	215	219	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 23	1990	263	12					1653	1657		10.1001/jama.263.12.1653	http://dx.doi.org/10.1001/jama.263.12.1653			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT964	1968518				2022-12-28	WOS:A1990CT96400029
J	[Anonymous]				[Anonymous]			CYSTIC HYGROMA	LANCET			English	Editorial Material																		BILL AH, 1965, SURG GYNECOL OBSTETR, V120, P79; BROOMHEAD I. W, 1964, BRIT J PLAST SURG, V17, P225, DOI 10.1016/S0007-1226(64)80039-4; COHEN SR, 1986, ANN OTO RHINOL LARYN, V95, P1; EMERY PJ, 1984, J LARYNGOL OTOL, V98, P613, DOI 10.1017/S0022215100147176; Goetsch E, 1938, ARCH SURG-CHICAGO, V36, P394, DOI 10.1001/archsurg.1938.01190210023005; KENNEDY TL, 1989, LARYNGOSCOPE, V99, P1, DOI 10.1288/00005537-198910001-00001; Sabin FR, 1902, AM J ANAT, V1, P367, DOI 10.1002/aja.1000010310	7	12	12	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 3	1990	335	8688					511	512						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT015	1968534				2022-12-28	WOS:A1990CT01500010
J	LOISANCE, D; DUBOISRANDE, JL; DELEUZE, P; OKUDE, J; ROSENVAL, O; GESCHWIND, H				LOISANCE, D; DUBOISRANDE, JL; DELEUZE, P; OKUDE, J; ROSENVAL, O; GESCHWIND, H			PROPHYLACTIC INTRAVENTRICULAR PUMPING IN HIGH-RISK CORONARY ANGIOPLASTY	LANCET			English	Article									FAC MED CRETEIL,DEPT SURG RES,CNRS,UNITE 591,F-94010 CRETEIL,FRANCE	Centre National de la Recherche Scientifique (CNRS); Universite Gustave-Eiffel; Universite Paris-Est-Creteil-Val-de-Marne (UPEC)	LOISANCE, D (corresponding author), FAC MED CRETEIL,DEPT CARDIAC SURG,CNRS,UNITE 591,8 RUE GEN SARRAIL,F-94010 CRETEIL,FRANCE.							FRAZIER OH, IN PRESS T AM SOC IN; HINGLAIS J., 1965, COEUR MED INTERN, V4, P85; LAKS H, 1986, CIRCULATION S3, V74, P15; LOISANCE D, 1989, LANCET, V1, P561; Wampler R K, 1988, ASAIO Trans, V34, P450	5	31	33	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	FEB 24	1990	335	8687					438	440		10.1016/0140-6736(90)90666-S	http://dx.doi.org/10.1016/0140-6736(90)90666-S			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CP907	1968170				2022-12-28	WOS:A1990CP90700004
J	PREMACHANDRA, DJ; WOODWARD, BM; MILTON, CM; SERGEANT, RJ; FABRE, JW				PREMACHANDRA, DJ; WOODWARD, BM; MILTON, CM; SERGEANT, RJ; FABRE, JW			TREATMENT OF POSTOPERATIVE OTORRHEA BY GRAFTING OF MASTOID CAVITIES WITH CULTURED AUTOLOGOUS EPIDERMAL-CELLS	LANCET			English	Article									QUEEN VICTORIA HOSP, BLOND MCINDOE CTR MED RES, E GRINSTEAD RH19 3DZ, W SUSSEX, ENGLAND; KENT & SUSSEX HOSP, DEPT EAR NOSE & THROAT SURG, TUNBRIDGE WELLS, ENGLAND; QUEEN VICTORIA HOSP, REG PLAST SURG UNIT, E GRINSTEAD RH19 3DZ, W SUSSEX, ENGLAND									AUBOCK J, 1988, TRANSPLANTATION, V45, P730, DOI 10.1097/00007890-198804000-00013; BRAIN A, 1989, BRIT MED J, V298, P917, DOI 10.1136/bmj.298.6678.917; BURT AM, 1989, BRIT MED J, V298, P915, DOI 10.1136/bmj.298.6678.915; FABRE JW, 1989, TRANSPLANTATION, V48, P306, DOI 10.1097/00007890-198908000-00024; GACEK RR, 1976, ANN OTO RHINOL LARYN, V85, P305, DOI 10.1177/000348947608500301; GALLICO GG, 1984, NEW ENGL J MED, V311, P448, DOI 10.1056/NEJM198408163110706; GREEN H, 1979, P NATL ACAD SCI USA, V76, P5665, DOI 10.1073/pnas.76.11.5665; HEFTON JM, 1983, LANCET, V2, P428; LEIGH IM, 1986, CLIN EXP DERMATOL, V11, P650, DOI 10.1111/j.1365-2230.1986.tb00526.x; Milstein S, 1980, Am J Otol, V1, P174; OCONNOR NE, 1981, LANCET, V1, P75; PALVA T, 1970, ARCHIV OTOLARYNGOL, V92, P366; PALVA T, 1960, ACTA OTO-LARYNGOL, V51, P175; RAMBO J H T, 1958, Laryngoscope, V68, P1216; SOLOMONS NB, 1988, J LARYNGOL OTOL, V102, P783, DOI 10.1017/S0022215100106437; THIVOLET J, 1986, TRANSPLANTATION, V42, P274, DOI 10.1097/00007890-198609000-00010	16	30	30	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 17	1990	335	8686					365	367		10.1016/0140-6736(90)90204-I	http://dx.doi.org/10.1016/0140-6736(90)90204-I			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN988	1968114				2022-12-28	WOS:A1990CN98800001
J	CLEMENS, JD; SACK, DA; HARRIS, JR; VANLOON, F; CHAKRABORTY, J; AHMED, F; RAO, MR; KHAN, MR; YUNUS, M; HUDA, N; STANTON, BF; KAY, BA; WALTER, S; EECKELS, R; SVENNERHOLM, AM; HOLMGREN, J				CLEMENS, JD; SACK, DA; HARRIS, JR; VANLOON, F; CHAKRABORTY, J; AHMED, F; RAO, MR; KHAN, MR; YUNUS, M; HUDA, N; STANTON, BF; KAY, BA; WALTER, S; EECKELS, R; SVENNERHOLM, AM; HOLMGREN, J			FIELD TRIAL OF ORAL CHOLERA VACCINES IN BANGLADESH - RESULTS FROM 3-YEAR FOLLOW-UP	LANCET			English	Article									INT CTR DIARRHOEL DIS RES,DHAKA,BANGLADESH; JOHNS HOPKINS UNIV,SCH PUBL HLTH,DEPT GEOG MED,BALTIMORE,MD 21218; CTR DIS CONTROL,DIV ENTER DIS,ATLANTA,GA 30333; UNIV MARYLAND,SCH MED,DEPT PEDIAT,BALTIMORE,MD 21201; MCMASTER UNIV,SCH MED,DEPT CLIN EPIDEMIOL & BIOSTAT,HAMILTON L8S 4L8,ONTARIO,CANADA; CATHOLIC UNIV LOUVAIN,DEPT PEDIAT,B-1348 LOUVAIN LA NEUVE,BELGIUM; GOTHENBURG UNIV,DEPT MED MICROBIOL,S-41124 GOTHENBURG,SWEDEN	International Centre for Diarrhoeal Disease Research (ICDDR); Johns Hopkins University; Centers for Disease Control & Prevention - USA; University System of Maryland; University of Maryland Baltimore; McMaster University; Universite Catholique Louvain; University of Gothenburg	CLEMENS, JD (corresponding author), UNIV MARYLAND,SCH MED,CTR VACCINE DEV,10 S PINE ST,BALTIMORE,MD 21201, USA.		Walter, Stephen/AAB-5548-2022	Walter, Stephen/0000-0003-4157-8928; Harris, Jeffrey/0000-0001-8728-7195				Benenson A, 1976, S CHOLERA, P228; BLACK RE, 1987, INFECT IMMUN, V55, P1116, DOI 10.1128/IAI.55.5.1116-1120.1987; CLEMENS JD, 1986, LANCET, V2, P124; CLEMENS JD, 1987, J INFECT DIS, V155, P79, DOI 10.1093/infdis/155.1.79; CLEMENS JD, 1988, J INFECT DIS, V158, P60, DOI 10.1093/infdis/158.1.60; CLEMENS JD, 1988, J INFECT DIS, V158, P372, DOI 10.1093/infdis/158.2.372; CLEMENS JD, 1988, LANCET, V1, P1375; GLASS RI, 1982, AM J EPIDEMIOL, V116, P959, DOI 10.1093/oxfordjournals.aje.a113498; HERRINGTON DA, 1988, J EXP MED, V168, P1487, DOI 10.1084/jem.168.4.1487; HOLMGREN J, 1983, PROG ALLERGY, V33, P106; JERTBORN M, 1984, INT ARCH ALLER A IMM, V75, P38, DOI 10.1159/000233587; LAIRD N, 1981, J AM STAT ASSOC, V76, P231, DOI 10.2307/2287816; LYCKE N, 1986, MICROB PATHOGENESIS, V1, P361, DOI 10.1016/0882-4010(86)90068-9; MILLER RG, 1986, SIMULTANEOUS STATIST; Rothman K, 1986, MODERN EPIDEMIOLOGY; SANCHEZ J, IN PRESS P NATL ACAD; SVENNERHOLM AM, 1984, J INFECT DIS, V149, P884, DOI 10.1093/infdis/149.6.884; SVENNERHOLM AM, 1986, DEV VACCINES DRUGS D, P33	18	370	384	0	17	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	FEB 3	1990	335	8684					270	273		10.1016/0140-6736(90)90080-O	http://dx.doi.org/10.1016/0140-6736(90)90080-O			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CL815	1967730				2022-12-28	WOS:A1990CL81500014
J	ROUSSEAU, F; HEITZ, D; BIANCALANA, V; BLUMENFELD, S; KRETZ, C; BOUE, J; TOMMERUP, N; VANDERHAGEN, C; DELOZIERBLANCHET, C; CROQUETTE, MF; GILGENKRANTZ, S; JALBERT, P; VOELCKEL, MA; OBERLE, I; MANDEL, JL				ROUSSEAU, F; HEITZ, D; BIANCALANA, V; BLUMENFELD, S; KRETZ, C; BOUE, J; TOMMERUP, N; VANDERHAGEN, C; DELOZIERBLANCHET, C; CROQUETTE, MF; GILGENKRANTZ, S; JALBERT, P; VOELCKEL, MA; OBERLE, I; MANDEL, JL			DIRECT DIAGNOSIS BY DNA ANALYSIS OF THE FRAGILE X-SYNDROME OF MENTAL-RETARDATION	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INHERITANCE; EXPRESSION; CHROMOSOME	Background. The fragile X syndrome, the most common form of inherited mental retardation, is caused by mutations that increase the size of a specific DNA fragment of the X chromosome (in Xq27.3). Affected persons have both a full mutation and abnormal DNA methylation. Persons with a smaller increase in the size of this DNA fragment (a premutation) have little or no risk of retardation but are at high risk of having affected children or grandchildren. The passage from premutation to full-mutation status occurs only with transmission from the mother. We have devised a method of identifying carriers of these mutations by direct DNA analysis. Method. We studied 511 persons from 63 families with the fragile X syndrome. Mutations and abnormal methylation were detected by Southern blotting with a probe adjacent to the mutation target. Analysis of EcoRI and Eagl digests of DNA distinguished clearly in a single test between the normal genotype, the premutation, and the full mutation. Results. DNA analysis unambiguously established the genetic status at the fragile X locus for all samples tested. This method was much more powerful and reliable than cytogenetic testing or segregation studies with closely linked polymorphic markers. The frequency of mental retardation in persons with premutations was similar to that in the general population, whereas all 103 males and 31 of 59 females with full mutations had mental retardation. About 15 percent of those with full mutations had some cells carrying only the premutation. All the mothers of affected children were carriers of either a premutation or a full mutation. Conclusions. Direct diagnosis by DNA analysis is now an efficient and reliable primary test for the diagnosis of the fragile X syndrome after birth, as well as for prenatal diagnosis and genetic counseling.	FAC MED STRASBOURG, CNRS,GENET MOLEC EUCARYOTES LAB,INSERM,U184, 11 RUE HUMANN, F-67085 STRASBOURG, FRANCE; INSERM, U73, F-75005 PARIS, FRANCE; ULLEVAL HOSP, DEPT MED GENET, OSLO 1, NORWAY; JF KENNEDY INST, GLOSTRUP, DENMARK; UNIV GENEVA, INST GENET MED, CH-1211 GENEVA 4, SWITZERLAND; HOP ST ANTOINE, LILLE, FRANCE; CTR TRANSFUS, VANDOEUVRE LES NANCY, FRANCE; CHR UNIV GRENOBLE, GRENOBLE, FRANCE; INSERM, U242, F-13258 MARSEILLE 09, FRANCE	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); University of Oslo; University of Geneva; UDICE-French Research Universities; Sorbonne Universite; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm)			Tommerup, Niels/T-8776-2017	Tommerup, Niels/0000-0003-2304-0112				BUNDEY S, 1974, J MENT DEFIC RES, V18, P115; CRONISTER A, 1991, AM J MED GENET, V38, P503, DOI 10.1002/ajmg.1320380272; FRYNS JP, 1989, FRAGILE X SYNDROME, P1; HEITZ D, 1991, SCIENCE, V251, P1236, DOI 10.1126/science.2006411; JACKY PB, 1991, AM J MED GENET, V38, P400, DOI 10.1002/ajmg.1320380249; JENKINS EC, 1991, AM J MED GENET, V38, P447, DOI 10.1002/ajmg.1320380262; KREMER EJ, 1991, SCIENCE, V252, P1711, DOI 10.1126/science.1675488; LAIRD CD, 1990, AM J HUM GENET, V46, P696; LAIRD CD, 1987, GENETICS, V117, P587; LUBS HA, 1969, AM J HUM GENET, V21, P231; MIGEON BR, 1985, P NATL ACAD SCI USA, V82, P3390, DOI 10.1073/pnas.82.10.3390; NUSSBAUM RL, 1986, AM J MED GENET, V23, P715, DOI 10.1002/ajmg.1320230162; OBERLE I, 1991, SCIENCE, V252, P1097, DOI 10.1126/science.252.5009.1097; PEMBREY ME, 1985, AM J MED GENET, V21, P709, DOI 10.1002/ajmg.1320210413; ROUSSEAU F, 1991, AM J HUM GENET, V48, P108; ROUSSEAU F, IN PRESS J MED GENET; SHERMAN SL, 1985, HUM GENET, V71, P184; SHERMAN SL, 1985, HUM GENET, V69, P289, DOI 10.1007/BF00291644; SHERMAN SL, 1984, ANN HUM GENET, V48, P21, DOI 10.1111/j.1469-1809.1984.tb00830.x; SUTHERLAND GR, 1977, SCIENCE, V197, P265, DOI 10.1126/science.877551; SUTHERS GK, 1991, AM J HUM GENET, V48, P460; TONIOLO D, 1988, EMBO J, V7, P401, DOI 10.1002/j.1460-2075.1988.tb02827.x; TURNER G, 1986, NEW ENGL J MED, V315, P607, DOI 10.1056/NEJM198609043151002; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; VINCENT A, 1991, NATURE, V349, P624, DOI 10.1038/349624a0; VOGEL F, 1990, HUM GENET, V86, P25; WEBB T, 1989, FRAGILE X SYNDROME, P40; YU S, 1991, SCIENCE, V252, P1179, DOI 10.1126/science.252.5009.1179	28	573	584	0	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 12	1991	325	24					1673	1681		10.1056/NEJM199112123252401	http://dx.doi.org/10.1056/NEJM199112123252401			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GU418	1944467				2022-12-28	WOS:A1991GU41800001
J	KESSLER, DA				KESSLER, DA			COMMUNICATING WITH PATIENTS ABOUT THEIR MEDICATIONS	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material											KESSLER, DA (corresponding author), US FDA,ROCKVILLE,MD 20857, USA.							JOYCE G, 1988, J PHARM MARK MANAGE, V3, P11; KORSCH BM, 1972, SCI AM, V227, P66, DOI 10.1038/scientificamerican0872-66; LEY P, 1972, J HEALTH SOC BEHAV, V13, P311, DOI 10.2307/2136768; MORRIS LA, 1986, NATIONAL SURVEY PRES; 1990, MED REGIMENS CAUSES, P12; 1984, PRESCRIPTION DRUG AD; 1991, DHHS PHS9150212 PUBL; 1988, MARKET FACTS	8	63	67	0	0	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 5	1991	325	23					1650	1652		10.1056/NEJM199112053252312	http://dx.doi.org/10.1056/NEJM199112053252312			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GR770	1944456				2022-12-28	WOS:A1991GR77000012
J	STRONG, TV; SMIT, LS; TURPIN, SV; COLE, JL; HON, CT; MARKIEWICZ, D; PETTY, TL; CRAIG, MW; ROSENOW, EC; TSUI, LC; IANNUZZI, MC; KNOWLES, MR; COLLINS, FS				STRONG, TV; SMIT, LS; TURPIN, SV; COLE, JL; HON, CT; MARKIEWICZ, D; PETTY, TL; CRAIG, MW; ROSENOW, EC; TSUI, LC; IANNUZZI, MC; KNOWLES, MR; COLLINS, FS			CYSTIC-FIBROSIS GENE MUTATION IN 2 SISTERS WITH MILD DISEASE AND NORMAL SWEAT ELECTROLYTE LEVELS	NEW ENGLAND JOURNAL OF MEDICINE			English	Note							CHLORIDE CONCENTRATION; IDENTIFICATION; DNA; PERMEABILITY; ABSORPTION; EPITHELIA; INVITRO; GLANDS; CL		UNIV MICHIGAN, HOWARD HUGHES MED INST, 4570 MSRBII, 1150 W MED CTR DR, ANN ARBOR, MI 48109 USA; UNIV MICHIGAN, DEPT INTERNAL MED, ANN ARBOR, MI 48109 USA; UNIV MICHIGAN, DEPT HUMAN GENET, ANN ARBOR, MI 48109 USA; UNIV N CAROLINA, DEPT MED, CHAPEL HILL, NC 27514 USA; HENRY FORD HOSP, DETROIT, MI 48202 USA; MIAMI VALLEY HOSP, DAYTON, OH USA; MAYO CLIN & MAYO FDN, ROCHESTER, MN 55905 USA; HOSP SICK CHILDREN, DEPT GENET, TORONTO M5G 1X8, ONTARIO, CANADA; PRESBYTERIAN ST LUKES MED CTR, DENVER, CO USA	Howard Hughes Medical Institute; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of North Carolina; University of North Carolina Chapel Hill; Henry Ford Health System; Henry Ford Hospital; Miami Valley Hospital; Mayo Clinic; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)			Strong, Theresa/GSM-6652-2022; Tsui, Lap-chee/A-1081-2010	Strong, Theresa/0000-0001-6783-8703; 	NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000046] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK039690, P01DK042718] Funding Source: NIH RePORTER; NCRR NIH HHS [M01-RR00046] Funding Source: Medline; NIDDK NIH HHS [P01-DK42718, R01-DK39690] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AMES GF, 1990, FEMS MICROBIOL LETT, V75, P429, DOI 10.1016/S0168-6445(05)80008-7; ANDERSON MP, 1991, SCIENCE, V251, P679, DOI 10.1126/science.1704151; BIGGIN MD, 1983, P NATL ACAD SCI-BIOL, V80, P3963, DOI 10.1073/pnas.80.13.3963; BIJMAN J, 1984, AM J PHYSIOL, V247, pC3, DOI 10.1152/ajpcell.1984.247.1.C3; Boat TF., 1989, CYSTIC FIBROSIS META, V6th, P2649; BOUCHER RC, 1988, J PHYSIOL-LONDON, V405, P77, DOI 10.1113/jphysiol.1988.sp017322; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; COTTON RGH, 1988, P NATL ACAD SCI USA, V85, P4397, DOI 10.1073/pnas.85.12.4397; CUTTING GR, 1990, NATURE, V346, P366, DOI 10.1038/346366a0; DAVIS PB, 1983, AM REV RESPIR DIS, V128, P34, DOI 10.1164/arrd.1983.128.1.34; DAVIS PB, 1980, AM J MED, V69, P643, DOI 10.1016/0002-9343(80)90482-9; DRUMM ML, 1990, CELL, V62, P1227, DOI 10.1016/0092-8674(90)90398-X; GASKIN K, 1982, J PEDIATR-US, V100, P857, DOI 10.1016/S0022-3476(82)80501-5; GIBSON AL, 1991, SCIENCE, V254, P109, DOI 10.1126/science.1718037; GIBSON LE, 1959, PEDIATRICS, V23, P545; GROMPE M, 1989, P NATL ACAD SCI USA, V86, P5888, DOI 10.1073/pnas.86.15.5888; HYDE SC, 1990, NATURE, V346, P362, DOI 10.1038/346362a0; KARTNER N, 1991, CELL, V64, P681, DOI 10.1016/0092-8674(91)90498-N; KEREM BS, 1990, P NATL ACAD SCI USA, V87, P8447, DOI 10.1073/pnas.87.21.8447; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; KEREM E, 1990, NEW ENGL J MED, V323, P1517, DOI 10.1056/NEJM199011293232203; KNOWLES M, 1981, NEW ENGL J MED, V305, P1489, DOI 10.1056/NEJM198112173052502; KNOWLES M, 1983, J CLIN INVEST, V71, P1410, DOI 10.1172/JCI110894; PERBAL BV, 1988, PRACTICAL GUIDE MOL, P463; QUINTON PM, 1983, NEW ENGL J MED, V308, P1185, DOI 10.1056/NEJM198305193082002; QUINTON PM, 1990, FASEB J, V4, P2709, DOI 10.1096/fasebj.4.10.2197151; RICH DP, 1990, NATURE, V347, P358, DOI 10.1038/347358a0; RIGOT JM, 1991, NEW ENGL J MED, V325, P64; RIORDAN JR, 1989, SCIENCE, V245, P1437; RIORDAN JR, 1989, SCIENCE, V245, P1066; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SATO K, 1984, J CLIN INVEST, V73, P1763, DOI 10.1172/JCI111385; SATO K, 1988, J LAB CLIN MED, V111, P511; STERN RC, 1978, JAMA-J AM MED ASSOC, V239, P2676, DOI 10.1001/jama.239.25.2676; WELSH MJ, 1990, FASEB J, V4, P2718, DOI 10.1096/fasebj.4.10.1695593	38	105	106	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 5	1991	325	23					1630	1634		10.1056/NEJM199112053252307	http://dx.doi.org/10.1056/NEJM199112053252307			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GR770	1944451	Bronze, Green Submitted			2022-12-28	WOS:A1991GR77000007
J	YEUNG, AC; VEKSHTEIN, VI; KRANTZ, DS; VITA, JA; RYAN, TJ; GANZ, P; SELWYN, AP				YEUNG, AC; VEKSHTEIN, VI; KRANTZ, DS; VITA, JA; RYAN, TJ; GANZ, P; SELWYN, AP			THE EFFECT OF ATHEROSCLEROSIS ON THE VASOMOTOR RESPONSE OF CORONARY-ARTERIES TO MENTAL STRESS	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ENDOTHELIUM-DEPENDENT RELAXATION; SILENT MYOCARDIAL ISCHEMIA; BLOOD-FLOW VELOCITY; SUBSELECTIVE MEASUREMENT; VASCULAR RELAXATION; ANGINA-PECTORIS; RELAXING FACTOR; RABBIT AORTA; DISEASE; ACETYLCHOLINE	Background. Mental stress can cause angina in patients with coronary artery disease, but its effects on coronary vasomotion and blood flow are poorly understood. Because atherosclerosis affects the reactivity of coronary arteries to various stimuli, such as exercise, we postulated that atherosclerosis might also influence the vasomotor response of coronary arteries to mental stress. Methods. We studied 26 patients who performed mental arithmetic under stressful conditions during cardiac catheterization. (An additonal four patients who did not perform the mental arithmetic served as controls.) Coronary segments were classified on the basis of angiographic findings as smooth, irregular, or stenosed. In 15 of the patients without focal stenoses in the left anterior descending artery, acetylcholine (10(-8) to 10(-6) Mol per liter) was infused into the artery to test endothelium-dependent vasodilation. Changes in coronary blood flow were measured with an intracoronary Doppler catheter in these 15 patients. Results. The response of the coronary arteries to mental stress varied from 38 percent constriction to 29 percent dilation, whereas the change in coronary blood flow varied from a decrease of 48 percent to an increase of 42 percent. The direction and magnitude of the change in the coronary diameter were not predicted by the changes in the heart rate, blood pressure, or plasma norepinephrine level. Segments with stenoses (n = 7) were constricted by a mean (+/- SE) of 24 +/- 4 percent, and irregular segments (n = 20) by 9 +/- 3 percent, whereas smooth segments (n = 25) did not change significantly (dilation, 3 +/- 3 percent; P < 0.002). Coronary blood flow increased by 10 +/- 10 percent in smooth vessels, whereas the flow in irregular vessels decreased by 27 +/- 5 percent. The degree of constriction or dilation during mental stress correlated with the response to the infusions of acetylcholine (P < 0.0003, r = 0.58). Conclusions. Atherosclerosis disturbs the normal vasomotor response (no change or dilation) of large coronary arteries to mental stress; in patients with atherosclerosis paradoxical constriction occurs during mental stress, particularly at points of stenosis. This vasomotor response correlates with the extent of atherosclerosis in the artery and with the endothelium-dependent response to an infusion of acetylcholine. These data suggest that in atherosclerosis unopposed constriction caused by a local failure of endothelium-dependent dilation causes the coronary arteries to respond abnormally to mental stress.	UNIFORMED SERV UNIV HLTH SCI,DEPT MED PSYCHOL,BETHESDA,MD 20814; HARVARD UNIV,SCH MED,BOSTON,MA 02115	Uniformed Services University of the Health Sciences - USA; Harvard University; Harvard Medical School	YEUNG, AC (corresponding author), BRIGHAM & WOMENS HOSP,DEPT MED,DIV CARDIOVASC,75 FRANCIS ST,BOSTON,MA 02115, USA.		Krantz, David S./L-5364-2015	Vita, Joseph/0000-0001-5607-1797; Ganz, Peter/0000-0002-0437-8882; Krantz, David/0000-0002-1671-1355				BARRY J, 1988, AM J CARDIOL, V61, P989, DOI 10.1016/0002-9149(88)90112-9; BASSAN MM, 1980, CIRCULATION, V62, P933, DOI 10.1161/01.CIR.62.5.933; BROWN BG, 1981, CIRCULATION, V64, P1089, DOI 10.1161/01.CIR.64.6.1089; COCKS TM, 1983, NATURE, V305, P627, DOI 10.1038/305627a0; COHEN RA, 1984, FED PROC, V43, P2862; COHEN RA, 1988, J PHARMACOL EXP THER, V244, P550; COHEN RA, 1988, AM J PHYSIOL, V254, pH871, DOI 10.1152/ajpheart.1988.254.5.H871; COX DA, 1989, CIRCULATION, V80, P458, DOI 10.1161/01.CIR.80.3.458; DEANFIELD JE, 1984, LANCET, V2, P1001; FISH RD, 1988, J CLIN INVEST, V81, P21, DOI 10.1172/JCI113297; FREYSCHUSS U, 1988, AM J PHYSIOL, V255, pH1443, DOI 10.1152/ajpheart.1988.255.6.H1443; FURCHGOTT RF, 1983, CIRC RES, V53, P557, DOI 10.1161/01.RES.53.5.557; GAGE JE, 1986, CIRCULATION, V73, P865, DOI 10.1161/01.CIR.73.5.865; GANZ W, 1971, CIRCULATION, V44, P181, DOI 10.1161/01.CIR.44.2.181; GORDON JB, 1989, J CLIN INVEST, V83, P1946, DOI 10.1172/JCI114103; HABIB JB, 1986, CIRC RES, V58, P305, DOI 10.1161/01.RES.58.2.305; HEUSCH G, 1990, CIRCULATION, V81, P1, DOI 10.1161/01.CIR.81.1.1; KIRKEEDIE RL, 1982, IEEE T COMPUT SOC CO, P215; LANGE RA, 1989, NEW ENGL J MED, V321, P1557, DOI 10.1056/NEJM198912073212301; LUDMER PL, 1986, NEW ENGL J MED, V315, P1046, DOI 10.1056/NEJM198610233151702; MARTIN W, 1986, J PHARMACOL EXP THER, V237, P529; MEREDITH IT, 1990, CIRCULATION, V82, P516; MINOR RL, 1990, J CLIN INVEST, V86, P2109, DOI 10.1172/JCI114949; NABEL EG, 1988, CIRCULATION, V77, P43, DOI 10.1161/01.CIR.77.1.43; NABEL EG, 1990, CIRCULATION, V81, P850, DOI 10.1161/01.CIR.81.3.850; OSBORNE JA, 1989, AM J PHYSIOL, V256, pC591, DOI 10.1152/ajpcell.1989.256.3.C591; PEULER JD, 1977, LIFE SCI, V21, P625, DOI 10.1016/0024-3205(77)90070-4; ROBERTSON D, 1979, CIRCULATION, V59, P637, DOI 10.1161/01.CIR.59.4.637; ROZANSKI A, 1988, NEW ENGL J MED, V318, P1005, DOI 10.1056/NEJM198804213181601; SANDOR T, 1985, COMPUT BIOMED RES, V18, P531, DOI 10.1016/0010-4809(85)90028-X; SELLKE FW, 1990, CIRCULATION, V81, P1586, DOI 10.1161/01.CIR.81.5.1586; SHIMOKAWA H, 1989, CIRC RES, V64, P900, DOI 10.1161/01.RES.64.5.900; SIBLEY DH, 1986, J AM COLL CARDIOL, V8, P1332, DOI 10.1016/S0735-1097(86)80305-9; SPECCHIA G, 1984, AM HEART J, V108, P56, DOI 10.1016/0002-8703(84)90544-1; SREEHARAN N, 1986, CAN J PHYSIOL PHARM, V64, P1451, DOI 10.1139/y86-246; TAGAWA H, 1991, CIRC RES, V68, P330, DOI 10.1161/01.RES.68.2.330; TODA N, 1986, AM J PHYSIOL, V250, pH718, DOI 10.1152/ajpheart.1986.250.5.H718; TREASURE CB, 1990, CIRCULATION, V81, P772, DOI 10.1161/01.CIR.81.3.772; VANHOUTTE PM, 1989, CIRCULATION, V80, P1, DOI 10.1161/01.CIR.80.1.1; VITA J A, 1990, Journal of the American College of Cardiology, V15, p158A; VITA JA, 1990, CIRCULATION, V81, P491, DOI 10.1161/01.CIR.81.2.491; WALLENSTEIN S, 1980, CIRC RES, V47, P1, DOI 10.1161/01.RES.47.1.1; WILSON RF, 1985, CIRCULATION, V72, P82, DOI 10.1161/01.CIR.72.1.82; YAMAMOTO H, 1988, J CLIN INVEST, V81, P1752, DOI 10.1172/JCI113516; YASUE H, 1990, CIRCULATION, V81, P482, DOI 10.1161/01.CIR.81.2.482	45	498	514	0	15	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 28	1991	325	22					1551	1556		10.1056/NEJM199111283252205	http://dx.doi.org/10.1056/NEJM199111283252205			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GR380	1944439				2022-12-28	WOS:A1991GR38000005
J	WOLFE, L				WOLFE, L			THE NATIONAL-HEALTH-SERVICE-CORPS - IMPROVING ON PAST EXPERIENCE	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material											WOLFE, L (corresponding author), US CONGRESS,OFF TECHNOL ASSESSMENT,HLTH PROGRAM,WASHINGTON,DC 20510, USA.							1990, HLTH CARE RURAL AM	1	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 27	1991	266	20					2808	2808		10.1001/jama.266.20.2808	http://dx.doi.org/10.1001/jama.266.20.2808			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GQ722	1942436				2022-12-28	WOS:A1991GQ72200004
J	DONALDSON, JG; KAHN, RA; LIPPINCOTTSCHWARTZ, J; KLAUSNER, RD				DONALDSON, JG; KAHN, RA; LIPPINCOTTSCHWARTZ, J; KLAUSNER, RD			BINDING OF ARF AND BETA-COP TO GOLGI MEMBRANES - POSSIBLE REGULATION BY A TRIMERIC G-PROTEIN	SCIENCE			English	Article							ADENYLATE-CYCLASE; ADP-RIBOSYLATION; CHOLERA-TOXIN; BREFELDIN-A; TRANSPORT; SECRETION; COMPONENT; PURIFICATION; APPARATUS; SUGGESTS	The binding of cytosolic coat proteins to organelles may regulate membrane structure and traffic. Evidence is presented that a small guanosine triphosphate (GTP)-binding protein, the adenosine diphosphate ribosylation factor (ARF), reversibly associates with the Golgi apparatus in an energy, GTP, and fungal metabolite brefeldin A (BFA)-sensitive manner similar to, but distinguishable from, the 110-kilodalton cytosolic coat protein beta-COP. Addition of beta-gamma-subunits of G proteins inhibited the association of both ARF and beta-COP with Golgi membranes that occurred upon incubation with guanosine 5'-O-(3-thiotriphosphate) (GTP-gamma-S). Thus, heterotrimeric G proteins may function to regulate the assembly of coat proteins onto the Golgi membrane.	NCI, DIV CANC TREATMENT, BIOL CHEM LAB, BETHESDA, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	DONALDSON, JG (corresponding author), NICHHD, CELL BIOL & METAB BRANCH, BETHESDA, MD 20892 USA.		Kahn, Richard/ABD-2666-2020	Kahn, Richard/0000-0002-0259-0601				ALLAN VJ, 1986, J CELL BIOL, V103, P2229, DOI 10.1083/jcb.103.6.2229; BALCH WE, 1984, CELL, V39, P405, DOI 10.1016/0092-8674(84)90019-9; BOURNE HR, 1988, CELL, V53, P669, DOI 10.1016/0092-8674(88)90081-5; COREY EJ, 1976, TETRAHEDRON LETT, P4701; DONALDSON JG, 1990, J CELL BIOL, V111, P2295, DOI 10.1083/jcb.111.6.2295; DONALDSON JG, 1991, J CELL BIOL, V112, P579, DOI 10.1083/jcb.112.4.579; DONALDSON JG, UNPUB; DUDEN R, 1991, CELL, V64, P649, DOI 10.1016/0092-8674(91)90248-W; ERCOLANI L, 1990, P NATL ACAD SCI USA, V87, P4635, DOI 10.1073/pnas.87.12.4635; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; HIGASHIJIMA T, 1991, J BIOL CHEM, V266, P3396; KAHN RA, 1984, J BIOL CHEM, V259, P6228; KAHN RA, 1991, J BIOL CHEM, V266, P15595; KAHN RA, 1986, J BIOL CHEM, V261, P7906; KAHN RA, UNPUB; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIPPINCOTTSCHWARTZ J, 1990, CELL, V60, P821, DOI 10.1016/0092-8674(90)90096-W; LIPPINCOTTSCHWARTZ J, 1989, CELL, V56, P801, DOI 10.1016/0092-8674(89)90685-5; MALHOTRA V, 1989, CELL, V58, P329, DOI 10.1016/0092-8674(89)90847-7; MELANCON P, 1987, CELL, V51, P1053, DOI 10.1016/0092-8674(87)90591-5; NAKANO A, 1989, J CELL BIOL, V109, P2677, DOI 10.1083/jcb.109.6.2677; NORTHUP JK, 1983, J BIOL CHEM, V258, P1369; OKABE K, 1990, J BIOL CHEM, V265, P12854; ORCI L, 1991, CELL, V64, P1183; SALMINEN A, 1987, CELL, V49, P527, DOI 10.1016/0092-8674(87)90455-7; SCHMITT HD, 1988, CELL, V53, P635, DOI 10.1016/0092-8674(88)90579-X; SEGEV N, 1988, CELL, V52, P915, DOI 10.1016/0092-8674(88)90433-3; SERAFINI T, 1991, NATURE, V349, P214, DOI 10.1038/349215a0; STEARNS T, 1990, P NATL ACAD SCI USA, V87, P1238, DOI 10.1073/pnas.87.3.1238; STERNWEIS PC, 1982, P NATL ACAD SCI-BIOL, V79, P4888, DOI 10.1073/pnas.79.16.4888; STERNWEIS PC, 1984, J BIOL CHEM, V259, P3806; WATERS MG, 1991, NATURE, V349, P248, DOI 10.1038/349248a0; ZAHROUI A, 1989, J BIOL CHEM, V264	33	325	328	1	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 22	1991	254	5035					1197	1199		10.1126/science.1957170	http://dx.doi.org/10.1126/science.1957170			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ834	1957170				2022-12-28	WOS:A1991GQ83400045
J	LAM, KS; SALMON, SE; HERSH, EM; HRUBY, VJ; KAZMIERSKI, WM; KNAPP, RJ				LAM, KS; SALMON, SE; HERSH, EM; HRUBY, VJ; KAZMIERSKI, WM; KNAPP, RJ			A NEW TYPE OF SYNTHETIC PEPTIDE LIBRARY FOR IDENTIFYING LIGAND-BINDING ACTIVITY	NATURE			English	Article							PHAGE	OUR aim was to improve techniques for drug development by facilitating the identification of small molecules that bind with high affinity to acceptor molecules (for example, cell-surface receptors, enzymes, antibodies) and so to mimic or block their interaction with the natural ligand 1,2. Previously such small molecules have been characterized individually on a serial basis. The systematic synthesis and screening of peptide libraries of defined structure represents a new approach. For relatively small libraries, predetermined sequence variations on solid-phase supports have been used 3,4, and large libraries have been produced using a bacteriophage vector into which random oligodeoxynucleotide sequences have been introduced 5-8, but these techniques have severe limitations. Here we investigate an alternative approach to synthesis and screening of peptide libraries. Our simple methodology greatly enhances the production and rapid evaluation of random libraries of millions of peptides so that acceptor-binding ligands of high affinity can be rapidly identified and sequenced, on the basis of a 'one-bead, one-peptide' approach.	UNIV ARIZONA,FAC SCI,DEPT CHEM,TUCSON,AZ 85721; SELECTIDE CORP,TUCSON,AZ 85737; COLL MED TUCSON,DEPT INTERNAL MED,TUCSON,AZ 85724	University of Arizona; Sanofi-Aventis	LAM, KS (corresponding author), COLL MED TUCSON,ARIZONA CANC CTR,TUCSON,AZ 85724, USA.							CWIRLA SE, 1990, P NATL ACAD SCI USA, V87, P6378, DOI 10.1073/pnas.87.16.6378; DEVLIN JJ, 1990, SCIENCE, V249, P404, DOI 10.1126/science.2143033; FODOR SPA, 1991, SCIENCE, V251, P767, DOI 10.1126/science.1990438; GEYSEN HM, 1984, P NATL ACAD SCI-BIOL, V81, P3998, DOI 10.1073/pnas.81.13.3998; HRUBY V, 1990, BIOCHEM J, V268, P246; HRUBY VJ, 1991, CURR OPIN BIOTECH, V2, P599, DOI 10.1016/0958-1669(91)90086-K; NIALL HD, 1972, CHEM BIOL PEPTIDES, P695; PARMLEY SF, 1988, GENE, V73, P305, DOI 10.1016/0378-1119(88)90495-7; SCOTT JK, 1990, SCIENCE, V249, P386, DOI 10.1126/science.1696028	9	1701	2519	6	197	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	NOV 7	1991	354	6348					82	84		10.1038/354082a0	http://dx.doi.org/10.1038/354082a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN829	1944576				2022-12-28	WOS:A1991GN82900064
J	YE, Q; HECK, GL; DESIMONE, JA				YE, Q; HECK, GL; DESIMONE, JA			THE ANION PARADOX IN SODIUM TASTE RECEPTION - RESOLUTION BY VOLTAGE-CLAMP STUDIES	SCIENCE			English	Article							CANINE LINGUAL EPITHELIUM; SALT TASTE; AMILORIDE INHIBITION; ION-TRANSPORT; RESPONSES; CELLS; NACL; RAT; TRANSDUCTION; MODEL	Sodium salts are potent taste stimuli, but their effectiveness is markedly dependent on the anion, with chloride yielding the greatest response. The cellular mechanisms that mediate this phenomenon are not known. This "anion paradox" has been resolved by considering the field potential that is generated by restricted electrodiffusion of the anion through paracellular shunts between taste-bud cells. Neural responses to sodium chloride, sodium acetate, and sodium gluconate were studied while the field potential was voltage-clamped. Clamping at electronegative values eliminated the anion effect, whereas clamping at electropositive potentials exaggerated it. Thus, field potentials across the lingual epithelium modulate taste reception, indicating that the functional unit of taste reception includes the taste cell and its paracellular microenvironment.	VIRGINIA COMMONWEALTH UNIV, DEPT PHYSIOL, BOX 551, RICHMOND, VA 23298 USA	Virginia Commonwealth University					NIDCD NIH HHS [DC00122] Funding Source: Medline	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		AVENET P, 1988, J MEMBRANE BIOL, V105, P245, DOI 10.1007/BF01871001; AVENET P, 1987, J MEMBRANE BIOL, V97, P223, DOI 10.1007/BF01869225; BARTOSHUK LM, 1978, HDB BEHAVIORAL NEURO, V1, P503; BEIDLER LM, 1967, OLFACTION TASTE, V2, P509; BRAND JG, 1985, BRAIN RES, V334, P207, DOI 10.1016/0006-8993(85)90212-4; DESIMONE JA, 1981, SCIENCE, V214, P1039, DOI 10.1126/science.7302576; DESIMONE JA, 1984, J GEN PHYSIOL, V83, P633, DOI 10.1085/jgp.83.5.633; ELLIOTT EJ, 1990, BRAIN RES, V535, P9, DOI 10.1016/0006-8993(90)91817-Z; FIDELMAN ML, 1988, J THEOR BIOL, V130, P73, DOI 10.1016/S0022-5193(88)80165-6; FIDELMAN ML, 1989, AM J PHYSIOL, V257, pG475, DOI 10.1152/ajpgi.1989.257.3.G475; FORMAKER BK, 1988, AM J PHYSIOL, V255, pR1002, DOI 10.1152/ajpregu.1988.255.6.R1002; HARPER HW, 1987, ANN NY ACAD SCI, V510, P349; HECK GL, 1984, SCIENCE, V223, P403, DOI 10.1126/science.6691151; HECK GL, 1989, BIOPHYS J, V55, P843, DOI 10.1016/S0006-3495(89)82884-X; HETTINGER TP, 1990, BRAIN RES, V513, P24, DOI 10.1016/0006-8993(90)91085-U; HILL DL, 1990, BEHAV NEUROSCI, V104, P734, DOI 10.1037/0735-7044.104.5.734; HILL DL, 1985, DEV BRAIN RES, V20, P310, DOI 10.1016/0165-3806(85)90121-X; HOLLAND VF, 1989, J COMP NEUROL, V279, P13, DOI 10.1002/cne.902790103; KINNAMON JC, 1985, J COMP NEUROL, V235, P48, DOI 10.1002/cne.902350105; LEW VL, 1979, PROC R SOC SER B-BIO, V206, P53, DOI 10.1098/rspb.1979.0091; MIERSON S, 1985, BIOCHIM BIOPHYS ACTA, V816, P283, DOI 10.1016/0005-2736(85)90496-1; MIERSON S, 1988, J GEN PHYSIOL, V92, P87, DOI 10.1085/jgp.92.1.87; MURPHY C, 1981, PHYSIOL BEHAV, V26, P1083, DOI 10.1016/0031-9384(81)90213-4; NINOMIYA Y, 1989, J COMP PHYSIOL A, V166, P1; SCHIFFMAN SS, 1980, PHYSIOL BEHAV, V24, P217, DOI 10.1016/0031-9384(80)90077-3; SCHIFFMAN SS, 1983, P NATL ACAD SCI-BIOL, V80, P6136, DOI 10.1073/pnas.80.19.6136; SCOTT TR, 1990, SCIENCE, V249, P1585, DOI 10.1126/science.2171145; SIMON SA, 1988, PHARMACOL BIOCHEM BE, V29, P257, DOI 10.1016/0091-3057(88)90154-2; SIMON SA, 1985, AM J PHYSIOL, V249, pC398, DOI 10.1152/ajpcell.1985.249.5.C398; TEETER JH, 1989, CHEM SENSES, V1, P151; TEETER JH, 1985, 19TH P JAP S TAST SM, P29; WEST CHK, 1978, J GEN PHYSIOL, V72, P305, DOI 10.1085/jgp.72.3.305; YANG J, 1987, J NEUROSCI, V7, P3561	33	146	146	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 1	1991	254	5032					724	726		10.1126/science.1948054	http://dx.doi.org/10.1126/science.1948054			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN474	1948054				2022-12-28	WOS:A1991GN47400046
J	ROWLEY, AH; WHITLEY, RJ; LAKEMAN, FD; WOLINSKY, SM				ROWLEY, AH; WHITLEY, RJ; LAKEMAN, FD; WOLINSKY, SM			RAPID DETECTION OF HERPES-SIMPLEX-VIRUS DNA IN CEREBROSPINAL-FLUID OF PATIENTS WITH HERPES-SIMPLEX ENCEPHALITIS	LANCET			English	Article									NORTHWESTERN UNIV,DEPT PEDIAT,CHICAGO,IL 60611; NORTHWESTERN UNIV,DEPT MED,CHICAGO,IL 60611; UNIV ALABAMA,DEPT PEDIAT,BIRMINGHAM,AL; UNIV ALABAMA,DEPT CLIN VIROL,BIRMINGHAM,AL	Northwestern University; Northwestern University; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham			Wolinsky, Steven/B-2893-2012	Rowley, Anne/0000-0003-4695-6676; Wolinsky, Steven/0000-0002-9625-6697				JOHNSON RT, 1968, ARCH NEUROL-CHICAGO, V18, P260, DOI 10.1001/archneur.1968.00470330050004; KAHLON J, 1987, J INFECT DIS, V155, P38, DOI 10.1093/infdis/155.1.38; KWOK S, 1988, BLOOD, V72, P1117; KWOK S, 1987, J VIROL, V61, P1690, DOI 10.1128/JVI.61.5.1690-1694.1987; LAKEMAN FD, 1987, J INFECT DIS, V155, P1172, DOI 10.1093/infdis/155.6.1172; MANOS MM, 1989, CANCER CEL, V7, P209; NAHMIAS AJ, 1982, J INFECT DIS, V145, P829, DOI 10.1093/infdis/145.6.829; ROWLEY AH, 1989, PEDIATR RES, V25, pA189; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SKOLDENBERG B, 1984, LANCET, V2, P707; WHITLEY RJ, 1988, AM J MED, V85, P61; WHITLEY RJ, 1977, NEW ENGL J MED, V297, P289, DOI 10.1056/NEJM197708112970601; WHITLEY RJ, 1989, JAMA-J AM MED ASSOC, V262, P234, DOI 10.1001/jama.262.2.234	13	222	233	0	5	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	FEB 24	1990	335	8687					440	441		10.1016/0140-6736(90)90667-T	http://dx.doi.org/10.1016/0140-6736(90)90667-T			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CP907	1968171				2022-12-28	WOS:A1990CP90700005
J	GENTLEMAN, D; JENNETT, B				GENTLEMAN, D; JENNETT, B			AUDIT OF TRANSFER OF UNCONSCIOUS HEAD-INJURED PATIENTS TO A NEUROSURGICAL UNIT	LANCET			English	Article									INST NEUROL SCI,DEPT NEUROSURG,GLASGOW,SCOTLAND	University of Glasgow								ANDERSON ID, 1988, BRIT MED J, V296, P1305, DOI 10.1136/bmj.296.6632.1305; [Anonymous], 1986, REPORT WORKING PARTY; BION JF, 1988, BRIT MED J, V296, P170, DOI 10.1136/bmj.296.6616.170; BRYDEN JS, 1983, BRIT MED J, V286, P1791, DOI 10.1136/bmj.286.6380.1791; DRAAISMA JMT, 1986, AMBULANCE, V7, P15; FREY CF, 1984, JAMA-J AM MED ASSOC, V251, P2698; GENTLEMAN D, 1981, LANCET, V2, P853; HEWER RL, 1989, BRIT MED J, V298, P1219, DOI 10.1136/bmj.298.6682.1219; JEFFREYS RV, 1981, LANCET, V2, P459; JENNETT B, 1979, BRIT MED J, V2, P955, DOI 10.1136/bmj.2.6196.955; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1978, INJURY, V10, P31; Jennett B, 1989, MILD HEAD INJURY, P23; Marsh H, 1989, Br J Neurosurg, V3, P13, DOI 10.3109/02688698909001021; McLaren C A, 1983, J R Coll Surg Edinb, V28, P399; OTTOSSON A, 1984, JAMA-J AM MED ASSOC, V251, P2668, DOI 10.1001/jama.251.20.2668; ROSE J, 1977, BRIT MED J, V2, P615, DOI 10.1136/bmj.2.6087.615; SMITH RW, 1986, J NEUROSURG, V65, P569; TEASDALE G, 1982, BRIT MED J, V285, P1965; van Alphen H A, 1985, Ned Tijdschr Geneeskd, V129, P645; WRIGHT IH, 1988, BRIT MED J, V296, P543, DOI 10.1136/bmj.296.6621.543; YATES DW, 1988, BRIT MED J, V297, P1419, DOI 10.1136/bmj.297.6661.1419; 1984, BRIT MED J, V288, P983	23	82	83	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	FEB 10	1990	335	8685					330	334		10.1016/0140-6736(90)90615-C	http://dx.doi.org/10.1016/0140-6736(90)90615-C			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CM846	1967777				2022-12-28	WOS:A1990CM84600012
J	BAKER, WB; KLEIN, MS; REARDON, MJ; VERANI, MS; ZOGHBI, WA				BAKER, WB; KLEIN, MS; REARDON, MJ; VERANI, MS; ZOGHBI, WA			REVERSIBLE CARDIAC DYSFUNCTION (HIBERNATION) FROM ISCHEMIA DUE TO COMPRESSION OF THE CORONARY-ARTERIES BY A PSEUDOANEURYSM	NEW ENGLAND JOURNAL OF MEDICINE			English	Note							AORTOCORONARY BYPASS SURGERY; LEFT-VENTRICULAR DYSFUNCTION; MYOCARDIAL-INFARCTION; SYSTOLIC COMPRESSION; POSTEXTRASYSTOLIC POTENTIATION; TL-201 SCINTIGRAPHY; REVASCULARIZATION; NITROGLYCERIN; PREDICTOR; EXERCISE		METHODIST HOSP, CARDIOL SECT,ECHOCARDIOG LAB,6535 FANNIN,MS F-905, HOUSTON, TX 77030 USA; BAYLOR COLL MED, DEPT MED, CARDIOL SECT, HOUSTON, TX 77030 USA	The Methodist Hospital System; The Methodist Hospital - Houston; Baylor College of Medicine			Reardon, Michael/ABF-8880-2021					AHMAD M, 1981, AM J CARDIOL, V48, P832, DOI 10.1016/0002-9149(81)90346-5; AKINS CW, 1980, AM J CARDIOL, V46, P695, DOI 10.1016/0002-9149(80)90522-6; ANGELINI P, 1983, PROG CARDIOVASC DIS, V26, P75, DOI 10.1016/0033-0620(83)90019-1; ANGELINI P, 1986, CATHETER CARDIO DIAG, V12, P39, DOI 10.1002/ccd.1810120110; BERGER BC, 1979, CIRCULATION, V60, P1114, DOI 10.1161/01.CIR.60.5.1114; BESTETTI RB, 1987, CLIN CARDIOL, V10, P129, DOI 10.1002/clc.4960100210; BJORK VO, 1977, J THORAC CARDIOV SUR, V73, P14; BONOW RO, 1991, CIRCULATION, V83, P26, DOI 10.1161/01.CIR.83.1.26; BOURASSA MG, 1972, CIRCULATION, V46, P724, DOI 10.1161/01.CIR.46.4.724; BRAUNWALD E, 1986, J AM COLL CARDIOL, V8, P1467, DOI 10.1016/S0735-1097(86)80325-4; CABIN HS, 1987, J AM COLL CARDIOL, V10, P743, DOI 10.1016/S0735-1097(87)80265-6; CHATTERJEE K, 1973, CIRCULATION, V47, P276, DOI 10.1161/01.CIR.47.2.276; CHESEBRO JH, 1978, CIRCULATION, V57, P952, DOI 10.1161/01.CIR.57.5.952; COHEN M, 1988, J AM COLL CARDIOL, V12, P1193, DOI 10.1016/0735-1097(88)92599-5; FELDMAN AM, 1986, AM HEART J, V111, P784, DOI 10.1016/0002-8703(86)90116-X; GRONDIN P, 1977, ANN THORAC SURG, V24, P422, DOI 10.1016/S0003-4975(10)63435-2; ILLERA JP, 1985, INT J CARDIOL, V8, P327, DOI 10.1016/0167-5273(85)90224-4; KLAUSNER SC, 1976, CIRCULATION, V54, P615, DOI 10.1161/01.CIR.54.4.615; LEWIS SJ, 1991, AM HEART J, V121, P1088, DOI 10.1016/0002-8703(91)90666-6; MINAMI KT, 1989, CATHETER CARDIO DIAG, V18, P31, DOI 10.1002/ccd.1810180110; NAVARROLOPEZ F, 1986, INT J CARDIOL, V12, P309, DOI 10.1016/0167-5273(86)90267-6; PICHARD AD, 1981, AM J CARDIOL, V47, P978, DOI 10.1016/0002-9149(81)90201-0; POPIO KA, 1977, AM J CARDIOL, V39, P944, DOI 10.1016/S0002-9149(77)80206-3; RAHIMTOOLA SH, 1989, AM HEART J, V117, P211, DOI 10.1016/0002-8703(89)90685-6; RAHIMTOOLA SH, 1985, CIRCULATION, V72, P123; REES G, 1971, NEW ENGL J MED, V284, P1116, DOI 10.1056/NEJM197105202842002; ROBERTS WC, 1967, J THORAC CARDIOV SUR, V54, P422, DOI 10.1016/S0022-5223(19)43083-3; Schiller N B, 1989, J Am Soc Echocardiogr, V2, P358; TILLISCH J, 1986, NEW ENGL J MED, V314, P884, DOI 10.1056/NEJM198604033141405; TOPOL EJ, 1984, J AM COLL CARDIOL, V4, P1123, DOI 10.1016/S0735-1097(84)80131-X; UGARTE M, 1984, AM HEART J, V107, P1039, DOI 10.1016/0002-8703(84)90853-6; VERANI MS, 1990, CIRCULATION, V82, P80, DOI 10.1161/01.CIR.82.1.80	32	25	25	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 26	1991	325	26					1858	1861		10.1056/NEJM199112263252606	http://dx.doi.org/10.1056/NEJM199112263252606			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GW528	1961224	Bronze			2022-12-28	WOS:A1991GW52800006
J	CLARKSON, K; ROSENFELD, B; FAIR, J; KLEIN, A; BELL, W				CLARKSON, K; ROSENFELD, B; FAIR, J; KLEIN, A; BELL, W			FACTOR-XI DEFICIENCY ACQUIRED BY LIVER-TRANSPLANTATION	ANNALS OF INTERNAL MEDICINE			English	Article						LIVER TRANSPLANTATION; FACTOR-XI DEFICIENCY; PARTIAL THROMBOPLASTIN TIME; HEREDITARY DISEASES; BLOOD COAGULATION DISORDERS	EXPERIENCE; ANTIGEN	Factor XI deficiency (the Rosenthal syndrome), an autosomal recessive genetic defect, was transmitted to a patient after orthotopic liver transplantation. The deficiency was manifested by an isolated prolonged activated partial thromboplastin time (aPTT) after surgery. Hematologic evaluation using specific factor analysis revealed an absolute deficiency of factor XI. Stored serum obtained from the organ recipient before transplantation showed normal factor XI levels. When the liver donor's family was questioned, it was discovered that he was of Ashkenazi Jewish descent and that he had a history of bleeding after dental procedures. Before his death from intracerebral bleeding, he was documented to have an isolated prolonged aPTT value. This case shows that potentially morbid genetic defects can be transmitted by organ transplantation. It also provides evidence confirming that the liver is the only site of factor XI production.	JOHNS HOPKINS MED INST, BALTIMORE, MD 21205 USA	Johns Hopkins University; Johns Hopkins Medicine								ALTMAN PL, 1977, BIOL HDB, V2, P121; BELL WR, 1977, ARCH INTERN MED, V137, P1471, DOI 10.1001/archinte.137.10.1471; ESQUIVEL CO, 1987, TRANSPLANT P, V19, P3798; FRIEND PJ, 1990, NEW ENGL J MED, V323, P807, DOI 10.1056/NEJM199009203231207; PASQUE MK, 1990, ANN THORAC SURG, V49, P785, DOI 10.1016/0003-4975(90)90023-Y; RAGNI MV, 1985, BLOOD, V65, P719; RIMON A, 1976, BLOOD, V48, P165; ROBERTS HR, 1990, HEMATOLOGY, P1468; ROSENTHAL RL, 1953, P SOC EXP BIOL MED, V82, P171	9	21	21	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 1	1991	115	11					877	879		10.7326/0003-4819-115-11-877	http://dx.doi.org/10.7326/0003-4819-115-11-877			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GR171	1952475				2022-12-28	WOS:A1991GR17100007
J	HIRSHFELD, EB				HIRSHFELD, EB			SHOULD PRACTICE PARAMETERS BE THE STANDARD OF CARE IN MALPRACTICE LITIGATION	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							LIABILITY				HIRSHFELD, EB (corresponding author), AMER MED ASSOC,CHICAGO,IL 60610, USA.							BRENNAN TA, 1991, J HEALTH POLIT POLIC, V16, P67, DOI 10.1215/03616878-16-1-67; CHENEY FW, 1989, JAMA-J AM MED ASSOC, V261, P1599, DOI 10.1001/jama.261.11.1599; EDDY DM, 1990, JAMA-J AM MED ASSOC, V264, P389, DOI 10.1001/jama.264.3.389; FRYE R L, 1984, Journal of the American College of Cardiology, V4, P434; GARNICK DW, 1991, JAMA-J AM MED ASSOC, V266, P2856, DOI 10.1001/jama.266.20.2856; HIRSHFELD EB, 1990, JAMA-J AM MED ASSOC, V263, P1556; Holzer J F, 1990, QRB Qual Rev Bull, V16, P71; KELLIE SE, 1991, JAMA-J AM MED ASSOC, V265, P1265, DOI 10.1001/jama.265.10.1265; Kelly J T, 1990, QRB Qual Rev Bull, V16, P54; KELLY JT, 1990, ARCH PATHOL LAB MED, V114, P1119; KINNEY ED, 1989, UC DAVIS L REV, V22, P421; Leape L L, 1990, QRB Qual Rev Bull, V16, P42; Pierce E C Jr, 1990, QRB Qual Rev Bull, V16, P61; ROPER W, 1988, NEW ENGL J MED, V319, P1179; [No title captured]; 1990, LEGAL IMPLICATIONS P; 1991, US GAOPEMD9111 GEN A; 1988, 3RD SCOPE WORK CONTR	18	42	42	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 27	1991	266	20					2886	2891		10.1001/jama.266.20.2886	http://dx.doi.org/10.1001/jama.266.20.2886			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GQ722	1942459				2022-12-28	WOS:A1991GQ72200040
J	TOSKES, PP				TOSKES, PP			HOPE FOR THE TREATMENT OF INTESTINAL SCLERODERMA	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material											TOSKES, PP (corresponding author), UNIV FLORIDA,GAINESVILLE,FL 32610, USA.							CAMILLERI M, 1989, GASTROENTEROLOGY, V96, P704; COHEN S, 1972, J CLIN INVEST, V51, P2663, DOI 10.1172/JCI107084; DIMARINO AJ, 1973, NEW ENGL J MED, V289, P1220, DOI 10.1056/NEJM197312062892304; PEACHEY RDG, 1969, GUT, V10, P285, DOI 10.1136/gut.10.4.285; REES WDW, 1982, GASTROENTEROLOGY, V83, P575; SOUDAH HC, 1991, NEW ENGL J MED, V325, P1461, DOI 10.1056/NEJM199111213252102; WITT K, 1989, SCAND J GASTROENTERO, V24, P1248, DOI 10.3109/00365528909090795	7	7	7	0	0	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 21	1991	325	21					1508	1509		10.1056/NEJM199111213252110	http://dx.doi.org/10.1056/NEJM199111213252110			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GQ406	1944429				2022-12-28	WOS:A1991GQ40600010
J	MIRKIN, G				MIRKIN, G			SIDE-EFFECTS OF RAW HONEY	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter											MIRKIN, G (corresponding author), GEORGETOWN UNIV HOSP,SCH MED,WASHINGTON,DC 20007, USA.							BEATY HN, 1987, PRINCIPLES INTERNAL, P561; BIBEROGLU S, 1988, JAMA-J AM MED ASSOC, V259, P1943, DOI 10.1001/jama.1988.03720130021010; LAMPE KF, 1988, JAMA-J AM MED ASSOC, V259, P2009; MCGEE MD, 1974, HOSP FORMUL MANAG, V9, P41; PATWARDHAN VN, 1973, TOXICANTS OCCURRING, P495; SEYAMA I, 1985, JPN J PHYSIOL, V35, P401, DOI 10.2170/jjphysiol.35.401	6	2	2	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 20	1991	266	19					2766	2766						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GP691	1942432				2022-12-28	WOS:A1991GP69100036
J	WINK, DA; KASPRZAK, KS; MARAGOS, CM; ELESPURU, RK; MISRA, M; DUNAMS, TM; CEBULA, TA; KOCH, WH; ANDREWS, AW; ALLEN, JS; KEEFER, LK				WINK, DA; KASPRZAK, KS; MARAGOS, CM; ELESPURU, RK; MISRA, M; DUNAMS, TM; CEBULA, TA; KOCH, WH; ANDREWS, AW; ALLEN, JS; KEEFER, LK			DNA DEAMINATING ABILITY AND GENOTOXICITY OF NITRIC-OXIDE AND ITS PROGENITORS	SCIENCE			English	Article							ESCHERICHIA-COLI; POINT MUTATIONS; 5-METHYLCYTOSINE; MACROPHAGES; NITROSATION; ACTIVATION; RATS; HYPOMETHYLATION; NUCLEOTIDES; CYTOSINE	Nitric oxide (NO), a multifaceted bioregulatory agent and an environmental pollutant, can also cause genomic alterations. In vitro, NO deaminated deoxynucleosides, deoxynucleotides, and intact DNA at physiological pH. That similar DNA damage can also occur in vivo was tested by treating Salmonella typhimurium strain TA1535 with three NO-releasing compounds, including nitroglycerin. All proved mutagenic. Observed DNA sequence changes were > 99% C --> T transitions in the hisG46 (CCC) target codon, consistent with a cytosine-deamination mechanism. Because exposure to endogenously and exogenously produced NO is extensive, this mechanism may contribute to the incidence of deamination-related genetic disease and cancer.	NCI,FREDERICK CANC RES & DEV CTR,COMPARAT CARCINOGENESIS NATL LAB,FREDERICK,MD 21701; US FDA,ROCKVILLE,MD 20852; GLAXO INC,RES TRIANGLE PK,NC 27709; US FDA,WASHINGTON,DC 20204; NCI,FREDERICK CANC RES & DEV CTR,PRI DYNCORP,FREDERICK,MD 21701	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; US Food & Drug Administration (FDA); GlaxoSmithKline; US Food & Drug Administration (FDA); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick			Keefer, Larry K/N-3247-2014	Keefer, Larry K/0000-0001-7489-9555; Wink, David/0000-0002-5652-7480; Azad, Mahan/0000-0002-8633-3513	OFFICE OF THE DIRECTOR, NCI [N01CO074102] Funding Source: NIH RePORTER; NCI NIH HHS [N01-CO-74102] Funding Source: Medline	OFFICE OF THE DIRECTOR, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BREDT DS, 1990, NATURE, V347, P768, DOI 10.1038/347768a0; BROWN TC, 1987, CELL, V50, P945, DOI 10.1016/0092-8674(87)90521-6; CEBULA TA, 1990, MUTAT RES, V229, P79, DOI 10.1016/0027-5107(90)90010-2; COPPER DN, 1990, HUM GENET, V85, P55; COULONDRE C, 1978, NATURE, V274, P775, DOI 10.1038/274775a0; EHRLICH M, 1990, MUTAT RES, V238, P277, DOI 10.1016/0165-1110(90)90019-8; FEDERN H, 1986, CHROMATOGRAPHIA, V22, P287, DOI 10.1007/BF02268776; FEINBERG AP, 1983, NATURE, V301, P89, DOI 10.1038/301089a0; FREDERICO LA, 1990, BIOCHEMISTRY-US, V29, P2532, DOI 10.1021/bi00462a015; GARTHWAITE J, 1988, NATURE, V336, P385, DOI 10.1038/336385a0; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; HIRSCHHORN R, 1990, P NATL ACAD SCI USA, V87, P6171, DOI 10.1073/pnas.87.16.6171; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; HSIAO K, 1989, NATURE, V338, P342, DOI 10.1038/338342a0; IGNARRO LJ, 1990, ANNU REV PHARMACOL, V30, P535, DOI 10.1146/annurev.pa.30.040190.002535; JI XB, 1988, APPL ENVIRON MICROB, V54, P1791, DOI 10.1128/AEM.54.7.1791-1794.1988; KASPRZAK KS, 1990, CARCINOGENESIS, V11, P647, DOI 10.1093/carcin/11.4.647; KOCHETKOV NK, 1972, ORGANIC CHEM NUCLE B, P362; KOSAKA H, 1989, CARCINOGENESIS, V10, P563, DOI 10.1093/carcin/10.3.563; LANCASTER JR, 1990, P NATL ACAD SCI USA, V87, P1223, DOI 10.1073/pnas.87.3.1223; LEAF CD, 1991, CARCINOGENESIS, V12, P537, DOI 10.1093/carcin/12.3.537; LINDAHL T, 1990, MUTAT RES, V238, P305, DOI 10.1016/0165-1110(90)90022-4; LOEB LA, 1990, MUTAT RES, V238, P297, DOI 10.1016/0165-1110(90)90021-3; MARAGOS CM, IN PRESS J MED CHEM; MARLETTA MA, 1988, CHEM RES TOXICOL, V1, P249, DOI 10.1021/tx00005a001; MARON DM, 1983, MUTAT RES, V113, P173, DOI 10.1016/0165-1161(83)90010-9; MONCADA S, 1990, NITRIC OXIDE L ARGIN; MOSCHEL RC, 1989, TETRAHEDRON LETT, V30, P1467, DOI 10.1016/S0040-4039(00)99492-9; NGUYEN T, IN PRESS P NATL ACAD; NGUYEN TT, 1991, P AM ASS CANCER RES, V32; PATTINSON JK, 1990, BLOOD, V76, P2242; PERUTZ MF, 1990, BIOPHYS CHEM, V37, P25, DOI 10.1016/0301-4622(90)88004-C; RALT D, 1988, J BACTERIOL, V170, P359, DOI 10.1128/jb.170.1.359-364.1988; RIDEOUT WM, 1990, SCIENCE, V249, P1288, DOI 10.1126/science.1697983; SAGHER D, 1983, BIOCHEMISTRY-US, V22, P4518, DOI 10.1021/bi00288a026; SHAPIRO HS, 1966, BIOCHEMISTRY-US, V5, P3012, DOI 10.1021/bi00873a034; SHAPIRO R, 1966, BIOCHEMISTRY-US, V5, P2358, DOI 10.1021/bi00871a026; SHIVAPURKAR N, 1984, CARCINOGENESIS, V5, P989, DOI 10.1093/carcin/5.8.989; Singer B., 1983, MOL BIOL MUTAGENS CA; STUEHR DJ, 1985, P NATL ACAD SCI USA, V82, P7738, DOI 10.1073/pnas.82.22.7738; SUKUMAR S, 1983, NATURE, V306, P658, DOI 10.1038/306658a0; TANNENBAUM SR, 1991, AM J CLIN NUTR, V53, pS247, DOI 10.1093/ajcn/53.1.247S; WALLACE SS, 1988, ENVIRON MOL MUTAGEN, V12, P431, DOI 10.1002/em.2860120411; Williams D. L. H., 1988, NITROSATION; WINK DA, 1991, P AM ASS CANCER RES, V32; YANDELL DW, 1989, NEW ENGL J MED, V321, P1689, DOI 10.1056/NEJM198912213212501; 1977, WHO ENV HLTH CRITERI, V4	47	1119	1158	1	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	NOV 15	1991	254	5034					1001	1003		10.1126/science.1948068	http://dx.doi.org/10.1126/science.1948068			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GP883	1948068				2022-12-28	WOS:A1991GP88300043
J	ARAL, SO; MOSHER, WD; CATES, W				ARAL, SO; MOSHER, WD; CATES, W			SELF-REPORTED PELVIC INFLAMMATORY DISEASE IN THE UNITED-STATES, 1988	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SEXUALLY-TRANSMITTED DISEASES; BEHAVIOR; RISK; CHLAMYDIA	Objective. - To assess any changes in the characteristics of women with self-reported pelvic inflammatory disease (PID) between 1982 and 1988 and to evaluate the role of additional behavioral factors. In 1982, PID was a frequent problem among American women of reproductive age, occurring in one in seven. It was also more common among older (greater-than-or-equal-to 30 years) than younger women, more common among blacks than among whites, and more common among formerly married women than among those currently married. Design. - We analyzed data on self-reported PID from the cycle IV National Survey of Family Growth, conducted in 1988. Sample. - The survey was conducted with a multistage probability sample of 8450 women. Results. - The findings from 1982 were all replicated. Additional variables available in 1988 show that PID is more common among women with multiple (two or more) sexual partners (10% to 22%) compared with those with only one lifetime partner (7%) and among women who report a history of sexually transmitted disease (STD) (26%) compared with those with no STD history (10%). Controlling for other variables, age, race, vaginal douching, age at first intercourse, STD history, and number of lifetime partners emerged as independent predictors of self-reported PID among American women of reproductive age. Conclusion. - PID is still a widely prevalent condition among American women; PID is associated with a variety of risk factors for STD. Prevention of lower genital tract infection is crucial to avoiding PID and its sequelae.	CTR DIS CONTROL,NATL CTR HLTH STAT,NATL SURVEY FAMILY GROWTH,ATLANTA,GA 30333	Centers for Disease Control & Prevention - USA; CDC National Center for Health Statistics (NCHS)	ARAL, SO (corresponding author), CTR DIS CONTROL,CTR PREVENT SERV,DIV STD HIV PREVENT,MAILSTOP E-44,ATLANTA,GA 30333, USA.							ARAL SO, 1985, AM J PUBLIC HEALTH, V75, P1216, DOI 10.2105/AJPH.75.10.1216; ARAL SO, 1989, SEX TRANSM DIS, V16, P173, DOI 10.1097/00007435-198910000-00003; ARAL SO, 1990, CURR OPIN INFECT DIS, V3, P20, DOI 10.1097/00001432-199002000-00004; ARAL SO, 1991, SEX TRANSM DIS, V18, P10, DOI 10.1097/00007435-199101000-00003; ARAL SO, 1990, SEXUALLY TRANSMITTED, P19; ARAL SO, 1991, SEX TRANSM DIS, V17, P208; BACHRACH CA, 1985, VITAL HLTH STAT 98, V2; CATES W, 1990, EPIDEMIOL REV, V12, P199, DOI 10.1093/oxfordjournals.epirev.a036054; CATES W, 1990, CURR OPIN INFECT DIS, V3, P10, DOI 10.1097/00001432-199002000-00003; NEWTON W, 1985, J REPROD MED, V30, P82; PADIAN N, 1990, SEX TRANSM DIS, V17, P200, DOI 10.1097/00007435-199010000-00010; ROLFS RT, 1979, IN PRESS AM J OBSTET; TEISALA K, 1988, ARCH GYNECOL OBSTET, V243, P225, DOI 10.1007/BF00932272; WASHINGTON AE, 1985, JAMA-J AM MED ASSOC, V253, P2246, DOI 10.1001/jama.253.15.2246; WOLNERHANSSEN P, 1990, JAMA-J AM MED ASSOC, V263, P1936, DOI 10.1001/jama.263.14.1936; WONNACOTT TH, 1984, INTRO STATISTICS BUS, P106; 1991, MMWR-MORBID M   SRR5, V40, P1; 1990, JAMA-J AM MED ASSOC, V263, P2344; 1989, 1989 CTR DIS CONTR D	19	96	99	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 13	1991	266	18					2570	2573		10.1001/jama.266.18.2570	http://dx.doi.org/10.1001/jama.266.18.2570			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GN660	1942402				2022-12-28	WOS:A1991GN66000033
J	SHARP, PA				SHARP, PA			5 EASY PIECES	SCIENCE			English	Editorial Material							RIBOSOMAL PROTEIN-S12		MIT,DEPT BIOL,CAMBRIDGE,MA 02139	Massachusetts Institute of Technology (MIT)	SHARP, PA (corresponding author), MIT,CTR CANC RES,CAMBRIDGE,MA 02139, USA.							CHAPDELAINE Y, 1991, CELL, V65, P465, DOI 10.1016/0092-8674(91)90464-A; FUKUZAWA H, 1986, FEBS LETT, V198, P11, DOI 10.1016/0014-5793(86)81174-7; GOLDSCHMIDTCLERMONT M, 1991, CELL, V65, P135, DOI 10.1016/0092-8674(91)90415-U; GUTHRIE C, 1991, SCIENCE, V253, P147; JARRELL KA, 1988, MOL CELL BIOL, V8, P2361, DOI 10.1128/MCB.8.6.2361; MICHEL F, 1989, GENE, V82, P5, DOI 10.1016/0378-1119(89)90026-7; WISSINGER B, 1991, CELL, V65, P473, DOI 10.1016/0092-8674(91)90465-B; ZAITA N, 1987, FEBS LETT, V210, P153, DOI 10.1016/0014-5793(87)81326-1	8	177	182	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	NOV 1	1991	254	5032					663	663		10.1126/science.1948046	http://dx.doi.org/10.1126/science.1948046			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN474	1948046				2022-12-28	WOS:A1991GN47400028
J	SMEYNE, RJ; OBERDICK, J; SCHILLING, K; BERREBI, AS; MUGNAINI, E; MORGAN, JI				SMEYNE, RJ; OBERDICK, J; SCHILLING, K; BERREBI, AS; MUGNAINI, E; MORGAN, JI			DYNAMIC ORGANIZATION OF DEVELOPING PURKINJE-CELLS REVEALED BY TRANSGENE EXPRESSION	SCIENCE			English	Article							CENTRAL-NERVOUS-SYSTEM; RAT CEREBELLAR CORTEX; MUTANT MICE; MOUSE; NEURONS; MUTATIONS; MABQ113; BANDS; GENE	The cerebellum has many properties that make it a useful model for investigating neural development. Purkinje cells, the major output neurons of the cerebellar cortex, have drawn special attention because of the availability of biochemical markers and mutants that affect their development. The spatial expression of L7, a protein specific for Purkinje cells, and L7-beta-Gal, a gene expressed in transgenic mice that was constructed from the L7 promoter and the marker beta-galactosidase, delineated bands of Purkinje cells that increased in number during early postnatal development. Expression of the transgene in adult reeler mutant mice, which show inverted cortical lamination, and in primary culture showed that the initial expression of L7 is intrinsic to Purkinje cells and does not depend on extracellular signals. This may reflect an underlying developmental map in cerebellum.	ROCHE INST MOLEC BIOL, ROCHE RES CTR, DEPT NEUROSCI, NUTLEY, NJ 07110 USA; UNIV CONNECTICUT, NEUROMORPHOL LAB, GRAD DEGREE PROGRAM BIOBEHAV SCI, STORRS, CT 06269 USA; UNIV MED & DENT NEW JERSEY, NEWARK, NJ 07103 USA	Roche Holding; University of Connecticut; Rutgers State University New Brunswick; Rutgers State University Medical Center			Morgan, James/GRO-2905-2022; Morgan, James/N-8104-2018	Morgan, James/0000-0002-8920-1065; Smeyne, Richard/0000-0002-8459-5472	NINDS NIH HHS [NS-09904] Funding Source: Medline; NINR NIH HHS [NRSA 08-08601] Funding Source: Medline	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))		AWGULEWITSCH A, 1986, NATURE, V320, P328, DOI 10.1038/320328a0; BERREBI AS, UNPUB; BERREBI AS, 1991, J COMP NEUROL, V309, P2; BROCHU G, 1990, J COMP NEUROL, V291, P538, DOI 10.1002/cne.902910405; CAVINESS VS, 1978, ANNU REV NEUROSCI, V1, P297, DOI 10.1146/annurev.ne.01.030178.001501; CHRISTAKOS S, 1989, ENDOCR REV, V10, P3, DOI 10.1210/edrv-10-1-3; FISCHER G, 1982, NEUROSCI LETT, V28, P325, DOI 10.1016/0304-3940(82)90079-9; GHETTI B, 1990, PROG BRAIN RES, V82, P197; GOFFINET AM, 1984, BRAIN RES REV, V7, P261, DOI 10.1016/0165-0173(84)90013-4; GOFFINET AM, 1983, ANAT EMBRYOL, V168, P73, DOI 10.1007/BF00305400; GREENBERG JM, 1990, NATURE, V344, P158, DOI 10.1038/344158a0; HAWKES R, 1987, J COMP NEUROL, V256, P29, DOI 10.1002/cne.902560104; HERRUP K, 1979, BRAIN RES, V178, P443, DOI 10.1016/0006-8993(79)90705-4; HSU SM, 1981, J HISTOCHEM CYTOCHEM, V29, P577, DOI 10.1177/29.4.6166661; KAWAMURA K, 1979, NEUROSCIENCE, V4, P1615, DOI 10.1016/0306-4522(79)90024-1; LECLERC N, 1988, J COMP NEUROL, V273, P399, DOI 10.1002/cne.902730310; MIALE IL, 1961, EXP NEUROL, V4, P277, DOI 10.1016/0014-4886(61)90055-3; OBERDICK J, 1990, SCIENCE, V248, P223, DOI 10.1126/science.2109351; SCHILLING K, UNPUB; SCHILLING KL, 1988, J NEUROSCI RES, V19, P27, DOI 10.1002/jnr.490190105; SMEYNE RJ, 1990, DEV BRAIN RES, V52, P211, DOI 10.1016/0165-3806(90)90237-S; SOTELO C, 1987, NEUROSCIENCE, V20, P1, DOI 10.1016/0306-4522(87)90002-9; WASSEF M, 1985, DEV BIOL, V111, P129, DOI 10.1016/0012-1606(85)90441-5; WASSEF M, 1987, DEV BIOL, V124, P379, DOI 10.1016/0012-1606(87)90490-8; WASSEF M, 1984, NEUROSCIENCE, V13, P1217, DOI 10.1016/0306-4522(84)90295-1; WETTS R, 1982, J EMBRYOL EXP MORPH, V68, P87; WILKINSON DG, 1989, NATURE, V341, P405, DOI 10.1038/341405a0; WILKINSON DG, 1989, NATURE, V337, P461, DOI 10.1038/337461a0	28	99	100	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 1	1991	254	5032					719	721		10.1126/science.1948052	http://dx.doi.org/10.1126/science.1948052			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN474	1948052				2022-12-28	WOS:A1991GN47400044
J	CHARTIERHARLIN, MC; CRAWFORD, F; HOULDEN, H; WARREN, A; HUGHES, D; FIDANI, L; GOATE, A; ROSSOR, M; ROQUES, P; HARDY, J; MULLAN, M				CHARTIERHARLIN, MC; CRAWFORD, F; HOULDEN, H; WARREN, A; HUGHES, D; FIDANI, L; GOATE, A; ROSSOR, M; ROQUES, P; HARDY, J; MULLAN, M			EARLY-ONSET ALZHEIMERS-DISEASE CAUSED BY MUTATIONS AT CODON-717 OF THE BETA-AMYLOID PRECURSOR PROTEIN GENE	NATURE			English	Article							POLYMORPHISMS	A MUTATION at codon 717 of the beta-amyloid precursor protein gene has been found to cosegregate with familial Alzheimer's disease in a single family 1. This mutation has been reported in a further five out of approximately 100 families multiply affected by Alzheimer's disease 1-4. We have identified another family, F19, in which we have detected linkage between the beta-amyloid precursor protein gene and Alzheimer's disease. Direct sequencing of exon 17 (ref. 5) in affected individuals from this family has revealed a base change producing a Val --> Gly substitution, also at codon 717. The occurrence of a second allelic variant at codon 717 linked to the Alzheimer's phenotype supports the hypothesis that they are pathogenic mutations.	UNIV LONDON IMPERIAL COLL SCI & TECHNOL, ST MARYS HOSP, SCH MED, DEPT BIOCHEM, LONDON W2 1PG, ENGLAND; UNIV LONDON IMPERIAL COLL SCI & TECHNOL, ST MARYS HOSP, SCH MED, DEPT NEUROL, LONDON W2 1PG, ENGLAND; JOHNS HOPKINS UNIV, SCH MED, DEPT PSYCHIAT, BALTIMORE, MD 21205 USA; JOHNS HOPKINS UNIV, SCH MED, DEPT BEHAV SCI, BALTIMORE, MD 21205 USA	Imperial College London; Imperial College London; Johns Hopkins University; Johns Hopkins University			Rossor, Martin/C-1598-2008; Chartier-Harlin, Marie-Christine/L-4527-2018; Hardy, John/C-2451-2009; Houlden, Henry J/C-1532-2008	Chartier-Harlin, Marie-Christine/0000-0001-6416-6526; Hardy, John/0000-0002-3122-0423; Houlden, Henry J/0000-0002-2866-7777; Mullan, Michael/0000-0002-1473-7527; Goate, Alison/0000-0002-0576-2472; Hughes, David John/0000-0003-1668-8770; Rossor, Martin/0000-0001-8215-3120	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ESCH FS, 1990, SCIENCE, V248, P1122, DOI 10.1126/science.2111583; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; HARDY J, 1991, LANCET, V337, P1342; HARLIN MCC, 1991, NEUROSCI LETT, V129, P134; HARRISON PJ, 1991, NEUROREPORT, V2, P152, DOI 10.1097/00001756-199103000-00011; JOHNSTONE EM, 1991, MOL BRAIN RES, V10, P299, DOI 10.1016/0169-328X(91)90088-F; KLAUSNER RD, 1989, SCIENCE, V246, P870, DOI 10.1126/science.2683086; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LEVY E, 1990, SCIENCE, V248, P1124, DOI 10.1126/science.2111584; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; MURRELL J, 1991, SCIENCE, V254, P97, DOI 10.1126/science.1925564; NARUSE S, 1991, LANCET, V337, P978, DOI 10.1016/0140-6736(91)91612-X; ORITA M, 1990, GENOMICS, V8, P271, DOI 10.1016/0888-7543(90)90282-Y; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; RUMBLE B, 1989, NEW ENGL J MED, V320, P1446, DOI 10.1056/NEJM198906013202203; TANZI RE, 1991, NATURE, V350, P564, DOI 10.1038/350564a0; VANDUIJN CM, 1991, LANCET, V337, P978, DOI 10.1016/0140-6736(91)91611-W; YOSHIKAI S, 1990, GENE, V87, P257, DOI 10.1016/0378-1119(90)90310-N	20	1069	1158	1	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 31	1991	353	6347					844	846		10.1038/353844a0	http://dx.doi.org/10.1038/353844a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM732	1944558				2022-12-28	WOS:A1991GM73200059
J	LINDSTEDT, SL; HOKANSON, JF; WELLS, DJ; SWAIN, SD; HOPPELER, H; NAVARRO, V				LINDSTEDT, SL; HOKANSON, JF; WELLS, DJ; SWAIN, SD; HOPPELER, H; NAVARRO, V			RUNNING ENERGETICS IN THE PRONGHORN ANTELOPE	NATURE			English	Article							BODY-MASS; MAMMALS; FLIGHT; CONSUMPTION; METABOLISM; FOXES; POWER; COST	THE pronghorn antelope (Antilocapra americana) has an alleged top speed of 100 km h-1, second only to the cheetah (Acionyx jubatus) among land vertebrates 1, a possible response to predation in the exposed habitat of the North American prairie 2. Unlike cheetahs, however, pronghorn antelope are distance runners rather than sprinters, and can run 11 km in 10 min, an average speed of 65 km h-1 (ref. 1). We measured maximum oxygen uptake in pronghorn antelope to distinguish between two potential explanations for this ability: either they have evolved a uniquely high muscular efficiency (low cost of transport) or they can supply oxygen to the muscles at unusually high levels. Because the cost of transport (energy per unit distance covered per unit body mass) varies as a predictable function of body mass among terrestrial vertebrates, we can calculate the predicted cost to maintain speeds of 65 and 100 km h-1 in an average 32-kg animal 3. The resulting range of predicted values, 3.2-5.1 ml O2 kg-1 s-1, far surpasses the predicted maximum aerobic capacity 4 of a 32-kg mammal (1.5 ml O2 kg-1 s-1). We conclude that their performance is achieved by an extraordinary capacity to consume and process enough oxygen to support a predicted running speed > 20 ms-1 (70 km h-1), attained without unique respiratory-system structures.	UNIV WYOMING,DEPT ZOOL & PHYSIOL,LARAMIE,WY 82071; UNIV BERN,DEPT ANAT,CH-3000 BERN 9,SWITZERLAND	University of Wyoming; University of Bern				Wells, Dominic/0000-0002-1425-6344				[Anonymous], 1981, Respir Physiol, V44, P1; Calder WA., 1984, SIZE FUNCTION LIFE H; CARPENTER RE, 1985, J EXP BIOL, V114, P619; Casey T.M., 1989, P257; COSTILL DL, 1976, MED SCI SPORT EXER, V8, P96; EPTING RJ, 1980, PHYSIOL ZOOL, V53, P347, DOI 10.1086/physzool.53.4.30157873; FEDAK MA, 1979, NATURE, V282, P713, DOI 10.1038/282713a0; GARLAND T, 1983, J ZOOL, V199, P157, DOI 10.1111/j.1469-7998.1983.tb02087.x; HEMMINGSEN A. M., 1950, Rep. Steno Mem. Hosp., V4, P7; HEMMINGSEN AXEL M., 1960, REPTS STENO HOSP COPENHAGEN, V9, P7; KLEIBER MAX, 1932, HILGARDIA, V6, P315; LASIEWSKI ROBERT C., 1963, PHYSIOL ZOOL, V36, P122; LECHNER AJ, 1978, RESP PHYSIOL, V34, P29, DOI 10.1016/0034-5687(78)90047-6; LINDSTEDT SL, 1988, INT J SPORTS MED, V9, P210, DOI 10.1055/s-2007-1025008; LONGWORTH KE, 1989, RESP PHYSIOL, V77, P263, DOI 10.1016/0034-5687(89)90115-1; MCKEAN T, 1974, RESP PHYSIOL, V21, P365, DOI 10.1016/0034-5687(74)90066-8; O'GARA B W, 1978, Mammalian Species, V90, P1; ROTHE HJ, 1987, J COMP PHYSIOL B, V157, P99, DOI 10.1007/BF00702734; Rubner M., 1883, Z BIOL, V19, P535; TAYLOR CR, 1981, RESP PHYSIOL, V44, P25, DOI 10.1016/0034-5687(81)90075-X; TAYLOR CR, 1970, AM J PHYSIOL, V219, P1104, DOI 10.1152/ajplegacy.1970.219.4.1104; THOMAS SP, 1975, J EXP BIOL, V63, P273; TUCKER VA, 1973, J EXP BIOL, V58, P689; TUCKER VA, 1975, AM SCI, V63, P413; TUCKER VA, 1966, SCIENCE, V154, P150, DOI 10.1126/science.154.3745.150; WELLS DJ, 1990, THESIS U WYOMING; [No title captured]	27	101	103	3	93	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	OCT 24	1991	353	6346					748	750		10.1038/353748a0	http://dx.doi.org/10.1038/353748a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL696	1944533				2022-12-28	WOS:A1991GL69600066
J	SCHUTZER, SE; COYLE, PK; BELMAN, AL; GOLIGHTLY, MG; DRULLE, J				SCHUTZER, SE; COYLE, PK; BELMAN, AL; GOLIGHTLY, MG; DRULLE, J			SEQUESTRATION OF ANTIBODY TO BORRELIA-BURGDORFERI IN IMMUNE-COMPLEXES IN SERONEGATIVE LYME-DISEASE	LANCET			English	Article									SUNY STONY BROOK, HLTH SCI CTR, DEPT NEUROL, STONY BROOK, NY 11794 USA; SUNY STONY BROOK, HLTH SCI CTR, DEPT PATHOL, STONY BROOK, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	SCHUTZER, SE (corresponding author), UNIV MED & DENT NEW JERSEY, NEW JERSEY MED SCH, DEPT MED, DIV ALLERGY & IMMUNOL, 185 S ORANGE AVE, NEWARK, NJ 07103 USA.							BARBOUR AG, 1989, ANN INTERN MED, V110, P501, DOI 10.7326/0003-4819-110-7-501; BENACH JL, 1983, NEW ENGL J MED, V308, P740, DOI 10.1056/NEJM198303313081302; BLAKE MS, 1984, ANAL BIOCHEM, V136, P175, DOI 10.1016/0003-2697(84)90320-8; COYLE PK, 1985, NEUROLOGY, V35, P429, DOI 10.1212/WNL.35.3.429; COYLE PK, 1987, J NEUROIMMUNOL, V15, P97, DOI 10.1016/0165-5728(87)90009-9; DATTWYLER RJ, 1988, NEW ENGL J MED, V319, P1441, DOI 10.1056/NEJM198812013192203; DIGEON M, 1977, J IMMUNOL METHODS, V16, P165, DOI 10.1016/0022-1759(77)90051-5; DOBSON SRM, 1988, J INFECT DIS, V158, P940, DOI 10.1093/infdis/158.5.940; HARDIN JA, 1984, YALE J BIOL MED, V57, P589; HARDIN JA, 1979, NEW ENGL J MED, V301, P1358, DOI 10.1056/NEJM197912203012502; HERRMANN K, 1978, BRIT J DERMATOL, V99, P635, DOI 10.1111/j.1365-2133.1978.tb07057.x; HOFFKEN K, 1982, J IMMUNOL METHODS, V53, P51, DOI 10.1016/0022-1759(82)90239-3; JONES VE, 1981, J IMMUNOL METHODS, V44, P249, DOI 10.1016/0022-1759(81)90045-4; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; STEERE AC, 1988, ANN NY ACAD SCI, V539, P87, DOI 10.1111/j.1749-6632.1988.tb31841.x; STEERE AC, 1989, NEW ENGL J MED, V321, P586, DOI 10.1056/NEJM198908313210906; STEERE AC, 1983, NEW ENGL J MED, V308, P733, DOI 10.1056/NEJM198303313081301; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; 1989, LANCET, V2, P198; 1978, J CLIN IMMUNOL, V1, P1	20	139	144	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 10	1990	335	8685					312	315		10.1016/0140-6736(90)90606-6	http://dx.doi.org/10.1016/0140-6736(90)90606-6			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CM846	1967770				2022-12-28	WOS:A1990CM84600004
J	JOHNSON, WA; HIRSH, J				JOHNSON, WA; HIRSH, J			BINDING OF A DROSOPHILA POU-DOMAIN PROTEIN TO A SEQUENCE ELEMENT REGULATING GENE-EXPRESSION IN SPECIFIC DOPAMINERGIC-NEURONS	NATURE			English	Article									HARVARD UNIV, SCH MED, DEPT BIOL CHEM & MOLEC PHARMACOL, BOSTON, MA 02115 USA	Harvard University; Harvard Medical School				Johnson, Wayne/0000-0002-6961-5498				ALTSCHUL SF, 1986, B MATH BIOL, V48, P603, DOI 10.1016/S0092-8240(86)90010-8; BEALL CJ, 1987, GENE DEV, V1, P510, DOI 10.1101/gad.1.5.510; BODNER M, 1988, CELL, V55, P505, DOI 10.1016/0092-8674(88)90037-2; BRAY SJ, 1989, GENE DEV, V3, P1130, DOI 10.1101/gad.3.8.1130; BRAY SJ, 1988, EMBO J, V7, P177, DOI 10.1002/j.1460-2075.1988.tb02798.x; BUDNIK V, 1988, J COMP NEUROL, V268, P400, DOI 10.1002/cne.902680309; CAMPOSORTEGA JA, 1988, TRENDS NEUROSCI, V11, P400, DOI 10.1016/0166-2236(88)90077-X; CLERC RG, 1988, GENE DEV, V2, P1570, DOI 10.1101/gad.2.12a.1570; DESAI C, 1988, NATURE, V336, P638, DOI 10.1038/336638a0; DOE CQ, 1988, NATURE, V333, P376, DOI 10.1038/333376a0; DOE CQ, 1985, COLD SPRING HARB SYM, V50, P891, DOI 10.1101/SQB.1985.050.01.106; DOE CQ, 1988, SCIENCE, V239, P170, DOI 10.1126/science.2892267; FINNEY M, 1988, CELL, V55, P757, DOI 10.1016/0092-8674(88)90132-8; GEHRING WJ, 1986, ANNU REV GENET, V20, P147, DOI 10.1146/annurev.ge.20.120186.001051; HEBERLEIN U, 1985, CELL, V41, P965, DOI 10.1016/S0092-8674(85)80077-5; HEBERLEIN U, 1988, NATURE, V331, P410, DOI 10.1038/331410a0; HERR W, 1988, GENE DEV, V2, P1513, DOI 10.1101/gad.2.12a.1513; INGRAHAM HA, 1988, CELL, V55, P519, DOI 10.1016/0092-8674(88)90038-4; JOHNSON WA, 1989, GENE DEV, V3, P676, DOI 10.1101/gad.3.5.676; KONRAD KD, 1987, DEV BIOL, V122, P172, DOI 10.1016/0012-1606(87)90343-5; LUNAN KD, 1969, ARCH BIOCHEM BIOPHYS, V132, P450, DOI 10.1016/0003-9861(69)90388-9; Maniatis T., 1982, MOL CLONING; NECKAMEYER WS, 1989, NEURON, V2, P1167, DOI 10.1016/0896-6273(89)90183-9; PATEL NH, 1989, GENE DEV, V3, P890, DOI 10.1101/gad.3.6.890; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; RUBIN GM, 1989, CELL, V57, P519, DOI 10.1016/0092-8674(89)90120-7; SCHOLNICK SB, 1983, CELL, V34, P37, DOI 10.1016/0092-8674(83)90134-4; SINGH H, 1988, CELL, V52, P415, DOI 10.1016/S0092-8674(88)80034-5; STURM RA, 1988, GENE DEV, V2, P1582, DOI 10.1101/gad.2.12a.1582; TABOR S, 1987, P NATL ACAD SCI USA, V84, P4767, DOI 10.1073/pnas.84.14.4767; TAYLOR JW, 1985, NUCLEIC ACIDS RES, V13, P8765; THOMAS JB, 1988, CELL, V52, P133, DOI 10.1016/0092-8674(88)90537-5; VINSON CR, 1988, GENE DEV, V2, P801, DOI 10.1101/gad.2.7.801; WRIGHT TRF, 1976, GENETICS, V84, P287; XI H, 1989, NATURE, V340, P35, DOI 10.1038/340035a0	35	165	167	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 1	1990	343	6257					467	470		10.1038/343467a0	http://dx.doi.org/10.1038/343467a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL818	1967821				2022-12-28	WOS:A1990CL81800062
J	BLACK, N				BLACK, N			MEDICAL LITIGATION AND THE QUALITY OF CARE	LANCET			English	Editorial Material											BLACK, N (corresponding author), UNIV LONDON LONDON SCH HYG & TROP MED,DEPT PUBL HLTH & POLICY,HLTH SERV RES UNIT,KEPPEL ST,LONDON WC1E 7HT,ENGLAND.							CHARLES SC, 1985, AM J PSYCHIAT, V142, P437; DANZON PM, 1985, MED MALPRACTICE THEO; Davenport O W, 1983, J Fla Med Assoc, V70, P293; Ham Christopher, 1988, MED NEGLIGENCE COMPE; HARVEY IM, 1987, LANCET, V1, P145; HILL G, 1988, J MED DEFENCE UNION, V49; JESSEE WF, 1987, P INT S QUALITY ASSU; JONES MA, 1989, J MED DEFENCE UNION, P40; LUFT HSA, 1988, QUALITY MED CARE INF, P165; MACFARLANE A, 1986, J MATERNAL CHILD HLT, V11, P38; PERRY S, 1987, P INT S QUALITY ASSU; SOMERS HM, 1977, MILBANK FUND Q, V55, P193, DOI 10.2307/3349643; TANCREDI LR, 1978, SCIENCE, V200, P879, DOI 10.1126/science.644329; WEISMAN CS, 1989, MED CARE, V27, P16, DOI 10.1097/00005650-198901000-00002; WYCKOFF RL, 1961, JAMA-J AM MED ASSOC, V176, P1096, DOI 10.1001/jama.1961.63040260001007; Zuckerman S, 1984, Health Aff (Millwood), V3, P128, DOI 10.1377/hlthaff.3.3.128; 1985, PROFESSIONAL LIABILI	17	20	20	0	1	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	JAN 6	1990	335	8680					35	37		10.1016/0140-6736(90)90151-T	http://dx.doi.org/10.1016/0140-6736(90)90151-T			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG766	1967339				2022-12-28	WOS:A1990CG76600016
J	JESILOW, P; GEIS, G; PONTELL, H				JESILOW, P; GEIS, G; PONTELL, H			FRAUD BY PHYSICIANS AGAINST MEDICAID	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GOVERNMENT; ABUSE	The inauguration of the Medicaid program in the mid 1960s ultimately led to the appearance of a wide range of new forms of illegal behavior by physicians. The fact that government authorities, instead of individual patients, were responsible for payments undoubtedly encouraged the large number of violations. A review of the background of sanctioned physicians shows an overrepresentation of psychiatrists and foreign medical graduates as well as minority-group physicians. Interviews with physicians sanctioned for Medicaid fraud and abuse indicated that they routinely placed the blame for their violations on the program, their employees, patients, or others. In particular, they find program guidelines confusing and irrational and insist that they intrude on what ought to be independent medical judgments. The enforcers, for their part, maintain that the convicted physicians are merely rationalizing self-serving and greedy behavior.			JESILOW, P (corresponding author), UNIV CALIF IRVINE,PROGRAM SOCIAL ECOL,IRVINE,CA 92717, USA.							BEYERS S, 1982, MIAMI HEARLD    0306, P1; BUCHANAN RJ, 1991, PUBLIC ADMIN REV, V51, P67, DOI 10.2307/976637; CATTERALL L, 1985, HONOLULU STAR B 0807, pA3; ELLERS RD, 1963, REGULATION BLUE CROS; FREIDSON E, 1975, DOCTORING TOGETHER; GEIS G, 1985, AM J PSYCHIAT, V142, P231; GRIMM F, 1983, MIAMI HERALD    0204, P1; HARRIS L, 1981, MED PRACTICE 1980S P; HOROSZOWSKI P, 1978, EC SPECIAL OPPORTUNI, P151; JESILOW P, IN PRESS PRESCRIPTIO; LAW SA, 1974, BLUE CROSS; Parsons T., 1951, SOCIAL SYSTEM; Pontell H N, 1984, Law Policy, V6, P405, DOI 10.1111/j.1467-9930.1984.tb00335.x; PONTELL HN, 1985, MED CARE, V23, P1028, DOI 10.1097/00005650-198508000-00010; PONTELL HN, 1984, PRACTITIONER FRAUD A; SMIGEL EO, 1956, AM SOCIOL REV, V21, P320, DOI 10.2307/2089287; SYKES GM, 1957, AM SOCIOL REV, V22, P664, DOI 10.2307/2089195; 1976, FRAUD ABUSE PRACTITI; 1984, SANTA ANA REGIS 0120, P14	19	24	24	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 18	1991	266	23					3318	3322		10.1001/jama.266.23.3318	http://dx.doi.org/10.1001/jama.266.23.3318			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GU964	1960831				2022-12-28	WOS:A1991GU96400031
J	SULLIVAN, LW				SULLIVAN, LW			THE NEED FOR MEDICAL-TREATMENT EFFECTIVENESS RESEARCH	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material											SULLIVAN, LW (corresponding author), US DEPT HHS,WASHINGTON,DC 20201, USA.								0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 18	1991	266	23					3264	3264						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GU964	1960817				2022-12-28	WOS:A1991GU96400006
J	ADAMS, AEM; BOTSTEIN, D; DRUBIN, DG				ADAMS, AEM; BOTSTEIN, D; DRUBIN, DG			REQUIREMENT OF YEAST FIMBRIN FOR ACTIN ORGANIZATION AND MORPHOGENESIS INVIVO	NATURE			English	Article								THE SAC6 gene was found by suppression of a yeast actin mutation 1. Its protein product, Sac6p (previously referred to as ABP67), was independently isolated by actin-filament affinity chromatography and colocalizes with actin in vivo 2. Thus Sac6p binds to actin in vitro, and functionally associates with actin structures involved in the development and maintenance of cell polarity in vivo 2,3. We report here that Sac6p is an actin-filament bundling protein 43% identical in amino-acid sequence to the vertebrate bundling protein fimbrin 4. This yeast fimbrin homologue contains two putative actin-binding regions 5 homologous to domains of dystrophin, beta-spectrin, filamin, actin-gelation protein and alpha-actinin. Mutants lacking Sac6p do not form normal actin structures and are defective in morphogenesis. These findings demonstrate an in vivo role for the well-documented biochemical interaction between fimbrin and actin.	STANFORD UNIV, MED CTR, SCH MED, DEPT GENET, STANFORD, CA 94305 USA; UNIV CALIF BERKELEY, DEPT MOLEC & CELL BIOL, BERKELEY, CA 94720 USA	Stanford University; University of California System; University of California Berkeley	ADAMS, AEM (corresponding author), UNIV ARIZONA, DEPT MOLEC & CELLULAR BIOL, LIFE SCI S, TUCSON, AZ 85721 USA.							ADAMS AEM, 1989, SCIENCE, V243, P231, DOI 10.1126/science.2643162; ADAMS AEM, 1989, GENETICS, V121, P675; ADAMS AEM, 1984, J CELL BIOL, V98, P934, DOI 10.1083/jcb.98.3.934; BRAY D, 1989, NATURE, V338, P203, DOI 10.1038/338203a0; BRESNICK AR, 1990, J BIOL CHEM, V265, P9236; BRETSCHER A, 1980, J CELL BIOL, V86, P335, DOI 10.1083/jcb.86.1.335; BYERS TJ, 1989, J CELL BIOL, V109, P1633, DOI 10.1083/jcb.109.4.1633; DEARRUDA MV, 1990, J CELL BIOL, V111, P1069, DOI 10.1083/jcb.111.3.1069; DRUBIN DG, 1990, NATURE, V343, P288, DOI 10.1038/343288a0; DRUBIN DG, 1988, J CELL BIOL, V107, P2551, DOI 10.1083/jcb.107.6.2551; GLENNEY JR, 1981, J BIOL CHEM, V256, P9283; GORLIN JB, 1990, J CELL BIOL, V111, P1089, DOI 10.1083/jcb.111.3.1089; HENIKOFF S, 1984, GENE, V28, P351, DOI 10.1016/0378-1119(84)90153-7; KILMARTIN JV, 1984, J CELL BIOL, V98, P922, DOI 10.1083/jcb.98.3.922; KOENIG M, 1988, CELL, V53, P219, DOI 10.1016/0092-8674(88)90383-2; LIN CS, 1990, MOL CELL BIOL, V10, P1818, DOI 10.1128/MCB.10.4.1818; LIN CS, 1988, MOL CELL BIOL, V8, P4659, DOI 10.1128/MCB.8.11.4659; MATSUDAIRA PT, 1979, J CELL BIOL, V83, P667, DOI 10.1083/jcb.83.3.667; MAYER SA, 1991, MOL CELL BIOL, V11, P813, DOI 10.1128/MCB.11.2.813; MAYER SA, 1989, MOL CELL BIOL, V9, P4161, DOI 10.1128/MCB.9.10.4161; MILLAKE DB, 1989, NUCLEIC ACIDS RES, V17, P6725, DOI 10.1093/nar/17.16.6725; NOEGEL AA, 1989, J CELL BIOL, V109, P607, DOI 10.1083/jcb.109.2.607; PICTON JM, 1982, J THEOR BIOL, V98, P15, DOI 10.1016/0022-5193(82)90054-6; PRINGLE JR, 1989, METHOD CELL BIOL, V31, P357; SIKORSKI RS, 1989, GENETICS, V122, P19; STRYNADKA NCJ, 1989, ANNU REV BIOCHEM, V58, P951, DOI 10.1146/annurev.bi.58.070189.004511; VIEIRA J, 1987, METHOD ENZYMOL, V153, P3; WOOLFORD JL, 1989, YEAST, V5, P439, DOI 10.1002/yea.320050604	28	186	188	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 5	1991	354	6352					404	408		10.1038/354404a0	http://dx.doi.org/10.1038/354404a0			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT761	1956405				2022-12-28	WOS:A1991GT76100055
J	GERBERT, B; MAGUIRE, BT; BLEECKER, T; COATES, TJ; MCPHEE, SJ				GERBERT, B; MAGUIRE, BT; BLEECKER, T; COATES, TJ; MCPHEE, SJ			PRIMARY CARE PHYSICIANS AND AIDS - ATTITUDINAL AND STRUCTURAL BARRIERS TO CARE	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HIV-INFECTION	Objective. - To explore the extent to which primary care physicians are providing health care for people with human immunodeficiency virus (HIV) infection and to document barriers to HIV care giving. Design. - National random-sample mailed survey Participants. - Population-based random sample of 2004 US general internists, family physicians, and general practitioners in 1990. Response rate was 59%. Main Outcome Measures. - HIV treatment experience, willingness to treat HIV-infected patients, negative attitudes toward homosexuals and intravenous drug users, fear of contagion of the acquired immunodeficiency syndrome (AIDS), perceived lack of information about AIDS, and time demands of HIV care. Results. - Most physicians (75%) had treated one or more patients with HIV infection. A majority (68%) believed that they had a responsibility to treat people with HIV infection, yet half (50%) indicated that they would not, if given a choice. Over 80% of respondents believed that they lacked information about AIDS and that caring for people with AIDS is time consuming. Further, 35% of respondents agreed that they "would feel nervous among a group of homosexuals" and 55% expressed discomfort about having intravenous drug users in their practice. Physicians who had treated 10 or more HIV-infected patients expressed less negativity toward members of these stigmatized groups who are likely to be HIV infected. Conclusions. - These data suggest that many primary care physicians are responding professionally to the AIDS epidemic but that attitudinal barriers may be hindering some physicians from providing treatment to HIV-infected patients.	UNIV CALIF SAN FRANCISCO,CTR AIDS PREVENT STUDIES,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,SCH MED,SAN FRANCISCO,CA 94143; UNIV WALES,DEPT PSYCHOL,BANGOR,WALES	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Bangor University	GERBERT, B (corresponding author), UNIV CALIF SAN FRANCISCO,SCH DENT,DIV BEHAV SCI,707 PARNASSUS D1012,SAN FRANCISCO,CA 94143, USA.				NIMH NIH HHS [MH42459] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH042459] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ALLEN BL, 1990, NEW ENGL J MED, V323, P755; ARNOW PM, 1989, PUBLIC HEALTH REP, V104, P121; Babbie ER, 1973, SURVEY RES METHODS, P165; BLENDON RJ, 1990, AIDS HLTH CARE SYSTE, P77; COOKE M, 1988, AIDS PUBLIC POLICY J, V3, P59; FREDMAN L, 1989, AM J PREV MED, V5, P188, DOI 10.1016/S0749-3797(18)31079-1; GEMSON DH, 1991, ARCH INTERN MED, V151, P1102, DOI 10.1001/archinte.151.6.1102; GERBERT B, 1991, NEW ENGL J MED, V324, P926; HAYWARD RA, 1991, ANN INTERN MED, V114, P23, DOI 10.7326/0003-4819-114-1-23; KELLY JA, 1987, AM J PUBLIC HEALTH, V77, P789, DOI 10.2105/AJPH.77.7.789; LEWIS CE, 1987, AM J PUBLIC HEALTH, V77, P795, DOI 10.2105/AJPH.77.7.795; LINK RN, 1988, AM J PUBLIC HEALTH, V78, P455, DOI 10.2105/AJPH.78.4.455; MCKUSICK L, 1986, WESTERN J MED, V144, P751; RICHARDSON JL, 1987, MED CARE, V25, P675, DOI 10.1097/00005650-198708000-00001; RIZZO JA, 1990, MED CARE, V28, P251, DOI 10.1097/00005650-199003000-00005; ROTHMAN DJ, 1990, NEW ENGL J MED, V323, P764, DOI 10.1056/NEJM199009133231129; SHULTZ JM, 1988, MINN MED, V71, P277; SMITH MD, 1991, J GEN INTERN MED, V6, pS56, DOI 10.1007/BF02599259; WARTENBERG AA, 1991, J GEN INTERN MED, V6, pS35, DOI 10.1007/BF02599256; 1991, CDC HIV AIDS PRE FEB, P5; 1988, JAMA-J AM MED ASSOC, V259, P1360; 1991, HIV AIDS SURVEILLANC, P7; [No title captured]	23	173	173	0	6	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 27	1991	266	20					2837	2842		10.1001/jama.266.20.2837	http://dx.doi.org/10.1001/jama.266.20.2837			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GQ722	1942450				2022-12-28	WOS:A1991GQ72200030
J	WILENSKY, GR				WILENSKY, GR			MEDICARES PROS CHANGE THEIR FOCUS, BROADEN THEIR MISSION	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	3	3	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 27	1991	266	20					2810	2810						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GQ722	1942437				2022-12-28	WOS:A1991GQ72200005
J	SOUDAH, HC; HASLER, WL; OWYANG, C				SOUDAH, HC; HASLER, WL; OWYANG, C			EFFECT OF OCTREOTIDE ON INTESTINAL MOTILITY AND BACTERIAL OVERGROWTH IN SCLERODERMA	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PROGRESSIVE SYSTEMIC-SCLEROSIS; ANALOG SMS 201-995; MIGRATING MOTOR COMPLEX; ESOPHAGEAL DYSFUNCTION; MYOELECTRIC ACTIVITY; TRANSIT-TIME; SOMATOSTATIN; CISAPRIDE; PSEUDOOBSTRUCTION; ABSORPTION	Background. Patients with scleroderma may have abnormal motility of the small intestine, with pseudoobstruction and bacterial overgrowth. Standard stimulatory agents are often ineffective in such patients. Because the somatostatin analogue octreotide evokes intestinal motor activity in normal subjects, we hypothesized that it might increase motility in patients with scleroderma. Methods. We studied the effects of octreotide on intestinal motility and plasma motilin concentrations in five fasting patients with scleroderma who had bacterial overgrowth and in six fasting normal subjects. The motor effects of octreotide were correlated with its effects on abdominal symptoms and bacterial overgrowth as determined by the level of breath hydrogen excretion. Results. In the normal subjects, octreotide (l0-mu-g subcutaneously) increased the mean (+/- SD) frequency of intestinal migrating complexes, which reflect intestinal motility, from 1.5 +/- 1.0 to 4.1 +/- 1.1 every three hours. In the patients with scleroderma, who had no spontaneous migrating complexes, octreotide (100-mu-g) induced 3.6 +/- 2.3 complexes every three hours. These complexes propagated at the same velocity and had two-thirds the amplitude of the spontaneous complexes in normal subjects. Plasma motilin concentrations, which were higher in the patients with scleroderma (229 +/- 74 pmol per liter) than in the normal subjects (112 +/- 37 pmol per liter), were inhibited by octreotide, suggesting that intestinal activity evoked by octreotide is independent of motilin. Treatment of the patients with scleroderma with octreotide (50-mu-g every evening) for three weeks reduced breath hydrogen excretion while they were fasting from 25 +/- 5 to 4 +/- 2 ppm (P = 0.001) and breath hydrogen excretion after they ingested 50 g of glucose from 46 +/- 24 to 8 +/- 7 ppm (P = 0.015); these reductions were accompanied by a significant decrease in nausea, bloating, and abdominal pain and by less frequent emesis. Conclusions. Octreotide stimulates intestinal motility in normal subjects and in patients with scleroderma. In such patients, the short-term administration of octreotide reduces bacterial overgrowth and improves abdominal symptoms. This agent may be useful for the treatment of intestinal dysmotility in patients with scleroderma.	UNIV MICHIGAN,MED CTR,DEPT INTERNAL MED,GASTROENTEROL RES UNIT,3912 TAUBMAN CTR,BOX 0362,ANN ARBOR,MI 48109	University of Michigan System; University of Michigan					NIDDK NIH HHS [R01 DK35783, P30 DK34933] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034933, R01DK035783] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AKESSON A, 1987, SCAND J RHEUMATOL, V16, P291, DOI 10.3109/03009748709102931; ANDERSON IH, 1981, NEW ENGL J MED, V304, P891, DOI 10.1056/NEJM198104093041507; BAUER W, 1982, LIFE SCI, V31, P1133, DOI 10.1016/0024-3205(82)90087-X; BUENO L, 1975, J PHYSIOL-LONDON, V249, P69, DOI 10.1113/jphysiol.1975.sp011003; CAMILLERI M, 1989, GASTROENTEROLOGY, V96, P704; CAMILLERI M, 1986, GASTROENTEROLOGY, V91, P619, DOI 10.1016/0016-5085(86)90631-1; CLARK M, 1967, BRIT J DERMATOL, V79, P449, DOI 10.1111/j.1365-2133.1967.tb11531.x; COHEN S, 1972, J CLIN INVEST, V51, P2663, DOI 10.1172/JCI107084; CORAZZA GR, 1990, GASTROENTEROLOGY, V98, P302, DOI 10.1016/0016-5085(90)90818-L; DIMARINO AJ, 1973, NEW ENGL J MED, V289, P1220, DOI 10.1056/NEJM197312062892304; FUESSL HS, 1987, DIGESTION, V36, P101, DOI 10.1159/000199407; Goetz Robert H., 1945, CLIN PROCEED, V4, P337; GORDEN P, 1989, ANN INTERN MED, V110, P35, DOI 10.7326/0003-4819-110-1-35; GREYDANUS MP, 1989, GASTROENTEROLOGY, V96, P110, DOI 10.1016/0016-5085(89)90770-1; Hale CH, 1944, AM J ROENTGENOL RADI, V51, P407; HAMELROY J, 1985, GASTROENTEROLOGY, V88, P1; HOROWITZ M, 1987, GASTROENTEROLOGY, V93, P311, DOI 10.1016/0016-5085(87)91020-1; HORSWELL RR, 1961, GASTROENTEROLOGY, V40, P580; HUNTER WM, 1962, NATURE, V194, P495, DOI 10.1038/194495a0; KAHN IJ, 1966, NEW ENGL J MED, V274, P1339, DOI 10.1056/NEJM196606162742402; KERLIN P, 1982, GASTROENTEROLOGY, V82, P701; KERLIN P, 1988, GASTROENTEROLOGY, V95, P982, DOI 10.1016/0016-5085(88)90173-4; KING CE, 1986, GASTROENTEROLOGY, V91, P1447, DOI 10.1016/0016-5085(86)90199-X; KREJS GJ, 1984, DIABETES, V33, P548, DOI 10.2337/diabetes.33.6.548; METZ G, 1976, LANCET, V1, P668; PEACHEY RDG, 1969, GUT, V10, P285, DOI 10.1136/gut.10.4.285; PEETERS TL, 1983, REGUL PEPTIDES, V5, P209, DOI 10.1016/0167-0115(83)90252-5; PEETERS TL, 1988, SCAND J GASTROENTERO, V23, P769, DOI 10.3109/00365528809090758; POITRAS P, 1980, AM J PHYSIOL, V239, pG215, DOI 10.1152/ajpgi.1980.239.3.G215; Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee, 1980, ARTHRITIS RHEUM, V23, P581; REES WDW, 1982, GASTROENTEROLOGY, V83, P575; REINHARDT JF, 1962, AMER J ROENTGENOL RA, V88, P687; ROHRMANN CA, 1981, AM J ROENTGENOL, V143, P933; SCHEMANN M, 1986, GASTROENTEROLOGY, V90, P1950, DOI 10.1016/0016-5085(86)90266-0; SCHUFFLER MD, 1981, MEDICINE, V60, P173, DOI 10.1097/00005792-198105000-00002; TREACY WL, 1962, MAYO CLIN PROC, V37, P607; VANTRAPPEN G, 1979, DIGEST DIS SCI, V24, P497, DOI 10.1007/BF01489315; VANTRAPPEN G, 1978, GASTROINTESTINAL MOT, P3; WHITEHEAD WE, 1989, GASTROENTEROLOGY, V96, P428, DOI 10.1016/0016-5085(89)91567-9; WITT K, 1989, SCAND J GASTROENTERO, V24, P1248, DOI 10.3109/00365528909090795	40	307	311	0	4	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 21	1991	325	21					1461	1467		10.1056/NEJM199111213252102	http://dx.doi.org/10.1056/NEJM199111213252102			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GQ406	1944424				2022-12-28	WOS:A1991GQ40600002
J	BI, E; LUTKENHAUS, J				BI, E; LUTKENHAUS, J			FTSZ RING STRUCTURE ASSOCIATED WITH DIVISION IN ESCHERICHIA-COLI	NATURE			English	Article							CELL-DIVISION; DNA-REPLICATION; INHIBITOR SULA; BEHAVIOR; MUTANTS; PROTEIN; SEPTUM; SHAPE; LOCUS	GENES for cell division have been identified in Escherichia coli by the isolation of conditional lethal mutations that block cell division, but do not affect DNA replication or segregation 1. Of these genes, ftsZ is of great interest as it acts earliest in the division pathway 2,3, is essential 4, its level dictates the frequency of division 5,6, and it is thought to be the target of two cell-division inhibitors 7-9, SulA, produced in response to DNA damage 10, and MinCD, which prevents division at old sites 11. Here we have used immunoelectronmicroscopy to localize the FtsZ protein to the division site. The results suggest that FtsZ self-assembles into a ring structure at the future division site and may function as a cytoskeletal element. The formation of this ring may be the point at which division is regulated.			BI, E (corresponding author), UNIV KANSAS,MED CTR,DEPT MICROBIOL MOLEC GENET & IMMUNOL,KANSAS CITY,KS 66103, USA.							BEALL B, 1991, GENE DEV, V5, P447, DOI 10.1101/gad.5.3.447; BEGG KJ, 1985, J BACTERIOL, V163, P615, DOI 10.1128/JB.163.2.615-622.1985; BI E, 1990, J BACTERIOL, V172, P2765, DOI 10.1128/jb.172.5.2765-2768.1990; BI E, 1990, J BACTERIOL, V172, P5602, DOI 10.1128/jb.172.10.5602-5609.1990; BI E, 1990, J BACTERIOL, V172, P5610, DOI 10.1128/jb.172.10.5610-5616.1990; BI E, IN PRESS PROKARYOTIC; BURTON P, 1983, MOL GEN GENET, V190, P309, DOI 10.1007/BF00330656; CASAREGOLA S, 1990, MOL MICROBIOL, V4, P505, DOI 10.1111/j.1365-2958.1990.tb00617.x; CORTON JC, J BACTERIOL, V169, P1; DAI K, 1991, J BACTERIOL, V172, P3500; DEBOER PAJ, 1989, CELL, V56, P641, DOI 10.1016/0092-8674(89)90586-2; DEBOER PAJ, 1990, P NATL ACAD SCI USA, V87, P1129, DOI 10.1073/pnas.87.3.1129; HUISMAN O, 1981, NATURE, V290, P797, DOI 10.1038/290797a0; ITO K, 1981, CELL, V24, P707, DOI 10.1016/0092-8674(81)90097-0; JAFFE A, 1986, J BACTERIOL, V165, P66, DOI 10.1128/jb.165.1.66-71.1986; NIKI H, 1991, EMBO J, V10, P183, DOI 10.1002/j.1460-2075.1991.tb07935.x; ROBIN A, 1990, J BACTERIOL, V172, P1392, DOI 10.1128/jb.172.3.1392-1399.1990; SCHROEDER TE, 1973, P NATL ACAD SCI USA, V70, P1688, DOI 10.1073/pnas.70.6.1688; TASCHNER PEM, 1988, J BACTERIOL, V170, P1533, DOI 10.1128/jb.170.4.1533-1540.1988; TEATHER RM, 1974, J BACTERIOL, V118, P407, DOI 10.1128/JB.118.2.407-413.1974; WARD JE, 1984, J BACTERIOL, V157, P815, DOI 10.1128/JB.157.3.815-820.1984; WARD JE, 1985, CELL, V42, P399; WIENTJES FB, 1989, J BACTERIOL, V171, P3412, DOI 10.1128/jb.171.6.3412-3419.1989	23	1133	1169	2	99	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	NOV 14	1991	354	6349					161	164		10.1038/354161a0	http://dx.doi.org/10.1038/354161a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GP880	1944597				2022-12-28	WOS:A1991GP88000064
J	BELLIVEAU, JW; KENNEDY, DN; MCKINSTRY, RC; BUCHBINDER, BR; WEISSKOFF, RM; COHEN, MS; VEVEA, JM; BRADY, TJ; ROSEN, BR				BELLIVEAU, JW; KENNEDY, DN; MCKINSTRY, RC; BUCHBINDER, BR; WEISSKOFF, RM; COHEN, MS; VEVEA, JM; BRADY, TJ; ROSEN, BR			FUNCTIONAL MAPPING OF THE HUMAN VISUAL-CORTEX BY MAGNETIC-RESONANCE-IMAGING	SCIENCE			English	Article							POSITRON-EMISSION TOMOGRAPHY; CEREBRAL BLOOD-VOLUME; HUMAN-BRAIN; COMPUTED-TOMOGRAPHY; COGNITIVE NEUROSCIENCE; STRIATE CORTEX; INSTANT IMAGES; FLOW; CONTRAST; NMR	Knowledge of regional cerebral hemodynamics has widespread application for both physiological research and clinical assessment because of the well-established interrelation between physiological function, energy metabolism, and localized blood supply. A magnetic resonance technique was developed for quantitative imaging of cerebral hemodynamics, allowing for measurement of regional cerebral blood volume during resting and activated cognitive states. This technique was used to generate the first functional magnetic resonance maps of human task activation, by using a visual stimulus paradigm. During photic stimulation, localized increases in blood volume (32 +/- 10 percent, n = 7 subjects) were detected in the primary visual cortex. Center-of-mass coordinates and linear extents of brain activation within the plane of the calcarine fissure are reported.	MASSACHUSETTS GEN HOSP,CTR NMR,DEPT RADIOL,BOSTON,MA 02114; HARVARD UNIV,SCH MED,BOSTON,MA 02115; MASSACHUSETTS GEN HOSP,CTR NMR,DEPT NEUROL,BOSTON,MA 02114	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital			Kennedy, David N/H-3627-2012; Cohen, Mark S/C-6610-2011	Cohen, Mark S/0000-0001-6731-4053	NATIONAL CANCER INSTITUTE [P01CA048729, R01CA040303] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL039810] Funding Source: NIH RePORTER; NCI NIH HHS [P01-CA48729, R01-CA40303] Funding Source: Medline; NHLBI NIH HHS [R01-HL39810] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ANDREASEN NC, 1988, SCIENCE, V239, P1381, DOI 10.1126/science.3279509; AXEL L, 1983, INVEST RADIOL, V18, P94, DOI 10.1097/00004424-198301000-00018; AXEL L, 1980, RADIOLOGY, V137, P679, DOI 10.1148/radiology.137.3.7003648; Belliveau J W, 1991, J Neuroimaging, V1, P36; BELLIVEAU JW, 1990, MAGNET RESON MED, V14, P538, DOI 10.1002/mrm.1910140311; CAVINESS VS, 1989, BRAIN DEV-JPN, V11, P1; CHURCHLAND PS, 1988, SCIENCE, V242, P741, DOI 10.1126/science.3055294; COHEN MS, 1991, MAGN RESON IMAGING, V9, P1, DOI 10.1016/0730-725X(91)90094-3; FISEL CR, 1991, MAGNET RESON MED, V17, P336, DOI 10.1002/mrm.1910170206; FOX PT, 1984, J NEUROPHYSIOL, V51, P1109, DOI 10.1152/jn.1984.51.5.1109; FOX PT, 1986, NATURE, V323, P806, DOI 10.1038/323806a0; FOX PT, 1985, ANN NEUROL, V17, P303, DOI 10.1002/ana.410170315; FOX PT, 1987, J NEUROSCI, V7, P913; GAZZANIGA MS, 1989, SCIENCE, V245, P947, DOI 10.1126/science.2672334; KENNEDY DN, 1989, IEEE T MED IMAGING, V8, P1, DOI 10.1109/42.20356; KENT TA, 1989, AM J NEURORADIOL, V10, P335; KOSSLYN SM, 1988, SCIENCE, V240, P1621, DOI 10.1126/science.3289115; Lassen N. A., 1983, HDB PHYSL 2, VIII, P21; LASSEN NA, 1984, J CEREBR BLOOD F MET, V4, P633, DOI 10.1038/jcbfm.1984.90; MANSFIELD P, 1977, J PHYS C SOLID STATE, V10, pL55, DOI 10.1088/0022-3719/10/3/004; MINTUN MA, 1989, J CEREBR BLOOD F MET, V9, P96, DOI 10.1038/jcbfm.1989.13; MOONEN CTW, 1990, SCIENCE, V250, P53, DOI 10.1126/science.2218514; MOSELEY ME, 1990, 1990 P SOC MAGN RES, P56; PETERSEN SE, 1988, NATURE, V331, P585, DOI 10.1038/331585a0; PHELPS ME, 1981, SCIENCE, V211, P1445, DOI 10.1126/science.6970412; PHELPS ME, 1985, SCIENCE, V228, P799, DOI 10.1126/science.2860723; POSNER MI, 1988, SCIENCE, V240, P1627, DOI 10.1126/science.3289116; PYKETT IL, 1987, MAGNET RESON MED, V5, P563; Raichle M. E., 1987, HDB PHYSL NERVOUS SY, V1, P643; ROSEN B R, 1989, Magnetic Resonance Quarterly, V5, P263; ROSEN BR, 1990, MAGNET RESON MED, V14, P249, DOI 10.1002/mrm.1910140211; RZEDZIAN RR, 1987, AM J ROENTGENOL, V149, P245, DOI 10.2214/ajr.149.2.245; SAKAI F, 1985, J CEREBR BLOOD F MET, V5, P207, DOI 10.1038/jcbfm.1985.27; SANDMAN CA, 1984, SCIENCE, V224, P1355, DOI 10.1126/science.6729458; SOKOLOFF L, 1985, BRAIN IMAGING BRAIN; STARMER CF, 1970, J APPL PHYSIOL, V28, P219, DOI 10.1152/jappl.1970.28.2.219; Talairach J, 1967, ATLAS ANATOMIE STERE; Talairach J., 1988, COPLANAR STEREOTAXIC; THOMPSON HK, 1964, CIRC RES, V14, P502, DOI 10.1161/01.RES.14.6.502; VILLRINGER A, 1988, MAGNET RESON MED, V6, P164, DOI 10.1002/mrm.1910060205; ZEKI S, 1988, NATURE, V335, P311, DOI 10.1038/335311a0	42	1303	1363	12	128	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	NOV 1	1991	254	5032					716	719		10.1126/science.1948051	http://dx.doi.org/10.1126/science.1948051			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN474	1948051				2022-12-28	WOS:A1991GN47400043
J	TIAN, QS; STREULI, M; SAITO, H; SCHLOSSMAN, SF; ANDERSON, P				TIAN, QS; STREULI, M; SAITO, H; SCHLOSSMAN, SF; ANDERSON, P			A POLYADENYLATE BINDING-PROTEIN LOCALIZED TO THE GRANULES OF CYTOLYTIC LYMPHOCYTES INDUCES DNA FRAGMENTATION IN TARGET-CELLS	CELL			English	Article							BACTERIOPHAGE-T7 RNA-POLYMERASE; MEMBRANE-GLYCOPROTEINS; CD8+ LYMPHOCYTES; LYSIS; EXPRESSION; APOPTOSIS; PERFORIN; ENDONUCLEASE; INHIBITION; MECHANISM	Cytolytic lymphocytes (CTLs) are characterized by their inclusion of cytoplasmic granules containing effector molecules such as perforin and the serine proteases. Here we describe the cDNA cloning and functional characterization of two related isoforms of a cytolytic granule protein designated TIA-1. Sequence analysis reveals that the 40 kd TIA-1 isoform (rp40-TIA-1) is structurally related to the poly(A)-binding proteins, possessing three RNA-binding domains and a carboxy-terminal, glutamine-rich auxiliary domain. The 15 kd TIA-1 isoform, the major species present in cytolytic granules, appears to be derived from the carboxy-terminal auxiliary domain of rp40-TIA-1 by proteolytic processing. Both natural and recombinant TIA-1 were found to induce DNA fragmentation in digitonin permeabilized thymocytes, suggesting that these molecules may be the granule components responsible for inducing apoptosis in CTL targets.	HARVARD UNIV, BRIGHAM & WOMENS HOSP, SCH MED, DEPT RHEUMATOL & IMMUNOL, BOSTON, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	TIAN, QS (corresponding author), HARVARD UNIV, SCH MED, DANA FARBER CANC INST, DIV TUMOR IMMUNOL, BOSTON, MA 02115 USA.		Saito, Haruo/AAF-6113-2019	Saito, Haruo/0000-0001-7891-1689	NATIONAL CANCER INSTITUTE [R01CA053595] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI012069, R01AI012069] Funding Source: NIH RePORTER; NCI NIH HHS [R01CA53595-01] Funding Source: Medline; NIAID NIH HHS [AI12069-17] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALLBRITTON NL, 1988, J EXP MED, V167, P514, DOI 10.1084/jem.167.2.514; ANDERSON P, 1990, J IMMUNOL, V144, P574; BANDZIULIS RJ, 1989, GENE DEV, V3, P431, DOI 10.1101/gad.3.4.431; BONTHRON DT, 1986, NATURE, V324, P270, DOI 10.1038/324270a0; BURKHARDT JK, 1989, P NATL ACAD SCI USA, V86, P7128, DOI 10.1073/pnas.86.18.7128; BURKHARDT JK, 1990, J CELL BIOL, V111, P1227; CHEN JW, 1988, J BIOL CHEM, V263, P8754; CULL M, 1990, METHOD ENZYMOL, V182, P147; DUKE RC, 1989, J EXP MED, V170, P1451, DOI 10.1084/jem.170.4.1451; DUKE RC, 1983, P NATL ACAD SCI-BIOL, V80, P6361, DOI 10.1073/pnas.80.20.6361; DUVALL E, 1986, IMMUNOL TODAY, V7, P115, DOI 10.1016/0167-5699(86)90152-0; FRUTH U, 1987, EUR J IMMUNOL, V17, P1625, DOI 10.1002/eji.1830171116; GOLSTEIN P, 1991, IMMUNOL REV, V121, P28; GRANGE T, 1987, NUCLEIC ACIDS RES, V15, P4771, DOI 10.1093/nar/15.12.4771; HAMEED A, 1989, J EXP MED, V169, P765, DOI 10.1084/jem.169.3.765; HAYES MP, 1989, J EXP MED, V170, P933, DOI 10.1084/jem.170.3.933; HOWE CL, 1988, P NATL ACAD SCI USA, V85, P7577, DOI 10.1073/pnas.85.20.7577; KING SM, 1985, P NATL ACAD SCI USA, V82, P4717, DOI 10.1073/pnas.82.14.4717; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P857, DOI 10.1093/nar/12.2.857; LAVIE G, 1985, J IMMUNOL, V135, P1470; LICHTENHELD MG, 1988, NATURE, V335, P448, DOI 10.1038/335448a0; MARTZ E, 1989, IMMUNOL TODAY, V10, P79, DOI 10.1016/0167-5699(89)90231-4; MATTAJ IW, 1989, CELL, V57, P1, DOI 10.1016/0092-8674(89)90164-5; MURPHY KM, 1990, SCIENCE, V250, P1720, DOI 10.1126/science.2125367; PASTERNACK MS, 1991, J BIOL CHEM, V266, P14703; PETERS PJ, 1989, EUR J IMMUNOL, V19, P1469, DOI 10.1002/eji.1830190819; PETERS PJ, 1991, J EXP MED, V173, P1099, DOI 10.1084/jem.173.5.1099; PODACK ER, 1984, J EXP MED, V160, P695, DOI 10.1084/jem.160.3.695; PRUSINER SB, 1989, ANNU REV MICROBIOL, V43, P345, DOI 10.1146/annurev.mi.43.100189.002021; RODGERS KE, 1988, J IMMUNOL, V140, P564; RUSSELL JH, 1983, IMMUNOL REV, V72, P97, DOI 10.1111/j.1600-065X.1983.tb01074.x; SACHS AB, 1986, CELL, V45, P827, DOI 10.1016/0092-8674(86)90557-X; Sambrook J, 1989, MOL CLONING LABORATO; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; SHIVER JW, 1991, CELL, V64, P1175, DOI 10.1016/0092-8674(91)90272-Z; SMITH CA, 1989, NATURE, V337, P181, DOI 10.1038/337181a0; SNYDER M, 1987, METHOD ENZYMOL, V154, P107; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; TABOR S, 1985, P NATL ACAD SCI USA, V82, P1074, DOI 10.1073/pnas.82.4.1074; TANAKA Y, 1984, J BIOL CHEM, V259, P6579; TSCHOPP J, 1990, ANNU REV IMMUNOL, V8, P279, DOI 10.1146/annurev.immunol.8.1.279; TSCHOPP J, 1989, NATURE, V337, P272, DOI 10.1038/337272a0; UCKER DS, 1987, NATURE, V327, P62, DOI 10.1038/327062a0; WILLIAMS MA, 1990, J CELL BIOL, V111, P955, DOI 10.1083/jcb.111.3.955; WYLLIE AH, 1980, NATURE, V284, P555, DOI 10.1038/284555a0; YOUNG JD, 1988, IMMUNOL TODAY, V9, P140; YOUNG JDE, 1986, P NATL ACAD SCI USA, V83, P150, DOI 10.1073/pnas.83.1.150; YUE CC, 1987, MOL IMMUNOL, V24, P647, DOI 10.1016/0161-5890(87)90046-0	48	359	371	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 1	1991	67	3					629	639		10.1016/0092-8674(91)90536-8	http://dx.doi.org/10.1016/0092-8674(91)90536-8			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GN664	1934064				2022-12-28	WOS:A1991GN66400018
J	HOLLAND, R; HENDRIKS, JHCL; VERBEEK, ALM; MRAVUNAC, M; STEKHOVEN, JHS				HOLLAND, R; HENDRIKS, JHCL; VERBEEK, ALM; MRAVUNAC, M; STEKHOVEN, JHS			EXTENT, DISTRIBUTION, AND MAMMOGRAPHIC HISTOLOGICAL CORRELATIONS OF BREAST DUCTAL CARCINOMA INSITU	LANCET			English	Article									CATHOLIC UNIV NIJMEGEN,DEPT RADIOL,6500 HB NIJMEGEN,NETHERLANDS; CATHOLIC UNIV NIJMEGEN,DEPT EPIDEMIOL,6500 HB NIJMEGEN,NETHERLANDS; CANISIUS WILHELMINA HOSP,DEPT PATHOL,NIJMEGEN,NETHERLANDS	Radboud University Nijmegen; Radboud University Nijmegen; Canisius-Wilhelmina Hospital	HOLLAND, R (corresponding author), CATHOLIC UNIV NIJMEGEN,DEPT PATHOL,6500 HB NIJMEGEN,NETHERLANDS.		Verbeek, A.L.M./H-8103-2014	Verbeek, A.L.M./0000-0002-2319-5002				BAKER LH, 1982, CA-CANCER J CLIN, V32, P194, DOI 10.3322/canjclin.32.4.194; EGAN RL, 1982, CANCER, V49, P1123, DOI 10.1002/1097-0142(19820315)49:6<1123::AID-CNCR2820490610>3.0.CO;2-R; Fagerberg CJG, 1988, SCREENING BREAST CAN, P33; FISHER ER, 1986, CANCER-AM CANCER SOC, V57, P197, DOI 10.1002/1097-0142(19860115)57:2<197::AID-CNCR2820570203>3.0.CO;2-N; HOLLAND R, 1990, J CLIN ONCOL, V8, P113, DOI 10.1200/JCO.1990.8.1.113; HOLLAND R, 1985, CANCER, V56, P979, DOI 10.1002/1097-0142(19850901)56:5<979::AID-CNCR2820560502>3.0.CO;2-N; LAGIOS MD, 1982, CANCER-AM CANCER SOC, V50, P1309, DOI 10.1002/1097-0142(19821001)50:7<1309::AID-CNCR2820500716>3.0.CO;2-#; Lanyi M., 1986, DIAGNOSIS DIFFERENTI; PEETERS PHM, 1989, INT J CANCER, V43, P226, DOI 10.1002/ijc.2910430209; PEETERS PHM, 1989, INT J EPIDEMIOL, V18, P295, DOI 10.1093/ije/18.2.295; ROSEN PP, 1979, ANN SURG, V189, P377, DOI 10.1097/00000658-197903000-00021; SCHNITT SJ, 1988, NEW ENGL J MED, V318, P898, DOI 10.1056/NEJM198804073181406; SICKLES EA, 1986, RADIOLOGY, V160, P289, DOI 10.1148/radiology.160.2.3726103; Tabar L, 1983, TEACHING ATLAS MAMMO, P138	14	424	430	0	5	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	MAR 3	1990	335	8688					519	522		10.1016/0140-6736(90)90747-S	http://dx.doi.org/10.1016/0140-6736(90)90747-S			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT015	1968538				2022-12-28	WOS:A1990CT01500014
J	ANDREWS, PJD; PIPER, IR; DEARDEN, NM; MILLER, JD				ANDREWS, PJD; PIPER, IR; DEARDEN, NM; MILLER, JD			SECONDARY INSULTS DURING INTRAHOSPITAL TRANSPORT OF HEAD-INJURED PATIENTS	LANCET			English	Article											ANDREWS, PJD (corresponding author), UNIV EDINBURGH,WESTERN GEN HOSP,DEPT CLIN NEUROSCI,EDINBURGH EH4 2UX,SCOTLAND.							BION JF, 1985, BRIT MED J, V291, P432, DOI 10.1136/bmj.291.6493.432; BRAMAN SS, 1987, ANN INTERN MED, V107, P469, DOI 10.7326/0003-4819-107-4-469; EHRENWERTH J, 1986, CRIT CARE MED, V14, P543, DOI 10.1097/00003246-198606000-00005; FRANKEL LR, 1987, INT ANESTHESIOL CLIN, V25, P77, DOI 10.1097/00004311-198702520-00006; GENTLEMAN D, 1981, LANCET, V2, P853; GERVAIS HW, 1987, CRIT CARE MED, V15, P761, DOI 10.1097/00003246-198708000-00010; GRAHAM DI, 1989, J NEUROL NEUROSUR PS, V52, P346, DOI 10.1136/jnnp.52.3.346; INSEL J, 1986, CRIT CARE MED, V14, P539, DOI 10.1097/00003246-198606000-00004; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; KOHI YM, 1984, INJURY, V16, P25, DOI 10.1016/0020-1383(84)90110-4; MILLER JD, 1981, J NEUROSURG, V54, P289, DOI 10.3171/jns.1981.54.3.0289; MILLER JD, 1978, JAMA-J AM MED ASSOC, V240, P439, DOI 10.1001/jama.240.5.439; PEARL RG, 1987, INT ANESTHESIOL CLIN, V25, P43, DOI 10.1097/00004311-198702520-00005; WADDELL G, 1975, BRIT MED J, V2, P417, DOI 10.1136/bmj.2.5968.417; WADDELL G, 1975, BRIT MED J, V1, P386, DOI 10.1136/bmj.1.5954.386; WRIGHT I, 1988, ANN INTERN MED, V108, P638, DOI 10.7326/0003-4819-108-4-638_1	16	185	192	0	1	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	FEB 10	1990	335	8685					327	330		10.1016/0140-6736(90)90614-B	http://dx.doi.org/10.1016/0140-6736(90)90614-B			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CM846	1967776				2022-12-28	WOS:A1990CM84600011
J	AHRONHEIM, JC; GASNER, MR				AHRONHEIM, JC; GASNER, MR			THE SLOGANISM OF STARVATION	LANCET			English	Editorial Material									NYU,SCH MED,DEPT MED,DIV GERIATR,NEW YORK,NY 10003; SOC RIGHT DIE,DEPT LEGAL SERV,NEW YORK,NY 10107	New York University								ABRAMS FR, 1988, WITHHOLDING WITHDRAW; American College of Physicians Ethics Manual, 1989, ANN INTERN MED, V111, P327; [Anonymous], 1989, NEUROLOGY, V39, P125; BASTOW MD, 1986, GUT, V27, P51, DOI 10.1136/gut.27.Suppl_1.51; BILLINGS JA, 1985, J AM GERIATR SOC, V33, P808, DOI 10.1111/j.1532-5415.1985.tb04196.x; CAMPBELLTAYLOR I, 1987, J AM GERIATR SOC, V35, P1100, DOI 10.1111/j.1532-5415.1987.tb04927.x; CIOCON JO, 1988, ARCH INTERN MED, V148, P429, DOI 10.1001/archinte.148.2.429; CRANFORD RE, 1984, SEMIN NEUROL, V4, P36, DOI 10.1055/s-2008-1041530; DERR PG, 1986, HASTINGS CENT REP, V16, P28; HILL TP, 1988, FINAL REPORT CITIZEN; LEBOWITZ LJ, 1987, MASS MED         JAN, P11; LO B, 1984, NEW ENGL J MED, V311, P402, DOI 10.1056/NEJM198408093110611; LYNN J, 1986, NO EXTRAORDINARY MEA; METHENY NA, 1986, HEART LUNG, V15, P256; MILLER PD, 1982, AM J MED, V73, P354, DOI 10.1016/0002-9343(82)90726-4; PHILLIPS PA, 1984, NEW ENGL J MED, V311, P753, DOI 10.1056/NEJM198409203111202; PRINTZ LA, 1988, GERIATRICS, V43, P84; RHODEN NK, 1988, HARVARD LAW REV, V102, P375, DOI 10.2307/1341384; ROWE JW, 1985, FLUID ELECTROLYTE AC, P1231; SCHMITZ P, 1986, NO EXTRAORDINARY MEA, P29; SIEGLER M, 1985, ARCH INTERN MED, V145, P129, DOI 10.1001/archinte.145.1.129; WALSHE TM, 1985, ARCH NEUROL-CHICAGO, V42, P1045, DOI 10.1001/archneur.1985.04060100027014; YAKOVLEV PI, 1954, J NEUROPATH EXP NEUR, V13, P267, DOI 10.1097/00005072-195401000-00021; 1987, GUIDELINES TERMINATI, P60; 1983, DECIDING FOREGO LIFE, P190; 1986, PUBLIC OPINION HLTH; 1989, JUN AMA HOUS DEL M; 1988, PHYSICIAN OPINION HL; 1987, J AM DIET ASSOC, V87, P78; 1988, AM J NURS, V6, P797; 1986, CURRENT OPINIONS COU, P12; 1986, NY TIMES        1202	32	44	44	0	1	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	FEB 3	1990	335	8684					278	279		10.1016/0140-6736(90)90084-I	http://dx.doi.org/10.1016/0140-6736(90)90084-I			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CL815	1967733	hybrid			2022-12-28	WOS:A1990CL81500017
J	LEVESQUE, H; SEVRAIN, L; FREGER, P; TADIE, M; COURTOIS, H; CREISSARD, P				LEVESQUE, H; SEVRAIN, L; FREGER, P; TADIE, M; COURTOIS, H; CREISSARD, P			RAISED PLASMA ENDOTHELIN IN ANEURYSMAL SUBARACHNOID HEMORRHAGE	LANCET			English	Letter											LEVESQUE, H (corresponding author), CHU ROUEN BOISGUILLAUME,SERV INTERNAL MED & NEUROSURG,F-76233 BOIS GUILLAUME,FRANCE.							ALLEN GS, 1983, NEW ENGL J MED, V308, P619, DOI 10.1056/NEJM198303173081103; CHABRIER PE, 1989, J CARDIOVASC PHARM, V13, pS32; CREISSARD P, 1988, NEUROCHIRURGIE, V34, P157; MASOAKA, 1989, LANCET, V2, P1402; SHIGENO T, 1989, J CARDIOVASC PHARM, V13, pS174, DOI 10.1097/00005344-198900135-00047; YANAGISAWA M, 1988, NATURE, V332, P411, DOI 10.1038/332411a0	6	8	8	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	FEB 3	1990	335	8684					290	290		10.1016/0140-6736(90)90106-F	http://dx.doi.org/10.1016/0140-6736(90)90106-F			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CL815	1967742				2022-12-28	WOS:A1990CL81500027
J	ROSE, G; SHIPLEY, M				ROSE, G; SHIPLEY, M			EFFECTS OF CORONARY RISK REDUCTION ON THE PATTERN OF MORTALITY	LANCET			English	Review											ROSE, G (corresponding author), UNIV LONDON LONDON SCH HYG & TROP MED,DEPT EPIDEMIOL & POPULAT SCI,LONDON WC1E 7HT,ENGLAND.							ISLES CG, 1989, BMJ-BRIT MED J, V298, P920, DOI 10.1136/bmj.298.6678.920; REID DD, 1974, LANCET, V1, P469; ROSE G, 1981, BMJ-BRIT MED J, V282, P1847, DOI 10.1136/bmj.282.6279.1847; ROSE G, 1980, LANCET, V1, P523; 1988, BRIT MED J, V296, P1565; 1982, JAMA-J AM MED ASSOC, V248, P2853	6	25	25	0	1	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	FEB 3	1990	335	8684					275	277		10.1016/0140-6736(90)90082-G	http://dx.doi.org/10.1016/0140-6736(90)90082-G			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CL815	1967732				2022-12-28	WOS:A1990CL81500016
J	GRANT, D; WALL, W; MIMEAULT, R; ZHONG, R; GHENT, C; GARCIA, B; STILLER, C; DUFF, J				GRANT, D; WALL, W; MIMEAULT, R; ZHONG, R; GHENT, C; GARCIA, B; STILLER, C; DUFF, J			SUCCESSFUL SMALL-BOWEL LIVER-TRANSPLANTATION	LANCET			English	Article									UNIV WESTERN ONTARIO, DEPT MED, LONDON N6A 3K7, ONTARIO, CANADA; UNIV WESTERN ONTARIO, DEPT PATHOL, LONDON N6A 3K7, ONTARIO, CANADA; UNIV WESTERN ONTARIO, DEPT SURG, LONDON N6A 3K7, ONTARIO, CANADA	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)								BJARNASON I, 1983, GASTROENTEROLOGY, V85, P318; CALNE RY, 1969, NATURE, V223, P472, DOI 10.1038/223472a0; COHEN Z, 1986, TRANSPLANTATION, V42, P613, DOI 10.1097/00007890-198612000-00008; DELTZ E, 1989, OCT INT S SMALL BOW; DIFLO T, 1988, TRANSPLANT P, V20, P200; Fung JJ, 1987, CLIN TRANSPLANT, V1, P187; GALE RP, 1986, LANCET, V1, P1468; GONWA TA, 1988, TRANSPLANTATION, V46, P690, DOI 10.1097/00007890-198811000-00013; GOULET O, 1989, OCT INT S SMALL BOW; GRANT D, 1989, TRANSPLANTATION, V48, P151, DOI 10.1097/00007890-198907000-00036; GRANT D, 1988, TRANSPLANTATION, V45, P279, DOI 10.1097/00007890-198802000-00005; GRANT D, 1989, J SURG RES, V46, P507, DOI 10.1016/0022-4804(89)90169-8; GRANT D, IN PRESS TRANSPLANT; KAMADA N, 1983, TRANSPLANTATION, V35, P304, DOI 10.1097/00007890-198304000-00008; MARTINELLI GP, 1988, TRANSPLANTATION, V45, P1021, DOI 10.1097/00007890-198806000-00005; MOORE FD, 1989, JAMA-J AM MED ASSOC, V261, P1483, DOI 10.1001/jama.261.10.1483; PRITCHARD TJ, 1985, WORLD J SURG, V9, P860, DOI 10.1007/BF01655390; SCHRAUT WH, 1988, GASTROENTEROLOGY, V94, P525, DOI 10.1016/0016-5085(88)90449-0; STARZL TE, 1989, JAMA-J AM MED ASSOC, V261, P1449, DOI 10.1001/jama.261.10.1449; WILLIAMS JW, 1989, JAMA-J AM MED ASSOC, V261, P1458, DOI 10.1001/jama.261.10.1458; WILMORE DW, 1988, SURGERY, V104, P917	21	385	399	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 27	1990	335	8683					181	184		10.1016/0140-6736(90)90275-A	http://dx.doi.org/10.1016/0140-6736(90)90275-A			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CL185	1967664				2022-12-28	WOS:A1990CL18500001
J	DIFRANZA, JR; RICHARDS, JW; PAULMAN, PM; WOLFGILLESPIE, N; FLETCHER, C; JAFFE, RD; MURRAY, D				DIFRANZA, JR; RICHARDS, JW; PAULMAN, PM; WOLFGILLESPIE, N; FLETCHER, C; JAFFE, RD; MURRAY, D			RJR NABISCOS CARTOON CAMEL PROMOTES CAMEL CIGARETTES TO CHILDREN	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SMOKELESS TOBACCO; DRUG-USE; SMOKING; ADVERTISEMENTS; ADOLESCENCE; SCHOOLCHILDREN; INITIATION; PATTERNS; BEHAVIOR; TRENDS	Objectives. - To determine if RJR Nabisco's cartoon-theme advertising is more effective in promoting Camel cigarettes to children or to adults. To determine if children see, remember, and are influenced by cigarette advertising. Design. - Use of four standard marketing measures to compare the effects of Camel's Old Joe cartoon advertising on children and adults. Subjects. - High school students, grades 9 through 12, from five regions of the United States, and adults, aged 21 years and over, from Massachusetts. Outcome Measures.-Recognition of Camel's Old Joe cartoon character, product and brand name recall, brand preference, appeal of advertising themes. Results. - Children were more likely to report prior exposure to the Old Joe cartoon character (97.7% vs 72.2%; P < .0001). Children were better able to identify the type of product being advertised (97.5% vs 67.0%; P < .0001) and the Camel cigarette brand name (93.6% vs 57.7%; P < .0001). Children also found the Camel cigarette advertisements more appealing (P < .0001). Camel's share of the illegal children's cigarette market segment has increased from 0.5% to 32.8%, representing sales estimated at $476 million per year. Conclusion. - Old Joe Camel cartoon advertisements are far more successful at marketing Camel cigarettes to children than to adults. This finding is consistent with tobacco industry documents that indicate that a major function of tobacco advertising is to promote and maintain tobacco addiction among children.	UNIV NEW MEXICO,SCH MED,DEPT FAMILY COMMUNITY & EMERGENCY MED,ALBUQUERQUE,NM 87131; UNIV WASHINGTON,DEPT FAMILY PRACTICE,SEATTLE,WA 98195; MED COLL GEORGIA,DEPT FAMILY MED,AUGUSTA,GA 30912; UNIV NEBRASKA,MED CTR,DEPT FAMILY PRACTICE,OMAHA,NE 68105; UNIV MINNESOTA,DEPT EPIDEMIOL,MINNEAPOLIS,MN 55455	University of New Mexico; University of Washington; University of Washington Seattle; University System of Georgia; Augusta University; University of Nebraska System; University of Nebraska Medical Center; University of Minnesota System; University of Minnesota Twin Cities	DIFRANZA, JR (corresponding author), UNIV MASSACHUSETTS,SCH MED,DEPT FAMILY PRACTICE,47 ASHBY STATE RD,FITCHBURG,MA 01420, USA.			Murray, David/0000-0003-0797-9269				Aitken P., 1986, HLTH ED RES, V1, P203, DOI DOI 10.1093/her/1.3.203; AITKEN PP, 1985, SOC SCI MED, V21, P785, DOI 10.1016/0277-9536(85)90127-3; AITKEN PP, 1987, BRIT J ADDICT, V82, P615; AITKEN PP, 1986, HLTH ED J; ALEXANDER HM, 1983, INT J EPIDEMIOL, V12, P59, DOI 10.1093/ije/12.1.59; BARTON J, 1982, CHILD DEV, V53, P1499, DOI 10.2307/1130077; BIRD L, 1991, ADWEEKS MARKETI 0520, P20; BLASI V, 1986, JAMA-J AM MED ASSOC, V256, P502, DOI 10.1001/jama.256.4.502; BLUM A, 1991, NEW ENGL J MED, V324, P913, DOI 10.1056/NEJM199103283241310; BLUM A, 1980, JAMA-J AM MED ASSOC, V244, P739; BORSCH B, 1991, PEDIATR MANAGEME MAR, P14; CHAPMAN S, 1982, AM J PUBLIC HEALTH, V72, P491, DOI 10.2105/AJPH.72.5.491; Charlton A., 1986, HLTH ED J, V45, P75; CHASSIN L, 1981, PERS SOC PSYCHOL B, V7, P670, DOI 10.1177/014616728174025; CONNOLLY GN, 1986, NEW ENGL J MED, V314, P1020, DOI 10.1056/NEJM198604173141605; DAVIS RM, 1987, NEW ENGL J MED, V316, P725, DOI 10.1056/NEJM198703193161206; DIFRANZA JR, 1990, JAMA-J AM MED ASSOC, V263, P2784, DOI 10.1001/jama.263.20.2784; DIFRANZA JR, 1986, MAY ANN M SOC TEACH; GOLDSTEIN AO, 1987, J PEDIATR-US, V110, P488, DOI 10.1016/S0022-3476(87)80523-1; HUNTER SM, 1986, AM J PUBLIC HEALTH, V76, P193, DOI 10.2105/AJPH.76.2.193; HUNTER SMD, 1980, PREV MED, V9, P701; JOHNSTON LD, 1985, USE LICIT ILLICIT DR; KANDEL DB, 1984, AM J PUBLIC HEALTH, V74, P660, DOI 10.2105/AJPH.74.7.660; KLEIN JD, IN PRESS PEDIATRICS; Ledwith F., 1984, HLTH ED J, V43, P85, DOI DOI 10.1177/001789698404300402; MCALPINE KE, 1988, AM ASSOC ADV SCI PUB, V88, P215; MCNEILL AD, 1985, LANCET, V2, P271; MINTZ M, 1991, NATION          0506, P591; PIERCE JP, 1989, JAMA-J AM MED ASSOC, V261, P61, DOI 10.1001/jama.261.1.61; REYNOLDS RJ, 1984, TIME MAGAZINE   0409, P91; THOMPSON JW, 1984, REPORT RJR MACDONALD; TYE J, 1989, TOBACCO YOUTH REPORT, V4, P1; Tye J B, 1987, J Public Health Policy, V8, P492, DOI 10.2307/3342275; TYE JB, 1987, TOBACCO YOUTH REP, V2, P1; 1975, AD11345; 1990, MMWR, V39, P665; 1983, VOLUNTARY INITIATIVE; 1990, TAX BURDEN TOBACCO, V25, P109; 1982, EXPORT FAMILY STRATE; 1977, RJR16 MACD INC IMP T; YOUTH 1987; 1986, DHHS PHS NIH862874; EXPORT FAMILY STRATE; RJR286 MACD INC IMP, P1980; 1979, TEENAGE SMOKING IMME; 1981, 3RD FAMILY QUALITATI; 1990, ADVERTISING AGE 1203, P56; 1982, PROJECT PLUS MINUS; 1986, JAMA-J AM MED ASSOC, V255, P1033; EXPORT A BRAND LONG; 1989, HLTH TOBACCO END TOB	51	218	218	0	18	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 11	1991	266	22					3149	3153		10.1001/jama.266.22.3149	http://dx.doi.org/10.1001/jama.266.22.3149			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GT654	1956102				2022-12-28	WOS:A1991GT65400023
J	GEISLER, FH				GEISLER, FH			CORRECTION	NEW ENGLAND JOURNAL OF MEDICINE			English	Correction, Addition																		GEISLER FH, 1991, NEW ENGL J MED, V324, P1829, DOI 10.1056/NEJM199106273242601	1	23	23	0	0	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 5	1991	325	23					1659	1660						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GR770	1944464				2022-12-28	WOS:A1991GR77000034
J	JACOB, J; KELSOE, G; RAJEWSKY, K; WEISS, U				JACOB, J; KELSOE, G; RAJEWSKY, K; WEISS, U			INTRACLONAL GENERATION OF ANTIBODY MUTANTS IN GERMINAL-CENTERS	NATURE			English	Article							B-CELL LINEAGES; IMMUNE-RESPONSE; SOMATIC HYPERMUTATION; PRIMARY IMMUNIZATION; MEMORY; AMPLIFICATION; POLYMERASE; FIDELITY; MICE; NP	THE generation and selection of somatic antibody mutants are key elements of acquired immunity, essential for the affinity maturation of antibody responses dependent on T cells. The mutants are generated through a mechanism that introduces point mutations at high rate into rearranged variable (V) region genes in the course of cell proliferation 1,2. Their appearance coincides with the generation of germinal centres, which are characterized by oligoclonal B-cell proliferation 3,4 and have been suggested to be the microenvironment in which antibody mutants are generated 5,6. We report here direct evidence for this hypothesis. Rearranged V-region genes were amplified from the genomic DNA of cells picked from individual germinal centres. The sequence analysis of these genes revealed that most represent cells of distinct B-cell clones which expanded locally, generating somatic antibody mutants at high rate. By contrast, antigen-induced proliferation of B cells at another site, periarteriolar lymphocyte sheath-associated foci, was not associated with somatic hypermutation.	UNIV COLOGNE,INST GENET,W-5000 COLOGNE 41,GERMANY	University of Cologne	JACOB, J (corresponding author), UNIV MARYLAND,SCH MED,DEPT MICROBIOL & IMMUNOL,BALTIMORE,MD 21201, USA.			Kelsoe, Garnett/0000-0002-8770-040X				ALLEN D, 1987, IMMUNOL REV, V96, P5, DOI 10.1111/j.1600-065X.1987.tb00506.x; APEL M, 1990, INT IMMUNOL, V2, P813, DOI 10.1093/intimm/2.9.813; BLIER PR, 1987, J IMMUNOL, V139, P3996; CUMANO A, 1985, EUR J IMMUNOL, V15, P512, DOI 10.1002/eji.1830150517; CUMANO A, 1986, EMBO J, V5, P2459, DOI 10.1002/j.1460-2075.1986.tb04522.x; DUNNING AM, 1988, NUCLEIC ACIDS RES, V16, P10393, DOI 10.1093/nar/16.21.10393; FOOTE J, 1991, NATURE, V352, P530, DOI 10.1038/352530a0; FRENCH DL, 1989, SCIENCE, V244, P1152, DOI 10.1126/science.2658060; JACOB J, 1991, J EXP MED, V173, P1165, DOI 10.1084/jem.173.5.1165; Kabat E. A., 1987, SEQUENCES PROTEINS I, DOI 10.1016/0003-2697(84)90805-4; KEOHAVONG P, 1989, P NATL ACAD SCI USA, V86, P9253, DOI 10.1073/pnas.86.23.9253; KOCKS C, 1989, ANNU REV IMMUNOL, V7, P537, DOI 10.1146/annurev.iy.07.040189.002541; Kroese F G, 1990, Curr Top Pathol, V84 ( Pt 1), P103; MACLENNAN ICM, 1986, IMMUNOL REV, V91, P61, DOI 10.1111/j.1600-065X.1986.tb01484.x; MANSER T, 1989, J EXP MED, V170, P1211, DOI 10.1084/jem.170.4.1211; MCKEAN D, 1984, P NATL ACAD SCI-BIOL, V81, P3180, DOI 10.1073/pnas.81.10.3180; PAABO S, 1990, J BIOL CHEM, V265, P4718; REYNAUD CA, 1991, CELL, V64, P995, DOI 10.1016/0092-8674(91)90323-Q; ROSE ML, 1980, NATURE, V284, P364, DOI 10.1038/284364a0; SCHITTEK B, 1990, NATURE, V346, P749, DOI 10.1038/346749a0; TAO W, 1990, J IMMUNOL, V145, P3216; TINDALL KR, 1988, BIOCHEMISTRY-US, V27, P6008, DOI 10.1021/bi00416a027; WEISS U, 1990, J EXP MED, V172, P1681, DOI 10.1084/jem.172.6.1681	23	902	913	1	30	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	DEC 5	1991	354	6352					389	392		10.1038/354389a0	http://dx.doi.org/10.1038/354389a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT761	1956400				2022-12-28	WOS:A1991GT76100050
J	ROSENBAUM, PR				ROSENBAUM, PR			DISCUSSING HIDDEN BIAS IN OBSERVATIONAL STUDIES	ANNALS OF INTERNAL MEDICINE			English	Editorial Material						BIAS (EPIDEMIOLOGY); CASE-CONTROL STUDIES; SELECTION BIAS; SENSITIVITY AND SPECIFICITY; STATISTICS	SENSITIVITY ANALYSIS; PERMUTATION INFERENCES; CANCER	In observational studies or nonrandomized experiments, treated and control groups may differ in their outcomes even if the treatment has no effect; this may happen if the groups were not comparable before the start of treatment. The groups may fail to be comparable in either of two ways: They may differ with respect to characteristics that have been measured, in which case there is an overt bias, or they may differ in ways that have not been measured, in which case there is a hidden bias. Overt biases are controlled through adjustments, such as matching. Hidden bias is more difficult to address because the relevant measurements are not available. A sensitivity analysis asks how much hidden bias would need to be present if hidden bias were to explain the differing outcomes in the treated and control groups. A sensitivity analysis provides a tangible and specific framework for discussing hidden biases.			ROSENBAUM, PR (corresponding author), UNIV PENN, WHARTON SCH, DEPT STAT, 3013 STEINBERG DIETRICH HALL, PHILADELPHIA, PA 19104 USA.		Rosenbaum, Paul R/H-8687-2012					CAMERON E, 1976, P NATL ACAD SCI USA, V73, P3685, DOI 10.1073/pnas.73.10.3685; Cochran W. G., 1965, J ROYAL STATISTICA A, V128, P134, DOI DOI 10.2307/2344179; CORNFIELD J, 1959, J NATL CANCER I, V22, P173; Cox DR., 1970, ANAL BINARY DATA; HAMMOND EC, 1964, J NATL CANCER I, V32, P1161; HOLLANDER M, 1973, NONPARAMETRIC STATIS; KELSEY JL, 1975, AM J EPIDEMIOL, V102, P63, DOI 10.1093/oxfordjournals.aje.a112135; MOERTEL CG, 1985, NEW ENGL J MED, V312, P137, DOI 10.1056/NEJM198501173120301; POINCARE H, 1952, SCI HYPOTHESIS 1905, P140; ROSENBAUM PR, 1989, SCAND J STAT, V16, P227; ROSENBAUM PR, 1991, BIOMETRICS, V47, P87, DOI 10.2307/2532498; ROSENBAUM PR, 1987, BIOMETRIKA, V74, P13, DOI 10.2307/2336017; ROSENBAUM PR, 1990, J AM STAT ASSOC, V85, P493, DOI 10.2307/2289789; ROSENBAUM PR, 1988, BIOMETRIKA, V75, P577, DOI 10.1093/biomet/75.3.577; ROSENBAUM PR, 1986, J EDUC STAT, V11, P207	15	153	155	0	11	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 1	1991	115	11					901	905		10.7326/0003-4819-115-11-901	http://dx.doi.org/10.7326/0003-4819-115-11-901			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GR171	1952480				2022-12-28	WOS:A1991GR17100012
J	ROTHROCK, JF; HART, RG				ROTHROCK, JF; HART, RG			ANTITHROMBOTIC THERAPY IN CEREBROVASCULAR-DISEASE	ANNALS OF INTERNAL MEDICINE			English	Review						CEREBROVASCULAR DISORDERS; FIBRINOLYTIC AGENTS; ANTICOAGULANTS; PLATELET AGGREGATION INHIBITORS; THROMBOSIS	TRANSIENT ISCHEMIC ATTACKS; HEPARIN-INDUCED THROMBOCYTOPENIA; MOLECULAR-WEIGHT HEPARIN; NONVALVULAR ATRIAL-FIBRILLATION; TISSUE PLASMINOGEN-ACTIVATOR; ACUTE MYOCARDIAL-INFARCTION; SYSTEM CEREBRAL INFARCTION; PROFILE CLINICAL COURSE; RANDOMIZED TRIAL; ANTICOAGULANT-THERAPY	For more than two decades, anticoagulant and antiplatelet agents have been used routinely to prevent and treat ischemic stroke. Although recent clinical trials have shown that such treatment can be helpful in certain cases, antithrombotic therapy currently remains of unproven benefit in many clinical settings of cerebrovascular disease. Although the absence of data confirming clinical efficacy has generated uncertainty and hesitancy in some clinicians, the lingering conviction that antithrombotic therapy is efficacious has led others to continue a policy of routine and active therapeutic intervention. A critical analysis of the literature on antithrombotic therapy and cerebrovascular disease suggests that many acceptable management options lie between the extremes of therapeutic nihilism and "routine" intervention.	UNIV TEXAS, HLTH SCI CTR, SAN ANTONIO, TX 78284 USA	University of Texas System; University of Texas Health San Antonio	ROTHROCK, JF (corresponding author), UNIV CALIF SAN DIEGO, MED CTR, DEPT NEUROL, H-815A, 225 DICKINSON ST, SAN DIEGO, CA 92103 USA.							[Anonymous], 1990, Stroke, V21, P1122; [Anonymous], 1985, Stroke, V16, P406; [Anonymous], 1988, LANCET, V2, P349; [Anonymous], 1988, BRIT MED J, V296, P316; [Anonymous], 1988, BRIT MED J, V296, P320; [Anonymous], 1988, Stroke, V19, P512; ANSELL JE, 1985, CHEST, V88, P878, DOI 10.1378/chest.88.6.878; BAKER RN, 1962, NEUROLOGY, V12, P823, DOI 10.1212/WNL.12.12.823; BARNETT HJM, 1985, CEREBROVASC DIS, P27; BECKER PS, 1989, STROKE, V20, P1449, DOI 10.1161/01.STR.20.11.1449; BELL WR, 1988, J LAB CLIN MED, V111, P600; BILLER J, 1989, STROKE, V20, P441, DOI 10.1161/01.STR.20.4.441; BILLER J, 1989, NEUROLOGY, V39, P262, DOI 10.1212/WNL.39.2.262; BOGOUSSLAVSKY J, 1990, STROKE, V21, P40, DOI 10.1161/01.STR.21.1.40; BOGOUSSLAVSKY J, 1985, ACTA NEUROL SCAND, V71, P464; BORSTEIN NM, 1991, NEUROLOGY S1, V41, P328; BOUSSER MG, 1983, STROKE, V14, P5, DOI 10.1161/01.STR.14.1.5; BRITTON M, 1985, STROKE, V16, P629, DOI 10.1161/01.STR.16.4.629; BRODERICK JP, 1990, STROKE, V21, P173; BRODY M, 1991, Neurology, V41, P126; BRUST JCM, 1977, NEUROLOGY, V27, P701, DOI 10.1212/WNL.27.8.701; BUREN A, 1981, STROKE, V12, P578, DOI 10.1161/01.STR.12.5.578; BYER JA, 1980, ANN INTERN MED, V93, P742, DOI 10.7326/0003-4819-93-5-742; CAIRNS JA, 1985, NEW ENGL J MED, V313, P1369, DOI 10.1056/NEJM198511283132201; Canadian Cooperative Study Group, 1978, N Engl J Med, V299, P53; CANDELISE L, 1982, STROKE, V13, P175, DOI 10.1161/01.STR.13.2.175; CARTER AB, 1961, BRIT MED J, V2, P70, DOI 10.1136/bmj.2.5244.70; CHANG JC, 1987, HEART LUNG, V16, P403; CONNEALLY PM, 1978, JAMA-J AM MED ASSOC, V240, P742, DOI 10.1001/jama.240.8.742; CONNOLLY SJ, 1990, CIRCULATION, V82, P108; CRAVEN L L, 1950, Ann West Med Surg, V4, P95; DAVALOS A, 1990, NEUROLOGY, V40, P1865, DOI 10.1212/WNL.40.12.1865; DELZOPPO GJ, 1988, ANN EMERG MED, V17, P1196, DOI 10.1016/S0196-0644(88)80068-4; DELZOPPO GJ, 1988, STROKE, V19, P307, DOI 10.1161/01.STR.19.3.307; DOBKIN BH, 1983, STROKE, V14, P421, DOI 10.1161/01.STR.14.3.421; DONNAN GA, 1987, STROKE, V18, P296; DUKE RJ, 1986, ANN INTERN MED, V105, P825, DOI 10.7326/0003-4819-105-6-825; Duke RJ, 1983, CEREBROVASCULAR DIS, P399; DYKEN ML, 1990, STROKE, V21, P10; DYKEN ML, 1981, PROPHYLAXIS VENOUS P, P141; Easton J D, 1983, Curr Probl Cardiol, V8, P1; FIELDS WS, 1977, STROKE, V8, P301, DOI 10.1161/01.STR.8.3.301; FISHER CM, 1988, ARCH NEUROL-CHICAGO, V45, P1301, DOI 10.1001/archneur.1988.00520360019004; FISHER CM, 1958, NEUROLOGY, V8, P311, DOI 10.1212/WNL.8.5.311; FISHER CM, 1961, NEUROLOGY, V11, P119, DOI 10.1212/WNL.11.4_Part_2.119; FISHER CM, 1982, ATRIAL FIBRILLATION, P192; GARDE A, 1983, STROKE, V14, P677, DOI 10.1161/01.STR.14.5.677; GAUTIER JC, 1985, STROKE, V16, P729, DOI 10.1161/01.STR.16.4.729; GENT M, 1989, LANCET, V1, P1215, DOI 10.1016/S0140-6736(89)92327-1; GREEN D, 1990, ANN INTERN MED, V113, P571, DOI 10.7326/0003-4819-113-8-571; GUERCI AD, 1987, NEW ENGL J MED, V317, P1613, DOI 10.1056/NEJM198712243172601; GUSTAFSSON C, 1987, STROKE, V18, P299; HALEY EC, 1988, STROKE, V19, P10, DOI 10.1161/01.STR.19.1.10; HARRIS WH, 1977, NEW ENGL J MED, V297, P1246, DOI 10.1056/NEJM197712082972302; HART RG, 1986, ARCH NEUROL-CHICAGO, V43, P71; HART RG, 1989, STROKE, V20, P1117, DOI 10.1161/01.STR.20.8.1117; HART RG, 1983, STROKE, V14, P688, DOI 10.1161/01.STR.14.5.688; HART RG, 1987, ARCH INTERN MED, V147, P636; HART RG, 1986, STROKE, V17, P586, DOI 10.1161/01.STR.17.4.586; HASS WK, 1989, NEW ENGL J MED, V321, P501, DOI 10.1056/NEJM198908243210804; HIRSH J, 1985, SEMIN THROMB HEMOST, V11, P13, DOI 10.1055/s-2007-1004352; HORNIG CR, 1986, STROKE, V17, P179, DOI 10.1161/01.STR.17.2.179; HOSSMANN V, 1983, ARCH NEUROL-CHICAGO, V40, P803, DOI 10.1001/archneur.1983.04050120053007; IRINO T, 1983, STROKE, V14, P363, DOI 10.1161/01.STR.14.3.363; JONAS S, 1988, STROKE, V19, P1043, DOI 10.1161/01.STR.19.8.1043; JONES HR, 1976, STROKE, V7, P64, DOI 10.1161/01.STR.7.1.64; JONES HR, 1980, STROKE, V11, P173, DOI 10.1161/01.STR.11.2.173; KEITH DS, 1987, MAYO CLIN PROC, V62, P1101, DOI 10.1016/S0025-6196(12)62503-8; KELTON JG, 1978, BLOOD, V52, P1073; KELTON JG, 1986, HAEMOSTASIS, V16, P173; KISTLER JP, 1990, NEW ENGL J MED, V323, P1505; KOPECKY SL, 1987, NEW ENGL J MED, V317, P669, DOI 10.1056/NEJM198709103171104; KOUDSTAAL PJ, 1988, BRIT MED J, V297, P1571, DOI 10.1136/bmj.297.6663.1571; LAURENO R, 1987, BRAIN, V110, P93, DOI 10.1093/brain/110.1.93; LEVINE M, 1986, STROKE, V17, P111, DOI 10.1161/01.STR.17.1.111; LEWIS HD, 1983, NEW ENGL J MED, V309, P396, DOI 10.1056/NEJM198308183090703; LODDER J, 1988, STROKE, V19, P1482, DOI 10.1161/01.STR.19.12.1482; LODDER J, 1985, ACTA NEUROL SCAND, V71, P328; LODDER J, 1988, BMJ-BRIT MED J, V296, P1435, DOI 10.1136/bmj.296.6634.1435; MARSH EE, 1989, NEUROLOGY, V39, P1631, DOI 10.1212/WNL.39.12.1631; MASSEY EW, 1990, STROKE, V21, P1289, DOI 10.1161/01.STR.21.9.1289; MCBRIDE R, 1990, NEW ENGL J MED, V322, P863; MCBRIDE R, 1991, CIRCULATION, V84, P527, DOI 10.1161/01.CIR.84.2.527; MCILRAITH DM, 1990, STROKE, V21, P174; MILLER VT, 1988, STROKE, V19, P403, DOI 10.1161/01.STR.19.3.403; MILLER VT, 1989, CIRCULATION S2, V80, P404; MOHR JP, 1978, NEUROLOGY, V28, P754, DOI 10.1212/WNL.28.8.754; MOSTER ML, 1983, ANN NEUROL, V14, P539, DOI 10.1002/ana.410140508; NORRVING B, 1986, ACTA NEUROL SCAND, V73, P520; OKADA Y, 1989, STROKE, V20, P598, DOI 10.1161/01.STR.20.5.598; OLINGER CP, 1988, STROKE, V19, P133; OLSSON JE, 1980, STROKE, V11, P4, DOI 10.1161/01.STR.11.1.4; PATRICK BK, 1980, STROKE, V11, P643, DOI 10.1161/01.STR.11.6.643; PETERSEN P, 1989, LANCET, V1, P175; PETO R, 1988, BRIT MED J, V296, P313, DOI 10.1136/bmj.296.6618.313; PHELAN BK, 1983, ANN INTERN MED, V99, P637, DOI 10.7326/0003-4819-99-5-637; PHILLIPS SJ, 1989, STROKE, V20, P295, DOI 10.1161/01.STR.20.2.295; POLLAK VE, 1990, AM J MED SCI, V299, P319, DOI 10.1097/00000441-199005000-00006; PRICE TR, 1986, STROKE, V17, P141; PRICE TR, 1986, STROKE PATHOPHYSIOLO, P1059; PUTNAM SF, 1985, ARCH NEUROL-CHICAGO, V42, P960; RAMIREZLASSEPAS M, 1986, ARCH NEUROL-CHICAGO, V43, P386, DOI 10.1001/archneur.1986.00520040066022; RAMIREZLASSEPAS M, 1984, NEUROLOGY, V34, P114, DOI 10.1212/WNL.34.1.114; RAO AK, 1989, ARCH INTERN MED, V149, P1285, DOI 10.1001/archinte.149.6.1285; ROTHROCK JF, 1989, STROKE, V20, P730, DOI 10.1161/01.STR.20.6.730; ROTHROCK JF, 1987, VASCULAR SURG, V21, P248, DOI 10.1177/153857448702100404; RUFF RL, 1981, NEUROLOGY, V31, P736, DOI 10.1212/WNL.31.6.736; SACKETT DL, 1986, CHEST, V89, pS2, DOI 10.1378/chest.89.2_Supplement.2S; SAGE JI, 1986, ANN NEUROL, V20, P155; SAGE JI, 1985, ARCH NEUROL-CHICAGO, V42, P315, DOI 10.1001/archneur.1985.04060040025008; SALZMAN EW, 1986, NEW ENGL J MED, V315, P957, DOI 10.1056/NEJM198610093151509; SANTAMARIA J, 1983, NEUROLOGY, V33, P1104, DOI 10.1212/WNL.33.8.1104; SATO Y, 1986, Kurume Medical Journal, V33, P89; SCHEINBERG P, 1988, NEUROLOGY, V38, P1609, DOI 10.1212/WNL.38.10.1609; SCHEINBERG P, 1989, STROKE, V20, P173, DOI 10.1161/01.STR.20.2.173; SHERMAN DG, 1986, ARCH NEUROL-CHICAGO, V43, P68, DOI 10.1001/archneur.1986.00520010062024; SHERMAN DG, 1986, CHEST, V89, pS82, DOI 10.1378/chest.89.2_Supplement.82S; SHI FL, 1989, STROKE, V20, P1581, DOI 10.1161/01.STR.20.11.1581; SHIELDS RW, 1984, STROKE, V15, P426, DOI 10.1161/01.STR.15.3.426; SLIVKA A, 1990, STROKE, V21, P1657, DOI 10.1161/01.STR.21.12.1657; SMITH P, 1990, NEW ENGL J MED, V323, P147, DOI 10.1056/NEJM199007193230302; SORENSEN PS, 1983, STROKE, V14, P15, DOI 10.1161/01.STR.14.1.15; TAYLOR DW, 1991, NEW ENGL J MED, V325, P445; TENCATE H, 1984, ANN NEUROL, V15, P268; TOOLE JF, 1984, CEREBROVASCULAR DISO, P187; TURPIE AGG, 1987, LANCET, V1, P523; WHISNANT JP, 1973, MAYO CLIN PROC, V48, P844; WHISNANT JP, 1973, MAYO CLIN PROC, V48, P194; WINTZEN AR, 1984, ANN NEUROL, V16, P553, DOI 10.1002/ana.410160505; YAMANOUCHI H, 1988, J NEUROL, V235, P407, DOI 10.1007/BF00314482; ZEUMER H, 1984, NEURORADIOLOGY, V26, P315; ZEUMER H, 1983, AM J NEURORADIOL, V4, P401; ZIVIN J, 1990, PROTECTION BRAIN ISC, P23; 1986, CENTRAL NERVOUS SYST, P229; 1990, STROKE, V21, P27; 1983, STROKE, V14, P668; 1991, STROKE, V22, P153; 1991, IN PRESS BMJ; 1984, STORKE, V15, P779; 1989, NEW ENGL J MED, V321, P130	140	54	57	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 1	1991	115	11					885	895		10.7326/0003-4819-115-11-885	http://dx.doi.org/10.7326/0003-4819-115-11-885			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GR171	1952478				2022-12-28	WOS:A1991GR17100010
J	SPRANG, SR; WITHERS, SG; GOLDSMITH, EJ; FLETTERICK, RJ; MADSEN, NB				SPRANG, SR; WITHERS, SG; GOLDSMITH, EJ; FLETTERICK, RJ; MADSEN, NB			STRUCTURAL BASIS FOR THE ACTIVATION OF GLYCOGEN PHOSPHORYLASE-B BY ADENOSINE-MONOPHOSPHATE	SCIENCE			English	Article							NUCLEAR MAGNETIC-RESONANCE; PYRIDOXAL-PHOSPHATE; AREA DETECTOR; LIVER; DIFFRACTOMETER; MECHANISM; BINDING; MUSCLE	The three-dimensional structure of the activated state of glycogen phosphorylase (GP) as induced by adenosine monophosphate (AMP) has been determined from crystals of pyridoxalpyrophosphoryl-GP. The same quaternary changes relative to the inactive conformation as those induced by phosphorylation are induced by AMP, although the two regulatory signals function through different local structural mechanisms. Moreover, previous descriptions of the phosphorylase active state have been extended by demonstrating that, on activation, the amino- and carboxyl-terminal domains of GP rotate apart by 5-degrees, thereby increasing access of substrates to the catalytic site. The structure also reveals previously unobserved interactions with the nucleotide that accounts for the specificity of the nucleotide binding site for AMP in preference to inosine monophosphate.	UNIV TEXAS,SW MED CTR,DEPT BIOCHEM,DALLAS,TX 75235; UNIV BRITISH COLUMBIA,DEPT CHEM,VANCOUVER V6T 1Y6,BC,CANADA; UNIV CALIF SAN FRANCISCO,DEPT BIOCHEM & BIOPHYS,SAN FRANCISCO,CA 94143; UNIV ALBERTA,DEPT BIOCHEM,EDMONTON T6G 2H7,ALBERTA,CANADA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of British Columbia; University of California System; University of California San Francisco; University of Alberta	SPRANG, SR (corresponding author), UNIV TEXAS,SW MED CTR,HOWARD HUGHES MED INST,DALLAS,TX 75235, USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK031507, R01DK026081] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK31507, R01 DK26081] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ACHARYA KR, 1991, GLYCOGEN PHOSPHORY B; BARFORD D, 1989, NATURE, V340, P609, DOI 10.1038/340609a0; BARFORD D, 1991, J MOL BIOL, V218, P233, DOI 10.1016/0022-2836(91)90887-C; BLACK WJ, 1968, J BIOL CHEM, V243, P5892; BRUNGER AT, 1991, ACTA CRYSTALLOGR A, V47, P195, DOI 10.1107/S0108767390011795; BRUNGER AT, 1987, SCIENCE, V235, P458, DOI 10.1126/science.235.4787.458; BUC H, 1967, BIOCHEM BIOPH RES CO, V28, P59, DOI 10.1016/0006-291X(67)90406-8; ENGERS HD, 1968, BIOCHEM BIOPH RES CO, V33, P49, DOI 10.1016/0006-291X(68)90253-2; ENGERS HD, 1970, CAN J BIOCHEM CELL B, V48, P746, DOI 10.1139/o70-117; FLETTERICK RJ, 1980, ANNU REV BIOCHEM, V49, P31, DOI 10.1146/annurev.bi.49.070180.000335; GOLDSMITH EJ, 1989, SCIENCE, V245, P528, DOI 10.1126/science.2756432; GRAVES DJ, 1968, J BIOL CHEM, V243, P6090; GUSEV NB, 1979, BIOCHEM BIOPH RES CO, V90, P70, DOI 10.1016/0006-291X(79)91591-2; HENDRICKSON WA, 1986, ACTA CRYSTALLOGR A, V34, P713; HOWARD AJ, 1985, METHOD ENZYMOL, V114, P452; KOBAYASHI M, 1982, J BIOL CHEM, V257, P4041; KRAUT J, 1963, ACTA CRYSTALLOGR, V16, P79, DOI 10.1107/S0365110X63000207; LEONIDAS DD, 1990, FEBS LETT, V261, P23, DOI 10.1016/0014-5793(90)80627-U; LUZATTI V, 1952, ACTA CRYSTALLOGR, V5, P802; MARTIN JL, 1990, BIOCHEMISTRY-US, V29, P10745, DOI 10.1021/bi00500a005; MATEO PL, 1984, J BIOL CHEM, V259, P9384; METZGER B, 1967, P NATL ACAD SCI USA, V57, P994, DOI 10.1073/pnas.57.4.994; MORGAN HE, 1964, J BIOL CHEM, V239, P2440; NEWGARD CB, 1986, P NATL ACAD SCI USA, V83, P8132, DOI 10.1073/pnas.83.21.8132; RATH VL, 1987, PROTEINS, V2, P225, DOI 10.1002/prot.340020307; REEKE GN, UNPUB; SPRANG S, 1979, J MOL BIOL, V131, P523, DOI 10.1016/0022-2836(79)90006-8; SPRANG S, 1987, SCIENCE, V237, P1012, DOI 10.1126/science.3616621; SPRANG SR, 1988, NATURE, V336, P215, DOI 10.1038/336215a0; Wang J. H, 1972, ENZYMES, V7, P435; WITHERS SG, 1982, BIOCHEMISTRY-US, V21, P6716, DOI 10.1021/bi00269a016; WITHERS SG, 1981, BIOCHEMISTRY-US, V20, P1748, DOI 10.1021/bi00510a007; WITHERS SG, 1981, J BIOL CHEM, V256, P759; XUONG NH, 1985, J APPL CRYSTALLOGR, V18, P342, DOI 10.1107/S0021889885010433	34	107	107	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	NOV 29	1991	254	5036					1367	1371						5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR777	1962195				2022-12-28	WOS:A1991GR77700053
J	WHITESIDES, GM; MATHIAS, JP; SETO, CT				WHITESIDES, GM; MATHIAS, JP; SETO, CT			MOLECULAR SELF-ASSEMBLY AND NANOCHEMISTRY - A CHEMICAL STRATEGY FOR THE SYNTHESIS OF NANOSTRUCTURES	SCIENCE			English	Article							CHARGED POLYMER LATTICES; ORDERED STRUCTURE; PROTEIN DESIGN; NOBEL LECTURE; COMPLEXES; HYDROPHOBICITY; RECOGNITION; ELECTRODES; MICROSCOPY; CHEMISTRY	Molecular self-assembly is the spontaneous association of molecules under equilibrium conditions into stable, structurally well-defined aggregates joined by noncovalent bonds. Molecular self-assembly is ubiquitous in biological systems and underlies the formation of a wide variety of complex biological structures. Understanding self-assembly and the associated noncovalent interactions that connect complementary interacting molecular surfaces in biological aggregates is a central concern in structural biochemistry. Self-assembly is also emerging as a new strategy in chemical synthesis, with the potential of generating nonbiological structures with dimensions of 1 to 10(2) nanometers (with molecular weights of 10(4) to 10(10) daltons). Structures in the upper part of this range of sizes are presently inaccessible through chemical synthesis, and the ability to prepare them would open a route to structures comparable in size (and perhaps complementary in function) to those that can be prepared by microlithography and other techniques of microfabrication.			WHITESIDES, GM (corresponding author), HARVARD UNIV, DEPT CHEM, CAMBRIDGE, MA 02138 USA.							AHLERS M, 1990, ANGEW CHEM INT EDIT, V29, P1269, DOI 10.1002/anie.199012691; ALBERTS B, 1989, MOL BIOL CELL, P84; [Anonymous], 1988, STRUCTURE LIQUID CRY; ARMSTRONG RW, 1989, J AM CHEM SOC, V111, P7525, DOI 10.1021/ja00201a037; BAIN CD, 1989, J AM CHEM SOC, V111, P321, DOI 10.1021/ja00183a049; BALDWIN RL, 1989, TRENDS BIOCHEM SCI, V14, P291, DOI 10.1016/0968-0004(89)90067-4; BASSETT JM, 1990, ANGEW CHEM INT EDIT, V29, P805; BERGER SD, 1990, APPL PHYS LETT, V57, P153, DOI 10.1063/1.103969; BOGDANOV AA, 1989, TRENDS BIOCHEM SCI, V14, P505, DOI 10.1016/0968-0004(89)90186-2; BOVEY FA, 1979, MACROMOLECULES; BRADER ML, 1991, TRENDS BIOCHEM SCI, V16, P341; BRESLOW R, 1982, SCIENCE, V218, P532, DOI 10.1126/science.7123255; Broers A. N., 1989, Microelectronic Engineering, V9, P187, DOI 10.1016/0167-9317(89)90044-0; BROOKS CL, 1986, PROTEINS THEORETICAL; Cantor C.R., 1980, BIOPHYSICAL CHEM, P1109; CHAN HS, 1990, P NATL ACAD SCI USA, V87, P6388, DOI 10.1073/pnas.87.16.6388; Collings P., 1997, INTRO LIQUID CRYSTAL, P314; Corey E. J., 1989, LOGIC CHEM SYNTHESIS; COTTER D, 1991, APPL PHYS LETT, V58, P1455, DOI 10.1063/1.105195; CRAM DJ, 1988, ANGEW CHEM INT EDIT, V27, P1009, DOI 10.1002/anie.198810093; CREIGHTON TE, 1990, BIOCHEM J, V270, P1; Creighton TE, 1983, PROTEINS STRUCTURES; DAGANI R, 1991, CHEM ENG NEWS, V69, P24, DOI 10.1021/cen-v069n002.p024; DECKMAN HW, 1988, J VAC SCI TECHNOL B, V6, P333, DOI 10.1116/1.583991; DEGRADO WF, 1989, SCIENCE, V243, P622, DOI 10.1126/science.2464850; Desiraju G. R., 1989, CRYSTAL ENG DESIGN O; DESIRAJU GR, 1987, ORGANIC SOLIDS STATE; DIEDERICH F, 1988, ANGEW CHEM INT EDIT, V27, P362, DOI 10.1002/anie.198803621; DILL KA, 1990, SCIENCE, V250, P297, DOI 10.1126/science.2218535; ELLIS RJ, 1989, TRENDS BIOCHEM SCI, V14, P339, DOI 10.1016/0968-0004(89)90168-0; ESCHENMOSER A, 1977, SCIENCE, V196, P1410, DOI 10.1126/science.867037; ETTER MC, 1991, J PHYS CHEM-US, V95, P4601, DOI 10.1021/j100165a007; ETTER MC, 1990, ACCOUNTS CHEM RES, V23, P120, DOI 10.1021/ar00172a005; FASMAN GD, 1989, TRENDS BIOCHEM SCI, V14, P295, DOI 10.1016/0968-0004(89)90068-6; Fendler J. H., 1982, MEMBRANE MIMETIC CHE; FRAENKELCONRAT H, 1955, P NATL ACAD SCI USA, V41, P690, DOI 10.1073/pnas.41.10.690; FRANKEL DA, 1989, J AM CHEM SOC, V111, P9262, DOI 10.1021/ja00208a038; HARADA A, 1989, CARBOHYD RES, V192, P1, DOI 10.1016/0008-6215(89)85159-6; HERZFELD J, 1991, SCIENCE, V253, P88, DOI 10.1126/science.253.5015.88; HUNTER CA, 1990, J AM CHEM SOC, V112, P5525, DOI 10.1021/ja00170a016; ISE N, 1983, J CHEM PHYS, V78, P536, DOI 10.1063/1.444479; ISE N, 1985, J AM CHEM SOC, V107, P8074, DOI 10.1021/ja00312a046; James T. H., 1977, THEORY PHOTOGRAPHIC, P1; JORGENSEN WL, 1991, CHEMTRACTS ORG CHEM, V4, P91; KERN K, 1991, PHYS REV LETT, V67, P855, DOI 10.1103/PhysRevLett.67.855; KLUG A, 1983, ANGEW CHEM INT EDIT, V22, P565, DOI 10.1002/anie.198305653; KOERT U, 1990, NATURE, V346, P339, DOI 10.1038/346339a0; KORTAN AR, 1990, J AM CHEM SOC, V112, P1327, DOI 10.1021/ja00160a005; LAUFFER MA, 1975, ENTROPY DRIVEN PROCE; LEHN JM, 1988, ANGEW CHEM INT EDIT, V27, P89, DOI 10.1002/anie.198800891; LEHN JM, 1990, ANGEW CHEM INT EDIT, V29, P1304, DOI 10.1002/anie.199013041; LINDSEY JS, 1991, NEW J CHEM, V15, P153; MACDOUGALL JE, 1989, J AM CHEM SOC, V111, P8006, DOI 10.1021/ja00202a047; MANKA JS, 1990, J AM CHEM SOC, V112, P2440, DOI 10.1021/ja00162a066; MATOUSCHEK A, 1989, NATURE, V340, P122, DOI 10.1038/340122a0; McCammon JA., 1987, DYNAMICS PROTEINS NU; MOEL A, 1989, J VAC SCI TECHNOL B, V7, P1692, DOI 10.1116/1.584484; MOEL A, 1990, J VAC SCI TECHNOL B, V8, P1648, DOI 10.1116/1.585133; MOFFAT AS, 1990, MOSAIC, V21, P30; MURPHY KP, 1990, SCIENCE, V247, P559, DOI 10.1126/science.2300815; MUTTER M, 1989, ANGEW CHEM INT EDIT, V28, P535, DOI 10.1002/anie.198905353; NOMURA M, 1973, SCIENCE, V179, P864, DOI 10.1126/science.179.4076.864; OLSHAVSKY MA, 1990, J AM CHEM SOC, V112, P9438, DOI 10.1021/ja00181a080; OZIN GA, 1989, ANGEW CHEM INT EDIT, V28, P359, DOI 10.1002/anie.198903591; OZIN GA, 1991, ADV MATER, V3, P306; PAVLETICH NP, 1991, SCIENCE, V252, P809, DOI 10.1126/science.2028256; PEDERSEN CJ, 1988, ANGEW CHEM INT EDIT, V27, P1021, DOI 10.1002/anie.198810211; PENNER RM, 1990, SCIENCE, V250, P1118, DOI 10.1126/science.250.4984.1118; PHILP D, 1991, SYNLETT, P445; PLEIJ CWA, 1990, TRENDS BIOCHEM SCI, V15, P143, DOI 10.1016/0968-0004(90)90214-V; PRAKASH G, 1991, J CHEM SOC CHEM COMM, P1161, DOI 10.1039/c39910001161; PRIVALOV PL, 1990, SCIENCE, V250, P298; PRIVALOV PL, 1988, ADV PROTEIN CHEM, V39, P191; REBEK J, 1990, ANGEW CHEM INT EDIT, V29, P245, DOI 10.1002/anie.199002451; RICHARDSON JS, 1989, TRENDS BIOCHEM SCI, V14, P304, DOI 10.1016/0968-0004(89)90070-4; RINGSDORF H, 1988, ANGEW CHEM INT EDIT, V27, P113, DOI 10.1002/anie.198801131; ROLISON DR, 1990, CHEM REV, V90, P867, DOI 10.1021/cr00103a011; Ross S., 1988, COLLOIDAL SYSTEMS IN; RUSLING JF, 1991, ACCOUNTS CHEM RES, V24, P75, DOI 10.1021/ar00003a003; SAALFRANK RW, 1990, ANGEW CHEM INT EDIT, V29, P311, DOI 10.1002/anie.199003111; SAENGER W, 1986, PRINCIPLES NUCLEIC A; SCHIMMEL P, 1987, ANNU REV BIOCHEM, V56, P125, DOI 10.1146/annurev.bi.56.070187.001013; SCHUMACHER R, 1990, ANGEW CHEM INT EDIT, V29, P329, DOI 10.1002/anie.199003293; SETO CT, 1991, J AM CHEM SOC, V113, P712, DOI 10.1021/ja00002a071; SETO CT, 1990, J AM CHEM SOC, V112, P6409, DOI 10.1021/ja00173a046; Seymour R.B., 1988, POLYM CHEM; SHARP KA, 1991, SCIENCE, V252, P106, DOI 10.1126/science.2011744; Shinoda K., 1986, EMULSIONS SOLUBILIZA; SHULL KR, 1991, MACROMOLECULES, V24, P2748, DOI 10.1021/ma00010a017; SMITH HI, 1990, PHYS TODAY, V43, P24, DOI 10.1063/1.881222; SMITHRUD DB, 1991, J AM CHEM SOC, V113, P5420, DOI 10.1021/ja00014a038; STODDART JF, 1989, ANNU REP PROG CHEM B, V86, P353; SUBRAMANIAN AR, 1985, ESSAYS BIOCHEM, V21, P45; TANFORD C, 1980, HYDROPHOBIC EFFECT; TANG SL, 1991, CHEMTECH, V21, P182; Taylor G. N., 1989, Microelectronic Engineering, V9, P513, DOI 10.1016/0167-9317(89)90112-3; THORNTON JM, 1989, TRENDS BIOCHEM SCI, V14, P300, DOI 10.1016/0968-0004(89)90069-8; UMBACH CP, 1990, J VAC SCI TECHNOL B, V8, P1614, DOI 10.1116/1.585126; VINSON PK, 1991, J COLLOID INTERF SCI, V142, P74, DOI 10.1016/0021-9797(91)90034-6; WEISSMAN JS, 1991, SCIENCE, V253, P1386, DOI 10.1126/science.1716783; WHITESIDES GM, 1990, LANGMUIR, V6, P87, DOI 10.1021/la00091a013; WOODWARD R B, 1973, Pure and Applied Chemistry, V33, P145, DOI 10.1351/pac197333010145; Wright J. G., 1987, MOL CRYSTALS; YI W, 1990, J CRYST SPECTROSC, V20, P79; ZERKOWSKI J, UNPUB; ZERKOWSKI JA, 1990, J AM CHEM SOC, V112, P9025, DOI 10.1021/ja00180a083	106	3140	3267	39	1528	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 29	1991	254	5036					1312	1319		10.1126/science.1962191	http://dx.doi.org/10.1126/science.1962191			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR777	1962191				2022-12-28	WOS:A1991GR77700041
J	LAGAKOS, S; FISCHL, MA; STEIN, DS; LIM, L; VOLBERDING, P				LAGAKOS, S; FISCHL, MA; STEIN, DS; LIM, L; VOLBERDING, P			EFFECTS OF ZIDOVUDINE THERAPY IN MINORITY AND OTHER SUBPOPULATIONS WITH EARLY HIV-INFECTION	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; CONTROLLED TRIAL; AIDS; ANTIGENEMIA; ANTIBODIES; COHORT	Objective. - The purpose of this study was to determine whether the beneficial effects of zidovudine seen overall in two recently completed placebo-controlled clinical trials are also apparent in blacks, Hispanics, women, and intravenous drug users. Design. - Two double-blind placebo-controlled randomized clinical trials, protocols 016 and 019, conducted by the AIDS Clinical Trials Group. Setting. - University-based referral centers. Participants. - Two thousand forty-eight persons with asymptomatic or mildly symptomatic human immunodeficiency virus infection were analyzed. Of these, 155 were black, 190 were Hispanic, 144 were women, and 221 were intravenous drug users. All randomized subjects were included in the analysis. Intervention. - Participants in the AIDS Clinical Trials Group protocol 016 were assigned to receive a placebo or a 1200-mg daily dose of zidovudine. Participants in the AIDS Clinical Trials Group protocol 019 were assigned to receive a placebo, a 500-mg daily dose of zidovudine, or a 1500-mg daily dose of zidovudine. Main Outcome Measure. - Progression to AIDS. Results. - The rates of progression to AIDS in subjects receiving zidovudine were significantly lower than those in subjects receiving a placebo among blacks (P = .03), whites (relative risk [RR] = 2.3, 95% confidence interval [Cl] = 1.5 to 3.6, P < .0001), Hispanics (RR = 4.4, Cl = 1.2 to 16.8, P =.02), non-Hispanics (RR = 2.3, Cl = 1.5 to 3.6, P =.0002), men (RR = 2.5, Cl = 1.6 to 3.8, P < .0001), and non-intravenous drug users (RR = 2.5, Cl = 1.6 to 4.0, P < .0001). The rates of disease progression for subjects receiving zidovudine were not statistically different from those receiving placebo for women (RR = 3.3, Cl = 0.3 to 36.3, P = .31) or for intravenous drug users (RR = 2.0, Cl = 0.7 to 6.2, P =.21); however, in both instances the estimated RRs were similar to those for men and non-intravenous drug users. Conclusions. - Although the two studies used for this analysis were not specifically designed to assess the effects of zidovudine in each separate subpopulation, the data suggest that the beneficial effects of zidovudine reported for the entire study population also apply to the subpopulations of blacks, Hispanics, women, and intravenous drug users.	UNIV MIAMI,DEPT MED,MIAMI,FL 33152; NIAID,DIV AIDS,BETHESDA,MD 20892; UNIV CALIF SAN FRANCISCO,DEPT MED,SAN FRANCISCO,CA 94143	University of Miami; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of California System; University of California San Francisco	LAGAKOS, S (corresponding author), HARVARD UNIV,SCH PUBL HLTH,DEPT BIOSTAT,677 HUNTINGTON AVE,BOSTON,MA 02115, USA.							BACCHETTI P, 1990, J AM STAT ASSOC, V85, P1002, DOI 10.2307/2289596; CHAMBERLAND ME, 1990, PRINCIPLES PRACTICE; Cox D. R., 1984, ANAL SURVIVAL DATA; Cox DR., 1970, ANAL BINARY DATA; CURRAN JW, 1988, AIDS 1988 AAAS S PAP; EYSTER ME, 1989, ANN INTERN MED, V110, P963, DOI 10.7326/0003-4819-110-12-963; FISCHL MA, 1990, ANN INTERN MED, V112, P727, DOI 10.7326/0003-4819-112-10-727; HAMILTON JD, 1991, CLIN RES, V39, pA216; MACDONELL KB, 1990, AM J MED, V89, P706, DOI 10.1016/0002-9343(90)90210-5; MOSS AR, 1988, BRIT MED J, V296, P745, DOI 10.1136/bmj.296.6624.745; MUNOZ A, 1988, J ACQ IMMUN DEF SYND, V1, P396; PAGANO M, 1991, HIV EPIDEMIC NEW YOR; SARNGADHARAN MG, 1984, SCIENCE, V224, P506, DOI 10.1126/science.6324345; STITES DP, 1986, CLIN IMMUNOL IMMUNOP, V38, P161, DOI 10.1016/0090-1229(86)90135-2; VOLBERDING PA, 1990, NEW ENGL J MED, V322, P941, DOI 10.1056/NEJM199004053221401; WITTEK AE, 1987, ANN INTERN MED, V107, P286, DOI 10.7326/0003-4819-107-2-286	16	49	49	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 20	1991	266	19					2709	2712		10.1001/jama.266.19.2709	http://dx.doi.org/10.1001/jama.266.19.2709			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GP691	1942422				2022-12-28	WOS:A1991GP69100025
J	JULIER, C; HYER, RN; DAVIES, J; MERLIN, F; SOULARUE, P; BRIANT, L; CATHELINEAU, G; DESCHAMPS, I; ROTTER, JI; FROGUEL, P; BOITARD, C; BELL, JI; LATHROP, GM				JULIER, C; HYER, RN; DAVIES, J; MERLIN, F; SOULARUE, P; BRIANT, L; CATHELINEAU, G; DESCHAMPS, I; ROTTER, JI; FROGUEL, P; BOITARD, C; BELL, JI; LATHROP, GM			INSULIN-IGF2 REGION ON CHROMOSOME-11P ENCODES A GENE IMPLICATED IN HLA-DR4-DEPENDENT DIABETES SUSCEPTIBILITY	NATURE			English	Article							WIEDEMANN-BECKWITH SYNDROME; MELLITUS; DNA; SEQUENCE; LOCUS; IDDM; INHERITANCE; LINKAGE; HLA	A CLASS of alleles at the VNTR (variable number of tandem repeat) locus in the 5' region of the insulin gene (INS) on chromosome 11p is associated with increased risk of insulin-dependent diabetes mellitus (IDDM) 1-6, but family studies have failed to demonstrate linkage 5,7. INS is thought to contribute to IDDM susceptibility but this view has been difficult to reconcile with the lack of linkage evidence 6-8. We thus investigated polymorphisms of INS and neighbouring loci in random diabetics, IDDM multiplex families and controls. HLA-DR4-positive diabetics showed an increased risk associated with common variants at polymorphic sites in a 19-kilobase segment spanned by the 5' INS VNTR and the third intron of the gene for insulin-like growth factor II (IGF2). As INS is the major candidate gene from this region, diabetic and control sequences were compared to identify all INS polymorphisms that could contribute to disease susceptibility. In multiplex families the IDDM-associated alleles were transmitted preferentially to HLA-DR4-positive diabetic offspring from heterozygous parents. The effect was strongest in paternal meioses, suggesting a possible role for maternal imprinting. Our results strongly support the existence of a gene or genes affecting HLA-DR4 IDDM susceptibility which is located in a 19-kilobase region of INS-IGF2. Our results also suggest new ways to map susceptibility loci in other common diseases.	JOHN RADCLIFFE HOSP,INST MOLEC MED,MOLEC IMMUNOL GRP,OXFORD OX3 9DU,ENGLAND; CTR ETUD POLYMORHISME HUMAIN,F-75010 PARIS,FRANCE; HOP ST LOUIS,SERV ENDOCRINOL,F-75010 PARIS,FRANCE; HOP NECKER ENFANTS MALAD,INSERM,U25,F-75730 PARIS 15,FRANCE; CEDARS SINAI MED CTR,DIV MED GENET,LOS ANGELES,CA 90048; UNIV CALIF LOS ANGELES,SCH MED,LOS ANGELES,CA 90024	University of Oxford; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA			JULIER, Cécile/M-9824-2017; FROGUEL, Philippe/O-6799-2017; Briant, Laurence/AAB-9281-2021	JULIER, Cécile/0000-0002-1538-0240; FROGUEL, Philippe/0000-0003-2972-0784; Briant, Laurence/0000-0002-1995-3501	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BEECHEY CV, 1990, MOUSE GENOME, V87, P64; BELL G I, 1985, American Journal of Human Genetics, V37, pA188; BELL GI, 1980, NATURE, V284, P26, DOI 10.1038/284026a0; BELL GI, 1982, NATURE, V295, P31, DOI 10.1038/295031a0; BELL GI, 1984, DIABETES, V33, P176, DOI 10.2337/diabetes.33.2.176; BELL GI, 1981, P NATL ACAD SCI-BIOL, V78, P5759, DOI 10.1073/pnas.78.9.5759; BELL GI, 1987, CIBA F S, V130; BELL GI, 1990, MOL BIOL ISLETS LANG; BIDWELL JL, 1988, TRANSPLANTATION, V45, P640, DOI 10.1097/00007890-198803000-00027; BROWN KW, 1990, AM J HUM GENET, V46, P1000; COX NJ, 1988, AM J HUM GENET, V43, P495; COX NJ, 1989, GENET EPIDEMIOL, V6, P65, DOI 10.1002/gepi.1370060113; COX NJ, 1988, AM J HUM GENET, V42, P167; DECHIARA TM, 1991, CELL, V64, P849, DOI 10.1016/0092-8674(91)90513-X; DIXON WJ, 1988, BMDP STATISTICAL SOF; FERNS GAA, 1986, J MED GENET, V23, P210, DOI 10.1136/jmg.23.3.210; GRUNT JA, 1972, YALE J BIOL MED, V45, P15; HITMAN GA, 1985, DIABETOLOGIA, V28, P218; HITMAN GA, 1990, J MED GENET, V27, P97; HYER RN, 1991, AM J HUM GENET, V48, P243; KOUFOS A, 1989, AM J HUM GENET, V44, P711; OWERBACH D, 1990, DIABETES, V39, P1504, DOI 10.2337/diabetes.39.12.1504; PETTENATI MJ, 1986, HUM GENET, V74, P143, DOI 10.1007/BF00282078; SPIELMAN RS, 1989, GENET EPIDEMIOL, V6, P43, DOI 10.1002/gepi.1370060111; SURES I, 1980, SCIENCE, V208, P57, DOI 10.1126/science.6927840; THOMSON G, 1989, GENET EPIDEMIOL, V6, P155, DOI 10.1002/gepi.1370060129; THOMSON G, 1988, AM J HUM GENET, V43, P799; ULLRICH A, 1980, SCIENCE, V209, P612, DOI 10.1126/science.6248962; ULLRICH A, 1982, NUCLEIC ACIDS RES, V10, P2225, DOI 10.1093/nar/10.7.2225; WARRAM JH, 1984, NEW ENGL J MED, V311, P149, DOI 10.1056/NEJM198407193110304; 1990, CYTOGENET CELL GENET, V55, P1; 1989, CYTOGENET CELL GENET, V51, P1	32	367	372	0	8	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	NOV 14	1991	354	6349					155	159		10.1038/354155a0	http://dx.doi.org/10.1038/354155a0			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GP880	1944595				2022-12-28	WOS:A1991GP88000062
J	RICE, PA; SCHACHTER, J				RICE, PA; SCHACHTER, J			PATHOGENESIS OF PELVIC INFLAMMATORY DISEASE - WHAT ARE THE QUESTIONS	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CHLAMYDIA-TRACHOMATIS INFECTION; GENITAL-TRACT INFECTION; ALTERNATIVE COMPLEMENT PATHWAY; FALLOPIAN-TUBE MUCOSA; ORAL-CONTRACEPTIVE USE; NEISSERIA-GONORRHOEAE; ACUTE SALPINGITIS; IMMUNE-RESPONSE; GONOCOCCAL URETHRITIS; DIFFERENTIAL SUSCEPTIBILITY	Pelvic inflammatory disease is usually caused by Chlamydia trachomatis or Neisseria gonorrhoeae. Chlamydiae and gonococci are primary pathogens of the cervix and often ascend. Resultant damage to the cervix may permit organisms to move upward, but this mechanism of action is not well understood. Puberty and hormones, particularly oral contraceptives, may enhance chlamydial infection, but the mechanisms and likelihood of spread to the upper tract are ill defined. Upper tract infection with C trachomatis involves an acute phase, characterized by an influx of polymorphonuclear leukocytes and a chronic or persistent phase characterized by the presence of mononuclear cells (delayed hypersensitivity). Gonococci invade nonciliated epithelial cells, but are toxic to ciliated cells, due to elaborated lipooligosaccharides and peptidoglycan, Certain gonococci stimulate chemotaxis of polymorphonuclear leukocytes whose release of toxic metabolites may damage tissue. The immunologic mechanisms that permit specific host responses to these two organisms are now being elucidated and should receive more attention by researchers.	UNIV CALIF SAN FRANCISCO, SAN FRANCISCO GEN HOSP, CHLAMYDIA LAB, SAN FRANCISCO, CA 94143 USA	San Francisco General Hospital Medical Center; University of California System; University of California San Francisco	RICE, PA (corresponding author), BOSTON UNIV, BOSTON CITY HOSP, SCH MED, MAXWELL FINLAND LAB, 774 ALBANY ST, BOSTON, MA 02118 USA.				NIAID NIH HHS [1 PO1 AI 24768, 1 PO1 AI 24760] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI024768, P01AI024760] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		APICELLA MA, 1990, J INFECT DIS, V162, P506, DOI 10.1093/infdis/162.2.506; ARYA OP, 1981, BRIT J VENER DIS, V57, P118; BARRON AL, 1981, J INFECT DIS, V143, P63, DOI 10.1093/infdis/143.1.63; BERNHEIM HA, 1986, YALE J BIOL MED, V59, P151; BLAKE MS, 1983, PROG ALLERGY, V33, P298; BOSE SK, 1986, INFECT IMMUN, V53, P646, DOI 10.1128/IAI.53.3.646-650.1986; BOWIE WR, 1978, SEX TRANSM DIS, V5, P151, DOI 10.1097/00007435-197810000-00007; BRIHMER C, 1987, EUR J OBSTET GYN R B, V24, P211, DOI 10.1016/0028-2243(87)90020-7; BRUNHAM RC, 1984, NEW ENGL J MED, V311, P1, DOI 10.1056/NEJM198407053110101; BRUNHAM RC, 1987, J INFECT DIS, V155, P749, DOI 10.1093/infdis/155.4.749; CHOW AW, 1975, AM J OBSTET GYNECOL, V122, P876, DOI 10.1016/0002-9378(75)90731-0; CROSS CE, 1987, ANN INTERN MED, V107, P526, DOI 10.7326/0003-4819-107-4-526; CURTIS AH, 1921, SURG GYNECOL OBSTET, V33, P621; DENSEN P, 1987, J CLIN INVEST, V80, P78, DOI 10.1172/JCI113067; DENSEN P, 1982, INFECT IMMUN, V38, P563, DOI 10.1128/IAI.38.2.563-572.1982; EDWARDS MS, 1982, J IMMUNOL, V128, P1278; ESCHENBACH DA, 1988, AM J OBSTET GYNECOL, V158, P819, DOI 10.1016/0002-9378(88)90078-6; ESCHENBACH DA, 1975, NEW ENGL J MED, V293, P166, DOI 10.1056/NEJM197507242930403; ESCHENBACH DA, 1977, AM J OBSTET GYNECOL, V128, P838, DOI 10.1016/0002-9378(77)90051-5; FAULKNER WL, 1976, JAMA-J AM MED ASSOC, V235, P1851, DOI 10.1001/jama.235.17.1851; FEARON DT, 1977, J EXP MED, V146, P22, DOI 10.1084/jem.146.1.22; FITZGERALD TJ, 1976, CAN J MICROBIOL, V22, P286, DOI 10.1139/m76-039; FRASER JJ, 1983, PEDIATRICS, V71, P333; FREDRICSSON B, 1984, GYNECOL OBSTET INVES, V17, P236, DOI 10.1159/000299155; GOLDACRE MJ, 1978, BRIT MED J, V1, P748, DOI 10.1136/bmj.1.6115.748; GRANEY DO, 1990, SEXUALLY TRANSMITTED, P105; GRAYSTON JT, 1985, REV INFECT DIS, V7, P717; GREGG CR, 1981, J INFECT DIS, V143, P432, DOI 10.1093/infdis/143.3.432; HALLBERG T, 1985, GENITOURIN MED, V61, P247; HALLEN A, 1987, GENITOURIN MED, V63, P386; HANNA L, 1979, INFECT IMMUN, V23, P412, DOI 10.1128/IAI.23.2.412-417.1979; HARRISON HR, 1985, AM J OBSTET GYNECOL, V153, P244, DOI 10.1016/S0002-9378(85)80105-8; HENSON PM, 1987, J CLIN INVEST, V79, P669, DOI 10.1172/JCI112869; HILTON AL, 1974, BRIT J VENER DIS, V50, P1; Hogan MJ., 1962, OPHTHALMIC PATHOLOGY, V2nd; HOLMES KK, 1980, AM J OBSTET GYNECOL, V138, P893, DOI 10.1016/0002-9378(80)91078-9; HUGHESJONES NC, 1984, EUR J IMMUNOL, V14, P974, DOI 10.1002/eji.1830141103; Humphrey J H, 1969, Adv Immunol, V11, P75, DOI 10.1016/S0065-2776(08)60478-2; HUNDLEY JM, 1950, AM J OBSTET GYNECOL, V60, P977, DOI 10.1016/0002-9378(50)90503-5; INMAN RD, 1987, CLIN EXP IMMUNOL, V69, P246; JAMES AN, 1978, CURR MICROBIOL, V1, P341, DOI 10.1007/BF02621366; JARVIS GA, 1989, J IMMUNOL, V143, P1703; JORDAN JA, 1976, CERVIX, P192; KASPER DL, 1977, J INFECT DIS, V135, P243, DOI 10.1093/infdis/135.2.243; KEARNS DH, 1973, NEW ENGL J MED, V289, P1170, DOI 10.1056/NEJM197311292892205; KINGHORN GR, 1981, BRIT J VENER DIS, V57, P187; KOCH ML, 1950, AM J OBSTET GYNECOL, V59, P168, DOI 10.1016/0002-9378(50)90362-0; KRAUS S J, 1970, Infection and Immunity, V2, P655; KRISTENSEN GB, 1985, GENITOURIN MED, V61, P179; LAKE AM, 1979, J IMMUNOL, V122, P834; LAMMEL CJ, 1985, J INFECT DIS, V152, P990, DOI 10.1093/infdis/152.5.990; LIP J, 1966, OBSTET GYNECOL, V28, P561; LUKASIK J, 1963, AM J OBSTET GYNECOL, V87, P1028, DOI 10.1016/0002-9378(63)90097-8; MAGNUSSON KE, 1978, ACTA PATH MICRO IM B, V86, P113; MAGNUSSON KE, 1979, IMMUNOLOGY, V36, P439; MAGNUSSON SS, 1986, AM J OBSTET GYNECOL, V155, P602, DOI 10.1016/0002-9378(86)90287-5; MANOR E, 1990, CHLAMYDIAL INFECTION, P209; MARDH PA, 1977, NEW ENGL J MED, V296, P1377, DOI 10.1056/NEJM197706162962403; MARDH PA, 1980, AM J OBSTET GYNECOL, V138, P933, DOI 10.1016/0002-9378(80)91084-4; MARDH PA, 1977, NONGONOCOCCAL URETHR, P77; MASLOW AS, 1988, AM J OBSTET GYNECOL, V159, P1006, DOI 10.1016/S0002-9378(88)80189-3; MCCHESNEY D, 1982, INFECT IMMUN, V36, P1006, DOI 10.1128/IAI.36.3.1006-1012.1982; MCGEE ZA, 1981, J INFECT DIS, V143, P413, DOI 10.1093/infdis/143.3.413; MCQUILLEN DP, 1991, NEISSERIA 1990, P229; MELLY MA, 1981, J INFECT DIS, V143, P423, DOI 10.1093/infdis/143.3.423; MELLY MA, 1984, J INFECT DIS, V149, P378, DOI 10.1093/infdis/149.3.378; MOLLER BR, 1979, BRIT J VENER DIS, V55, P422; MORRISON RP, 1989, J EXP MED, V169, P663, DOI 10.1084/jem.169.3.663; MORSE SA, 1974, INFECT IMMUN, V10, P1370, DOI 10.1128/IAI.10.6.1370-1377.1974; MOSLER BR, 1981, SEX TRANSM DIS, V8, P198; MULKS MH, 1978, NEW ENGL J MED, V299, P973, DOI 10.1056/NEJM197811022991802; NAYYAR KC, 1976, BRIT J VENER DIS, V52, P396; NEEDLEMAN P, 1986, ANNU REV BIOCHEM, V55, P69, DOI 10.1146/annurev.biochem.55.1.69; NOONAN AS, 1974, AM J PUBLIC HEALTH, V64, P700; ODEBLAD E, 1968, ACTA OBSTET GYN SCAN, VS 47, P57, DOI 10.3109/00016346809156845; OKADA N, 1982, NATURE, V299, P261, DOI 10.1038/299261a0; ORIEL JD, 1978, J INFECT DIS, V137, P443, DOI 10.1093/infdis/137.4.443; ORIEL JD, 1974, BRIT J VENER DIS, V50, P11; OSSER S, 1980, LANCET, V1, P386; PAAVONEN J, 1986, AM J OBSTET GYNECOL, V154, P556, DOI 10.1016/0002-9378(86)90601-0; PAAVONEN J, 1987, BRIT J OBSTET GYNAEC, V94, P454, DOI 10.1111/j.1471-0528.1987.tb03125.x; PAAVONEN J, 1980, CONTRACEPTION, V22, P107, DOI 10.1016/0010-7824(80)90055-4; PASLEY JN, 1985, SEX TRANSM DIS, V12, P8, DOI 10.1097/00007435-198501000-00003; PASLEY JN, 1990, CHLAMYDIAL INFECTION, P245; PATTON DL, 1983, FERTIL STERIL, V40, P829; PATTON DL, 1989, J REPROD FERTIL, V85, P647; PATTON DL, 1989, J INFECT DIS, V159, P1105, DOI 10.1093/infdis/159.6.1105; PATTON DL, 1987, J INFECT DIS, V155, P1292, DOI 10.1093/infdis/155.6.1292; PATTON DL, 1987, J INFECT DIS, V155, P229, DOI 10.1093/infdis/155.2.229; PEREZ HD, 1986, J CLIN INVEST, V78, P1589, DOI 10.1172/JCI112751; PEREZ HD, 1981, J IMMUNOL, V126, P800; PERSSON E, 1983, ACTA OBSTET GYN SCAN, V62, P563, DOI 10.3109/00016348309156249; Piot P, 1982, Eur J Clin Microbiol, V1, P301, DOI 10.1007/BF02019976; PLAUT AG, 1974, J CLIN INVEST, V54, P1295, DOI 10.1172/JCI107875; PLAUT AG, 1975, SCIENCE, V190, P1103, DOI 10.1126/science.810892; PRICE RJ, 1979, FERTIL STERIL, V32, P61; QUIE PG, 1968, J EXP MED, V128, P553, DOI 10.1084/jem.128.4.553; RABE LK, 1988, J CLIN MICROBIOL, V26, P1156, DOI 10.1128/JCM.26.6.1156-1160.1988; RANK RG, 1987, INFECT IMMUN, V55, P2317, DOI 10.1128/IAI.55.9.2317-2319.1987; RANK RG, 1982, INFECT IMMUN, V38, P699, DOI 10.1128/IAI.38.2.699-705.1982; RANK RG, 1990, CHLAMYDIAL INFECT, P249; Rank RG, 1982, CHLAMYDIAL INFECTION, P391; Rees E., 1977, NONGONOCOCCAL URETHR, P67; RICE PA, 1980, J IMMUNOL, V124, P2105; RIPA KT, 1980, AM J OBSTET GYNECOL, V138, P960, DOI 10.1016/0002-9378(80)91087-X; RUBIN GL, 1982, AM J OBSTET GYNECOL, V144, P630, DOI 10.1016/0002-9378(82)90430-6; RUSSELL MW, 1988, REV INFECT DIS, V10, pS440; RYDEN G, 1979, CONTRACEPTION, V20, P149, DOI 10.1016/0010-7824(79)90087-8; SALIT IE, 1982, CAN J MICROBIOL, V28, P301, DOI 10.1139/m82-044; SCHACHTER J, 1983, WESTERN J MED, V138, P375; SCHOOLNIK GK, 1976, J CLIN INVEST, V58, P1163, DOI 10.1172/JCI108569; SENANAYAKE P, 1980, AM J OBSTET GYNECOL, V138, P852, DOI 10.1016/0002-9378(80)91070-4; SHAFER MA, 1984, J PEDIATR-US, V104, P141, DOI 10.1016/S0022-3476(84)80614-9; Strober W, 1982, RECENT ADV MUCOSAL I; SVENSSON L, 1981, BRIT J VENER DIS, V57, P259; SVENSSON L, 1984, JAMA-J AM MED ASSOC, V251, P2553, DOI 10.1001/jama.251.19.2553; SWEET RL, 1981, OBSTET GYNECOL, V58, P62; SWEET RL, 1980, AM J OBSTET GYNECOL, V138, P985, DOI 10.1016/0002-9378(80)91093-5; SWINKER ML, 1988, SEX TRANSM DIS, V15, P133, DOI 10.1097/00007435-198807000-00002; TAIT IA, 1980, BRIT J VENER DIS, V56, P37; TARGUM SD, 1974, AM J EPIDEMIOL, V100, P262, DOI 10.1093/oxfordjournals.aje.a112034; TAYLORROBINSON D, 1982, CHLAMYDIAL INFECTION, P375; THOMPSON SE, 1980, AM J OBSTET GYNECOL, V136, P179, DOI 10.1016/0002-9378(80)90592-X; TORVALD K, 1978, OBSTET GYNECOL, V52, P698; TRAMONT EC, 1977, J CLIN INVEST, V59, P117, DOI 10.1172/JCI108608; TUFFREY M, 1981, FEMS MICROBIOL LETT, V12, P111; TUFFREY M, 1982, BRIT J EXP PATHOL, V63, P539; UNANUE ER, 1987, SCIENCE, V236, P551, DOI 10.1126/science.2437650; VANEPPS DE, 1978, CELL IMMUNOL, V36, P363, DOI 10.1016/0008-8749(78)90280-0; VAUGHANJACKSON JD, 1977, BRIT J VENER DIS, V53, P180; WAGAR EA, 1990, J INFECT DIS, V162, P922, DOI 10.1093/infdis/162.4.922; WASHINGTON AE, 1985, JAMA-J AM MED ASSOC, V253, P2246, DOI 10.1001/jama.253.15.2246; WASSERHEIT JN, 1986, ANN INTERN MED, V104, P187, DOI 10.7326/0003-4819-104-2-187; WATT PJ, 1978, IMMUNOBIOLOGY NEISSE, P239; WESTROM L, 1983, BRIT MED BULL, V39, P145, DOI 10.1093/oxfordjournals.bmb.a071806; WESTROM L, 1980, AM J OBSTET GYNECOL, V138, P880, DOI 10.1016/0002-9378(80)91077-7; WESTROM L, 1982, SCAND J INFECT DIS, P157; WIDHOLM O, 1965, GYNAECOLOGIA, V160, P321, DOI 10.1159/000303404; WILSON JMA, 1978, CLIN EXP IMMUNOL, V34, P423; WOLNERHANSSEN P, 1985, OBSTET GYNECOL, V66, P233; WOLNERHANSSEN P, 1986, BRIT J OBSTET GYNAEC, V93, P619, DOI 10.1111/j.1471-0528.1986.tb08036.x; WRIGHT DG, 1977, J IMMUNOL, V119, P1068; WYRICK PB, 1982, CHLAMYDIAL INFECTION, P275; YOUNG D, 1988, P NATL ACAD SCI USA, V85, P4267, DOI 10.1073/pnas.85.12.4267; ZEGANS M, 1990, CHLAMYDIAL INFECTION, P181; 1989, MMWR-MORBID MORTAL W, V38, P22; 1987, WHO TECH REP SER, V753	147	67	70	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 13	1991	266	18					2587	2593		10.1001/jama.266.18.2587	http://dx.doi.org/10.1001/jama.266.18.2587			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GN660	1942405				2022-12-28	WOS:A1991GN66000036
J	WASHINGTON, AE; CATES, W; WASSERHEIT, JN				WASHINGTON, AE; CATES, W; WASSERHEIT, JN			PREVENTING PELVIC INFLAMMATORY DISEASE	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SEXUALLY-TRANSMITTED DISEASES; CHLAMYDIA-TRACHOMATIS INFECTION; ORAL-CONTRACEPTIVE USE; ADOLESCENT SEXUALITY; COST-EFFECTIVENESS; CLINICAL-TRIAL; BARRIER-METHOD; UNITED-STATES; PRIMARY CARE; RISK	Effective strategies for preventing pelvic inflammatory disease (PID) are crucial to protect women from adverse reproductive consequences and to avoid substantial economic losses. To identify current PID prevention options and assess their efficacy, we conducted a literature search and examined relevant data in published reports. We organized our review by level of participation (ie, individuals, providers, and communities) and prevention (ie, primary, secondary, and tertiary). For individuals, several prevention strategies related to personal protection appear promising, but few have been appropriately evaluated. For providers of health care, five prevention measures are recommended, including such primary prevention activities as counseling and patient education in addition to the usual diagnosis and treatment. Specific evidence supporting the efficacy of these provider practices, however, is limited. For communities, maintaining comprehensive sexually transmitted disease control strategies to prevent lower genital tract chlamydial and gonococcal infection is most important in reducing both symptomatic and asymptomatic PID. We provide specific recommendations for preventing PID and outline research needs.	CTR DIS CONTROL,CTR PREVENT SERV,DIV SEXUALLY TRANSMITTED DIS HIV PREVENT,ATLANTA,GA 30333; NIAID,SEXUALLY TRANSMITTED DIS BRANCH,BETHESDA,MD 20892	Centers for Disease Control & Prevention - USA; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	WASHINGTON, AE (corresponding author), UNIV CALIF SAN FRANCISCO,SCH MED,CTR REPROD HLTH POLICY RES,1388 SUTTER ST,11TH FLOOR,SAN FRANCISCO,CA 94109, USA.				NIAID NIH HHS [AI24768] Funding Source: Medline; PHS HHS [282-88-0018] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI024768] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		[Anonymous], 1989, GUIDE CLIN PREVENTIV; AUSTIN H, 1984, JAMA-J AM MED ASSOC, V251, P2822, DOI 10.1001/jama.251.21.2822; BECKER MH, 1988, AM J PUBLIC HEALTH, V78, P394, DOI 10.2105/AJPH.78.4.394; BERT AO, 1990, SEXUALLY TRANSMITTED, P1095; BROWN JD, 1990, J ADOLESCENT HEALTH, V11, P62, DOI 10.1016/0197-0070(90)90131-K; Cates Jr, 1990, Adolesc Med, V1, P409; CATES W, 1990, EPIDEMIOL REV, V12, P199, DOI 10.1093/oxfordjournals.epirev.a036054; CHOW JM, 1990, JAMA-J AM MED ASSOC, V263, P3164, DOI 10.1001/jama.263.23.3164; CRAMER DW, 1987, JAMA-J AM MED ASSOC, V257, P2446, DOI 10.1001/jama.257.18.2446; DARROW WW, 1989, SEX TRANSM DIS, V16, P157, DOI 10.1097/00007435-198907000-00008; DEBUONO BA, 1990, NEW ENGL J MED, V322, P821, DOI 10.1056/NEJM199003223221206; EHRHARDT AA, IN PRESS RES ISSUES; FORREST KA, 1989, J NATL MED ASSOC, V81, P159; GELPHMAN KA, 1987, 7 INT M INT SOC STD; GORDON SM, 1990, APR PREV 90 ATL; GRIMES DA, 1986, JAMA-J AM MED ASSOC, V256, P3223, DOI 10.1001/jama.256.23.3223; GRIMES DA, 1990, SEXUALLY TRANSMITTED, P1087; GUINAN ME, 1986, DEAR COLLEAGUE  1001; HANDSFIELD HH, 1986, JAMA-J AM MED ASSOC, V255, P1730, DOI 10.1001/jama.255.13.1730; HART G, 1980, SEX TRANSM DIS, V7, P149; HEARST N, 1988, JAMA-J AM MED ASSOC, V259, P2428, DOI 10.1001/jama.259.16.2428; HOWARD M, 1990, FAM PLANN PERSPECT, V22, P21, DOI 10.2307/2135434; JOHANSSON E, 1987, 7 INT M INT SOC STD; JOHNS MB, 1987, AM J PREV MED, V3, P346; JUDSON FN, 1989, SEX TRANSM DIS, V16, P51, DOI 10.1097/00007435-198904000-00001; KATZ BP, 1988, SEX TRANSM DIS, V15, P11, DOI 10.1097/00007435-198801000-00003; KELAGHAN J, 1982, JAMA-J AM MED ASSOC, V248, P184, DOI 10.1001/jama.248.2.184; KROGER F, 1980, SEX TRANSM DIS, V7, P178, DOI 10.1097/00007435-198010000-00007; LEE NC, 1988, OBSTET GYNECOL, V72, P1; LEWIS CE, 1987, WESTERN J MED, V147, P165; LOUV WC, 1988, J INFECT DIS, V158, P518, DOI 10.1093/infdis/158.3.518; MACDONALD NE, 1990, JAMA-J AM MED ASSOC, V263, P3155, DOI 10.1001/jama.263.23.3155; MARGOLIS S, 1981, SEX TRANSM DIS, V8, P87; MERRILL JM, 1990, SOUTHERN MED J, V83, P613, DOI 10.1097/00007611-199006000-00004; ORDUNA BC, 1980, POLK COUNTY MED B, V51, P79; OREILLY KR, 1985, J ADOLESCENT HEALTH, V6, P262, DOI 10.1016/S0197-0070(85)80063-2; PARRA W, 1990, SEXUALLY TRANSMITTED, P1057; PLUMMER FA, 1990, SEXUALLY TRANSMITTED, P71; PLUMMER FA, 1987, 7 INT M INT SOC STD; POTTERAT JJ, 1983, SEX TRANSM DIS, V10, P29, DOI 10.1097/00007435-198301000-00006; POTTERAT JJ, 1980, AM J OBSTET GYNECOL, V138, P1101, DOI 10.1016/0002-9378(80)91116-3; POTTS M, 1987, JAMA-J AM MED ASSOC, V258, P1729, DOI 10.1001/jama.258.13.1729; ROLFS RT, 1990, SEP P CTR DIS CONTR; ROSENBERG MJ, 1987, JAMA-J AM MED ASSOC, V257, P2308, DOI 10.1001/jama.257.17.2308; SCHACHTER J, 1983, SEX TRANSM DIS, V10, P123, DOI 10.1097/00007435-198307000-00004; SELLORS J, 1987, 7 INT M INT SOC STD; SOLOMON MZ, 1989, AM J PUBLIC HEALTH, V79, P453, DOI 10.2105/AJPH.79.4.453; SPENCE MR, 1990, J ADOLESCENT HEALTH, V11, P304, DOI 10.1016/0197-0070(90)90040-9; STAMM WE, 1984, NEW ENGL J MED, V310, P545, DOI 10.1056/NEJM198403013100901; STAMM WE, 1982, JAMA-J AM MED ASSOC, V248, P2020, DOI 10.1001/jama.248.16.2020; STONE KM, 1986, AM J OBSTET GYNECOL, V155, P180, DOI 10.1016/0002-9378(86)90108-0; STRASBURGER VC, 1989, PEDIATR CLIN N AM, V36, P747; TEISALA K, 1987, OBSTET GYNECOL, V69, P343; TUCKER CW, 1977, GONORRHEA RECIDIVISM; WASHINGTON AE, 1991, JAMA-J AM MED ASSOC, V266, P2565, DOI 10.1001/jama.266.18.2565; WASHINGTON AE, 1991, JAMA-J AM MED ASSOC, V266, P2581, DOI 10.1001/jama.266.18.2581; WASHINGTON AE, 1985, J ADOLESCENT HEALTH, V6, P298, DOI 10.1016/S0197-0070(85)80067-X; WASHINGTON AE, 1987, JAMA-J AM MED ASSOC, V257, P2056, DOI 10.1001/jama.257.15.2056; WASSERHEIT J N, 1987, MMJ (Maryland Medical Journal), V36, P58; WESTROM L, 1979, CURR THER RES CLIN E, V26, P752; WOLNERHANSSEN P, 1990, JAMA-J AM MED ASSOC, V263, P1936, DOI 10.1001/jama.263.14.1936; WOLNERHANSSEN P, 1990, JAMA-J AM MED ASSOC, V263, P54, DOI 10.1001/jama.263.1.54; YARBER WL, 1987, AIDS WHAT YOUNG ADUL; 1986, POPULATION REPORTS S, V50, pL274; 1987, FINAL REGULATIONS PR; 1985, MMWR-MORBID MORTAL W, V34, pS53; 1989, GENITAL SELF EXAMINA; [No title captured]; 1986, QUALITY ASSURANCE GU; 1991, MMWR-MORBID MORTAL W, V40, P1; 1988, GUIDE PUBLIC HLTH PR, P1; 1990, STD 90 SEXUALLY TRAN; 1989, MMWR-MORBID MORTAL W, V38, pS1; 1988, MMWR-MORBID MORTAL W, V37, P133; 1979, STUDY EPIDEMIOLOGIC	75	32	32	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 13	1991	266	18					2574	2580		10.1001/jama.266.18.2574	http://dx.doi.org/10.1001/jama.266.18.2574			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GN660	1942403				2022-12-28	WOS:A1991GN66000034
J	HUNTER, S				HUNTER, S			JUNIOR DOCTORS - THE NEW-DEAL - COMMITMENT VITAL FOR NEW-DEAL	BRITISH MEDICAL JOURNAL			English	Article							HOUSE OFFICERS				HUNTER, S (corresponding author), ST CADOCS HOSP,CAERLEON,GWENT,WALES.							Allen, 1988, DOCTORS THEIR CAREER; BARTHOLOMEW DJ, 1990, STUDY JUNIOR HOSPITA; DELAMOTHE T, 1990, BRIT MED J, V301, P1235; DOWIE R, 1989, PATTERNS HOSPITAL ME; FINN A, 1988, BMJ-BRIT MED J, V296, P343, DOI 10.1136/bmj.296.6618.343; FIRTHCOZENS J, 1989, BRIT J HOSP MED, V41, P161; FIRTHCOZENS J, 1987, BRIT MED J, V295, P533, DOI 10.1136/bmj.295.6597.533; NASMYTH DG, 1991, BRIT MED J, V302, P93, DOI 10.1136/bmj.302.6768.93; POULTON EC, 1978, ERGONOMICS, V21, P279, DOI 10.1080/00140137808931725; 1991, JUNIOR DOCTORS NEW D; 1991, SURVEY UPTAKE COSTS; 1990, HEADS AGREEMENT MINI; 1978, CMND7176; 1987, HOSPITAL MED STAFFIN; 1990, CMND937	15	3	3	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	OCT 5	1991	303	6806					840	841		10.1136/bmj.303.6806.840	http://dx.doi.org/10.1136/bmj.303.6806.840			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GH946	1932979	Green Published, Bronze			2022-12-28	WOS:A1991GH94600031
J	CANDRINA, R; BALESTRIERI, G; SALVI, A; DISTEFANO, O; SPANDRIO, S; GIUSTINA, G				CANDRINA, R; BALESTRIERI, G; SALVI, A; DISTEFANO, O; SPANDRIO, S; GIUSTINA, G			CORTISOL SECRETION IN PATIENTS ON SIMVASTATIN	LANCET			English	Letter									SPEDALI CIVIL BRESCIA,DEPT MED 2A,I-25100 BRESCIA,ITALY	Hospital Spedali Civili Brescia	CANDRINA, R (corresponding author), UNIV BRESCIA,DEPT MED PATHOL,I-25100 BRESCIA,ITALY.							FANSWORTH WH, 1987, J CLIN ENDOCR METAB, V65, P546; FRENCH, 1989, LANCET, V2, P807; ILLINGWORTH DR, 1984, J CLIN ENDOCR METAB, V58, P206, DOI 10.1210/jcem-58-1-206; ILLINGWORTH DR, 1985, P NATL ACAD SCI USA, V82, P6291, DOI 10.1073/pnas.82.18.6291; LAUE L, 1987, J CLIN ENDOCR METAB, V64, P531, DOI 10.1210/jcem-64-3-531	5	17	18	0	1	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	JAN 6	1990	335	8680					53	53		10.1016/0140-6736(90)90182-5	http://dx.doi.org/10.1016/0140-6736(90)90182-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG766	1967358				2022-12-28	WOS:A1990CG76600044
J	COX, NH; SHARPE, G				COX, NH; SHARPE, G			EMOLLIENTS, SALICYLIC-ACID, AND ULTRAVIOLET ERYTHEMA	LANCET			English	Letter											COX, NH (corresponding author), ROYAL VICTORIA INFIRM,DEPT DERMATOL,NEWCASTLE TYNE NE1 4LP,TYNE & WEAR,ENGLAND.							FARR PM, 1984, BRIT J DERMATOL, V111, P673, DOI 10.1111/j.1365-2133.1984.tb14150.x; KRISTENSEN, 1989, LANCET, V2, P1109; LOWE JG, 1988, BR J DERMATOL S33, V119, P52; WEIRICH EG, 1975, DERMATOLOGICA, V151, P268, DOI 10.1159/000251346; WEIRICH EG, 1976, DERMATOLOGICA, V152, P87, DOI 10.1159/000251167	5	9	9	0	1	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	JAN 6	1990	335	8680					53	54		10.1016/0140-6736(90)90183-6	http://dx.doi.org/10.1016/0140-6736(90)90183-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG766	1967359				2022-12-28	WOS:A1990CG76600045
J	KIYINGI, A; FIELD, MJ; PAWSEY, CC; YIANNIKAS, J; LAWRENCE, JR; ARTER, WJ				KIYINGI, A; FIELD, MJ; PAWSEY, CC; YIANNIKAS, J; LAWRENCE, JR; ARTER, WJ			METOLAZONE IN TREATMENT OF SEVERE REFRACTORY CONGESTIVE CARDIAC-FAILURE	LANCET			English	Article									CONCORD REPATRIAT GEN HOSP,DEPT MED,CONCORD,NSW 2139,AUSTRALIA; UNIV SYDNEY,SYDNEY,NSW 2006,AUSTRALIA	Concord Repatriation General Hospital; University of Sydney	KIYINGI, A (corresponding author), CONCORD REPATRIAT GEN HOSP,DEPT CARDIOL,CONCORD,NSW 2139,AUSTRALIA.							BENDERSKY R, 1981, AM J CARDIOL, V48, P554, DOI 10.1016/0002-9149(81)90087-4; DIES F, 1986, CIRCULATION S2, V74, P11; GHOSE RR, 1981, BRIT MED J, V812, P1432; GILLESPIE TA, 1977, AM J CARDIOL, V39, P588, DOI 10.1016/S0002-9149(77)80170-7; GOWLER MB, 1984, CIRCULATION S1, V70, P1103; GROSSKOPF I, 1986, ISRAEL J MED SCI, V22, P787; GUNSTONE RF, 1971, POSTGRAD MED J, V47, P789, DOI 10.1136/pgmj.47.554.789; LEIER CV, 1977, CIRCULATION, V56, P468, DOI 10.1161/01.CIR.56.3.468; LEVEY BA, 1975, CURR THER RES CLIN E, V18, P641; LIANG CS, 1979, J CLIN INVEST, V64, P613, DOI 10.1172/JCI109501; PUSCHETT JB, 1986, AM J CARDIOL, V57, pA6, DOI 10.1016/0002-9149(86)91000-3; ROFFMAN DS, 1985, CLIN PHARMACY, V4, P195; SULLIVAN MJ, 1985, J CLIN INVEST, V76, P1632, DOI 10.1172/JCI112148; UNVERFERTH DV, 1983, AM HEART J, V106, P29, DOI 10.1016/0002-8703(83)90434-9; UNVERFERTH DV, 1980, AM HEART J, V100, P622, DOI 10.1016/0002-8703(80)90226-4	15	65	65	0	7	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	JAN 6	1990	335	8680					29	31		10.1016/0140-6736(90)90148-X	http://dx.doi.org/10.1016/0140-6736(90)90148-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG766	1967337				2022-12-28	WOS:A1990CG76600014
J	SUGARMAN, J; POWERS, M				SUGARMAN, J; POWERS, M			HOW THE DOCTOR GOT GAGGED - THE DISINTEGRATING RIGHT OF PRIVACY IN THE PHYSICIAN-PATIENT RELATIONSHIP	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HYPERTENSIVE PATIENTS; HEALTH-EDUCATION		JOHNS HOPKINS UNIV,SCH HYG & PUBL HLTH,PROGRAM LAW ETH HLTH,BALTIMORE,MD 21218; GEORGETOWN UNIV,KENNEDY INST ETH,WASHINGTON,DC 20057; GEORGETOWN UNIV,DEPT PHILOSOPHY,WASHINGTON,DC 20057	Johns Hopkins University; Georgetown University; Georgetown University	SUGARMAN, J (corresponding author), JOHNS HOPKINS UNIV,SCH MED,DIV PHARMACOL,1830 E MONUMENT ST,8TH FLOOR,BALTIMORE,MD 21205, USA.			Sugarman, Jeremy/0000-0001-7022-8332	NCRR NIH HHS [2S07RR7136-20] Funding Source: Medline; NHLBI NIH HHS [2T32HLO7180] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [S07RR007136] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007180] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ANNAS GJ, 1990, NEW ENGL J MED, V323, P670, DOI 10.1056/NEJM199009063231010; ANNAS GJ, 1990, JAMA-J AM MED ASSOC, V263, P858, DOI 10.1001/jama.263.6.858; [Anonymous], 1986, HIST THEORY INFORM C; BURNETT CB, 1989, THESIS J HOPKINS SCH; ERAKER SA, 1984, ANN INTERN MED, V100, P258, DOI 10.7326/0003-4819-100-2-258; GOSTIN LO, 1989, JAMA-J AM MED ASSOC, V261, P1621; GREENFIELD S, 1988, J GEN INTERN MED, V3, P448, DOI 10.1007/BF02595921; HALL JA, 1988, MED CARE, V26, P657, DOI 10.1097/00005650-198807000-00002; LEVINE DM, 1979, JAMA-J AM MED ASSOC, V241, P1700, DOI 10.1001/jama.241.16.1700; LEVINE DM, 1987, BIBL CARDIOL, V42, P8; MCKENNA RJ, 1987, BREAST CANCER DIAGNO, P544; MORISKY DE, 1983, AM J PUBLIC HEALTH, V73, P153, DOI 10.2105/AJPH.73.2.153; ROTER DL, 1990, J GEN INTERN MED, V5, P347, DOI 10.1007/BF02600404; Rozovsky F.A., 1990, CONSENT TREATMENT PR	14	11	11	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 18	1991	266	23					3323	3327		10.1001/jama.266.23.3323	http://dx.doi.org/10.1001/jama.266.23.3323			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GU964	1960832				2022-12-28	WOS:A1991GU96400032
J	KELLEY, PW; PETRUCCELLI, BP; STEHRGREEN, P; ERICKSON, RL; MASON, CJ				KELLEY, PW; PETRUCCELLI, BP; STEHRGREEN, P; ERICKSON, RL; MASON, CJ			THE SUSCEPTIBILITY OF YOUNG-ADULT AMERICANS TO VACCINE-PREVENTABLE INFECTIONS - A NATIONAL SEROSURVEY OF UNITED-STATES-ARMY RECRUITS	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LINKED IMMUNOSORBENT-ASSAY; VARICELLA-ZOSTER VIRUS; EPIDEMIC MEASLES; RUBELLA; POPULATION; IMMUNIZATION; ANTIBODY; MUMPS	Objective. - Due to recent resurgences of measles, mumps, and rubella among young US adults, we sought to generate antibody prevalence data for national and military immunization policy evaluations. Design. - We used a questionnaire and serological survey of Army recruits to assess antibody status to measles, mumps, rubella, and varicella by enzyme-linked immunosorbent assay and to poliovirus types 1, 2, and 3 by microneutralization assay. Setting. - Basic training reception centers at Fort Benning, Ga, and Fort Jackson, SC. Patients. - The study included 1547 US Army recruits who were inducted during September and October 1989. Outcome Measures. - Seronegativity by various demographic factors. Results. - Seronegativity rates, directly adjusted to the 15- to 24-year-old US population in 1980, were 20.7% for measles, 15.6% for mumps, 17.5% for rubella, and 6.9% for varicella. For measles, mumps, and rubella, susceptibility was less in females, blacks, and college-educated recruits, and varicella susceptibility was greater in females and blacks. Recruits who were born after 1969 lacked measles, mumps, and rubella antibodies more often than older recruits. The adjusted seronegativity rates for poliovirus types 1, 2, and 3 were 2.3%, 0.6%, and 14.6%, respectively; trends by age, sex, and race-ethnicity were generally unremarkable. Conclusions. - Among young adult Americans, susceptibility to measles, mumps, and rubella is unevenly distributed and may be substantial. Our findings support national objectives to further improve immunization coverage in school-age and adult populations and provide further impetus for legislation requiring college entrants to present evidence of having received at least two doses of measles vaccine, with one on or after entry into elementary school.	CTR DIS CONTROL,CTR PREVENT SERV,DIV IMMUNIZAT,ATLANTA,GA 30333	Centers for Disease Control & Prevention - USA	KELLEY, PW (corresponding author), WALTER REED ARMY MED CTR,DIV PREVENT MED,ADV PREVENT MED STUDIES BRANCH,WASHINGTON,DC 20307, USA.		Mason, Carl J/F-3538-2010; Mason, Carl/ABH-3298-2021	Mason, Carl J/0000-0002-3676-2811; Mason, Carl/0000-0002-3676-2811				ARDAY DR, 1989, AM J PUBLIC HEALTH, V79, P471, DOI 10.2105/AJPH.79.4.471; ARMITAGE P, 1987, STATISTICAL METHODS, P400; BURKE DS, 1979, J INFECT DIS, V139, P225, DOI 10.1093/infdis/139.2.225; BURKE DS, 1987, NEW ENGL J MED, V317, P131, DOI 10.1056/NEJM198707163170302; CHEN RT, 1990, J INFECT DIS, V162, P1036, DOI 10.1093/infdis/162.5.1036; COCHI SL, 1988, AM J DIS CHILD, V142, P499, DOI 10.1001/archpedi.1988.02150050037025; COCHI SL, 1988, AM J DIS CHILD, V142, P1021, DOI 10.1001/archpedi.1988.02150100015006; COHEN ZB, 1985, CLIN PEDIATR, V24, P387, DOI 10.1177/000992288502400705; CRAWFORD GE, 1981, J INFECT DIS, V144, P403, DOI 10.1093/infdis/144.5.403; DEFOREST A, 1989, 89TH ANN M AM SOC MI, P136; DEMMLER GJ, 1988, J INFECT DIS, V157, P2211; DORFMAN SF, 1985, MT SINAI J MED, V52, P248; Fleiss JL, 1981, STAT METHODS RATES P, P218; GERSHON AA, 1976, PEDIATRICS, V58, P692; Hardy I R, 1990, Infect Dis Clin North Am, V4, P159; LIAO SJ, 1954, AM J HYG, V59, P273, DOI 10.1093/oxfordjournals.aje.a119640; LONGFIELD JN, 1990, ARCH INTERN MED, V150, P970, DOI 10.1001/archinte.150.5.970; MARKOWITZ LE, 1990, NEW ENGL J MED, V322, P580, DOI 10.1056/NEJM199003013220903; MARKOWITZ LE, 1990, PEDIATR INFECT DIS J, V9, P101, DOI 10.1097/00006454-199002000-00008; MCKINNEY WP, 1989, AM J INFECT CONTROL, V17, P26, DOI 10.1016/S0196-6553(89)80009-4; Melnick JL, 1979, DIAGNOSTIC PROCEDURE, V5th, P471; MUMM AH, 1990, PROGRAM ABSTRACTS PR; MURRAY DL, 1988, AM J PUBLIC HEALTH, V78, P836, DOI 10.2105/AJPH.78.7.836; NEUMANN PW, 1985, J CLIN MICROBIOL, V22, P296, DOI 10.1128/JCM.22.2.296-298.1985; NKOWANE BM, 1987, JAMA-J AM MED ASSOC, V257, P1335, DOI 10.1001/jama.257.10.1335; Orenstein W A, 1986, Dev Biol Stand, V65, P75; PAUL JR, 1964, AM J HYG, V80, P286, DOI 10.1093/oxfordjournals.aje.a120477; SHASBY DM, 1977, NEW ENGL J MED, V296, P585, DOI 10.1056/NEJM197703172961102; SHEHAB Z, 1983, J INFECT DIS, V148, P472; STRASSBURG MA, 1984, INFECT CONT HOSP EP, V5, P123, DOI 10.1017/S019594170005997X; Wharton M, 1990, Infect Dis Clin North Am, V4, P47; 1989, PEDIATRICS, V84, P1110; 1990, GUIDE ADULT IMMUNIZA; 1988, MMWR, V37, P527; 1989, MMWR, V38, P101; 1985, REV INFECT IDS, V7, pS177; 1990, MMWR, V38, P35; 1983, 1980 CENSUS POPULATI; 1988, IOM8804 NAT AC SCI I; 1989, MMWR, V38, P1; 1990, MMWR, V39, P353; 1991, MMWR, V40, P93	42	119	121	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 20	1991	266	19					2724	2729		10.1001/jama.266.19.2724	http://dx.doi.org/10.1001/jama.266.19.2724			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GP691	1942425				2022-12-28	WOS:A1991GP69100028
J	MULLER, F; WICKY, C; SPICHER, A; TOBLER, H				MULLER, F; WICKY, C; SPICHER, A; TOBLER, H			NEW TELOMERE FORMATION AFTER DEVELOPMENTALLY REGULATED CHROMOSOMAL BREAKAGE DURING THE PROCESS OF CHROMATIN DIMINUTION IN ASCARIS-LUMBRICOIDES	CELL			English	Article							GERM-LINE; DNA; SEQUENCE; ORGANIZATION; GENOME	During the process of chromatin diminution, which takes place in all presomatic cells of the early Ascaris embryo, the heterochromatic termini of the chromosomes are lost. Here we show that the newly formed ends of the reduced somatic chromosomes carry tandem repeats of the telomeric sequence TTAGGC. Comparison of a cloned somatic telomere with the corresponding germline chromosomal region revealed that these telomeric repeats are not present at or near the chromosomal breakage site. They are most likely added by a telomerase-mediated event. Chromosomal breakage, which precedes the telomere addition process, takes place within a short, specific chromosomal region (CBR); however, it does not occur at a single locus, but rather at many different sites. Altogether, our data show that chromatin diminution in Ascaris is a complex molecular process that includes site-specific chromosomal breakage, new telomere formation, and DNA degradation.			MULLER, F (corresponding author), UNIV FRIBOURG,INST ZOOL,CH-1700 FRIBOURG,SWITZERLAND.			Wicky, Chantal/0000-0002-0034-4992				AEBY P, 1986, EMBO J, V5, P3353, DOI 10.1002/j.1460-2075.1986.tb04650.x; ALLSHIRE RC, 1988, NATURE, V332, P656, DOI 10.1038/332656a0; BACK E, 1984, NUCLEIC ACIDS RES, V12, P1313, DOI 10.1093/nar/12.3.1313; BAROIN A, 1987, NUCLEIC ACIDS RES, V15, P1717, DOI 10.1093/nar/15.4.1717; BLACKBURN EH, 1991, NATURE, V350, P569, DOI 10.1038/350569a0; Boveri T., 1910, ZUGLEICHEIN BEITRAG, P131; Boveri T, 1887, ANAT ANZEIGER, V2, P688; BOWERI T, 1910, ANAT ANZEIGER, V3, P131; ETTER A, 1991, P NATL ACAD SCI USA, V88, P1593, DOI 10.1073/pnas.88.5.1593; FORNEY JD, 1988, MOL CELL BIOL, V8, P251, DOI 10.1128/MCB.8.1.251; GREIDER CW, 1990, BIOESSAYS, V12, P363, DOI 10.1002/bies.950120803; Maniatis T., 1982, MOL CLONING; MORITZ KB, 1976, NATURE, V259, P55, DOI 10.1038/259055a0; MULLER F, 1982, NUCLEIC ACIDS RES, V10, P7493, DOI 10.1093/nar/10.23.7493; PIMPINELLI S, 1989, TRENDS GENET, V5, P310, DOI 10.1016/0168-9525(89)90114-5; PONZI M, 1985, EMBO J, V4, P2991, DOI 10.1002/j.1460-2075.1985.tb04034.x; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; TARTOF KD, 1991, CELL, V65, P201, DOI 10.1016/0092-8674(91)90153-P; TOBLER H, 1972, DEV BIOL, V27, P190, DOI 10.1016/0012-1606(72)90097-8; TOBLER H, 1985, EXPERIENTIA, V41, P1311, DOI 10.1007/BF01952073; TOBLER H, 1986, CELL DIFFER, V13, P2; YAO MC, 1990, CELL, V63, P763, DOI 10.1016/0092-8674(90)90142-2; Yao MC, 1989, MOBILE DNA, P715; ZAKIAN VA, 1989, ANNU REV GENET, V23, P579, DOI 10.1146/annurev.genet.23.1.579	24	116	131	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	NOV 15	1991	67	4					815	822		10.1016/0092-8674(91)90076-B	http://dx.doi.org/10.1016/0092-8674(91)90076-B			8	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GQ407	1934070				2022-12-28	WOS:A1991GQ40700018
J	BURROWS, A				BURROWS, A			THE MAN WHO DIDNT KNOW HE HAD CANCER	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 13	1991	266	18					2550	2550						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GN660	1942391				2022-12-28	WOS:A1991GN66000009
J	ELKELES, RS; WOLFE, JHN				ELKELES, RS; WOLFE, JHN			ABC OF VASCULAR DISEASES - THE DIABETIC FOOT	BRITISH MEDICAL JOURNAL			English	Article											ELKELES, RS (corresponding author), ST MARYS HOSP,LONDON,ENGLAND.								0	15	15	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	OCT 26	1991	303	6809					1053	1055		10.1136/bmj.303.6809.1053	http://dx.doi.org/10.1136/bmj.303.6809.1053			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GM478	1954463	Bronze, Green Published			2022-12-28	WOS:A1991GM47800030
J	MELZER, D; HALE, AS; MALIK, SJ; HOGMAN, GA; WOOD, S				MELZER, D; HALE, AS; MALIK, SJ; HOGMAN, GA; WOOD, S			COMMUNITY CARE FOR PATIENTS WITH SCHIZOPHRENIA ONE YEAR AFTER HOSPITAL DISCHARGE	BRITISH MEDICAL JOURNAL			English	Article							FOLLOW-UP	Objectives - To document the circumstances and care of patients with schizophrenia who had recently been discharged from local psychiatric inpatient services, and to establish the extent to which misgivings about community care might be justified. Design - Cross sectional surveys with review of case notes. Follow up interviews with questionnaires administered one year after discharge. Setting - Two inner London districts (West Lambeth and Lewisham) with high levels of social deprivation and at different stages of developing community services. Patients - 90 and 50 patients in the two services respectively, aged 18 to 65, who satisfied the Research Diagnostic Criteria for schizophrenia and who were discharged from inpatient services. Main outcome measures - Diagnosis elicited by present state examination, global social disability rating, use of services during the three months before interview. Results - 89 of the 140 patients (64%) had been ill for five or more years, yet few were former long stay inpatients. 55% (50/91; 95% confidence interval 45% to 65%) of those interviewed had current psychotic mental states and 22% (27/124; 16% to 31%) were functioning socially at very poor or severely maladjusted levels. 86% (107/124) were unemployed. The majority of patients had seen a mental health or social service professional, yet only 16% (20/124) were in specialised accommodation (excluding hospitals) and only 23% (17/73) of those eligible had used day care. Small numbers of people had experienced homelessness (two) or imprisonment (four over six months). Conclusions - Many schizophrenic patients leaving local psychiatric inpatient care have active symptomatology and profound social disabilities. Community care was characterised by high rates of contact with service professionals but little supported accommodation or day activity. This group of clients may require dedicated provision, which would actively encourage them to use services protected from the demands of those with less severe illness.	ST THOMAS HOSP,W LAMBETH HLTH AUTHOR,DIRECTORATE PUBL HLTH,LONDON SE1 7EH,ENGLAND; UNITED MED & DENT SCH GUYS & ST THOMAS HOSP,ST THOMAS HOSP,LONDON SE1 7EH,ENGLAND; GUYS HOSP,PSYCHIAT,LONDON SE1 9RT,ENGLAND	Guy's & St Thomas' NHS Foundation Trust; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust				Melzer, David/0000-0002-0170-3838				BACHRACH LL, 1984, HOMELESS MENTALLY IL; BEECHAM J, IN PRESS SCHIZOPH B; CHEADLE AJ, 1978, BRIT J PSYCHIAT, V132, P221, DOI 10.1192/S0007125000283268; COID JW, 1988, BRIT MED J, V296, P1779, DOI 10.1136/bmj.296.6639.1779; CRAMER P, 1989, BRIT J PSYCHIAT, V155, P225, DOI 10.1192/bjp.155.2.225; Davis A., 1974, SCHIZOPHRENICS NEW C; DEAN AG, 1990, EPIINFO VERSION 5; ELLIS RH, 1984, COMMUNITY MENT HLT J, V20, P72; FRY AH, 1989, HLTH TRENDS, V21, P70; GROVES T, 1990, BRIT MED J, V300, P923, DOI 10.1136/bmj.300.6729.923; HOGG LI, 1990, ACTA PSYCHIAT SCAND, V81, P271, DOI 10.1111/j.1600-0447.1990.tb06495.x; JOHNSTONE EC, 1984, BRIT J PSYCHIAT, V145, P586, DOI 10.1192/bjp.145.6.586; JONES K, 1986, BRIT J PSYCHIAT, V149, P537, DOI 10.1192/bjp.149.5.537; KHOOSAL D, 1991, HLTH TRENDS, V22, P137; KNAPP M, 1990, CARE COMMUNITY LESSO; KNAPP M, IN PRESS PSYCHOL MED; KUIPERS L, 1988, PSYCHOL MED, V18, P893, DOI 10.1017/S0033291700009831; MCCREADIE RG, 1982, BRIT J PSYCHIAT, V140, P582, DOI 10.1192/bjp.140.6.582; MILNER G, 1991, HLTH TRENDS, V4, P141; NORUSIS MJ, 1986, STATISTICAL PACKAGE; OLFSON M, 1990, HOSP COMMUNITY PSYCH, V41, P634; RICE P, 1984, INFORMATION DISTRICT; SAYCE L, 1991, SOC PSYCH PSYCH EPID, V26, P14, DOI 10.1007/BF00783575; Spitzer RL, 1975, RES DIAGNOSTIC CRITE; TANTAM D, 1985, BRIT J PSYCHIAT, V146, P1, DOI 10.1192/bjp.146.1.1; THORNICROFT G, 1989, BRIT J PSYCHIAT, V155, P739, DOI 10.1192/bjp.155.6.739; WATT DC, 1983, PSYCHOL MED, V13, P663, DOI 10.1017/S0033291700048091; WELLER M, 1989, LANCET, V2, P1509; Wing J. K. C., 1974, MEASUREMENT CLASSIFI; WOOD S, 1990, CLOSURE MENTAL HOSPI; 1989, SLIPPING NET; 1990, CARE PROGRAMME APPRO; 1989, INFORMED ACTION HLTH; 1989, 4TH ANN C TEAM ASS P; 1988, WHO PSYCHIATRIC DISA	35	58	59	0	4	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	OCT 26	1991	303	6809					1023	1026		10.1136/bmj.303.6809.1023	http://dx.doi.org/10.1136/bmj.303.6809.1023			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GM478	1954452	Green Published, Bronze			2022-12-28	WOS:A1991GM47800018
J	SCHIFF, GD; HEGDE, HK; LACLOCHE, L; HRYHORCZUK, DO				SCHIFF, GD; HEGDE, HK; LACLOCHE, L; HRYHORCZUK, DO			INPATIENT THEOPHYLLINE TOXICITY - PREVENTABLE FACTORS	ANNALS OF INTERNAL MEDICINE			English	Article							SERUM CONCENTRATIONS; ACUTE EXACERBATIONS; ACUTE ASTHMA; AMINOPHYLLINE; INTOXICATION; HEMOPERFUSION; INGESTION; EFFICACY; OVERDOSE; DISEASE	Objective: To identify preventable factors contributing to inpatient theophylline toxicity. Design: Case series. Setting: Tertiary care public hospital. Patients: Forty consecutive adult inpatients (mean age, 56.5 years) with theophylline levels > 140-mu-mol/L (25.0 mg/L). Measurements and Main Results: A retrospective chart audit was done. Toxicity was produced in 27 of 40 patients by inpatient or emergency department theophylline administration. Management errors found included delay (> 10 hours) in taking action from time toxic blood levels were drawn (20 patients), inappropriately high dosing of patients with congestive heart failure (17 patients), failure to recognize obvious symptoms (16 patients), recurrent toxicity (11 patients), additional emergency department treatment of already toxic patients (7 patients), overlap of intravenous and oral therapy (6 patients), patient discharged with no physician awareness of toxicity or dosage change (5 patients). Conclusions: A set of recurring management errors was identified as contributing to inpatient theophylline toxicity. Effective preventive mechanisms could have prevented most toxicity and associated morbidity. Theophylline's overall risk-benefit ratio in the inpatient setting may be less than that measured in well-controlled studies of the drug's efficacy because of these management errors.			SCHIFF, GD (corresponding author), COOK CTY HOSP, GEN MED CLIN, 1835 W HARRISON, CHICAGO, IL 60612 USA.		Hryhorczuk, Daniel/X-6409-2019	Hryhorczuk, Daniel/0000-0001-7625-6756				AITKEN ML, 1987, CHEST, V91, P10, DOI 10.1378/chest.91.1.10; ANDERSON JR, 1983, ARCH INTERN MED, V143, P559, DOI 10.1001/archinte.143.3.559; ARBAB OA, 1985, BRIT J DIS CHEST, V79, P161; BERTINO JS, 1987, ARCH INTERN MED, V147, P757, DOI 10.1001/archinte.147.4.757; BERWICK DM, 1989, NEW ENGL J MED, V320, P53, DOI 10.1056/NEJM198901053200110; BRENNAN TA, 1990, ANN INTERN MED, V112, P221, DOI 10.7326/0003-4819-112-3-221; BROOK RH, 1985, MED CARE, V23, P710, DOI 10.1097/00005650-198505000-00030; BUKOWSKYJ M, 1984, ANN INTERN MED, V101, P63, DOI 10.7326/0003-4819-101-1-63; CHANG KC, 1978, LANCET, V1, P1132; CORSER BC, 1985, CHEST, V88, P749, DOI 10.1378/chest.88.5.749; DEMMING WE, 1986, CRISIS; DULL WL, 1984, ARCH INTERN MED, V144, P2399, DOI 10.1001/archinte.144.12.2399; EHLERS SM, 1978, JAMA-J AM MED ASSOC, V240, P474, DOI 10.1001/jama.240.5.474; FANTA CH, 1986, AM J MED, V80, P5, DOI 10.1016/0002-9343(86)90041-0; HENDELES L, 1977, DRUG INTEL CLIN PHAR, V11, P12, DOI 10.1177/106002807701100101; JOHNSTON IDA, 1990, BRIT MED J, V300, P929, DOI 10.1136/bmj.300.6729.929; KNODEL AR, 1984, WESTERN J MED, V140, P741; KOTULAK R, 1986, CHICAGO TRIBUNE 1214, P1; LEGLER JD, 1990, M D COMPUT, V7, P155; LITTENBERG B, 1988, JAMA-J AM MED ASSOC, V259, P1678, DOI 10.1001/jama.259.11.1678; MOUNTAIN RD, 1984, ARCH INTERN MED, V144, P724, DOI 10.1001/archinte.144.4.724; OLSON KR, 1985, AM J EMERG MED, V3, P386, DOI 10.1016/0735-6757(85)90195-0; REITBERG DP, 1981, ANN INTERN MED, V95, P582, DOI 10.7326/0003-4819-95-5-582; RICE KL, 1987, ANN INTERN MED, V107, P305, DOI 10.7326/0003-4819-107-2-305; ROGERS RM, 1985, CHEST, V87, P280, DOI 10.1378/chest.87.3.280; RUSSO ME, 1979, NEW ENGL J MED, V300, P24, DOI 10.1056/NEJM197901043000107; Schiff G D, 1990, QRB Qual Rev Bull, V16, P149; SESSLER CN, 1990, AM J MED, V88, P567, DOI 10.1016/0002-9343(90)90519-J; SIEGEL D, 1985, AM REV RESPIR DIS, V132, P283; SILLS JM, 1986, AM J HOSP PHARM, V43, P2764, DOI 10.1093/ajhp/43.11.2764; SKINNER MH, 1989, AM J MED, V86, P129, DOI 10.1016/0002-9343(89)90246-5; STEEL K, 1981, NEW ENGL J MED, V304, P638, DOI 10.1056/NEJM198103123041104; TOGNONI G, 1986, LANCET, V2, P1028; Weinberg N S, 1989, QRB Qual Rev Bull, V15, P266; WOODCOCK AA, 1983, LANCET, V2, P610; WYSZEWIANSKI L, 1988, INQUIRY-J HEALTH CAR, V25, P13; ZWILLICH CW, 1975, ANN INTERN MED, V82, P784, DOI 10.7326/0003-4819-82-6-784; 1983, LANCET, V2, P607; 1980, LANCET, V1, P746; 1990, PERFORMANCE BASED QU, pCH2	40	39	39	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 1	1991	114	9					748	753		10.7326/0003-4819-114-9-748	http://dx.doi.org/10.7326/0003-4819-114-9-748			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FJ117	1953845				2022-12-28	WOS:A1991FJ11700007
J	VOOGT, PJ; FIBBE, WE; MARIJT, WAF; GOULMY, E; VEENHOF, WFJ; HAMILTON, M; BRAND, A; ZWANN, FE; WILLEMZE, R; VANROOD, JJ; FALKENBURG, JHF				VOOGT, PJ; FIBBE, WE; MARIJT, WAF; GOULMY, E; VEENHOF, WFJ; HAMILTON, M; BRAND, A; ZWANN, FE; WILLEMZE, R; VANROOD, JJ; FALKENBURG, JHF			REJECTION OF BONE-MARROW GRAFT BY RECIPIENT-DERIVED CYTOTOXIC LYMPHOCYTES-T AGAINST MINOR HISTOCOMPATIBILITY ANTIGENS	LANCET			English	Article									STATE UNIV LEIDEN HOSP,DEPT HAEMATOL,EXPTL HAEMATOL LAB,2333 AA LEIDEN,NETHERLANDS; STATE UNIV LEIDEN HOSP,DEPT IMMUNOHAEMATOL,2333 AA LEIDEN,NETHERLANDS	Leiden University; Leiden University Medical Center (LUMC); Leiden University; Leiden University Medical Center (LUMC)								BARRETT A J, 1986, Bone Marrow Transplantation, V1, P95; BENNETT JM, 1982, BRIT J HAEMATOL, V51, P189, DOI 10.1111/j.1365-2141.1982.tb08475.x; BUTTURINI A, 1986, BLOOD, V68, P954; DENNERT G, 1985, J IMMUNOL, V135, P3729; GOULMY E, 1977, NATURE, V266, P544, DOI 10.1038/266544a0; GOULMY E, 1982, HLA TYPING METHODOLO, V2, P105; HOWS J, 1985, EXP HEMATOL, V13, P114; MARTIN PJ, 1985, BLOOD, V66, P664; NEUDORF S, 1984, SEMIN HEMATOL, V21, P91; PATTERSON J, 1985, EXP HEMATOL, V13, P117; REISNER Y, 1985, EXP HEMATOL, V13, P321; SCHWARTZ E, 1987, J IMMUNOL, V138, P460; VOOGT PJ, 1988, J EXP MED, V168, P2337, DOI 10.1084/jem.168.6.2337; VOOGT PJ, 1988, J CLIN INVEST, V82, P906, DOI 10.1172/JCI113697; VOOGT PJ, 1987, LEUKEMIA, V1, P427; WALMA EP, 1987, TRANSPLANTATION, V43, P818, DOI 10.1097/00007890-198743060-00009; 1972, CYTOGENETICS, V11, P313	17	108	109	0	1	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	JAN 20	1990	335	8682					131	134		10.1016/0140-6736(90)90003-N	http://dx.doi.org/10.1016/0140-6736(90)90003-N			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CJ979	1967432	Green Submitted			2022-12-28	WOS:A1990CJ97900003
J	COLLINS, P; FOX, KM				COLLINS, P; FOX, KM			PATHO-PHYSIOLOGY OF ANGINA	LANCET			English	Review											COLLINS, P (corresponding author), NATL HEART HOSP,LONDON W1M 8BA,ENGLAND.							BUSSE R, 1983, PFLUG ARCH EUR J PHY, V397, P78, DOI 10.1007/BF00585175; COCKS TM, 1983, NATURE, V305, P627, DOI 10.1038/305627a0; COHEN RA, 1984, AM J PHYSIOL, V247, pH403, DOI 10.1152/ajpheart.1984.247.3.H403; COHEN RA, 1983, SCIENCE, V221, P273, DOI 10.1126/science.6574604; COX DA, 1983, J PHARMACOL EXP THER, V225, P764; CROSSMAN D, 1988, EUR HEART J S1, V9, P1775; FEIGL EO, 1975, CIRC RES, V37, P175, DOI 10.1161/01.RES.37.2.175; FORSTERMANN U, 1988, CIRC RES, V62, P185, DOI 10.1161/01.RES.62.2.185; FURCHGOTT RF, 1983, CIRC RES, V53, P557, DOI 10.1161/01.RES.53.5.557; FURCHGOTT RF, 1980, NATURE, V288, P377; FURLONG B, 1987, BRIT J PHARMACOL, V90, P687, DOI 10.1111/j.1476-5381.1987.tb11221.x; GEROVA M, 1979, CIRC RES, V44, P459, DOI 10.1161/01.RES.44.4.459; GINSBURG R, 1984, CIRCULATION, V70, P122; GRIFFITH TM, 1984, J MOL CELL CARDIOL, V16, P479, DOI 10.1016/S0022-2828(84)80619-7; GROSS GJ, 1981, AM J PHYSIOL, V240, pH941, DOI 10.1152/ajpheart.1981.240.6.H941; HOLTZ J, 1984, J CARDIOVASC PHARM, V6, P1161; Holtz J, 1983, Z Kardiol, V72 Suppl 3, P98; HORIO Y, 1988, AM J CARDIOL, V62, P887, DOI 10.1016/0002-9149(88)90887-9; KATUSIC ZS, 1984, CIRC RES, V55, P575, DOI 10.1161/01.RES.55.5.575; KU DD, 1982, SCIENCE, V218, P576, DOI 10.1126/science.7123259; LOSAY J, 1977, SUBSTANCE P, P287; LUDMER PL, 1986, NEW ENGL J MED, V315, P1046, DOI 10.1056/NEJM198610233151702; MASERI A, 1982, PROG CARDIOVASC DIS, V25, P169, DOI 10.1016/0033-0620(82)90015-9; MCALPIN RN, 1980, CIRCULATION, V60, P296; PALMER RMJ, 1987, NATURE, V327, P524, DOI 10.1038/327524a0; PEACH MJ, 1985, BIOCHEM PHARMACOL, V34, P1867, DOI 10.1016/0006-2952(85)90300-4; QUYYUMI AA, 1986, BRIT HEART J, V56, P346; RADOMSKI MW, 1987, BRIT J PHARMACOL, V92, P181, DOI 10.1111/j.1476-5381.1987.tb11310.x; REGOLI D, 1977, CAN J PHYSIOL PHARM, V55, P307, DOI 10.1139/y77-044; ROSENFELD MG, 1983, NATURE, V304, P129, DOI 10.1038/304129a0; SELWYN AP, 1979, CIRCULATION, V60, P1335, DOI 10.1161/01.CIR.60.6.1335; SMITHERMAN TC, 1982, VASOACTIVE INTESTINA, P169; WEIHE E, 1984, CELL TISSUE RES, V236, P527; YANAGISAWA M, 1988, NATURE, V332, P411, DOI 10.1038/332411a0	34	46	46	0	4	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	JAN 13	1990	335	8681					94	96		10.1016/0140-6736(90)90551-F	http://dx.doi.org/10.1016/0140-6736(90)90551-F			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CH516	1967428				2022-12-28	WOS:A1990CH51600014
J	MCNICOL, LR; MARTIN, CS; SMART, NG; LOGAN, RW				MCNICOL, LR; MARTIN, CS; SMART, NG; LOGAN, RW			PEROPERATIVE BUPIVACAINE FOR PYLOROMYOTOMY PAIN	LANCET			English	Letter									ROYAL HOSP SICK CHILDREN, DEPT BIOCHEM, GLASGOW G3 8SJ, SCOTLAND	University of Glasgow	MCNICOL, LR (corresponding author), ROYAL HOSP SICK CHILDREN, DEPT ANAESTHESIA, GLASGOW G3 8SJ, SCOTLAND.							ANAND KJS, 1987, LANCET, V1, P243; ANAND KJS, 1987, NEW ENGL J MED, V317, P1321, DOI 10.1056/NEJM198711193172105; BOOKER PD, 1987, ANAESTHESIA, V42, P343, DOI 10.1111/j.1365-2044.1987.tb03971.x; HATCH DJ, 1987, BRIT MED J, V294, P970, DOI 10.1136/bmj.294.6577.920; MACDONALD NJ, 1987, BRIT J ANAESTH, V59, P672, DOI 10.1093/bja/59.6.672; MARSHALL RE, 1980, INFANT BEHAV DEV, V3, P1, DOI 10.1016/S0163-6383(80)80003-8; MCGRATH PA, 1987, PAIN, V31, P147, DOI 10.1016/0304-3959(87)90033-9; OWENS ME, 1984, PAIN, V20, P213, DOI 10.1016/0304-3959(84)90012-5; PURCELLJONES G, 1987, ANAESTHESIA, V42, P1316, DOI 10.1111/j.1365-2044.1987.tb05283.x	10	6	6	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 6	1990	335	8680					54	55		10.1016/0140-6736(90)90184-7	http://dx.doi.org/10.1016/0140-6736(90)90184-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG766	1967360				2022-12-28	WOS:A1990CG76600046
J	HOLDEN, C				HOLDEN, C			SELLING SHARES IN THE SSC	SCIENCE			English	Editorial Material																			0	9	9	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	OCT 25	1991	254	5031					522	523						2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL799	1948026				2022-12-28	WOS:A1991GL79900032
J	HOLDEN, C				HOLDEN, C			FISH RESEARCH STOCK IN JEOPARDY	SCIENCE			English	Editorial Material																			0	9	9	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	OCT 25	1991	254	5031					522	522						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL799	1948026				2022-12-28	WOS:A1991GL79900030
